PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Corn, BW				Corn, Benjamin W.			Ending End-of-Life Phobia - A Prescription for Enlightened Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Corn, Benjamin W.] Tel Aviv Med Ctr & Sch Med, Inst Radiotherapy, Tel Aviv, Israel; [Corn, Benjamin W.] Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel; [Corn, Benjamin W.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Radiat Oncol, Philadelphia, PA 19107 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Jefferson University	Corn, BW (corresponding author), Tel Aviv Med Ctr & Sch Med, Inst Radiotherapy, Tel Aviv, Israel.							BLUMENAUER E, 2009, NY TIMES        1115; Burns JP, 2007, CHEST, V132, P1987, DOI 10.1378/chest.07-1441; Rosenbaum ME, 2005, J PALLIAT MED, V8, P1186, DOI 10.1089/jpm.2005.8.1186; Shanafelt T, 2003, J CLIN ONCOL, V21, P2616, DOI 10.1200/JCO.2003.06.075; Yalom I.D., 2008, STARING SUN OVERCOMI	5	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					E63	E63		10.1056/NEJMp0909740	http://dx.doi.org/10.1056/NEJMp0909740			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538JV	20018960				2022-12-24	WOS:000273181300005
J	Honigman, B				Honigman, Benjamin			The Heart of the Matter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												benjamin.honigman@ucdenver.edu						Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2638	2639		10.1001/jama.2009.1808	http://dx.doi.org/10.1001/jama.2009.1808			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040544				2022-12-24	WOS:000272965300001
J	Bethell, T; Bergin, E				Bethell, Thomas; Bergin, Edwin			Formation and Survival of Water Vapor in the Terrestrial Planet-Forming Region	SCIENCE			English	Article							T-TAURI STARS; ORGANIC-MOLECULES; PROTOPLANETARY; PHOTODISSOCIATION; CHEMISTRY	Recent astronomical observations have revealed what may prove to be the ubiquity of water vapor during the early stages of planet formation. We present here a simple mechanism showing how water vapor forms in situ and is capable of shielding itself from molecule-destroying stellar radiation. The absorption of this radiation by water can control the thermodynamics of the terrestrial planet-forming zone. Similar to Earth's ozone layer, which shelters the chemistry of life, the water layer protects other water molecules and allows for a rich organic chemistry. The total abundance of water vapor in the natal habitable zone is equal to that of several thousand oceans.	[Bethell, Thomas; Bergin, Edwin] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bethell, T (corresponding author), Univ Michigan, Dept Astron, 830 Dennison Bldg,500 Church St, Ann Arbor, MI 48109 USA.	tbethell@astro.umich.edu			NASA [NN08 AH23G]	NASA(National Aeronautics & Space Administration (NASA))	We gratefully acknowledge funding by NASA under grant NN08 AH23G from the Astrophysics Theory and Fundamental Physics and Origins of Solar System programs.	Agundez M, 2008, ASTRON ASTROPHYS, V483, P831, DOI 10.1051/0004-6361:20077927; Baulch D.L., 1972, EVALUATED KINETIC DA; BERGIN EA, 2007, PROTOSTARS PLANETS, V5, pCH8; Carr JS, 2008, SCIENCE, V319, P1504, DOI 10.1126/science.1153807; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Ciesla FJ, 2006, ICARUS, V181, P178, DOI 10.1016/j.icarus.2005.11.009; Ciesla FJ, 2007, SCIENCE, V318, P613, DOI 10.1126/science.1147273; Dullemond CP, 2005, ASTRON ASTROPHYS, V434, P971, DOI 10.1051/0004-6361:20042080; Furlan E, 2006, ASTROPHYS J SUPPL S, V165, P568, DOI 10.1086/505468; Glassgold AE, 2009, ASTROPHYS J, V701, P142, DOI 10.1088/0004-637X/701/1/142; Glassgold AE, 2004, ASTROPHYS J, V615, P972, DOI 10.1086/424509; Grevesse N, 2007, SPACE SCI REV, V130, P105, DOI 10.1007/s11214-007-9173-7; Hartmann L., 2001, ACCRETION PROCESSES; Ikoma M, 2006, ASTROPHYS J, V648, P696, DOI 10.1086/505780; Jonkheid B, 2007, ASTRON ASTROPHYS, V463, P203, DOI 10.1051/0004-6361:20065668; JOSEPH T, 1988, J CHEM PHYS, V88, P6982, DOI 10.1063/1.454396; MORDAUNT DH, 1994, J CHEM PHYS, V100, P7360, DOI 10.1063/1.466880; Reipurth B., 2007, PROTOSTARS PLANETS, VV, P507; Salyk C, 2008, ASTROPHYS J LETT, V676, pL49, DOI 10.1086/586894; Stimpfl M, 2006, J CRYST GROWTH, V294, P83, DOI 10.1016/j.jcrysgro.2006.05.057; Tappe A, 2008, ASTROPHYS J LETT, V680, pL117, DOI 10.1086/589998; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; VANDISHOECK EF, 1984, ASTROPHYS J, V277, P576, DOI 10.1086/161729; Weidenschilling S.J., 1993, PROTOSTARS PLANETS, P1031; Yoshino K, 1996, CHEM PHYS, V211, P387, DOI 10.1016/0301-0104(96)00210-8	25	75	75	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1675	1677		10.1126/science.1176879	http://dx.doi.org/10.1126/science.1176879			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019283				2022-12-24	WOS:000272839000047
J	Nesbitt, SJ; Smith, ND; Irmis, RB; Turner, AH; Downs, A; Norell, MA				Nesbitt, Sterling J.; Smith, Nathan D.; Irmis, Randall B.; Turner, Alan H.; Downs, Alex; Norell, Mark A.			A Complete Skeleton of a Late Triassic Saurischian and the Early Evolution of Dinosaurs	SCIENCE			English	Article							JURASSIC BOUNDARY; NEW-MEXICO; TERRESTRIAL; ARCHOSAURIA; EXTINCTION; ASSEMBLAGE; PHYLOGENY; DISPERSAL; THEROPODA; SKULL	Characterizing the evolutionary history of early dinosaurs is central to understanding their rise and diversification in the Late Triassic. However, fossils from basal lineages are rare. A new theropod dinosaur from New Mexico is a representative of the early North American diversification. Known from several nearly complete skeletons, it reveals a mosaic of plesiomorphic and derived features that clarify early saurischian dinosaur evolution and provide evidence for the antiquity of novel avian character systems including skeletal pneumaticity. The taxon further reveals latitudinal differences among saurischian assemblages during the Late Triassic, demonstrates that the theropod fauna from the Late Triassic of North America was not endemic, and suggests that intercontinental dispersal was prevalent during this time.	[Nesbitt, Sterling J.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Nesbitt, Sterling J.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Smith, Nathan D.] Univ Chicago, Comm Evolut Biol, Chicago, IL 60637 USA; [Smith, Nathan D.] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; [Irmis, Randall B.] Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; [Irmis, Randall B.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Turner, Alan H.] SUNY Stony Brook, Dept Anat Sci, Hlth Sci Ctr T8 040, Stony Brook, NY 11794 USA; [Downs, Alex] Ghost Ranch Conf Ctr, Ruth Hall Museum Paleontol, Abiquiu, NM 87510 USA	American Museum of Natural History (AMNH); Columbia University; University of Chicago; Field Museum of Natural History (Chicago); Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Nesbitt, SJ (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	nesbitt@jsg.utexas.edu		Nesbitt, Sterling/0000-0002-7017-1652	National Geographic Society [8014-06]; David Clark Inc.; Jean Butz Memorial Fund; Theodore Roosevelt Memorial Fund; Jurassic Foundation; Explorers Club Exploration Grant; NSF; Samuel & Doris Welles Research Fund; Bryan Patterson Memorial Grant; University of California-Berkeley Department of Integrative Biology; University of Utah; Systematics Research Fund	National Geographic Society(National Geographic Society); David Clark Inc.; Jean Butz Memorial Fund; Theodore Roosevelt Memorial Fund; Jurassic Foundation; Explorers Club Exploration Grant; NSF(National Science Foundation (NSF)); Samuel & Doris Welles Research Fund; Bryan Patterson Memorial Grant; University of California-Berkeley Department of Integrative Biology; University of Utah; Systematics Research Fund	Fieldwork and research were funded by the National Geographic Society (grant no. 8014-06 to K. Padian), David Clark Inc., the Jean Butz Memorial Fund, the Theodore Roosevelt Memorial Fund (to R. B. I.), the Jurassic Foundation (to S. J. N.), an Explorers Club Exploration Grant (to S. J. N.), an NSF Graduate Fellowship (to S. J. N. and R. B. I.), the Samuel & Doris Welles Research Fund (to R. B. I. and K. Padian), a Bryan Patterson Memorial Grant (to R. B. I.), the University of California-Berkeley Department of Integrative Biology (to R. B. I.), the University of Utah (to R. B. I.), and the Systematics Research Fund (to N. D. S.). We thank the reviewers, R. Ree, and the Field Museum (Chicago) VertMorph discussion group; and the staff, volunteers, and paleontology seminar participants at Ghost Ranch for assistance with fieldwork. Ghost Ranch, the American Museum of Natural History, the Field Museum of Natural History, and the University of California Museum of Paleontology all facilitated the preparation of specimens.	Butler RJ, 2009, BIOL LETTERS, V5, P557, DOI 10.1098/rsbl.2009.0139; Clark JM, 2004, NATURE, V430, P1021, DOI 10.1038/nature02802; Ezcurra MD, 2006, GEODIVERSITAS, V28, P649; Fraser NC, 2002, PALAEONTOLOGY, V45, P79, DOI 10.1111/1475-4983.00228; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hopson JA, 2006, PALAEONTOL Z, V80, P124, DOI 10.1007/BF02988972; Irmis R, 2008, J VERTEBR PALEONTOL, V28, p95A; Irmis Randall B., 2007, Historical Biology, V19, P3, DOI 10.1080/08912960600719988; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P769, DOI 10.1007/s00114-007-0258-7; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; MUNDIL R, 2008, EOS, V89; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Parker WG, 2007, J SYST PALAEONTOL, V5, P41, DOI 10.1017/S1477201906001994; Rauhut O.M.W., 2000, GAIA, V15, P75; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Sellwood BW, 2006, SEDIMENT GEOL, V190, P269, DOI 10.1016/j.sedgeo.2006.05.013; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1992, SCIENCE, V258, P1137, DOI 10.1126/science.258.5085.1137; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; Smith ND, 2005, SYST BIOL, V54, P166, DOI 10.1080/10635150590906000	28	165	170	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 11	2009	326	5959					1530	1533		10.1126/science.1180350	http://dx.doi.org/10.1126/science.1180350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007898				2022-12-24	WOS:000272623600056
J	Chang, HY				Chang, Howard Y.			Anatomic Demarcation of Cells: Genes to Patterns	SCIENCE			English	Editorial Material							NONCODING RNAS; POSITIONAL INFORMATION; EXPRESSION PROGRAMS; HOXD GENES; CHROMATIN; DIFFERENTIATION; POLYCOMB; MOUSE; FATE; COLLINEARITY	An organizing principle of the diverse cell types in multicellular organisms is their anatomic location. In turn, anatomic location is patterned by the positional identities of cells along developmental axes. Recent progress in functional genomics and chromatin biology illustrates how cells use specific gene expression programs to encode location. Dynamic chromatin states of key genes, notably the Hox loci, serve as the internal representation in cells of their positional identity within the animal.	[Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	howchang@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ackema KB, 2008, STEM CELLS DEV, V17, P979, DOI 10.1089/scd.2007.0220; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chi JT, 2007, PLOS GENET, V3, P1770, DOI 10.1371/journal.pgen.0030164; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Morey C, 2008, J CELL SCI, V121, P571, DOI 10.1242/jcs.023234; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; WOLPERT L, 1994, DEV GENET, V15, P485, DOI 10.1002/dvg.1020150607; WOLPERT L, 1989, DEVELOPMENT, V107, P3	27	36	38	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 27	2009	326	5957					1206	1207		10.1126/science.1175686	http://dx.doi.org/10.1126/science.1175686			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	524BD	19965461				2022-12-24	WOS:000272117900032
J	Martinez, E; Antoine, D; D'Ortenzio, F; Gentili, B				Martinez, Elodie; Antoine, David; D'Ortenzio, Fabrizio; Gentili, Bernard			Climate-Driven Basin-Scale Decadal Oscillations of Oceanic Phytoplankton	SCIENCE			English	Article							ZONE COLOR SCANNER; EXPORT PRODUCTION; PACIFIC-OCEAN; PRODUCTIVITY; VARIABILITY	Phytoplankton-the microalgae that populate the upper lit layers of the ocean-fuel the oceanic food web and affect oceanic and atmospheric carbon dioxide levels through photosynthetic carbon fixation. Here, we show that multidecadal changes in global phytoplankton abundances are related to basin-scale oscillations of the physical ocean, specifically the Pacific Decadal Oscillation and the Atlantic Multidecadal Oscillation. This relationship is revealed in similar to 20 years of satellite observations of chlorophyll and sea surface temperature. Interaction between the main pycnocline and the upper ocean seasonal mixed layer is one mechanism behind this correlation. Our findings provide a context for the interpretation of contemporary changes in global phytoplankton and should improve predictions of their future evolution with climate change.	[Martinez, Elodie] Univ Paris 06, UMR 7093, LOV, F-06230 Villefranche Sur Mer, France; CNRS, UMR 7093, LOV, F-06230 Villefranche Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Martinez, E (corresponding author), Univ Paris 06, UMR 7093, LOV, F-06230 Villefranche Sur Mer, France.	martinez@obs-vlfr.fr	Antoine, David/C-3817-2013; Martinez, Elodie/E-3237-2012; Martinez, Elodie/N-3297-2019	Antoine, David/0000-0002-9082-2395; Martinez, Elodie/0000-0001-6507-6119; Martinez, Elodie/0000-0001-6507-6119	NASA (U.S.)	NASA (U.S.)(National Aeronautics & Space Administration (NASA))	We thank the Agence Nationale de la Recherche (Paris) for the financial support for this work carried out within the frame of the Globphy project, NASA (U.S.) for providing the SeaWiFS global chlorophyll data, and the U. S. National Oceanographic and Atmospheric Administration National Climatic Data Center for the ERSST v3 data set. We thank D. Siegel, H. Claustre, Y. Huot, and A. Morel for the comments they provided on early versions of the manuscript, and three anonymous reviewers for their comments and helpful suggestions.	Antoine D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002620; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; EVANS RH, 1994, J GEOPHYS RES-OCEANS, V99, P7293, DOI 10.1029/93JC02151; FALKOWSKI PG, 1992, NATURE, V358, P741, DOI 10.1038/358741a0; Gregg WW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014689; HOVIS WA, 1980, SCIENCE, V210, P60, DOI 10.1126/science.210.4465.60; Hua Jiang, 2006, Chinese Journal of Oceanology and Limnology, V24, P111, DOI 10.1007/BF02842808; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; McCain C., 2006, EOS T AM GEOPHYSUNIO, V87, P337, DOI DOI 10.1029/2006EO340002; McClain CR, 2004, DEEP-SEA RES PT II, V51, P281, DOI 10.1016/j.dsr2.2003.08.002; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Schneider B, 2008, BIOGEOSCIENCES, V5, P597, DOI 10.5194/bg-5-597-2008; Schneider N, 2005, J CLIMATE, V18, P4355, DOI 10.1175/JCLI3527.1; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Yoder J. A., 2006, OCEANOGRAPHY, V19, P152, DOI [10.5670/oceanog.2006.98, DOI 10.5670/OCEANOG.2006.98]	24	214	215	6	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1253	1256		10.1126/science.1177012	http://dx.doi.org/10.1126/science.1177012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965473				2022-12-24	WOS:000272117900045
J	Hase, K; Kawano, K; Nochi, T; Pontes, GS; Fukuda, S; Ebisawa, M; Kadokura, K; Tobe, T; Fujimura, Y; Kawano, S; Yabashi, A; Waguri, S; Nakato, G; Kimura, S; Murakami, T; Iimura, M; Hamura, K; Fukuoka, SI; Lowe, AW; Itoh, K; Kiyono, H; Ohno, H				Hase, Koji; Kawano, Kazuya; Nochi, Tomonori; Pontes, Gemilson Soares; Fukuda, Shinji; Ebisawa, Masashi; Kadokura, Kazunori; Tobe, Toru; Fujimura, Yumiko; Kawano, Sayaka; Yabashi, Atsuko; Waguri, Satoshi; Nakato, Gaku; Kimura, Shunsuke; Murakami, Takaya; Iimura, Mitsutoshi; Hamura, Kimiyo; Fukuoka, Shin-Ichi; Lowe, Anson W.; Itoh, Kikuji; Kiyono, Hiroshi; Ohno, Hiroshi			Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response	NATURE			English	Article							GRANULE MEMBRANE-PROTEIN; FOLLICLE-ASSOCIATED EPITHELIUM; IMMUNOGLOBULIN-A RESPONSES; TAMM-HORSFALL PROTEIN; PATCH M-CELLS; ESCHERICHIA-COLI; PEYERS-PATCHES; SALMONELLA-TYPHIMURIUM; RECOMBINANT SALMONELLA; ANTIBODY-RESPONSES	The mucosal immune system forms the largest part of the entire immune system, containing about three-quarters of all lymphocytes and producing grams of secretory IgA daily to protect the mucosal surface from pathogens(1-3). To evoke the mucosal immune response, antigens on the mucosal surface must be transported across the epithelial barrier into organized lymphoid structures such as Peyer's patches(4). This function, called antigen transcytosis, is mediated by specialized epithelial M cells(5,6). The molecular mechanisms promoting this antigen uptake, however, are largely unknown. Here we report that glycoprotein 2 (GP2), specifically expressed on the apical plasma membrane of M cells among enterocytes, serves as a transcytotic receptor for mucosal antigens. Recombinant GP2 protein selectively bound a subset of commensal and pathogenic enterobacteria, including Escherichia coli and Salmonella enterica serovar Typhimurium (S. Typhimurium), by recognizing FimH, a component of type I pili on the bacterial outer membrane. Consistently, these bacteria were colocalized with endogenous GP2 on the apical plasma membrane as well as in cytoplasmic vesicles in M cells. Moreover, deficiency of bacterial FimH or host GP2 led to defects in transcytosis of type-I-piliated bacteria through M cells, resulting in an attenuation of antigen-specific immune responses in Peyer's patches. GP2 is therefore a previously unrecognized transcytotic receptor on M cells for type-I-piliated bacteria and is a prerequisite for the mucosal immune response to these bacteria. Given that M cells are considered a promising target for oral vaccination against various infectious diseases(7,8), the GP2-dependent transcytotic pathway could provide a new target for the development of M-cell-targeted mucosal vaccines.	[Hase, Koji; Kawano, Kazuya; Fukuda, Shinji; Ebisawa, Masashi; Kadokura, Kazunori; Fujimura, Yumiko; Kawano, Sayaka; Nakato, Gaku; Kimura, Shunsuke; Murakami, Takaya; Ohno, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Kanagawa 2300045, Japan; [Nochi, Tomonori; Pontes, Gemilson Soares; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Fukuda, Shinji; Ebisawa, Masashi; Kadokura, Kazunori; Nakato, Gaku; Ohno, Hiroshi] Yokohama City Univ, Int Grad Sch Bionanosci, Kanagawa 2300045, Japan; [Tobe, Toru] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yabashi, Atsuko; Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan; [Iimura, Mitsutoshi; Hamura, Kimiyo] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo 1628666, Japan; [Fukuoka, Shin-Ichi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Kanagawa 2298558, Japan; [Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Lowe, Anson W.] Stanford Univ, Ctr Digest Dis, Stanford, CA 94305 USA; [Itoh, Kikuji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	RIKEN; University of Tokyo; Yokohama City University; Osaka University; Fukushima Medical University; Tokyo Women's Medical University; Aoyama Gakuin University; Stanford University; Stanford University; University of Tokyo	Ohno, H (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Kanagawa 2300045, Japan.	ohno@rcai.riken.jp	Kimura, Shunsuke/D-7093-2012; Nochi, Tomonori/U-2533-2019; Pontes, Gemilson Soares/B-6103-2016; Kiyono, Hiroshi/AAC-6735-2022; Ohno, Hiroshi/L-7899-2014	Kimura, Shunsuke/0000-0001-9408-2884; Nochi, Tomonori/0000-0003-1800-6972; Pontes, Gemilson Soares/0000-0001-9001-7954; Ohno, Hiroshi/0000-0001-8776-9661; Hase, Koji/0000-0001-9550-2334; Fukuda, Shinji/0000-0001-5161-9880	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; NIH [DK56339, DK43294]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043294, P30DK056339, R29DK043294] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Kanno and A. Yamada for help in immunoelectron microscopy; Y. Yamada for secretarial assistance; M. Ohmae for technical assistance; H. Watarai for pertinent advice and discussion; P. D. Burrows, T. Takemori, S. Yamasaki and H. Kitamura for critical review of the manuscript; and the National BioResource Project (NIG, Japan) for E. coli (the Keio collection). This study was supported in part by Grants-in-Aid for Young Scientists (B) (K. H.), Scientific research (B) (H. O.), Scientific Research in Priority Areas (H. O. and K. H.), and Scientific Research on Innovative Areas (H. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Takeda Science Foundation (K. H.), and NIH awards DK56339 and DK43294 (A. W. L.).	CARTER PB, 1974, INFECT IMMUN, V9, P851, DOI 10.1128/IAI.9.5.851-857.1974; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ewen SWB, 1997, FEMS IMMUNOL MED MIC, V18, P185, DOI 10.1016/S0928-8244(97)00038-2; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; FUKUOKA SI, 1992, P NATL ACAD SCI USA, V89, P1189, DOI 10.1073/pnas.89.4.1189; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Gulig PA, 1998, INFECT IMMUN, V66, P2471, DOI 10.1128/IAI.66.6.2471-2485.1998; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hashizume T, 2008, INFECT IMMUN, V76, P927, DOI 10.1128/IAI.01145-07; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; HOOPS TC, 1991, J BIOL CHEM, V266, P4257; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; JACKSON RJ, 1993, INFECT IMMUN, V61, P4272, DOI 10.1128/IAI.61.10.4272-4279.1993; Kobayashi K, 2004, BIOCHEM BIOPH RES CO, V322, P659, DOI 10.1016/j.bbrc.2004.07.197; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; OWEN RL, 1974, GASTROENTEROLOGY, V66, P189, DOI 10.1016/s0016-5085(74)80102-2; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; RINDLER MJ, 1990, EUR J CELL BIOL, V53, P154; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Sirard JC, 1999, IMMUNOL REV, V171, P5, DOI 10.1111/j.1600-065X.1999.tb01340.x; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; VanCott JL, 1996, J IMMUNOL, V156, P1504; Verbrugghe P, 2008, HISTOCHEM CELL BIOL, V129, P311, DOI 10.1007/s00418-007-0369-4; Waguri S, 2009, METHOD ENZYMOL, V453, P181, DOI 10.1016/S0076-6879(08)04009-3; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184; Yu S, 2004, J BIOL CHEM, V279, P50274, DOI 10.1074/jbc.M410599200; Yu S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-58	39	429	451	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 12	2009	462	7270					226	U101		10.1038/nature08529	http://dx.doi.org/10.1038/nature08529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907495				2022-12-24	WOS:000271655100044
J	Finckh, A; Bansback, N; Marra, CA; Anis, AH; Michaud, K; Lubin, S; White, M; Sizto, S; Liang, MH				Finckh, Axel; Bansback, Nick; Marra, Carlo A.; Anis, Aslam H.; Michaud, Kaleb; Lubin, Stanley; White, Marc; Sizto, Sonia; Liang, Matthew H.			Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ONSET UNDIFFERENTIATED ARTHRITIS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; METHOTREXATE TREATMENT; TREATMENT STRATEGIES; RADIOGRAPHIC DAMAGE; COMBINATION THERAPY; PLUS METHOTREXATE; PREDICTION RULE; CLINICAL-TRIALS	Background: Long-term control or remission of rheumatoid arthritis (RA) may be possible with very early treatment. However, no optimal first therapeutic strategy has been determined. Objective: To assess the potential cost-effectiveness of major therapeutic strategies for very early RA. Design: Decision analytic model with probabilistic sensitivity analyses. Data Sources: Published data, the National Data Bank for Rheumatic Diseases, and actual 2007 hospital costs. Target Population: U.S. adults with very early RA (symptom duration <= 3 months). Time Horizon: Lifetime. Perspective: Health care provider and societal. Intervention: 3 management strategies were compared: a symptomatic or "pyramid" strategy with initial nonsteroidal anti-inflammatory drugs, patient education, pain management, and low-dose glucocorticoids, and disease-modifying antirheumatic drugs (DMARDs) at 1 year for nonresponders; early DMARD therapy with methotrexate; and early therapy with biologics and methotrexate. Outcome Measures: Cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: By reducing the progression of joint erosions and subsequent functional disability, both early inter-vention strategies increase quality-adjusted life more than the pyramid strategy and save long-term costs. When the cost of very early intervention is factored in, the cost-effectiveness ratio of the early DMARD strategy is $4849 per QALY (95% CI, $0 to $16 354 per QALY) compared with the pyramid strategy, whereas the benefits gained through the early biologic strategy come at a substantial incremental cost. The early DMARD strategy maximizes the effectiveness of early DMARDs and reserves the use of biologics for patients with more treatment-resistant disease of longer duration, for which the incremental benefit of biologics is greater. Results of Sensitivity Analysis: The early biologic strategy becomes more cost-effective if drug prices are reduced, risk for death is permanently lowered through biologic therapy, patients experience drug-free remission, responders can be selected before therapy initiation, or effective alternative antirheumatic agents are available for patients for whom several biologics have failed. Limitations: Data on the long-term effect of very early therapeutic interventions on the natural progression in disability and joint erosions are limited. The study considered only tumor necrosis factor inhibitors and not the newer biologics. Conclusion: According to the most objective measures of RA progression, very early intervention with conventional DMARDs is cost-effective. The cost-effectiveness of very early intervention with biologics remains uncertain.	Univ Geneva, Geneva, Switzerland; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ Nebraska Med Ctr, Omaha, NE USA; Natl Data Bank Rheumat Dis, Wichita, KS USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	University of Geneva; University of British Columbia; University of Nebraska System; University of Nebraska Medical Center; National Data Bank for Rheumatic Diseases; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Finckh, A (corresponding author), Univ Hosp Geneva, Dept Internal Med, Div Rheumatol, 26 Ave Beau Sejour, CH-1211 Geneva 14, Switzerland.		White, Marc/N-8404-2015; Marra, Carlo/AAE-4904-2021	White, Marc/0000-0001-7623-1268; Marra, Carlo/0000-0002-2625-2121; Finckh, Axel/0000-0002-1210-4347; Bansback, Nick/0000-0002-1510-3462	Arthritis Foundation	Arthritis Foundation	By an unrestricted research grant from the Arthritis Foundation and an anonymous donor.	Aletaha D, 2002, ANN RHEUM DIS, V61, P630, DOI 10.1136/ard.61.7.630; Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; ARIAS E, 2004, NATL VITAL STAT REPO; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Brennan A, 2007, RHEUMATOLOGY, V46, P1345, DOI 10.1093/rheumatology/kem115; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; CHAN KWA, 1994, ARTHRITIS RHEUM-US, V37, P814, DOI 10.1002/art.1780370606; Chen YF, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10420; Chen YF, 2006, HEALTH TECHNOL ASSES, V10, pxi; Choi HK, 2002, J RHEUMATOL, V29, P1156; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P221, DOI 10.1001/jama.298.2.221; Donahue KE, 2008, ANN INTERN MED, V148, P124, DOI 10.7326/0003-4819-148-2-200801150-00192; Drossaers-Bakker KW, 2000, RHEUMATOLOGY, V39, P998, DOI 10.1093/rheumatology/39.9.998; Feldman DE, 2007, ARTHRIT RHEUM-ARTHR, V57, P1419, DOI 10.1002/art.23086; Finckh A, 2006, ANN RHEUM DIS, V65, P746, DOI 10.1136/ard.2005.045062; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Fleurence R, 2006, J RHEUMATOL, V33, P2124; FRIES JF, 1982, J RHEUMATOL, V9, P789; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gold MR, 1996, COST EFFECTIVENESS H; Gorman JD, 2004, ARTHRITIS RHEUM-US, V50, P400, DOI 10.1002/art.20006; Hwang A, 2008, NAT CLIN PRACT RHEUM, V4, P114, DOI 10.1038/ncprheum0724; Ikeda K, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2177; Jacobsson LTH, 2007, ANN RHEUM DIS, V66, P670, DOI 10.1136/ard.2006.062497; JOHANNESSON M, 1993, J HEALTH ECON, V12, P459, DOI 10.1016/0167-6296(93)90005-Y; Keystone EC, 2003, CLIN EXP RHEUMATOL, V21, pS200; Kumar K, 2007, RHEUMATOLOGY, V46, P1438, DOI 10.1093/rheumatology/kem130; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Landewe R, 2006, ARTHRITIS RHEUM-US, V54, P3119, DOI 10.1002/art.22143; Machold KP, 2003, CLIN EXP RHEUMATOL, V21, pS113; Nell VPK, 2004, RHEUMATOLOGY, V43, P906, DOI 10.1093/rheumatology/keh199; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Nixon R, 2007, RHEUMATOLOGY, V46, P1140, DOI 10.1093/rheumatology/kem072; Pincus T, 1997, CLIN EXP RHEUMATOL, V15, pS27; Potter T, 2002, RHEUMATOLOGY, V41, P953, DOI 10.1093/rheumatology/41.8.953; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Schmajuk G, 2007, ARTHRIT RHEUM-ARTHR, V57, P928, DOI 10.1002/art.22890; Scott DL, 2000, RHEUMATOLOGY, V39, P122, DOI 10.1093/rheumatology/39.2.122; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Symmons D, 2000, GLOBAL BURDEN RHEUMA; Tamal M, 2007, J RHEUMATOL, V34, P2154; *US BUR LAB STAT, 2008, CONS PRIC IND DAT; van Aken J, 2006, ANN RHEUM DIS, V65, P20, DOI 10.1136/ard.2005.038471; van den Hout WB, 2009, ARTHRIT RHEUM-ARTHR, V61, P291, DOI 10.1002/art.24169; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P49, DOI 10.1002/art.20775; van der Helm-van Mil AH, 2008, ARTHRITIS RHEUM-US, V58, P2241, DOI 10.1002/art.23681; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; van der Kooij SM, 2009, ANN RHEUM DIS, V68, P914, DOI 10.1136/ard.2008.092254; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044; VANDERBIJL AE, 2006, ANN RHEUM DIS, pP180; Wailoo A, 2006, MODELING COST EFFECT; Wailoo AJ, 2008, ARTHRITIS RHEUM-US, V58, P939, DOI 10.1002/art.23374; Wolfe F, 2005, CLIN EXP RHEUMATOL, V23, pS168; Wolfe F, 2000, ARTHRITIS RHEUM-US, V43, P2751, DOI 10.1002/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6; WOLFE F, 2007, ARTHRITIS RHEUM, pS403	61	75	79	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					612	W198		10.7326/0003-4819-151-9-200911030-00006	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514IM	19884622				2022-12-24	WOS:000271387700003
J	Glocker, EO; Hennigs, A; Nabavi, M; Schaffer, AA; Woellner, C; Salzer, U; Pfeifer, D; Veelken, H; Warnatz, K; Tahami, F; Jamal, S; Manguiat, A; Rezaei, N; Amirzargar, AA; Plebani, A; Hannesschlager, N; Gross, O; Ruland, J; Grimbacher, B				Glocker, Erik-Oliver; Hennigs, Andre; Nabavi, Mohammad; Schaeffer, Alejandro A.; Woellner, Cristina; Salzer, Ulrich; Pfeifer, Dietmar; Veelken, Hendrik; Warnatz, Klaus; Tahami, Fariba; Jamal, Sarah; Manguiat, Annabelle; Rezaei, Nima; Amirzargar, Ali Akbar; Plebani, Alessandro; Hannesschlaeger, Nicole; Gross, Olaf; Ruland, Juergen; Grimbacher, Bodo			A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; HYPER-IGE SYNDROME; COMMON VARIABLE IMMUNODEFICIENCY; PATTERN-RECOGNITION RECEPTOR; INNATE IMMUNE-RESPONSES; LINKAGE ANALYSIS; TH17 CELLS; ANTIFUNGAL IMMUNITY; SINGLE-FAMILY; HOST-DEFENSE	BACKGROUND Chronic mucocutaneous candidiasis may be manifested as a primary immunodeficiency characterized by persistent or recurrent infections of the mucosa or the skin with candida species. Most cases are sporadic, but both autosomal dominant inheritance and autosomal recessive inheritance have been described. METHODS We performed genetic studies in 36 members of a large, consanguineous five-generation family, in which 4 members had recurrent fungal infections and an additional 3 members died during adolescence, 2 after invasive infection of the brain with candida species. All 36 family members were enrolled in the study, and 22 had blood samples taken for DNA analysis. Homozygosity mapping was used to locate the mutated gene. In the 4 affected family members (patients) and the 18 unaffected members we sequenced CARD9, the gene encoding the caspase recruitment domain-containing protein 9, carried out T-cell phenotyping, and performed functional studies, with the use of either leukocytes from the patients or a reconstituted murine model of the genetic defect. RESULTS We found linkage (lod score, 3.6) to a genomic interval on chromosome 9q, including CARD9. All four patients had a homozygous point mutation in CARD9, resulting in a premature termination codon (Q295X). Healthy family members had wild-type expression of the CARD9 protein; the four patients lacked wild-type expression, which was associated with low numbers of Th17 cells (helper T cells producing interleukin- 17). Functional studies based on genetic reconstitution of myeloid cells from Card9(-/-) mice showed that the Q295X mutation impairs innate signaling from the antifungal pattern-recognition receptor dectin-1. CONCLUSIONS An autosomal recessive form of susceptibility to chronic mucocutaneous candidiasis is associated with homozygous mutations in CARD9.	[Glocker, Erik-Oliver; Woellner, Cristina; Tahami, Fariba; Jamal, Sarah; Manguiat, Annabelle; Grimbacher, Bodo] Royal Free Hosp, Dept Immunol & Mol Pathol, London NW3 2QG, England; [Glocker, Erik-Oliver; Woellner, Cristina; Tahami, Fariba; Jamal, Sarah; Manguiat, Annabelle; Grimbacher, Bodo] UCL, London, England; [Hennigs, Andre; Salzer, Ulrich; Warnatz, Klaus] Univ Hosp Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Pfeifer, Dietmar; Veelken, Hendrik] Univ Hosp Freiburg, Dept Hematol & Oncol, Freiburg, Germany; [Nabavi, Mohammad] Semnan Univ Med Sci, Semnan, Iran; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Rezaei, Nima] Univ Tehran Med Sci, Sch Med, Childrens Med Ctr, Growth & Dev Res Ctr,Ctr Excellence Pediat, Tehran, Iran; [Amirzargar, Ali Akbar] Univ Tehran Med Sci, Sch Med, Dept Immunol, Immunogenet Lab, Tehran, Iran; [Plebani, Alessandro] Univ Brescia, Pediat Clin, Brescia, Italy; [Plebani, Alessandro] Spedali Civil Brescia, Ist Med Mol Angelo Nocivelli, I-25125 Brescia, Italy; [Hannesschlaeger, Nicole; Gross, Olaf; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-8000 Munich, Germany; [Ruland, Juergen] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Lab Signaling Immune Syst, Neuherberg, Germany	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of Freiburg; University of Freiburg; Semnan University of Medical Sciences; National Institutes of Health (NIH) - USA; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Brescia; Hospital Spedali Civili Brescia; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Grimbacher, B (corresponding author), Royal Free Hosp, Dept Immunol & Mol Pathol, Pond St, London NW3 2QG, England.	b.grimbacher@ucl.ac.uk	Schaffer, Alejandro A/F-2902-2012; Gross, Olaf/E-4570-2010; Schaffer, Alejandro/N-1222-2019; Ruland, Jürgen/Q-6680-2018; Plebani, Alessandro/C-8593-2011; Warnatz, Klaus/AAD-3464-2022; Rezaei, Nima/B-4245-2008	Gross, Olaf/0000-0001-8660-3619; Ruland, Jürgen/0000-0002-8381-3597; Rezaei, Nima/0000-0002-3836-1827; Veelken, Hendrik/0000-0002-9108-3125; Hennigs, Andre/0000-0002-7998-3796; Nabavi, Mohammad/0000-0001-6558-0390; Salzer, Ulrich/0000-0002-1769-1157	European Commission [MEXT-CT-2006-042316]; European Society for Immunodeficiencies; National Institutes of Health (NIH), National Library of Medicine; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); European Society for Immunodeficiencies; National Institutes of Health (NIH), National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported in part by a European Commission Marie Curie Excellence Grant (MEXT-CT-2006-042316); the young investigator award of 2008 from the European Society for Immunodeficiencies; the Intramural Research Program of the National Institutes of Health (NIH), National Library of Medicine; a Max Eder Program Grant from Deutsche Krebshilfe (to Dr. Ruland); and Sonderforschungsbereich grants from the Deutsche Forschungsgemeinschaft (to Dr. Ruland).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Atkinson TP, 2001, AM J HUM GENET, V69, P791, DOI 10.1086/323611; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; CANALES L, 1969, LANCET, V2, P567; Colonna M, 2007, NAT IMMUNOL, V8, P554, DOI 10.1038/ni0607-554; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; DROUHET E, 1980, REV INFECT DIS, V2, P606; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Finck A, 2006, EUR J HUM GENET, V14, P867, DOI 10.1038/sj.ejhg.5201634; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Giovannetti A, 2002, BLOOD, V100, P4082, DOI 10.1182/blood-2002-03-0976; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hruz P, 2008, CURR OPIN GASTROEN, V24, P108, DOI 10.1097/MOG.0b013e3282f50fdf; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; KAUFFMAN CA, 1981, ARCH INTERN MED, V141, P1076, DOI 10.1001/archinte.141.8.1076; Kirkpatrick CH, 2001, PEDIATR INFECT DIS J, V20, P197, DOI 10.1097/00006454-200102000-00017; KROLL JJ, 1973, ARCH DERMATOL, V108, P259, DOI 10.1001/archderm.108.2.259; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lilic D, 2002, CURR OPIN INFECT DIS, V15, P143, DOI 10.1097/00001432-200204000-00007; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Loeys BL, 1999, EUR J PEDIATR, V158, P650, DOI 10.1007/s004310051169; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mangino M, 2003, EUR J HUM GENET, V11, P433, DOI 10.1038/sj.ejhg.5200985; Miething C, 2003, ONCOGENE, V22, P4642, DOI 10.1038/sj.onc.1206575; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Pfeifer D, 2007, IMMUNOGENETICS, V59, P913, DOI 10.1007/s00251-007-0257-z; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rogers NC, 2005, IMMUNITY, V22, P773, DOI 10.1016/j.immuni.2005.06.005; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392; SAMS WM, 1979, AM J MED, V67, P948, DOI 10.1016/0002-9343(79)90635-1; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thorpe E., 1929, ARCH PEDIAT ADOL MED, V38, P328, DOI 10.1001/archpedi.1929.01930080104011; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; VANSCOY RE, 1975, ANN INTERN MED, V82, P766, DOI 10.7326/0003-4819-82-6-766; VANTWOUT JW, 1988, SCAND J INFECT DIS, V20, P193, DOI 10.3109/00365548809032437; WELLS RS, 1972, J MED GENET, V9, P302, DOI 10.1136/jmg.9.3.302; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	59	567	588	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1727	1735		10.1056/NEJMoa0810719	http://dx.doi.org/10.1056/NEJMoa0810719			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864672	Green Accepted			2022-12-24	WOS:000271185600005
J	Harris, SR; Olivotto, IA				Harris, Susan R.; Olivotto, Ivo A.			A Patient's Journey Communication during breast cancer treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harris, Susan R.] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC V6T 1Z3, Canada; [Olivotto, Ivo A.] British Columbia Canc Agcy, Radiat Therapy Program, Vancouver, BC V5Z 4E6, Canada; [Olivotto, Ivo A.] Univ British Columbia, Radiat Therapy Program, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Harris, SR (corresponding author), Univ British Columbia, Fac Med, Dept Phys Therapy, 212-2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	shar@interchange.ubc.ca; iolivott@bccancer.bc.ca	Harris, Susan/GSE-3905-2022	Harris, Susan/0000-0003-2679-6548					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2009	339								b4166	10.1136/bmj.b4166	http://dx.doi.org/10.1136/bmj.b4166			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PP	19854841				2022-12-24	WOS:000271102700004
J	Ahmed, HU				Ahmed, Hashim Uddin			The Index Lesion and the Origin of Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MORTALITY; MEN		[Ahmed, Hashim Uddin] Univ Coll, Div Surg & Intervent Sci, London, England; [Ahmed, Hashim Uddin] Univ Coll Hosp, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London, England	University of London; University College London; University of London; University College London	Ahmed, HU (corresponding author), Univ Coll, Div Surg & Intervent Sci, London, England.		Ahmed, Hashim U./AAU-1037-2020; Ahmed, Hashim U/C-5744-2008	Ahmed, Hashim U./0000-0003-1674-6723; 	MRC [G0701302] Funding Source: UKRI; Medical Research Council [G0701302, G1002509] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed HU, 2007, NAT CLIN PRACT ONCOL, V4, P632, DOI 10.1038/ncponc0959; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Andriole GL, 2009, NEW ENGL J MED, V360, P1797; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Liu WN, 2009, NAT MED, V15, P819, DOI 10.1038/nm0709-819a; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Stamey TA, 2001, EUR UROL, V39, P22, DOI 10.1159/000052577	7	249	258	2	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1704	1706		10.1056/NEJMcibr0905562	http://dx.doi.org/10.1056/NEJMcibr0905562			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508YW	19846858				2022-12-24	WOS:000270977400016
J	Eisenstein, M				Eisenstein, Michael			Putting neurons on the map	NATURE			English	Editorial Material							NERVOUS-SYSTEM											Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Chi KR, 2009, NAT METHODS, V6, P15, DOI 10.1038/NMETH.F.234; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	9	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 22	2009	461	7267					1149	1154		10.1038/4611149a	http://dx.doi.org/10.1038/4611149a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847270	Bronze			2022-12-24	WOS:000270987600050
J	Volkman, HE; Pozos, TC; Zheng, J; Davis, JM; Rawls, JF; Ramakrishnan, L				Volkman, Hannah E.; Pozos, Tamara C.; Zheng, John; Davis, J. Muse; Rawls, John F.; Ramakrishnan, Lalita			Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium	SCIENCE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IN-VIVO; CALMETTE-GUERIN; INFECTION; MATRIX-METALLOPROTEINASE-9; MACROPHAGES; EXPRESSION; ACTIVATION; ZEBRAFISH; RELEASE	Granulomas, organized aggregates of immune cells, are a hallmark of tuberculosis and have traditionally been thought to restrict mycobacterial growth. However, analysis of Mycobacterium marinum in zebrafish has shown that the early granuloma facilitates mycobacterial growth; uninfected macrophages are recruited to the granuloma where they are productively infected by M. marinum. Here, we identified the molecular mechanism by which mycobacteria induce granulomas: The bacterial secreted protein 6-kD early secreted antigenic target (ESAT-6), which has long been implicated in virulence, induced matrix metalloproteinase-9 (MMP9) in epithelial cells neighboring infected macrophages. MMP9 enhanced recruitment of macrophages, which contributed to nascent granuloma maturation and bacterial growth. Disruption of MMP9 function attenuated granuloma formation and bacterial growth. Thus, interception of epithelial MMP9 production could hold promise as a host-targeting tuberculosis therapy.	[Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98155 USA; [Volkman, Hannah E.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98155 USA; [Pozos, Tamara C.; Zheng, John] Univ Washington, Dept Pediat, Seattle, WA 98155 USA; [Davis, J. Muse] Emory Univ, Immunol & Mol Pathogenesis Grad Program, Atlanta, GA 30322 USA; [Rawls, John F.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Rawls, John F.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98155 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98155 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98155 USA.	lalitar@u.washington.edu	Rawls, John F/C-9169-2009	Rawls, John F/0000-0002-5976-5206; Ramakrishnan, Lalita/0000-0003-0692-5533; Davis, J. Muse/0000-0001-9959-6921	Burroughs Wellcome Fund; Pew Scholars Program; NIH; American Heart Association; Pediatric Infectious Diseases Society; Children's Health Research Center; National Defense Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054503, R01AI036396, R37AI054503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK062675, K01DK073695, R01DK081426] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Pew Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Pediatric Infectious Diseases Society; Children's Health Research Center; National Defense Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. I. Gordon, W. Parks, D. Raible, D. Sherman, K. Urdahl, and P. Elkington for advice and discussion; D. Beery and R. Kim for help with microinjections; and J. Cameron, L. Swaim, and H. Wiedenhoft for fish facility maintenance. We also thank K. Winglee for developing FPC analysis methods, R. Burmeister for graphic design, and D. Tobin, B. Cormack, W. Parks, D. Stetson, R. Berg, and F. Chu for review of the manuscript. This work was supported by the Burroughs Wellcome Fund (L. R.), the Pew Scholars Program (J. F. R.), the NIH (L. R. and J. F. R.), an American Heart Association predoctoral fellowship (H. E. V.), a Pediatric Infectious Diseases Society postdoctoral award, the Children's Health Research Center new investigator award, an NIH diversity supplement (T. C. P.), and a National Defense Science and Engineering predoctoral fellowship (J. M. D.).	ADAMS DO, 1976, AM J PATHOL, V84, P164; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Elkington PT, 2007, AM J RESP CELL MOL, V37, P431, DOI 10.1165/rcmb.2007-0011OC; Greenfield SP, 2007, UROLOGY, V69, P166, DOI 10.1016/j.urology.2006.10.018; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Park KJ, 2005, RESPIRATION, V72, P166, DOI 10.1159/000084048; Price NM, 2003, J IMMUNOL, V171, P5579, DOI 10.4049/jimmunol.171.10.5579; Price NM, 2001, J IMMUNOL, V166, P4223, DOI 10.4049/jimmunol.166.6.4223; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sheen P, 2009, EUR RESPIR J, V33, P134, DOI 10.1183/09031936.00127807; Sherman DR, 2004, J INFECT DIS, V190, P123, DOI 10.1086/421472; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Zhu XW, 2007, J INFECT DIS, V196, P1076, DOI 10.1086/521030	30	338	349	4	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					466	469		10.1126/science.1179663	http://dx.doi.org/10.1126/science.1179663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20007864	Green Accepted, Green Submitted			2022-12-24	WOS:000273783100038
J	Raines, KS; Salha, S; Sandberg, RL; Jiang, HD; Rodriguez, JA; Fahimian, BP; Kapteyn, HC; Du, JC; Miao, JW				Raines, Kevin S.; Salha, Sara; Sandberg, Richard L.; Jiang, Huaidong; Rodriguez, Jose A.; Fahimian, Benjamin P.; Kapteyn, Henry C.; Du, Jincheng; Miao, Jianwei			Three-dimensional structure determination from a single view	NATURE			English	Article							X-RAY-DIFFRACTION; RESOLUTION; MICROSCOPY	The ability to determine the structure of matter in three dimensions has profoundly advanced our understanding of nature. Traditionally, the most widely used schemes for three-dimensional (3D) structure determination of an object are implemented by acquiring multiple measurements over various sample orientations, as in the case of crystallography and tomography(1,2), or by scanning a series of thin sections through the sample, as in confocal microscopy(3). Here we present a 3D imaging modality, termed ankylography (derived from the Greek words ankylos meaning 'curved' and graphein meaning 'writing'), which under certain circumstances enables complete 3D structure determination from a single exposure using a monochromatic incident beam. We demonstrate that when the diffraction pattern of a finite object is sampled at a sufficiently fine scale on the Ewald sphere, the 3D structure of the object is in principle determined by the 2D spherical pattern. We confirm the theoretical analysis by performing 3D numerical reconstructions of a sodium silicate glass structure at 2 angstrom resolution, and a single poliovirus at 2-3nm resolution, from 2D spherical diffraction patterns alone. Using diffraction data from a soft X-ray laser, we also provide a preliminary demonstration that ankylography is experimentally feasible by obtaining a 3D image of a test object from a single 2D diffraction pattern. With further development, this approach of obtaining complete 3D structure information from a single view could find broad applications in the physical and life sciences.	[Raines, Kevin S.; Salha, Sara; Jiang, Huaidong; Fahimian, Benjamin P.; Miao, Jianwei] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Raines, Kevin S.; Salha, Sara; Jiang, Huaidong; Fahimian, Benjamin P.; Miao, Jianwei] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Rodriguez, Jose A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sandberg, Richard L.; Kapteyn, Henry C.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Sandberg, Richard L.; Kapteyn, Henry C.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Du, Jincheng] Univ N Texas, Dept Mat Sci & Engn, Denton, TX 76203 USA; [Du, Jincheng] Univ N Texas, Ctr Adv Sci Comp & Modeling, Denton, TX 76203 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Miao, JW (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	miao@physics.ucla.edu	Du, Jincheng/A-8052-2011; Sandberg, Richard/F-8790-2011; Wang, Ge/AAH-8592-2020; Kapteyn, Henry C/H-6559-2011	Wang, Ge/0000-0002-2656-7705; Kapteyn, Henry C/0000-0001-8386-6317; Sandberg, Richard/0000-0001-9719-8188	US DOE, Office of Basic Energy Sciences; US NSF, Division of Materials Research and Engineering Research Center; UCLA MBI Whitcome; NSF Center in EUV Science and Technology	US DOE, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US NSF, Division of Materials Research and Engineering Research Center(National Science Foundation (NSF)); UCLA MBI Whitcome; NSF Center in EUV Science and Technology	We thank P. Thibault for commenting on our manuscript, P. Thibault, M. M. Murnane, C.-C. Chen and R. Fung for discussions, C. Song for performing data analysis, Y. Mao for implementing an interpolation code, A. E. Sakdinawat for fabricating a test sample, P. Wachulak, M. Marconi, C. Menoni, J. J. Rocca and M. M. Murnane for help with data acquisition and T. Singh for parallelization of our phase retrieval codes. This work was supported by the US DOE, Office of Basic Energy Sciences, and the US NSF, Division of Materials Research and Engineering Research Center, an HHMI Gilliam fellowship for advanced studies and the UCLA MBI Whitcome fellowship. We used facilities supported by the NSF Center in EUV Science and Technology.	Abbey B, 2008, NAT PHYS, V4, P394, DOI 10.1038/nphys896; Barty A, 2008, NAT PHOTONICS, V2, P415, DOI 10.1038/nphoton.2008.128; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Giacovazzo C., 2002, FUNDAMENTALS CRYSTAL; Jiang HD, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038103; Kak A. C., 2001, PRINCIPLES COMPUTERI; Mancuso AP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.035502; Miao J, 1998, J OPT SOC AM A, V15, P1662, DOI 10.1364/JOSAA.15.001662; Miao J., 2009, RESPONSE FEASIBILITY; Miao JW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.215503; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Miao JW, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.088303; Miao JW, 2003, P NATL ACAD SCI USA, V100, P110, DOI 10.1073/pnas.232691299; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Nugent KA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.203902; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Pfeifer MA, 2006, NATURE, V442, P63, DOI 10.1038/nature04867; Robinson IK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.195505; Sandberg RL, 2008, P NATL ACAD SCI USA, V105, P24, DOI 10.1073/pnas.0710761105; Sandberg RL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098103; Sayre D., 1980, LECT NOTE PHYS, V112, P229; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Song CY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.158101; Spence JCH, 2002, PHILOS T R SOC A, V360, P875, DOI 10.1098/rsta.2001.0972; Thibault P., 2009, FEASIBILITY 3D RECON; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Williams GJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.025506; Zuo JM, 2003, SCIENCE, V300, P1419, DOI 10.1126/science.1083887	31	116	123	5	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					214	217		10.1038/nature08705	http://dx.doi.org/10.1038/nature08705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20016484	Green Submitted			2022-12-24	WOS:000273582700032
J	Liu, X; Bushnell, DA; Wang, D; Calero, G; Kornberg, RD				Liu, Xin; Bushnell, David A.; Wang, Dong; Calero, Guillermo; Kornberg, Roger D.			Structure of an RNA Polymerase II-TFIIB Complex and the Transcription Initiation Mechanism	SCIENCE			English	Article							CORE PROMOTER ELEMENT; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; YEAST TFIIB; DNA; HOLOENZYME; ELONGATION; MODEL	Previous x-ray crystal structures have given insight into the mechanism of transcription and the role of general transcription factors in the initiation of the process. A structure of an RNA polymerase II-general transcription factor TFIIB complex at 4.5 angstrom resolution revealed the amino-terminal region of TFIIB, including a loop termed the "B finger," reaching into the active center of the polymerase where it may interact with both DNA and RNA, but this structure showed little of the carboxyl-terminal region. A new crystal structure of the same complex at 3.8 angstrom resolution obtained under different solution conditions is complementary with the previous one, revealing the carboxyl-terminal region of TFIIB, located above the polymerase active center cleft, but showing none of the B finger. In the new structure, the linker between the amino-and carboxyl-terminal regions can also be seen, snaking down from above the cleft toward the active center. The two structures, taken together with others previously obtained, dispel long-standing mysteries of the transcription initiation process.	[Liu, Xin; Bushnell, David A.; Wang, Dong; Calero, Guillermo; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA.	kornberg@stanford.edu	Wang, Dong/C-8943-2012		NIH [GM049985, AI21144, K99 GM085136]; Jane Coffin Childs Memorial Fund; Department of Energy, Office of Biological and Environmental Research [DE-AC02-05CH11231, DE-AC02-06CH11357]; NIH; National Center for Research Resources, Biomedical Technology Program; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM085136, R01GM036659, K99GM085136, R01GM049985] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants GM049985 and AI21144 to R. D. K. X. L. was supported by the Jane Coffin Childs Memorial Fund fellowship. D. W. was supported by the NIH Pathway to Independence Award (K99 GM085136). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the NIH, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy under contract DE-AC02-05CH11231. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Coordinates and structure factors have been deposited at the Protein Data Bank under accession code 3K7A.	Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hayashi F, 1998, BIOCHEMISTRY-US, V37, P7941, DOI 10.1021/bi9801098; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Schimanski B, 2006, NUCLEIC ACIDS RES, V34, P1676, DOI 10.1093/nar/gkl090; Shaw SP, 1996, MOL CELL BIOL, V16, P3651; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Wu WH, 1999, GENETICS, V153, P643	28	161	165	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					206	209		10.1126/science.1182015	http://dx.doi.org/10.1126/science.1182015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965383	Green Accepted			2022-12-24	WOS:000273394000036
J	Gardino, AK; Villali, J; Kivenson, A; Lei, M; Liu, CF; Steindel, P; Eisenmesser, EZ; Labeikovsky, W; Wolf-Watz, M; Clarkson, MW; Kern, D				Gardino, Alexandra K.; Villali, Janice; Kivenson, Aleksandr; Lei, Ming; Liu, Ce Feng; Steindel, Phillip; Eisenmesser, Elan Z.; Labeikovsky, Wladimir; Wolf-Watz, Magnus; Clarkson, Michael W.; Kern, Dorothee			Transient Non-native Hydrogen Bonds Promote Activation of a Signaling Protein	CELL			English	Article							FREE-ENERGY LANDSCAPES; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGES; LIGAND-BINDING; STRING METHOD; TRANSITION; DOMAIN; SWITCH; PERSPECTIVE; SIMULATION	Phosphorylation is a common mechanism for activating proteins within signaling pathways. Yet, the molecular transitions between the inactive and active conformational states are poorly understood. Here we quantitatively characterize the free-energy landscape of activation of a signaling protein, nitrogen regulatory protein C (NtrC), by connecting functional protein dynamics of phosphorylation-dependent activation to protein folding and show that only a rarely populated, pre-existing active conformation is energetically stabilized by phosphorylation. Using nuclear magnetic resonance (NMR) dynamics, we test an atomic scale pathway for the complex conformational transition, inferred from molecular dynamics simulations (Lei et al., 2009). The data show that the loss of native stabilizing contacts during activation is compensated by non-native transient atomic interactions during the transition. The results unravel atomistic details of native-state protein energy landscapes by expanding the knowledge about ground states to transition landscapes.	[Gardino, Alexandra K.; Villali, Janice; Kivenson, Aleksandr; Lei, Ming; Liu, Ce Feng; Steindel, Phillip; Eisenmesser, Elan Z.; Labeikovsky, Wladimir; Wolf-Watz, Magnus; Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Dept Biochem, Waltham, MA 02452 USA; [Gardino, Alexandra K.; Villali, Janice; Kivenson, Aleksandr; Lei, Ming; Liu, Ce Feng; Steindel, Phillip; Eisenmesser, Elan Z.; Labeikovsky, Wladimir; Wolf-Watz, Magnus; Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02452 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02452 USA.	dkern@brandeis.edu	Labeikovsky, Wladimir/K-1648-2019	Labeikovsky, Wladimir/0000-0001-6074-3269; Clarkson, Michael W/0000-0002-4323-3424	Howard Hughes Medical Institute; NIH [GM62117, GM67963]; DOE (Office of Basic Energy Sciences) [DE-FG02-05ER15699]; NSF; Keck foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009, S10RR019090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596, R01GM067963, R01GM062117] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE (Office of Basic Energy Sciences)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Keck foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Martin Karplus for a fruitful collaboration and helpful discussions in the computational studies that led to the predicted pathway, Dr. Chunyu Wang at Columbia University for providing us with a pulse sequence to measure R<INF>ex</INF> in large proteins and for helpful discussions, Dr. Lewis E. Kay at the University of Toronto for the R<INF>1</INF><SUP>HzNz</SUP> pulse sequence, and Dr. Jack Skalicky at the NHMFL at Florida with support from NSF for NMR time. This work was supported by the Howard Hughes Medical Institute, NIH grants to D. K. (GM62117 and GM67963), a DOE grant (Office of Basic Energy Sciences) to D. K (DE-FG02-05ER15699), and instrumentation grants by the NSF and the Keck foundation to D. K.	ANTHONY MAW, 2007, J CHEM PHYS, V126; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Banavali NK, 2005, STRUCTURE, V13, P1715, DOI 10.1016/j.str.2005.09.005; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bolhuis PG, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2976011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 2001, SCIENCE, V291, P2329, DOI 10.1126/science.1060383; Christen M, 2008, J COMPUT CHEM, V29, P157, DOI 10.1002/jcc.20725; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dellago C, 2007, TOP CURR CHEM, V268, P291, DOI 10.1007/128_085; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Elber R, 2005, CURR OPIN STRUC BIOL, V15, P151, DOI 10.1016/j.sbi.2005.02.004; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gardino AK, 2007, METHOD ENZYMOL, V423, P149, DOI 10.1016/S0076-6879(07)23006-X; Hastings CA, 2003, BIOCHEMISTRY-US, V42, P9081, DOI 10.1021/bi0273866; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hu XH, 2006, J BIOMOL STRUCT DYN, V23, P509, DOI 10.1080/07391102.2006.10507075; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Karplus M, 2005, PHILOS T R SOC A, V363, P331, DOI 10.1098/rsta.2004.1496; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Khalili M, 2008, J PHYS CHEM B, V112, P2456, DOI 10.1021/jp076628e; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kumar S, 2000, PROTEIN SCI, V9, P10; Latzer J, 2008, BIOCHEMISTRY-US, V47, P2110, DOI 10.1021/bi701350v; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Lei M, 2009, J MOL BIOL, V392, P823, DOI 10.1016/j.jmb.2009.06.065; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Ma JP, 1997, P NATL ACAD SCI USA, V94, P11905, DOI 10.1073/pnas.94.22.11905; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pan AC, 2008, J PHYS CHEM B, V112, P3432, DOI 10.1021/jp0777059; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Ravindranathan KP, 2005, J MOL BIOL, V353, P196, DOI 10.1016/j.jmb.2005.08.009; Rogal J, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3029696; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; SCHUTKOWSKI M, 1994, EUR J BIOCHEM, V221, P455, DOI 10.1111/j.1432-1033.1994.tb18758.x; Silversmith RE, 1999, TRENDS MICROBIOL, V7, P16, DOI 10.1016/S0966-842X(98)01409-7; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stock AM, 2006, J BACTERIOL, V188, P7328, DOI 10.1128/JB.01268-06; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; van der Vaart A, 2006, THEOR CHEM ACC, V116, P183, DOI 10.1007/s00214-005-0004-1; Vanden-Eijnden E, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3130083; Vendruscolo M, 2005, PHILOS T R SOC A, V363, P433, DOI 10.1098/rsta.2004.1501; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Weikl TR, 2007, J MOL BIOL, V365, P1578, DOI 10.1016/j.jmb.2006.10.082; Wolynes PG, 2005, Q REV BIOPHYS, V38, P405, DOI 10.1017/S0033583505004075; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106	60	94	95	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1109	1118		10.1016/j.cell.2009.11.022	http://dx.doi.org/10.1016/j.cell.2009.11.022			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005804	Green Accepted, Bronze			2022-12-24	WOS:000272622800013
J	Wang, H; Westin, L; Nong, Y; Birnbaum, S; Bendor, J; Brismar, H; Nestler, E; Aperia, A; Flajolet, M; Greengard, P				Wang, Hong; Westin, Linda; Nong, Yi; Birnbaum, Shari; Bendor, Jacob; Brismar, Hjalmar; Nestler, Eric; Aperia, Anita; Flajolet, Marc; Greengard, Paul			Norbin Is an Endogenous Regulator of Metabotropic Glutamate Receptor 5 Signaling	SCIENCE			English	Article							LONG-TERM POTENTIATION; PREPULSE INHIBITION; ALLOSTERIC MODULATORS; NEURITE-OUTGROWTH; MGLUR5 ANTAGONIST; PROTEIN; BRAIN; NMDA; MICE; PHOSPHORYLATION	Metabotropic glutamate receptor 5 (mGluR5) is highly expressed in the mammalian central nervous system (CNS). It is involved in multiple physiological functions and is a target for treatment of various CNS disorders, including schizophrenia. We report that Norbin, a neuron-specific protein, physically interacts with mGluR5 in vivo, increases the cell surface localization of the receptor, and positively regulates mGluR5 signaling. Genetic deletion of Norbin attenuates mGluR5-dependent stable changes in synaptic function measured as long-term depression or long-term potentiation of synaptic transmission in the hippocampus. As with mGluR5 knockout mice or mice treated with mGluR5-selective antagonists, Norbin knockout mice showed a behavioral phenotype associated with a rodent model of schizophrenia, as indexed by alterations both in sensorimotor gating and psychotomimetic-induced locomotor activity.	[Wang, Hong; Nong, Yi; Bendor, Jacob; Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Westin, Linda; Brismar, Hjalmar; Aperia, Anita] Astrid Lindgren Childrens Hosp Q2 09, Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [Birnbaum, Shari] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Brismar, Hjalmar] Royal Inst Technol, Dept Appl Phys, S-10691 Stockholm, Sweden; [Nestler, Eric] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA	Rockefeller University; Karolinska Institutet; University of Texas System; University of Texas Southwestern Medical Center Dallas; Royal Institute of Technology; Icahn School of Medicine at Mount Sinai	Flajolet, M (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA.	flajolm@rockefeller.edu	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Greengard, Paul/0000-0002-4437-0893; Bendor, Jacob/0000-0003-1455-4891	NIH [MH074866, DA 10044, MH66172]; Swedish Research Council [03644-37-3]; Family Persson Foundation; USA Medical Research and Materiel Command [W81XWH-08-1-0111]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866, P50MH066172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Persson Foundation; USA Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Schuetz, A. Nishi, and A. Schaefer for providing mouse lines used in this study; A. Nairn, L. Wennogle, W. Luo, M. Zhou, J. Warner-Schmidt, and K. Lee for helpful discussions; C. Brocia for technical assistance; and H. Zebroski III for peptide synthesis. This work was supported in part by grants from the NIH (MH074866, DA 10044) (P. G.) and MH66172 (E. N.), the Swedish Research Council (03644-37-3) (A. A.), and the Family Persson Foundation (A. A.), and by award W81XWH-08-1-0111 from The USA Medical Research and Materiel Command to P. G.	AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brody SA, 2004, MOL PSYCHIATR, V9, P35, DOI 10.1038/sj.mp.4001404; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P25, DOI 10.1016/j.tips.2008.10.006; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Flajolet M, 2003, P NATL ACAD SCI USA, V100, P16006, DOI 10.1073/pnas.2136600100; Henry SA, 2002, NEUROPHARMACOLOGY, V43, P1199, DOI 10.1016/S0028-3908(02)00332-5; Homayoun H, 2004, NEUROPSYCHOPHARMACOL, V29, P1259, DOI 10.1038/sj.npp.1300417; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Ishizuka Y, 1999, BBA-MOL CELL RES, V1450, P92, DOI 10.1016/S0167-4889(99)00039-7; Jia ZP, 1998, LEARN MEMORY, V5, P331; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; Lu YM, 1997, J NEUROSCI, V17, P5196; Marino MJ, 2006, CURR OPIN PHARMACOL, V6, P98, DOI 10.1016/j.coph.2005.09.006; Minakami R, 1997, J BIOL CHEM, V272, P20291, DOI 10.1074/jbc.272.32.20291; Pietraszek M, 2004, J PHYSIOL PHARMACOL, V55, P587; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Shigemoto R, 2000, HAND CHEM N, V18, P63; Shinozaki K, 1999, MOL BRAIN RES, V71, P364, DOI 10.1016/S0169-328X(99)00181-3; Shinozaki K, 1997, BIOCHEM BIOPH RES CO, V240, P766, DOI 10.1006/bbrc.1997.7660; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630	25	82	86	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1554	1557		10.1126/science.1178496	http://dx.doi.org/10.1126/science.1178496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007903	Green Accepted			2022-12-24	WOS:000272623600062
J	Sadri-Ardekani, H; Mizrak, SC; van Daalen, SKM; Korver, CM; Roepers-Gajadien, HL; Koruji, M; Hovingh, S; de Reijke, TM; de la Rosette, JJMCH; van der Veen, F; de Rooij, DG; Repping, S; van Pelt, AMM				Sadri-Ardekani, Hooman; Mizrak, Sefika C.; van Daalen, Saskia K. M.; Korver, Cindy M.; Roepers-Gajadien, Hermien L.; Koruji, Morteza; Hovingh, Suzanne; de Reijke, Theo M.; de la Rosette, Jean J. M. C. H.; van der Veen, Fulco; de Rooij, Dirk G.; Repping, Sjoerd; van Pelt, Ans M. M.			Propagation of Human Spermatogonial Stem Cells In Vitro	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM CULTURE; SELF-RENEWAL; MOUSE TESTES; GERM-CELLS; TRANSPLANTATION; SPERMATOGENESIS; EXPANSION; MICE; PROLIFERATION; COLONIZATION	Context Young boys treated with high-dose chemotherapy are often confronted with infertility once they reach adulthood. Cryopreserving testicular tissue before chemotherapy and autotransplantation of spermatogonial stem cells at a later stage could theoretically allow for restoration of fertility. Objective To establish in vitro propagation of human spermatogonial stem cells from small testicular biopsies to obtain an adequate number of cells for successful transplantation. Design, Setting, and Participants Study performed from April 2007 to July 2009 using testis material donated by 6 adult men who underwent orchidectomy as part of prostate cancer treatment. Testicular cells were isolated and cultured in supplemented StemPro medium; germline stem cell clusters that arose were subcultured on human placental laminin-coated dishes in the same medium. Presence of spermatogonia was determined by reverse transcriptase polymerase chain reaction and immunofluorescence for spermatogonial markers. To test for the presence of functional spermatogonial stem cells in culture, xenotransplantation to testes of immunodeficient mice was performed, and migrated human spermatogonial stem cells after transplantation were detected by COT-1 fluorescence in situ hybridization. The number of colonized spermatogonial stem cells transplanted at early and later points during culture were counted to determine propagation. Main Outcome Measures Propagation of spermatogonial stem cells over time. Results Testicular cells could be cultured and propagated up to 15 weeks. Germline stem cell clusters arose in the testicular cell cultures from all 6 men and could be subcultured and propagated for up to 28 weeks. Expression of spermatogonial markers on both the RNA and protein level was maintained throughout the entire culture period. In 4 of 6 men, xenotransplantation to mice demonstrated the presence of functional spermatogonial stem cells, even after prolonged in vitro culture. Spermatogonial stem cell numbers increased 53-fold within 19 days in the testicular cell culture and increased 18 450-fold within 64 days in the germline stem cell subculture. Conclusions Long-term culture and propagation of human spermatogonial stem cells in vitro is achievable. JAMA. 2009; 302(19): 2127-2134	[Sadri-Ardekani, Hooman; Mizrak, Sefika C.; van Daalen, Saskia K. M.; Korver, Cindy M.; Roepers-Gajadien, Hermien L.; Koruji, Morteza; Hovingh, Suzanne; van der Veen, Fulco; de Rooij, Dirk G.; Repping, Sjoerd; van Pelt, Ans M. M.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [de Reijke, Theo M.; de la Rosette, Jean J. M. C. H.] Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1105 AZ Amsterdam, Netherlands; [Sadri-Ardekani, Hooman] Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Pelt, AMM (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med F2 131 2, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.m.vanpelt@amc.uva.nl	de Rooij, D.G./AAW-1195-2021; Koruji, Morteza -/AAE-9264-2022; Koruji, Morteza/N-2393-2017	Koruji, Morteza -/0000-0003-2661-0117; Koruji, Morteza/0000-0003-2661-0117; de Rooij, Dirk/0000-0003-3932-4419; Repping, Sjoerd/0000-0002-6959-149X; van Pelt, Ans/0000-0001-9155-548X				Aponte PM, 2008, REPRODUCTION, V136, P543, DOI 10.1530/REP-07-0419; Aponte PM, 2005, APMIS, V113, P727, DOI 10.1111/j.1600-0463.2005.apm_302.x; Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; BERES J, 1989, International Urology and Nephrology, V21, P159, DOI 10.1007/BF02550804; Blatt J, 1999, MED PEDIATR ONCOL, V33, P29, DOI 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO;2-2; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Creemers LB, 2002, BIOL REPROD, V66, P1579, DOI 10.1095/biolreprod66.6.1579; Dobrinski I, 1999, MOL REPROD DEV, V53, P142, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;142::AID-MRD3&gt;3.0.CO;2-O; Ebata KT, 2008, DIS MARKERS, V24, P267, DOI 10.1155/2008/536020; Fujita K, 2006, CANCER RES, V66, P11166, DOI 10.1158/0008-5472.CAN-06-2326; Geens M, 2007, HUM REPROD, V22, P733, DOI 10.1093/humrep/del418; Golestaneh N, 2009, STEM CELLS DEV, V18, P1115, DOI 10.1089/scd.2008.0347; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Honaramooz A, 2003, MOL REPROD DEV, V64, P422, DOI 10.1002/mrd.10205; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Izadyar F, 2003, REPRODUCTION, V126, P765, DOI 10.1530/rep.0.1260765; Izadyar F, 2002, REPRODUCTION, V124, P85, DOI 10.1530/rep.0.1240085; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kim J, 2008, STEM CELLS, V26, P2516, DOI 10.1634/stemcells.2008-0379; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; MIZRAK SC, HUM REPROD, DOI DOI 10.1093/HUMREP/DEP354; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Orwig KE, 2002, BIOL REPROD, V66, P944, DOI 10.1095/biolreprod66.4.944; Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55; Sullivan GJ, 2001, EMBO J, V20, P2867, DOI 10.1093/emboj/20.11.2867; van Pelt AMM, 2002, ENDOCRINOLOGY, V143, P1845, DOI 10.1210/en.143.5.1845; vanPelt AMM, 1996, BIOL REPROD, V55, P439, DOI 10.1095/biolreprod55.2.439	37	245	262	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2127	2134		10.1001/jama.2009.1689	http://dx.doi.org/10.1001/jama.2009.1689			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920237	Bronze			2022-12-24	WOS:000271873900022
J	Estrada-Oyuela, R				Estrada-Oyuela, Raul			Copenhagen needs a strong lead negotiator	NATURE			English	Editorial Material												eoy@estrada-oyuela.com.ar							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1056	1057		10.1038/4611056a	http://dx.doi.org/10.1038/4611056a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509BU	19847245				2022-12-24	WOS:000270987600020
J	Bhalla, R; Kalkut, G				Bhalla, Rohit; Kalkut, Gary			Could Medicare Readmission Policy Exacerbate Health Care System Inequity?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEART-FAILURE	The Centers for Medicare & Medicaid Services recently started publicly reporting hospital readmission rates. Health care reform proposals include readmission provisions as vehicles to promote care coordination and achieve savings. Current approaches ascribe variability in hospital readmission primarily to differences in patient medical risk and hospital performance. These approaches do not adequately account for the effect of patient sociodemographic and community factors that influence health care utilization and outcomes. The evidence base on cost-effective and generalizable care management techniques to reduce readmission is still evolving. Although readmission-related policies may prove to be a transformational force in health care reform, their incorrect application in facilities serving vulnerable communities may increase health care system inequity. Policy options can mitigate this potential.	[Bhalla, Rohit] Montefiore Med Ctr, Orange Zone Res Ctr, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Bhalla, R (corresponding author), Montefiore Med Ctr, Orange Zone Res Ctr, Room 131,111 E 210th St, Bronx, NY 10467 USA.	rbhalla@montefiore.org		Kalkut, Gary/0000-0002-6160-2262				*AG HEALTHC RES QU, 2007, NAT HLTH CAR DISP RE; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Centers for Medicare &amp Medicaid Services, 2009, ROADM IMPL VAL HEALT; *CTR MED MED SERV, 2009, PAT MIX COEFF MARCH; *CTR MED MED SERV, 2009, HOSP COMP; Egerter S, 2009, REACHING AM HLTH POT; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Gawande A., 2009, NEW YORKER; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; KRUMHOLZ HM, 2009, CIRC CARDIOVASC QUAL; Krumholz HNS, 2008, HOSP 30 DAY HEART FA; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; Sochalski J, 2009, HEALTH AFFAIR, V28, P179, DOI 10.1377/hlthaff.28.1.179; Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (full printed version), 2003, UN TREATM CONFR RAC; *US HR, 2009, HOUS TRIC HLTH REF D; *US SEN FIN COMM, 2009, DESCR POL OPT TRANSF; 2009, NY TIMES        0416, pA28	19	69	69	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					114	117		10.7326/0003-4819-152-2-201001190-00185	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00185			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	19949133				2022-12-24	WOS:000273953000006
J	Partridge, AH; Winer, EP				Partridge, Ann H.; Winer, Eric P.			On Mammography - More Agreement Than Disagreement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SERVICES TASK-FORCE; BREAST-CANCER		[Partridge, Ann H.; Winer, Eric P.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Partridge, AH (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009	4	28	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2499	2501		10.1056/NEJMp0911288	http://dx.doi.org/10.1056/NEJMp0911288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	19940286				2022-12-24	WOS:000273003700002
J	Muller, F; Mutch, NJ; Schenk, WA; Smith, SA; Esterl, L; Spronk, HM; Schmidbauer, S; Gahl, WA; Morrissey, JH; Renne, T				Muller, Felicitas; Mutch, Nicola J.; Schenk, Wolfdieter A.; Smith, Stephanie A.; Esterl, Lucie; Spronk, Henri M.; Schmidbauer, Stefan; Gahl, William A.; Morrissey, James H.; Renne, Thomas			Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo	CELL			English	Article							COAGULATION-FACTOR-XII; BLOOD-COAGULATION; CONTACT-PHASE; INORGANIC POLYPHOSPHATE; THROMBUS FORMATION; INTRINSIC PATHWAY; ACTIVATION; DEFICIENCY; DISEASE; SYSTEM	Platelets play a central role in thrombosis, hemostasis, and inflammation. We show that activated platelets release inorganic polyphosphate (polyP), a polymer of 60-100 phosphate residues that directly bound to and activated the plasma protease factor XII. PolyP-driven factor XII activation triggered release of the inflammatory mediator bradykinin by plasma kallikrein-mediated kininogen processing. PolyP increased vascular permeability and induced fluid extravasation in skin microvessels of mice. Mice deficient in factor XII or bradykinin receptors were resistant to polyP-induced leakage. PolyP initiated clotting of plasma via the contact pathway. Ablation of intrinsic coagulation pathway proteases factor XII and factor XI protected mice from polyP-triggered lethal pulmonary embolism. Targeting polyP with phosphatases interfered with procoagulant activity of activated platelets and blocked platelet-induced thrombosis in mice. Addition of polyP restored defective plasma clotting of Hermansky-Pudlak Syndrome patients, who lack platelet polyP. The data identify polyP as a new class of mediator having fundamental roles in platelet-driven proinflammatory and procoagulant disorders.	[Muller, Felicitas; Esterl, Lucie; Renne, Thomas] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Muller, Felicitas; Esterl, Lucie; Renne, Thomas] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Mutch, Nicola J.] Univ Leeds, Fac Biol Sci, Dept Cardiovasc Med, Leeds LS2 9JT, W Yorkshire, England; [Schenk, Wolfdieter A.] Univ Wurzburg, Inst Inorgan Chem, D-97074 Wurzburg, Germany; [Smith, Stephanie A.; Morrissey, James H.] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Spronk, Henri M.] Maastricht Univ, Dept Internal Med, Lab Clin Thrombosis & Haemostasis, NL-6200 MD Maastricht, Netherlands; [Schmidbauer, Stefan] CSL Behring GmbH, D-35041 Marburg, Germany; [Gahl, William A.] NHGRI, Human Biochem Genet Sect, Bethesda, MD 20892 USA	Karolinska Institutet; Karolinska Institutet; University of Leeds; University of Wurzburg; University of Illinois System; University of Illinois Urbana-Champaign; Maastricht University; CSL; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Renne, T (corresponding author), Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden.	thomas@renne.net	Morrissey, James H./GLR-5645-2022; Morrissey, James H/H-4933-2011	Morrissey, James H/0000-0002-1570-1569; Renne, Thomas/0000-0003-4594-5975; Smith, Stephanie/0000-0003-4895-6215; Mutch, Nicola/0000-0002-7452-0813; Spronk, Henri/0000-0002-3858-334X	Deutsche Forschungsgemeinschaft [SFB 688]; EU; NIH [R01 HL47014]; National Human Genome Research Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047014] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; British Heart Foundation [PG/07/122/24195] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); British Heart Foundation(British Heart Foundation)	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (SFB 688) and the EU-funded ERARE program (T. R.); by NIH grant R01 HL47014 (J.H.M.); and by the Intramural Research Program of the National Human Genome Research Institute, NIH (W. A. G.). We thank Dr. T. Staffel (BK Giulini, Ludwigshafen, Germany) for donating synthetic polyP. We are grateful to Dr. David Gailani (Vanderbilt University, Nashville, TN, USA) for providing FXI null mice and Dr. Alan E. Mast (Blood Center of Wisconsin, Milwaukee, WI, USA) for anti-TFPI antibodies. We cordially thank Dr. Ulrich Walter (Julius-Maximilians-University Wurzburg, Wurzburg, Germany) for continuous mentoring and support. F. M. is supported by a Rudolf-Marx Grant of the Society for Thrombosis and Hemostasis Research (GTH). Three of the authors (N.J.M., S. A. S., and J.H.M.) are coinventors on pending patent applications on medical uses of polyP.	CASTALDI PA, 1965, NATURE, V207, P422, DOI 10.1038/207422a0; COLMAN RW, 2006, CONTACT ACTIVATION K, P107; del Conde I, 2005, J EXP MED, V201, P871, DOI 10.1084/jem.20041497; Endler G, 2007, J THROMB HAEMOST, V5, P1143, DOI 10.1111/j.1538-7836.2007.02530.x; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; Gailani D, 2007, J THROMB HAEMOST, V5, P1106, DOI 10.1111/j.1538-7836.2007.02446.x; Gailani D, 2007, ARTERIOSCL THROM VAS, V27, P2507, DOI 10.1161/ATVBAHA.107.155952; GHEBREHIWET B, 1981, J EXP MED, V153, P665, DOI 10.1084/jem.153.3.665; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; MANGAL AK, 1980, LANCET, V315, P774; Muller F, 2008, CURR OPIN HEMATOL, V15, P516, DOI 10.1097/MOH.0b013e328309ec85; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; Ponczek MB, 2008, J THROMB HAEMOST, V6, P1876, DOI 10.1111/j.1538-7836.2008.03143.x; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109; RATNOFF OD, 1968, NEW ENGL J MED, V279, P760, DOI 10.1056/NEJM196810032791407; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; SCHMIDBAUER S, 2009, HAMOSTASEOLOGIE, V29, P22; Smith SA, 2008, J THROMB HAEMOST, V6, P1750, DOI 10.1111/j.1538-7836.2008.03104.x; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; Tucker EI, 2009, BLOOD, V113, P936, DOI 10.1182/blood-2008-06-163675; von Hundelshausen P, 2007, CIRC RES, V100, P27, DOI 10.1161/01.RES.0000252802.25497.b7; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; WALSH PN, 1981, BLOOD, V57, P106; Wang XK, 2006, J THROMB HAEMOST, V4, P1982, DOI 10.1111/j.1538-7836.2006.02093.x; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977	41	564	578	1	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1143	1156		10.1016/j.cell.2009.11.001	http://dx.doi.org/10.1016/j.cell.2009.11.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005807	Green Accepted, Bronze			2022-12-24	WOS:000272622800016
J	Andrea, G; Reuss, R				Andrea, G.; Reuss, Reinhard			Commentary: Patient's view	BRITISH MEDICAL JOURNAL			English	Editorial Material												reinhard.reuss@neuro.med.uni-giessen.de							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2009	339								b5178	10.1136/bmj.b5178	http://dx.doi.org/10.1136/bmj.b5178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007658				2022-12-24	WOS:000272697600005
J	Firth, PG; Zheng, H; Biller, JA				Firth, P. G.; Zheng, H.; Biller, J. A.			CHRISTMAS: YEARS LIKE THIS Ingested foreign bodies and societal wealth: three year observational study of swallowed coins	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EURO	Objective To examine the relation between coins ingested by children and the Dow Jones Industrial Average. Design Observational study. Main outcome measures Total value of coins ingested and number of incidents of coins versus other objects swallowed, measured before and after the stock market crash of October 2008. Results Eighteen objects, including 11 coins, were ingested (NASDAQ ( numismatic and sundry detritus acquired) composite of 18). The total value of the 11 coins swallowed was $1.03 (FTSE 100 (fraction of the US$ or 100 cents) index of 103). The pecuniary extraction ratio ( PE ratio) was 0.57 (9/16). Comparing values for a period before and after October 2008, the mean monthly NASDAQ composite (0.41 (SD 0.67) v 0.5 (0.85), P=0.75), FTSE 100 index in cents (2.3 (6.8) v 3.1 (7.8), P=0.77), and PE ratio (0.54 (0.52) v 0.66 (0.29), P=0.50) did not change. The mean end-of-month closing value of the Dow Jones, however, decreased significantly (12537 (841.4) v 8388 (699.8), P<0.001) Conclusion There was no detectable difference in the total value of coins ingested, or ratio of coins to other objects swallowed, before or after a massive stock market crash.	[Firth, P. G.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Zheng, H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Biostat, Boston, MA 02114 USA; [Biller, J. A.] Harvard Univ, Sch Med, Dept Gastroenterol, Waltham, MA 02451 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Firth, PG (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA.	pfirth@partners.org		Firth, Paul/0000-0003-1909-5225				[Anonymous], DOW JONES IND AVERAG; Brynjolfsson E., 2010, WIRED INNOVATION IT; Cantu S, 2002, AM SURGEON, V68, P417; DORST JP, 1982, PEDIATRICS, V69, P224; Gill DG, 2004, ARCH DIS CHILD, V89, P795, DOI 10.1136/adc.2003.045419; Marlow Troy J., 1997, Journal of Emergency Medicine, V15, P487, DOI 10.1016/S0736-4679(97)00086-3; MORRISON JB, 1966, BRIT MED J, V2, P1052, DOI 10.1136/bmj.2.5521.1052; Papadopoulos FC, 2004, ARCH DIS CHILD, V89, P382, DOI 10.1136/adc.2003.033985; Philip J, 2004, PEDIATR ANESTH, V14, P1016, DOI 10.1111/j.1460-9592.2004.01510.x; REY M, 1966, C GEORGE GOES HOSP; Saxena AK, 2008, EUR J PEDIATR, V167, P243, DOI 10.1007/s00431-007-0449-4; Tsagkaropoulos S, 2009, EUR J CARDIO-THORAC, V36, P185, DOI 10.1016/j.ejcts.2009.02.053	12	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2009	339								b5066	10.1136/bmj.b5066	http://dx.doi.org/10.1136/bmj.b5066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NU	19965938	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000272453700004
J	Islam, MS; Midzi, SM; Charimari, L; Cravioto, A; Endtz, HP				Islam, M. Sirajul; Midzi, Stanley M.; Charimari, Lincoln; Cravioto, Alejandro; Endtz, Hubert P.			Susceptibility to Fluoroquinolones of Vibrio cholerae O1 Isolated From Diarrheal Patients in Zimbabwe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BANGLADESH		[Islam, M. Sirajul; Cravioto, Alejandro; Endtz, Hubert P.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Charimari, Lincoln] WHO, Harare, Zimbabwe	International Centre for Diarrhoeal Disease Research (ICDDR); World Health Organization	Islam, MS (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	sislam@icddrb.org						Bhattacharya S, 2009, SCIENCE, V324, P885, DOI 10.1126/science.1173890; FARUQUE SM, 1995, J CLIN MICROBIOL, V33, P2833, DOI 10.1128/JCM.33.11.2833-2838.1995; Garg P, 2001, ANTIMICROB AGENTS CH, V45, P1605, DOI 10.1128/AAC.45.5.1605-1606.2001; Islam MS, 2007, MICROBIOL IMMUNOL, V51, P369, DOI 10.1111/j.1348-0421.2007.tb03924.x; Opintan JA, 2008, J ANTIMICROB CHEMOTH, V62, P929, DOI 10.1093/jac/dkn334; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493	6	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2321	2322		10.1001/jama.2009.1750	http://dx.doi.org/10.1001/jama.2009.1750			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952318	Bronze			2022-12-24	WOS:000272239000015
J	Centor, RM				Centor, Robert M.			Expand the Pharyngitis Paradigm for Adolescents and Young Adults	ANNALS OF INTERNAL MEDICINE			English	Article							FUSOBACTERIUM-NECROPHORUM; MANAGEMENT; THROAT; NECROBACILLOSIS; DIAGNOSIS	Current guidelines and review articles emphasize that clinicians should consider group A beta-hemolytic streptococcus in the diagnosis and management of patients with acute pharyngitis. Recent data suggest that in adolescents and young adults (persons aged 15 to 24 years), Fusobacterium necrophorum causes endemic pharyngitis at a rate similar to that of group A beta-hemolytic streptococcus. On the basis of published epidemiologic data, F. necrophorum is estimated to cause the Lemierre syndrome-a life-threatening suppurative complication-at a higher incidence than that at which group A streptococcus causes acute rheumatic fever. Moreover, these estimates suggest greater morbidity and mortality from the Lemierre syndrome. The diagnostic paradigm for adolescent pharyngitis should therefore be expanded to consider F. necrophorum in addition to group A streptococcus. Expanding the pharyngitis paradigm will have several important implications. Further epidemiologic research is needed on both F. necrophorum pharyngitis (especially clinical presentation) and the Lemierre syndrome. Clinicians need reliable diagnostic techniques for F. necrophorum pharyngitis. In the meantime, adolescents and young adults who develop bacteremic symptoms should be aggressively treated with antibiotics for F. necrophorum infection. Physicians should avoid macrolides if they choose to treat streptococcus-negative pharyngitis empirically. Finally, pediatricians, internists, family physicians, and emergency department physicians should know the red flags for adolescent and young adult pharyngitis: worsening symptoms or neck swelling (especially unilateral neck swelling). Adolescent and young adult pharyngitis is more complicated than previously considered.	[Centor, Robert M.] Univ Alabama Birmingham, Huntsville, AL 35801 USA	University of Alabama System; University of Alabama Birmingham	Centor, RM (corresponding author), Univ Alabama Birmingham, Huntsville Reg Med Campus,301 Governors Dr, Huntsville, AL 35801 USA.	rcentor@uab.edu						Aliyu SH, 2004, J MED MICROBIOL, V53, P1029, DOI 10.1099/jmm.0.45648-0; Amess JA, 2007, BRIT J BIOMED SCI, V64, P63, DOI 10.1080/09674845.2007.11732757; Batty A, 2005, BRIT J BIOMED SCI, V62, P66, DOI 10.1080/09674845.2005.11732687; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; Centor RM, 2007, J GEN INTERN MED, V22, P127, DOI 10.1007/s11606-006-0020-4; Cherry Donald K, 2007, Adv Data, P1; Chirinos JA, 2002, MEDICINE, V81, P458, DOI 10.1097/00005792-200211000-00006; EYKYN SJ, 1989, SCAND J INFECT DIS, P41; Gehrt Britta, 2009, Ugeskr Laeger, V171, P991; Hagelskjaer LH, 1998, EUR J CLIN MICROBIOL, V17, P561, DOI 10.1007/BF01708619; Jensen A, 2007, CLIN MICROBIOL INFEC, V13, P695, DOI 10.1111/j.1469-0691.2007.01719.x; Kristensen LH, 2008, EUR J CLIN MICROBIOL, V27, P779, DOI 10.1007/s10096-008-0496-4; Lemierre A, 1936, LANCET, V1, P701; Neuner JM, 2003, ANN INTERN MED, V139, P113, DOI 10.7326/0003-4819-139-2-200307150-00011; Riordan T, 2007, CLIN MICROBIOL REV, V20, P622, DOI 10.1128/CMR.00011-07; Rusan M, 2009, EUR J CLIN MICROBIOL, V28, P243, DOI 10.1007/s10096-008-0619-y; Shah M, 2007, J GEN INTERN MED, V22, P272, DOI 10.1007/s11606-006-0049-4; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018	18	64	65	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2009	151	11					812	815		10.7326/0003-4819-151-11-200912010-00011	http://dx.doi.org/10.7326/0003-4819-151-11-200912010-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EJ	19949147				2022-12-24	WOS:000272727900007
J	Hawkes, N				Hawkes, Nigel			Health Policy Handing over the prescription pad	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NURSES VIEWS; DOCTORS					nigel.hawkes1@btinternet.com						Courtenay M, 2009, J CLIN NURS, V18, P2668, DOI 10.1111/j.1365-2702.2009.02799.x; Marks D, 2009, ALLIED HLTH PROFESSI; Stenner K, 2009, J ADV NURS, V65, P851, DOI 10.1111/j.1365-2648.2008.04944.x; WATTERSON A, EVALUATION EXPANSION	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2009	339								b4835	10.1136/bmj.b4835	http://dx.doi.org/10.1136/bmj.b4835			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AX	19945998				2022-12-24	WOS:000272186600003
J	Stewart, AM				Stewart, Alexandra M.			Mandatory Vaccination of Health Care Workers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stewart, Alexandra M.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Stewart, Alexandra M.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA	George Washington University; George Washington University	Stewart, AM (corresponding author), George Washington Univ, Med Ctr, Washington, DC 20037 USA.							DAINES RF, 2009, COMMUNICATION   0924	1	69	72	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2015	2017		10.1056/NEJMp0910151	http://dx.doi.org/10.1056/NEJMp0910151			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19890107				2022-12-24	WOS:000271898600003
J	Konopka, G; Bomar, JM; Winden, K; Coppola, G; Jonsson, ZO; Gao, FY; Peng, S; Preuss, TM; Wohlschlegel, JA; Geschwind, DH				Konopka, Genevieve; Bomar, Jamee M.; Winden, Kellen; Coppola, Giovanni; Jonsson, Zophonias O.; Gao, Fuying; Peng, Sophia; Preuss, Todd M.; Wohlschlegel, James A.; Geschwind, Daniel H.			Human-specific transcriptional regulation of CNS development genes by FOXP2	NATURE			English	Article							HUMAN BRAIN; ACCELERATED EVOLUTION; MASS-SPECTROMETRY; LANGUAGE; SPEECH; EXPRESSION; IDENTIFICATION; MICE; MUTATIONS; DYSPRAXIA	The signalling pathways controlling both the evolution and development of language in the human brain remain unknown. So far, the transcription factor FOXP2 (forkhead box P2) is the only gene implicated in Mendelian forms of human speech and language dysfunction(1-3). It has been proposed that the amino acid composition in the human variant of FOXP2 has undergone accelerated evolution, and this two-amino-acid change occurred around the time of language emergence in humans(4,5). However, this remains controversial, and whether the acquisition of these amino acids in human FOXP2 has any functional consequence in human neurons remains untested. Here we demonstrate that these two human-specific amino acids alter FOXP2 function by conferring differential transcriptional regulation in vitro. We extend these observations in vivo to human and chimpanzee brain, and use network analysis to identify novel relationships among the differentially expressed genes. These data provide experimental support for the functional relevance of changes in FOXP2 that occur on the human lineage, highlighting specific pathways with direct consequences for human brain development and disease in the central nervous system (CNS). Because FOXP2 has an important role in speech and language in humans, the identified targets may have a critical function in the development and evolution of language circuitry in humans.	[Konopka, Genevieve; Bomar, Jamee M.; Winden, Kellen; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; [Konopka, Genevieve; Bomar, Jamee M.; Winden, Kellen; Coppola, Giovanni; Gao, Fuying; Peng, Sophia; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Wohlschlegel, James A.; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Preuss, Todd M.] Emory Univ, Sch Med, Div Neurosci, Atlanta, GA 30329 USA; [Preuss, Todd M.] Emory Univ, Sch Med, Ctr Behav Neurosci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Preuss, Todd M.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30329 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Emory University; Emory University; Emory University	Konopka, G (corresponding author), Univ Calif Los Angeles, Program Neurogenet, Los Angeles, CA 90095 USA.	gena@alum.mit.edu; dhg@ucla.edu	Preuss, Todd/GSI-6571-2022; Jónsson, Zophonías/E-1960-2015; Jónsson, Zophonías Oddur/AAO-1354-2020	Jónsson, Zophonías Oddur/0000-0001-5798-9647; Konopka, Genevieve/0000-0002-3363-7302	A. P. Giannini Foundation Medical Research Fellowship; NARSAD; NIH/NCRR [RR00165]; McDonnell Foundation [JSMF 21002093];  [R21MH075028];  [R37MH60233-06A1];  [T32HD007032];  [T32MH073526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233, T32MH073526, R21MH075028] Funding Source: NIH RePORTER	A. P. Giannini Foundation Medical Research Fellowship; NARSAD(NARSAD); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); McDonnell Foundation; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Oldham for generating the Illumina microarray mask file; J. Ou and E. Spiteri for performing site-directed mutagenesis; L. Chen for technical assistance; and L. Kawaguchi for laboratory management. Human tissue was obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland (NICHD Contract numbers N01-HD-4-3368 and N01-HD-4-3383). The role of the NICHD Brain and Tissue Bank is to distribute tissue, and therefore cannot endorse the studies performed or the interpretation of results. This work was supported by grant R21MH075028, R37MH60233-06A1 (D. H. G.), T32HD007032, an A. P. Giannini Foundation Medical Research Fellowship, and a NARSAD Young Investigator Award (G. K.), T32MH073526 (K. W.) NIH/NCRR grant RR00165 and a James S. McDonnell Foundation grant, JSMF 21002093 (T. M. P).	Acampora D, 1999, DEVELOPMENT, V126, P3795; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; COPPOLA G, 2009, NATURE PROTOCOLS, DOI DOI 10.1038/NPROT.2009.215; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Konopka G, 2007, J BIOL CHEM, V282, P28137, DOI 10.1074/jbc.M703592200; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; Van Camp G, 2006, AM J HUM GENET, V79, P449, DOI 10.1086/506478; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang JZ, 2002, GENETICS, V162, P1825	31	265	273	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					213	U89		10.1038/nature08549	http://dx.doi.org/10.1038/nature08549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907493	Green Submitted, Green Accepted			2022-12-24	WOS:000271655100042
J	Ferwerda, B; Ferwerda, G; Plantinga, TS; Willment, JA; van Spriel, AB; Venselaar, H; Elbers, CC; Johnson, MD; Cambi, A; Huysamen, C; Jacobs, L; Jansen, T; Verheijen, K; Masthoff, L; Morre, SA; Vriend, G; Williams, DL; Perfect, JR; Joosten, LAB; Wijmenga, C; van der Meer, JWM; Adema, GJ; Kullberg, BJ; Brown, GD; Netea, MG				Ferwerda, Bart; Ferwerda, Gerben; Plantinga, Theo S.; Willment, Janet A.; van Spriel, Annemiek B.; Venselaar, Hanka; Elbers, Clara C.; Johnson, Melissa D.; Cambi, Alessandra; Huysamen, Cristal; Jacobs, Liesbeth; Jansen, Trees; Verheijen, Karlijn; Masthoff, Laury; Morre, Servaas A.; Vriend, Gert; Williams, David L.; Perfect, John R.; Joosten, Leo A. B.; Wijmenga, Cisca; van der Meer, Jos W. M.; Adema, Gosse J.; Kullberg, Bart Jan; Brown, Gordon D.; Netea, Mihai G.			Human Dectin-1 Deficiency and Mucocutaneous Fungal Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOLL-LIKE RECEPTORS; VAGINAL EPITHELIAL-CELLS; BETA-GLUCAN RECEPTOR; HYPER-IGE SYNDROME; CANDIDA-ALBICANS; HOST-DEFENSE; RECOGNITION; LECTIN; ASSOCIATION; INDUCTION	Mucocutaneous fungal infections are typically found in patients who have no known immune defects. We describe a family in which four women who were affected by either recurrent vulvovaginal candidiasis or onychomycosis had the early-stop-codon mutation Tyr238X in the beta-glucan receptor dectin-1. The mutated form of dectin-1 was poorly expressed, did not mediate beta-glucan binding, and led to defective production of cytokines (interleukin-17, tumor necrosis factor, and interleukin-6) after stimulation with beta-glucan or Candida albicans. In contrast, fungal phagocytosis and fungal killing were normal in the patients, explaining why dectin-1 deficiency was not associated with invasive fungal infections and highlighting the specific role of dectin-1 in human mucosal antifungal defense.	[Netea, Mihai G.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med 463, Nijmegen Inst Infect Inflammat & Immun, NL-6525 GA Nijmegen, Netherlands; [Ferwerda, Bart; Ferwerda, Gerben; Plantinga, Theo S.; Jacobs, Liesbeth; Jansen, Trees; Verheijen, Karlijn; Masthoff, Laury; Joosten, Leo A. B.; van der Meer, Jos W. M.; Kullberg, Bart Jan; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [van Spriel, Annemiek B.; Cambi, Alessandra; Adema, Gosse J.] Radboud Univ Nijmegen, Dept Tumor Immunol, NL-6525 GA Nijmegen, Netherlands; [Venselaar, Hanka; Vriend, Gert] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Elbers, Clara C.; Wijmenga, Cisca] Univ Med Ctr Utrecht, Div Biomed Genet, Dept Med Genet, Complex Genet Sect, Utrecht, Netherlands; [Elbers, Clara C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Morre, Servaas A.] Vrije Univ Amsterdam, Immunogenet Lab, Amsterdam, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Willment, Janet A.; Huysamen, Cristal; Brown, Gordon D.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Johnson, Melissa D.; Perfect, John R.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC USA; [Williams, David L.] E Tennessee State Univ, Dept Surg, Johnson City, TN 37614 USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; University of Groningen; University of Cape Town; Duke University; East Tennessee State University	Netea, MG (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med 463, Nijmegen Inst Infect Inflammat & Immun, Geert Grootepl 8, NL-6525 GA Nijmegen, Netherlands.	m.netea@aig.umcn.nl	Venselaar, Hanka/D-2009-2016; brown, gordon/B-4249-2012; van Spriel, Annemiek/O-1639-2013; Johnson, Melissa D/AAT-2078-2020; Kullberg, BJ/C-8520-2013; van der Meer, Jos W.M./C-8521-2013; van Spriel, Annemiek/Q-6044-2019; Ferwerda, J.G./L-4305-2015; Vriend, Gert/D-6730-2011; Vriend, G./H-8112-2014; Wijmenga, Cisca/AAE-7719-2019; Plantinga, Theo S./A-6895-2015; Netea, Mihai/N-5155-2014; Wijmenga, Cisca/D-2173-2009; Joosten, Leo AB/H-3138-2015; Adema, G.J./H-8007-2014; Cambi, Alessandra/L-4242-2015	Venselaar, Hanka/0000-0001-9824-6559; Johnson, Melissa D/0000-0002-6606-9460; Kullberg, BJ/0000-0002-6813-8167; van der Meer, Jos W.M./0000-0001-5120-3690; van Spriel, Annemiek/0000-0002-3590-2368; Wijmenga, Cisca/0000-0002-5635-1614; Plantinga, Theo S./0000-0003-4990-6084; Joosten, Leo AB/0000-0001-6166-9830; Cambi, Alessandra/0000-0003-1597-1582; brown, gordon/0000-0002-0287-5383; Willment, Janet/0000-0002-7040-0857; Ferwerda, Bart/0000-0002-7050-5931	Netherlands Organization for Scientific Research; Wellcome Trust [068545/Z/02]; Dutch Cancer Society [2007-3917]; U.K. Medical Research Council [G0000934]; Medical Research Council [G0000934] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI051537] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission); Dutch Cancer Society(KWF Kankerbestrijding); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the Netherlands Organization for Scientific Research (a Vidi Grant to Dr. Netea and Veni Grants to Drs. Cambi and van Spriel), the Wellcome Trust (to Dr. Brown), and the Dutch Cancer Society (2007-3917, to Dr. van Spriel). The use of genotypes from the British 1958 birth cohort collection was funded by grants from the U.K. Medical Research Council (G0000934) and the Wellcome Trust (068545/Z/02).	Babula O, 2005, CLIN INFECT DIS, V40, P1258, DOI 10.1086/429246; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barousse MM, 2001, J INFECT DIS, V184, P1489, DOI 10.1086/324532; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Scher RK, 2007, J AM ACAD DERMATOL, V56, P939, DOI 10.1016/j.jaad.2006.12.019; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Spellberg BJ, 2006, CLIN INFECT DIS, V42, P244, DOI 10.1086/499057; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vonk AG, 2002, J MICROBIOL METH, V49, P55, DOI 10.1016/S0167-7012(01)00348-7; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200	32	540	565	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1760	1767		10.1056/NEJMoa0901053	http://dx.doi.org/10.1056/NEJMoa0901053			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511RY	19864674	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000271185600008
J	Spencer, JR; Denk, T				Spencer, John R.; Denk, Tilmann			Formation of Iapetus' Extreme Albedo Dichotomy by Exogenically Triggered Thermal Ice Migration	SCIENCE			English	Article							GALILEAN SATELLITES; DARK SIDE; HIGH-RESOLUTION; SATURN SYSTEM; LAPETUS; PHOEBE; HYPERION; ORIGIN; DIONE; RHEA	The extreme albedo asymmetry of Saturn's moon Iapetus, which is about 10 times as bright on its trailing hemisphere as on its leading hemisphere, has been an enigma for three centuries. Deposition of exogenic dark material on the leading side has been proposed as a cause, but this alone cannot explain the global shape, sharpness, and complexity of the transition between Iapetus' bright and dark terrain. We demonstrate that all these characteristics, and the asymmetry's large amplitude, can be plausibly explained by runaway global thermal migration of water ice, triggered by the deposition of dark material on the leading hemisphere. This mechanism is unique to Iapetus among the saturnian satellites because its slow rotation produces unusually high daytime temperatures and water ice sublimation rates for a given albedo.	[Spencer, John R.] SW Res Inst, Boulder, CO 80304 USA; [Denk, Tilmann] Free Univ Berlin, D-12249 Berlin, Germany	Free University of Berlin	Spencer, JR (corresponding author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80304 USA.	spencer@boulder.swri.edu		Denk, Tilmann/0000-0003-0764-3677	Cassini project; NASA [NNX07AU40G, NNG04GK67G]; German Aerospace Center	Cassini project; NASA(National Aeronautics & Space Administration (NASA)); German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR))	We dedicate this paper to the late Steve Ostro, for his invaluable insights into the subsurface structure of Iapetus. We acknowledge the magnificent work by the Cassini project that made possible the observations presented here, and in particular the work of J. Pearl, M. Segura, and other members of the Cassini CIRS team. Supported by the Cassini project and by NASA grants NNX07AU40G and NNG04GK67G, and by the German Aerospace Center (DLR).	BELL JF, 1985, ICARUS, V61, P192, DOI 10.1016/0019-1035(85)90101-0; Black GJ, 2004, SCIENCE, V304, P553, DOI 10.1126/science.1096470; BRYSON CE, 1974, J CHEM ENG DATA, V19, P107, DOI 10.1021/je60061a021; BURATTI B, 1984, ICARUS, V58, P254, DOI 10.1016/0019-1035(84)90042-3; BURATTI BJ, 1995, ICARUS, V115, P219, DOI 10.1006/icar.1995.1093; BURATTI BJ, 1991, ICARUS, V90, P1, DOI 10.1016/0019-1035(91)90064-Z; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; Buratti BJ, 1998, ICARUS, V136, P223, DOI 10.1006/icar.1998.6026; Burns JA, 1996, ASTR SOC P, V104, P179; Cassini J.D., 1677, PHILOS T R SOC, V12, P831; COOK AF, 1970, ICARUS, V13, P282, DOI 10.1016/0019-1035(70)90057-6; Cruikshank DP, 2008, ICARUS, V193, P334, DOI 10.1016/j.icarus.2007.04.036; CRUIKSHANK DP, 1983, ICARUS, V53, P90, DOI 10.1016/0019-1035(83)90023-4; DENK T, 2009, SCIENCE, V10; DENK T, 2000, LUNAR PLANET SCI C, V31, P1660; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; GAULT DE, 1974, P LUNAR PLANET SCI C, V3, P2365; Hendrix AR, 2008, ICARUS, V193, P344, DOI 10.1016/j.icarus.2007.07.025; Howett CJA, 2010, ICARUS, V206, P573, DOI 10.1016/j.icarus.2009.07.016; Marchi S, 2002, ASTRON ASTROPHYS, V381, P1059, DOI 10.1051/0004-6361:20011587; MATTHEWS RAJ, 1992, Q J ROY ASTRON SOC, V33, P253; Mendis DA, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013532; MENDIS DA, 1974, ANNU REV EARTH PL SC, V2, P419, DOI 10.1146/annurev.ea.02.050174.002223; Moore JM, 1999, ICARUS, V140, P294, DOI 10.1006/icar.1999.6132; Morrison D., 1977, PLANETARY SATELLITES, P363; Ostro SJ, 2006, ICARUS, V183, P479, DOI 10.1016/j.icarus.2006.02.019; Owen TC, 2001, ICARUS, V149, P160, DOI 10.1006/icar.2000.6521; PETERSON C, 1975, ICARUS, V24, P499, DOI 10.1016/0019-1035(75)90069-X; Porco CC, 2005, SCIENCE, V307, P1237, DOI 10.1126/science.1107981; Prockter LM, 1998, ICARUS, V135, P317, DOI 10.1006/icar.1998.5981; PURVES NG, 1980, ICARUS, V43, P51, DOI 10.1016/0019-1035(80)90086-X; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; SOTER S, 1974, IAU C CORN U ITH NY, V28; SPENCER JR, 1987, ICARUS, V69, P297, DOI 10.1016/0019-1035(87)90107-2; SPENCER JR, 1989, ICARUS, V78, P337, DOI 10.1016/0019-1035(89)90182-6; SQUYRES SW, 1983, NATURE, V303, P782, DOI 10.1038/303782a0; TABAK RG, 1989, EARTH MOON PLANETS, V44, P251, DOI 10.1007/BF00054241; Wilson PD, 1996, ICARUS, V122, P92, DOI 10.1006/icar.1996.0111; [No title captured]	40	58	58	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					432	435		10.1126/science.1177132	http://dx.doi.org/10.1126/science.1177132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20007862				2022-12-24	WOS:000273783100028
J	Falconer, E; Chavez, EA; Henderson, A; Poon, SSS; McKinney, S; Brown, L; Huntsman, DG; Lansdorp, PM				Falconer, Ester; Chavez, Elizabeth A.; Henderson, Alexander; Poon, Steven S. S.; McKinney, Steven; Brown, Lindsay; Huntsman, David G.; Lansdorp, Peter M.			Identification of sister chromatids by DNA template strand sequences	NATURE			English	Article							ADENOMATOUS POLYPOSIS-COLI; IN-SITU HYBRIDIZATION; APC TUMOR-SUPPRESSOR; EMBRYONIC STEM-CELLS; SATELLITE DNA; SEGREGATION; CHROMOSOMES; CENTROSOME; PROTEIN; ORIENTATION	It is generally assumed that sister chromatids are genetically and functionally identical and that segregation to daughter cells is a random process. However, functional differences between sister chromatids regulate daughter cell fate in yeast(1) and sister chromatid segregation is not random in Escherichia coli(2). Differentiated sister chromatids, coupled with non-random segregation, have been proposed to regulate cell fate during the development of multicellular organisms(3). This hypothesis has not been tested because molecular features to reliably distinguish between sister chromatids are not obvious. Here we show that parental 'Watson' and 'Crick' DNA template strands can be identified in sister chromatids of murine metaphase chromosomes using CO-FISH(chromosome orientation fluorescence in situ hybridization(4)) with unidirectional probes specific for centromeric and telomeric repeats. All chromosomes were found to have a uniform orientation with the 5' end of the short arm on the same strand as T-rich major satellite repeats. The invariable orientation of repetitive DNA was used to differentially label sister chromatids and directly study mitotic segregation patterns in different cell types. Whereas sister chromatids appeared to be randomly distributed between daughter cells in cultured lung fibroblasts and embryonic stem cells, significant non-random sister chromatid segregation was observed in a subset of colon crypt epithelial cells, including cells outside positions reported for colon stem cells(5). Our results establish that DNA template sequences can be used to distinguish sister chromatids and follow their mitotic segregation in vivo.	[Falconer, Ester; Chavez, Elizabeth A.; Henderson, Alexander; Poon, Steven S. S.; Lansdorp, Peter M.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Poon, Steven S. S.; McKinney, Steven] British Columbia Canc Agcy, Mol Oncol & Breast Canc Program, Vancouver, BC V5Z 1L3, Canada; [Brown, Lindsay; Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V6H 3Z6, Canada; [Lansdorp, Peter M.] Univ British Columbia, Dept Med, Div Hematol, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia	Lansdorp, PM (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	plansdor@bccrc.ca	Huntsman, David/ABE-6082-2020	Lansdorp, Peter/0000-0001-7435-1071; Brown, Lindsay/0000-0002-2790-5112	Canadian Institutes of Health Research [RMF-92093]; Michael Smith Foundation for Health Research; Canadian Cancer Society Research Institute; Terry Fox Foundation; British Columbia Cancer Agency; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; British Columbia Cancer Foundation; Blossom Fund of the University of British Columbia; Mahon family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094146] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; British Columbia Cancer Agency; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; British Columbia Cancer Foundation; Blossom Fund of the University of British Columbia; Mahon family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K. Lisaingo helped acquire images for this study, J. Tan helped with image analysis and C. J. S. Smith assisted with in vivo studies. We thank S. Selig, T. de Lange and R. C. Wang for help with CO-FISH protocols. S. Aparicio, L. Lefebvre, L. F. Lansdorp, B. M. Lansdorp and members of the Lansdorp laboratory are thanked for discussions and for critically reading the manuscript. This study was funded in part by grants from the Canadian Institutes of Health Research (RMF-92093), the Michael Smith Foundation for Health Research, the Canadian Cancer Society Research Institute and the Terry Fox Foundation. We are grateful to the British Columbia Cancer Agency, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the British Columbia Cancer Foundation, the Blossom Fund of the University of British Columbia and the Mahon family for funding the infrastructure that enabled this work.	ALLEN JW, 1976, NATURE, V260, P449, DOI 10.1038/260449a0; ALVES P, 1978, J CELL SCI, V32, P185; Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; Bailey SM, 2004, CYTOGENET GENOME RES, V107, P14, DOI 10.1159/000079565; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bell CD, 2005, HISTOL HISTOPATHOL, V20, P1313, DOI 10.14670/HH-20.1313; Bouck DC, 2007, CURR BIOL, V17, P741, DOI 10.1016/j.cub.2007.03.033; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Garagna S, 2001, P NATL ACAD SCI USA, V98, P171, DOI 10.1073/pnas.98.1.171; Gertsenstein M, 2002, Methods Mol Biol, V185, P285; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P683, DOI 10.1093/nar/9.3.683; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; JOHNSON GD, 1982, J IMMUNOL METHODS, V55, P231, DOI 10.1016/0022-1759(82)90035-7; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Karpowicz P, 2009, EUR J CELL BIOL, V88, P397, DOI 10.1016/j.ejcb.2009.03.001; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; KLAR AJS, 1987, NATURE, V326, P466, DOI 10.1038/326466a0; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lew DJ, 2008, CELL, V133, P21, DOI 10.1016/j.cell.2008.03.016; LIN MS, 1974, SCIENCE, V185, P1179, DOI 10.1126/science.185.4157.1179; Luo S, 2003, P NATL ACAD SCI USA, V100, P11133, DOI 10.1073/pnas.1831011100; Meyne J, 1994, Methods Mol Biol, V33, P141; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; RUDERT F, 1995, MAMM GENOME, V6, P76, DOI 10.1007/BF00303248; SCHNEIDER EL, 1977, P NATL ACAD SCI USA, V74, P2041, DOI 10.1073/pnas.74.5.2041; Thorpe PH, 2009, P NATL ACAD SCI USA, V106, P6673, DOI 10.1073/pnas.0811248106; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; White MA, 2008, NATURE, V455, P1248, DOI 10.1038/nature07282; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	35	74	76	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					93	U103		10.1038/nature08644	http://dx.doi.org/10.1038/nature08644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20016487	Green Accepted			2022-12-24	WOS:000273344900037
J	Routes, JM; Grossman, WJ; Verbsky, J; Laessig, RH; Hoffman, GL; Brokopp, CD; Baker, MW				Routes, John M.; Grossman, William J.; Verbsky, James; Laessig, Ronald H.; Hoffman, Gary L.; Brokopp, Charles D.; Baker, Mei W.			Statewide Newborn Screening for Severe T-Cell Lymphopenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; RAC2; MUTATION; GTPASE	Context A newborn blood screening (NBS) test that could identify infants with a profound deficiency of T cells may result in a reduction in mortality. Objective To determine if quantitating T-cell receptor excision circles (TRECs) using real-time quantitative polymerase chain reaction on DNA extracted from dried blood spots on NBS cards can detect infants with T-cell lymphopenia in a statewide program. Design, Setting, and Participants Between January 1 and December 31, 2008, the Wisconsin State Laboratory of Hygiene screened all infants born in Wisconsin for T-cell lymphopenia by quantitating the number of TRECs contained in a 3.2-mm punch (approximately 3 mu L of whole blood) of the NBS card. Flow cytometry to enumerate the number of T cells was performed on full-term infants and preterm infants when they reached the equivalent of at least 37 weeks' gestation with TREC values of less than 25/mu L. Infants with T-cell lymphopenia were evaluated by a clinical immunologist. Main Outcome Measures The number of infants with TREC values of less than 25/mu L with T-cell lymphopenia confirmed by flow cytometry. Results Exactly 71 000 infants were screened by the TREC assay. Seventeen infants aged at least 37 weeks' gestation had at least 1 abnormal TREC assay (TREC values <25/mu L), 11 of whom had samples analyzed by flow cytometry to enumerate T cells. Eight infants demonstrated T-cell lymphopenia. The causes of the T-cell lymphopenia included DiGeorge syndrome (n=2), idiopathic T-cell lymphopenia (n=2), extravascular extravasation of lymphocytes (n=3), and a Rac2 mutation (n=1). The infant with the Rac2 mutation underwent successful cord blood transplantation. Conclusion In a statewide screening program, use of the TREC assay performed on NBS cards was able to identify infants with T-cell lymphopenia. JAMA. 2009; 302(22): 2465-2470	[Routes, John M.; Grossman, William J.; Verbsky, James] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Routes, John M.; Grossman, William J.; Verbsky, James] Childrens Res Inst, Milwaukee, WI USA; [Laessig, Ronald H.; Hoffman, Gary L.; Brokopp, Charles D.; Baker, Mei W.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin State Lab Hyg, Madison, WI 53706 USA; [Laessig, Ronald H.; Brokopp, Charles D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53706 USA; [Baker, Mei W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA	Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Routes, JM (corresponding author), Med Coll Wisconsin, Dept Pediat, 9000 W Wisconsin Ave, Milwaukee, WI 53226 USA.	jroutes@mcw.edu	Routes, john/AAA-4833-2021	Routes, john/0000-0001-8378-3773	Children's Hospital of Wisconsin; Jeffrey Modell Foundation; Wisconsin State Laboratory of Hygiene; Centers for Disease Control and Prevention [U01 EH000365]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000365] Funding Source: NIH RePORTER	Children's Hospital of Wisconsin; Jeffrey Modell Foundation; Wisconsin State Laboratory of Hygiene; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by funding from the Children's Hospital of Wisconsin, the Jeffrey Modell Foundation, the Wisconsin State Laboratory of Hygiene, and the Centers for Disease Control and Prevention (grant U01 EH000365).	Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; [Anonymous], 2006, GENET MED S1, V8, p1S; Baker MW, 2009, J ALLERGY CLIN IMMUN, V124, P522, DOI 10.1016/j.jaci.2009.04.007; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Gu Y, 2001, J BIOL CHEM, V276, P15929, DOI 10.1074/jbc.M010445200; McGhee SA, 2005, J PEDIATR-US, V147, P603, DOI 10.1016/j.jpeds.2005.06.001; Morinishi Y, 2009, J PEDIATR-US, V155, P829, DOI 10.1016/j.jpeds.2009.05.026; Puck JM, 2007, J ALLERGY CLIN IMMUN, V120, P760, DOI 10.1016/j.jaci.2007.08.043; Verschuren MCM, 1997, J IMMUNOL, V158, P1208; Werther RL, 2009, J ALLERGY CLIN IMMUN, V124, P600, DOI 10.1016/j.jaci.2009.07.005; Williams DA, 2000, BLOOD, V96, P1646	13	145	152	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2465	2470		10.1001/jama.2009.1806	http://dx.doi.org/10.1001/jama.2009.1806			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996402	Bronze			2022-12-24	WOS:000272520500026
J	Tsai, TT; Maddox, TM; Roe, MT; Dai, D; Alexander, KP; Ho, PM; Messenger, JC; Nallamothu, BK; Peterson, ED; Rumsfeld, JS				Tsai, Thomas T.; Maddox, Thomas M.; Roe, Matthew T.; Dai, David; Alexander, Karen P.; Ho, P. Michael; Messenger, John C.; Nallamothu, Brahmajee K.; Peterson, Eric D.; Rumsfeld, John S.		Natl Cardiovasc Data Registry	Contraindicated Medication Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; DRUG-RELATED PROBLEMS; RENAL-INSUFFICIENCY; ENOXAPARIN; ANTICOAGULATION; REGISTRY	Context The US Food and Drug Administration guides clinicians through drug labeling of medications that are contraindicated or not recommended for use in specific patient groups. Little is known about the use of such medications and their effects on outcomes in clinical practice. Objective To investigate the use of the contraindicated/not-recommended agents enoxaparin and eptifibatide among dialysis patients undergoing percutaneous coronary intervention (PCI) and their association with outcomes. Design, Setting, and Participants Data from 829 US hospitals on 22 778 dialysis patients who underwent PCI between January 1, 2004, and August 31, 2008. Main Outcome Measures In-hospital bleeding and death. Results Five thousand eighty-four patients (22.3%) received a contraindicated antithrombotic; of these patients, 2375 (46.7%) received enoxaparin, 3261 (64.1%) received eptifibatide, and 552 (10.9%) received both. Compared with patients who did not receive a contraindicated antithrombotic, patients who did had higher rates of in-hospital bleeding (5.6% vs 2.9%; odds ratio [OR], 1.93; 95% confidence interval [CI], 1.66-2.23) and death (6.5% vs 3.9%; OR, 1.68; 95% CI, 1.46-1.95). After multivariable adjustment, patients receiving contraindicated antithrombotics had significantly higher risks of in-hospital bleeding (OR, 1.66; 95% CI, 1.43-1.92) and death (OR, 1.24; 95% CI, 1.04-1.48). In 10 158 patients matched by propensity scores, receipt of contraindicated antithrombotics remained significantly associated with in-hospital bleeding (OR, 1.63; 95% CI, 1.35-1.98) but not in-hospital death (OR, 1.15; 95% CI, 0.97-1.36). Conclusions In a sample of dialysis patients undergoing PCI, 22.3% received a contraindicated antithrombotic medication. In propensity-matched analysis, receipt of these medications was significantly associated with an increased risk of in-hospital major bleeding. JAMA. 2009; 302(22): 2458-2464	[Tsai, Thomas T.] Denver VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA; [Tsai, Thomas T.; Maddox, Thomas M.; Ho, P. Michael; Messenger, John C.; Rumsfeld, John S.] Univ Colorado, Denver, CO USA; [Tsai, Thomas T.; Maddox, Thomas M.; Ho, P. Michael; Rumsfeld, John S.] Colorado Cardiovasc Outcomes Res Grp, Denver, CO USA; [Roe, Matthew T.; Dai, David; Alexander, Karen P.; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Nallamothu, Brahmajee K.] Univ Michigan Hosp, Ann Arbor VA Med Ctr, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Denver; Duke University; University of Michigan System; University of Michigan	Tsai, TT (corresponding author), Denver VA Med Ctr, Cardiol Sect 111B, 1055 Clermont St, Denver, CO 80220 USA.	thomas.tsai@va.gov	Peterson, Eric David/ABF-5033-2021		NCDR CathPCI Registry; VA Health Services Research and Development Service (HSR&D) Career Development Award	NCDR CathPCI Registry; VA Health Services Research and Development Service (HSR&D) Career Development Award	This analysis was funded by the NCDR CathPCI Registry, which oversees the collection and management of data in the registry. Dr Ho is supported by a VA Health Services Research and Development Service (HSR&D) Career Development Award.	ANDERSON RJ, 1982, ARCH INTERN MED, V142, P1305, DOI 10.1001/archinte.142.7.1305; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Busby LT, 2001, AM J HEMATOL, V67, P54, DOI 10.1002/ajh.1077; Ebbesen J, 2001, ARCH INTERN MED, V161, P2317, DOI 10.1001/archinte.161.19.2317; Gerlach AT, 2000, PHARMACOTHERAPY, V20, P771, DOI 10.1592/phco.20.9.771.35210; Gurm HS, 2008, J AM COLL CARDIOL, V51, P529, DOI 10.1016/j.jacc.2007.09.053; KAPLAN B, 1994, ANN PHARMACOTHER, V28, P320, DOI 10.1177/106002809402800304; KAPLAN B, 1994, ANN PHARMACOTHER, V28, P316, DOI 10.1177/106002809402800303; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Long CL, 2004, ANN PHARMACOTHER, V38, P853, DOI 10.1345/aph.1D399; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Manley Harold J, 2003, BMC Nephrol, V4, P10, DOI 10.1186/1471-2369-4-10; Manley HJ, 2003, AM J KIDNEY DIS, V41, P386, DOI 10.1053/ajkd.2003.50048; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Shaw RE, 2002, J AM COLL CARDIOL, V39, P1104, DOI 10.1016/S0735-1097(02)01731-X; Thorevska N, 2004, CHEST, V125, P856, DOI 10.1378/chest.125.3.856; Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459	18	60	60	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2458	2464		10.1001/jama.2009.1800	http://dx.doi.org/10.1001/jama.2009.1800			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996401	Bronze			2022-12-24	WOS:000272520500025
J	Glynn, SE; Martin, A; Nager, AR; Baker, TA; Sauer, RT				Glynn, Steven E.; Martin, Andreas; Nager, Andrew R.; Baker, Tania A.; Sauer, Robert T.			Structures of Asymmetric ClpX Hexamers Reveal Nucleotide-Dependent Motions in a AAA plus Protein-Unfolding Machine	CELL			English	Article							ZINC-BINDING DOMAIN; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGE; SUBSTRATE-BINDING; PORE LOOPS; ATP; TRANSLOCATION; MECHANISM; CHAPERONE; RECOGNITION	ClpX is a AAA+ machine that uses the energy of ATP binding and hydrolysis to unfold native proteins and translocate unfolded polypeptides into the ClpP peptidase. The crystal structures presented here reveal striking asymmetry in ring hexamers of nucleotide-free and nucleotide-bound ClpX. Asymmetry arises from large changes in rotation between the large and small AAA+ domains of individual subunits. These differences prevent nucleotide binding to two subunits, generate a staggered arrangement of ClpX subunits and pore loops around the hexameric ring, and provide a mechanism for coupling conformational changes caused by ATP binding or hydrolysis in one subunit to flexing motions of the entire ring. Our structures explain numerous solution studies of ClpX function, predict mechanisms for pore elasticity during translocation of irregular polypeptides, and suggest how repetitive conformational changes might be coupled to mechanical work during the ATPase cycle of ClpX and related molecular machines.	[Glynn, Steven E.; Martin, Andreas; Nager, Andrew R.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Martin, Andreas/0000-0003-0923-3284; Sauer, Robert/0000-0002-1719-5399; Glynn, Steven/0000-0001-6247-8913	National Institutes of Health (NIH) [AI-15706]; NIH National Center for Research Resources [RR-15301]; Department of Energy Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015706, R37AI015706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Grant, S. Harrison, D. Jerulzami, L. Joshua-Tor, H. Saibil, T. Schwartz, J. Whittle, and the staff at the 24-ID-C NE-CAT beamline of the Advanced Photon Source, Argonne National Laboratories for help and discussions. This work was supported by National Institutes of Health (NIH) grant AI-15706. T. A. B. is an employee of the Howard Hughes Medical Institute. Studies using the NE-CAT beamline were supported by award RR-15301 from NIH National Center for Research Resources and by the Department of Energy Office of Basic Energy Sciences under contract W-31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; DeLano W, 2002, PYMOL 0 99; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Donaldson LW, 2003, J BIOL CHEM, V278, P48991, DOI 10.1074/jbc.M307826200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Farrell CM, 2007, MOL CELL, V25, P161, DOI 10.1016/j.molcel.2006.11.018; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Joshi SA, 2003, MOL MICROBIOL, V48, P67, DOI 10.1046/j.1365-2958.2003.03424.x; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon AR, 2003, J MOL BIOL, V330, P185, DOI 10.1016/S0022-2836(03)00580-1; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park EY, 2007, J MOL BIOL, V367, P514, DOI 10.1016/j.jmb.2007.01.003; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070	53	205	207	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					744	756		10.1016/j.cell.2009.09.034	http://dx.doi.org/10.1016/j.cell.2009.09.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914167	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000271747200018
J	Tushir, JS; Zamore, PD; Zhang, Z				Tushir, Jogender S.; Zamore, Phillip D.; Zhang, Zhao			SnapShot: Fly piRNAs, PIWI Proteins, and the Ping-Pong Cycle	CELL			English	Editorial Material							DROSOPHILA; GERMLINE; ELEMENTS		[Tushir, Jogender S.] Univ Massachusetts, Sch Med, HHMI, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tushir, JS (corresponding author), Univ Massachusetts, Sch Med, HHMI, Worcester, MA 01605 USA.		Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BRENNECKE J, 2007, DROSOPHILA CELL, V128, P1089; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lim AK, 2009, J CELL BIOL, V186, P333, DOI 10.1083/jcb.200904063; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	10	13	14	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 30	2009	139	3					634	U196	634.e1	10.1016/j.cell.2009.10.021	http://dx.doi.org/10.1016/j.cell.2009.10.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879848	Bronze			2022-12-24	WOS:000271259600026
J	Gill, M; Stott, R				Gill, Mike; Stott, Robin			Health professionals must act to tackle climate change	LANCET			English	Editorial Material									[Gill, Mike] Univ Surrey, Fac Med & Hlth Sci, Surrey, England	University of Surrey		stott@dircon.co.uk						*CHATH HOUS, 2009, POL CLIM CHANG AGREE; Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; *DEP EN CLIM CHANG, 2009, ROAD COP UK GOV CAS; *GLOB HUM FOR, 2009, HUM IMP REP AN SIL C; Global Commons Institute, CONTR CONV GLOB SOL; Haines A, 2009, LANCET, V374, P2035, DOI 10.1016/S0140-6736(09)61667-6; McMichael A.J., 1996, CLIMATE CHANGE HUMAN; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ	8	19	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1953	1955		10.1016/S0140-6736(09)61830-4	http://dx.doi.org/10.1016/S0140-6736(09)61830-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	19942275				2022-12-24	WOS:000272727000008
J	Purdy, D; Leedham, W				Purdy, Debbie; Leedham, Wendy			A Patient's Journey Multiple sclerosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Leedham, Wendy] Farrow Med Ctr, Bradford BD3 0HX, W Yorkshire, England			debbie.purdy@btinternet.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2009	339								b4470	10.1136/bmj.b4470	http://dx.doi.org/10.1136/bmj.b4470			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AW	19942666				2022-12-24	WOS:000272186500011
J	Bodmer, M; Brauchli, YB; Krahenbuhl, S; Jick, SS; Meier, CR				Bodmer, Michael; Brauchli, Yolanda B.; Krahenbuhl, Stephan; Jick, Susan S.; Meier, Christoph R.			Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATIC CHOLESTEROL-METABOLISM; GALLBLADDER-DISEASE; PHYSICAL-ACTIVITY; LIPID-COMPOSITION; BILE COMPOSITION; SIMVASTATIN; PRAVASTATIN; ASSOCIATION; CONSUMPTION; DISSOLUTION	Context Gallstone disease is a leading cause of morbidity in western countries and carries a high economic burden. Statins decrease hepatic cholesterol biosynthesis and may therefore lower the risk of cholesterol gallstones by reducing the cholesterol concentration in the bile. Data on this association in humans are scarce. Objective To study the association between the use of statins, fibrates, or other lipid-lowering agents and the risk of incident gallstone disease followed by cholecystectomy. Design, Setting, and Participants Case-control analysis using the UK-based General Practice Research Database. Incident patients between 1994 and 2008 and 4 controls per each patient were identified and matched on age, sex, general practice, calendar time, and years of history in the database. The study population was 76% women and the mean (SD) age was 53.4 (15.0) years at the index date. Conditional logistic regression was used to estimate the odds ratio (OR) of developing gallstones followed by cholecystectomy in relation to exposure to lipid-lowering agents, stratified by exposure timing and duration. The ORs and 95% confidence intervals (CIs) were adjusted for smoking, body mass index, ischemic heart disease, stroke, and estrogen use. Main Outcome Measure The adjusted OR (AOR) for developing gallstone disease followed by cholecystectomy in relation to exposure to lipid-lowering agents. Results A total of 27 035 patients with cholecystectomy and 106 531 matched controls were identified, including 2396 patients and 8868 controls who had statin use. Compared with nonuse, current statin use (last prescription recorded within 90 days before the first-time diagnosis of the disease) was 1.0% for patients and 0.8% for controls (AOR, 1.10; 95% CI, 0.95-1.27) for 1 to 4 prescriptions; 2.6% vs 2.4% (AOR, 0.85; 95% CI, 0.77-0.93) for 5 to 19 prescriptions, and 3.2% vs 3.7% (AOR, 0.64; 95% CI, 0.59-0.70) for 20 or more prescriptions. The AORs for current use of statins defined as 20 or more prescriptions were similar (around 0.6) across age, sex, and body mass index categories, and across the statin class. Conclusion Long-term use of statins was associated with a decreased risk of gallstones followed by cholecystectomy. JAMA. 2009; 302(18): 2001-2007	[Meier, Christoph R.] Univ Basel Hosp, Hosp Pharm, Basel Pharmacoepidemiol Unit, CH-4031 Basel, Switzerland; [Bodmer, Michael; Krahenbuhl, Stephan] Univ Basel Hosp, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland; [Brauchli, Yolanda B.; Meier, Christoph R.] Univ Basel, Dept Pharmaceut Sci, Div Clin Pharm & Epidemiol, Basel Pharmacoepidemiol Unit, Basel, Switzerland; [Jick, Susan S.; Meier, Christoph R.] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA USA	University of Basel; University of Basel; University of Basel; Boston University	Meier, CR (corresponding author), Univ Basel Hosp, Hosp Pharm, Basel Pharmacoepidemiol Unit, Spitalstr 26, CH-4031 Basel, Switzerland.	meierch@uhbs.ch	Bodmer, Michael/K-1873-2013; Bodmer, Michael/F-3178-2012; Krähenbühl, Stephan/Z-4744-2019	Jick, Susan/0000-0002-2215-1067	AstraZeneca	AstraZeneca(AstraZeneca)	The Division of Clinical Pharmacology and Toxicology, University Hospital Basel (Drs Bodmer and Krahenbuhl), Basel Pharmacoepidemiology Unit, University of Basel (Drs Brauchli and Meier), and the Boston Collaborative Drug Surveillance Program (Drs Jick and Meier) reported having a research collaboration with various companies in the pharmaceutical industry. Regarding drug companies producing and selling statins, the Basel Pharmacoepidemiology Unit as well as the Boston Collaborative Drug Surveillance Program had or currently have a research collaboration with AstraZeneca and Novartis. The Division of Clinical Pharmacology and Toxicology at the University Hospital Basel currently receives an unconditional grant from AstraZeneca. All of these funded research collaborations are unrelated to this article. We have conducted numerous studies using the UK-based General Practice Research Database in the past, and we are presently working on several projects. Some, but not all of the studies are industry-sponsored. This particular study was not funded. Our group has been conducting research for the pharmaceutical industry for many years, and these collaborations involve numerous companies including Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, and Merck Sharp & Dohme. Drs Brauchli, Jick, and Meier reported conducting research related to psoriasis in the past for MerckSerono, Switzerland. Additional Information: The eFigure and eTables 1 through 7 are available at http://www.jama.com.	Abedin MZ, 2002, DIGEST DIS SCI, V47, P2192, DOI 10.1023/A:1020174908650; Caroli-Bosc FX, 2001, DIGEST DIS SCI, V46, P540, DOI 10.1023/A:1005643014395; Chapman BA, 1998, DIGEST DIS SCI, V43, P349, DOI 10.1023/A:1018862507469; Davidson MH, 2007, AM J CARDIOL, V99, p3C, DOI 10.1016/j.amjcard.2006.11.016; Davis KG, 2003, OBES SURG, V13, P865, DOI 10.1381/096089203322618678; Filion KB, 2007, PHARMACOEPIDEM DR S, V16, P1, DOI 10.1002/pds.1314; Fruchart JC, 1998, AM J CARDIOL, V81, P912; Gonzalez-Perez A, 2007, PHARMACOEPIDEM DR S, V16, P524, DOI 10.1002/pds.1346; Jick H, 1997, LANCET, V350, P1045, DOI 10.1016/S0140-6736(05)70451-7; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Kallien G, 1999, HEPATOLOGY, V30, P14, DOI 10.1002/hep.510300119; Lammert F, 2008, J HEPATOL, V48, pS124, DOI 10.1016/j.jhep.2008.01.012; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Leitzmann MF, 2005, ARCH INTERN MED, V165, P567, DOI 10.1001/archinte.165.5.567; Leitzmann MF, 1999, JAMA-J AM MED ASSOC, V281, P2106, DOI 10.1001/jama.281.22.2106; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Marschall HU, 2007, J INTERN MED, V261, P529, DOI 10.1111/j.1365-2796.2007.01783.x; Miettinen TE, 1998, HEPATOLOGY, V27, P649, DOI 10.1002/hep.510270302; Pagliarulo M, 2004, DIGEST LIVER DIS, V36, P130, DOI 10.1016/j.dld.2003.10.007; PETITTI DB, 1981, NEW ENGL J MED, V304, P1396, DOI 10.1056/NEJM198106043042305; Porsch-Ozcurumez M, 2001, EUR J CLIN PHARMACOL, V56, P873, DOI 10.1007/s002280000254; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Post SM, 2001, ARTERIOSCL THROM VAS, V21, P1840, DOI 10.1161/hq1101.098228; Reid FDA, 2002, HEART, V88, P15, DOI 10.1136/heart.88.1.15; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Sharma BC, 1997, J CLIN GASTROENTEROL, V25, P433, DOI 10.1097/00004836-199709000-00007; SMIT JWA, 1995, HEPATOLOGY, V21, P1523; Smith JL, 2000, J GASTROEN HEPATOL, V15, P871, DOI 10.1046/j.1440-1746.2000.02231.x; STAHLBERG D, 1995, HEPATOLOGY, V21, P1025, DOI 10.1016/0270-9139(95)90250-3; Sun H, 2009, WORLD J GASTROENTERO, V15, P1886, DOI 10.3748/wjg.15.1886; SYLWESTROWICZ TA, 1988, GASTROENTEROLOGY, V95, P740, DOI 10.1016/S0016-5085(88)80023-4; THIJS C, 1990, GASTROENTEROLOGY, V99, P843, DOI 10.1016/0016-5085(90)90978-A; Tsai CJ, 2006, AM J MED, V119, P760, DOI 10.1016/j.amjmed.2006.02.040; Tsai CJ, 2009, GASTROENTEROLOGY, V136, P1593, DOI 10.1053/j.gastro.2009.01.042; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; WILSON IR, 1994, J GASTROEN HEPATOL, V9, P447, DOI 10.1111/j.1440-1746.1994.tb01272.x; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004	40	79	82	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					2001	2007		10.1001/jama.2009.1601	http://dx.doi.org/10.1001/jama.2009.1601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903921				2022-12-24	WOS:000271619700027
J	Wolan, DW; Zorn, JA; Gray, DC; Wells, JA				Wolan, Dennis W.; Zorn, Julie A.; Gray, Daniel C.; Wells, James A.			Small-Molecule Activators of a Proenzyme	SCIENCE			English	Article							IN-VITRO; CASPASE ACTIVATION; CYSTEINE PROTEASE; ALLOSTERIC SITE; APOPTOSIS; INHIBITION; MECHANISMS; INDUCTION; DOMAIN; DEATH	Virtually all of the 560 human proteases are stored as inactive proenyzmes and are strictly regulated. We report the identification and characterization of the first small molecules that directly activate proenzymes, the apoptotic procaspases-3 and -6. It is surprising that these compounds induce autoproteolytic activation by stabilizing a conformation that is both more active and more susceptible to intermolecular proteolysis. These procaspase activators bypass the normal upstream proapoptotic signaling cascades and induce rapid apoptosis in a variety of cell lines. Systematic biochemical and biophysical analyses identified a cluster of mutations in procaspase-3 that resist small-molecule activation both in vitro and in cells. Compounds that induce gain of function are rare, and the activators reported here will enable direct control of the executioner caspases in apoptosis and in cellular differentiation. More generally, these studies presage the discovery of other proenzyme activators to explore fundamental processes of proenzyme activation and their fate-determining roles in biology.	[Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Byers Hall,1700 4th St, San Francisco, CA 94158 USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016	Wolan, Dennis/0000-0001-9879-8353	National Institutes of Health [R21 N5057022, R01 CA136779]; National Cancer Institute Postdoctoral Fellowship [F32 CA119641-03]; UC Cancer Research Committee Fellowship; Hartwell Foundation; NATIONAL CANCER INSTITUTE [F32CA119641, R01CA136779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Postdoctoral Fellowship; UC Cancer Research Committee Fellowship; Hartwell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Williams, B. Wolff and the University of California, San Francisco (UCSF) Small Molecule Discovery Center for assistance in the HTS of procaspase-3 activators; S. Mahrus, H. Yoshihara, A. Renslo, M. Burlingame, and J. Sadowsky for critical suggestions; I. Wilson, J. Taunton, and Z. Gartner for critical reading of the manuscript, J. Gao for procaspase-1; J. Gray for cell lines; and C. Craik and D. Hostetter for granzyme B. This research was supported by grants from the National Institutes of Health (R21 N5057022, R01 CA136779), National Cancer Institute Postdoctoral Fellowship (F32 CA119641-03) ( to D. W. W.), UC Cancer Research Committee Fellowship ( to D. C. G.) and the Hartwell Foundation.	Abdul-Ghani M, 2008, CELL STEM CELL, V2, P515, DOI 10.1016/j.stem.2008.05.013; ASBOTH B, 1985, BIOCHEMISTRY-US, V24, P606, DOI 10.1021/bi00324a010; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Blanc C, 2000, CANCER RES, V60, P4386; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Denault JB, 2007, NAT CHEM BIOL, V3, P519, DOI 10.1038/nchembio0907-519; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; PORTER AG, 2007, NAT CHEM BIOL, V3, P520; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Rominger CM, 2007, ARCH BIOCHEM BIOPHYS, V464, P130, DOI 10.1016/j.abb.2007.04.004; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; STACK MS, 1993, J BIOL CHEM, V268, P18924; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; WALKER PR, 1991, CANCER RES, V51, P1078; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012	32	127	134	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					853	858		10.1126/science.1177585	http://dx.doi.org/10.1126/science.1177585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	515KG	19892984	Green Accepted			2022-12-24	WOS:000271468000044
J	Robinson, D				Robinson, David			Christmas 2009: Afterlife From flower graves to breast clinics	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London SE1 3QD, England	University of London; King's College London	Robinson, D (corresponding author), Kings Coll London, London SE1 3QD, England.	dave.robinson@kcl.ac.uk						BOSELEY S, 2009, GUARDIAN        0322; CAO XQ, 1986, STORY STONE CHINESE; DEBRUXELLES S, 2005, TIMES           1027; Tsao Hsueh-Chin, 1978, DREAM RED MANSIONS; Twine C, 2006, BREAST, V15, P667, DOI 10.1016/j.breast.2006.03.006; 2007, TODAY MORNING E 0519	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2009	339								b4932	10.1136/bmj.b4932	http://dx.doi.org/10.1136/bmj.b4932			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XF	20008440				2022-12-24	WOS:000272930100001
J	Zarzeczny, A; Scott, C; Hyun, I; Bennett, J; Chandler, J; Charge, S; Heine, H; Isasi, R; Kato, K; Lovell-Badge, R; McNagny, K; Pei, DQ; Rossant, J; Surani, A; Taylor, PL; Ogbogu, U; Caulfield, T				Zarzeczny, Amy; Scott, Christopher; Hyun, Insoo; Bennett, Jami; Chandler, Jennifer; Charge, Sophie; Heine, Heather; Isasi, Rosario; Kato, Kazuto; Lovell-Badge, Robin; McNagny, Kelly; Pei, Duanqing; Rossant, Janet; Surani, Azim; Taylor, Patrick L.; Ogbogu, Ubaka; Caulfield, Timothy			iPS Cells: Mapping the Policy Issues	CELL			English	Editorial Material							STEM-CELLS; INTELLECTUAL PROPERTY; INFORMED-CONSENT; ETHICS	Given the explosion of research on induced pluripotent stem (iPS) cells, it is timely to consider the various ethical, legal, and social issues engaged by this fast-moving field. Here, we review issues associated with the procurement, basic research, and clinical translation of iPS cells.	[Caulfield, Timothy] Univ Alberta, Fac Law, Edmonton, AB T6G 2H5, Canada; [Caulfield, Timothy] Univ Alberta, Sch Publ Hlth, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Scott, Christopher] Stanford Univ, Ctr Biomed Eth, Stanford, CA 94305 USA; [Hyun, Insoo] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; [Bennett, Jami; McNagny, Kelly] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Chandler, Jennifer] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [Charge, Sophie] Stem Cell Network, Ottawa, ON K1H 8L6, Canada; [Isasi, Rosario] McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 1A4, Canada; [Kato, Kazuto] Kyoto Univ, Inst Res Humanities, Grad Sch Biostudies, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan; [Lovell-Badge, Robin] Natl Inst Med Res, London NW7 1AA, England; [Pei, Duanqing] Guangzhou Inst Biomed, Guangzhou 510663, Guangdong, Peoples R China; [Pei, Duanqing] Guangzhou Inst Hlth, Guangzhou 510663, Guangdong, Peoples R China; [Rossant, Janet] Hosp Sick Children, Toronto, ON M5G 2L3, Canada; [Surani, Azim] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Taylor, Patrick L.] Childrens Hosp Boston, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ogbogu, Ubaka] Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada	University of Alberta; University of Alberta; Stanford University; Case Western Reserve University; University of British Columbia; University of Ottawa; McGill University; Kyoto University; MRC National Institute for Medical Research; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge; Harvard University; Boston Children's Hospital; University of Toronto	Caulfield, T (corresponding author), Univ Alberta, Fac Law, Edmonton, AB T6G 2H5, Canada.	tcaulfld@law.ualberta.ca	McNagny, Kelly/P-5239-2014	McNagny, Kelly/0000-0003-4737-3499; Ogbogu, Ubaka/0000-0001-7764-6799; Surani, Azim/0000-0002-8640-4318; Kato, Kazuto/0000-0001-9006-9551; Lovell-Badge, Robin/0000-0001-9364-4179	MRC [G0800784, MC_U117562207] Funding Source: UKRI; Medical Research Council [G0800784, MC_U117562207] Funding Source: Medline; Medical Research Council [G0800784B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aalto-Setala K, 2009, PLOS BIOL, V7, P204, DOI 10.1371/journal.pbio.1000042; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Caulfield T, 2008, REGEN MED, V3, P483, DOI 10.2217/17460751.3.4.483; Caulfield T, 2007, CAN MED ASSOC J, V176, P1722, DOI 10.1503/cmaj.061675; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Isasi RM, 2006, EUR J HEALTH LAW, V13, P9, DOI 10.1163/157180906777036328; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Loring JF, 2006, SCIENCE, V311, P1716, DOI 10.1126/science.1120953; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Mascalzoni D, 2008, PLOS MED, V5, P1302, DOI 10.1371/journal.pmed.0050192; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Sugarman J, 2008, CELL STEM CELL, V2, P529, DOI 10.1016/j.stem.2008.05.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vrtovec KT, 2008, NAT BIOTECHNOL, V26, P393, DOI 10.1038/nbt0408-393; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935	15	56	57	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1032	1037		10.1016/j.cell.2009.11.039	http://dx.doi.org/10.1016/j.cell.2009.11.039			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005794	Bronze, Green Published			2022-12-24	WOS:000272622800002
J	Horton, R				Horton, Richard			The climate dividend	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; Lim V, 2009, LANCET, V374, P973, DOI 10.1016/S0140-6736(09)61641-X; Pencheon D, 2009, GUARDIAN        1021, P31	3	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 5	2009	374	9705					1869	1870		10.1016/S0140-6736(09)61994-2	http://dx.doi.org/10.1016/S0140-6736(09)61994-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531EQ	19942279				2022-12-24	WOS:000272646900004
J	Brodlie, M; Mckean, MC				Brodlie, Malcolm; Mckean, Michael C.			Picture Quiz Dyspnoea and cough in a toddler	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONGENITAL DIAPHRAGMATIC-HERNIA; PARAESOPHAGEAL HERNIA; HIATAL-HERNIA; DIAGNOSIS; CHILDREN		[Mckean, Michael C.] Univ Newcastle, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Mckean, MC (corresponding author), Univ Newcastle, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	michael.mckean@nuth.nhs.uk		Brodlie, Malcolm/0000-0003-4591-8299	MRC [G0800419] Funding Source: UKRI; Medical Research Council [G0800419] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Salem AH, 2000, SAUDI MED J, V21, P164; Baglaj M, 2005, PEDIATR RADIOL, V35, P478, DOI 10.1007/s00247-004-1389-z; Baglaj M, 2004, PEDIATR SURG INT, V20, P658, DOI 10.1007/s00383-004-1269-5; Barnewolt CE, 2007, J PEDIATR SURG, V42, P193, DOI 10.1016/j.jpedsurg.2006.09.018; Bonfils M, 2006, ARCH DIS CHILD-FETAL, V91, P363, DOI 10.1136/adc.2005.079392; Coakley FV, 1999, RADIOLOGY, V213, P691, DOI 10.1148/radiology.213.3.r99dc39691; Coren ME, 1997, PEDIATR PULM, V24, P119, DOI 10.1002/(SICI)1099-0496(199708)24:2<119::AID-PPUL8>3.3.CO;2-Y; Dipali RB, 2007, INDIAN J PEDIATR, V74, P310, DOI 10.1007/s12098-007-0054-6; Garne E, 2002, ULTRASOUND OBST GYN, V19, P329, DOI 10.1046/j.1469-0705.2002.00635.x; Holt PD, 2004, PEDIATR RADIOL, V34, P462, DOI 10.1007/s00247-004-1151-6; Imamoglu M, 2005, J PEDIATR SURG, V40, P1128, DOI 10.1016/j.jpedsurg.2005.03.060; Jawad AJ, 1998, PEDIATR SURG INT, V13, P91, DOI 10.1007/s003830050256; Karpelowsky JS, 2006, J PEDIATR SURG, V41, P1588, DOI 10.1016/j.jpedsurg.2006.05.020; Rees JE, 2004, EMERG MED J, V21, P749, DOI 10.1136/emj.2003.007310; Robinson PD, 2007, PAEDIATR RESPIR REV, V8, P323, DOI 10.1016/j.prrv.2007.08.004; Taylor GA, 2009, PEDIATR RADIOL, V39, P1, DOI 10.1007/s00247-008-0917-7; 2002, THORAX S1, V57, P1	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2009	339								b4436	10.1136/bmj.b4436	http://dx.doi.org/10.1136/bmj.b4436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HM	19906741				2022-12-24	WOS:000271833900003
J	Burke, CJ; Thomas, R; Howlett, DC				Burke, C. J.; Thomas, R.; Howlett, D. C.			Picture Quiz An occult breast mass	BRITISH MEDICAL JOURNAL			English	Editorial Material							MUTATION CARRIERS; HIGH-RISK; CANCER; MAMMOGRAPHY; MRI; ULTRASOUND; BRCA1		[Burke, C. J.; Thomas, R.; Howlett, D. C.] Eastbourne Gen Hosp, Dept Radiol, Eastbourne BN21 2UD, E Sussex, England		Burke, CJ (corresponding author), 42 Arminger Rd, London W12 7BB, England.	drchristopherburke@gmail.com	Burke, Christopher/AAI-6000-2020	Burke, Christopher/0000-0001-7609-1146				Dahnert W, 2007, RADIOLOGY REV MANUAL; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Lalonde L, 2005, CAN ASSOC RADIOL J, V56, P301; Lee CH, 2004, RADIOL CLIN N AM, V42, P919, DOI 10.1016/j.rcl.2004.05.001; Lee JM, 2008, RADIOLOGY, V246, P763, DOI 10.1148/radiol.2463070224; Lopez JK, 2009, RADIOGRAPHICS, V29, P165, DOI 10.1148/rg.291085100; Lord SJ, 2007, EUR J CANCER, V43, P1905, DOI 10.1016/j.ejca.2007.06.007; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Pediconi F, 2007, RADIOLOGY, V243, P670, DOI 10.1148/radiol.2433060838; Vandermeer FQ, 2007, CANCER INVEST, V25, P384, DOI 10.1080/07357900701360013; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317	11	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 4	2009	339								b4316	10.1136/bmj.b4316	http://dx.doi.org/10.1136/bmj.b4316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UC	19889732				2022-12-24	WOS:000271567800001
J	Seiffert, ER; Perry, JMG; Simons, EL; Boyer, DM				Seiffert, Erik R.; Perry, Jonathan M. G.; Simons, Elwyn L.; Boyer, Doug M.			Convergent evolution of anthropoid-like adaptations in Eocene adapiform primates	NATURE			English	Article							MIDDLE EOCENE; FISSURE-FILLINGS; MOLECULAR-DATA; EGYPT; PHYLOGENY; FOSSIL; PALEOGENE; MYANMAR; AFRICA; CHINA	Adapiform or 'adapoid' primates first appear in the fossil record in the earliest Eocene epoch (similar to 55 million years (Myr) ago), and were common components of Palaeogene primate communities in Europe, Asia and North America(1). Adapiforms are commonly referred to as the 'lemur-like' primates of the Eocene epoch, and recent phylogenetic analyses have placed adapiforms as stem members of Strepsirrhini(2-4), a primate suborder whose crown clade includes lemurs, lorises and galagos. An alternative view is that adapiforms are stem anthropoids(5). This debate has recently been rekindled by the description of a largely complete skeleton of the adapiform Darwinius(6), from the middle Eocene of Europe, which has been widely publicised as an important 'link' in the early evolution of Anthropoidea(7). Here we describe the complete dentition and jaw of a large-bodied adapiform (Afradapis gen. nov.) from the earliest late Eocene of Egypt (similar to 37 Myr ago) that exhibits a striking series of derived dental and gnathic features that also occur in younger anthropoid primates-notably the earliest catarrhine ancestors of Old World monkeys and apes. Phylogenetic analysis of 360 morphological features scored across 117 living and extinct primates (including all candidate stem anthropoids) does not place adapiforms as haplorhines (that is, members of a Tarsius-Anthropoidea clade) or as stem anthropoids, but rather as sister taxa of crown Strepsirrhini; Afradapis and Darwinius are placed in a geographically widespread clade of caenopithecine adapiforms that left no known descendants. The specialized morphological features that these adapiforms share with anthropoids are therefore most parsimoniously interpreted as evolutionary convergences. As the largest non-anthropoid primate ever documented in Afro-Arabia, Afradapis nevertheless provides surprising new evidence for prosimian diversity in the Eocene of Africa, and raises the possibility that ecological competition between adapiforms and higher primates might have played an important role during the early evolution of stem and crown Anthropoidea in Afro-Arabia.	[Seiffert, Erik R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Perry, Jonathan M. G.] Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA; [Simons, Elwyn L.] Duke Lemur Ctr, Div Fossil Primates, Durham, NC 27705 USA; [Boyer, Doug M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Midwestern University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Seiffert, ER (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	erik.seiffert@stonybrook.edu		Boyer, Douglas/0000-0002-8697-2999	Research Foundation of SUNY; US National Science Foundation; The Leakey Foundation; Duke Lemur Center publication [1155]	Research Foundation of SUNY; US National Science Foundation(National Science Foundation (NSF)); The Leakey Foundation; Duke Lemur Center publication	We thank K. C. Beard, P. Chatrath, B. Engesser, M. Hellmund, J. Galkin, P. D. Gingerich, M. Godinot, G. Gunnell, E. Ladier, B. Marandat, L. Marivaux, K. D. Rose, I. Rutzky and P. Tassy for access to adapiform fossils and casts. F. Ankel-Simons and J. Fleagle provided comments on the manuscript. Collaborative palaeontological research in Egypt is made possible through cooperation with the Egyptian Mineral Resources Authority and the Egyptian Geological Museum. Fieldwork in Egypt is managed by P. Chatrath. This research has been funded by the Research Foundation of SUNY, and grants from the US National Science Foundation and The Leakey Foundation to E. R. S. and E. L. S. This is Duke Lemur Center publication 1155.	Beard K. Christopher, 2007, Bulletin of Carnegie Museum of Natural History, V39, P67, DOI 10.2992/0145-9058(2007)39[67:NSPFTE]2.0.CO;2; Beard KC, 2005, J HUM EVOL, V49, P468, DOI 10.1016/j.jhevol.2005.05.008; BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Chaimanee Y, 1997, NATURE, V385, P429, DOI 10.1038/385429a0; Ciochon RL, 2001, P NATL ACAD SCI USA, V98, P7672, DOI 10.1073/pnas.051003298; Clochon RL, 2002, EVOL ANTHROPOL, V11, P156, DOI 10.1002/evan.10032; CONROY GC, 1987, INT J PRIMATOL, V8, P115, DOI 10.1007/BF02735160; Dagosto M, 1999, ANN CARNEGIE MUS, V68, P175; Franzen JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005723; Franzen Jens Lorenz, 2000, Senckenbergiana Lethaea, V80, P289; Gebo DL, 2001, AM J PHYS ANTHROPOL, V116, P83, DOI 10.1002/ajpa.1105; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; GINGERICH PD, 1992, U MICH PAP PALEONT, V30, P84; Godinot M, 1998, FOLIA PRIMATOL, V69, P218, DOI 10.1159/000052715; Gunnell Gregg F., 2002, Contributions from the Museum of Paleontology University of Michigan, V30, P337; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Kay R.F., 1980, International Journal of Primatology, V1, P21, DOI 10.1007/BF02692256; Kay Richard F., 2004, P91; MacPhee RDE, 1995, J HUM EVOL, V29, P501, DOI 10.1006/jhev.1995.1073; Marivaux L, 2005, P NATL ACAD SCI USA, V102, P8436, DOI 10.1073/pnas.0503469102; Masters JC, 2002, AM J PHYS ANTHROPOL, V117, P79, DOI 10.1002/ajpa.10001; Miller ER, 1997, P NATL ACAD SCI USA, V94, P13760, DOI 10.1073/pnas.94.25.13760; Rasmussen D. Tab, 1994, P335; RASMUSSEN DT, 1990, INT J PRIMATOL, V11, P439, DOI 10.1007/BF02196131; Roos C, 2004, P NATL ACAD SCI USA, V101, P10650, DOI 10.1073/pnas.0403852101; Rose KD, 2009, J HUM EVOL, V56, P366, DOI 10.1016/j.jhevol.2009.01.008; Ross C, 1998, J HUM EVOL, V35, P221, DOI 10.1006/jhev.1998.0254; Ross Callum, 1994, P469; Ross CF, 2000, J HUM EVOL, V39, P225, DOI 10.1006/jhev.2000.0417; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; Seiffert ER, 2006, P NATL ACAD SCI USA, V103, P5000, DOI 10.1073/pnas.0600689103; Seiffert ER, 2005, SCIENCE, V310, P300, DOI 10.1126/science.1116569; Seiffert ER, 2005, P NATL ACAD SCI USA, V102, P11396, DOI 10.1073/pnas.0505310102; Seiffert ER, 2003, NATURE, V422, P421, DOI 10.1038/nature01489; Seiffert ER, 2008, DEV PRIMATOL-PROG PR, P71, DOI 10.1007/978-0-387-73896-3_8; SIMONS EL, 1990, SCIENCE, V247, P1567, DOI 10.1126/science.2108499; Simons EL, 1996, AM J PHYS ANTHROPOL, V100, P261, DOI 10.1002/(SICI)1096-8644(199606)100:2<261::AID-AJPA7>3.0.CO;2-#; Simons EL, 1995, J HUM EVOL, V29, P577, DOI 10.1006/jhev.1995.1076; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Stehlin H.G, 1916, ABHANDL SCHWEIZERISC, V41, P1299; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tabuce R, 2005, ANTHROPOL SCI, V113, P27, DOI 10.1537/ase.04S004; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; TUDGE C, 2009, LINK UNCOVERING OUR; Uhen MD, 2008, J SYST PALAEONTOL, V6, P433, DOI 10.1017/S1477201908002472; WILSON JA, 1976, FOLIA PRIMATOL, V25, P294, DOI 10.1159/000155722; YODER AD, 1994, AM J PHYS ANTHROPOL, V94, P25, DOI 10.1002/ajpa.1330940104; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801	48	84	90	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1118	U214		10.1038/nature08429	http://dx.doi.org/10.1038/nature08429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509BU	19847263				2022-12-24	WOS:000270987600043
J	Bishop, JF; Murnane, MP; Owen, R				Bishop, James F.; Murnane, Mary P.; Owen, Rhonda			Australia's Winter with the 2009 Pandemic Influenza A (H1N1) Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bishop, James F.; Murnane, Mary P.; Owen, Rhonda] Dept Hlth & Ageing, Canberra, ACT, Australia		Bishop, JF (corresponding author), Dept Hlth & Ageing, Canberra, ACT, Australia.							*AUSTR GOV DEP HLT, 2009, AUSTR INFL SURV REP; Australian Government Department of Health and Ageing, 2008, AUSTR HLTH MAN PLAN; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Shinde V, 2009, NEW ENGL J MED, V361, P102; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	6	132	137	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2591	2594		10.1056/NEJMp0910445	http://dx.doi.org/10.1056/NEJMp0910445			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538JV	19940287				2022-12-24	WOS:000273181300002
J	Racki, LR; Yang, JG; Naber, N; Partensky, PD; Acevedo, A; Purcell, TJ; Cooke, R; Cheng, YF; Narlikar, GJ				Racki, Lisa R.; Yang, Janet G.; Naber, Nariman; Partensky, Peretz D.; Acevedo, Ashley; Purcell, Thomas J.; Cooke, Roger; Cheng, Yifan; Narlikar, Geeta J.			The chromatin remodeller ACF acts as a dimeric motor to space nucleosomes	NATURE			English	Article							DNA TRANSLOCATION; ISWI; COMPLEX; PROTEIN; FAMILY; CHRAC; RECOGNITION; DISRUPTION; MECHANISM; HELICASES	Evenly spaced nucleosomes directly correlate with condensed chromatin and gene silencing. The ATP-dependent chromatin assembly factor (ACF) forms such structures in vitro and is required for silencing in vivo. ACF generates and maintains nucleosome spacing by constantly moving a nucleosome towards the longer flanking DNA faster than the shorter flanking DNA. How the enzyme rapidly moves back and forth between both sides of a nucleosome to accomplish bidirectional movement is unknown. Here we show that nucleosome movement depends cooperatively on two ACF molecules, indicating that ACF functions as a dimer of ATPases. Further, the nucleotide state determines whether the dimer closely engages one or both sides of the nucleosome. Three-dimensional reconstruction by single-particle electron microscopy of the ATPase-nucleosome complex in an activated ATP state reveals a dimer architecture in which the two ATPases face each other. Our results indicate a model in which the two ATPases work in a coordinated manner, taking turns to engage either side of a nucleosome, thereby allowing processive bidirectional movement. This novel dimeric motor mechanism differs from that of dimeric motors such as kinesin and dimeric helicases that processively translocate unidirectionally and reflects the unique challenges faced by motors that move nucleosomes.	[Cheng, Yifan; Narlikar, Geeta J.] Univ Calif San Francisco, Dept Biochem & Biophys, WM Keck Adv Microscopy Lab, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Narlikar, GJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, WM Keck Adv Microscopy Lab, 600 16th St, San Francisco, CA 94158 USA.	ycheng@ucsf.edu; geeta.narlikar@ucsf.edu	Yang, Janet/P-2003-2015	Acevedo, Ashley/0000-0002-3002-9854; Cheng, Yifan/0000-0001-9535-0369	Sandler Family Supporting Foundation; UCSF Academic Senate Shared Equipment Grant; National Institutes of Health; Beckman Foundation; US National Science Foundation Graduate Research Fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073767] Funding Source: NIH RePORTER	Sandler Family Supporting Foundation; UCSF Academic Senate Shared Equipment Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; US National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Widom for the 601 plasmid. We thank H. Madhani, M. D. Simon, and members of the Narlikar laboratory for helpful discussion and comments on the manuscript. We thank R. Howard for help with equilibrium analytical ultracentrifugation; W. Ross, J. Lin, S. Hota and B. Bartholomew for advice on footprinting, and C. Cunningham for assistance with nucleosome depiction. This work was supported by grants from the Sandler Family Supporting Foundation ( Sandler Opportunity Award and New Technology Award in Basic Science to Y. C., Program for Breakthrough Biomedical Research (PBBR) Award to G. J. N.), UCSF Academic Senate Shared Equipment Grant ( to Y. C.), grants from the National Institutes of Health ( to R. C. and G. J. N.) and by the Beckman Foundation ( to G. J. N.). P. D. P. and J. G. Y. were supported by US National Science Foundation Graduate Research Fellowships. G. J. N. is a Leukemia and Lymphoma Society Scholar. G. J. N. wishes to acknowledge D. Herschlag's generative mentorship.	Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; BLOSSER TR, NATURE IN PRESS, DOI DOI 10.1038/NATURE08627; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chin J, 2004, METHOD ENZYMOL, V376, P3; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Langst G, 2004, BBA-GENE STRUCT EXPR, V1677, P58, DOI 10.1016/j.bbaexp.2003.10.011; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lohman TM, 1998, CELL, V93, P9, DOI 10.1016/S0092-8674(00)81139-3; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Naber N, 2007, BIOPHYS J, V92, P172, DOI 10.1529/biophysj.106.090035; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Racki LR, 2008, CURR OPIN GENET DEV, V18, P137, DOI 10.1016/j.gde.2008.01.007; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	47	134	134	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1016	1021		10.1038/nature08621	http://dx.doi.org/10.1038/nature08621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033039	Green Accepted, Green Submitted			2022-12-24	WOS:000272996000038
J	Matute, DR; Butler, IA; Coyne, JA				Matute, Daniel R.; Butler, Ian A.; Coyne, Jerry A.			Little Effect of the tan Locus on Pigmentation in Female Hybrids between Drosophila santomea and D. melanogaster	CELL			English	Article							CIS-REGULATORY EVOLUTION; GENETIC-CONTROL; DIFFERENCE; PATTERNS; MUTATION; YELLOW; YAKUBA	Previous work on Drosophila santomea suggested that its absence of abdominal pigmentation, compared to the other darkly pigmented species, is based on mutations in the cis-regulatory region of tan, inactivating the expression of that gene in the abdomen of D. santomea males and females. Our discovery that D. santomea males can produce viable hybrids when mated to D. melanogaster females enables us to use the armamentarium of genetic tools in the latter species to study the genetic basis of this interspecific difference in pigmentation. Hybridization tests using D. melanogaster deficiencies that include tan show no evidence that this locus is involved in the lighter pigmentation of D. santomea females; rather, the pigmentation difference appears to involve at least four other loci in the region. Earlier results implicating tan may have been based on a type of transgenic analysis that can give misleading results about the genes involved in an evolutionary change.	[Matute, Daniel R.; Butler, Ian A.; Coyne, Jerry A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Coyne, JA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57 St, Chicago, IL 60637 USA.	j-coyne@uchicago.edu		Butler, Ian/0000-0002-1386-2430	National Institutes of Health [R01GM058260]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jean Gladstone for technical assistance. This work was funded by National Institutes of Health grant R01GM058260 to J.A.C.	Carbone MA, 2005, GENETICS, V171, P211, DOI 10.1534/genetics.105.044412; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CARROLL SB, 2005, ENDLESS FORMS MOST B; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Coyne JA, 2002, EVOLUTION, V56, P2424, DOI 10.1111/j.0014-3820.2002.tb00168.x; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hyodo-Taguchi Y, 1997, MECH DEVELOP, V68, P27, DOI 10.1016/S0925-4773(97)00128-7; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Llopart A, 2002, EVOLUTION, V56, P2262; Llopart A, 2002, NATURE, V419, P360, DOI 10.1038/419360a; Matute DR, 2009, EVOLUTION, V63, P595, DOI 10.1111/j.1558-5646.2008.00588.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	30	10	10	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1180	1188		10.1016/j.cell.2009.10.033	http://dx.doi.org/10.1016/j.cell.2009.10.033			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005810	Green Accepted, Bronze			2022-12-24	WOS:000272622800019
J	Melillo, JM; Reilly, JM; Kicklighter, DW; Gurgel, AC; Cronin, TW; Paltsev, S; Felzer, BS; Wang, XD; Sokolov, AP; Schlosser, CA				Melillo, Jerry M.; Reilly, John M.; Kicklighter, David W.; Gurgel, Angelo C.; Cronin, Timothy W.; Paltsev, Sergey; Felzer, Benjamin S.; Wang, Xiaodong; Sokolov, Andrei P.; Schlosser, C. Adam			Indirect Emissions from Biofuels: How Important?	SCIENCE			English	Article							LAND-USE; CARBON SEQUESTRATION; CLIMATE-CHANGE; CONSEQUENCES; OZONE	A global biofuels program will lead to intense pressures on land supply and can increase greenhouse gas emissions from land-use changes. Using linked economic and terrestrial biogeochemistry models, we examined direct and indirect effects of possible land-use changes from an expanded global cellulosic bioenergy program on greenhouse gas emissions over the 21st century. Our model predicts that indirect land use will be responsible for substantially more carbon loss ( up to twice as much) than direct land use; however, because of predicted increases in fertilizer use, nitrous oxide emissions will be more important than carbon losses themselves in terms of warming potential. A global greenhouse gas emissions policy that protects forests and encourages best practices for nitrogen fertilizer use can dramatically reduce emissions associated with biofuels production.	[Melillo, Jerry M.; Kicklighter, David W.; Cronin, Timothy W.; Felzer, Benjamin S.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Reilly, John M.; Gurgel, Angelo C.; Cronin, Timothy W.; Paltsev, Sergey; Wang, Xiaodong; Sokolov, Andrei P.; Schlosser, C. Adam] MIT, Joint Program Sci & Policy Global Change, Cambridge, MA 02139 USA; [Gurgel, Angelo C.] Univ Sao Paulo, Dept Econ, BR-14049 Ribeirao Preto, Brazil; [Felzer, Benjamin S.] Lehigh Univ, Dept Earth & Environm Sci, Bethlehem, PA 18015 USA; [Wang, Xiaodong] Zhejiang Univ, Sch Publ Adm, Hangzhou 310000, Zhejiang, Peoples R China	Marine Biological Laboratory - Woods Hole; Massachusetts Institute of Technology (MIT); Universidade de Sao Paulo; Lehigh University; Zhejiang University	Melillo, JM (corresponding author), Marine Biol Lab, Ctr Ecosyst, 7 MBL St, Woods Hole, MA 02543 USA.	jmelillo@mbl.edu	Felzer, Benjamin S/AAB-3456-2021; Gurgel, Angelo C/D-9446-2013	Felzer, Benjamin S/0000-0002-3990-3739; Gurgel, Angelo/0000-0001-8331-9508; Paltsev, Sergey/0000-0003-3287-0732	David and Lucile Packard Foundation; Department of Energy, Office of Science (BER) [DE-FG02-94ER61937, DE-FG02-93ER61677, DE-FG02-08ER64648]; EPA [XA-83240101]; NSF [BCS-0410344]; MIT JPSPGC	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Department of Energy, Office of Science (BER)(United States Department of Energy (DOE)); EPA(United States Environmental Protection Agency); NSF(National Science Foundation (NSF)); MIT JPSPGC	This research was supported in part by the David and Lucile Packard Foundation to the MBL, Department of Energy, Office of Science (BER) grants DE-FG02-94ER61937, DE-FG02-93ER61677, and DE-FG02-08ER64648; EPA grant XA-83240101; NSF grant BCS-0410344; and the industrial and foundation sponsors of the MIT JPSPGC.	*CA EPA, 2009, PROP REG IMPL LOW CA, V1; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Felzer B, 2005, CLIMATIC CHANGE, V73, P345, DOI 10.1007/s10584-005-6776-4; Felzer B, 2004, TELLUS B, V56, P230, DOI 10.1111/j.1600-0889.2004.00097.x; GURGEL A, J AGR FOOD IND ORG; Herzog H, 2003, CLIMATIC CHANGE, V59, P293, DOI 10.1023/A:1024801618900; Hurtt GC, 2006, GLOBAL CHANGE BIOL, V12, P1208, DOI 10.1111/j.1365-2486.2006.01150.x; Leemans R, 1996, GLOBAL ENVIRON CHANG, V6, P335, DOI 10.1016/S0959-3780(96)00028-3; MELILLO J, 2009, 168 MIT JPSPGC; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Paltsev S., 2005, MIT EMISSIONS PREDIC; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Reilly J, 2007, GREENHOUSE GAS SINKS, P115, DOI 10.1079/9781845931896.0115; Renewable Fuels Agency (RFA), 2008, GALL REV IND EFF BIO; Robertson G. Philip, 1997, P347; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Strengers B., 2004, GeoJournal, V61, P381, DOI 10.1007/s10708-004-5054-8; WANG X, 2008, THESIS MIT; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	22	376	385	8	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1397	1399		10.1126/science.1180251	http://dx.doi.org/10.1126/science.1180251			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933101				2022-12-24	WOS:000272351100041
J	Sousa, RM; Ferri, CP; Acosta, D; Albanese, E; Guerra, M; Huang, YQ; Jacob, KS; Jotheeswaran, AT; Rodriguez, JJL; Pichardo, GR; Rodriguez, MC; Salas, A; Sosa, AL; Williams, J; Zuniga, T; Prince, M				Sousa, Renata M.; Ferri, Cleusa P.; Acosta, Daisy; Albanese, Emiliano; Guerra, Marietta; Huang, Yueqin; Jacob, K. S.; Jotheeswaran, A. T.; Llibre Rodriguez, Juan J.; Rodriguez Pichardo, Guillermina; Calvo Rodriguez, Marina; Salas, Aquiles; Luisa Sosa, Ana; Williams, Joseph; Zuniga, Tirso; Prince, Martin			Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey	LANCET			English	Article							ASSESSMENT SCHEDULE-II; PSYCHOMETRIC PROPERTIES; HEALTH; EPIDEMIOLOGY; METHODOLOGY; PREVALENCE; DEPRESSION; DIAGNOSIS; COSTS; ONSET	Background Disability in elderly people in countries with low and middle incomes is little studied; according to Global Burden of Disease estimates, visual impairment is the leading contributor to years lived with disability in this population. We aimed to assess the contribution of physical, mental, and cognitive chronic diseases to disability, and the extent to which sociodemographic and health characteristics account for geographical variation in disability. Methods We undertook cross-sectional surveys of residents aged older than 65 years (n=15 022) in 11 sites in seven countries with low and middle incomes (China, India, Cuba, Dominican Republic, Venezuela, Mexico, and Peru). Disability was assessed with the 12-item WHO disability assessment schedule 2.0. Dementia, depression, hypertension, and chronic obstructive pulmonary disease were ascertained by clinical assessment; diabetes, stroke, and heart disease by self-reported diagnosis; and sensory, gastrointestinal, skin, limb, and arthritic disorders by self-reported impairment. Independent contributions to disability scores were assessed by zero-inflated negative binomial regression and Poisson regression to generate population-attributable prevalence fractions (PAPF). Findings In regions other than rural India and Venezuela, dementia made the largest contribution to disability (median PAPF 25.1% [IQR 19.2-43.6]). Other substantial contributors were stroke (11.4% [1.8-21.4]), limb impairment (10.5% [5.7-33.8]), arthritis (9.9% [3.2-34.8]), depression (8.3% [0.5-23.0]), eyesight problems (6.8% [1.7-17.6]), and gastrointestinal impairments (6.5% [0.3-23.1]). Associations with chronic diseases accounted for around two-thirds of prevalent disability. When zero inflation was taken into account, between-site differences in disability scores were largely attributable to compositional differences in health and sociodemographic characteristics. Interpretation On the basis of empirical research, dementia, not blindness, is overwhelmingly the most important independent contributor to disability for elderly people in countries with low and middle incomes. Chronic diseases of the brain and mind deserve increased prioritisation. Besides disability, they lead to dependency and present stressful, complex, long-term challenges to carers. Societal costs are enormous.	[Sousa, Renata M.; Ferri, Cleusa P.; Albanese, Emiliano; Prince, Martin] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Ctr Publ Mental Hlth, London SE5 8AF, England; [Acosta, Daisy] Univ Nacl Pedro Henriquez Urena, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Guerra, Marietta] Natl Inst Mental Hlth Honorio Delgado Hideyo Nogu, Psychogeriatr Unit, Lima, Peru; [Huang, Yueqin] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Jacob, K. S.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Jotheeswaran, A. T.; Williams, Joseph] Voluntary Hlth Serv, Dept Community Hlth, Madras, Tamil Nadu, India; [Llibre Rodriguez, Juan J.; Calvo Rodriguez, Marina] Med Univ Havana, Fac Med Finlay Albarran, Havana, Cuba; [Rodriguez Pichardo, Guillermina] Colegio Dominicano Estadist & Demografos, Santo Domingo, Dominican Rep; [Salas, Aquiles] Cent Univ Venezuela, Fac Med, Hop Univ Caracas, Dept Med, Caracas, Venezuela; [Luisa Sosa, Ana; Zuniga, Tirso] Univ Nacl Autonoma Mexico, Natl Inst Neurol & Neurosurg Mexico, Mexico City 04510, DF, Mexico	University of London; King's College London; Universidad Nacional Pedro Henriquez Urena; Peking University; Christian Medical College & Hospital (CMCH) Vellore; University of Central Venezuela; Universidad Nacional Autonoma de Mexico	Sousa, RM (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Ctr Publ Mental Hlth, Crespigny Pk,POB 60, London SE5 8AF, England.	r.sousa@iop.kcl.ac.uk	Ortiz, Ana Luisa Sosa/AAU-9376-2021; Prince, Martin J/A-9170-2010; Bryce, Renata/B-1057-2011; Rodriguez, Juan J Llibre/D-2380-2010; Sosa, Ana L/A-8593-2012; Ferri, Cleusa Pinheiro/B-2922-2010	Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Prince, Martin J/0000-0003-1379-7146; Rodriguez, Juan J Llibre/0000-0002-8215-3160; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Guerra, Mariella/0000-0001-8923-349X; Zuniga Santamaria, Tirso/0000-0003-2086-8459; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X; Acosta Castillo, Gilberto Isaac/0000-0002-8664-9542	Wellcome Trust (UK) [GR066133]; WHO; US Alzheimer's Association [11RG-04-1286]; Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela); GlaxoSmithKline; Novartis; Lundbeck; Pfizer; Eisai	Wellcome Trust (UK)(Wellcome Trust); WHO(World Health Organization); US Alzheimer's Association(Alzheimer's Association); Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Eisai(Eisai Co Ltd)	The 10/66 Dementia Research Group population-based surveys were funded by: the Wellcome Trust (UK) (GR066133); WHO; the US Alzheimer's Association (11RG-04-1286); and the Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela). The Rockefeller Foundation supported our dissemination meeting in their Bellagio Centre. Alzheimer's Disease International (ADI) has provided support for networking and infrastructure. The 10/66 Dementia Research Group works closely with ADI, which is a non-profit federation of 77 Alzheimer associations around the world. ADI is committed to strengthening Alzheimer associations worldwide, raising awareness regarding dementia and Alzheimer's disease, and advocating for more and better services for people with dementia and their caregivers. ADI is supported in part by grants from GlaxoSmithKline, Novartis, Lundbeck, Pfizer, and Lisai.	Acosta D, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-285; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baron M, 2008, ARTHRIT RHEUM-ARTHR, V59, P382, DOI 10.1002/art.23314; Chavez Ligia M, 2005, Ment Health Serv Res, V7, P145, DOI 10.1007/s11020-005-5783-4; Chisolm Theresa H, 2005, Trends Amplif, V9, P111, DOI 10.1177/108471380500900303; Chopra PK, 2004, AUST NZ J PSYCHIAT, V38, P753, DOI 10.1080/j.1440-1614.2004.01448.x; Chwastiak LA, 2003, J CLIN EPIDEMIOL, V56, P507, DOI 10.1016/S0895-4356(03)00051-9; Copeland JRM, 2002, INT J GERIATR PSYCH, V17, P729, DOI 10.1002/gps.667; Deepa M, 2003, J Assoc Physicians India, V51, P863; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; GEORGE LK, 1985, J AM GERIATR SOC, V33, P607, DOI 10.1111/j.1532-5415.1985.tb06317.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hudson M, 2008, ARTHRIT RHEUM-ARTHR, V59, P270, DOI 10.1002/art.23343; McKibbin C, 2004, J NERV MENT DIS, V192, P405, DOI 10.1097/01.nmd.0000130133.32276.83; Murray CJL, 2000, HEALTH ECON, V9, P69, DOI 10.1002/(SICI)1099-1050(200001)9:1<69::AID-HEC493>3.0.CO;2-I; Ng N, 2006, SCAND J PUBLIC HEALT, V34, P199, DOI 10.1080/14034940500204506; Posl M, 2007, QUAL LIFE RES, V16, P1521, DOI 10.1007/s11136-007-9259-4; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2008, INT REV PSYCHIATR, V20, P332, DOI 10.1080/09540260802094712; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Prince MJ, 1998, PSYCHOL MED, V28, P337, DOI 10.1017/S0033291797006478; Rehm J., 1999, INT J METH PSYCH RES, V8, P110, DOI DOI 10.1002/MPR.61; Rodriguez JL, 2008, NEUROEPIDEMIOLOGY, V31, P243, DOI 10.1159/000165362; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; SOUSA RM, INT J METHO IN PRESS; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Thomas R, 2001, NETW COMPUT, V12, P20; USTUN TB, MEASURING H IN PRESS; van Tubergen A, 2003, ANN RHEUM DIS, V62, P140, DOI 10.1136/ard.62.2.140; Von Korff M, 2008, J CLIN EPIDEMIOL, V61, P1132, DOI 10.1016/j.jclinepi.2007.12.009; WHO, 2001, WHO INT CLASS FUNCT; *WHOSIS, 2006, WORLD HLTH STAT; Wimo A, 2007, ALZHEIMERS DEMENT, V3, P81, DOI 10.1016/j.jalz.2007.02.001; Wolff JL, 2005, J AM GERIATR SOC, V53, P851, DOI 10.1111/j.1532-5415.2005.53262.x; WOO J, 1994, NEUROEPIDEMIOLOGY, V13, P50, DOI 10.1159/000110358	40	281	298	4	90	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1821	1830		10.1016/S0140-6736(09)61829-8	http://dx.doi.org/10.1016/S0140-6736(09)61829-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944863	Green Published			2022-12-24	WOS:000272370200027
J	Zhou, WJ; Ercan, D; Chen, L; Yun, CH; Li, DN; Capelletti, M; Cortot, AB; Chirieac, L; Iacob, RE; Padera, R; Engen, JR; Wong, KK; Eck, MJ; Gray, NS; Janne, PA				Zhou, Wenjun; Ercan, Dalia; Chen, Liang; Yun, Cai-Hong; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Chirieac, Lucian; Iacob, Roxana E.; Padera, Robert; Engen, John R.; Wong, Kwok-Kin; Eck, Michael J.; Gray, Nathanael S.; Jaenne, Pasi A.			Novel mutant-selective EGFR kinase inhibitors against EGFR T790M	NATURE			English	Article							PAN-ERBB INHIBITOR; CELL LUNG-CANCER; TYROSINE KINASE; RESISTANCE; MUTATION; GEFITINIB; SENSITIVITY; NILOTINIB; IMATINIB; HKI-272	The clinical efficacy of epidermal growth factor receptor ( EGFR) kinase inhibitors in EGFR-mutant non-small-cell lung cancer (NSCLC) is limited by the development of drug-resistance mutations, including the gatekeeper T790M mutation(1-3). Strategies targeting EGFR T790M with irreversible inhibitors have had limited success and are associated with toxicity due to concurrent inhibition of wild-type EGFR(4,5). All current EGFR inhibitors possess a structurally related quinazoline-based core scaffold and were identified as ATP-competitive inhibitors of wild-type EGFR. Here we identify a covalent pyrimidine EGFR inhibitor by screening an irreversible kinase inhibitor library specifically against EGFR T790M. These agents are 30- to 100-fold more potent against EGFR T790M, and up to 100-fold less potent against wildtype EGFR, than quinazoline-based EGFR inhibitors in vitro. They are also effective in murine models of lung cancer driven by EGFR T790M. Co-crystallization studies reveal a structural basis for the increased potency and mutant selectivity of these agents. These mutant-selective irreversible EGFR kinase inhibitors may be clinically more effective and better tolerated than quinazoline-based inhibitors. Our findings demonstrate that functional pharmacological screens against clinically important mutant kinases represent a powerful strategy to identify new classes of mutant-selective kinase inhibitors.	[Zhou, Wenjun; Yun, Cai-Hong; Eck, Michael J.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhou, Wenjun; Yun, Cai-Hong; Eck, Michael J.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ercan, Dalia; Chen, Liang; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Wong, Kwok-Kin; Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Ercan, Dalia; Chen, Liang; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Wong, Kwok-Kin; Jaenne, Pasi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chirieac, Lucian; Padera, Robert] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Dept Chem & Biol Chem, Boston, MA 02115 USA; [Wong, Kwok-Kin; Jaenne, Pasi A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wong, Kwok-Kin; Jaenne, Pasi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wong, Kwok-Kin; Jaenne, Pasi A.] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Northeastern University; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	Nathanael_Gray@dfci.harvard.edu; pjanne@partners.org	Cortot, Alexis B/F-7006-2019; 云, 彩红/E-1437-2018; Chirieac, Lucian R./AAD-2030-2019; Capelletti, Marzia/L-6317-2016	Cortot, Alexis B/0000-0003-0098-2238; Capelletti, Marzia/0000-0001-5095-7060; Engen, John R./0000-0002-6918-9476; wong, kwok kin/0000-0001-6323-235X; Chen, Liang/0000-0001-7300-6604	National Institutes of Health [RO1CA11446, R01CA135257, R01CA080942, R01CA130876-02, R01CA116020, R01AG2400401, R01 CA122794, R01GM070590]; National Cancer Institute Lung SPORE [P50CA090578]; Cecily and Robert Harris Foundation; Uniting Against Lung Cancer; Flight Attendant Medical Research Institute; Hazel and Samuel Bellin Research Fund; Damon Runyon Foundation Cancer Innovation Award; NATIONAL CANCER INSTITUTE [R01CA122794, R01CA116020, P50CA090578, R01CA130876, R01CA135257, R01CA080942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Lung SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cecily and Robert Harris Foundation; Uniting Against Lung Cancer; Flight Attendant Medical Research Institute; Hazel and Samuel Bellin Research Fund; Damon Runyon Foundation Cancer Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by grants from the National Institutes of Health RO1CA11446 ( P. A. J.), R01CA135257 ( P. A. J.), R01CA080942 ( M. J. E.), R01CA130876-02 ( N. S. G.), R01CA116020 ( M. J. E.), R01AG2400401 (K.-K.W.), R01 CA122794 ( K.- K. W.), R01GM070590 ( J. R. E.), National Cancer Institute Lung SPORE P50CA090578 ( P. A. J. and K.- K. W.), the Cecily and Robert Harris Foundation ( K.- K. W.), Uniting Against Lung Cancer ( K.- K. W.), the Flight Attendant Medical Research Institute ( K.- K. W.)., the Hazel and Samuel Bellin Research Fund ( P. A. J.) and the Damon Runyon Foundation Cancer Innovation Award ( N. S. G.). This work is contribution 948 from the Barnett Institute. The authors thank Sai Advantium Pharma for performing the pharmacokinetic studies.	Alam M, 2007, BIOORG MED CHEM LETT, V17, P3463, DOI 10.1016/j.bmcl.2007.03.078; Besse B, 2008, EJC SUPPL, V6, P64, DOI 10.1016/S1359-6349(08)72135-9; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Breault GA, 2003, BIOORG MED CHEM LETT, V13, P2961, DOI 10.1016/S0960-894X(03)00203-8; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Godin-Heymann N, 2008, MOL CANCER THER, V7, P874, DOI 10.1158/1535-7163.MCT-07-2387; Gontarewicz A, 2008, LEUKEMIA RES, V32, P1857, DOI 10.1016/j.leukres.2008.04.012; Hur W, 2008, BIOORG MED CHEM LETT, V18, P5916, DOI 10.1016/j.bmcl.2008.07.062; Janne PA, 2007, J CLIN ONCOL, V25, P3936, DOI 10.1200/JCO.2007.11.1336; Janne PA, 2008, J CLIN ONCOL, V26; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Lietha D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003800; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Yuza Y, 2007, CANCER BIOL THER, V6, P661, DOI 10.4161/cbt.6.5.4003	28	758	874	9	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1070	1074		10.1038/nature08622	http://dx.doi.org/10.1038/nature08622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	535UB	20033049	Green Accepted			2022-12-24	WOS:000272996000050
J	Ezra, DG; Rose, G; Coombes, A; Plant, G				Ezra, Daniel G.; Rose, Geoff; Coombes, Andrew; Plant, Gordon			Christmas 2009: Diagnosis Animated ophthalmology	BRITISH MEDICAL JOURNAL			English	Editorial Material							EYE		[Ezra, Daniel G.] Moorfields Eye Hosp, Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England; [Ezra, Daniel G.] UCL Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England; [Ezra, Daniel G.; Rose, Geoff; Plant, Gordon] Moorfields Eye Hosp NHS Trust, London EC1V 2PD, England; [Coombes, Andrew] St Bartholomews & Royal London NHS Trust, London E1 1BB, England; [Plant, Gordon] Natl Hosp Neurol & Neurosurg, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Ezra, DG (corresponding author), Moorfields Eye Hosp, Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England.	d.ezra@ucl.ac.uk						Darzi A., 2008, HIGH QUALITY CARE AL; Ertan A, 2006, J CATARACT REFR SURG, V32, P2039, DOI 10.1016/j.jcrs.2006.08.032; Ezra DG, 2008, ORBIT, V27, P55, DOI 10.1080/01676830601174593; Francis BA, 2008, AM J OPHTHALMOL, V146, P741, DOI 10.1016/j.ajo.2008.05.048; Haymes SA, 2009, OPHTHAL EPIDEMIOL, V16, P163, DOI 10.1080/09286580902738167; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Meda N, 2001, J FR OPHTALMOL, V24, P463; Whitnall SE, 1921, ANATOMY HUMAN ORBIT; Yip JLY, 2008, BRIT J OPHTHALMOL, V92, P30, DOI 10.1136/bjo.2007.123471	9	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2009	339								b4948	10.1136/bmj.b4948	http://dx.doi.org/10.1136/bmj.b4948			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XF	20008441				2022-12-24	WOS:000272930100002
J	Depuydt, M; Leonard, SE; Vertommen, D; Denoncin, K; Morsomme, P; Wahni, K; Messens, J; Carroll, KS; Collet, JF				Depuydt, Matthieu; Leonard, Stephen E.; Vertommen, Didier; Denoncin, Katleen; Morsomme, Pierre; Wahni, Khadija; Messens, Joris; Carroll, Kate S.; Collet, Jean-Francois			A Periplasmic Reducing System Protects Single Cysteine Residues from Oxidation	SCIENCE			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; IN-VIVO; THIOREDOXIN; PROTEINS; PEPTIDOGLYCAN; MECHANISMS; DIVERSITY; ISOMERASE; PEROXIDE	The thiol group of the amino acid cysteine can be modified to regulate protein activity. The Escherichia coli periplasm is an oxidizing environment in which most cysteine residues are involved in disulfide bonds. However, many periplasmic proteins contain single cysteine residues, which are vulnerable to oxidation to sulfenic acids and then irreversibly modified to sulfinic and sulfonic acids. We discovered that DsbG and DsbC, two thioredoxin-related proteins, control the global sulfenic acid content of the periplasm and protect single cysteine residues from oxidation. DsbG interacts with the YbiS protein and, along with DsbC, regulates oxidation of its catalytic cysteine residue. Thus, a potentially widespread mechanism controls sulfenic acid modification in the cellular environment.	[Depuydt, Matthieu; Vertommen, Didier; Denoncin, Katleen; Collet, Jean-Francois] Univ Catholique Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Leonard, Stephen E.; Carroll, Kate S.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Morsomme, Pierre] Univ Catholique Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Wahni, Khadija; Messens, Joris] Vrije Univ Brussel VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium	Universite Catholique Louvain; University of Michigan System; University of Michigan; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Collet, JF (corresponding author), Univ Catholique Louvain, de Duve Inst, B-1200 Brussels, Belgium.	jfcollet@uclouvain.be	Collet, Jean Francois/F-2105-2010; Messens, Joris/AAH-3008-2020; Morsomme, Pierre/AAD-9600-2019	Messens, Joris/0000-0002-2128-8264; Morsomme, Pierre/0000-0001-7780-7230; Vertommen, Didier/0000-0001-7648-8282; Carroll, Kate/0000-0002-7624-9617; Depuydt, Matthieu/0000-0002-4069-3521; Collet, Jean-Francois/0000-0001-8069-7036	FNRS; Leukemia and Lymphoma Society [3100-07]; American Heart Association [0835419N]	FNRS(Fonds de la Recherche Scientifique - FNRS); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association)	We thank G. Connerotte and H. Degand for technical help, and E. VanSchaftingen, M. VeigadaCunha, F. Swisser, P. Leverrier, A. Hiniker, J. Bardwell, and U. Jakob for discussions. J. F. C. and P. M. are Chercheur Qualifie and D. V. is Collaborateur Logistique of the Fonds de la Recherche Scientifique. M. D. is a research fellow of the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, and J. M. is a project leader of the VIB. This research was supported by grants from the FNRS to J. F. C. and from the Leukemia and Lymphoma Society (Special Fellows Award 3100-07) and the American Heart Association (Scientist Development Grant 0835419N) to K. S. C. Conflict of Interest Statement: Patent protection has been applied for for the DAz-1 and DAz-2 chemical probes. These compounds will soon be commercially available from Cayman Chemical (Ann Arbor, MI, USA). For inquiries regarding the DAz probes: katesc@umich.edu.	Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Eser M, 2009, P NATL ACAD SCI USA, V106, P1572, DOI 10.1073/pnas.0812596106; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Magnet S, 2007, J BACTERIOL, V189, P3927, DOI 10.1128/JB.00084-07; Mainardi JL, 2007, J BIOL CHEM, V282, P30414, DOI 10.1074/jbc.M704286200; Messens J, 2004, J MOL BIOL, V339, P527, DOI 10.1016/j.jmb.2004.04.016; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Reddie KG, 2008, MOL BIOSYST, V4, P521, DOI 10.1039/b719986d; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Takanishi CL, 2007, BIOCHEMISTRY-US, V46, P14725, DOI 10.1021/bi701625s	19	133	141	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1109	1111		10.1126/science.1179557	http://dx.doi.org/10.1126/science.1179557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965429				2022-12-24	WOS:000271951000043
J	Mead, S; Whitfield, J; Poulter, M; Shah, P; Uphill, J; Campbell, T; Al-Dujaily, H; Hummerich, H; Beck, J; Mein, CA; Verzilli, C; Whittaker, J; Alpers, MP; Collinge, J				Mead, Simon; Whitfield, Jerome; Poulter, Mark; Shah, Paresh; Uphill, James; Campbell, Tracy; Al-Dujaily, Huda; Hummerich, Holger; Beck, Jon; Mein, Charles A.; Verzilli, Claudio; Whittaker, John; Alpers, Michael P.; Collinge, John			A Novel Protective Prion Protein Variant that Colocalizes with Kuru Exposure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; AGE	BACKGROUND Kuru is a devastating epidemic prion disease that affected a highly restricted geographic area of the Papua New Guinea highlands; at its peak, it predominantly affected adult women and children of both sexes. Its incidence has steadily declined since the cessation of its route of transmission, endocannibalism. METHODS We performed genetic and selected clinical and genealogic assessments of more than 3000 persons from Eastern Highland populations, including 709 who participated in cannibalistic mortuary feasts, 152 of whom subsequently died of kuru. RESULTS Persons who were exposed to kuru and survived the epidemic in Papua New Guinea are predominantly heterozygotes at the known resistance factor at codon 129 of the prion protein gene ( PRNP). We now report a novel PRNP variant - G127V - that was found exclusively in people who lived in the region in which kuru was prevalent and that was present in half of the otherwise susceptible women from the region of highest exposure who were homozygous for methionine at PRNP codon 129. Although this allele is common in the area with the highest incidence of kuru, it is not found in patients with kuru and in unexposed population groups worldwide. Genealogic analysis reveals a significantly lower incidence of kuru in pedigrees that harbor the protective allele than in geographically matched control families. CONCLUSIONS The 127V polymorphism is an acquired prion disease resistance factor selected during the kuru epidemic, rather than a pathogenic mutation that could have triggered the kuru epidemic. Variants at codons 127 and 129 of PRNP demonstrate the population genetic response to an epidemic of prion disease and represent a powerful episode of recent selection in humans.	[Mead, Simon; Whitfield, Jerome; Poulter, Mark; Shah, Paresh; Uphill, James; Campbell, Tracy; Al-Dujaily, Huda; Hummerich, Holger; Beck, Jon; Alpers, Michael P.; Collinge, John] UCL, MRC, Inst Neurol, Prion Unit,Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England; [Mein, Charles A.] Barts & London Queen Marys Sch Med & Dent, Genome Ctr, John Vane Sci Ctr, London, England; [Verzilli, Claudio; Whittaker, John] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Whitfield, Jerome; Alpers, Michael P.] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Alpers, Michael P.] Curtin Univ, Ctr Int Hlth, Perth, WA, Australia	University of London; University College London; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; PNG Institute Of Medical Research; Curtin University	Collinge, J (corresponding author), UCL, MRC, Inst Neurol, Prion Unit,Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Beck, Jon/GRX-8457-2022; Whittaker, John C/B-8609-2012; Mead, Simon/E-9414-2011	Whittaker, John C/0000-0002-3529-2379; Mead, Simon/0000-0002-4326-1468; Mein, Charles/0000-0003-0811-9658	Wellcome Trust Principal Research Fellowship; Department of Health National Institute for Health Research Biomedical Research Centres; Medical Research Council [MC_U123192748, MC_U123160651, MC_U123160657] Funding Source: researchfish; MRC [MC_U123192748, MC_U123160657, MC_U123160651] Funding Source: UKRI	Wellcome Trust Principal Research Fellowship(Wellcome Trust); Department of Health National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported initially by a Wellcome Trust Principal Research Fellowship in the Clinical Sciences ( to Dr. Collinge) and since 2001 by the Medical Research Council. Some of this work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health National Institute for Health Research Biomedical Research Centres funding scheme.	Alpers MP, 2005, COMMUN DIS INTELL, V29, P391; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Cervenakova L, 1998, P NATL ACAD SCI USA, V95, P13239, DOI 10.1073/pnas.95.22.13239; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Collinge J, 2008, PHILOS T R SOC B, V363, P3725, DOI 10.1098/rstb.2008.0068; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Colombo R, 2000, AM J HUM GENET, V67, P528, DOI 10.1086/303021; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hedrick P, 2004, J EVOLUTION BIOL, V17, P221, DOI 10.1046/j.1420-9101.2003.00635.x; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2008, HUM MUTAT, V29, P1452, DOI 10.1002/humu.20782; PALMER MS, 1991, NATURE, V352, P547, DOI 10.1038/352547a0; Poso D, 2000, J BIOL CHEM, V275, P35723, DOI 10.1074/jbc.M001747200; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Shibuya S, 1998, LANCET, V351, P419, DOI 10.1016/S0140-6736(05)78358-6; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; ZIGAS V., 1959, Papua and New Guinea Medical Journal, V3, P1	30	117	119	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2056	2065		10.1056/NEJMoa0809716	http://dx.doi.org/10.1056/NEJMoa0809716			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19923577	Green Accepted			2022-12-24	WOS:000271898600010
J	Cheng, KCC; Klancer, R; Singson, A; Seydoux, G				Cheng, Ken Chih-Chien; Klancer, Richard; Singson, Andrew; Seydoux, Geraldine			Regulation of MBK-2/DYRK by CDK-1 and the Pseudophosphatases EGG-4 and EGG-5 during the Oocyte-to-Embryo Transition	CELL			English	Article							CYCLIN-DEPENDENT KINASE; C-ELEGANS; CAENORHABDITIS-ELEGANS; PROTEIN-KINASE; DUAL-SPECIFICITY; ACTIVATION; MATURATION; DYRK; DEGRADATION; OMA-1	DYRKs are kinases that self-activate in vitro by autophosphorylation of a YTY motif in the kinase domain, but their regulation in vivo is not well understood. In C. elegans zygotes, MBK-2/DYRK phosphorylates oocyte proteins at the end of the meiotic divisions to promote the oocyte-to-embryo transition. Here we demonstrate that MBK-2 is under both positive and negative regulation during the transition. MBK-2 is activated during oocyte maturation by CDK-1-dependent phosphorylation of serine 68, a residue outside of the kinase domain required for full activity in vivo. The pseudotyrosine phosphatases EGG-4 and EGG-5 sequester activated MBK-2 until the meiotic divisions by binding to the YTY motif and inhibiting MBK-20s kinase activity directly, using a mixed-inhibition mechanism that does not involve tyrosine dephosphorylation. Our findings link cell-cycle progression to MBK-2/DYRK activation and the oocyte-to-embryo transition.	[Cheng, Ken Chih-Chien; Seydoux, Geraldine] Johns Hopkins Sch Med, Ctr Cell Dynam, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Cheng, Ken Chih-Chien; Seydoux, Geraldine] Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Klancer, Richard; Singson, Andrew] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Klancer, Richard; Singson, Andrew] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Seydoux, G (corresponding author), Johns Hopkins Sch Med, Ctr Cell Dynam, Dept Mol Biol & Genet, 725 N Wolfe St,PCTB 706, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu	SEYDOUX, Geraldine/AAA-2005-2020	Seydoux, Geraldine/0000-0001-8257-0493	National Institutes of Health [R01HD37047, R01HD054681]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047, R01HD054681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We gratefully thank Chih-Long Chang for hosting K.C.-C.C. in 2009; Miranda Darby, Hani Zaher, and Rachel Green for help and advice; J. Pellettieri for strains; and Rueyling Lin and members of the Seydoux lab for comments on the manuscript. This research was supported by the National Institutes of Health (Grants R01HD37047 [G.S.] and R01HD054681 [A.S.]) and a Johnson & Johnson Discovery Award (A.S.). G. S. is an Investigator of the Howard Hughes Medical Institute.	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Berg JM, 2006, BIOCHEMISTRY; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Bowerman B, 2006, DEVELOPMENT, V133, P773, DOI 10.1242/dev.02276; BRENNER S, 1974, GENETICS, V77, P71; Burrows AE, 2006, DEVELOPMENT, V133, P697, DOI 10.1242/dev.02241; D'Agostino I, 2006, DEV BIOL, V292, P244, DOI 10.1016/j.ydbio.2005.11.046; Da Costa M, 2006, PLANT CELL, V18, P1426, DOI 10.1105/tpc.105.040485; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Guven-Ozkan T, 2008, CELL, V135, P149, DOI 10.1016/j.cell.2008.07.040; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Hunter T, 1998, NAT GENET, V18, P303; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Lim S, 2002, J BIOL CHEM, V277, P49438, DOI 10.1074/jbc.M206840200; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lu CG, 2007, DEV BIOL, V302, P438, DOI 10.1016/j.ydbio.2006.09.053; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Maruyama R, 2007, CURR BIOL, V17, P1555, DOI 10.1016/j.cub.2007.08.011; McNally KL, 2005, DEV BIOL, V282, P218, DOI 10.1016/j.ydbio.2005.03.009; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Nishi Y, 2008, DEVELOPMENT, V135, P687, DOI 10.1242/dev.013425; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Parry JM, 2009, CURR BIOL, V19, P1752, DOI 10.1016/j.cub.2009.09.015; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Pils B, 2004, MOL BIOL EVOL, V21, P625, DOI 10.1093/molbev/msh055; Praitis V, 2001, GENETICS, V157, P1217; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Stitzel ML, 2007, CURR BIOL, V17, P1545, DOI 10.1016/j.cub.2007.08.049; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voronina E, 2003, CURR TOP DEV BIOL, V58, P53, DOI 10.1016/S0070-2153(03)58003-6; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	41	71	82	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					560	572		10.1016/j.cell.2009.08.047	http://dx.doi.org/10.1016/j.cell.2009.08.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879842	Green Accepted, Bronze			2022-12-24	WOS:000271259600020
J	Morris, JK; Alberman, E				Morris, Joan K.; Alberman, Eva			Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register	BRITISH MEDICAL JOURNAL			English	Article							PREGNANCY TERMINATIONS; AGE; ASCERTAINMENT; PREVALENCE; RATES	Objectives To describe trends in the numbers of Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008. Design and setting The National Down Syndrome Cytogenetic Register holds details of 26488 antenatal and postnatal diagnoses of Down's syndrome made by all cytogenetic laboratories in England and Wales since 1989. Interventions Antenatal screening, diagnosis, and subsequent termination of Down's syndrome pregnancies. Main outcome measures The number of live births with Down's syndrome. Results Despite the number of births in 1989/90 being similar to that in 2007/8, antenatal and postnatal diagnoses of Down's syndrome increased by 71% (from 1075 in 1989/90 to 1843 in 2007/8). However, numbers of live births with Down's syndrome fell by 1% (752 to 743; 1.10 to 1.08 per 1000 births) because of antenatal screening and subsequent terminations. In the absence of such screening, numbers of live births with Down's syndrome would have increased by 48% (from 959 to 1422), since couples are starting families at an older age. Among mothers aged 37 years and older, a consistent 70% of affected pregnancies were diagnosed antenatally. In younger mothers, the proportions of pregnancies diagnosed antenatally increased from 3% to 43% owing to improvements in the availability and sensitivity of screening tests. Conclusions Since 1989, expansion of and improvements in antenatal screening have offset an increase in Down's syndrome resulting from rising maternal age. The proportion of antenatal diagnoses has increased most strikingly in younger women, whereas that in older women has stayed relatively constant. This trend suggests that, even with future improvements in screening, a large number of births with Down's syndrome are still likely, and that monitoring of the numbers of babies born with Down's syndrome is essential to ensure adequate provision for their needs.	[Morris, Joan K.; Alberman, Eva] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Morris, JK (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	j.k.morris@qmul.ac.uk	Morris, Joan/AAT-9211-2020	Morris, Joan/0000-0002-7164-612X	NHS	NHS	The NHS Fetal Anomaly Screening Programme funded the National Down Syndrome Cytogenetic Register to collect the data until March 2009. The funders played no role in the analysis or write up of this paper. JM and EA are independent of the Fetal Anomaly Screening Programme. JM and EA had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.	ALBERMAN E, 1995, BRIT J OBSTET GYNAEC, V102, P445, DOI 10.1111/j.1471-0528.1995.tb11315.x; Boyd PA, 2005, BMJ-BRIT MED J, V330, P27, DOI 10.1136/bmj.38300.665301.3A; Collins VR, 2008, J PEDIATR-US, V152, P20, DOI 10.1016/j.jpeds.2007.07.045; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; Ekelund CK, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2547; Iliyasu Z, 2002, Health Bull (Edinb), V60, P20; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Melve KK, 2008, ACTA OBSTET GYN SCAN, V87, P824, DOI 10.1080/00016340802217184; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; MUTTON DE, 1991, BRIT MED J, V303, P1295, DOI 10.1136/bmj.303.6813.1295; NICHOLSON A, 1992, J INTELL DISABIL RES, V36, P505; *OFF NAT STAT FM1, BIRTH STAT, P18; Savva GM, 2009, ARCH DIS CHILD-FETAL, V94, pF23, DOI 10.1136/adc.2007.136465; Savva GM, 2006, PRENATAL DIAG, V26, P499, DOI 10.1002/pd.1443; Siffel C, 2004, BIRTH DEFECTS RES A, V70, P565, DOI 10.1002/bdra.20064; *UK NAT SCREEN COM, FET AN SCREEN PROGR	16	131	135	1	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 26	2009	339								b3794	10.1136/bmj.b3794	http://dx.doi.org/10.1136/bmj.b3794			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514AI	19858532	hybrid, Green Published			2022-12-24	WOS:000271365300001
J	Bernskoetter, WH; Schauer, CK; Goldberg, KI; Brookhart, M				Bernskoetter, Wesley H.; Schauer, Cynthia K.; Goldberg, Karen I.; Brookhart, Maurice			Characterization of a Rhodium(I) sigma-Methane Complex in Solution	SCIENCE			English	Article							C-H BOND; ALKANE COMPLEXES; ACTIVATION; COORDINATION; PHOTOCHEMISTRY; REACTIVITY; CHEMISTRY; IRIDIUM; IR	Numerous transition metal-mediated reactions, including hydrogenations, hydrosilations, and alkane functionalizations, result in the cleavage of strong sigma bonds. Key intermediates in these reactions often involve coordination of the sigma bond of dihydrogen, silanes (Si-H), or alkanes (C-H) to the metal center without full scission of the bond. These sigma complexes have been characterized to varying degrees in solid state and solution. However, a sigma complex of the simplest hydrocarbon, methane, has eluded full solution characterization. Here, we report nuclear magnetic resonance spectra of a rhodium(I) sigma-methane complex obtained by protonation of a rhodium-methyl precursor in CDCl2F solvent at -110 degrees C. The sigma-methane complex is shown to be more stable than the corresponding rhodium(III)methyl hydride complex. Even at -110 degrees C, methane rapidly tumbles in the coordination sphere of rhodium, exchanging free and bound hydrogens. Kinetic studies reveal a half-life of about 83 minutes at-87 degrees C for dissociation of methane ( free energy of activation is 14.5 kilocalories per mole).	[Bernskoetter, Wesley H.; Schauer, Cynthia K.; Brookhart, Maurice] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Goldberg, Karen I.] Univ Washington, Dept Chem Box 351700, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Brookhart, M (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	mbrookhart@unc.edu			S. Kloek Hanson; NSF [CHE-0650456]; Center for Enabling New Technologies Through Catalysis (CENTC); NIH [GM28938]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028938] Funding Source: NIH RePORTER	S. Kloek Hanson; NSF(National Science Foundation (NSF)); Center for Enabling New Technologies Through Catalysis (CENTC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge S. Kloek Hanson for experimental assistance and funding by the NSF ( grant no. CHE-0650456) as part of the Center for Enabling New Technologies Through Catalysis (CENTC) and the NIH ( grant no. GM28938).	Ball GE, 2007, P NATL ACAD SCI USA, V104, P6927, DOI 10.1073/pnas.0610212104; Bercaw JE, 2007, P NATL ACAD SCI USA, V104, P6899, DOI 10.1073/pnas.0700902104; Bernskoetter WH, 2009, J AM CHEM SOC, V131, P8603, DOI 10.1021/ja901706b; BROOKHART M, 1988, PROG INORG CHEM, V36, P1; Brookhart M, 2007, P NATL ACAD SCI USA, V104, P6908, DOI 10.1073/pnas.0610747104; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P15734, DOI 10.1021/ja0379316; Cobar EA, 2007, P NATL ACAD SCI USA, V104, P6963, DOI 10.1073/pnas.0610295104; Cowan AJ, 2007, P NATL ACAD SCI USA, V104, P6933, DOI 10.1073/pnas.0610567104; Cowan AJ, 2008, COORDIN CHEM REV, V252, P2504, DOI 10.1016/j.ccr.2008.05.008; Evans DR, 1997, J AM CHEM SOC, V119, P3633, DOI 10.1021/ja970008h; Hall C, 1996, CHEM REV, V96, P3125, DOI 10.1021/cr9502615; Heiberg H, 2003, INT J QUANTUM CHEM, V92, P391, DOI 10.1002/qua.10525; HERMANN H, 1982, J PHYS CHEM-US, V86, P5151, DOI 10.1021/j100223a019; Jensen MP, 2003, J AM CHEM SOC, V125, P8614, DOI 10.1021/ja028477t; Jones WD, 2003, ACCOUNTS CHEM RES, V36, P140, DOI 10.1021/ar020148i; KELLY JM, 1987, J CHEM SOC CHEM COMM, P1821, DOI 10.1039/c39870001821; Kubas G.J., 2001, METAL DIHYDROGEN SIG; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Lawes DJ, 2006, ANGEW CHEM INT EDIT, V45, P4486, DOI 10.1002/anie.200600313; McNamara BK, 1999, J AM CHEM SOC, V121, P6437, DOI 10.1021/ja9904282; PERUTZ RN, 1975, J AM CHEM SOC, V97, P4791, DOI 10.1021/ja00850a001; PIERS WE, 1990, J AM CHEM SOC, V112, P9406, DOI 10.1021/ja00181a060; Siegbahn PEM, 1996, J AM CHEM SOC, V118, P1487, DOI 10.1021/ja952338c; Stahl SS, 1996, J AM CHEM SOC, V118, P5961, DOI 10.1021/ja960110z; Xavier ES, 2005, ORGANOMETALLICS, V24, P2262, DOI 10.1021/om049036g; Zaric S, 1997, J PHYS CHEM A, V101, P4646, DOI 10.1021/jp970792s	26	203	206	1	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					553	556		10.1126/science.1177485	http://dx.doi.org/10.1126/science.1177485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900892				2022-12-24	WOS:000271019400035
J							UNAIDS Reference Grp Estimates Mod	HIV: consensus indicators are needed for concurrency	LANCET			English	Editorial Material							SEXUAL PARTNERSHIPS							McGrath, Nuala/0000-0002-1039-0159; Eaton, Jeffrey/0000-0001-7728-728X; Hallett, Timothy/0000-0002-9681-0424	MRC [MC_U950080926] Funding Source: UKRI; Medical Research Council [MC_U950080926] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AIDSSTAR One, 2009, ADDR MULT CONC SEX P; [Anonymous], [No title captured]; CARAEL M, 1995, SOC AS AIDS, P75; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Gorbach PM, 2002, SEX TRANSM DIS, V29, P453, DOI 10.1097/00007435-200208000-00004; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; Lurie MN, 2010, AIDS BEHAV, V14, P34, DOI 10.1007/s10461-009-9640-0; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; SHEKHAR N, 2008, MEASURING SEXUAL PAR; Shelton JD, 2009, LANCET, V374, P367, DOI 10.1016/S0140-6736(09)61399-4; UNAIDS (United National Programme on AIDS), 2009, CONS CONC SEX PARTN	13	78	78	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					621	622		10.1016/S0140-6736(09)62040-7	http://dx.doi.org/10.1016/S0140-6736(09)62040-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JT	19954832	Green Accepted			2022-12-24	WOS:000275210900009
J	Grundy, C; Steinbach, R; Edwards, P; Green, J; Armstrong, B; Wilkinson, P				Grundy, Chris; Steinbach, Rebecca; Edwards, Phil; Green, Judith; Armstrong, Ben; Wilkinson, Paul			Effect of 20 mph traffic speed zones on road injuries in London, 1986-2006: controlled interrupted time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE; SAFETY; BURDEN; RISK	Objective To quantify the effect of the introduction of 20 mph ( 32 km an hour) traffic speed zones on road collisions, injuries, and fatalities in London. Design Observational study based on analysis of geographically coded police data on road casualties, 1986-2006. Analyses were made of longitudinal changes in counts of road injuries within each of 119 029 road segments with at least one casualty with conditional fixed effects Poisson models. Estimates of the effect of introducing 20 mph zones on casualties within those zones and in adjacent areas were adjusted for the underlying downward trend in traffic casualties. Setting London. Main outcome measures All casualties from road collisions; those killed and seriously injured (KSI). Results The introduction of 20 mph zones was associated with a 41.9% (95% confidence interval 36.0% to 47.8%) reduction in road casualties, after adjustment for underlying time trends. The percentage reduction was greatest in younger children and greater for the category of killed or seriously injured casualties than for minor injuries. There was no evidence of casualty migration to areas adjacent to 20 mph zones, where casualties also fell slightly by an average of 8.0% (4.4% to 11.5%). Conclusions 20 mph zones are effective measures for reducing road injuries and deaths.	[Grundy, Chris; Green, Judith; Armstrong, Ben; Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Edwards, Phil] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Grundy, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	chris.grundy@lshtm.ac.uk		Green, Judith/0000-0002-2315-5326; Edwards, Phil/0000-0003-4431-8822; Steinbach, Rebecca/0000-0002-5674-2455; armstrong, benedict/0000-0003-4407-0409; Wilkinson, Paul/0000-0001-7456-259X	Transport for London [TfL2218]	Transport for London	This study was funded by Transport for London ( contract No TfL2218). The views expressed in the publication are those of the authors and not necessarily those of Transport for London.	Aarts L, 2006, ACCIDENT ANAL PREV, V38, P215, DOI 10.1016/j.aap.2005.07.004; BANNISTER D, 2005, ROLE TRANSPORT SUPPO; Bunn F, 2003, INJURY PREV, V9, P200, DOI 10.1136/ip.9.3.200; Bunn F., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003110, DOI 10.1002/14651858.CD003110]; Cook C., 2005, ASSESSING IMPACT TRA; Department for Transport, 2007, ROAD CAS GREAT BRIT; Department for Transport, 2000, TOM ROADS SAF EV; Elvik R, 2001, ACCIDENT ANAL PREV, V33, P327, DOI 10.1016/S0001-4575(00)00046-4; Grundy C., 2008, 20 MPH ZONES ROAD SA; Hyder AA, 2003, LANCET, V362, P2034, DOI 10.1016/S0140-6736(03)15145-8; Hyder Adnan A, 2004, J Coll Physicians Surg Pak, V14, P742; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Persaud B, 2007, ACCIDENT ANAL PREV, V39, P546, DOI 10.1016/j.aap.2006.09.009; Ward H, 2006, 69 DEP TRANSP; WEBSTER D, 2003, PPR243	16	114	116	1	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2009	339								b4469	10.1136/bmj.b4469	http://dx.doi.org/10.1136/bmj.b4469			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007666	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-24	WOS:000272697600002
J	Shu, XO; Zheng, Y; Cai, H; Gu, K; Chen, Z; Zheng, W; Lu, W				Shu, Xiao Ou; Zheng, Ying; Cai, Hui; Gu, Kai; Chen, Zhi; Zheng, Wei; Lu, Wei			Soy Food Intake and Breast Cancer Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK; TAMOXIFEN; GENISTEIN; ISOFLAVONES; SUPPLEMENTATION; PHYTOESTROGENS; DIET; CONSUMPTION; PROGNOSIS; WOMEN	Context Soy foods are rich in isoflavones, a major group of phytoestrogens that have been hypothesized to reduce the risk of breast cancer. However, the estrogen-like effect of isoflavones and the potential interaction between isoflavones and tamoxifen have led to concern about soy food consumption among breast cancer patients. Objective To evaluate the association of soy food intake after diagnosis of breast cancer with total mortality and cancer recurrence. Design, Setting, and Participants The Shanghai Breast Cancer Survival Study, a large, population-based cohort study of 5042 female breast cancer survivors in China. Women aged 20 to 75 years with diagnoses between March 2002 and April 2006 were recruited and followed up through June 2009. Information on cancer diagnosis and treatment, lifestyle exposures after cancer diagnosis, and disease progression was collected at approximately 6 months after cancer diagnosis and was reassessed at 3 follow-up interviews conducted at 18, 36, and 60 months after diagnosis. Annual record linkage with the Shanghai Vital Statistics Registry database was carried out to obtain survival information for participants who were lost to follow-up. Medical charts were reviewed to verify disease and treatment information. Main Outcome Measures Total mortality and breast cancer recurrence or breast cancer-related deaths. Cox regression analysis was carried out with adjustment for known clinical predictors and other lifestyle factors. Soy food intake was treated as a time-dependent variable. Results During the median follow-up of 3.9 years (range, 0.5-6.2 years), 444 deaths and 534 recurrences or breast cancer-related deaths were documented in 5033 surgically treated breast cancer patients. Soy food intake, as measured by either soy protein or soy isoflavone intake, was inversely associated with mortality and recurrence. The hazard ratio associated with the highest quartile of soy protein intake was 0.71 (95% confidence interval [CI], 0.54-0.92) for total mortality and 0.68 (95% CI, 0.54-0.87) for recurrence compared with the lowest quartile of intake. The multivariate-adjusted 4-year mortality rates were 10.3% and 7.4%, and the 4-year recurrence rates were 11.2% and 8.0%, respectively, for women in the lowest and highest quartiles of soy protein intake. The inverse association was evident among women with either estrogen receptor-positive or-negative breast cancer and was present in both users and nonusers of tamoxifen. Conclusion Among women with breast cancer, soy food consumption was significantly associated with decreased risk of death and recurrence. JAMA. 2009; 302(22): 2437-2443	[Shu, Xiao Ou; Cai, Hui; Chen, Zhi; Zheng, Wei] Vanderbilt Univ, Med Ctr, Dept Med, Vanderbilt Epidemiol Ctr,Div Epidemiol, Nashville, TN 37203 USA; [Shu, Xiao Ou; Cai, Hui; Chen, Zhi; Zheng, Wei] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37203 USA; [Zheng, Ying; Gu, Kai; Lu, Wei] Shanghai Inst Prevent Med, Shanghai, Peoples R China	Vanderbilt University; Vanderbilt University	Shu, XO (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Vanderbilt Epidemiol Ctr,Div Epidemiol, 2525 W End Ave,Ste 600, Nashville, TN 37203 USA.	xiao-ou.shu@vanderbilt.edu	Zheng, Wei/O-3351-2013; Lu, Wei/AAE-2921-2022; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; Lu, Wei/0000-0002-4150-8674; 	US Department of Defense [DAMD17-02-1-0607]; National Cancer Institute [R01 CA118229]; NATIONAL CANCER INSTITUTE [R01CA118229] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the US Department of Defense Breast Cancer Research Program (grant DAMD17-02-1-0607) and the National Cancer Institute (grant R01 CA118229).	Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Albertazzi P, 1998, OBSTET GYNECOL, V91, P6, DOI 10.1016/S0029-7844(97)00597-8; [Anonymous], 1998, INT CLASSIFICATION D; CASSIDY A, 1994, AM J CLIN NUTR, V60, P333, DOI 10.1093/ajcn/60.3.333; Cassidy Aedin, 2006, J Br Menopause Soc, V12, P49, DOI 10.1258/136218006777525776; Clarkson TB, 2002, J NUTR, V132, p566S, DOI 10.1093/jn/132.3.566S; Constantinou AI, 2005, EUR J CANCER, V41, P647, DOI 10.1016/j.ejca.2004.12.005; Duncan AM, 1999, J CLIN ENDOCR METAB, V84, P192, DOI 10.1210/jc.84.1.192; Grunau GL, 2006, J CLIN EPIDEMIOL, V59, P274, DOI 10.1016/j.jclinepi.2005.08.007; Guha N, 2009, BREAST CANCER RES TR, V118, P395, DOI 10.1007/s10549-009-0321-5; Harrell FE, 2001, REGRESSION MODELING; Helferich W. G., 2008, Inflammopharmacology, V16, P219, DOI 10.1007/s10787-008-8020-0; Horn-Ross PL, 2003, J NATL CANCER I, V95, P1158, DOI 10.1093/jnci/djg015; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Ishimi Y, 2009, FORUM NUTR, V61, P104, DOI 10.1159/000212743; Ju YH, 2002, CANCER RES, V62, P2474; Lee SA, 2009, AM J CLIN NUTR, V89, P1920, DOI 10.3945/ajcn.2008.27361; Lu LJW, 1996, CANCER EPIDEM BIOMAR, V5, P63; Messina MJ, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-17; Mouridsen HT, 2003, BREAST, V12, pS2, DOI 10.1016/S0960-9776(03)80158-3; MURKIES AL, 1995, MATURITAS, V21, P189, DOI 10.1016/0378-5122(95)00899-V; Nagata C, 1998, JNCI-J NATL CANCER I, V90, P1830, DOI 10.1093/jnci/90.23.1830; Pierce JP, 2007, J CLIN ONCOL, V25, P2345, DOI 10.1200/JCO.2006.08.6819; Pierce JP, 2007, JAMA-J AM MED ASSOC, V298, P289, DOI 10.1001/jama.298.3.289; Pierce JP, 2009, CURR OPIN OBSTET GYN, V21, P86, DOI 10.1097/GCO.0b013e32831da7f2; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; Schwartz JA, 1998, BIOCHEM BIOPH RES CO, V253, P38, DOI 10.1006/bbrc.1998.9751; Shen F, 1999, ANTICANCER RES, V19, P1657; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Tanos V, 2002, EUR J OBSTET GYN R B, V102, P188, DOI 10.1016/S0301-2115(01)00582-6; Taylor CK, 2009, NUTR REV, V67, P398, DOI 10.1111/j.1753-4887.2009.00213.x; Trock BJ, 2006, JNCI-J NATL CANCER I, V98, P459, DOI 10.1093/jnci/djj102; *UN SOYB BOARD, NAT REP CONS ATT NUT; Velentzis LS, 2008, EUR J CANCER, V44, P1799, DOI 10.1016/j.ejca.2008.05.019; Washburn S, 1999, MENOPAUSE, V6, P7; Wu AH, 2008, BRIT J CANCER, V98, P9, DOI 10.1038/sj.bjc.6604145; Yang Y, 2002, CHINESE FOOD COMPOSI	37	276	289	2	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2437	2443		10.1001/jama.2009.1783	http://dx.doi.org/10.1001/jama.2009.1783			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996398	Green Accepted, Bronze			2022-12-24	WOS:000272520500022
J	Echevarria-Zuno, S; Mejia-Arangure, JM; Mar-Obeso, AJ; Grajales-Muniz, C; Robles-Perez, E; Gonzalez-Leon, M; Ortega-Alvarez, MC; Gonzalez-Bonilla, C; Rascon-Pacheco, RA; Borja-Aburto, VH				Echevarria-Zuno, Santiago; Manuel Mejia-Arangure, Juan; Mar-Obeso, Alvaro J.; Grajales-Muniz, Concepcion; Robles-Perez, Eduardo; Gonzalez-Leon, Margot; Carlos Ortega-Alvarez, Manuel; Gonzalez-Bonilla, Cesar; Alberto Rascon-Pacheco, Ramon; Hugo Borja-Aburto, Victor			Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis	LANCET			English	Article							SWINE; OUTBREAK; HUMANS	Background in April, 2009, the first cases of influenza A H1N1 were registered in Mexico and associated with an unexpected number of deaths. We report the timing and spread of H1N1 in cases, and explore protective and risk factors for infection, severe disease, and death. Methods We analysed information gathered by the influenza surveillance system from April 28 to July 31, 2009, for patients with influenza-like illness who attended clinics that were part of the Mexican Institute for Social Security network. We calculated odds ratios (ORs) to compare risks of testing positive for H1N1 in those with influenza-like illness at clinic visits, the risk of admission for laboratory-confirmed cases of H1N1, and of death for inpatients according to demographic characteristics, clinical symptoms, seasonal influenza vaccine status, and elapsed time from symptom onset to admission. Findings By July 31, 63 479 cases of influenza-like illness were reported; 6945 (11%) cases of H1N1 were confirmed, 6407 (92%) were outpatients, 475 (7%) were admitted and survived, and 63 (<1%) died. Those aged 10-39 years were most affected (3922 [56%]). Mortality rates showed a J-shaped curve, with greatest risk in those aged 70 years and older (10.3%). Risk of infection was lowered in those who had been vaccinated for seasonal influenza (OR 0.65 [95% CI 0.55-0.77]). Delayed admission (1.19 [1.11-1.28] per day) and presence of chronic diseases (6.1 [2.37-15.99]) were associated with increased risk of dying. Interpretation Risk communication and hospital preparedness are key factors to reduce mortality from H1N1 infection. Protective effects of seasonal influenza vaccination for the virus need to be investigated.	[Manuel Mejia-Arangure, Juan; Mar-Obeso, Alvaro J.; Grajales-Muniz, Concepcion; Robles-Perez, Eduardo; Gonzalez-Leon, Margot; Carlos Ortega-Alvarez, Manuel; Gonzalez-Bonilla, Cesar; Alberto Rascon-Pacheco, Ramon; Hugo Borja-Aburto, Victor] Inst Mexicano Seguro Social, Direcc Prestaciones Med, Unidad Salud Publ, Mexico City 03100, DF, Mexico	Instituto Mexicano del Seguro Social	Borja-Aburto, VH (corresponding author), Inst Mexicano Seguro Social, Direcc Prestaciones Med, Unidad Salud Publ, Mier & Pesado 120, Mexico City 03100, DF, Mexico.	victor.borja@imss.gob.mx	León, Margot González/ABD-4622-2020; Mejia-Arangure, Juan Manuel/T-6743-2019	León, Margot González/0000-0002-3798-6729; Mejia-Arangure, Juan Manuel/0000-0001-8027-6231; Grajales Muniz, Concepcion/0000-0001-7923-5344; Gonzalez Bonilla, Cesar/0000-0002-2225-5069				Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cohen J, 2009, SCIENCE, V324, P996, DOI 10.1126/science.324_996; Cutler J, 2009, CAN MED ASSOC J, V181, P159, DOI 10.1503/cmaj.090859; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, P2840; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Lopez-Cervantes M, 2009, J INFECT DEV COUNTR, V3, P327, DOI 10.3855/jidc.238; Mangtani P, 2009, LANCET, V374, P429, DOI 10.1016/S0140-6736(09)61431-8; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; *NOV SWIN ORG INFL, 2009, NEW ENGL J MED, V260, P2605; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; *SECR SAL, 2009, 252 SECR SAL; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; World Health Organization, 2009, PAND H1N1 2009 UPD 6; World Health Organization, 2009, WHO INF LAB DIAGN PA; World Health Organization (WHO), 2009, INFL LIK ILLN US MEX; ZIMMER SM, 2000, NEW ENGL J MED, V361, P279; 2009, LANCET INFECT DIS, V9, P331; INTERIM GUIDANCE DET	25	281	299	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2072	2079		10.1016/S0140-6736(09)61638-X	http://dx.doi.org/10.1016/S0140-6736(09)61638-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	19913290				2022-12-24	WOS:000273122900030
J	Miller, AI; Foote, M				Miller, Arnold I.; Foote, Michael			Epicontinental Seas Versus Open-Ocean Settings: The Kinetics of Mass Extinction and Origination	SCIENCE			English	Article							ENVIRONMENTAL DETERMINANTS; ORDOVICIAN RADIATION; GEOGRAPHIC-VARIATION; NORTH-AMERICA; SELECTIVITY; RECOVERY; DYNAMICS; FOSSIL	Environmental perturbations during mass extinctions were likely manifested differently in epicontinental seas than in open-ocean-facing habitats of comparable depth. Here, we present a dissection of origination and extinction in epicontinental seas versus open-ocean-facing coastal regions in the Permian through Cretaceous periods, an interval through which both settings are well represented in the fossil record. Results demonstrate that extinction rates were significantly higher in open-ocean settings than in epicontinental seas during major mass extinctions but not at other times and that origination rates were significantly higher in open-ocean settings for a protracted interval from the Late Jurassic through the Late Cretaceous. These patterns are manifested even when other paleogeographic and environmental variables are held fixed, indicating that epicontinental seas and open-ocean-facing coastlines carry distinct macroevolutionary signatures.	[Miller, Arnold I.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Foote, Michael] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Cincinnati; University of Chicago	Miller, AI (corresponding author), Univ Cincinnati, Dept Geol, POB 210013, Cincinnati, OH 45221 USA.	arnold.miller@uc.edu			NASA; NSF	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank D. Buick, W. Kiessling, S. Kolbe, A. Lagomarcino, and J. Wittmer for discussions; two anonymous reviewers for helpful comments; A. Lagomarcino for assistance in drafting figures; and NASA (program in Exobiology) and NSF (programs in Biocomplexity and in Geology and Paleontology) for financial support. This is Paleobiology Database publication no. 102.	Allison PA, 2006, PALAIOS, V21, P513, DOI 10.2110/palo.2006.S06; Clapham ME, 2009, PALEOBIOLOGY, V35, P32, DOI 10.1666/08033.1; Emery K.O., 1984, GEOLOGY ATLANTIC OCE; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2006, PALEOBIOLOGY, V32, P345, DOI 10.1666/05062.1; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski D, 2003, P ROY SOC B-BIOL SCI, V270, P401, DOI 10.1098/rspb.2002.2243; Kiessling W, 2007, PALEOBIOLOGY, V33, P414, DOI 10.1666/06069.1; Krug AZ, 2007, PALEOBIOLOGY, V33, P435, DOI 10.1666/06039.1; Krug AZ, 2009, ASTROBIOLOGY, V9, P113, DOI 10.1089/ast.2008.0253; Miller AI, 1997, PALEOBIOLOGY, V23, P410, DOI 10.1017/S0094837300019813; Miller AI, 2001, PALEOBIOLOGY, V27, P768, DOI 10.1666/0094-8373(2001)027<0768:SAOHTA>2.0.CO;2; Miller AI, 2009, PALEOBIOLOGY, V35, P612, DOI 10.1666/0094-8373-35.4.612; Miller Arnold I., 1997, Geobios Memoire Special (Villeurbanne), V20, P397; Peters SE, 2008, NATURE, V454, P626, DOI 10.1038/nature07032; Peters SE, 2007, PALEOBIOLOGY, V33, P165, DOI 10.1666/06067.1; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; Shen SZ, 2002, PALEOBIOLOGY, V28, P449, DOI 10.1666/0094-8373(2002)028<0449:PEPOPB>2.0.CO;2; SLINGERLAND R, 1986, SEDIMENTOLOGY, V33, P487, DOI 10.1111/j.1365-3091.1986.tb00756.x; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318; Wells MR, 2007, J SEDIMENT RES, V77, P843, DOI 10.2110/jsr.2007.075	21	33	33	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 20	2009	326	5956					1106	1109		10.1126/science.1180061	http://dx.doi.org/10.1126/science.1180061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965428				2022-12-24	WOS:000271951000042
J	Baldi, C; Cho, S; Ellis, RE				Baldi, Chris; Cho, Soochin; Ellis, Ronald E.			Mutations in Two Independent Pathways Are Sufficient to Create Hermaphroditic Nematodes	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS HERMAPHRODITES; SEX DETERMINATION; REPRODUCTIVE ISOLATION; MOLECULAR ANALYSIS; SPERM ACTIVATION; GERM-LINE; C-ELEGANS; EVOLUTION; GENE; TRA-2	Although the nematode Caenorhabditis elegans produces self-fertile hermaphrodites, it descended from a male/female species, so hermaphroditism provides a model for the origin of novel traits. In the related species C. remanei, which has only male and female sexes, lowering the activity of tra-2 by RNA interference created XX animals that made spermatids as well as oocytes, but their spermatids could not activate without the addition of male seminal fluid. However, by lowering the expression of both tra-2 and swm-1, a gene that regulates sperm activation in C. elegans, we produced XX animals with active sperm that were self-fertile. Thus, the evolution of hermaphroditism in Caenorhabditis probably required two steps: a mutation in the sex-determination pathway that caused XX spermatogenesis and a mutation that allowed these spermatids to self-activate.	[Ellis, Ronald E.] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA; [Baldi, Chris] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Cho, Soochin] Creighton Univ, Dept Biol, Omaha, NE 68178 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Creighton University	Ellis, RE (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA.	ron.ellis@umdnj.edu			NSF [0543828]	NSF(National Science Foundation (NSF))	We thank the NSF for support ( grant 0543828), D. Greenstein for antibodies, Y. Shifmann for technical assistance, A. Singson and S. L'Hernault for advice, and E. Moss and R. Dutch for comments on this manuscript.	BAIRD SE, 1992, EVOLUTION, V46, P585, DOI [10.2307/2409629, 10.1111/j.1558-5646.1992.tb02067.x]; Baird SE, 2000, EVOL DEV, V2, P9, DOI 10.1046/j.1525-142x.2000.00031.x; Barriere A, 2009, GENOME RES, V19, P470, DOI 10.1101/gr.081851.108; Chasnov JR, 2007, P NATL ACAD SCI USA, V104, P6730, DOI 10.1073/pnas.0608050104; Chen PJ, 2001, GENETICS, V158, P1513; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Ellis RE, 2008, CURR TOP DEV BIOL, V83, P41, DOI 10.1016/S0070-2153(08)00402-X; Geldziler B, 2006, DEV GENES EVOL, V216, P198, DOI 10.1007/s00427-005-0045-4; Geldziler B, 2005, DEV BIOL, V283, P424, DOI 10.1016/j.ydbio.2005.04.036; GUO Y, CURRENT BIO IN PRESS; Haag ES, 2002, CURR BIOL, V12, P2035, DOI 10.1016/S0960-9822(02)01333-7; Haag ES, 2000, GENETICS, V155, P105; Hansen D, 1998, GENETICS, V149, P1353; Hill RC, 2006, DEV CELL, V10, P531, DOI 10.1016/j.devcel.2006.02.002; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Kuwabara PE, 1996, GENETICS, V144, P597; LHERNAULT SW, 2006, WORMBOOK C ELEGANS R, DOI DOI 10.1895/WORMBOOK.1.85.1; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Minniti AN, 1996, GENETICS, V143, P213; Nayak S, 2005, PLOS BIOL, V3, P57, DOI 10.1371/journal.pbio.0030006; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; ROBERTS TM, 1995, CURR OPIN CELL BIOL, V7, P13, DOI 10.1016/0955-0674(95)80039-5; SCHEDL T, 1988, GENETICS, V119, P43; SHAKES DC, 1989, DEV BIOL, V134, P189, DOI 10.1016/0012-1606(89)90088-2; Stanfield GM, 2006, CURR BIOL, V16, P252, DOI 10.1016/j.cub.2005.12.041; Stothard P, 2006, J MOL EVOL, V62, P281, DOI 10.1007/s00239-005-0084-5; Wang SP, 2001, EMBO J, V20, P1363, DOI 10.1093/emboj/20.6.1363; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; ZARKOWER D, 2006, WORMBOOK C ELEGANS R, DOI DOI 10.1895/WORMBOOK.1.84.1; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812	31	54	57	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					1002	1005		10.1126/science.1176013	http://dx.doi.org/10.1126/science.1176013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965511				2022-12-24	WOS:000271712300042
J	Bland, B				Bland, Ben			Global Health Commercial solutions to malnutrition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												theasiafile@gmail.com						[Anonymous], 2008, LANCET; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Darnton-Hill I, 2002, P NUTR SOC, V61, P231, DOI 10.1079/PNS2002150; *WORLD FOOD PROGR, 2008, HOUS FOOD SEC NUTR A; Zlotkin SH, 2005, PLOS MED, V2, P24, DOI 10.1371/journal.pmed.0020001	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2009	339								b4482	10.1136/bmj.b4482	http://dx.doi.org/10.1136/bmj.b4482			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UC	19889735				2022-12-24	WOS:000271567800003
J	Crowley, S; Rollins, N; Shaffer, N; Guerma, T; Vitoria, M; Lo, YR				Crowley, Siobhan; Rollins, Nigel; Shaffer, Nathan; Guerma, Teguest; Vitoria, Marco; Lo, Ying-ru			New WHO HIV treatment and prevention guidelines	LANCET			English	Editorial Material									[Crowley, Siobhan; Shaffer, Nathan; Guerma, Teguest; Vitoria, Marco; Lo, Ying-ru] WHO, Dept HIV AIDS, CH-1211 Geneva 27, Switzerland; [Rollins, Nigel] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland	World Health Organization; University of Geneva; World Health Organization	Crowley, S (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva 27, Switzerland.	crowleys@who.int						*GLOB HIV TREATM W, 2009, TREATM WHIT PAP; Severe P, 2009, 49 INT C ANT AG CHEM; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; *UN, 2001, DECL COMM HIV AIDS; *UNAIDS, 2009, 09 HIV EP UPD; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; *WHO, 2009, ANT THER HIV PREV; World Health Organization, ANT THER; 2008, BMJ, V336, P924	9	13	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					874	875		10.1016/S0140-6736(09)62064-X	http://dx.doi.org/10.1016/S0140-6736(09)62064-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	574NA	19954834				2022-12-24	WOS:000275995300008
J	Jha, AK; Orav, EJ; Epstein, AM				Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.			Public Reporting of Discharge Planning and Rates of Readmissions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; QUALITY-OF-CARE; MEDICARE BENEFICIARIES; RANDOMIZED-TRIALS; MORTALITY-RATES; UNITED-STATES; PERFORMANCE; SYSTEM	BACKGROUND A reduction in hospital readmissions may improve quality and reduce costs. The Centers for Medicare and Medicaid Services has initiated a national effort to measure and publicly report on the conduct of discharge planning. We know little about how U. S. hospitals perform on the current discharge metrics, the factors that underlie better performance, and whether better performance is related to lower readmission rates. METHODS We examined hospital performance on the basis of two measures of discharge planning: the adequacy of documentation in the chart that discharge instructions were provided to patients with congestive heart failure, and patient-reported experiences with discharge planning. We examined the association between performance on these measures and rates of readmission for congestive heart failure and pneumonia. RESULTS We found a weak correlation in performance between the two discharge measures (r = 0.05, P<0.001). Although larger hospitals performed better on the chart-based measure, smaller hospitals and those with higher nurse-staffing levels performed better on the patient-reported measure. We found no association between performance on the chart-based measure and readmission rates among patients with congestive heart failure ( readmission rates among hospitals performing in the highest quartile vs. the lowest quartile, 23.7% vs. 23.5%; P = 0.54) and only a very modest association between performance on the patient-reported measure and readmission rates for congestive heart failure ( readmission rates among hospitals performing in the highest quartile vs. the lowest quartile, 22.4% vs. 24.7%; P<0.001) and pneumonia (17.5% vs. 19.5%, P<0.001). CONCLUSIONS Our findings suggest that current efforts to collect and publicly report data on discharge planning are unlikely to yield large reductions in unnecessary readmissions.	[Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu			Commonwealth Fund	Commonwealth Fund	Supported by the Commonwealth Fund.	[Anonymous], 2007, MPA COMMITTEE REPORT; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AM, 2009, NEW ENGL J MED, V360, P1457, DOI 10.1056/NEJMe0901006; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; *QUALITYNET, 2009, SPEC MAN NAT HOSP IN; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Schoen C, 2006, HEALTH AFFAIR, V25, pW457, DOI 10.1377/hlthaff.25.w457; Wennberg JE, 1998, DARTMOUTH ATLAS HLTH	19	185	186	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2637	2645		10.1056/NEJMsa0904859	http://dx.doi.org/10.1056/NEJMsa0904859			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042755	Bronze			2022-12-24	WOS:000273181300011
J	Seaman, MNJ				Seaman, Matthew N. J.			Enhanced SnapShot: Endosome-to-Golgi Retrieval	CELL			English	Editorial Material							RETROGRADE TRANSPORT; COMPLEX; RECRUITMENT; RECOGNITION; NETWORK; YEAST; RAB7		Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Seaman, MNJ (corresponding author), Cambridge Inst Med Res, Cambridge CB2 0XY, England.				MRC [G0700750] Funding Source: UKRI; Medical Research Council [G0700750] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Perez-Victoria FJ, 2008, MOL BIOL CELL, V19, P2350, DOI 10.1091/mbc.E07-11-1189; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016	10	4	4	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 11	2009	139	6							1198.e1	10.1016/j.cell.2009.11.040	http://dx.doi.org/10.1016/j.cell.2009.11.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005812	Bronze			2022-12-24	WOS:000272622800021
J	Birnkrant, D; Cox, E				Birnkrant, Debra; Cox, Edward			The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Birnkrant, Debra; Cox, Edward] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Birnkrant, D (corresponding author), US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							*FOOD DRUG ADM, 2009, EM US AUTH PER FACT; *FOOD DRUG ADM, 2009, EM US AUTH MED PROD	2	147	152	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2204	2207		10.1056/NEJMp0910479	http://dx.doi.org/10.1056/NEJMp0910479			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525ZM	19884645	Bronze			2022-12-24	WOS:000272257100002
J	Galiana, I; Green, C				Galiana, Isabel; Green, Christopher			Let the global technology race begin	NATURE			English	Editorial Material							ENERGY; STABILIZATION; EMISSION		[Galiana, Isabel; Green, Christopher] McGill Univ, Dept Econ, Montreal, PQ H3A 2T7, Canada	McGill University	Galiana, I (corresponding author), McGill Univ, Dept Econ, Montreal, PQ H3A 2T7, Canada.	isabel.galiana@mail.mcgill.ca; chris.green@mcgill.ca						Barrett AJ, 2009, LEUKEMIA, V23, P53, DOI 10.1038/leu.2008.273; Caldeira K, 2003, SCIENCE, V299, P2052, DOI 10.1126/science.1078938; Galiana I., 2009, ANAL TECHNOLOGY LED; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Hoffert MI, 1998, NATURE, V395, P881, DOI 10.1038/27638; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Nemet GF, 2009, RES POLICY, V38, P700, DOI 10.1016/j.respol.2009.01.004; Pielke R, 2008, NATURE, V452, P531, DOI 10.1038/452531a; Schlesinger ME, 2007, HUMAN-INDUCED CLIMATE CHANGE: AN INTERDISCIPLINARY ASSESSMENT, P1, DOI 10.1017/CBO9780511619472; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0	10	34	34	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					570	571		10.1038/462570a	http://dx.doi.org/10.1038/462570a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	526HH	19956241				2022-12-24	WOS:000272277900018
J	Smith, DP; King, MT; Egger, S; Berry, MP; Stricker, PD; Cozzi, P; Ward, J; O'Connell, DL; Armstrong, BK				Smith, David P.; King, Madeleine T.; Egger, Sam; Berry, Martin P.; Stricker, Phillip D.; Cozzi, Paul; Ward, Jeanette; O'Connell, Dianne L.; Armstrong, Bruce K.			Quality of life three years after diagnosis of localised prostate cancer: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RADICAL PROSTATECTOMY; HEALTH; OUTCOMES; URINARY; MEN; RECALL	Objective To quantify the risk and severity of negative effects of treatment for localised prostate cancer on long term quality of life. Design Population based, prospective cohort study with follow-up over three years. Setting New South Wales, Australia. Participants Men with localised prostate cancer were eligible if aged less than 70 years, diagnosed between October 2000 and October 2002, and notified to the New South Wales central cancer registry. Controls were randomly selected from the New South Wales electoral roll and matched to cases by age and postcode. Main outcome measures General health specific and disease specific function up to three years after diagnosis, according to the 12 item short form health survey and the University of California, Los Angeles prostate cancer index. Results 1642 (64%) cases and 495 (63%) eligible and contacted controls took part in the study. After adjustment for confounders, all active treatment groups had low odds of having better sexual function than controls, in particular men on androgen deprivation therapy ( adjusted odds ratio ( OR) 0.02, 95% CI 0.01 to 0.07). Men treated surgically reported the worst urinary function ( adjusted OR 0.17, 95% CI 0.13 to 0.22). Bowel function was poorest in cases who had external beam radiotherapy (adjusted OR 0.44, 95% CI 0.30 to 0.64). General physical and mental health scores were similar across treatment groups, but poorest in men who had androgen deprivation therapy. Conclusions The various treatments for localised prostate cancer each have persistent effects on quality of life. Sexual dysfunction three years after diagnosis was common in all treatment groups, whereas poor urinary function was less common. Bowel function was most compromised in those who had external beam radiotherapy. Men with prostate cancer and the clinicians who treat them should be aware of the effects of treatment on quality of life, and weigh them up against the patient's age and the risk of progression of prostate cancer if untreated to make informed decisions about treatment.	[Smith, David P.; Egger, Sam; O'Connell, Dianne L.] NSW Canc Council, Kings Cross, NSW 1340, Australia; [King, Madeleine T.] Univ Sydney, PoCoG, Qual Life Off, Sydney, NSW 2006, Australia; [Berry, Martin P.] Liverpool Canc Therapy Ctr, Canc Serv, Liverpool, NSW 2170, Australia; [Stricker, Phillip D.] St Vincents Clin, St Vincents Prostate Canc Ctr, Darlinghurst, NSW 2010, Australia; [Cozzi, Paul] St George Hosp, Dept Urol, Kogarah, NSW 2217, Australia; [Ward, Jeanette] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Armstrong, Bruce K.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	Cancer Council New South Wales; University of Sydney; St George Hospital; University of Ottawa; University of Sydney	Smith, DP (corresponding author), NSW Canc Council, Kings Cross, NSW 1340, Australia.	dsmith@nswcc.org.au	Armstrong, Bruce K/K-9464-2015	Armstrong, Bruce K/0000-0001-8940-7525; Stricker, Phillip/0000-0002-0934-0656; Egger, Sam/0000-0003-1808-6909; Smith, David/0000-0002-1474-3214	Australian Commonwealth Department of Veterans Affairs; National Health and Medical Research Council of Australia [387700]; University of Sydney Medical Foundation	Australian Commonwealth Department of Veterans Affairs; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Medical Foundation(University of Sydney)	This research was funded by grants from the Australian Commonwealth Department of Veterans Affairs and project grant 387700 from the National Health and Medical Research Council of Australia. BKA is supported by a University of Sydney Medical Foundation Program Grant. The funder had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of data; the writing of the manuscript; or the decision to submit the manuscript for publication.	*AIHW, 2007, ACIM AUSTR CANC INC; Arredondo SA, 2004, J UROLOGY, V172, P1830, DOI 10.1097/01.ju.0000140758.04424.77; *AUSTR BUR STAT, 2004, 81593 AUSTR BUR STAT; *AUSTR CANC NETW W, 2002, CLIN PRACT GUID EV B; Australian Bureau of Statistics, 1997, NAT HLTH SURV SF 36; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P1650, DOI 10.1002/cncr.23373; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Eton DT, 2002, PSYCHO-ONCOL, V11, P307, DOI 10.1002/pon.572; Hoffman RM, 2004, CANCER, V101, P2011, DOI 10.1002/cncr.20608; Johnson TK, 2004, J CLIN ONCOL, V22, P4193, DOI 10.1200/JCO.2004.09.127; Korfage IJ, 2005, INT J CANCER, V116, P291, DOI 10.1002/ijc.21043; Legler J, 2000, MED CARE, V38, P847, DOI 10.1097/00005650-200008000-00008; Litwin MS, 1999, J CLIN ONCOL, V17, P2882, DOI 10.1200/JCO.1999.17.9.2882; Litwin MS, 1998, J UROLOGY, V159, P1988, DOI 10.1016/S0022-5347(01)63222-1; LITWIN MS, 2002, RAND 12 ITEM HLTH SU; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Mols F, 2006, CANCER-AM CANCER SOC, V107, P2186, DOI 10.1002/cncr.22231; Penson DF, 2007, CANCER J, V13, P318, DOI 10.1097/PPO.0b013e3181570121; Penson DF, 2005, J UROLOGY, V173, P1701, DOI 10.1097/01.ju.0000154637.38262.3a; Penson DF, 2003, J CLIN ONCOL, V21, P1147, DOI 10.1200/JCO.2003.07.139; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; Rabbani F, 2000, J UROLOGY, V164, P1929, DOI 10.1016/S0022-5347(05)66921-2; Ries LAG, 2007, SEER CANC STAT REV 1; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schwartz CE, 2000, ADAPTATION CHANGING; Smith DP, 2007, J CLIN ONCOL, V25, P2560, DOI 10.1200/JCO.2006.09.8046; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Tracey E, 2007, CANC NEW S WALES INC; Vickers AJ, 2007, JNCI-J NATL CANCER I, V99, P1171, DOI 10.1093/jnci/djm060; Walsh PC, 2000, UROLOGY, V55, P58, DOI 10.1016/S0090-4295(99)00397-0; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Wei J T, 2000, Semin Urol Oncol, V18, P76; Wilt T, 2008, COMP EFFECTIVENESS T; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Zeliadt SB, 2007, MED CARE, V45, P154, DOI 10.1097/01.mlr.0000241044.09778.3f	39	190	190	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2009	339								b4817	10.1136/bmj.b4817	http://dx.doi.org/10.1136/bmj.b4817			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525AX	19945997	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000272186600001
J	Hergott, LJ				Hergott, Lawrence J.			Feeding the Turkey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lhergott@comcast.net						Hergott LJ, 2009, ANN INTERN MED, V151, P753	1	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2188	2189		10.1001/jama.2009.1586	http://dx.doi.org/10.1001/jama.2009.1586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	19934409				2022-12-24	WOS:000272080500001
J	Richter, DD; Mobley, ML				Richter, Daniel deB., Jr.; Mobley, Megan L.			Monitoring Earth's Critical Zone	SCIENCE			English	Editorial Material									[Richter, Daniel deB., Jr.; Mobley, Megan L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University	Richter, DD (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	drichter@duke.edu	Mobley, Megan/AAF-3560-2020; Mobley, Megan L/A-5402-2010; Richter, D.D./AAN-4583-2021	Mobley, Megan/0000-0002-6046-8380; Mobley, Megan L/0000-0002-6046-8380; 				[Anonymous], 2001, UNDERSTANDING SOIL C; [Anonymous], 2009, INTEGRATED CROP RESO; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Franzluebbers AJ, 2005, SOIL TILL RES, V83, P1, DOI 10.1016/j.still.2005.02.020; Fuchs JW, 2009, J ENVIRON QUAL, V38, P473, DOI 10.2134/jeq2008.0201; Janzen HH, 2009, GLOBAL CHANGE BIOL, V15, P2770, DOI 10.1111/j.1365-2486.2009.01971.x; National Research Council, 2009, OBS WEATH CLIM GROUN; National Research Council, 2001, BAS RES OPP EARTH SC; National Research Council, 2009, RESTR FED CLIM RES M; Richter DD, 2007, SOIL SCI SOC AM J, V71, P266, DOI 10.2136/sssaj2006.0181; Robertson GP, 2008, BIOSCIENCE, V58, P640, DOI 10.1641/B580711; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Weaver JE., 1922, DEV ACTIVITIES ROOTS; Zalasiewicz J., 2008, GSA TODAY, V18, P4, DOI DOI 10.1130/GSAT01802A.1; Zhao XR, 2007, GEODERMA, V142, P237, DOI 10.1016/j.geoderma.2007.07.012	15	84	92	15	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 20	2009	326	5956					1067	1068		10.1126/science.1179117	http://dx.doi.org/10.1126/science.1179117			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521UW	19965414				2022-12-24	WOS:000271951000025
J	Visscher, PM; Montgomery, GW				Visscher, Peter M.; Montgomery, Grant W.			Genome-wide Association Studies and Human Disease From Trickle to Flood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Visscher, Peter M.] Queensland Inst Med Res, Dept Stat Genet, Brisbane, Qld 4006, Australia; [Montgomery, Grant W.] Queensland Inst Med Res, Dept Mol Epidemiol, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute	Visscher, PM (corresponding author), Queensland Inst Med Res, Dept Stat Genet, 300 Herston Rd, Brisbane, Qld 4006, Australia.	peter.visscher@qimr.edu.au	Montgomery, Grant W/B-7148-2008; Visscher, Peter/ABB-6151-2020	Montgomery, Grant W/0000-0002-4140-8139; Visscher, Peter/0000-0002-2143-8760				Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Majithia AR, 2009, CURR OPIN ENDOCRINOL, V16, P100, DOI 10.1097/MED.0b013e3283292354; National Human Genome Research Institute, CAT GEN WID ASS STUD; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489	9	43	45	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					2028	2029		10.1001/jama.2009.1643	http://dx.doi.org/10.1001/jama.2009.1643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903925				2022-12-24	WOS:000271619700032
J	Parker, JM; Bhattacharjee, M				Parker, Jason M.; Bhattacharjee, Modushudan			Peripartum Diastasis of the Symphysis Pubis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas Houston, Sch Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Parker, JM (corresponding author), Univ Texas Houston, Sch Med, Houston, TX 77030 USA.	modushudan.bhattacharjee@uth.tmc.edu							0	17	20	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1886	1886		10.1056/NEJMicm0807117	http://dx.doi.org/10.1056/NEJMicm0807117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514OZ	19890131				2022-12-24	WOS:000271405800014
J	Yabroff, KR; Saraiya, M; Meissner, HI; Haggstrom, DA; Wideroff, L; Yuan, G; Berkowitz, Z; Davis, WW; Benard, VB; Coughlin, SS				Yabroff, K. Robin; Saraiya, Mona; Meissner, Helen I.; Haggstrom, David A.; Wideroff, Louise; Yuan, Gigi; Berkowitz, Zahava; Davis, William W.; Benard, Vicki B.; Coughlin, Steven S.			Specialty Differences in Primary Care Physician Reports of Papanicolaou Test Screening Practices: A National Survey, 2006 to 2007	ANNALS OF INTERNAL MEDICINE			English	Article							CERVICAL-CANCER PREVENTION; HUMAN-PAPILLOMAVIRUS; UNITED-STATES; WOMEN; HEALTH; BREAST; NEOPLASIA; SERVICES; IMPACT; RECOMMENDATIONS	Background: Cervical cancer screening guidelines were substantially revised in 2002 and 2003. Little information is available about primary care physicians' current Papanicolaou (Pap) test screening practices, including initiation, frequency, and stopping. Objective: To assess current Pap test screening practices in the United States. Design: Cross-sectional survey. Setting: Nationally representative sample of physicians during 2006 to 2007. Participants: 1212 primary care physicians. Measurements: The survey included questions about physician and practice characteristics and recommendations for Pap screening presented as clinical vignettes describing women by age and by sexual and screening histories. A composite measure-guideline-consistent recommendations-was created by using responses to vignettes in which major guidelines were uniform. Results: Most physicians reported providing Pap tests to their eligible patients (91.0% [95% CI, 89.0% to 92.6%]). Among Pap test providers (n = 1114), screening practices, including number of tests ordered or performed, use of patient reminder systems, and cytology method used, varied by physician specialty (P < 0.001). Although most Pap test providers reported that screening guidelines were very influential in their clinical practice, few had guideline-consistent recommendations for starting and stopping Pap screening across multiple vignettes (22.3% [CI, 19.9% to 25.0%]). Guideline-consistent recommendations varied by specialty (obstetrics/gynecology, 16.4%; internal medicine, 27.5%; and family or general practice, 21.1%). Compared with obstetricians/gynecologists, internal medicine specialists and family or general practice specialists were more likely to have guideline-consistent screening recommendations (odds ratio, 1.98 [CI, 1.22 to 3.23] and 1.45 [CI, 0.99 to 2.13], respectively) in multivariate analysis. Limitation: Physician self-report may reflect idealized rather than actual practice. Conclusion: Primary care physicians' recommendations for Pap test screening are not consistent with screening guidelines, reflecting overuse of screening. Implementation of effective interventions that focus on potentially modifiable physician and practice factors is needed to improve screening practice. Primary Funding Source: National Cancer Institute, Centers for Disease Control and Prevention, and Agency for Healthcare Research and Quality.	[Yabroff, K. Robin] NCI, Hlth Serv, Bethesda, MD 20892 USA; NIH, Bethesda, MD 20892 USA; Informat Management Serv Inc, Silver Spring, MD USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Regenstrief Inst Hlth Care, Vet Affairs Med Ctr, Indianapolis, IN USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Dept Vet Affairs, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Information Management Services, Inc.; Centers for Disease Control & Prevention - USA; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Indiana University System; Indiana University-Purdue University Indianapolis	Yabroff, KR (corresponding author), NCI, Hlth Serv, Execut Plaza N,Room 4005,6130 Execut Blvd, Bethesda, MD 20892 USA.	yabroffr@mail.nih.gov	Hernandez, Jessica/G-6527-2011	Yabroff, K. Robin/0000-0003-0644-5572	National Cancer Institute [N02-PC51308]; Centers for Disease Control and Prevention [Y3-PC-6017-01]; Agency for Healthcare Research and Quality [Y3-PC-5019-01, Y3-PC-5019-02]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the National Cancer Institute (contract N02-PC51308), Centers for Disease Control and Prevention (interagency agreement Y3-PC-6017-01), and Agency for Healthcare Research and Quality ( interagency agreements Y3-PC-5019-01 and Y3-PC-5019-02).	ACOG Comm Obstet Practice, 2003, OBSTET GYNECOL, V102, P415; [Anonymous], 2003, AM J NURS, V103, P108; Aro AR, 2000, EUR J CANCER, V36, P1089, DOI 10.1016/S0959-8049(00)00065-4; AVORN JL, 2001, ANTIBIOTIC RESISTANC, P1; Berg AO, 2003, AM J NURS, V103, P101; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Cooper CP, 2005, J WOMENS HEALTH, V14, P670, DOI 10.1089/jwh.2005.14.670; Coughlin SS, 2005, CANCER EPIDEM BIOMAR, V14, P1143, DOI 10.1158/1055-9965.EPI-04-0559; Coughlin SS, 2002, CANCER-AM CANCER SOC, V94, P2801, DOI 10.1002/cncr.10577; Goldrick BA, 2003, AM J NURS, V103, P105, DOI 10.1097/00000446-200303000-00043; Hawley ST, 2001, CANCER DETECT PREV, V25, P309; Heflin MT, 2006, J GERONTOL A-BIOL, V61, P844, DOI 10.1093/gerona/61.8.844; Helms LJ, 1999, MED CARE, V37, P652, DOI 10.1097/00005650-199907000-00005; Huang AJ, 2008, J GEN INTERN MED, V23, P1324, DOI 10.1007/s11606-008-0633-x; Klabunde CN, 2003, PREV MED, V36, P352, DOI 10.1016/S0091-7435(02)00066-X; Lafata JE, 2004, CANCER EPIDEM BIOMAR, V13, P2126; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Leyden WA, 2005, JNCI-J NATL CANCER I, V97, P675, DOI 10.1093/jnci/dji115; Lipkus IM, 2000, PSYCHO-ONCOLOGY, V9, P402, DOI 10.1002/1099-1611(200009/10)9:5<402::AID-PON475>3.3.CO;2-L; Lowe JB, 1999, CANCER, V85, P1114, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1114::AID-CNCR15>3.0.CO;2-Y; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; MAMON JA, 1990, PREV MED, V19, P363, DOI 10.1016/0091-7435(90)90036-J; Meissner HI, 2008, J GEN INTERN MED, V23, P1822, DOI 10.1007/s11606-008-0775-x; Melanson SEF, 2007, AM J CLIN PATHOL, V127, P604, DOI 10.1309/ELH5BPQ0T17RRK0M; MONTANO DE, 1995, AM J PUBLIC HEALTH, V85, P795, DOI 10.2105/AJPH.85.6.795; Murphy PA, 2008, J MIDWIFERY WOM HEAL, V53, P11, DOI 10.1016/j.jmwh.2007.06.014; *NAT CANC I CDCP A, NAT SURV PRIM CAR PH; *NCQA, 2003, HEDIS HLTH PLAN EMPL; Noller KL, 2003, OBSTET GYNECOL, V102, P259, DOI 10.1016/S0029-7844(03)00565-9; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; RANSOHOFF DF, 1991, ANN INTERN MED, V114, P177, DOI 10.7326/0003-4819-114-3-177; *RES TRIANGL I, 2004, SUDAAN LANG MAN REL; Ries L MD, 2008, SEER CANC STAT REV 1; Sabatino SA, 2008, AM J PREV MED, V35, pS67, DOI 10.1016/j.amepre.2008.04.008; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Saint M, 2005, AM J OBSTET GYNECOL, V192, P414, DOI 10.1016/j.ajog.2004.09.026; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; SCHWARTZ JS, 1991, ANN INTERN MED, V114, P46, DOI 10.7326/0003-4819-114-1-46; Sirovich BE, 2005, AM J MED, V118, P151, DOI 10.1016/j.amjmed.2004.08.021; Sirovich BE, 2004, JAMA-J AM MED ASSOC, V291, P2990, DOI 10.1001/jama.291.24.2990; Solomon DH, 1998, JAMA-J AM MED ASSOC, V280, P2020, DOI 10.1001/jama.280.23.2020; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; Stout NK, 2008, ARCH INTERN MED, V168, P1881, DOI 10.1001/archinte.168.17.1881; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; The American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C; Tiro JA, 2008, CANCER-AM CANCER SOC, V113, P3013, DOI 10.1002/cncr.23760; Tsui J, 2007, J WOMENS HEALTH, V16, P1447, DOI 10.1089/jwh.2006.0279; Yabroff KR, 2005, MED CARE RES REV, V62, P79, DOI 10.1177/1077558704271725; Yeazel MW, 2006, PREV MED, V43, P86, DOI 10.1016/j.ypmed.2006.03.021	49	80	82	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2009	151	9					602	W197		10.7326/0003-4819-151-9-200911030-00005	http://dx.doi.org/10.7326/0003-4819-151-9-200911030-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514IM	19884621				2022-12-24	WOS:000271387700002
J	Liu, X; Long, FH; Peng, HC; Aerni, SJ; Jiang, M; Sanchez-Blanco, A; Murray, JI; Preston, E; Mericle, B; Batzoglou, S; Myers, EW; Kim, SK				Liu, Xiao; Long, Fuhui; Peng, Hanchuan; Aerni, Sarah J.; Jiang, Min; Sanchez-Blanco, Adolfo; Murray, John I.; Preston, Elicia; Mericle, Barbara; Batzoglou, Serafim; Myers, Eugene W.; Kim, Stuart K.			Analysis of Cell Fate from Single-Cell Gene Expression Profiles in C. elegans	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; SPECIFICATION; LINEAGE; EMBRYOS; PAL-1; BLASTOMERE; SIGNATURES; INDUCTION; PROTEIN; SYSTEM	The C. elegans cell lineage provides a unique opportunity to look at how cell lineage affects patterns of gene expression. We developed an automatic cell lineage analyzer that converts high-resolution images of worms into a data table showing fluorescence expression with single-cell resolution. We generated expression profiles of 93 genes in 363 specific cells from L1 stage larvae and found that cells with identical fates can be formed by different gene regulatory pathways. Molecular signatures identified repeating cell fate modules within the cell lineage and enabled the generation of a molecular differentiation map that reveals points in the cell lineage when developmental fates of daughter cells begin to diverge. These results demonstrate insights that become possible using computational approaches to analyze quantitative expression from many genes in parallel using a digital gene expression atlas.	[Liu, Xiao; Jiang, Min; Sanchez-Blanco, Adolfo; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Long, Fuhui; Peng, Hanchuan; Myers, Eugene W.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Aerni, Sarah J.; Batzoglou, Serafim] Stanford Univ, Med Ctr, Dept Comp Sci, Stanford, CA 94305 USA; [Murray, John I.; Preston, Elicia; Mericle, Barbara] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Washington; University of Washington Seattle	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	kim@cmgm.stanford.edu	Peng, Hanchuan/A-1798-2011; Kersebaum, Kurt Christian/A-7558-2010; 2009, Secribsal/A-1266-2012	Kersebaum, Kurt Christian/0000-0002-3679-8427; Liu, Xiao/0000-0001-8354-4000	National Institutes of Aging; Howard Hughes Medical Foundation; Larry L. Hillblom Foundation; William R. Hewlett Stanford Graduate Fellowship; National Science Foundation Fellowship; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Foundation(Howard Hughes Medical Institute); Larry L. Hillblom Foundation; William R. Hewlett Stanford Graduate Fellowship; National Science Foundation Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Denis Dupuy and Marc Vidal for promoter DNA, Andy Fire for the myo-3: GFP strain, and Erik Jorgensen for the dpy-30: mCherry strain. We thank Robert Waterston for mCherry strains. We thank members of the Kim and Batzoglou labs for discussion. This work was funded by the National Institutes of Aging and the Howard Hughes Medical Foundation. X. L. was funded by the Larry L. Hillblom Foundation. S. J. A. is supported by a William R. Hewlett Stanford Graduate Fellowship and a National Science Foundation Fellowship.	Baugh LR, 2005, DEVELOPMENT, V132, P1843, DOI 10.1242/dev.01782; Bird AF, 1991, STRUCTURE NEMATODES; Bowerman B, 1997, DEVELOPMENT, V124, P3815; Broitman-Maduro G, 2006, DEVELOPMENT, V133, P3097, DOI 10.1242/dev.02475; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Edgar LG, 2001, DEV BIOL, V229, P71, DOI 10.1006/dbio.2000.9977; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Good K, 2004, DEVELOPMENT, V131, P1967, DOI 10.1242/dev.01088; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lecuyer E, 2008, CURR OPIN GENET DEV, V18, P506, DOI 10.1016/j.gde.2008.08.003; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/NMETH.1366, 10.1038/nmeth.1366]; Maduro MF, 2006, BIOESSAYS, V28, P1010, DOI 10.1002/bies.20480; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Peng HC, 2008, BIOINFORMATICS, V24, P234, DOI 10.1093/bioinformatics/btm569; Peng HC, 2009, BIOINFORMATICS, V25, P695, DOI 10.1093/bioinformatics/btp046; Potti A, 2008, CURR OPIN GENET DEV, V18, P62, DOI 10.1016/j.gde.2008.01.018; Praitis V, 2001, GENETICS, V157, P1217; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; SCHNABEL R, 1994, SCIENCE, V263, P1449, DOI 10.1126/science.8128230; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	31	97	100	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					623	633		10.1016/j.cell.2009.08.044	http://dx.doi.org/10.1016/j.cell.2009.08.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879847	Green Accepted, Bronze			2022-12-24	WOS:000271259600025
J	Yue, R; Kang, JH; Zhao, C; Hu, WX; Tang, YW; Liu, XS; Pei, G				Yue, Rui; Kang, Jiuhong; Zhao, Cong; Hu, Wenxiang; Tang, Yawei; Liu, Xiaosong; Pei, Gang			beta-Arrestin1 Regulates Zebrafish Hematopoiesis through Binding to YY1 and Relieving Polycomb Group Repression	CELL			English	Article							EMBRYONIC STEM-CELLS; CDX-HOX PATHWAY; DEVELOPMENTAL REGULATORS; EPIGENETIC REGULATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; COMPLEXES; PROTEINS; NUCLEAR; METHYLATION	beta-Arrestin1 is a multifunctional protein critically involved in signal transduction. Recently, it is also identified as a nuclear transcriptional regulator, but the underlying mechanisms and physiological significance remain to be explored. Here, we identified beta-arrestin1 as an evolutionarily conserved protein essential for zebrafish development. Zebrafish embryos depleted of beta-arrestin1 displayed severe posterior defects and especially failed to undergo hematopoiesis. In addition, the expression of cdx4, a critical regulator of embryonic blood formation, and its downstream hox genes were downregulated by depletion of beta-arrestin1, while injection of cdx4, hoxa9a or hoxb4a mRNA rescued the hematopoietic defects. Further mechanistic studies revealed that beta-arrestin1 bound to and sequestered the polycomb group (PcG) recruiter YY1, and relieved PcG-mediated repression of cdx4-hox pathway, thus regulating hematopoietic lineage specification. Taken together, this study demonstrated a critical role of beta-arrestin1 during zebrafish primitive hematopoiesis, as well as an important regulator of PcG proteins and cdx4-hox pathway.	[Yue, Rui; Kang, Jiuhong; Zhao, Cong; Hu, Wenxiang; Tang, Yawei; Liu, Xiaosong; Pei, Gang] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Lab Mol Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Kang, Jiuhong; Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Lab Mol Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Hu, Wenxiang/W-3737-2017	Hu, Wenxiang/0000-0002-6754-5625; Kang, Jiuhong/0000-0001-7538-1889	Ministry of Science and Technology [2005CB522406, 2006CB943901, 2007CB947904, 2007CB947103, 2007CB948003, 2009CB941100]; National Natural Science Foundation of China [30621091, 30625014, 30871285, 90919028]; Shanghai Municipal Commission for Science and Technology [07PJ14099, 08dj1400500]; Chinese Academy of Sciences [2007KIP204, SIBS2008001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Dr. Jiulin Du, Jiwen Bu and National Zebrafish Resources of China for providing the zebrafish facilities, and performing the blastula transplant experiments. We thank Dr. Tingxi Liu for critical reading of the manuscript, his generous gifts of riboprobe plasmids and transgenic embryos. We are also grateful for Dr. Dangsheng Li for helpful discussions, Drs. John Kanki and Thomas Look at Dana-Farber Cancer Institute for offering the tp53 (M214K) zebrafish mutant (Berghmans et al., 2005), Ying Xi, Yanfang Fu, Ting Zhou and Yi Jin for technical assistance. This research was supported by grants from the Ministry of Science and Technology (2005CB522406, 2006CB943901, 2007CB947904, 2007CB947103, 2007CB948003, 2009CB941100), National Natural Science Foundation of China (30621091, 30625014, 30871285, 90919028), Shanghai Municipal Commission for Science and Technology (07PJ14099, 08dj1400500), Chinese Academy of Sciences (2007KIP204, SIBS2008001).	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Beaulieu JM, 2005, CELL, V123, P755, DOI 10.1016/j.cell.2005.11.010; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Ficzycz A, 2001, J BIOL CHEM, V276, P22819, DOI 10.1074/jbc.M011188200; FU YF, 2008, BLOOD; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; Kim SY, 2006, DEVELOPMENT, V133, P4957, DOI 10.1242/dev.02677; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Lengerke C, 2007, ANN NY ACAD SCI, V1106, P197, DOI 10.1196/annals.1392.006; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016/S0301-472X(99)00087-9; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; RAICH N, 1995, EMBO J, V14, P801, DOI 10.1002/j.1460-2075.1995.tb07058.x; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Wang L, 2008, DEV DYNAM, V237, P2139, DOI 10.1002/dvdy.21630; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Wang Y, 2008, P NATL ACAD SCI USA, V105, P7756, DOI 10.1073/pnas.0708951105; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193	45	41	44	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					535	546		10.1016/j.cell.2009.08.038	http://dx.doi.org/10.1016/j.cell.2009.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879840	Bronze			2022-12-24	WOS:000271259600018
J	Lau, JTF; Yeung, NCY; Choi, KC; Cheng, MYM; Tsui, HY; Griffiths, S				Lau, Joseph T. F.; Yeung, Nelson C. Y.; Choi, K. C.; Cheng, Mabel Y. M.; Tsui, H. Y.; Griffiths, Sian			Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE RESPIRATORY SYNDROME; HUMAN AVIAN INFLUENZA; BEHAVIORAL-RESPONSES; OUTBREAK; PERCEPTIONS; SARS; ASSOCIATIONS; TRANSMISSION; PREVENTION; EPIDEMIC	Objective To investigate the intention of the Hong Kong general population to take up vaccination against influenza A/H1N1. Setting Cross sectional population based anonymous survey. Participants Random sample of 301 adults interviewed by telephone (response rate 80%). Main outcome measure Intention to take up vaccination against influenza A/H1N1 under five hypothetical scenarios: vaccination is free; vaccination per dosage costs less than $HK100 (8; pound (sic)9; $13), $HK101-200, or more than $HK200; and no data are available on the efficacy and safety of the vaccine. Results 45% (n=135) of the participants reported that they would be highly likely take up vaccination if it was free. When vaccination incurred a cost, however, the prevalence of uptake decreased: 36%(n=108) would take up vaccination if it cost less than $HK100, 24% (n=72) if it cost $HK101-200, and 15% (n=45) if it cost more than $HK200; and in absence of proved efficacy and safety decreased to 5% (n=14). Moreover, 32% (n=95) considered universal A/H1N1 vaccination unnecessary. Overall, 39% (n=117) of participants believed that A/H1N1 vaccination would prevent the virus being contracted; 63% (n=189) erroneously believed that efficacy of the vaccine had been confirmed by clinical trials, and 16% (n=49) believed that it is necessary for everyone in Hong Kong to take up vaccination against influenza A/H1N1. Conclusions The uptake of vaccination against influenza A/H1N1 by the general population of Hong Kong is unlikely to be high and would be sensitive to personal cost. Evidence about safety and efficacy is critical in determining the prevalence of uptake of vaccination.	[Lau, Joseph T. F.; Yeung, Nelson C. Y.; Choi, K. C.; Cheng, Mabel Y. M.; Tsui, H. Y.; Griffiths, Sian] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Lau, JTF (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Choi, Kai Chow/F-1398-2018	Choi, Kai Chow/0000-0001-7157-8668	Research Fund for the Control of Infectious Diseases, Food and Health Bureau; Hong Kong Special Administrative Region; Li Ka Shing Institue of Health Sciences	Research Fund for the Control of Infectious Diseases, Food and Health Bureau; Hong Kong Special Administrative Region; Li Ka Shing Institue of Health Sciences	This study was supported by the Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region and the Li Ka Shing Institue of Health Sciences.	[Anonymous], US OUTBR SWIN OR INF; *CENS STAT DEP, 2009, POP AG GROUP SEX; *CENS STAT DEP HON, 2009, CENS STAT DEP ANN RE; Chan SSC, 2007, INT J NURS STUD, V44, P1120, DOI 10.1016/j.ijnurstu.2006.04.019; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; *DEP HLTH AG AUSTR, 2009, VACC PROT PAND H1N1; *DIRECTGOV, 2009, SWIN FLU TREATM PREV; *ED BUR HONG KONG, 2009, EDB CALLS SCH PREP N; Fielding R, 2005, EMERG INFECT DIS, V11, P677, DOI 10.3201/eid1105.041225; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; *GOVHK, 2009, FIGHT PAND 3 NEW CAS; *GOVHK, 2009, FAT CAS HUM SWIN INF; *GOVHK, 2009, FIGHT PAND TEND HUM; *GOVHK, 2009, FIGHT PAND 492 NEW C; LAU J, 2006, INFLUENZA VACCINATIO; Lau JTF, 2008, INFECTION, V36, P434, DOI [10.1007/s15010-008-7277-y, 10.1007/s15010-008-7277-Y]; Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18; Lau JTF, 2007, AM J INFECT CONTROL, V35, P38, DOI 10.1016/j.ajic.2006.07.010; Lau JTF, 2006, PREV MED, V43, P406, DOI 10.1016/j.ypmed.2006.06.007; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; Lau JTF, 2005, PREV MED, V41, P454, DOI 10.1016/j.ypmed.2004.11.023; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Lee S, 2009, PAIN MED, V10, P155, DOI 10.1111/j.1526-4637.2008.00541.x; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; Leung GM, 2004, INFECT CONT HOSP EP, V25, P1033, DOI 10.1086/502340; *MSNBC, 2009, 1 BATCH SWIN FLU VAC; *MSNBC, 2009, BEST WAY STOP FLU VA; *MSNBC, 2009, WHO AS WILL BE SHORT; *NEW GOV HK, 2009, 4 GROUPS PEOPL WILL; *NEWS GOV HK, 2009, 10 BILL DOLL HAV BEE; Schooling CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001070; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; *US DEP HHS, 2009, VACC VACC ALL VACC R; World Health Organization, PAND H1N1 2009 UPD 6 PAND H1N1 2009 UPD 6; World Health Organization, 2009, WORLD NOW START 2009	36	66	66	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2009	339								b4164	10.1136/bmj.b4164	http://dx.doi.org/10.1136/bmj.b4164			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AK	19861377	Green Published, hybrid			2022-12-24	WOS:000271365500004
J	Bhutani, N; Brady, JJ; Damian, M; Sacco, A; Corbel, SY; Blau, HM				Bhutani, Nidhi; Brady, Jennifer J.; Damian, Mara; Sacco, Alessandra; Corbel, Stephane Y.; Blau, Helen M.			Reprogramming towards pluripotency requires AID-dependent DNA demethylation	NATURE			English	Article							CLASS SWITCH RECOMBINATION; STEM-CELLS; GENE-EXPRESSION; SOMATIC-CELLS; ACTIVATION; DIFFERENTIATION; FIBROBLASTS; HETEROKARYONS; GENERATION; DEAMINASE	Reprogramming of somatic cell nuclei to yield induced pluripotent stem (iPS) cells makes possible derivation of patient-specific stem cells for regenerative medicine. However, iPS cell generation is asynchronous and slow (2-3 weeks), the frequency is low (<0.1%), and DNA demethylation constitutes a bottleneck. To determine regulatory mechanisms involved in reprogramming, we generated interspecies heterokaryons ( fused mouse embryonic stem (ES) cells and human fibroblasts) that induce reprogramming synchronously, frequently and fast. Here we show that reprogramming towards pluripotency in single heterokaryons is initiated without cell division or DNA replication, rapidly ( 1 day) and efficiently (70%). Short interfering RNA (siRNA)-mediated knockdown showed that activation-induced cytidine deaminase ( AID, also known as AICDA) is required for promoter demethylation and induction of OCT4 (also known as POU5F1) and NANOG gene expression. AID protein bound silent methylated OCT4 and NANOG promoters in fibroblasts, but not active demethylated promoters in ES cells. These data provide the first evidence that mammalian AID is required for active DNA demethylation and initiation of nuclear reprogramming towards pluripotency in human somatic cells.	[Bhutani, Nidhi; Brady, Jennifer J.; Damian, Mara; Sacco, Alessandra; Corbel, Stephane Y.; Blau, Helen M.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med,Sch Med, Stanford, CA 94305 USA; [Damian, Mara] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Blau, HM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med,Sch Med, Stanford, CA 94305 USA.	hblau@stanford.edu			National Science Foundation; National Institutes of Health (NIH) [AI007328, AG009521, AG024987]; Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG024987, R01AG009521] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank O. Alkan for generating retroviral constructs for GFP and DsRed expression; R. Doyonnas for helping to standardize FACS isolation of heterokaryons; Y. Liao for performing the initial experiments showing demethylation in heterokaryons; M. Pajcini for technical assistance with the BrdU experiments; D. Schatz and S. Unniraman for providing the human AID construct; F. Alt for his generous provision of antibody to AID; J. A. Dahl for discussions about chromatin immunoprecipitation assays; H. Chang for use of the Bioruptor sonicator; and M. Wernig, G. Sen, C.-Z. Chen and J. Pomerantz for comments on the manuscript. This work was supported by a National Science Foundation Graduate Research Fellowship awarded to J. J. B., National Institutes of Health (NIH) training grant AI007328 to M. D., and NIH grants AG009521, AG024987 and support from the Baxter Foundation to H. M. B.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; BARON MH, 1986, CELL, V46, P591, DOI 10.1016/0092-8674(86)90885-8; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; CHIU CP, 1984, CELL, V37, P879, DOI 10.1016/0092-8674(84)90423-9; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Deb K, 2006, SCIENCE, V311, P992, DOI 10.1126/science.1120925; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PAVLATH GK, 1986, J CELL BIOL, V102, P124, DOI 10.1083/jcb.102.1.124; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; SPEAR BT, 1990, MOL CELL BIOL, V10, P5047, DOI 10.1128/MCB.10.10.5047; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WRIGHT WE, 1984, EXP CELL RES, V151, P55, DOI 10.1016/0014-4827(84)90355-0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104	49	528	556	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1042	U57		10.1038/nature08752	http://dx.doi.org/10.1038/nature08752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20027182	Green Accepted			2022-12-24	WOS:000275108400028
J	Ofri, D				Ofri, Danielle			The Emotional Epidemiology of H1N1 Influenza Vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ofri, Danielle] NYU, Sch Med, New York, NY 10016 USA; [Ofri, Danielle] Bellevue Hosp Ctr, New York, NY 10016 USA	New York University; Bellevue Hospital Center	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10016 USA.			Ofri, Danielle/0000-0001-9865-7104				Wald P., 2008, CONTAGIOUS CULTURES, DOI [10.1215/9780822390572, DOI 10.1215/9780822390572]	1	58	58	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2594	2595		10.1056/NEJMp0911047	http://dx.doi.org/10.1056/NEJMp0911047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538JV	19940291	Bronze			2022-12-24	WOS:000273181300003
J	Castellani, C; Picci, L; Tamanini, A; Girardi, P; Rizzotti, P; Assael, BM				Castellani, Carlo; Picci, Luigi; Tamanini, Anna; Girardi, Paolo; Rizzotti, Paolo; Assael, Baroukh Maurice			Association Between Carrier Screening and Incidence of Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPRODUCTIVE-BEHAVIOR; DIAGNOSIS; CONSENSUS; POPULATION; COHORT; MODEL; GENE	Context A downward trend in cystic fibrosis (CF) birth incidence has been reported in some areas. Objective To evaluate the association between carrier screening and CF birth incidence. Design, Setting, and Participants In northeastern Italy, CF birth incidence is monitored by means of a long-standing neonatal screening program. In the same area, 2 sections using different carrier detection approaches were identified-the western region, in which CF carrier tests are offered only to relatives of patients or to couples planning in vitro fertilization; and the eastern region, in which carrier testing is offered to relatives and carrier screening to infertile couples and to couples of reproductive age. A total of 779 631 newborns underwent CF neonatal screening between January 1993 and December 2007, of whom 195 had CF detected. Main Outcome Measure Cystic fibrosis birth incidence in the 2 regions. Results A time-related decrease in birth incidence was found, with a mean annual percentage decrease of 0.16 per 10 000 neonates (P < .001). In the western region, 2559 carrier tests were performed, 314 carriers were identified, and 9 carrier couples were detected. In the eastern region, 87 025 carrier tests were performed, 3650 carriers were identified, and 82 carrier couples were detected. The birth rate decrease was greater in the eastern region (decrease rate, 0.24; 95% confidence interval [CI], 0.12-0.36) than in the western region (decrease rate, 0.04; 95% CI, -0.16 to 0.08; P = .01). The increase in the number of screened carriers over time was significantly correlated with the decrease in CF birth incidence (correlation coefficient=-0.53; 95% CI, -0.20 to -0.74; P = .003). Conclusion In northeastern Italy, carrier screening was associated with a decrease in the incidence of CF. JAMA. 2009;302(23):2573-2579	[Castellani, Carlo; Assael, Baroukh Maurice] Verona Hosp, Cyst Fibrosis Ctr, I-37126 Verona, Italy; [Tamanini, Anna; Rizzotti, Paolo] Verona Hosp, Clin Chem & Hematol Lab, I-37126 Verona, Italy; [Picci, Luigi] Univ Padua, Dept Pediat, Padua, Italy; [Girardi, Paolo] Univ Verona, Dept Med & Publ Hlth, Unit Epidemiol & Med Stat, I-37100 Verona, Italy	University of Padua; University of Verona	Castellani, C (corresponding author), Verona Hosp, Cyst Fibrosis Ctr, Piazzale Stefani 1, I-37126 Verona, Italy.	carlo.castellani@azosp.vr.it	Tamanini, Anna/AAC-3510-2022; Castellani, Carlo/AAB-3847-2019	Tamanini, Anna/0000-0002-7427-0981; girardi, Paolo/0000-0001-8330-9414				Berwouts S, 2008, HUM MUTAT, V29, P1063, DOI 10.1002/humu.20764; BORGO G, 1992, PRENATAL DIAG, V12, P821, DOI 10.1002/pd.1970121008; Borgo G, 1999, Community Genet, V2, P82, DOI 10.1159/000016191; Cao A, 2002, OBSTET GYN CLIN N AM, V29, P305, DOI 10.1016/S0889-8545(01)00006-7; Castellani C, 1997, ACTA PAEDIATR, V86, P497, DOI 10.1111/j.1651-2227.1997.tb08920.x; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Castellani C, 2009, J CYST FIBROS, V8, P153, DOI 10.1016/j.jcf.2009.01.004; Cunningham S, 1998, ARCH DIS CHILD, V78, P345, DOI 10.1136/adc.78.4.345; Dudding T, 2000, ARCH DIS CHILD-FETAL, V82, pF124, DOI 10.1136/fn.82.2.F124; Dupuis A, 2005, J PEDIATR-US, V147, P312, DOI 10.1016/j.jpeds.2005.06.043; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; GREEN MR, 1993, ARCH DIS CHILD, V68, P464, DOI 10.1136/adc.68.4.464; Grody WW, 2001, GENET MED, V3, P87, DOI 10.1097/00125817-200103000-00001; Hale JE, 2008, NEW ENGL J MED, V358, P973, DOI 10.1056/NEJMc0707530; HEELEY ME, 1991, PEDIATR PULM, P72; Howell RR, 1999, ARCH INTERN MED, V159, P1529; Kaback MM, 2000, EUR J PEDIATR, V159, pS192, DOI 10.1007/PL00014401; Mayell SJ, 2009, J CYST FIBROS, V8, P71, DOI 10.1016/j.jcf.2008.09.005; MENNIE ME, 1992, LANCET, V340, P214, DOI 10.1016/0140-6736(92)90476-J; Mischler EH, 1998, PEDIATRICS, V102, P44, DOI 10.1542/peds.102.1.44; Morea A, 2005, MOL HUM REPROD, V11, P607, DOI 10.1093/molehr/gah214; Polnay JC, 2002, ARCH DIS CHILD, V87, P284, DOI 10.1136/adc.87.4.284; RIORDAN JR, 1989, SCIENCE, V245, P1066; Scotet V, 2008, J PEDIATR, V152, P25, DOI 10.1016/j.jpeds.2007.07.046; Slieker MG, 2005, CHEST, V128, P2309, DOI 10.1378/chest.128.4.2309; SONTAG MK, 2008, PED PULMONOL S, V31, P272; Southern KW, 2007, J CYST FIBROS, V6, P57, DOI 10.1016/j.jcf.2006.05.008; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C	28	63	65	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2573	2579		10.1001/jama.2009.1758	http://dx.doi.org/10.1001/jama.2009.1758			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009057	Green Published			2022-12-24	WOS:000272737200025
J	Greenfield, S; Billimek, J; Pellegrini, F; Franciosi, M; De Berardis, G; Nicolucci, A; Kaplan, SH				Greenfield, Sheldon; Billimek, John; Pellegrini, Fabio; Franciosi, Monica; De Berardis, Giorgia; Nicolucci, Antonio; Kaplan, Sherrie H.			Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE GLUCOSE CONTROL; ILLNESS BURDEN INDEX; QUED STUDY-GROUP; METABOLIC CONTROL; AMERICAN-COLLEGE; TYPE-2; DISEASE; QUALITY; STATEMENT; MELLITUS	Background: Recent studies have shown mixed results regarding the effectiveness of intensive glucose-lowering therapy in reducing risk for cardiovascular events. Objective: To determine whether attaining hemoglobin A(1c) (HbA(1c)) targets of 6.5% or less or 7.0% or less for glycemic control at baseline provides differential benefits for patients with high versus low-to-moderate levels of comorbidity. Design: 5-year longitudinal observational study of patients with type 2 diabetes. Patients were categorized into high and low-to-moderate comorbidity subgroups by using the Total Illness Burden Index (TIBI), a validated patient-reported measure of comorbidity. Setting: 101 diabetes outpatient clinics and 103 general practitioners' clinics in Italy. Patients: 2613 (83%) of 3074 patients with type 2 diabetes, sampled randomly from diabetes outpatient clinic rosters and recruited consecutively from general practitioners' clinics, who completed the baseline questionnaire. Measurements: TIBI score, total mortality, and incident cardiovascular events. Hazard ratios (HRs) were adjusted for age and sex. Results: Attaining an HbA(1c) level of 6.5% or less at baseline was associated with lower 5-year incidence of cardiovascular events in the low-to-moderate comorbidity subgroup (adjusted HR, 0.60 [95% CI, 0.42 to 0.85]; P = 0.005) but not in the high comorbidity subgroup (adjusted HR, 0.92 [CI, 0.68 to 1.25]; P = 0.61; P for subgroup by HbA(1c) interaction = 0.048). Similarly, attaining a baseline HbA(1c) level of 7.0% predicted fewer cardiovascular events in the low-to-moderate comorbidity subgroup (adjusted HR, 0.61 (CI, 0.44 to 0.83; P = 0.001) but not in the high comorbidity subgroup (adjusted HR, 0.88 [CI, 0.66 to 1.17]; P = 0.38; P for subgroup by HbA(1c) interaction = 0.093). Limitations: The observational nature of the study does not allow causal inference. The length of the data collection period was limited. Information on clinical management was not available. Conclusion: Patients with the high levels of comorbidity common in type 2 diabetes may receive diminished cardiovascular benefit from intensive blood glucose control. Comorbidity should be considered when tailoring glucose-lowering therapy in patients with type 2 diabetes.	Univ Calif Irvine, Irvine, CA USA; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy	University of California System; University of California Irvine; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Greenfield, S (corresponding author), Hlth Policy Res Inst, 100 Theory,Suite 110, Irvine, CA 92697 USA.	sgreenfi@uci.edu		Kaplan, Sherrie/0000-0002-8644-5849; Greenfield, Sheldon/0000-0003-4628-1998	Pfizer of Italy	Pfizer of Italy	Primary Funding Source: Pfizer of Italy.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Belfiglio M, 2001, DIABETES CARE, V24, P423, DOI 10.2337/diacare.24.3.423; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corser W, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-85; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Franciosi M, 2001, DIABETES CARE, V24, P1870, DOI 10.2337/diacare.24.11.1870; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GREENFIELD S, 1995, MED CARE, V33, pAS47; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2008, ANN INTERN MED, V149, P11, DOI 10.7326/0003-4819-149-1-200807010-00005; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Lee TA, 2008, ANN INTERN MED, V149, P380, DOI 10.7326/0003-4819-149-6-200809160-00004; Litwin MS, 2007, CANCER-AM CANCER SOC, V109, P1777, DOI 10.1002/cncr.22615; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pellegrini F, 2003, ARCH INTERN MED, V163, P473, DOI 10.1001/archinte.163.4.473; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; Stier DM, 1999, UROLOGY, V54, P424, DOI 10.1016/S0090-4295(99)00203-4; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	22	124	132	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2009	151	12					854	U4		10.7326/0003-4819-151-12-200912150-00005	http://dx.doi.org/10.7326/0003-4819-151-12-200912150-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532ET	20008761				2022-12-24	WOS:000272728900003
J	Louicharoen, C; Patin, E; Paul, R; Nuchprayoon, I; Witoonpanich, B; Peerapittayamongkol, C; Casademont, I; Sura, T; Laird, NM; Singhasivanon, P; Quintana-Murci, L; Sakuntabhai, A				Louicharoen, Chalisa; Patin, Etienne; Paul, Richard; Nuchprayoon, Issarang; Witoonpanich, Bhee; Peerapittayamongkol, Chayanon; Casademont, Isabelle; Sura, Thanyachai; Laird, Nan M.; Singhasivanon, Pratap; Quintana-Murci, Lluis; Sakuntabhai, Anavaj			Positively Selected G6PD-Mahidol Mutation Reduces Plasmodium vivax Density in Southeast Asians	SCIENCE			English	Article							HUMAN-POPULATIONS; KAREN POPULATION; HUMAN GENOME; MALARIA; FALCIPARUM; DEFICIENCY; RESISTANCE; THAILAND; ORIGIN; G6PD	Glucose-6-phosphate dehydrogenase (G6PD) deficiency-the most common known enzymopathy-is associated with neonatal jaundice and hemolytic anemia usually after exposure to certain infections, foods, or medications. Although G6PD-deficient alleles appear to confer a protective effect against malaria, the link with clinical protection from Plasmodium infection remains unclear. We investigated the effect of a common G6PD deficiency variant in Southeast Asia-the G6PD-Mahidol(487A) variant-on human survival related to vivax and falciparum malaria. Our results show that strong and recent positive selection has targeted the Mahidol variant over the past 1500 years. We found that the G6PD-Mahidol(487A) variant reduces vivax, but not falciparum, parasite density in humans, which indicates that Plasmodium vivax has been a driving force behind the strong selective advantage conferred by this mutation.	[Patin, Etienne; Quintana-Murci, Lluis] Inst Pasteur, CNRS, URA3012, Human Evolutionary Genet Unit, F-75015 Paris, France; [Louicharoen, Chalisa; Paul, Richard; Witoonpanich, Bhee; Peerapittayamongkol, Chayanon; Casademont, Isabelle; Sakuntabhai, Anavaj] Inst Pasteur, Lab Genet Reponse Infect Chez Homme, F-75724 Paris, France; [Louicharoen, Chalisa] Chulalongkorn Univ, Fac Grad Sch, Interdept Program Biomed Sci, Bangkok, Thailand; [Nuchprayoon, Issarang] Chulalongkorn Univ, Fac Med, Dept Pediat, Bangkok 10330, Thailand; [Sura, Thanyachai; Sakuntabhai, Anavaj] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Laird, Nan M.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Chulalongkorn University; Chulalongkorn University; Mahidol University; Harvard University; Harvard T.H. Chan School of Public Health; Mahidol University	Quintana-Murci, L (corresponding author), Inst Pasteur, CNRS, URA3012, Human Evolutionary Genet Unit, F-75015 Paris, France.	lluis.quintana-murci@pasteur.fr; anavaj.sakuntabhai@pasteur.fr	Peerapittayamongkol, Chayanon/B-4920-2010; Patin, Etienne/G-6768-2012; Quintana-Murci, Lluis/AAB-7468-2022; Peerapittayamongkol, Chayanon/K-7965-2019	Quintana-Murci, Lluis/0000-0003-2429-6320; Paul, Richard/0000-0002-0665-5089; Patin, Etienne/0000-0002-9911-4459; Singhasivanon, Pratap/0000-0002-9759-1702; Nuchprayoon, Issarang/0000-0002-4014-5082	BIOTEC [BT-B06-MG-14-4507]; Thailand Research Fund [BRG/16/2544]; Mahidol University [OR-9123]; Institut Pasteur program [PTR202]; CNRS; Agence Nationale de la Recherche (ANR) [ANR-05-JCJC-0124-01]; Gates Grand Challenge program; Wellcome Trust; U. K. Medical Research Council; Royal Golden Jubilee Program; French Embassy in Thailand; French Medical Research Foundation (FRM); Medical Scholar Program; Mahidol University	BIOTEC; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Institut Pasteur program; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Gates Grand Challenge program; Wellcome Trust(Wellcome Trust); U. K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Golden Jubilee Program; French Embassy in Thailand; French Medical Research Foundation (FRM)(Fondation pour la Recherche Medicale); Medical Scholar Program; Mahidol University	We thank all study participants and their families, and the staff of the Rajanagarindra Tropical Diseases International Center, Faculty of Tropical Medicine, Bangkok, who helped in data collection. We also thank O. Mercereau-Puijalon and L. Abel for critical comments on the manuscript, and P. Sabeti and I. Schlyakhter for providing a command-line version of Sweep. This work was funded in part by Thailand's biotechnology funding agency BIOTEC (BT-B06-MG-14-4507), the Thailand Research Fund (BRG/16/2544), and Mahidol University (OR-9123) to A. S.; by the Institut Pasteur program PTR202 to L. Q.-M. and A. S.; and by the CNRS and an Agence Nationale de la Recherche (ANR) grant (ANR-05-JCJC-0124-01) to L. Q.-M. This work is part of the MalariaGEN Consortium supported by the Gates Grand Challenge program, the Wellcome Trust, and the U. K. Medical Research Council. C. L. was supported by the Royal Golden Jubilee Program, the Thailand Research Fund, and the French Embassy in Thailand; E. P. by the French Medical Research Foundation (FRM); and B. W. by the Medical Scholar Program, Mahidol University, and the French Embassy in Thailand.	ALLISON AC, 1956, ANN HUM GENET, V21, P67, DOI 10.1111/j.1469-1809.1971.tb00266.x; Austerlitz F, 2003, GENETICS, V165, P1579; Besaggio D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S12; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; Carter R, 2003, TRENDS PARASITOL, V19, P214, DOI 10.1016/S1471-4922(03)00070-9; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garnham PCC, 1966, MALARIA PARASITES OT; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Huang YX, 2008, MOL GENET METAB, V93, P44, DOI 10.1016/j.ymgme.2007.08.122; Hume JCC, 2003, TRENDS PARASITOL, V19, P144, DOI 10.1016/S1471-4922(03)00008-4; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; MARTIN SK, 1979, LANCET, V1, P524; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Nuchprayoon I, 2008, J HUM GENET, V53, P48, DOI 10.1007/s10038-007-0217-3; PANICH V, 1972, Journal of the Medical Association of Thailand, V55, P576; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Phimpraphi W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003887; POWELL RD, 1965, AM J TROP MED HYG, V14, P358, DOI 10.4269/ajtmh.1965.14.358; Prchal Josef T, 2005, Hematology Am Soc Hematol Educ Program, P19, DOI 10.1182/asheducation-2005.1.19; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saunders MA, 2002, GENETICS, V162, P1849; Schliekelman P, 2001, NATURE, V411, P545, DOI 10.1038/35079176; Slatkin M, 2008, GENET RES, V90, P129, DOI 10.1017/S0016672307008944; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Williams TN, 1997, QJM-INT J MED, V90, P751; Wood ET, 2005, AM J HUM GENET, V77, P637, DOI 10.1086/491748	32	128	131	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1546	1549		10.1126/science.1178849	http://dx.doi.org/10.1126/science.1178849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007901				2022-12-24	WOS:000272623600060
J	Cohen, D				Cohen, Deborah			Complications: tracking down the data on oseltamivir	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; HEALTHY-ADULTS; NEURAMINIDASE INHIBITORS; ACUTE INFLUENZA; METAANALYSIS; EFFICACY; SAFETY; ROCHE					dcohen@bmj.com						*DEP HLTH, US ANT DRUGS INFL PA; DONALDSON L, 2006, J ROY SOC MED, V99; Freemantle N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5248; Graf C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4330; Hama R., 2005, SESS JAP SOC PED INF; Hayden Frederick G, 2004, Pediatr Infect Dis J, V23, pS262, DOI 10.1097/01.inf.0000144680.39895.ce; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kashiwagi S, 2000, Kansenshogaku Zasshi, V74, P1044; Li LY, 2003, CHINESE MED J-PEKING, V116, P44; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; Smith J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5364; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Treanor JohnJ., 2000, 38 ANN M INF DIS SOC; 2008, HOFFMAN LA ROCHE PRO	19	37	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2009	339								b5387	10.1136/bmj.b5387	http://dx.doi.org/10.1136/bmj.b5387			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VE	19995818				2022-12-24	WOS:000272697300014
J	Sologub, M; Litonin, D; Anikin, M; Mustaev, A; Temiakov, D				Sologub, Marina; Litonin, Dmitry; Anikin, Michael; Mustaev, Arkady; Temiakov, Dmitry			TFB2 Is a Transient Component of the Catalytic Site of the Human Mitochondrial RNA Polymerase	CELL			English	Article							TRANSCRIPTION FACTOR; RIBOSOMAL-RNA; STRUCTURAL BASIS; METHYLTRANSFERASE ACTIVITY; PROMOTER CLEARANCE; ACTIVE-CENTER; INITIATION; SPECIFICITY; DNA; SUBUNIT	Transcription in human mitochondria is carried out by a single-subunit, T7-like RNA polymerase assisted by several auxiliary factors. We demonstrate that an essential initiation factor, TFB2, forms a network of interactions with DNA near the transcription start site and facilitates promoter melting but may not be essential for promoter recognition. Unexpectedly, catalytic autolabeling reveals that TFB2 interacts with the priming substrate, suggesting that TFB2 acts as a transient component of the catalytic site of the initiation complex. Mapping of TFB2 identifies a region of its N-terminal domain that is involved in simultaneous interactions with the priming substrate and the templating (+1) DNA base. Our data indicate that the transcriptional machinery in human mitochondria has evolved into a system that combines features inherited from self-sufficient, T7-like RNA polymerase and those typically found in systems comprising cellular multi-subunit polymerases, and provide insights into the molecular mechanisms of transcription regulation in mitochondria.	[Sologub, Marina; Litonin, Dmitry; Anikin, Michael; Temiakov, Dmitry] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA; [Mustaev, Arkady] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem, Newark, NJ 07103 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Temiakov, D (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, 2 Med Ct Dr, Stratford, NJ 08084 USA.	d.temiakov@umdnj.edu			UMDNJ Foundation; National Institutes of Health [GM30317, GM38147]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030717, R01GM038147, R01GM030317] Funding Source: NIH RePORTER	UMDNJ Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to Drs Vadim G Nikiforov, William T McAllister and Patrick Cramer for fruitful discussion and critical reading of the manuscript. This work was supported in part by UMDNJ Foundation Grant (to D. T.) and by National Institutes of Health Grants GM30317 (to A. M.) and GM38147 (to W. T. M).	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; GAINES G, 1987, J BIOL CHEM, V262, P1907; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; GRACHEV MA, 1987, EUR J BIOCHEM, V163, P113, DOI 10.1111/j.1432-1033.1987.tb10743.x; Kazmierczak KM, 2002, EMBO J, V21, P5815, DOI 10.1093/emboj/cdf584; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; MAKSIMOVA T G, 1989, Bioorganicheskaya Khimiya, V15, P18; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; OSUMIDAVIS PA, 1992, J MOL BIOL, V226, P37, DOI 10.1016/0022-2836(92)90122-Z; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; RIVA M, 1990, J BIOL CHEM, V265, P16498; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; Woody AYM, 1998, BIOCHEMISTRY-US, V37, P15958, DOI 10.1021/bi9805801	35	98	102	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					934	944		10.1016/j.cell.2009.10.031	http://dx.doi.org/10.1016/j.cell.2009.10.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945377	Bronze, Green Accepted			2022-12-24	WOS:000272169400017
J	Salvador-Carulla, L; Saxena, S				Salvador-Carulla, Luis; Saxena, Shekhar			Intellectual disability: between disability and clinical nosology	LANCET			English	Editorial Material							MENTAL-RETARDATION; ADULTS; PREVALENCE; DISORDERS; SERVICES		[Salvador-Carulla, Luis] Univ Cadiz, Cadiz 11003, Spain; [Saxena, Shekhar] WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland	Universidad de Cadiz; World Health Organization	Salvador-Carulla, L (corresponding author), Univ Cadiz, Cadiz 11003, Spain.	luis.salvador@telefonica.net	Salvador-Carulla, Luis/K-6512-2013; PRISMA, Grupo/AAI-6753-2021	Salvador-Carulla, Luis/0000-0002-5742-9866; 				Bouras N, 2004, BRIT J PSYCHIAT, V184, P291, DOI 10.1192/bjp.184.4.291; Centers for Disease Control and Prevention (CDC), 2004, MMWR-MORBID MORTAL W, V53, P57, DOI DOI 10.1016/S1479-3547(03)03011-2; Durkin M, 2002, MENT RETARD DEV D R, V8, P206, DOI 10.1002/mrdd.10039; Fletcher RJ, 2009, J CLIN PSYCHIAT, V70, P967, DOI 10.4088/JCP.08m04429; Hemmings CP, 2009, J INTELL DISABIL RES, V53, P677, DOI 10.1111/j.1365-2788.2008.01146.x; Luckasson R, 2002, MENTAL RETARDATION D; Salvador-Carulla L, 2009, PSYCHIATRY, V8, P452; Salvador-Carulla L, 2008, PSYCHOPATHOLOGY, V41, P10, DOI 10.1159/000109950; Simonoff E, 2006, J CHILD PSYCHOL PSYC, V47, P828, DOI 10.1111/j.1469-7610.2006.01630.x; Smiley E, 2003, J INTELL DISABIL RES, V47, P62, DOI 10.1046/j.1365-2788.47.s1.26.x; Ustun B, 2009, WORLD PSYCHIATRY, V8, P82; Wehmeyer ML, 2008, INTELLECT DEV DISAB, V46, P311, DOI 10.1352/1934-9556(2008)46[311:TIDCAI]2.0.CO;2; Westerinen H, 2007, J INTELL DISABIL RES, V51, P715, DOI 10.1111/j.1365-2788.2007.00970.x; *WHO, 2007, ATL GLOB RES PERS IN	14	23	23	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1798	1799		10.1016/S0140-6736(09)62034-1	http://dx.doi.org/10.1016/S0140-6736(09)62034-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944847				2022-12-24	WOS:000272370200006
J	Tikkanen, JT; Anttonen, O; Junttila, J; Aro, AL; Kerola, T; Rissanen, HA; Reunanen, A; Huikuri, HV				Tikkanen, Jani T.; Anttonen, Olli; Junttila, Juhani; Aro, Aapo L.; Kerola, Tuomas; Rissanen, Harri A.; Reunanen, Antti; Huikuri, Heikki V.			Long-Term Outcome Associated with Early Repolarization on Electrocardiography	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CLINICAL CHARACTERISTICS; MYOCARDIAL-INFARCTION; DEATH; FIBRILLATION; POPULATION; ELEVATION; RISK	BACKGROUND Early repolarization, which is characterized by an elevation of the QRS-ST junction (J point) in leads other than V-1 through V-3 on 12-lead electrocardiography, has been associated with vulnerability to ventricular fibrillation, but little is known about the prognostic significance of this pattern in the general population. METHODS We assessed the prevalence and prognostic significance of early repolarization on 12-lead electrocardiography in a community-based general population of 10,864 middle-aged subjects (mean [+/- SD] age, 44 +/- 8 years). The primary end point was death from cardiac causes, and secondary end points were death from any cause and death from arrhythmia during a mean follow-up of 30 +/- 11 years. Early repolarization was stratified according to the degree of J-point elevation (>= 0.1 mV or >0.2 mV) in either inferior or lateral leads. RESULTS The early-repolarization pattern of 0.1 mV or more was present in 630 subjects (5.8%): 384 (3.5%) in inferior leads and 262 (2.4%) in lateral leads, with elevations in both leads in 16 subjects (0.1%). J-point elevation of at least 0.1 mV in inferior leads was associated with an increased risk of death from cardiac causes (adjusted relative risk, 1.28; 95% confidence interval [CI], 1.04 to 1.59; P=0.03); 36 subjects (0.3%) with J-point elevation of more than 0.2 mV in inferior leads had a markedly elevated risk of death from cardiac causes (adjusted relative risk, 2.98; 95% CI, 1.85 to 4.92; P<0.001) and from arrhythmia (adjusted relative risk, 2.92; 95% CI, 1.45 to 5.89; P=0.01). Other electrocardiographic risk markers, such as a prolonged QT interval corrected for heart rate (P=0.03) and left ventricular hypertrophy (P=0.004), were weaker predictors of the primary end point. CONCLUSIONS An early-repolarization pattern in the inferior leads of a standard electrocardiogram is associated with an increased risk of death from cardiac causes in middle-aged subjects.	[Huikuri, Heikki V.] Univ Oulu, Dept Internal Med, Inst Clin Med, Ctr Excellence Res, Oulu 90014, Finland; [Anttonen, Olli; Aro, Aapo L.; Kerola, Tuomas] Paijat Hame Cent Hosp, Dept Internal Med, Lahti, Finland; [Rissanen, Harri A.; Reunanen, Antti] Natl Inst Hlth & Welf, Helsinki, Finland	University of Oulu; Paijat Hame Central Hospital; Finland National Institute for Health & Welfare	Huikuri, HV (corresponding author), Univ Oulu, Dept Internal Med, Inst Clin Med, Ctr Excellence Res, POB 5000, Oulu 90014, Finland.	heikki.huikuri@oulu.fi		Aro, Aapo/0000-0001-7030-6740	Sigrid Juselius Foundation; Instrumentarium Science Foundation; Orion Pharmos Science Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Instrumentarium Science Foundation; Orion Pharmos Science Foundation	Supported by a research grant from the Sigrid Juselius Foundation.; Dr. Junttila reports receiving grant support from the Instrumentarium Science Foundation and Orion Pharmos Science Foundation. No other potential conflict of interest relevant to this article was reported.	ALGRA A, 1991, CIRCULATION, V83, P1888, DOI 10.1161/01.CIR.83.6.1888; Boineau JP, 2007, J ELECTROCARDIOL, V40, P392, DOI 10.1016/j.jelectrocard.2007.07.012; GREENE HL, 1989, AM J CARDIOL, V63, P1, DOI 10.1016/0002-9149(89)91065-5; Gussak I, 2000, J ELECTROCARDIOL, V33, P299, DOI 10.1054/jelc.2000.18106; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Jousilahti P, 2003, EUR HEART J, V24, P685, DOI 10.1016/S0195-668X(03)96131-8; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3; Myerburg RJ, 2008, NAT CLIN PRACT CARD, V5, P760, DOI 10.1038/ncpcardio1354; Nam GB, 2008, NEW ENGL J MED, V358, P2078, DOI 10.1056/NEJMc0708182; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; REUNANEN A, 1983, ACTA MED SCAND, P1; Rosso R, 2008, J AM COLL CARDIOL, V52, P1231, DOI 10.1016/j.jacc.2008.07.010; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; SUHONEN O, 1985, ACTA MED SCAND, V217, P457; Sullivan JM, 1993, J AM COLL CARDIOL, V22, P508, DOI 10.1016/0735-1097(93)90057-8; Takagi M, 2000, J CARDIOVASC ELECTR, V11, P844, DOI 10.1111/j.1540-8167.2000.tb00062.x; Yan GX, 1996, CIRCULATION, V93, P372, DOI 10.1161/01.CIR.93.2.372	18	572	591	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2529	2537		10.1056/NEJMoa0907589	http://dx.doi.org/10.1056/NEJMoa0907589			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	19917913				2022-12-24	WOS:000273003700008
J	Banfield, JF; Young, M				Banfield, Jillian F.; Young, Mark			Variety-the Splice of Life-in Microbial Communities	SCIENCE			English	Editorial Material							ACQUIRED-RESISTANCE; PROKARYOTES; VIRUSES; DEFENSE; GENOMES; SYSTEM		[Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Young, Mark] Montana State Univ, Dept Plant Sci, Bozeman, MT 59715 USA; [Young, Mark] Montana State Univ, Dept Microbiol, Bozeman, MT 59715 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu; myoung@montana.edu						Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Wilhelm LJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-27	15	17	17	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 27	2009	326	5957					1198	1199		10.1126/science.1181501	http://dx.doi.org/10.1126/science.1181501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965457				2022-12-24	WOS:000272117900028
J	Letvin, NL				Letvin, Norman L.			Moving Forward in HIV Vaccine Development	SCIENCE			English	Editorial Material									Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Letvin, NL (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02115 USA.	nletvin@bidmc.harvard.edu						Belshe R, 2004, SCIENCE, V305, P177; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; MICHAEL N, COMMUNICATION; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff	8	21	21	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1196	1198		10.1126/science.1183278	http://dx.doi.org/10.1126/science.1183278			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	524BD	19965456				2022-12-24	WOS:000272117900027
J	Guenou, H; Nissan, X; Larcher, F; Feteira, J; Lemaitre, G; Saidani, M; Del Rio, M; Barrault, CC; Bernard, FX; Peschanski, M; Baldeschi, C; Waksman, G				Guenou, Hind; Nissan, Xavier; Larcher, Fernando; Feteira, Jessica; Lemaitre, Gilles; Saidani, Manoubia; Del Rio, Marcelo; Barrault, Christine C.; Bernard, Francois-Xavier; Peschanski, Marc; Baldeschi, Christine; Waksman, Gilles			Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study	LANCET			English	Article							GENE-EXPRESSION; RETINOIC ACID; SKIN; DIFFERENTIATION; KERATINOCYTES; LINES; REGENERATION; MECHANISMS; BANKING; BURNS	Background Cell therapy for large burns is dependent upon autologous epidermis reconstructed in vitro. However, the effectiveness of current procedures is limited by the delay needed to culture the patient's own keratinocytes. To assess whether the keratinocyte progeny of human embryonic stem cells (hESCs) could be used to form a temporary skin substitute for use in patients awaiting autologous grafts, we investigated the cells' capability of constructing a pluristratified epidermis. Methods hESCs from lines H9 and SA01 were seeded at least in triplicate on fibroblast feeder cells for 40 days in a medium supplemented with bone morphogenetic protein 4 and ascorbic acid. Molecular characterisation of cell differentiation was done throughout the process by quantitative PCR, fluorescence-activated cell sorting, and immunocytochemical techniques. Keratinocyte molecular differentiation and functional capacity to construct a human epidermis were assessed in vitro and in vivo. Findings From hESCs, we generated a homogeneous population of cells that showed phenotypic characteristics of basal keratinocytes. Expression levels of genes encoding keratin 14, keratin 5, integrin alpha 6, integrin beta 4, Collagen VII, and laminin 5 in these cells were similar to those in basal keratinocytes. After seeding on an artificial matrix, keratinocytes derived from hESCs (K-hESCs) formed a pluristratified epidermis. Keratin-14 immunostaining was seen in the basal compartment, with keratin 10 present in layers overlying the basal layer. Involucrin and filaggrin, late markers of epidermal differentiation, were detected in the uppermost layers only. 12 weeks after grafting onto five immunodeficient mice, epidermis derived from K-hESCs had a structure consistent with that of mature human skin. Human involucrin was appropriately located in spinous and granular layers and few Ki67-positive cells were detected in the basal layer. Interpretation hESCs can be differentiated into basal keratinocytes that are fully functional-ie, able to construct a pluristratified epidermis. This resource could be developed to provide temporary skin substitutes for patients awaiting autologous grafts.	[Guenou, Hind; Nissan, Xavier; Feteira, Jessica; Lemaitre, Gilles; Saidani, Manoubia; Peschanski, Marc; Baldeschi, Christine; Waksman, Gilles] INSERM, I STEM, Inst Stem Cell Therapy & Explorat Monogen Dis, AFM,UEVE U 861, F-91030 Evry, France; [Larcher, Fernando; Del Rio, Marcelo] CIEMAT CIBER ER, Epithelial Biomed Div, Madrid, Spain; [Barrault, Christine C.; Bernard, Francois-Xavier] BIOalternat SAS, Gencay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Baldeschi, C (corresponding author), INSERM, I STEM, Inst Stem Cell Therapy & Explorat Monogen Dis, AFM,UEVE U 861, 5 Rue Henri Desbrueres, F-91030 Evry, France.	cbaldeschi@istem.genethon.fr	Larcher, Fernando/J-1527-2016; Nissan, Xavier/C-2304-2018; Lemaître, Gilles/AAL-5889-2021; baldeschi, christine/U-9386-2018; Guenou, Hind/Q-3811-2018	Larcher, Fernando/0000-0002-6771-3561; Nissan, Xavier/0000-0003-3374-6274; baldeschi, christine/0000-0001-6624-0507; Del Rio Nechaevsky, Marcela/0000-0003-2910-7189; Guenou, Hind/0000-0003-3906-2519; Saidani, Manoubia/0000-0002-2805-4639; Lemaitre, Gilles/0000-0002-0898-1582	Institut National de la Sante et de la Recherche Medicale (INSERM); University Evry Val d'Essonne (UEVE); Association Francaise contre les Myopathies (AFM); Fondation Rene Touraine; Genopole	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Evry Val d'Essonne (UEVE); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Rene Touraine; Genopole	We thank G Meneguzzi and L Gagnoux for providing biological resources. M Martin for constant support, and C Hechard for managing partnerships of this project. This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), University Evry Val d'Essonne (UEVE), Association Francaise contre les Myopathies (AFM), Fondation Rene Touraine, and Genopole.	Aberdam D, 2008, CELL TISSUE RES, V331, P103, DOI 10.1007/s00441-007-0497-0; ALSBJORN B, 1984, SCAND J PLAST RECONS, V18, P127, DOI 10.3109/02844318409057414; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Bamberger C, 2002, J INVEST DERMATOL, V118, P133, DOI 10.1046/j.0022-202x.2001.01649.x; Blome-Eberwein S, 2002, Burns, V28 Suppl 1, pS10; Burd A, 2005, CLIN DERMATOL, V23, P376, DOI 10.1016/j.clindermatol.2004.07.019; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Catani MV, 2005, NUTR REV, V63, P81, DOI 10.1111/j.1753-4887.2005.tb00125.x; Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3; Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069; FUCHS E, 1993, J CELL SCI, P197; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; *GER, GER REC FDA CLEAR BE; Green H, 2003, P NATL ACAD SCI USA, V100, P15625, DOI 10.1073/pnas.0307226100; Hohlfeld J, 2005, LANCET, V366, P840, DOI 10.1016/S0140-6736(05)67107-3; Iuchi S, 2006, P NATL ACAD SCI USA, V103, P1792, DOI 10.1073/pnas.0510953103; Kearney JN, 2001, BURNS, V27, P545, DOI 10.1016/S0305-4179(01)00020-1; Medawar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003441; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Stottmann RW, 2006, DEV BIOL, V295, P647, DOI 10.1016/j.ydbio.2006.03.051; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Tomfscot A, 2007, STEM CELLS, V25, P2200, DOI 10.1634/stemcells.2007-0133; Turksen K, 1998, BIOCHEM CELL BIOL, V76, P889, DOI 10.1139/bcb-76-6-889	31	165	186	3	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1745	1753		10.1016/S0140-6736(09)61496-3	http://dx.doi.org/10.1016/S0140-6736(09)61496-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19932355				2022-12-24	WOS:000272207700023
J	Danchin, MH; Bines, JE				Danchin, Margaret H.; Bines, Julie E.			Global Health: Defeating Rotavirus? The Global Recommendation for Rotavirus Vaccination.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Danchin, Margaret H.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Royal Childrens Hosp, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne	Danchin, MH (corresponding author), Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.		Danchin, Margie/ABE-3391-2020	Bines, Julie/0000-0002-5452-6601				Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; Clark HF, 2009, CLIN VACCINE IMMUNOL, V16, P382, DOI 10.1128/CVI.00382-08; Newburg DS, 1998, LANCET, V351, P1160, DOI 10.1016/S0140-6736(97)10322-1; Parashar UD, 2009, NEW ENGL J MED, V360, P1063, DOI 10.1056/NEJMp0810154; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6	5	20	20	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1919	1921		10.1056/NEJMp0905091	http://dx.doi.org/10.1056/NEJMp0905091			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19907040				2022-12-24	WOS:000271660500002
J	Clarke, NMP; Kendrick, T				Clarke, N. M. P.; Kendrick, Tony			Easily missed? Slipped capital femoral epiphysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Clarke, N. M. P.; Kendrick, Tony] Southampton Gen Hosp, Southampton Univ Hosp NHS Trust, Southampton SO16 6YD, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust	Clarke, NMP (corresponding author), Southampton Gen Hosp, Southampton Univ Hosp NHS Trust, Southampton SO16 6YD, Hants, England.	ortho@soton.ac.uk	Kendrick, Tony/H-8558-2014	Kendrick, Tony/0000-0003-1618-9381				Aronsson DD, 2006, J AM ACAD ORTHOP SUR, V14, P666, DOI 10.5435/00124635-200611000-00010; Bhatia NN, 2006, J PEDIATR ORTHOPED, V26, P197, DOI 10.1097/01.bpo.0000218526.36362.3f; CARNEY BT, 1991, J BONE JOINT SURG AM, V73A, P667, DOI 10.2106/00004623-199173050-00004; Green Daniel W, 2005, HSS J, V1, P103, DOI 10.1007/s11420-005-0118-y; JONES JR, 1990, J BONE JOINT SURG BR, V72, P568; KALLIO P, 1995, J BONE JOINT SURG BR, V77, P752, DOI 10.1302/0301-620X.77B5.7559704; KLEIN A, 1951, AM J ROENTGENOL, V66, P361; Lehmann CL, 2006, J PEDIATR ORTHOPED, V26, P286, DOI 10.1097/01.bpo.0000217718.10728.70; LODER RT, 2007, PEDIAT ORTHOPAEDIC S, P353; Matava MJ, 1999, J PEDIATR ORTHOPED, V19, P455, DOI 10.1097/00004694-199907000-00007; Rahme D, 2006, J PEDIATR ORTHOP B, V15, P93, DOI 10.1097/01.bpb.0000188251.24771.c9	11	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2009	339								b4457	10.1136/bmj.b4457	http://dx.doi.org/10.1136/bmj.b4457			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UE	19897664				2022-12-24	WOS:000271568000001
J	Kastrinos, F; Mukherjee, B; Tayob, N; Wang, F; Sparr, J; Raymond, VM; Bandipalliam, P; Stoffel, EM; Gruber, SB; Syngal, S				Kastrinos, Fay; Mukherjee, Bhramar; Tayob, Nabihah; Wang, Fei; Sparr, Jennifer; Raymond, Victoria M.; Bandipalliam, Prathap; Stoffel, Elena M.; Gruber, Stephen B.; Syngal, Sapna			Risk of Pancreatic Cancer in Families With Lynch Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MSH2 MUTATION CARRIERS; DNA-MISMATCH-REPAIR; MEDULLARY CARCINOMA; ENDOMETRIAL CANCER; HISTORY; ACCURACY; INDIVIDUALS; PATIENT; GENE	Context Lynch syndrome is an inherited cause of colorectal cancer caused by mutations of DNA mismatch repair (MMR) genes. A number of extracolonic tumors have been associated with the disorder, including pancreatic cancer; however, the risk of pancreatic cancer in Lynch syndrome is uncertain and not quantified. Objective To estimate pancreatic cancer risk in families with germline MMR gene mutations. Design, Setting, and Patients Cancer histories of probands and their relatives were evaluated in MMR gene mutation carriers in the familial cancer registries of the Dana-Farber Cancer Institute (n=80), Boston, Massachusetts, and University of Michigan Comprehensive Cancer Center (n=67), Ann Arbor, Michigan. Families enrolled before the study start date ( June 2008) were eligible. Age-specific cumulative risks and hazard ratio estimates of pancreatic cancer risk were calculated and compared with the general population using modified segregation analysis, with correction for ascertainment. Main Outcome Measures Age-specific cumulative risks and hazard ratio estimates of pancreatic cancer risk. Results Data on 6342 individuals from 147 families with MMR gene mutations were analyzed. Thirty-one families (21.1%) reported at least 1 case of pancreatic cancer. Forty-seven pancreatic cancers were reported ( 21 men and 26 women), with no sex-related difference in age of diagnosis (51.5 vs 56.5 years for men and women, respectively). The cumulative risk of pancreatic cancer in these families with gene mutations was 1.31% (95% confidence interval [CI], 0.31%-2.32%) up to age 50 years and 3.68% ( 95% CI, 1.45%-5.88%) up to age 70 years, which represents an 8.6-fold increase ( 95% CI, 4.7-15.7) compared with the general population. Conclusions Among 147 families with germline MMR gene mutations, the risk of pancreatic cancer was increased compared with the US population. Individuals with MMR gene mutations and a family history of pancreatic cancer are appropriate to include in studies to further define the risk of premalignant and malignant pancreatic neoplasms and potential benefits and limitations of surveillance. JAMA. 2009; 302(16):1790-1795 www.jama.com	[Sparr, Jennifer; Bandipalliam, Prathap; Stoffel, Elena M.; Syngal, Sapna] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; [Kastrinos, Fay; Stoffel, Elena M.; Syngal, Sapna] Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA; [Kastrinos, Fay] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Mukherjee, Bhramar; Tayob, Nabihah; Wang, Fei] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Raymond, Victoria M.; Gruber, Stephen B.] Univ Michigan, Sch Publ Hlth, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gruber, Stephen B.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol & Human Genet, Ann Arbor, MI 48109 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Columbia University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Syngal, S (corresponding author), Dana Farber Canc Inst, Div Populat Sci, 1 Jimmy Fund Way,SM 209, Boston, MA 02115 USA.	sgruber@med.umich.edu; ssyngal@partners.org			National Cancer Institute [R01CA81488, K24CA113433, R01CA97075, 5P30CA46592]; The Karp Family; H. H. & M. Metals Inc Fund; Leake Gift for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [R01CA097075, K24CA113433, P30CA046592, R01CA081488] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Karp Family; H. H. & M. Metals Inc Fund; Leake Gift for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grants R01CA81488, K24CA113433, R01CA97075, and 5P30CA46592 from the National Cancer Institute, The Karp Family, H. H. & M. Metals Inc Fund, and the Leake Gift for Pancreatic Cancer Research.	Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Banville N, 2006, HUM PATHOL, V37, P1498, DOI 10.1016/j.humpath.2006.06.024; Brand RE, 2000, MED CLIN N AM, V84, P665, DOI 10.1016/S0025-7125(05)70249-2; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brentnall TA, 1999, ANN INTERN MED, V131, P247, DOI 10.7326/0003-4819-131-4-199908170-00003; Canto MI, 2006, CLIN GASTROENTEROL H, V4, P766, DOI 10.1016/j.cgh.2006.02.005; Canto MI, 2004, CLIN GASTROENTEROL H, V2, P606, DOI 10.1016/S1542-3565(04)00244-7; Douglas FS, 1999, J MED GENET, V36, P309; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Geary J, 2008, FAM CANCER, V7, P163, DOI 10.1007/s10689-007-9164-6; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Goecke T, 2006, J CLIN ONCOL, V24, P4285, DOI 10.1200/JCO.2005.03.7333; Hruban RH, 2001, DIGEST DIS, V19, P76, DOI 10.1159/000050656; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LOVE RR, 1985, J CHRON DIS, V38, P289, DOI 10.1016/0021-9681(85)90074-8; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Lynch HT, 1996, SEMIN ONCOL, V23, P251; LYNCH HT, 1967, AM J MED SCI, V254, P322, DOI 10.1097/00000441-196709000-00007; Maple JT, 2005, PANCREATOLOGY, V5, P220, DOI 10.1159/000085275; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; Petersen GM, 2006, CANCER EPIDEM BIOMAR, V15, P704, DOI 10.1158/1055-9965.EPI-05-0734; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; Rulyak SJ, 2001, PANCREATOLOGY, V1, P477, DOI 10.1159/000055851; Sijmons RH, 2000, EUR J HUM GENET, V8, P181, DOI 10.1038/sj.ejhg.5200441; Sparr JA, 2009, AM J SURG PATHOL, V33, P309, DOI 10.1097/PAS.0b013e3181882c3d; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Vasen HFA, 2000, INT J CANCER, V87, P809, DOI 10.1002/1097-0215(20000915)87:6<809::AID-IJC8>3.3.CO;2-L; Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074; Wang WY, 2007, J CLIN ONCOL, V25, P1417, DOI 10.1200/JCO.2006.09.2452; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508; Wilentz RE, 2000, AM J PATHOL, V156, P1641, DOI 10.1016/S0002-9440(10)65035-3	38	310	316	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1790	1795		10.1001/jama.2009.1529	http://dx.doi.org/10.1001/jama.2009.1529			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861671	Green Accepted, Bronze			2022-12-24	WOS:000271150300022
J	Sibanda, BL; Chirgadze, DY; Blundell, TL				Sibanda, Bancinyane L.; Chirgadze, Dimitri Y.; Blundell, Tom L.			Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; 3-DIMENSIONAL STRUCTURE; COMPLEX; DOMAIN; END; SUGGESTS; 3-KINASE; DAMAGE	Broken chromosomes arising from DNA double-strand breaks result from endogenous events such as the production of reactive oxygen species during cellular metabolism, as well as from exogenous sources such as ionizing radiation(1-3). Left unrepaired or incorrectly repaired they can lead to genomic changes that may result in cell death or cancer. DNA-dependent protein kinase (DNA-PK), a holoenzyme that comprises the DNA-PK catalytic subunit (DNA-PKcs) 4,5 and the heterodimer Ku70/Ku80, has a major role in non-homologous end joining-the main pathway in mammals used to repair double-strand breaks(6-8). DNA-PKcs is a serine/threonine protein kinase comprising a single polypeptide chain of 4,128 amino acids and belonging to the phosphatidylinositol-3-OH kinase (PI(3) K)-related protein family(9). DNA-PKcs is involved in the sensing and transmission of DNA damage signals to proteins such as p53, setting off events that lead to cell cycle arrest(10,11). It phosphorylates a wide range of substrates in vitro, including Ku70/Ku80, which is translocated along DNA(12). Here we present the crystal structure of human DNA-PKcs at 6.6 angstrom resolution, in which the overall fold is clearly visible, to our knowledge, for the first time. The many alpha-helical HEAT repeats (helix-turn-helix motifs) facilitate bending and allow the polypeptide chain to fold into a hollow circular structure. The carboxy-terminal kinase domain is located on top of this structure, and a small HEAT repeat domain that probably binds DNA is inside. The structure provides a flexible cradle to promote DNA double-strand-break repair.	[Sibanda, Bancinyane L.; Chirgadze, Dimitri Y.; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Sibanda, BL (corresponding author), Univ Cambridge, Dept Biochem, Old Addenbrookes Site,80 Tennis Court Rd, Cambridge CB2 1GA, England.	lynn@cryst.bioc.cam.ac.uk; dima@cryst.bioc.cam.ac.uk		Chirgadze, Dimitri/0000-0001-9942-0993	Wellcome Trust; CR-UK	Wellcome Trust(Wellcome TrustEuropean Commission); CR-UK(Cancer Research UK)	We wish to thank G. Smith for providing pure DNA-PKcs that was used in the initial experiments as a marker and also for providing the DNA-PKcs and Ku70 antibodies, L. Pellegrini for help and advice at the beginning of the project, and S. Jackson for discussions. We are also grateful to R. Peat for preparing HeLa cells, L. Packman for help in identifying DNA-PKcs in polyacrylamide gels, N. Ban for providing Ta<INF>6</INF>Br<INF>12</INF><SUP>2+</SUP> and C. Muller-Dieckmann at the ESRF for support during the diffraction data collection experiments. This work was funded by the Wellcome Trust and CR-UK.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; Chiu CY, 1998, J MOL BIOL, V284, P1075, DOI 10.1006/jmbi.1998.2212; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; DVIR A, 1993, J BIOL CHEM, V268, P10440; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Harris R, 2004, J MOL BIOL, V335, P573, DOI 10.1016/j.jmb.2003.10.047; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; KEMP LM, 1984, MUTAT RES, V132, P189, DOI 10.1016/0167-8817(84)90037-3; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Leonard GA, 2009, J APPL CRYSTALLOGR, V42, P333, DOI 10.1107/S0021889809001721; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; SCHNEIDER G, 1994, ACTA CRYSTALLOGR D, V50, P186, DOI 10.1107/S0907444993009679; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; ZDZIENICKA MZ, 1988, MUTAT RES, V194, P239; Zhang ZM, 2004, STRUCTURE, V12, P495, DOI 10.1016/j.str.2004.02.007	40	162	166	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					118	U132		10.1038/nature08648	http://dx.doi.org/10.1038/nature08648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20023628	Green Accepted, Green Submitted			2022-12-24	WOS:000273344900042
J	Day, G; Carter, N				Day, Giskin; Carter, Naiome			Christmas 2009: Professional matters Wards of the roses	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Day, Giskin; Carter, Naiome] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Day, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	giskin.day@imperial.ac.uk		Day, Giskin/0000-0002-9901-9267				*BRIT FLOR ASS, BFA TAK LEAD HOSP FL; GALE R, 1977, INT ARCH OCC ENV HEA, V40, P255, DOI 10.1007/BF00381413; GOULD D, 2004, J RES NURS, V9, P366; Gould D, 2005, BRIT J INFECT CONTRO, V6, P18; Haviland-Jones J., 2005, EVOL PSYCHOL-US, V3, P104, DOI [DOI 10.1177/147470490500300109,147470490500300109, 10.1177/147470490500300109, DOI 10.1177/147470490500300109]; Humphreys H, 2006, J HOSP INFECT, V64, P302, DOI 10.1016/j.jhin.2006.06.018; LaCharity Linda A, 2003, Crit Care Nurs Clin North Am, V15, P119, DOI 10.1016/S0899-5885(02)00037-0; Park SH, 2008, HORTTECHNOLOGY, V18, P563, DOI 10.21273/HORTTECH.18.4.563; Ruskin John, 1889, FRONDES AGRESTES REA; TAPLIN D, 1973, LANCET, V2, P1279; URQUHART F, 1996, SCOTSMAN        1012, P5	11	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 16	2009	339								b5257	10.1136/bmj.b5257	http://dx.doi.org/10.1136/bmj.b5257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XH	20015904	Green Submitted			2022-12-24	WOS:000272930300012
J	Hibbitts, S				Hibbitts, Sam			Should boys receive the human papillomavirus vaccine? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HPV VACCINE; CANCER; BURDEN; IMMUNOGENICITY; IMPACT		Cardiff Univ, Sch Med, Dept Obstet & Gynaecol, HPV Res Grp, Cardiff CF14 4XN, Wales	Cardiff University	Hibbitts, S (corresponding author), Cardiff Univ, Sch Med, Dept Obstet & Gynaecol, HPV Res Grp, Cardiff CF14 4XN, Wales.	hibbittssj@cf.ac.uk						Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4127; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3884; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Petaja T, 2009, J ADOLESCENT HEALTH, V44, P33, DOI 10.1016/j.jadohealth.2008.10.002; Powell N, 2009, INT J CANCER, V125, P2425, DOI 10.1002/ijc.24571; Robertson SE, 1997, B WORLD HEALTH ORGAN, V75, P69; Udesky L, 2007, LANCET, V369, P979, DOI 10.1016/S0140-6736(07)60475-9; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758	15	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2009	339								b4928	10.1136/bmj.b4928	http://dx.doi.org/10.1136/bmj.b4928			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VD	19969602				2022-12-24	WOS:000272697200003
J	Lamont, T; Scarpello, J				Lamont, Tara; Scarpello, John			Safety Alerts National Patient Safety Agency: combining stories with statistics to minimise harm	BRITISH MEDICAL JOURNAL			English	Editorial Material							INCIDENTS		[Lamont, Tara; Scarpello, John] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						Department of Health, 2006, SAF 1 REP PAT CLIN H; Lamont T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4459; *NAT PAT SAF AG, 2009, RAP RESP REP PREV DE; National Patient Safety Agency, 2008, RAP RESP REP RED RIS; National Patient Safety Agency, 2009, ACT SER RISKS PAT; Newman TB, 2003, BRIT MED J, V327, P1424, DOI 10.1136/bmj.327.7429.1424; *NHS, 2009, J HUBL FAITH NHS; O'Dowd A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4153; PANESAR SS, 2009, ROY SOC MED INT CONG, V102, P256; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Vincent C, 2007, BRIT MED J, V334, P51, DOI 10.1136/bmj.39071.441609.80	12	14	14	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 19	2009	339								b4489	10.1136/bmj.b4489	http://dx.doi.org/10.1136/bmj.b4489			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TD	19926688				2022-12-24	WOS:000272096500004
J	Lamont, T; Matthew, L; Cousins, D; Green, J				Lamont, Tara; Matthew, Linda; Cousins, David; Green, Jonathan			Safety Alerts Avoiding midazolam overdose: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Matthew, Linda; Cousins, David] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Green, Jonathan] British Soc Gastroenterol Endoscopy, London NW1 4LB, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						[Anonymous], 2004, SCOP OUR PRACT; British Society of Gastroenterology, 2003, SAF SED DUR END PROC; *COMM NPSA NHS PUR, 2009, NAT US QUANT SINGL E; QUINE MA, 1995, GUT, V36, P462, DOI 10.1136/gut.36.3.462	4	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 19	2009	339								b4459	10.1136/bmj.b4459	http://dx.doi.org/10.1136/bmj.b4459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TD	19926687				2022-12-24	WOS:000272096500003
J	Howell, AS; Savage, NS; Johnson, SA; Bose, I; Wagner, AW; Zyla, TR; Nijhout, HF; Reed, MC; Goryachev, AB; Lew, DJ				Howell, Audrey S.; Savage, Natasha S.; Johnson, Sam A.; Bose, Indrani; Wagner, Allison W.; Zyla, Trevin R.; Nijhout, H. Frederik; Reed, Michael C.; Goryachev, Andrew B.; Lew, Daniel J.			Singularity in Polarization: Rewiring Yeast Cells to Make Two Buds	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; SITE SELECTION; ACTIN CYTOSKELETON; CDC42 GTPASE; POLARITY; PROTEINS; CYCLE; PHOSPHORYLATION; MORPHOGENESIS; LOCALIZATION	For budding yeast to ensure formation of only one bud, cells must polarize toward one, and only one, site. Polarity establishment involves the Rho family GTPase Cdc42, which concentrates at polarization sites via a positive feedback loop. To assess whether singularity is linked to the specific Cdc42 feedback loop, we disabled the yeast cell's endogenous amplification mechanism and synthetically rewired the cells to employ a different positive feedback loop. Rewired cells violated singularity, occasionally making two buds. Even cells that made only one bud sometimes initiated two clusters of Cdc42, but then one cluster became dominant. Mathematical modeling indicated that, given sufficient time, competition between clusters would promote singularity. In rewired cells, competition occurred slowly and sometimes failed to develop a single "winning'' cluster before budding. Slowing competition in normal cells also allowed occasional formation of two buds, suggesting that singularity is enforced by rapid competition between Cdc42 clusters.	[Howell, Audrey S.; Bose, Indrani; Wagner, Allison W.; Zyla, Trevin R.; Lew, Daniel J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Savage, Natasha S.; Goryachev, Andrew B.] Univ Edinburgh, Sch Biol Sci, Ctr Syst Biol Edinburgh, Edinburgh EH9 3JR, Midlothian, Scotland; [Johnson, Sam A.] Duke Univ, Light Microscopy Core Facil, Durham, NC 27708 USA; [Johnson, Sam A.; Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Reed, Michael C.] Duke Univ, Dept Math, Durham, NC 27708 USA	Duke University; University of Edinburgh; Duke University; Duke University; Duke University	Lew, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	daniel.lew@duke.edu	Goryachev, Andrew B/A-6553-2013	Goryachev, Andrew B/0000-0002-1332-4819; McClure, Allison/0000-0002-5321-2483	National Science Foundation (NSF) [G001855]; UK Biotechnology and Biological Sciences Research Council [G001855]; National Institutes of Health [GM62300]; BBSRC [BB/G001855/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G001855/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062300] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank David Amberg, Erfei Bi, Tony Bretscher, John Cooper, David Drubin, and Bruce Goode for advice and reagents and Steve Haase, Joe Heitman, Dan Kiehart, Sally Kornbluth, John York, and members of the Lew lab for comments on the manuscript. A. S. H. was supported by a National Science Foundation (NSF) predoctoral fellowship. Work by N.S.S. and A. B. G. was supported by UK Biotechnology and Biological Sciences Research Council grant G001855. Work by H.F.N. and M. C. R. was supported by NSF grant DMS-061670. This work was supported by National Institutes of Health grant GM62300 to D.J.L.	Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Grote E, 2000, MOL BIOL CELL, V11, P4051, DOI 10.1091/mbc.11.12.4051; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; JAFFE LA, 1976, NATURE, V261, P68, DOI 10.1038/261068a0; Keaton MA, 2008, MOL BIOL CELL, V19, P4006, DOI 10.1091/mbc.E08-03-0286; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2003, NAT CELL BIOL, V5, P267, DOI 10.1038/ncb0403-267; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Zahner JE, 1996, MOL CELL BIOL, V16, P1857	33	126	126	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					731	743		10.1016/j.cell.2009.10.024	http://dx.doi.org/10.1016/j.cell.2009.10.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914166	Green Accepted, Bronze			2022-12-24	WOS:000271747200017
J	Tushir, JS; Zamore, PD; Zhang, Z				Tushir, Jogender S.; Zamore, Phillip D.; Zhang, Zhao			SnapShot: Mouse piRNAs, PIWI Proteins, and the Ping-Pong Cycle	CELL			English	Editorial Material							DROSOPHILA; GERMLINE; ELEMENTS		[Tushir, Jogender S.] Univ Massachusetts, Sch Med, HHMI, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tushir, JS (corresponding author), Univ Massachusetts, Sch Med, HHMI, Worcester, MA 01605 USA.		Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	9	9	9	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 13	2009	139	4					830	U5		10.1016/j.cell.2009.10.042	http://dx.doi.org/10.1016/j.cell.2009.10.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914174	Bronze			2022-12-24	WOS:000271747200026
J	Ahmed, T; Ahmed, AMS				Ahmed, Tahmeed; Ahmed, A. M. Shamsir			Reducing the burden of malnutrition in Bangladesh	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tahmeed@icddrb.org						AHMED T, 2007, POLICY BRIEF CHILD M; *BANGL BUR STAT, 2005, HOUS INC EXP SURV 20; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Brown KH, 2003, J NUTR, V133, p328S, DOI 10.1093/jn/133.1.328S; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Shekar M, 2006, REPOSITIONING NUTR C	6	18	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2009	339								b4490	10.1136/bmj.b4490	http://dx.doi.org/10.1136/bmj.b4490			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UC	19889736				2022-12-24	WOS:000271567800004
J	Bourjeily, G; Paidas, M; Khalil, H; Rosene-Montella, K; Rodger, M				Bourjeily, Ghada; Paidas, Michael; Khalil, Hanan; Rosene-Montella, Karen; Rodger, Marc			Pulmonary embolism in pregnancy	LANCET			English	Article							MOLECULAR-WEIGHT HEPARIN; RECURRENT VENOUS THROMBOEMBOLISM; FACTOR-V-LEIDEN; D-DIMER LEVELS; TISSUE-PLASMINOGEN ACTIVATOR; SIMPLE CLINICAL-MODEL; VENA-CAVA FILTERS; UNFRACTIONATED HEPARIN; RISK-FACTORS; COMPUTED-TOMOGRAPHY	Pulmonary embolism (PE) is the leading cause of maternal mortality in the developed world. Mortality from PE in pregnancy might be related to challenges in targeting the right population for prevention, ensuring that diagnosis is suspected and adequately investigated, and initiating timely and best possible treatment of this disease. Pregnancy is an example of Virchow's triad: hypercoagulability, venous stasis, and vascular damage; together these factors lead to an increased incidence of venous thromboembolism. This disorder is often suspected in pregnant women because some of the physiological changes of pregnancy mimic its signs and symptoms. Despite concerns for fetal teratogenicity and oncogenicity associated with diagnostic testing, and potential adverse effects of pharmacological treatment, an accurate diagnosis of PE and a timely therapeutic intervention are crucial. Appropriate prophylaxis should be weighed against the risk of complications and offered according to risk stratification.	[Bourjeily, Ghada; Rosene-Montella, Karen] Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Med, Providence, RI 02905 USA; [Khalil, Hanan] Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Diagnost Imaging, Providence, RI 02905 USA; [Paidas, Michael] Yale Univ, Sch Med, Yale New Haven Hosp, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Rodger, Marc] Univ Ottawa, Dept Med, Ottawa Hosp, Ottawa, ON, Canada	Brown University; Women & Infants Hospital Rhode Island; Brown University; Women & Infants Hospital Rhode Island; Yale University; University of Ottawa; Ottawa Hospital Research Institute	Bourjeily, G (corresponding author), Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Med Pulm & Crit Care Med, 100 Dudley St,3rd Floor, Providence, RI 02905 USA.	GBourjeily@wihri.org		Rodger, Marc/0000-0001-8166-3487; Bourjeily, Ghada/0000-0002-0543-4719	GTC Biotherapeutics; Novo-Nordisk; BioIncept; Celera; Hologic; Kronos Longevity Research Institute; Pfizer; Sanofi-Aventis; Leo Pharma	GTC Biotherapeutics; Novo-Nordisk(Novo Nordisk); BioIncept; Celera; Hologic; Kronos Longevity Research Institute; Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Leo Pharma(LEO Pharma)	MP has received honoraria from GTC Biotherapeutics, Novo-Nordisk, CSL Behring, Telacris, and Hologic, and research funding from GTC Biotherapeutics, Novo-Nordisk, BioIncept, Celera, and Hologic. MP was a coauthor of a consensus panel document whose meetings and editorial assistance were provided by Sanofi-Aventis, although funding was not received from the company. He is a consultant for the KEEPS trial, sponsored by the Kronos Longevity Research Institute. MR has received grant funding from Pfizer, Sanofi-Aventis, and Leo Pharma, and served on advisory boards for Sanofi-Aventis without payment. GB, HK, and KR-M declare that they have no conflicts of interest.	Abou-Nassar K, 2007, THROMB HAEMOSTASIS, V98, P163, DOI 10.1160/TH06-10-0574; Ahearn GS, 2002, ARCH INTERN MED, V162, P1221, DOI 10.1001/archinte.162.11.1221; AlMeshari A, 1996, INT J GYNECOL OBSTET, V52, P25, DOI 10.1016/0020-7292(95)02556-1; Andersen BS, 1998, ACTA OBSTET GYN SCAN, V77, P170, DOI 10.1034/j.1600-0412.1998.770207.x; Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Andreou A, 2008, EUR RADIOL, V18, P2716, DOI 10.1007/s00330-008-1114-7; Balan KK, 1997, BRIT J RADIOL, V70, P338, DOI 10.1259/bjr.70.832.9166067; Barrellier MT, 2001, J MAL VASCUL, V26, P23; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Bauersachs RM, 2007, J THROMB HAEMOST, V5, P438, DOI 10.1111/j.1538-7836.2007.02339.x; Beer JH, 2003, J THROMB HAEMOST, V1, P186, DOI 10.1046/j.1538-7836.2003.00005.x; Blanco-Molina A, 2007, THROMB HAEMOSTASIS, V97, P186, DOI 10.1160/TH06-11-0650; Boehlen F, 2005, Rev Med Suisse, V1, P296; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; BRENT RL, 1972, CURRENT PROBLEMS RAD, V2, P1; Brent RL, 2009, AM J OBSTET GYNECOL, V200, P4, DOI 10.1016/j.ajog.2008.06.032; Brieger D, 1996, THROMB HAEMOSTASIS, V75, P740; Brill-Edwards P, 2000, NEW ENGL J MED, V343, P1439, DOI 10.1056/NEJM200011163432002; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Campbell IA, 2003, THORAX, V58, P470; Carrier M, 2006, THROMB RES, V117, P469, DOI 10.1016/j.thromres.2005.04.005; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Casele HL, 1999, AM J OBSTET GYNECOL, V181, P1113, DOI 10.1016/S0002-9378(99)70091-8; Chabloz P, 2001, BRIT J HAEMATOL, V115, P150, DOI 10.1046/j.1365-2141.2001.03082.x; Chan WS, 2007, ANN INTERN MED, V147, P165, DOI 10.7326/0003-4819-147-3-200708070-00005; Chan WS, 2002, ARCH INTERN MED, V162, P1170, DOI 10.1001/archinte.162.10.1170; Chunilal SD, 2002, THROMB HAEMOSTASIS, V87, P92; Clark P, 1998, THROMB HAEMOSTASIS, V79, P1166; Couturaud F, 2001, THROMB HAEMOSTASIS, V86, P980; Dager WE, 2005, ANN PHARMACOTHER, V39, P1182, DOI 10.1345/aph.1E677; Danilenko-Dixon DR, 2001, AM J OBSTET GYNECOL, V184, P104, DOI 10.1067/mob.2001.107919; Das SK, 1996, WORLD J SURG, V20, P521, DOI 10.1007/s002689900081; De Stefano V, 2006, BRIT J HAEMATOL, V135, P386, DOI 10.1111/j.1365-2141.2006.06317.x; DESWIET M, 1977, NEW ENGL J MED, V297, P1471; Dizon-Townson D, 2005, OBSTET GYNECOL, V106, P517, DOI 10.1097/01.AOG.0000173986.32528.ca; Dolovich LR, 2000, ARCH INTERN MED, V160, P181, DOI 10.1001/archinte.160.2.181; Doshi SK, 2008, BRIT J RADIOL, V81, P653, DOI 10.1259/bjr/22775594; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Douma RA, 2007, SEMIN THROMB HEMOST, V33, P821, DOI 10.1055/s-2007-1000371; Doyle NM, 2004, AM J OBSTET GYNECOL, V191, P1019, DOI 10.1016/j.ajog.2004.06.048; Duhl AJ, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.022; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Epiney M, 2005, J THROMB HAEMOST, V3, P268, DOI 10.1111/j.1538-7836.2004.01108.x; GATES S, 2002, COCHRANE DB SYST REV, V2, P1689; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3; Ginsberg JS, 1998, CHEST, V114, p524S, DOI 10.1378/chest.114.5_Supplement.524S; GINSBERG JS, 1995, BLOOD, V86, P3685, DOI 10.1182/blood.V86.10.3685.bloodjournal86103685; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; Grandone E, 1998, AM J OBSTET GYNECOL, V179, P1324, DOI 10.1016/S0002-9378(98)70155-3; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Groves AM, 2006, RADIOLOGY, V240, P765, DOI 10.1148/radiol.2403050910; HALL JG, 1980, AM J MED, V68, P122, DOI 10.1016/0002-9343(80)90181-3; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Hirsh J, 2008, CHEST, V133, p141S, DOI 10.1378/chest.08-0689; Hopper KD, 1997, RADIOLOGY, V205, P853, DOI 10.1148/radiology.205.3.9393547; HOWELL R, 1983, BRIT J OBSTET GYNAEC, V90, P1124, DOI 10.1111/j.1471-0528.1983.tb06458.x; Huang WH, 2000, OBSTET GYNECOL, V96, P838, DOI 10.1016/S0029-7844(00)00966-2; HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602; Hunt BJ, 1997, THROMB HAEMOSTASIS, V77, P39; Hurwitz LM, 2006, AM J ROENTGENOL, V186, P1718, DOI 10.2214/AJR.04.1917; Hurwitz LM, 2006, AM J ROENTGENOL, V186, P871, DOI 10.2214/AJR.04.1915; ICRP, 2003, ANN ICRP, P1, DOI [10.1016/S0146-6453(03)00024-1, DOI 10.1016/S0146-6453(03)00024-1, DOI 10.1016/S0146-6453(03)00021-6]; *INT COMM RAD PROT, 2000, ANN ICRP, P3; Jacobsen AF, 2008, J THROMB HAEMOST, V6, P905, DOI 10.1111/j.1538-7836.2008.02961.x; Jacobsen AF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.041; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James AH, 2005, AM J OBSTET GYNECOL, V193, P216, DOI 10.1016/j.ajog.2004.11.037; Jamjute P, 2006, J MATERN-FETAL NEO M, V19, P741, DOI 10.1080/14767050600631443; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Kalva SP, 2008, J VASC INTERV RADIOL, V19, P1041, DOI 10.1016/j.jvir.2008.03.026; Kearon C, 2004, J THROMB HAEMOST, V2, P743, DOI 10.1046/j.1538-7836.2004.00698.x; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; Kearon C, 2006, JAMA-J AM MED ASSOC, V296, P935, DOI 10.1001/jama.296.8.935; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kjellberg U, 1999, THROMB HAEMOSTASIS, V81, P527; Kobayashi T, 2008, CIRC J, V72, P753, DOI 10.1253/circj.72.753; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Kovacs MJ, 2000, THROMB HAEMOSTASIS, V83, P209; Larsen TB, 2007, THROMB RES, V120, P505, DOI 10.1016/j.thromres.2006.12.003; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lee KW, 2003, ARCH INTERN MED, V163, P2368, DOI 10.1001/archinte.163.19.2368; LEGNAIN M, 2000, E MEDITERR HEALTH J, V66, P283; Leonhardt G, 2006, J THROMB THROMBOLYS, V21, P271, DOI 10.1007/s11239-006-5709-z; LEVINE MN, 1994, ARCH INTERN MED, V154, P49, DOI 10.1001/archinte.154.1.49; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Lopaciuk S, 1999, THROMB HAEMOSTASIS, V81, P26; Mac Gillavry MR, 2000, THROMB HAEMOSTASIS, V84, P973; Macklon NS, 1997, BRIT J OBSTET GYNAEC, V104, P191, DOI 10.1111/j.1471-0528.1997.tb11043.x; Malcolm Janine C, 2002, J Obstet Gynaecol Can, V24, P568; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; McColl MD, 1997, THROMB HAEMOSTASIS, V78, P1183; McConville RM, 2009, CARDIOVASC INTER RAD, V32, P174, DOI 10.1007/s00270-008-9393-6; Middeldorp S, 2001, ANN INTERN MED, V135, P322, DOI 10.7326/0003-4819-135-5-200109040-00008; Morse M, 2004, J THROMB HAEMOST, V2, P1202, DOI 10.1111/j.1538-7836.2004.00776.x; National Council on Radiation Protection and Measurement, 1977, 54 NAT COUNC RAD PRO; ORME ML, 1977, BRIT MED J, V1, P1564, DOI 10.1136/bmj.1.6076.1564; Pabinger I, 2005, J THROMB HAEMOST, V3, P949, DOI 10.1111/j.1538-7836.2005.01307.x; Panting-Kemp A, 2000, AM J OBSTET GYNECOL, V183, P1207, DOI 10.1067/mob.2000.108846; Payne SM, 2003, ANN PHARMACOTHER, V37, P655, DOI 10.1345/aph.1C327; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Pettila V, 2002, THROMB HAEMOSTASIS, V87, P182; Pomp ER, 2008, J THROMB HAEMOST, V6, P632, DOI 10.1111/j.1538-7836.2008.02921.x; Powrie RO, 1998, AM J OBSTET GYNECOL, V178, P394, DOI 10.1016/S0002-9378(98)80031-8; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Ray J G, 1999, Obstet Gynecol Surv, V54, P265, DOI 10.1097/00006254-199904000-00023; Richter C, 2001, BRIT J CLIN PHARMACO, V52, P708, DOI 10.1046/j.0306-5251.2001.01517.x; Rodger M, 2000, AM J CARDIOL, V86, P807, DOI 10.1016/S0002-9149(00)01090-0; Rodger MA, 2000, AM J RESP CRIT CARE, V162, P2105, DOI 10.1164/ajrccm.162.6.2004204; Rodger MA, 2005, THROMB RES, V116, P101, DOI 10.1016/j.thromres.2004.10.011; Rosenkranz A, 2008, THROMB HAEMOSTASIS, V99, P331, DOI 10.1160/TH07-05-0359; Rosito GA, 2004, THROMB HAEMOSTASIS, V91, P683, DOI 10.1160/TH03-01-0014; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Russell JR, 1997, HEALTH PHYS, V73, P756, DOI 10.1097/00004032-199711000-00003; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; STEIN PD, 1994, ANN INTERN MED, V121, P313, DOI 10.7326/0003-4819-121-5-199409010-00001; STEIN PD, 1995, CHEST, V108, P978, DOI 10.1378/chest.108.4.978; Sullivan EA, 2004, AUST NZ J OBSTET GYN, V44, P452, DOI 10.1111/j.1479-828X.2004.00313.x; Torres JA, 1999, ANGIOLOGIA, V51, P71; TREFFERS PE, 1983, INT J GYNECOL OBSTET, V21, P327, DOI 10.1016/0020-7292(83)90024-3; Trukhacheva E, 2005, OBSTET GYNECOL, V106, P1156, DOI 10.1097/01.AOG.0000164059.72933.9c; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; van Walraven C, 2003, BRIT MED J, V326, P791, DOI 10.1136/bmj.326.7393.791; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Warkentin TE, 2004, CHEST, V126, p311S, DOI 10.1378/chest.126.3_suppl.311S; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; Winer-Muram HT, 2004, RADIOLOGY, V233, P806, DOI 10.1148/radiol.2333031744; Winer-Muram HT, 2002, RADIOLOGY, V224, P487, DOI 10.1148/radiol.2242011581	135	170	186	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					500	512		10.1016/S0140-6736(09)60996-X	http://dx.doi.org/10.1016/S0140-6736(09)60996-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	19889451				2022-12-24	WOS:000274757900033
J	David, CJ; Chen, M; Assanah, M; Canoll, P; Manley, JL				David, Charles J.; Chen, Mo; Assanah, Marcela; Canoll, Peter; Manley, James L.			HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer	NATURE			English	Article							TRACT-BINDING-PROTEIN; EXPRESSION; GROWTH; A1; CELLS; GENE; PTB; DIFFERENTIATION; SPECIFICITY; REPRESSION	When oxygen is abundant, quiescent cells efficiently extract energy from glucose primarily by oxidative phosphorylation, whereas under the same conditions tumour cells consume glucose more avidly, converting it to lactate. This long-observed phenomenon is known as aerobic glycolysis(1), and is important for cell growth(2,3). Because aerobic glycolysis is only useful to growing cells, it is tightly regulated in a proliferation-linked manner(4). In mammals, this is partly achieved through control of pyruvate kinase isoform expression. The embryonic pyruvate kinase isoform, PKM2, is almost universally re-expressed in cancer(2), and promotes aerobic glycolysis, whereas the adult isoform, PKM1, promotes oxidative phosphorylation(2). These two isoforms result from mutually exclusive alternative splicing of the PKM pre-mRNA, reflecting inclusion of either exon 9 (PKM1) or exon 10 (PKM2). Here we show that three heterogeneous nuclear ribonucleoprotein (hnRNP) proteins, polypyrimidine tract binding protein (PTB, also known as hnRNPI), hnRNPA1 and hnRNPA2, bind repressively to sequences flanking exon 9, resulting in exon 10 inclusion. We also demonstrate that the oncogenic transcription factor c-Myc upregulates transcription of PTB, hnRNPA1 and hnRNPA2, ensuring a high PKM2/PKM1 ratio. Establishing a relevance to cancer, we show that human gliomas overexpress c-Myc, PTB, hnRNPA1 and hnRNPA2 in a manner that correlates with PKM2 expression. Our results thus define a pathway that regulates an alternative splicing event required for tumour cell proliferation.	[David, Charles J.; Chen, Mo; Manley, James L.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Assanah, Marcela; Canoll, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu		Chen, Mo/0000-0002-6647-8483; Manley, James/0000-0002-8341-1459	Avon Foundation; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048259] Funding Source: NIH RePORTER	Avon Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Black for BB7 antibody; T. Kashima for hnRNP A1/A2 siRNA; R. Prywes and E. Henckles for C2C12 cells; M. Sheetz and X. Zhang for NIH-3T3 cells; C. Prives, T. Barsotti and L. Biderman for MCF-7 cells, Rb and E2F1 siRNA; R. Dalla-Favera and Q. Shen for anti-c-Myc antibodies and c-Myc expression vector; R. Eisenman for N-Myc antibody; and members of the Manley laboratory for discussions. This work was supported by grants from the Avon Foundation and the NIH.	BIAMONTI G, 1993, J MOL BIOL, V230, P77, DOI 10.1006/jmbi.1993.1127; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hanamura A, 1998, RNA, V4, P430; HARADA Y, 1995, J BIOCHEM-TOKYO, V118, P780, DOI 10.1093/oxfordjournals.jbchem.a124980; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jin W, 2000, CANCER RES, V60, P1221; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Takenaka M, 1996, EUR J BIOCHEM, V235, P366, DOI 10.1111/j.1432-1033.1996.00366.x; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu KJ, 2002, ONCOGENE, V21, P7872, DOI 10.1038/sj.onc.1205986; Zerbe LK, 2004, MOL CARCINOGEN, V41, P187, DOI 10.1002/mc.20053; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhou J, 2001, BREAST CANCER RES TR, V66, P217, DOI 10.1023/A:1010631915831	31	741	776	5	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					364	U114		10.1038/nature08697	http://dx.doi.org/10.1038/nature08697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20010808	Green Accepted			2022-12-24	WOS:000273748100046
J	Alvarez, HM; Xue, Y; Robinson, CD; Canalizo-Hernandez, MA; Marvin, RG; Kelly, RA; Mondragon, A; Penner-Hahn, JE; O'Halloran, TV				Alvarez, Hamsell M.; Xue, Yi; Robinson, Chandler D.; Canalizo-Hernandez, Monica A.; Marvin, Rebecca G.; Kelly, Rebekah A.; Mondragon, Alfonso; Penner-Hahn, James E.; O'Halloran, Thomas V.			Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation	SCIENCE			English	Article							WILSONS-DISEASE; ATX1 METALLOCHAPERONE; CELL-PROLIFERATION; SUPEROXIDE-DISMUTASE-1; THIOMOLYBDATE; ANGIOGENESIS; RESOLUTION; THERAPY; GROWTH; CANCER	Tetrathiomolybdate (TM) is an orally active agent for treatment of disorders of copper metabolism. Here we describe how TM inhibits proteins that regulate copper physiology. Crystallographic results reveal that the surprising stability of the drug complex with the metallochaperone Atx1 arises from formation of a sulfur-bridged copper-molybdenum cluster reminiscent of those found in molybdenum and iron sulfur proteins. Spectroscopic studies indicate that this cluster is stable in solution and corresponds to physiological clusters isolated from TM-treated Wilson's disease animal models. Finally, mechanistic studies show that the drug-metallochaperone inhibits metal transfer functions between copper-trafficking proteins. The results are consistent with a model wherein TM can directly and reversibly down-regulate copper delivery to secreted metalloenzymes and suggest that proteins involved in metal regulation might be fruitful drug targets.	[Alvarez, Hamsell M.; Xue, Yi; Robinson, Chandler D.; Canalizo-Hernandez, Monica A.; Marvin, Rebecca G.; O'Halloran, Thomas V.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Mondragon, Alfonso; O'Halloran, Thomas V.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Kelly, Rebekah A.; Penner-Hahn, James E.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Northwestern University; Northwestern University; University of Michigan System; University of Michigan	O'Halloran, TV (corresponding author), Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.	t-ohalloran@northwestern.edu	Penner-Hahn, James/GYD-3750-2022; Kelly, Rebekah/AAD-8651-2020; O'Halloran, Thomas/ABE-6125-2021	Penner-Hahn, James/0000-0003-0314-1274; O'Halloran, Thomas/0000-0001-8732-5059	NIH [GM54222, GM38784, GM38047]; Robert H. Lurie Comprehensive Cancer Center; U.S. Department of Energy, Office of Basic Energy Sciences; National Center for Research Resources, NIH; National Aeronautics and Space Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038047, R01GM038047, R29GM038784, R01GM054111, R01GM038784, R37GM038784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert H. Lurie Comprehensive Cancer Center; U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This manuscript is dedicated to the memory of E. Stiefel and his contributions to the field of molybdenum sulfide chemistry. This work was supported by grant GM54222 and GM38784 (T. V. O.) and GM38047 (J. E. P.-H.) from the NIH. The Robert H. Lurie Comprehensive Cancer Center provided a Malkin Fellowship (H. M. A.) and support for Structural Biology Facility. Use of the Advanced Photon Source [Structural Biology Center-Collaborative Access Team (CAT) and Industrial Macromolecular Crystallography Association CAT] and the Stanford Synchrotron Radiation Laboratory (SSRL) was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, with additional support (at SSRL) from the National Center for Research Resources, NIH. Use of the Chicago Biomedical Consortium (CBC)-University of Illinois at Chicago Proteomics Facility was supported by The Searle Funds at the CBC, and use of LA-ICP-MS was supported by a National Aeronautics and Space Administration grant to the Quantitative Bioelement Imaging Center in the Chemistry of Life Processes Institute at Northwestern University. We thank P. Focia for assistance with x-ray diffraction collection, M. Clausen for assistance in the early stages of XAS measurements, Y. Wang for assistance with the protein MS, A. Davis for providing apo-Ccc2a, and A. Mazar for helpful discussions. The atomic coordinates have been deposited at the Protein Data Bank with code 3K7R.	Bissig KD, 2001, FEBS LETT, V507, P367, DOI 10.1016/S0014-5793(01)03009-5; Brewer GJ, 2000, CLIN CANCER RES, V6, P1; BREWER GJ, 1991, ARCH NEUROL-CHICAGO, V48, P42, DOI 10.1001/archneur.1991.00530130050019; Brewer GJ, 2001, EXP BIOL MED, V226, P665, DOI 10.1177/153537020222600712; CHIDAMBARAM MV, 1984, J INORG BIOCHEM, V22, P231, DOI 10.1016/0162-0134(84)85008-4; *CLINICALTRIALS GO, 2006, ACT TRIALS TM 2001 A; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Ferguson WS, 1938, NATURE, V141, P553, DOI 10.1038/141553a0; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; JIGUO L, 1991, J CHEM SOC CHEM COMM, P249; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Juarez JC, 2006, CLIN CANCER RES, V12, P4974, DOI 10.1158/1078-0432.CCR-06-0171; Lee VE, 2007, J INORG BIOCHEM, V101, P1707, DOI 10.1016/j.jinorgbio.2007.07.015; Mandinov L, 2003, P NATL ACAD SCI USA, V100, P6700, DOI 10.1073/pnas.1231994100; MARSTON HR, 1952, PHYSIOL REV, V32, P66, DOI 10.1152/physrev.1952.32.1.66; MILLS CF, 1979, PHILOS T ROY SOC B, V288, P51, DOI 10.1098/rstb.1979.0090; MILLS CF, 1960, NATURE, V185, P20, DOI 10.1038/185020a0; Pan Q, 2002, CANCER RES, V62, P4854; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Quagraine EK, 2001, J INORG BIOCHEM, V85, P53, DOI 10.1016/S0162-0134(00)00223-3; Redman BG, 2003, CLIN CANCER RES, V9, P1666; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Sadler P. J, 2007, BIOL INORGANIC CHEM, P95; SUZUKI KT, 1995, RES COMMUN MOL PATH, V88, P187; Walshe JM, 1986, ORPHAN DIS ORPHAN DR, P76; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; ZHANG C, 2002, EUR J INORG CHEM, V55, P2002; Zhang LM, 2009, BIOCHEMISTRY-US, V48, P891, DOI 10.1021/bi801926e	31	120	124	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					331	334		10.1126/science.1179907	http://dx.doi.org/10.1126/science.1179907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	19965379	Green Accepted			2022-12-24	WOS:000273629700043
J	Shizuka, D; Lyon, BE				Shizuka, Daizaburo; Lyon, Bruce E.			Coots use hatch order to learn to recognize and reject conspecific brood parasitic chicks	NATURE			English	Article							AVIAN EGG-RECOGNITION; AMERICAN COOTS; HOST-DEFENSE; ARMS-RACE; MODEL; EVOLUTION; DISCRIMINATION; COEVOLUTION; MECHANISMS; NESTLINGS	Avian brood parasites and their hosts provide model systems for investigating links between recognition, learning, and their fitness consequences(1-4). One major evolutionary puzzle has continued to capture the attention of naturalists for centuries: why do hosts of brood parasites generally fail to recognize parasitic offspring after they have hatched from the egg(5-9), even when the host and parasitic chicks differ to almost comic degrees(7)? One prominent theory to explain this pattern proposes that the costs of mistakenly learning to recognize the wrong offspring make recognition maladaptive(10). Here we show that American coots, Fulica americana, can recognize and reject parasitic chicks in their brood by using learned cues, despite the fact that the hosts and the brood parasites are of the same species. A series of chick cross-fostering experiments confirm that coots use first-hatched chicks in a brood as referents to learn to recognize their own chicks and then discriminate against later-hatched parasitic chicks in the same brood. When experimentally provided with the wrong reference chicks, coots can be induced to discriminate against their own offspring, confirming that the learning errors proposed by theory can exist(10). However, learning based on hatching order is reliable in naturally parasitized coot nests because host eggs hatch predictably ahead of parasite eggs. Conversely, a lack of reliable information may help to explain why the evolution of chick recognition is not more common in hosts of most interspecific brood parasites.	[Shizuka, Daizaburo; Lyon, Bruce E.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Shizuka, D (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	shizuka@biology.ucsc.edu	Lyon, Bruce E/E-8491-2011		National Geographic Society; National Science Foundation [DDIG IOS-0808579, IOS 0443807]; Chapman Fund; Sigma Xi Society	National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Chapman Fund; Sigma Xi Society	We thank J. Herrick and W. Messner for access to their property; B. Bair, L. Cargill, E. Clancey, J. Clark, J. Click, R. Drobek, S. Everding, K. Funk, J. Garcia, L. Hamilton, D. Hansen, E. Hoosier, M. Magrath, J. Melhaff, C. Morrill, C. Nelson, A. O'Brien, L. Orr, G. Peters, G. Taylor, K. Tjernell and J. Sapp for assistance in the field; B. Sinervo for advice on the study design; J. Eadie, A. Lotem, D. Mock, R. Montgomerie, R. Mulder, K. Wasson and A. Zink for helpful comments on the paper; and P. Raimondi and R. Montgomerie for statistical advice. Funding was provided by the National Geographic Society, the National Science Foundation (DDIG IOS-0808579 to D. S., and IOS 0443807 to B. E. L.), the Chapman Fund and the Sigma Xi Society. Fieldwork was conducted under permits from the Canadian Wildlife Service and the University of California, Santa Cruz, Institutional Animal Care and Use Committee.	Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BRISKIE JV, 1990, AUK, V107, P789, DOI 10.2307/4088016; Britton NF, 2007, B MATH BIOL, V69, P957, DOI 10.1007/s11538-006-9178-5; Davies N. B, 2000, COWBIRDS OTHER CHEAT; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; Davies NB, 2009, SCIENCE, V324, P1318, DOI 10.1126/science.1172227; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Foley D. D., 1956, NY FISH GAME J, V3, P240; Grim T, 2006, EVOL ECOL RES, V8, P785; GULLION GORDON W., 1950, CONDOR, V52, P272; HORSFALL JA, 1984, ANIM BEHAV, V32, P216, DOI 10.1016/S0003-3472(84)80340-1; Jenner E, 1788, PHILOS T ROY SOC LON, V78, P219, DOI DOI 10.1098/RSTL.1788.0016; Langmore NE, 2009, BEHAV ECOL, V20, P978, DOI 10.1093/beheco/arp086; Langmore NE, 2003, NATURE, V422, P157, DOI 10.1038/nature01460; Lawes MJ, 2003, BEHAV ECOL, V14, P757, DOI 10.1093/beheco/arg068; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; LYON BE, 1994, NATURE, V371, P240, DOI 10.1038/371240a0; LYON BE, 1993, ANIM BEHAV, V46, P911, DOI 10.1006/anbe.1993.1273; Lyon BE, 2002, EVOLUTION, V56, P1253, DOI 10.1111/j.0014-3820.2002.tb01436.x; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; LYON BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P87; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; R Development Core Team, 2009, R FDN STAT COMP; Reed WL, 2009, AM NAT, V174, P685, DOI 10.1086/605962; Rodriguez-Girones MA, 1999, AM NAT, V153, P633, DOI 10.1086/303198; ROTHSTEIN SI, 1982, AM ZOOL, V22, P547; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; ROTHSTEIN SI, 1978, ANIM BEHAV, V26, P671, DOI 10.1016/0003-3472(78)90133-1; ROTHSTEIN SI, 1975, CONDOR, V77, P250, DOI 10.2307/1366221; ROTHSTEIN SI, 1974, AUK, V91, P796, DOI 10.2307/4084731; Sato NJ, 2010, BIOL LETTERS, V6, P67, DOI 10.1098/rsbl.2009.0540; Soler M, 2009, J AVIAN BIOL, V40, P237, DOI 10.1111/j.1600-048X.2009.04676.x; Strausberger BM, 2009, BEHAV ECOL, V20, P691, DOI 10.1093/beheco/arp042	34	62	65	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 14	2010	463	7278					223	U108		10.1038/nature08655	http://dx.doi.org/10.1038/nature08655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20016486	Green Published			2022-12-24	WOS:000273582700034
J	Schwickart, M; Huang, XD; Lill, JR; Liu, JF; Ferrando, R; French, DM; Maecker, H; O'Rourke, K; Bazan, F; Eastham-Anderson, J; Yue, P; Dornan, D; Huang, DCS; Dixit, VM				Schwickart, Martin; Huang, XiaoDong; Lill, Jennie R.; Liu, Jinfeng; Ferrando, Ronald; French, Dorothy M.; Maecker, Heather; O'Rourke, Karen; Bazan, Fernando; Eastham-Anderson, Jeffrey; Yue, Peng; Dornan, David; Huang, David C. S.; Dixit, Vishva M.			Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival	NATURE			English	Article							MULTIPLE-MYELOMA; BCL-2 FAMILY; UBIQUITIN LIGASE; BREAST-CANCER; IN-VITRO; APOPTOSIS; EXPRESSION; PROTEINS; PATHWAY; ACTIVATION	MCL1 is essential for the survival of stem and progenitor cells of multiple lineages(1,2), and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases(3-6). B-and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma(7-9), however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse. The mechanism of MCL1 overexpression in cancer is not well understood. Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival. USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degradation. Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas. Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis. Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737. These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.	[Schwickart, Martin; Huang, XiaoDong; O'Rourke, Karen; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Liu, Jinfeng; Yue, Peng] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Ferrando, Ronald; French, Dorothy M.; Eastham-Anderson, Jeffrey] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Bazan, Fernando] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Maecker, Heather] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Dornan, David] Genentech Inc, Dept Res Oncol Diagnost, San Francisco, CA 94080 USA; [Huang, David C. S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	Huang, David C. S./C-7586-2013; dixit, vishva m/A-4496-2012; Bazan, J. Fernando/B-4562-2010	Huang, David C. S./0000-0002-3101-4873; dixit, vishva m/0000-0001-6983-0326; Maecker, Heather/0000-0002-5378-1141; Liu, Jinfeng/0000-0002-0343-8222				Austin M, 2005, J BIOL CHEM, V280, P33280, DOI 10.1074/jbc.M508187200; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jourdan M, 2003, ONCOGENE, V22, P2950, DOI 10.1038/sj.onc.1206423; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wang JM, 2003, MOL CELL BIOL, V23, P1896, DOI 10.1128/MCB.23.6.1896-1909.2003; Warr MR, 2008, CURR MOL MED, V8, P138; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	31	475	493	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					103	U114		10.1038/nature08646	http://dx.doi.org/10.1038/nature08646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20023629				2022-12-24	WOS:000273344900039
J	Katan, MB; Ludwig, DS				Katan, Martijn B.; Ludwig, David S.			Extra Calories Cause Weight Gain-But How Much?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Katan, Martijn B.] Vrije Univ Amsterdam, Inst Hlth Sci, NL-1081 HV Amsterdam, Netherlands; [Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Vrije Universiteit Amsterdam; Harvard University; Boston Children's Hospital	Katan, MB (corresponding author), Vrije Univ Amsterdam, Inst Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	katan99@falw.vu.nl	Katan, Martijn/ABB-6613-2021	Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Mc Dowell MA, 2005, ADV DATA, V361, P1; OGDEN CL, 2004, ADV DATA, V347, P1, DOI DOI 10.1377/HLTHAFF.28.5.W822; Shils ME, 2006, MODERN NUTR HLTH DIS, P982; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; WEINSIER RL, 1993, INT J OBESITY, V17, P693	10	67	68	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					65	66		10.1001/jama.2009.1912	http://dx.doi.org/10.1001/jama.2009.1912			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051571	Green Published			2022-12-24	WOS:000273296900021
J	Nachega, JB; Leisegang, R; Bishai, D; Nguyen, H; Hislop, M; Cleary, S; Regensberg, L; Maartens, G				Nachega, Jean B.; Leisegang, Rory; Bishai, David; Nguyen, Hoang; Hislop, Michael; Cleary, Susan; Regensberg, Leon; Maartens, Gary			Association of Antiretroviral Therapy Adherence and Health Care Costs	ANNALS OF INTERNAL MEDICINE			English	Article							RESOURCE-LIMITED SETTINGS; HIV-INFECTED PATIENTS; PHARMACY RECORDS; VIRAL LOAD; BASE-LINE; 1ST YEAR; RESISTANCE; MORTALITY; SURVIVAL; OUTCOMES	Background: Antiretroviral therapy (ART) adherence predicts HIV disease progression and survival, but its effect on direct health care costs is unclear. Objective: To determine the effect of ART adherence on direct health care costs among adults in a resource-limited setting. Design: Cohort study. Setting: Aid for AIDS, a private-sector disease management program in South Africa. Patients: 6833 HIV-infected adults who started ART between 6 August 2000 and 30 April 2006. Measurements: Monthly direct health care costs authorized by Aid for AIDS were averaged over all months. Pharmacy claim adherence, expressed as a percentage, was categorized into quartiles, from 1 (lowest) to 4 (highest). Effects of covariates on monthly total costs were assessed with a 2-step model with logit for probability of nonzero costs and a generalized linear model (GLM). Results: Total mean monthly costs were $370 (SD, $644). Mean monthly costs of ART were $32 (SD, $18); hospitalizations, $151 (SD, $436); consultations, $76 (SD, $66); investigations, $37 (SD, $50); and non-ART medications, $53 (SD, $180). Total mean monthly costs ranged from $313 (SD, $598) for quartile 4 to $376 (SD, $657) for quartile 1. Hospitalization costs increased from 29% to 51% of total costs as adherence decreased. In the GLM 2-step model, moving from adherence quartile 1 to quartile 2, 3, or 4 increased the probability of having nonzero total monthly costs by 0.078, 0.15, and 0.21 percentage point, respectively (P < 0.001). For patients with nonzero costs, increasing adherence from quartile 1 to quartile 2, 3, or 4 decreased total monthly costs by $70, $133, and $192, respectively (P < 0.001). Moving from adherence quartiles 1 to 4 had the highest decrease in net overall median monthly health care costs (-$85 [interquartile range,-$116 to-$41]). Limitations: Indirect health care costs were not included. Experience may not reflect that of public HIV/AIDS programs. Conclusion: High ART adherence was associated with lower mean monthly direct health care costs, particularly reduced hospitalization costs, in this South African HIV cohort.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Groote Schuur Hosp, Cape Town, South Africa; Univ Cape Town, ZA-7925 Cape Town, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; University of Cape Town	Nachega, JB (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, 651 Huntington Ave,SPH 2 Bldg,Room 437C, Boston, MA 02115 USA.	jnachega@hsph.harvard.edu	Maartens, Gary/S-2788-2019; , David Bishai/GRO-4211-2022; Maartens, Gary/F-3836-2014; Cleary, Susan/AHE-7259-2022	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Cleary, Susan/0000-0002-9071-7958; Bishai, David/0000-0003-0714-9062; Nachega, Jean/0000-0002-2862-4443	Division of AIDS, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health [R01 AI 5535901, R01 AI 016137]; Mentored Patient-Oriented Research Career Award [K23 AI068582-01]; European Developing Countries Clinical Trial Partnership Senior Fellowship Award [TA-08-40200-021]; Center for Biostatistics in AIDS Research, Harvard School of Public of Health; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055359, R01AI016137, K23AI068582] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mentored Patient-Oriented Research Career Award; European Developing Countries Clinical Trial Partnership Senior Fellowship Award; Center for Biostatistics in AIDS Research, Harvard School of Public of Health; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By the Division of AIDS, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health, grants R01 AI 5535901 and R01 AI 016137 (Drs. Nachega and Maartens) and Mentored Patient-Oriented Research Career Award K23 AI068582-01 (Dr. Nachega); the European Developing Countries Clinical Trial Partnership Senior Fellowship Award, TA-08-40200-021 (Dr. Nachega); the 2009 John McGoldrick Senior Fellowship Award, Center for Biostatistics in AIDS Research, Harvard School of Public of Health (Dr. Nachega); and the Doris Duke Charitable Foundation Operations Research on AIDS Care and Treatment in Africa Award (Dr. Maartens).	Bangsberg DR, 2008, J INFECT DIS, V197, pS272, DOI 10.1086/533415; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Blough DK, 1999, J HEALTH ECON, V18, P153, DOI 10.1016/S0167-6296(98)00032-0; Bodri M, 2006, ANTIVIR THER, V11, P63; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Chesney MA, 2006, JAIDS-J ACQ IMM DEF, V43, pS149, DOI 10.1097/01.qai.0000243112.91293.26; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Acurcio FDA, 2006, REV ESP SALUD PUBLIC, V80, P41, DOI [10.1590/S1135-57272006000100005, 10.1590/s1135-57272006000100005]; Egger M., 2007, C RETR OPP INF CROI; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freedberg KA, 2006, JAIDS-J ACQ IMM DEF, V43, pS113, DOI 10.1097/01.qai.0000248334.52072.25; Gardner EM, 2008, APPL HEALTH ECON HEA, V6, P145, DOI 10.2165/00148365-200806020-00006; Gross R, 2008, HIV CLIN TRIALS, V9, P202, DOI 10.1310/hct0903-202; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hirsch JD, 2009, J MANAGE CARE PHARM, V15, P32, DOI 10.18553/jmcp.2009.15.1.32; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Jones A, 2000, HDB HLTH EC, P265; Kilian Reinhold, 2002, J Ment Health Policy Econ, V5, P21; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Mills E, 2007, LANCET, V370, P1885, DOI 10.1016/S0140-6736(07)61790-5; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; *OAND CORP, 2009, FXCONVERTER CURR CON; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Purdum AG, 2004, AIDS CARE, V16, P767, DOI 10.1080/09540120412331269602; REGENSBERG L, 2009, AFA CLIN GUIDELINES; *STAT S AFR, 2009, CONS PRIC IND IND; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wood E, 2006, AIDS, V20, P1117, DOI 10.1097/01.aids.0000226951.49353.ed	48	49	50	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					18	W5		10.7326/0003-4819-152-1-201001050-00006	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FJ	20048268				2022-12-24	WOS:000273556600003
J	Kapahi, P; Vijg, J				Kapahi, Pankaj; Vijg, Jan			Aging - Lost in Translation?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXTENDS LIFE-SPAN; MICE		[Kapahi, Pankaj] Buck Inst Age Res, Novato, CA USA; [Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Buck Institute for Research on Aging; Yeshiva University; Albert Einstein College of Medicine	Kapahi, P (corresponding author), Buck Inst Age Res, Novato, CA USA.				NATIONAL INSTITUTE ON AGING [R01AG031337] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG031337] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216	4	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2669	2670		10.1056/NEJMcibr0909815	http://dx.doi.org/10.1056/NEJMcibr0909815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042759				2022-12-24	WOS:000273181300018
J	Faasse, K; Cundy, T; Petrie, KJ				Faasse, Kate; Cundy, Tim; Petrie, Keith J.			Medicine and the Media Thyroxine: anatomy of a health scare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Faasse, Kate; Petrie, Keith J.] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand; [Cundy, Tim] Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland; University of Auckland	Petrie, KJ (corresponding author), Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand.	kj.petrie@auckland.ac.nz		Cundy, Timothy/0000-0003-4890-9400; Faasse, Kate/0000-0003-3073-3718				Page LA, 2006, J PSYCHOSOM RES, V60, P413, DOI 10.1016/j.jpsychores.2005.11.008; Petrie KJ, 2004, BRIT J HEALTH PSYCH, V9, P101, DOI 10.1348/135910704322778759; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x	3	43	43	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2009	339								b5613	10.1136/bmj.b5613	http://dx.doi.org/10.1136/bmj.b5613			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	539JA	20040484				2022-12-24	WOS:000273249000013
J	Husale, S; Persson, HHJ; Sahin, O				Husale, Sudhir; Persson, Henrik H. J.; Sahin, Ozgur			DNA nanomechanics allows direct digital detection of complementary DNA and microRNA targets	NATURE			English	Article							LABEL-FREE DETECTION; GENE-EXPRESSION; ELECTRICAL DETECTION; HYBRIDIZATION; NANOPARTICLES; PCR	Techniques to detect and quantify DNA and RNA molecules in biological samples have had a central role in genomics research(1-3). Over the past decade, several techniques have been developed to improve detection performance and reduce the cost of genetic analysis(4-10). In particular, significant advances in label-free methods have been reported(11-17). Yet detection of DNA molecules at concentrations below the femtomolar level requires amplified detection schemes(1,8). Here we report a unique nanomechanical response of hybridized DNA and RNA molecules that serves as an intrinsic molecular label. Nanomechanical measurements on a microarray surface have sufficient background signal rejection to allow direct detection and counting of hybridized molecules. The digital response of the sensor provides a large dynamic range that is critical for gene expression profiling. We have measured differential expressions of microRNAs in tumour samples; such measurements have been shown to help discriminate between the tissue origins of metastatic tumours(18). Two hundred picograms of total RNA is found to be sufficient for this analysis. In addition, the limit of detection in pure samples is found to be one attomolar. These results suggest that nanomechanical read-out of microarrays promises attomolar-level sensitivity and large dynamic range for the analysis of gene expression, while eliminating biochemical manipulations, amplification and labelling.	[Husale, Sudhir; Sahin, Ozgur] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02142 USA; [Persson, Henrik H. J.] Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Harvard University; Stanford University	Sahin, O (corresponding author), Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02142 USA.	sahin@rowland.harvard.edu	Sahin, Ozgur/A-7988-2013	Sahin, Ozgur/0000-0003-2766-2816	Rowland Junior Fellows Program; US National Institutes of Health [HG000205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	Rowland Junior Fellows Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research is supported by the Rowland Junior Fellows Program. H. H. J. P. was supported in part by US National Institutes of Health grant HG000205. We thank R. W. Davis for discussions.	Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng MMC, 2006, CURR OPIN CHEM BIOL, V10, P11, DOI 10.1016/j.cbpa.2006.01.006; Clack NG, 2008, NAT BIOTECHNOL, V26, P825, DOI 10.1038/nbt1416; Demers LM, 2002, SCIENCE, V296, P1836, DOI 10.1126/science.1071480; Fang SP, 2006, J AM CHEM SOC, V128, P14044, DOI 10.1021/ja065223p; Fritz J, 2002, P NATL ACAD SCI USA, V99, P14142, DOI 10.1073/pnas.232276699; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; HE L, 2004, NAT REV GENET, V5, P522; Herne TM, 1997, J AM CHEM SOC, V119, P8916, DOI 10.1021/ja9719586; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Ilic B, 2005, NANO LETT, V5, P925, DOI 10.1021/nl050456k; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Mertens J, 2008, NAT NANOTECHNOL, V3, P301, DOI 10.1038/nnano.2008.91; Mirmomtaz E, 2008, NANO LETT, V8, P4134, DOI 10.1021/nl802722k; Nam JM, 2004, J AM CHEM SOC, V126, P5932, DOI 10.1021/ja049384+; Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sahin O, 2007, NAT NANOTECHNOL, V2, P507, DOI 10.1038/nnano.2007.226; Sahin O, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445717; Sahin O, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2801009; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sinensky AK, 2007, NAT NANOTECHNOL, V2, P653, DOI 10.1038/nnano.2007.293; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Yu AA, 2005, NANO LETT, V5, P1061, DOI 10.1021/nl050495w; Zhang J, 2006, NAT NANOTECHNOL, V1, P214, DOI 10.1038/nnano.2006.134; Zhou DJ, 2003, ANGEW CHEM INT EDIT, V42, P4934, DOI 10.1002/anie.200352178	31	117	119	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1075	U138		10.1038/nature08626	http://dx.doi.org/10.1038/nature08626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20010806	Green Accepted			2022-12-24	WOS:000272996000051
J	Krahmer, N; Guo, Y; Farese, RV; Walther, TC				Krahmer, Natalie; Guo, Yi; Farese, Robert V., Jr.; Walther, Tobias C.			SnapShot: Lipid Droplets	CELL			English	Editorial Material							TRIACYLGLYCEROL; PROTEINS		[Krahmer, Natalie; Walther, Tobias C.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Guo, Yi; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, San Francisco, CA 94158 USA	Max Planck Society; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Krahmer, N (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.		Krahmer, Natalie/AAL-9467-2020	Krahmer, Natalie/0000-0003-4063-7367; Walther, Tobias/0000-0003-1442-1327				Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; ZIMMERMANN R, 2008, BIOCHIM BIOPHYS ACTA, V1791, P494	7	51	53	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 25	2009	139	5					1024	U192		10.1016/j.cell.2009.11.023	http://dx.doi.org/10.1016/j.cell.2009.11.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945384	Bronze			2022-12-24	WOS:000272169400026
J	Hingorani, AD; Psaty, BM				Hingorani, Aroon D.; Psaty, Bruce M.			Primary Prevention of Cardiovascular Disease Time to Get More or Less Personal?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTORS; INDIVIDUALS		[Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London WC1E 9BT, England; [Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London WC1E 9BT, England; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Ctr Hlth Studies, Seattle, WA USA	University of London; University College London; University of London; University College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hingorani, AD (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, 1-19 Torrington Pl, London WC1E 9BT, England.	a.hingorani@ucl.ac.uk		Hingorani, Aroon/0000-0001-8365-0081	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, R01HL080295, R01HL087652, R01HL085251, U01HL080295] Funding Source: NIH RePORTER; British Heart Foundation [FS05/125] Funding Source: Medline; NHLBI NIH HHS [HL080295, HL087652, HL74745, HL085251] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Committee on Comparative Effectiveness Research Prioritization Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; *NAT I HLTH CLIN E, PUTT PREV 1 VASC CHE; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; Wald NJ, 2005, J MED SCREEN, V12, P197, DOI 10.1258/096914105775220642; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	10	22	24	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2144	2145		10.1001/jama.2009.1698	http://dx.doi.org/10.1001/jama.2009.1698			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920239				2022-12-24	WOS:000271873900024
J	Wang, DH; Engle, KM; Shi, BF; Yu, JQ				Wang, Dong-Hui; Engle, Keary M.; Shi, Bing-Feng; Yu, Jin-Quan			Ligand-Enabled Reactivity and Selectivity in a Synthetically Versatile Aryl C-H Olefination	SCIENCE			English	Article							CARBON-HYDROGEN BONDS; KEDARCIDIN CHROMOPHORE; ACTIVATION; FUNCTIONALIZATION; ACIDS; CYCLIZATION; LITHIATION; ARYLATION	The Mizoroki-Heck reaction, which couples aryl halides with olefins, has been widely used to stitch together the carbogenic cores of numerous complex organic molecules. Given that the position-selective introduction of a halide onto an arene is not always straightforward, direct olefination of aryl carbon-hydrogen (C-H) bonds would obviate the inefficiencies associated with generating halide precursors or their equivalents. However, methods for carrying out such a reaction have suffered from narrow substrate scope and low positional selectivity. We report an operationally simple, atom-economical, carboxylate-directed Pd(II)-catalyzed C-H olefination reaction with phenylacetic acid and 3-phenylpropionic acid substrates, using oxygen at atmospheric pressure as the oxidant. The positional selectivity can be tuned by introducing amino acid derivatives as ligands. We demonstrate the versatility of the method through direct elaboration of commercial drug scaffolds and efficient syntheses of 2-tetralone and naphthoic acid natural product cores.	[Wang, Dong-Hui; Engle, Keary M.; Shi, Bing-Feng; Yu, Jin-Quan] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Shi, Bing-Feng/E-4248-2012; Engle, Keary/A-9223-2015	Shi, Bing-Feng/0000-0003-0375-955X; Wang, Dong-Hui/0000-0002-4318-5450; Engle, Keary/0000-0003-2767-6556	A. P. Sloan Foundation; NSF [CHE-0910014]; U.S. Department of Defense; Scripps Research Institute; Skaggs Oxford Scholarship program; National Institute of General Medical Sciences [1 R01 GM084019-02]; Amgen; Eli Lilly Co; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	A. P. Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF)); U.S. Department of Defense(United States Department of Defense); Scripps Research Institute; Skaggs Oxford Scholarship program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Amgen(Amgen); Eli Lilly Co(Eli Lilly); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by an A. P. Sloan Foundation fellowship (J.-Q. Y.); predoctoral fellowships from NSF, the U.S. Department of Defense, the Scripps Research Institute, and the Skaggs Oxford Scholarship program (K. M. E.); and the Scripps Research Institute, National Institute of General Medical Sciences grant 1 R01 GM084019-02, NSF grant CHE-0910014, Amgen, and Eli Lilly & Co.	Baran PS, 2002, J AM CHEM SOC, V124, P7904, DOI 10.1021/ja026663t; BEAK P, 1982, ACCOUNTS CHEM RES, V15, P306, DOI 10.1021/ar00082a002; Beck EM, 2008, ANGEW CHEM INT EDIT, V47, P3004, DOI 10.1002/anie.200705005; Boele MDK, 2002, J AM CHEM SOC, V124, P1586, DOI 10.1021/ja0176907; Bowie AL, 2005, ORG LETT, V7, P5207, DOI 10.1021/ol052033v; Campeau LC, 2007, ALDRICHIM ACTA, V40, P35; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Dangel BD, 2002, J AM CHEM SOC, V124, P11856, DOI 10.1021/ja027311p; Daugulis O, 2006, SYNLETT, P3382, DOI 10.1055/s-2006-956468; Davies HML, 2006, J AM CHEM SOC, V128, P2485, DOI 10.1021/ja056877l; Dick AR, 2006, TETRAHEDRON, V62, P2439, DOI 10.1016/j.tet.2005.11.027; Garg NK, 2004, J AM CHEM SOC, V126, P9552, DOI 10.1021/ja046695b; Gorka A, 2005, SYNTHETIC COMMUN, V35, P2371, DOI 10.1080/00397910500187753; Gorth FC, 2000, EUR J ORG CHEM, V2000, P2605; Hartwig JF, 2008, NATURE, V455, P314, DOI 10.1038/nature07369; Hinman A, 2003, J AM CHEM SOC, V125, P11510, DOI 10.1021/ja0368305; Ji N, 2004, ORG LETT, V6, P4551, DOI 10.1021/ol048075l; Jia CG, 2000, SCIENCE, V287, P1992, DOI 10.1126/science.287.5460.1992; Kawata S, 1997, J AM CHEM SOC, V119, P12012, DOI 10.1021/ja973231n; Martin R, 2008, ACCOUNTS CHEM RES, V41, P1461, DOI 10.1021/ar800036s; Mei TS, 2008, ANGEW CHEM INT EDIT, V47, P5215, DOI 10.1002/anie.200705613; Miura M, 1998, J ORG CHEM, V63, P5211, DOI 10.1021/jo980584b; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Myers AG, 1997, TETRAHEDRON LETT, V38, P4363, DOI 10.1016/S0040-4039(97)00844-7; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4442, DOI 10.1002/anie.200500368; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Shi BF, 2008, ANGEW CHEM INT EDIT, V47, P4882, DOI 10.1002/anie.200801030; Stang EM, 2009, NAT CHEM, V1, P547, DOI [10.1038/NCHEM.351, 10.1038/nchem.351]; TROST BM, 1978, J AM CHEM SOC, V100, P3930, DOI 10.1021/ja00480a047; Tsai AS, 2008, J AM CHEM SOC, V130, P6316, DOI 10.1021/ja8012159; Wang DH, 2008, J AM CHEM SOC, V130, P17676, DOI 10.1021/ja806681z; Yu JQ, 2006, ORG BIOMOL CHEM, V4, P4041, DOI 10.1039/b611094k; Zhang YH, 2009, J AM CHEM SOC, V131, P5072, DOI 10.1021/ja900327e	33	614	615	9	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					315	319		10.1126/science.1182512	http://dx.doi.org/10.1126/science.1182512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	544CM	19965380	Green Accepted			2022-12-24	WOS:000273629700038
J	Liu, HT; He, J; Tang, JY; Liu, H; Pang, P; Cao, D; Krstic, P; Joseph, S; Lindsay, S; Nuckolls, C				Liu, Haitao; He, Jin; Tang, Jinyao; Liu, Hao; Pang, Pei; Cao, Di; Krstic, Predrag; Joseph, Sony; Lindsay, Stuart; Nuckolls, Colin			Translocation of Single-Stranded DNA Through Single-Walled Carbon Nanotubes	SCIENCE			English	Article							SOLID-STATE NANOPORES; TRANSPORT; MOLECULES; CHANNEL; FABRICATION; MEMBRANES; ACID	We report the fabrication of devices in which one single-walled carbon nanotube spans a barrier between two fluid reservoirs, enabling direct electrical measurement of ion transport through the tube. A fraction of the tubes pass anomalously high ionic currents. Electrophoretic transport of small single-stranded DNA oligomers through these tubes is marked by large transient increases in ion current and was confirmed by polymerase chain reaction analysis. Each current pulse contains about 10(7) charges, an enormous amplification of the translocated charge. Carbon nanotubes simplify the construction of nanopores, permit new types of electrical measurements, and may open avenues for control of DNA translocation.	[He, Jin; Liu, Hao; Pang, Pei; Cao, Di; Lindsay, Stuart] Biodesign Inst, Tempe, AZ 85287 USA; [Liu, Haitao; Tang, Jinyao; Nuckolls, Colin] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Liu, Hao; Lindsay, Stuart] Dept Chem & Biochem, Tempe, AZ 85287 USA; [Pang, Pei; Cao, Di; Lindsay, Stuart] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Krstic, Predrag; Joseph, Sony] Oak Ridge Natl Lab, Div Phys, Oak Ridge, TN 37831 USA	Columbia University; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Oak Ridge National Laboratory	Lindsay, S (corresponding author), Biodesign Inst, Tempe, AZ 85287 USA.	Stuart.Lindsay@asu.edu; cn37@columbia.edu	he, jin/AAV-8045-2021; he, jin/C-6256-2009; Tang, Jinyao/I-3851-2012	he, jin/0000-0002-2633-9809; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004770] Funding Source: NIH RePORTER; NHGRI NIH HHS [R21 HG004770-01, R21 HG004770] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chang H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2179131; Chow KF, 2008, J AM CHEM SOC, V130, P7544, DOI 10.1021/ja802013q; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Fan R, 2005, NANO LETT, V5, P1633, DOI 10.1021/nl0509677; Guo XF, 2006, SCIENCE, V311, P356, DOI 10.1126/science.1120986; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Ito T, 2003, CHEM COMMUN, P1482, DOI 10.1039/b302511j; Jin XZ, 2007, LANGMUIR, V23, P13209, DOI 10.1021/la702326v; Joseph S, 2003, NANO LETT, V3, P1399, DOI 10.1021/nl0346326; Joseph S, 2008, NANO LETT, V8, P452, DOI 10.1021/nl072385q; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kasianowicz JJ, 2001, ANAL CHEM, V73, P2268, DOI 10.1021/ac000958c; Kim MJ, 2006, ADV MATER, V18, P3149, DOI 10.1002/adma.200601191; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Liang XG, 2008, NANO LETT, V8, P1472, DOI 10.1021/nl080473k; Meller A, 2002, ELECTROPHORESIS, V23, P2583, DOI 10.1002/1522-2683(200208)23:16<2583::AID-ELPS2583>3.0.CO;2-H; Rhee M, 2007, TRENDS BIOTECHNOL, V25, P174, DOI 10.1016/j.tibtech.2007.02.008; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Warakulwit C, 2008, NANO LETT, V8, P500, DOI 10.1021/nl072652s; Xie YH, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799989; Yeh IC, 2004, P NATL ACAD SCI USA, V101, P12177, DOI 10.1073/pnas.0402699101	26	256	270	6	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					64	67		10.1126/science.1181799	http://dx.doi.org/10.1126/science.1181799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044570	Green Accepted			2022-12-24	WOS:000273395400030
J	Lin, CR; Yang, LQ; Tanasa, B; Hutt, K; Ju, BG; Ohgi, K; Zhang, J; Rose, DW; Fu, XD; Glass, CK; Rosenfeld, MG				Lin, Chunru; Yang, Liuqing; Tanasa, Bogdan; Hutt, Kasey; Ju, Bong-gun; Ohgi, Kenny; Zhang, Jie; Rose, David W.; Fu, Xiang-Dong; Glass, Christopher K.; Rosenfeld, Michael G.			Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer	CELL			English	Article							CLASS-SWITCH RECOMBINATION; GENOME INSTABILITY; ANDROGEN RECEPTOR; HISTONE H3; TRANSCRIPTION; GENE; FUSION; MECHANISM; LEUKEMIA; DYNAMICS	Chromosomal translocations are a hallmark of leukemia/lymphoma and also appear in solid tumors, but the underlying mechanism remains elusive. By establishing a cellular model that mimics the relative frequency of authentic translocation events without proliferation selection, we report mechanisms of nuclear receptor-dependent tumor translocations. Intronic binding of liganded androgen receptor (AR) first juxtaposes translocation loci by triggering intra-and interchromosomal interactions. AR then promotes site-specific DNA double-stranded breaks (DSBs) at translocation loci by recruiting two types of enzymatic activities induced by genotoxic stress and liganded AR, including activation-induced cytidine deaminase and the LINE-1 repeat-encoded ORF2 endonuclease. These enzymes synergistically generate site-selective DSBs at juxtaposed translocation loci that are ligated by nonhomologous end joining pathway for specific translocations. Our data suggest that the confluence of two parallel pathways initiated by liganded nuclear receptor and genotoxic stress underlies nonrandom tumor translocations, which may function in many types of tumors and pathological processes.	[Lin, Chunru; Yang, Liuqing; Tanasa, Bogdan; Ju, Bong-gun; Ohgi, Kenny; Zhang, Jie; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Hutt, Kasey] Univ Calif San Diego, Sch Med, Bioinformat Grad Program, La Jolla, CA 92093 USA; [Rose, David W.; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Fu, Xiang-Dong; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ju, Bong-gun] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sogang University	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Yang, Liuqing/B-7935-2011; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	National Institutes of Health (NIH) [DK39949, DK18477, CA97134, NS34934]; Department of Defense (DoD) [00325108]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R01DK018477, R37DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DoD)(United States Department of Defense); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Nelson for various cell culture assistance, J. Hightower for artwork, D. Benson for assistance with the manuscript, V. Lunyak and X. Zhu for critical comments, M. Schwartz and E. Nunez for assistance with fluorescence microscopy and FISH technology, Y. Zhang for providing the FLAG-DOT1L construct, M. B. Kastan for providing the HA-ER-I-PpoI construct, J. L. Goodier for providing LINE-1 ORF1, ORF2 constructs, Ankara vaccinia virus that expresses T7 polymerase, and polyclonal antibody against ORF2, S. Heinz for providing PIWIL1 and PIWIL2 expression constructs, and AstraZeneca for providing Casodex. M. G. R. is a Howard Hughes Medical Institute Investigator. This study was funded by grants from The National Institutes of Health (NIH; DK39949, DK18477, CA97134, NS34934), the Department of Defense (DoD), and Prostate Cancer Foundation to M. G. R., and X. D. F., and NIH grants to X. D. F. and C. K. G. C. L. is a fellow of Susan G. Komen for the Cure (KG080247), and L. Yang is an awardee of Era of Hope Postdoctoral Award supported by the DoD (grant 00325108).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aplan PD, 2006, TRENDS GENET, V22, P46, DOI 10.1016/j.tig.2005.10.002; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Banerjee S, 2008, J CELL BIOL, V181, P1083, DOI 10.1083/jcb.200711146; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Deininger MWN, 1998, CANCER RES, V58, P421; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goodier JL, 2004, HUM MOL GENET, V13, P1041, DOI 10.1093/hmg/ddh118; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hofmann WA, 2006, J CELL BIOL, V172, P495, DOI 10.1083/jcb.200601095; Holzinger A, 2001, METH MOL B, V161, P109; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lucas J, 2008, J PATHOL, V215, P118, DOI 10.1002/path.2330; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Prak NL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/37049; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rajewsky K, 2008, CURR OPIN IMMUNOL, V20, P127, DOI 10.1016/j.coi.2008.04.005; Rizk RS, 2005, CURR BIOL, V15, pR841, DOI 10.1016/j.cub.2005.10.004; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Santourlidis S, 1999, PROSTATE, V39, P166; Shaffer DR, 2006, NAT MED, V12, P14, DOI 10.1038/nm0106-14; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193	55	428	454	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1069	1083		10.1016/j.cell.2009.11.030	http://dx.doi.org/10.1016/j.cell.2009.11.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	19962179	Bronze, Green Accepted			2022-12-24	WOS:000272622800010
J	Rebeiz, M; Ramos-Womack, M; Jeong, S; Andolfatto, P; Werner, T; True, J; Stern, DL; Carroll, SB				Rebeiz, Mark; Ramos-Womack, Margarita; Jeong, Sangyun; Andolfatto, Peter; Werner, Thomas; True, John; Stern, David L.; Carroll, Sean B.			Evolution of the tan Locus Contributed to Pigment Loss in Drosophila santomea: A Response to Matute et al.	CELL			English	Article							QUANTITATIVE TRAIT LOCI; MORPHOLOGICAL DIFFERENCES; PCR	We have shown previously that the loss of abdominal pigmentation in D. santomea relative to its sister species D. yakuba resulted, in part, from cis-regulatory mutations at the tan locus. Matute et al. claim, based solely upon extrapolation from genetic crosses of D. santomea and D. melanogaster, a much more divergent species, that at least four X chromosome regions but not tan are responsible for pigmentation differences. Here, we provide additional evidence from introgressions of D. yakuba genes into D. santomea that support a causative role for tan in the loss of pigmentation and present analyses that contradict Matute et al.'s claims. We discuss how the choice of parental species and other factors affect the ability to identify loci responsible for species divergence, and we affirm that all of our previously reported results and conclusions stand.	[Rebeiz, Mark; Jeong, Sangyun; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Rebeiz, Mark; Jeong, Sangyun; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Ramos-Womack, Margarita; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Ramos-Womack, Margarita; Andolfatto, Peter; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Princeton University; Princeton University; Princeton University	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu		Stern, David/0000-0002-1847-6483; True, John/0000-0001-5124-5495; Andolfatto, Peter/0000-0003-3393-4574; Rebeiz, Mark/0000-0001-5731-5570	National Institutes of Health (NIH) [F32-GM78972, GM063622-06A1]; Balzan Foundation; National Science Foundation (NSF) [IOS-0640339]; Harold W. Dodds Honorific Fellowship; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078972, R01GM063622] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Balzan Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); Harold W. Dodds Honorific Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Postdoctoral Fellowship F32-GM78972 (M.R.); the Balzan Foundation, a National Science Foundation (NSF) Doctoral Dissertation Improvement Grant (M.R.-W.), and Harold W. Dodds Honorific Fellowship 2008-2009 (M.R.-W.); NIH grant GM063622-06A1 and NSF grant IOS-0640339 (D.L.S,); and the Howard Hughes Medical Institute (S.B.C. and D.L.S.).	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; BEADLE GW, 1980, SCI AM, V242, P112, DOI 10.1038/scientificamerican0180-112; DOEBLEY J, 1993, GENETICS, V134, P559; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Gupta M, 2005, ANAL BIOCHEM, V344, P292, DOI 10.1016/j.ab.2005.05.018; Hawley RS, 2006, GENETICS, V174, P5, DOI 10.1534/genetics.106.064550; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Landry CR, 2007, HEREDITY, V99, P483, DOI 10.1038/sj.hdy.6801045; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Matute DR, 2009, CELL, V139, P1180, DOI 10.1016/j.cell.2009.10.033; Papp AC, 2003, BIOTECHNIQUES, V34, P1068, DOI 10.2144/03345dd03; SERVICE PM, 2004, SCI AGING KNOWLEDGE, V12, pPE13; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052	17	22	22	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1189	1196		10.1016/j.cell.2009.11.004	http://dx.doi.org/10.1016/j.cell.2009.11.004			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005811	Bronze			2022-12-24	WOS:000272622800020
J	Dilks, P; Shawyer, A; Booth, TC				Dilks, Philip; Shawyer, Andrew; Booth, Thomas C.			Picture Quiz An unusual cause of acute renal failure	BRITISH MEDICAL JOURNAL			English	Editorial Material							IDIOPATHIC RETROPERITONEAL FIBROSIS; URETEROLYSIS; NEPHROSTOMY; DIAGNOSIS		[Dilks, Philip; Shawyer, Andrew] Barts & London NHS Trust, London EC1A 7BE, England; [Booth, Thomas C.] Royal Free Hosp NHS Trust, London NW3 2XA, England	Barts Health NHS Trust; University of London; University College London	Dilks, P (corresponding author), Barts & London NHS Trust, London EC1A 7BE, England.	philip.dilks@bartsandthelondon.nhs.uk						Cronin CG, 2008, AM J ROENTGENOL, V191, P423, DOI 10.2214/AJR.07.3629; DIXON AK, 1984, CLIN RADIOL, V35, P39, DOI 10.1016/S0009-9260(84)80231-7; Fong BC, 2006, J ENDOUROL, V20, P820, DOI 10.1089/end.2006.20.820; GOODWIN WE, 1955, JAMA-J AM MED ASSOC, V157, P891, DOI 10.1001/jama.1955.02950280015005; Hausegger KA, 2006, EUR RADIOL, V16, P2016, DOI 10.1007/s00330-005-0136-7; Moroni G, 2006, NEPHROL DIAL TRANSPL, V21, P2485, DOI 10.1093/ndt/gfl228; Scheel PJ, 2009, MEDICINE, V88, P202, DOI 10.1097/MD.0b013e3181afc439; Srinivasan AK, 2008, J UROLOGY, V179, P1875, DOI 10.1016/j.juro.2008.01.030; Staios D, 2007, EXPERT REV MED DEVIC, V4, P99, DOI 10.1586/17434440.4.2.99; SWARZ RD, 2009, AM J KIDNEY DIS; Vaglio A, 2005, ARTHRIT RHEUM-ARTHR, V53, P122, DOI 10.1002/art.20914; Vaglio A, 2009, MEDICINE, V88, P208, DOI 10.1097/MD.0b013e3181afc4d1; van Bommel EFH, 2007, J INTERN MED, V262, P224, DOI 10.1111/j.1365-2796.2007.01805.x; van Bommel EFH, 2009, MEDICINE, V88, P193, DOI 10.1097/MD.0b013e3181afc420; Vivas I, 2000, BRIT J RADIOL, V73, P214, DOI 10.1259/bjr.73.866.10884739; ZIMSKIND PD, 1967, J UROLOGY, V97, P840, DOI 10.1016/S0022-5347(17)63130-6	16	0	0	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2009	339								b4574	10.1136/bmj.b4574	http://dx.doi.org/10.1136/bmj.b4574			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TA	19923149				2022-12-24	WOS:000272096200003
J	Wang, BM; Primeau, TM; Myers, N; Rohrs, HW; Gross, ML; Lybarger, L; Hansen, TH; Connolly, JM				Wang, Baomei; Primeau, Tina M.; Myers, Nancy; Rohrs, Henry W.; Gross, Michael L.; Lybarger, Lonnie; Hansen, Ted H.; Connolly, Janet M.			A Single Peptide-MHC Complex Positively Selects a Diverse and Specific CD8 T Cell Repertoire	SCIENCE			English	Article							SELF-PEPTIDES; NEGATIVE SELECTION; MICE; THYMUS; LYMPHOCYTES; SEQUENCE	Pathogen recognition by T cells is dependent on their exquisite specificity for self-major histocompatibility complex (MHC) molecules presenting a bound peptide. Although this specificity results from positive and negative selection of developing T cells in the thymus, the relative contribution of these two processes remains controversial. To address the relation between the selecting peptide-MHC complex and the specificity of mature T cells, we generated transgenic mice that express a single peptide-MHC class I complex. We demonstrate that positive selection of CD8 T cells in these mice results in an MHC-specific repertoire. Although selection on a single complex is peptide promiscuous, mature T cells are highly peptide specific. Thus, positive selection imparts MHC and peptide specificity on the peripheral CD8 T cell repertoire.	[Wang, Baomei; Primeau, Tina M.; Myers, Nancy; Hansen, Ted H.; Connolly, Janet M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Rohrs, Henry W.; Gross, Michael L.] Washington Univ, Sch Med, Dept Chem, St Louis, MO 63110 USA; [Lybarger, Lonnie] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA	Washington University (WUSTL); Washington University (WUSTL); University of Arizona	Connolly, JM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	connolly@wustl.edu			National Center for Research Resources MS Resource [2P41RR000954]; NIH [AI 027568, AI 055849]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055849, R01AI055849, R01AI027568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Center for Research Resources MS Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Allen, C.-S. Hsieh, Y. Huang, K. Murphy, E. Unanue, and A. Singer for critical comments, and Y. Y. Yu for making the transgene constructs. Mass spectrometry was performed at the Washington University National Center for Research Resources MS Resource ( grant 2P41RR000954). This work was supported by NIH grants AI 027568 and AI 055849.	APASOV SG, 1994, J IMMUNOL, V152, P2087; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Barton GM, 2002, P NATL ACAD SCI USA, V99, P6937, DOI 10.1073/pnas.102645699; Barton GM, 1999, SCIENCE, V283, P67, DOI 10.1126/science.283.5398.67; BEVAN MJ, 1981, P NATL ACAD SCI-BIOL, V78, P1843, DOI 10.1073/pnas.78.3.1843; Chmielowski B, 1999, J IMMUNOL, V162, P95; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu QH, 1997, IMMUNITY, V7, P221, DOI 10.1016/S1074-7613(00)80525-7; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Huseby ES, 2003, P NATL ACAD SCI USA, V100, P11565, DOI 10.1073/pnas.1934636100; Ignatowicz L, 1997, IMMUNITY, V7, P179, DOI 10.1016/S1074-7613(00)80521-X; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Primeau T, 2005, IMMUNOL RES, V32, P109, DOI 10.1385/IR:32:1-3:109; Sandberg JK, 1996, EUR J IMMUNOL, V26, P288, DOI 10.1002/eji.1830260203; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Suri A, 2006, EUR J IMMUNOL, V36, P544, DOI 10.1002/eji.200526235; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	29	37	38	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					871	874		10.1126/science.1177627	http://dx.doi.org/10.1126/science.1177627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892989	Green Accepted			2022-12-24	WOS:000271468000049
J	Park, AW; Daly, JM; Lewis, NS; Smith, DJ; Wood, JLN; Grenfell, BT				Park, Andrew W.; Daly, Janet M.; Lewis, Nicola S.; Smith, Derek J.; Wood, James L. N.; Grenfell, Bryan T.			Quantifying the Impact of Immune Escape on Transmission Dynamics of Influenza	SCIENCE			English	Article							EQUINE INFLUENZA; PANDEMIC INFLUENZA; INFECTION; VIRUS; EVOLUTION	Influenza virus evades prevailing natural and vaccine-induced immunity by accumulating antigenic change in the haemagglutinin surface protein. Linking amino acid substitutions in haemagglutinin epitopes to epidemiology has been problematic because of the scarcity of data connecting these scales. We use experiments on equine influenza virus to address this issue, quantifying how key parameters of viral establishment and shedding increase the probability of transmission with genetic distance between previously immunizing virus and challenge virus. Qualitatively similar patterns emerge from analyses based on antigenic distance and from a published human influenza study. Combination of the equine data and epidemiological models allows us to calculate the effective reproductive number of transmission as a function of relevant genetic change in the virus, illuminating the probability of influenza epidemics as a function of immunity.	[Park, Andrew W.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Park, Andrew W.] Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA; [Daly, Janet M.; Lewis, Nicola S.] Anim Hlth Trust, Newmarket CB8 7UU, Suffolk, England; [Daly, Janet M.] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Lewis, Nicola S.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Lewis, Nicola S.; Wood, James L. N.] Cambridge Infect Dis Consortium, Dept Vet Med, Cambridge CB3 0ES, England; [Smith, Derek J.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Smith, Derek J.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Grenfell, Bryan T.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Grenfell, Bryan T.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08540 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Animal Health Trust; University of Nottingham; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Princeton University; Princeton University	Park, AW (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	awpark@uga.edu	Smith, Derek/Z-3075-2019; Wood, James/A-1626-2008; Daly, Janet/G-9797-2011	Smith, Derek/0000-0002-2393-1890; Wood, James/0000-0002-0258-3188; Daly, Janet/0000-0002-1912-4500	Horserace Betting Levy Board; University of Georgia; Cambridge Infectious Diseases Consortium; NIH [DP1-OD000490-01, R01GM083983-02]; European Union [223498]; Human Frontiers Science Program; Defra [VT0105]; Alborada Trust; Department of Homeland Security; NSF [0742373]; Fogarty International Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	Horserace Betting Levy Board; University of Georgia; Cambridge Infectious Diseases Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Human Frontiers Science Program(Human Frontier Science Program); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Alborada Trust; Department of Homeland Security(United States Department of Homeland Security (DHS)); NSF(National Science Foundation (NSF)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to R. Pyhala, National Public Health Institute, Finland, for providing the HA1 sequence for A/Finland/74 (H3N2) and L. Yipu, National Institute for Medical Research, UK, for providing a sample of A/Scotland/74 (H3N2) from which we obtained the HA1 sequence. We also thank J. Gog, S. Gandon, J. Drake, P. Rohani, and Y. Michalakis for helpful discussions. Financial support came from Horserace Betting Levy Board (A. P. and J. D.), University of Georgia (A. P.), Cambridge Infectious Diseases Consortium (N. L.), NIH Director's pioneer award DP1-OD000490-01 (D. S.), European Union 223498 (D. S.), Human Frontiers Science Program (D. S.), Defra grant VT0105 (J. W.), Alborada Trust (J. W.), Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security (J. W. and B. G.), NIH grant R01GM083983-02 (B. G.), NSF grant 0742373 (B. G.), Fogarty International Center, and NIH (B. G., D. S., J. W.). The authors declare no competing financial interests.	ANDERSON R M, 1991; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Daly JM, 2004, VACCINE, V22, P4101, DOI 10.1016/j.vaccine.2004.02.048; DANIELS RS, 1985, J GEN VIROL, V66, P457, DOI 10.1099/0022-1317-66-3-457; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; MUMFORD JA, 1990, EQUINE VET J, V22, P93, DOI 10.1111/j.2042-3306.1990.tb04217.x; Nasell I., 1995, EPIDEMIC MODELS THEI; Newton JR, 1999, VET REC, V145, P449, DOI 10.1136/vr.145.16.449; POTTER CW, 1977, J HYG-CAMBRIDGE, V79, P321, DOI 10.1017/S0022172400053158; Riley S, 2007, PLOS MED, V4, P1032, DOI 10.1371/journal.pmed.0040218; Satou K, 2006, J EQUINE VET SCI, V26, P310, DOI 10.1016/j.jevs.2006.05.003; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; STUDDERT MJ, 1996, VIRUS INFECT INVERTE; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053	24	77	78	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					726	728		10.1126/science.1175980	http://dx.doi.org/10.1126/science.1175980			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900931	Green Accepted			2022-12-24	WOS:000271233200037
J	Khazeni, N; Hutton, DW; Garber, AM; Hupert, N; Owens, DK				Khazeni, Nayer; Hutton, David W.; Garber, Alan M.; Hupert, Nathaniel; Owens, Douglas K.			Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009	ANNALS OF INTERNAL MEDICINE			English	Article							CROSS-REACTIVE IMMUNITY; HEALTH-CARE WORKERS; A H5N1 INFECTION; AVIAN INFLUENZA; ANTI-H5 ANTIBODY; SIMPLE-MODELS; HONG-KONG; TRANSMISSION; VIRUS; RISK	Background: Decisions on the timing and extent of vaccination against pandemic (H1N1) 2009 virus are complex. Objective: To estimate the effectiveness and cost-effectiveness of pandemic influenza (H1N1) vaccination under different scenarios in October or November 2009. Design: Compartmental epidemic model in conjunction with a Markov model of disease progression. Data Sources: Literature and expert opinion. Target Population: Residents of a major U. S. metropolitan city with a population of 8.3 million. Time Horizon: Lifetime. Perspective: Societal. Interventions: Vaccination in mid-October or mid-November 2009. Outcome Measures: Infections and deaths averted, costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness. Results of Base-Case Analysis: Assuming each primary infection causes 1.5 secondary infections, vaccinating 40% of the population in October or November would be cost-saving. Vaccination in October would avert 2051 deaths, gain 69 679 QALYs, and save $469 million compared with no vaccination; vaccination in November would avert 1468 deaths, gain 49 422 QALYs, and save $302 million. Results of Sensitivity Analysis: Vaccination is even more cost-saving if longer incubation periods, lower rates of infectiousness, or increased implementation of nonpharmaceutical interventions delay time to the peak of the pandemic. Vaccination saves fewer lives and is less cost-effective if the epidemic peaks earlier than mid-October. Limitations: The model assumed homogenous mixing of case-patients and contacts; heterogeneous mixing would result in faster initial spread, followed by slower spread. Additional costs and savings not included in the model would make vaccination more cost-saving. Conclusion: Earlier vaccination against pandemic (H1N1) 2009 prevents more deaths and is more cost-saving. Complete population coverage is not necessary to reduce the viral reproductive rate sufficiently to help shorten the pandemic.	[Khazeni, Nayer] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Cornell Univ, Weill Med Coll, New York, NY 10065 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Cornell University	Khazeni, N (corresponding author), Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, 300 Pasteur Dr,H3143, Stanford, CA 94305 USA.		Garber, Alan M/F-1476-2010		Agency for Healthcare Research and Quality [1 F32 HS018003-01A1]; National Institute on Drug Abuse [2 R01 DA15612-016]; Stanford Graduate Fellowship; Department of Veterans Affairs; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS018003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Stanford Graduate Fellowship(Stanford University); Department of Veterans Affairs(US Department of Veterans Affairs); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By the Agency for Healthcare Research and Quality (1 F32 HS018003-01A1; Dr. Khazeni), the National Institute on Drug Abuse (2 R01 DA15612-016; Dr. Owens), a Stanford Graduate Fellowship (Mr. Hutton), and the Department of Veterans Affairs (Drs. Owens and Garber).	ANDERSON RM, 1990, LANCET, V335, P641, DOI 10.1016/0140-6736(90)90420-A; Apisarnthanarak A, 2005, CLIN INFECT DIS, V40, pE16, DOI 10.1086/427034; Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; *BUR VIT STAT, 2007, SUMM VIT STAT 2007; *CDCP, SEAS INFL FLU DIS; *CDCP, QUEST ANSW MON INFL; *CDCP, 2009, INT CDC GUID NONPH C; *CDCP, SEAS INFL FLU KEY FA; *CDCP, BRIEF PUBL HLTH INV; *CDCP, 2002, SMALLP VACC CLIN GUI; *CDCP, 2006, FLUSURGE VERS 2 0; Centers for Disease Control and Prevention, 2009, 2008 2009 INFL SEAS; Centers for Disease Control and Prevention, 2009 H1N1 FLU SWIN F; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0; CLARK TW, 2009, N ENGL J MED; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; DAVIES JR, 1984, J HYG-CAMBRIDGE, V92, P125, DOI 10.1017/S002217240006410X; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DENOON DJ, 2009, SWINE FLU VACCINE TI; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; GREENBERG ME, 2009, N ENGL J MED; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; LANDAU E, 2009, CDC US MAY NEED 600; Larson RC, 2007, OPER RES, V55, P399, DOI 10.1287/opre.1070.0399; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Liem NT, 2005, EMERG INFECT DIS, V11, P210, DOI 10.3201/eid1102.041075; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MCKAY B, 2009, PREGNANT WOMEN KIDS; McKibbin WJ, 2006, GLOBAL MACROECONOMIC; MENDEL JR, 2001, DIAGNOSIS MANAGEMENT, P145; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Neustadt RE, 1978, SWINE FLU AFFAIR DEC, DOI [10.17226/12660, DOI 10.17226/12660]; *NY CIT DEP HLTH M, PREV INFL GET VACC; *NY CIT DEP HLTH M, 2009, HLTH AL 22 PAND H1N1; *NY CITY DEP HLTH, 2009, 27 NY CITY DEP HLTH; *NY CITY DEP HLTH, 2009, 21 NY CITY DEP HLTH; *NY CITY DEP HLTH, 2009, 19 NY CITY DEP HLTH; *NY CITY DEP HLTH, 2009, 17 NY CITY DEP HLTH; PINE AE, 2005, VACCINATION VENTURES; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; ROOS R, 2009, HHS ADVISORS URGE FU; ROOS R, 2009, MORE RESULTS POINT 1; SCHNIRRING L, 2009, OFFICIALS LOWER EXPE; SCHNIRRING L, 2009, FDA CLEARS CSS VACC; Smith CB, 2002, J INFECT DIS, V185, P980, DOI 10.1086/339416; SONOGUCHI T, 1986, J INFECT DIS, V153, P33, DOI 10.1093/infdis/153.1.33; Talbird SE, 2009, AM J HEALTH-SYST PH, V66, P469, DOI 10.2146/ajhp080296; Thorpe LE, 2004, EMERG INFECT DIS, V10, P917; Thorson A, 2006, ARCH INTERN MED, V166, P119, DOI 10.1001/archinte.166.1.119; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Turner DA, 2006, VACCINE, V24, P1035, DOI 10.1016/j.vaccine.2004.12.033; U. S. Bureau of theCensus, 2009, STAT ABSTR US; U.S. Department of Health and Human Services, PAND INFL PLAN; *US DEP HHS, 2006, HHS BUYS ADD VACC PO; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WHO, 2009, PAND INFL VACC MAN P; *WHO, 2009, GLOB AL RESP GAR PAN; *WHO, 2009, SUMM WHO VIRT CONS S; World Health Organization, 2009, PAND H1N1 2009; World Health Organization, 2009, WORLD NOW START 2009; World Health Organization, 2009, SAF PAND VACC; Yang Y, 2009, SCIENCE; 2007, SAN JOSE MERCUR 0617; 2006, METLIFE SURVEY NURSI; 2009, NY1 NEWS        0701	85	77	77	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2009	151	12					829	U2		10.7326/0000605-200912150-00157	http://dx.doi.org/10.7326/0000605-200912150-00157			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532ET	20008759				2022-12-24	WOS:000272728900001
J	Hakoyama, T; Niimi, K; Watanabe, H; Tabata, R; Matsubara, J; Sato, S; Nakamura, Y; Tabata, S; Li, JC; Matsumoto, T; Tatsumi, K; Nomura, M; Tajima, S; Ishizaka, M; Yano, K; Imaizumi-Anraku, H; Kawaguchi, M; Kouchi, H; Suganuma, N				Hakoyama, Tsuneo; Niimi, Kaori; Watanabe, Hirokazu; Tabata, Ryohei; Matsubara, Junichi; Sato, Shusei; Nakamura, Yasukazu; Tabata, Satoshi; Li Jichun; Matsumoto, Tsuyoshi; Tatsumi, Kazuyuki; Nomura, Mika; Tajima, Shigeyuki; Ishizaka, Masumi; Yano, Koji; Imaizumi-Anraku, Haruko; Kawaguchi, Masayoshi; Kouchi, Hiroshi; Suganuma, Norio			Host plant genome overcomes the lack of a bacterial gene for symbiotic nitrogen fixation	NATURE			English	Article							ALPHA-ISOPROPYLMALATE SYNTHASE; IRON-MOLYBDENUM COFACTOR; SOYBEAN ROOT-NODULES; LOTUS-JAPONICUS; HOMOCITRATE SYNTHASE; FIXING SYMBIOSIS; RHIZOBIUM; PURIFICATION; MUTANTS; LEGUMES	Homocitrate is a component of the iron-molybdenum cofactor in nitrogenase, where nitrogen fixation occurs(1,2). NifV, which encodes homocitrate synthase (HCS)(3), has been identified from various diazotrophs but is not present in most rhizobial species that perform efficient nitrogen fixation only in symbiotic association with legumes. Here we show that the FEN1 gene of a model legume, Lotus japonicus, overcomes the lack of NifV in rhizobia for symbiotic nitrogen fixation. A Fix(-) (non-fixing) plant mutant, fen1, forms morphologically normal but ineffective nodules(4,5). The causal gene, FEN1, was shown to encode HCS by its ability to complement a HCS-defective mutant of Saccharomyces cerevisiae. Homocitrate was present abundantly in wild-type nodules but was absent from ineffective fen1 nodules. Inoculation with Mesorhizobium loti carrying FEN1 or Azotobacter vinelandii NifV rescued the defect in nitrogen-fixing activity of the fen1 nodules. Exogenous supply of homocitrate also recovered the nitrogen-fixing activity of the fen1 nodules through de novo nitrogenase synthesis in the rhizobial bacteroids. These results indicate that homocitrate derived from the host plant cells is essential for the efficient and continuing synthesis of the nitrogenase system in endosymbionts, and thus provide a molecular basis for the complementary and indispensable partnership between legumes and rhizobia in symbiotic nitrogen fixation.	[Hakoyama, Tsuneo; Niimi, Kaori; Watanabe, Hirokazu; Tabata, Ryohei; Matsubara, Junichi; Suganuma, Norio] Aichi Univ Educ, Dept Life Sci, Aichi 4488542, Japan; [Hakoyama, Tsuneo; Yano, Koji; Imaizumi-Anraku, Haruko; Kouchi, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Sato, Shusei; Nakamura, Yasukazu; Tabata, Satoshi] Kazusa DNA Res Inst, Chiba 2920812, Japan; [Li Jichun; Matsumoto, Tsuyoshi; Tatsumi, Kazuyuki] Nagoya Univ, Grad Sch Sci, Dept Chem, Aichi 4648602, Japan; [Li Jichun; Matsumoto, Tsuyoshi; Tatsumi, Kazuyuki] Nagoya Univ, Res Ctr Mat Sci, Aichi 4648602, Japan; [Nomura, Mika; Tajima, Shigeyuki] Kagawa Univ, Fac Agr, Kita Ku, Kagawa 7610795, Japan; [Ishizaka, Masumi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Kawaguchi, Masayoshi] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	Aichi University Education; National Institute of Agrobiological Sciences - Japan; Kazusa DNA Research Institute; Nagoya University; Nagoya University; Kagawa University; National Institute for Agro-Environmental Sciences (NIAES) Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Suganuma, N (corresponding author), Aichi Univ Educ, Dept Life Sci, Aichi 4488542, Japan.	nsuganum@auecc.aichi-edu.ac.jp	Nakamura, Yasukazu/T-9038-2019; Sato, Shusei/A-3616-2015; Matsumoto, Tsuyoshi/E-8638-2013	Sato, Shusei/0000-0002-0293-5366; Nakamura, Yasukazu/0000-0002-6782-5715; Kawaguchi, Masayoshi/0000-0002-1032-6261; Yano, Koji/0000-0002-4322-3525	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank E. Casalone and E. Dubois for providing Saccharomyces cerevisiae mutants; T. Bisseling for providing nitrogenase antibodies; Y. Kawaharada and H. Mitsui for technical help; and R. W. Ridge for critical reading of the manuscript. This work was supported by the Special Coordination Funds for Promoting Science and Technology of the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Asamizu E, 2004, PLANT MOL BIOL, V54, P405, DOI 10.1023/B:PLAN.0000036372.46942.b8; Casalone E, 2000, YEAST, V16, P539, DOI 10.1002/(SICI)1097-0061(200004)16:6<539::AID-YEA547>3.0.CO;2-K; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; Diaz CL, 2005, LOTUS JAPONICUS HANDBOOK, P261, DOI 10.1007/1-4020-3735-X_26; DREYFUS BL, 1983, APPL ENVIRON MICROB, V45, P711, DOI 10.1128/AEM.45.2.711-713.1983; Feller A, 1999, EUR J BIOCHEM, V261, P163, DOI 10.1046/j.1432-1327.1999.00262.x; GAUTHIER D, 1981, APPL ENVIRON MICROB, V41, P306, DOI 10.1128/AEM.41.1.306-308.1981; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Hata S, 1998, PLANT J, V13, P267, DOI 10.1046/j.1365-313X.1998.00022.x; HOOVER TR, 1988, BIOCHEMISTRY-US, V27, P3647, DOI 10.1021/bi00410a019; HOOVER TR, 1989, BIOCHEMISTRY-US, V28, P2768, DOI 10.1021/bi00433a004; HOOVER TR, 1987, NATURE, V329, P855, DOI 10.1038/329855a0; ImaizumiAnraku H, 1997, PLANT CELL PHYSIOL, V38, P871, DOI 10.1093/oxfordjournals.pcp.a029246; JACOBSENLYON K, 1995, PLANT CELL, V7, P213, DOI 10.1105/tpc.7.2.213; Kawaguchi M, 2002, MOL PLANT MICROBE IN, V15, P17, DOI 10.1094/MPMI.2002.15.1.17; Kneip C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-55; KOHLHAW G, 1969, J BIOL CHEM, V244, P2218; KOUCHI H, 1995, MOL PLANT MICROBE IN, V8, P172, DOI 10.1094/MPMI-8-0172; KOUCHI H, 1991, J GEN MICROBIOL, V137, P2901, DOI 10.1099/00221287-137-12-2901; Kumagai H, 2007, PLANT PHYSIOL, V143, P1293, DOI 10.1104/pp.106.095356; KURZ WGW, 1975, NATURE, V256, P407, DOI 10.1038/256407a0; MCCOMB JA, 1975, NATURE, V256, P409, DOI 10.1038/256409a0; PAGAN JD, 1975, NATURE, V256, P406, DOI 10.1038/256406a0; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; RONSON CW, 1981, P NATL ACAD SCI-BIOL, V78, P4284, DOI 10.1073/pnas.78.7.4284; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Shimomura K, 2006, PLANT CELL PHYSIOL, V47, P1572, DOI 10.1093/pcp/pcl022; Suganuma N, 2003, MOL GENET GENOMICS, V269, P312, DOI 10.1007/s00438-003-0840-4; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Takane K, 1997, MOL PLANT MICROBE IN, V10, P735, DOI 10.1094/MPMI.1997.10.6.735; ULM EH, 1972, J BACTERIOL, V110, P1118, DOI 10.1128/JB.110.3.1118-1126.1972; WILSON KJ, 1995, MICROBIOL-SGM, V141, P1691, DOI 10.1099/13500872-141-7-1691; Xu PF, 2005, TETRAHEDRON LETT, V46, P3815, DOI 10.1016/j.tetlet.2005.03.180; Zheng LM, 1997, J BACTERIOL, V179, P5963, DOI 10.1128/jb.179.18.5963-5966.1997	35	70	72	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					514	U210		10.1038/nature08594	http://dx.doi.org/10.1038/nature08594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940927				2022-12-24	WOS:000272144200046
J	Kumbhani, DJ; Cannon, CP; Fonarow, GC; Liang, L; Askari, AT; Peacock, WF; Peterson, ED; Bhatt, DL				Kumbhani, Dharam J.; Cannon, Christopher P.; Fonarow, Gregg C.; Liang, Li; Askari, Arman T.; Peacock, W. Frank; Peterson, Eric D.; Bhatt, Deepak L.		Get Guidelines Steering Comm Inves	Association of Hospital Primary Angioplasty Volume in ST-Segment Elevation Myocardial Infarction With Quality and Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; MORTALITY	Context Earlier studies indicate an inverse relationship between hospital volume and mortality after primary angioplasty for patients presenting with ST-segment elevation myocardial infarction (STEMI). However, contemporary data are lacking. Objective To assess the relationship between hospital primary angioplasty volume and outcomes and quality of care measures in patients presenting with STEMI. Design, Setting, and Patients An observational analysis of data on 29 513 patients presenting with STEMI and undergoing primary angioplasty in the American Heart Association's Get With the Guidelines registry. Patients were treated between July 5, 2001, and December 31, 2007, at 166 angioplasty-capable hospitals across the United States. Hospitals were divided into tertiles (<36 procedures per year, 36-70 procedures per year, and >70 procedures per year) based on their annual primary angioplasty volume. Main Outcome Measures Door-to-balloon (DTB) times, length of hospital stay, adherence with evidence-based quality of care measures, and in-hospital mortality. Results Compared with low-and medium-volume centers, high-volume centers had better median DTB times (98 vs 90 vs 88 minutes, respectively; P for trend <.001). High-volume centers were more likely than low-volume centers to follow evidence-based guidelines at discharge. Length of stay was similar between the 3 groups (P for trend = .13). There was no significant difference in the crude mortality between the tertiles of volume (incidence rate, 3.9% vs 3.2% vs 3.0% for low-, medium-, and high-volume centers, respectively; P = .26 and P = .99 for low-and medium-vs high-volume hospitals, respectively). Sequential multivariable modeling using generalized estimating equations revealed no significant association between hospital primary angioplasty volume and in-hospital mortality (adjusted odds ratio [OR], 1.22; 95% confidence interval [CI], 0.78-1.91; P = .38 and adjusted OR, 1.14; 95% CI, 0.78-1.66; P = .49 for low-and medium-vs high-volume hospitals, respectively). Conclusion In a contemporary registry of patients with STEMI, higher-volume primary angioplasty centers vs lower-volume centers were associated with shorter DTB times and more use of evidence-based therapies, but not with adjusted in-hospital mortality or length of hospital stay. JAMA. 2009;302(20):2207-2213	[Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA 02115 USA; [Kumbhani, Dharam J.; Askari, Arman T.; Peacock, W. Frank] Cleveland Clin, Cleveland, OH 44106 USA; [Cannon, Christopher P.] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA; [Fonarow, Gregg C.] Ahmanson Univ Calif Los Angeles, Univ Calif Los Angeles, Cardiomyopathy Ctr, Div Cardiol, Los Angeles, CA USA; [Liang, Li; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; Duke University	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, 75 Francis St,PBB 146, Boston, MA 02115 USA.	dlbhattmd@post.harvard.edu	Cannon, Christopher P/AAY-7644-2020; Peterson, Eric David/ABF-5033-2021; Fonarow, Gregg C/D-5988-2014	Cannon, Christopher P/0000-0003-4596-2791; Fonarow, Gregg C/0000-0002-3192-8093	Merck/Schering-Plough Pharmaceutical; AHA	Merck/Schering-Plough Pharmaceutical(Merck & Company); AHA(American Heart Association)	The Get With the Guidelines-Coronary Artery Disease is a program of the American Heart Association (AHA) and is supported by an unrestricted educational grant from Merck/Schering-Plough Pharmaceutical. Data collection and management were performed by Outcome Inc (Cambridge, Massachusetts). The analysis of registry data was performed at Duke Clinical Research Institute (Durham, North Carolina), which also receives funding from the AHA.	Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Antman EM, 2008, J AM COLL CARDIOL, V52, P1216, DOI 10.1016/j.jacc.2008.07.011; Bhatt DL, 2000, JAMA-J AM MED ASSOC, V284, P1549, DOI 10.1001/jama.284.12.1549; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Califf RM, 2009, J AM COLL CARDIOL, V53, P831, DOI 10.1016/j.jacc.2008.10.056; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Epstein AJ, 2004, J AM COLL CARDIOL, V43, P1755, DOI 10.1016/j.jacc.2003.09.070; Kansagra SM, 2007, AM J CARDIOL, V99, P339, DOI 10.1016/j.amjcard.2006.08.037; Kastrati A, 2007, EUR HEART J, V28, P2706, DOI 10.1093/eurheartj/ehm402; Khuri SF, 2005, WORLD J SURG, V29, P1222, DOI 10.1007/s00268-005-7987-6; Kumbhani D, 2005, J AM COLL SURGEONS, V201, pS65, DOI 10.1016/j.jamcollsurg.2005.06.150; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; LaBresh Kenneth A, 2003, Jt Comm J Qual Saf, V29, P539; *LEAPFROG GROUP, EV BAS HOSP REF; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Magid DJ, 2000, JAMA-J AM MED ASSOC, V284, P3131, DOI 10.1001/jama.284.24.3131; Pottenger BC, 2008, ANN EMERG MED, V52, P677, DOI 10.1016/j.annemergmed.2008.06.004; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Srinivas VS, 2009, J AM COLL CARDIOL, V53, P574, DOI 10.1016/j.jacc.2008.09.056; Vakili BA, 2001, CIRCULATION, V104, P2171, DOI 10.1161/hc3901.096668; Venkitachalam L, 2009, CIRC-CARDIOVASC INTE, V2, P6, DOI 10.1161/CIRCINTERVENTIONS.108.825323; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	24	69	70	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2207	2213		10.1001/jama.2009.1715	http://dx.doi.org/10.1001/jama.2009.1715			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	19934421				2022-12-24	WOS:000272080500024
J	Chen, L; Kwon, YD; Zhou, TQ; Wu, XL; O'Dell, S; Cavacini, L; Hessell, AJ; Pancera, M; Tang, M; Xu, L; Yang, ZY; Zhang, MY; Arthos, J; Burton, DR; Dimitrov, DS; Nabel, GJ; Posner, MR; Sodroski, J; Wyatt, R; Mascola, JR; Kwong, PD				Chen, Lei; Kwon, Young Do; Zhou, Tongqing; Wu, Xueling; O'Dell, Sijy; Cavacini, Lisa; Hessell, Ann J.; Pancera, Marie; Tang, Min; Xu, Ling; Yang, Zhi-Yong; Zhang, Mei-Yun; Arthos, James; Burton, Dennis R.; Dimitrov, Dimiter S.; Nabel, Gary J.; Posner, Marshall R.; Sodroski, Joseph; Wyatt, Richard; Mascola, John R.; Kwong, Peter D.			Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; NEUTRALIZING ANTIBODIES; BINDING-SITE; EFFICIENT NEUTRALIZATION; ENVELOPE GLYCOPROTEINS; INFECTED INDIVIDUALS; PROTEIN; PANEL; CRYSTALLIZATION	The site on HIV-1 gp120 that binds to the CD4 receptor is vulnerable to antibodies. However, most antibodies that interact with this site cannot neutralize HIV-1. To understand the basis of this resistance, we determined co-crystal structures for two poorly neutralizing, CD4-binding site (CD4BS) antibodies, F105 and b13, in complexes with gp120. Both antibodies exhibited approach angles to gp120 similar to those of CD4 and a rare, broadly neutralizing CD4BS antibody, b12. Slight differences in recognition, however, resulted in substantial differences in F105- and b13-bound conformations relative to b12-bound gp120. Modeling and binding experiments revealed these conformations to be poorly compatible with the viral spike. This incompatibility, the consequence of slight differences in CD4BS recognition, renders HIV-1 resistant to all but the most accurately targeted antibodies.	[Chen, Lei; Kwon, Young Do; Zhou, Tongqing; Wu, Xueling; O'Dell, Sijy; Pancera, Marie; Tang, Min; Xu, Ling; Yang, Zhi-Yong; Nabel, Gary J.; Wyatt, Richard; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Cavacini, Lisa; Posner, Marshall R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Head & Neck Oncol Program, Boston, MA 02115 USA; [Hessell, Ann J.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Hessell, Ann J.; Burton, Dennis R.] Scripps Res Inst, Dept Microbial Sci, La Jolla, CA 92037 USA; [Hessell, Ann J.; Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Zhang, Mei-Yun; Dimitrov, Dimiter S.] NCI, Ctr Canc Res, Frederick, MD 21702 USA; [Arthos, James] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA; [Burton, Dennis R.] Harvard Univ, Boston, MA 02114 USA; [Sodroski, Joseph] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	pdkwong@nih.gov; pdkwong@nih.gov	Zhang, Mei-Yun/E-9908-2010; Zhou, Tongqing/A-6880-2010; Mascola, John/AAI-7193-2021; Do Kwon, Young/A-6957-2010	Zhou, Tongqing/0000-0002-3935-4637; Do Kwon, Young/0000-0002-1188-7458; Hessell, Ann/0000-0001-7471-9366	NIH; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation Grand Challenges in Global Heath Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005023, ZIAAI005089, ZIAAI005095, ZIAAI000883, ZIAAI005010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation Grand Challenges in Global Heath Initiative(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	L. Chen produced and assessed for crystallization CD4BS antibodies with unconstrained gp120, crystallized the F105-gp120 complex, assisted with F105-gp120 data collection and structure solution, and carried out mutagenesis and SPR binding experiments. Y. D. K. assisted with F105-gp120 crystallization, data collection, and structure solution and refined and analyzed the F105-gp120 structure. T. Z. purified, crystallized, solved, and analyzed the b13-gp120 complex. X. W., S. O.' D. and J. R. M. assessed neutralization potency and breadth of CD4, patient sera, and CD4BS antibodies. L. Chen and M. P. carried out cell-surface JR-FL binding experiments. M. T. and R. W. provided YU2 core gp120; L. X. and G. J. N. provided stabilized-core gp120; Z.-Y. Y. and G. J. N. converted b13 from Fab to IgG format and provided b13 IgG; L. Cavacini and M. R. P. provided F105; M.-Y. Z. and D. S. D. provided m6, m14, and m18; A. J. H. and D. R. B. provided b3, b6, b11, b12; and J. A. provided dodecameric CD4. J. A., D. R. B., D. S. D., G. J. N., M. R. P., J. S., R. W., and J. R. M. assisted with analysis and writing, and P. D. K. assisted with crystallography and experimental planning and wrote the first draft. Figures, tables, and supporting online material were produced by L. Chen, Y. D. K., M. P., T. Z. and X. W. We thank L. Shapiro and members of the Structural Biology Section, Vaccine Research Center (VRC), for discussions and comments on the manuscript, M. Connors for patient serum, M. Fung for antibodies G3-42 and G3-299, J. Robinson for antibodies 1.5e and F91, J. Stuckey for assistance with figures and tables, S. Subramaniam for EM tomograms, C. Winter and C. Huang for S2 production of core YU2 gp120, X. Yang for preparation of JR-FL gp120, and the Flow Cytometry Core, VRC, for assistance with antibody binding to cell-surface-expressed HIV-1 spikes. Support for this work was provided by the Intramural Research Program of NIH, the International AIDS Vaccine Initiative, a grant from the Bill and Melinda Gates Foundation Grand Challenges in Global Heath Initiative, and grants from NIH. The use of insertion device 22 (Southeast Region Collaborative Access Team) at the Advanced Photon Source was supported by the U. S. Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. Coordinates and structure factors for the F105-gp120 complex (accession code 3HI1) and the b13-gp120 complexes (accession codes 3IDX and 3IDY for C222 and C2221 forms, respectively) have been deposited with the Protein Data Bank.	Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Kabat EA, 1991, SEQUENCES PROTEINS I; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; MORRIS DW, 1989, BIOTECHNIQUES, V7, P522; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; POSNER MR, 1991, J IMMUNOL, V146, P4325; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; TRAUNECKER A, 1989, NATURE, V339, P68, DOI 10.1038/339068a0; UNAIDS, 2006, REP GLOB AIDS EP; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilkinson RA, 2005, J VIROL, V79, P13060, DOI 10.1128/JVI.79.20.13060-13069.2005; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	33	233	255	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1123	1127		10.1126/science.1175868	http://dx.doi.org/10.1126/science.1175868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965434	Green Accepted			2022-12-24	WOS:000271951000048
J	Gheorghiade, M; Braunwald, E				Gheorghiade, Mihai; Braunwald, Eugene			Reconsidering the Role for Digoxin in the Management of Acute Heart Failure Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; TRIAL; MORBIDITY		[Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Dept Med, Ctr Cardiovasc Qual & Outcomes, Chicago, IL 60611 USA; [Braunwald, Eugene] Harvard Univ, Sch Med, Dept Med, Div Cardiovasc Med, Boston, MA USA	Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Ctr Cardiovasc Qual & Outcomes, 676 N St Clair,Ste 600, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu						Adams KF, 2005, J AM COLL CARDIOL, V46, P497, DOI 10.1016/j.jacc.2005.02.091; Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gheorghiade M, 2006, CIRCULATION, V113, P2556, DOI 10.1161/CIRCULATIONAHA.105.560110; Gheorghiade M, 2009, AM HEART J, V157, P957, DOI 10.1016/j.ahj.2009.04.010; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; OCONNOR MC, 2009, 13 ANN SCI M HEART F; Perry G, 1997, NEW ENGL J MED, V336, P525; Rathore SS, 2002, NEW ENGL J MED, V347, P1403, DOI 10.1056/NEJMoa021266; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900	10	45	48	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2146	2147		10.1001/jama.2009.1657	http://dx.doi.org/10.1001/jama.2009.1657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920240				2022-12-24	WOS:000271873900025
J	de Lange, T				de Lange, Titia			How Telomeres Solve the End-Protection Problem	SCIENCE			English	Article							DNA-DAMAGE CHECKPOINT; BINDING-PROTEIN; FISSION YEAST; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; DYSFUNCTIONAL TELOMERES; UNPROTECTED TELOMERES; MAMMALIAN TELOMERES; POT1 PROTEINS	The ends of eukaryotic chromosomes have the potential to be mistaken for damaged or broken DNA and must therefore be protected from cellular DNA damage response pathways. Otherwise, cells might permanently arrest in the cell cycle, and attempts to "repair" the chromosome ends would have devastating consequences for genome integrity. This end-protection problem is solved by protein-DNA complexes called telomeres. Studies of mammalian cells have recently uncovered the mechanism by which telomeres disguise the chromosome ends. Comparison to unicellular eukaryotes reveals key differences in the DNA damage response systems that inadvertently threaten chromosome ends. Telomeres appear to be tailored to these variations, explaining their variable structure and composition.	Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10021 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIH [CA076027, GM049046, AG016642]; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046, R01GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank M. Wellinger, J. Petrini, J. Haber, V. Lundblad, and M. Godinho Ferreira for helpful discussion; Y. Doksani, P. Wu, F. Lottersberger, and A. Sfeir for their comments on this manuscript; and J. Griffith for providing the t-loop EM in Fig. 1. Supported by NIH grants CA076027, GM049046, and AG016642.	Attwooll CL, 2009, MOL CELL BIOL, V29, P5540, DOI 10.1128/MCB.00479-09; Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Barrientos KS, 2008, MOL CELL BIOL, V28, P5251, DOI 10.1128/MCB.00048-08; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; Callegari AJ, 2007, CELL CYCLE, V6, P660, DOI 10.4161/cc.6.6.3984; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; Cesare AJ, 2008, MOL CELL BIOL, V28, P20, DOI 10.1128/MCB.01122-07; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2009, NATURE, V460, P914, DOI 10.1038/nature08196; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dimitrova N, 2009, MOL CELL BIOL, V29, P5552, DOI 10.1128/MCB.00476-09; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Stansel RM, 2001, EMBO J, V20, P5532; Stern JL, 2008, CYTOGENET GENOME RES, V122, P243, DOI 10.1159/000167810; Subramanian L, 2008, MOL CELL BIOL, V28, P1443, DOI 10.1128/MCB.01614-07; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Vodenicharov MD, 2007, CELL CYCLE, V6, P1161, DOI 10.4161/cc.6.10.4224; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang YB, 2009, P NATL ACAD SCI USA, V106, P12430, DOI 10.1073/pnas.0903362106; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037	64	570	574	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					948	952		10.1126/science.1170633	http://dx.doi.org/10.1126/science.1170633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965504	Green Accepted			2022-12-24	WOS:000271712300025
J	Wardlaw, JM; Sandercock, PAG; Murray, V				Wardlaw, Joanna M.; Sandercock, Peter A. G.; Murray, Veronica			Uncertainties Page Should more patients with acute ischaemic stroke receive thrombolytic treatment?	BRITISH MEDICAL JOURNAL			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; ALTEPLASE; THERAPY; ECASS		[Wardlaw, Joanna M.; Sandercock, Peter A. G.] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Murray, Veronica] Karolinska Inst, Danderyd Hosp, Div Med, SE-18288 Stockholm, Sweden	University of Edinburgh; Danderyds Hospital; Karolinska Institutet	Wardlaw, JM (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	joanna.wardlaw@ed.ac.uk	Hernandez, María/GYU-3543-2022; Wardlaw, Joanna M/Y-3456-2019	Wardlaw, Joanna M/0000-0002-9812-6642; Sandercock, Peter/0000-0001-8484-0135				Cocho D, 2005, NEUROLOGY, V64, P719, DOI 10.1212/01.WNL.0000152041.20486.2F; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Heuschmann PU, 2003, STROKE, V34, P1106, DOI 10.1161/01.STR.0000065198.80347.C5; Kapral MK, 2004, STROKE, V35, P1756, DOI 10.1161/01.STR.0000130423.50191.9f; Leys D, 2007, STROKE, V38, P2985, DOI 10.1161/STROKEAHA.107.487967; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Qureshi AI, 2005, NEUROLOGY, V64, P2115, DOI 10.1212/01.WNL.0000165951.03373.25; SANDERCOCK P, 2008, 3 INT STROK TRIAL IS; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000213; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	15	16	16	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 11	2009	339								b4584	10.1136/bmj.b4584	http://dx.doi.org/10.1136/bmj.b4584			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HM	19906748				2022-12-24	WOS:000271833900004
J	McCalley, CK; Sparks, JP				McCalley, Carmody K.; Sparks, Jed P.			Abiotic Gas Formation Drives Nitrogen Loss from a Desert Ecosystem	SCIENCE			English	Article							NITRIC-OXIDE EMISSIONS; SOIL EMISSIONS; MINERALIZATION; MECHANISMS; PATTERN; NO	In arid environments such as deserts, nitrogen is often the most limiting nutrient for biological activity. The majority of the ecosystem nitrogen flux is typically thought to be driven by production and loss of reactive nitrogen species by microorganisms in the soil. We found that high soil-surface temperatures (greater than 50 degrees C), driven by solar radiation, are the primary cause of nitrogen loss in Mojave Desert soils. This abiotic pathway not only enables the balancing of arid ecosystem nitrogen budgets, but also changes our view of global nitrogen cycling and the predicted impact of climate change and increased temperatures on nitrogen bioavailability.	[McCalley, Carmody K.; Sparks, Jed P.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	McCalley, CK (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Corson Hall,Room E149, Ithaca, NY 14853 USA.	ckm27@cornell.edu			NSF [DEB-0709642, DEB-0237674]; Cornell University's NSF Integrative Graduate Education and Research Traineeship; Cornell University's Andrew Mellon Student Research	NSF(National Science Foundation (NSF)); Cornell University's NSF Integrative Graduate Education and Research Traineeship; Cornell University's Andrew Mellon Student Research	Funding for this project was provided by the NSF Doctoral Dissertation Improvement Award DEB-0709642, NSF Award DEB-0237674, Cornell University's NSF Integrative Graduate Education and Research Traineeship program in Biogeochemistry and Environmental Biocomplexity Student Research Grants, and Cornell University's Andrew Mellon Student Research Grants.	Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Barger NN, 2005, BIOGEOCHEMISTRY, V75, P373, DOI 10.1007/s10533-005-1378-9; Belnap J, 2001, ECOL STU AN, V150, P241; Billings SA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002137; Billings SA, 2002, SOIL BIOL BIOCHEM, V34, P1777, DOI 10.1016/S0038-0717(02)00166-9; Davidson EA, 1997, NUTR CYCL AGROECOSYS, V48, P37, DOI 10.1023/A:1009738715891; DAVIDSON EA, 1991, J GEOPHYS RES-ATMOS, V96, P15439, DOI 10.1029/91JD01476; DAVIDSON EA, 1993, ECOLOGY, V74, P130, DOI 10.2307/1939508; Feig GT, 2008, BIOGEOSCIENCES, V5, P1723, DOI 10.5194/bg-5-1723-2008; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Grannas AM, 2007, ATMOS CHEM PHYS, V7, P4329, DOI 10.5194/acp-7-4329-2007; Honrath RE, 2000, GEOPHYS RES LETT, V27, P2237, DOI 10.1029/1999GL011286; Honrath RE, 2002, ATMOS ENVIRON, V36, P2629, DOI 10.1016/S1352-2310(02)00132-2; Jacob D. J., 1999, INTRO ATMOSPHERIC CH, DOI [10.1515/9781400841547, DOI 1001852/INTRODUCTION-TOATMOSPHERIC-CHEMISTRY, DOI 10.1515/9781400841547]; Johnson SL, 2007, ENVIRON MICROBIOL, V9, P680, DOI 10.1111/j.1462-2920.2006.01187.x; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Luxhoi J, 2008, AUST J SOIL RES, V46, P710, DOI 10.1071/SR08044; McCalley CK, 2008, OECOLOGIA, V156, P871, DOI 10.1007/s00442-008-1031-0; *NV DES RES CTR, NEV DES FACE LONG TE; Passianoto CC, 2004, PLANT SOIL, V258, P21, DOI 10.1023/B:PLSO.0000016500.47714.30; PETERJOHN WT, 1990, BIOGEOCHEMISTRY, V10, P67; PHILLIPS L, 1947, NATURE, V160, P753, DOI 10.1038/160753a0; Rosentreter R, 2001, ECOL STU AN, V150, P31; Rundel PW, 1996, ECOLOGICAL COMMUNITI; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Sierra J, 2000, SOIL SCI SOC AM J, V64, P2002, DOI 10.2136/sssaj2000.6462002x; STERN KH, 2001, HIGH TEMPERATURE PRO, P135; Venterea RT, 2000, GLOBAL CHANGE BIOL, V6, P303, DOI 10.1046/j.1365-2486.2000.00309.x; West NE, 1978, NITROGEN DESERT ECOS, P1; Whitford W., 2002, ECOLOGY DESERT SYSTE	30	99	105	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					837	840		10.1126/science.1178984	http://dx.doi.org/10.1126/science.1178984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892980				2022-12-24	WOS:000271468000040
J	Yoshida-Moriguchi, T; Yu, LP; Stalnaker, SH; Davis, S; Kunz, S; Madson, M; Oldstone, MBA; Schachter, H; Wells, L; Campbell, KP				Yoshida-Moriguchi, Takako; Yu, Liping; Stalnaker, Stephanie H.; Davis, Sarah; Kunz, Stefan; Madson, Michael; Oldstone, Michael B. A.; Schachter, Harry; Wells, Lance; Campbell, Kevin P.			O-Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin Binding	SCIENCE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; LASSA FEVER VIRUS; ABNORMAL GLYCOSYLATION; RECEPTOR; MUTATIONS; GLYCOSYLTRANSFERASE; GLYCOPROTEINS; GLYCANS; FORM	Alpha-dystroglycan (alpha-DG) is a cell-surface glycoprotein that acts as a receptor for both extracellular matrix proteins containing laminin-G domains and certain arenaviruses. Receptor binding is thought to be mediated by a posttranslational modification, and defective binding with laminin underlies a subclass of congenital muscular dystrophy. Using mass spectrometry- and nuclear magnetic resonance (NMR)-based structural analyses, we identified a phosphorylated O-mannosyl glycan on the mucin-like domain of recombinant alpha-DG, which was required for laminin binding. We demonstrated that patients with muscle-eye-brain disease and Fukuyama congenital muscular dystrophy, as well as mice with myodystrophy, commonly have defects in a postphosphoryl modification of this phosphorylated O-linked mannose, and that this modification is mediated by the like-acetylglucosaminyltransferase (LARGE) protein. These findings expand our understanding of the mechanisms that underlie congenital muscular dystrophy.	[Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Dept Neurol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, Med Nucl Magnet Resonance Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Stalnaker, Stephanie H.; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Kunz, Stefan] Univ Lausanne, Lausanne, Switzerland; [Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Madson, Michael] Bio Logist, Clear Lake, IA 50428 USA; [Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Schachter, Harry] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University System of Georgia; University of Georgia; University of Lausanne; Scripps Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Wells, Lance/H-3118-2013; Kishore, Gade/C-6943-2011; Kunz, Stefan/K-5840-2017	Kishore, Gade/0000-0003-0911-4381; Yu, Liping/0000-0003-3536-6427; Wells, Lance/0000-0003-4956-5363; Kunz, Stefan/0000-0001-6030-9550; Campbell, Kevin/0000-0003-2066-5889	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055540, R21AI055540, R01AI009484, R01AI045927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P41 RR018502] Funding Source: Medline; NIAID NIH HHS [R01 AI045927, AI55540, R01 AI055540, R01 AI045927-09, R01 AI045927-10, R01 AI009484, R01 AI045927-08, R01 AI009484-40, R21 AI055540, R01 AI009484-41] Funding Source: Medline; NIDDK NIH HHS [P30 DK054759, P30 DK 54759] Funding Source: Medline; NINDS NIH HHS [U54 NS053672, 1U54NS053672] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chiba A, 1997, J BIOL CHEM, V272, P2156; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; GANDER JE, 1974, ANNU REV MICROBIOL, V28, P103, DOI 10.1146/annurev.mi.28.100174.000535; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; ILG T, 1994, J BIOL CHEM, V269, P24073; Ilg T, 1996, J BIOL CHEM, V271, P21583, DOI 10.1074/jbc.271.35.21583; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kunz S, 2005, J VIROL, V79, P5979, DOI 10.1128/JVI.79.10.5979-5987.2005; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manzini MC, 2008, HUM MUTAT, V29, pE231, DOI 10.1002/humu.20844; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	25	244	251	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					88	92		10.1126/science.1180512	http://dx.doi.org/10.1126/science.1180512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044576	Green Accepted, Green Submitted			2022-12-24	WOS:000273395400037
J	Nugus, P; Bridges, J; Braithwaite, J				Nugus, Peter; Bridges, Jackie; Braithwaite, Jeffrey			Christmas 2009: Professional Matters Selling patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Braithwaite, Jeffrey] Univ New S Wales, Fac Med, Australian Inst Hlth Innovat, Ctr Clin Governance Res, Sydney, NSW 2052, Australia	University of New South Wales Sydney		p.nugus@unsw.edu.au	Braithwaite, Jeffrey/AAN-1467-2020	Braithwaite, Jeffrey/0000-0003-0296-4957; Bridges, Jackie/0000-0001-6776-736X				BLOOR M, 1976, SOCIOLOGY, V10, P43, DOI 10.1177/003803857601000103; Eisenberg EM, 2005, COMMUN MONOGR, V72, P390, DOI 10.1080/03637750500322602; EMERSON RM, 1991, SOC PROBL, V38, P198, DOI 10.1525/sp.1991.38.2.03a00060; HAMMERSLEY M, 1990, SOCIOLOGY, V24, P597, DOI 10.1177/0038038590024004003; Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Hartswood M., 2003, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V12, P241, DOI 10.1023/A:1025055829026; Hewett DG, 2009, SOC SCI MED, V69, P1732, DOI 10.1016/j.socscimed.2009.09.048; Hughes Geoffrey, 2004, Emerg Med Australas, V16, P387, DOI 10.1111/j.1742-6723.2004.00641.x; Innes G, 2000, CJEM, V2, P47; Jean YA, 2004, SOCIOL HEALTH ILL, V26, P385, DOI 10.1111/j.0141-9889.2004.00396.x; Merton Robert K., 1957, STUDENT PHYS INTRO S; Nugus P, 2010, SOC SCI MED, V70, P511, DOI 10.1016/j.socscimed.2009.11.001; Ragin C., 1994, CONSTRUCTING SOCIAL; Salhan D, 2009, SOC SCI MED, V68, P1221, DOI 10.1016/j.socscimed.2009.01.041; Shem Samuel, 1978, HOUSE GOD; Strauss AL., 1985, SOCIAL ORG MED WORK; Sudnow D., 1967, PASSING SOCIAL ORG D; Tesch R., 1990, QUALITATIVE RES ANAL; WHALEN MR, 1990, LANG SOC, V19, P465, DOI 10.1017/S0047404500014779	19	14	14	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2009	339								b5201	10.1136/bmj.b5201	http://dx.doi.org/10.1136/bmj.b5201			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	534XF	20008442				2022-12-24	WOS:000272930100003
J	Bayes, JJ; Malik, HS				Bayes, Joshua J.; Malik, Harmit S.			Altered Heterochromatin Binding by a Hybrid Sterility Protein in Drosophila Sibling Species	SCIENCE			English	Article							SPECIATION GENE; ODYSSEUS LOCUS; MEIOTIC DRIVE; MELANOGASTER; SPERMATOGENESIS; SEGREGATION; DISTORTION; HOMEOBOX; COMPLEX; ORIGIN	Hybrid sterility of the heterogametic sex is one of the first postzygotic reproductive barriers to evolve during speciation, yet the molecular basis of hybrid sterility is poorly understood. We show that the hybrid male sterility gene Odysseus-site homeobox (OdsH) encodes a protein that localizes to evolutionarily dynamic loci within heterochromatin and leads to their decondensation. In Drosophila mauritiana x Drosophila simulans male hybrids, OdsH from D. mauritiana (OdsHmau) acts as a sterilizing factor by associating with the heterochromatic Y chromosome of D. simulans, whereas D. simulans OdsH (OdsHsim) does not. Characterization of sterile hybrid testes revealed that OdsH abundance and localization in the premeiotic phases of spermatogenesis differ between species. These results reveal that rapid heterochromatin evolution affects the onset of hybrid sterility.	[Bayes, Joshua J.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Bayes, Joshua J.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98185 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; 	NIH [PHS NRSA T32 GM07270, R01-GM74108]; Mathers foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM074108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C-I. Wu for the D. simulans fertile and sterile introgression lines; C. Ting for scientific discussions and sharing data; G. Findlay for initial observations on OdsH cytology; and K. Ahmad, S. Biggins, N. Elde, S. Henikoff, N. Phadnis, T. Tsukiyama, and D. Vermaak for comments on the manuscript. Supported by NIH training grant PHS NRSA T32 GM07270 (J. J. B.), and grants from the Mathers foundation and NIH R01-GM74108 (H. S. M.). H. S. M. is an Early-Career Scientist of the Howard Hughes Medical Institute.	Ashburner M., 2004, DROSOPHILA LAB HDB; Aulner N, 2002, MOL CELL BIOL, V22, P1218, DOI 10.1128/MCB.22.4.1218-1232.2002; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; CENCI G, 1994, J CELL SCI, V107, P3521; Coyne JA, 2004, SPECIATION, V37; Daniel A, 2002, AM J MED GENET, V111, P450, DOI 10.1002/ajmg.10618; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Henikoff S, 2002, NATURE, V417, P227, DOI 10.1038/417227a; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Kliman RM, 2000, GENETICS, V156, P1913; Laurie CC, 1997, GENETICS, V147, P937; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Mayr E., 1942, SYSTEMATICS ORIGIN S; McKee BD, 1998, CURR TOP DEV BIOL, V37, P77; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Nei M, 1998, SCIENCE, V282, P1428, DOI 10.1126/science.282.5393.1428; PEREZ DE, 1993, GENETICS, V134, P261; PEREZ DE, 1995, GENETICS, V140, P201; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; SAWAMURA K, 1993, GENETICS, V133, P307; Sun S, 2004, SCIENCE, V305, P81, DOI 10.1126/science.1093904; Tabuchi K, 1998, NEUROSCI LETT, V257, P49, DOI 10.1016/S0304-3940(98)00799-X; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Ting CT, 2004, P NATL ACAD SCI USA, V101, P12232, DOI 10.1073/pnas.0401975101; Tomkiel JE, 2000, GENETICA, V109, P95, DOI 10.1023/A:1026544402411	28	118	121	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1538	1541		10.1126/science.1181756	http://dx.doi.org/10.1126/science.1181756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	19933102	Green Accepted			2022-12-24	WOS:000272623600058
J	Peile, E				Peile, Ed			Commentary: Learning out of your depth	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Warwick, Warwick Med Sch, Med Teaching Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick	Peile, E (corresponding author), Univ Warwick, Warwick Med Sch, Med Teaching Ctr, Coventry CV4 7AL, W Midlands, England.	ed.peile@warwick.ac.uk						Gopnik A., 2009, PHILOS BABY; OVERTON WF, 1981, INT J BEHAV DEV, V4, P99, DOI 10.1177/016502548100400107; Reuss R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3862; Slotnick HB, 1999, ACAD MED, V74, P1106, DOI 10.1097/00001888-199910000-00014; van Lohuizen MT, 2009, MED TEACH, V31, pE494, DOI 10.3109/01421590902744894	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2009	339								b5180	10.1136/bmj.b5180	http://dx.doi.org/10.1136/bmj.b5180			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007660				2022-12-24	WOS:000272697600007
J	Frihagen, F; Nordsletten, L; Bahr, R				Frihagen, Frede; Nordsletten, Lars; Bahr, Roald			Picture Quiz An 80 year old woman who fell in her home	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIP-FRACTURES; HEMIARTHROPLASTY; OSTEOPOROSIS; DIAGNOSIS; SURGERY		[Frihagen, Frede; Nordsletten, Lars] Oslo Univ Hosp, Orthopaed Ctr, N-0407 Oslo, Norway; [Nordsletten, Lars] Univ Oslo, Fac Med, N-0318 Oslo, Norway; [Bahr, Roald] Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway	University of Oslo; University of Oslo; Norwegian School of Sport Sciences	Frihagen, F (corresponding author), Oslo Univ Hosp, Orthopaed Ctr, N-0407 Oslo, Norway.	j.f.frihagen@medisin.uio.no	Bahr, Roald/B-6964-2014	Frihagen, Frede/0000-0002-4811-669X; Bahr, Roald/0000-0001-5725-4237				Damany DS, 2005, INJURY, V36, P131, DOI 10.1016/j.injury.2004.05.023; Figved W, 2009, CLIN ORTHOP RELAT R, V467, P2426, DOI 10.1007/s11999-008-0672-y; Frihagen F, 2005, ACTA ORTHOP, V76, P524, DOI 10.1080/17453670510041510; Frihagen F, 2007, BMJ-BRIT MED J, V335, P1251, DOI 10.1136/bmj.39399.456551.25; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Parker MJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001708.pub2; Parker MJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001706.pub3; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; PARVIZI J, 1999, CLIN ORTHOP RELAT R, V369, P39; Rogmark C, 2009, INJURY, V40, P274, DOI 10.1016/j.injury.2008.05.023; Woolf AD, 2003, BMJ-BRIT MED J, V327, P89, DOI 10.1136/bmj.327.7406.89	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2009	339								b4839	10.1136/bmj.b4839	http://dx.doi.org/10.1136/bmj.b4839			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NS	19955129				2022-12-24	WOS:000272453300002
J	Kuhner, S; van Noort, V; Betts, MJ; Leo-Macias, A; Batisse, C; Rode, M; Yamada, T; Maier, T; Bader, S; Beltran-Alvarez, P; Castano-Diez, D; Chen, WH; Devos, D; Guell, M; Norambuena, T; Racke, I; Rybin, V; Schmidt, A; Yus, E; Aebersold, R; Herrmann, R; Bottcher, B; Frangakis, AS; Russell, RB; Serrano, L; Bork, P; Gavin, AC				Kuehner, Sebastian; van Noort, Vera; Betts, Matthew J.; Leo-Macias, Alejandra; Batisse, Claire; Rode, Michaela; Yamada, Takuji; Maier, Tobias; Bader, Samuel; Beltran-Alvarez, Pedro; Castano-Diez, Daniel; Chen, Wei-Hua; Devos, Damien; Gueell, Marc; Norambuena, Tomas; Racke, Ines; Rybin, Vladimir; Schmidt, Alexander; Yus, Eva; Aebersold, Ruedi; Herrmann, Richard; Boettcher, Bettina; Frangakis, Achilleas S.; Russell, Robert B.; Serrano, Luis; Bork, Peer; Gavin, Anne-Claude			Proteome Organization in a Genome-Reduced Bacterium	SCIENCE			English	Article							TRANSFER-RNA SYNTHETASES; MYCOPLASMA-PNEUMONIAE; ESCHERICHIA-COLI; INTERACTION MAP; HELICOBACTER-PYLORI; COMPLEX-FORMATION; CELL-CYCLE; PROTEINS; SEQUENCE; DNA	The genome of Mycoplasma pneumoniae is among the smallest found in self-replicating organisms. To study the basic principles of bacterial proteome organization, we used tandem affinity purification-mass spectrometry (TAP-MS) in a proteome-wide screen. The analysis revealed 62 homomultimeric and 116 heteromultimeric soluble protein complexes, of which the majority are novel. About a third of the heteromultimeric complexes show higher levels of proteome organization, including assembly into larger, multiprotein complex entities, suggesting sequential steps in biological processes, and extensive sharing of components, implying protein multifunctionality. Incorporation of structural models for 484 proteins, single-particle electron microscopy, and cellular electron tomograms provided supporting structural details for this proteome organization. The data set provides a blueprint of the minimal cellular machinery required for life.	[Kuehner, Sebastian; van Noort, Vera; Betts, Matthew J.; Leo-Macias, Alejandra; Batisse, Claire; Rode, Michaela; Yamada, Takuji; Bader, Samuel; Beltran-Alvarez, Pedro; Castano-Diez, Daniel; Chen, Wei-Hua; Devos, Damien; Racke, Ines; Rybin, Vladimir; Boettcher, Bettina; Frangakis, Achilleas S.; Russell, Robert B.; Bork, Peer; Gavin, Anne-Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Maier, Tobias; Gueell, Marc; Yus, Eva; Serrano, Luis] Univ Pompeu Fabra, Ctr Regulac Genom, Barcelona 08003, Spain; [Norambuena, Tomas] Pontificia Univ Catolica Chile, Santiago, Chile; [Schmidt, Alexander; Aebersold, Ruedi] ETH, CH-8093 Zurich, Switzerland; [Herrmann, Richard] Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Serrano, Luis] ICREA, Barcelona 08010, Spain	European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pontificia Universidad Catolica de Chile; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg; ICREA	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de; gavin@embl.de	Chen, Weihua/GRS-9256-2022; van Noort, Vera/GWZ-9038-2022; devos, damien/ABH-5348-2020; Güell, Marc/AAB-3054-2021; Beltran-Alvarez, Pedro/AAU-5826-2021; Bork, Peer/F-1813-2013; Güell, Marc/J-2970-2017; van Noort, Vera/E-1053-2011; Russell, Robert/GWU-6389-2022; Bottcher, Bettina/E-9397-2010; Herrmann, Richard/K-2809-2016; Leo-Macias, Alejandra/B-3159-2017; Serrano, Luis/B-3355-2013; Russell, Rob/AAH-9145-2019; Schmidt, Alexander/D-6426-2011	Güell, Marc/0000-0003-4000-7912; Bork, Peer/0000-0002-2627-833X; Güell, Marc/0000-0003-4000-7912; van Noort, Vera/0000-0002-8436-6602; Russell, Robert/0000-0002-7213-1398; Bottcher, Bettina/0000-0002-7962-4849; Herrmann, Richard/0000-0003-2788-3715; Leo-Macias, Alejandra/0000-0002-7579-9764; Serrano, Luis/0000-0002-5276-1392; Russell, Rob/0000-0002-1905-4717; Schmidt, Alexander/0000-0002-3149-2381; Norambuena, Tomas/0000-0001-6477-0301; Gavin, Anne-Claude/0000-0003-4917-2340; Devos, Damien/0000-0002-9453-4753; Frangakis, Achilleas/0000-0002-8067-6611; Chen, Wei-Hua/0000-0003-2168-6147; BATISSE, Claire/0000-0003-3064-6569; Castano-Diez, Daniel/0000-0002-0197-163X; Beltran-Alvarez, Pedro/0000-0001-8136-8963; Betts, Matthew/0000-0003-4583-9814	European Commission; SystemsX.ch, the Swiss initiative for systems biology; Netherlands Organization for Scientific Research (NWO); Foundation Marcelino Botin; Spanish Ministry of Education and Science (MEC)-Consolider; European Research Council; ICREA Funding Source: Custom	European Commission(European CommissionEuropean Commission Joint Research Centre); SystemsX.ch, the Swiss initiative for systems biology; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation Marcelino Botin; Spanish Ministry of Education and Science (MEC)-Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	We are grateful to M. Wilm, T. Franz, F. Thommen, E. Dalton, M. Schulz, E. Sawa, M. Diepholz, E. Pirkl, A. Seybert, C. Davis, J. Stulke, Gavin's and Bork's groups, and the EMBL Proteomic and Gene Core Facilities for expert help and discussion. This work is in part supported by the European Commission 6th and 7th Framework Integrated Projects "3D-Repertoire" and "Prospects," respectively; SystemsX.ch, the Swiss initiative for systems biology; the Netherlands Organization for Scientific Research (NWO); the Foundation Marcelino Botin; the Spanish Ministry of Education and Science (MEC)-Consolider; and the European Research Council. The data set has been submitted to the International Molecular Exchange Consortium (http://imex.sf.net) through IntAct (pmid is 17145710; identifier is IM-11644). The electron microscopy maps have been submitted to the Electron Microscopy Data Bank (www.ebi.ac.uk/pdbe-srv/emsearch/) (identification codes EMD-1637, EMD-1638, and EMD-1639).	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bork P, 2005, CELL, V121, P507, DOI 10.1016/j.cell.2005.05.001; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim DS, 2005, J CERAM PROCESS RES, V6, P63; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Praetorius-Ibba M, 2007, J BIOL CHEM, V282, P3680, DOI 10.1074/jbc.M609988200; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Resing KA, 2004, ANAL CHEM, V76, P3556, DOI 10.1021/ac035229m; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Seto S, 2001, J BACTERIOL, V183, P1621, DOI 10.1128/JB.183.5.1621-1630.2001; Seybert A, 2006, J STRUCT BIOL, V156, P342, DOI 10.1016/j.jsb.2006.04.010; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terradot L, 2004, MOL CELL PROTEOMICS, V3, P809, DOI 10.1074/mcp.M400048-MCP200; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Wright R, 1996, GENE DEV, V10, P1532, DOI 10.1101/gad.10.12.1532; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; ZECHIEDRICH EL, 1995, GENE DEV, V9, P2859, DOI 10.1101/gad.9.22.2859; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	48	356	360	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1235	1240		10.1126/science.1176343	http://dx.doi.org/10.1126/science.1176343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965468				2022-12-24	WOS:000272117900040
J	Fang, C; Frontiera, RR; Tran, R; Mathies, RA				Fang, Chong; Frontiera, Renee R.; Tran, Rosalie; Mathies, Richard A.			Mapping GFP structure evolution during proton transfer with femtosecond Raman spectroscopy	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; EXCITED-STATE DYNAMICS; STIMULATED RAMAN; MOLECULAR-DYNAMICS; AEQUOREA; ISOMERIZATION; PERTURBATION; VISION; LIGHT	Tracing the transient atomic motions that lie at the heart of chemical reactions requires high-resolution multidimensional structural information on the timescale of molecular vibrations, which commonly range from 10 fs to 1 ps. For simple chemical systems, it has been possible to map out in considerable detail the reactive potential-energy surfaces describing atomic motions and resultant reaction dynamics(1), but such studies remain challenging for complex chemical and biological transformations(2). A case in point is the green fluorescent protein (GFP)(3-5) from the jellyfish Aequorea victoria, which is a widely used gene expression marker owing to its efficient bioluminescence. This feature is known to arise from excited-state proton transfer (ESPT)(6-8), yet the atomistic details of the process are still not fully understood. Here we show that femtosecond stimulated Raman spectroscopy(9,10) provides sufficiently detailed and time-resolved vibrational spectra of the electronically excited chromophore of GFP to reveal skeletal motions involved in the proton transfer that produces the fluorescent form of the protein. In particular, we observe that the frequencies and intensities of two marker bands, the C-O and C=N stretching modes at opposite ends of the conjugated chromophore, oscillate out of phase with a period of 280 fs; we attribute these oscillations to impulsively excited low-frequency phenoxyl-ring motions, which optimize the geometry of the chromophore for ESPT. Our findings illustrate that femtosecond simulated Raman spectroscopy is a powerful approach to revealing the real-time nuclear dynamics that make up a multidimensional polyatomic reaction coordinate.	[Fang, Chong; Frontiera, Renee R.; Tran, Rosalie; Mathies, Richard A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mathies, RA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	ramathies@berkeley.edu	Frontiera, Renee/D-8131-2011; Fang, Chong/D-3681-2009	Fang, Chong/0000-0002-8879-1825; Frontiera, Renee/0000-0001-8218-7574	Mathies Royalty Fund	Mathies Royalty Fund	Plasmids were provided by R. Wachter. Wethank M. Marletta for the use of his laboratory facilities to express and purify GFP samples. We thank J. Dasgupta for discussions. This work was supported by the Mathies Royalty Fund.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Cerullo G, 2002, SCIENCE, V298, P2395, DOI 10.1126/science.1074685; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Coe JD, 2007, J PHYS CHEM A, V111, P11302, DOI 10.1021/jp072027b; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; *GAUSS INC, 2004, GAUSS 03; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KASHA M, 1986, J CHEM SOC FARAD T 2, V82, P2379, DOI 10.1039/f29868202379; Kennis JTM, 2004, P NATL ACAD SCI USA, V101, P17988, DOI 10.1073/pnas.0404262102; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Kukura P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238303; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Levine BG, 2007, ANNU REV PHYS CHEM, V58, P613, DOI 10.1146/annurev.physchem.57.032905.104612; Maddalo SL, 2006, PHOTOCHEM PHOTOBIOL, V82, P367, DOI 10.1562/2005-04-11-RA-485; Mandal D, 2004, J PHYS CHEM B, V108, P1102, DOI 10.1021/jp035816b; McCamant DW, 2005, J PHYS CHEM B, V109, P10449, DOI 10.1021/jp050095x; McCamant DW, 2004, REV SCI INSTRUM, V75, P4971, DOI 10.1063/1.1807566; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Shim S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356318; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Stoner-Ma D, 2006, J PHYS CHEM B, V110, P22009, DOI 10.1021/jp065326u; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; Weber W, 1999, P NATL ACAD SCI USA, V96, P6177, DOI 10.1073/pnas.96.11.6177; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; ZEWAIL AH, 1994, FEMTOCHEMISTRY ULTRA, P217; ZHU LY, 1994, SCIENCE, V266, P629, DOI 10.1126/science.7939716	29	354	361	3	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					200	U74		10.1038/nature08527	http://dx.doi.org/10.1038/nature08527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907490				2022-12-24	WOS:000271655100039
J	Dise, NB				Dise, Nancy B.			Peatland Response to Global Change	SCIENCE			English	Editorial Material							CARBON; GROWTH		Manchester Metropolitan Univ, Dept Geog & Environm Sci, Manchester M1 5GD, Lancs, England	Manchester Metropolitan University	Dise, NB (corresponding author), Manchester Metropolitan Univ, Dept Geog & Environm Sci, John Dalton Bldg,Chester St, Manchester M1 5GD, Lancs, England.	n.dise@mmu.ac.uk			NERC [NE/G002363/1] Funding Source: UKRI; Natural Environment Research Council [NE/G002363/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Belyea LR, 2006, ECOL MONOGR, V76, P299, DOI 10.1890/0012-9615(2006)076[0299:BTLTPB]2.0.CO;2; Belyea LR, 2004, GLOBAL CHANGE BIOL, V10, P1043, DOI 10.1111/j.1529-8817.2003.00783.x; Bridgham SD, 2008, ECOLOGY, V89, P3041, DOI 10.1890/08-0279.1; Frolking S, 2007, GLOBAL CHANGE BIOL, V13, P1079, DOI 10.1111/j.1365-2486.2007.01339.x; Limpens J, 2008, BIOGEOSCIENCES, V5, P1475, DOI 10.5194/bg-5-1475-2008; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Strack M, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002715; SVENSSON G, 1988, BOREAS, V17, P89; Tomassen HBM, 2003, J ECOL, V91, P357, DOI 10.1046/j.1365-2745.2003.00771.x; Turetsky MR, 2007, GLOBAL CHANGE BIOL, V13, P1922, DOI 10.1111/j.1365-2486.2007.01381.x	11	225	235	13	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					810	811		10.1126/science.1174268	http://dx.doi.org/10.1126/science.1174268			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892972				2022-12-24	WOS:000271468000030
J	Achard, C; Courtillot, C; Lahuna, O; Meduri, G; Soufir, JC; Liere, P; Bachelot, A; Benyounes, H; Schumacher, M; Kuttenn, F; Touraine, P; Misrahi, M				Achard, Caroline; Courtillot, Carine; Lahuna, Olivier; Meduri, Geri; Soufir, Jean-Claude; Liere, Philippe; Bachelot, Anne; Benyounes, Hassani; Schumacher, Michael; Kuttenn, Frederique; Touraine, Philippe; Misrahi, Micheline			Brief Report: Normal Spermatogenesis in a Man with Mutant Luteinizing Hormone.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOLLICLE-STIMULATING-HORMONE; MALE CONTRACEPTION; BETA-SUBUNIT; HYPOGONADISM; TESTOSTERONE; GONADOTROPIN; MEN; SUFFICIENT; INSIGHTS; MUTATION	Men with mutations in LHB, the gene encoding the beta subunit of luteinizing hormone (LHB), have azoospermia with absent or few fetal Leydig cells. We report a mutation in LHB in a man and his sister. The man presented with absence of virilization, undetectable luteinizing hormone, and a low serum testosterone level. He had complete spermatogenesis with a normal sperm count. The mutant luteinizing hormone had a low level of partial activity in vitro. We concluded that the residual luteinizing hormone activity, resulting in the expression of steroidogenic enzymes in few mature Leydig cells producing small amounts of intratesticular testosterone (20.2 ng per gram), was sufficient for complete and quantitatively normal spermatogenesis.	[Misrahi, Micheline] Hop Bicetre, AP HP, Lab Mol Genet Pharmacol & Hormonol, INSERM,U854, F-94275 Le Kremlin Bicetre, France; [Soufir, Jean-Claude] Hop Bicetre, Lab Biol Androl, F-94275 Le Kremlin Bicetre, France; [Liere, Philippe; Schumacher, Michael] Hop Bicetre, INSERM, U788, F-94275 Le Kremlin Bicetre, France; [Achard, Caroline; Lahuna, Olivier; Misrahi, Micheline] Univ Paris S 11, INSERM, Bicetre Hosp, U854, Le Kremlin Bicetre, France; [Courtillot, Carine; Bachelot, Anne; Kuttenn, Frederique; Touraine, Philippe] Univ Paris 06, Dept Endocrinol & Reprod Med, Pitie Salpetriere Hosp, Paris, France; [Courtillot, Carine; Bachelot, Anne; Kuttenn, Frederique; Touraine, Philippe] Ctr Malad Endocriniennes Rares Croissance, Paris, France; [Lahuna, Olivier; Soufir, Jean-Claude; Misrahi, Micheline] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Misrahi, M (corresponding author), Hop Bicetre, AP HP, Lab Mol Genet Pharmacol & Hormonol, INSERM,U854, F-94275 Le Kremlin Bicetre, France.	micheline.misrahi@bct.aphp.fr	Schumacher, Michael/G-3581-2013; lahuna, olivier/O-7840-2017; Bachelot, Anne/GQZ-0551-2022	Schumacher, Michael/0000-0001-6117-5371; lahuna, olivier/0000-0002-6286-3923; 	INSERM; Socete Francaise d'Endocrinologie, Assistance Publique-H pitaux de Paris; French Ministry of Health (DHOS)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Socete Francaise d'Endocrinologie, Assistance Publique-H pitaux de Paris; French Ministry of Health (DHOS)	Supported by grants from INSERM, the Socete Francaise d'Endocrinologie, Assistance Publique-H pitaux de Paris, and the French Ministry of Health (DHOS).	Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Bougneres P, 2008, J CLIN ENDOCR METAB, V93, P2202, DOI 10.1210/jc.2008-0121; Coviello AD, 2004, J ANDROL, V25, P931; DALY AF, 2006, ANN M END SOC BOST J; Dohle GR, 2003, WORLD J UROL, V21, P341, DOI 10.1007/s00345-003-0365-9; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Huhtaniemi IT, 2005, ENDOCRINE, V26, P207, DOI 10.1385/ENDO:26:3:207; Kamischke A, 2004, TRENDS PHARMACOL SCI, V25, P49, DOI 10.1016/j.tips.2003.11.009; Lewis G, 2009, EUR J WOMENS STUD, V16, P5, DOI 10.1177/1350506808098531; Lofrano-Porto A, 2007, NEW ENGL J MED, V357, P897, DOI 10.1056/NEJMoa071999; Lombardo F, 2005, J Endocrinol Invest, V28, P51; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; McLachlan RI, 2002, J ANDROL, V23, P149; Meduri G, 2008, MOL CELL ENDOCRINOL, V282, P130, DOI 10.1016/j.mce.2007.11.027; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Page ST, 2008, ENDOCR REV, V29, P465, DOI 10.1210/er.2007-0041; Plant TM, 2001, ENDOCR REV, V22, P764, DOI 10.1210/er.22.6.764; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; Valdes-Socin H, 2004, NEW ENGL J MED, V351, P2619, DOI 10.1056/NEJMoa040326; Valdes-Socin H, 2009, J CLIN ENDOCR METAB, V94, P3, DOI 10.1210/jc.2008-1584; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; Wu XF, 2007, J CELL PHYSIOL, V213, P429, DOI 10.1002/jcp.21231; Zhang FP, 2003, P NATL ACAD SCI USA, V100, P13692, DOI 10.1073/pnas.2232815100	24	41	44	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1856	1863		10.1056/NEJMoa0805792	http://dx.doi.org/10.1056/NEJMoa0805792			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890128				2022-12-24	WOS:000271405800010
J	Daley, L; Gordon, J; Weston, C; Webb-Peploe, K				Daley, Liana; Gordon, Jackie; Weston, Charlotte; Webb-Peploe, Kathy			A Patient's Journey Cardiomyopathy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gordon, Jackie; Weston, Charlotte] Worthing Dist Hosp, Mental Hlth Liaison Team, Worthing BN11 2DH, England		Gordon, J (corresponding author), Worthing Dist Hosp, Mental Hlth Liaison Team, Worthing BN11 2DH, England.	Jackie.Gordon@sussexpartnership.nhs.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2009	339								b4210	10.1136/bmj.b4210	http://dx.doi.org/10.1136/bmj.b4210			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AI	19858173				2022-12-24	WOS:000271365300004
J	Lavallo, V; Grubbs, RH				Lavallo, Vincent; Grubbs, Robert H.			Carbenes As Catalysts for Transformations of Organometallic Iron Complexes	SCIENCE			English	Article							N-HETEROCYCLIC CARBENES; OLEFIN-METATHESIS CATALYSTS; STABLE COMPOUND; ACTIVATION; CHEMISTRY; BOND; NHC	Compared with the enormous arsenal of catalysts used to produce organic compounds, complementary species that are able to mediate sophisticated organometallic transformations are virtually nonexistent. We found that stable N-heterocyclic carbenes (NHCs) can mediate unusual organometallic transformations in solution at room temperature. Depending on the choice of NHC initiator, stoichiometric or catalytic reactions of bis(cyclooctatetraene) iron [Fe(COT)(2)] ensue. The stoichiometric reaction leads to the isolation of a previously unknown mixed-valent species, featuring distinct and directly bonded Fe(0) and Fe(1) centers. In the catalytic process, three iron atoms are fused to afford the tri-iron cluster Fe-3(COT)(3), which is a hydrocarbon analog of Dewar's classic Fe-3(CO)(12) complex. The key step in both of these processes is proposed to involve the NHC's ability to induce metal-metal bond formation. These NHC-mediated reactions provide a foundation on which to develop future organometallic transformations that are catalyzed by organic species.	[Lavallo, Vincent; Grubbs, Robert H.] CALTECH, Arnold & Mabel Beckman Lab Chem Synth, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Grubbs, RH (corresponding author), CALTECH, Arnold & Mabel Beckman Lab Chem Synth, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	rhg@caltech.edu	grubbs, robert h/D-4293-2009	grubbs, robert h/0000-0002-0057-7817	NIH [5RO1 GM31332]; National Research Service Award Postdoctoral Fellowship; NSF [CHE-0639094];  [CCDC-724011];  [CCDC-728138]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM085916, R01GM031332] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge financial support from NIH for grant 5RO1 GM31332 and a National Research Service Award Postdoctoral Fellowship ( to V. L.). We thank L. M. Henling and M. W. Day ( California Institute of Technology) for x- ray crystallographic analysis. The Bruker KAPPA APEX II x-ray diffractometer was purchased via an NSF Chemistry Research Instrumentation and Facilities: Multi-User award to the California Institute of Technology, CHE-0639094. Crystallographic data for complexes 3 and 8 are available free of charge from the Cambridge Crystallographic Data Center under reference numbers CCDC-724011 and CCDC-728138, respectively.	Alcarazo M, 2009, NAT CHEM, V1, P295, DOI [10.1038/NCHEM.248, 10.1038/nchem.248]; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; Bolm C, 2004, CHEM REV, V104, P6217, DOI 10.1021/cr040664h; BRESLOW R, 1959, J AM CHEM SOC, V81, P3080, DOI 10.1021/ja01521a042; CARBONARO A, 1969, J ORGANOMET CHEM, V20, P177, DOI 10.1016/S0022-328X(00)80103-5; Clement ND, 2006, ORGANOMETALLICS, V25, P4155, DOI 10.1021/om0602759; Crabtree RH, 2007, COORDIN CHEM REV, V251, P595, DOI 10.1016/j.ccr.2006.08.005; Culkin DA, 2007, ANGEW CHEM INT EDIT, V46, P2627, DOI 10.1002/anie.200604740; Darensbourg MY, 2003, P NATL ACAD SCI USA, V100, P3683, DOI 10.1073/pnas.0536955100; DESIDERATO R, 1982, J CHEM EDUC, V59, P752, DOI 10.1021/ed059p752; Dorta R, 2005, J AM CHEM SOC, V127, P2485, DOI 10.1021/ja0438821; Dyson P. J., 2000, TRANSITION METAL CAR; ENDERS D, 1995, ANGEW CHEM INT EDIT, V34, P1021, DOI 10.1002/anie.199510211; Enders D, 2008, J ORG CHEM, V73, P7857, DOI 10.1021/jo801374j; FELKIN H, 1978, J ORGANOMET CHEM, V157, pC64, DOI 10.1016/S0022-328X(00)94034-8; Frey GD, 2007, SCIENCE, V316, P439, DOI 10.1126/science.1141474; Furstner A, 2009, ANGEW CHEM INT EDIT, V48, P1364, DOI 10.1002/anie.200805728; GERLACH DH, 1974, INORG SYNTH, V15, P2; Green SP, 2007, SCIENCE, V318, P1754, DOI 10.1126/science.1150856; Grubbs RH, 2006, ANGEW CHEM INT EDIT, V45, P3760, DOI 10.1002/anie.200600680; Hahn FE, 2008, ANGEW CHEM INT EDIT, V47, P3122, DOI 10.1002/anie.200703883; Hess CR, 2009, ANGEW CHEM INT EDIT, V48, P3703, DOI 10.1002/anie.200900725; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Kaufhold O, 2008, ANGEW CHEM INT EDIT, V47, P4057, DOI 10.1002/anie.200800846; Lavallo V, 2006, ANGEW CHEM INT EDIT, V45, P3488, DOI 10.1002/anie.200600987; Le Floch P, 1998, EUR J INORG CHEM, P119; MACKENZI.R, 1974, J CHEM SOC CHEM COMM, P650, DOI 10.1039/c39740000650; Marion N, 2007, ANGEW CHEM INT EDIT, V46, P2988, DOI 10.1002/anie.200603380; Masuda JD, 2007, ANGEW CHEM INT EDIT, V46, P7052, DOI 10.1002/anie.200703055; Nguyen T, 2005, SCIENCE, V310, P844, DOI 10.1126/science.1116789; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Resa I, 2004, SCIENCE, V305, P1136, DOI 10.1126/science.1101356; Samojlowicz C, 2009, CHEM REV, V109, P3708, DOI 10.1021/cr800524f; Schuster O, 2009, CHEM REV, V109, P3445, DOI 10.1021/cr8005087; Sherry BD, 2008, ACCOUNTS CHEM RES, V41, P1500, DOI 10.1021/ar800039x; Vignolle J, 2009, CHEM REV, V109, P3333, DOI 10.1021/cr800549j; Wang YZ, 2008, SCIENCE, V321, P1069, DOI 10.1126/science.1160768	38	86	86	4	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					559	562		10.1126/science.1178919	http://dx.doi.org/10.1126/science.1178919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	509LN	19900894	Green Accepted			2022-12-24	WOS:000271019400037
J	Ramachandran, A; Ma, RCW; Snehalatha, C				Ramachandran, Ambady; Ma, Ronald Ching Wan; Snehalatha, Chamukuttan			Diabetes in Asia	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR RISK-FACTORS; GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; HIGH PREVALENCE; INSULIN-RESISTANCE; TCF7L2 GENE; HONG-KONG; PREVENTION PROGRAM; URBAN-POPULATION	Prevalence of type 2 diabetes has rapidly increased in native and migrant Asian populations. Diabetes develops at a younger age in Asian populations than in white populations, hence the morbidity and mortality associated with the disease and its complications are also common in young Asian people. The young age of these populations and the high rates of cardiovascular risk factors seen in Asian people substantially increase lifetime risk of cardiovascular disease. Several distinctive features are apparent in pathogenetic factors for diabetes and their thresholds in Asian populations. The economic burden due to diabetes at personal, societal, and national levels is huge. National strategies to raise public awareness about the disease and to improve standard of care and implementation of programmes for primary prevention are urgently needed.	[Ramachandran, Ambady; Snehalatha, Chamukuttan] India Diabet Res Fdn, Madras 600008, Tamil Nadu, India; [Ramachandran, Ambady; Snehalatha, Chamukuttan] Dr A Ramachandrans Diabet Hosp, Madras 600008, Tamil Nadu, India; [Ma, Ronald Ching Wan] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ramachandran, A (corresponding author), India Diabet Res Fdn, Madras 600008, Tamil Nadu, India.	ramachandran@vsnl.com	Ma, Ronald/C-2788-2009	Ma, Ronald/0000-0002-1227-803X	Department of Medicine and Therapeutics, Chinese University of Hong Kong; Research Grants Council of Hong Kong [CUHK4724/07M]; Government of the Hong Kong Special Administrative Region [ITS/088/08]	Department of Medicine and Therapeutics, Chinese University of Hong Kong(Chinese University of Hong Kong); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Government of the Hong Kong Special Administrative Region	We drank S Selvam and C J Thirupurasundari for help with compiling the references, L Vijaya and A Bobby for secretarial assistance, I Chan for her helpful comments, and J C Florez for permission to reproduce figure 2. RM acknowledges research funding support from the research fund of the Department of Medicine and Therapeutics, Chinese University of Hong Kong, the Research Grants Council of Hong Kong (CUHK4724/07M), and the Innovation and Technology Fund of the Government of the Hong Kong Special Administrative Region (ITS/088/08).	Abate N, 2004, J CLIN ENDOCR METAB, V89, P2750, DOI 10.1210/jc.2003-031843; Abate N, 2007, INDIAN J MED RES, V125, P251; AbuSayeed M, 1997, DIABETES RES CLIN PR, V34, P149, DOI 10.1016/S0168-8227(96)01337-X; Aekplakorn W, 2003, DIABETES CARE, V26, P2758, DOI 10.2337/diacare.26.10.2758; Aekplakorn W, 2007, DIABETES CARE, V30, P2007, DOI 10.2337/dc06-2319; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; [Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; Baltazar JC, 2004, DIABETES RES CLIN PR, V64, P107, DOI 10.1016/j.diabres.2003.10.013; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bodhini D, 2007, METABOLISM, V56, P1174, DOI 10.1016/j.metabol.2007.04.012; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; CHAN JC, 2008, EPIDEMIOLOGY DIABETE, P179; Chan JCN, 1997, DIABETES CARE, V20, P1785, DOI 10.2337/diacare.20.11.1785; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Chang C, 2009, BIOMARK MED, V3, P33, DOI 10.2217/17520363.3.1.33; Chang YC, 2007, DIABETES, V56, P2631, DOI 10.2337/db07-0421; Chi ZS, 2001, DIABETOLOGIA, V44, pS82, DOI 10.1007/PL00002944; Chin K, 1996, CIRCULATION, V100, P706; COCKRAM CS, 1993, DIABETES RES CLIN PR, V21, P67, DOI 10.1016/0168-8227(93)90099-Q; de Courten M, 1997, INT TXB DIABETES MEL, P143; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; Ehtisham S, 2000, DIABETIC MED, V17, P867, DOI 10.1046/j.1464-5491.2000.00409.x; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Florez JC, 2008, J CLIN ENDOCR METAB, V93, P4633, DOI 10.1210/jc.2008-1345; Forouhi NG, 1999, DIABETOLOGIA, V42, P932, DOI 10.1007/s001250051250; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gill T, 2007, DIABETES VOICE, V52, P20; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; International Diabetes Federation (IDF), 2006, DEF DIAGN DIAB MELL; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; JARVINEN HY, 2002, J ROY SOC MED, V95, P39; Joshi Shashank R, 2003, J Assoc Physicians India, V51, P445; Kapur A, 2007, INDIAN J MED RES, V125, P473; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Kawate R, 1979, Diabetes Care, V2, P161, DOI 10.2337/diacare.2.2.161; Kim SM, 2006, DIABETES CARE, V29, P226, DOI 10.2337/diacare.29.02.06.dc05-0481; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Ko GTC, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-10; Lee WRW, 2000, DIABETES RES CLIN PR, V50, pS35, DOI 10.1016/S0168-8227(00)00184-4; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Leon DA, 2008, INT J EPIDEMIOL, V37, P4, DOI 10.1093/ije/dym271; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 1996, CHINESE MED J-PEKING, V109, P599; Li Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240802376389; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Ma RCW, 2009, INT J GYNECOL OBSTET, V104, pS42, DOI 10.1016/j.ijgo.2008.11.032; Mafauzy M, 1999, Asia Pac J Public Health, V11, P16, DOI 10.1177/101053959901100104; MARGUERITE J, 2008, EPIDEMIOLOGY DIABETE, P323; Martin M, 2008, DIABETES CARE, V31, P798, DOI 10.2337/dc07-1781; MCKEIGUE PM, 1992, DIABETOLOGIA, V35, P785; *MIN HLTH MAL, 1985, NAT HLTH MORB SURV, V1; *MIN HLTH MAL, 1996, NAT HLTH MORB SURV, V2; Misra A, 2006, DIABETES RES CLIN PR, V71, P101, DOI 10.1016/j.diabres.2005.06.006; Misra A, 2009, J Assoc Physicians India, V57, P163; MISRA A, 2001, INT J OBESITY, V125, P1722; Mohan V, 2006, DIABETOLOGIA, V49, P1175, DOI 10.1007/s00125-006-0219-2; MOHAN V, 1985, DIABETES CARE, V8, P371, DOI 10.2337/diacare.8.4.371; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Murugesan N, 2007, DIABETES RES CLIN PR, V77, P433, DOI 10.1016/j.diabres.2007.01.004; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Ng MCY, 2001, DIABETES CARE, V24, P663, DOI 10.2337/diacare.24.4.663; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Radha V, 2006, DIABETES CARE, V29, P1046, DOI 10.2337/dc05-1473; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2004, DIABETOLOGIA, V47, P860, DOI 10.1007/s00125-004-1387-6; Ramachandran A, 2003, DIABETES CARE, V26, P1022, DOI 10.2337/diacare.26.4.1022; RAMACHANDRAN A, 1988, BRIT MED J, V297, P587, DOI 10.1136/bmj.297.6648.587; RAMACHANDRAN A, 1992, DIABETES CARE, V15, P1348, DOI 10.2337/diacare.15.10.1348; Ramachandran A, 2002, DIABETIC MED, V19, P130, DOI 10.1046/j.1464-5491.2002.00656.x; Ramachandran A, 1997, DIABETOLOGIA, V40, P232, DOI 10.1007/s001250050668; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Ramachandran A, 1998, DIABETES CARE, V21, P666, DOI 10.2337/diacare.21.4.666; RAMACHANDRAN A, 1987, J MED ASS THAI, V2, P180; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Ramachandran A, 2007, DIABETES CARE, V30, P1828, DOI 10.2337/dc06-2097; Ramachandran A, 2007, DIABETES CARE, V30, P252, DOI 10.2337/dc06-0144; Retnakaran R, 2006, DIABETES CARE, V29, P1950, DOI 10.2337/dc06-0867; Sakamoto Y, 2007, J HUM GENET, V52, P781, DOI 10.1007/s10038-007-0190-x; SAMRAGE SM, 1995, THESIS U COLOMBO; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Sayeed MA, 2003, DIABETES CARE, V26, P1034, DOI 10.2337/diacare.26.4.1034; Shera AS, 2007, DIABETES RES CLIN PR, V76, P219, DOI 10.1016/j.diabres.2006.08.011; Shera AS, 1999, DIABETES RES CLIN PR, V44, P49, DOI 10.1016/S0168-8227(99)00017-0; Sicree R, 2006, DIABETES ATLAS, V3, P16; Sicree R, 2003, DIABETES ATLAS; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Snehalatha C, 2000, DIABETES RES CLIN PR, V47, P129, DOI 10.1016/S0168-8227(99)00109-6; Snehalatha C, 2003, DIABETES CARE, V26, P3226, DOI 10.2337/diacare.26.12.3226; Snehalatha C, 1997, METABOLISM, V46, P1220, DOI 10.1016/S0026-0495(97)90221-3; Snehalatha C, 2000, DIABETES RES CLIN PR, V48, P57, DOI 10.1016/S0168-8227(99)00136-9; Snehalatha C, 1998, DIABETES CARE, V21, P76, DOI 10.2337/diacare.21.1.76; Snehalatha C, 2008, DIABETES CARE, V31, P2374, DOI 10.2337/dc08-1083; Son LENTD, 2004, DIABETIC MED, V21, P371, DOI 10.1111/j.1464-5491.2004.01159.x; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tam WH, 2008, PEDIATRICS, V122, P1229, DOI 10.1542/peds.2008-0158; Taylor R, 2008, DIABETOLOGIA, V51, P1781, DOI 10.1007/s00125-008-1116-7; Tian HG, 2009, DIABETES RES CLIN PR, V84, P273, DOI 10.1016/j.diabres.2009.03.015; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; UN, WORLD POP PROSP 2007; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Viswanathan M, 1996, DIABETIC MED, V13, P232, DOI 10.1002/(SICI)1096-9136(199603)13:3<232::AID-DIA27>3.0.CO;2-7; Wang K, 1998, Zhonghua Liu Xing Bing Xue Za Zhi, V19, P282; Wei JN, 2003, JAMA-J AM MED ASSOC, V290, P1345, DOI 10.1001/jama.290.10.1345; WHO, 2004, LANCET, V363, P902; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolk R, 2007, EXP PHYSIOL, V92, P67, DOI 10.1113/expphysiol.2006.033787; World Health Organization, 2004, WORLD HLTH REP 2004; Wu AYT, 2005, DIABETOLOGIA, V48, P17, DOI 10.1007/s00125-004-1599-9; Wu DM, 2001, INT J OBESITY, V25, P1189, DOI 10.1038/sj.ijo.0801679; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhai F, 2008, OBES REV, V9, P107, DOI 10.1111/j.1467-789X.2007.00450.x; Zhao HL, 2003, DIABETES, V52, P2759, DOI 10.2337/diabetes.52.11.2759; 1996, P 3 INT DIAB FED W P, P91	140	512	521	0	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2010	375	9712					408	418		10.1016/S0140-6736(09)60937-5	http://dx.doi.org/10.1016/S0140-6736(09)60937-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552PK	19875164				2022-12-24	WOS:000274305500028
J	Blosser, TR; Yang, JG; Stone, MD; Narlikar, GJ; Zhuang, XW				Blosser, Timothy R.; Yang, Janet G.; Stone, Michael D.; Narlikar, Geeta J.; Zhuang, Xiaowei			Dynamics of nucleosome remodelling by individual ACF complexes	NATURE			English	Article							DNA TRANSLOCATION; SINGLE-MOLECULE; HISTONE OCTAMER; ENERGY-TRANSFER; CORE PARTICLE; CHROMATIN; ISWI; SWI/SNF; MECHANISM; CATALYSIS	The ATP-dependent chromatin assembly and remodelling factor (ACF) functions to generate regularly spaced nucleosomes, which are required for heritable gene silencing. The mechanism by which ACF mobilizes nucleosomes remains poorly understood. Here we report a single-molecule FRET study that monitors the remodelling of individual nucleosomes by ACF in real time, revealing previously unknown remodelling intermediates and dynamics. In the presence of ACF and ATP, the nucleosomes exhibit gradual translocation along DNA interrupted by well-defined kinetic pauses that occurred after approximately seven or three to four base pairs of translocation. The binding of ACF, translocation of DNA and exiting of translocation pauses are all ATP-dependent, revealing three distinct functional roles of ATP during remodelling. At equilibrium, a continuously bound ACF complex can move the nucleosome back-and-forth many times before dissociation, indicating that ACF is a highly processive and bidirectional nucleosome translocase.	[Blosser, Timothy R.; Stone, Michael D.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Blosser, Timothy R.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Yang, Janet G.; Narlikar, Geeta J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94107 USA; [Stone, Michael D.; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; University of California System; University of California San Francisco; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	geeta.narlikar@ucsf.edu; zhuang@chemistry.harvard.edu	Yang, Janet/P-2003-2015		Howard Hughes Medical Institute; National Institutes of Health [GM073767]; Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073767] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Widom for providing the plasmid containing the 601 positioning sequence and R. E. Kingston for the plasmids containing the SNF2h and Acf1 genes. We also thank L. Racki and E. Abbondanzieri for helpful discussions, and W. Huang and B. Harada for help with some experiments. This work is supported in part by Howard Hughes Medical Institute ( to X. Z.) and the National Institutes of Health (GM073767) and the Beckman Foundation ( to G. J. N). X. Z. is a Howard Hughes Medical Institute investigator. M. D. S. was a NIH Ruth L. Kirschstein NSRA Fellow, G. J. N is a Leukemia and Lymphoma Society Scholar.	Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Partensky PD, 2009, J MOL BIOL, V391, P12, DOI 10.1016/j.jmb.2009.04.085; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	41	141	143	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1022	U79		10.1038/nature08627	http://dx.doi.org/10.1038/nature08627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033040	Green Submitted, Green Accepted			2022-12-24	WOS:000272996000039
J	Tao, X; Avalos, JL; Chen, JY; MacKinnon, R				Tao, Xiao; Avalos, Jose L.; Chen, Jiayun; MacKinnon, Roderick			Crystal Structure of the Eukaryotic Strong Inward-Rectifier K+ Channel Kir2.2 at 3.1 angstrom Resolution	SCIENCE			English	Article							POTASSIUM CHANNEL; INTRACELLULAR SPERMINE; VENTRICULAR CELLS; CYTOPLASMIC PORE; ION SELECTIVITY; DISULFIDE BOND; INNER PORE; RECTIFICATION; BLOCK; POLYAMINES	Inward-rectifier potassium (K+) channels conduct K+ ions most efficiently in one direction, into the cell. Kir2 channels control the resting membrane voltage in many electrically excitable cells, and heritable mutations cause periodic paralysis and cardiac arrhythmia. We present the crystal structure of Kir2.2 from chicken, which, excluding the unstructured amino and carboxyl termini, is 90% identical to human Kir2.2. Crystals containing rubidium (Rb+), strontium (Sr2+), and europium (Eu3+) reveal binding sites along the ion conduction pathway that are both conductive and inhibitory. The sites correlate with extensive electrophysiological data and provide a structural basis for understanding rectification. The channel's extracellular surface, with large structured turrets and an unusual selectivity filter entryway, might explain the relative insensitivity of eukaryotic inward rectifiers to toxins. These same surface features also suggest a possible approach to the development of inhibitory agents specific to each member of the inward-rectifier K+ channel family.	[Tao, Xiao; Avalos, Jose L.; Chen, Jiayun; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu		Avalos, Jose L./0000-0002-7209-4208	Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Hoff and members of D. Gadsby's laboratory (Rockefeller University) for assistance with oocyte preparation; R. Molday ( University of British Columbia) for providing the anti-1D4 tag cell line; K. R. Rajashankar and K. Perry at beamline 24ID-C (Advanced Photon Source, Argonne National Laboratory) and H. Robinson at beamline X29 (National Synchrotron Light Source, Brookhaven National Laboratory) for assistance at the synchrotron; members of the MacKinnon laboratory for assistance; and A. Banerjee, J. Butterwick, M. Whorton, and J. Chen (Purdue University) for comments on the manuscript. J. L. A. was a fellow of the Damon Runyon Cancer Research Foundation. R. M. is an investigator in the Howard Hughes Medical Institute. The x-ray crystallographic coordinates and structure factor files have been deposited in the Protein Data Bank with accession ID 3JYC.	Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Cotton A. F., 1988, ADV INORGANIC CHEM; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Felix JP, 2006, BIOCHEMISTRY-US, V45, P10129, DOI 10.1021/bi060509s; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Garcia M L, 1999, Methods Enzymol, V294, P624; Guo DL, 2000, J GEN PHYSIOL, V115, P799, DOI 10.1085/jgp.115.6.799; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Guo DL, 2001, J GEN PHYSIOL, V117, P395, DOI 10.1085/jgp.117.5.395; HAGIWARA S, 1979, J PHYSIOL-LONDON, V292, P251, DOI 10.1113/jphysiol.1979.sp012849; Harvey AL, 2004, CURR MED CHEM, V11, P3065, DOI 10.2174/0929867043363820; Henry P, 1996, J PHYSIOL-LONDON, V495, P681, DOI 10.1113/jphysiol.1996.sp021625; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1949, ARCH SCI PHYSIOL, V3, P129; HODGKIN AL, 1959, J PHYSIOL-LONDON, V148, P127, DOI 10.1113/jphysiol.1959.sp006278; HORIE M, 1987, J PHYSIOL-LONDON, V387, P251, DOI 10.1113/jphysiol.1987.sp016572; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Imredy JP, 1998, BIOCHEMISTRY-US, V37, P14867, DOI 10.1021/bi980929k; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14294, DOI 10.1021/bi991206j; KATZ B, 1949, ARCH SCI PHYSIOL, V3, P285; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; LEECH CA, 1981, J PHYSIOL-LONDON, V319, P295, DOI 10.1113/jphysiol.1981.sp013909; Leyland ML, 1999, PFLUG ARCH EUR J PHY, V438, P778, DOI 10.1007/s004240051106; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; NOBLE D, 1968, J PHYSIOL-LONDON, V195, P185, DOI 10.1113/jphysiol.1968.sp008454; Oliver D, 1998, BIOPHYS J, V74, P2318, DOI 10.1016/S0006-3495(98)77941-X; Pearson WL, 1998, J GEN PHYSIOL, V112, P351, DOI 10.1085/jgp.112.3.351; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Ramu Y, 2004, BIOCHEMISTRY-US, V43, P10701, DOI 10.1021/bi049125x; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Shin HG, 2005, J GEN PHYSIOL, V126, P123, DOI 10.1085/jgp.200509296; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V282, pF826, DOI 10.1152/ajprenal.00300.2001; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhou Y, 2004, BIOCHEMISTRY-US, V43, P4978, DOI 10.1021/bi049876z; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	66	252	257	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1668	1674		10.1126/science.1180310	http://dx.doi.org/10.1126/science.1180310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019282	Green Accepted			2022-12-24	WOS:000272839000046
J	Nilsson, M; Beaglehole, R; Sauerborn, R				Nilsson, Maria; Beaglehole, Robert; Sauerborn, Rainer			Climate policy: lessons from tobacco control	LANCET			English	Editorial Material							HEALTH		[Nilsson, Maria; Sauerborn, Rainer] Umea Univ, Umea Ctr Global Hlth Res, SE-90187 Umea, Sweden; [Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand; [Sauerborn, Rainer] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	Umea University; University of Auckland; Ruprecht Karls University Heidelberg	Nilsson, M (corresponding author), Umea Univ, Umea Ctr Global Hlth Res, SE-90187 Umea, Sweden.	maria.nilsson@epiph.umu.se						*COP15, 2009, UN CLIM CHANG C DEC; Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Friel S, 2008, LANCET, V372, P1677, DOI 10.1016/S0140-6736(08)61692-X; International Energy Agency, 2009, CO2 EM FUEL COMB 200; International Panel on Climate Change, 1996, IPCC 2 ASS CLIM CHAN; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Michaels D, 2005, AM J PUBLIC HEALTH, V95, pS39, DOI 10.2105/AJPH.2004.043059; Office on Smoking and Health (US), 1986, HLTH CONS INV SMOK R; SAUERBORN R, 2009, GLOBAL HLTH ACTION; STERN N, 2007, STERN REV EC CLIMATE; *SURG GEN ADV COMM, 1964, SMOK HLTH; UNFCC, 1997, KYOT PROT; WHO, FRAM CONV TOB CONTR; World Health Organization, 2008, WHO REP GLOB TOB EP	16	8	8	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1955	1956		10.1016/S0140-6736(09)61959-0	http://dx.doi.org/10.1016/S0140-6736(09)61959-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	20006121				2022-12-24	WOS:000272727000009
J	Walck, J; Dixon, K				Walck, Jeffrey; Dixon, Kingsley			Time to future-proof plants in storage	NATURE			English	Editorial Material									[Walck, Jeffrey] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA; [Dixon, Kingsley] Kings Pk & Bot Gardens, Perth 6005, Australia; [Dixon, Kingsley] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia	Middle Tennessee State University; University of Western Australia	Walck, J (corresponding author), Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA.	jwalck@mtsu.edu; kdixon@bgpa.wa.gov.au	Dixon, Kingsley W/A-8133-2016; Dixon, Kingsley W/B-1042-2011	Dixon, Kingsley W/0000-0001-5989-2929; 					0	11	11	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 10	2009	462	7274					721	721		10.1038/462721a	http://dx.doi.org/10.1038/462721a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	529ZZ	20010667	Bronze			2022-12-24	WOS:000272559900016
J	Crickmore, MA				Crickmore, Michael A.			GE PRIZE ESSAY The Molecular Basis of Size Differences	SCIENCE			English	Editorial Material							HOX CONTROL; DROSOPHILA; ULTRABITHORAX; MOBILITY; GENES		Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA	Rockefeller University	Crickmore, MA (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.	mcrickmore@rockefeller.edu						Crickmore MA, 2008, BIOESSAYS, V30, P843, DOI 10.1002/bies.20806; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737; Crickmore MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000633; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; SMOLIKUTLAUT SM, 1990, GENETICS, V124, P357; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474	8	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1360	1361		10.1126/science.1184444	http://dx.doi.org/10.1126/science.1184444			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965749				2022-12-24	WOS:000272351100030
J	Yus, E; Maier, T; Michalodimitrakis, K; van Noort, V; Yamada, T; Chen, WH; Wodke, JAH; Guell, M; Martinez, S; Bourgeois, R; Kuhner, S; Raineri, E; Letunic, I; Kalinina, OV; Rode, M; Herrmann, R; Gutierrez-Gallego, R; Russell, RB; Gavin, AC; Bork, P; Serrano, L				Yus, Eva; Maier, Tobias; Michalodimitrakis, Konstantinos; van Noort, Vera; Yamada, Takuji; Chen, Wei-Hua; Wodke, Judith A. H.; Gueell, Marc; Martinez, Sira; Bourgeois, Ronan; Kuehner, Sebastian; Raineri, Emanuele; Letunic, Ivica; Kalinina, Olga V.; Rode, Michaela; Herrmann, Richard; Gutierrez-Gallego, Ricardo; Russell, Robert B.; Gavin, Anne-Claude; Bork, Peer; Serrano, Luis			Impact of Genome Reduction on Bacterial Metabolism and Its Regulation	SCIENCE			English	Article							MYCOPLASMA-PNEUMONIAE; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; MOLLICUTES; GENES; ANNOTATION; SEQUENCE; GROWTH	To understand basic principles of bacterial metabolism organization and regulation, but also the impact of genome size, we systematically studied one of the smallest bacteria, Mycoplasma pneumoniae. A manually curated metabolic network of 189 reactions catalyzed by 129 enzymes allowed the design of a defined, minimal medium with 19 essential nutrients. More than 1300 growth curves were recorded in the presence of various nutrient concentrations. Measurements of biomass indicators, metabolites, and C-13-glucose experiments provided information on directionality, fluxes, and energetics; integration with transcription profiling enabled the global analysis of metabolic regulation. Compared with more complex bacteria, the M. pneumoniae metabolic network has a more linear topology and contains a higher fraction of multifunctional enzymes; general features such as metabolite concentrations, cellular energetics, adaptability, and global gene expression responses are similar, however.	[van Noort, Vera; Yamada, Takuji; Chen, Wei-Hua; Kuehner, Sebastian; Letunic, Ivica; Kalinina, Olga V.; Rode, Michaela; Russell, Robert B.; Gavin, Anne-Claude; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Yus, Eva; Maier, Tobias; Michalodimitrakis, Konstantinos; Wodke, Judith A. H.; Gueell, Marc; Martinez, Sira; Bourgeois, Ronan; Raineri, Emanuele; Serrano, Luis] CRG, Barcelona 08003, Spain; [Yus, Eva; Maier, Tobias; Michalodimitrakis, Konstantinos; Wodke, Judith A. H.; Gueell, Marc; Martinez, Sira; Bourgeois, Ronan; Raineri, Emanuele; Serrano, Luis] Univ Pompeu Fabra, Barcelona 08003, Spain; [Kalinina, Olga V.; Herrmann, Richard] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia; [Gutierrez-Gallego, Ricardo] ZMBH, D-69120 Heidelberg, Germany; Univ Pompeu Fabra, Dept Expt & Hlth Sci, Inst Municipal Invest Med, Hosp del Mar, Barcelona 08003, Spain; [Serrano, Luis] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Ruprecht Karls University Heidelberg; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; ICREA	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de; luis.serrano@crg.es	van Noort, Vera/GWZ-9038-2022; van Noort, Vera/E-1053-2011; Herrmann, Richard/K-2809-2016; Bork, Peer/F-1813-2013; Russell, Robert/GWU-6389-2022; Letunic, Ivica/K-1102-2019; Letunic, Ivica/A-6032-2009; Kalinina, Olga V/M-8482-2016; Raineri, Emanuele/AAX-7874-2020; Chen, Weihua/GRS-9256-2022; Serrano, Luis/B-3355-2013; Güell, Marc/AAB-3054-2021; Russell, Rob/AAH-9145-2019; Güell, Marc/J-2970-2017	van Noort, Vera/0000-0002-8436-6602; Herrmann, Richard/0000-0003-2788-3715; Bork, Peer/0000-0002-2627-833X; Russell, Robert/0000-0002-7213-1398; Letunic, Ivica/0000-0003-3560-4288; Kalinina, Olga V/0000-0002-9445-477X; Serrano, Luis/0000-0002-5276-1392; Güell, Marc/0000-0003-4000-7912; Russell, Rob/0000-0002-1905-4717; Güell, Marc/0000-0003-4000-7912; Chen, Wei-Hua/0000-0003-2168-6147; Gutierrez Gallego, Ricardo/0000-0001-9639-2181; Gavin, Anne-Claude/0000-0003-4917-2340	ICREA Funding Source: Custom	ICREA(ICREA)		Cocaign-Bousquet M, 2002, APPL MICROBIOL BIOT, V60, P24, DOI 10.1007/s00253-002-1065-x; Dallo SF, 2000, MICROB PATHOGENESIS, V29, P301, DOI 10.1006/mpat.2000.0395; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; Even S, 2002, MOL MICROBIOL, V45, P1143, DOI 10.1046/j.1365-2958.2002.03086.x; Even S, 2003, MICROBIOL-SGM, V149, P1935, DOI 10.1099/mic.0.26146-0; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goebel W, 2006, CURR OPIN MICROBIOL, V9, P123, DOI 10.1016/j.mib.2006.02.011; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Halbedel S, 2004, J BACTERIOL, V186, P7936, DOI 10.1128/JB.186.23.7936-7943.2004; Halbedel S, 2007, J MOL BIOL, V371, P596, DOI 10.1016/j.jmb.2007.05.098; Halbedel S, 2007, J MOL MICROB BIOTECH, V12, P147, DOI 10.1159/000096470; Hasselbring BM, 2006, P NATL ACAD SCI USA, V103, P16478, DOI 10.1073/pnas.0608051103; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; MANOLUKAS JT, 1988, J GEN MICROBIOL, V134, P791; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Nomura M, 1999, J BACTERIOL, V181, P6857, DOI 10.1128/JB.181.22.6857-6864.1999; Oxman E, 2008, EVOLUTION, V62, P1547, DOI 10.1111/j.1558-5646.2008.00397.x; Pachkov M, 2007, GENE, V396, P215, DOI 10.1016/j.gene.2007.02.033; Pipe LZ, 2008, MOL BIOSYST, V4, P192, DOI 10.1039/b708241j; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Pollack JD, 1997, TRENDS MICROBIOL, V5, P413; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; PROFT T, 1994, MOL MICROBIOL, V13, P337, DOI 10.1111/j.1365-2958.1994.tb00427.x; Renesto P, 2003, LANCET, V362, P447, DOI 10.1016/S0140-6736(03)14071-8; SMART JB, 1987, APPL ENVIRON MICROB, V53, P533, DOI 10.1128/AEM.53.3.533-541.1987; Su HC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-63; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	34	218	225	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1263	1268		10.1126/science.1177263	http://dx.doi.org/10.1126/science.1177263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965476				2022-12-24	WOS:000272117900048
J	Biastoch, A; Boning, CW; Schwarzkopf, FU; Lutjeharms, JRE				Biastoch, A.; Boening, C. W.; Schwarzkopf, F. U.; Lutjeharms, J. R. E.			Increase in Agulhas leakage due to poleward shift of Southern Hemisphere westerlies	NATURE			English	Article							THERMOHALINE CIRCULATION; OCEAN; ATLANTIC; VARIABILITY; MODEL; ICE	The transport of warm and salty Indian Ocean waters into the Atlantic Ocean-the Agulhas leakage-has a crucial role in the global oceanic circulation(1) and thus the evolution of future climate. At present these waters provide the main source of heat and salt for the surface branch of the Atlantic meridional overturning circulation (MOC)(2). There is evidence from past glacial-to-interglacial variations in foraminiferal assemblages(3) and model studies(4) that the amount of Agulhas leakage and its corresponding effect on the MOC has been subject to substantial change, potentially linked to latitudinal shifts in the Southern Hemisphere westerlies(5). A progressive poleward migration of the westerlies has been observed during the past two to three decades and linked to anthropogenic forcing(6), but because of the sparse observational records it has not been possible to determine whether there has been a concomitant response of Agulhas leakage. Here we present the results of a high-resolution ocean general circulation model(7,8) to show that the transport of Indian Ocean waters into the South Atlantic via the Agulhas leakage has increased during the past decades in response to the change in wind forcing. The increased leakage has contributed to the observed salinification(9) of South Atlantic thermocline waters. Both model and historic measurements off South America suggest that the additional Indian Ocean waters have begun to invade the North Atlantic, with potential implications for the future evolution of the MOC.	[Biastoch, A.; Boening, C. W.; Schwarzkopf, F. U.] Leibniz Inst Meereswissensch, D-24105 Kiel, Germany; [Lutjeharms, J. R. E.] Univ Cape Town, Dept Oceanog, ZA-7700 Rondebosch, South Africa	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Cape Town	Biastoch, A (corresponding author), Leibniz Inst Meereswissensch, Dusternbrooker Weg 20, D-24105 Kiel, Germany.	abiastoch@ifm-geomar.de	Boening, Claus W/B-1686-2012; Boening, Claus/AAW-6387-2020; Schwarzkopf, Franziska/P-7621-2019; Biastoch, Arne/B-5219-2014	Boening, Claus W/0000-0002-6251-5777; Boening, Claus/0000-0002-6251-5777; Schwarzkopf, Franziska/0000-0002-2747-8456; Biastoch, Arne/0000-0003-3946-4390	DFG [BO 907/2-2, SFB 754]; BMBF [SUA 07/004]; South African National Research Foundation	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); South African National Research Foundation(National Research Foundation - South Africa)	The integrations of the experiments have been performed at the Hochstleistungsrechenzentrum Stuttgart (HLRS) and the Computing Centre at Kiel University. We thank the NEMO, AGRIF and Ariane System Teams for their technical support. The analysis was supported by the DFG projects BO 907/2-2 and SFB 754 (TP A2, http://www.sfb754.de). J. R. E. L. received support from the International Bureau of the BMBF ( SUA 07/004) and from the South African National Research Foundation.	Alory G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028044; Bard E, 2009, NATURE, V460, P380, DOI 10.1038/nature08189; Barnier B, 2006, OCEAN DYNAM, V56, P543, DOI 10.1007/s10236-006-0082-1; Beranger K, 2006, OCEAN DYNAM, V56, P104, DOI 10.1007/s10236-006-0065-2; Biastoch A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035132; Biastoch A, 2008, NATURE, V456, P489, DOI 10.1038/nature07426; Biastoch A, 1999, GEOPHYS RES LETT, V26, P3321, DOI 10.1029/1999GL002349; Biastoch A, 2009, J PHYS OCEANOGR, V39, P2417, DOI 10.1175/2009JPO4184.1; Biastoch A, 2008, J CLIMATE, V21, P6599, DOI 10.1175/2008JCLI2404.1; Blanke B, 1999, J PHYS OCEANOGR, V29, P2753, DOI 10.1175/1520-0485(1999)029<2753:WWPITE>2.0.CO;2; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; Cai W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024911; CONKRIGHT ME, 2002, WORLD OCEAN DATABASE, V1, P1; Curry R, 2005, SCIENCE, V308, P1772, DOI 10.1126/science.1109477; Debreu L, 2008, COMPUT GEOSCI-UK, V34, P8, DOI 10.1016/j.cageo.2007.01.009; DERUIJTER WPM, 2002, GEOPHYS RES LETT, V29, P1401, DOI DOI 10.1029/2001GL013714; Friocourt Y, 2005, J PHYS OCEANOGR, V35, P1206, DOI 10.1175/JPO2748.1; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Griffies SM, 2009, OCEAN MODEL, V26, P1, DOI 10.1016/j.ocemod.2008.08.007; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Large W. G., 2004, NCARTN460 STR CGD DI, DOI [10.5065/D6KK98Q6, DOI 10.5065/D6KK98Q6]; Latif M, 2006, J CLIMATE, V19, P4631, DOI 10.1175/JCLI3876.1; Lutjeharms JRE, 2006, AGULHAS CURRENT; MADEC G, 2006, 27 I P SIM LAPL; Matano RP, 2002, J PHYS OCEANOGR, V32, P1228, DOI 10.1175/1520-0485(2002)032<1228:LSFOTA>2.0.CO;2; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Oke PR, 2004, J CLIMATE, V17, P1040, DOI 10.1175/1520-0442(2004)017<1040:ORTCIT>2.0.CO;2; OU HW, 1986, J PHYS OCEANOGR, V16, P280, DOI 10.1175/1520-0485(1986)016<0280:SOAIBC>2.0.CO;2; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Ridderinkhof H, 2003, DEEP-SEA RES PT II, V50, P1933, DOI 10.1016/S0967-0645(03)00041-9; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rouault M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037987; Sen Gupta A, 2009, J CLIMATE, V22, P3047, DOI 10.1175/2008JCLI2827.1; Speich S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031583; Steele M, 2001, J CLIMATE, V14, P2079, DOI 10.1175/1520-0442(2001)014<2079:PAGOHW>2.0.CO;2; Swart S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004223; van Sebille E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036614; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2; ZALESAK ST, 1979, J COMPUT PHYS, V31, P335, DOI 10.1016/0021-9991(79)90051-2	40	222	224	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					495	U188		10.1038/nature08519	http://dx.doi.org/10.1038/nature08519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940923				2022-12-24	WOS:000272144200041
J	Turner, WR; Oppenheimer, M; Wilcove, DS				Turner, Will R.; Oppenheimer, Michael; Wilcove, David S.			A force to fight global warming	NATURE			English	Editorial Material									[Turner, Will R.] Conservat Int, Ctr Appl Biodivers Sci, Arlington, VA 22202 USA; [Oppenheimer, Michael; Wilcove, David S.] Princeton Univ, Princeton, NJ 08544 USA	Conservation International; Princeton University	Turner, WR (corresponding author), Conservat Int, Ctr Appl Biodivers Sci, 2011 Crystal Dr,Suite 500, Arlington, VA 22202 USA.	w.turner@conservation.org		Oppenheimer, Michael/0000-0002-9708-5914; Wilcove, David S./0000-0002-1354-0503				Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; IUCN, 2008, 2008 IUCN RED LIST T; Locke H., 2009, INT J WILDERNESS, V15, P7; Transparency International, 2009, GLOB CORR REP 2009	6	65	68	4	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					278	279		10.1038/462278a	http://dx.doi.org/10.1038/462278a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521DF	19924191				2022-12-24	WOS:000271899300018
J	Hamilton, W; Menon, U				Hamilton, William; Menon, Usha			Easily missed? Ovarian cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material							SYMPTOMS; DIAGNOSIS; INDEX; WOMEN; RISK		[Menon, Usha] UCL EGA Inst Womens Hlth, Acad Gynaecol Oncol, London W1T 7DN, England; [Hamilton, William] Univ Bristol, Acad Unit Primary Hlth Care, Dept Community Based Med, Bristol BS6 2AA, Avon, England	University of London; University College London; University of Bristol	Menon, U (corresponding author), UCL EGA Inst Womens Hlth, Acad Gynaecol Oncol, Maple House, London W1T 7DN, England.	u.menon@ucl.ac.uk	Menon, Usha/C-4716-2008; Hamilton, Willie/G-8612-2014	Menon, Usha/0000-0003-3708-1732; Hamilton, William/0000-0003-1611-1373	Department of Health [PDA/03/07/029] Funding Source: Medline; National Institute for Health Research [PDA/03/07/029] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Bankhead CR, 2008, BJOG-INT J OBSTET GY, V115, P1008, DOI 10.1111/j.1471-0528.2008.01772.x; Department of Health, 2009, OV CANC KEY MESS HLT; Fitch Margaret, 2002, Can Oncol Nurs J, V12, P152; Friedman GD, 2005, FAM PRACT, V22, P548, DOI 10.1093/fampra/cmi044; Goff BA, 2000, CANCER, V89, P2068, DOI 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Hamilton W, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2998; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Myers Evan R, 2006, Evid Rep Technol Assess (Full Rep), P1; National Institute for Health and Clinical Excellence, 2005, REF GUID SUSP CANC; Rufford BD, 2007, BJOG-INT J OBSTET GY, V114, P59, DOI 10.1111/j.1471-0528.2006.01153.x; Ryerson AB, 2007, OBSTET GYNECOL, V109, P1053, DOI 10.1097/01.AOG.0000260392.70365.5e; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2	13	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 18	2009	339								b4650	10.1136/bmj.b4650	http://dx.doi.org/10.1136/bmj.b4650			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TA	19923146	Green Accepted			2022-12-24	WOS:000272096200005
J	Homer, H; Gui, L; Carroll, J				Homer, Hayden; Gui, Liming; Carroll, John			A Spindle Assembly Checkpoint Protein Functions in Prophase I Arrest and Prometaphase Progression	SCIENCE			English	Article							MOUSE OOCYTES; PREVENTS ANEUPLOIDY; APC(CDH1) ACTIVITY; CYCLIN-B; M-PHASE; SECURIN; MAD2; PROTEOLYSIS; COMPLEX; ENTRY	Two critical stages of mammalian oocyte regulation are prophase I arrest, which is important for sustaining the oocyte pool, and the progression through meiosis I (MI) to produce fertilizable eggs. We have found that the spindle assembly checkpoint protein BubR1 regulates both stages in mouse oocytes. We show that oocytes depleted of BubR1 cannot sustain prophase I arrest and readily undergo germinal vesicle breakdown, a marker for reentry into MI. BubR1-depleted oocytes then arrest before completing MI, marked by failure of polar body extrusion. Both meiotic defects in BubR1-depleted oocytes are due to reduced activity of the master regulator known as the anaphase-promoting complex (APC), brought about through diminished levels of the APC coactivator Cdh1.	[Homer, Hayden] UCL, Oocyte & Embryo Res Lab, Dept Cell & Dev Biol, Div Biosci, London, England; UCL, Inst Womens Hlth, London, England	University of London; University College London; University of London; University College London	Homer, H (corresponding author), UCL, Oocyte & Embryo Res Lab, Dept Cell & Dev Biol, Div Biosci, London, England.	h.homer@ucl.ac.uk	Homer, Hayden/K-1517-2014; Holt, Janet E/B-2415-2013	Homer, Hayden/0000-0002-3104-0449; Carroll, John/0000-0001-9644-5861	Medical Research Council [082587/Z/07/Z]; Medical Research Council [G0400530] Funding Source: researchfish; MRC [G0400530] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust Clinical Fellowship (082587/Z/07/Z) to H. H. J. C. is funded by a Medical Research Council grant. We thank S. Taylor, W. Earnshaw, and K. Wassmann for reagents.	Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Malmanche N, 2007, CURR BIOL, V17, P1489, DOI 10.1016/j.cub.2007.07.042; Marangos P, 2008, NAT CELL BIOL, V10, P445, DOI 10.1038/ncb1707; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181	14	112	113	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					991	994		10.1126/science.1175326	http://dx.doi.org/10.1126/science.1175326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965510	Green Accepted			2022-12-24	WOS:000271712300039
J	Ma, SM; Li, JWH; Choi, JW; Zhou, H; Lee, KKM; Moorthie, VA; Xie, XK; Kealey, JT; Da Silva, NA; Vederas, JC; Tang, Y				Ma, Suzanne M.; Li, Jesse W. -H.; Choi, Jin W.; Zhou, Hui; Lee, K. K. Michael; Moorthie, Vijayalakshmi A.; Xie, Xinkai; Kealey, James T.; Da Silva, Nancy A.; Vederas, John C.; Tang, Yi			Complete Reconstitution of a Highly Reducing Iterative Polyketide Synthase	SCIENCE			English	Article							LOVASTATIN NONAKETIDE SYNTHASE; NONRIBOSOMAL PEPTIDE SYNTHETASE; CRYSTAL-STRUCTURE; ADH2 PROMOTER; GENE-CLUSTER; BIOSYNTHESIS; EXPRESSION; PROTEINS; VERSATILITY; CLONING	Highly reducing iterative polyketide synthases are large, multifunctional enzymes that make important metabolites in fungi, such as lovastatin, a cholesterol-lowering drug from Aspergillus terreus. We report efficient expression of the lovastatin nonaketide synthase (LovB) from an engineered strain of Saccharomyces cerevisiae, as well as complete reconstitution of its catalytic function in the presence and absence of cofactors ( the reduced form of nicotinamide adenine dinucleotide phosphate and S-adenosylmethionine) and its partner enzyme, the enoyl reductase LovC. Our results demonstrate that LovB retains correct intermediates until completion of synthesis of dihydromonacolin L, but off-loads incorrectly processed compounds as pyrones or hydrolytic products. Experiments replacing LovC with analogous MlcG from compactin biosynthesis demonstrate a gate-keeping function for this partner enzyme. This study represents a key step in the understanding of the functions and structures of this family of enzymes.	[Li, Jesse W. -H.; Moorthie, Vijayalakshmi A.; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Ma, Suzanne M.; Zhou, Hui; Xie, Xinkai; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Choi, Jin W.; Lee, K. K. Michael; Da Silva, Nancy A.] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA 92697 USA; [Kealey, James T.] Amyris Biotechnol, Emeryville, CA 94608 USA	University of Alberta; University of California System; University of California Los Angeles; University of California System; University of California Irvine	Vederas, JC (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	john.vederas@ualberta.ca; yitang@ucla.edu		Vederas, John/0000-0002-2996-0326	NIH [1R21GM077264, 1R01GM085128]; David and Lucile Packard Fellowship in Science and Engineering; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry; NSF [BES0432307]; Kosan Biosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085128, R21GM077264] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Fellowship in Science and Engineering(The David & Lucile Packard Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs); NSF(National Science Foundation (NSF)); Kosan Biosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Khosla for plasmid pRSG33 and L. Du for LovC cDNA. This work was supported in part by NIH ( grants 1R21GM077264 and 1R01GM085128) and a David and Lucile Packard Fellowship in Science and Engineering to Y. T. These studies were also supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chair in Bioorganic and Medicinal Chemistry, NSF ( Grant Opportunities for Academic Liaison with Industry program, grant BES0432307 to N. A. D. S.), and Kosan Biosciences. J. T. K. was formerly affiliated with Kosan Biosciences.	Abe Y, 2002, MOL GENET GENOMICS, V267, P636, DOI 10.1007/s00438-002-0697-y; An JH, 1998, EUR J BIOCHEM, V257, P395, DOI 10.1046/j.1432-1327.1998.2570395.x; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Burr DA, 2007, ORG LETT, V9, P161, DOI 10.1021/ol062763i; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Halo LM, 2008, CHEMBIOCHEM, V9, P585, DOI 10.1002/cbic.200700390; HUTCHINSON CR, 2005, HDB IND MYCOLOGY, pCH17; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Lee KM, 2005, YEAST, V22, P431, DOI 10.1002/yea.1221; Ma SM, 2007, J AM CHEM SOC, V129, P10642, DOI 10.1021/ja074865p; Ma SM, 2007, FEBS J, V274, P2854, DOI 10.1111/j.1742-4658.2007.05818.x; Maggon K, 2005, DRUG DISCOV TODAY, V10, P739, DOI 10.1016/S1359-6446(05)03468-9; MOORE RN, 1985, J AM CHEM SOC, V107, P3694, DOI 10.1021/ja00298a046; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; PRICE VL, 1990, METHOD ENZYMOL, V185, P308; Sims JW, 2005, CHEM COMMUN, P186, DOI 10.1039/b413523g; Song ZS, 2004, CHEMBIOCHEM, V5, P1196, DOI 10.1002/cbic.200400138; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105	23	252	273	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					589	592		10.1126/science.1175602	http://dx.doi.org/10.1126/science.1175602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900898	Green Accepted			2022-12-24	WOS:000271019400046
J	Wittkopp, PJ; Stewart, EE; Arnold, LL; Neidert, AH; Haerum, BK; Thompson, EM; Akhras, S; Smith-Winberry, G; Shefner, L				Wittkopp, Patricia J.; Stewart, Emma E.; Arnold, Lisa L.; Neidert, Adam H.; Haerum, Belinda K.; Thompson, Elizabeth M.; Akhras, Saleh; Smith-Winberry, Gabriel; Shefner, Laura			Intraspecific Polymorphism to Interspecific Divergence: Genetics of Pigmentation in Drosophila	SCIENCE			English	Article							EVOLUTIONARY HISTORY; AMERICANA; PATTERNS; GENOMES; GENES	Genetic changes contributing to phenotypic differences within or between species have been identified for a handful of traits, but the relationship between alleles underlying intraspecific polymorphism and interspecific divergence is largely unknown. We found that noncoding changes in the tan gene, as well as changes linked to the ebony gene, contribute to pigmentation divergence between closely related Drosophila species. Moreover, we found that alleles linked to tan and ebony fixed in one Drosophila species also contribute to variation within another species, and that multiple genotypes underlie similar phenotypes even within the same population. These alleles appear to predate speciation, which suggests that standing genetic variation present in the common ancestor gave rise to both intraspecific polymorphism and interspecific divergence.	[Wittkopp, Patricia J.; Stewart, Emma E.; Neidert, Adam H.; Haerum, Belinda K.; Akhras, Saleh; Smith-Winberry, Gabriel; Shefner, Laura] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Wittkopp, Patricia J.; Arnold, Lisa L.; Thompson, Elizabeth M.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wittkopp, PJ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	wittkopp@umich.edu			NSF [DEB140640485]; Margaret and Herman Sokol Endowment for Faculty and Graduate Student Research Projects; University of Michigan; Alfred P. Sloan Research Fellow	NSF(National Science Foundation (NSF)); Margaret and Herman Sokol Endowment for Faculty and Graduate Student Research Projects; University of Michigan(University of Michigan System); Alfred P. Sloan Research Fellow	We thank G. Kalay, X. Heng, M. Weisel, A. Ratnala, and E. Larimore for technical assistance; P. Mena and B. McAllister for sharing unpublished data ( including the images shown in fig. S7) and lines of D. americana; C. Dick for use of the Mixer Mill, M. Rebeiz for sharing an unpublished in situ protocol; N. Rosenberg, G. Coop, and other colleagues for discussions of incomplete lineage sorting and introgression; and J. Gruber, J. Coolon, A. Cooley, G. Kalay, D. Yuan, B. McAllister, A. Kopp, B. Prud'homme, and N. Gompel for comments on the manuscript. Supported by NSF grant DEB140640485, the Margaret and Herman Sokol Endowment for Faculty and Graduate Student Research Projects, and the University of Michigan. P. J. W. is an Alfred P. Sloan Research Fellow. DNA sequences are available from GenBank ( accession numbers GQ457336 to GQ457453).	Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; BRIDGES CB, 1923, PUBL CARNEGIE I, V327; Caletka BC, 2004, MOL PHYLOGENET EVOL, V33, P664, DOI 10.1016/j.ympev.2004.08.007; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; HSU TC, 1951, THESIS U TEXAS AUSTI; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; LAURIE CC, 1994, GENETICS, V138, P379; Maside XL, 2004, CURR BIOL, V14, P150, DOI 10.1016/j.cub.2003.12.055; McAllister BF, 2003, GENETICS, V165, P1317; McAllister BF, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000112; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; MENA P, COMMUNICATION; Morales-Hojas R, 2008, MOL ECOL, V17, P2910, DOI 10.1111/j.1365-294X.2008.03796.x; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Schafer MA, 2006, HEREDITY, V97, P291, DOI 10.1038/sj.hdy.6800860; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Throckmorton L.H., 1982, Genetics and Biology of Drosophila, V3b, P227; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Vieira CP, 2003, GENETICS, V164, P1459; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849	28	110	113	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					540	544		10.1126/science.1176980	http://dx.doi.org/10.1126/science.1176980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900891				2022-12-24	WOS:000271019400032
J	Pan, JH				Pan, Jiahua			China expects leadership from rich nations	NATURE			English	Editorial Material									Chinese Acad Social Sci, Inst Urban & Environm Studies, Beijing 100005, Peoples R China	Chinese Academy of Social Sciences	Pan, JH (corresponding author), Chinese Acad Social Sci, Inst Urban & Environm Studies, 10 Xianxiao Hutong, Beijing 100005, Peoples R China.	jiahuapan@163.com							0	5	6	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 22	2009	461	7267					1055	1055		10.1038/4611055a	http://dx.doi.org/10.1038/4611055a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509BU	19847244	Bronze			2022-12-24	WOS:000270987600019
J	Levin, EJ; Quick, M; Zhou, M				Levin, Elena J.; Quick, Matthias; Zhou, Ming			Crystal structure of a bacterial homologue of the kidney urea transporter	NATURE			English	Article							AMMONIA TRANSPORT; COLLECTING DUCT; MOLECULAR-BASIS; CHANNEL; WATER; MECHANISM; PHOSPHORYLATION; CLONING; FAMILY; UT-A1	Urea is highly concentrated in the mammalian kidney to produce the osmotic gradient necessary for water re-absorption. Free diffusion of urea across cell membranes is slow owing to its high polarity, and specialized urea transporters have evolved to achieve rapid and selective urea permeation. Here we present the 2.3 angstrom structure of a functional urea transporter from the bacterium Desulfovibrio vulgaris. The transporter is a homotrimer, and each subunit contains a continuous membrane-spanning pore formed by the two homologous halves of the protein. The pore contains a constricted selectivity filter that can accommodate several dehydrated urea molecules in single file. Backbone and side-chain oxygen atoms provide continuous coordination of urea as it progresses through the filter, and well-placed alpha-helix dipoles provide further compensation for dehydration energy. These results establish that the urea transporter operates by a channel-like mechanism and reveal the physical and chemical basis of urea selectivity.	[Levin, Elena J.; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mz2140@columbia.edu			US National Institutes of Health [HL086392, T32HL087745]; NIH [GM075026]; American Heart Association [0630148N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392, T32HL087745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. MacKinnon for advice and support throughout the project, C. Miller and E. Gouaux for comments on the manuscript, J. Love and NYCOMPS for cloning and the initial screen of protein expression levels, Y. Pan for messenger RNA preparation and oocyte injection, and J. Weng and Y. Cao for crystal screening and data collection at the synchrotrons. Data for this study were measured at beamlines X4A, X4C, X25 and X29 of the NSLS and the NE-CAT 24ID- E at the Advanced Photon Source. This work was supported by the US National Institutes of Health (HL086392 to M. Z. and T32HL087745 to E. J. L.), the NYCOMPS that is supported by the NIH Protein Structure Initiatives PSI- II (GM075026 to W. A. Hendrickson), and the American Heart Association (0630148N to M. Z.). M. Z. is a Pew Scholar in Biomedical Sciences.	Bagnasco SM, 2005, PFLUG ARCH EUR J PHY, V450, P217, DOI 10.1007/s00424-005-1403-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blount MA, 2007, AM J PHYSIOL-RENAL, V293, pF1308, DOI 10.1152/ajprenal.00197.2007; Bradford AD, 2001, AM J PHYSIOL-RENAL, V281, pF133, DOI 10.1152/ajprenal.2001.281.1.F133; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHOU CL, 1989, AM J PHYSIOL, V257, pF359, DOI 10.1152/ajprenal.1989.257.3.F359; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Hediger MA, 1996, KIDNEY INT, V49, P1615, DOI 10.1038/ki.1996.235; Imai YN, 2009, J COMPUT CHEM, V30, P2267, DOI 10.1002/jcc.21212; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kojima S, 2006, J MEMBRANE BIOL, V212, P83, DOI 10.1007/s00232-006-0868-6; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Levin MH, 2007, FASEB J, V21, P551, DOI 10.1096/fj.06-6979com; Lucien N, 2002, J BIOL CHEM, V277, P34101, DOI 10.1074/jbc.M205073200; MacIver B, 2008, AM J PHYSIOL-RENAL, V294, pF956, DOI 10.1152/ajprenal.00229.2007; MANNUZZU LM, 1993, J MEMBRANE BIOL, V133, P85; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minocha R, 2003, RECEPTOR CHANNEL, V9, P345, DOI 10.3109/714041015; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Raunser S, 2009, J MOL BIOL, V387, P619, DOI 10.1016/j.jmb.2009.02.005; Sands JM, 2003, ANNU REV PHYSIOL, V65, P543, DOI 10.1146/annurev.physiol.65.092101.142638; Sebbane F, 2002, MOL MICROBIOL, V45, P1165, DOI 10.1046/j.1365-2958.2002.03096.x; Shayakul C, 2004, PFLUG ARCH EUR J PHY, V447, P603, DOI 10.1007/s00424-003-1124-x; Shayakul C, 1996, J CLIN INVEST, V98, P2580, DOI 10.1172/JCI119077; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Terris JM, 2001, AM J PHYSIOL-RENAL, V280, pF325, DOI 10.1152/ajprenal.2001.280.2.F325; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Valladares A, 2002, MOL MICROBIOL, V43, P703, DOI 10.1046/j.1365-2958.2002.02778.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang BX, 2002, J BIOL CHEM, V277, P36782, DOI 10.1074/jbc.M206948200; YOU GF, 1993, NATURE, V365, P844, DOI 10.1038/365844a0; Zhang C, 2002, AM J PHYSIOL-RENAL, V282, pF85, DOI 10.1152/ajprenal.0054.2001; Zhao D, 2007, BBA-BIOMEMBRANES, V1768, P1815, DOI 10.1016/j.bbamem.2007.04.010; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	47	78	85	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					757	U72		10.1038/nature08558	http://dx.doi.org/10.1038/nature08558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	19865084	Green Accepted			2022-12-24	WOS:000272559900031
J	Ludwig, DS				Ludwig, David S.			Artificially Sweetened Beverages Cause for Concern	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; FOOD-INTAKE; MECHANISMS; SUCROSE; OBESITY; WEIGHT; HUMANS; TASTE		Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Optimal Weight Life Program, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Mann J, 2007, EUR J CLIN NUTR, V61, pS100, DOI 10.1038/sj.ejcn.1602940; Mattes RD, 2009, AM J CLIN NUTR, V89, P1, DOI 10.3945/ajcn.2008.26792; Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; Sorensen LB, 2005, AM J CLIN NUTR, V82, P421, DOI 10.1093/ajcn/82.2.421; Swithers SE, 2008, BEHAV NEUROSCI, V122, P161, DOI 10.1037/0735-7044.122.1.161	10	50	55	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2477	2478		10.1001/jama.2009.1822	http://dx.doi.org/10.1001/jama.2009.1822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996404				2022-12-24	WOS:000272520500028
J	Silva, JP; von Meyenn, F; Howell, J; Thorens, B; Wolfrum, C; Stoffel, M				Silva, Jose P.; von Meyenn, Ferdinand; Howell, Jessica; Thorens, Bernard; Wolfrum, Christian; Stoffel, Markus			Regulation of adaptive behaviour during fasting by hypothalamic Foxa2	NATURE			English	Article							MELANIN-CONCENTRATING HORMONE; CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; COGNITIVE FUNCTION; MICE; OREXIN; OBESITY; POPULATION; METABOLISM	The lateral hypothalamic area is considered the classic 'feeding centre', regulating food intake, arousal and motivated behaviour through the actions of orexin and melanin-concentrating hormone (MCH)(1-3). These neuropeptides are inhibited in response to feeding-related signals and are released during fasting. However, the molecular mechanisms that regulate and integrate these signals remain poorly understood. Here we show that the forkhead box transcription factor Foxa2,a downstream target of insulin signalling(4-6), regulates the expression of orexin and MCH. During fasting, Foxa2 binds to MCH and orexin promoters and stimulates their expression. In fed and in hyperinsulinemic obese mice, insulin signalling leads to nuclear exclusion of Foxa2 and reduced expression of MCH and orexin. Constitutive activation of Foxa2 in the brain (Nes-Cre/1; Foxa2T156A(flox/flox) genotype) results in increased neuronal MCH and orexin expression and increased food consumption, metabolism and insulin sensitivity. Spontaneous physical activity of these animals in the fed state is significantly increased and is similar to that in fasted mice. Conditional activation of Foxa2 through the T156A mutation expression in the brain of obese mice also resulted in improved glucose homeostasis, decreased fat and increased lean body mass. Our results demonstrate that Foxa2 can act as a metabolic sensor in neurons of the lateral hypothalamic area to integrate metabolic signals, adaptive behaviour and physiological responses.	[Silva, Jose P.; Howell, Jessica; Stoffel, Markus] Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; [von Meyenn, Ferdinand; Howell, Jessica; Wolfrum, Christian; Stoffel, Markus] ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	Rockefeller University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne	Stoffel, M (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.	stoffel@imsb.biol.ethz.ch	von Meyenn, Ferdinand/O-4517-2017	von Meyenn, Ferdinand/0000-0001-9920-3075; Wolfrum, Christian/0000-0002-3862-6805; Stoffel, Markus/0000-0003-1304-5817	SystemsX; Swiss National Science Foundation	SystemsX; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grants from SystemsX and the Swiss National Science Foundation (LiverX grant). We would like to thank S. Metref for technical support and expertise.	Aadahl M, 2007, EUR J EPIDEMIOL, V22, P369, DOI 10.1007/s10654-006-9100-3; Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; Assah FK, 2008, DIABETOLOGIA, V51, P1399, DOI 10.1007/s00125-008-1033-9; Baranowska B, 2005, NEUROENDOCRINOL LETT, V26, P293; BERNARDIS LL, 1993, NEUROSCI BIOBEHAV R, V17, P141, DOI 10.1016/S0149-7634(05)80149-6; Byberg L, 2001, DIABETOLOGIA, V44, P2134, DOI 10.1007/s001250100022; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gomori A, 2003, AM J PHYSIOL-ENDOC M, V284, pE583, DOI 10.1152/ajpendo.00350.2002; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Komulainen P, 2007, DEMENT GERIATR COGN, V23, P29, DOI 10.1159/000096636; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Stolk RP, 1997, DIABETES CARE, V20, P792, DOI 10.2337/diacare.20.5.792; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Young SE, 2006, DIABETES CARE, V29, P2688, DOI 10.2337/dc06-0915	22	56	60	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					646	U119		10.1038/nature08589	http://dx.doi.org/10.1038/nature08589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956259				2022-12-24	WOS:000272277900040
J	Okada, C; Yamashita, E; Lee, SJ; Shibata, S; Katahira, J; Nakagawa, A; Yoneda, Y; Tsukihara, T				Okada, Chimari; Yamashita, Eiki; Lee, Soo Jae; Shibata, Satoshi; Katahira, Jun; Nakagawa, Atsushi; Yoneda, Yoshihiro; Tsukihara, Tomitake			A High-Resolution Structure of the Pre-microRNA Nuclear Export Machinery	SCIENCE			English	Article							TRANSFER-RNA; C-ELEGANS; BINDING; PROTEIN; COMPLEX; RANGTP; KARYOPHERIN; PRECURSORS; LIN-14; DOMAIN	Nuclear export of microRNAs (miRNAs) by exportin-5 (Exp-5) is an essential step in miRNA biogenesis. Here, we present the 2.9 angstrom structure of the pre-miRNA nuclear export machinery formed by pre-miRNA complexed with Exp-5 and a guanine triphosphate (GTP)-bound form of the small nuclear guanine triphosphatase (GTPase) Ran (RanGTP). The x-ray structure shows that Exp-5: RanGTP recognizes the 2-nucleotide 3' overhang structure and the double-stranded stem of the pre-miRNA. Exp-5: RanGTP shields the pre-miRNA stem from degradation in a baseball mitt-like structure where it is held by broadly distributed weak interactions, whereas a tunnel-like structure of Exp-5 interacts strongly with the 2-nucleotide 3' overhang through hydrogen bonds and ionic interactions. RNA recognition by Exp-5: RanGTP does not depend on RNA sequence, implying that Exp-5: RanGTP can recognize a variety of pre-miRNAs.	[Lee, Soo Jae] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Okada, Chimari; Yamashita, Eiki; Nakagawa, Atsushi; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Shibata, Satoshi; Katahira, Jun; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka 5650871, Japan; [Katahira, Jun; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan; [Yoneda, Yoshihiro] Osaka Univ, Grad Sch Frontier Biosci, CREST, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; [Okada, Chimari; Tsukihara, Tomitake] Univ Hyogo, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Chungbuk National University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University; University of Hyogo	Lee, SJ (corresponding author), Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea.	sjlee@chungbuk.ac.kr; yyoneda@anat3.med.osaka-u.ac.jp; tsuki@protein.osaka-u.ac.jp	Nakagawa, Atsushi/M-5731-2019; Yamashita, Eiki/V-6758-2019; Nakagawa, Atsushi/D-4329-2009	Nakagawa, Atsushi/0000-0002-1700-7861; Yamashita, Eiki/0000-0002-4278-0039; Nakagawa, Atsushi/0000-0002-1700-7861; Katahira, Jun/0000-0001-5188-0368	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [A-041]; Japan Science and Technology Agency; Takeda Science Foundation; Chungbuk BIT Research-Oriented University Consortium;  [16087101];  [16087206];  [21227003]	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Chungbuk BIT Research-Oriented University Consortium; ; ; 	This work was supported in part by grants-in-aid for scientific research (16087101, 16087206, and 21227003), the GCOE program (A-041) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan (to T. T.), the Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency (to T. T.), a grant from Takeda Science Foundation (to Y. Y.), and a grant from Chungbuk BIT Research-Oriented University Consortium (to S. J. L.). Coordinates and structure factures have been deposited to the PDB under accession code 3A6P.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Gwizdek C, 2003, J BIOL CHEM, V278, P5505, DOI 10.1074/jbc.C200668200; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Ruvkun Gary B, 2003, Harvey Lect, V99, P1; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824	25	264	271	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1275	1279		10.1126/science.1178705	http://dx.doi.org/10.1126/science.1178705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965479				2022-12-24	WOS:000272117900051
J	Nutt, D				Nutt, David			Government vs science over drug and alcohol policy	LANCET			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Neuropsychopharmacol Unit, London W12 0NN, England	Imperial College London	Nutt, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Neuropsychopharmacol Unit, London W12 0NN, England.	d.nutt@imperial.ac.uk		nutt, david/0000-0002-1286-1401				Advisory Council on the Misuse of Drugs, 2008, CANN CLASS PUBL HLTH; Frisher M, 2009, SCHIZOPHR RES, V113, P123, DOI 10.1016/j.schres.2009.05.031; HENCKE D, 2009, GUARDIAN        0316; *INN U SCI SKILLS, 2009, PUTT SCI ENG HEART G, V1; MURRAY R, 2009, TIMES           1103; Nutt D., 2009, CTR CRIME JUSTICE ST, P10; Nutt DJ, 2009, J PSYCHOPHARMACOL, V23, P3, DOI 10.1177/0269881108099672; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; 1963, LANCET, V282, P989	9	13	13	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 21	2009	374	9703					1731	1733		10.1016/S0140-6736(09)61956-5	http://dx.doi.org/10.1016/S0140-6736(09)61956-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525ID	19910043				2022-12-24	WOS:000272207700008
J	Joshi, D; Center, JR; Eisman, JA				Joshi, Devina; Center, Jacqueline R.; Eisman, John A.			Rational Testing Investigation of incidental hypercalcaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY HYPERPARATHYROIDISM; GUIDELINES; SCAN		[Joshi, Devina; Center, Jacqueline R.; Eisman, John A.] Garvan Inst Med Res, Osteoporosis & Bone Biol Program, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research	Eisman, JA (corresponding author), Garvan Inst Med Res, Osteoporosis & Bone Biol Program, 384 Victoria St, Sydney, NSW 2010, Australia.	j.eisman@garvan.org.au	Center, Jacqueline/AAY-8712-2021; Eisman, John A/C-2886-2014	Center, Jacqueline/0000-0002-5278-4527; 				Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bilezikian JP, 2005, J INTERN MED, V257, P6, DOI 10.1111/j.1365-2796.2004.01422.x; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Gordon Leonie, 2002, J Nucl Med Technol, V30, P179; Hinnie J, 2001, CALCIFIED TISSUE INT, V68, P216, DOI 10.1007/s002230001201; Johnston LB, 1996, J CLIN ENDOCR METAB, V81, P346, DOI 10.1210/jc.81.1.346; Kamaya Aya, 2006, Ultrasound Q, V22, P253, DOI 10.1097/01.ruq.0000237260.33509.4f; *NAT COMM CLIN LAB, 1986, EP7P NCCLS; Rodgers SE, 2008, CURR OPIN ONCOL, V20, P52, DOI 10.1097/CCO.0b013e3282f2838f; Sadik M, 2008, EUR J NUCL MED MOL I, V35, P1464, DOI 10.1007/s00259-008-0721-5; Shepard MM, 2007, AM J MED SCI, V334, P381, DOI 10.1097/MAJ.0b013e31812f4947; Silverberg SJ, 2008, PRIMER METABOLIC BON, P302; SINCLAIR D, 1989, ANN EMERG MED, V18, P556, DOI 10.1016/S0196-0644(89)80843-1; Sukan A, 2008, ANN NUCL MED, V22, P123, DOI 10.1007/s12149-007-0086-z; Wermers RA, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.07.044	15	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2009	339								b4613	10.1136/bmj.b4613	http://dx.doi.org/10.1136/bmj.b4613			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TI	19933303				2022-12-24	WOS:000272097000001
J	Sukhdev, P				Sukhdev, Pavan			Costing the Earth	NATURE			English	Editorial Material									Econ Ecosyst & Biodivers TEEB Project, D-53113 Bonn, Germany		Sukhdev, P (corresponding author), Econ Ecosyst & Biodivers TEEB Project, United Nations Campus,Hermann Ehlers Str 10, D-53113 Bonn, Germany.	teeb@unep-teeb.org							0	36	38	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					277	277		10.1038/462277a	http://dx.doi.org/10.1038/462277a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521DF	19915547	Bronze			2022-12-24	WOS:000271899300017
J	Bonneau, F; Basquin, J; Ebert, J; Lorentzen, E; Conti, E				Bonneau, Fabien; Basquin, Jerome; Ebert, Judith; Lorentzen, Esben; Conti, Elena			The Yeast Exosome Functions as a Macromolecular Cage to Channel RNA Substrates for Degradation	CELL			English	Article							ARCHAEAL EXOSOME; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; STRUCTURAL BASIS; COMPLEX; CORE; SUBUNIT; RECOGNITION; EXORIBONUCLEASE	The exosome is a conserved macromolecular complex essential for RNA degradation. The nine-subunit core of the eukaryotic exosome shares a similar barrel-like architecture with prokaryotic complexes, but is catalytically inert. Here, we investigate how the Rrp44 nuclease functions in the active ten-subunit exosome. The 3.0 A resolution crystal structure of the yeast Rrp44-Rrp41-Rrp45 complex shows how the nuclease interacts with the exosome core and the relative accessibility of its endoribonuclease and exoribonuclease sites. Biochemical studies indicate that RNAs thread through the central channel of the core to reach the Rrp44 exoribonuclease site. This channeling mechanism involves evolutionary conserved residues. It allows the processive unwinding and degradation of RNA duplexes containing a sufficiently long single-stranded 30 extension, without the requirement for helicase activities. Although the catalytic function of the exosome core has been lost during evolution, the substrate recruitment and binding properties have been conserved from prokaryotes to eukaryotes.	[Bonneau, Fabien; Basquin, Jerome; Ebert, Judith; Conti, Elena] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Lorentzen, Esben] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England	Max Planck Society; University of London; Birkbeck University London	Conti, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	conti@biochem.mpg.de	Lorentzen, Esben/AAX-8077-2020	Lorentzen, Esben/0000-0001-6493-7220; Bonneau, Fabien/0000-0001-8787-7662; Conti, Elena/0000-0003-1254-5588	Max Planck Gesellschaft; European Union [LSHG-CT-2005-512028]; Sonderforschungsbereich [SFB646]; Deutsche Forschungsgemeinschaft; Federation of European Biochemical Societies and Human Frontier Science	Max Planck Gesellschaft(Max Planck Society); European Union(European Commission); Sonderforschungsbereich(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federation of European Biochemical Societies and Human Frontier Science	We would like to thank Petra Birle and Tatjana Krywcun for mutagenesis, Mark Baumgartner, Markus Mittelhauser, and Uma Jayachandran for help in producing individual exosome components, and Karina Valer Saldana and Sabine Pleyer at the MPI crystallization facility. We also thank Herve Le Hir for advice on biochemical assays, Berndt Haas for RNA synthesis, Chris Lima for the kind gift of Sumo-tagged vectors and Senp2 protease, and the staff of the PXII beamline at the Swiss Light Source (Villigen, Switzerland) for assistance during data collection. We thank Peter Brick and members of our laboratory for discussions and critical reading of the manuscript and Atlanta Cook for the drawing in Figure 3A. This study was supported by the Max Planck Gesellschaft, the European Union grant 3D Repertoire contract number LSHG-CT-2005-512028, the Sonderforschungsbereich SFB646, and the Leibniz Program of the Deutsche Forschungsgemeinschaft. E. L. was supported by Federation of European Biochemical Societies and Human Frontier Science Program postdoctoral fellowships.	Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Buttner K, 2006, MOL MICROBIOL, V61, P1372, DOI 10.1111/j.1365-2958.2006.05331.x; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Cristodero M, 2008, MOL BIOCHEM PARASIT, V159, P24, DOI 10.1016/j.molbiopara.2007.12.012; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Ibrahim H, 2008, BBA-GENE REGUL MECH, V1779, P256, DOI 10.1016/j.bbagrm.2007.11.004; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lorentzen E, 2007, EMBO REP, V8, P470, DOI 10.1038/sj.embor.7400945; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Lorentzen E, 2008, CURR OPIN STRUC BIOL, V18, P709, DOI 10.1016/j.sbi.2008.10.004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro MVAS, 2008, J BIOL CHEM, V283, P14120, DOI 10.1074/jbc.M801005200; Oddone A, 2007, EMBO REP, V8, P63, DOI 10.1038/sj.embor.7400856; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Shi ZH, 2008, RNA, V14, P2361, DOI 10.1261/rna.1244308; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	40	188	193	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					547	559		10.1016/j.cell.2009.08.042	http://dx.doi.org/10.1016/j.cell.2009.08.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879841	Green Accepted, Bronze			2022-12-24	WOS:000271259600019
J	Nakanishi, K; Bonnefond, L; Kimura, S; Suzuki, T; Ishitani, R; Nureki, O				Nakanishi, Kotaro; Bonnefond, Luc; Kimura, Satoshi; Suzuki, Tsutomu; Ishitani, Ryuichiro; Nureki, Osamu			Structural basis for translational fidelity ensured by transfer RNA lysidine synthetase	NATURE			English	Article							ISOLEUCINE TRANSFER-RNA; AMINO-ACID SPECIFICITIES; CRYSTAL-STRUCTURE; ANTICODON; RECOGNITION; CODON; REFINEMENT; RESOLUTION; COMPLEX; GENE	Maturation of precursor transfer RNA (pre-tRNA) includes excision of the 5' leader and 3' trailer sequences, removal of introns and addition of the CCA terminus(1-3). Nucleotide modifications are incorporated at different stages of tRNA processing, after the RNA molecule adopts the proper conformation. In bacteria, tRNA(Ile2) lysidine synthetase (TilS) modifies cytidine into lysidine (L; 2-lysyl-cytidine) at the first anticodon of tRNA(Ile2) (refs 4-9). This modification switches tRNA(Ile2) from a methionine-specific to an isoleucine-specific tRNA(9). However, the aminoacylation of tRNA(Ile2) by methionyl-tRNA synthetase (MetRS), before the modification by TilS, might lead to the misincorporation of methionine in response to isoleucine codons. The mechanism used by bacteria to avoid this pitfall is unknown. Here we show that the TilS enzyme specifically recognizes and modifies tRNA(Ile2) in its precursor form, thereby avoiding translation errors. We identified the lysidine modification in pre-tRNA(Ile2) isolated from RNase-Edeficient Escherichia coli and did not detect mature tRNA(Ile2) lacking this modification. Our kinetic analyses revealed that TilS can modify both types of RNA molecule with comparable efficiencies. X-ray crystallography and mutational analyses revealed that TilS specifically recognizes the entire L-shape structure in pre-tRNA(Ile2) through extensive interactions coupled with sequential domain movements. Our results demonstrate how TilS prevents the recognition of tRNA(Ile2) by MetRS and achieves high specificity for its substrate. These two key points form the basis for maintaining the fidelity of isoleucine codon translation in bacteria. Our findings also provide a rationale for the necessity of incorporating specific modifications at the precursor level during tRNA biogenesis.	[Nakanishi, Kotaro; Nureki, Osamu] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Kanagawa 2258501, Japan; [Bonnefond, Luc; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Minato Ku, Tokyo 1088639, Japan; [Kimura, Satoshi; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Tokyo Institute of Technology; University of Tokyo; University of Tokyo	Nureki, O (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Kanagawa 2258501, Japan.	nureki@ims.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015; NUREKI, OSAMU/G-4960-2014; Bonnefond, Luc/P-3926-2016	Suzuki, Tsutomu/0000-0002-9731-1731; Bonnefond, Luc/0000-0002-1164-742X; Kimura, Satoshi/0000-0003-3555-5877; Nakanishi, Kotaro/0000-0002-9857-6010	SORST program grant from Japan Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Japan Society for the Promotion of Science	SORST program grant from Japan Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the beamline staff at BL41XU of SPring-8 (Harima, Japan) and NW12 of PF-AR (Tsukuba, Japan) for help during data collection. We thank H. Aiba for providing the temperature- sensitive E. coli strain of RNase E, A. Soma and Y. Sekine for discussions, and T. Suzuki and Y. Sakaguchi for support with mass spectrometry. This work was supported by a SORST program grant from Japan Science and Technology to O. N., by a grant for the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to O. N. and T. S., by grants from MEXT to R. I. and O. N., and by Mitsubishi Foundation and Kurata Memorial Hitachi Science and Technology Foundation grants to O. N. L. B. and K. N. were supported by a postdoctoral fellowship for foreign researchers and a young scientist fellowship, respectively, from the Japan Society for the Promotion of Science.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bjork GR, 1995, TRNA STRUCTURE BIOSY, P165; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ETCHEVERRY T, 1979, CELL, V18, P11, DOI 10.1016/0092-8674(79)90349-0; HARADA F, 1974, BIOCHEMISTRY-US, V13, P300, DOI 10.1021/bi00699a011; Hendrickson TL, 2003, MOL B INT U, P34; Hoang C, 2006, MOL CELL, V24, P535, DOI 10.1016/j.molcel.2006.09.017; Ikeuchi Y, 2005, MOL CELL, V19, P235, DOI 10.1016/j.molcel.2005.06.007; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kimata K, 2001, EMBO J, V20, P3587, DOI 10.1093/emboj/20.13.3587; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Matsugi J, 1996, J BIOCHEM, V119, P811; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; MURAMATSU T, 1988, J BIOL CHEM, V263, P9261; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagaswamy U, 2000, NUCLEIC ACIDS RES, V28, P375, DOI 10.1093/nar/28.1.375; Nakanishi K, 2005, NAT STRUCT MOL BIOL, V12, P931, DOI 10.1038/nsmb988; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P7487, DOI 10.1073/pnas.0501003102; Nakanishi K, 2005, MOL CELLS, V19, P157; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROULD MA, 1991, NATURE, V352, P213, DOI 10.1038/352213a0; SAKANO H, 1978, J MOL BIOL, V123, P287, DOI 10.1016/0022-2836(78)90082-7; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Sugiura I, 2000, STRUCTURE, V8, P197, DOI 10.1016/S0969-2126(00)00095-2; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; WEBER F, 1990, NUCLEIC ACIDS RES, V18, P5027, DOI 10.1093/nar/18.17.5027; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xie W, 2003, NAT STRUCT BIOL, V10, P781, DOI 10.1038/nsb976	39	45	45	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1144	U249		10.1038/nature08474	http://dx.doi.org/10.1038/nature08474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847269				2022-12-24	WOS:000270987600049
J	Sugano, SS; Shimada, T; Imai, Y; Okawa, K; Tamai, A; Mori, M; Hara-Nishimura, I				Sugano, Shigeo S.; Shimada, Tomoo; Imai, Yu; Okawa, Katsuya; Tamai, Atsushi; Mori, Masashi; Hara-Nishimura, Ikuko			Stomagen positively regulates stomatal density in Arabidopsis	NATURE			English	Article							SECRETORY PEPTIDE; CELL-DIVISION; DIFFERENTIATION; MOUTHS; TOO	Stomata in the epidermal tissues of leaves are valves through which passes CO2, and as such they influence the global carbon cycle(1). The two-dimensional pattern and density of stomata in the leaf epidermis are genetically and environmentally regulated to optimize gas exchange(2). Two putative intercellular signalling factors, EPF1 and EPF2, function as negative regulators of stomatal development in Arabidopsis, possibly by interacting with the receptor-like protein TMM3-6. One or more positive intercellular signalling factors are assumed to be involved in stomatal development, but their identities are unknown(7). Here we show that a novel secretory peptide, which we designate as stomagen, is a positive intercellular signalling factor that is conserved among vascular plants. Stomagen is a 45-amino-acid, cysteine-rich peptide that is generated from a 102-amino-acid precursor protein designated as STOMAGEN. Both an in planta analysis and a semi-in-vitro analysis with recombinant and chemically synthesized stomagen peptides showed that stomagen has stomata-inducing activity in a dose-dependent manner. A genetic analysis showed that TMM is epistatic to STOMAGEN (At4g12970), suggesting that stomatal development is finely regulated by competitive binding of positive and negative regulators to the same receptor. Notably, STOMAGEN is expressed in inner tissues (the mesophyll) of immature leaves but not in the epidermal tissues where stomata develop. This study provides evidence of a mesophyll-derived positive regulator of stomatal density. Our findings provide a conceptual advancement in understanding stomatal development: inner photosynthetic tissues optimize their function by regulating stomatal density in the epidermis for efficient uptake of CO2.	[Sugano, Shigeo S.; Shimada, Tomoo; Imai, Yu; Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co Ltd, Innovat Drug Res Labs, Taksasaki 3701295, Japan; [Tamai, Atsushi; Mori, Masashi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	Kyoto University; Kyowa Kirin Ltd; Ishikawa Prefecture University	Hara-Nishimura, I (corresponding author), Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [16085203, 17107002]; Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	We thank T. Nakagawa for donating the TMM:: GFP seeds; K. Yamada for his technical support of quantitative PCR; and Y. Nakata for her technical support of in situ hybridization. We thank J. Raymond for reading and editing the manuscript. We thank the ABRC for providing seeds of Arabidopsis T-DNA insertion lines. This work was supported by Grants-in-Aid for Scientific Research (no. 16085203 and 17107002) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, by the Global Center of Excellence Program 'Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem' of MEXT, and by Japan Science and Technology Agency (JST).	Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, CURR OPIN PLANT BIOL, V7, P26, DOI 10.1016/j.pbi.2003.10.001; Dohi K, 2008, ARCH VIROL, V153, P1667, DOI 10.1007/s00705-008-0165-z; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kono A, 2007, PLANT CELL, V19, P1265, DOI 10.1105/tpc.106.046763; Kunieda T, 2008, PLANT CELL, V20, P2631, DOI 10.1105/tpc.108.060160; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; Nadeau JA, 2009, CURR OPIN PLANT BIOL, V12, P29, DOI 10.1016/j.pbi.2008.10.006; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; SACHS T, 1987, CLONAL BASIS DEV, P161; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Serna L, 2002, NEW PHYTOL, V153, P399, DOI 10.1046/j.0028-646X.2001.00343.x; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016	27	298	329	8	370	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					241	U130		10.1038/nature08682	http://dx.doi.org/10.1038/nature08682			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20010603	Green Published			2022-12-24	WOS:000273582700038
J	Omland, T; de Lemos, JA; Sabatine, MS; Christophi, CA; Rice, MM; Jablonski, KA; Tjora, S; Domanski, MJ; Gersh, BJ; Rouleau, JL; Pfeffer, MA; Braunwald, E				Omland, Torbjorn; de Lemos, James A.; Sabatine, Marc S.; Christophi, Costas A.; Rice, Madeline Murguia; Jablonski, Kathleen A.; Tjora, Solve; Domanski, Michael J.; Gersh, Bernard J.; Rouleau, Jean L.; Pfeffer, Marc A.; Braunwald, Eugene		Prevention Events Angiotensin Conv	A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM MORTALITY; PROGNOSTIC VALUE; HEART; POPULATION; ELEVATION; TRIAL; RISK	BACKGROUND In most patients with stable coronary artery disease, plasma cardiac troponin T levels are below the limit of detection for the conventional assay. The distribution and determinants of very low circulating troponin T levels, as well as their association with cardiovascular events, in such patients are unknown. METHODS We used a new, high-sensitivity assay to determine the concentration of cardiac troponin T in plasma samples from 3679 patients with stable coronary artery disease and preserved left ventricular function. Results of the assay were analyzed in relation to the incidence of cardiovascular events during a median follow-up period of 5.2 years. RESULTS With the highly sensitive assay, concentrations of cardiac troponin T were at or above the limit of detection (0.001 mu g per liter) in 3593 patients (97.7%) and at or above the 99th percentile for apparently healthy subjects (0.0133 mu g per liter) in 407 patients (11.1%). After adjustment for other independent prognostic indicators, there was a strong and graded increase in the cumulative incidence of cardiovascular death (adjusted hazard ratio per unit increase in the natural logarithm of the troponin T level, 2.09; 95% confidence interval [CI], 1.60 to 2.74; P<0.001) and of heart failure (adjusted hazard ratio, 2.20; 95% CI, 1.66 to 2.90; P<0.001) in this study group. Increased risk associated with higher levels of troponin T was evident well below the limit of detection of conventional cardiac troponin T assays and below the 99th percentile of values in a healthy population. There was no association between troponin T levels as measured with the highly sensitive assay and the incidence of myocardial infarction (adjusted hazard ratio, 1.16; 95% CI, 0.97 to 1.40; P = 0.11). CONCLUSIONS After adjustment for other independent prognostic indicators, cardiac troponin T concentrations as measured with a highly sensitive assay were significantly associated with the incidence of cardiovascular death and heart failure but not with myocardial infarction in patients with stable coronary artery disease.	[Omland, Torbjorn] Akershus Univ Hosp, Div Med, NO-1478 Lorenskog, Norway; [Tjora, Solve] Akershus Univ Hosp, Ctr Lab Med, NO-1478 Lorenskog, Norway; [Omland, Torbjorn] Univ Oslo, Akershus Univ Hosp, Fac Div, Oslo, Norway; [Omland, Torbjorn] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Sabatine, Marc S.; Pfeffer, Marc A.; Braunwald, Eugene] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sabatine, Marc S.; Pfeffer, Marc A.; Braunwald, Eugene] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Christophi, Costas A.; Rice, Madeline Murguia; Jablonski, Kathleen A.] George Washington Univ, Ctr Biostat, Rockville, MD USA; [Domanski, Michael J.] NHLBI, Bethesda, MD 20892 USA; [Gersh, Bernard J.] Mayo Clin, Div Cardiovasc Dis, Dept Med, Rochester, MN USA; [Rouleau, Jean L.] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Rouleau, Jean L.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; George Washington University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic; Universite de Montreal; Universite de Montreal	Omland, T (corresponding author), Akershus Univ Hosp, Div Med, NO-1478 Lorenskog, Norway.	torbjorn.omland@medisin.uio.no	Sabatine, Marc/AAJ-6751-2020; de Lemos, James/ABD-6669-2021	Sabatine, Marc/0000-0002-0691-3359; 	NHLBI NIH HHS [N01 HC065149-15] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC065149] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; BELSLEY D. A, 1980, REGRESSION DIAGNOSTI; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Eggers KM, 2007, CIRCULATION, V116, P1907, DOI 10.1161/CIRCULATIONAHA.107.708529; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Gupta S, 2007, PROG CARDIOVASC DIS, V50, P151, DOI 10.1016/j.pcad.2007.01.002; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; James S, 2003, AM J MED, V115, P178, DOI 10.1016/S0002-9343(03)00348-6; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Lindahl B, 2001, J AM COLL CARDIOL, V38, P979, DOI 10.1016/S0735-1097(01)01501-7; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Omland T, 2007, J AM COLL CARDIOL, V50, P205, DOI 10.1016/j.jacc.2007.03.038; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Roberts WL, 2001, CLIN CHEM, V47, P980; Roberts WL, 2001, CLIN CHEM, V47, P418; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wong GC, 2002, CIRCULATION, V106, P202, DOI 10.1161/01.CIR.0000021921.14653.28; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762	21	679	699	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2538	2547		10.1056/NEJMoa0805299	http://dx.doi.org/10.1056/NEJMoa0805299			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	19940289	Green Accepted, Bronze			2022-12-24	WOS:000273003700009
J	Khazeni, N; Hutton, DW; Garber, AM; Owens, DK				Khazeni, Nayer; Hutton, David W.; Garber, Alan M.; Owens, Douglas K.			Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic	ANNALS OF INTERNAL MEDICINE			English	Article							CROSS-REACTIVE IMMUNITY; GUILLAIN-BARRE-SYNDROME; HEALTH-CARE WORKERS; AVIAN INFLUENZA; CLINICAL-TRIAL; OSELTAMIVIR-RESISTANCE; INFECTIOUS-DISEASES; CYTOKINE RESPONSES; ANTI-H5 ANTIBODY; RANDOMIZED-TRIAL	Background: The pandemic potential of influenza A (H5N1) virus is a prominent public health concern of the 21st century. Objective: To estimate the effectiveness and cost-effectiveness of alternative pandemic (H5N1) mitigation and response strategies. Design: Compartmental epidemic model in conjunction with a Markov model of disease progression. Data Sources: Literature and expert opinion. Target Population: Residents of a U. S. metropolitan city with a population of 8.3 million. Time Horizon: Lifetime. Perspective: Societal. Interventions: 3 scenarios: 1) vaccination and antiviral pharmacotherapy in quantities similar to those currently available in the U. S. stockpile (stockpiled strategy), 2) stockpiled strategy but with expanded distribution of antiviral agents (expanded prophylaxis strategy), and 3) stockpiled strategy but with adjuvanted vaccine (expanded vaccination strategy). All scenarios assumed standard nonpharmaceutical interventions. Outcome Measures: Infections and deaths averted, costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness. Results of Base-Case Analysis: Expanded vaccination was the most effective and cost-effective of the 3 strategies, averting 68% of infections and deaths and gaining 404 030 QALYs at $10 844 per QALY gained relative to the stockpiled strategy. Results of Sensitivity Analysis: Expanded vaccination remained incrementally cost-effective over a wide range of assumptions. Limitations: The model assumed homogenous mixing of cases and contacts; heterogeneous mixing would result in faster initial spread, followed by slower spread. We did not model interventions for children or older adults; the model is not designed to target interventions to specific groups. Conclusion: Expanded adjuvanted vaccination is an effective and cost-effective mitigation strategy for an influenza A (H5N1) pandemic. Expanded antiviral prophylaxis can help delay the pandemic while additional strategies are implemented.	[Khazeni, Nayer] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khazeni, N (corresponding author), Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, 300 Pasteur Dr,H3143, Stanford, CA 94305 USA.		Garber, Alan M/F-1476-2010		National Institutes of Health; Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS018003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health and Agency for Healthcare Research and Quality.	Apisarnthanarak A, 2005, CLIN INFECT DIS, V40, pE16, DOI 10.1086/427034; Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Brahmbhatt M, 2006, 1 INT C AV INFL HUM; Bravata DM, 2006, BIOSECUR BIOTERROR, V4, P244, DOI 10.1089/bsp.2006.4.244; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; *BUR VIT STAT, 2007, SUMM VIT STAT 2007 C; *CDCP, SEAS INFL DIS; *CDCP, 2006, FLUSURGE VERS 2 0; Centers for Disease Control and Prevention, KEY FACTS SEAS FLU V; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; CHENG M, 2009, UKS ATTEMPTS STOP SW; Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0; Chotpitayasunondh T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004028; Chutinimitkul S, 2007, J VIROL METHODS, V139, P44, DOI 10.1016/j.jviromet.2006.09.007; *CIDRAP, 2006, NEWS HHS ADDS REL ST; CLARK TW, 2009, N ENGL J MED; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; DAVIES JR, 1984, J HYG-CAMBRIDGE, V92, P125, DOI 10.1017/S002217240006410X; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Evans D, 2009, J INFECT DIS, V200, P321, DOI 10.1086/603560; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; *GLAXOSMITHKLINE P, 2008, REL PACK INS; Goji NA, 2008, J INFECT DIS, V198, P635, DOI 10.1086/590916; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Keitel WA, 2008, J INFECT DIS, V198, P1309, DOI 10.1086/592172; Khazeni N, 2009, ANN INTERN MED, V151, P464, DOI 10.7326/0003-4819-151-7-200910060-00143; KISSEL JT, 2001, DIAGNOSIS MANAGEMENT; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; KUNG H, 2005, NATL VITAL STAT REPO, V56; Larson RC, 2007, OPER RES, V55, P399, DOI 10.1287/opre.1070.0399; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; Liem NT, 2005, EMERG INFECT DIS, V11, P210, DOI 10.3201/eid1102.041075; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Massarella JW, 2000, J CLIN PHARMACOL, V40, P836, DOI 10.1177/00912700022009567; Matassov D, 2007, VIRAL IMMUNOL, V20, P441, DOI 10.1089/vim.2007.0027; McKibbin WJ, 2006, GLOBAL MACROECONOMIC; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Neustadt RE, 1978, SWINE FLU AFFAIR DEC, DOI [10.17226/12660, DOI 10.17226/12660]; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Nolan T, 2008, VACCINE, V26, P6383, DOI 10.1016/j.vaccine.2008.08.046; *ROCH PHARM, 2008, TAM PACK INS; Rumke HC, 2008, VACCINE, V26, P2378, DOI 10.1016/j.vaccine.2008.02.068; Sangrujee N, 2004, B WORLD HEALTH ORGAN, V82, P9; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Smith CB, 2002, J INFECT DIS, V185, P980, DOI 10.1086/339416; SONOGUCHI T, 1986, J INFECT DIS, V153, P33, DOI 10.1093/infdis/153.1.33; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Talbird SE, 2009, AM J HEALTH-SYST PH, V66, P469, DOI 10.2146/ajhp080296; Taubenberger JK, 2005, ARCH VIROL, P101; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thorpe LE, 2004, EMERG INFECT DIS, V10, P917; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699; Turner DA, 2006, VACCINE, V24, P1035, DOI 10.1016/j.vaccine.2004.12.033; U.S. Department of Health and Human Services, PAND INFL PLAN; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; *US BUR CENS, 2009 STAT ABSTR US; *US DEP HHS, PAND FLU PLAN; *US DEP HHS, COMM STRAT PAND INFL; *US DEP HHS, PAND PLANN UPD 6; *US DEP HHS, PAND PAND SCAR 20 CE; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; *WHO, 2009, GLOB AL RESP GAR; *WHO, 2009, SUMM WHO VIRT CONS S; *WHO, GLOB AL RESP GAR VAC; WHO (World Health Organization), 2011, GLOB AL RESP GAR INF; World Health Organization, GLOB AL RESP GAR AV; Wright PF, 2008, NEW ENGL J MED, V358, P2540, DOI 10.1056/NEJMp0803650; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321; Zverev V. V., 2007, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P10; 2006, METLIFE SURVEY NURS; 2007, SAN JOSE MERCUR 0617	103	30	30	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2009	151	12					840	U3		10.7326/0000605-200912150-00156	http://dx.doi.org/10.7326/0000605-200912150-00156			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532ET	20008760				2022-12-24	WOS:000272728900002
J	Sinsabaugh, RL; Hill, BH; Shah, JJF				Sinsabaugh, Robert L.; Hill, Brian H.; Shah, Jennifer J. Follstad			Ecoenzymatic stoichiometry of microbial organic nutrient acquisition in soil and sediment	NATURE			English	Article							ECOLOGICAL STOICHIOMETRY; THEORETICAL-MODEL; METABOLIC THEORY; ENZYME-ACTIVITY; CARBON BUDGET; GLOBAL-SCALE; TEMPERATURE; TERRESTRIAL; LIMITATION; PHOSPHORUS	Biota can be described in terms of elemental composition, expressed as an atomic ratio of carbon: nitrogen: phosphorus (refs 1-3). The elemental stoichiometry of microoorganisms is fundamental for understanding the production dynamics and biogeochemical cycles of ecosystems because microbial biomass is the trophic base of detrital food webs(4-6). Here we show that heterotrophic microbial communities of diverse composition from terrestrial soils and freshwater sediments share a common functional stoichiometry in relation to organic nutrient acquisition. The activities of four enzymes that catalyse the hydrolysis of assimilable products from the principal environmental sources of C, N and P show similar scaling relationships over several orders of magnitude, with a mean ratio for C: N: P activities near 1:1:1 in all habitats. We suggest that these ecoenzymatic ratios reflect the equilibria between the elemental composition of microbial biomass and detrital organic matter and the efficiencies of microbial nutrient assimilation and growth. Because ecoenzymatic activities intersect the stoichiometric and metabolic theories of ecology(7-9), they provide a functional measure of the threshold at which control of community metabolism shifts from nutrient to energy flow.	[Sinsabaugh, Robert L.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Hill, Brian H.] US EPA, Natl Hlth & Environm Effects Lab, Duluth, MN 55804 USA; [Shah, Jennifer J. Follstad] Duke Univ, Dept Biol, Durham, NC 27708 USA	University of New Mexico; United States Environmental Protection Agency; Duke University	Sinsabaugh, RL (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rlsinsab@unm.edu			National Science Foundation [DBI-0630558]	National Science Foundation(National Science Foundation (NSF))	J.J.F.S. was supported by the National Science Foundation (DBI-0630558).	Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Allison SD, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P704; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burns R. G., 2002, ENZYMES ENV ACTIVITY; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Frost PC, 2006, ECOL LETT, V9, P774, DOI 10.1111/j.1461-0248.2006.00919.x; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P11923, DOI 10.1073/pnas.0504756102; Herron PM, 2009, SOIL BIOL BIOCHEM, V41, P1262, DOI 10.1016/j.soilbio.2009.03.010; Hill BH, 2006, FRESHWATER BIOL, V51, P1670, DOI 10.1111/j.1365-2427.2006.01606.x; Hill BH, 2010, BIOGEOCHEMISTRY, V97, P195, DOI 10.1007/s10533-009-9366-0; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; REDFIELD AC, 1958, AM SCI, V46, P205; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sand-Jensen K, 2007, FRESHWATER BIOL, V52, P2340, DOI 10.1111/j.1365-2427.2007.01852.x; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Sinsabaugh RL, 2005, BIOGEOCHEMISTRY, V75, P201, DOI 10.1007/s10533-004-7112-1; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; SINSABAUGH RL, ECOL MONOGR IN PRESS; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; [No title captured]	30	690	803	135	1117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					795	U117		10.1038/nature08632	http://dx.doi.org/10.1038/nature08632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010687				2022-12-24	WOS:000272559900040
J	Brown, RE				Brown, Raeford E., Jr.			Don't Touch Me	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rbrow1@email.uky.edu		Brown, Raeford/0000-0002-2295-2657					0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2409	2410		10.1001/jama.2009.1675	http://dx.doi.org/10.1001/jama.2009.1675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996391				2022-12-24	WOS:000272520500001
J	Zempsky, WT				Zempsky, William T.			Treatment of Sickle Cell Pain Fostering Trust and Justice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOSPITAL-CARE; DISEASE; HEALTH		Univ Connecticut, Sch Med, Pain Relief Program, Connecticut Childrens Med Ctr, Hartford, CT 06106 USA	Connecticut Children's Medical Center; University of Connecticut	Zempsky, WT (corresponding author), Univ Connecticut, Sch Med, Pain Relief Program, Connecticut Childrens Med Ctr, 282 Washington St, Hartford, CT 06106 USA.	wzempsk@ccmckids.org			NHLBI NIH HHS [1 K23 HL090832-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL090832] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brousseau DC, 2009, PEDIATR BLOOD CANCER, V53, P174, DOI 10.1002/pbc.22039; Jackson B, 2006, REV GEN PSYCHOL, V10, P21, DOI 10.1037/1089-2680.10.1.21; Kirsh KL, 2002, CLIN J PAIN, V18, pS52, DOI 10.1097/00002508-200207001-00006; Maxwell K, 1999, BRIT MED J, V318, P1585, DOI 10.1136/bmj.318.7198.1585; Shapiro BS, 1997, J PAIN SYMPTOM MANAG, V14, P168, DOI 10.1016/S0885-3924(97)00019-5; Solomon LR, 2008, BLOOD, V111, P997, DOI 10.1182/blood-2007-07-089144; Substance Abuse and Mental Health Services Administration, 2007, NSDUH SER H, VSMA 06-4194; Tanabe P, 2007, ACAD EMERG MED, V14, P419, DOI 10.1197/j.aem.2006.11.033; Todd KH, 2006, J PAIN, V7, P453, DOI 10.1016/j.jpain.2006.05.004; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0	10	48	48	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2479	2480		10.1001/jama.2009.1811	http://dx.doi.org/10.1001/jama.2009.1811			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996405				2022-12-24	WOS:000272520500029
J	Seidelt, B; Innis, CA; Wilson, DN; Gartmann, M; Armache, JP; Villa, E; Trabuco, LG; Becker, T; Mielke, T; Schulten, K; Steitz, TA; Beckmann, R				Seidelt, Birgit; Innis, C. Axel; Wilson, Daniel N.; Gartmann, Marco; Armache, Jean-Paul; Villa, Elizabeth; Trabuco, Leonardo G.; Becker, Thomas; Mielke, Thorsten; Schulten, Klaus; Steitz, Thomas A.; Beckmann, Roland			Structural Insight into Nascent Polypeptide Chain-Mediated Translational Stalling	SCIENCE			English	Article							PEPTIDYL TRANSFERASE CENTER; TNA OPERON EXPRESSION; RIBOSOMAL EXIT TUNNEL; TRYPTOPHAN INDUCTION; TRANSFER-RNA; MECHANISM; ARREST; REQUIRES; FEATURES	Expression of the Escherichia coli tryptophanase operon depends on ribosome stalling during translation of the upstream TnaC leader peptide, a process for which interactions between the TnaC nascent chain and the ribosomal exit tunnel are critical. We determined a 5.8 angstrom-resolution cryo-electron microscopy and single-particle reconstruction of a ribosome stalled during translation of the tnaC leader gene. The nascent chain was extended within the exit tunnel, making contacts with ribosomal components at distinct sites. Upon stalling, two conserved residues within the peptidyltransferase center adopted conformations that preclude binding of release factors. We propose a model whereby interactions within the tunnel are relayed to the peptidyltransferase center to inhibit translation. Moreover, we show that nascent chains adopt distinct conformations within the ribosomal exit tunnel.	[Innis, C. Axel; Steitz, Thomas A.] Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Seidelt, Birgit; Wilson, Daniel N.; Gartmann, Marco; Armache, Jean-Paul; Becker, Thomas; Beckmann, Roland] Univ Munich, Dept Chem & Biochem, CIPSM, D-81377 Munich, Germany; [Seidelt, Birgit; Wilson, Daniel N.; Gartmann, Marco; Armache, Jean-Paul; Becker, Thomas; Beckmann, Roland] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Villa, Elizabeth; Steitz, Thomas A.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Villa, Elizabeth; Trabuco, Leonardo G.; Schulten, Klaus] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Schulten, Klaus] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Howard Hughes Medical Institute; Yale University; University of Munich; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society; University of Illinois System; University of Illinois Urbana-Champaign	Steitz, TA (corresponding author), Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	thomas.steitz@yale.edu; beckmann@lmb.uni-muenchen.de	Trabuco, Leonardo G/E-3191-2010; Wilson, Daniel/AAE-8504-2019; Steitz, Thomas A./C-6559-2009; Schulten, Klaus/D-5561-2009; Innis, Axel/P-9863-2019; Armache, Jean-Paul/U-3113-2019; Villa, Elizabeth/D-1811-2010; Innis, Axel/A-5927-2009	Wilson, Daniel/0000-0003-3816-3828; Innis, Axel/0000-0003-3153-9490; Villa, Elizabeth/0000-0003-4677-9809; Innis, Axel/0000-0003-3153-9490; Armache, Jean-Paul/0000-0001-9195-2282	Deutsche Forschungsgemeinschaft [SFB594, SFB646, SFB740, WI3285/1-1]; NIH [GM022778, P41-RR05969]; NSF [PHY0822613, MCA93S028]; European Union and Senatsverwaltung fur Wissenschaft; Forschung und Kultur Berlin; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Union and Senatsverwaltung fur Wissenschaft(European Commission); Forschung und Kultur Berlin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grants from the Deutsche Forschungsgemeinschaft SFB594 and SFB646 ( to R. B.), SFB740 ( to T. M.), and WI3285/1-1 ( to D. N. W.); by NIH grants GM022778 ( to T. A. S.) and P41-RR05969 ( to K. S.); by NSF grant PHY0822613 ( to K. S.); and by the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum). Computer time for MDFF was provided through an NSF Large Resources Allocation Committee grant MCA93S028. Coordinates of the atomic models of TnaC-70S complex have been deposited in the PDB under accession numbers 2WWL (30S) and 2WWQ (50S). The cryo-EM map has been deposited in the 3D-EM database under accession number EMD-1657.	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; Cruz-Vera LR, 2008, J BACTERIOL, V190, P4791, DOI 10.1128/JB.00290-08; Cruz-Vera LR, 2007, J BACTERIOL, V189, P3140, DOI 10.1128/JB.01869-06; de Bakker PI, 2006, CURR OPIN STRUC BIOL, V16, P160, DOI 10.1016/j.sbi.2006.02.001; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Mitra K, 2006, MOL CELL, V22, P533, DOI 10.1016/j.molcel.2006.05.003; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Oliver D, 1998, J BACTERIOL, V180, P5240, DOI 10.1128/JB.180.19.5240-5242.1998; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Simonovic M, 2009, BBA-GENE REGUL MECH, V1789, P612, DOI 10.1016/j.bbagrm.2009.06.006; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yang R, 2009, J BACTERIOL, V191, P3445, DOI 10.1128/JB.00096-09; Yap MN, 2009, MOL CELL, V34, P201, DOI 10.1016/j.molcel.2009.04.002	26	207	212	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1412	1415		10.1126/science.1177662	http://dx.doi.org/10.1126/science.1177662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933110	Green Accepted			2022-12-24	WOS:000272351100046
J	Krepkiy, D; Mihailescu, M; Freites, JA; Schow, EV; Worcester, DL; Gawrisch, K; Tobias, DJ; White, SH; Swartz, KJ				Krepkiy, Dmitriy; Mihailescu, Mihaela; Freites, J. Alfredo; Schow, Eric V.; Worcester, David L.; Gawrisch, Klaus; Tobias, Douglas J.; White, Stephen H.; Swartz, Kenton J.			Structure and hydration of membranes embedded with voltage-sensing domains	NATURE			English	Article							DEPENDENT K+ CHANNEL; MOLECULAR-DYNAMICS SIMULATIONS; NEUTRON-DIFFRACTION DATA; FOCUSED ELECTRIC-FIELD; PARTICLE MESH EWALD; POTASSIUM CHANNEL; GATING-CHARGE; X-RAY; LIPID-MEMBRANE; FUNCTIONAL RECONSTITUTION	Despite the growing number of atomic-resolution membrane protein structures, direct structural information about proteins in their native membrane environment is scarce. This problem is particularly relevant in the case of the highly charged S1-S4 voltage-sensing domains responsible for nerve impulses, where interactions with the lipid bilayer are critical for the function of voltage-activated ion channels. Here we use neutron diffraction, solid-state nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics simulations to investigate the structure and hydration of bilayer membranes containing S1-S4 voltage-sensing domains. Our results show that voltage sensors adopt transmembrane orientations and cause a modest reshaping of the surrounding lipid bilayer, and that water molecules intimately interact with the protein within the membrane. These structural findings indicate that voltage sensors have evolved to interact with the lipid membrane while keeping energetic and structural perturbations to a minimum, and that water penetrates the membrane, to hydrate charged residues and shape the transmembrane electric field.	[Mihailescu, Mihaela; Freites, J. Alfredo; Worcester, David L.; White, Stephen H.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Mihailescu, Mihaela; Freites, J. Alfredo; Worcester, David L.; White, Stephen H.] Univ Calif Irvine, Ctr Biomembrane Syst, Irvine, CA 92697 USA; [Freites, J. Alfredo; Tobias, Douglas J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Freites, J. Alfredo; Tobias, Douglas J.] Univ Calif Irvine, Inst Surface & Interface Sci, Irvine, CA 92697 USA; [Schow, Eric V.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Schow, Eric V.] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Mihailescu, Mihaela; Worcester, David L.; White, Stephen H.] NIST, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Worcester, David L.] Univ Missouri, Div Biol, Columbia, MO 65211 USA; [Gawrisch, Klaus] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA; [Krepkiy, Dmitriy; Swartz, Kenton J.] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National Institute of Standards & Technology (NIST) - USA; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	White, SH (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	stephen.white@uci.edu; swartzk@ninds.nih.gov	Freites, J. Alfredo/S-8027-2017; White, Stephen H/B-1053-2009; Tobias, Douglas J/B-6799-2015	Freites, J. Alfredo/0000-0001-5842-7443; White, Stephen H/0000-0001-8540-7907; 	Intramural Research Programs of the NINDS, NIH [GM86685]; National Institute on Alcohol Abuse and Alcoholism, NIH [GM74737]; National Institute of General Medical Science; US National Science Foundation (NSF) [CHE-0750175]; Division Of Chemistry [0750175] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074637, R01GM074737, P01GM086685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER	Intramural Research Programs of the NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Alcohol Abuse and Alcoholism, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank the US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) DNA sequencing facility for DNA sequencing, H. Jaffe in the NINDS protein sequencing facility for mass spectrometry and peptide sequencing and T. Kitaguchi for cloning KvAP. We also thank T. Kimura, M. Mayer, M. Milescu, J. Mindell and S. Silberberg for discussions. This work was supported by the Intramural Research Programs of the NINDS, NIH ( K. J. S.), and the National Institute on Alcohol Abuse and Alcoholism, NIH ( K. G.); NIH grants GM74737 ( S. H. W.) and Program Project GM86685 from the NINDS and the National Institute of General Medical Science ( S. H. W., D. J. T.); and US National Science Foundation (NSF) grant CHE-0750175 ( D. J. T.). We are grateful for allocation of computer time on the NSF-supported Teragrid resources provided by the Texas Advanced Computing Center, and the support of the National Institute of Standards and Technology, US Department of Commerce, in providing the neutron research facilities used for neutron diffraction experiments. The identification of any commercial product or trade name does not imply endorsement or recommendation by the US National Institute of Standards and Technology.	ABRAMS FS, 1993, BIOCHEMISTRY-US, V32, P10826, DOI 10.1021/bi00091a038; Ader C, 2009, J AM CHEM SOC, V131, P170, DOI 10.1021/ja806306e; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Benz RW, 2005, BIOPHYS J, V88, P805, DOI 10.1529/biophysj.104.046821; BLASIE JK, 1976, BROOKHAVEN SYM BIOL, pR58; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Dura JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219744; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Freites JA, 2006, BIOPHYS J, V91, pL90, DOI 10.1529/biophysj.106.096065; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Grubmuller H, 1991, MOL SIMULAT, V6, P121, DOI 10.1080/08927029108022142; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hristova K, 1998, BIOPHYS J, V74, P2419, DOI 10.1016/S0006-3495(98)77950-0; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HURST RO, 1964, CAN J BIOCHEM PHYS, V42, P287, DOI 10.1139/o64-033; JACOBS RE, 1989, BIOCHEMISTRY-US, V28, P3421, DOI 10.1021/bi00434a042; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2005, J PHYS CHEM B, V109, P5300, DOI 10.1021/jp0468096; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Laitko U, 2006, J GEN PHYSIOL, V127, P687, DOI 10.1085/jgp.200509394; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee A G, 1994, Methods Mol Biol, V27, P101; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Lindahl E, 2008, CURR OPIN STRUC BIOL, V18, P425, DOI 10.1016/j.sbi.2008.02.003; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P1783, DOI 10.1021/bi00380a042; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Neale EJ, 2007, J BIOL CHEM, V282, P37597, DOI 10.1074/jbc.M706437200; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roux B, 1997, BIOPHYS J, V73, P2980, DOI 10.1016/S0006-3495(97)78327-9; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Soubias O, 2005, J AM CHEM SOC, V127, P13110, DOI 10.1021/ja0538942; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Tabarean IV, 1999, BIOPHYS J, V77, P758, DOI 10.1016/S0006-3495(99)76930-4; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Treptow W, 2006, BIOPHYS J, V90, pL64, DOI 10.1529/biophysj.106.080754; Vamvouka M, 2008, PROTEIN SCI, V17, P506, DOI 10.1110/ps.073310008; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; WIENER MC, 1991, BIOPHYS J, V60, P568, DOI 10.1016/S0006-3495(91)82086-0; WIENER MC, 1991, BIOCHEMISTRY-US, V30, P6997, DOI 10.1021/bi00242a027; WORCESTER DL, 1976, J MOL BIOL, V100, P359, DOI 10.1016/S0022-2836(76)80068-X; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	81	160	160	0	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					473	U168		10.1038/nature08542	http://dx.doi.org/10.1038/nature08542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940918	Green Accepted, Green Submitted			2022-12-24	WOS:000272144200036
J	Aanen, DK; Licht, HHD; Debets, AJM; Kerstes, NAG; Hoekstra, RF; Boomsma, JJ				Aanen, Duur K.; Licht, Henrik H. de Fine; Debets, Alfons J. M.; Kerstes, Niels A. G.; Hoekstra, Rolf F.; Boomsma, Jacobus J.			High Symbiont Relatedness Stabilizes Mutualistic Cooperation in Fungus-Growing Termites	SCIENCE			English	Article							MACROTERMES-NATALENSIS; EVOLUTION; TERMITOMYCES; AGRICULTURE; ISOPTERA; HOST; ANTS; INCOMPATIBILITY; TRANSMISSION; CONFLICT	It is unclear how mutualistic relationships can be stable when partners disperse freely and have the possibility of forming associations with many alternative genotypes. Theory predicts that high symbiont relatedness should resolve this problem, but the mechanisms to enforce this have rarely been studied. We show that African fungus-growing termites propagate single variants of their Termitomyces symbiont, despite initiating cultures from genetically variable spores from the habitat. High inoculation density in the substrate followed by fusion among clonally related mycelia enhances the efficiency of spore production in proportion to strain frequency. This positive reinforcement results in an exclusive lifetime association of each host colony with a single fungal symbiont and hinders the evolution of cheating. Our findings explain why vertical symbiont transmission in fungus-growing termites is rare and evolutionarily derived.	[Aanen, Duur K.; Debets, Alfons J. M.; Kerstes, Niels A. G.; Hoekstra, Rolf F.] Wageningen Univ, Genet Lab, NL-6700 AH Wageningen, Netherlands; [Licht, Henrik H. de Fine; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark	Wageningen University & Research; University of Copenhagen	Aanen, DK (corresponding author), Wageningen Univ, Genet Lab, NL-6700 AH Wageningen, Netherlands.	duur.aanen@wur.nl	de Fine Licht, Henrik Hjarvard/G-3307-2014; Boomsma, Jacobus J/M-2785-2014	de Fine Licht, Henrik Hjarvard/0000-0003-3326-5729; Boomsma, Jacobus J/0000-0002-3598-1609	Netherlands Organization for Scientific Research-Vidi; C. T. de Wit Graduate School for Production Ecology and Resource Conservation; Wageningen University, Netherlands; Danish National Research Foundation; Danish Natural Science Research Council-STENO	Netherlands Organization for Scientific Research-Vidi(Netherlands Organization for Scientific Research (NWO)); C. T. de Wit Graduate School for Production Ecology and Resource Conservation; Wageningen University, Netherlands(Netherlands Government); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council-STENO	We were supported by fellowships from the Netherlands Organization for Scientific Research-Vidi (D. K. A.); the C. T. de Wit Graduate School for Production Ecology and Resource Conservation, Wageningen University, Netherlands (D. K. A.); the Danish National Research Foundation (J. J. B.); and the Danish Natural Science Research Council-STENO (D. K. A.). We thank A. de Visser for help with statistical analyses and for comments on an earlier version of the manuscript, T. Nobre for comments, B. Nieuwenhuis for help with the figures, and the Forestry and Agricultural Biotechnology Institute (FABI) team led by M. Wingfield at the University of Pretoria for providing facilities during field and laboratory work.	Aanen DK, 2005, CURR BIOL, V15, P851, DOI 10.1016/j.cub.2005.03.043; Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Aanen DK, 2006, BIOL LETT-UK, V2, P209, DOI 10.1098/rsbl.2005.0424; Aanen DK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-115; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P189; Brandl R, 2007, MOL PHYLOGENET EVOL, V45, P239, DOI 10.1016/j.ympev.2007.07.007; BULL JJ, 1991, J THEOR BIOL, V149, P63, DOI 10.1016/S0022-5193(05)80072-4; Chamberlain M, 1997, ADV BOT RES, V24, P71; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Darlington Johanna P. E. C., 1994, P105; de Fine Licht HH, 2005, MYCOL RES, V109, P314, DOI 10.1017/S0953756204001844; EMERSON ALFRED E., 1955, FIELDIANA ZOOL, V37, P465; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Frank SA, 1997, AM NAT, V150, pS80, DOI 10.1086/286051; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Kambhampati S, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P1; Katoh H, 2002, MOL ECOL, V11, P1565, DOI 10.1046/j.1365-294X.2002.01535.x; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Korb J, 2003, BEHAV ECOL SOCIOBIOL, V53, P65, DOI 10.1007/s00265-002-0559-y; LEUTHOLD RH, 1989, INSECT SOC, V36, P328, DOI 10.1007/BF02224884; Licht HHF, 2006, MOL ECOL, V15, P3131, DOI 10.1111/j.1365-294X.2006.03008.x; Micali CO, 2003, FUNGAL GENET BIOL, V38, P209, DOI 10.1016/S1087-1845(02)00533-9; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Rouland-Lefevre C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P289; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Szathmary E, 1995, MAJOR TRANSITIONS EV; Wood T.G., 1989, P69; Worrall JJ, 1997, MYCOLOGIA, V89, P24, DOI 10.2307/3761169	34	103	108	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 20	2009	326	5956					1103	1106		10.1126/science.1173462	http://dx.doi.org/10.1126/science.1173462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965427				2022-12-24	WOS:000271951000041
J	Yazaki-Sugiyama, Y; Kang, S; Cateau, H; Fukai, T; Hensch, TK				Yazaki-Sugiyama, Yoko; Kang, Siu; Cateau, Hideyuki; Fukai, Tomoki; Hensch, Takao K.			Bidirectional plasticity in fast-spiking GABA circuits by visual experience	NATURE			English	Article							CRITICAL PERIOD PLASTICITY; DEPENDENT PLASTICITY; INTRACELLULAR BLOCKADE; MONOCULAR DEPRIVATION; OCULAR DOMINANCE; CORTEX; INHIBITION; RESPONSES; NEURONS; SYNAPSES	Experience-dependent plasticity in the brain requires balanced excitation-inhibition1. How individual circuit elements contribute to plasticity outcome in complex neocortical networks remains unknown. Here we report an intracellular analysis of ocular dominance plasticity-the loss of acuity and cortical responsiveness for an eye deprived of vision in early life2,3. Unlike the typical progressive loss of pyramidal-cell bias, direct recording from fast-spiking cells in vivo reveals a counterintuitive initial shift towards the occluded eye followed by a late preference for the open eye, consistent with a spike-timing-dependent plasticity rule for these inhibitory neurons. Intracellular pharmacology confirms a dynamic switch of GABA (c-aminobutyric acid) impact to pyramidal cells following deprivation in juvenile mice only. Together these results suggest that the bidirectional recruitment of an initially binocular GABA circuit may contribute to experience-dependent plasticity in the developing visual cortex.	[Yazaki-Sugiyama, Yoko; Hensch, Takao K.] CREST, JST, Osaka 5600082, Japan; [Yazaki-Sugiyama, Yoko; Hensch, Takao K.] RIKEN Brain Sci Inst, Lab Neuronal Circuit Dev, Saitama 3510198, Japan; [Kang, Siu; Cateau, Hideyuki; Fukai, Tomoki] RIKEN Brain Science Institute, Lab Neural Circuit Theory, Saitama 3510198, Japan	Japan Science & Technology Agency (JST); RIKEN; RIKEN			Hensch, Takao/L-4182-2019; Yazaki-Sugiyama, Yoko/G-4950-2015; Fukai, Tomoki/A-3936-2015; Cateau, Hideyuki/R-9446-2016	Yazaki-Sugiyama, Yoko/0000-0003-2052-4162; Fukai, Tomoki/0000-0001-6977-5638; Cateau, Hideyuki/0000-0002-8861-0916				Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Dudek SM, 1996, J NEUROPHYSIOL, V75, P2167, DOI 10.1152/jn.1996.75.5.2167; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; Erisir A, 2005, J COMP NEUROL, V485, P11, DOI 10.1002/cne.20507; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; INOMATA N, 1988, NEUROSCI RES, V6, P72, DOI 10.1016/0168-0102(88)90007-7; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Levi DM, 2009, PHILOS T R SOC B, V364, P399, DOI 10.1098/rstb.2008.0203; Lu JT, 2007, J NEUROSCI, V27, P9711, DOI 10.1523/JNEUROSCI.2513-07.2007; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mainardi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004342; Mancilla JG, 2001, VISUAL NEUROSCI, V18, P9, DOI 10.1017/S0952523801181022; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	30	142	144	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 12	2009	462	7270					218	221		10.1038/nature08485	http://dx.doi.org/10.1038/nature08485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907494				2022-12-24	WOS:000271655100048
J	Keel, SB; Abkowitz, JL				Keel, Sioban B.; Abkowitz, Janis L.			The Microcytic Red Cell and the Anemia of Inflammation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IRON; FERROPORTIN		[Keel, Sioban B.; Abkowitz, Janis L.] Univ Washington, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Keel, SB (corresponding author), Univ Washington, Div Hematol, Seattle, WA 98195 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031823] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL031823] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; MCANS R, 2006, CLIN HEMATOLOGY; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	5	36	37	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1904	1906		10.1056/NEJMcibr0906391	http://dx.doi.org/10.1056/NEJMcibr0906391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514OZ	19890136	Green Accepted			2022-12-24	WOS:000271405800021
J	Trimboli, AJ; Cantemir-Stone, CZ; Li, F; Wallace, JA; Merchant, A; Creasap, N; Thompson, JC; Caserta, E; Wang, H; Chong, JL; Naidu, S; Wei, G; Sharma, SM; Stephens, JA; Fernandez, SA; Gurcan, MN; Weinstein, MB; Barsky, SH; Yee, L; Rosol, TJ; Stromberg, PC; Robinson, ML; Pepin, F; Hallett, M; Park, M; Ostrowski, MC; Leone, G				Trimboli, Anthony J.; Cantemir-Stone, Carmen Z.; Li, Fu; Wallace, Julie A.; Merchant, Anand; Creasap, Nicholas; Thompson, John C.; Caserta, Enrico; Wang, Hui; Chong, Jean-Leon; Naidu, Shan; Wei, Guo; Sharma, Sudarshana M.; Stephens, Julie A.; Fernandez, Soledad A.; Gurcan, Metin N.; Weinstein, Michael B.; Barsky, Sanford H.; Yee, Lisa; Rosol, Thomas J.; Stromberg, Paul C.; Robinson, Michael L.; Pepin, Francois; Hallett, Michael; Park, Morag; Ostrowski, Michael C.; Leone, Gustavo			Pten in stromal fibroblasts suppresses mammary epithelial tumours	NATURE			English	Article							BREAST-CANCER; GENE-EXPRESSION; ETS-2 PHOSPHORYLATION; EXTRACELLULAR-MATRIX; NEGATIVE REGULATION; CELL-SURVIVAL; PI3K PATHWAY; GROWTH; ACTIVATION; SIGNATURE	The tumour stroma is believed to contribute to some of the most malignant characteristics of epithelial tumours. However, signalling between stromal and tumour cells is complex and remains poorly understood. Here we show that the genetic inactivation of Pten in stromal fibroblasts of mouse mammary glands accelerated the initiation, progression and malignant transformation of mammary epithelial tumours. This was associated with the massive remodelling of the extracellular matrix (ECM), innate immune cell infiltration and increased angiogenesis. Loss of Pten in stromal fibroblasts led to increased expression, phosphorylation (T72) and recruitment of Ets2 to target promoters known to be involved in these processes. Remarkably, Ets2 inactivation in Pten stroma-deleted tumours ameliorated disruption of the tumour microenvironment and was sufficient to decrease tumour growth and progression. Global gene expression profiling of mammary stromal cells identified a Pten-specific signature that was highly represented in the tumour stroma of patients with breast cancer. These findings identify the Pten-Ets2 axis as a critical stroma-specific signalling pathway that suppresses mammary epithelial tumours.	[Cantemir-Stone, Carmen Z.; Li, Fu; Wallace, Julie A.; Merchant, Anand; Wei, Guo; Sharma, Sudarshana M.; Ostrowski, Michael C.] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Trimboli, Anthony J.; Li, Fu; Creasap, Nicholas; Thompson, John C.; Caserta, Enrico; Wang, Hui; Chong, Jean-Leon; Naidu, Shan; Wei, Guo; Weinstein, Michael B.; Leone, Gustavo] Ohio State Univ, Dept Mol Genet, Coll Biol Sci, Columbus, OH 43210 USA; [Trimboli, Anthony J.; Creasap, Nicholas; Thompson, John C.; Caserta, Enrico; Wang, Hui; Chong, Jean-Leon; Naidu, Shan; Weinstein, Michael B.; Leone, Gustavo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Naidu, Shan; Rosol, Thomas J.; Stromberg, Paul C.] Ohio State Univ, Dept Vet Biosci, Coll Vet Med, Columbus, OH 43210 USA; [Stephens, Julie A.; Fernandez, Soledad A.] Ohio State Univ, Ctr Biostat, Off Hlth Sci, Columbus, OH 43210 USA; [Gurcan, Metin N.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Barsky, Sanford H.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Yee, Lisa] Ohio State Univ, Dept Surg, Sch Med, Columbus, OH 43210 USA; [Robinson, Michael L.] Columbus Childrens Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; [Pepin, Francois; Hallett, Michael; Park, Morag] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Pepin, Francois; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; [Ostrowski, Michael C.; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Tumor Microenvironm Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; McGill University; McGill University; McGill University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Ostrowski, MC (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu; gustavo.leone@osumc.edu	Rosol, Thomas/G-9585-2011; Li, Fu/E-7072-2011; Sharma, Sudarshana Mangalore/AAI-2475-2019; Merchant, Anand/B-3467-2010; Peng, Chunwei/F-6788-2010; Ostrowski, Michael/H-3108-2011	Rosol, Thomas/0000-0003-3737-1190; Hallett, Michael/0000-0001-6738-6786; Sharma, Sudarshana/0000-0002-9745-0061; Gurcan, Metin/0000-0002-2421-8229; Ostrowski, Michael/0000-0003-2948-6297	National Institutes of Health [R01CA85619, R01HD47470, P01CA097189, R01CA053271]; Komen Breast Cancer Foundation; Evelyn Simmers Charitable Trust; Terry Fox New Frontiers Group Grant; Natural Science and Engineering Research Council of Canada Discovery Grants Program; Department of Defense Pre- doctoral Fellowships; Department of Defense Postdoctoral Fellowship; Pew Charitable Trusts Scholar Award; Leukemia and Lymphoma Society Scholar Award; Diane and Sal Guerrera Chair in Cancer Genetics at McGill University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA053271, R01CA085619, R01CA121275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Evelyn Simmers Charitable Trust; Terry Fox New Frontiers Group Grant; Natural Science and Engineering Research Council of Canada Discovery Grants Program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Defense Pre- doctoral Fellowships(United States Department of Defense); Department of Defense Postdoctoral Fellowship(United States Department of Defense); Pew Charitable Trusts Scholar Award; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Diane and Sal Guerrera Chair in Cancer Genetics at McGill University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Rawahneh and J. Moffitt for histotechnical assistance, K. Kornacker, S. Cory and I. Vasudeva Murthy for bioinformatics assistance, P. Gulati for statistics assistance, the Ohio State University Human Tissue Resource Network and the Ohio State University Comprehensive Cancer Center Microarray, Nucleic Acids, Trangenics and Flow Cytometry Shared Facilities for technical assistance. MMTV-ErbB2 mice were provided by W. Muller. This work was funded by the National Institutes of Health to G. L. (R01CA85619, R01HD47470, P01CA097189) and to M. C. O. (R01CA053271, P01CA097189), by the Komen Breast Cancer Foundation and Evelyn Simmers Charitable Trust to M. C. O., by the Terry Fox New Frontiers Group Grant to M. P., and by the Natural Science and Engineering Research Council of Canada Discovery Grants Program grant to M. H. F. L. and F. P. were funded by Department of Defense Pre- doctoral Fellowships and J.-L. C. was funded by a Department of Defense Postdoctoral Fellowship. G. L. is the recipient of the Pew Charitable Trusts Scholar Award and the Leukemia and Lymphoma Society Scholar Award. M. P. holds the Diane and Sal Guerrera Chair in Cancer Genetics at McGill University.	Allred DC, 1998, MODERN PATHOL, V11, P155; Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Auer H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-111; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Buggy Y, 2006, EUR J CANCER, V42, P485, DOI 10.1016/j.ejca.2005.10.018; Cases S, 2004, DEVELOPMENT, V131, P3047, DOI 10.1242/dev.01158; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fowles LF, 1998, MOL CELL BIOL, V18, P5148, DOI 10.1128/MCB.18.9.5148; Gibson GE, 2002, FRONT BIOSCI, V7, pD1007, DOI 10.2741/gibson; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Ludwig T, 2005, BIOESSAYS, V27, P1181, DOI 10.1002/bies.20306; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Pap T, 2000, ARTHRITIS RES, V2, P59, DOI 10.1186/ar69; Park ES, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000145; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SOULE HD, 1986, IN VITRO CELL DEV B, V22, P6, DOI 10.1007/BF02623435; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tynan JA, 2005, ONCOGENE, V24, P6870, DOI 10.1038/sj.onc.1208856; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Wei G, 2004, J IMMUNOL, V173, P1374, DOI 10.4049/jimmunol.173.2.1374; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Weng LP, 2002, HUM MOL GENET, V11, P1687, DOI 10.1093/hmg/11.15.1687; WESTALL PH, 1993, RESAMPLING BASED MUL; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315	54	410	422	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1084	U181		10.1038/nature08486	http://dx.doi.org/10.1038/nature08486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847259	Green Accepted			2022-12-24	WOS:000270987600036
J	Gostissa, M; Yan, CT; Bianco, JM; Cogne, M; Pinaud, E; Alt, FW				Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Cogne, Michel; Pinaud, Eric; Alt, Frederick W.			Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3 ' regulatory region	NATURE			English	Article							HEAVY-CHAIN LOCUS; CLASS-SWITCH RECOMBINATION; B-CELL DEVELOPMENT; CHROMOSOMAL TRANSLOCATIONS; V(D)J RECOMBINATION; GENE AMPLIFICATION; TRANSGENIC MICE; DNA BREAKS; END; MECHANISM	B-cell malignancies, such as human Burkitt's lymphoma, often contain translocations that link c-myc or other proto-oncogenes to the immunoglobulin heavy chain locus (IgH, encoded by Igh)(1). The nature of elements that activate oncogenes within such translocations has been a long-standing question. Translocations within Igh involve DNA double-strand breaks initiated either by the RAG1/2 endonuclease during variable, diversity and joining gene segment (V(D)J) recombination, or by activation-induced cytidine deaminase (AID, also known as AICDA) during class switch recombination (CSR)(2-4). V(D)J recombination in progenitor B (pro-B) cells assembles Igh variable region exons upstream of mu constant region (C mu) exons, which are the first of several sets of CH exons ('C-H genes') within a CH locus that span several hundred kilobases (kb)(5,6). In mature B cells, CSR deletes C mu and replaces it with a downstream C-H gene(6). An intronic enhancer (iE mu) between the variable region exons and C mu promotes V(D)J recombination in developing B cells(7). Furthermore, the Igh 3' regulatory region (Igh3' RR) lies downstream of the C-H locus and modulates CSR by long-range transcriptional enhancement of C-H genes(8-10). Transgenic mice bearing iE mu or Igh3' RR sequences fused to c-myc are predisposed to B lymphomas, demonstrating that such elements can confer oncogenic c-myc expression(11-16). However, in many B-cell lymphomas, Igh-c-myc translocations delete iE mu and place c-myc up to 200 kb upstream of the Igh3' RR1. Here we address the oncogenic role of the Igh3' RR by inactivating it in two distinct mouse models for B-cell lymphoma with Igh-c-myc translocations. We show that the Igh3' RR is dispensable for pro-B-cell lymphomas with V( D) J recombination-initiated translocations, but is required for peripheral B-cell lymphomas with CSR-associated translocations. As the Igh3' RR is not required for CSR-associated Igh breaks or Igh-c-myc translocations in peripheral B-cell lymphoma progenitors, we conclude that this regulatory region confers oncogenic activity by long-range and developmental stage-specific activation of translocated c-myc genes.	[Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Alt, Frederick W.] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; [Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Alt, Frederick W.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Cogne, Michel; Pinaud, Eric] Univ Limoges, CNRS, Fac Med, UMR 6101, Limoges, France	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Universite de Limoges	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	PINAUD, Eric/O-8443-2016; cogné, michel/D-7370-2015	PINAUD, Eric/0000-0001-7405-9273; cogné, michel/0000-0002-8519-4427	National Institutes of Health (NIH) [CA92625]; Leukemia and Lymphoma Society of America (LLS) SCORE; NCI; de Villiers International Achievement Award; Fondation pour la Recherche Medicale; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America (LLS) SCORE(Leukemia and Lymphoma Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); de Villiers International Achievement Award; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. G. Jiang for help with cloning translocation breakpoints. This work was supported by National Institutes of Health (NIH) grant CA92625 and the Leukemia and Lymphoma Society of America (LLS) SCORE grant to F. W. A. M. G. was a Special Fellow of the LLS and C.T.Y. was supported by an NCI training grant. M. G. and C. T. Y. were also supported by the de Villiers International Achievement Award of the LLS to F. W. A. E. P. was a Fellow of the Fondation pour la Recherche Medicale. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Ramiro Almudena, 2007, Adv Immunol, V94, P75, DOI 10.1016/S0065-2776(06)94003-6; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; Truffinet V, 2007, J IMMUNOL, V179, P6033, DOI 10.4049/jimmunol.179.9.6033; Wang JH, 2005, J BIOL CHEM, V280, P12766, DOI 10.1074/jbc.M412446200; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yan Y, 2007, GENE CHROMOSOME CANC, V46, P950, DOI 10.1002/gcc.20480; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	30	65	69	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					803	U128		10.1038/nature08633	http://dx.doi.org/10.1038/nature08633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010689	Green Accepted			2022-12-24	WOS:000272559900042
J	Schwarzman, MR; Wilson, MP				Schwarzman, Megan R.; Wilson, Michael P.			New Science for Chemicals Policy	SCIENCE			English	Editorial Material							HEALTH; WILDLIFE		[Schwarzman, Megan R.; Wilson, Michael P.] Univ Calif Berkeley, Sch Publ Hlth, Ctr Occupat & Environm Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schwarzman, MR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Ctr Occupat & Environm Hlth, Berkeley, CA 94720 USA.	mschwarzman@berkeley.edu	Wilson, Michael/AAK-4918-2021		NCEH CDC HHS [5U19EH000097-04] Funding Source: Medline; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U19EH000097] Funding Source: NIH RePORTER	NCEH CDC HHS; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		*BERK CTR ENV PUBL, 5U19EH00009704 CDC U; Carpenter DO, 2002, ENVIRON HEALTH PERSP, V110, P25, DOI 10.1289/ehp.02110s125; Dernbach JC, 1997, HARVARD ENVIRON LAW, V21, P1; *EPA, 2009, ESS PRINC REF CHEM M; EPA (Environmental Protection Agency), 2006, PUBL EPA, V738-R-05-005; *EUR COMM ENV DIR, 2003, ASS IMP NEW CHEM POL; Gee D, 2006, ENVIRON HEALTH PERSP, V114, P152, DOI 10.1289/ehp.8134; Government Accounting Office (GAO), 2009, GAO09271; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P73, DOI 10.1111/j.1742-7843.2007.00114.x; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; NILSSON AE, 2009, ARCTIC POLLUTION 200; NRC, 2008, SCI DEC ADV RISK ASS; NRC, 1984, TOX TEST STRAT DET N; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; *U MA LOW, 2009, STAT LEAD FORM REF C; *US CDCP, 2005, PUBL US CDCP; *US GOV ACC OFF, 2005, PUBL GAO, P18; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176; WHO, 2002, GLOB ASS STAT OF THE; Wilson MP, 2009, ENVIRON HEALTH PERSP, V117, P1202, DOI 10.1289/ehp.0800404; Woodruff TJ, 2008, ENVIRON HEALTH PERSP, V116, P1568, DOI 10.1289/ehp.11516	21	45	47	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1065	1066		10.1126/science.1177537	http://dx.doi.org/10.1126/science.1177537			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521UW	19965413	Green Submitted			2022-12-24	WOS:000271951000024
J	Kuklina, EV; Yoon, PW; Keenan, NL				Kuklina, Elena V.; Yoon, Paula W.; Keenan, Nora L.			Trends in High Levels of Low-Density Lipoprotein Cholesterol in the United States, 1999-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; NATIONAL-HEALTH; DYSLIPIDEMIA; GUIDELINES; PREVENTION; DIAGNOSIS; QUALITY; RISK; CARE	Context Studies show that a large proportion of adults with high levels of low-density lipoprotein cholesterol (LDL-C) remain untreated or undertreated despite growing use of lipid-lowering medications. Objective To investigate trends in screening prevalence, use of cholesterol-lowering medications, and LDL-C levels across 4 study cycles (1999-2000, 20012002, 2003-2004, and 2005-2006). Design, Setting, and Participants The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional, stratified, multistage probability sample survey of the US civilian, noninstitutionalized population. After we restricted the study sample to fasting participants aged 20 years or older (n=8018) and excluded pregnant women (n=464) and participants with missing data (n=510), our study sample consisted of 7044 participants. Main Outcome Measure High LDL-C levels, defined as levels above the specific goal for each risk category outlined in guidelines from the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III). All presented results are weighted and age-standardized to 2000 standard population estimates. Results Prevalence of high LDL-C levels among persons aged 20 years or older decreased from 31.5% in 1999-2000 to 21.2% in 2005-2006 (P<.001 for linear trend) but varied by risk category. By the 2005-2006 study cycle, prevalence of high LDL-C was 58.9%, 30.2%, and 11.0% for high-, intermediate-, and low-risk categories, respectively. Self-reported use of lipid-lowering medications increased from 8.0% to 13.4% (P<.001 for linear trend), but screening rates did not change significantly, remaining less than 70% (P=.16 for linear trend) during the study periods. Conclusions Among the NHANES population aged 20 years or older, the prevalence of high LDL-C levels decreased from 1999-2000 to 2005-2006. In the most recent period, the prevalence was 21.2%. JAMA. 2009; 302(19): 2104-2110	[Kuklina, Elena V.; Yoon, Paula W.; Keenan, Nora L.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Kuklina, EV (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K-37, Atlanta, GA 30341 USA.	ekuklina@cdc.gov	Kuklina, Elena/AAF-3532-2020	Kuklina, Elena/0000-0002-9686-6495				*AETN, CLIN POL B SCREEN LI; Becker DJ, 2008, MAYO CLIN PROC, V83, P758, DOI 10.4065/83.7.758; *CDCP, RES ETH REV BOARD ER; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P117; Choi BG, 2006, CURR MOL MED, V6, P571, DOI 10.2174/156652406778018590; Christian AH, 2006, J GEN INTERN MED, V21, P231, DOI 10.1111/j.1525-1497.2006.00331.x; COOPER GR, 1990, SCAND J CLIN LAB INV, V50, P27, DOI 10.3109/00365519009091082; Ghandehari H, 2008, AM HEART J, V156, P112, DOI 10.1016/j.ahj.2008.03.005; Grundy SM, 2001, AM J CARDIOL, V88, p23J; Hildemann S, 2008, CURR MED RES OPIN, V24, P1659, DOI 10.1185/03007990802134755; Jacobs MJ, 2005, DIABETES RES CLIN PR, V70, P263, DOI 10.1016/j.diabres.2005.03.032; Jenkins DJA, 2003, JAMA-J AM MED ASSOC, V290, P502, DOI 10.1001/jama.290.4.502; Keevil JG, 2007, CIRCULATION, V115, P1363, DOI 10.1161/CIRCULATIONAHA.106.645473; Klein RJ., 2001, HLTH PEOPLE 2010 STA, DOI DOI 10.1037/E583772012-001; Klingman D, 2005, AM HEART J, V150, P595, DOI 10.1016/j.ahj.2004.09.039; Ma YS, 2008, J AM DIET ASSOC, V108, P240, DOI 10.1016/j.jada.2007.10.047; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Morrison Alan, 2003, J Manag Care Pharm, V9, P544; Nag SS, 2007, J MANAGE CARE PHARM, V13, P652, DOI 10.18553/jmcp.2007.13.8.652; *RES TRIANGL I, 2004, SUDAAN EX MAN; Sisson SD, 2007, AM J CARDIOL, V99, P1234, DOI 10.1016/j.amjcard.2006.12.033; Stone NJ, 2005, AM J CARDIOL, V96, p53E, DOI 10.1016/j.amjcard.2005.06.006; *US DEP HHS, 1999, NATH HLTH NUTR EX SU; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; 3 REPORT EXPERT PANE	26	98	100	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2104	2110		10.1001/jama.2009.1672	http://dx.doi.org/10.1001/jama.2009.1672			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920234				2022-12-24	WOS:000271873900019
J	Truog, RD				Truog, Robert D.			Screening Mammography and the "R" Word	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SERVICES TASK-FORCE; BREAST-CANCER		[Truog, Robert D.] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Truog, Robert D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Truog, Robert D.] Childrens Hosp Boston, Div Crit Care Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA.							Ahern CH, 2009, CANCER EPIDEM BIOMAR, V18, P718, DOI 10.1158/1055-9965.EPI-08-0918; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; CREWDSON J, 2009, ATLANTIC        1119; GRADY D, 2009, NY TIMES        1103; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009	5	30	30	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2501	2503		10.1056/NEJMp0911447	http://dx.doi.org/10.1056/NEJMp0911447			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	19940292				2022-12-24	WOS:000273003700003
J	Chappell, LC				Chappell, Lucy C.			Commentary: Complex medical conditions in pregnancy need appropriate multidisciplinary input	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, Div Reprod & Endocrinol, London SE1 7EH, England	University of London; King's College London	Chappell, LC (corresponding author), Kings Coll London, Div Reprod & Endocrinol, London SE1 7EH, England.	lucy.chappell@kcl.ac.uk						Brent RL, 2009, AM J OBSTET GYNECOL, V200, P4, DOI 10.1016/j.ajog.2008.06.032; Buyon JP, 1998, J LEUKOCYTE BIOL, V63, P281, DOI 10.1002/jlb.63.3.281; *CTR MAT CHILD ENQ, SAV MOTH LIV; Reuss R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3862; Shah PS, 2009, BJOG-INT J OBSTET GY, V116, P1425, DOI 10.1111/j.1471-0528.2009.02278.x	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2009	339								b5179	10.1136/bmj.b5179	http://dx.doi.org/10.1136/bmj.b5179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007659				2022-12-24	WOS:000272697600006
J	Goldacre, B				Goldacre, Ben			Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PUBLICATION; INHIBITORS		Univ Oxford Nuffield Coll, Oxford OX1 1NF, England	University of Oxford	Goldacre, B (corresponding author), Univ Oxford Nuffield Coll, Oxford OX1 1NF, England.	ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728				Alper BS, 2004, J MED LIBR ASSOC, V92, P429; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Ramsey S, 2008, ONCOLOGIST, V13, P925, DOI 10.1634/theoncologist.2008-0133; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Safer DJ, 2002, J NERV MENT DIS, V190, P583, DOI 10.1097/00005053-200209000-00002; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779	9	21	23	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 29	2009	339								b4949	10.1136/bmj.b4949	http://dx.doi.org/10.1136/bmj.b4949			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525AY	19946143	Green Accepted			2022-12-24	WOS:000272186700002
J	Li, HY; Xin, HL; Muller, DA; Estroff, LA				Li, Hanying; Xin, Huolin L.; Muller, David A.; Estroff, Lara A.			Visualizing the 3D Internal Structure of Calcite Single Crystals Grown in Agarose Hydrogels	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; ELECTRON-MICROSCOPY; CRYSTALLIZATION; BIOMINERALIZATION; MORPHOLOGIES; FABRICATION; INTERFACES; MOLECULES; PHASE	Single crystals are usually faceted solids with homogeneous chemical compositions. Biogenic and synthetic calcite single crystals, however, have been found to incorporate macromolecules, spurring investigations of how large molecules are distributed within the crystals without substantially disrupting the crystalline lattice. Here, electron tomography reveals how random, three-dimensional networks of agarose nanofibers are incorporated into single crystals of synthetic calcite by allowing both high- and low-energy fiber/crystal interface facets to satisfy network curvatures. These results suggest that physical entrapment of polymer aggregates is a viable mechanism by which macromolecules can become incorporated inside inorganic single crystals. As such, this work has implications for understanding the structure and formation of biominerals as well as toward the development of new high-surface area, single-crystal composite materials.	[Li, Hanying; Estroff, Lara A.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Xin, Huolin L.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Estroff, LA (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	lae37@cornell.edu	Spratt, Brian G/A-1676-2009; Muller, David/A-7745-2010; Xin, Huolin L./E-2747-2010	Muller, David/0000-0003-4129-0473; Xin, Huolin L./0000-0002-6521-868X; Estroff, Lara/0000-0002-7658-1265	NSF [DMR 0845212]; New York State Office of Science, Technology, and Academic Research [C050017]; Cornell Center for Materials Research (CCMR), a Materials Research Science and Engineering Center of NSF [DMR 0520404]	NSF(National Science Foundation (NSF)); New York State Office of Science, Technology, and Academic Research; Cornell Center for Materials Research (CCMR), a Materials Research Science and Engineering Center of NSF	L. A. E. acknowledges partial support from NSF (DMR 0845212), the J. D. Watson Investigator Program (New York State Office of Science, Technology, and Academic Research contract C050017), and the Cornell Center for Materials Research (CCMR), a Materials Research Science and Engineering Center of NSF (DMR 0520404). H. L. X. and D. M. acknowledge the Semiconductor Research Corporation and CCMR. Particular acknowledgement is made of the use of the EM and polymer characterization facilities of CCMR.	Aizenberg J, 1997, J AM CHEM SOC, V119, P881, DOI 10.1021/ja9628821; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; BERMAN A, 1990, SCIENCE, V250, P664, DOI 10.1126/science.250.4981.664; De Yoreo JJ, 2004, SCIENCE, V306, P1301, DOI 10.1126/science.1100889; Du DX, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155503; Estroff LA, 2004, J AM CHEM SOC, V126, P2, DOI 10.1021/ja037614z; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; Hyun JK, 2008, ULTRAMICROSCOPY, V109, P1, DOI 10.1016/j.ultramic.2008.07.003; Kulak AN, 2007, J AM CHEM SOC, V129, P3729, DOI 10.1021/ja067422e; Li C, 2008, ANGEW CHEM INT EDIT, V47, P2388, DOI 10.1002/anie.200705403; Li HY, 2007, CRYSTENGCOMM, V9, P1153, DOI 10.1039/b709068d; Li HY, 2007, J AM CHEM SOC, V129, P5480, DOI 10.1021/ja067901d; Li HY, 2009, ADV MATER, V21, P470, DOI 10.1002/adma.200801498; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Nudelman F, 2007, FARADAY DISCUSS, V136, P9, DOI 10.1039/b704418f; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Park RJ, 2002, ADV MATER, V14, P1167, DOI 10.1002/1521-4095(20020816)14:16<1167::AID-ADMA1167>3.0.CO;2-X; Pokroy B, 2006, J STRUCT BIOL, V155, P96, DOI 10.1016/j.jsb.2006.03.008; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Robach JS, 2005, J STRUCT BIOL, V151, P18, DOI 10.1016/j.jsb.2005.04.001; Sindhu S, 2007, ADV FUNCT MATER, V17, P1698, DOI 10.1002/adfm.200600547; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; Song RQ, 2009, ANGEW CHEM INT EDIT, V48, P395, DOI 10.1002/anie.200803383; Travaille AM, 2003, J AM CHEM SOC, V125, P11571, DOI 10.1021/ja034624r; Volkmer D, 2004, J MATER CHEM, V14, P2249, DOI 10.1039/b403132f	30	218	223	12	316	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1244	1247		10.1126/science.1178583	http://dx.doi.org/10.1126/science.1178583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965470				2022-12-24	WOS:000272117900042
J	Dickman, DK; Davis, GW				Dickman, Dion K.; Davis, Graeme W.			The Schizophrenia Susceptibility Gene dysbindin Controls Synaptic Homeostasis	SCIENCE			English	Article							HIPPOCAMPAL-FORMATION; TRANSMITTER RELEASE; DROSOPHILA; PROTEIN; GLUTAMATE; DTNBP1; RECEPTORS; DEFINES; CHANNEL; SYSTEM	The molecular mechanisms that achieve homeostatic stabilization of neural function remain largely unknown. To better understand how neural function is stabilized during development and throughout life, we used an electrophysiology-based forward genetic screen and assessed the function of more than 250 neuronally expressed genes for a role in the homeostatic modulation of synaptic transmission in Drosophila. This screen ruled out the involvement of numerous synaptic proteins and identified a critical function for dysbindin, a gene linked to schizophrenia in humans. We found that dysbindin is required presynaptically for the retrograde, homeostatic modulation of neurotransmission, and functions in a dose-dependent manner downstream or independently of calcium influx. Thus, dysbindin is essential for adaptive neural plasticity and may link altered homeostatic signaling with a complex neurological disease.	[Dickman, Dion K.; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	graeme.davis@ucsf.edu			A. P. Giannini Foundation; Jane Coffin Childs Memorial Fund; NIH [NS39313]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039313] Funding Source: NIH RePORTER	A. P. Giannini Foundation; Jane Coffin Childs Memorial Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	members of the Davis laboratory for comments and discussion. Supported by postdoctoral fellowships from the A. P. Giannini Foundation and Jane Coffin Childs Memorial Fund (D. K. D.) and by NIH grant NS39313 (G. W. D.).	Benson MA, 2004, TRENDS NEUROSCI, V27, P516, DOI 10.1016/j.tins.2004.06.004; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Collier DA, 2003, EUR J PHARMACOL, V480, P177, DOI 10.1016/j.ejphar.2003.08.105; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Kendler KS, 2004, AM J PSYCHIAT, V161, P1533, DOI 10.1176/appi.ajp.161.9.1533; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; Macleod GT, 2006, EUR J NEUROSCI, V23, P3230, DOI 10.1111/j.1460-9568.2006.04873.x; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Norton N, 2006, CURR OPIN PSYCHIATR, V19, P158, DOI 10.1097/01.yco.0000214341.52249.59; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Owen MJ, 2004, J CLIN INVEST, V113, P1255, DOI 10.1172/JCI200421470; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sodhi Monsheel, 2008, Expert Rev Neurother, V8, P1389, DOI 10.1586/14737175.8.9.1389; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Williams NM, 2005, SCHIZOPHRENIA BULL, V31, P800, DOI 10.1093/schbul/sbi061	27	158	160	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1127	1130		10.1126/science.1179685	http://dx.doi.org/10.1126/science.1179685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965435	Green Accepted			2022-12-24	WOS:000271951000049
J	Swanson-Wagner, RA; DeCook, R; Jia, Y; Bancroft, T; Ji, TM; Zhao, XF; Nettleton, D; Schnable, PS				Swanson-Wagner, Ruth A.; DeCook, Rhonda; Jia, Yi; Bancroft, Tim; Ji, Tieming; Zhao, Xuefeng; Nettleton, Dan; Schnable, Patrick S.			Paternal Dominance of Trans-eQTL Influences Gene Expression Patterns in Maize Hybrids	SCIENCE			English	Article							IDENTIFICATION; ARCHITECTURE; REVEALS; MOUSE	Heterosis refers to the superior performance of hybrid progeny relative to their inbred parents, but the mechanisms responsible are unknown. Hybrids between the maize inbred lines B73 and Mo17 exhibit heterosis regardless of cross direction. These reciprocal hybrids differ from each other phenotypically, and 30 to 50% of their genes are differentially expressed. We identified similar to 4000 expression quantitative trait loci (eQTL) that allowed us to identify markers linked to variation in expression. We found that over three-quarters of these eQTL act in trans (78%) and that 86% of these differentially regulate transcript accumulation in a manner consistent with gene expression in the hybrid being regulated exclusively by the paternally transmitted allele. This result suggests that widespread imprinting contributes to the regulation of gene expression in maize hybrids.	[Swanson-Wagner, Ruth A.; DeCook, Rhonda; Jia, Yi; Bancroft, Tim; Ji, Tieming; Zhao, Xuefeng; Nettleton, Dan; Schnable, Patrick S.] Iowa State Univ, Ames, IA 50011 USA	Iowa State University	Schnable, PS (corresponding author), Iowa State Univ, Ames, IA 50011 USA.	schnable@iastate.edu	Jia, Yi/F-7476-2010	Schnable, Patrick/0000-0001-9169-5204; Nettleton, Dan/0000-0002-6045-1036	NSF [DBI-0527192]; Iowa State University's Plant Sciences Institute	NSF(National Science Foundation (NSF)); Iowa State University's Plant Sciences Institute	We thank S. Hargreaves, M. Smith, M. Wilkening, T. Kemmerer, P. Lu, C.-T. Yeh, and L. Coffey for sample and data processing and the maize genome sequence project (NSF DBI-0527192) for sharing genome sequences before publication. Funding provided by Iowa State University's Plant Sciences Institute. Microarray and sequencing data are available at the National Center for Biotechnology Information GEO database in series GSE16136.	Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Gonzalo M, 2007, HEREDITY, V99, P14, DOI 10.1038/sj.hdy.6800955; Goodrich JA, 2009, CRIT REV BIOCHEM MOL, V44, P3, DOI [10.1080/10409230802593995, 10.1080/10409230802593995 ]; Guo M, 2008, PLANT MOL BIOL, V66, P551, DOI 10.1007/s11103-008-9290-z; Hansen BG, 2008, TRENDS PLANT SCI, V13, P72, DOI 10.1016/j.tplants.2007.11.008; Hoecker N, 2006, THEOR APPL GENET, V112, P421, DOI 10.1007/s00122-005-0139-4; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Nogueira FTS, 2006, COLD SPRING HARB SYM, V71, P157, DOI 10.1101/sqb.2006.71.045; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schnable Patrick S., 2009, P457, DOI 10.1007/978-0-387-79418-1_23; Shi C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-22; Shull G.H., 1908, J HERED, V4, P296, DOI [10.1093/jhered/os-4.1.296, DOI 10.1093/JHERED/OS-4.1.296]; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Springer NM, 2007, PLANT CELL, V19, P2391, DOI 10.1105/tpc.107.052258; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Stupar RM, 2007, PLANT PHYSIOL, V145, P411, DOI 10.1104/pp.107.101428; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wittkopp PJ, 2006, GENETICS, V173, P1817, DOI 10.1534/genetics.105.054684; Yandeau-Nelson MD, 2006, GENETICS, V174, P101, DOI 10.1534/genetics.105.049270; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	32	87	89	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1118	1120		10.1126/science.1178294	http://dx.doi.org/10.1126/science.1178294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965432				2022-12-24	WOS:000271951000046
J	Denk, T; Neukum, G; Roatsch, T; Porco, CC; Burns, JA; Galuba, GG; Schmedemann, N; Helfenstein, P; Thomas, PC; Wagner, RJ; West, RA				Denk, Tilmann; Neukum, Gerhard; Roatsch, Thomas; Porco, Carolyn C.; Burns, Joseph A.; Galuba, Goetz G.; Schmedemann, Nico; Helfenstein, Paul; Thomas, Peter C.; Wagner, Roland J.; West, Robert A.			Iapetus: Unique Surface Properties and a Global Color Dichotomy from Cassini Imaging	SCIENCE			English	Article							IRREGULAR SATELLITES; GALILEAN SATELLITES; SOLAR-SYSTEM; E-RING; PHOEBE; HYPERION; LAPETUS; SATURN; ENCELADUS; SCIENCE	Since 2004, Saturn's moon Iapetus has been observed repeatedly with the Imaging Science Subsystem of the Cassini spacecraft. The images show numerous impact craters down to the resolution limit of similar to 10 meters per pixel. Small, bright craters within the dark hemisphere indicate a dark blanket thickness on the order of meters or less. Dark, equator-facing and bright, poleward-facing crater walls suggest temperature-driven water-ice sublimation as the process responsible for local albedo patterns. Imaging data also reveal a global color dichotomy, wherein both dark and bright materials on the leading side have a substantially redder color than the respective trailing-side materials. This global pattern indicates an exogenic origin for the redder leading-side parts and suggests that the global color dichotomy initiated the thermal formation of the global albedo dichotomy.	[Denk, Tilmann; Neukum, Gerhard; Galuba, Goetz G.; Schmedemann, Nico] Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; [Roatsch, Thomas; Wagner, Roland J.] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetenforschung, D-12489 Berlin, Germany; [Porco, Carolyn C.] Space Sci Inst, Cassini Imaging Cent Lab Operat CICLOPS, Boulder, CO 80301 USA; [Burns, Joseph A.; Helfenstein, Paul; Thomas, Peter C.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [West, Robert A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Denk, T (corresponding author), Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany.	Tilmann.Denk@fu-berlin.de		Denk, Tilmann/0000-0003-0764-3677	German Aerospace Center; NASA/JPL	German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); NASA/JPL(National Aeronautics & Space Administration (NASA))	We acknowledge the individuals at CICLOPS (at the Space Science Institute in Boulder, CO) and JPL (Pasadena, CA), as well as the members and associates of the Imaging Team for the successful conduct of the ISS experiment onboard the Cassini spacecraft. This paper is dedicated to Steve Ostro, whose work helped considerably to explain the nature of Iapetus' dark terrain. This work has been funded by the German Aerospace Center (DLR) and NASA/JPL.	Black GJ, 2004, SCIENCE, V304, P553, DOI 10.1126/science.1096470; BURATTI BJ, 1991, ICARUS, V90, P1, DOI 10.1016/0019-1035(91)90064-Z; BURATTI BJ, 1990, ICARUS, V87, P339, DOI 10.1016/0019-1035(90)90138-Y; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; Burns JA, 1999, SCIENCE, V284, P1146, DOI 10.1126/science.284.5417.1146; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; Burns JA, 1996, ASTR SOC P, V104, P179; CASSINI JD, 1677, J SCAVANS, P70; CHAPMAN CR, 1986, SATELLITES, P492; COOK AF, 1970, ICARUS, V13, P282, DOI 10.1016/0019-1035(70)90057-6; DAVIES ME, 1984, ICARUS, V59, P199, DOI 10.1016/0019-1035(84)90023-X; DENK T, 2002, LISB EUR JUP GAL CAS, P118; Giese B, 2008, ICARUS, V193, P359, DOI 10.1016/j.icarus.2007.06.005; HAMILTON DP, 1994, SCIENCE, V264, P550, DOI 10.1126/science.264.5158.550; Jarvis KS, 2000, ICARUS, V146, P125, DOI 10.1006/icar.2000.6311; JOHNSON TV, 1983, J GEOPHYS RES, V88, P5789, DOI 10.1029/JB088iB07p05789; Nesvorny D, 2003, ASTRON J, V126, P398, DOI 10.1086/375461; Neukum G., 1994, HAZARDS DUE COMETS A, P359; Ostro SJ, 2006, ICARUS, V183, P479, DOI 10.1016/j.icarus.2006.02.019; PANG KD, 1984, J GEOPHYS RES, V89, P9459, DOI 10.1029/JB089iB11p09459; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Porco CC, 2005, SCIENCE, V307, P1237, DOI 10.1126/science.1107981; Roatsch T, 2009, PLANET SPACE SCI, V57, P83, DOI 10.1016/j.pss.2008.10.014; SOTER S, 1974, IAU C CORN U ITH NY, V28; Spencer JR, 2010, SCIENCE, V327, P432, DOI 10.1126/science.1177132; SPENCER JR, 1987, ICARUS, V69, P297, DOI 10.1016/0019-1035(87)90107-2; THOLEN DJ, 1983, ICARUS, V53, P341, DOI 10.1016/0019-1035(83)90154-9; THOMAS P, 1985, ICARUS, V64, P414, DOI 10.1016/0019-1035(85)90065-X; TOSI F, 2009, PREPRINT; Turrini D, 2008, MON NOT R ASTRON SOC, V391, P1029, DOI 10.1111/j.1365-2966.2008.13909.x; Verbiscer AJ, 2009, NATURE, V461, P1098, DOI 10.1038/nature08515; Wilson PD, 1996, ICARUS, V122, P92, DOI 10.1006/icar.1996.0111; Zahnle K, 2003, ICARUS, V163, P263, DOI 10.1016/S0019-1035(03)00048-4	33	29	29	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					435	439		10.1126/science.1177088	http://dx.doi.org/10.1126/science.1177088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20007863				2022-12-24	WOS:000273783100029
J	Tissari, P; Zumla, A; Tarkka, E; Mero, S; Savolainen, L; Vaara, M; Aittakorpi, A; Laakso, S; Lindfors, M; Piiparinen, H; Maki, M; Carder, C; Huggett, J; Gant, V				Tissari, Paivi; Zumla, Alimuddin; Tarkka, Eveliina; Mero, Sointu; Savolainen, Laura; Vaara, Martti; Aittakorpi, Anne; Laakso, Sanna; Lindfors, Merja; Piiparinen, Heli; Maki, Minna; Carder, Caroline; Huggett, Jim; Gant, Vanya			Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study	LANCET			English	Article							REAL-TIME PCR; DIAGNOSIS; ASSAY; PATHOGENS	Background New DNA-based microarray platforms enable rapid detection and species identification of many pathogens, including bacteria. We assessed the sensitivity, specificity, and turnaround time of a new molecular sepsis assay. Methods 2107 positive blood-culture samples of 3318 blood samples from patients with clinically suspected sepsis were investigated for bacterial species by both conventional culture and Prove-it sepsis assay (Mobidiag, Helsinki, Finland) in two centres (UK and Finland). The assay is a novel PCR and microarray method that is based on amplification and detection of gyrB, parE, and mecA genes of 50 bacterial species. Operators of the test assay were not aware of culture results. We calculated sensitivity, specificity, and turnaround time according to Clinical and Laboratory Standards Institute recommendations. Findings 1807 of 2107 (86%) positive blood-culture samples included a pathogen covered by the assay. The assay had a clinical sensitivity of 94.7% (95% CI 93.6-95.7) and a specificity of 98.8% (98.1-99.2), and 100% for both measures for meticillin-resistant Staphylococcus aureus bacteraemia. The assay was a mean 18 h faster than was the conventional culture-based method, which takes an additional 1-2 working days. 34 of 3284 (1.0%) samples were excluded because of technical and operator errors. Interpretation Definitive identification of bacterial species with this microarray platform was highly sensitive, specific, and faster than was the gold-standard culture-based method. This assay could enable fast and earlier evidence-based management for clinical sepsis.	[Tissari, Paivi; Tarkka, Eveliina; Mero, Sointu; Savolainen, Laura; Vaara, Martti] Univ Helsinki, Hosp Lab, Div Clin Microbiol, Helsinki, Finland; [Zumla, Alimuddin; Carder, Caroline; Huggett, Jim; Gant, Vanya] UCL, Dept Clin Microbiol, Univ Coll London Hosp NHS Fdn Trust, Med Sch,Windeyer Inst Med Sci, London W1T 4JF, England; [Zumla, Alimuddin; Carder, Caroline; Huggett, Jim; Gant, Vanya] UCL, Ctr Infect Dis & Int Hlth, Sch Med, Windeyer Inst Med Sci, London W1T 4JF, England; [Aittakorpi, Anne; Laakso, Sanna; Lindfors, Merja; Piiparinen, Heli; Maki, Minna] Mobidiag, Helsinki, Finland	University of Helsinki; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School	Gant, V (corresponding author), UCL, Dept Clin Microbiol, Univ Coll London Hosp NHS Fdn Trust, Windeyer Inst, 46 Cleveland St, London W1T 4JF, England.	vanya.gant@uclh.nhs.uk	Vaara, Martti S/D-1698-2013; ZUMLA, Alimuddin/ABA-8208-2020; Huggett, Jim/N-9316-2013	ZUMLA, Alimuddin/0000-0002-5111-5735; Huggett, Jim/0000-0002-0945-1911; Savolainen, Laura/0000-0003-2527-4211	UK Comprehensive Biomedical Research Centre and National Institute for Health Research support through University College London Hospitals NHS Foundation Trust	UK Comprehensive Biomedical Research Centre and National Institute for Health Research support through University College London Hospitals NHS Foundation Trust	We thank Mobidiag for providing equipment and reagents for the Prove-it sepsis assay, and all UCLH and HUSLAB clinical and laboratory staff who helped with this study. VG and AZ receive UK Comprehensive Biomedical Research Centre and National Institute for Health Research support through University College London Hospitals NHS Foundation Trust. The study was done with normal clinical microbiology services of UCLH and HUSLAB. VG's personal discretionary funds were used.	Andrade SS, 2008, SHOCK, V30, P41, DOI 10.1097/SHK.0b013e3181819f6c; Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Cenciarini-Borde C, 2009, FUTURE MICROBIOL, V4, P45, DOI 10.2217/17460913.4.1.45; *CLSI, 2003, M2A9 CLSI, V23; Davey PG, 2008, CLIN MICROBIOL INFEC, V14, P15, DOI 10.1111/j.1469-0691.2008.01959.x; Deborggraeve S, 2008, J INFECT DIS, V198, P1565, DOI 10.1086/592509; Eigner U, 2005, J CLIN MICROBIOL, V43, P5256, DOI 10.1128/JCM.43.10.5256-5262.2005; *EUR COMM STAND, 2002, 136122002 BS EN EUR; GERBERT S, 2008, J INFECTION, V57, P307; Howard D, 2001, CLIN INFECT DIS, V33, P1573, DOI 10.1086/323758; Kompalic-Cristo A, 2007, PARASITOL RES, V101, P619, DOI 10.1007/s00436-007-0524-9; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Mancini N, 2009, J CLIN MICROBIOL, V47, P1274, DOI 10.1128/JCM.00011-09; Mens P, 2007, TROP MED INT HEALTH, V12, P238, DOI 10.1111/j.1365-3165.2006.01779.x; National Clinical Committee Laboratory Standards NCCLS, 2006, PERFORMANCE STANDARD; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Reier-Nilsen T, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-5; Roth SB, 2004, J CLIN MICROBIOL, V42, P4268, DOI 10.1128/JCM.42.9.4268-4274.2004; SALVADOR RB, 2008, ENFERM INFECC MIC S9, V26, P50; Vince A, 2008, J MED MICROBIOL, V57, P1306, DOI 10.1099/jmm.0.47797-0; WAYNE PA, 2002, EP12A CLSI; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Zaidi AK, 2009, PEDIAT INFECT DIS S1, V28, P10	24	153	174	0	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					224	230		10.1016/S0140-6736(09)61569-5	http://dx.doi.org/10.1016/S0140-6736(09)61569-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20004964				2022-12-24	WOS:000273853800032
J	Reavell, GT				Reavell, G. Thomas			Jobs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tomreavell@msn.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2523	2524		10.1001/jama.2009.1809	http://dx.doi.org/10.1001/jama.2009.1809			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009046				2022-12-24	WOS:000272737200001
J	Flora, A; Klisch, TJ; Schuster, G; Zoghbi, HY				Flora, Adriano; Klisch, Tiemo J.; Schuster, Gabriele; Zoghbi, Huda Y.			Deletion of Atoh1 Disrupts Sonic Hedgehog Signaling in the Developing Cerebellum and Prevents Medulloblastoma	SCIENCE			English	Article							MATH1; GENES; MOUSE; SUBTYPES; NEURONS; BINDING	Granule neuron precursors (GNPs) are the most actively proliferating cells in the postnatal nervous system, and mutations in pathways that control the GNP cell cycle can result in medulloblastoma. The transcription factor Atoh1 has been suspected to contribute to GNP proliferation, but its role in normal and neoplastic postnatal cerebellar development remains unexplored. We show that Atoh1 regulates the signal transduction pathway of Sonic Hedgehog, an extracellular factor that is essential for GNP proliferation, and demonstrate that deletion of Atoh1 prevents cerebellar neoplasia in a mouse model of medulloblastoma. Our data shed light on the function of Atoh1 in postnatal cerebellar development and identify a new mechanism that can be targeted to regulate medulloblastoma formation.	[Flora, Adriano; Klisch, Tiemo J.; Schuster, Gabriele; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Klisch, Tiemo J.; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Klisch, Tiemo/0000-0001-8182-384X; Zoghbi, Huda/0000-0002-0700-3349	Intellectual and Developmental Disabilities Research Center at Baylor College of Medicine [5 P30 HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER	Intellectual and Developmental Disabilities Research Center at Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank H.-T. Chao, X. Liu, and R. Atkinson for experimental support and V. Brandt for helping in editing the manuscript. We thank H. Bellen, G. Dotti, M. B. Bhattacharjee, E. Battaglioli, J. Neul, and members of the Zoghbi lab for critical reading of the manuscript. The confocal microscopy was supported by the Intellectual and Developmental Disabilities Research Center at Baylor College of Medicine ( 5 P30 HD024064). H. Y. Z. is an investigator and T. J. K. is a postdoctoral	Badea TC, 2003, J NEUROSCI, V23, P2314; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Krizhanovsky V, 2006, J MOL NEUROSCI, V28, P211, DOI 10.1385/JMN:28:2:211; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Salsano E, 2004, NEUROSCI LETT, V370, P180, DOI 10.1016/j.neulet.2004.08.053; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	22	120	128	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1424	1427		10.1126/science.1181453	http://dx.doi.org/10.1126/science.1181453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965762	Green Accepted			2022-12-24	WOS:000272351100049
J	Nishimura, N; Hitomi, K; Arvai, AS; Rambo, RP; Hitomi, C; Cutler, SR; Schroeder, JI; Getzoff, ED				Nishimura, Noriyuki; Hitomi, Kenichi; Arvai, Andrew S.; Rambo, Robert P.; Hitomi, Chiharu; Cutler, Sean R.; Schroeder, Julian I.; Getzoff, Elizabeth D.			Structural Mechanism of Abscisic Acid Binding and Signaling by Dimeric PYR1	SCIENCE			English	Article							PROTEIN PHOSPHATASE 2C; X-RAY; NEGATIVE REGULATOR; GUARD-CELLS; ARABIDOPSIS; ABI1; TRANSDUCTION; GERMINATION; EXPRESSION; UPSTREAM	The phytohormone abscisic acid (ABA) acts in seed dormancy, plant development, drought tolerance, and adaptive responses to environmental stresses. Structural mechanisms mediating ABA receptor recognition and signaling remain unknown but are essential for understanding and manipulating abiotic stress resistance. Here, we report structures of pyrabactin resistance 1 (PYR1), a prototypical PYR/PYR1-like (PYL)/regulatory component of ABA receptor (RCAR) protein that functions in early ABA signaling. The crystallographic structure reveals an alpha/beta helix-grip fold and homodimeric assembly, verified in vivo by coimmunoprecipitation. ABA binding within a large internal cavity switches structural motifs distinguishing ABA-free "open-lid" from ABA-bound "closed-lid" conformations. Small-angle x-ray scattering suggests that ABA signals by converting PYR1 to a more compact, symmetric closed-lid dimer. Site-directed PYR1 mutants designed to disrupt hormone binding lose ABA-triggered interactions with type 2C protein phosphatase partners in planta.	[Hitomi, Kenichi; Arvai, Andrew S.; Hitomi, Chiharu; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Arvai, Andrew S.; Hitomi, Chiharu; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Nishimura, Noriyuki; Schroeder, Julian I.] Univ Calif San Diego, Cell & Dev Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Hitomi, Kenichi; Rambo, Robert P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Cutler, Sean R.] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Riverside	Getzoff, ED (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edg@scripps.edu	Cutler, Sean R/D-6617-2011; Nishimura, Noriyuki/E-3580-2010	Nishimura, Noriyuki/0000-0003-2946-3124; Schroeder, Julian/0000-0002-3283-5972	NIH [GM060396, ES010337, GM37684]; NSF [MCB-0918220, IOS0820508]; U. S. Department of Energy [DE-FG02-03ER15449, DE-AC02-05CH11231]; LBNL-LDRI; The Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396, R01GM037684] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); LBNL-LDRI; The Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Bhabha, J. Christie, M. Hammel, G. L. Hura, D. G. Mendoza-Cozatl, M. E. Pique, D. S. Shin, and J. A. Tainer for discussions, plus the Structurally Integrated BiologY for Life Sciences beamline staff and Arabidopsis Biological Resource Center. This research was supported by NIH grants GM060396, ES010337 ( J. I. S.), and GM37684 ( E. D. G.); NSF grants MCB-0918220 ( J. I. S.) and IOS0820508 ( S. R. C.); U. S. Department of Energy grants DE-FG02-03ER15449 ( J. I. S.) plus DE-AC02-05CH11231 and LBNL-LDRI ( R. P. R.); and The Skaggs Institute for Chemical Biology ( K. H.). J. I. S. and E. D. G. conceived of the project; E. D. G., J. I. S., K. H., N. N., A. S. A., and R. P. R. designed research; N. N., K. H., A. S. A., R. P. R., and C. H. performed experiments; S. R. C. provided reagents and results before publication; K. H., N. N., A. S. A., R. P. R., J. I. S., and E. D. G. analyzed data; and E. D. G., J. I. S., K. H., and N. N. wrote the paper. Crystallographic coordinates and structure factors are deposited in the Protein Data Bank with accession code	Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; EAGLES CF, 1963, NATURE, V199, P874, DOI 10.1038/199874a0; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; OHKUMA K, 1963, SCIENCE, V142, P1592, DOI 10.1126/science.142.3599.1592; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; SONDHEIM.E, 1971, SCIENCE, V174, P829, DOI 10.1126/science.174.4011.829; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128	34	354	393	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1373	1379		10.1126/science.1181829	http://dx.doi.org/10.1126/science.1181829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933100	Green Accepted			2022-12-24	WOS:000272351100034
J	Baumgardt, M; Karlsson, D; Terriente, J; Diaz-Benjumea, FJ; Thor, S				Baumgardt, Magnus; Karlsson, Daniel; Terriente, Javier; Diaz-Benjumea, Fernando J.; Thor, Stefan			Neuronal Subtype Specification within a Lineage by Opposing Temporal Feed-Forward Loops	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; DROSOPHILA CNS; NEUROBLAST COMPETENCE; NEURAL PROLIFERATION; IDENTITY FACTORS; GENE-EXPRESSION; NETWORK MOTIFS; CELL IDENTITY; HUNCHBACK	Neural progenitors generate distinct cell types at different stages, but the mechanisms controlling these temporal transitions are poorly understood. In the Drosophila CNS, a cascade of transcription factors, the "temporal gene cascade," has been identified that acts to alter progenitor competence over time. However, many CNS lineages display broad temporal windows, and it is unclear how broad windows progress into subwindows that generate unique cell types. We have addressed this issue in an identifiable Drosophila CNS lineage and find that a broad castor temporal window is subdivided by two different feed-forward loops, both of which are triggered by castor itself. The first loop acts to specify a unique cell fate, whereas the second loop suppresses the first loop, thereby allowing for the generation of alternate cell fates. This mechanism of temporal and "subtemporal" genes acting in opposing feed-forward loops may be used by many stem cell lineages to generate diversity.	[Baumgardt, Magnus; Karlsson, Daniel; Thor, Stefan] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Terriente, Javier; Diaz-Benjumea, Fernando J.] Univ Autonoma Madrid Canto Blanco, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Linkoping University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Thor, S (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	stefan.thor@liu.se	Thor, Stefan/Y-5804-2019; Diaz-Benjumea, Fernando/K-7667-2014; Terriente, Javier/M-3292-2014	Thor, Stefan/0000-0001-5095-541X; Diaz-Benjumea, Fernando/0000-0003-3007-2489; Terriente, Javier/0000-0002-0426-9862	Swedish Research Council; Swedish Strategic Research Foundation; Knut and Alice Wallenberg foundation; Swedish "Hjarnfonden," "Cancerfonden"; Swedish Royal Academy of Sciences; Spanish Ministerio de Ciencia e Innovacion [BFU2008-04683-CO2-01/BMC]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish "Hjarnfonden," "Cancerfonden"(Swedish Cancer Society); Swedish Royal Academy of Sciences; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	We are grateful to S. Cohen, M. Crozatier, A. DiAntonio, C. Q. Doe, L. Fessler, A. Gould, R. Holmgren, K. Jagla, T. M. Laufer, W. Odenwald, R. Pflanz, J. Skeath, P. H. Taghert, A. Uv, D. Vasiliauskas, A. Vincent, the Drosophila Genomic Resource Center, the Developmental Studies Hybridoma Bank, and the Bloomington Stock Center for sharing antibodies, fly lines, and DNA. We thank D. van Meyel, I. Miguel-Aliaga, A. Gould and J. B. Thomas for critically reading the manuscript. H. Ekman and A. Angel provided excellent technical assistance. This work was supported by the Swedish Research Council, the Swedish Strategic Research Foundation, the Knut and Alice Wallenberg foundation, the Swedish "Hjarnfonden," "Cancerfonden," the Swedish Royal Academy of Sciences (support to S. T.), and the Spanish Ministerio de Ciencia e Innovacion (grant BFU2008-04683-CO2-01/BMC to F. J. D.).	Allan DW, 2005, NEURON, V45, P689, DOI 10.1016/j.neuron.2005.01.026; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Atkinson S, 2008, CELL TISSUE RES, V331, P23, DOI 10.1007/s00441-007-0536-x; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Benveniste RJ, 1998, DEVELOPMENT, V125, P4757; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Brody T, 2002, DEVELOPMENT, V129, P3763; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; Clements M, 2003, DEV DYNAM, V226, P67, DOI 10.1002/dvdy.10209; De Graeve F, 2004, DEV BIOL, V270, P122, DOI 10.1016/j.ydbio.2004.02.014; DOE CQ, 1993, TRENDS NEUROSCI, V16, P510, DOI 10.1016/0166-2236(93)90195-R; Felix JT, 2007, DEVELOPMENT, V134, P1845, DOI 10.1242/dev.003830; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnston RJ, 2006, DEVELOPMENT, V133, P3317, DOI 10.1242/dev.02494; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Karcavich R, 2005, J COMP NEUROL, V481, P240, DOI 10.1002/cne.20371; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Mechta-Grigoriou F, 2000, DEVELOPMENT, V127, P119; Mettler U, 2006, DEVELOPMENT, V133, P429, DOI 10.1242/dev.02229; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P5837, DOI 10.1242/dev.01447; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Novotny T, 2002, DEVELOPMENT, V129, P1027; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Park DK, 2004, DEV BIOL, V269, P95, DOI 10.1016/j.ydbio.2004.01.015; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; Vogler G, 2008, DEV BIOL, V319, P78, DOI 10.1016/j.ydbio.2008.04.008; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006	53	130	130	3	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					969	982		10.1016/j.cell.2009.10.032	http://dx.doi.org/10.1016/j.cell.2009.10.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945380	Bronze, Green Submitted			2022-12-24	WOS:000272169400020
J	Erwin, D				Erwin, Douglas			A call to the custodians of deep time	NATURE			English	Editorial Material							DIVERSITY		[Erwin, Douglas] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Erwin, Douglas] Santa Fe Inst, Santa Fe, NM 87501 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; The Santa Fe Institute	Erwin, D (corresponding author), Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA.	erwind@si.edu		Erwin, Douglas/0000-0003-2518-5614				Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186	4	8	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					282	283		10.1038/462282a	http://dx.doi.org/10.1038/462282a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924193				2022-12-24	WOS:000271899300020
J	Alarcon, C; Zaromytidou, AI; Xi, QR; Gao, S; Yu, JZ; Fujisawa, S; Barlas, A; Miller, AN; Manova-Todorova, K; Macias, MJ; Sapkota, G; Pan, DJ; Massague, J				Alarcon, Claudio; Zaromytidou, Alexia-Ileana; Xi, Qiaoran; Gao, Sheng; Yu, Jianzhong; Fujisawa, Sho; Barlas, Afsar; Miller, Alexandria N.; Manova-Todorova, Katia; Macias, Maria J.; Sapkota, Gopal; Pan, Duojia; Massague, Joan			Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-beta Pathways	CELL			English	Article							CELL CONTACT INHIBITION; RNA-POLYMERASE-II; IN-VITRO; SIGNALING PATHWAYS; TERMINAL DOMAIN; HIPPO PATHWAY; SIZE-CONTROL; DROSOPHILA; GROWTH; PROLIFERATION	TGF-beta and BMP receptor kinases activate Smad transcription factors by C-terminal phosphorylation. We have identified a subsequent agonist-induced phosphorylation that plays a central dual role in Smad transcriptional activation and turnover. As receptor-activated Smads form transcriptional complexes, they are phosphorylated at an interdomain linker region by CDK8 and CDK9, which are components of transcriptional mediator and elongation complexes. These phosphorylations promote Smad transcriptional action, which in the case of Smad1 is mediated by the recruitment of YAP to the phosphorylated linker sites. An effector of the highly conserved Hippo organ size control pathway, YAP supports Smad1-dependent transcription and is required for BMP suppression of neural differentiation of mouse embryonic stem cells. The phosphorylated linker is ultimately recognized by specific ubiquitin ligases, leading to proteasome-mediated turnover of activated Smad proteins. Thus, nuclear CDK8/9 drive a cycle of Smad utilization and disposal that is an integral part of canonical BMP and TGF-beta pathways.	[Pan, Duojia; Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Alarcon, Claudio; Zaromytidou, Alexia-Ileana; Xi, Qiaoran; Gao, Sheng; Miller, Alexandria N.; Sapkota, Gopal; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Fujisawa, Sho; Barlas, Afsar; Manova-Todorova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA; [Macias, Maria J.] Inst Biomed Res, Struct & Computat Biol Programme, Barcelona 08028, Spain; [Yu, Jianzhong; Pan, Duojia] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Johns Hopkins University	Massague, J (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	massaguj@mskcc.org	Sapkota, Gopal/C-7300-2014; Macias, Maria J/K-3898-2014; Yu, Jianzhong/F-6050-2010	Sapkota, Gopal/0000-0001-9931-3338; Macias, Maria J/0000-0002-6915-963X; Massague, Joan/0000-0001-9324-8408; Miller, Alexandria N./0000-0003-3986-7923	NIH [CA34610, EY015708, BFU2008-02795]; NATIONAL CANCER INSTITUTE [R37CA034610, P30CA008748, R01CA034610] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Yaffe, R. P. Fisher, and F. Liu for reagents; S. Malik, S. Tavazoie, D. Nguyen, S. Keeney, and R. Benezra for helpful discussions; X.H.-F. Zhang for valuable help with microarray analysis; E. Lai for providing the S2 Cells; and M. Squatrito, M. Tavazoie, E. Montalvo, P.Y. Chen, and N. Fan for technical support. This work was supported by NIH grants CA34610 (J. M.), EY015708 (D. P.), and BFU2008-02795 (M. J. M.). J. M. and D. P. are investigators of the Howard Hughes Medical Institute.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Blain SW, 2000, J BIOL CHEM, V275, P32066, DOI 10.1074/jbc.M006496200; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Durand LO, 2005, J VIROL, V79, P6757, DOI 10.1128/JVI.79.11.6757-6762.2005; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Omura-Minamisawa M, 2000, CANCER RES, V60, P6573; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; PAN D, 2007, GENE DEV, V17, P3023; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shapiro GI, 2004, CLIN CANCER RES, V10, p4270S, DOI 10.1158/1078-0432.CCR-040020; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Xiao Z, 2001, J BIOL CHEM, V276, P39404, DOI 10.1074/jbc.M103117200; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	58	533	550	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					757	769		10.1016/j.cell.2009.09.035	http://dx.doi.org/10.1016/j.cell.2009.09.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914168	Green Accepted, Bronze			2022-12-24	WOS:000271747200019
J	Genander, M; Halford, MM; Xu, NJ; Eriksson, M; Yu, ZR; Qiu, ZZ; Martling, A; Greicius, G; Thakar, S; Catchpole, T; Chumley, MJ; Zdunek, S; Wang, CG; Holm, T; Goff, SP; Pettersson, S; Pestell, RG; Henkemeyer, M; Frisen, J				Genander, Maria; Halford, Michael M.; Xu, Nan-Jie; Eriksson, Malin; Yu, Zuoren; Qiu, Zhaozhu; Martling, Anna; Greicius, Gedas; Thakar, Sonal; Catchpole, Timothy; Chumley, Michael J.; Zdunek, Sofia; Wang, Chenguang; Holm, Torbjorn; Goff, Stephen P.; Pettersson, Sven; Pestell, Richard G.; Henkemeyer, Mark; Frisen, Jonas			Dissociation of EphB2 Signaling Pathways Mediating Progenitor Cell Proliferation and Tumor Suppression	CELL			English	Article							COLORECTAL-CANCER PROGRESSION; RECEPTOR TYROSINE KINASE; CENTRAL-NERVOUS-SYSTEM; CYCLIN D1; BETA-CATENIN; PHOSPHATIDYLINOSITOL-3 KINASE; ADULT NEUROGENESIS; IN-VIVO; MIGRATION; EXPRESSION	Signaling proteins driving the proliferation of stem and progenitor cells are often encoded by protooncogenes. EphB receptors represent a rare exception; they promote cell proliferation in the intestinal epithelium and function as tumor suppressors by controlling cell migration and inhibiting invasive growth. We show that cell migration and proliferation are controlled independently by the receptor EphB2. EphB2 regulated cell positioning is kinase-independent and mediated via phosphatidylinositol 3-kinase, whereas EphB2 tyrosine kinase activity regulates cell proliferation through an Abl-cyclin D1 pathway. Cyclin D1 regulation becomes uncoupled from EphB signaling during the progression from adenoma to colon carcinoma in humans, allowing continued proliferation with invasive growth. The dissociation of EphB2 signaling pathways enables the selective inhibition of the mitogenic effect without affecting the tumor suppressor function and identifies a pharmacological strategy to suppress adenoma growth.	[Genander, Maria; Eriksson, Malin; Zdunek, Sofia; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Halford, Michael M.; Xu, Nan-Jie; Thakar, Sonal; Catchpole, Timothy; Chumley, Michael J.; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Yu, Zuoren; Wang, Chenguang; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Qiu, Zhaozhu; Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Martling, Anna; Holm, Torbjorn] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Greicius, Gedas; Pettersson, Sven] Natl Canc Ctr Singapore, Dept Cellular & Mol Res, Lab Inflammat Biol, Singapore 169612, Singapore; [Greicius, Gedas; Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; University of Texas System; University of Texas Southwestern Medical Center Dallas; Jefferson University; Columbia University; Howard Hughes Medical Institute; Karolinska Institutet; Karolinska University Hospital; National Cancer Centre Singapore (NCCS); Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	XU, Nan-Jie/AAJ-4363-2020; Pettersson, Sven/F-9511-2015; Xu, Nan-Jie/N-3391-2016; Qiu, Zhaozhu/F-4171-2010; Goff, Stephen P/K-6337-2014; Yu, Zuoren/G-5684-2010	XU, Nan-Jie/0000-0003-2147-3352; Xu, Nan-Jie/0000-0003-2147-3352; Goff, Stephen P/0000-0003-0693-5547; Henkemeyer, Mark/0000-0002-7525-1061; Genander, Maria/0000-0002-2428-8040; Martling, Anna/0000-0001-5998-4735; Greicius, Gediminas/0000-0001-8333-787X	NIH [R01CA70896, R01CA75503, R01CA86072, 2R01 MH66332]; Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; Swedish Cancer Society; Swedish Research Council; Knut och Alice Wallenbergs Stiftelse; Karolinska Institute; Tobias Foundation; NIH Cancer Center [P30CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA070896, R01CA086072, R01CA075503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Karolinska Institute(Karolinska Institutet); Tobias Foundation; NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank F. Granath, J. Holmberg, L. Huminiecki, J. Lindholm, A. Simon, and members of the Frisen lab for valuable discussions, M.-L. Spangberg and M. Toro for technical assistance, and Novartis for providing Gleevec and AEW-541. This study was supported by grants from the NIH (R01CA70896, R01CA75503, and R01CA86072 to R. G. P. and 2R01 MH66332 to M. H.), the Dr. Ralph and Marian C. Falk Medical Research Trust, the Pennsylvania Department of Health (which specifically disclaims responsibility for analyses, interpretations, or conclusions) (R. G. P.), the Swedish Cancer Society, the Swedish Research Council, Knut och Alice Wallenbergs Stiftelse, the Karolinska Institute, and the Tobias Foundation (J. F.). The Kimmel Cancer Center was supported by the NIH Cancer Center Core grant P30CA56036 (R. G. P).	Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Davalos V, 2006, CANCER RES, V66, P8943, DOI 10.1158/0008-5472.CAN-05-4640; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Donovan EA, 2008, CRIT REV ONCOL HEMAT, V66, P91, DOI 10.1016/j.critrevonc.2007.09.003; Dufour A, 2006, DEVELOPMENT, V133, P4415, DOI 10.1242/dev.02623; Gu C, 2001, MOL CELL BIOL, V21, P4579, DOI 10.1128/MCB.21.14.4579-4597.2001; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Harbott LK, 2005, MOL CELL NEUROSCI, V30, P1, DOI 10.1016/j.mcn.2005.05.002; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Lynch PM, 2007, DIGESTION, V76, P68, DOI 10.1159/000108395; Maekawa H, 2003, ARTERIOSCL THROM VAS, V23, P2008, DOI 10.1161/01.ATV.0000096655.56262.56; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vearing CJ, 2005, GROWTH FACTORS, V23, P67, DOI 10.1080/08977190500055869	38	131	136	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					679	692		10.1016/j.cell.2009.08.048	http://dx.doi.org/10.1016/j.cell.2009.08.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914164	Bronze, Green Accepted			2022-12-24	WOS:000271747200013
J	Jelinek, M; Barraclough, K				Jelinek, Michael; Barraclough, Kevin			Diagnosis in General Practice Chest pain	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-ARTERY DISEASE; EXERCISE TEST		[Jelinek, Michael] St Vincents Hosp, Melbourne, Vic, Australia; [Jelinek, Michael] Univ Melbourne, Melbourne, Vic, Australia	St Vincent's Hospital Melbourne; University of Melbourne	Jelinek, M (corresponding author), St Vincents Hosp, Melbourne, Vic, Australia.	michael.jelinek@svhm.org.au						Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Doust J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3823; ELLESTAD MH, 1975, CIRCULATION, V51, P363, DOI 10.1161/01.CIR.51.2.363; Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001; Glasziou P., 2001, EVID BASED MED, V6, P164, DOI DOI 10.1136/EBM.6.6.164; GOLDMAN L, 1982, CIRCULATION, V66, P945, DOI 10.1161/01.CIR.66.5.945; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; RIFKIN RD, 1977, NEW ENGL J MED, V297, P686; Williams SV, 2001, ANN INTERN MED, V135, P530, DOI 10.7326/0003-4819-135-7-200110020-00014	10	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 3	2009	339								b4117	10.1136/bmj.b4117	http://dx.doi.org/10.1136/bmj.b4117			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UB	19887529				2022-12-24	WOS:000271567700002
J	Cui, HG; Pashuck, ET; Velichko, YS; Weigand, SJ; Cheetham, AG; Newcomb, CJ; Stupp, SI				Cui, Honggang; Pashuck, E. Thomas; Velichko, Yuri S.; Weigand, Steven J.; Cheetham, Andrew G.; Newcomb, Christina J.; Stupp, Samuel I.			Spontaneous and X-ray-Triggered Crystallization at Long Range in Self-Assembling Filament Networks	SCIENCE			English	Article							RADIATION-DAMAGE; LIPID-MEMBRANES; PROTEINS; MECHANOTRANSDUCTION; CONDENSATION; MESOPHASES; SCATTERING; CRYSTAL; ORDER	We report here crystallization at long range in networks of like-charge supramolecular peptide filaments mediated by repulsive forces. The crystallization is spontaneous beyond a given concentration of the molecules that form the filaments but can be triggered by x-rays at lower concentrations. The crystalline domains formed by x-ray irradiation, with interfilament separations of up to 320 angstroms, can be stable for hours after the beam is turned off, and ions that screen charges on the filaments suppress ordering. We hypothesize that the stability of crystalline domains emerges from a balance of repulsive tensions linked to native or x-ray-induced charges and the mechanical compressive entrapment of filaments within a network. Similar phenomena may occur naturally in the cytoskeleton of cells and, if induced externally in biological or artificial systems, lead to possible biomedical and lithographic functions.	[Cui, Honggang; Pashuck, E. Thomas; Velichko, Yuri S.; Newcomb, Christina J.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Weigand, Steven J.] Northwestern Univ, APS, Argonne Natl Lab, Synchrotron Res Ctr,DND CAT, Argonne, IL 60439 USA; [Cheetham, Andrew G.; Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Evanston, IL 60208 USA	Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; Northwestern University; Northwestern University	Stupp, SI (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.	s-stupp@northwestern.edu	Velichko, Yuri/D-8596-2011; Cui, Honggang/C-6550-2008; Pashuck, E./AAG-1741-2021; Cui, Honggang/E-8012-2010; Weigand, Steven/G-6181-2015; Pashuck, Eugene/ABC-2634-2021; Stupp, Samuel/AGV-1942-2022; Stupp, Samuel/B-6737-2009	Weigand, Steven/0000-0003-3137-0672; Pashuck III, Eugene/0000-0003-2881-4965; Cheetham, Andrew/0000-0002-9933-9877; Velichko, Yury S/0000-0002-2287-5727	U.S. Department of Energy [DE-FG02-00ER45810]; E. I. DuPont de Nemours and Company; Dow Chemical Company; state of Illinois; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH National Institute of Dental and Craniofacial Research [5R01 DE015920]; NSF [DMR-0605427]; Direct For Mathematical & Physical Scien [1006713] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA119341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015920] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); E. I. DuPont de Nemours and Company; Dow Chemical Company; state of Illinois; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the U.S. Department of Energy (grant no. DE-FG02-00ER45810). The SAXS experiments were performed at the DND-CAT located at Sector 5 of the APS. DND-CAT is supported by E. I. DuPont de Nemours and Company, Dow Chemical Company, and the state of Illinois. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. Some additional support for this work was obtained from NIH National Institute of Dental and Craniofacial Research grant 5R01 DE015920 and NSF grant DMR-0605427. We thank the Biological Imaging Facility (BIF) at Northwestern for the use of TEM equipment.	Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Cheng AC, 1996, BIOPHYS J, V70, P2212, DOI 10.1016/S0006-3495(96)79787-4; Cherezov V, 2002, J SYNCHROTRON RADIAT, V9, P333, DOI 10.1107/S0909049502014528; Chu B, 2001, CHEM REV, V101, P1727, DOI 10.1021/cr9900376; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; Nakata M, 2007, SCIENCE, V318, P1276, DOI 10.1126/science.1143826; NAVE C, 1995, RADIAT PHYS CHEM, V45, P483, DOI 10.1016/0969-806X(95)92800-E; Needleman DJ, 2004, P NATL ACAD SCI USA, V101, P16099, DOI 10.1073/pnas.0406076101; PARSEGIAN VA, 2005, VANDERWAALS; Pelletier O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148102; Pelta J, 1996, BIOPHYS J, V71, P48, DOI 10.1016/S0006-3495(96)79232-9; Pizzey CL, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2955745; Ravelli RBG, 2000, STRUCTURE, V8, P315, DOI 10.1016/S0969-2126(00)00109-X; Song WH, 2003, SCIENCE, V302, P1363, DOI 10.1126/science.1089764; STARK G, 1991, BIOCHIM BIOPHYS ACTA, V1071, P103, DOI 10.1016/0304-4157(91)90020-W; Teng TY, 2000, J SYNCHROTRON RADIAT, V7, P313, DOI 10.1107/S0909049500008694; Velichko YS, 2008, J PHYS CHEM B, V112, P2326, DOI 10.1021/jp074420n; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623	26	140	143	0	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					555	559		10.1126/science.1182340	http://dx.doi.org/10.1126/science.1182340			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	549CT	20019248	Green Accepted			2022-12-24	WOS:000274020500031
J	Opperman, JJ; Galloway, GE; Fargione, J; Mount, JF; Richter, BD; Secchi, S				Opperman, Jeffrey J.; Galloway, Gerald E.; Fargione, Joseph; Mount, Jeffrey F.; Richter, Brian D.; Secchi, Silvia			Sustainable Floodplains Through Large-Scale Reconnection to Rivers	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BIOMASS; FUTURE; TRENDS		[Opperman, Jeffrey J.; Fargione, Joseph; Richter, Brian D.] Nature Conservancy, Arlington, VA 22203 USA; [Opperman, Jeffrey J.; Mount, Jeffrey F.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Galloway, Gerald E.] Univ Maryland, Dept Civil & Environm Engn, College Pk, MD 20742 USA; [Galloway, Gerald E.] Univ Maryland, Sch Publ Policy, College Pk, MD 20742 USA; [Secchi, Silvia] So Illinois Univ, Dept Agribusiness Econ, Carbondale, IL 62901 USA	Nature Conservancy; University of California System; University of California Davis; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Southern Illinois University System; Southern Illinois University	Opperman, JJ (corresponding author), Nature Conservancy, Arlington, VA 22203 USA.	jopperman@tnc.org	Secchi, Silvia/C-9124-2013	Secchi, Silvia/0000-0003-0095-0789				Akanbi A.A., 1999, 4 ILL STAT WAT SURV; Bates B.C., 2008, CLIMATE CHANGE WATER; BORMAN M, 2008, ALTON TELEGRAPH 0619; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Jercich SA, 1997, J WATER RES PL-ASCE, V123, P59, DOI 10.1061/(ASCE)0733-9496(1997)123:1(59); Kelley R., 1989, BATTLING INLAND SEA; Klijn F, 2004, AMBIO, V33, P141, DOI 10.1639/0044-7447(2004)033[0141:FMSFAU]2.0.CO;2; National Committee on Levee Safety, 2009, REC NAT LEV SAF PROG; *NOAA, COSTS AR NORM 2007 D; Pielke R.A., 2002, FLOOD DAMAGE US 1926; Pinter N, 2005, SCIENCE, V308, P207, DOI 10.1126/science.1108411; Sommer T, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026<0006:CYB>2.0.CO;2; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; *USA, 1999, POSTFL ASS SACR SAN; Volk TA, 2004, FRONT ECOL ENVIRON, V2, P411, DOI 10.1890/1540-9295(2004)002[0411:GFASAO]2.0.CO;2; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; 2007, SACRAMENTO BEE  0712, pB6; 1980, FED REG, V45, P64366	19	220	222	8	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 11	2009	326	5959					1487	1488		10.1126/science.1178256	http://dx.doi.org/10.1126/science.1178256			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007887				2022-12-24	WOS:000272623600041
J	Guo, M; Chong, YE; Shapiro, R; Beebe, K; Yang, XL; Schimmel, P				Guo, Min; Chong, Yeeting E.; Shapiro, Ryan; Beebe, Kirk; Yang, Xiang-Lei; Schimmel, Paul			Paradox of mistranslation of serine for alanine caused by AlaRS recognition dilemma	NATURE			English	Article							TRANSFER-RNA-SYNTHETASE; AMINO-ACID; STRUCTURAL BASIS; DISCRIMINATION; ISOLEUCINE; MECHANISM; SIEVE; MOTIF	Mistranslation arising from confusion of serine for alanine by alanyl-tRNA synthetases (AlaRSs) has profound functional consequences(1-3). Throughout evolution, two editing checkpoints prevent disease-causing mistranslation from confusing glycine or serine for alanine at the active site of AlaRS. In both bacteria and mice, Ser poses a bigger challenge than Gly(1,2). One checkpoint is the AlaRS editing centre, and the other is from widely distributed AlaXps-free-standing, genome-encoded editing proteins that clear Ser-tRNA(Ala). The paradox of misincorporating both a smaller (glycine) and a larger (serine) amino acid suggests a deep conflict for nature-designed AlaRS. Here we show the chemical basis for this conflict. Nine crystal structures, together with kinetic and mutational analysis, provided snapshots of adenylate formation for each amino acid. An inherent dilemma is posed by constraints of a structural design that pins down the alpha-amino group of the bound amino acid by using an acidic residue. This design, dating back more than 3 billion years, creates a serendipitous interaction with the serine OH that is difficult to avoid. Apparently because no better architecture for the recognition of alanine could be found, the serine misactivation problem was solved through free-standing AlaXps, which appeared contemporaneously with early AlaRSs. The results reveal unconventional problems and solutions arising from the historical design of the protein synthesis machinery.	[Guo, Min; Chong, Yeeting E.; Shapiro, Ryan; Beebe, Kirk; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Guo, Min; Chong, Yeeting E.; Shapiro, Ryan; Beebe, Kirk; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, BCC 379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [GM 15539]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R.J. Read for pointing out the errors in the previous AlaRS-ligand structures and for crystallographic discussions; and G. J. Kleywegt, Z. Otwinowski and A. Perrakis for technical assistance. X-ray diffraction data were collected at Stanford Synchrotron Radiation Laboratory (SSRL) beamlines 7-1, 9-1 and 11-1. This work was supported by grant GM 15539 from the National Institutes of Health and by a fellowship from the National Foundation for Cancer Research.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; BELRHALI H, 1994, SCIENCE, V263, P1432, DOI 10.1126/science.8128224; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Cieslik M, 2009, ACTA CRYSTALLOGR D, V65, P500, DOI 10.1107/S0907444909009500; DAVIS MW, 1994, BIOCHEMISTRY-US, V33, P9904, DOI 10.1021/bi00199a012; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; Fersht AR., 1977, ENZYME STRUCTURE MEC; First E.A., 2005, AMINOACYL TRNA SYNTH, P328; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Giege R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Itoh Y, 2008, RNA BIOL, V5, P169, DOI 10.4161/rna.5.3.6876; Jakubowsky H., 2005, AMINOACYL TRNA SYNTH, P384; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; Malde AK, 2009, J AM CHEM SOC, V131, P3848, DOI 10.1021/ja9002124; NORRIS AT, 1964, P NATL ACAD SCI USA, V52, P330, DOI 10.1073/pnas.52.2.330; Nureki O, 2001, COLD SPRING HARB SYM, V66, P167, DOI 10.1101/sqb.2001.66.167; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SHI JP, 1994, BIOCHEMISTRY-US, V33, P5312, DOI 10.1021/bi00183a039; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Swairjo MA, 2005, P NATL ACAD SCI USA, V102, P988, DOI 10.1073/pnas.0409024102; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Xin Y, 2000, J MOL BIOL, V303, P299, DOI 10.1006/jmbi.2000.4126	34	71	79	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					808	U134		10.1038/nature08612	http://dx.doi.org/10.1038/nature08612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010690	Green Accepted			2022-12-24	WOS:000272559900043
J	Rubenstein, DR; Lovette, IJ				Rubenstein, Dustin R.; Lovette, Irby J.			Reproductive skew and selection on female ornamentation in social species	NATURE			English	Article							SEXUAL SELECTION; GENETIC VARIANCE; VARIABILITY; COMPETITION; EVOLUTION; DICHROMATISM; PHYLOGENY; BEHAVIOR; DRIVES	Male animals are typically more elaborately ornamented than females(1). Classic sexual selection theory notes that because sperm are cheaper to produce than eggs(2), and because males generally compete more intensely for reproductive opportunities and invest less in parental care than females(3), males can obtain greater fitness benefits from mating multiply(2,4). Therefore, sexual selection typically results in male-biased sex differences in secondary sexual characters(1,4). This generality has recently been questioned, because in cooperatively breeding vertebrates, the strength of selection on traits used in intra-sexual competition for access to mates (sexual selection(1,4)) or other resources linked to reproduction (social selection(5,6)) is similar in males and females(7,8). Because selection is acting with comparable intensity in both sexes in cooperatively breeding species, the degree of sexual dimorphism in traits used in intrasexual competition should be reduced in cooperative breeders(6). Here we use the socially diverse African starlings (Sturnidae) to demonstrate that the degree of sexual dimorphism in plumage and body size is reduced in cooperatively breeding species as a result of increased selection on females for traits that increase access to reproductive opportunities, other resources, or higher social status. In cooperative breeders such as these, where there is unequal sharing of reproduction (reproductive skew) among females, and where female dominance rank influences access to mates and other resources, intrasexual competition among females may be intense(7) and ultimately select for female trait elaboration(9). Selection is thereby acting with different intensities on males and females in cooperatively versus non-cooperatively breeding species, and female-female interactions in group-living vertebrates will have important consequences for the evolution of female morphological, physiological and behavioural traits.	[Rubenstein, Dustin R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Rubenstein, Dustin R.] Univ Calif Berkeley, Dept Integrat Biol, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Rubenstein, Dustin R.; Lovette, Irby J.] Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY 14850 USA	Columbia University; University of California System; University of California Berkeley; Cornell University	Rubenstein, DR (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, 10th Floor Schermerhorn Extens,1200 Amsterdam Ave, New York, NY 10027 USA.	dr2497@columbia.edu	Rubenstein, Dustin R./N-9302-2019; Rubenstein, Dustin R/A-3451-2015; Wang, Anna/F-6418-2014	Rubenstein, Dustin R./0000-0002-4999-3723; Rubenstein, Dustin R/0000-0002-4999-3723; 	NSF [DEB-0515981]; Miller Institute for Basic Research in Science at the University of California, Berkeley	NSF(National Science Foundation (NSF)); Miller Institute for Basic Research in Science at the University of California, Berkeley(University of California System)	This research was supported by grants from NSF to I. J. L. (DEB-0515981) and a postdoctoral fellowship from the Miller Institute for Basic Research in Science at the University of California, Berkeley to D. R. R. We thank E. Lacey, B. Lyon, B. McCleery, D. I. Rubenstein, R. Safran, A. L. Talaba and the Lacey laboratory for advice and assistance. P. Hohohnle helped conduct and interpret the MIPoD analyses. We acknowledge S. Edwards, J. Trimble ( Harvard Museum of Comparative Zoology), R. Prum, K. Zyskowski ( Yale Peabody Museum), J. Cracraft, P. Sweet ( American Museum of Natural History), N. Rice ( Academy of Natural Sciences, Philadelphia), M. Braun, D. James ( National Museum of Natural History) and R. Prys-Jones ( British Museum) for access to their collections.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Andersson Malte, 1994; ARNOLD SJ, 1994, AM NAT, V144, pS1, DOI 10.1086/285650; Badyaev AV, 2003, ANNU REV ECOL EVOL S, V34, P27, DOI 10.1146/annurev.ecolsys.34.011802.132441; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Clutton-Brock T.H., 1983, P457; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Clutton-Brock T.H., 1988, P1; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; CRAIG AJFK, 1985, AUK, V102, P629, DOI 10.1093/auk/102.3.629; Darwin G., 1871, P423; Delhey K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001689; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; Hauber ME, 2005, INTEGR COMP BIOL, V45, P903, DOI 10.1093/icb/45.5.903; IRWIN RE, 1994, AM NAT, V144, P890, DOI 10.1086/285717; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; Lovette IJ, 2007, MOL PHYLOGENET EVOL, V44, P1031, DOI 10.1016/j.ympev.2007.03.017; Roughgarden J, 2006, SCIENCE, V311, P965, DOI 10.1126/science.1110105; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rubenstein DR, 2007, CURR BIOL, V17, P1414, DOI 10.1016/j.cub.2007.07.032; Rubenstein DR, 2007, P R SOC B, V274, P1895, DOI 10.1098/rspb.2007.0424; Rubenstein DR, 2007, AM NAT, V170, P155, DOI 10.1086/518671; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Van Homrigh A, 2007, CURR BIOL, V17, P528, DOI 10.1016/j.cub.2007.01.055; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WILKINSON R, 1982, ANIM BEHAV, V30, P1118, DOI 10.1016/S0003-3472(82)80202-9	30	113	113	0	99	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					786	U106		10.1038/nature08614	http://dx.doi.org/10.1038/nature08614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010686				2022-12-24	WOS:000272559900038
J	Verschuren, D; Damste, JSS; Moernaut, J; Kristen, I; Blaauw, M; Fagot, M; Haug, GH				Verschuren, Dirk; Damste, Jaap S. Sinninghe; Moernaut, Jasper; Kristen, Iris; Blaauw, Maarten; Fagot, Maureen; Haug, Gerald H.		CHALLACEA Project Members	Half-precessional dynamics of monsoon rainfall near the East African Equator	NATURE			English	Article							ATLANTIC THERMOHALINE CIRCULATION; LAST GLACIAL MAXIMUM; MILLENNIAL-SCALE; CLIMATE; INSOLATION; HOLOCENE; COLLAPSE; TANZANIA; RECORD; BP	External climate forcings-such as long-term changes in solar insolation-generate different climate responses in tropical and high latitude regions(1). Documenting the spatial and temporal variability of past climates is therefore critical for understanding how such forcings are translated into regional climate variability. In contrast to the data-richmiddle and high latitudes, high-quality climate-proxy records from equatorial regions are relatively few(2-4), especially from regions experiencing the bimodal seasonal rainfall distribution associated with twice-annual passage of the Intertropical Convergence Zone. Here we present a continuous and well-resolved climate-proxy record of hydrological variability during the past 25,000 years from equatorial East Africa. Our results, based on complementary evidence from seismic-reflection stratigraphy and organic biomarker molecules in the sediment record of Lake Challa near Mount Kilimanjaro, reveal that monsoon rainfall in this region varied at half-precessional (similar to 11,500-year) intervals in phase with orbitally controlled insolation forcing. The southeasterly and northeasterly monsoons that advect moisture from the western Indian Ocean were strengthened in alternation when the inter-hemispheric insolation gradient was at a maximum; dry conditions prevailed when neither monsoon was intensified and modest local March or September insolation weakened the rain season that followed. On sub-millennial timescales, the temporal pattern of hydrological change on the East African Equator bears clear high-northern-latitude signatures, but on the orbital timescale it mainly responded to low-latitude insolation forcing. Predominance of low-latitude climate processes in this monsoon region can be attributed to the low-latitude position of its continental regions of surface air flow convergence, and its relative isolation from the Atlantic Ocean, where prominent meridional overturning circulation more tightly couples low-latitude climate regimes to high-latitude boundary conditions.	[Verschuren, Dirk; Fagot, Maureen] Univ Ghent, Dept Biol, Limnol Unit, B-9000 Ghent, Belgium; [Damste, Jaap S. Sinninghe] Univ Utrecht, Fac Geosci, NL-3508 TA Utrecht, Netherlands; [Damste, Jaap S. Sinninghe] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Netherlands; [Moernaut, Jasper] Univ Ghent, Dept Geol & Soil Sci, Renard Ctr Marine Geol, B-9000 Ghent, Belgium; [Kristen, Iris] Geoforschungszentrum Potsdam, Sekt Klimadynam & Sedimente 3 3, D-14473 Potsdam, Germany; [Blaauw, Maarten] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT9 6AX, Antrim, North Ireland; [Haug, Gerald H.] ETH, Inst Geol, Dept Earth Sci, CH-8092 Zurich, Switzerland; [Haug, Gerald H.] Univ Potsdam, DFG Leibniz Ctr Earth Surface Proc & Climate Stud, D-14476 Potsdam, Germany	Ghent University; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Ghent University; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Queens University Belfast; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Potsdam	Verschuren, D (corresponding author), Univ Ghent, Dept Biol, Limnol Unit, Ledeganckstr 35, B-9000 Ghent, Belgium.	dirk.verschuren@UGent.be	Blaauw, Maarten/E-4539-2011; De Batist, Marc/F-5722-2012; Damste, Jaap S Sinninghe/F-6128-2011; Barker, Philip/J-5938-2012; Blaauw, Maarten/N-9576-2019; van der Plicht, Johannes/B-9994-2013; Moernaut, Jasper/R-5188-2018	Blaauw, Maarten/0000-0002-5680-1515; De Batist, Marc/0000-0002-1625-2080; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Blaauw, Maarten/0000-0002-5680-1515; Moernaut, Jasper/0000-0003-3164-4274; Hurrell, Elizabeth/0000-0003-4290-9047; Barker, Philip/0000-0002-5334-9201	Belgium (FWO-Vlaanderen); Denmark ( Danish National Research Council), Germany (DFG); The Netherlands (NWO); EuroCLIMATE; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Natural Environment Research Council [bgs04003, nigl010001] Funding Source: researchfish; NERC [bgs04003, nigl010001] Funding Source: UKRI	Belgium (FWO-Vlaanderen)(FWO); Denmark ( Danish National Research Council), Germany (DFG)(German Research Foundation (DFG)Danmarks Grundforskningsfond); The Netherlands (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); EuroCLIMATE(European Science Foundation (ESF)); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was sponsored by funding agencies in Belgium (FWO-Vlaanderen), Denmark ( Danish National Research Council), Germany (DFG) and The Netherlands (NWO) through the European Science Foundation (ESF) EuroCORES programme, EuroCLIMATE. Fieldwork was conducted with permission of the Kenyan Ministry of Education, Science and Technology (MOEST) and the Tanzania Commission for Science and Technology (COSTECH). We thank A. Alcantara, M. Kohler, S. Lauterbach, R. Niederreiter and S. Opitz for assistance with core collection and processing; D. Engstrom for 210 Pb dating, A. Berger, D. Fleitmann, J. Kutzbach and Z. Liu for discussion, and E. Odada for support. J. M. acknowledges the support of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen).	Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Barker PA, 2001, SCIENCE, V292, P2307, DOI 10.1126/science.1059612; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Berger A, 2006, CLIM PAST, V2, P131, DOI 10.5194/cp-2-131-2006; Clement AC, 2004, CLIM DYNAM, V22, P327, DOI 10.1007/s00382-003-0375-8; Cruz FW, 2009, NAT GEOSCI, V2, P210, DOI 10.1038/NGEO444; Cruz FW, 2005, NATURE, V434, P63, DOI 10.1038/nature03365; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; Garcin Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025531; Gasse F, 2008, QUATERNARY SCI REV, V27, P2316, DOI 10.1016/j.quascirev.2008.08.027; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; KUTZBACH JE, 1981, SCIENCE, V214, P59, DOI 10.1126/science.214.4516.59; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mumbi CT, 2008, QUATERNARY RES, V69, P326, DOI 10.1016/j.yqres.2007.10.012; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Peyron O, 2000, QUATERNARY RES, V54, P90, DOI 10.1006/qres.2000.2136; Pinot S, 1999, CLIM DYNAM, V15, P857, DOI 10.1007/s003820050318; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Ruddiman WF, 2006, QUATERNARY SCI REV, V25, P657, DOI 10.1016/j.quascirev.2006.02.004; TAIBOT MR, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI DOI 10.1029/2006GC001465; Thevenon F, 2002, PALAEOGEOGR PALAEOCL, V187, P285, DOI 10.1016/S0031-0182(02)00481-9; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Verschuren D., 2008, NATURAL CLIMATE VARI, P189, DOI [DOI 10.1002/9781444300932.CH8, 10.1002/9781444300932.ch8]; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1	30	211	222	5	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 3	2009	462	7273					637	641		10.1038/nature08520	http://dx.doi.org/10.1038/nature08520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956257	Green Published			2022-12-24	WOS:000272277900038
J	Wang, Y; Huang, YJ; Wang, JW; Cheng, C; Huang, WJ; Lu, PL; Xu, YN; Wang, PY; Yan, N; Shi, YG				Wang, Yi; Huang, Yongjian; Wang, Jiawei; Cheng, Chao; Huang, Weijiao; Lu, Peilong; Xu, Ya-Nan; Wang, Pengye; Yan, Nieng; Shi, Yigong			Structure of the formate transporter FocA reveals a pentameric aquaporin-like channel	NATURE			English	Article							ESCHERICHIA-COLI; PROTEIN; NITRATE; GLYCEROL; NARU; IDENTIFICATION; RECONSTITUTION; SOFTWARE; OPERON; FAMILY	FocA is a representative member of the formate-nitrite transporter family, which transports short-chain acids in bacteria, archaea, fungi, algae and parasites. The structure and transport mechanism of the formate-nitrite transporter family remain unknown. Here we report the crystal structure of Escherichia coli FocA at 2.25 angstrom resolution. FocA forms a symmetric pentamer, with each protomer consisting of six transmembrane segments. Despite a lack of sequence homology, the overall structure of the FocA protomer closely resembles that of aquaporin and strongly argues that FocA is a channel, rather than a transporter. Structural analysis identifies potentially important channel residues, defines the channel path and reveals two constriction sites. Unlike aquaporin, FocA is impermeable to water but allows the passage of formate. A structural and biochemical investigation provides mechanistic insights into the channel activity of FocA.	[Huang, Yongjian; Wang, Jiawei; Cheng, Chao; Huang, Weijiao; Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Yongjian; Wang, Jiawei; Cheng, Chao; Huang, Weijiao; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wang, Yi; Lu, Peilong; Shi, Yigong] Tsinghua Univ, Minist Educ Prot Sci Lab, Beijing 100084, Peoples R China; [Xu, Ya-Nan; Wang, Pengye] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Physics, CAS	Yan, N (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; 王, 鹏业/A-9811-2012; Huang, Yongjian/GPK-5986-2022	Wang, Jiawei/0000-0001-9893-8539; Huang, Yongjian/0000-0002-1168-6111; Shi, Yigong/0000-0003-2030-168X; Lu, Peilong/0000-0001-5894-9268; Wang, Peng-Ye/0000-0002-9765-0610; Huang, Weijiao/0000-0002-6253-7765	Ministry of Science and Technology of China [2009CB918801, 2009CB918802]; National Natural Science Foundation of China [30888001]; Beijing Municipal Commissions of Education and Science and Technology; Yuyuan Foundation; Li's Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology; Yuyuan Foundation; Li's Foundation	We thank N. Shimizu, S. Baba and T. Kumasaka at the Spring-8 beamline BL41XU for assistance, and J. He and S. Huang for help at Shanghai Synchrotron Radiation Facility (SSRF). This work was supported by funds from the Ministry of Science and Technology of China ( grants 2009CB918801 and 2009CB918802), Tsinghua University 985 Phase II funds, Project 30888001 supported by National Natural Science Foundation of China, and the Beijing Municipal Commissions of Education and Science and Technology. N. Y. acknowledges support from the Yuyuan Foundation and Li's Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; CARBREY JM, 2009, HDB EXP PHARM, V190, P3, DOI DOI 10.1007/978-3-540-79885-9_; Clegg S, 2002, MOL MICROBIOL, V44, P143, DOI 10.1046/j.1365-2958.2002.02858.x; Clegg SJ, 2006, MICROBIOL-SGM, V152, P2091, DOI 10.1099/mic.0.28688-0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L., 2002, PYMOL MOL VIEWER; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jia W, 2005, BIOCHEM SOC T, V33, P159, DOI 10.1042/BST0330159; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Leonhartsberger S, 2002, J MOL MICROB BIOTECH, V4, P269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nolling J, 1997, J BACTERIOL, V179, P899; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Stephenson M, 1932, BIOCHEM J, V26, P712, DOI 10.1042/bj0260712; Stroud RM, 2003, ADV PROTEIN CHEM, V63, P291; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WHITE WB, 1992, J BACTERIOL, V174, P4997, DOI 10.1128/JB.174.15.4997-5004.1992	38	118	119	7	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					467	U158		10.1038/nature08610	http://dx.doi.org/10.1038/nature08610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940917				2022-12-24	WOS:000272144200035
J	Lyle, K; Dent, L; Bailey, S; Kerridge, L; Roberts, I; Milne, R				Lyle, Katy; Dent, Louise; Bailey, Sally; Kerridge, Lynn; Roberts, Ian; Milne, Ruairidh			Carbon cost of pragmatic randomised controlled trials: retrospective analysis of sample of trials	BRITISH MEDICAL JOURNAL			English	Article								Objective To calculate the global warming potential, in carbon dioxide (CO(2)) equivalent emissions, from a sample of pragmatic randomised controlled trials. Design Retrospective analysis. Data source Internal data held by NIHR Evaluation, Trials and Studies Coordinating Centre. Studies included All eligible pragmatic randomised controlled trials funded by the NIHR Health Technology Assessment programme during 2002 and 2003. Main outcome measure CO(2) equivalents for trial activities calculated with standard conversion factors. Results 12 pragmatic randomised controlled trials involving more than 4800 participants and a wide range of technologies were included. The average CO(2) emission generated by the trials was 78.4 (range 42.1-112.7) tonnes. This is equivalent to that produced in one year by approximately nine people in the United Kingdom. Commuting to work by the trial team generated the most emissions (average 21 (11.5-35.0) tonnes per trial), followed by study centres' fuel use (18(9.3-32.2) tonnes per trial), trial team related travel (15(2.0-29.0) tonnes per trial), and participant related travel (13(0-46.7) tonnes per trial). Conclusions CO(2) emissions from pragmatic randomised controlled trials are generated in areas where steps could be taken to reduce them. A large proportion of the CO(2) emissions come from travel related to various aspects of a trial. The results of this research are likely to underestimate the total CO(2) emissions associated with the trials studied, because of the sources of information available. Further research is needed to explore the additional CO(2) emissions generated by clinical trials, over and above those generated by routine care. The results from this project will feed into NIHR guidelines that will advise researchers on how to reduce CO(2) emissions.	[Bailey, Sally; Kerridge, Lynn; Milne, Ruairidh] Univ Southampton, NIHR Evaluat Trials & Studies Coordinating Ctr, Southampton SO16 7NS, Hants, England; [Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Southampton; University of London; London School of Hygiene & Tropical Medicine		k.lyle@southamtpon.ac.uk		Milne, Ruairidh/0000-0002-5117-4380; Lyle, Kate/0000-0001-9265-7648; Stanton, Louise/0000-0001-8181-840X				Burnett J, 2007, BMJ-BRIT MED J, V334, P671; *CHART I PERS DEV, 2008, ABS MAN SURV POL PRA; Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; *DEP FOOD ENV RUR, 2008, GUID DEFR GHG CONV F; *DEP TRANSP, 2007, TRANSP STAT B; Department of Trade and Industry, 2006, EN ITS IMP ENV SOC; NHS Sustainable Development Unit, 2009, SAV CARB IMPR HLTH N; PROPPER C, 2006, DISTANCE TRAVELLED N; Richardson Katherine, 2009, CLIMATE CHANGE GLOBA; *SUST DEV COMM, 2008, NHS ENGL CARB EMM CA; World Business Council for Sustainable Development World Resources Institute., 2004, GREENH GAS PROT CORP; [No title captured]	12	17	17	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 30	2009	339								b4187	10.1136/bmj.b4187	http://dx.doi.org/10.1136/bmj.b4187			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514AQ	19880529	Green Accepted, hybrid, Green Published			2022-12-24	WOS:000271366100002
J	Crawford, JM; Korman, TP; Labonte, JW; Vagstad, AL; Hill, EA; Kamari-Bidkorpeh, O; Tsai, SC; Townsend, CA				Crawford, Jason M.; Korman, Tyler P.; Labonte, Jason W.; Vagstad, Anna L.; Hill, Eric A.; Kamari-Bidkorpeh, Oliver; Tsai, Shiou-Chuan; Townsend, Craig A.			Structural basis for biosynthetic programming of fungal aromatic polyketide cyclization	NATURE			English	Article							CRYSTAL-STRUCTURE; CRYSTALLOGRAPHY	Polyketides are a class of natural products with diverse structures and biological activities. The structural variability of aromatic products of fungal nonreducing, multidomain iterative polyketide synthases (NR-PKS group of IPKSs) results from regiospecific cyclizations of reactive poly-beta-keto intermediates(1-3). How poly-beta-keto species are synthesized and stabilized, how their chain lengths are determined, and, in particular, how specific cyclization patterns are controlled have been largely inaccessible and functionally unknown until recently(4). A product template (PT) domain is responsible for controlling specific aldol cyclization and aromatization of these mature polyketide precursors, but the mechanistic basis is unknown. Here we present the 1.8 angstrom crystal structure and mutational studies of a dissected PT monodomain from PksA, the NR-PKS that initiates the biosynthesis of the potent hepatocarcinogen aflatoxin B-1 in Aspergillus parasiticus. Despite having minimal sequence similarity to known enzymes, the structure displays a distinct `double hot dog' (DHD) fold. Co-crystal structures with palmitate or a bicyclic substrate mimic illustrate that PT can bind both linear and bicyclic polyketides. Docking and mutagenesis studies reveal residues important for substrate binding and catalysis, and identify a phosphopantetheine localization channel and a deep two-part interior binding pocket and reaction chamber. Sequence similarity and extensive conservation of active site residues in PT domains suggest that the mechanistic insights gleaned from these studies will prove general for this class of IPKSs, and lay a foundation for defining the molecular rules controlling NR-PKS cyclization specificity.	[Crawford, Jason M.; Labonte, Jason W.; Vagstad, Anna L.; Hill, Eric A.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Townsend, Craig A.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Townsend, Craig A.] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Korman, Tyler P.; Tsai, Shiou-Chuan] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Kamari-Bidkorpeh, Oliver; Tsai, Shiou-Chuan] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Tsai, Shiou-Chuan] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Townsend, CA (corresponding author), Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA.	sctsai@uci.edu; ctownsend@jhu.edu	Tsai, Shiou-Chuan/C-1188-2010	Vagstad, Anna Lisa/0000-0001-8074-0137	US National Institutes of Health [ES001670]; Pew Foundation; Stanford Synchrotron Radiation Laboratory (SSRL); Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences; Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Damon Runyon Cancer Research Foundation [DRG-2002-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES001670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080189, R01GM100305, R01GM076330] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation; Stanford Synchrotron Radiation Laboratory (SSRL); Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. M. Harris for his gift of HC8. The work at Johns Hopkins was supported by the US National Institutes of Health grant ES001670 awarded to C. A. T. S.-C. T. is supported by the Pew Foundation. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231. J. M. C. is currently a fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2002-09, Harvard Medical School).	Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hibbert F., 1990, ADV PHYS ORG CHEM, V26, P255, DOI DOI 10.1016/S0065-3160(08)60047-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jordan DB, 2000, BIOCHEMISTRY-US, V39, P2276, DOI 10.1021/bi991839y; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ma SM, 2008, J AM CHEM SOC, V130, P38, DOI 10.1021/ja078091o; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; MILLS SG, 1985, J ORG CHEM, V50, P1216, DOI 10.1021/jo00208a014; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thomas R, 2001, CHEMBIOCHEM, V2, P612, DOI 10.1002/1439-7633(20010903)2:9<612::AID-CBIC612>3.0.CO;2-Z; TOWNSEND CA, 1999, COMPREHENSIVE NATURA, V1, P443; Udwary DW, 2002, J MOL BIOL, V323, P585, DOI 10.1016/S0022-2836(02)00972-5; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465	30	132	136	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1139	U243		10.1038/nature08475	http://dx.doi.org/10.1038/nature08475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847268	Green Accepted			2022-12-24	WOS:000270987600048
J	Falagas, ME; Karageorgopoulos, DE				Falagas, Matthew E.; Karageorgopoulos, Drosos E.			Adjustment of dosing of antimicrobial agents for bodyweight in adults	LANCET			English	Editorial Material							BODY-MASS; OBESITY; PREVALENCE; MANAGEMENT; INFECTIONS; GUIDELINES; SOCIETY; WEIGHT		[Falagas, Matthew E.; Karageorgopoulos, Drosos E.] Alfa Inst Biomed Sci, Athens 15123, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Henry Dunant Hospital; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, 9 Neapoleos St, Athens 15123, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018	Karageorgopoulos, Drosos/0000-0002-9959-9978				Bartelink IH, 2006, CLIN PHARMACOKINET, V45, P1077, DOI 10.2165/00003088-200645110-00003; Bauer LA, 1998, EUR J CLIN PHARMACOL, V54, P621, DOI 10.1007/s002280050524; BENEDEK IH, 1984, BRIT J CLIN PHARMACO, V18, P941, DOI 10.1111/j.1365-2125.1984.tb02567.x; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Blouin RA, 1999, J PHARM SCI, V88, P1, DOI 10.1021/js980173a; Bond CA, 2008, PHARMACOTHERAPY, V28, P1, DOI 10.1592/phco.28.1.1; Bosma RJ, 2006, CONTRIB NEPHROL, V151, P184, DOI 10.1159/000095329; Carpenter CF, 2004, CLIN INFECT DIS, V38, P994, DOI 10.1086/383472; Erstad BL, 2002, AM J HEALTH-SYST PH, V59, P2105, DOI 10.1093/ajhp/59.21.2105; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Falagas ME, 2009, OBES REV, V10, P280, DOI 10.1111/j.1467-789X.2008.00546.x; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Hall RG, 2008, AM J MED, V121, P515, DOI 10.1016/j.amjmed.2008.01.046; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Janmahasatian S, 2005, CLIN PHARMACOKINET, V44, P1051, DOI 10.2165/00003088-200544100-00004; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meisel C, 2000, CLIN CHEM LAB MED, V38, P869, DOI 10.1515/CCLM.2000.126; Nawaratne S, 1998, BRIT J CLIN PHARMACO, V46, P447, DOI 10.1046/j.1365-2125.1998.00812.x; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pai MP, 2007, ANTIMICROB AGENTS CH, V51, P2741, DOI 10.1128/AAC.00059-07; Pai MP, 2007, PHARMACOTHERAPY, V27, P1081, DOI 10.1592/phco.27.8.1081; PEARSON TC, 1995, BRIT J HAEMATOL, V89, P748; Peck CC, 2007, CLIN PHARMACOL THER, V82, P12, DOI 10.1038/sj.clpt.6100215; Roberts JA, 2008, CRIT CARE MED, V36, P2433, DOI 10.1097/CCM.0b013e318180fe62; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; TRAYNOR AM, 1995, ANTIMICROB AGENTS CH, V39, P545, DOI 10.1128/AAC.39.2.545; *US FDA, 2004, INN STAGN CHALL OPP; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409	30	105	106	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					248	251		10.1016/S0140-6736(09)60743-1	http://dx.doi.org/10.1016/S0140-6736(09)60743-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	19875163				2022-12-24	WOS:000273853800035
J	Nechaev, S; Fargo, DC; dos Santos, G; Liu, LW; Gao, Y; Adelman, K				Nechaev, Sergei; Fargo, David C.; dos Santos, Gilberto; Liu, Liwen; Gao, Yuan; Adelman, Karen			Global Analysis of Short RNAs Reveals Widespread Promoter-Proximal Stalling and Arrest of Pol II in Drosophila	SCIENCE			English	Article							CLEAVAGE FACTOR TFIIS; POLYMERASE-II; TRANSCRIPTION INITIATION; ELONGATION; MELANOGASTER; GENES; NELF; EXPRESSION; STABILITY; INVITRO	Emerging evidence indicates that gene expression in higher organisms is regulated by RNA polymerase II stalling during early transcription elongation. To probe the mechanisms responsible for this regulation, we developed methods to isolate and characterize short RNAs derived from stalled RNA polymerase II in Drosophila cells. Significant levels of these short RNAs were generated from more than one-third of all genes, indicating that promoter-proximal stalling is a general feature of early polymerase elongation. Nucleotide composition of the initially transcribed sequence played an important role in promoting transcriptional stalling by rendering polymerase elongation complexes highly susceptible to backtracking and arrest. These results indicate that the intrinsic efficiency of early elongation can greatly affect gene expression.	[Nechaev, Sergei; dos Santos, Gilberto; Adelman, Karen] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Fargo, David C.] NIEHS, Lib Serv, NIH, Res Triangle Pk, NC 27709 USA; [Fargo, David C.] NIEHS, Informat Serv, NIH, Res Triangle Pk, NC 27709 USA; [Liu, Liwen] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Gao, Yuan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Virginia Commonwealth University	Adelman, K (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA.	adelmank@niehs.nih.gov	Gao, Yuan/E-1706-2011; Nechaev, Sergei/AAQ-3450-2021	Adelman, Karen/0000-0001-5364-334X	NIH, National Institute of Environmental Health Sciences [Z01 ES101987]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101987, ZICES102445, ZIAES101987] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank P. Wade, T. Kunkel, and members of the Adelman laboratory for insightful discussions. We acknowledge S. Dai and J. Grovenstein for computational support. Sequence data are in the Gene Expression Omnibus (GEO) database under accession number GSE18643. This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES101987).	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Ahsan B, 2009, NUCLEIC ACIDS RES, V37, pD49, DOI 10.1093/nar/gkn694; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; COPPOLA JA, 1983, P NATL ACAD SCI-BIOL, V80, P1251, DOI 10.1073/pnas.80.5.1251; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; JOVE R, 1984, J BIOL CHEM, V259, P8513; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; KAINZ M, 1992, SCIENCE, V255, P838, DOI 10.1126/science.1536008; KEPHART DD, 1992, MOL CELL BIOL, V12, P2067, DOI 10.1128/MCB.12.5.2067; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Pal M, 2001, MOL CELL BIOL, V21, P5815, DOI 10.1128/MCB.21.17.5815-5825.2001; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; RASMUSSEN EB, 1995, J MOL BIOL, V252, P522, DOI 10.1006/jmbi.1995.0517; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	28	300	302	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					335	338		10.1126/science.1181421	http://dx.doi.org/10.1126/science.1181421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20007866	Green Accepted			2022-12-24	WOS:000273629700044
J	Alperson-Afil, N; Sharon, G; Kislev, M; Melamed, Y; Zohar, I; Ashkenazi, S; Rabinovich, R; Biton, R; Werker, E; Hartman, G; Feibel, C; Goren-Inbar, N				Alperson-Afil, Nira; Sharon, Gonen; Kislev, Mordechai; Melamed, Yoel; Zohar, Irit; Ashkenazi, Shosh; Rabinovich, Rivka; Biton, Rebecca; Werker, Ella; Hartman, Gideon; Feibel, Craig; Goren-Inbar, Naama			Spatial Organization of Hominin Activities at Gesher Benot Ya'aqov, Israel	SCIENCE			English	Article							ACHEULEAN SITE; WATER FISH	The spatial designation of discrete areas for different activities reflects formalized conceptualization of a living space. The results of spatial analyses of a Middle Pleistocene Acheulian archaeological horizon ( about 750,000 years ago) at Gesher Benot Ya'aqov, Israel, indicate that hominins differentiated their activities (stone knapping, tool use, floral and faunal processing and consumption) across space. These were organized in two main areas, including multiple activities around a hearth. The diversity of human activities and the distinctive patterning with which they are organized implies advanced organizational skills of the Gesher Benot Ya'aqov hominins.	[Alperson-Afil, Nira; Sharon, Gonen; Rabinovich, Rivka; Goren-Inbar, Naama] Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel; [Kislev, Mordechai; Melamed, Yoel] Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; [Zohar, Irit] Univ Haifa, Leon Recanati Inst Maritime Studies, IL-31905 Haifa, Israel; [Zohar, Irit] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Werker, Ella] Hebrew Univ Jerusalem, Dept Bot, IL-91904 Jerusalem, Israel; [Hartman, Gideon] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Feibel, Craig] Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA	Hebrew University of Jerusalem; Bar Ilan University; University of Haifa; Tel Aviv University; Hebrew University of Jerusalem; Max Planck Society; Rutgers State University New Brunswick	Alperson-Afil, N (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel.	alperson@mscc.huji.ac.il; goren@cc.huji.ac.il	Biton, Rebecca/G-6719-2012	Biton, Rebecca/0000-0003-4710-0538; Rabinovich, Rivka/0000-0002-1343-3134; Zohar, Irit/0000-0002-5943-2751; Sharon, Gonen/0000-0002-1226-2556	Israel Science Foundation [300/06, 886/02]; German-Israeli Foundation [I-896-208.4/2005]; Irene Levi Sala CARE Archaeological Foundation	Israel Science Foundation(Israel Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Irene Levi Sala CARE Archaeological Foundation	Supported by Israel Science Foundation grant 300/06 to the Center of Excellence Project "The Effect of Climate Change on the Environment and Hominins of the Upper Jordan Valley between ca. 800 ka and 700 ka as a Basis for Prediction of Future Scenarios." The study of burned flint microartifacts was supported by grants from the German-Israeli Foundation ( GIF I-896-208.4/2005) and the Israel Science Foundation (886/02). The study of fish remains was supported by the Irene Levi Sala CARE Archaeological Foundation and carried out at the Department of Zoology and the I. Meier Segals Garden for Zoological Research at Tel Aviv University and at the Natural History Museum (NHM) in London and Brussels. We thank M. Goren for his help and support in the study and collection of freshwater fish; W. Van Neer (NHM Brussels), M. Richter, P. Campbell, and O. Crimmen (NHM UK) for providing access to labs and collections as well as helpful comments; A. Ben-Nun, head of the GIS center at the Hebrew University of Jerusalem, and I. Sharon and I. Gilead for greatly assisting in establishing the methodology for this study; M. Haber and S. Gorodetsky, who edited the manuscript with their usual professionalism; and two anonymous reviewers for their constructive and helpful comments.	Alperson-Afil N, 2008, QUATERNARY SCI REV, V27, P1733, DOI 10.1016/j.quascirev.2008.06.009; [Anonymous], 2005, EURASIAN PREHISTORY; Ashkenazi S, 2005, J ARCHAEOL SCI, V32, P675, DOI 10.1016/j.jas.2004.12.003; ASHKENAZI S, 2007, J ISR PREHIST SOC, V37, P135; Ashkenazi S, 2010, LETHAIA, V43, P116, DOI 10.1111/j.1502-3931.2009.00178.x; Binford LR., 1983, PURSUIT DECODING ARC; Dimentman C., 1992, LAKE HULA RECONSTRUC; ELDER RL, 1988, PALAEOGEOGR PALAEOCL, V62, P577, DOI 10.1016/0031-0182(88)90072-7; Farrand, 2001, SEDIMENTS ARCHAEOLOG, P127; Feibel C. S., 2004, HUMAN PALEOECOLOGY L, P21; Goren M, 1999, BIOL CONSERV, V89, P1, DOI 10.1016/S0006-3207(98)00127-X; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Goren-Inbar N., 1994, PALEORIENT, V20, P99, DOI DOI 10.3406/PALEO.1994.4604; Goren-Inbar N., 2002, ACHEULIAN SITE GESHE, VI; Madsen B., 2004, EURASIAN PREHISTORY, V2, P3; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Purdy B. A, 1975, LITHIC TECHNOLOGY MA, P133; Rabinovich R, 2008, J HUM EVOL, V54, P134, DOI 10.1016/j.jhevol.2007.07.007; Sergant J, 2006, J ARCHAEOL SCI, V33, P999, DOI 10.1016/j.jas.2005.11.011; SHARON G, 1999, J ISR PREHIST SOC, V28, P55; Speth J.D., 2007, MIDDLE UPPER PALAEOL, P165; Vaquero M, 2001, J ARCHAEOL SCI, V28, P1209, DOI 10.1006/jasc.2001.0656; Wadley L, 2001, CAMB ARCHAEOL J, V11, P201, DOI 10.1017/S0959774301000117; Yellen J.E., 1977, STUDIES ARCHEOLOGY; Zohar I, 2008, PALAEOGEOGR PALAEOCL, V258, P292, DOI 10.1016/j.palaeo.2007.11.004	26	105	108	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1677	1680		10.1126/science.1180695	http://dx.doi.org/10.1126/science.1180695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533QJ	20019284				2022-12-24	WOS:000272839000048
J	Friel, S; Dangour, AD; Garnett, T; Lock, K; Chalabi, Z; Roberts, I; Butler, A; Butler, CD; Waage, J; McMichael, AJ; Haines, A				Friel, Sharon; Dangour, Alan D.; Garnett, Tara; Lock, Karen; Chalabi, Zaid; Roberts, Ian; Butler, Ainslie; Butler, Colin D.; Waage, Jeff; McMichael, Anthony J.; Haines, Andy			Health and Climate Change 4 Public health benefits of strategies to reduce greenhouse-gas emissions: food and agriculture	LANCET			English	Article							CONSUMPTION PATTERNS; FATTY-ACIDS; DIETARY-FAT; NUTRITION; LIVESTOCK; MORTALITY; DISEASES; TRENDS; IMPACT; TAXES	Agricultural food production and agriculturally-related change in land use substantially contribute to greenhouse-gas emissions worldwide. Four-fifths of agricultural emissions arise from the livestock sector. Although livestock products are a source of some essential nutrients, they provide large amounts of saturated fat, which is a known risk factor for cardiovascular disease. We considered potential strategies for the agricultural sector to meet the target recommended by the UK Committee on Climate Change to reduce UK emissions from the concentrations recorded in 1990 by 80% by 2050, which would require a 50% reduction by 2030. With use of the UK as a case study, we identified that a combination of agricultural technological improvements and a 30% reduction in livestock production would be needed to meet this target; in the absence of good emissions data from Brazil, we assumed for illustrative purposes that the required reductions would be the same for our second case study in Sao Paulo city. We then used these data to model the potential benefits of reduced consumption of livestock products on the burden of ischaemic heart disease: disease burden would decrease by about 15% in the UK (equivalent to 2850 disability-adjusted life-years [DALYs] per million population in 1 year) and 16% in Sao Paulo city (equivalent to 2180 DALYs per million population in 1 year). Although likely to yield benefits to health, such a strategy will probably encounter cultural, political, and commercial resistance, and face technical challenges. Coordinated intersectoral action is needed across agricultural, nutritional, public health, and climate change communities worldwide to provide affordable, healthy, low-emission diets for all societies.	[Friel, Sharon; Butler, Ainslie; Butler, Colin D.; McMichael, Anthony J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; [Dangour, Alan D.; Lock, Karen; Chalabi, Zaid; Roberts, Ian; Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Garnett, Tara] Univ Surrey, Food Climate Res Network, Guildford GU2 5XH, Surrey, England; [Waage, Jeff] London Int Dev Ctr, London, England	Australian National University; University of London; London School of Hygiene & Tropical Medicine; University of Surrey	Friel, S (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, GPO Box 4, Canberra, ACT 0200, Australia.	Sharon.friel@anu.edu.au	Butler, Colin D./H-2267-2019; Butler, Ainslie/P-8343-2015	Butler, Colin D./0000-0002-2942-5294; Butler, Ainslie/0000-0001-8668-0761; Dangour, Alan/0000-0001-6908-1273; Haines, Andy/0000-0002-8053-4605; Friel, Sharon/0000-0002-8345-5435	Wellcome Trust; Department of Health, National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; Engineering and Physical Sciences Research Council [GR/T29123/01] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health, National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The project that led to this Series was funded by the Wellcome Trust (coordinating funder); Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences; the Economic and Social Research Council; the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by an unrestricted educational grant from Pfizer. The funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies. For their expert advice, we thank A Aikenhead (International Association for the Study of Obesity, London, UK), R Beaglehole (University of Auckland, Auckland, New Zealand), M A de Castro (University of Sao Paulo, Sao Paulo city, Brazil), G Edwards-Jones (Bangor University, Bangor, UK), R M Fisberg (University of Sao Paulo, Sao Paulo city, Brazil), R Jackson (University of Auckland, Auckland, New Zealand), P C Jaime (University of Sao Paulo, Sao Paulo city, Brazil), G Jones (ADAS, Wolverhampton, UK), M Lawrence (Deakin University, Burwood, VIC, Australia), C Mathers (WHO, Geneva, Switzerland), and R Uauy (London School of Hygiene and Tropical Medicine, London, UK).	ADAS (Agricultural Land Advisory Service), 2009, RMP 5142 AN POL INST; AEA, 2009, GREENH GAS INV ENGL; Alexandratos N, 2008, POPUL DEV REV, V34, P663, DOI 10.1111/j.1728-4457.2008.00245.x; Allard V, 2007, AGR ECOSYST ENVIRON, V121, P47, DOI 10.1016/j.agee.2006.12.004; Allender S., 2008, CORONARY HEART DIS S; [Anonymous], 2008, WORLD HLTH STAT 2008; Bates CJ, 2000, NATL DIET NUTR SURVE; Bellarby J., 2008, COOL FARMING CLIMATE; Carlsson-Kanyama A, 2009, AM J CLIN NUTR, V89, pS1704, DOI 10.3945/ajcn.2009.26736AA; Cederberg C., 2009, 792 SIK SWED I FOOD; COTTRILL B, 2007, OPPORTUNITIES IMPLIC; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; Curioni C, 2009, REV PANAM SALUD PUBL, V25, P9, DOI 10.1590/S1020-49892009000100002; *DAN AC TECHN SCI, 2007, EC NUTR POL TOOLS US; Darmon N, 2006, J NUTR EDUC BEHAV, V38, P82, DOI 10.1016/j.jneb.2005.11.028; DENKE MA, 1991, AM J CLIN NUTR, V54, P1036, DOI 10.1093/ajcn/54.6.1036; *DEP ENV FOOD RUR, 2007, AGR UK; Department of Economic and Social Affairs Population Division., 2008, WORLD POP PROSP 2008; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Elmadfa I, 2009, ANN NUTR METAB, V54, P8, DOI 10.1159/000220822; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Fearnside PM, 2000, ADV SOIL S, P231; Finch S, 1998, NATL DIET NUTR SURVE; Fisberg RM, 2006, J AM DIET ASSOC, V106, P2067, DOI 10.1016/j.jada.2006.09.010; Food and Agriculture Organization of the United Nations, 2006, LIV LONG SHAD ENV IS; Friel S, 2008, LANCET, V372, P1677, DOI 10.1016/S0140-6736(08)61692-X; Garnett T., 2008, COOKING STORM FOOD G; Garnett T, 2009, ENVIRON SCI POLICY, V12, P491, DOI 10.1016/j.envsci.2009.01.006; Gerbens-Leenes PW, 2002, ECOL ECON, V42, P185, DOI 10.1016/S0921-8009(02)00049-6; Gold Mark, 2004, GLOBAL BENEFITS EATI; Goodland R, 1997, ECOL ECON, V23, P189, DOI 10.1016/S0921-8009(97)00579-X; Hawkes C, 2005, PUBLIC HEALTH NUTR, V8, P357, DOI 10.1079/PHN2004706; Hawkes C, 2007, AM J PUBLIC HEALTH, V97, P1962, DOI 10.2105/AJPH.2006.101162; Henderson L, 2003, NATL DIET NUTR SURVE; HMGovernment, 2009, UK LOW CARB TRANS PL; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; Hunt JR, 2002, NUTR REV, V60, P127, DOI 10.1301/00296640260093788; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; KEYS A, 1984, AM J CLIN NUTR, V40, P351, DOI 10.1093/ajcn/40.2.351; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lock Karen, 2009, BMJ, V339, pb2403, DOI 10.1136/bmj.b2403; Mangels AR, 2003, J AM DIET ASSOC, V103, P748, DOI 10.1053/jada.2003.50142; Marlow HJ, 2009, AM J CLIN NUTR, V89, pS1699, DOI 10.3945/ajcn.2009.26736Z; MASON C, 2009, BBC NEWS        0512; McAlpine CA, 2009, GLOBAL ENVIRON CHANG, V19, P21, DOI 10.1016/j.gloenvcha.2008.10.008; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Monteiro CA, 2000, REV SAUDE PUBL, V34, P251, DOI 10.1590/S0034-89102000000300007; Moran D., 2008, UK MARGINAL ABATEMEN; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Nellemann C., 2009, UNEP RAPID RESPONSE; Pekka P, 2002, PUBLIC HEALTH NUTR, V5, P245, DOI 10.1079/PHN2001300; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Ratnayake WMN, 2009, EUR J CLIN NUTR, V63, P808, DOI 10.1038/ejcn.2008.39; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Scharlemann JPW, 2008, SCIENCE, V319, P43, DOI 10.1126/science.1153103; Sen A., 1981, POVERTY FAMINES ESSA; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Smith K, 2009, NEW SCI, V202, P24, DOI 10.1016/S0262-4079(09)61702-4; Smith P, 2007, CLIMATE CHANGE 2007; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; *SWED NAT FOOD ADM, ENV EFF FOOD CHOIC; Thiebaut ACM, 2009, JNCI-J NATL CANCER I, V101, P1001, DOI 10.1093/jnci/djp168; THOW AM, 2009, PUBLIC HEALTH NUTR, V12, P1; Thow AM, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-5; UK Committee on Climate Change, 2008, BUILD LOW CARB EC UK; *UN FAO, FAOSTAT FOOD CONS DA; USA-Department of Agriculture, 2008, RIS FOOD PRIC INT FO; Uusitalo U, 1996, BRIT MED J, V313, P1044, DOI 10.1136/bmj.313.7064.1044; Walker P, 2005, PUBLIC HEALTH NUTR, V8, P348, DOI 10.1079/PHN2005727; *WHO, 2003, TECHN REP SER WHO, V916; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Williams A., 2006, FINAL REPORT DEFRA P; World Bank, 2008, INT TRADE CLIMATE CH; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	80	319	321	5	143	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					2016	2025		10.1016/S0140-6736(09)61753-0	http://dx.doi.org/10.1016/S0140-6736(09)61753-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	19942280				2022-12-24	WOS:000272727000025
J	Sorensen, R; Hansen, ML; Abildstrom, SZ; Hvelplund, A; Andersson, C; Jorgensen, C; Madsen, JK; Hansen, PR; Kober, L; Torp-Pedersen, C; Gislason, GH				Sorensen, Rikke; Hansen, Morten L.; Abildstrom, Steen Z.; Hvelplund, Anders; Andersson, Charlotte; Jorgensen, Casper; Madsen, Jan K.; Hansen, Peter R.; Kober, Lars; Torp-Pedersen, Christian; Gislason, Gunnar H.			Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data	LANCET			English	Article							ACUTE CORONARY SYNDROMES; TASK-FORCE; ANTITHROMBOTIC THERAPY; ANTIPLATELET THERAPY; ATRIAL-FIBRILLATION; EUROPEAN-SOCIETY; GLOBAL REGISTRY; WARFARIN; DIAGNOSIS; EVENTS	Background Combinations of aspirin, clopidogrel, and vitamin K antagonists are widely used in patients after myocardial infarction. However, data for the safety of combinations are sparse. We examined the risk of hospital admission for bleeding associated with different antithrombotic regimens. Methods By use of nationwide registers from Denmark, we identified 40 812 patients aged 30 years or older who had been admitted to hospital with first-time myocardial infarction between 2000 and 2005. Claimed prescriptions starting at hospital discharge were used to determine the regimen prescribed according to the following groups: monotherapy with aspirin, clopidogrel, or vitamin K antagonist; dual therapy with aspirin plus clopidogrel, aspirin plus vitamin K antagonist, or clopidogrel plus vitamin K antagonist; or triple therapy including all three drugs. Risk of hospital admission for bleeding, recurrent myocardial infarction, and death were assessed by Cox proportional hazards models with the drug exposure groups as time-varying covariates. Findings During a mean follow-up of 476.5 days (SD 142.0), 1891 (4.6%) patients were admitted to hospital with bleeding. The yearly incidence of bleeding was 2.6% for the aspirin group, 4.6% for clopidogrel, 4.3% for vitamin K antagonist, 3.7% for aspirin plus clopidogrel, 5.1% for aspirin plus vitamin K antagonist, 12.3% for clopidogrel plus vitamin K antagonist, and 12.0% for triple therapy. With aspirin as reference, adjusted hazard ratios for bleeding were 1.33 (95% CI 1.11-1.59) for clopidogrel, 1.23 (0.94-1.61) for vitamin K antagonist, 1.47 (1.28-1.69) for aspirin plus clopidogrel, 1.84 (1.51-2.23) for aspirin plus vitamin K antagonist, 3.52 (2.42-5.11) for clopidogrel plus vitamin K antagonist, and 4.05 (3.08-5.33) for triple therapy. Numbers needed to harm were 81.2 for aspirin plus clopidogrel, 45.4 for aspirin plus vitamin K antagonist, 15.2 for clopidogrel plus vitamin K antagonist, and 12.5 for triple therapy. 702 (37.9%) of 1852 patients with non-fatal bleeding had recurrent myocardial infarction or died during the study period compared with 7178 (18.4%) of 38 960 patients without non-fatal bleeding, (HR 3.00, 2.75-3.27, p<0.0001). Interpretation In patients with myocardial infarction, risk of hospital admission for bleeding increased with the number of antithrombotic drugs used. Treatment with triple therapy or dual therapy with clopidogrel plus vitamin K antagonist should be prescribed only after thorough individual risk assessment.	[Sorensen, Rikke; Hansen, Morten L.; Andersson, Charlotte; Jorgensen, Casper; Madsen, Jan K.; Hansen, Peter R.; Torp-Pedersen, Christian; Gislason, Gunnar H.] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Abildstrom, Steen Z.] Univ Copenhagen, Gentofte Hosp, Dept Internal Med, Cardiovasc Res Unit, DK-2900 Hellerup, Denmark; [Abildstrom, Steen Z.; Hvelplund, Anders] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Kober, Lars] Rigshosp, Univ Copenhagen Hosp, Ctr Heart, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Sorensen, R (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Niels Andersens Vej 65,Post 4210, DK-2900 Hellerup, Denmark.	rs@heart.dk	Gislason, Gunnar/B-7561-2009; Hansen, Peter Riis/AAR-7659-2020; Torp-Pedersen, Christian/E-5931-2013; Andersson, Charlotte/P-4849-2014	Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466; Hansen, Peter Riis/0000-0002-9056-535X; Sorensen, Rikke/0000-0001-9238-6681	Danish Heart Foundation [08-4-R64-A1885-B641-22470]; Danish Medical Research Council [271-06-0572]	Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Danish Heart Foundation (08-4-R64-A1885-B641-22470) and the Danish Medical Research Council (271-06-0572).	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Buresly K, 2005, ARCH INTERN MED, V165, P784, DOI 10.1001/archinte.165.7.784; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gaist D, 1997, DAN MED BULL, V44, P445; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Jackevicius CA, 2008, NEW ENGL J MED, V359, P1802, DOI 10.1056/NEJMsa0803410; Karjalainen PP, 2007, EUR HEART J, V28, P726, DOI 10.1093/eurheartj/ehl488; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Manzano-Fernandez S, 2008, CHEST, V134, P559, DOI 10.1378/chest.08-0350; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mortensen J, 2008, CARDIOLOGY, V111, P41, DOI 10.1159/000113426; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Nguyen MC, 2007, EUR HEART J, V28, P1717, DOI 10.1093/eurheartj/ehm186; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Ruiz-Nodar JM, 2008, J AM COLL CARDIOL, V51, P818, DOI 10.1016/j.jacc.2007.11.035; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6; Yusuf S, 2001, NEW ENGL J MED, V345, P494	31	440	459	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1967	1974		10.1016/S0140-6736(09)61751-7	http://dx.doi.org/10.1016/S0140-6736(09)61751-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EA	20006130				2022-12-24	WOS:000272727000020
J	Karberg, S				Karberg, Sascha			Switching on Epigenetic Therapy	CELL			English	Editorial Material								Reversible epigenetic changes that alter gene expression are a characteristic of many cancers and other diseases. Biotech companies are taking note and are starting to develop new drugs to reverse such pathogenic "epimutations."											0	36	39	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 11	2009	139	6					1029	1031		10.1016/j.cell.2009.11.038	http://dx.doi.org/10.1016/j.cell.2009.11.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005793	Bronze			2022-12-24	WOS:000272622800001
J	Cohen, AB; Bianchi, MT				Cohen, Adam B.; Bianchi, Matt T.			Commentary: Neurological perspective	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bianchi, Matt T.] Massachusetts Gen Hosp, Dept Neurol, SL Div, Boston, MA 02114 USA; [Cohen, Adam B.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Bianchi, MT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, SL Div, Boston, MA 02114 USA.	mtbianchi@partners.org		Cohen, Adam/0000-0002-6163-0562				Brinar VV, 2008, CLIN NEUROL NEUROSUR, V110, P919, DOI 10.1016/j.clineuro.2008.07.002; Gurcan HM, 2009, INT IMMUNOPHARMACOL, V9, P10, DOI 10.1016/j.intimp.2008.10.004; Reuss R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3862; Sawle GV, 1998, J NEUROL NEUROSUR PS, V64, P717, DOI 10.1136/jnnp.64.6.717; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2009	339								b5250	10.1136/bmj.b5250	http://dx.doi.org/10.1136/bmj.b5250			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007661				2022-12-24	WOS:000272697600009
J	Rink, JC; Gurley, KA; Elliott, SA; Alvarado, AS				Rink, Jochen C.; Gurley, Kyle A.; Elliott, Sarah A.; Alvarado, Alejandro Sanchez			Planarian Hh Signaling Regulates Regeneration Polarity and Links Hh Pathway Evolution to Cilia	SCIENCE			English	Article							ZINC-FINGER PROTEIN; SONIC HEDGEHOG; ZEBRAFISH EMBRYO; STEM-CELLS; GENE; DROSOPHILA; HOMOLOG; MOUSE; CONSERVATION; MICE	The Hedgehog (Hh) signaling pathway plays multiple essential roles during metazoan development, homeostasis, and disease. Although core protein components are highly conserved, the variations in Hh signal transduction mechanisms exhibited by existing model systems ( Drosophila, fish, and mammals) are difficult to understand. We characterized the Hh pathway in planarians. Hh signaling is essential for establishing the anterior/posterior axis during regeneration by modulating wnt expression. Moreover, RNA interference methods to reduce signal transduction proteins Cos2/Kif27/Kif7, Fused, or Iguana do not result in detectable Hh signaling defects; however, these proteins are essential for planarian ciliogenesis. Our study expands the understanding of Hh signaling in the animal kingdom and suggests an ancestral mechanistic link between Hh signaling and the function of cilia.	[Rink, Jochen C.; Gurley, Kyle A.; Elliott, Sarah A.; Alvarado, Alejandro Sanchez] Univ Utah, Howard Hughes Med Inst, Dept Neurobiol & Anat, Sch Med, Salt Lake City, UT 84103 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Alvarado, AS (corresponding author), Univ Utah, Howard Hughes Med Inst, Dept Neurobiol & Anat, Sch Med, 401 MREB,20 N 1900 E, Salt Lake City, UT 84103 USA.	sanchez@neuro.utah.edu			NIH National Institute of General Medical Sciences [RO-1 GM57260]; European Molecular Biology Association [F32GM082016]; Howard Hughes Medical Institute investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057260, F32GM082016, R01GM057260] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); European Molecular Biology Association; Howard Hughes Medical Institute investigator(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Sanchez laboratory for helpful comments and C. Adler for sharing data on iguana. Work supported by NIH National Institute of General Medical Sciences grants RO-1 GM57260 to A. S. A. and F32GM082016 to K. A. G. J. C. R. was funded by the European Molecular Biology Association. A. S. A. is a Howard Hughes Medical Institute investigator. All sequences associated with this study have been deposited in GenBank and have accession numbers GQ337474 to GQ337490.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Burglin Thomas R, 2006, WormBook, P1; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kang DM, 2003, DEVELOPMENT, V130, P1645, DOI 10.1242/dev.00395; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Marigo V, 1996, DEVELOPMENT, V122, P1225; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; PREAT T, 1992, GENETICS, V132, P725; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Simonnet F, 2004, DEV GENES EVOL, V214, P537, DOI 10.1007/s00427-004-0435-z; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Trowbridge JJ, 2006, P NATL ACAD SCI USA, V103, P14134, DOI 10.1073/pnas.0604568103; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0	38	173	179	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1406	1410		10.1126/science.1178712	http://dx.doi.org/10.1126/science.1178712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933103	Green Accepted			2022-12-24	WOS:000272351100044
J	Nakanishi, Y; Lu, B; Gerard, C; Iwasaki, A				Nakanishi, Yusuke; Lu, Bao; Gerard, Craig; Iwasaki, Akiko			CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help	NATURE			English	Article							HERPES-SIMPLEX-VIRUS; DENDRITIC CELLS; TYPE-2 INFECTION; MEMORY; LOCALIZATION; RESPONSES; EFFECTOR; IMMUNITY; CTL	CD4(+) T helper cells are well known for their role in providing critical signals during priming of cytotoxic CD8(+) T lymphocyte (CTL) responses in vivo. T-cell help is required for the generation of primary CTL responses as well as in promoting protective CD8(+) memory T-cell development(1). However, the role of CD4 help in the control of CTL responses at the effector stage is unknown. Here we show that fully helped effector CTLs are themselves not self-sufficient for entry into the infected tissue, but rely on the CD4(+) T cells to provide the necessary cue. CD4(+) T helper cells control the migration of CTL indirectly through the secretion of IFN-gamma and induction of local chemokine secretion in the infected tissue. Our results reveal a previously unappreciated role of CD4 help in mobilizing effector CTL to the peripheral sites of infection where they help to eliminate infected cells.	[Nakanishi, Yusuke; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Lu, Bao; Gerard, Craig] Harvard Univ, Childrens Hosp, Div Pulm, Sch Med, Boston, MA 02115 USA	Yale University; Harvard University; Boston Children's Hospital; Harvard Medical School	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	NIH [AI054359, AI062428, AI39759, HL51366]; Japan Society for the Promotion of Science; Burroughs Wellcome Investigators; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039759, R56AI062428, R01AI062428, R01AI054359] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Burroughs Wellcome Investigators(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. R. Carbone and W. R. Heath for the gBT-I transgenic mouse, A. Rudensky for the foxp3 knock-in mouse, R. Medzhitov and J. M. Thompson for critical reading of the manuscript, and N. Iijima for technical assistance. This work is supported by NIH grants to A. I. (AI054359 and AI062428) and to C. G. (AI39759 and HL51366). Y. N. was a Japan Society for the Promotion of Science fellow. A. I. is a recipient of the Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease.	Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Iijima N, 2007, P NATL ACAD SCI USA, V104, P19061, DOI 10.1073/pnas.0707179104; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Milligan GN, 1997, VIROLOGY, V229, P259, DOI 10.1006/viro.1997.8441; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Stock AT, 2007, IMMUNOL CELL BIOL, V85, P394, DOI 10.1038/sj.icb.7100076; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Thapa M, 2008, J IMMUNOL, V180, P1098, DOI 10.4049/jimmunol.180.2.1098; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	25	405	421	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					510	U205		10.1038/nature08511	http://dx.doi.org/10.1038/nature08511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19898495	Green Accepted			2022-12-24	WOS:000272144200045
J	Willis, KJ; Bhagwat, SA				Willis, Kathy J.; Bhagwat, Shonil A.			Biodiversity and Climate Change	SCIENCE			English	Editorial Material							AREA		[Willis, Kathy J.; Bhagwat, Shonil A.] Univ Oxford, Long Term Ecol Lab, Ctr Environm, Oxford OX1 3QY, England; [Willis, Kathy J.] Univ Bergen, Dept Biol, N-5007 Bergen, Norway	University of Oxford; University of Bergen	Willis, KJ (corresponding author), Univ Oxford, Long Term Ecol Lab, Ctr Environm, S Parks Rd, Oxford OX1 3QY, England.	kathy.willis@ouce.ox.ac.uk		Willis, Katherine/0000-0002-6763-2489	Natural Environment Research Council [NE/G010730/1, NE/C510667/1] Funding Source: researchfish; NERC [NE/G010730/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Huntingford C, 2008, PHILOS T R SOC B, V363, P1857, DOI 10.1098/rstb.2007.0028; Lapola DM, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003357; Larsen TB, 2008, BIODIVERS CONSERV, V17, P2833, DOI 10.1007/s10531-008-9399-z; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; Parry ML, 2007, CLIMATE CHANGE 2007; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	15	169	181	21	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					806	807		10.1126/science.1178838	http://dx.doi.org/10.1126/science.1178838			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892969				2022-12-24	WOS:000271468000027
J	Coombes, R				Coombes, Rebecca			Don't try this at home?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Aust T., 2009, BRIT MED J, V339, pB3220	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 5	2009	339								b4421	10.1136/bmj.b4421	http://dx.doi.org/10.1136/bmj.b4421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516UD	19892800				2022-12-24	WOS:000271567900005
J	Kett, M; van Ommeren, M				Kett, Maria; van Ommeren, Mark			Disability, conflict, and emergencies	LANCET			English	Editorial Material							SERVICE		[Kett, Maria] UCL, Leonard Cheshire Cente Disabil & Inclus Dev, London WC1H 0BT, England; [van Ommeren, Mark] WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland	University of London; University College London; World Health Organization	Kett, M (corresponding author), UCL, Leonard Cheshire Cente Disabil & Inclus Dev, London WC1H 0BT, England.	m.kett@ucl.ac.uk	Kett, Maria/AAA-3421-2022	Kett, Maria/0000-0002-1975-7674				Atijosan O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002851; CEVRA N, 2009, J DISABIL INT DEV, V1, P4; Department for International Development, 2000, DISABILITY POVERTY D; dos Santos-Zingale M, 2006, DISABIL SOC, V21, P243, DOI 10.1080/09687590600617428; Jones L, 2009, LANCET, V374, P654, DOI 10.1016/S0140-6736(09)61253-8; Kett, 2007, DISABILITY DISASTERS; PARR AR, 1987, DISASTERS, V11, P148, DOI 10.1111/j.1467-7717.1987.tb00629.x; Rockhold P, 2009, J DISABIL INT DEV, V1, P4; Silove D, 2004, AUST NZ J PSYCHIAT, V38, P929, DOI 10.1080/j.1440-1614.2004.01483.x; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; van Ommeren M, 2003, LANCET, V362, P574, DOI 10.1016/S0140-6736(03)14123-2; Women's Commission for Refugee Women and Children, 2008, DIS REF CONFL AFF PO	12	23	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2009	374	9704					1801	1803		10.1016/S0140-6736(09)62024-9	http://dx.doi.org/10.1016/S0140-6736(09)62024-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527MC	19944849				2022-12-24	WOS:000272370200008
J	Rosengren, AH; Jokubka, R; Tojjar, D; Granhall, C; Hansson, O; Li, DQ; Nagaraj, V; Reinbothe, TM; Tuncel, J; Eliasson, L; Groop, L; Rorsman, P; Salehi, A; Lyssenko, V; Luthman, H; Renstrom, E				Rosengren, Anders H.; Jokubka, Ramunas; Tojjar, Damon; Granhall, Charlotte; Hansson, Ola; Li, Dai-Qing; Nagaraj, Vini; Reinbothe, Thomas M.; Tuncel, Jonatan; Eliasson, Lena; Groop, Leif; Rorsman, Patrik; Salehi, Albert; Lyssenko, Valeriya; Luthman, Holger; Renstrom, Erik			Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELLS; EXOCYTOSIS; LOCI; IDENTIFICATION; ACTIVATION; SECRETION; DEFECTS; RISK	Several common genetic variations have been associated with type 2 diabetes, but the exact disease mechanisms are still poorly elucidated. Using congenic strains from the diabetic Goto-Kakizaki rat, we identified a 1.4-megabase genomic locus that was linked to impaired insulin granule docking at the plasma membrane and reduced beta cell exocytosis. In this locus, Adra2a, encoding the alpha2A-adrenergic receptor [alpha(2A)AR], was significantly overexpressed. Alpha(2A) AR mediates adrenergic suppression of insulin secretion. Pharmacological receptor antagonism, silencing of receptor expression, or blockade of downstream effectors rescued insulin secretion in congenic islets. Furthermore, we identified a single-nucleotide polymorphism in the human ADRA2A gene for which risk allele carriers exhibited overexpression of alpha(2A) AR, reduced insulin secretion, and increased type 2 diabetes risk. Human pancreatic islets from risk allele carriers exhibited reduced granule docking and secreted less insulin in response to glucose; both effects were counteracted by pharmacological alpha(2A) AR antagonists.	[Rosengren, Anders H.; Jokubka, Ramunas; Tojjar, Damon; Granhall, Charlotte; Hansson, Ola; Nagaraj, Vini; Reinbothe, Thomas M.; Eliasson, Lena; Groop, Leif; Salehi, Albert; Lyssenko, Valeriya; Luthman, Holger; Renstrom, Erik] Lund Univ, Ctr Diabet, SE-20502 Malmo, Sweden; [Li, Dai-Qing] Tianjin Med Univ, Tianjin Metab Dis Hosp, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Tuncel, Jonatan] Karolinska Inst, Dept Med Biochem & Biophys, Sect Med Inflammat Res, SE-17177 Stockholm, Sweden; [Rorsman, Patrik] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	Lund University; Tianjin Medical University; Karolinska Institutet; University of Oxford	Renstrom, E (corresponding author), Lund Univ, Ctr Diabet, SE-20502 Malmo, Sweden.	erik.renstrom@med.lu.se	Salehi, Albert/F-7768-2018; Eliasson, Lena/E-9294-2012; Hansson, Ola/F-1793-2011; Rorsman, Patrik/A-4331-2016; Rosengren, Anders/E-8371-2012; Nagaraj, Vini/P-3866-2019; Tuluc, Petronel/C-2527-2011; Reinbothe, Thomas M./N-1532-2014	Salehi, Albert/0000-0001-6120-3539; Eliasson, Lena/0000-0002-6467-5029; Hansson, Ola/0000-0002-7394-7639; Rorsman, Patrik/0000-0001-7578-0767; Rosengren, Anders/0000-0002-9333-5736; Nagaraj, Vini/0000-0001-6959-3623; Tuncel, Jonatan/0000-0001-6749-2327; Reinbothe, Thomas M./0000-0002-8934-6109	Swedish Research Council; European Foundation for the Study of Diabetes; Novo Nordisk and Albert Pahlsson foundations; Kungliga Fysiografiska Sallskapet; Nordic Centre of Excellence in Disease Genetics (NCoEDG); Lund University Diabetes Centre; Knut and Alice Wallenberg Foundation; Novo Nordisk Fonden [NNF10OC1013350] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Foundation for the Study of Diabetes; Novo Nordisk and Albert Pahlsson foundations; Kungliga Fysiografiska Sallskapet; Nordic Centre of Excellence in Disease Genetics (NCoEDG); Lund University Diabetes Centre; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank I. Lundquist and T. Andersson for help with the in vivo and fura-2 data, and B.-M. Nilsson and M. Neptin for technical assistance. Supported by project grants from the Swedish Research Council, the European Foundation for the Study of Diabetes, the Novo Nordisk and Albert Pahlsson foundations (E. R), Kungliga Fysiografiska Sallskapet (A. R.), The Nordic Centre of Excellence in Disease Genetics (NCoEDG) (R.J.), a Linnaeus grant to the Lund University Diabetes Centre, and the Knut and Alice Wallenberg Foundation. Access to human pancreatic islets was granted by J. Taneera in collaboration with the Nordic Network for Clinical Islet Transplantation	Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Devedjian JC, 2000, DIABETOLOGIA, V43, P899, DOI 10.1007/s001250051467; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Fagerholm V, 2004, EUR J PHARMACOL, V505, P243, DOI 10.1016/j.ejphar.2004.10.023; Finley JC, 2004, J APPL PHYSIOL, V96, P2231, DOI 10.1152/japplphysiol.00527.2003; GALITZKY J, 1990, J PHARMACOL EXP THER, V252, P312; Galli J, 1999, DIABETES, V48, P2463, DOI 10.2337/diabetes.48.12.2463; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Granhall C, 2006, DIABETES, V55, P3494, DOI 10.2337/db06-0796; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hoy M, 2003, EUR J PHARMACOL, V466, P213, DOI 10.1016/S0014-2999(03)01537-1; Lin JM, 2001, DIABETES, V50, P2737, DOI 10.2337/diabetes.50.12.2737; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Philipp M, 2002, AM J PHYSIOL-REG I, V283, pR287, DOI 10.1152/ajpregu.00123.2002; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Small KM, 2006, P NATL ACAD SCI USA, V103, P5472, DOI 10.1073/pnas.0601345103; Svetkey LP, 1996, HYPERTENSION, V27, P1210, DOI 10.1161/01.HYP.27.6.1210; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	24	194	207	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					217	220		10.1126/science.1176827	http://dx.doi.org/10.1126/science.1176827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965390				2022-12-24	WOS:000273394000039
J	Cohen, E; Paulsson, JF; Blinder, P; Burstyn-Cohen, T; Du, DG; Estepa, G; Adame, A; Pham, HM; Holzenberger, M; Kelly, JW; Masliah, E; Dillin, A				Cohen, Ehud; Paulsson, Johan F.; Blinder, Pablo; Burstyn-Cohen, Tal; Du, Deguo; Estepa, Gabriela; Adame, Anthony; Pham, Hang M.; Holzenberger, Martin; Kelly, Jeffery W.; Masliah, Eliezer; Dillin, Andrew			Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice	CELL			English	Article							BETA-AMYLOID PEPTIDE; FACTOR-I RECEPTOR; ALZHEIMERS-DISEASE; OXIDATIVE-STRESS; INSULIN-RECEPTOR; MOUSE MODEL; LIFE-SPAN; LONGEVITY; MUTANT; IMPAIRMENT	The insulin/insulin growth factor (IGF) signaling (IIS) pathway is a key regulator of aging of worms, flies, mice, and likely humans. Delayed aging by IIS reduction protects the nematode C. elegans from toxicity associated with the aggregation of the Alzheimer's disease-linked human peptide, A beta. We reduced IGF signaling in Alzheimer's model mice and discovered that these animals are protected from Alzheimer's-like disease symptoms, including reduced behavioral impairment, neuroinflammation, and neuronal loss. This protection is correlated with the hyperaggregation of A beta leading to tightly packed, ordered plaques, suggesting that one aspect of the protection conferred by reduced IGF signaling is the sequestration of soluble A beta oligomers into dense aggregates of lower toxicity. These findings indicate that the IGF signaling-regulated mechanism that protects from A beta toxicity is conserved from worms to mammals and point to the modulation of this signaling pathway as a promising strategy for the development of Alzheimer's disease therapy.	[Cohen, Ehud; Estepa, Gabriela; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Paulsson, Johan F.; Du, Deguo; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem & Mol & Expt Med, La Jolla, CA 92037 USA; [Paulsson, Johan F.; Du, Deguo; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Blinder, Pablo] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Burstyn-Cohen, Tal] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Adame, Anthony; Pham, Hang M.; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Holzenberger, Martin] INSERM, F-75571 Paris 12, France; [Holzenberger, Martin] Univ Paris 06, Hop St Antoine, UMRS 938, F-75571 Paris 12, France	Howard Hughes Medical Institute; Salk Institute; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Blinder, Pablo/AAX-7980-2020; Burstyn-Cohen, Tal/A-2848-2011; Burstyn-Cohen, Tal/K-8846-2012; Blinder, Pablo/GQI-2237-2022; Blinder, Pablo/D-2472-2009; Holzenberger, Martin/N-9732-2018	Blinder, Pablo/0000-0002-4042-214X; Burstyn-Cohen, Tal/0000-0002-2324-2921; Estepa, Gabriela/0000-0002-8380-1596; Cohen, Ehud/0000-0001-5552-7086; Holzenberger, Martin/0000-0003-4869-725X; Paulsson, Johan F/0000-0001-6601-8383	McKnight Foundation; NIA [P01 AG031097]; NATIONAL INSTITUTE ON AGING [P01AG031097] Funding Source: NIH RePORTER	McKnight Foundation; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	.We thank Dr. Hyun-Eui Kim for expert assistance with size-exclusion chromatography and Dr. Gustavo Dziewczapolski for assistance with behavioral assay. We thank the McKnight Foundation (A.D.) and NIA P01 AG031097 (A.D., J.W.K., E.M.) for funding. E.C. and A.D. designed and initiated this study. E.C. crossed the mouse strains and performed the behavioral assays, quantitative PCR, ELISA, size exclusion, and WB experiments. T. B. C. performed IHC assays. Immunoelectron microscopy was carried out by J.F.P. D. D. executed in vitro kinetic aggregation assays. P. B. performed image processing of the EM data. A. A. assisted with IHC. G. E. assisted with mice genotyping and behavioral assays. H. M. P. assisted with WB. M. H. provided Igf1r<SUP>+/-</SUP> mice and expertise pertinent to Igf1r. E. C., A. D., J.W.K., and E. M. wrote the manuscript. A. D. and J.W.K. are founders of Proteostasis Therepeutics Inc. and disclose no conflict of interest in this study	AMADUCCI L, 1994, CURR OPIN NEUROL, V7, P283, DOI 10.1097/00019052-199408000-00001; Bar-On P, 2006, J NEUROCHEM, V98, P1032, DOI 10.1111/j.1471-4159.2006.04017.x; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Blanchard J, 2008, NEUROBIOL AGING, V29, P1011, DOI 10.1016/j.neurobiolaging.2007.02.010; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Carro E, 2006, NEUROBIOL AGING, V27, P1618, DOI 10.1016/j.neurobiolaging.2005.09.039; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Ghosh HS, 2008, CURR OPIN INVEST DR, V9, P1095; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jensen MT, 2005, NEUROSCIENCE, V130, P667, DOI 10.1016/j.neuroscience.2004.09.055; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; MANCARDI GL, 1983, ACTA NEUROPATHOL, V61, P76, DOI 10.1007/BF00688390; Masliah E, 2000, J NEURAL TRANSM-SUPP, P175; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nadjar A, 2009, NEUROBIOL AGING, V30, P2021, DOI 10.1016/j.neurobiolaging.2008.02.009; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Partridge L, 2008, ONCOGENE, V27, P2351, DOI 10.1038/onc.2008.28; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wirths O, 2010, NEUROBIOL AGING, V31, P747, DOI 10.1016/j.neurobiolaging.2008.06.011; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	47	352	362	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1157	1169		10.1016/j.cell.2009.11.014	http://dx.doi.org/10.1016/j.cell.2009.11.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005808	Green Accepted, Bronze			2022-12-24	WOS:000272622800017
J	Uhlenhaut, NH; Jakob, S; Anlag, K; Eisenberger, T; Sekido, R; Kress, J; Treier, AC; Klugmann, C; Klasen, C; Holter, NI; Riethmacher, D; Schutz, G; Cooney, AJ; Lovell-Badge, R; Treier, M				Uhlenhaut, N. Henriette; Jakob, Susanne; Anlag, Katrin; Eisenberger, Tobias; Sekido, Ryohei; Kress, Jana; Treier, Anna-Corina; Klugmann, Claudia; Klasen, Christian; Holter, Nadine I.; Riethmacher, Dieter; Schuetz, Guenther; Cooney, Austin J.; Lovell-Badge, Robin; Treier, Mathias			Somatic Sex Reprogramming of Adult Ovaries to Testes by FOXL2 Ablation	CELL			English	Article							TRANSCRIPTION FACTOR FOXL2; GENE-TRANSCRIPTION; SERTOLI-CELLS; BETA-CATENIN; SRY ACTION; SOX9; REVERSAL; DIFFERENTIATION; FOLLICLE; MOUSE	In mammals, the transcription factor SRY, encoded by the Y chromosome, is normally responsible for triggering the indifferent gonads to develop as testes rather than ovaries. However, testis differentiation can occur in its absence. Here we demonstrate in the mouse that a single factor, the forkhead transcriptional regulator FOXL2, is required to prevent transdifferentiation of an adult ovary to a testis. Inducible deletion of Foxl2 in adult ovarian follicles leads to immediate upregulation of testis-specific genes including the critical SRY target gene Sox9. Concordantly, reprogramming of granulosa and theca cell lineages into Sertoli-like and Leydig-like cell lineages occurs with testosterone levels comparable to those of normal XY male littermates. Our results show that maintenance of the ovarian phenotype is an active process throughout life. They might also have important medical implications for the understanding and treatment of some disorders of sexual development in children and premature menopause in women. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Uhlenhaut, N. Henriette; Anlag, Katrin; Eisenberger, Tobias; Kress, Jana; Treier, Anna-Corina; Klugmann, Claudia; Klasen, Christian; Holter, Nadine I.; Treier, Mathias] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Jakob, Susanne; Sekido, Ryohei; Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; [Riethmacher, Dieter] Univ Southampton, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England; [Schuetz, Guenther] German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany; [Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Treier, Mathias] Univ Cologne, Fac Med, D-50931 Cologne, Germany	European Molecular Biology Laboratory (EMBL); MRC National Institute for Medical Research; University of Southampton; Helmholtz Association; German Cancer Research Center (DKFZ); Baylor College of Medicine; University of Cologne	Treier, M (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	treier@embl.de	Riethmacher, Dieter/AAB-8690-2022; Uhlenhaut, Nina Henriette/C-6288-2014; Riethmacher, Dieter/A-6242-2010; Uhlenhaut, Henriette/AFR-1141-2022; Riethmacher, Dieter/AAP-2227-2021; Treier, Mathias/AAD-6388-2021; Uhlenhaut, Henriette/AAP-5400-2020	Riethmacher, Dieter/0000-0002-4206-5529; Uhlenhaut, Henriette/0000-0002-4220-4779; Lovell-Badge, Robin/0000-0001-9364-4179; Sekido, Ryohei/0000-0003-2364-1882	Deutsche Forschungsgemeinschaft [DFG-TR341]; MRC [U117512772]; Louis Jeantet Foundation; Medical Research Council [MC_U117562207] Funding Source: researchfish; MRC [MC_U117562207] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Louis Jeantet Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff of the EMBL Laboratory Animal Resources for expert animal husbandry, and S. Fehsenfeld and T. Ivacevic for technical assistance. We thank A. F. Parlow at the National Hormone and Peptide Program; HUMC for help with serum testosterone measurements; and M. Wegner and D. Zarkower for SOX9 and DMRT1 antibodies. This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG-TR341, M. T.) and by the MRC (U117512772) and Louis Jeantet Foundation (S.J., R. S., and R. L. B.).	Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Barske LA, 2008, CURR OPIN GENET DEV, V18, P499, DOI 10.1016/j.gde.2008.11.004; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bouma GJ, 2005, DEVELOPMENT, V132, P3045, DOI 10.1242/dev.01890; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; BURGOYNE PS, 1988, DEVELOPMENT, V104, P683; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Coveney D, 2001, BIOL REPROD, V65, P613, DOI 10.1095/biolreprod65.2.613; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; DiNapoli L, 2008, MOL ENDOCRINOL, V22, P1, DOI 10.1210/me.2007-0250; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Guigon CJ, 2006, BIOL REPROD, V74, P450, DOI 10.1095/biolreprod.105.047134; GUIGUEN Y, 2009, GEN COMP ENDOCRINOL; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; HOAGE TR, 1976, ANAT REC, V184, P699, DOI 10.1002/ar.1091840409; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Mandel H, 2008, AM J HUM GENET, V82, P39, DOI 10.1016/j.ajhg.2007.08.005; MCLAREN A, 1991, BIOESSAYS, V13, P151, DOI 10.1002/bies.950130402; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Nakamura M, 2009, SEMIN CELL DEV BIOL, V20, P271, DOI 10.1016/j.semcdb.2008.10.003; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pannetier Maelle, 2004, Pediatr Endocrinol Rev, V1, P274; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Salmon NA, 2005, MOL REPROD DEV, V70, P271, DOI 10.1002/mrd.20208; Schmahl J, 2008, GENE DEV, V22, P3255, DOI 10.1101/gad.1723908; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SHOEMAKER CM, 2009, CELL DEV BIOL, V20, P293; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2006, MOL GENET METAB, V88, P225, DOI 10.1016/j.ymgme.2006.03.005; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	59	625	657	5	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1130	1142		10.1016/j.cell.2009.11.021	http://dx.doi.org/10.1016/j.cell.2009.11.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005806	Bronze			2022-12-24	WOS:000272622800015
J	Chan, M				Chan, Margaret			Cutting carbon, improving health	LANCET			English	Editorial Material									WHO, CH-1211 Geneva, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva, Switzerland.	MediaEnquiries@who.int						Lim V, 2009, LANCET, V374, P973, DOI 10.1016/S0140-6736(09)61641-X; McMichael A. J., 2004, COMP QUANTIFICATION; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; WHO, 2008, CLIM CHANG HLTH RES; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Medical Association, 2009, WMA DECL DELH HLTH C	6	17	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1870	1871		10.1016/S0140-6736(09)61993-0	http://dx.doi.org/10.1016/S0140-6736(09)61993-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531EQ	19942272				2022-12-24	WOS:000272646900005
J	Vielle-Calzada, JP; de la Vega, OM; Hernandez-Guzman, G; Ibarra-Laclette, E; Alvarez-Mejia, C; Vega-Arreguin, JC; Jimenez-Moraila, B; Fernandez-Cortes, A; Corona-Armenta, G; Herrera-Estrella, L; Herrera-Estrella, A				Vielle-Calzada, Jean-Philippe; Martinez de la Vega, Octavio; Hernandez-Guzman, Gustavo; Ibarra-Laclette, Enrique; Alvarez-Mejia, Cesar; Vega-Arreguin, Julio C.; Jimenez-Moraila, Beatriz; Fernandez-Cortes, Araceli; Corona-Armenta, Guillermo; Herrera-Estrella, Luis; Herrera-Estrella, Alfredo			The Palomero Genome Suggests Metal Effects on Domestication	SCIENCE			English	Article							MAIZE		[Vielle-Calzada, Jean-Philippe; Martinez de la Vega, Octavio; Hernandez-Guzman, Gustavo; Ibarra-Laclette, Enrique; Alvarez-Mejia, Cesar; Vega-Arreguin, Julio C.; Jimenez-Moraila, Beatriz; Fernandez-Cortes, Araceli; Corona-Armenta, Guillermo; Herrera-Estrella, Luis; Herrera-Estrella, Alfredo] CINVESTAV, Lab Nacl Genom Biodiversidad, Irapuato 36500, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Herrera-Estrella, L (corresponding author), CINVESTAV, Lab Nacl Genom Biodiversidad, Km 9-6 Libramiento Norte Carretera Irapuato Leon, Irapuato 36500, Mexico.	lherrera@ira.cinvestav.mx	Herrera-Estrella, Luis/ABC-7431-2020; Martinez, Octavio/F-3951-2014; Herrera-Estrella, Alfredo/F-3185-2011; Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Herrera-Estrella, Luis/AAL-2472-2020; Herrera-Estrella, Alfredo/J-8210-2019; Estrella, Luis R Herrera/G-7351-2011	Martinez, Octavio/0000-0002-7590-0041; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Luis/0000-0001-7936-3856; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Estrella, Luis R Herrera/0000-0001-7936-3856; Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490; Vega-Arreguin, Julio C./0000-0002-4509-4122; Hernandez-Guzman, Gustavo/0000-0002-3686-8122; Alvarez-Mejia, Cesar/0000-0002-1016-4557	Consejo Nacional de Ciencia y Tecnologia; la Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion [ZEA-2006]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); la Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion	We thank D. Torrent (Barcelona Supercomputing Center, Spain) for facilities and technical support; J. Sanchez, J. M. Hernandez Casillas, and Centro Internacional de Mejoramiento de Maiz y Trigo (CIMMYT) for access to their seed collections; G. Palomino and G. Acosta for help with flow cytometry; J. Bennetzen, S. Wessler, and N. Jiang for help with repetitive DNA analysis; J. Sanchez and A. Avendano (Centro Universitario de Ciencias Biologicas y Agropecuarias) for providing plant material; J. Doebley, J. Yan, and C. Bedolla for backup DNA samples; and two anonymous reviewers for helpful suggestions. Funded by Consejo Nacional de Ciencia y Tecnologia and the ZEA-2006 grant from la Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion. Genbank assession numbers are GU112491 to GU112502.	Briggs WH, 2007, GENETICS, V177, P1915, DOI 10.1534/genetics.107.076497; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; DORWEILER J, 1993, SCIENCE, V262, P233, DOI 10.1126/science.262.5131.233; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299	8	55	60	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1078	1078		10.1126/science.1178437	http://dx.doi.org/10.1126/science.1178437			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965420				2022-12-24	WOS:000271951000031
J	Wood, P; Peckham, D				Wood, Philip; Peckham, Daniel			Rational Testing Investigating recurrent respiratory infections in primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMON VARIABLE IMMUNODEFICIENCY; INTRAVENOUS IMMUNOGLOBULIN; PREVENTION; PNEUMONIA; EFFICACY		[Wood, Philip] St James Univ Hosp, Dept Clin Immunol, Leeds LS9 7TF, W Yorkshire, England; [Peckham, Daniel] St James Univ Hosp, Dept Resp Med, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; Saint James's University Hospital	Wood, P (corresponding author), St James Univ Hosp, Dept Clin Immunol, Leeds LS9 7TF, W Yorkshire, England.	philip.wood@leedsth.nhs.uk		Peckham, Daniel/0000-0001-7723-1868				Aghamohammadi A, 2004, FEMS IMMUNOL MED MIC, V40, P113, DOI 10.1016/S0928-8244(03)00304-3; Busse PJ, 2002, J ALLERGY CLIN IMMUN, V109, P1001, DOI 10.1067/mai.2002.124999; Cancer Research UK, 2008, CANCERSTATS INC UK; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Joshi AY, 2009, MAYO CLIN PROC, V84, P16, DOI [10.4065/84.1.16, 10.1016/S0025-6196(11)60802-1]; Kainulainen L, 2001, J CLIN IMMUNOL, V21, P145, DOI 10.1023/A:1011012023616; Notarangelo L, 2006, J ALLERGY CLIN IMMUN, V117, P883, DOI 10.1016/j.jaci.2005.12.1347; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; *ROYAL COLL GEN PR, 2007, ANN PREV REP 2007; Wood P, 2007, CLIN EXP IMMUNOL, V149, P410, DOI 10.1111/j.1365-2249.2007.03432.x	11	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 12	2009	339								b4118	10.1136/bmj.b4118	http://dx.doi.org/10.1136/bmj.b4118			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HN	19910402				2022-12-24	WOS:000271834000002
J	Chung, JW; Meltzer, DO				Chung, Jeanette W.; Meltzer, David O.			Estimate of the Carbon Footprint of the US Health Care Sector	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chung, Jeanette W.; Meltzer, David O.] Univ Chicago, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA	University of Chicago	Chung, JW (corresponding author), Univ Chicago, Dept Med, Sect Hosp Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jchung1@bsd.uchicago.edu	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG031326] Funding Source: NIH RePORTER; AHRQ HHS [U18 HS016967-01] Funding Source: Medline; NIA NIH HHS [K24-AG31326] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Carnegie Mellon University Green Design Institute, EC INP OUTP LIF CYCL; EPA (US Environmental Protection Agency), 2009, 430R09004 US EPA; Hartman M, 2009, HEALTH AFFAIR, V28, P246, DOI 10.1377/hlthaff.28.1.246; Hendrickson CT, 2006, ENV LIFE CYCLE ASSES; NHS Sustainable Development Unit, 2008, NHS ENGL CARB EM CAR; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P351	6	191	193	4	24	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					1970	1972		10.1001/jama.2009.1610	http://dx.doi.org/10.1001/jama.2009.1610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903917	Bronze			2022-12-24	WOS:000271619700019
J	Davies, J				Davies, Justine			Swine Flu Vaccines: Reaching the Finish Line	CELL			English	Editorial Material														Davies, Justine/0000-0001-6834-1838					0	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 30	2009	139	3					449	451		10.1016/j.cell.2009.10.018	http://dx.doi.org/10.1016/j.cell.2009.10.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879829	Bronze			2022-12-24	WOS:000271259600005
J	de Jager, DJ; Grootendorst, DC; Jager, KJ; van Dijk, PC; Tomas, LMJ; Ansell, D; Collart, F; Finne, P; Heaf, JG; De Meester, J; Wetzels, JFM; Rosendaal, FR; Dekker, FW				de Jager, Dinanda J.; Grootendorst, Diana C.; Jager, Kitty J.; van Dijk, Paul C.; Tomas, Lonneke M. J.; Ansell, David; Collart, Frederic; Finne, Patrik; Heaf, James G.; De Meester, Johan; Wetzels, Jack F. M.; Rosendaal, Frits R.; Dekker, Friedo W.			Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; RISK-FACTOR; HEMODIALYSIS; DEATH; DYSFUNCTION; PREVALENCE; REGISTRY; FRAILTY; GENDER	Context Cardiovascular mortality is considered the main cause of death in patients receiving dialysis and is 10 to 20 times higher in such patients than in the general population. Objective To evaluate if high overall mortality in patients starting dialysis is a consequence of increased cardiovascular mortality risk only or whether noncardiovascular mortality is equally increased. Design, Setting, and Patients Using data from between January 1, 1994, and January 1, 2007, age-stratified mortality in a European cohort of adults starting dialysis and receiving follow-up for a mean of 1.8 (SD, 1.1) years ( European Renal Association-European Dialysis and Transplant Association [ERA-EDTA] Registry [N=123 407]) was compared with the European general population (Eurostat). Main Outcome Measures Cause of death was recorded by ERA-EDTA codes in patients and matching International Statistical Classification of Diseases, 10th Revision codes in the general population. Standardized cardiovascular and noncardiovascular mortality rates, their ratio, difference, and relative excess of cardiovascular over noncardiovascular mortality were calculated. Results Overall all-cause mortality rates in patients and the general population were 192 per 1000 person-years (95% confidence interval [CI], 190-193) and 12.055 per 1000 person-years ( 95% CI, 12.05-12.06), respectively. Cause of death was known for 90% of the patients and 99% of the general population. In patients, 16 654 deaths (39%) were cardiovascular and 21 654 (51%) were noncardiovascular. In the general population, 7 041 747 deaths (40%) were cardiovascular and 10 183 322 (58%) were noncardiovascular. Cardiovascular and noncardiovascular mortality rates in patients were respectively 38.1 per 1000 person-years ( 95% CI, 37.2-39.0) and 50.1 per 1000 person-years ( 95% CI, 48.9-51.2) higher than in the general population. On a relative scale, standardized cardiovascular and noncardiovascular mortality were respectively 8.8 ( 95% CI, 8.6-9.0) and 8.1 ( 95% CI, 7.9-8.3) times higher than in the general population. The ratio of these rates, ie, relative excess of cardiovascular over noncardiovascular mortality in patients starting dialysis compared with the general population, was 1.09 ( 95% CI, 1.06-1.12). Relative excess in a sensitivity analysis in which unknown/missing causes of death were regarded either as noncardiovascular or cardiovascular varied between 0.90 ( 95% CI, 0.88-0.93) and 1.39 ( 95% CI, 1.35-1.43). Conclusion Patients starting dialysis have a generally increased risk of death that is not specifically caused by excess cardiovascular mortality. JAMA. 2009; 302(16):1782-1789 www.jama.com	[de Jager, Dinanda J.; Grootendorst, Diana C.; Tomas, Lonneke M. J.; Rosendaal, Frits R.; Dekker, Friedo W.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; [Jager, Kitty J.; van Dijk, Paul C.] Univ Amsterdam, Acad Med Ctr, ERA EDTA Registry, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [Ansell, David] United Kingdom Renal Registry, Bristol, Avon, England; [Collart, Frederic] French Speaking Belgium ESRD Registry, Brussels, Belgium; [Finne, Patrik] Finnish Registry Kidney Dis, Helsinki, Finland; [Heaf, James G.] Copenhagen Univ Hosp, Dept Nephrol, Herlev, Denmark; [De Meester, Johan] AZ Nikolaas, Dept Nephrol Dialysis & Hypertens, St Niklaas, Belgium; [Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Universite Libre de Bruxelles; University of Copenhagen; Radboud University Nijmegen	de Jager, DJ (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, C7-104,POB 9600, NL-2300 RC Leiden, Netherlands.	d.j.de_jager@lumc.nl	Rosendaal, Frits/Q-3842-2017; Dekker, Friedo W/B-6452-2011; Wetzels, Jack F.M./A-1720-2014	Rosendaal, Frits/0000-0003-2558-7496; Dekker, Friedo W/0000-0002-2433-2494; Wetzels, Jack F.M./0000-0002-0650-6921; Ansell, David/0000-0001-9575-1509; Collart, Frederic/0000-0003-1673-5450	European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)	European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)	The ERA-EDTA Registry is funded by the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA).	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Aucella F, 2009, ATHEROSCLEROSIS, V207, P541, DOI 10.1016/j.atherosclerosis.2009.05.011; BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; den Elzen WPJ, 2006, NEPHROL DIAL TRANSPL, V21, P1588, DOI 10.1093/ndt/gfk092; *ERA EDTA REG, 2007, ERA EDTA REG 2006 AN, P129; *EUR COMM, CAUS DEATH ABS NUMB; *EUR COMM, POP 1 JAN SEX AG 199; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Foley RN, 2006, ADV CHRONIC KIDNEY D, V13, P205, DOI 10.1053/j.ackd.2006.04.006; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Havekes B, 2006, AM J KIDNEY DIS, V47, P823, DOI 10.1053/j.ajkd.2006.01.019; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Jager KJ, 2000, PERITON DIALYSIS INT, V20, pS118; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Ketteler M, 2006, KIDNEY INT, V70, pS5, DOI 10.1038/sj.ki.5001996; Kielstein JT, 2005, AM J KIDNEY DIS, V46, P186, DOI 10.1053/j.ajkd.2005.05.009; Langman CB, 2005, AM J KIDNEY DIS, V46, pS6, DOI 10.1053/j.ajkd.2005.07.024; Lastra G, 2006, ADV CHRONIC KIDNEY D, V13, P365, DOI 10.1053/j.ackd.2006.07.011; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Locatelli F, 2001, NEPHROL DIAL TRANSPL, V16, P459, DOI 10.1093/ndt/16.3.459; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Shanahan CM, 2005, CURR OPIN NEPHROL HY, V14, P361, DOI 10.1097/01.mnh.0000172723.52499.38; Stack AG, 2001, J AM SOC NEPHROL, V12, P1516, DOI 10.1681/ASN.V1271516; Stel VS, 2005, NEPHROL DIAL TRANSPL, V20, P2803, DOI 10.1093/ndt/gfi099; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Stompor T, 2007, PERITON DIALYSIS INT, V27, pS215; US Renal Data System, USRDS 2008 ANN DAT R; van Dijk PCW, 2001, NEPHROL DIAL TRANSPL, V16, P1120, DOI 10.1093/ndt/16.6.1120; Villar E, 2007, J AM SOC NEPHROL, V18, P2125, DOI 10.1681/ASN.2006091048; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; World Health Organization, 1992, INT STAT CLASS DIS 1; 1992, AM J KIDNEY DIS S2, V20, P32	40	500	513	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1782	1789		10.1001/jama.2009.1488	http://dx.doi.org/10.1001/jama.2009.1488			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861670	Bronze			2022-12-24	WOS:000271150300021
J	Giardini, D				Giardini, Domenico			Geothermal quake risks must be faced	NATURE			English	Editorial Material									ETH, Swiss Seismol Serv, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Giardini, D (corresponding author), ETH, Swiss Seismol Serv, Sonneggstr 5, CH-8092 Zurich, Switzerland.	giardini@sed.ethz.ch	Giardini, Domenico/F-5406-2011						0	168	173	4	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 17	2009	462	7275					848	849		10.1038/462848a	http://dx.doi.org/10.1038/462848a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016577				2022-12-24	WOS:000272795400020
J	Pandey, M; Syed, S; Donmez, I; Patel, G; Ha, T; Patel, SS				Pandey, Manjula; Syed, Salman; Donmez, Ilker; Patel, Gayatri; Ha, Taekjip; Patel, Smita S.			Coordinating DNA replication by means of priming loop and differential synthesis rate	NATURE			English	Article							LAGGING-STRAND SYNTHESIS; RING-SHAPED HELICASE; ESCHERICHIA-COLI; MINICIRCLE SUBSTRATE; REPLISOME; PRIMASE; PROCESSIVITY; DEFICIENT; MECHANISM; TEMPLATE	Genomic DNA is replicated by two DNA polymerase molecules, one of which works in close association with the helicase to copy the leading-strand template in a continuous manner while the second copies the already unwound lagging-strand template in a discontinuous manner through the synthesis of Okazaki fragments(1,2). Considering that the lagging-strand polymerase has to recycle after the completion of every Okazaki fragment through the slowsteps of primer synthesis and hand-off to the polymerase(3-5), it is not understood how the two strands are synthesized with the same net rate(6-9). Here we show, using the T7 replication proteins(10,11), that RNA primers are made 'on the fly' during ongoing DNA synthesis and that the leading-strand T7 replisome does not pause during primer synthesis, contrary to previous reports(12,13). Instead, the leading-strand polymerase remains limited by the speed of the helicase(14); it therefore synthesizes DNA more slowly than the lagging-strand polymerase. We show that the primase-helicase T7 gp4 maintains contact with the priming sequence during ongoing DNA synthesis; the nascent lagging-strand template therefore organizes into a priming loop that keeps the primer in physical proximity to the replication complex. Our findings provide three synergistic mechanisms of coordination: first, primers are made concomitantly with DNA synthesis; second, the priming loop ensures efficient primer use and hand-off to the polymerase; and third, the lagging-strand polymerase copies DNA faster, which allows it to keep up with leading-strand DNA synthesis overall.	[Syed, Salman; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Pandey, Manjula; Donmez, Ilker; Patel, Gayatri; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ha, T (corresponding author), Howard Hughes Med Inst, Urbana, IL 61801 USA.	tjha@illinois.edu; patelss@umdnj.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258	NIH [GM55310, GM065367]; NSF [0822613, 0646550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM055310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. M. Drain for a critical reading of the paper, K. Picha and S. Patel for preparation of the minicircle DNA, and S. Arslan and K. S. Lee for help with single-molecule FRET data analysis. This work was supported by NIH grants GM55310 ( S. S. P.) and GM065367 ( T. H.) and NSF grants 0822613 and 0646550 ( T. H.). T. H. is an investigator with the Howard Hughes Medical Institute.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Donmez I, 2008, EMBO J, V27, P1718, DOI 10.1038/emboj.2008.100; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Sanborn ME, 2007, J PHYS CHEM B, V111, P11064, DOI 10.1021/jp072912u; SELICK HE, 1987, DNA REPLICATION RECO, P183; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; WU CA, 1992, J BIOL CHEM, V267, P4030; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106	31	85	87	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					940	U137		10.1038/nature08611	http://dx.doi.org/10.1038/nature08611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	19924126	Green Accepted			2022-12-24	WOS:000272795400047
J	Woodcock, J				Woodcock, Janet			A Difficult Balance - Pain Management, Drug Safety, and the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], 2009, M MAT JUN 29 2009 JO; Bailey JE, 2009, ANN EMERG MED, V53, P419, DOI 10.1016/j.annemergmed.2008.07.015; *DRUG AB WARN NETW, 2008, DHHS PUBL SMA; *NSDUH, 2009, REP TRENDS NONM US P	4	109	111	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2009	361	22					2105	2107		10.1056/NEJMp0908913	http://dx.doi.org/10.1056/NEJMp0908913			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	524BC	19940297				2022-12-24	WOS:000272117800001
J	King, A				King, Anthony			Researchers Find Their Nemo	CELL			English	Editorial Material																			0	8	11	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 25	2009	139	5					843	846		10.1016/j.cell.2009.11.019	http://dx.doi.org/10.1016/j.cell.2009.11.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945369	Bronze			2022-12-24	WOS:000272169400006
J	Zehr, JP; Kudela, RM				Zehr, Jonathan P.; Kudela, Raphael M.			Photosynthesis in the Open Ocean	SCIENCE			English	Editorial Material							PHYTOPLANKTON; ENVIRONMENT		[Zehr, Jonathan P.; Kudela, Raphael M.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, 1156 High St, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	Zehr, Jonathan P/B-3513-2014	Zehr, Jonathan P/0000-0002-5691-5408				Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Behrenfeld MJ, 2009, BIOGEOSCIENCES, V6, P779, DOI 10.5194/bg-6-779-2009; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; MARTIN JH, 1991, LIMNOL OCEANOGR, V36, P1793, DOI 10.4319/lo.1991.36.8.1793; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303	11	26	29	5	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					945	946		10.1126/science.1181277	http://dx.doi.org/10.1126/science.1181277			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965502				2022-12-24	WOS:000271712300023
J	Vedula, SS; Bero, L; Scherer, RW; Dickersin, K				Vedula, S. Swaroop; Bero, Lisa; Scherer, Roberta W.; Dickersin, Kay			Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAINFUL DIABETIC-NEUROPATHY; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; CLINICAL-TRIALS; PHARMACEUTICAL-INDUSTRY; MIGRAINE PROPHYLAXIS; BIPOLAR DISORDER; PUBLICATION; REGISTRATION	Background: There is good evidence of selective outcome reporting in published reports of randomized trials. Methods: We examined reporting practices for trials of gabapentin funded by Pfizer and Warner-Lambert's subsidiary, Parke-Davis (hereafter referred to as Pfizer and Parke-Davis) for off-label indications (prophylaxis against migraine and treatment of bipolar disorders, neuropathic pain, and nociceptive pain), comparing internal company documents with published reports. Results: We identified 20 clinical trials for which internal documents were available from Pfizer and Parke-Davis; of these trials, 12 were reported in publications. For 8 of the 12 reported trials, the primary outcome defined in the published report differed from that described in the protocol. Sources of disagreement included the introduction of a new primary outcome (in the case of 6 trials), failure to distinguish between primary and secondary outcomes (2 trials), relegation of primary outcomes to secondary outcomes (2 trials), and failure to report one or more protocol-defined primary outcomes (5 trials). Trials that presented findings that were not significant (P greater/equal 0.05) for the protocol-defined primary outcome in the internal documents either were not reported in full or were reported with a changed primary outcome. The primary outcome was changed in the case of 5 of 8 published trials for which statistically significant differences favoring gabapentin were reported. Of the 21 primary outcomes described in the protocols of the published trials, 6 were not reported at all and 4 were reported as secondary outcomes. Of 28 primary outcomes described in the published reports, 12 were newly introduced. Conclusions: We identified selective outcome reporting for trials of off-label use of gabapentin. This practice threatens the validity of evidence for the effectiveness of off-label interventions. N Engl J Med 2009;361:1963-71.	[Vedula, S. Swaroop; Scherer, Roberta W.; Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Dept Epidemiol, Baltimore, MD USA; [Bero, Lisa] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Bero, Lisa] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vedula, SS (corresponding author), 615 N Wolfe St, Baltimore, MD 21205 USA.	svedula@jhsph.edu		Bero, Lisa/0000-0003-1893-6651				Backonja M, 1998, JAMA-J AM MED ASSOC, V280, P1831, DOI 10.1001/jama.280.21.1831; Backonja M, 2003, CLIN THER, V25, P81, DOI 10.1016/S0149-2918(03)90011-7; BACKONJA M, 2002, EUR J NEUROL S2, V9, P191; BACKONJA M, 1997, 16 ANN SCI M AM PAIN; Caraceni A, 2004, J CLIN ONCOL, V22, P2909, DOI 10.1200/jco.2004.08.141; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Dallocchio C, 2000, J PAIN SYMPTOM MANAG, V20, P280, DOI 10.1016/S0885-3924(00)00181-0; De Angelis C, 2004, ANN INTERN MED, V141, P477, DOI 10.7326/0003-4819-141-6-200409210-00109; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dickersin K, 1993, ONLINE J CURR CLIN T, V31, P4967; Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Evans Scott, 2007, PLoS Clin Trials, V2, pe18, DOI 10.1371/journal.pctr.0020018; FRIEDMAN LM, 1998, FUNDAMENTALS CLIN TR, P284; Gomez-Perez FJ, 2004, BRIT J DIABETES VASC, V4, P173; GOMEZPEREZ FJ, 2002, 5 INT C MECH TREATM; GORDH TE, 2002, 10 WORLD C PAIN SAN; Gordh TE, 2008, PAIN, V138, P255, DOI 10.1016/j.pain.2007.12.011; Gorson KC, 1999, J NEUROL NEUROSUR PS, V66, P251, DOI 10.1136/jnnp.66.2.251; Gorson KC, 1998, NEUROLOGY, V50, pA103; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P1258; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Mathew NT, 1999, CEPHALALGIA, V19, P380; Mathew NT, 2001, HEADACHE, V41, P119, DOI 10.1046/j.1526-4610.2001.111006119.x; MATHEW NT, 1998, 17 ANN SCI M AM PAIN; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Pande AC, 2000, BIPOLAR DISORD, V2, P249, DOI 10.1034/j.1399-5618.2000.20305.x; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1949, DOI 10.1001/jama.299.16.1949; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Rising K, 2009, PLOS MED, V6, P117, DOI 10.1371/journal.pmed.1000017; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Serpell MG, 2002, PAIN, V99, P557, DOI 10.1016/S0304-3959(02)00255-5; SERPELL MG, 2002, 5 INT C MECH TREATM; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vieta E, 2006, J CLIN PSYCHIAT, V67, P473, DOI 10.4088/JCP.v67n0320; Wang PW, 2002, BIPOLAR DISORD, V4, P296, DOI 10.1034/j.1399-5618.2002.01211.x; Wessely P, 1987, CEPHALALGIA, V7, P477; Wiffen PJ, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005452, 10.1002/14651858.CD005451]	49	232	235	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1963	1971		10.1056/NEJMsa0906126	http://dx.doi.org/10.1056/NEJMsa0906126			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19907043	Bronze			2022-12-24	WOS:000271660500010
J	Parrish, DD; Zhu, T				Parrish, David D.; Zhu, Tong			Clean Air for Megacities	SCIENCE			English	Editorial Material							BLACK CARBON; POLLUTION; CITIES; LIFE; CITY		[Parrish, David D.] NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA; [Zhu, Tong] Peking Univ, State Key Lab Environm Simulat & Pollut Control, Coll Environm Sci & Engn, Beijing 100871, Peoples R China	National Oceanic Atmospheric Admin (NOAA) - USA; Peking University	Parrish, DD (corresponding author), NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA.	david.d.parrish@noaa.gov; tzhu@pku.edu.cn	Parrish, David/E-8957-2010; ZHU, TONG/H-6501-2011	Parrish, David/0000-0001-6312-2724; ZHU, TONG/0000-0002-2752-7924				Arneth A, 2009, SCIENCE, V326, P672, DOI 10.1126/science.1181568; *BEIJ MUN ENV PROT, COMM ENV STAT BEIJ 1; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bravo HA, 2000, ATMOS ENVIRON, V34, P499, DOI 10.1016/S1352-2310(99)00382-9; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Marshall JD, 2008, ENVIRON SCI TECHNOL, V42, P3133, DOI 10.1021/es087047l; Molina MJ, 2004, J AIR WASTE MANAGE, V54, P644, DOI 10.1080/10473289.2004.10470936; PANDEY KD, 2006, AMBIENT PARTICULATE; PARRISH DD, 2009, ATMOS ENV; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Shao M, 2006, FRONT ECOL ENVIRON, V4, P353, DOI 10.1890/1540-9295(2006)004[0353:CCICAA]2.0.CO;2; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Stevenson DS, 1998, GEOPHYS RES LETT, V25, P3819, DOI 10.1029/1998GL900037; Stoeger T, 2006, ENVIRON HEALTH PERSP, V114, P328, DOI 10.1289/ehp.8266; UN, 2008, WORLD URB PROSP 2007; *UN POP DIV, WORLD URB PROSP 2007	20	158	196	13	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 30	2009	326	5953					674	675		10.1126/science.1176064	http://dx.doi.org/10.1126/science.1176064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900921				2022-12-24	WOS:000271233200021
J	Klein, MB; Kramer, CB; Nelson, J; Rivara, FP; Gibran, NS; Concannon, T				Klein, Matthew B.; Kramer, C. Bradley; Nelson, Jason; Rivara, Frederick P.; Gibran, Nicole S.; Concannon, Thomas			Geographic Access to Burn Center Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMA; TRANSPORT; CARE; RESUSCITATION; INJURIES; TIMES	Context The delivery of burn care is a resource-intensive endeavor that requires specialized personnel and equipment. The optimal geographic distribution of burn centers has long been debated; however, the current distribution of centers relative to geographic area and population is unknown. Objective To estimate the proportion of the US population living within 1 and 2 hours by rotary air transport ( helicopter) or ground transport of a burn care facility. Design and Setting A cross-sectional analysis of geographic access to US burn centers utilizing the 2000 US census, road and speed limit data, the Atlas and Database of Air Medical Services database, and the 2008 American Burn Association Directory. Main Outcome Measure The proportion of state, regional, and national population living within 1 and 2 hours by air transport or ground transport of a burn care facility. Results In 2008, there were 128 self-reported burn centers in the United States including 51 American Burn Association-verified centers. An estimated 25.1% and 46.3% of the US population live within 1 and 2 hours by ground transport, respectively, of a verified burn center. By air, 53.9% and 79.0% of the population live within 1 and 2 hours, respectively, of a verified center. There was significant regional variation in access to verified burn centers by both ground and rotary air transport. The greatest proportion of the population with access was highest in the northeast region and lowest in the southern United States. Conclusion Nearly 80% of the US population lives within 2 hours by ground or rotary air transport of a verified burn center; however, there is both state and regional variation in geographic access to these centers. JAMA. 2009; 302( 16):1774-1781 www.jama.com	[Klein, Matthew B.; Kramer, C. Bradley; Gibran, Nicole S.] Univ Washington, Burn Ctr, Seattle, WA 98195 USA; [Klein, Matthew B.] Univ Washington, Div Plast Surg, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Nelson, Jason; Concannon, Thomas] Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Nelson, Jason; Concannon, Thomas] Tufts Med Ctr, Boston, MA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tufts University; Tufts Medical Center	Klein, MB (corresponding author), Harborview Med Ctr, UW Burn Ctr, 325 Ninth Ave,POB 359796, Seattle, WA 98104 USA.	mbklein@u.washington.edu	Concannon, Thomas/A-1610-2013		National Center for Research Resources [1KL2RR025015-01]; Centers for Disease Control and Prevention [R49/CE000197]; David and Nancy Auth-Washington Research Foundation Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE000197] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); David and Nancy Auth-Washington Research Foundation Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Center for Research Resources grant 1KL2RR025015-01, Harborview Injury Prevention and Research Center (HIPRC) grant R49/CE000197 from the Centers for Disease Control and Prevention, and by the David and Nancy Auth-Washington Research Foundation Endowment.	*AM BURN ASS, BURN CAR FAC US; American Burn Association, BURN INC TREATM US 2; Berkebile B L, 1986, J Burn Care Rehabil, V7, P411, DOI 10.1097/00004630-198609000-00007; Branas CC, 2000, HEALTH SERV RES, V35, P489; Branas Charles C, 2005, LDI Issue Brief, V11, P1; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; *CTR TRANSP INJ RE, 2006, ATL DAT AIR MED SERV; Diaz MA, 2005, J TRAUMA, V58, P148, DOI 10.1097/01.TA.0000124264.43941.41; Falcone R E, 1998, Air Med J, V17, P161, DOI 10.1016/S1067-991X(98)90043-8; Faucher LD, 2004, J BURN CARE REHABIL, V25, P464, DOI 10.1097/01.BCR.0000144534.93523.DC; HAMMOND JS, 1987, J TRAUMA, V27, P1161, DOI 10.1097/00005373-198710000-00011; Ivy ME, 2000, J TRAUMA, V49, P387, DOI 10.1097/00005373-200009000-00001; KEARNEY PA, 1991, ANN EMERG MED, V20, P882, DOI 10.1016/S0196-0644(05)81431-3; Klein MB, 2006, BURNS, V32, P940, DOI 10.1016/j.burns.2006.04.001; Klein MB, 2007, J BURN CARE RES, V28, P49, DOI 10.1097/BCR.0B013E31802C894B; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; O'Mara MS, 2005, J TRAUMA, V58, P1011, DOI 10.1097/01.TA.0000162732.39083.15; PALMER JH, 1987, INJURY, V18, P250, DOI 10.1016/0020-1383(87)90008-8; Pruitt B A Jr, 1979, J Trauma, V19, P868; Pruitt BA, 2000, J TRAUMA, V49, P567, DOI 10.1097/00005373-200009000-00030; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; Saffle JR, 2004, J TRAUMA, V57, P57, DOI 10.1097/01.TA.0000103992.21727.8F; Sheridan R, 1999, J BURN CARE REHABIL, V20, P347, DOI 10.1097/00004630-199909000-00002; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; The American College of Surgeons, 2006, RES OPT CAR INJ PAT; Warden GD, 2003, J BURN CARE REHABIL, V24, P173, DOI 10.1097/01.BCR.0000066784.94077.C6; Wong K, 2004, ANZ J SURG, V74, P318, DOI 10.1111/j.1445-1433.2003.02738.x; Young JS, 1998, AM SURGEON, V64, P88; ZONIES D, 2009, J BURN CARE RES, V30, pS85, DOI DOI 10.1097/BCR0B013E3181998FC2	29	84	84	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1774	1781		10.1001/jama.2009.1548	http://dx.doi.org/10.1001/jama.2009.1548			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861669	Bronze, Green Accepted			2022-12-24	WOS:000271150300020
J	Searchinger, TD; Hamburg, SP; Melillo, J; Chameides, W; Havlik, P; Kammen, DM; Likens, GE; Lubowski, RN; Obersteiner, M; Oppenheimer, M; Robertson, GP; Schlesinger, WH; Tilman, GD				Searchinger, Timothy D.; Hamburg, Steven P.; Melillo, Jerry; Chameides, William; Havlik, Petr; Kammen, Daniel M.; Likens, Gene E.; Lubowski, Ruben N.; Obersteiner, Michael; Oppenheimer, Michael; Robertson, G. Philip; Schlesinger, William H.; Tilman, G. David			Fixing a Critical Climate Accounting Error	SCIENCE			English	Editorial Material							LAND-USE		[Searchinger, Timothy D.; Oppenheimer, Michael] Princeton Univ, Princeton, NJ 08544 USA; [Hamburg, Steven P.; Lubowski, Ruben N.] Environm Def Fund, Boston, MA 02108 USA; [Melillo, Jerry] Marine Biol Lab, Woods Hole, MA 02543 USA; [Chameides, William] Duke Univ, Durham, NC 27708 USA; [Havlik, Petr; Obersteiner, Michael] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Kammen, Daniel M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Likens, Gene E.; Schlesinger, William H.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Robertson, G. Philip] Michigan State Univ, Hickory Corners, MI 49060 USA; [Tilman, G. David] Univ Minnesota, St Paul, MN 55108 USA	Princeton University; Environmental Defense Fund; Marine Biological Laboratory - Woods Hole; Duke University; International Institute for Applied Systems Analysis (IIASA); University of California System; University of California Berkeley; Cary Institute of Ecosystem Studies; Michigan State University; University of Minnesota System; University of Minnesota Twin Cities	Searchinger, TD (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	tsearchi@princeton.edu; shamburg@edf.org	Robertson, G Philip/H-3885-2011; Tilman, David/ABD-5309-2021	Robertson, G Philip/0000-0001-9771-9895; Oppenheimer, Michael/0000-0002-9708-5914; Obersteiner, Michael/0000-0001-6981-2769; Havlik, Petr/0000-0001-5551-5085				Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; *INT EN AG, 2008, EN TECHN PERSP SUPP; *IPCC, 2007, 2006 IPCC GUID NAT G; MANICHETTI E, 2009, BIOFUELS ENV SEQUENC, P81; MELILLO JM, 2009, MIT JOINT PROGRAM RE; Searchinger T, 2009, BIOFUELS ENV CONSEQU, P37; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; *UNFCC, 2002, REP C PART ITS 7 SES; *UNFCC, 2006, UPD UNFCC REP GUID A, P23; Watson RT, 2000, LAND USE LAND USE CH; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	11	306	314	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					527	528		10.1126/science.1178797	http://dx.doi.org/10.1126/science.1178797			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509LN	19900885				2022-12-24	WOS:000271019400024
J	Yang, Y; Kim, AH; Yamada, T; Wu, B; Bilimoria, PM; Ikeuchi, Y; de la Iglesia, N; Shen, J; Bonni, A				Yang, Yue; Kim, Albert H.; Yamada, Tomoko; Wu, Bei; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; de la Iglesia, Nuria; Shen, Jie; Bonni, Azad			A Cdc20-APC Ubiquitin Signaling Pathway Regulates Presynaptic Differentiation	SCIENCE			English	Article							GROWTH	Presynaptic axonal differentiation is essential for synapse formation and the establishment of neuronal circuits. However, the mechanisms that coordinate presynaptic development in the brain are largely unknown. We found that the major mitotic E3 ubiquitin ligase Cdc20-anaphase promoting complex (Cdc20-APC) regulates presynaptic differentiation in primary postmitotic mammalian neurons and in the rat cerebellar cortex. Cdc20-APC triggered the degradation of the transcription factor NeuroD2 and thereby promoted presynaptic differentiation. The NeuroD2 target gene encoding Complexin II, which acts locally at presynaptic sites, mediated the ability of NeuroD2 to suppress presynaptic differentiation. Thus, our findings define a Cdc20-APC ubiquitin signaling pathway that governs presynaptic development, which holds important implications for neuronal connectivity and plasticity in the brain.	[Yang, Yue; Kim, Albert H.; Yamada, Tomoko; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; de la Iglesia, Nuria; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Yang, Yue; Bilimoria, Parizad M.; Shen, Jie; Bonni, Azad] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Kim, Albert H.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Wu, Bei; Shen, Jie] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Ikeuchi, Yoshiho/N-1057-2019; Shen, Jie/GXH-9449-2022; Kim, Albert H./HGF-0057-2022; de la Iglesia, Nuria/E-1420-2015; Wu, Bei/F-6659-2012; Ikeuchi, Yoshiho/C-1713-2014	de la Iglesia, Nuria/0000-0002-1083-7715; Ikeuchi, Yoshiho/0000-0002-2829-3840; Yang, Yue/0000-0002-6201-8818	NIH [NS051255, NS041021]; NSF; Lefler Fellowship; Ryan Foundation; National Research Service Award Research Training; National Cancer Institute, and Brain Science Foundation; Japan Society for the Promotion of Science; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [F32CA124028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255, R01NS041021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Lefler Fellowship; Ryan Foundation; National Research Service Award Research Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, and Brain Science Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Bonni laboratory for helpful discussions. This work was supported by NIH grants NS051255 and NS041021 ( A. B.); a NSF fellowship, the Lefler Fellowship, and the Ryan Foundation ( Y. Y.); a National Research Service Award Research Training grant, National Cancer Institute, and Brain Science Foundation grant ( A. H. K.); the Japan Society for the Promotion of Science ( T. Y.); and a Human Frontier Science Program long-term fellowship ( Y. I.).	Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lin CH, 2005, P NATL ACAD SCI USA, V102, P14877, DOI 10.1073/pnas.0506785102; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001	10	95	99	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					575	578		10.1126/science.1177087	http://dx.doi.org/10.1126/science.1177087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900895	Green Accepted			2022-12-24	WOS:000271019400042
J	Lessler, J; Reich, NG; Cummings, DAT				Lessler, Justin; Reich, Nicholas G.; Cummings, Derek A. T.		New York City Dept Hlth; Mental Hyg Swine Influenza Invest	Outbreak of 2009 Pandemic Influenza A (H1N1) at a New York City School	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY TRANSMISSION; INFECTIONS; HOUSEHOLD; DISTRIBUTIONS; CHILDREN; VIRUS	BACKGROUND In April 2009, an outbreak of novel swine-origin influenza A ( 2009 H1N1 influenza) occurred at a high school in Queens, New York. We describe the outbreak and characterize the clinical and epidemiologic aspects of this novel virus. METHODS The New York City Department of Health and Mental Hygiene characterized the outbreak through laboratory confirmation of the presence of the 2009 H1N1 virus in nasopharyngeal and oropharyngeal specimens and through information obtained from an online survey. Detailed information on exposure and the onset of symptoms was used to estimate the incubation period, generation time, and within-school reproductive number associated with 2009 H1N1 influenza, with the use of established techniques. RESULTS From April 24 through May 8, infection with the 2009 H1N1 virus was confirmed in 124 high-school students and employees. In responses to the online questionnaire, more than 800 students and employees (35% of student respondents and 10% of employee respondents) reported having an influenza-like illness during this period. No persons with confirmed 2009 H1N1 influenza or with influenza-like illness had severe symptoms. A linkage with travel to Mexico was identified. The estimated median incubation period for confirmed 2009 H1N1 influenza was 1.4 days (95% confidence interval [CI], 1.0 to 1.8), with symptoms developing in 95% of cases by 2.2 days (95% CI, 1.7 to 2.6). The estimated median generation time was 2.7 days (95% CI, 2.0 to 3.5). We estimate that the within-school reproductive number was 3.3. CONCLUSIONS The findings from this investigation suggest that 2009 H1N1 influenza in the high school was widespread but did not cause severe illness. The reasons for the rapid and extensive spread of influenza-like illnesses are unknown. The natural history and transmission of the 2009 H1N1 influenza virus appear to be similar to those of previously observed circulating pandemic and interpandemic influenza viruses.	[Lessler, Justin; Cummings, Derek A. T.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Reich, Nicholas G.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St,E6545, Baltimore, MD 21205 USA.	jlessler@jhsph.edu	Reich, Nicholas/L-1168-2019; Tsoi, Benjamin/T-2766-2018	Reich, Nicholas/0000-0003-3503-9899; Lessler, Justin/0000-0002-9741-8109; Marx, Melissa/0000-0001-9735-6342; Tsoi, Benjamin/0000-0003-2927-6687; DiGrande, Laura/0000-0002-7742-0164	National Institutes of Health [1 R01 TW008246-01, 1U01-GM070708]; Bill and Melinda Gates Foundation; U. S. Department of Homeland Security [N00014-06-1-0991]; Burroughs Wellcome Fund; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); U. S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health (1 R01 TW008246-01, to Drs. Lessler and Cummings; and 1U01-GM070708, to Dr. Cummings), the Bill and Melinda Gates Foundation ( to Drs. Lessler and Cummings), and the U. S. Department of Homeland Security (N00014-06-1-0991, to Mr. Reich). Dr. Cummings is the recipient of a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	[Anonymous], MMWR MORB MORTAL WKL; BECKER NG, 1989, ANAL INFECT DIS DATA; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Klein J., 1992, SURVIVAL ANAL STATE; Lessler J, 2007, J R SOC INTERFACE, V4, P755, DOI 10.1098/rsif.2007.0228; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; MACKENZIE D, 2009, DEADLY NEW FLU VIRUS; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura Hiroshi, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1075; Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; 2009, MMWR MORB MORTAL WKL, V58, P470	19	236	242	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2628	2636		10.1056/NEJMoa0906089	http://dx.doi.org/10.1056/NEJMoa0906089			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042754				2022-12-24	WOS:000273181300010
J	Tang, JWT; Settles, GS				Tang, Julian Wei-Tze; Settles, Gary S.			Coughing and Masks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tang, Julian Wei-Tze] Natl Univ Singapore Hosp, Singapore 117548, Singapore; [Settles, Gary S.] Penn State Univ, University Pk, PA 16802 USA	National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tang, JWT (corresponding author), Natl Univ Singapore Hosp, Singapore 117548, Singapore.		Settles, Gary S/D-5260-2009	Tang, Julian/0000-0002-4963-1028					0	16	17	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					E62	E62		10.1056/NEJMicm0904279	http://dx.doi.org/10.1056/NEJMicm0904279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	20032322				2022-12-24	WOS:000273003700013
J	Reyes, N; Ginter, C; Boudker, O				Reyes, Nicolas; Ginter, Christopher; Boudker, Olga			Transport mechanism of a bacterial homologue of glutamate transporters	NATURE			English	Article							DEPENDENT ASPARTATE TRANSPORTER; GATED ANION CONDUCTANCE; AMINO-ACID TRANSPORTERS; PYROCOCCUS-HORIKOSHII; EXTRACELLULAR GATE; NEUROTRANSMITTER TRANSPORTERS; SULFHYDRYL MODIFICATION; INDIVIDUAL SUBUNITS; MEMBRANE-TRANSPORT; PERMEATION PATHWAY	Glutamate transporters are integral membrane proteins that catalyse a thermodynamically uphill uptake of the neurotransmitter glutamate from the synaptic cleft into the cytoplasm of glia and neuronal cells by harnessing the energy of pre-existing electrochemical gradients of ions. Crucial to the reaction is the conformational transition of the transporters between outward and inward facing states, in which the substrate binding sites are accessible from the extracellular space and the cytoplasm, respectively. Here we describe the crystal structure of a double cysteine mutant of a glutamate transporter homologue from Pyrococcus horikoshii, Glt(Ph), which is trapped in the inward facing state by cysteine crosslinking. Together with the previously determined crystal structures of Glt(Ph) in the outward facing state, the structure of the crosslinked mutant allows us to propose a molecular mechanism by which Glt(Ph) and, by analogy, mammalian glutamate transporters mediate sodium-coupled substrate uptake.	[Reyes, Nicolas; Ginter, Christopher; Boudker, Olga] Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave,Box 75, New York, NY 10065 USA	Cornell University	Boudker, O (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave,Box 75, New York, NY 10065 USA.	olb2003@med.cornell.edu		Reyes, Nicolas/0000-0001-6618-8307	National Institute of Health; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064357] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Patel and H. Li for the help with isothermal titration calorimetry and H. Weinstein for constructive criticism. X-ray diffraction data were measured at X25 beamline at the National Synchrotron Light Source. This work was supported by the National Institute of Health (O.B.) and by a Jane Coffin Childs Memorial Fund postdoctoral fellowship (N.R.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; *COMP COLL PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, P760; CRISMAN TJ, P NATL ACAD IN PRESS; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dieckmann GR, 1997, J AM CHEM SOC, V119, P6195, DOI 10.1021/ja964351i; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Gouaux E, 2009, PHILOS T R SOC B, V364, P149, DOI 10.1098/rstb.2008.0181; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Leighton BH, 2002, J BIOL CHEM, V277, P29847, DOI 10.1074/jbc.M202508200; Manceau A, 2008, DALTON T, P1421, DOI 10.1039/b718372k; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATLAK CLIFFORD S., 1957, BULL MATH BIOPHYS, V19, P209, DOI 10.1007/BF02477764; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Seal RP, 1998, METHOD ENZYMOL, V296, P318; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Shachnai L, 2005, NEUROPHARMACOLOGY, V49, P862, DOI 10.1016/j.neuropharm.2005.07.005; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Shlaifer I, 2007, MOL PHARMACOL, V71, P1341, DOI 10.1124/mol.106.032607; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	51	330	335	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					880	885		10.1038/nature08616	http://dx.doi.org/10.1038/nature08616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	19924125	Green Accepted			2022-12-24	WOS:000272795400034
J	Kraft, P; Gadeholt, O; Wieser, MJ; Jennings, J; Classen, J				Kraft, Peter; Gadeholt, Ottar; Wieser, Matthias J.; Jennings, Jenifer; Classen, Joseph			CHRISTMAS 2009: YOUNG AND OLD Lying obliquely-a clinical sign of cognitive impairment: cross sectional observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY STANDARDS SUBCOMMITTEE; MINI-MENTAL-STATE; OBJECT ORIENTATION; PRACTICE PARAMETER; DEMENTIA; VERTICALITY; PREVALENCE; PERCEPTION; DIAGNOSIS	Objective To determine if failure to spontaneously orient the body along the longitudinal axis of a hospital bed when asked to lie down is associated with cognitive impairment in older patients. Design Cross sectional observational study. Setting Neurology department of a university hospital in Germany. Participants Convenience sample of 110 older (>= 60 years) inpatients with neurological conditions and 23 staff neurologists. Main outcome measures The main outcome measure was the association between the angle of the body axis and the results of three cognitive screening tests (mini-mental state examination, DemTect, and clock drawing test). Staff doctors were shown photographs of a model taken at a natural viewing able to determine their subjective perspective of what constitutes oblique. Results 110 neurological inpatients (mean age 70.9 (SD 6.8) years) were included after exclusions. Evidence of cognitive impairment was found in 34, with scores indicating dementia in eight, according to the mini-mental state examination, and in 11 according to the DemTect. Across all patients, the mean angular deviation of the body axis from the longitudinal axis of the bed (range 023) correlated linearly with the mini-mental state examination (r=-0.480), DemTect (r=-0.527), and the clock drawing test (r=-0.552) scores (P<0.001 for all), even after removing age as a covariate. Overall, 90% of staff neurologists considered a minimal body angle of 7 to be oblique. Angular deviation of at least 7 predicted cognitive impairment according to the three different tests, with specificities between 89% and 96% and sensitivities between 27% and 50%. Conclusion Clinicians might suspect cognitive impairment in mobile older inpatients with neurological disorders who spontaneously position themselves obliquely when asked to lie on a bed.	[Kraft, Peter; Gadeholt, Ottar; Jennings, Jenifer; Classen, Joseph] Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany; [Wieser, Matthias J.] Univ Wurzburg, Dept Psychol 1, D-97070 Wurzburg, Germany; [Classen, Joseph] Univ Leipzig, Dept Neurol, D-04103 Leipzig, Germany	University of Wurzburg; University of Wurzburg; Leipzig University	Classen, J (corresponding author), Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany.	joseph.classen@medizin.uni-leipzig.de	Wieser, Matthias J./AAV-7930-2020; Wieser, Matthias J/E-7614-2010; Gadeholt, Ottar/AAM-1030-2021	Wieser, Matthias J./0000-0002-0429-1541; Classen, Joseph/0000-0001-7182-6967	State of Bavaria	State of Bavaria	This study was part of OG's MD thesis. The study was supported by research funds from the State of Bavaria. The sponsor did not have any active role in the study. The researchers were independent of the funders.	Bickel H, 2006, DEMENT GERIATR COGN, V21, P242, DOI 10.1159/000091397; Caterini F, 2002, NEUROPSYCHOLOGY, V16, P146, DOI 10.1037//0894-4105.16.2.146; Cohen J., 1983, APPL MULTIPLE REGRES; Critchley M., 1953, PARIETAL LOBES; Cullen B, 2007, J NEUROL NEUROSUR PS, V78, P790, DOI 10.1136/jnnp.2006.095414; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedman M., 1994, CLOCK DRAWING NEUROP; Hickey A, 1997, INT J GERIATR PSYCH, V12, P27, DOI 10.1002/(SICI)1099-1166(199701)12:1<27::AID-GPS446>3.0.CO;2-F; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; Kalbe E, 2004, INT J GERIATR PSYCH, V19, P136, DOI 10.1002/gps.1042; Karnath HO, 2007, J NEUROL, V254, P415, DOI 10.1007/s00415-006-0341-6; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; KUKULL WA, 1994, J CLIN EPIDEMIOL, V47, P1061, DOI 10.1016/0895-4356(94)90122-8; Manckoundia P, 2007, CLIN NEUROPHYSIOL, V118, P786, DOI 10.1016/j.clinph.2006.11.274; OCONNOR DW, 1988, BMJ-BRIT MED J, V297, P1107, DOI 10.1136/bmj.297.6656.1107; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; SHULMAN KI, 1993, INT J GERIATR PSYCH, V8, P487, DOI 10.1002/gps.930080606; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x; TOBIS JS, 1981, ARCH PHYS MED REHAB, V62, P619; Troyer Angela K, 2004, Evid Based Ment Health, V7, P70; Turnbull OH, 1997, NEUROPSYCHOLOGIA, V35, P153, DOI 10.1016/S0028-3932(96)00063-2	27	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2009	339								b5273	10.1136/bmj.b5273	http://dx.doi.org/10.1136/bmj.b5273			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	534XH	20015907	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000272930300014
J	Markandya, A; Armstrong, BG; Hales, S; Chiabai, A; Criqui, P; Mima, S; Tonne, C; Wilkinson, P				Markandya, Anil; Armstrong, Ben G.; Hales, Simon; Chiabai, Aline; Criqui, Patrick; Mima, Silvana; Tonne, Cathryn; Wilkinson, Paul			Health and Climate Change 3 Public health benefits of strategies to reduce greenhouse-gas emissions: low-carbon electricity generation	LANCET			English	Article							AIR-POLLUTION; ANCILLARY BENEFITS; EXPOSURE; IMPACTS; ENERGY; POLICY	In this report, the third in this Series on health and climate change, we assess the changes in particle air pollution emissions and consequent effects on health that are likely to result from greenhouse-gas mitigation measures in the electricity generation sector in the European Union (EU), China, and India. We model the effect in 2030 of policies that aim to reduce total carbon dioxide (CO2) emissions by 50% by 2050 globally compared with the effect of emissions in 1990. We use three models: the POLES model, which identifies the distribution of production modes that give the desired CO2 reductions and associated costs; the GAINS model, which estimates fine particulate matter with aerodynamic diameter 2.5 mu m or less (PM2.5) concentrations; and a model to estimate the effect of PM2.5 on mortality on the basis of the WHO'S Comparative Risk Assessment methods. Changes in modes of production of electricity to reduce CO2 emissions would, in all regions, reduce PM2.5 and deaths caused by it, with the greatest effect in India and the smallest in the EU. Health benefits greatly offset costs of greenhouse-gas mitigation, especially in India where pollution is high and costs of mitigation are low. Our estimates are approximations but suggest dear health gains (co-benefits) through decarbonising electricity production, and provide additional information about the extent of such gains.	[Markandya, Anil; Chiabai, Aline] BC3, Bilbao, Spain; [Markandya, Anil; Chiabai, Aline] Univ Bath, Bath BA2 7AY, Avon, England; [Armstrong, Ben G.; Tonne, Cathryn; Wilkinson, Paul] London Sch Hyg & Trop Med, London WC1, England; [Hales, Simon] WHO, CH-1211 Geneva, Switzerland; [Criqui, Patrick; Mima, Silvana] Univ Grenoble, Grenoble, France; [Criqui, Patrick; Mima, Silvana] CNRS, Grenoble, France	Basque Centre for Climate Change (BC3); University of Bath; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Markandya, A (corresponding author), BC3, Gran Via 35-2, Bilbao, Spain.	anil.markandya@bc3research.org	Markandya, Anil/K-9381-2013; hales, simon/E-5768-2010; Azkarate, Ainhoa/K-9087-2013; Tonne, Cathryn/F-5020-2017; CHIABAI, ALINE/M-7447-2013	Azkarate, Ainhoa/0000-0003-0471-3094; Tonne, Cathryn/0000-0003-3919-8264; armstrong, benedict/0000-0003-4407-0409; Chiabai, Aline/0000-0002-0792-640X; Wilkinson, Paul/0000-0001-7456-259X; Hales, Simon/0000-0002-4529-7595	Wellcome Trust; Department of Health, National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; Medical Research Council [G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health, National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project that led to this Series was funded by the Wellcome Trust (coordinating funder); Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences; the Economic and Social Research Council; the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by an unrestricted educational grant from Pfizer. The funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies. We thank Colin Mathers (WHO, Geneva, Switzerland), who supplied the global burden of disease data from on which the burden estimates presented here are based.	[Anonymous], 2008, GAINS ASIA TOOL COMB; Aunan K, 2004, ENERG POLICY, V32, P567, DOI 10.1016/S0301-4215(03)00156-3; Bollen JC, 2009, 5001116005 PBL NETH; Burtraw D, 2003, J ENVIRON ECON MANAG, V45, P650, DOI 10.1016/S0095-0696(02)00022-0; Bussolo M, 2001, OECD DEV CTR WORKING, V182; CAO J, 2008, 0810 EFD; COHEN AJ, 2004, COMP ASSESSMENT RISK; CRIQUI P, 2008, POLES, V5; Dessus S, 2003, ENVIRON RESOUR ECON, V25, P287, DOI 10.1023/A:1024469430532; EEA (European Environment Agency), 2006, AIR QUAL ANC BEN CLI; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Frischknecht R, 2000, ENVIRON IMPACT ASSES, V20, P159, DOI 10.1016/S0195-9255(99)00042-6; Holland M, 2006, ASSESSING AIR POLLUT; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; JOH S, 2003, INT J SUSTAIN DEV, V6, P311; Koornneef J, 2009, ENRGY PROCED, V1, P3787, DOI 10.1016/j.egypro.2009.02.179; Krol M, 2005, ATMOS CHEM PHYS, V5, P417, DOI 10.5194/acp-5-417-2005; Markandya A, 2007, LANCET, V370, P979, DOI 10.1016/S0140-6736(07)61253-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McKinley G, 2005, ENVIRON SCI TECHNOL, V39, P1954, DOI 10.1021/es035183e; Metz B., 2005, IPCC SPECIAL REPORT; Metz B., 2001, CLIMATE CHANGE 2001; Metz ORDB, 2007, CLIMATE CHANGE 2007; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Morgenstern RD, 2004, J ENVIRON DEV, V13, P140, DOI DOI 10.1177/1070496503260972; *OECD, 2000, P IPCC COSP WORKSH; Schreiber A, 2009, INT J LIFE CYCLE ASS, V14, P547, DOI 10.1007/s11367-009-0102-8; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Wang XD, 1999, ENVIRON SCI TECHNOL, V33, P3056, DOI 10.1021/es981360d; Wilkinson P, 2007, LANCET, V370, P965, DOI 10.1016/S0140-6736(07)61252-5; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; [No title captured]	33	115	118	11	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					2006	2015		10.1016/S0140-6736(09)61715-3	http://dx.doi.org/10.1016/S0140-6736(09)61715-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	19942282				2022-12-24	WOS:000272727000024
J	Wilkinson, P; Smith, KR; Davies, M; Adair, H; Armstrong, BG; Barrett, M; Bruce, N; Haines, A; Hamilton, I; Oreszczyn, T; Ridley, I; Tonne, C; Chalabi, Z				Wilkinson, Paul; Smith, Kirk R.; Davies, Michael; Adair, Heather; Armstrong, Ben G.; Barrett, Mark; Bruce, Nigel; Haines, Andy; Hamilton, Ian; Oreszczyn, Tadj; Ridley, Ian; Tonne, Cathryn; Chalabi, Zaid			Health and Climate Change 1 Public health benefits of strategies to reduce greenhouse-gas emissions: household energy	LANCET			English	Article							INDOOR AIR-POLLUTION; LONG-TERM EXPOSURE; RESPIRATORY HEALTH; LUNG-CANCER; CHILDREN; MORTALITY; HOME; IMPACTS; SMOKE; MOLD	Energy used in dwellings is an important target for actions to avert climate change. Properly designed and implemented, such actions could have major co-benefits for public health. To investigate, we examined the effect of hypothetical strategies to improve energy efficiency in UK housing stock and to introduce 150 million low-emission household cookstoves in India. Methods similar to those of WHO's Comparative Risk Assessment exercise were applied to assess the effect on health that changes in the indoor environment could have. For UK housing, the magnitude and even direction of the changes in health depended on details of the intervention, but interventions were generally beneficial for health. For a strategy of combined fabric, ventilation, fuel switching, and behavioural changes, we estimated 850 fewer disability-adjusted life-years (DALYs), and a saving of 0.6 megatonnes of carbon dioxide (CO2), per million population in 1 year (on the basis of calculations comparing the health of the 2010 population with and without the specified outcome measures). The cookstove programme in India showed substantial benefits for acute lower respiratory infection in children, chronic obstructive pulmonary disease, and ischaemic heart disease. Calculated on a similar basis to the UK case study, the avoided burden of these outcomes was estimated to be 12 500 fewer DALYs and a saving of 0.1-0.2 megatonnes CO2-equivalent per million population in 1 year, mostly in short-lived greenhouse pollutants. Household energy interventions have potential for important co-benefits in pursuit of health and climate goals.	[Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, PEHRU, London WC1E 7HT, England; [Smith, Kirk R.; Adair, Heather] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Davies, Michael; Hamilton, Ian; Ridley, Ian] UCL, Bartlett Sch Grad Studies, London, England; [Barrett, Mark; Oreszczyn, Tadj] UCL, Energy Inst, London, England; [Bruce, Nigel] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Berkeley; University of London; University College London; University of London; University College London; University of Liverpool	Wilkinson, P (corresponding author), Univ London London Sch Hyg & Trop Med, PEHRU, Keppel St, London WC1E 7HT, England.	paul.wilkinson@lshtm.ac.uk	Hamilton, Ian/O-6234-2014; Tonne, Cathryn/F-5020-2017; Davies, Michael/GWV-2527-2022; Hamilton, Ian/O-6756-2019	Hamilton, Ian/0000-0003-2582-2361; Tonne, Cathryn/0000-0003-3919-8264; Hamilton, Ian/0000-0003-2582-2361; Barrett, Mark/0000-0003-3655-2424; Davies, Michael/0000-0003-2173-7063; armstrong, benedict/0000-0003-4407-0409; Wilkinson, Paul/0000-0001-7456-259X; Oreszczyn, Tadeusz/0000-0002-9667-7336; Haines, Andy/0000-0002-8053-4605; RIDLEY, Ian Alexander/0000-0001-9240-5088	Wellcome Trust; Department of Health, National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; EPSRC [EP/D506859/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D506859/1] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Department of Health, National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project that led to this Series was funded by the Wellcome Trust (coordinating funder); Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences; the Economic and Social Research Council; the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by an unrestricted educational grant from Pfizer. The funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies. We thank Colin Mathers (WHO, Geneva, Switzerland) for his kind assistance in providing health data, Sumi Mehta for assistance with data, and Zoe Chafe for comments.	Barnard Lucy F. Telfar, 2008, Reviews on Environmental Health, V23, P203; BARNES DF, 1993, WORLD BANK RES OBSER, V8, P119, DOI 10.1093/wbro/8.2.119; *COMM CLIM CHANG, 2008, 1 CLIM CHANG COMM 1; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; *DEP BUS INN SKILL, 2008, EN CONS UK; *DEP ENV FOOD RUR, 2009, NAT ATM EM INV UK CO; *DEP ENV FOOD RUR, 2007, AIR QUAL STRAT ENGL, V2; *DEP TRAD IND, 2005, HOM SAF NETW CARB MO; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Evans J, 2000, J EPIDEMIOL COMMUN H, V54, P677, DOI 10.1136/jech.54.9.677; Ezzati M., 2004, GLOBAL REGIONAL BURD; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Gilbertson J, 2006, SOC SCI MED, V63, P946, DOI 10.1016/j.socscimed.2006.02.021; *GOLD STAND FDN, GOLD STAND PREM QUAL; GOLDEMBERG J, 2000, WORLD ENERGY ASSESSM, pCH10; Gray A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3110; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Harrington BE, 2005, HEALTH SOC CARE COMM, V13, P259, DOI 10.1111/j.1365-2524.2005.00558.x; Howden-Chapman P, 2007, BMJ-BRIT MED J, V334, P460, DOI 10.1136/bmj.39070.573032.80; Howden-Chapman P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1411; HUTTON G, 2007, GUIDELINES CONDUCTIN; Hutton G., 2006, EVALUATION COSTS BEN; *IND I POP STUD, 2006, NAT FAM HLTH SURV; Jetter JJ, 2009, BIOMASS BIOENERG, V33, P294, DOI 10.1016/j.biombioe.2008.05.014; Kapil U, 2000, J Indian Med Assoc, V98, P559; KAPIL U, 2000, J INDIAN MED ASSOC, V98, P571; KAPIL U, 2000, J INDIAN MED ASSOC, V98, P562; Lai HK, 2004, ATMOS ENVIRON, V38, P6399, DOI 10.1016/j.atmosenv.2004.07.013; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lee Peter N, 2006, J Stroke Cerebrovasc Dis, V15, P190, DOI 10.1016/j.jstrokecerebrovasdis.2006.05.002; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Lowe JA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014012; Markandya A, 2007, LANCET, V370, P979, DOI 10.1016/S0140-6736(07)61253-7; Martinez-Donate AP, 2009, PREV MED, V48, P207, DOI 10.1016/j.ypmed.2008.12.011; MEHTA S, 2002, THESIS U CALIFORNIA; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; Metz B., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1017/CBO9780511546013; Millman A, 2008, PEDIATRICS, V122, P620, DOI 10.1542/peds.2007-3143; *MIN INF BROADC GO, 2005, R GANDH GRAM VID YOJ; Mishra V, 2007, INT J EPIDEMIOL, V36, P117, DOI 10.1093/ije/dyl234; Monastersky R, 2009, NATURE, V458, P1091, DOI 10.1038/4581091a; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; Oreszczyn T, 2006, INDOOR BUILT ENVIRON, V15, P125, DOI 10.1177/1420326X06063051; ORESZCZYN T, 2000, CUTTING COST COLD AF, P122; PANDEY MR, 1989, LANCET, V1, P427; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Peat JK, 1998, ALLERGY, V53, P120, DOI 10.1111/j.1398-9995.1998.tb03859.x; Perera FP, 2008, ENVIRON HEALTH PERSP, V116, P987, DOI 10.1289/ehp.11173; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Qian ZM, 2004, J EXPO ANAL ENV EPID, V14, pS78, DOI 10.1038/sj.jea.7500362; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Ramanathan V, 2009, ATMOS ENVIRON, V43, P37, DOI 10.1016/j.atmosenv.2008.09.063; Simoni M, 2005, OCCUP ENVIRON MED, V62, P616, DOI 10.1136/oem.2004.018291; Sinton JE, 2004, ENERGY SUSTAIN DEV, V8, P33, DOI [10.1016/S0973-0826(08)60465-2, DOI 10.1016/S0973-0826(08)60465-2]; SMITH K, 2004, COMP QUANTIFICATION, V2, P143; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Smith KR, 2010, J EXPO SCI ENV EPID, V20, P406, DOI 10.1038/jes.2009.30; SMITH KR, 1993, WORLD DEV, V21, P941, DOI 10.1016/0305-750X(93)90053-C; Smith KR, 2000, ANNU REV ENERG ENV, V25, P741, DOI 10.1146/annurev.energy.25.1.741; SMITH KR, 1995, ENERGY SUSTAIN DEV, V1, P23; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Thun M, 1999, ENVIRON HEALTH PERSP, V107, P841, DOI 10.2307/3434563; *US EN INF ADM, DAT TABL H 1CO2 WORL; Walker JJ, 2006, EUR J PUBLIC HEALTH, V16, P463, DOI 10.1093/eurpub/cki186; *WARM FRONT STUD G, 2004, HLTH IMP ENGL HOM EN; *WHO, DIS INJ REG EST 2004; *WHO, 2009, WHO GUID IND AIR DAM; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; Wilkinson P, 2001, COLD COMFORT SOCIAL; Wilkinson P, 2007, LANCET, V370, P1175, DOI 10.1016/S0140-6736(07)61255-0; World Health Organization, 2006, WHO HOUS EN DAT; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479	74	257	259	1	129	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1917	1929		10.1016/S0140-6736(09)61713-X	http://dx.doi.org/10.1016/S0140-6736(09)61713-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531EQ	19942273				2022-12-24	WOS:000272646900025
J	Woodcock, J; Edwards, P; Tonne, C; Armstrong, BG; Ashiru, O; Banister, D; Beevers, S; Chalabi, Z; Chowdhury, Z; Cohen, A; Franco, OH; Haines, A; Hickman, R; Lindsay, G; Mittal, I; Mohan, D; Tiwari, G; Woodward, A; Roberts, I				Woodcock, James; Edwards, Phil; Tonne, Cathryn; Armstrong, Ben G.; Ashiru, Olu; Banister, David; Beevers, Sean; Chalabi, Zaid; Chowdhury, Zohir; Cohen, Aaron; Franco, Oscar H.; Haines, Andy; Hickman, Robin; Lindsay, Graeme; Mittal, Ishaan; Mohan, Dinesh; Tiwari, Geetam; Woodward, Alistair; Roberts, Ian			Health and Climate Change 2 Public health benefits of strategies to reduce greenhouse-gas emissions: urban land transport	LANCET			English	Article							PHYSICAL-ACTIVITY; BREAST-CANCER; RISK; WALKING; MORTALITY; DISEASE; INJURY; METAANALYSIS; DEMENTIA; EXERCISE	We used Comparative Risk Assessment methods to estimate the health effects of alternative urban land transport scenarios for two settings-London, UK, and Delhi, India. For each setting, we compared a business-as-usual 2030 projection (without policies for reduction of greenhouse gases) with alternative scenarios-lower-carbon-emission motor vehicles, increased active travel, and a combination of the two. We developed separate models that linked transport scenarios with physical activity, air pollution, and risk of road traffic injury. in both cities, we noted that reduction in carbon dioxide emissions through an increase in active travel and less use of motor vehicles had larger health benefits per million population (7332 disability-adjusted life-years [DALYs] in London, and 12 516 in Delhi in 1 year) than from the increased use of lower-emission motor vehicles (160 DALYs in London, and 1696 in Delhi). However, combination of active travel and lower-emission motor vehicles would give the largest benefits (7439 DALYs in London, 12 995 in Delhi), notably from a reduction in the number of years of life lost from ischaemic heart disease (10-19% in London, 11-25% in Delhi). Although uncertainties remain, climate change mitigation in transport should benefit public health substantially. Policies to increase the acceptability, appeal, and safety of active urban travel, and discourage travel in private motor vehicles would provide larger health benefits than would policies that focus solely on lower-emission motor vehicles.	[Tonne, Cathryn; Armstrong, Ben G.; Chalabi, Zaid] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Ashiru, Olu] Takedo Int, London, England; [Woodcock, James; Edwards, Phil; Roberts, Ian] Dept Epidemiol & Populat Hlth, London, England; [Banister, David; Hickman, Robin] Univ Oxford, Oxford Univ Ctr, Sch Geog & Environm, Oxford, England; [Beevers, Sean] Kings Coll London, Environm Res Grp, Sch Biomed & Hlth Sci, London WC2R 2LS, England; [Chowdhury, Zohir] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Cohen, Aaron] Hlth Effects Inst, Boston, MA USA; [Franco, Oscar H.] Univ Warwick, Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Lindsay, Graeme; Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Mittal, Ishaan; Mohan, Dinesh; Tiwari, Geetam] Indian Inst Technol Delhi, Transport Res & Injury Prevent Programme, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of London; King's College London; California State University System; San Diego State University; Health Effects Institute (HEI); University of Warwick; University of Auckland; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Woodcock, J (corresponding author), Univ London London Sch Hyg & Trop Med, Nutr & Publ Hlth Res Unit, Keppel St, London WC1E 7HT, England.	james.woodcock@lshtm.ac.uk	Mohan, Dinesh/E-3475-2010; Woodcock, James/AAH-6753-2021; Tiwari, Geetam/ABH-5766-2020; Tonne, Cathryn/F-5020-2017; Franco, Óscar H/ABE-2305-2020	Mohan, Dinesh/0000-0002-3251-2946; Tonne, Cathryn/0000-0003-3919-8264; Franco, Óscar H/0000-0002-4606-4929; armstrong, benedict/0000-0003-4407-0409; Edwards, Phil/0000-0003-4431-8822; Woodcock, James/0000-0003-4769-5375; Haines, Andy/0000-0002-8053-4605; Woodward, Alistair/0000-0001-5425-6018	Wellcome Trust; Department of Health, National Institute for Health Research; Royal College of Physicians; Academy of Medical Sciences; Economic and Social Research Council; US National Institute of Environmental Health Sciences; WHO; Pfizer; MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Department of Health, National Institute for Health Research(National Institute for Health Research (NIHR)); Royal College of Physicians; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHO(World Health Organization); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project that led to this Series was funded by the Wellcome Trust (coordinating funder); Department of Health, National Institute for Health Research; the Royal College of Physicians; the Academy of Medical Sciences; the Economic and Social Research Council; the US National Institute of Environmental Health Sciences; and WHO. The Royal College of Physicians was supported by an unrestricted educational grant from Pfizer. The funders had no role in the design, analysis, or interpretation of the study. The views expressed are those of the authors and do not necessarily reflect the position of the funding bodies or the Health Effects Institute or its sponsors. We thank K Blackball and L Felix (both London School of Hygiene and Tropical Medicine, London, UK) for help with die searches; I Dowie (London School of Hygiene and Tropical Medicine) and M Joffe (imperial College, London, UK) for commenting on drafts of the report; P Wilkinson (London School of Hygiene and Tropical Medicine) for methodological advice; C Mathers (WHO, Geneva, Switzerland) for provision of data; C Fuller (Environmental Research Group, School of Biomedical and Health Sciences, King's College London, London, UK) for help with the air pollution modelling; and R West (University College London, London, UK) for advice about physical activity and smoking cessation. Slides for teaching are available for download.	Abbott RD, 2004, JAMA-J AM MED ASSOC, V292, P1447, DOI 10.1001/jama.292.12.1447; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; *AIR QUAL GROUP, 2007, AIR QUAL CLIM CHANG; Andre M, 2009, ATMOS ENVIRON, V43, P986, DOI 10.1016/j.atmosenv.2008.03.013; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; Ball K, 2009, OBESITY, V17, P66, DOI 10.1038/oby.2008.497; BANISTER D, 2009, CITIES MOBILITY CLIM; Bhalla K, 2007, RISK ANAL, V27, P125, DOI 10.1111/j.1539-6924.2006.00864.x; BULL F, 2003, COMP QUANTIFICATION; Carslaw DC, 2005, ATMOS ENVIRON, V39, P4793, DOI 10.1016/j.atmosenv.2005.06.023; *COP CIT CYCL, BIC ACC 2008; Cozens PM, 2008, URBAN POLICY RES, V26, P429, DOI 10.1080/08111140802084759; Daley A, 2008, J CLIN PSYCHOL MED S, V15, P140, DOI 10.1007/s10880-008-9105-z; *DEP HLTH, HLTH SURV ENGL 2003; *DEP TRANSP, 2003, TRANSP SOC EXCL MAK; *DEP TRANSP, 2008, TRANSP STAT GREAT BR; Edwards P, 2006, BMJ-BRIT MED J, V333, P119, DOI 10.1136/bmj.38875.757488.4F; Edwards P, 2009, INT J EPIDEMIOL, V38, P1137, DOI 10.1093/ije/dyp172; Favez JY, 2009, ATMOS ENVIRON, V43, P996, DOI 10.1016/j.atmosenv.2008.03.037; FRANCO M, 2009, CMAJ, V178, P1032; Gehl J., 1987, LIFE BUILDINGS USING, VVolume 23; Greater London Authority, 2007, ACT TOD PROT TOM MAY; GRUNDY C, BMJ IN PRESS; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Harriss DJ, 2009, COLORECTAL DIS, V11, P689, DOI 10.1111/j.1463-1318.2009.01767.x; HICKMAN R, 2008, BREAKING TREND VISIO; HICKMAN R, 2009, VISIONING BACKCASTIN; HICKMAN R, 2009, TRANSPORTATION RES R; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Kahn R., 2007, CLIMATE CHANGE 2007; KELLY F, 2009, ASSESSMENT IMPACT CO; Krzyzanowski M., 2004, COMP QUANTIFICATION, P1353; Kumar Rajesh, 2006, Indian Heart J, V58, P126; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; *MIN TRANSP PUBL W, 2009, CYCL NETH; Mohan D., 2009, ROAD SAFETY INDIA CH; Mohan Dinesh, 2008, Salud pública Méx, V50, ps93; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; *NHS, 2004, LEAST 5 WEEK EV IMP; NICAJ L, 2006, BICYCLIST FATALITIES; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; *NYC DOT, 2008, SAF STREETS NYC TRAF; Pachauri R.K, 2007, CLIMATE CHANGE 2007, P104; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x; Peden M., 2004, WORLD REPORT ROAD TR; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; ROBERTS I, 1995, BRIT MED J, V310, P91, DOI 10.1136/bmj.310.6972.91; ROBERTS I, 1995, EPIDEMIOLOGY, V6, P169, DOI 10.1097/00001648-199503000-00014; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; *STATS19, STATS 19 HELP FIL; Tehard B, 2006, CANCER EPIDEM BIOMAR, V15, P57, DOI 10.1158/1055-9965.EPI-05-0603; Tiwari G, 2002, CITIES, V19, P95, DOI 10.1016/S0264-2751(02)00004-5; TIWARI G, 1998, BICYCLE MASTER PLAN; Tonne C, 2008, OCCUP ENVIRON MED, V65, P620, DOI 10.1136/oem.2007.036533; *TRANSP LOND, 2001, LOND AR TRANSP SURV; *URB EM, SIMPL INT MOD BETT A; Ussher MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub3; *W SMITH ASS, 2008, TRAFF TRANSP POL STR; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9; World Health Organization (WHO), STEPWISE APPR SURV S; Zheng H, 2009, EUR J EPIDEMIOL, V24, P181, DOI 10.1007/s10654-009-9328-9; LONDON TRAVEL REPORT	69	682	686	9	317	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2009	374	9705					1930	1943		10.1016/S0140-6736(09)61714-1	http://dx.doi.org/10.1016/S0140-6736(09)61714-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531EQ	19942277				2022-12-24	WOS:000272646900026
J	Reich, PB				Reich, Peter B.			Elevated CO2 Reduces Losses of Plant Diversity Caused by Nitrogen Deposition	SCIENCE			English	Article							SPECIES RICHNESS; GRASSLAND RESPONSES; COMPETITION; ENRICHMENT; LIGHT; PHOTOSYNTHESIS; FERTILIZATION; PRODUCTIVITY; ECOSYSTEMS; MECHANISMS	The interactive effects of rising atmospheric carbon dioxide (CO2) concentrations and elevated nitrogen (N) deposition on plant diversity are not well understood. This is of concern because both factors are important components of global environmental change and because each might suppress diversity, with their combined effects possibly additive or synergistic. In a long-term open-air experiment, grassland assemblages planted with 16 species were grown under all combinations of ambient and elevated CO2 and ambient and elevated N. Over 10 years, elevated N reduced species richness by 16% at ambient CO2 but by just 8% at elevated CO2. This resulted from multiple effects of CO2 and N on plant traits and soil resources that altered competitive interactions among species. Elevated CO2 thus ameliorated the negative effects of N enrichment on species richness.	Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, 1530 Cleveland Ave N, St Paul, MN 55108 USA.	preich@umn.edu		Reich, Peter/0000-0003-4424-662X	U. S. Department of Energy, National Institute for Climate Change Research; NSF, Long Term Ecological Research (LTER), Biocomplexity, and Long Term Research in Environmental Biology (LTREB) programs	U. S. Department of Energy, National Institute for Climate Change Research(United States Department of Energy (DOE)); NSF, Long Term Ecological Research (LTER), Biocomplexity, and Long Term Research in Environmental Biology (LTREB) programs	Funding was provided by the U. S. Department of Energy, National Institute for Climate Change Research; and the NSF, Long Term Ecological Research (LTER), Biocomplexity, and Long Term Research in Environmental Biology (LTREB) programs. Thanks to S. Hobbie, K. Worm, J. Trost, and D. Bahauddin in particular, and to many others for their contributions to the BioCON project; and to R. Dybzinski, K. Suding, I. Woodward, and B. Medlyn for critiquing an earlier version of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Belote RT, 2004, NEW PHYTOL, V161, P827, DOI 10.1111/j.1469-8137.2004.00977.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; Davis MA, 1999, PLANT ECOL, V145, P341, DOI 10.1023/A:1009802211896; Dybzinski R, 2007, AM NAT, V170, P305, DOI 10.1086/519857; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; IPCC, 2007, CLIM CHANG 2007 PHYS; Niklaus PA, 2004, ECOL MONOGR, V74, P491, DOI 10.1890/03-4047; Novotny AM, 2007, OECOLOGIA, V151, P687, DOI 10.1007/s00442-006-0599-5; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Potvin C, 1997, ECOLOGY, V78, P666; Rajaniemi TK, 2003, J ECOL, V91, P407, DOI 10.1046/j.1365-2745.2003.00768.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stevens CJ, 2006, GLOBAL CHANGE BIOL, V12, P1823, DOI 10.1111/j.1365-2486.2006.01217.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100	25	109	124	4	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1399	1402		10.1126/science.1178820	http://dx.doi.org/10.1126/science.1178820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965757				2022-12-24	WOS:000272351100042
J	Smith, SR				Smith, Steven R.			A Look at the Low-Carbohydrate Diet	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Florida Hosp, Burnham Inst, Translat Res Inst, Orlando, FL USA	Adventist Health Services; AdventHealth	Smith, SR (corresponding author), Florida Hosp, Burnham Inst, Translat Res Inst, Orlando, FL USA.		Smith, Steven/HDM-9496-2022	Smith, Steven/0000-0002-5098-8147				FOO SY, 2009, P NATL ACAD SCI 0824; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Smith SR, 2006, J CLIN ENDOCR METAB, V91, P2506, DOI 10.1210/jc.2006-1018; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953	5	16	16	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2009	361	23					2286	2288		10.1056/NEJMcibr0908756	http://dx.doi.org/10.1056/NEJMcibr0908756			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ZM	19955530				2022-12-24	WOS:000272257100016
J	Hanada, R; Leibbrandt, A; Hanada, T; Kitaoka, S; Furuyashiki, T; Fujihara, H; Trichereau, J; Paolino, M; Qadri, F; Plehm, R; Klaere, S; Komnenovic, V; Mimata, H; Yoshimatsu, H; Takahashi, N; von Haeseler, A; Bader, M; Kilic, SS; Ueta, Y; Pifl, C; Narumiya, S; Penninger, JM				Hanada, Reiko; Leibbrandt, Andreas; Hanada, Toshikatsu; Kitaoka, Shiho; Furuyashiki, Tomoyuki; Fujihara, Hiroaki; Trichereau, Jean; Paolino, Magdalena; Qadri, Fatimunnisa; Plehm, Ralph; Klaere, Steffen; Komnenovic, Vukoslav; Mimata, Hiromitsu; Yoshimatsu, Hironobu; Takahashi, Naoyuki; von Haeseler, Arndt; Bader, Michael; Kilic, Sara Sebnem; Ueta, Yoichi; Pifl, Christian; Narumiya, Shuh; Penninger, Josef M.			Central control of fever and female body temperature by RANKL/RANK	NATURE			English	Article							OSTEOCLAST DIFFERENTIATION FACTOR; FEBRILE RESPONSE; MICE LACKING; C-FOS; RECEPTOR; INFLAMMATION; MECHANISMS; DENOSUMAB; PROTEIN; LIGAND	Receptor-activator of NF-kappa B ligand (TNFSF11, also known as RANKL, OPGL, TRANCE and ODF) and its tumour necrosis factor (TNF)-family receptor RANK are essential regulators of bone remodelling, lymph node organogenesis and formation of a lactating mammary gland(1-4). RANKL and RANK are also expressed in the central nervous system(5,6). However, the functional relevance of RANKL/RANK in the brain was entirely unknown. Here we report that RANKL and RANK have an essential role in the brain. In both mice and rats, central RANKL injections trigger severe fever. Using tissue-specific Nestin-Cre and GFAP-Cre rank(floxed) deleter mice, the function of RANK in the fever response was genetically mapped to astrocytes. Importantly, Nestin-Cre and GFAP-Cre rank(floxed) deleter mice are resistant to lipopolysaccharide-induced fever as well as fever in response to the key inflammatory cytokines IL-1 beta and TNF alpha. Mechanistically, RANKL activates brain regions involved in thermoregulation and induces fever via the COX2-PGE(2)/EP3R pathway. Moreover, female Nestin-Cre and GFAP-Cre rank(floxed) mice exhibit increased basal body temperatures, suggesting that RANKL and RANK control thermoregulation during normal female physiology. We also show that two children with RANK mutations exhibit impaired fever during pneumonia. These data identify an entirely novel and unexpected function for the key osteoclast differentiation factors RANKL/RANK in female thermoregulation and the central fever response in inflammation.	[Hanada, Reiko; Leibbrandt, Andreas; Hanada, Toshikatsu; Trichereau, Jean; Paolino, Magdalena; Komnenovic, Vukoslav; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Kitaoka, Shiho; Furuyashiki, Tomoyuki; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; [Fujihara, Hiroaki; Ueta, Yoichi] Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Kitakyushu, Fukuoka 8078555, Japan; [Qadri, Fatimunnisa; Plehm, Ralph; Bader, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Klaere, Steffen; von Haeseler, Arndt] Ctr Integrated Bioinformat, Max F Perutz Labs, A-1030 Vienna, Austria; [Mimata, Hiromitsu; Yoshimatsu, Hironobu] Oita Univ, Fac Med, Oita 8795593, Japan; [Takahashi, Naoyuki] Matsumoto Dent Univ, Inst Oral Sci, Nagano 3990781, Japan; [Kilic, Sara Sebnem] Uludag Univ, Fac Med, TR-16059 Bursa, Turkey; [Pifl, Christian] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Kyoto University; University of Occupational & Environmental Health - Japan; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Oita University; Matsumoto Dental University; Uludag University; Medical University of Vienna	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	von Haeseler, Arndt/HCI-9958-2022; Penninger, Josef M/I-6860-2013; Furuyashiki, Tomoyuki/AAG-5283-2019; Bader, Michael/K-2124-2013; Klaere, Steffen/B-4202-2013; Furuyashiki, Tomoyuki/B-8760-2014; Paolino, Magdalena/AAN-9417-2020; Kilic, Sara Sebnem/AAH-1658-2021	von Haeseler, Arndt/0000-0002-3366-4458; Penninger, Josef M/0000-0002-8194-3777; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Klaere, Steffen/0000-0002-4570-6109; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Bader, Michael/0000-0003-4780-4164; Paolino, Magdalena/0000-0001-9724-9029; Pifl, Christian/0000-0003-1456-4264; kilic, sara sebnem/0000-0001-8571-2581	UEHARA Foundation; Japan Foundation for Applied Enzymology; Austrian Ministry for Science and Research; Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU ( AustroMouse); EU Marie Curie Excellence; EU ERC	UEHARA Foundation(Uehara Memorial Foundation); Japan Foundation for Applied Enzymology; Austrian Ministry for Science and Research; Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU ( AustroMouse); EU Marie Curie Excellence(European Commission); EU ERC(European Research Council (ERC)European Commission)	We thank C. Xia, A. Muto, T. Mizoguchi, T. Katakai, T. Mitsumori, D. Sakata, T. Matsuoka, I. Williams, M. Iehara, T. Katafuchi, K. Matsuo, J. Wojciechowski, C. Theussl, T. Nakashima, T. Wada and R. Koglgruber for their assistance and all members of our laboratory for discussions. We thank E. Wagner for the c-Fos-GFP reporter mice and M. Kopf for the IL-1R alpha mutant mice. This work was in part supported by UEHARA Foundation and Japan Foundation for Applied Enzymology grants. S. K. and A. v. H. are supported by the Austrian Ministry for Science and Research (GEN-AU Bioinformatics Integration Network II) and the Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF). J. M. P. is supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU ( AustroMouse), an EU Marie Curie Excellence Grant, and an EU ERC Advanced Grant.	Blatteis CM, 2005, PROSTAG OTH LIPID M, V76, P1, DOI 10.1016/j.prostaglandins.2005.01.001; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; ISSELBACHER KJ, 1994, HARRISONS PRINCIPLES, V2, P2021; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marino S, 2000, GENE DEV, V14, P994; McDermott MF, 2007, TRENDS MOL MED, V13, P381, DOI 10.1016/j.molmed.2007.07.005; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233	22	174	179	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					505	509		10.1038/nature08596	http://dx.doi.org/10.1038/nature08596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940926				2022-12-24	WOS:000272144200044
J	Ebbing, M; Bonaa, KH; Nygard, O; Arnesen, E; Ueland, PM; Nordrehaug, JE; Rasmussen, K; Njolstad, I; Refsum, H; Nilsen, DW; Tverdal, A; Meyer, K; Vollset, SE				Ebbing, Marta; Bonaa, Kaare Harald; Nygard, Ottar; Arnesen, Egil; Ueland, Per Magne; Nordrehaug, Jan Erik; Rasmussen, Knut; Njolstad, Inger; Refsum, Helga; Nilsen, Dennis W.; Tverdal, Aage; Meyer, Klaus; Vollset, Stein Emil			Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B-12	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; MICROBIOLOGICAL ASSAY; GENETIC POLYMORPHISMS; CARDIOVASCULAR EVENTS; FOOD FORTIFICATION; COLORECTAL-CANCER; FOLATE INTAKE; METABOLISM; RISK; HOMOCYSTEINE	Context Recently, concern has been raised about the safety of folic acid, particularly in relation to cancer risk. Objective To evaluate effects of treatment with B vitamins on cancer outcomes and all-cause mortality in 2 randomized controlled trials. Design, Setting, and Participants Combined analysis and extended follow-up of participants from 2 randomized, double-blind, placebo-controlled clinical trials (Norwegian Vitamin Trial and Western Norway B Vitamin Intervention Trial). A total of 6837 patients with ischemic heart disease were treated with B vitamins or placebo between 1998 and 2005, and were followed up through December 31, 2007. Interventions Oral treatment with folic acid (0.8 mg/d) plus vitamin B-12 (0.4 mg/d) and vitamin B-6 (40 mg/d) (n=1708); folic acid (0.8 mg/d) plus vitamin B-12 (0.4 mg/d) (n=1703); vitamin B-6 alone (40 mg/d) (n=1705); or placebo (n=1721). Main Outcome Measures Cancer incidence, cancer mortality, and all-cause mortality. Results During study treatment, median serum folate concentration increased more than 6-fold among participants given folic acid. After a median 39 months of treatment and an additional 38 months of posttrial observational follow-up, 341 participants (10.0%) who received folic acid plus vitamin B-12 vs 288 participants (8.4%) who did not receive such treatment were diagnosed with cancer (hazard ratio [HR], 1.21; 95% confidence interval [CI], 1.03-1.41; P=.02). A total of 136 (4.0%) who received folic acid plus vitamin B-12 vs 100 (2.9%) who did not receive such treatment died from cancer (HR, 1.38; 95% CI, 1.07-1.79; P=.01). A total of 548 patients (16.1%) who received folic acid plus vitamin B-12 vs 473 (13.8%) who did not receive such treatment died from any cause (HR, 1.18; 95% CI, 1.04-1.33; P=.01). Results were mainly driven by increased lung cancer incidence in participants who received folic acid plus vitamin B-12. Vitamin B-6 treatment was not associated with any significant effects. Conclusion Treatment with folic acid plus vitamin B-12 was associated with increased cancer outcomes and all-cause mortality in patients with ischemic heart disease in Norway, where there is no folic acid fortification of foods. Trial Registration clinicaltrials.gov Identifier: NCT00671346 JAMA. 2009; 302(19): 2119-2126	[Ebbing, Marta; Nygard, Ottar; Nordrehaug, Jan Erik] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Bonaa, Kaare Harald; Rasmussen, Knut] Univ Hosp N Norway, Dept Heart Dis, Tromso, Norway; [Bonaa, Kaare Harald; Arnesen, Egil; Njolstad, Inger] Univ Tromso, Dept Community Med, Tromso, Norway; [Rasmussen, Knut] Univ Tromso, Dept Clin Med, Tromso, Norway; [Nygard, Ottar; Ueland, Per Magne; Nordrehaug, Jan Erik; Nilsen, Dennis W.] Univ Bergen, Inst Med, Bergen, Norway; [Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Refsum, Helga] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Nilsen, Dennis W.] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Tverdal, Aage; Vollset, Stein Emil] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Meyer, Klaus] Bevital AS, Bergen, Norway; [Vollset, Stein Emil] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway	University of Bergen; Haukeland University Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Bergen; University of Oslo; University of Oxford; Stavanger University Hospital; Norwegian Institute of Public Health (NIPH); University of Bergen	Ebbing, M (corresponding author), Haukeland Hosp, Dept Heart Dis, Jonas Liesvei 65, N-5021 Bergen, Norway.	marta.ebbing@helse-bergen.no	Njolstad, Inger/X-3784-2019; Nilsen, Dennis/AAM-4344-2020; Refsum, Helga/A-4073-2010; Ueland, Per M/C-7340-2013	Ueland, Per Magne/0000-0002-1903-0571; Tverdal, Aage/0000-0002-2909-5678	Advanced Research Program and Research Council of Norway; Norwegian Foundation for Health and Rehabilitation; Norwegian Council on Cardiovascular Disease; Norwegian Heart and Lung Patient Organization; Norwegian Red Cross; Northern Norway Regional Health Authority; Western Norway Regional Health Authority; Norwegian Ministry of Health and Care Services; University of Tromso, Tromso, Norway; University of Bergen, Bergen, Norway; Department of Heart Disease at Haukeland University Hospital, Bergen, Norway; Foundation to Promote Research Into Functional Vitamin B<INF>12</INF> Deficiency, Bergen, Norway	Advanced Research Program and Research Council of Norway(Research Council of Norway); Norwegian Foundation for Health and Rehabilitation; Norwegian Council on Cardiovascular Disease; Norwegian Heart and Lung Patient Organization; Norwegian Red Cross; Northern Norway Regional Health Authority; Western Norway Regional Health Authority; Norwegian Ministry of Health and Care Services; University of Tromso, Tromso, Norway; University of Bergen, Bergen, Norway; Department of Heart Disease at Haukeland University Hospital, Bergen, Norway; Foundation to Promote Research Into Functional Vitamin B<INF>12</INF> Deficiency, Bergen, Norway	Funding/Support: The NORVIT and WENBIT trials were funded by the Advanced Research Program and Research Council of Norway; the Norwegian Foundation for Health and Rehabilitation; The Norwegian Council on Cardiovascular Disease; the Norwegian Heart and Lung Patient Organization; the Norwegian Red Cross; the Northern Norway Regional Health Authority; the Western Norway Regional Health Authority; the Norwegian Ministry of Health and Care Services; the University of Tromso, Tromso, Norway; the University of Bergen, Bergen, Norway; Department of Heart Disease at Haukeland University Hospital, Bergen, Norway; the Foundation to Promote Research Into Functional Vitamin B<INF>12</INF> Deficiency, Bergen, Norway; by an unrestricted private donation; and by Alpharma Inc, Copenhagen, Denmark, who provided study medication. The posttrial follow-up was supported by the Norwegian Foundation for Health and Rehabilitation; Department of Heart Disease at Haukeland University Hospital, Bergen, Norway; the University of Tromso, Tromso, Norway; and by the University of Bergen, Bergen, Norway.	Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217; Bazzano LA, 2009, AM J MED SCI, V338, P48, DOI 10.1097/MAJ.0b013e3181aaefd6; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; *CANC REG NORW, 2008, CANC NORW 2007 CANC; Cho E, 2006, INT J CANCER, V118, P970, DOI 10.1002/ijc.21441; Clarke R, 2008, BRIT J NUTR, V100, P1054, DOI 10.1017/S0007114508958001; CLEVES M, 2008, COX MODEL DIAGNOSTIC, P197; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Fredriksen A, 2007, HUM MUTAT, V28, P856, DOI 10.1002/humu.20522; Hoey L, 2007, AM J CLIN NUTR, V86, P1405, DOI 10.1093/ajcn/86.5.1405; Institute of Medicine, 1998, DIET REF INT THIAM R; Kalmbach RD, 2008, AM J CLIN NUTR, V88, P763, DOI 10.1093/ajcn/88.3.763; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; LARSEN IK, 2007, CANC NORWAY 2006 CAN, pS1; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Maberly G., 2008, Morbidity and Mortality Weekly Report, V57, P8; Mariolis P., 2006, Morbidity and Mortality Weekly Report, V55, P1145; Maruti SS, 2009, AM J CLIN NUTR, V89, P624, DOI 10.3945/ajcn.2008.26568; Meyer K, 2009, CLIN CHEM, V55, P139, DOI 10.1373/clinchem.2008.115378; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Peto R, 2008, NEW ENGL J MED, V359, P1357, DOI 10.1056/NEJMsa0806603; Pfeiffer CM, 2007, AM J CLIN NUTR, V86, P718, DOI 10.1093/ajcn/86.3.718; Quinlivan EP, 2003, AM J CLIN NUTR, V77, P221, DOI 10.1093/ajcn/77.1.221; Rosenberg IH, 2005, AM J CLIN NUTR, V82, P279, DOI 10.1093/ajcn/82.2.279; Sanjoaquin MA, 2005, INT J CANCER, V113, P825, DOI 10.1002/ijc.20648; Slatore CG, 2008, AM J RESP CRIT CARE, V177, P524, DOI 10.1164/rccm.200709-1398OC; Smith AD, 2008, AM J CLIN NUTR, V87, P517; *STAT NORW, CAUS DEATHS 2007; Stevens VL, 2006, AM J EPIDEMIOL, V163, P989, DOI 10.1093/aje/kwj126; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Timbo BB, 2006, J AM DIET ASSOC, V106, P1966, DOI 10.1016/j.jada.2006.09.002; Troen AM, 2006, J NUTR, V136, P189, DOI 10.1093/jn/136.1.189; Ulrich CM, 2008, CANCER EPIDEM BIOMAR, V17, P1822, DOI 10.1158/1055-9965.EPI-07-2937; Ulrich CM, 2007, JAMA-J AM MED ASSOC, V297, P2408, DOI 10.1001/jama.297.21.2408; Wright AJA, 2007, BRIT J NUTR, V98, P667, DOI 10.1017/S0007114507777140; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555	40	274	284	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2119	2126		10.1001/jama.2009.1622	http://dx.doi.org/10.1001/jama.2009.1622			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920236				2022-12-24	WOS:000271873900021
J	Ebrahim, SH; Memish, ZA; Uyeki, TM; Khoja, TKAM; Marano, N; McNabb, SJN				Ebrahim, Shahul H.; Memish, Ziad A.; Uyeki, Timothy M.; Khoja, Tawfi K. A. M.; Marano, Nina; McNabb, Scott J. N.			Pandemic H1N1 and the 2009 Hajj	SCIENCE			English	Editorial Material							INFLUENZA-A H1N1; PNEUMONIA; PILGRIMS		[Ebrahim, Shahul H.; Uyeki, Timothy M.; Marano, Nina; McNabb, Scott J. N.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia; [Khoja, Tawfi K. A. M.] Council Gulf States, Hlth Minist Council Cooperat, Execut Board, Riyadh, Saudi Arabia	Centers for Disease Control & Prevention - USA; Ministry of Health - Saudi Arabia	Ebrahim, SH (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	Sbe2@cdc.gov	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8; Alborzi A, 2009, J TRAVEL MED, V16, P239, DOI 10.1111/j.1708-8305.2009.00301.x; ALNAJA BA, 2009, ARAB NEWS       0919; Alzeer A, 1998, J INFECTION, V36, P303, DOI 10.1016/S0163-4453(98)94315-8; [Anonymous], 2002, J ISLAMIC FIQH COUNC, V13; Arishi H, 2000, JAMA-J AM MED ASSOC, V284, P2989; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hayden EC, 2009, NATURE, V459, P756, DOI 10.1038/459756a; MAHDI W, 2009, NATIONAL ABU DH 0728; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; *MOH, KINGD SAUD AR; Neuzil Kathleen M, 2009, N Engl J Med, V361, pe59, DOI 10.1056/NEJMe0908224; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rashid H, 2008, VACCINE, V26, P4809, DOI 10.1016/j.vaccine.2008.07.001; Stone R, 2009, SCIENCE, V325, P1482, DOI 10.1126/science.325_1482; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; WHO, 2009, WHO GUID PHARM MAN P; *WHO, 2009, TECHN M REP JEDD KIN; Wilder-Smith A, 2002, LANCET, V360, P644, DOI 10.1016/S0140-6736(02)09796-9; 2009, ALJAZEERA       0723; 2009, ARAB NEWS       0811; 2009, ARAB NEWS       1007	24	63	65	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					938	940		10.1126/science.1183210	http://dx.doi.org/10.1126/science.1183210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	518SB	19933105				2022-12-24	WOS:000271712300018
J	Ren, D; Labandeira, CC; Santiago-Blay, JA; Rasnitsyn, A; Shih, C; Bashkuev, A; Logan, MAV; Hotton, CL; Dilcher, D				Ren, Dong; Labandeira, Conrad C.; Santiago-Blay, Jorge A.; Rasnitsyn, Alexandr; Shih, ChungKun; Bashkuev, Alexei; Logan, M. Amelia V.; Hotton, Carol L.; Dilcher, David			A Probable Pollination Mode Before Angiosperms: Eurasian, Long-Proboscid Scorpionflies	SCIENCE			English	Article							REPRODUCTIVE STRUCTURES; INSECT POLLINATION; POLLEN MORPHOLOGY; FOSSIL EVIDENCE; DIVERSIFICATION; BRACHYCERA; MOUTHPARTS; DIVERSITY; TABANIDAE; EVOLUTION	The head and mouthpart structures of 11 species of Eurasian scorpionflies represent three extinct and closely related families during a 62-million-year interval from the late Middle Jurassic to the late Early Cretaceous. These taxa had elongate, siphonate ( tubular) proboscides and fed on ovular secretions of extinct gymnosperms. Five potential ovulate host-plant taxa co-occur with these insects: a seed fern, conifer, ginkgoopsid, pentoxylalean, and gnetalean. The presence of scorpionfly taxa suggests that siphonate proboscides fed on gymnosperm pollination drops and likely engaged in pollination mutualisms with gymnosperms during the mid-Mesozoic, long before the similar and independent coevolution of nectar-feeding flies, moths, and beetles on angiosperms. All three scorpionfly families became extinct during the later Early Cretaceous, coincident with global gymnosperm-to-angiosperm turnover.	[Ren, Dong; Shih, ChungKun] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Labandeira, Conrad C.; Santiago-Blay, Jorge A.; Hotton, Carol L.; Dilcher, David] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Labandeira, Conrad C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Santiago-Blay, Jorge A.] Gallaudet Univ, Dept Biol, Washington, DC 20003 USA; [Rasnitsyn, Alexandr] Russian Acad Sci, Inst Paleontol, Moscow 117997, Russia; [Rasnitsyn, Alexandr] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Logan, M. Amelia V.] Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20013 USA; [Hotton, Carol L.] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Dilcher, David] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Capital Normal University; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Russian Academy of Sciences; Natural History Museum London; Smithsonian Institution; Smithsonian National Museum of Natural History; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); State University System of Florida; University of Florida	Labandeira, CC (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China.	labandec@si.edu	Rasnitsyn, Alexandr/P-2393-2015	Bashkuev, Alexey/0000-0001-7929-8759; Ren, Dong/0000-0001-8660-0901; Rasnitsyn, Alexandr/0000-0002-6350-0040	National Science Foundation of China [30430100, 40872022]; Natural Science Foundation of Beijing [5082002]; Key and PHR Program of the Beijing Municipal Commission of Education; Origin and Evolution of the Biosphere program of the Presidium of the Russian Academy of Sciences; Intramural Research Program of the National Library of Medicine	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Key and PHR Program of the Beijing Municipal Commission of Education; Origin and Evolution of the Biosphere program of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Intramural Research Program of the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This is contribution 152 of the Evolution of Terrestrial Ecosystems consortium at the National Museum of Natural History and contribution 614 of the Florida Museum of Natural History. Supported by the National Science Foundation of China ( grants 30430100 and 40872022), the Natural Science Foundation of Beijing ( grant 5082002), and the Key and PHR Program of the Beijing Municipal Commission of Education ( D. R.); the Origin and Evolution of the Biosphere program of the Presidium of the Russian Academy of Sciences ( A. B.); and the Intramural Research Program of the National Library of Medicine. We thank F. Marsh for drafting the figures, T. Lott for a presubmission review, P. Crane for comments, T. Rose for assistance on the geochemical analyses, J. Corman for collection of data, B. Wagner and R. Johnson for translations, P. Peltier for proofreading, and W. Wu for general assistance. X. Wang provided data and images for Problematospermum ovale, and D. Grimaldi of the American Museum of Natural History ( New York) made an important specimen available for study.	Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; ANDERSON JM, 2008, STRELITZIA, V20; Axsmith BJ, 2004, J PALEONTOL, V78, P402, DOI 10.1666/0022-3360(2004)078<0402:CPCFTC>2.0.CO;2; Beutel RG, 2008, J ZOOL SYST EVOL RES, V46, P346, DOI 10.1111/j.1439-0469.2008.00473.x; Beutel RG, 2009, ARTHROPOD STRUCT DEV, V38, P427, DOI 10.1016/j.asd.2009.05.002; Borrell BJ, 2006, ECOLOGY AND BIOMECHANICS, P185; BOSE MN, 1985, PHILOS T ROY SOC B, V310, P77, DOI 10.1098/rstb.1985.0100; BURGER JF, 1988, P ENTOMOL SOC WASH, V90, P12; BYERS GW, 1983, ANNU REV ENTOMOL, V28, P203, DOI 10.1146/annurev.en.28.010183.001223; CAZIER MA, 1985, B AM MUS NAT HIST, V182, P183; Chaudonneret J, 1990, PIECES BUCCALES INSE; Crepet WL, 2008, ANN MO BOT GARD, V95, P3, DOI 10.3417/2007065; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; CREPET WL, 1972, AM J BOT, V59, P1048, DOI 10.2307/2441490; DEHGAN B, 1988, AM J BOT, V75, P1501, DOI 10.2307/2444700; Friis EM, 1999, ANN MO BOT GARD, V86, P259, DOI 10.2307/2666179; Gonzalez CR, 2004, ZOOTAXA, P1; Gorelick R, 2001, BIOL J LINN SOC, V74, P407, DOI 10.1111/j.1095-8312.2001.tb01403.x; Grimaldi D, 2005, INSECT SYST EVOL, V36, P443, DOI 10.1163/187631205794761021; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi David, 2005, pi; GRINFEL'D E K, 1975, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V54, P18; HARRIS T. M., 1951, PHYTOMORPHOLOGY [DELHI], V1, P29; HARRIS T. M., 1933, NEW PHYTOLOGIST, V32, P97, DOI 10.1111/j.1469-8137.1933.tb07001.x; HARRIS TM, 1951, PHILOS T ROY SOC B, V235, P483, DOI 10.1098/rstb.1951.0006; Harris TM, 1940, ANN BOT-LONDON, V4, P713, DOI 10.1093/aob/4.4.713; Holmes P. L., 1993, FOSS REC, P809; KNIEPERT FW, 1980, OECOLOGIA, V46, P125, DOI 10.1007/BF00346976; Krassillov VA, 2007, AFR INVERTEBR, V48, P3; Krenn HW, 2005, ARTHROPOD STRUCT DEV, V34, P1, DOI 10.1016/j.asd.2004.10.002; Krenn HW, 2002, ARTHROPOD STRUCT DEV, V31, P103, DOI 10.1016/S1467-8039(02)00025-7; Kvacek J, 2000, REV PALAEOBOT PALYNO, V112, P51, DOI 10.1016/S0034-6667(00)00035-X; Labandeira CC, 1997, ANNU REV ECOL SYST, V28, P153, DOI 10.1146/annurev.ecolsys.28.1.153; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; Labandeira CC, 2007, TAXON, V56, P663, DOI 10.2307/25065853; Labandeira Conrad C., 2005, P217; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; MIDGLEY JJ, 1991, PHILOS T R SOC B, V333, P209, DOI 10.1098/rstb.1991.0069; Nepi M, 2009, ANN BOT-LONDON, V104, P205, DOI 10.1093/aob/mcp124; NOVOKSHONOV VG, 1997, EARLY EVOLUTION SCOR; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Porsch O, 1957, OSTERR BOT Z, V104, P115; Proctor M., 1996, NATURAL HIST POLLINA; Rasnitsyn A. P., 1991, T USSR ACAD SCI EART, V310, P233; Ren D, 1998, SCIENCE, V280, P85, DOI 10.1126/science.280.5360.85; SAHNI B, 1948, BOT GAZ, V110, P47, DOI 10.1086/335517; Snodgrass R. E., 1943, SMITHSONIAN MISC COLL, V104, P1; Soltis PS, 2004, AM J BOT, V91, P1614, DOI 10.3732/ajb.91.10.1614; STELLEMAN P, 1976, Tijdschrift voor Entomologie, V119, P15; Stuckenberg Brian R., 2000, Annals of the Natal Museum, V41, P181; Sun G, 2001, EARLY ANGIOSPERMS TH; Szucsich NU, 2000, ZOOMORPHOLOGY, V120, P79, DOI 10.1007/s004350000025; Tekleva MV, 2009, REV PALAEOBOT PALYNO, V156, P130, DOI 10.1016/j.revpalbo.2008.12.007; WANG X, 2009, COMMUNICATION    JUL	54	201	223	7	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					840	847		10.1126/science.1178338	http://dx.doi.org/10.1126/science.1178338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892981	Green Accepted			2022-12-24	WOS:000271468000041
J	Cagatay, T; Turcotte, M; Elowitz, MB; Garcia-Ojalvo, J; Suel, GM				Cagatay, Tolga; Turcotte, Marc; Elowitz, Michael B.; Garcia-Ojalvo, Jordi; Suel, Guerol M.			Architecture-Dependent Noise Discriminates Functionally Analogous Differentiation Circuits	CELL			English	Article							COMPETENCE TRANSCRIPTION FACTOR; SUBTILIS K-STATE; BACILLUS-SUBTILIS; FLUCTUATING ENVIRONMENTS; DESIGN PRINCIPLES; GENE-EXPRESSION; CIRCADIAN CLOCK; NETWORKS; COMK; OSCILLATOR	Gene regulatory circuits with different architectures (patterns of regulatory interactions) can generate similar dynamics. This raises the question of why a particular circuit architecture is selected to implement a given cellular process. To investigate this problem, we compared the Bacillus subtilis circuit that regulates differentiation into the competence state to an engineered circuit with an alternative architecture (SynEx) in silico and in vivo. Time-lapse microscopy measurements showed that SynEx cells generated competence dynamics similar to native cells and reconstituted the physiology of differentiation. However, architectural differences between the circuits altered the dynamic distribution of stochastic fluctuations (noise) during circuit operation. This distinction in noise causes functional differences between the circuits by selectively controlling the timing of competence episodes and response of the system to various DNA concentrations. These results reveal a tradeoff between temporal precision and physiological response range that is controlled by distinct noise characteristics of alternative circuit architectures.	[Cagatay, Tolga; Suel, Guerol M.] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Cagatay, Tolga; Turcotte, Marc; Suel, Guerol M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Elowitz, Michael B.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Garcia-Ojalvo, Jordi] Univ Politecn Cataluna, Dept Fis & Engn Nucl, E-08222 Terrassa, Spain	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; California Institute of Technology; California Institute of Technology; Universitat Politecnica de Catalunya	Suel, GM (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	gurol.suel@utsouthwestern.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520	National Institutes of Health [K25 GM071957]; Ministerio de Ciencia e Innovacion; European Commission; Welch Foundation [I-1674]; James S. McDonnell Foundation [220020141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088428, K25GM071957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Welch Foundation(The Welch Foundation); James S. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Steve Altschuler, Robin Hiesinger, Rama Ranganathan, Michael Rosen, Elliott Ross, Katherine Suel, and Lani Wu for critical reading of this manuscript and helpful discussions. We also thank Alma Alvarado of the Suel laboratory for technical assistance. The authors acknowledge the Texas Advanced Computing Center at University of Texas, Austin, for providing computing resources. M. T. is supported by National Institutes of Health grant K25 GM071957. J.G.-O. acknowledges financial support from Ministerio de Ciencia e Innovacion (Spain, project ORDEN and I3 program) and from the European Commission (project GABA). This work was supported by research grants to G. M. S. by the Welch Foundation (I-1674) and the James S. McDonnell Foundation (220020141). G. M. S. is a W. W. Caruth Jr. Scholar of Biomedical Research. This work is dedicated to the memory of Merdol and Nursxat Suel.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Dekel E, 2005, PHYS BIOL, V2, P81, DOI 10.1088/1478-3975/2/2/001; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Igoshin OA, 2007, J MOL BIOL, V369, P1333, DOI 10.1016/j.jmb.2007.04.021; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Klemm K, 2005, P NATL ACAD SCI USA, V102, P18414, DOI 10.1073/pnas.0509132102; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Ogura M, 1999, MOL MICROBIOL, V32, P799, DOI 10.1046/j.1365-2958.1999.01399.x; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Quisel JD, 2001, J BACTERIOL, V183, P6573, DOI 10.1128/JB.183.22.6573-6578.2001; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Savageau MA, 2001, CHAOS, V11, P142, DOI 10.1063/1.1349892; Smits WK, 2007, MOL MICROBIOL, V65, P103, DOI 10.1111/j.1365-2958.2007.05776.x; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Susanna KA, 2007, J BACTERIOL, V189, P4718, DOI 10.1128/JB.00281-07; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Turcotte M, 2008, P NATL ACAD SCI USA, V105, P15732, DOI 10.1073/pnas.0806349105; Turgay K, 1998, EMBO J, V17, P6730; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Wall ME, 2003, J MOL BIOL, V332, P861, DOI 10.1016/S0022-2836(03)00948-3; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	42	204	214	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					512	522		10.1016/j.cell.2009.07.046	http://dx.doi.org/10.1016/j.cell.2009.07.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19853288	Bronze			2022-12-24	WOS:000271259600016
J	Knipscheer, P; Raschle, M; Smogorzewska, A; Enoiu, M; Ho, TV; Scharer, OD; Elledge, SJ; Walter, JC				Knipscheer, Puck; Raeschle, Markus; Smogorzewska, Agata; Enoiu, Milica; Ho, The Vinh; Schaerer, Orlando D.; Elledge, Stephen J.; Walter, Johannes C.			The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair	SCIENCE			English	Article							MONOUBIQUITINATED FANCD2; S-PHASE; PROTEINS	Fanconi anemia is a human cancer predisposition syndrome caused by mutations in 13 Fanc genes. The disorder is characterized by genomic instability and cellular hypersensitivity to chemicals that generate DNA interstrand cross-links (ICLs). A central event in the activation of the Fanconi anemia pathway is the mono-ubiquitylation of the FANCI-FANCD2 complex, but how this complex confers ICL resistance remains enigmatic. Using a cell-free system, we showed that FANCI-FANCD2 is required for replication-coupled ICL repair in S phase. Removal of FANCD2 from extracts inhibits both nucleolytic incisions near the ICL and translesion DNA synthesis past the lesion. Reversal of these defects requires ubiquitylated FANCI-FANCD2. Our results show that multiple steps of the essential S-phase ICL repair mechanism fail when the Fanconi anemia pathway is compromised.	[Knipscheer, Puck; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Raeschle, Markus] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Smogorzewska, Agata; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Smogorzewska, Agata; Elledge, Stephen J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Smogorzewska, Agata] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Enoiu, Milica; Schaerer, Orlando D.] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Ho, The Vinh; Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Ho, The Vinh; Schaerer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Scharer, Orlando/B-8908-2008; Smogorzewska, Agata/B-8891-2011; Schärer, Orlando D./AAF-8613-2021	Scharer, Orlando/0000-0003-2425-2715; Walter, Johannes/0000-0002-4186-7570; Smogorzewska, Agata/0000-0001-6285-1562	NIH [GM62267]; Leukemia and Lymphoma Society [1406-07]; New York State of Science, Technology and Academic Research (NYSTAR) [C040069]; Swiss Cancer League [OCS-01413-08-2003]; Dutch Cancer Society [T32CA09216]; Burroughs Wellcome Fund; Max Planck Institute; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM062267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); New York State of Science, Technology and Academic Research (NYSTAR); Swiss Cancer League; Dutch Cancer Society(KWF Kankerbestrijding); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Max Planck Institute(Max Planck Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM62267 and Leukemia and Lymphoma Society Award 1406-07 to J. C. W.; New York State of Science, Technology and Academic Research (NYSTAR) Faculty Development Award C040069 and Swiss Cancer League grant OCS-01413-08-2003 to O. D. S.; and a Dutch Cancer Society fellowship to P. K. A. S. was supported by T32CA09216 to the Pathology Department at the Massachusetts General Hospital and by the Burroughs Wellcome Fund. S. J. E. is an investigator of the Howard Hughes Medical Institute. We thank M. Hoatlin for the Xenopus FANCD2 cDNA, K. Cimprich for phospho-Rad1 antibody, and the Walter laboratory for feedback. M. R. thanks S. Jentsch and the Max Planck Institute for generous support. The Xenopus FANCI cDNA sequence was deposited to the National Center for Biotechnology Information, NIH, database (accession no. GU144566).	Akkari YMN, 2001, MOL GENET METAB, V74, P403, DOI 10.1006/mgme.2001.3259; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Klein HL, 2009, CELL, V138, P20, DOI 10.1016/j.cell.2009.06.039; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Shen X, 2009, MOL CELL, V35, P716, DOI 10.1016/j.molcel.2009.06.034; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004	17	383	391	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1698	1701		10.1126/science.1182372	http://dx.doi.org/10.1126/science.1182372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19965384	Green Accepted			2022-12-24	WOS:000272839000054
J	Bennett, J				Bennett, Jean			Gene Therapy for Color Blindness.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Bennett, J (corresponding author), Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA.		Hassall, Mark M/J-4660-2018	Hassall, Mark M/0000-0002-6180-7954				*FED AV ADM, 2009, 2009 GUID AV MED EX, P140; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	3	10	12	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2483	2484		10.1056/NEJMcibr0908643	http://dx.doi.org/10.1056/NEJMcibr0908643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533CE	20018970				2022-12-24	WOS:000272798900016
J	Chen, DN; Pacal, M; Wenzel, P; Knoepfler, PS; Leone, G; Bremner, R				Chen, Danian; Pacal, Marek; Wenzel, Pamela; Knoepfler, Paul S.; Leone, Gustavo; Bremner, Rod			Division and apoptosis of E2f-deficient retinal progenitors	NATURE			English	Article							E2F FAMILY-MEMBERS; CELL-CYCLE; C-MYC; CHROMATIN IMMUNOPRECIPITATION; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; TARGET GENE; PROLIFERATION; P53	The activating E2f transcription factors (E2f1, E2f2 and E2f3) induce transcription and are widely viewed as essential positive cell cycle regulators. Indeed, they drive cells out of quiescence, and the 'cancer cell cycle' in Rb1 null cells is E2f-dependent(1,2). Absence of activating E2fs in flies or mammalian fibroblasts causes cell cycle arrest(3,4), but this block is alleviated by removing repressive E2f or the tumour suppressor p53, respectively(5-7). Thus, whether activating E2fs are indispensable for normal division is an area of debate(1). Activating E2fs are also well known pro-apoptotic factors, providing a defence against oncogenesis(8), yet E2f1 can limit irradiation-induced apoptosis(9,10). In flies this occurs through repression of hid (also called Wrinkled; Smac/Diablo in mammals). However, in mammals the mechanism is unclear because Smac/Diablo is induced, not repressed, by E2f1(11), and in keratinocytes survival is promoted indirectly through induction of DNA repair targets(12). Thus, a direct pro-survival function for E2f1-3 and/or its relevance beyond irradiation has not been established. To address E2f1-3 function in normal cells in vivo we focused on the mouse retina, which is a relatively simple central nervous system component that can be manipulated genetically without compromising viability and has provided considerable insight into development and cancer(2,13). Here we show that unlike fibroblasts, E2f1-3 null retinal progenitor cells or activated Muller glia can divide. We attribute this effect to functional interchangeability with Mycn. However, loss of activating E2fs caused down-regulation of the p53 deacetylase Sirt1, p53 hyperacetylation and elevated apoptosis, establishing a novel E2f-Sirt1-p53 survival axis in vivo. Thus, activating E2fs are not universally required for normal mammalian cell division, but have an unexpected pro-survival role in development.	[Chen, Danian; Pacal, Marek; Bremner, Rod] Univ Toronto, Univ Hlth Network, Toronto Western Res Inst, Dept Ophthalmol & Visual Sci, Toronto, ON M5T 2S8, Canada; [Chen, Danian; Pacal, Marek; Bremner, Rod] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5T 2S8, Canada; [Wenzel, Pamela; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; [Wenzel, Pamela; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Genet, Columbus, OH 43210 USA; [Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Dept Cell Biol, Davis, CA 95616 USA; [Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Dept Human Anat, Davis, CA 95616 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of California System; University of California Davis; University of California System; University of California Davis	Bremner, R (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Western Res Inst, Dept Ophthalmol & Visual Sci, Toronto, ON M5T 2S8, Canada.	rbremner@uhnres.utoronto.ca	Wenzel, Pamela/A-2992-2010; Wenzel, Pamela/AAJ-1944-2021; Chen, Danian/GXV-7996-2022; Bremner, Rod/I-6490-2012	Wenzel, Pamela/0000-0002-4530-015X; Bremner, Rod/0000-0001-9184-7212; Knoepfler, Paul/0000-0001-5444-334X; Chen, Danian/0000-0002-6916-2978	Canadian Institutes for Health Research [MOP-74570]; NATIONAL CANCER INSTITUTE [R01CA121275] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. van Parijs and R. Weinberg for plasmids; R. Eisenman for mice; L. Penn for advice on Myc; and M. Cayouette and J. Wrana for comments. This work was supported by a grant from the Canadian Institutes for Health Research to R. B. (MOP-74570).	Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; DeGregori J, 2006, CURR MOL MED, V6, P739; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fogal V, 2005, CELL DEATH DIFFER, V12, P369, DOI 10.1038/sj.cdd.4401562; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Livne-Bar I, 2006, P NATL ACAD SCI USA, V103, P4988, DOI 10.1073/pnas.0600083103; Lyons TE, 2006, AM J PHYSIOL-CELL PH, V290, pC189, DOI 10.1152/ajpcell.00630.2004; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Moon NS, 2005, DEV CELL, V9, P463, DOI 10.1016/j.devcel.2005.08.015; Ozono E, 2009, GENES CELLS, V14, P89, DOI 10.1111/j.1365-2443.2008.01248.x; Pacal M, 2006, CURR MOL MED, V6, P759; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Sharma N, 2006, J BIOL CHEM, V281, P36124, DOI 10.1074/jbc.M604152200; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wikonkal NM, 2003, NAT CELL BIOL, V5, P655, DOI 10.1038/ncb1001; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xie W, 2006, NUCLEIC ACIDS RES, V34, P2046, DOI 10.1093/nar/gkl150; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	46	116	122	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 17	2009	462	7275					925	U120		10.1038/nature08544	http://dx.doi.org/10.1038/nature08544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016601	Green Accepted			2022-12-24	WOS:000272795400044
J	Hyun, S; Lee, JH; Jin, H; Nam, J; Namkoong, B; Lee, G; Chung, J; Kim, VN				Hyun, Seogang; Lee, Jung Hyun; Jin, Hua; Nam, JinWu; Namkoong, Bumjin; Lee, Gina; Chung, Jongkyeong; Kim, V. Narry			Conserved MicroRNA miR-8/miR-200 and Its Target USH/FOG2 Control Growth by Regulating PI3K	CELL			English	Article							ZINC-FINGER PROTEINS; PROTHORACIC GLAND; DROSOPHILA; INSULIN; EXPRESSION; FRIEND; FOG-2; GENE; SIZE; FLIES	How body size is determined is a long-standing question in biology, yet its regulatory mechanisms remain largely unknown. Here, we find that a conserved microRNA miR-8 and its target, USH, regulate body size in Drosophila. miR-8 null flies are smaller in size and defective in insulin signaling in fat body that is the fly counterpart of liver and adipose tissue. Fat body-specific expression and clonal analyses reveal that miR-8 activates PI3K, thereby promoting fat cell growth cell-autonomously and enhancing organismal growth non-cell-autonomously. Comparative analyses identify USH and its human homolog, FOG2, as the targets of fly miR-8 and human miR-200, respectively. USH/FOG2 inhibits PI3K activity, suppressing cell growth in both flies and humans. FOG2 directly binds to p85 alpha, the regulatory subunit of PI3K, and interferes with the formation of a PI3K complex. Our study identifies two novel regulators of insulin signaling, miR-8/miR-200 and USH/FOG2, and suggests their roles in adolescent growth, aging, and cancer.	[Hyun, Seogang; Lee, Jung Hyun; Jin, Hua; Nam, JinWu; Namkoong, Bumjin; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Hyun, Seogang; Lee, Jung Hyun; Jin, Hua; Nam, JinWu; Namkoong, Bumjin; Kim, V. Narry] Seoul Natl Univ, Natl Creat Res Ctr, Seoul 151742, South Korea; [Lee, Gina; Chung, Jongkyeong] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Gina; Chung, Jongkyeong] Korea Adv Inst Sci & Technol, Natl Creat Res Ctr, Taejon 305701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Jin, Hua/AAS-9079-2020; Xie, Huangming/B-2260-2012	Jin, Hua/0000-0001-9829-0306; 	Creative Research Initiatives Programs [20090063603, R16-2001-002-01001-0]; National Research Foundation of Korea; Ministry of Education, Science and Technology of Korea; Seoul Science Fellowship	Creative Research Initiatives Programs; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul Science Fellowship	We are very grateful to Drs. Steve Cohen, Pascal Heitzler, Pat Simpson, K. VijayRaghavan, Bruce Edgar, YoungJoon Kim and Marc Haenlin for kindly sharing fly lines. We appreciate the help of Drs. Kweon Yu and Kyu-Sun Lee for immunostaining. We thank Dr. Elisa Izaurralde for the pAC5.1 luciferase vector and Dr. Seunghwan Hong for GST-p85 alpha. We are also grateful to Dr. Jeongbin Yim and his lab members for providing the equipment for fly work, Jisun Yoo for help with reporter cloning, and Dr. Walton Jones, Dr. Chirlmin Joo, Jinju Han, and David Jee for critical reading of the manuscript. This work was supported by the Creative Research Initiatives Programs (grant 20090063603 to V.N.K. and grant R16-2001-002-01001-0 to J.C.), the National Research Foundation of Korea, BK21 Research Fellowships from the Ministry of Education, Science and Technology of Korea (support to H.J.), and the Seoul Science Fellowship (support H.J.).	Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Asha H, 2003, GENETICS, V163, P203; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bielinska M, 2005, ENDOCRINOLOGY, V146, P3975, DOI 10.1210/en.2004-1643; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Clugston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL665, DOI 10.1152/ajplung.00027.2008; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Cubadda Y, 1997, GENE DEV, V11, P3083, DOI 10.1101/gad.11.22.3083; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Fossett N, 2001, TRENDS CARDIOVAS MED, V11, P185, DOI 10.1016/S1050-1738(01)00092-5; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kim SK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-411; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Smibert P, 2008, CELL CYCLE, V7, P2500, DOI 10.4161/cc.7.16.6454; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Takata K, 2004, GENETICS, V168, P855, DOI 10.1534/genetics.103.025965; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Zinke I, 1999, DEVELOPMENT, V126, P5275	54	233	256	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1096	1108		10.1016/j.cell.2009.11.020	http://dx.doi.org/10.1016/j.cell.2009.11.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005803	Bronze			2022-12-24	WOS:000272622800012
J	Le Goff, A; Artero, V; Jousselme, B; Tran, PD; Guillet, N; Metaye, R; Fihri, A; Palacin, S; Fontecave, M				Le Goff, Alan; Artero, Vincent; Jousselme, Bruno; Tran, Phong Dinh; Guillet, Nicolas; Metaye, Romain; Fihri, Aziz; Palacin, Serge; Fontecave, Marc			From Hydrogenases to Noble Metal-Free Catalytic Nanomaterials for H-2 Production and Uptake	SCIENCE			English	Article							CARBON NANOTUBES; DIAZONIUM SALTS; CRYSTAL-STRUCTURE; ONLY HYDROGENASE; REDUCTION; COMPLEXES; OXIDATION; MODELS	Interconversion of water and hydrogen in unitized regenerative fuel cells is a promising energy storage framework for smoothing out the temporal fluctuations of solar and wind power. However, replacement of presently available platinum catalysts by lower-cost and more abundant materials is a requisite for this technology to become economically viable. Here, we show that the covalent attachment of a nickel bisdiphosphine-based mimic of the active site of hydrogenase enzymes onto multiwalled carbon nanotubes results in a high-surface area cathode material with high catalytic activity under the strongly acidic conditions required in proton exchange membrane technology. Hydrogen evolves from aqueous sulfuric acid solution with very low overvoltages (20 millivolts), and the catalyst exhibits exceptional stability ( more than 100,000 turnovers). The same catalyst is also very efficient for hydrogen oxidation in this environment, exhibiting current densities similar to those observed for hydrogenase-based materials.	[Artero, Vincent; Tran, Phong Dinh; Fihri, Aziz; Fontecave, Marc] Univ Grenoble 1, Lab Chim & Biol Met, CEA, CNRS UMR 5249,Inst Rech Technol & Sci Vivant, F-38054 Grenoble 9, France; [Le Goff, Alan; Jousselme, Bruno; Metaye, Romain; Palacin, Serge] CEA, Inst Rayonnement Mat Saclay, Serv Phys & Chim Surfaces & Interfaces, Chem Surfaces & Interfaces Grp, F-91191 Gif Sur Yvette, France; [Guillet, Nicolas] CEA, Inst Laboratoire Innovat Technol Energies Nouvell, Dept Technol Hydrogene, Lab Composants Pile Combustible Electrolyse & Mod, F-38054 Grenoble 9, France; [Fontecave, Marc] Coll France, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; PSL Research University Paris; College de France	Artero, V (corresponding author), Univ Grenoble 1, Lab Chim & Biol Met, CEA, CNRS UMR 5249,Inst Rech Technol & Sci Vivant, 17 Rue Martyrs, F-38054 Grenoble 9, France.	vincent.artero@cea.fr; serge.palacin@cea.fr	le goff, alan/B-9152-2008; TRAN, Phong/F-8470-2012; Tran, Phong/GZA-8504-2022; Jousselme, Bruno/N-4522-2013; Artero, Vincent/C-6853-2008; PALACIN, Serge/H-1067-2012; Le Goff, Alan/AGZ-3449-2022; TRAN, Phong/F-8483-2012	Artero, Vincent/0000-0002-6148-8471; PALACIN, Serge/0000-0003-0738-8557; Le Goff, Alan/0000-0002-6765-5859; Guillet, Nicolas/0000-0002-6880-967X; Jousselme, Bruno/0000-0002-4964-5120	CEA; CNRS; Agence Nationale de la Recherche [PAN-H 2008]	CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the CEA (Nanosciences program, grant Grafthydro), the CNRS ("Materials" program, grant 961 "projets exploratoires: Interface Science des Materiaux/Vivant") and the Agence Nationale de la Recherche (PAN-H 2008, EnzHyd). The authors thank E. Mayousse and P.-A. Jacques for experimental contribution and V. Derycke for assistance in the SEM characterizations. The authors have filed a European patent application (EP-08 290 988.8) for the grafting procedure of catalysts presented here.	Abe T, 1998, POLYM ADVAN TECHNOL, V9, P559, DOI 10.1002/(SICI)1099-1581(199809)9:9<559::AID-PAT818>3.0.CO;2-1; Alonso-Lomillo MA, 2007, NANO LETT, V7, P1603, DOI 10.1021/nl070519u; Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s; Bashyam R, 2006, NATURE, V443, P63, DOI 10.1038/nature05118; Canaguier S, 2008, DALTON T, P315, DOI 10.1039/b713567j; COSNIER S, 1989, J CHEM SOC CHEM COMM, P1259, DOI 10.1039/c39890001259; Fontecilla-Camps JC, 2007, CHEM REV, V107, P5411, DOI 10.1021/cr078107t; Grivea S, 2007, ELECTROCHEM COMMUN, V9, P2768, DOI 10.1016/j.elecom.2007.09.004; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; Jousselme B, 2008, J ELECTROANAL CHEM, V621, P277, DOI 10.1016/j.jelechem.2008.01.026; Li ZL, 2005, J AM CHEM SOC, V127, P8950, DOI 10.1021/ja051590+; Mealli C, 2007, ANGEW CHEM INT EDIT, V46, P8942, DOI 10.1002/anie.200703413; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pinson J, 2005, CHEM SOC REV, V34, P429, DOI 10.1039/b406228k; Sgobba V, 2009, CHEM SOC REV, V38, P165, DOI 10.1039/b802652c; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Singleton ML, 2008, ANGEW CHEM INT EDIT, V47, P9492, DOI 10.1002/anie.200803939; Tard C, 2005, NATURE, V433, P610, DOI 10.1038/nature03298; Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Wilson AD, 2007, P NATL ACAD SCI USA, V104, P6951, DOI 10.1073/pnas.0608928104; Wilson AD, 2006, J AM CHEM SOC, V128, P358, DOI 10.1021/ja056442y; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243	25	736	744	8	528	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1384	1387		10.1126/science.1179773	http://dx.doi.org/10.1126/science.1179773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965754	Green Published			2022-12-24	WOS:000272351100037
J	Morran, LT; Parmenter, MD; Phillips, PC				Morran, Levi T.; Parmenter, Michelle D.; Phillips, Patrick C.			Mutation load and rapid adaptation favour outcrossing over self-fertilization	NATURE			English	Article							CAENORHABDITIS-ELEGANS; INBREEDING DEPRESSION; SEX DETERMINATION; SELECTION; ADVANTAGE; GENE; EXTINCTION; EVOLUTION; MALES	The tendency of organisms to reproduce by cross-fertilization despite numerous disadvantages relative to self-fertilization is one of the oldest puzzles in evolutionary biology. For many species, the primary obstacle to the evolution of outcrossing is the cost of production of males(1), individuals that do not directly contribute offspring and thus diminish the long-term reproductive output of a lineage. Self-fertilizing ('selfing') organisms do not incur the cost of males and therefore should possess at least a twofold numerical advantage over most outcrossing organisms(2). Two competing explanations for the widespread prevalence of outcrossing in nature despite this inherent disadvantage are the avoidance of inbreeding depression generated by selfing(3-5) and the ability of outcrossing populations to adapt more rapidly to environmental change(1,6,7). Here we show that outcrossing is favoured in populations of Caenorhabditis elegans subject to experimental evolution both under conditions of increased mutation rate and during adaptation to a novel environment. In general, fitness increased with increasing rates of outcrossing. Thus, each of the standard explanations for the maintenance of outcrossing are correct, and it is likely that outcrossing is the predominant mode of reproduction inmost species because it is favoured under ecological conditions that are ubiquitous in natural environments.	[Morran, Levi T.; Parmenter, Michelle D.; Phillips, Patrick C.] 5289 Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Phillips, PC (corresponding author), 5289 Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	pphil@uoregon.edu		Phillips, Patrick/0000-0001-7271-342X	NSF [DEB-0236180, DEB-0710386, DEB-0641066]; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007413] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We thank S. Scholz, A. Ohdera and J. Chiem for logistical help, S. Katz for providing the S. marcescens 2170 strain, and J. Thornton for use of laboratory space and equipment. We also thank B. Cresko, C. Lively, J. Thornton and the members of the Phillips and Cresko laboratories for comments and discussion pertaining to this work. Funding was provided by NSF grants DEB-0236180, DEB-0710386 and DEB-0641066, and an NIH Genetics Fellowship awarded to L. T. M. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; BARTON NH, 1995, GENETICS, V140, P821; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Chasnov JR, 2002, GENETICS, V160, P983; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; CROW JF, 1992, J HERED, V83, P169, DOI 10.1093/oxfordjournals.jhered.a111187; Cutter AD, 2005, J EVOLUTION BIOL, V18, P27, DOI 10.1111/j.1420-9101.2004.00804.x; Estes S, 2004, GENETICS, V166, P1269, DOI 10.1534/genetics.166.3.1269; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Heller J., 1979, GENET RES, V8, P269; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LIVELY CM, 1990, AM NAT, V135, P489, DOI 10.1086/285058; Loewe L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-125; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Manoel D, 2007, P ROY SOC B-BIOL SCI, V274, P417, DOI 10.1098/rspb.2006.3739; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; SCHEDL T, 1988, GENETICS, V119, P43; Schultz ST, 1997, EVOLUTION, V51, P1363, DOI [10.1111/j.1558-5646.1997.tb01459.x, 10.2307/2411188]; Sivasundar A, 2003, GENETICS, V163, P147; SMITH JM, 1978, EVOLUTION SEX; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stewart AD, 2002, GENETICS, V160, P975; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	30	150	152	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					350	352		10.1038/nature08496	http://dx.doi.org/10.1038/nature08496			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19847164	Green Accepted			2022-12-24	WOS:000271899300044
J	Nojiri, M; Koteishi, H; Nakagami, T; Kobayashi, K; Inoue, T; Yamaguchi, K; Suzuki, S				Nojiri, Masaki; Koteishi, Hiroyasu; Nakagami, Takuya; Kobayashi, Kazuo; Inoue, Tsuyoshi; Yamaguchi, Kazuya; Suzuki, Shinnichiro			Structural basis of inter-protein electron transfer for nitrite reduction in denitrification	NATURE			English	Article							X-RAY-STRUCTURE; CYTOCHROME-C; ALCALIGENES-XYLOSOXIDANS; PSEUDOMONAS-AERUGINOSA; TRANSFER COMPLEX; CRYSTAL-STRUCTURE; REDOX PROPERTIES; MOLECULAR-BASIS; COPPER; ACHROMOBACTER	Recent earth science studies have pointed out that massive acceleration of the global nitrogen cycle by anthropogenic addition of bio-available nitrogen has led to a host of environmental problems(1). Nitrous oxide (N2O) is a greenhouse gas that is an intermediate during the biological process known as denitrification(2). Copper-containing nitrite reductase (CuNIR) is a key enzyme in the process; it produces a precursor for N2O by catalysing the one-electron reduction of nitrite (NO2-) to nitric oxide (NO)(3). The reduction step is performed by an efficient electron-transfer reaction with a redox-partner protein(4-6). However, details of the mechanism during the electron-transfer reaction are still unknown. Here we show the high-resolution crystal structure of the electron-transfer complex for CuNIR with its cognate cytochrome c as the electron donor. The hydrophobic electron-transfer path is formed at the docking interface by desolvation owing to close contact between the two proteins. Structural analysis of the interface highlights an essential role for the loop region with a hydrophobic patch for protein-protein recognition; it also shows how interface construction allows the variation in atomic components to achieve diverse biological electron transfers.	[Nojiri, Masaki; Koteishi, Hiroyasu; Nakagami, Takuya; Yamaguchi, Kazuya; Suzuki, Shinnichiro] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; [Kobayashi, Kazuo] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Dept Chem Mat, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Nojiri, M (corresponding author), Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan.	nojiri@ch.wani.osaka-u.ac.jp; bic@ch.wani.osaka-u.ac.jp	Kobayashi, Kazuo/H-9279-2012; Koteishi, Hiroyasu/AAU-8752-2020	Kobayashi, Kazuo/0000-0002-5586-9112; Koteishi, Hiroyasu/0000-0001-5115-0963	Ministry of Education, Culture, Sports, Science and Technology of Japan [20750137]; Sumitomo Foundation;  [20350078]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; 	We thank A. Nakagawa, M. Suzuki, M. Yoshimura and E. Yamashita (beamline 44XU at SPring-8) for their support in the collection of X-ray data (proposal numbers 2007A6918 and 2007B6918, to M. N.). This work was supported in part byGrants-in-Aids for Scientific Research 20350078 (to S. S.) and Encouragement of Young Scientists 20750137 (to M. N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant for Basic Science Research Projects from the Sumitomo Foundation (to M. N.).	Axelrod HL, 2002, J MOL BIOL, V319, P501, DOI 10.1016/S0022-2836(02)00168-7; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Boulanger MJ, 2002, J MOL BIOL, V315, P1111, DOI 10.1006/jmbi.2001.5251; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bueno Emilio, 2008, FEMS Microbiol Lett, V279, P188, DOI 10.1111/j.1574-6968.2007.01034.x; Canters GW, 2000, FARADAY DISCUSS, V116, P205, DOI 10.1039/b003822i; COYNE MS, 1989, APPL ENVIRON MICROB, V55, P2924, DOI 10.1128/AEM.55.11.2924-2931.1989; Deligeer, 2000, B CHEM SOC JPN, V73, P1839, DOI 10.1246/bcsj.73.1839; DODD FE, 1995, BIOCHEMISTRY-US, V34, P10180, DOI 10.1021/bi00032a011; Ellis MJ, 2003, J MOL BIOL, V328, P429, DOI 10.1016/S0022-2836(03)00308-5; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ferguson Stuart J., 2004, V16, P169; FIRESTONE MK, 1980, SCIENCE, V208, P749, DOI 10.1126/science.208.4445.749; GLOCKNER AB, 1993, ARCH MICROBIOL, V160, P18; GODDEN JW, 1991, SCIENCE, V253, P438, DOI 10.1126/science.1862344; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hasegawa N, 2001, BIOCHEM BIOPH RES CO, V288, P1223, DOI 10.1006/bbrc.2001.5919; IWASAKI H, 1986, PLANT CELL PHYSIOL, V27, P733; Kataoka K, 2004, J BIOL CHEM, V279, P53374, DOI 10.1074/jbc.M410198200; Kataoka K, 2000, J BIOCHEM-TOKYO, V127, P345, DOI 10.1093/oxfordjournals.jbchem.a022613; Kukimoto M, 1996, FEBS LETT, V394, P87, DOI 10.1016/0014-5793(96)00934-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MASUKO M, 1984, J BIOCHEM, V96, P447, DOI 10.1093/oxfordjournals.jbchem.a134856; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miyashita O, 2003, BIOCHEMISTRY-US, V42, P11651, DOI 10.1021/bi0350250; Murphy LM, 2002, J MOL BIOL, V315, P859, DOI 10.1006/jmbi.2001.5253; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ONUCHIC JN, 1992, ANNU REV BIOPH BIOM, V21, P349, DOI 10.1146/annurev.biophys.21.1.349; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; SUZUKI H, 1962, J BIOCHEM-TOKYO, V52, P193, DOI 10.1093/oxfordjournals.jbchem.a127596; Suzuki S, 1997, J BIOL INORG CHEM, V2, P265, DOI 10.1007/s007750050132; Suzuki S, 2000, ACCOUNTS CHEM RES, V33, P728, DOI 10.1021/ar9900257; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vijgenboom E, 1997, MICROBIOL-SGM, V143, P2853, DOI 10.1099/00221287-143-9-2853; Vlasie MD, 2008, J MOL BIOL, V375, P1405, DOI 10.1016/j.jmb.2007.11.056; WILLIAMS PA, 1995, NAT STRUCT BIOL, V2, P975, DOI 10.1038/nsb1195-975; Yabuuchi E, 1998, MICROBIOL IMMUNOL, V42, P429, DOI 10.1111/j.1348-0421.1998.tb02306.x; Zhu ZY, 1998, BIOCHEMISTRY-US, V37, P17128, DOI 10.1021/bi9817919; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	43	80	82	5	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					117	U132		10.1038/nature08507	http://dx.doi.org/10.1038/nature08507			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890332				2022-12-24	WOS:000271419200044
J	Yanai, H; Ban, T; Wang, ZC; Choi, MK; Kawamura, T; Negishi, H; Nakasato, M; Lu, Y; Hangai, S; Koshiba, R; Savitsky, D; Ronfani, L; Akira, S; Bianchi, ME; Honda, K; Tamura, T; Kodama, T; Taniguchi, T				Yanai, Hideyuki; Ban, Tatsuma; Wang, ZhiChao; Choi, Myoung Kwon; Kawamura, Takeshi; Negishi, Hideo; Nakasato, Makoto; Lu, Yan; Hangai, Sho; Koshiba, Ryuji; Savitsky, David; Ronfani, Lorenza; Akira, Shizuo; Bianchi, Marco E.; Honda, Kenya; Tamura, Tomohiko; Kodama, Tatsuhiko; Taniguchi, Tadatsugu			HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses	NATURE			English	Article							RIG-I; CYTOSOLIC DNA; RNA; RECOGNITION; CELLS; INDUCTION; ACTIVATION; FAMILY; MEMBER	The activation of innate immune responses by nucleic acids is crucial to protective and pathological immunities and is mediated by the transmembrane Toll-like receptors (TLRs) and cytosolic receptors(1,2). However, it remains unknown whether a mechanism exists that integrates these nucleic-acid-sensing systems. Here we show that high-mobility group box (HMGB) proteins 1, 2 and 3 function as universal sentinels for nucleic acids. HMGBs bind to all immunogenic nucleic acids examined with a correlation between affinity and immunogenic potential. Hmgb1(-/-) and Hmgb2(-/-) mouse cells are defective in type-I interferon and inflammatory cytokine induction by DNA or RNA targeted to activate the cytosolic nucleic-acid-sensing receptors; cells in which the expression of all three HMGBs is suppressed show a more profound defect, accompanied by impaired activation of the transcription factors interferon regulatory factor 3 (IRF3) and nuclear factor (NF)-kappa B. The absence of HMGBs also severely impairs the activation of TLR3, TLR7 and TLR9 by their cognate nucleic acids. Our results therefore indicate a hierarchy in the nucleic-acid-mediated activation of immune responses, wherein the selective activation of nucleic-acid-sensing receptors is contingent on the more promiscuous sensing of nucleic acids by HMGBs. These findings may have implications for understanding the evolution of the innate immune system and for the treatment of immunological disorders.	[Yanai, Hideyuki; Ban, Tatsuma; Wang, ZhiChao; Choi, Myoung Kwon; Negishi, Hideo; Nakasato, Makoto; Lu, Yan; Hangai, Sho; Koshiba, Ryuji; Savitsky, David; Honda, Kenya; Tamura, Tomohiko; Taniguchi, Tadatsugu] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Yanai, Hideyuki; Ban, Tatsuma; Wang, ZhiChao; Choi, Myoung Kwon; Negishi, Hideo; Nakasato, Makoto; Lu, Yan; Hangai, Sho; Koshiba, Ryuji; Savitsky, David; Honda, Kenya; Tamura, Tomohiko; Taniguchi, Tadatsugu] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kawamura, Takeshi; Kodama, Tatsuhiko] Univ Tokyo, RCAST, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Ronfani, Lorenza; Bianchi, Marco E.] San Raffaele Univ, Fac Med, I-20132 Milan, Italy; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Vita-Salute San Raffaele University; Osaka University	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Akira, Shizuo/C-3134-2009; Honda, Kenya/N-5297-2015; Ronfani, Lorenza/AAN-7807-2020; Yanai, Hideyuki/AGK-5933-2022; Bianchi, Marco Emilio/K-3417-2018	Yanai, Hideyuki/0000-0002-0115-9000; Bianchi, Marco Emilio/0000-0002-5329-6445; Ronfani, Lorenza/0000-0002-4602-3502; Hangai, Sho/0000-0003-3657-9731	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Korea Science and Engineering Foundation; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank C. Reis e Sousa and J. Rehwinkel for 59-triphosphate RNA;, Y. Kawaguchi for HSV-1 DNA; A. Katoh and M. Kidokoro for the vaccinia virus (MO) genome for ligand stimulation; J. Vilcek, R. Medzhitov, R. Schekman, J. V. Ravetch and H. Ohno for invaluable advice; and R. Takeda, M. Shishido, Y. Nakaima and T. Oh for technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas 'Integrative Research Toward the Conquest of Cancer,' Grant-in-Aid for Scientific Research (A), and Global Center of Excellence Program 'Integrative Life Science Based on the Study of Biosignaling Mechanisms' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the Korea Science and Engineering Foundation Grant. T. B. and Z. W. are research fellows of the Japan Society for the Promotion of Science.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; CHOI MK, 2009, P NATL ACAD SCI 1001, P1, DOI DOI 10.1073/PNAS.0910983106; Grasser KD, 2007, BBA-GENE STRUCT EXPR, V1769, P346, DOI 10.1016/j.bbaexp.2006.12.004; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ronfani L, 2001, DEVELOPMENT, V128, P1265; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Vaccari T, 1998, GENOMICS, V49, P247, DOI 10.1006/geno.1998.5214; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	33	471	505	5	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					99	U110		10.1038/nature08512	http://dx.doi.org/10.1038/nature08512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890330				2022-12-24	WOS:000271419200040
J	MacLeod, A				MacLeod, Alison			NCEPOD report on acute kidney injury-must do better	LANCET			English	Editorial Material									Univ Aberdeen, Sch Med, Aberdeen AB25 2ZG, Scotland	University of Aberdeen	MacLeod, A (corresponding author), Univ Aberdeen, Sch Med, Foresterhill, Aberdeen AB25 2ZG, Scotland.	mmd175@abdn.ac.uk						Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; ANSELL D, 2008, UK RENAL REGISTRY UK; FEEHALLY J, VIEW UK NEPHROLOGY B; *KDIGO, 2008, KIDN DIS IMPR GLOB O; National Institute for Health and Clinical Excellence, 2008, EARL ID MAN CHRON KI; NICE, 2007, AC ILL PAT HOSP; NIVET H, 2002, DEMOGRAPHY FRENCH NE; Stewart J, 2009, ADDING INSULT INJURY	8	45	51	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1405	1406		10.1016/S0140-6736(09)61843-2	http://dx.doi.org/10.1016/S0140-6736(09)61843-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MZ	19854359				2022-12-24	WOS:000271255000010
J	Pachauri, RK				Pachauri, Rajendra K.			India pushes for common responsibility	NATURE			English	Editorial Material												pachauri@teri.res.in						Pathak H, 2003, FIELD CROP RES, V80, P223, DOI 10.1016/S0378-4290(02)00194-6	1	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 22	2009	461	7267					1054	1054		10.1038/4611054a	http://dx.doi.org/10.1038/4611054a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509BU	19847243	Bronze			2022-12-24	WOS:000270987600018
J	Konig, R; Stertz, S; Zhou, Y; Inoue, A; Hoffmann, HH; Bhattacharyya, S; Alamares, JG; Tscherne, DM; Ortigoza, MB; Liang, YH; Gao, QS; Andrews, SE; Bandyopadhyay, S; De Jesus, P; Tu, BP; Pache, L; Shih, C; Orth, A; Bonamy, G; Miraglia, L; Ideker, T; Garcia-Sastre, A; Young, JAT; Palese, P; Shaw, ML; Chanda, SK				Koenig, Renate; Stertz, Silke; Zhou, Yingyao; Inoue, Atsushi; Hoffmann, H. -Heinrich; Bhattacharyya, Suchita; Alamares, Judith G.; Tscherne, Donna M.; Ortigoza, Mila B.; Liang, Yuhong; Gao, Qinshan; Andrews, Shane E.; Bandyopadhyay, Sourav; De Jesus, Paul; Tu, Buu P.; Pache, Lars; Shih, Crystal; Orth, Anthony; Bonamy, Ghislain; Miraglia, Loren; Ideker, Trey; Garcia-Sastre, Adolfo; Young, John A. T.; Palese, Peter; Shaw, Megan L.; Chanda, Sumit K.			Human host factors required for influenza virus replication	NATURE			English	Article							FUNCTIONAL GENOMIC SCREEN; PROTEIN-KINASE-II; INFECTION; IDENTIFICATION; RNA	Influenza A virus is an RNA virus that encodes up to 11 proteins and this small coding capacity demands that the virus use the host cellular machinery for many aspects of its life cycle(1). Knowledge of these host cell requirements not only informs us of the molecular pathways exploited by the virus but also provides further targets that could be pursued for antiviral drug development. Here we use an integrative systems approach, based on genome-wide RNA interference screening, to identify 295 cellular cofactors required for early-stage influenza virus replication. Within this group, those involved in kinase-regulated signalling, ubiquitination and phosphatase activity are the most highly enriched, and 181 factors assemble into a highly significant host-pathogen interaction network. Moreover, 219 of the 295 factors were confirmed to be required for efficient wild-type influenza virus growth, and further analysis of a subset of genes showed 23 factors necessary for viral entry, including members of the vacuolar ATPase (vATPase) and COPI-protein families, fibroblast growth factor receptor (FGFR) proteins, and glycogen synthase kinase 3 (GSK3)-beta. Furthermore, 10 proteins were confirmed to be involved in post-entry steps of influenza virus replication. These include nuclear import components, proteases, and the calcium/calmodulin-dependent protein kinase (CaM kinase) II beta (CAMK2B). Notably, growth of swine-origin H1N1 influenza virus is also dependent on the identified host factors, and we show that small molecule inhibitors of several factors, including vATPase and CAMK2B, antagonize influenza virus replication.	[Koenig, Renate; Inoue, Atsushi; De Jesus, Paul; Pache, Lars; Shih, Crystal; Chanda, Sumit K.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Bhattacharyya, Suchita; Young, John A. T.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA; [Andrews, Shane E.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Stertz, Silke; Hoffmann, H. -Heinrich; Alamares, Judith G.; Tscherne, Donna M.; Ortigoza, Mila B.; Liang, Yuhong; Gao, Qinshan; Garcia-Sastre, Adolfo; Palese, Peter; Shaw, Megan L.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo; Palese, Peter] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Zhou, Yingyao; Tu, Buu P.; Orth, Anthony; Bonamy, Ghislain; Miraglia, Loren] Genom Inst, San Diego, CA 92121 USA; [Zhou, Yingyao; Tu, Buu P.; Orth, Anthony; Bonamy, Ghislain; Miraglia, Loren] Novartis Res Fdn, San Diego, CA 92121 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Salk Institute; Salk Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Novartis; University of California System; University of California San Diego; University of California System; University of California San Diego	Chanda, SK (corresponding author), Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	megan.shaw@mssm.edu; schanda@burnham.org	Stertz, Silke/D-5254-2015; Bhattacharyya, Suchita/V-5390-2019; König, Renate/AAB-8918-2019; Califano, Andrea/F-7239-2012	Bhattacharyya, Suchita/0000-0002-6775-630X; König, Renate/0000-0003-4882-9179; Bonamy, Ghislain/0000-0002-2826-5225; Palese, Peter/0000-0002-0337-5823; Ideker, Trey/0000-0002-1708-8454; Stertz, Silke/0000-0001-9491-2892; Young, John/0000-0003-1824-2561; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Brum Ortigoza, Mila/0000-0002-4522-0184; Ortigoza, Mila/0000-0002-9428-1469; Shaw, Megan/0000-0002-1267-0891	National Institutes of Health (NIH), (Northeast Biodefense Center) [U01 AI1074539, U54 AI057158]; National Institutes of Health (NIH) [HHSN272200900032C, HHSN266200700010C, 1 PO1 AI058113, 1R21AI083673, 1F32AI081428, 1 T32 AI07647, U54 AI057159, 1S10RR09145-01]; German Research Foundation; Mount Sinai Medical Scientist Training Program [T32 GM007280]; Japan Society for the Promotion of Science; NIH-NCI [5R24 CA095823-04]; NSF [DBI-9724504]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083673, U54AI057159, U01AI074539, F32AI081428, U54AI057158, P01AI058113, T32AI007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007280] Funding Source: NIH RePORTER	National Institutes of Health (NIH), (Northeast Biodefense Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Mount Sinai Medical Scientist Training Program; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) grants U01 AI1074539, U54 AI057158 (Northeast Biodefense Center), HHSN272200900032C, HHSN266200700010C, 1 PO1 AI058113 and 1R21AI083673. S. S. is supported by a fellowship from the German Research Foundation and D. M. T. is supported by NIH fellowship 1F32AI081428. M.B.O. is supported by NIH training grant 1 T32 AI07647 and Mount Sinai Medical Scientist Training Program T32 GM007280. A. I. is supported by a Japan Society for the Promotion of Science Fellowship. The small molecule screen was performed at the National Screening Laboratory for the Regional Centers of Excellence in Biodefense (NSRB), Harvard Medical School, Boston and was supported by NIH grant U54 AI057159. Confocal laser scanning microscopy was performed at the MSSM-Microscopy Shared Resource Facility, supported with funding from NIH-NCI shared resources grant (5R24 CA095823-04), NSF Major Research Instrumentation grant (DBI-9724504) and NIH shared instrumentation grant (1S10RR09145-01). We thank R. Fouchier for providing influenza A/Netherlands/602/2009 (H1N1) virus.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Layne SP, 2009, SCIENCE, V323, P1560, DOI 10.1126/science.323.5921.1560; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Sui BQ, 2009, VIROLOGY, V387, P473, DOI 10.1016/j.virol.2009.02.046; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; TSCHERNE DM, 2009, J VIROL METHODS 1029, DOI DOI 10.1016/J.JVIROMET; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; WHITNEY JA, 1995, CELL, V83, P703; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	29	619	655	2	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					813	817		10.1038/nature08699	http://dx.doi.org/10.1038/nature08699			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20027183	Green Accepted, Green Submitted			2022-12-24	WOS:000274394300041
J	Pleasance, ED; Stephens, PJ; O'Meara, S; McBride, DJ; Meynert, A; Jones, D; Lin, ML; Beare, D; Lau, KW; Greenman, C; Varela, I; Nik-Zainal, S; Davies, HR; Ordonez, GR; Mudie, LJ; Latimer, C; Edkins, S; Stebbings, L; Chen, LN; Jia, MM; Leroy, C; Marshall, J; Menzies, A; Butler, A; Teague, JW; Mangion, J; Sun, YA; McLaughlin, SF; Peckham, HE; Tsung, EF; Costa, GL; Lee, CC; Minna, JD; Gazdar, A; Birney, E; Rhodes, MD; McKernan, KJ; Stratton, MR; Futreal, PA; Campbell, PJ				Pleasance, Erin D.; Stephens, Philip J.; O'Meara, Sarah; McBride, David J.; Meynert, Alison; Jones, David; Lin, Meng-Lay; Beare, David; Lau, King Wai; Greenman, Chris; Varela, Ignacio; Nik-Zainal, Serena; Davies, Helen R.; Ordonez, Gonzalo R.; Mudie, Laura J.; Latimer, Calli; Edkins, Sarah; Stebbings, Lucy; Chen, Lina; Jia, Mingming; Leroy, Catherine; Marshall, John; Menzies, Andrew; Butler, Adam; Teague, Jon W.; Mangion, Jonathon; Sun, Yongming A.; McLaughlin, Stephen F.; Peckham, Heather E.; Tsung, Eric F.; Costa, Gina L.; Lee, Clarence C.; Minna, John D.; Gazdar, Adi; Birney, Ewan; Rhodes, Michael D.; McKernan, Kevin J.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.			A small-cell lung cancer genome with complex signatures of tobacco exposure	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; HOLLIDAY JUNCTION RESOLVASE; SOMATIC MUTATIONS; CIGARETTE-SMOKING; P53 MUTATIONS; DNA-DAMAGE; GENE; BINDING; REPAIR; CARCINOGENESIS	Cancer is driven by mutation. Worldwide, tobacco smoking is the principal lifestyle exposure that causes cancer, exerting carcinogenicity through >60 chemicals that bind and mutate DNA. Using massively parallel sequencing technology, we sequenced a small-cell lung cancer cell line, NCI-H209, to explore the mutational burden associated with tobacco smoking. A total of 22,910 somatic substitutions were identified, including 134 in coding exons. Multiple mutation signatures testify to the cocktail of carcinogens in tobacco smoke and their proclivities for particular bases and surrounding sequence context. Effects of transcription-coupled repair and a second, more general, expression-linked repair pathway were evident. We identified a tandem duplication that duplicates exons 3-8 of CHD7 in frame, and another two lines carrying PVT1-CHD7 fusion genes, indicating that CHD7 may be recurrently rearranged in this disease. These findings illustrate the potential for next-generation sequencing to provide unprecedented insights into mutational processes, cellular repair pathways and gene networks associated with cancer.	[Pleasance, Erin D.; Stephens, Philip J.; O'Meara, Sarah; McBride, David J.; Jones, David; Lin, Meng-Lay; Beare, David; Lau, King Wai; Greenman, Chris; Varela, Ignacio; Nik-Zainal, Serena; Davies, Helen R.; Ordonez, Gonzalo R.; Mudie, Laura J.; Latimer, Calli; Edkins, Sarah; Stebbings, Lucy; Chen, Lina; Jia, Mingming; Leroy, Catherine; Marshall, John; Menzies, Andrew; Butler, Adam; Teague, Jon W.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [O'Meara, Sarah; Mangion, Jonathon] Life Technol, Warrington WA3 7QH, Cheshire, England; [Meynert, Alison; Birney, Ewan] European Bioinformat Inst, Hinxton CB10 1SD, England; [Sun, Yongming A.; Rhodes, Michael D.] Life Technol, Foster City, CA 94404 USA; [McLaughlin, Stephen F.; Peckham, Heather E.; Tsung, Eric F.; Costa, Gina L.; Lee, Clarence C.; McKernan, Kevin J.] Life Technol, Beverley, MA 01915 USA; [Minna, John D.; Gazdar, Adi] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Thermo Fisher Scientific; European Molecular Biology Laboratory (EMBL); Thermo Fisher Scientific; Thermo Fisher Scientific; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; Institute of Cancer Research - UK; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	pc8@sanger.ac.uk	Varela, Ignacio/G-1699-2016; Wang, Weili/D-1546-2011; Nik-Zainal, Serena/ABD-4437-2020; Varela, Ignacio/AAA-7680-2021	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Edkins, Sarah/0000-0003-0717-1972; Marshall, John/0000-0002-1216-5457; McKernan, Kevin/0000-0002-3908-1122; Nik-Zainal, Serena/0000-0001-5054-1727; Birney, Ewan/0000-0001-8314-8497	Wellcome Trust [077012/Z/05/Z]; Human Frontiers Science Programme; NCI [NCI P50CA70907]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontiers Science Programme(Human Frontier Science Program); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z). P.J.C. is a Kay Kendall Leukaemia Fund Intermediate Clinical Fellow. I. V. is supported by the Human Frontiers Science Programme. J. Minna. and A. G. are supported by an NCI grant (NCI P50CA70907).	Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbone F, 1997, CHEST, V112, P1474, DOI 10.1378/chest.112.6.1474; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; CARNEY DN, 1985, CANCER RES, V45, P2913; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; DALGLIESH GL, NATURE IN PRESS, DOI DOI 10.1038/NATURE08672; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Denissenko MF, 1997, P NATL ACAD SCI USA, V94, P3893, DOI 10.1073/pnas.94.8.3893; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Jackson MA, 2006, TOXICOL SCI, V90, P400, DOI 10.1093/toxsci/kfj101; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Liu YY, 2005, BIOCHEM J, V385, P519, DOI 10.1042/BJ20041151; Lubin JH, 2007, AM J EPIDEMIOL, V166, P479, DOI 10.1093/aje/kwm089; LUBIN JH, 1984, JNCI-J NATL CANCER I, V73, P383, DOI 10.1093/jnci/73.2.383; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; MORI N, 1990, ONCOGENE, V5, P1713; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Rodin SN, 2005, SEMIN CANCER BIOL, V15, P103, DOI 10.1016/j.semcancer.2004.08.005; Rozman M, 2004, GENE CHROMOSOME CANC, V40, P140, DOI 10.1002/gcc.20022; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Toh Chee-Keong, 2009, V472, P397, DOI 10.1007/978-1-60327-492-0_19; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956; ZEIDLER R, 1994, GENE CHROMOSOME CANC, V9, P282, DOI 10.1002/gcc.2870090408	43	800	908	2	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					184	U66		10.1038/nature08629	http://dx.doi.org/10.1038/nature08629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20016488	hybrid, Green Accepted, Green Submitted			2022-12-24	WOS:000273582700026
J	Hu, H; Martina, M; Jonas, P				Hu, Hua; Martina, Marco; Jonas, Peter			Dendritic Mechanisms Underlying Rapid Synaptic Activation of Fast-Spiking Hippocampal Interneurons	SCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; GATED K+ CHANNELS; ACTION-POTENTIALS; RAT HIPPOCAMPUS; IN-VIVO; FEEDFORWARD INHIBITION; SOMATOSENSORY CORTEX; RECURRENT INHIBITION; ACTIVE PROPAGATION; DENTATE GYRUS	Fast-spiking, parvalbumin-expressing basket cells (BCs) are important for feedforward and feedback inhibition. During network activity, BCs respond with short latency and high temporal precision. It is thought that the specific properties of input synapses are responsible for rapid recruitment. However, a potential contribution of active dendritic conductances has not been addressed. We combined confocal imaging and patch-clamp techniques to obtain simultaneous somatodendritic recordings from BCs. Action potentials were initiated in the BC axon and backpropagated into the dendrites with reduced amplitude and little activity dependence. These properties were explained by a high K+ to Na+ conductance ratio in BC dendrites. Computational analysis indicated that dendritic K+ channels convey unique integration properties to BCs, leading to the rapid and temporally precise activation by excitatory inputs.	[Hu, Hua; Martina, Marco; Jonas, Peter] Univ Freiburg, Inst Physiol 1, D-79108 Freiburg, Germany; [Hu, Hua] Univ Oslo, Dept Physiol, Inst Basic Med Sci, NO-0317 Oslo, Norway; [Hu, Hua] Univ Oslo, CMBN, NO-0317 Oslo, Norway; [Martina, Marco] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Jonas, Peter] Freiburg Inst Adv Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Oslo; University of Oslo; Northwestern University; Feinberg School of Medicine	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol 1, Engesserstr 4, D-79108 Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de		martina, marco/0000-0002-9648-2918; Jonas, Peter/0000-0001-5001-4804; Hu, Hua/0000-0001-8187-4735				ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1981, BRAIN RES, V230, P346, DOI 10.1016/0006-8993(81)90413-3; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Du J, 1996, J NEUROSCI, V16, P506; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Goldberg EM, 2005, J NEUROSCI, V25, P5230, DOI 10.1523/JNEUROSCI.0722-05.2005; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kaiser KMM, 2001, J PHYSIOL-LONDON, V535, P17, DOI 10.1111/j.1469-7793.2001.t01-1-00017.x; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Martina M, 1998, J NEUROSCI, V18, P8111; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; NORENBERG A, 2010, P NATL ACAD SCI USA, DOI DOI 10.1013/PNAS.0910716107; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SIK A, 1995, J NEUROSCI, V15, P6651; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Stuart G, 2007, DENDRITES; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0	45	133	133	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					52	58		10.1126/science.1177876	http://dx.doi.org/10.1126/science.1177876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	19965717				2022-12-24	WOS:000273395400027
J	Sawaya, GF				Sawaya, George F.			Cervical-Cancer Screening - New Guidelines and the Balance between Benefits and Harms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sawaya, George F.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Sawaya, George F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Sawaya, GF (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.							*AM COLL OBST GYN, 2009, OBSTET GYNECOL, V114, P1409; American College of Obstetricians and Gynecologist, 2008, OBSTET GYNECOL, V112, P1419, DOI DOI 10.1097/AOG.0B013E318192497C; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Sawaya GF, 2007, ANN INTERN MED, V147, P871, DOI 10.7326/0003-4819-147-12-200712180-00007; Sawaya GF, 2003, NEW ENGL J MED, V349, P1501, DOI 10.1056/NEJMoa035419	5	28	28	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2503	2505		10.1056/NEJMp0911380	http://dx.doi.org/10.1056/NEJMp0911380			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	19940285				2022-12-24	WOS:000273003700004
J	de Souza, JA; Bines, J				de Souza, Jonas A.; Bines, Jose			The Global Breast Cancer Disparity Strategies for Bridging the Gap	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENDOCRINE THERAPY; LAPATINIB		[Bines, Jose] INCA, Inst Nacl Canc, BR-20560200 Rio De Janeiro, Brazil; [de Souza, Jonas A.] Univ Chicago, Med Ctr, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [de Souza, Jonas A.] Univ Chicago, Global Hlth Initiat, Chicago, IL 60637 USA	National Cancer Institute (Inca); University of Chicago; University of Chicago Medical Center; University of Chicago	Bines, J (corresponding author), INCA, Inst Nacl Canc, Rua Visconde de Santa Isabel 274, BR-20560200 Rio De Janeiro, Brazil.	jose_bines@yahoo.com						Bines J, 2008, CANCER-AM CANCER SOC, V113, P2353, DOI 10.1002/cncr.23837; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Eniu A, 2008, CANCER-AM CANCER SOC, V113, P2269, DOI 10.1002/cncr.23843; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Gronwald J, 2009, J CLIN ONCOL, V27; OLOPADE OL, 2009, ASCO ED BOOK, P681; Phillips KA, 2009, CANCER-AM CANCER SOC, V115, P5166, DOI 10.1002/cncr.24574; Punglia RS, 2008, JNCI-J NATL CANCER I, V100, P642, DOI 10.1093/jnci/djn100; Ratain MJ, 2007, J CLIN ONCOL, V25, P3397, DOI 10.1200/JCO.2007.12.0758	10	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2589	2590		10.1001/jama.2009.1857	http://dx.doi.org/10.1001/jama.2009.1857			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009060				2022-12-24	WOS:000272737200028
J	Doshi, P				Doshi, Peter			Neuraminidase inhibitors-the story behind the Cochrane review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; ACUTE INFLUENZA; OSELTAMIVIR; RECOMMENDATIONS; PREVENTION; EFFICACY; SAFETY		MIT, Program Hist Anthropol Sci Technol & Soc, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Doshi, P (corresponding author), MIT, Program Hist Anthropol Sci Technol & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pnd@mit.edu						Abraham J, 1996, SCI POLITICS PHARM I; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2005, HHS PAND INFL PLAN; BROWNLEE S, 2009, ATLANTIC         NOV; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; *CHUG PHARM CO, 2009, PROD INF; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; *HOFFM LA ROCH, 2008, PROD LAB; HOFFMANLAROCHE, 2005, INVESTOR UPDATE TAMI; HUSEREAU DR, 2002, 7 CCOHTA; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; KELLY HA, 2010, MED J AUSTRALIA, V192, P1; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; *ROCH LAB, IMP INFL; *ROCH PROD PTY LTD, 2009, PROD INF; *ROCH REG, 2009, PROD INF; Smith J, 2006, LANCET, V367, P1571, DOI 10.1016/S0140-6736(06)68683-2; STURCKE J, 2009, GUARDIAN        0816; Tappenden P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13110; Toovey S, 2008, DRUG SAFETY, V31, P1097, DOI 10.2165/0002018-200831120-00006; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350	26	61	63	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2009	339								b5164	10.1136/bmj.b5164	http://dx.doi.org/10.1136/bmj.b5164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VE	19995813	Green Submitted			2022-12-24	WOS:000272697300005
J	Cheer, K; Pearce, S				Cheer, Kelly; Pearce, Sushmita			Lesson of the Week Osteoarticular infection of the symphysis pubis and sacroiliac joints in active young sportsmen	BRITISH MEDICAL JOURNAL			English	Article							OSTEITIS PUBIS; OSTEOMYELITIS		[Cheer, Kelly; Pearce, Sushmita] Royal Albert Edward Infirm, Ctr Diabet, Wrightington Wigan & Leigh NHS Trust, Wigan WN1 2NN, England		Cheer, K (corresponding author), Royal Albert Edward Infirm, Ctr Diabet, Wrightington Wigan & Leigh NHS Trust, Wigan WN1 2NN, England.	kellycheer@doctors.net.uk						Bindal M, 2007, ARCH PHYS MED REHAB, V88, P1357, DOI 10.1016/j.apmr.2007.07.004; BOUZA E, 1978, Urology, V12, P663, DOI 10.1016/0090-4295(78)90428-4; Calza L, 2002, J MED MICROBIOL, V51, P620, DOI 10.1099/0022-1317-51-7-620; CHOI H, 2008, BR J SPORTS MED 0930; FRICKER PA, 1991, SPORTS MED, V12, P266, DOI 10.2165/00007256-199112040-00005; HAKEEM MJM, 2006, SCOT MED J, V51, P57; Meirovitz A, 2004, J BONE JOINT SURG AM, V86A, P1057, DOI 10.2106/00004623-200405000-00027; Pauli S, 2002, BRIT J SPORT MED, V36, P71, DOI 10.1136/bjsm.36.1.71; PHARM DV, 2007, PERMANENTE J, V11; SHANAHAN MDG, 1985, J BONE JOINT SURG BR, V67, P605, DOI 10.1302/0301-620X.67B4.4030859	10	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2009	339								b5019	10.1136/bmj.b5019	http://dx.doi.org/10.1136/bmj.b5019			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VD	19969603				2022-12-24	WOS:000272697200004
J	Sarewitz, D				Sarewitz, Daniel			A tale of two sciences	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com							0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 3	2009	462	7273					566	566		10.1038/462566a	http://dx.doi.org/10.1038/462566a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	526HH	19956236	Bronze			2022-12-24	WOS:000272277900013
J	Weinberg, Z; Perreault, J; Meyer, MM; Breaker, RR				Weinberg, Zasha; Perreault, Jonathan; Meyer, Michelle M.; Breaker, Ronald R.			Exceptional structured noncoding RNAs revealed by bacterial metagenome analysis	NATURE			English	Article							COMPARATIVE GENOMICS; SECONDARY STRUCTURE; SEQUENCE-ANALYSIS; 6S RNA; IDENTIFICATION; REGULATOR; DATABASE; RIBOSWITCHES; EXPRESSION; DIVERSITY	Estimates of the total number of bacterial species(1-3) indicate that existing DNA sequence databases carry only a tiny fraction of the total amount of DNA sequence space represented by this division of life. Indeed, environmental DNA samples have been shown to encode many previously unknown classes of proteins(4) and RNAs5. Bioinformatics searches(6-10) of genomic DNA from bacteria commonly identify new noncoding RNAs (ncRNAs)(10-12) such as riboswitches(13,14). In rare instances, RNAs that exhibit more extensive sequence and structural conservation across a wide range of bacteria are encountered(15,16). Given that large structured RNAs are known to carry out complex biochemical functions such as protein synthesis and RNA processing reactions, identifying more RNAs of great size and intricate structure is likely to reveal additional biochemical functions that can be achieved by RNA. We applied an updated computational pipeline(17) to discover ncRNAs that rival the known large ribozymes in size and structural complexity or that are among the most abundant RNAs in bacteria that encode them. These RNAs would have been difficult or impossible to detect without examining environmental DNA sequences, indicating that numerous RNAs with extraordinary size, structural complexity, or other exceptional characteristics remain to be discovered in unexplored sequence space.	[Weinberg, Zasha; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Weinberg, Zasha; Perreault, Jonathan; Meyer, Michelle M.; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, Box 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Perreault, Jonathan/0000-0003-4726-6319; Breaker, Ronald/0000-0002-2165-536X; Weinberg, Zasha/0000-0002-6681-3624	NIH [RR19895-02]; Canadian Institutes of Health Research and National Institutes of Health; Howard Hughes Medical Institute Investigator; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778, F32GM079974] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research and National Institutes of Health(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute Investigator(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Carriero and R. Bjornson for assisting our use of the Yale Life Sciences High Performance Computing Center (NIH grant RR19895-02), T. Gruczka for advice and assistance in ocean water collection, J. Yang for assistance with the analysis of the dct-1 motif, D. Rodrigues for E. sibiricum, D. Bryant for A. maxima genomic DNA and P. O'Donoghue, M. Hammond, N. Sudarsan, S. Li, J. Barrick, Z. Yao, W. L. Ruzzo and E. Tseng for advice. J. P. and M. M. M. were supported by postdoctoral fellowships from the Canadian Institutes of Health Research and National Institutes of Health, respectively. R. R. B. is a Howard Hughes Medical Institute Investigator.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; [Anonymous], BACTERIOPHAGES METHO; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Dai LX, 2002, NUCLEIC ACIDS RES, V30, P1091, DOI 10.1093/nar/30.5.1091; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; HAAS ES, 1994, P NATL ACAD SCI USA, V91, P2527, DOI 10.1073/pnas.91.7.2527; Klein RJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-44; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Liu CN, 2005, NUCLEIC ACIDS RES, V33, pD112, DOI 10.1093/nar/gki041; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; PACE NR, 1999, RNA WORLD, P113; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Puerta-Fernandez E, 2006, P NATL ACAD SCI USA, V103, P19490, DOI 10.1073/pnas.0607493103; REGULSKI EE, 2008, METHODS MOL BIOL, V419; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2009, CURR OPIN STRUC BIOL, V19, P260, DOI 10.1016/j.sbi.2009.04.002; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tseng Huei-Hun, 2009, Journal of Bioinformatics and Computational Biology, V7, P373, DOI 10.1142/S0219720009004126; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Weinberg Z, 2006, BIOINFORMATICS, V22, P35, DOI 10.1093/bioinformatics/bti743; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; WU TF, 1989, NUCLEIC ACIDS RES, V17, P3501, DOI 10.1093/nar/17.9.3501; YAO Z, 2008, THESIS U WASHINGTON; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zwieb C, 1999, NUCLEIC ACIDS RES, V27, P2063, DOI 10.1093/nar/27.10.2063	62	75	76	2	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					656	U131		10.1038/nature08586	http://dx.doi.org/10.1038/nature08586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956260	Green Accepted			2022-12-24	WOS:000272277900042
J	Hidalgo, M; Maitra, A				Hidalgo, Manuel; Maitra, Anirban			The Hedgehog Pathway and Pancreatic Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INHIBITION		[Hidalgo, Manuel] Ctr Nacl Invest Oncol, Clin Res Program, Madrid, Spain; [Maitra, Anirban] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA	Johns Hopkins University	Hidalgo, M (corresponding author), Ctr Nacl Invest Oncol, Clin Res Program, Madrid, Spain.		HIDALGO, MANUEL/I-4995-2015	HIDALGO, MANUEL/0000-0002-3765-3318				Feldmann G, 2008, GUT, V57, P1420, DOI 10.1136/gut.2007.148189; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360	5	84	86	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2094	2096		10.1056/NEJMcibr0905857	http://dx.doi.org/10.1056/NEJMcibr0905857			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19923581				2022-12-24	WOS:000271898600017
J	Kilpatrick, ES; Bloomgarden, ZT; Zimmet, PZ				Kilpatrick, Eric S.; Bloomgarden, Zachary T.; Zimmet, Paul Z.			Is haemoglobin A(1c) a step forward for diagnosing diabetes?	BRITISH MEDICAL JOURNAL			English	Editorial Material							EXPERT COMMITTEE; IRON-DEFICIENCY; A1C; CLASSIFICATION; MELLITUS; GLUCOSE		[Kilpatrick, Eric S.] Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Kilpatrick, Eric S.] Hull York Med Sch, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bloomgarden, Zachary T.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Zimmet, Paul Z.] Baker IDI Heart & Diabet Inst, Caulfield 3162, Australia	University of Hull; University of Hull; University of York - UK; Icahn School of Medicine at Mount Sinai; Baker Heart and Diabetes Institute	Kilpatrick, ES (corresponding author), Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England.	eric.kilpatrick@hey.nhs.uk	Zimmet, Paul/O-8486-2019; Bloomgarden, Zachary/AAF-5163-2020	Zimmet, Paul/0000-0003-0627-0776; 				Bloomgarden ZT, 2008, DIABETOLOGIA, V51, P1111, DOI 10.1007/s00125-008-1027-7; Coban E, 2004, ACTA HAEMATOL-BASEL, V112, P126, DOI 10.1159/000079722; El-Agouza I, 2002, CLIN LAB HAEMATOL, V24, P285, DOI 10.1046/j.1365-2257.2002.00464.x; Gallagher EJ, 2009, J DIABETES, V1, P9, DOI 10.1111/j.1753-0407.2009.00009.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Miedema K, 2004, DIABETOLOGIA, V47, P1143, DOI 10.1007/s00125-004-1453-0; *NAT DIAB INF CLEA, SICKL CELL TRAIT OTH; *NAT GLYC STAND PR, 2009, HBA1C METH HEM VAR H; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Roberts WL, 2002, CLIN CHEM, V48, P383; Sabanayagam C, 2009, DIABETOLOGIA, V52, P1279, DOI 10.1007/s00125-009-1360-5; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; W.H. Organization, 1999, DEFINITION DIAGNOSIS	17	67	67	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2009	339								b4432	10.1136/bmj.b4432	http://dx.doi.org/10.1136/bmj.b4432			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520HL	19903702				2022-12-24	WOS:000271833800003
J	Eldakar, OT; Dlugos, MJ; Pepper, JW; Wilson, DS				Eldakar, Omar Tonsi; Dlugos, Michael J.; Pepper, John W.; Wilson, David Sloan			Population Structure Mediates Sexual Conflict in Water Striders	SCIENCE			English	Article							TRAGEDY; COMMONS		[Eldakar, Omar Tonsi; Pepper, John W.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Eldakar, Omar Tonsi; Dlugos, Michael J.; Wilson, David Sloan] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; [Pepper, John W.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Arizona	Eldakar, OT (corresponding author), Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA.		Pepper, John W/O-1662-2013; Pepper, John/W-5578-2019	Pepper, John W/0000-0001-9888-0437; Pepper, John/0000-0001-9888-0437; Eldakar, Omar/0000-0002-4807-4979	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 K12 GM000708, K12 GM000708] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNQVIST G, 1997, SOCIAL COMPETITION C, V1, P146; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Eldakar OT, 2009, BEHAV ECOL SOCIOBIOL, V64, P25, DOI 10.1007/s00265-009-0814-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; KRUPA JJ, 1993, BEHAV ECOL SOCIOBIOL, V33, P107, DOI 10.1007/BF00171662; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rankin DJ, 2005, OIKOS, V111, P616; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051	8	61	61	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					816	816		10.1126/science.1180183	http://dx.doi.org/10.1126/science.1180183			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892974				2022-12-24	WOS:000271468000032
J	Gottlieb, CA; Maenner, MJ; Cappa, C; Durkin, MS				Gottlieb, Carissa A.; Maenner, Matthew J.; Cappa, Claudia; Durkin, Maureen S.			Child disability screening, nutrition, and early learning in 18 countries with low and middle incomes: data from the third round of UNICEF's Multiple Indicator Cluster Survey (2005-06)	LANCET			English	Article							10 QUESTIONS SCREEN; SEVERELY MALNOURISHED CHILDREN; PSYCHOSOCIAL STIMULATION; RISK-FACTORS; INTELLECTUAL DISABILITY; VALIDITY; SUPPLEMENTATION; RELIABILITY; IMPAIRMENT; PREVALENCE	Background Child disability is an emerging global health priority. To address the need for internationally comparable information about the frequency and situation of children with disabilities, UNICEF has recommended that countries include the Ten Questions screen for disability in the Multiple indicator Cluster Survey (MICS) programme. We examined child disability screening and its association with nutrition and early learning in countries with low and middle incomes. Methods Cross-sectional data for the percentage of children screening positive for or at risk of disability were obtained for 191199 children aged 2-9 years in 18 countries participating in the third round of MICS in 2005-06. Screening results were descriptively analysed according to sociodemographic, nutritional, early-learning, and schooling variables. We constructed a weighted analysis to account for the sampling design in every country and tested for differences within countries using chi(2) analyses. Findings A median 23% (range 3-48) of children aged 2-9 years screened positive for disability in the 18 participating countries. For children aged 2-4 years, screening positive for disability was significantly more likely in children who were not breastfed versus those who were (median 36% [9-56] vs 26% [4-51]) in eight of 18 countries, in children who had not received vitamin A supplementation versus those who had (36% [7-53] vs 29% [4-50]) in five of ten countries assessed, in children who met criteria for stunting (26% [6-54]) or being underweight (36% [3-61]) versus those who did not (25% [3-42] and 26% [4-43], respectively) in five of 15 countries assessed for stunting and in seven of 15 countries assessed for being underweight, and in those who participated in few early-learning activities versus others (31% [7-54] vs 24% [4-51]) in eight of 18 countries. Children aged 6-9 years who did not attend school screened positive for disability more often than did children attending school (29% [2-83] vs 22% [3-47]) in eight of 18 countries. Interpretation Our results draw attention to the need for improved global capacity to assess and provide services for children at risk of disability. Further research is needed in countries with low and middle incomes to understand and address the role of nutritional deficiencies and restricted access to learning opportunities as both potential antecedents of childhood disability and consequences of discrimination.	[Gottlieb, Carissa A.; Maenner, Matthew J.; Durkin, Maureen S.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53726 USA; [Durkin, Maureen S.] Univ Wisconsin, Dept Pediat, Madison, WI 53726 USA; [Maenner, Matthew J.; Durkin, Maureen S.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53726 USA; [Maenner, Matthew J.; Durkin, Maureen S.] Univ Wisconsin, Waisman Ctr, Madison, WI 53726 USA; [Cappa, Claudia] UNICEF, Div Policy & Practice, Stat & Monitoring Sect, New York, NY USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; UNICEF	Durkin, MS (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, 789 WARF,610 Walnut St, Madison, WI 53726 USA.	mdurkin@wisc.edu	Durkin, Maureen/B-7834-2015		UNICEF; Department of Population Health Sciences, University of Wisconsin-Madison, USA	UNICEF; Department of Population Health Sciences, University of Wisconsin-Madison, USA	We thank people who participated in MICS3, including the staff who assisted with data collection, the survey respondents, and the statisticians; and other colleagues at UNICEF and the Department of Population Health Sciences, University of Wisconsin-Madison, USA, for their valuable insights and important contributions to the idea, design, initiation, and implementation of the project. This research was funded by UNICEF and the Department of Population Health Sciences, University of Wisconsin-Madison, USA.	Belmont L., 1986, SCI TECHNOLOGY MENTA, P389; Christianson AL, 2002, J INTELL DISABIL RES, V46, P179, DOI 10.1046/j.1365-2788.2002.00390.x; Durkin M, 2002, MENT RETARD DEV D R, V8, P206, DOI 10.1002/mrdd.10039; DURKIN M, 1991, INT J MENT HEALTH, V20, P47, DOI 10.1080/00207411.1991.11449195; Durkin M, 2008, MONITORING CHILD DIS; DURKIN MS, 1994, EPIDEMIOLOGY, V5, P283, DOI 10.1097/00001648-199405000-00005; DURKIN MS, 1995, J CLIN EPIDEMIOL, V48, P657, DOI 10.1016/0895-4356(94)00163-K; Durkin MS, 2000, AM J EPIDEMIOL, V152, P1024, DOI 10.1093/aje/152.11.1024; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GRANTHAMMCGREGOR S, 1994, CHILD DEV, V65, P428; GRANTHAMMCGREGOR S, 1987, PEDIATRICS, V79, P247; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Hamadani JD, 2006, J NUTR, V136, P2645, DOI 10.1093/jn/136.10.2645; *I MED COMM NERV S, 2001, NEUR PSYCH DEV DIS M, P113; Khan NZ, 1998, DEV MED CHILD NEUROL, V40, P749, DOI 10.1111/j.1469-8749.1998.tb12343.x; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; Mung'ala-Odera V, 2006, INT J EPIDEMIOL, V35, P683, DOI 10.1093/ije/dyl023; Mung'ala-Odera V, 2004, NEUROEPIDEMIOLOGY, V23, P67, DOI 10.1159/000073977; *NAT STAT OFF THAI, THAIL MULT IND CLUST; Singhi P, 2007, J TROP PEDIATRICS, V53, P383, DOI 10.1093/tropej/fmm047; Thorburn M, 1992, Int J Rehabil Res, V15, P115, DOI 10.1097/00004356-199206000-00003; UN Enable, FREQ ASK QUEST REG C; UNICEF, CHILD MON SIT CHILDR; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; World Bank, WORLD DEV IND DAT PO; World Health Organization, 2002, COMMON LANGUAGE FUNC; World Health Organization, WHO GLOB DAT CHILD G; Yaqoob M, 2004, J INTELL DISABIL RES, V48, P663, DOI 10.1111/j.1365-2788.2003.00573.x; ZAMAN SS, 1990, INT J EPIDEMIOL, V19, P613, DOI 10.1093/ije/19.3.613	32	84	85	3	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2009	374	9704					1831	1839		10.1016/S0140-6736(09)61871-7	http://dx.doi.org/10.1016/S0140-6736(09)61871-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527MC	19944864				2022-12-24	WOS:000272370200028
J	Chan, YF; Marks, ME; Jones, FC; Villarreal, G; Shapiro, MD; Brady, SD; Southwick, AM; Absher, DM; Grimwood, J; Schmutz, J; Myers, RM; Petrov, D; Jonsson, B; Schluter, D; Bell, MA; Kingsley, DM				Chan, Yingguang Frank; Marks, Melissa E.; Jones, Felicity C.; Villarreal, Guadalupe, Jr.; Shapiro, Michael D.; Brady, Shannon D.; Southwick, Audrey M.; Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.; Petrov, Dmitri; Jonsson, Bjarni; Schluter, Dolph; Bell, Michael A.; Kingsley, David M.			Adaptive Evolution of Pelvic Reduction in Sticklebacks by Recurrent Deletion of a Pitx1 Enhancer	SCIENCE			English	Article							COMMON FRAGILE SITE; GASTEROSTEUS-ACULEATUS; THREESPINE STICKLEBACK; MORPHOLOGICAL EVOLUTION; PHENOTYPIC DIVERSITY; PARALLEL EVOLUTION; GENETIC THEORY; EVO-DEVO; ADAPTATION; EXPRESSION	The molecular mechanisms underlying major phenotypic changes that have evolved repeatedly in nature are generally unknown. Pelvic loss in different natural populations of threespine stickleback fish has occurred through regulatory mutations deleting a tissue-specific enhancer of the Pituitary homeobox transcription factor 1 (Pitx1) gene. The high prevalence of deletion mutations at Pitx1 may be influenced by inherent structural features of the locus. Although Pitx1 null mutations are lethal in laboratory animals, Pitx1 regulatory mutations show molecular signatures of positive selection in pelvic-reduced populations. These studies illustrate how major expression and morphological changes can arise from single mutational leaps in natural populations, producing new adaptive alleles via recurrent regulatory alterations in a key developmental control gene.	[Chan, Yingguang Frank; Marks, Melissa E.; Jones, Felicity C.; Villarreal, Guadalupe, Jr.; Shapiro, Michael D.; Brady, Shannon D.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Chan, Yingguang Frank; Marks, Melissa E.; Jones, Felicity C.; Villarreal, Guadalupe, Jr.; Shapiro, Michael D.; Brady, Shannon D.; Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Southwick, Audrey M.] Stanford Univ, Stanford Human Genome Ctr, Stanford, CA 94305 USA; [Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.] HudsonAlpha Inst, Huntsville, AL 35806 USA; [Petrov, Dmitri] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Jonsson, Bjarni] Inst Freshwater Fisheries, IS-550 Sauoarkrokur, Iceland; [Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Bell, Michael A.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; HudsonAlpha Institute for Biotechnology; Stanford University; University of British Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kingsley, DM (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	kingsley@stanford.edu	Chan, Yingguang Frank/ABG-9852-2020; Jones, Felicity C/AAY-3523-2021; Marks, Melissa/V-6587-2019; Schmutz, Jeremy/N-3173-2013; Grimwood, Jane/ABD-5737-2021; Chan, Yingguang/A-7654-2011	Chan, Yingguang Frank/0000-0001-6292-9681; Jones, Felicity C/0000-0002-5027-1031; Marks, Melissa/0000-0003-2625-6322; Schmutz, Jeremy/0000-0001-8062-9172; Chan, Yingguang/0000-0001-6292-9681; Schluter, Dolph/0000-0003-1683-7836	Stanford Affymetrix Bio-X Graduate Fellowship; Howard Hughes Medical Insititute (HHMI); Burroughs Wellcome Fund; NSF [DEB0211391, DEB0322818]; Natural Sciences and Engineering Research Council of Canada; Guggenheim Foundation; NIH [P50 HG02568]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER	Stanford Affymetrix Bio-X Graduate Fellowship; Howard Hughes Medical Insititute (HHMI)(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Guggenheim Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. McLaughlin for fish husbandry, M. Nonet for the gift of the pBH-mcs-YFP vector, Broad Institute for the public gasAcu1 genome assembly, and many individuals for valuable fish samples (table S1). This work was supported by a Stanford Affymetrix Bio-X Graduate Fellowship (Y. F. C.); the Howard Hughes Medical Insititute (HHMI) Exceptional Research Opportunities Program (G. V.); the Burroughs Wellcome Fund (M. D. S.); NSF grants DEB0211391 and DEB0322818 (M. A. B.); a Canada Research Chair and grants from the Natural Sciences and Engineering Research Council of Canada and the Guggenheim Foundation (D. S.); NIH grant P50 HG02568 (R. M. M., D. P., and D. M. K.); and an HHMI investigatorship (D. M. K.). Sequences generated for this study are available in GenBank (accession GU130433-7).	BELL MA, 1987, BIOL J LINN SOC, V31, P347, DOI 10.1111/j.1095-8312.1987.tb01998.x; BELL MA, 1993, EVOLUTION, V47, P906, DOI 10.1111/j.1558-5646.1993.tb01243.x; Bell MA, 2007, J EXP ZOOL PART B, V308B, P189, DOI 10.1002/jez.b.21132; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cockram J, 2007, GENETICS, V177, P2535, DOI 10.1534/genetics.107.074765; Cole NJ, 2003, CURR BIOL, V13, pR951, DOI 10.1016/S0960-9822(03)00881-9; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Coyle SM, 2007, J HERED, V98, P581, DOI 10.1093/jhered/esm066; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Fay JC, 2000, GENETICS, V155, P1405; GILES N, 1983, J ZOOL, V199, P535; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hunt G, 2008, EVOLUTION, V62, P700, DOI 10.1111/j.1558-5646.2007.00310.x; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kingsley David M., 2007, P41; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Mayr E, 1970, POPULATIONS SPECIES; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Nagayoshi S, 2008, DEVELOPMENT, V135, P159, DOI 10.1242/dev.009050; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; REIST JD, 1980, CAN J ZOOL, V58, P1253, DOI 10.1139/z80-175; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Stam LF, 1996, GENETICS, V144, P1559; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; SWARUP H, 1958, J EMBRYOL EXP MORPH, V6, P373; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	34	694	698	7	296	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					302	305		10.1126/science.1182213	http://dx.doi.org/10.1126/science.1182213			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20007865	Green Accepted			2022-12-24	WOS:000273629700034
J	Galanty, Y; Belotserkovskaya, R; Coates, J; Polo, S; Miller, KM; Jackson, SP				Galanty, Yaron; Belotserkovskaya, Rimma; Coates, Julia; Polo, Sophie; Miller, Kyle M.; Jackson, Stephen P.			Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks	NATURE			English	Article							DAMAGE RESPONSE; UBIQUITIN; REPAIR; MDC1; UBIQUITYLATION; PROTEINS; DYNAMICS; ROLES; BINDS; ATM	DNA double-strand breaks (DSBs) are highly cytotoxic lesions that are generated by ionizing radiation and various DNA-damaging chemicals. Following DSB formation, cells activate the DNA-damage response (DDR) protein kinases ATM, ATR and DNA-PK (also known as PRKDC). These then trigger histone H2AX (also known as H2AFX) phosphorylation and the accumulation of proteins such as MDC1, 53BP1 (also known as TP53BP1), BRCA1, CtIP (also known as RBBP8), RNF8 and RNF168/RIDDLIN into ionizing radiation-induced foci (IRIF) that amplify DSB signalling and promote DSB repair(1,2). Attachment of small ubiquitin-related modifier (SUMO) to target proteins controls diverse cellular functions(3-6). Here, we show that SUMO1, SUMO2 and SUMO3 accumulate at DSB sites in mammalian cells, with SUMO1 and SUMO2/3 accrual requiring the E3 ligase enzymes PIAS4 and PIAS1. We also establish that PIAS1 and PIAS4 are recruited to damage sites via mechanisms requiring their SAP domains, and are needed for the productive association of 53BP1, BRCA1 and RNF168 with such regions. Furthermore, we show that PIAS1 and PIAS4 promote DSB repair and confer ionizing radiation resistance. Finally, we establish that PIAS1 and PIAS4 are required for effective ubiquitin-adduct formation mediated by RNF8, RNF168 and BRCA1 at sites of DNA damage(7-11). These findings thus identify PIAS1 and PIAS4 as components of the DDR and reveal how protein recruitment to DSB sites is controlled by coordinated SUMOylation and ubiquitylation.	[Galanty, Yaron; Belotserkovskaya, Rimma; Coates, Julia; Polo, Sophie; Miller, Kyle M.; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Galanty, Yaron; Belotserkovskaya, Rimma; Coates, Julia; Polo, Sophie; Miller, Kyle M.; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Galanty, Yaron/0000-0001-7167-9004; Polo, Sophie/0000-0003-4821-9354; Miller, Kyle/0000-0002-4544-0013	Cancer Research UK; European Union [LSHG-CT-2005-512113, HEALTH-F2-2007-201630]	Cancer Research UK(Cancer Research UK); European Union(European Commission)	We thank S. P. J. lab members for support, in particular J. Harrigan, P. Huertas, S. Gravel, K. Dry and R. Chapman. We also thank C. Lukas for U2OS cells expressing GFP-BRCA1/Flag-BARD1, D. Durocher and G. Stewart for hTERT RIDDLE syndrome fibroblasts complemented with vector or HA-RNF168 and RNF168 antibody, T. Halazonetis for RNF8 antibody, R. Baer for the Flag-BARD1 construct, P. Harkin for the HA-BRCA1 construct, K. Iwabuchi for HA-tagged, full length, N, C, CDBRCT and BRCT 53BP1 constructs, R. Walker for help with FACS, and J. R. Morris for sharing results before publication. Research in the S. P. J. lab is supported by grants from Cancer Research UK and the European Union ( Integrated Project DNA repair, LSHG-CT-2005-512113, and Genomic Instability in Cancer and Precancer, HEALTH-F2-2007-201630).	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Durant ST, 2005, CELL CYCLE, V4, P1216, DOI 10.4161/cc.4.9.2027; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005	30	402	422	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					935	U132		10.1038/nature08657	http://dx.doi.org/10.1038/nature08657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016603	Green Accepted			2022-12-24	WOS:000272795400046
J	Xu, TH; Yu, XZ; Perlik, AJ; Tobin, WF; Zweig, JA; Tennant, K; Jones, T; Zuo, Y				Xu, Tonghui; Yu, Xinzhu; Perlik, Andrew J.; Tobin, Willie F.; Zweig, Jonathan A.; Tennant, Kelly; Jones, Theresa; Zuo, Yi			Rapid formation and selective stabilization of synapses for enduring motor memories	NATURE			English	Article							DENDRITIC SPINE STABILITY; TERM SYNAPTIC PLASTICITY; FORELIMB CORTEX; CEREBRAL-CORTEX; ADULT CORTEX; IN-VIVO; EXPERIENCE; SYNAPTOGENESIS; REORGANIZATION; NEOCORTEX	Novel motor skills are learned through repetitive practice and, once acquired, persist long after training stops(1,2). Earlier studies have shown that such learning induces an increase in the efficacy of synapses in the primary motor cortex, the persistence of which is associated with retention of the task(3-5). However, how motor learning affects neuronal circuitry at the level of individual synapses and how long-lasting memory is structurally encoded in the intact brain remain unknown. Here we show that synaptic connections in the living mouse brain rapidly respond to motor-skill learning and permanently rewire. Training in a forelimb reaching task leads to rapid (within an hour) formation of postsynaptic dendritic spines on the output pyramidal neurons in the contralateral motor cortex. Although selective elimination of spines that existed before training gradually returns the overall spine density back to the original level, the new spines induced during learning are preferentially stabilized during subsequent training and endure long after training stops. Furthermore, we show that different motor skills are encoded by different sets of synapses. Practice of novel, but not previously learned, tasks further promotes dendritic spine formation in adulthood. Our findings reveal that rapid, but long-lasting, synaptic reorganization is closely associated with motor learning. The data also suggest that stabilized neuronal connections are the foundation of durable motor memory.	[Xu, Tonghui; Yu, Xinzhu; Perlik, Andrew J.; Tobin, Willie F.; Zweig, Jonathan A.; Zuo, Yi] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Tennant, Kelly; Jones, Theresa] Univ Texas Austin, Dept Psychol, Inst Neurosci, Austin, TX 78712 USA	University of California System; University of California Santa Cruz; University of Texas System; University of Texas Austin	Zuo, Y (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	zuo@biology.ucsc.edu	Jones, Theresa A/F-1182-2010; Jones, Theresa/F-1182-2010	Jones, Theresa A/0000-0003-0906-6439; Zweig, Jonathan/0000-0002-7015-9821; Jones, Theresa/0000-0003-2854-8003; Zuo, Yi/0000-0001-9020-0003	Ellison Medical Foundation; DANA Foundation; National Institute on Aging; NATIONAL INSTITUTE ON AGING [R01AG031871] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); DANA Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. States, W. Thompson, L. Hinck, D. Feldheim, J. Ding, X. Li, A. Lin and C. Cirelli for critical comments on this manuscript; A. Sitko for her pilot studies of skilled reaching in mice, and D. Adkins, J. Kleim and N. Thomas for their assistance with intracortical microstimulation procedures. This work was supported by grants from the Ellison Medical Foundation, the DANA Foundation, and the National Institute on Aging to Y. Z.	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; Dailey ME, 1996, J NEUROSCI, V16, P2983; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; GREENOUGH WT, 1985, BEHAV NEURAL BIOL, V44, P301, DOI 10.1016/S0163-1047(85)90310-3; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Harms KJ, 2008, J NEUROSCI, V28, P5686, DOI 10.1523/JNEUROSCI.0584-08.2008; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; KARNI A, 1995, NATURE, V377, P155; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 1997, J NEUROSCI, V17, P717; Kolb B, 2008, NEUROBIOL LEARN MEM, V90, P295, DOI 10.1016/j.nlm.2008.04.012; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; WITHERS GS, 1989, NEUROPSYCHOLOGIA, V27, P61, DOI 10.1016/0028-3932(89)90090-0; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	31	758	769	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					915	U108		10.1038/nature08389	http://dx.doi.org/10.1038/nature08389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	19946267	Green Accepted			2022-12-24	WOS:000272795400042
J	Moscou, MJ; Bogdanove, AJ				Moscou, Matthew J.; Bogdanove, Adam J.			A Simple Cipher Governs DNA Recognition by TAL Effectors	SCIENCE			English	Article							BACTERIAL-BLIGHT; GENE; RICE; RESISTANCE		[Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol & Bioinformat, Ames, IA 50011 USA; Iowa State Univ, Computat Biol Program, Ames, IA 50011 USA	Iowa State University; Iowa State University	Bogdanove, AJ (corresponding author), Iowa State Univ, Dept Plant Pathol & Bioinformat, Ames, IA 50011 USA.	ajbog@iastate.edu	Wilson, Matthew H/K-3193-2013; Bogdanove, Adam/ABE-6252-2020; Ha, Dat Thinh/D-4995-2015; Moscou, Matthew/D-5266-2011	Ha, Dat Thinh/0000-0003-4260-4876; Moscou, Matthew/0000-0003-2098-6818				Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Schornack S, 2008, NEW PHYTOL, V179, P546, DOI 10.1111/j.1469-8137.2008.02487.x; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103	7	1342	1838	15	326	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1501	1501		10.1126/science.1178817	http://dx.doi.org/10.1126/science.1178817			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	19933106				2022-12-24	WOS:000272623600048
J	Salazar, JD; Saithong, T; Brown, PE; Foreman, J; Locke, JCW; Halliday, KJ; Carre, IA; Rand, DA; Millar, AJ				Salazar, Jose Domingo; Saithong, Treenut; Brown, Paul E.; Foreman, Julia; Locke, James C. W.; Halliday, Karen J.; Carre, Isabelle A.; Rand, David A.; Millar, Andrew J.			Prediction of Photoperiodic Regulators from Quantitative Gene Circuit Models	CELL			English	Article							ARABIDOPSIS-THALIANA; CIRCADIAN CLOCK; FLOWERING RESPONSE; MOLECULAR-BASIS; FLORAL INDUCTION; NETWORK MODEL; CONSTANS; TIME; EXPRESSION; PATHWAYS	Photoperiod sensors allow physiological adaptation to the changing seasons. The prevalent hypothesis is that day length perception is mediated through coupling of an endogenous rhythm with an external light signal. Sufficient molecular data are available to test this quantitatively in plants, though not yet in mammals. In Arabidopsis, the clock-regulated genes CONSTANS (CO) and FLAVIN, KELCH, F-BOX (FKF1) and their light-sensitive proteins are thought to form an external coincidence sensor. Here, we model the integration of light and timing information by CO, its target gene FLOWERING LOCUS T (FT), and the circadian clock. Among other predictions, our models show that FKF1 activates FT. We demonstrate experimentally that this effect is independent of the known activation of CO by FKF1, thus we locate a major, novel controller of photoperiodism. External coincidence is part of a complex photoperiod sensor: modeling makes this complexity explicit and may thus contribute to crop improvement.	[Saithong, Treenut; Brown, Paul E.; Foreman, Julia; Halliday, Karen J.; Millar, Andrew J.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Salazar, Jose Domingo; Locke, James C. W.; Carre, Isabelle A.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Salazar, Jose Domingo; Rand, David A.] Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; [Salazar, Jose Domingo; Brown, Paul E.; Locke, James C. W.; Rand, David A.] Univ Warwick, Interdisciplinary Programme Cellular Regulat, Coventry CV4 7AL, W Midlands, England; [Salazar, Jose Domingo; Brown, Paul E.; Locke, James C. W.; Rand, David A.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Locke, James C. W.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Millar, Andrew J.] Ctr Syst Biol Edinburgh, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh; University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Warwick	Millar, AJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Mayfield Rd, Edinburgh EH9 3JH, Midlothian, Scotland.	andrew.millar@ed.ac.uk	Rand, David A/J-9085-2012; CARRE, Isabelle A/D-8802-2011; Millar, Andrew J/G-2423-2012; Saithong, Treenut/L-1395-2019	Rand, David A/0000-0002-2217-3274; CARRE, Isabelle A/0000-0002-0548-7378; Millar, Andrew J/0000-0003-1756-3654; Saithong, Treenut/0000-0003-2888-6854; Locke, James/0000-0003-0670-1943; Halliday, Karen/0000-0003-0467-104X	BBSRC [BEP17427]; BBSRC/EPSRC SABR award [F0052371]; Gatsby Charitable Trust; Royal Thai Government; EU [005137]; EPSRC [D019621]; BBSRC [BB/D019621/1, BB/F005237/1] Funding Source: UKRI; EPSRC [EP/C544587/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [P19861/2, BB/F005237/1, BB/D019621/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/C544587/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC/EPSRC SABR award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Trust; Royal Thai Government; EU(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	A.J.M. gratefully acknowledges discussions with Carl Johnson, Steve Welch, and Peter Crawford; seed stocks provided by George Coupland; and the hospitality of Luis Serrano and the Centre de Regulacio Genomica, Barcelona during revision of the manuscript. J.D.S. and T.S. performed modeling studies; J.F. performed experimental work; P.E.B. and J.C.W.L. provided modeling tools; J.D.S., T.S., I.A.C., D.A.R. and A.J.M. designed modeling studies; K.J.H. and A.J.M. designed experimental work; A.J.M. wrote the paper with comments from all authors. This work was supported by BBSRC award BEP17427 to A.J.M., D.A.R. and I.A.C., and by BBSRC/EPSRC SABR award F0052371 to K.J.H., A.J.M., D.A.R. and others. J.C.W.L. was supported by a Sainsbury Postgraduate Scholarship from the Gatsby Charitable Trust. T.S. was supported by a Postgraduate Scholarship from the Royal Thai Government. D.A.R. holds an EPSRC Senior Fellowship and is supported by EU BioSim Network Contract 005137. The Centre for Systems Biology at Edinburgh is a Centre for Integrative Systems Biology supported by BBSRC and EPSRC award D019621.	Adams SR, 2001, J EXP BOT, V52, P655, DOI 10.1093/jexbot/52.357.655; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; B?nning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Borchert R, 2005, NATURE, V433, P627, DOI 10.1038/nature03259; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; CARRE IA, 2006, ENDOGENOUS PLANT RHY, P167; Corbesier L, 1996, PLANT J, V9, P947, DOI 10.1046/j.1365-313X.1996.9060947.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; ELLIOTT JA, 1974, PHOTOPERIODIC REGULA; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fukamatsu Y, 2005, PLANT CELL PHYSIOL, V46, P1340, DOI 10.1093/pcp/pci144; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Guckenheimer J, 2013, APPL MATH SCI, V42; Hammer G, 2006, TRENDS PLANT SCI, V11, P587, DOI 10.1016/j.tplants.2006.10.006; HAMNER KC, 1964, AM NAT, V98, P295, DOI 10.1086/282328; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Hazlerigg D, 2008, CURR BIOL, V18, pR795, DOI 10.1016/j.cub.2008.07.040; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Izawa T, 2007, INT REV CYTOL, V256, P191, DOI 10.1016/S0074-7696(07)56006-7; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Niwa Y, 2007, PLANT CELL PHYSIOL, V48, P925, DOI 10.1093/pcp/pcm067; OOSTEROM E, 2004, 4 INT CROP SCI C BRI; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Pouteau S, 2008, PLANT PHYSIOL, V148, P1465, DOI 10.1104/pp.108.127639; Roden LC, 2002, P NATL ACAD SCI USA, V99, P13313, DOI 10.1073/pnas.192365599; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Thomas B., 1997, PHOTOPERIODISM PLANT; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Welch SM, 2003, AGRON J, V95, P71, DOI 10.2134/agronj2003.0071; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	48	79	81	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1170	1179		10.1016/j.cell.2009.11.029	http://dx.doi.org/10.1016/j.cell.2009.11.029			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005809	Bronze, Green Submitted			2022-12-24	WOS:000272622800018
J	Shechner, DM; Grant, RA; Bagby, SC; Koldobskaya, Y; Piccirilli, JA; Bartel, DP				Shechner, David M.; Grant, Robert A.; Bagby, Sarah C.; Koldobskaya, Yelena; Piccirilli, Joseph A.; Bartel, David P.			Crystal Structure of the Catalytic Core of an RNA-Polymerase Ribozyme	SCIENCE			English	Article							LIGASE RIBOZYME; NUCLEOSIDE TRIPHOSPHATES; PRIMER EXTENSION; POLYMERIZATION; CRYSTALLIZATION; RECOGNITION; SEQUENCES; MECHANISM; EVOLUTION; INTRON	Primordial organisms of the putative RNA world would have required polymerase ribozymes able to replicate RNA. Known ribozymes with polymerase activity best approximating that needed for RNA replication contain at their catalytic core the class I RNA ligase, an artificial ribozyme with a catalytic rate among the fastest of known ribozymes. Here we present the 3.0 angstrom crystal structure of this ligase. The architecture resembles a tripod, its three legs converging near the ligation junction. Interacting with this tripod scaffold through a series of 10 minor-groove interactions (including two A-minor triads) is the unpaired segment that contributes to and organizes the active site. A cytosine nucleobase and two backbone phosphates abut the ligation junction; their location suggests a model for catalysis resembling that of proteinaceous polymerases.	[Shechner, David M.; Bagby, Sarah C.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shechner, David M.; Bagby, Sarah C.; Bartel, David P.] Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Shechner, David M.; Grant, Robert A.; Bagby, Sarah C.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Koldobskaya, Yelena; Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Koldobskaya, Yelena; Piccirilli, Joseph A.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Chicago; Howard Hughes Medical Institute; University of Chicago	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	daehun, lee/H-2435-2013	Bagby, Sarah/0000-0002-1795-3161; Shechner, David/0000-0002-0574-256X	NIH [GM61835]; NSF; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM061835, R01GM061835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Ferre-D'Amare, J. Doudna, R. Batey, and K. Zhou for the generous donation of reagents and protocols; K. Rajashankar for assistance in phasing; E. Duguid, V. Malashkevich, C. Drennan, T. Schwartz, U. RajBhandary, J. Cochrane, M. Stahley, S. Strobel, M. Robertson, and W. Scott for advice, encouragement, and helpful discussions; and members of the Bartel laboratory for support and comments. Supported by NIH grant GM61835. X-ray data were collected with the Northeastern Collaborative Access Team at the Advanced Photo Source, Argonne National Laboratory (11). D. M. S. was an NSF predoctoral fellow; S. C. B. was a Howard Hughes Medical Institute (HHMI) predoctoral fellow. D. B. and J. A. P. are HHMI investigators. Coordinates for the U1A-bound and Fab-bound ribozymes are deposited in the Protein Data Bank (3HHN and 3IVK, respectively).	BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Bergman NH, 2004, RNA, V10, P176, DOI 10.1261/rna.5177504; Bevilacqua PC, 2006, CURR OPIN CHEM BIOL, V10, P455, DOI 10.1016/j.cbpa.2006.08.014; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; EKLAND EH, 1995, NUCLEIC ACIDS RES, V23, P3231, DOI 10.1093/nar/23.16.3231; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; Glasner ME, 2002, BIOCHEMISTRY-US, V41, P8103, DOI 10.1021/bi012179b; Glasner ME, 2000, BIOCHEMISTRY-US, V39, P15556, DOI 10.1021/bi002174z; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Joyce G. F., 1993, COLD SPRING HARB SYM, V24, P49; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Lawrence MS, 2003, BIOCHEMISTRY-US, V42, P8748, DOI 10.1021/bi034228l; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Muller UF, 2003, CHEM BIOL, V10, P799, DOI 10.1016/S1074-5521(03)00171-6; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Robertson MP, 2007, SCIENCE, V315, P1549, DOI 10.1126/science.1136231; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; STEWART SHEILA A., 2003, RNA, V9, P493, DOI [10.1261/rna.2192803, DOI 10.1261/RNA.2192803, DOI 10.1261/RNA.191250]; Strater N, 1996, ANGEW CHEM INT EDIT, V35, P2024, DOI 10.1002/anie.199620241; Strobel SA, 1999, CURR OPIN STRUC BIOL, V9, P346, DOI 10.1016/S0959-440X(99)80046-3; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614; Ye JD, 2008, P NATL ACAD SCI USA, V105, P82, DOI 10.1073/pnas.0709082105; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	27	82	83	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1271	1275		10.1126/science.1174676	http://dx.doi.org/10.1126/science.1174676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965478	Green Accepted			2022-12-24	WOS:000272117900050
J	Peers, G; Truong, TB; Ostendorf, E; Busch, A; Elrad, D; Grossman, AR; Hippler, M; Niyogi, KK				Peers, Graham; Truong, Thuy B.; Ostendorf, Elisabeth; Busch, Andreas; Elrad, Dafna; Grossman, Arthur R.; Hippler, Michael; Niyogi, Krishna K.			An ancient light-harvesting protein is critical for the regulation of algal photosynthesis	NATURE			English	Article							CARBON-CONCENTRATING MECHANISM; CHLAMYDOMONAS-REINHARDTII; PHOTOOXIDATIVE STRESS; BIOENERGETIC PATHWAYS; ENERGY-DISSIPATION; IRON-DEFICIENCY; GENOME REVEALS; GENES; CYCLE; EXPRESSION	Light is necessary for photosynthesis, but its absorption by pigment molecules such as chlorophyll can cause severe oxidative damage and result in cell death. The excess absorption of light energy by photosynthetic pigments has led to the evolution of protective mechanisms that operate on the timescale of seconds to minutes and involve feedback-regulated de-excitation of chlorophyll molecules in photosystem II (qE). Despite the significant contribution of eukaryotic algae to global primary production(1), little is known about their qE mechanism, in contrast to that in flowering plants(2,3). Here we show that a qE-deficient mutant of the unicellular green alga Chlamydomonas reinhardtii, npq4, lacks two of the three genes encoding LHCSR (formerly called LI818). This protein is an ancient member of the light-harvesting complex superfamily, and orthologues are found throughout photosynthetic eukaryote taxa(4), except in red algae and vascular plants. The qE capacity of Chlamydomonas is dependent on environmental conditions and is inducible by growth under high light conditions. We show that the fitness of the npq4 mutant in a shifting light environment is reduced compared to wild-type cells, demonstrating that LHCSR is required for survival in a dynamic light environment. Thus, these data indicate that plants and algae use different proteins to dissipate harmful excess light energy and protect the photosynthetic apparatus from damage.	[Peers, Graham; Truong, Thuy B.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Truong, Thuy B.; Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ostendorf, Elisabeth; Busch, Andreas; Hippler, Michael] Univ Munster, Inst Plant Biochem & Biotechnol, D-48143 Munster, Germany; [Elrad, Dafna; Grossman, Arthur R.] Carnegie Inst, Dept Plant Biol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Munster; Carnegie Institution for Science	Niyogi, KK (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	mhippler@uni-muenster.de; niyogi@berkeley.edu		Peers, Graham/0000-0002-3590-7820; Michael, Hippler/0000-0001-9670-6101	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy; Deutsche Forschungsgemeinschaft; National Science Foundation	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	We thank M. Guertin for providing the anti-LHCSR (LI818) antibody. This work was supported by grants from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy ( K. K. N.), the Deutsche Forschungsgemeinschaft ( M. H.), and the National Science Foundation ( A. R. G.).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; Allmer J, 2006, PROTEOMICS, V6, P6207, DOI 10.1002/pmic.200600208; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; Casper-Lindley C, 1998, PHOTOSYNTH RES, V56, P277, DOI 10.1023/A:1006037516479; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GAGNE G, 1992, PLANT MOL BIOL, V18, P429, DOI 10.1007/BF00040659; Golan T, 2006, PLANT CELL ENVIRON, V29, P879, DOI 10.1111/j.1365-3040.2005.01467.x; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Ledford HK, 2004, MOL GENET GENOMICS, V272, P470, DOI 10.1007/s00438-004-1078-5; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Richard C, 2000, PLANT MOL BIOL, V42, P303, DOI 10.1023/A:1006340308077; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Savard F, 1996, PLANT MOL BIOL, V32, P461, DOI 10.1007/BF00019098; SCHENCK H, 1957, J OPT SOC AM, V47, P653, DOI 10.1364/JOSA.47.000653; Turkina MV, 2006, MOL CELL PROTEOMICS, V5, P1412, DOI 10.1074/mcp.M600066-MCP200; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Yamano T, 2008, PLANT PHYSIOL, V147, P340, DOI 10.1104/pp.107.114652; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	33	484	497	4	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					518	U215		10.1038/nature08587	http://dx.doi.org/10.1038/nature08587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940928				2022-12-24	WOS:000272144200047
J	Gore, MA; Chia, JM; Elshire, RJ; Sun, Q; Ersoz, ES; Hurwitz, BL; Peiffer, JA; McMullen, MD; Grills, GS; Ross-Ibarra, J; Ware, DH; Buckler, ES				Gore, Michael A.; Chia, Jer-Ming; Elshire, Robert J.; Sun, Qi; Ersoz, Elhan S.; Hurwitz, Bonnie L.; Peiffer, Jason A.; McMullen, Michael D.; Grills, George S.; Ross-Ibarra, Jeffrey; Ware, Doreen H.; Buckler, Edward S.			A First-Generation Haplotype Map of Maize	SCIENCE			English	Article							ARTIFICIAL SELECTION; ARABIDOPSIS-THALIANA; GENOME; POPULATION; DOMESTICATION; DIVERSITY; DNA; POLYMORPHISM; DIVERGENCE; ZEA	Maize is an important crop species of high genetic diversity. We identified and genotyped several million sequence polymorphisms among 27 diverse maize inbred lines and discovered that the genome was characterized by highly divergent haplotypes and showed 10- to 30-fold variation in recombination rates. Most chromosomes have pericentromeric regions with highly suppressed recombination that appear to have influenced the effectiveness of selection during maize inbred development and may be a major component of heterosis. We found hundreds of selective sweeps and highly differentiated regions that probably contain loci that are key to geographic adaptation. This survey of genetic diversity provides a foundation for uniting breeding efforts across the world and for dissecting complex traits through genome-wide association studies.	[Gore, Michael A.; McMullen, Michael D.; Ware, Doreen H.; Buckler, Edward S.] Cornell Univ, USDA ARS, Ithaca, NY 14853 USA; [Gore, Michael A.; Peiffer, Jason A.; Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Gore, Michael A.; Elshire, Robert J.; Ersoz, Elhan S.; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Chia, Jer-Ming; Hurwitz, Bonnie L.; Ware, Doreen H.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Grills, George S.] Cornell Univ, Inst Biotechnol & Life Sci Technol, Ithaca, NY 14853 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Cornell University; United States Department of Agriculture (USDA); Cornell University; Cornell University; Cold Spring Harbor Laboratory; Cornell University; University of Missouri System; University of Missouri Columbia; Cornell University; University of California System; University of California Davis	Ware, DH (corresponding author), Cornell Univ, USDA ARS, Ithaca, NY 14853 USA.	ware@cshl.edu; esb33@cornell.edu	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Chia, Jer-Ming/C-9992-2012; Ross-Ibarra, Jeffrey/D-7782-2011	Buckler, Edward/0000-0002-3100-371X; Ross-Ibarra, Jeffrey/0000-0003-1656-4954; Gore, Michael/0000-0001-6896-8024; Elshire, Robert/0000-0003-1753-6920	NSF [DBI-0321467, DBI-0638566, DBI-0820619]; USDA-ARS	NSF(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	We thank D. Costich and L. Rigamer Lirette for technical editing of the manuscript; researchers at the Lita Annenberg Hazen Genome Sequencing Center of Cold Spring Harbor Laboratory for discussion about sequencing and library construction; and T. Stelick, P. Schweitzer, and J. I. VanEe for assistance with the SBS data, all of which was generated at the Cornell University Life Sciences Core Laboratories Center. Mention of trade names or commercial products was solely to provide specific information and does not imply recommendation or endorsement by the USDA. This work was supported by NSF grants DBI-0321467, DBI-0638566, and DBI-0820619, and by the USDA-ARS. Sequences have been deposited at National Center for Biotechnology Information Short Read Archive with accession number SRP001145, and SNP calls are available at www.panzea.org.	Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242	22	543	562	5	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1115	1117		10.1126/science.1177837	http://dx.doi.org/10.1126/science.1177837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965431				2022-12-24	WOS:000271951000045
J	Hu, SH; Xie, Z; Onishi, A; Yu, XP; Jiang, LZ; Lin, J; Rho, HS; Woodard, C; Wang, H; Jeong, JS; Long, SY; He, XF; Wade, H; Blackshaw, S; Qian, J; Zhu, H				Hu, Shaohui; Xie, Zhi; Onishi, Akishi; Yu, Xueping; Jiang, Lizhi; Lin, Jimmy; Rho, Hee-sool; Woodard, Crystal; Wang, Hong; Jeong, Jun-Seop; Long, Shunyou; He, Xiaofei; Wade, Herschel; Blackshaw, Seth; Qian, Jiang; Zhu, Heng			Profiling the Human Protein-DNA Interactome Reveals ERK2 as a Transcriptional Repressor of Interferon Signaling	CELL			English	Article							REGULATORY MOTIFS; GENE-EXPRESSION; SYSTEMATIC DISCOVERY; BINDING; MICROARRAY; DATABASE; GENOME; IDENTIFICATION; PREDICTION; SEQUENCES	Protein-DNA interactions (PDIs) mediate a broad range of functions essential for cellular differentiation, function, and survival. However, it is still a daunting task to comprehensively identify and profile sequence-specific PDIs in complex genomes. Here, we have used a combined bioinformatics and protein microarray-based strategy to systematically characterize the human protein-DNA interactome. We identified 17,718 PDIs between 460 DNA motifs predicted to regulate transcription and 4,191 human proteins of various functional classes. Among them, we recovered many known PDIs for transcription factors (TFs). We identified a large number of unanticipated PDIs for known TFs, as well as for previously uncharacterized TFs. We also found that over three hundred unconventional DNA-binding proteins (uDBPs)-which include RNA-binding proteins, mitochondrial proteins, and protein kinases-showed sequence-specific PDIs. One such uDBP, ERK2, acts as a transcriptional repressor for interferon gamma-induced genes, suggesting important biological roles for such proteins.	[Xie, Zhi; Yu, Xueping; Blackshaw, Seth; Qian, Jiang] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Hu, Shaohui; Rho, Hee-sool; Woodard, Crystal; Jeong, Jun-Seop; He, Xiaofei; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Onishi, Akishi; Jiang, Lizhi; Wang, Hong; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Hu, Shaohui; Onishi, Akishi; Jiang, Lizhi; Rho, Hee-sool; Woodard, Crystal; Wang, Hong; Jeong, Jun-Seop; Long, Shunyou; He, Xiaofei; Blackshaw, Seth; Zhu, Heng] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD 21205 USA; [Onishi, Akishi; Jiang, Lizhi; Wang, Hong; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Lin, Jimmy] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Wade, Herschel] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Qian, Jiang; Zhu, Heng] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.	sblack@jhmi.edu; jiang.qian@jhmi.edu; heng.zhu@jhmi.edu	Hu, Shaohui/AAE-4433-2020; Xie, Zhi/A-3108-2012	Xie, Zhi/0000-0002-5589-4836	National Institutes of Health [GM076102, RR020839]; NEI Vision Core; Ruth and Milton Steinbach Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI Vision Core; Ruth and Milton Steinbach Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. J. Boeke, P. Cole, J. Nathans, G. Seydoux, T. Shimogori, S. Chen, D. Griffin, S. Taverna, J. Pomerantz, and D. Zack for their comments and suggestions. We also thank Drs. K. Dalby, D. Kalvakolanu, and R. Weiner for providing reagents; and D. McClellan for editorial assistance. This work was supported by the National Institutes of Health (GM076102 to H. Z., J. Q., RR020839 to H. Z., NEI Vision Core Grant to J. Q.), a W. M. Keck Foundation Distinguished Young Investigator in Medical Research Award to S. B., a grant from the Ruth and Milton Steinbach Fund to S. B., and a generous gift from Mr. and Mrs. Robert and Clarice Smith.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Ho SW, 2006, P NATL ACAD SCI USA, V103, P9940, DOI 10.1073/pnas.0509185103; Huang C, 2008, CELL BIOL INT, V32, P1081, DOI 10.1016/j.cellbi.2008.04.019; Jensen Pia Honnerup, 2005, J Biomol Tech, V16, P336; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; KIPREOS ET, 1992, SCIENCE, V256, P382, DOI 10.1126/science.256.5055.382; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Liang F, 2004, NUCLEIC ACIDS RES, V32, pD595, DOI 10.1093/nar/gkh118; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; MCKNIGHT SL, 1981, CELL, V25, P385, DOI 10.1016/0092-8674(81)90057-X; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Roy SK, 2000, J BIOL CHEM, V275, P12626, DOI 10.1074/jbc.275.17.12626; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xiao WH, 1997, P NATL ACAD SCI USA, V94, P103, DOI 10.1073/pnas.94.1.103; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	41	279	288	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					610	622		10.1016/j.cell.2009.08.037	http://dx.doi.org/10.1016/j.cell.2009.08.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879846	Green Accepted, Bronze			2022-12-24	WOS:000271259600024
J	Olah, S; Miklos, F; Gergely, K; Csaba, V; Rita, B; Pal, B; Gabor, T				Olah, Szabolcs; Miklos Fuele; Gergely Komlosi; Csaba Varga; Rita Baldi; Pal Barzo; Gabor Tamas			Regulation of cortical microcircuits by unitary GABA-mediated volume transmission	NATURE			English	Article							NEURONAL EXCITABILITY; TONIC INHIBITION; RECEPTORS; ACTIVATION; INTERNEURONS; MODULATION; SPILLOVER; CELLS	GABA (gamma-aminobutyric acid) is predominantly released by local interneurons in the cerebral cortex to particular subcellular domains of the target cells(1,2). This suggests that compartmentalized, synapse-specific action of GABA is required in cortical networks for phasic inhibition(2-4). However, GABA released at the synaptic cleft diffuses to receptors outside the postsynaptic density and thus tonically activates extrasynaptic GABA(A) and GABA(B) receptors, which include subtypes of both receptor families especially sensitive to low concentrations of GABA(3-7). The synaptic and extrasynaptic action of GABA corroborates the idea that neurons of the brain use synaptic (or wiring) transmission and non-synaptic (or volume) transmission for communication(8,9). However, re-uptake mechanisms restrict the spatial extent of extrasynaptic GABA-mediated effects(10,11), and it has been proposed that the concerted action of several presynaptic interneurons, the sustained firing of individual cells or an increase in release-site density is required to reach ambient GABA levels sufficient to activate extrasynaptic receptors(4,9,11-13). Here we show that individual neurogliaform cells release enough GABA for volume transmission within the axonal cloud and, thus, that neurogliaform cells do not require synapses to produce inhibitory responses in the overwhelming majority of nearby neurons. Neurogliaform cells suppress connections between other neurons acting on presynaptic terminals that do not receive synapses at all in the cerebral cortex. They also reach extrasynaptic, delta-subunit-containing GABA(A) (GABA(A delta)) receptors responsible for tonic inhibition. We show that GABA(A delta) receptors are localized to neurogliaform cells preferentially among cortical interneurons. Neurosteroids, which are modulators of GABA(A delta) receptors, alter unitary GABA-mediated effects between neurogliaform cells. In contrast to the specifically placed synapses formed by other interneurons, the output of neurosteroid-sensitive neurogliaform cells represents the ultimate form of the lack of spatial specificity in GABA-mediated systems, leading to long-lasting network hyperpolarization combined with widespread suppression of communication in the local circuit.	[Olah, Szabolcs; Miklos Fuele; Gergely Komlosi; Csaba Varga; Rita Baldi; Gabor Tamas] Univ Szeged, Dept Physiol Anat & Neurosci, Res Grp Cort Microcircuits, Hungarian Acad Sci, H-6726 Szeged, Hungary; [Pal Barzo] Univ Szeged, Dept Neurosurg, H-6725 Szeged, Hungary	Hungarian Academy of Sciences; Szeged University; Szeged University	Gabor, T (corresponding author), Univ Szeged, Dept Physiol Anat & Neurosci, Res Grp Cort Microcircuits, Hungarian Acad Sci, Kozep Fasor 52, H-6726 Szeged, Hungary.	gtamas@bio.u-szeged.hu	Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001; Varga, Csaba/0000-0002-9188-1282	European Young Investigator Award; Hungarian National Office for Research and Technology Polanyi Award; Howard Hughes Medical Institute; US National Institutes of Health [NS535915]; Boehringer Ingelheim Fonds; Hungarian Academy of Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035915] Funding Source: NIH RePORTER	European Young Investigator Award; Hungarian National Office for Research and Technology Polanyi Award(National Office for Research and Technology); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Hungarian Academy of Sciences(Hungarian Academy of Sciences); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank W. Sieghart for donating antibody, A. Lorincz and Z. Nusser for initial testing of the GABA<INF>A delta</INF> antibody, I. Mody for the GABA<INF>A delta</INF> -/- animals, and A. Simon and E. Toth for reconstructions. This work was supported by the European Young Investigator Award, the Hungarian National Office for Research and Technology Polanyi Award, the Howard Hughes Medical Institute, US National Institutes of Health grant NS535915, the Boehringer Ingelheim Fonds and the Hungarian Academy of Sciences.	Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kulik A, 2003, J NEUROSCI, V23, P11026; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nusser Z, 1998, J NEUROSCI, V18, P1693; Overstreet LS, 2003, J NEUROSCI, V23, P2618; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Peters A., 1991, FINE STRUCTURE NERVO; Price CJ, 2008, J NEUROSCI, V28, P6974, DOI 10.1523/JNEUROSCI.4673-07.2008; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Vardya I, 2008, J NEUROPHYSIOL, V100, P526, DOI 10.1152/jn.01224.2007; Vizi ES, 2000, PHARMACOL REV, V52, P63	30	256	260	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1278	U113		10.1038/nature08503	http://dx.doi.org/10.1038/nature08503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865171	Green Accepted			2022-12-24	WOS:000271190800048
J	Tawar, RG; Duquerroy, S; Vonrhein, C; Varela, PF; Damier-Piolle, L; Castagne, N; MacLellan, K; Bedouelle, H; Bricogne, G; Bhella, D; Eleouet, JF; Rey, FA				Tawar, Rajiv G.; Duquerroy, Stephane; Vonrhein, Clemens; Varela, Paloma F.; Damier-Piolle, Laurence; Castagne, Nathalie; MacLellan, Kirsty; Bedouelle, Hugues; Bricogne, Gerard; Bhella, David; Eleouet, Jean-Francois; Rey, Felix A.			Crystal Structure of a Nucleocapsid-Like Nucleoprotein-RNA Complex of Respiratory Syncytial Virus	SCIENCE			English	Article							PROTEIN; REPLICATION; TRANSCRIPTION; POLYMERASE	The respiratory syncytial virus (RSV) is an important human pathogen, yet neither a vaccine nor effective therapies are available to treat infection. To help elucidate the replication mechanism of this RNA virus, we determined the three-dimensional (3D) crystal structure at 3.3 angstrom resolution of a decameric, annular ribonucleoprotein complex of the RSV nucleoprotein (N) bound to RNA. This complex mimics one turn of the viral helical nucleocapsid complex, which serves as template for viral RNA synthesis. The RNA wraps around the protein ring, with seven nucleotides contacting each N subunit, alternating rows of four and three stacked bases that are exposed and buried within a protein groove, respectively. Combined with electron microscopy data, this structure provides a detailed model for the RSV nucleocapsid, in which the bases are accessible for readout by the viral polymerase. Furthermore, the nucleoprotein structure highlights possible key sites for drug targeting.	[Castagne, Nathalie; Eleouet, Jean-Francois] INRA, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France; [Tawar, Rajiv G.; Duquerroy, Stephane; Varela, Paloma F.; Damier-Piolle, Laurence; Rey, Felix A.] Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris 15, France; [Tawar, Rajiv G.; Duquerroy, Stephane; Varela, Paloma F.; Damier-Piolle, Laurence; Rey, Felix A.] CNRS, URA 3015, F-75724 Paris 15, France; [Duquerroy, Stephane] Univ Paris 11, Fac Orsay, F-91405 Orsay, France; [Vonrhein, Clemens; Bricogne, Gerard] Global Phasing, Cambridge CB3 0AX, England; [MacLellan, Kirsty; Bhella, David] Univ Glasgow, MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Bedouelle, Hugues] Inst Pasteur, CNRS, URA 3012, F-75724 Paris 15, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Eleouet, JF (corresponding author), INRA, Unite Virol & Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France.	jean-francois.eleouet@jouy.inra.fr; rey@pasteur.fr	Bhella, David/J-8514-2012; Eléouët, Jean-François/AAD-1994-2019; Varela, Paloma/AFT-0478-2022; Rey, Felix/B-6497-2012	Bhella, David/0000-0003-2096-8310; Varela, Paloma/0000-0001-5078-7102; Rey, Felix/0000-0002-9953-7988; ELeouet, Jean-Francois/0000-0002-7361-4885; Gibson, Kirsty/0000-0002-6734-4452; Duquerroy, Stephane/0000-0003-4386-8013	Marie-Curie RTN fellowship [MRTN-CT-2006-035599]; French Fondation pour la Recherche Medicale; French Agence Nationale pour la Recherche; Merck-Serono; MRC [MC_U130115834] Funding Source: UKRI	Marie-Curie RTN fellowship(European Commission); French Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Agence Nationale pour la Recherche(French National Research Agency (ANR)); Merck-Serono(Merck & Company); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was initiated as part of the sixth European Union Framework Programme consortium (http://cordis.europa.eu/life/src/control/qlk2-ct-2001-01225.htm). We thank A. Albertini, J. Bernard, D. Gerlier, A. Haouz, J. Lepault, M. Moudjou, C. Schulze-Briese, E. Stura, P. Weber, and R. P. Yeo for help and/or discussion; M. Backovic, D. Kolakovsky, J. Melero, L. Roux, and A. Tortorici for comments on the manuscript. Diffraction data collection was done at beamline X06SA of the Swiss Light Source and ID23-2 of the European Synchrotron Radiation Facility. R. G. T. benefits from a Marie-Curie RTN fellowship (consortium MRTN-CT-2006-035599, acronym EIHCV). This work was also supported by the French Fondation pour la Recherche Medicale (postdoctoral fellowship to P. F. V.), by a grant from the French Agence Nationale pour la Recherche (Programme MIME) to F. A. R., and by Merck-Serono. The coordinates and structure factors of the N-RNA rings were deposited in the Protein Data Bank with accession number 2wj8. The 3D EM reconstruction was deposited in the Electron Microscopy Data Bank with accession code EMD-1622.	Albertini AAV, 2008, CELL MOL LIFE SCI, V65, P282, DOI 10.1007/s00018-007-7298-1; Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; BACHI T, 1973, J VIROL, V12, P1173; Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; BRUNT AA, 2005, VIRUS TAXONOMY, P655; Chapman J, 2007, ANTIMICROB AGENTS CH, V51, P3346, DOI 10.1128/AAC.00211-07; Collins PL, 2007, FIELDS VIROLOGY, P1601; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; Dupuy LC, 1999, J VIROL, V73, P8384, DOI 10.1128/JVI.73.10.8384-8392.1999; El Omari K, 2008, ACTA CRYSTALLOGR F, V64, P1019, DOI 10.1107/S1744309108031059; Frogel Michael P, 2008, Manag Care, V17, P7; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; Juozapaitis M, 2006, BIOLOGIJA, V3, P79; MacLellan K, 2007, J VIROL, V81, P9519, DOI 10.1128/JVI.00526-07; Murray J, 2001, VIROLOGY, V289, P252, DOI 10.1006/viro.2001.1150; PRINGLE CR, 2005, VIRUS TAXONOMY, P609; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Rudolph MG, 2003, STRUCTURE, V11, P1219, DOI 10.1016/j.str.2003.08.011	21	237	248	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1279	1283		10.1126/science.1177634	http://dx.doi.org/10.1126/science.1177634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965480				2022-12-24	WOS:000272117900052
J	Pinto-Tomas, AA; Anderson, MA; Suen, G; Stevenson, DM; Chu, FST; Cleland, WW; Weimer, PJ; Currie, CR				Pinto-Tomas, Adrian A.; Anderson, Mark A.; Suen, Garret; Stevenson, David M.; Chu, Fiona S. T.; Cleland, W. Wallace; Weimer, Paul J.; Currie, Cameron R.			Symbiotic Nitrogen Fixation in the Fungus Gardens of Leaf-Cutter Ants	SCIENCE			English	Article							TROPICAL RAIN-FOREST; ATTA-CEPHALOTES; CUTTING ANTS; DIVERSITY; ABUNDANCE; REFUSE; NESTS	Bacteria-mediated acquisition of atmospheric N-2 serves as a critical source of nitrogen in terrestrial ecosystems. Here we reveal that symbiotic nitrogen fixation facilitates the cultivation of specialized fungal crops by leaf-cutter ants. By using acetylene reduction and stable isotope experiments, we demonstrated that N-2 fixation occurred in the fungus gardens of eight leaf-cutter ant species and, further, that this fixed nitrogen was incorporated into ant biomass. Symbiotic N-2-fixing bacteria were consistently isolated from the fungus gardens of 80 leaf-cutter ant colonies collected in Argentina, Costa Rica, and Panama. The discovery of N-2 fixation within the leaf-cutter ant-microbe symbiosis reveals a previously unrecognized nitrogen source in neotropical ecosystems.	[Pinto-Tomas, Adrian A.; Suen, Garret; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Pinto-Tomas, Adrian A.] Univ Costa Rica, Dept Bioquim, Fac Med, San Jose, Costa Rica; [Pinto-Tomas, Adrian A.] Univ Costa Rica, Ctr Invest Estruct Microscop, San Jose, Costa Rica; [Anderson, Mark A.; Chu, Fiona S. T.; Cleland, W. Wallace] Univ Wisconsin, Dept Biochem, Inst Enzyme Res, Madison, WI 53726 USA; [Suen, Garret; Currie, Cameron R.] Univ Wisconsin, US DOE, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Stevenson, David M.; Weimer, Paul J.] ARS, USDA, US Dairy Forage Res Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Universidad Costa Rica; Universidad Costa Rica; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Currie, CR (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	currie@bact.wisc.edu	Weimer, Paul James/AAY-6485-2020; Suen, Garret/AAF-2080-2019	Weimer, Paul James/0000-0002-9278-6535; Suen, Garret/0000-0002-6170-711X	NSF [MCB-0731822, MCB-0702025, DEB-0747002]; NIH [GM 18938]; OTS; U. S. Department of Energy's Great Lakes Bioenergy Research Center [DE-FC02-07ER64494]; U. S. Department of Agriculture-Agricultural Research Service Current Research Information System [3655-41000-005-00D]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018938, R37GM018938] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OTS; U. S. Department of Energy's Great Lakes Bioenergy Research Center(United States Department of Energy (DOE)); U. S. Department of Agriculture-Agricultural Research Service Current Research Information System(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Steffensen, L. Schwab, L. Uribe, M. Mora, B. Matarrita, D. Brenes, R. Araya, H. Read, J. Mentzer, D. Maly, and G. Pine for technical assistance; Y. Zhang, E. Pohlmann, and G. Roberts for assistance with acetylene reduction assays; A. Little, S. Price, and U. Mueller for leaf-cutter ant colony collection; M. Rogel-Hernandez and E. Martinez-Romero for providing isolate K. variicola F2R9; B. Ma, A. Charkowski, and N. Perna for assistance with phylogenetic analyses; E. Sanchez, R. Moreira, and T. Escalante for assistance with microscopic analyses; N. Keuler for statistical advice; the sequencing and production teams at the Joint Genome Institute; and S. Adams, F. Aylward, E. Caldera, N. Gerardo, H. Goodrich-Blair, K. Grubbs, S. Marsh, M. Poulsen, K. Raffa, G. Roberts, E. Ruby, T. Schultz, and J. Scott for comments on the manuscript. We acknowledge the Organization for Tropical Studies (OTS) and the Ministerio de Ambiente y Energia in Costa Rica, the Autoridad Nacional del Ambiente in Panama, and the Government of Argentina for facilitating the research and granting collecting permits. This work was funded by NSF grants MCB-0731822, MCB-0702025, and DEB-0747002 to C. R. C.; NIH grant GM 18938 to W. W. C., and an OTS research fellowship to A. A. P.-T. G. S. and C. R. C. were supported by the U. S. Department of Energy's Great Lakes Bioenergy Research Center under contract DE-FC02-07ER64494; D. M. S. and P. J. W. were supported by U. S. Department of Agriculture-Agricultural Research Service Current Research Information System project 3655-41000-005-00D. DNA sequence data were deposited in GenBank under accession numbers FJ593730 to FJ593840 and GQ342603 to GQ342604.	Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; BREZNAK JA, 1973, NATURE, V244, P577, DOI 10.1038/244577a0; Bucher EH, 2004, BIOTROPICA, V36, P327, DOI 10.1646/04005; Burris R H, 1972, Methods Enzymol, V24, P415; Cherrett J.M., 1989, P93; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Davidson D. W., 1996, NEOTROPICAL BIODIVER, P127; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Doolittle M, 2008, BIORESOURCE TECHNOL, V99, P3297, DOI 10.1016/j.biortech.2007.07.013; Farji-Brener AG, 2000, BIOTROPICA, V32, P120, DOI 10.1646/0006-3606(2000)032[0120:TIOWTD]2.0.CO;2; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Garrettson M, 1998, J TROP ECOL, V14, P17, DOI 10.1017/S0266467498000029; HAINES BL, 1978, BIOTROPICA, V10, P270, DOI 10.2307/2387679; Holldobler B., 1990, pi; Nardi JB, 2002, J INSECT PHYSIOL, V48, P751, DOI 10.1016/S0022-1910(02)00105-1; PERFECTO I, 1993, BIOTROPICA, V25, P316, DOI 10.2307/2388789; Schoonhoven L. M., 2005, Insect-plant biology; Schultz Ted R., 2005, P149; SCRIBER JM, 1979, ECOLOGY, V60, P829, DOI 10.2307/1936618; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Weber N. A., 1972, GARDENING ANTS ATTIN; Wilson E.O., 1986, P1; Wilson EO., 1990, SUCCESS DOMINANCE EC, V2; Wirth R, 2003, HERBIVORY LEAF CUTTI; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x	27	220	229	5	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1120	1123		10.1126/science.1173036	http://dx.doi.org/10.1126/science.1173036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965433				2022-12-24	WOS:000271951000047
J	Correll, CU; Manu, P; Olshanskiy, V; Napolitano, B; Kane, JM; Malhotra, AK				Correll, Christoph U.; Manu, Peter; Olshanskiy, Vladimir; Napolitano, Barbara; Kane, John M.; Malhotra, Anil K.			Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; 3RD NATIONAL-HEALTH; INDUCED WEIGHT-GAIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; DOUBLE-BLIND; CARDIOVASCULAR RISK; GLUCOSE-TOLERANCE	Context Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychotic medication. Objective To study the association of second-generation antipsychotic medications with body composition and metabolic parameters in patients without prior antipsychotic medication exposure. Design, Setting, and Patients Nonrandomized Second-Generation Antipsychotic Treatment Indications, Effectiveness and Tolerability in Youth ( SATIETY) cohort study, conducted between December 2001 and September 2007 at semi-urban, tertiary care, academic inpatient and outpatient clinics in Queens, New York, with a catchment area of 4.5-million individuals. Of 505 youth aged 4 to 19 years with 1 week or less of antipsychotic medication exposure, 338 were enrolled (66.9%). Of these patients, 272 had at least 1 postbaseline assessment (80.5%), and 205 patients who completed the study ( 60.7%). Patients had mood spectrum (n=130; 47.8%), schizophrenia spectrum (n=82; 30.1%), and disruptive or aggressive behavior spectrum (n=60; 22.1%) disorders. Fifteen patients who refused participation or were non-adherent served as a comparison group. Intervention Treatment with aripiprazole, olanzapine, quetiapine, or risperidone for 12 weeks. Main Outcome Measures Weight gain and changes in lipid and metabolic parameters. Results After a median of 10.8 weeks (interquartile range, 10.5-11.2 weeks) of treatment, weight increased by 8.5 kg (95% confidence interval [CI], 7.4 to 9.7 kg) with olanzapine (n=45), by 6.1 kg ( 95% CI, 4.9 to 7.2 kg) with quetiapine (n=36), by 5.3 kg ( 95% CI, 4.8 to 5.9 kg) with risperidone (n=135), and by 4.4 kg ( 95% CI, 3.7 to 5.2 kg) with aripiprazole (n=41) compared with the minimal weight change of 0.2 kg ( 95% CI, -1.0 to 1.4 kg) in the untreated comparison group (n=15). With olanzapine and quetiapine, respectively, mean levels increased significantly for total cholesterol (15.6 mg/dL [ 95% CI, 6.9 to 24.3 mg/dL] P < .001 and 9.1 mg/dL [ 95% CI, 0.4 to 17.7 mg/dL] P=.046), triglycerides ( 24.3 mg/dL [ 95% CI, 9.8 to 38.9 mg/dL] P=.002 and 37.0 mg/dL [ 95% CI, 10.1 to 63.8 mg/dL] P=.01), non-high-density lipoprotein (HDL) cholesterol (16.8 mg/dL [ 95% CI, 9.3 to 24.3 mg/dL] P < .001 and 9.9 mg/dL [ 95% CI, 1.4 to 18.4 mg/dL] P=.03), and ratio of triglycerides to HDL cholesterol (0.6 [95% CI, 0.2 to 0.9] P=.002 and (1.2 [ 95% CI, 0.4 to 2.0] P=.004). With risperidone, triglycerides increased significantly ( mean level, 9.7 mg/dL [95% CI, 0.5 to 19.0 mg/dL]; P=.04). Metabolic baseline-to-end-point changes were not significant with aripiprazole or in the untreated comparison group. Conclusions First-time second-generation antipsychotic medication use was associated with significant weight gain with each medication. Metabolic changes varied among the 4 antipsychotic medications. JAMA. 2009;302(16):1765-1773 www.jama.com	[Correll, Christoph U.; Manu, Peter; Olshanskiy, Vladimir; Napolitano, Barbara; Kane, John M.; Malhotra, Anil K.] Zucker Hillside Hosp, Glen Oaks, NY 11004 USA; [Correll, Christoph U.; Manu, Peter; Kane, John M.; Malhotra, Anil K.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Correll, Christoph U.; Napolitano, Barbara; Kane, John M.; Malhotra, Anil K.] Feinstein Inst Med Res, Manhasset, NY USA; [Napolitano, Barbara] N Shore Univ Hosp, Manhasset, NY USA	Northwell Health; Yeshiva University; Albert Einstein College of Medicine; Northwell Health; Northwell Health; North Shore University Hospital	Correll, CU (corresponding author), Zucker Hillside Hosp, 75-59 263rd St, Glen Oaks, NY 11004 USA.	ccorrell@lij.edu	Correll, Christoph U/AAY-3179-2021; Correll, Christoph/D-3530-2011	Correll, Christoph/0000-0002-7254-5646	National Institutes of Health [MH01760]; National Alliance for Research in Schizophrenia and Depression Independent Investigator [074543-01]; National Center for Research Resources [M01 RR018535]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH074543, K23MH001760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research in Schizophrenia and Depression Independent Investigator(NARSAD); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported in parts by grant MH01760 to Dr Malhotra from the National Institutes of Health, a National Alliance for Research in Schizophrenia and Depression Independent Investigator Award to Dr Malhotra, grant MH 074543-01 to Dr Kane for the Zucker Hillside Hospital National Institute of Mental Health Advanced Center for Intervention and Services Research for the Study of Schizophrenia, and by funding from the Feinstein Institute for Medical Research North Shore-Long Island Jewish Health System General Clinical Research Center, and grant M01 RR018535 from the National Center for Research Resources, which is a component of the National Institutes of Health.	Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Calarge CA, 2009, J CHILD ADOL PSYCHOP, V19, P101, DOI 10.1089/cap.2008.007; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Correll CU, 2008, INT REV PSYCHIATR, V20, P195, DOI 10.1080/09540260801889179; Correll CU, 2008, J CLIN PSYCHIAT, V69, P26; Daumit GL, 2008, SCHIZOPHR RES, V105, P175, DOI 10.1016/j.schres.2008.07.006; De Michele M, 2002, STROKE, V33, P2923, DOI 10.1161/01.STR.0000038989.90931.BE; Fleischhacker WW, 2008, J CLIN PSYCHIAT, V69, P514, DOI 10.4088/JCP.v69n0401; Fraguas D, 2008, J CLIN PSYCHIAT, V69, P1166, DOI 10.4088/JCP.v69n0717; Henderson DC, 2005, ARCH GEN PSYCHIAT, V62, P19, DOI 10.1001/archpsyc.62.1.19; Hoffman RP, 2008, PEDIATR DIABETES, V9, P57, DOI 10.1111/j.1399-5448.2007.00350.x; Juonala M, 2006, ATHEROSCLEROSIS, V185, P388, DOI 10.1016/j.atherosclerosis.2005.06.016; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kelley GA, 2006, ATHEROSCLEROSIS, V184, P207, DOI 10.1016/j.atherosclerosis.2005.04.005; Kryzhanovskaya LA, 2009, J CLIN PSYCHIAT, V70, P247, DOI 10.4088/JCP.08m03538; Lee JM, 2006, DIABETES CARE, V29, P2427, DOI 10.2337/dc06-0709; Lloyd-Jones DM, 2007, CIRCULATION, V115, P1004, DOI 10.1161/CIRCULATIONAHA.106.648642; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McEvoy JP, 2007, AM J PSYCHIAT, V164, P1050, DOI 10.1176/appi.ajp.164.7.1050; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; Meyer JM, 2008, SCHIZOPHR RES, V103, P104, DOI 10.1016/j.schres.2008.04.023; Morrato EH, 2008, J CLIN PSYCHIAT, V69, P316, DOI 10.4088/JCP.v69n0219; Olfson M, 2006, ARCH GEN PSYCHIAT, V63, P679, DOI 10.1001/archpsyc.63.6.679; Perez-Iglesias R, 2007, J CLIN PSYCHIAT, V68, P1733, DOI 10.4088/JCP.v68n1113; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Robinson DG, 2006, AM J PSYCHIAT, V163, P2096, DOI 10.1176/ajp.2006.163.12.2096; Safer DJ, 2004, J CLIN PSYCHOPHARM, V24, P429, DOI 10.1097/01.jcp.0000130558.86125.5b; Schimmelmann BG, 2007, J CHILD ADOL PSYCHOP, V17, P768, DOI 10.1089/cap.2007.0048; Sikich L, 2004, NEUROPSYCHOPHARMACOL, V29, P133, DOI 10.1038/sj.npp.1300327; Sikich L, 2008, AM J PSYCHIAT, V165, P1420, DOI 10.1176/appi.ajp.2008.08050756; Simon V, 2009, J CLIN PSYCHIAT, V70, P1041, DOI 10.4088/JCP.08r04392; Sinaiko AR, 1999, CIRCULATION, V99, P1471, DOI 10.1161/01.CIR.99.11.1471; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; Straker D, 2005, AM J PSYCHIAT, V162, P1217, DOI 10.1176/appi.ajp.162.6.1217; Verma S, 2009, AUST NZ J PSYCHIAT, V43, P812, DOI 10.1080/00048670903107609; Winkleby MA, 1999, JAMA-J AM MED ASSOC, V281, P1006, DOI 10.1001/jama.281.11.1006	39	701	710	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 28	2009	302	16					1765	1773		10.1001/jama.2009.1549	http://dx.doi.org/10.1001/jama.2009.1549			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511FW	19861668	Green Accepted, Bronze			2022-12-24	WOS:000271150300019
J	Weisz, C; Glowatzki, E; Fuchs, P				Weisz, Catherine; Glowatzki, Elisabeth; Fuchs, Paul			The postsynaptic function of type II cochlear afferents	NATURE			English	Article							OUTER HAIR-CELLS; GUINEA-PIG COCHLEA; SPIRAL GANGLION NEURONS; RIBBON SYNAPSE; RAT COCHLEA; HORSERADISH-PEROXIDASE; TRANSMITTER RELEASE; RECEPTOR SUBUNITS; INNERVATION; FIBERS	The mammalian cochlea is innervated by two classes of sensory neurons. Type I neurons make up 90-95% of the cochlear nerve and contact single inner hair cells to provide acoustic analysis as we know it. In contrast, the far less numerous type II neurons arborize extensively among outer hair cells (OHCs)(1,2) and supporting cells(3,4). Their scarcity and smaller calibre axons have made them the subject of much speculation, but little experimental progress for the past 50 years. Here we record from type II fibres near their terminal arbors under OHCs to show that they receive excitatory glutamatergic synaptic input. The type II peripheral arbor conducts action potentials, but the small and infrequent glutamatergic excitation indicates a requirement for strong acoustic stimulation. Furthermore, we show that type II neurons are excited by ATP. Exogenous ATP depolarized type II neurons, both directly and by evoking glutamatergic synaptic input(5). These results prove that type II neurons function as cochlear afferents, and can be modulated by ATP. The lesser magnitude of synaptic drive dictates a fundamentally different role in auditory signalling from that of type I afferents.	[Weisz, Catherine; Glowatzki, Elisabeth; Fuchs, Paul] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Glowatzki, Elisabeth; Fuchs, Paul] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA; [Glowatzki, Elisabeth; Fuchs, Paul] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Fuchs, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pfuchs1@jhmi.edu		Weisz, Catherine/0000-0002-2595-835X; Glowatzki, Elisabeth/0000-0003-3135-658X	NIDCD [R01 DC000276, R01 DC006476, T32 DC000023]; Blaustein Pain Foundation of Johns Hopkins; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000023, P30DC005211, R01DC000276, R01DC006476] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Blaustein Pain Foundation of Johns Hopkins; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by NIDCD grants R01 DC000276 and R01 DC006476, T32 DC000023 and a grant from the Blaustein Pain Foundation of Johns Hopkins.	BERGLUND AM, 1987, J COMP NEUROL, V255, P560, DOI 10.1002/cne.902550408; BERGLUND AM, 1994, HEARING RES, V75, P121, DOI 10.1016/0378-5955(94)90063-9; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; BROWN MC, 1987, J COMP NEUROL, V260, P591, DOI 10.1002/cne.902600411; BROWN MC, 1988, J COMP NEUROL, V278, P591, DOI 10.1002/cne.902780410; Burgess BJ, 1997, HEARING RES, V108, P74, DOI 10.1016/S0378-5955(97)00040-3; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; DUNN RA, 1975, P NATL ACAD SCI USA, V72, P3599, DOI 10.1073/pnas.72.9.3599; Fechner FP, 2001, J COMP NEUROL, V429, P289, DOI 10.1002/1096-9861(20000108)429:2<289::AID-CNE9>3.0.CO;2-Z; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; HASHIMOTO S, 1988, ACTA OTO-LARYNGOL, V105, P64, DOI 10.3109/00016488809119447; Huang LC, 2005, J COMP NEUROL, V484, P133, DOI 10.1002/cne.20442; Jagger DJ, 2003, J PHYSIOL-LONDON, V552, P525, DOI 10.1111/j.1469-7793.2003.00525.x; Jarlebark LE, 2000, J COMP NEUROL, V421, P289, DOI 10.1002/(SICI)1096-9861(20000605)421:3<289::AID-CNE1>3.0.CO;2-0; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Lorente de No R, 1937, LARYNGOSCOPE, V47, P373; Matsubara A, 1996, J NEUROSCI, V16, P4457; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Munoz DJB, 2001, ACTA OTO-LARYNGOL, V121, P10; NAKAGAWA T, 1990, J NEUROPHYSIOL, V63, P1068, DOI 10.1152/jn.1990.63.5.1068; Neef A, 2007, J NEUROSCI, V27, P12933, DOI 10.1523/JNEUROSCI.1996-07.2007; PERKINS RE, 1975, J COMP NEUROL, V163, P129, DOI 10.1002/cne.901630202; Reid MA, 2004, J NEUROSCI, V24, P733, DOI 10.1523/JNEUROSCI.3923-03.2004; ROBERTSON D, 1984, HEARING RES, V15, P113, DOI 10.1016/0378-5955(84)90042-X; SIMMONS DD, 1988, J COMP NEUROL, V270, P145, DOI 10.1002/cne.902700112; Thiers FA, 2008, JARO-J ASSOC RES OTO, V9, P477, DOI 10.1007/s10162-008-0135-x; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Wang JCC, 2003, NEUROREPORT, V14, P817, DOI 10.1097/00001756-200305060-00008	30	108	109	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1126	U226		10.1038/nature08487	http://dx.doi.org/10.1038/nature08487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847265	Green Accepted			2022-12-24	WOS:000270987600045
J	Yeh, HC; Duncan, BB; Schmidt, MI; Wang, NY; Brancati, FL				Yeh, Hsin-Chieh; Duncan, Bruce B.; Schmidt, Maria Ines; Wang, Nae-Yuh; Brancati, Frederick L.			Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ATHEROSCLEROSIS RISK; WEIGHT-GAIN; INSULIN-RESISTANCE; COMMUNITIES; OBESITY; INFLAMMATION; EFFICIENCY	Background: Cigarette smoking is an established predictor of incident type 2 diabetes mellitus, but the effects of smoking cessation on diabetes risk are unknown. Objective: To test the hypothesis that smoking cessation increases diabetes risk in the short term, possibly owing to cessation-related weight gain. Design: Prospective cohort study. Setting: The ARIC (Atherosclerosis Risk in Communities) Study. Patients: 10 892 middle-aged adults who initially did not have diabetes in 1987 to 1989. Measurements: Smoking was assessed by interview at baseline and at subsequent follow-up. Incident diabetes was ascertained by fasting glucose assays through 1998 and self-report of physician diagnosis or use of diabetes medications through 2004. Results: During 9 years of follow-up, 1254 adults developed type 2 diabetes. Compared with adults who never smoked, the adjusted hazard ratio of incident diabetes in the highest tertile of pack-years was 1.42 (95% CI, 1.20 to 1.67). In the first 3 years of follow-up, 380 adults quit smoking. After adjustment for age, race, sex, education, adiposity, physical activity, lipid levels, blood pressure, and ARIC Study center, compared with adults who never smoked, the hazard ratios of diabetes among former smokers, new quitters, and continuing smokers were 1.22 (CI, 0.99 to 1.50), 1.73 (CI, 1.19 to 2.53), and 1.31 (CI, 1.04 to 1.65), respectively. Further adjustment for weight change and leukocyte count attenuated these risks substantially. In an analysis of long-term risk after quitting, the highest risk occurred in the first 3 years (hazard ratio, 1.91 [CI, 1.19 to 3.05]), then gradually decreased to 0 at 12 years. Limitation: Residual confounding is possible even with meticulous adjustment for established diabetes risk factors. Conclusion: Cigarette smoking predicts incident type 2 diabetes, but smoking cessation leads to higher short-term risk. For smokers at risk for diabetes, smoking cessation should be coupled with strategies for diabetes prevention and early detection.	[Yeh, Hsin-Chieh] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Univ Fed Rio Grande do Sul, BR-90470280 Porto Alegre, RS, Brazil; Univ N Carolina, Chapel Hill, NC USA	Johns Hopkins University; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill	Yeh, HC (corresponding author), Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	hyeh1@jhmi.edu	Schmidt, Maria/V-3196-2019; Schmidt, Maria Inês/AGT-5691-2022; Duncan, Bruce B/L-4140-2016; Schmidt, Maria Inês/AGP-6441-2022	Duncan, Bruce B/0000-0002-7491-2630; Schmidt, Maria Inês/0000-0002-3837-0731; Wang, Nae-Yuh/0000-0001-6513-9730	NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; NIDDK [5R01-DK56918-03]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055020, N01HC055015, N01HC055018, N01HC055016, N01HC055022, N01HC055019] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R41HL055019, R42HL055018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, P60DK079637, R01DK056918] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The ARIC Study is supported by contracts from the NHLBI (N01-HC-55015, N01-HC-55016, N01-HC-55018, N01HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022) and a grant from the NIDDK (5R01-DK56918-03).	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Balkau B, 2006, EUR J CARDIOV PREV R, V13, P334, DOI 10.1097/00149831-200606000-00007; Blaschke F, 2006, ARTERIOSCL THROM VAS, V26, P28, DOI 10.1161/01.ATV.0000191663.12164.77; Chinn S, 2005, LANCET, V365, P1629, DOI 10.1016/S0140-6736(05)66511-7; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Duncan BB, 2003, OBES RES, V11, P1339, DOI 10.1038/oby.2003.181; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Ferrara CM, 2001, INT J OBESITY, V25, P1322, DOI 10.1038/sj.ijo.0801716; Hur NW, 2007, EUR J CARDIOV PREV R, V14, P244, DOI 10.1097/01.hjr.0000239474.41379.79; Liu R, 2001, METABOLISM, V50, P79, DOI 10.1053/meta.2001.19436; Liu S, 2007, ARCH INTERN MED, V167, P1676, DOI 10.1001/archinte.167.15.1676; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; O'Malley SS, 2006, ARCH INTERN MED, V166, P667, DOI 10.1001/archinte.166.6.667; Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; *U N CAR ARIC COOR, 1987, 2 U N CAR ARIC COORD; *U N CAR ARIC COOR, 1987, 11 U N CAR ARIC COOR; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; WARNICK GR, 1982, CLIN CHEM, V28, P1574; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wittebole X, 2007, CLIN EXP IMMUNOL, V147, P28, DOI 10.1111/j.1365-2249.2006.03248.x; Yeh HC, 2005, DIABETES CARE, V28, P1472, DOI 10.2337/diacare.28.6.1472	29	232	239	2	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					10	W3		10.7326/0003-4819-152-1-201001050-00005	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FJ	20048267	Green Accepted			2022-12-24	WOS:000273556600002
J	Costello, EK; Lauber, CL; Hamady, M; Fierer, N; Gordon, JI; Knight, R				Costello, Elizabeth K.; Lauber, Christian L.; Hamady, Micah; Fierer, Noah; Gordon, Jeffrey I.; Knight, Rob			Bacterial Community Variation in Human Body Habitats Across Space and Time	SCIENCE			English	Article							MICROBIAL COMMUNITIES; DIVERSITY; FLORA	Elucidating the biogeography of bacterial communities on the human body is critical for establishing healthy baselines from which to detect differences associated with diseases. To obtain an integrated view of the spatial and temporal distribution of the human microbiota, we surveyed bacteria from up to 27 sites in seven to nine healthy adults on four occasions. We found that community composition was determined primarily by body habitat. Within habitats, interpersonal variability was high, whereas individuals exhibited minimal temporal variability. Several skin locations harbored more diverse communities than the gut and mouth, and skin locations differed in their community assembly patterns. These results indicate that our microbiota, although personalized, varies systematically across body habitats and time; such trends may ultimately reveal how microbiome changes cause or prevent disease.	[Costello, Elizabeth K.; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Lauber, Christian L.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Hamady, Micah] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Knight, Rob] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL); Howard Hughes Medical Institute	Knight, R (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	rob.knight@colorado.edu	Knight, Rob/D-1299-2010	FIERER, NOAH/0000-0002-6432-4261; Knight, Rob/0000-0002-0975-9019	Howard Hughes Medical Institute; NIH [DK78669, DK64540]; Bill and Melinda Gates Foundation; Crohns and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, P50DK064540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Crohns and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the volunteers for their participation; J. Manchester for pyrosequencing; D. McDonald and J. Kuczynski for bioinformatics support; K. Ramirez and R. Gesumaria for sample collection and processing; L. Kyro for graphical design; and M. Blaser, P. Hugenholtz, G. Huttley, N. Pace, and members of the Knight laboratory for valuable feedback. This work was supported in part by the Howard Hughes Medical Institute, and by grants from the NIH (DK78669, DK64540), the Bill and Melinda Gates Foundation, and the Crohns and Colitis Foundation of America. Sequences were deposited in the European Read Archive (accession number ERA000159).	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wilson M., 2008, BACTERIOLOGY HUMANS	17	2017	2111	27	794	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1694	1697		10.1126/science.1177486	http://dx.doi.org/10.1126/science.1177486			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19892944	Green Accepted			2022-12-24	WOS:000272839000053
J	Perez-Caballero, D; Zang, T; Ebrahimi, A; McNatt, MW; Gregory, DA; Johnson, MC; Bieniasz, PD				Perez-Caballero, David; Zang, Trinity; Ebrahimi, Alaleh; McNatt, Matthew W.; Gregory, Devon A.; Johnson, Marc C.; Bieniasz, Paul D.			Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells	CELL			English	Article							PARTICLE RELEASE; VPU PROTEIN; RESTRICTION; SURFACE; CLONING	Tetherin is an interferon-induced protein whose expression blocks the release of HIV-1 and other enveloped viral particles. The underlying mechanism by which tetherin functions and whether it directly or indirectly causes virion retention are unknown. Here, we elucidate the mechanism by which tetherin exerts its antiviral activity. We demonstrate, through mutational analyses and domain replacement experiments, that tetherin configuration rather than primary sequence is critical for antiviral activity. These findings allowed the design of a completely artificial protein, lacking sequence homology with native tetherin, that nevertheless mimicked its antiviral activity. We further show that tetherin is incorporated into HIV-1 particles as a parallel homodimer using either of its two membrane anchors. These results indicate that tetherin functions autonomously and directly and that infiltration of virion envelopes by one or both of tetherin's membrane anchors is necessary, and likely sufficient, to tether enveloped virus particles that bud through the plasma membrane.	[Perez-Caballero, David; Zang, Trinity; Ebrahimi, Alaleh; McNatt, Matthew W.; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Perez-Caballero, David; Zang, Trinity; Ebrahimi, Alaleh; McNatt, Matthew W.; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10016 USA; [Zang, Trinity; Bieniasz, Paul D.] Aaron Diamond AIDS Res Ctr, Howard Hughes Med Inst, New York, NY 10016 USA; [Gregory, Devon A.; Johnson, Marc C.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; University of Missouri System; University of Missouri Columbia	Bieniasz, PD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	pbienias@adarc.org	Sánchez, Juan/D-2036-2016; Moretón, Auxiliadora/D-1334-2016	Sánchez, Juan/0000-0003-4703-3435; Moretón, Auxiliadora/0000-0003-4703-3435	National Institutes of Health [RO1AI50111]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073098, R01AI050111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Bieniasz laboratory for helpful discussions and T. Kinoshita for PIGL-defective cells. This work was supported by National Institutes of Health grant RO1AI50111. P. D. B. is an Investigator of the Howard Hughes Medical Institute.	Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2008, NAT MED, V14, P641, DOI 10.1038/nm1778; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	22	442	461	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					499	511		10.1016/j.cell.2009.08.039	http://dx.doi.org/10.1016/j.cell.2009.08.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879838	Bronze, Green Accepted			2022-12-24	WOS:000271259600015
J	Kong, A; Steinthorsdottir, V; Masson, G; Thorleifsson, G; Sulem, P; Besenbacher, S; Jonasdottir, A; Sigurdsson, A; Kristinsson, KT; Jonasdottir, A; Frigge, ML; Gylfason, A; Olason, PI; Gudjonsson, SA; Sverrisson, S; Stacey, SN; Sigurgeirsson, B; Benediktsdottir, KR; Sigurdsson, H; Jonsson, T; Benediktsson, R; Olafsson, JH; Johannsson, OT; Hreidarsson, AB; Sigurdsson, G; Ferguson-Smith, AC; Gudbjartsson, DF; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Steinthorsdottir, Valgerdur; Masson, Gisli; Thorleifsson, Gudmar; Sulem, Patrick; Besenbacher, Soren; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Kristinsson, Kari Th.; Jonasdottir, Adalbjorg; Frigge, Michael L.; Gylfason, Arnaldur; Olason, Pall I.; Gudjonsson, Sigurjon A.; Sverrisson, Sverrir; Stacey, Simon N.; Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Sigurdsson, Helgi; Jonsson, Thorvaldur; Benediktsson, Rafn; Olafsson, Jon H.; Johannsson, Oskar Th.; Hreidarsson, Astradur B.; Sigurdsson, Gunnar; Ferguson-Smith, Anne C.; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Stefansson, Kari		DIAGRAM Consortium	Parental origin of sequence variants associated with complex diseases	NATURE			English	Article							GENOME-WIDE ASSOCIATION; IMPRINTED GENES; SUSCEPTIBILITY; EXPRESSION; IMPUTATION; KCNQ1	Effects of susceptibility variants may depend on from which parent they are inherited. Although many associations between sequence variants and human traits have been discovered through genome-wide associations, the impact of parental origin has largely been ignored. Here we show that for 38,167 Icelanders genotyped using single nucleotide polymorphism ( SNP) chips, the parental origin of most alleles can be determined. For this we used a combination of genealogy and long-range phasing. We then focused on SNPs that associate with diseases and are within 500 kilobases of known imprinted genes. Seven independent SNP associations were examined. Five-one with breast cancer, one with basal-cell carcinoma and three with type 2 diabetes-have parental-origin-specific associations. These variants are located in two genomic regions, 11p15 and 7q32, each harbouring a cluster of imprinted genes. Furthermore, we observed a novel association between the SNP rs2334499 at 11p15 and type 2 diabetes. Here the allele that confers risk when paternally inherited is protective when maternally transmitted. We identified a differentially methylated CTCF-binding site at 11p15 and demonstrated correlation of rs2334499 with decreased methylation of that site.	[Kong, Augustine; Steinthorsdottir, Valgerdur; Masson, Gisli; Thorleifsson, Gudmar; Sulem, Patrick; Besenbacher, Soren; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Frigge, Michael L.; Gylfason, Arnaldur; Olason, Pall I.; Gudjonsson, Sigurjon A.; Sverrisson, Sverrir; Stacey, Simon N.; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Benediktsdottir, Kristrun R.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Sigurdsson, Helgi; Johannsson, Oskar Th.] Landspitali Univ Hosp, Dept Oncol, IS-101 Reykjavik, Iceland; [Jonsson, Thorvaldur] Landspitali Univ Hosp, Dept Surg, IS-101 Reykjavik, Iceland; [Benediktsson, Rafn; Hreidarsson, Astradur B.; Sigurdsson, Gunnar] Landspitali Univ Hosp, Dept Endocrinol & Metab, IS-101 Reykjavik, Iceland; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Cambridge; University of Iceland	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kstefans@decode.is	Abecasis, Goncalo R/B-7840-2010; Stefansson, Kari/AAE-7187-2019; Sigurgeirsson, Bárður/B-6130-2011; Altshuler, David M/A-4476-2009; Sijbrands, Eric/A-1065-2009; Boehm, Bernhard Otto/F-8750-2015; FROGUEL, Philippe/O-6799-2017; Hide, Winston/R-3815-2019; Rudan, Igor/I-1467-2012; Ferguson-Smith, Anne C/G-7534-2011; Sigurgeirsson, Bardur/AAP-7755-2020; Aulchenko, Yurii/M-8270-2013; Elliott, Amanda/G-5120-2012; Hide, Winston A/V-2727-2017; Hide, Winston Hide/C-7217-2009; Campbell, Harry/E-2959-2010; Langenberg, Claudia/ABG-9067-2021; Walters, G. Bragi/L-4215-2013; Benediktsson, Rafn/R-2457-2018; Meitinger, Thomas/O-1318-2015; Griffin, Simon/K-3106-2013; McCarthy, Mark/M-3763-2015	Altshuler, David M/0000-0002-7250-4107; Sijbrands, Eric/0000-0001-8857-7389; FROGUEL, Philippe/0000-0003-2972-0784; Hide, Winston/0000-0002-8621-3271; Rudan, Igor/0000-0001-6993-6884; Aulchenko, Yurii/0000-0002-7899-1575; Hide, Winston A/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Campbell, Harry/0000-0002-6169-6262; Langenberg, Claudia/0000-0002-5017-7344; Walters, G. Bragi/0000-0002-5415-6487; Benediktsson, Rafn/0000-0002-2954-9801; Sigurgeirsson, Bardur/0000-0002-9733-9742; Kong, Augustine/0000-0001-8193-5438; Weedon, Michael/0000-0002-6174-6135; Van Duijn, Cornelia/0000-0002-2374-9204; Griffin, Simon/0000-0002-2157-4797; Bergman, Richard/0000-0003-1539-4471; Gudbjartsson, Daniel/0000-0002-5222-9857; Zeggini, Eleftheria/0000-0003-4238-659X; Gloyn, Anna/0000-0003-1205-1844; Saxena, Richa/0000-0003-2233-1065; Hattersley, Andrew/0000-0001-5620-473X; bennett, amanda/0000-0003-2140-8710; Ferguson-Smith, Anne/0000-0002-7608-5894; Lindgren, Cecilia/0000-0002-4903-9374; Pramstaller, Peter P/0000-0002-9831-8302; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Besenbacher, Soren/0000-0003-1455-1738; McCarthy, Mark/0000-0002-4393-0510; Jorgensen, Torben/0000-0001-9453-2830; Meitinger, Thomas/0000-0002-8838-8403; Dina, Christian/0000-0002-7722-7348; Abecasis, Goncalo/0000-0003-1509-1825; Gudjonsson, Sigurjon A./0000-0001-9314-7412	FP7-MC-IAPP [218071]; Medical Research Council [MC_U106179471, MC_U127592696, G9723500, MC_U106179474] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029867] Funding Source: NIH RePORTER; MRC [MC_U106179474, G9723500, MC_U127592696] Funding Source: UKRI	FP7-MC-IAPP; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded in part by FP7-MC-IAPP Grant agreement no. 218071 (CancerGene) to deCODE genetics.	Authier F, 2002, J BIOL CHEM, V277, P9437, DOI 10.1074/jbc.M110188200; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Goldberg M, 2003, HUM GENET, V112, P334, DOI 10.1007/s00439-003-0907-7; Hindorff LA, 2009, CATALOG PUBLISHED GE; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Rampersaud E, 2008, CURR DIABETES REV, V4, P329, DOI 10.2174/157339908786241179; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207	24	412	424	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					868	U59		10.1038/nature08625	http://dx.doi.org/10.1038/nature08625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016592	Green Accepted			2022-12-24	WOS:000272795400032
J	Pleasance, ED; Cheetham, RK; Stephens, PJ; McBride, DJ; Humphray, SJ; Greenman, CD; Varela, I; Lin, ML; Ordonez, GR; Bignell, GR; Ye, K; Alipaz, J; Bauer, MJ; Beare, D; Butler, A; Carter, RJ; Chen, LN; Cox, AJ; Edkins, S; Kokko-Gonzales, PI; Gormley, NA; Grocock, RJ; Haudenschild, CD; Hims, MM; James, T; Jia, MM; Kingsbury, Z; Leroy, C; Marshall, J; Menzies, A; Mudie, LJ; Ning, ZM; Royce, T; Schulz-Trieglaff, OB; Spiridou, A; Stebbings, LA; Szajkowski, L; Teague, J; Williamson, D; Chin, L; Ross, MT; Campbell, PJ; Bentley, DR; Futreal, PA; Stratton, MR				Pleasance, Erin D.; Cheetham, R. Keira; Stephens, Philip J.; McBride, David J.; Humphray, Sean J.; Greenman, Chris D.; Varela, Ignacio; Lin, Meng-Lay; Ordonez, Gonzalo R.; Bignell, Graham R.; Ye, Kai; Alipaz, Julie; Bauer, Markus J.; Beare, David; Butler, Adam; Carter, Richard J.; Chen, Lina; Cox, Anthony J.; Edkins, Sarah; Kokko-Gonzales, Paula I.; Gormley, Niall A.; Grocock, Russell J.; Haudenschild, Christian D.; Hims, Matthew M.; James, Terena; Jia, Mingming; Kingsbury, Zoya; Leroy, Catherine; Marshall, John; Menzies, Andrew; Mudie, Laura J.; Ning, Zemin; Royce, Tom; Schulz-Trieglaff, Ole B.; Spiridou, Anastassia; Stebbings, Lucy A.; Szajkowski, Lukasz; Teague, Jon; Williamson, David; Chin, Lynda; Ross, Mark T.; Campbell, Peter J.; Bentley, David R.; Futreal, P. Andrew; Stratton, Michael R.			A comprehensive catalogue of somatic mutations from a human cancer genome	NATURE			English	Article							NUCLEOTIDE EXCISION-REPAIR; ETS TRANSCRIPTION FACTOR; CARCINOGENESIS; EPIDEMIOLOGY; MECHANISMS; PATHWAYS; RECEPTOR; BREAST	All cancers carry somatic mutations. A subset of these somatic alterations, termed driver mutations, confer selective growth advantage and are implicated in cancer development, whereas the remainder are passengers. Here we have sequenced the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The catalogue provides remarkable insights into the forces that have shaped this cancer genome. The dominant mutational signature reflects DNA damage due to ultraviolet light exposure, a known risk factor for malignant melanoma, whereas the uneven distribution of mutations across the genome, with a lower prevalence in gene footprints, indicates that DNA repair has been preferentially deployed towards transcribed regions. The results illustrate the power of a cancer genome sequence to reveal traces of the DNA damage, repair, mutation and selection processes that were operative years before the cancer became symptomatic.	[Pleasance, Erin D.; Stephens, Philip J.; McBride, David J.; Greenman, Chris D.; Varela, Ignacio; Lin, Meng-Lay; Ordonez, Gonzalo R.; Bignell, Graham R.; Beare, David; Butler, Adam; Chen, Lina; Edkins, Sarah; Jia, Mingming; Leroy, Catherine; Marshall, John; Menzies, Andrew; Mudie, Laura J.; Ning, Zemin; Stebbings, Lucy A.; Teague, Jon; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Cheetham, R. Keira; Humphray, Sean J.; Bauer, Markus J.; Carter, Richard J.; Cox, Anthony J.; Kokko-Gonzales, Paula I.; Gormley, Niall A.; Grocock, Russell J.; Hims, Matthew M.; James, Terena; Kingsbury, Zoya; Schulz-Trieglaff, Ole B.; Spiridou, Anastassia; Szajkowski, Lukasz; Ross, Mark T.; Bentley, David R.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Ye, Kai] Leiden Univ, Med Ctr, Dept Mol Epidemiol, NL-2333 ZC Leiden, Netherlands; [Ye, Kai] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, NL-2333 ZC Leiden, Netherlands; [Alipaz, Julie; Royce, Tom] Illumina Inc, Corp Headquarters, San Diego, CA 92121 USA; [Haudenschild, Christian D.; Williamson, David] Illumina Hayward, Hayward, CA 94545 USA; [Chin, Lynda] Dana Farber Canc Inst, Boston, MA 02115 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; Illumina; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Illumina; Illumina; Harvard University; Dana-Farber Cancer Institute; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Ye, Kai/GSD-9856-2022; Varela, Ignacio/AAA-7680-2021; Ning, Zemin/D-2411-2013; Weinstock, George M/C-6314-2013; Ye, Kai/B-3640-2012; Varela, Ignacio/G-1699-2016	Ye, Kai/0000-0002-2851-6741; Varela, Ignacio/0000-0002-0969-506X; Weinstock, George M/0000-0002-2997-4592; Varela, Ignacio/0000-0002-0969-506X; Cox, Anthony/0000-0002-6534-749X; Ning, Zemin/0000-0003-4359-776X; Marshall, John/0000-0002-1216-5457; Edkins, Sarah/0000-0003-0717-1972	Wellcome Trust [077012/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors acknowledge the support of C. Henry, S. Kahn, D. Evers, G. Smith, K. Hall and the technical and administrative support staff at Illumina. I. V. is supported by the Human Frontiers Science Program and P.J.C. by the Kay Kendall Leukaemia Fund. We would like to acknowledge the Wellcome Trust for support under grant reference 077012/Z/05/Z.	Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Daya-Grosjean L, 2005, MUTAT RES-FUND MOL M, V571, P43, DOI 10.1016/j.mrfmmm.2004.11.013; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Ghadersohi A, 2008, INT J CANCER, V123, P1376, DOI 10.1002/ijc.23667; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kawanishi S, 2001, MUTAT RES-REV MUTAT, V488, P65, DOI 10.1016/S1383-5742(00)00059-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MORSE HG, 1993, CANCER GENET CYTOGEN, V69, P108, DOI 10.1016/0165-4608(93)90083-X; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Scaglioni PP, 2007, CURR TOP MICROBIOL, V313, P85; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Sood AK, 2007, HUM PATHOL, V38, P1628, DOI 10.1016/j.humpath.2007.03.010; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; TEITZ T, 1990, GENE, V87, P295, DOI 10.1016/0378-1119(90)90316-J; Winkler GS, 2006, EMBO J, V25, P3089, DOI 10.1038/sj.emboj.7601194; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	1190	1245	1	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					191	U73		10.1038/nature08658	http://dx.doi.org/10.1038/nature08658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20016485	Green Accepted, hybrid			2022-12-24	WOS:000273582700027
J	Schurger, A; Pereira, F; Treisman, A; Cohen, JD				Schurger, Aaron; Pereira, Francisco; Treisman, Anne; Cohen, Jonathan D.			Reproducibility Distinguishes Conscious from Nonconscious Neural Representations	SCIENCE			English	Article							INVISIBLE STIMULI; VISUAL-CORTEX; AWARENESS; PERCEPTION; ATTENTION; ACTIVATION; RESPONSES; PATIENT; FACES; MRI	What qualifies a neural representation for a role in subjective experience? Previous evidence suggests that the duration and intensity of the neural response to a sensory stimulus are factors. We introduce another attribute-the reproducibility of a pattern of neural activity across different episodes-that predicts specific and measurable differences between conscious and nonconscious neural representations indepedently of duration and intensity. We found that conscious neural activation patterns are relatively reproducible when compared with nonconscious neural activation patterns corresponding to the same perceptual content. This is not adequately explained by a difference in signal-to-noise ratio.	[Schurger, Aaron; Pereira, Francisco; Treisman, Anne; Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Schurger, Aaron; Pereira, Francisco; Cohen, Jonathan D.] Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08540 USA	Princeton University; Princeton University	Schurger, A (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA.	schurger@princeton.edu	Schurger, Aaron/Y-4459-2018	Schurger, Aaron/0000-0003-2985-3253	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH075342] Funding Source: NIH RePORTER; NIMH NIH HHS [MH075342] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Haynes JD, 2009, TRENDS COGN SCI, V13, P194, DOI 10.1016/j.tics.2009.02.004; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Kinsbourne M, 1997, CARN S COGN, P335; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Pessoa L, 2003, J NEUROSCI, V23, P3990; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Sackur J, 2009, COGNITION, V111, P187, DOI 10.1016/j.cognition.2009.01.010; Schurger A, 2008, NEUROPSYCHOLOGIA, V46, P2189, DOI 10.1016/j.neuropsychologia.2008.02.020; Schurger A, 2008, TRENDS COGN SCI, V12, P209, DOI 10.1016/j.tics.2008.02.012; Schurger A, 2009, J NEUROSCI METH, V177, P199, DOI 10.1016/j.jneumeth.2008.09.028; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008	22	96	98	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					97	99		10.1126/science.1180029	http://dx.doi.org/10.1126/science.1180029			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	19965385				2022-12-24	WOS:000273395400040
J	Zhang, FR; Huang, W; Chen, SM; Sun, LD; Liu, H; Li, Y; Cui, Y; Yan, XX; Yang, HT; Yang, RD; Chu, TS; Zhang, C; Zhang, L; Han, JW; Yu, GQ; Quan, C; Yu, YX; Zhang, Z; Shi, BQ; Zhang, LH; Cheng, H; Wang, CY; Lin, Y; Zheng, HF; Fu, XA; Zuo, XB; Wang, Q; Long, H; Sun, YP; Cheng, YL; Tian, HQ; Zhou, FS; Liu, HX; Lu, WS; He, SM; Du, WL; Shen, M; Jin, QY; Wang, Y; Low, HQ; Erwin, T; Yang, NH; Li, JY; Zhao, X; Jiao, YL; Mao, LG; Yin, G; Jiang, ZX; Wang, XD; Yu, JP; Hu, ZH; Gong, CH; Liu, YQ; Liu, RY; Wang, DM; Wei, D; Liu, JX; Cao, WK; Cao, HZ; Li, YP; Yan, WG; Wei, SY; Wang, KJ; Hibberd, ML; Yang, S; Zhang, XJ; Liu, JJ				Zhang, Fu-Ren; Huang, Wei; Chen, Shu-Min; Sun, Liang-Dan; Liu, Hong; Li, Yi; Cui, Yong; Yan, Xiao-Xiao; Yang, Hai-Tao; Yang, Rong-De; Chu, Tong-Sheng; Zhang, Chi; Zhang, Lin; Han, Jian-Wen; Yu, Gong-Qi; Quan, Cheng; Yu, Yong-Xiang; Zhang, Zheng; Shi, Ben-Qing; Zhang, Lian-Hua; Cheng, Hui; Wang, Chang-Yuan; Lin, Yan; Zheng, Hou-Feng; Fu, Xi-An; Zuo, Xian-Bo; Wang, Qiang; Long, Heng; Sun, Yi-Ping; Cheng, Yi-Lin; Tian, Hong-Qing; Zhou, Fu-Sheng; Liu, Hua-Xu; Lu, Wen-Sheng; He, Su-Min; Du, Wen-Li; Shen, Min; Jin, Qi-Yi; Wang, Ying; Low, Hui-Qi; Erwin, Tantoso; Yang, Ning-Han; Li, Jin-Yong; Zhao, Xin; Jiao, Yue-Lin; Mao, Li-Guo; Yin, Gang; Jiang, Zhen-Xia; Wang, Xiao-Dong; Yu, Jing-Ping; Hu, Zong-Hou; Gong, Cui-Hua; Liu, Yu-Qiang; Liu, Rui-Yu; Wang, De-Min; Wei, Dong; Liu, Jin-Xian; Cao, Wei-Kun; Cao, Hong-Zhong; Li, Yong-Ping; Yan, Wei-Guo; Wei, Shi-Yu; Wang, Kui-Jun; Hibberd, Martin L.; Yang, Sen; Zhang, Xue-Jun; Liu, Jian-Jun			Genomewide Association Study of Leprosy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; SUSCEPTIBILITY; IMMUNITY; MYCOBACTERIA; GENETICS; GENES; HLA	BACKGROUND The narrow host range of Mycobacterium leprae and the fact that it is refractory to growth in culture has limited research on and the biologic understanding of leprosy. Host genetic factors are thought to influence susceptibility to infection as well as disease progression. METHODS We performed a two-stage genomewide association study by genotyping 706 patients and 1225 controls using the Human610-Quad BeadChip (Illumina). We then tested three independent replication sets for an association between the presence of leprosy and 93 single-nucleotide polymorphisms (SNPs) that were most strongly associated with the disease in the genomewide association study. Together, these replication sets comprised 3254 patients and 5955 controls. We also carried out tests of heterogeneity of the associations (or lack thereof) between these 93 SNPs and disease, stratified according to clinical subtype (multibacillary vs. paucibacillary). RESULTS We observed a significant association (P<1.00x10(-10)) between SNPs in the genes CCDC122, C13orf31, NOD2, TNFSF15, HLA-DR, and RIPK2 and a trend toward an association (P = 5.10x10(-5)) with a SNP in LRRK2. The associations between the SNPs in C13orf31, LRRK2, NOD2, and RIPK2 and multibacillary leprosy were stronger than the associations between these SNPs and paucibacillary leprosy. CONCLUSIONS Variants of genes in the NOD2-mediated signaling pathway ( which regulates the innate immune response) are associated with susceptibility to infection with M. leprae.	[Zhang, Fu-Ren] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan 250022, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhang, FR (corresponding author), Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, 57 Jiyan Lu, Jinan 250022, Shandong, Peoples R China.	zhangfuren@hotmail.com; ayzxj@vip.sina.com; liuj3@gis.a-star.edu.sg	Netea, Mihai/N-5155-2014; Chen, Gang/G-2722-2010; Zheng, Houfeng/K-4424-2012; Wang, Demin/AAX-4449-2020; Hibberd, Martin L/D-5050-2009; Liu, Jianjun/AAK-4989-2020; Kullberg, BJ/C-8520-2013; van der Meer, Jos W.M./C-8521-2013	Zheng, Houfeng/0000-0001-5681-8598; Wang, Demin/0000-0001-5549-3795; Liu, Jianjun/0000-0002-3255-3019; Kullberg, BJ/0000-0002-6813-8167; van der Meer, Jos W.M./0000-0001-5120-3690; Hibberd, Martin/0000-0001-8587-1849	Research Foundation of Shandong Provincial Institute of Dermatology and Venereology; Research Foundation of Shandong Academy of Medical Science; Shandong Provincial Leprosy Control Special Financial Support; Shandong Provincial Research Fund of Science and Technology [2006GG2302029]; Shandong Provincial Health System; Shandong Provincial Taishan Scholar Construction Project; National Natural Science Foundation [30771943/C030116]; Anhui Provincial Special Scientific Program; Agency for Science, Technology, and Research of Singapore	Research Foundation of Shandong Provincial Institute of Dermatology and Venereology; Research Foundation of Shandong Academy of Medical Science; Shandong Provincial Leprosy Control Special Financial Support; Shandong Provincial Research Fund of Science and Technology; Shandong Provincial Health System; Shandong Provincial Taishan Scholar Construction Project; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Anhui Provincial Special Scientific Program; Agency for Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR))	Supported by grants from the Research Foundation of Shandong Provincial Institute of Dermatology and Venereology (2008-7), the Research Foundation of Shandong Academy of Medical Science ( 2005), the Shandong Provincial Leprosy Control Special Financial Support ( 2007), the Shandong Provincial Research Fund of Science and Technology (2006GG2302029), the Outstanding Scholarship 1020 Project of Shandong Provincial Health System ( 2008), the Shandong Provincial Taishan Scholar Construction Project ( 2009), the National Natural Science Foundation (30771943/C030116), the Anhui Provincial Special Scientific Program (2007-7), and the Agency for Science, Technology, and Research of Singapore.	ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; [Anonymous], 1982, World Health Organ Tech Rep Ser, V675, P1; Behr MA, 2006, INFLAMM BOWEL DIS, V12, P1000, DOI 10.1097/01.mib.0000228183.70197.dd; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; CHAKRAVARTTI MR, 1973, TOPICS HUMAN GENETIC, V1; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; FINE PEM, 1983, INT J LEPROSY, V51, P553; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Geluk A, 2006, HUM IMMUNOL, V67, P439, DOI 10.1016/j.humimm.2006.03.009; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hastings RC, 1994, LEPROSY, P291; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; MODLIN RL, 1994, J INVEST DERMATOL, V102, P828, DOI 10.1111/1523-1747.ep12381958; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Moraes MO, 2006, LEPROSY REV, V77, P189; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; OTTENHOFF THM, 1987, INT J LEPROSY, V55, P521; Pierce ES, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000234; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Schurr E, 2006, SEMIN IMMUNOL, V18, P404, DOI 10.1016/j.smim.2006.07.005; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Thiebaut R, 2009, AM J GASTROENTEROL, V104, P384, DOI 10.1038/ajg.2008.36; TODD JR, 1990, REV INFECT DIS, V12, P63	38	522	539	2	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2609	2618		10.1056/NEJMoa0903753	http://dx.doi.org/10.1056/NEJMoa0903753			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20018961	Green Accepted			2022-12-24	WOS:000273181300008
J	Chong, JL; Wenzel, PL; Saenz-Robles, MT; Nair, V; Ferrey, A; Hagan, JP; Gomez, YM; Sharma, N; Chen, HZ; Ouseph, M; Wang, SH; Trikha, P; Culp, B; Mezache, L; Winton, DJ; Sansom, OJ; Chen, DN; Bremner, R; Cantalupo, PG; Robinson, ML; Pipas, JM; Leone, G				Chong, Jean-Leon; Wenzel, Pamela L.; Saenz-Robles, M. Teresa; Nair, Vivek; Ferrey, Antoney; Hagan, John P.; Gomez, Yorman M.; Sharma, Nidhi; Chen, Hui-Zi; Ouseph, Madhu; Wang, Shu-Huei; Trikha, Prashant; Culp, Brian; Mezache, Louise; Winton, Douglas J.; Sansom, Owen J.; Chen, Danian; Bremner, Rod; Cantalupo, Paul G.; Robinson, Michael L.; Pipas, James M.; Leone, Gustavo			E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells	NATURE			English	Article							INTESTINAL EPITHELIUM; CELLULAR PROLIFERATION; TRANSCRIPTION FACTORS; BINDING PROTEIN; S-PHASE; EXPRESSION; E2F3; CYCLE; ROLES; MICE	In the established model of mammalian cell cycle control, the retinoblastoma protein (Rb) functions to restrict cells from entering S phase by binding and sequestering E2f activators (E2f1, E2f2 and E2f3), which are invariably portrayed as the ultimate effectors of a transcriptional program that commit cells to enter and progress through S phase(1,2). Using a panel of tissue-specific cre-transgenic mice and conditional E2f alleles we examined the effects of E2f1, E2f2 and E2f3 triple deficiency in murine embryonic stem cells, embryos and small intestines. We show that in normal dividing progenitor cells E2f1-3 function as transcriptional activators, but contrary to the current view, are dispensable for cell division and instead are necessary for cell survival. In differentiating cells E2f1-3 function in a complex with Rb as repressors to silence E2f targets and facilitate exit from the cell cycle. The inactivation of Rb in differentiating cells resulted in a switch of E2f1-3 from repressors to activators, leading to the superactivation of E2f responsive targets and ectopic cell divisions. Loss of E2f1-3 completely suppressed these phenotypes caused by Rb deficiency. This work contextualizes the activator versus repressor functions of E2f1-3 in vivo, revealing distinct roles in dividing versus differentiating cells and in normal versus cancer-like cell cycles.	[Chong, Jean-Leon; Wenzel, Pamela L.; Nair, Vivek; Ferrey, Antoney; Hagan, John P.; Gomez, Yorman M.; Sharma, Nidhi; Chen, Hui-Zi; Ouseph, Madhu; Wang, Shu-Huei; Trikha, Prashant; Culp, Brian; Mezache, Louise; Leone, Gustavo] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Chong, Jean-Leon; Wenzel, Pamela L.; Nair, Vivek; Ferrey, Antoney; Gomez, Yorman M.; Sharma, Nidhi; Chen, Hui-Zi; Ouseph, Madhu; Wang, Shu-Huei; Trikha, Prashant; Culp, Brian; Mezache, Louise; Leone, Gustavo] Ohio State Univ, Coll Biol Sci, Dept Mol Genet, Columbus, OH 43210 USA; [Chong, Jean-Leon; Wenzel, Pamela L.; Nair, Vivek; Ferrey, Antoney; Hagan, John P.; Gomez, Yorman M.; Sharma, Nidhi; Chen, Hui-Zi; Ouseph, Madhu; Wang, Shu-Huei; Trikha, Prashant; Culp, Brian; Mezache, Louise; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Saenz-Robles, M. Teresa; Cantalupo, Paul G.; Pipas, James M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Winton, Douglas J.] Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England; [Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Chen, Danian; Bremner, Rod] Univ Toronto, Toronto Western Res Inst, Univ Hlth Network, Dept Ophthalmol & Visual Sci, Toronto, ON M5T 2S8, Canada; [Chen, Danian; Bremner, Rod] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5T 2S8, Canada; [Robinson, Michael L.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CRUK Cambridge Institute; University of Cambridge; Beatson Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University System of Ohio; Miami University	Leone, G (corresponding author), Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	Gustavo.Leone@osumc.edu	Ouseph, Madhu/B-8940-2009; Wenzel, Pamela/A-2992-2010; Trikha, Prashant/B-5897-2012; Wenzel, Pamela/AAJ-1944-2021; Bremner, Rod/I-6490-2012; Chen, Danian/GXV-7996-2022	Ouseph, Madhu/0000-0002-3422-1675; Wenzel, Pamela/0000-0002-4530-015X; Bremner, Rod/0000-0001-9184-7212; Chen, Danian/0000-0002-6916-2978; Sansom, Owen J./0000-0001-9540-3010; Hagan, John/0000-0003-0295-4898	NIH [R01CA85619, R01CA82259, R01HD04470, P01CA097189, CA098956, 5 T32 CA106196-04]; DoD award [BC061730]; NATIONAL CANCER INSTITUTE [R01CA085619, T32CA106196, P01CA097189, R01CA098956, R01CA082259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Rawahneh, J. Moffitt and R. Rajmohan for technical assistance with histology. We also thank A. de Bruin and S. Naidu for assistance in analysing histological slides. We are thankful to J. Groden, A. Simcox and D. Guttridge for their critical comments. This work was funded by NIH grants to G. L. (R01CA85619, R01CA82259, R01HD04470, P01CA097189) and NIH grant to J. M. P. ( CA098956); J.- L. C. is the recipient of a DoD award ( BC061730). P. L. W. was supported by NIH training grant 5 T32 CA106196-04.	Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; Coopersmith CM, 1997, ONCOGENE, V15, P131, DOI 10.1038/sj.onc.1201176; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iglesias A, 2004, J CLIN INVEST, V113, P1398, DOI 10.1172/JCI200418879; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; NEVINS JR, 1992, NATURE, V358, P375, DOI 10.1038/358375a0; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; RUSSELL P, 1986, CELL, V45, P781, DOI 10.1016/0092-8674(86)90550-7; Saenz-Robles MT, 2007, J VIROL, V81, P13191, DOI 10.1128/JVI.01658-07; Sharma N, 2006, J BIOL CHEM, V281, P36124, DOI 10.1074/jbc.M604152200; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507	30	180	185	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					930	934		10.1038/nature08677	http://dx.doi.org/10.1038/nature08677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016602	Green Accepted, Green Submitted			2022-12-24	WOS:000272795400045
J	Nepstad, D; Soares, BS; Merry, F; Lima, A; Moutinho, P; Carter, J; Bowman, M; Cattaneo, A; Rodrigues, H; Schwartzman, S; McGrath, DG; Stickler, CM; Lubowski, R; Piris-Cabezas, P; Rivero, S; Alencar, A; Almeida, O; Stella, O				Nepstad, Daniel; Soares-Filho, Britaldo S.; Merry, Frank; Lima, Andre; Moutinho, Paulo; Carter, John; Bowman, Maria; Cattaneo, Andrea; Rodrigues, Hermann; Schwartzman, Stephan; McGrath, David G.; Stickler, Claudia M.; Lubowski, Ruben; Piris-Cabezas, Pedro; Rivero, Sergio; Alencar, Ane; Almeida, Oriana; Stella, Osvaldo			The End of Deforestation in the Brazilian Amazon	SCIENCE			English	Editorial Material							FORESTS		[Nepstad, Daniel; Merry, Frank; Moutinho, Paulo; Bowman, Maria; Cattaneo, Andrea; McGrath, David G.; Stickler, Claudia M.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Nepstad, Daniel; Merry, Frank; Lima, Andre; Moutinho, Paulo; Bowman, Maria; McGrath, David G.; Stickler, Claudia M.; Alencar, Ane; Almeida, Oriana; Stella, Osvaldo] Inst Pesquisa Ambiental Amazonia, BR-71503505 Brasilia, DF, Brazil; [Soares-Filho, Britaldo S.; Rodrigues, Hermann] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil; [Carter, John] Alianca Terra, BR-74670600 Goiania, Go, Brazil; [Schwartzman, Stephan; Lubowski, Ruben; Piris-Cabezas, Pedro] Environm Def Fund, Washington, DC 20009 USA; [McGrath, David G.; Lubowski, Ruben; Piris-Cabezas, Pedro] Univ Florida, Gainesville, FL 32611 USA; [Stickler, Claudia M.; Alencar, Ane] Univ Rey Juan Carlos, Mostoles 28933, Spain; [Piris-Cabezas, Pedro] Fed Univ Para, BR-66075110 Belem, Para, Brazil	Woods Hole Research Center; Universidade Federal de Minas Gerais; Environmental Defense Fund; State University System of Florida; University of Florida; Universidad Rey Juan Carlos; Universidade Federal do Para	Nepstad, D (corresponding author), Woods Hole Res Ctr, Falmouth, MA 02540 USA.	dnepstad@whrc.org; britaldo@csr.ufmg.br	/AAX-3684-2020	/0000-0001-5605-7469				Angelsen A., 2009, REDUCING EMISSIONS D; *GOV BRAZ, 2008, NAT CLIM CHANG PLAN; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Houghton R.A., 2005, TROPICAL DEFORESTATI, P13; IBGE-Instituto Brasileiro de Geografia e Estatistica, CENS AGR 2006; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; LIMA A, 2005, ZONEAMENTO ECOLOGICO; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; NEPSTAD DC, 2007, COSTS BENEFITS REDUC; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares-Filho BS, 2008, REDUCING CARBON EMIS; Stickler CM, 2009, GLOBAL CHANGE BIOL, V15, P2803, DOI 10.1111/j.1365-2486.2009.02109.x; Tollefson J, 2009, NATURE, V460, P936, DOI 10.1038/460936a; [No title captured]	15	351	364	1	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1350	1351		10.1126/science.1182108	http://dx.doi.org/10.1126/science.1182108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965742				2022-12-24	WOS:000272351100023
J	Hanna, J; Saha, K; Pando, B; van Zon, J; Lengner, CJ; Creyghton, MP; van Oudenaarden, A; Jaenisch, R				Hanna, Jacob; Saha, Krishanu; Pando, Bernardo; van Zon, Jeroen; Lengner, Christopher J.; Creyghton, Menno P.; van Oudenaarden, Alexander; Jaenisch, Rudolf			Direct cell reprogramming is a stochastic process amenable to acceleration	NATURE			English	Article							PLURIPOTENT STEM-CELLS; TUMOR-SUPPRESSOR; NANOG; INDUCTION; FIBROBLASTS; EXPRESSION; GENERATION; CIRCUITRY; OCT4; KLF4	Direct reprogramming of somatic cells into induced pluripotent stem (iPS) cells can be achieved by overexpression of Oct4, Sox2, Klf4 and c-Myc transcription factors, but only a minority of donor somatic cells can be reprogrammed to pluripotency. Here we demonstrate that reprogramming by these transcription factors is a continuous stochastic process where almost all mouse donor cells eventually give rise to iPS cells on continued growth and transcription factor expression. Additional inhibition of the p53/p21 pathway or overexpression of Lin28 increased the cell division rate and resulted in an accelerated kinetics of iPS cell formation that was directly proportional to the increase in cell proliferation. In contrast, Nanog overexpression accelerated reprogramming in a predominantly cell-division-rate-independent manner. Quantitative analyses define distinct cell-division-rate-dependent and -independent modes for accelerating the stochastic course of reprogramming, and suggest that the number of cell divisions is a key parameter driving epigenetic reprogramming to pluripotency.	[Hanna, Jacob; Saha, Krishanu; Lengner, Christopher J.; Creyghton, Menno P.; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Pando, Bernardo; van Zon, Jeroen; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02142 USA; [van Zon, Jeroen; van Oudenaarden, Alexander; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	Hanna@wi.mit.edu; Jaenisch@wi.mit.edu	van Oudenaarden, Alexander/AAA-1705-2019; van Zon, Jeroen/C-8313-2018; Hanna, Jacob/K-1339-2012; Saha, Krishanu/J-3980-2014	van Zon, Jeroen/0000-0002-6021-2924; Hanna, Jacob/0000-0003-2042-9974; Saha, Krishanu/0000-0003-2837-0858; Lengner, Christopher/0000-0002-0574-5189	NIH [RO1-HDO45022, R37-CA084198, RO1-CA087869]; Helen Hay Whitney Foundation; Society in Science: The Brano- Weiss fellowship; Human Frontiers Science Program; National Cancer Institute [U54CA143874]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA087869, U54CA143874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Society in Science: The Brano- Weiss fellowship; Human Frontiers Science Program(Human Frontier Science Program); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank N. Maheshri, K. Wood, Y. Bugnanim, B. Carey, J. Cassady and F. Soldner for commenting on the manuscript; J. Dausmann, S. Markoulaki, P. Schorderet and M. Pawlak for conducting blastocysts injections; and members of the Jaenisch laboratory for discussions. R. J. is supported by grants from the NIH (RO1-HDO45022, R37-CA084198, RO1-CA087869). J. H. is supported by a postdoctoral fellowship from Helen Hay Whitney Foundation. K. S. is supported by the Society in Science: The Brano- Weiss fellowship. J. v. Z. is supported by the Human Frontiers Science Program. A. v. O. is supported by a National Institutes of Health ( NIH) Director's Pioneer award and an award from the National Cancer Institute (U54CA143874).	Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hanna J, 2008, COLD SH Q B, V73, P147, DOI 10.1101/sqb.2008.73.025; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	46	729	790	2	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					595	U63		10.1038/nature08592	http://dx.doi.org/10.1038/nature08592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19898493	Green Accepted, Green Published			2022-12-24	WOS:000272277900030
J	Carette, JE; Guimaraes, CP; Varadarajan, M; Park, AS; Wuethrich, I; Godarova, A; Kotecki, M; Cochran, BH; Spooner, E; Ploegh, HL; Brummelkamp, TR				Carette, Jan E.; Guimaraes, Carla P.; Varadarajan, Malini; Park, Annie S.; Wuethrich, Irene; Godarova, Alzbeta; Kotecki, Maciej; Cochran, Brent H.; Spooner, Eric; Ploegh, Hidde L.; Brummelkamp, Thijn R.			Haploid Genetic Screens in Human Cells Identify Host Factors Used by Pathogens	SCIENCE			English	Article							ADP-RIBOSYLATING TOXINS; SACCHAROMYCES-CEREVISIAE; DIPHTHERIA-TOXIN; PROTEIN; IDENTIFICATION; DIPHTHAMIDE; BIOSYNTHESIS; INFLUENZA; RECEPTOR; TARGET	Loss-of-function genetic screens in model organisms have elucidated numerous biological processes, but the diploid genome of mammalian cells has precluded large-scale gene disruption. We used insertional mutagenesis to develop a screening method to generate null alleles in a human cell line haploid for all chromosomes except chromosome 8. Using this approach, we identified host factors essential for infection with influenza and genes encoding important elements of the biosynthetic pathway of diphthamide, which are required for the cytotoxic effects of diphtheria toxin and exotoxin A. We also identified genes needed for the action of cytolethal distending toxin, including a cell-surface protein that interacts with the toxin. This approach has both conceptual and practical parallels with genetic approaches in haploid yeast.	[Carette, Jan E.; Guimaraes, Carla P.; Varadarajan, Malini; Park, Annie S.; Wuethrich, Irene; Godarova, Alzbeta; Spooner, Eric; Ploegh, Hidde L.; Brummelkamp, Thijn R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kotecki, Maciej; Cochran, Brent H.] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; [Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Tufts University; Massachusetts Institute of Technology (MIT)	Brummelkamp, TR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	brummelkamp@wi.mit.edu		Cochran, Brent/0000-0002-7598-5604; Carette, Jan/0000-0002-5187-8070				Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; CHEN JYC, 1988, J BIOL CHEM, V263, P11692; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532	31	362	395	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1231	1235		10.1126/science.1178955	http://dx.doi.org/10.1126/science.1178955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965467				2022-12-24	WOS:000272117900039
J	Mani, RS; Tomlins, SA; Callahan, K; Ghosh, A; Nyati, MK; Varambally, S; Palanisamy, N; Chinnaiyan, AM				Mani, Ram-Shankar; Tomlins, Scott A.; Callahan, Kaitlin; Ghosh, Aparna; Nyati, Mukesh K.; Varambally, Sooryanarayana; Palanisamy, Nallasivam; Chinnaiyan, Arul M.			Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer	SCIENCE			English	Article									[Mani, Ram-Shankar; Tomlins, Scott A.; Callahan, Kaitlin; Ghosh, Aparna; Varambally, Sooryanarayana; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Mani, Ram-Shankar; Tomlins, Scott A.; Callahan, Kaitlin; Ghosh, Aparna; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Nyati, Mukesh K.; Varambally, Sooryanarayana; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Nyati, Mukesh K.] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Palanisamy, Nallasivam/ABC-8844-2020	Palanisamy, Nallasivam/0000-0002-0633-9772; Tomlins, Scott/0000-0001-8661-9821; Mani, Ram/0000-0003-3552-7905; Varambally, Sooryanarayana/0000-0002-2277-1127	NIH [P50CA69568, R01CA132874, DOD W81XWH-09-2-0014]; NATIONAL CANCER INSTITUTE [R01CA132874, P50CA069568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants P50CA69568, R01CA132874, and DOD W81XWH-09-2-0014. A. M. C. is a paid consultant to Gen-Probe, Incorporated. A. M. C. and S. A. T. are named as co-inventors on a patent related to gene fusions in prostate cancer that is licensed to Gen-Probe, Incorporated.	Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679	4	289	299	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1230	1230		10.1126/science.1178124	http://dx.doi.org/10.1126/science.1178124			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19933109	Green Accepted			2022-12-24	WOS:000272117900038
J	Khatiwala, S; Primeau, F; Hall, T				Khatiwala, S.; Primeau, F.; Hall, T.			Reconstruction of the history of anthropogenic CO2 concentrations in the ocean	NATURE			English	Article							DEEP-WATER; CARBON; TRANSPORT	The release of fossil fuel CO2 to the atmosphere by human activity has been implicated as the predominant cause of recent global climate change(1). The ocean plays a crucial role in mitigating the effects of this perturbation to the climate system, sequestering 20 to 35 per cent of anthropogenic CO2 emissions(2-4). Although much progress has been made in recent years in understanding and quantifying this sink, considerable uncertainties remain as to the distribution of anthropogenic CO2 in the ocean, its rate of uptake over the industrial era, and the relative roles of the ocean and terrestrial biosphere in anthropogenic CO2 sequestration. Here we address these questions by presenting an observationally based reconstruction of the spatially resolved, time-dependent history of anthropogenic carbon in the ocean over the industrial era. Our approach is based on the recognition that the transport of tracers in the ocean can be described by a Green's function, which we estimate from tracer data using a maximum entropy deconvolution technique. Our results indicate that ocean uptake of anthropogenic CO2 has increased sharply since the 1950s, with a small decline in the rate of increase in the last few decades. We estimate the inventory and uptake rate of anthropogenic CO2 in 2008 at 140 +/- 25 Pg C and 2.3 +/- 0.6 Pg C yr(-1), respectively. We find that the Southern Ocean is the primary conduit by which this CO2 enters the ocean (contributing over 40 per cent of the anthropogenic CO2 inventory in the ocean in 2008). Our results also suggest that the terrestrial biosphere was a source of CO2 until the 1940s, subsequently turning into a sink. Taken over the entire industrial period, and accounting for uncertainties, we estimate that the terrestrial biosphere has been anywhere from neutral to a net source of CO2, contributing up to half as muchCO(2) as has been taken up by the ocean over the same period.	[Khatiwala, S.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Primeau, F.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Hall, T.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA	Columbia University; University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Khatiwala, S (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	spk@ldeo.columbia.edu	Primeau, Francois W/A-7310-2011	Primeau, Francois W/0000-0001-7452-9415; Hall, Timothy/0000-0003-1755-4889	US NSF [OCE 06-23366, OCE 07-26871]	US NSF(National Science Foundation (NSF))	This work was supported by US NSF grants OCE 06-23366 (to S. K. and T. H.) and OCE 07-26871 (to F. P.).	Antonov JI, 2006, NOAA ATLAS NESDIS, V62; Boden T. A., 2012, GLOBAL REGIONAL NATL, DOI [10.3334/CDIAC/00001_V2012, DOI 10.3334/CDIAC/00001, 10.3334/CDIAC/00001]; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; BREWER PG, 1978, GEOPHYS RES LETT, V5, P997, DOI 10.1029/GL005i012p00997; Broecker WS, 1998, J GEOPHYS RES-OCEANS, V103, P15833, DOI 10.1029/98JC00248; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cao L, 2009, BIOGEOSCIENCES, V6, P375, DOI 10.5194/bg-6-375-2009; *CARB DIOX INF AN, 2009, ATM TRAC GAS CARB DI; CHEN GT, 1979, NATURE, V277, P205, DOI 10.1038/277205a0; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Fletcher SEM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002530; Garcia H. E., 2006, NOAA ATLAS NESDIS, V63; Garcia H. E., 2006, NOAA ATLAS NESDIS, V64; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Hall TM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002120; Hall TM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001835; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton R.A., 2008, TRENDS COMPENDIUM DA; Joos F, 1999, GEOPHYS RES LETT, V26, P1437, DOI 10.1029/1999GL900250; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Khatiwala S, 2001, DEEP-SEA RES PT I, V48, P1423, DOI 10.1016/S0967-0637(00)00094-7; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; LOCARNINI RA, 2006, NOAA ATLAS NESDIS, V61; LOMONACO C, 2005, J GEOPHYS RES, V110, P9502, DOI DOI 10.1029/2004JC002571; Lovenduski NS, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002900; Matsumoto K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002397; Matsumoto K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018970; Rhein M, 2002, J PHYS OCEANOGR, V32, P648, DOI 10.1175/1520-0485(2002)032<0648:LSWPCI>2.0.CO;2; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SARMIENTO JL, 1992, J GEOPHYS RES-OCEANS, V97, P3621, DOI 10.1029/91JC02849; Smethie WM, 2001, DEEP-SEA RES PT I, V48, P189, DOI 10.1016/S0967-0637(00)00048-0; Sweeney C, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002784; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Tanhua T, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004868; Tarantola A, 2005, INVERSE PROBLEM THEO; Walker SJ, 2000, J GEOPHYS RES-OCEANS, V105, P14285, DOI 10.1029/1999JC900273; Wallace DWR, 2001, GLOBAL BIOGEOCHEM CY, V15, P3, DOI 10.1029/2000GB001354; Waugh DW, 2006, TELLUS B, V58, P376, DOI 10.1111/j.1600-0889.2006.00222.x; Waugh DW, 2004, DEEP-SEA RES PT I, V51, P1475, DOI [10.1016/S0967-0637(04)00145-1, 10.1016/j.dsr.2004.06.011]; Zickfeld K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028797	41	381	397	9	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					346	U110		10.1038/nature08526	http://dx.doi.org/10.1038/nature08526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924213	Green Published			2022-12-24	WOS:000271899300043
J	Fullwood, MJ; Liu, MH; Pan, YF; Liu, J; Xu, H; Bin Mohamed, Y; Orlov, YL; Velkov, S; Ho, A; Mei, PH; Chew, EGY; Huang, PYH; Welboren, WJ; Han, YY; Ooi, HS; Ariyaratne, PN; Vega, VB; Luo, YQ; Tan, PY; Choy, PY; Wansa, KDSA; Zhao, B; Lim, KS; Leow, SC; Yow, JS; Joseph, R; Li, HX; Desai, KV; Thomsen, JS; Lee, YK; Karuturi, RKM; Herve, T; Bourque, G; Stunnenberg, HG; Ruan, XL; Cacheux-Rataboul, V; Sung, WK; Liu, ET; Wei, CL; Cheung, E; Ruan, YJ				Fullwood, Melissa J.; Liu, Mei Hui; Pan, You Fu; Liu, Jun; Xu, Han; Bin Mohamed, Yusoff; Orlov, Yuriy L.; Velkov, Stoyan; Ho, Andrea; Mei, Poh Huay; Chew, Elaine G. Y.; Huang, Phillips Yao Hui; Welboren, Willem-Jan; Han, Yuyuan; Ooi, Hong Sain; Ariyaratne, Pramila N.; Vega, Vinsensius B.; Luo, Yanquan; Tan, Peck Yean; Choy, Pei Ye; Wansa, K. D. Senali Abayratna; Zhao, Bing; Lim, Kar Sian; Leow, Shi Chi; Yow, Jit Sin; Joseph, Roy; Li, Haixia; Desai, Kartiki V.; Thomsen, Jane S.; Lee, Yew Kok; Karuturi, R. Krishna Murthy; Herve, Thoreau; Bourque, Guillaume; Stunnenberg, Hendrik G.; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Sung, Wing-Kin; Liu, Edison T.; Wei, Chia-Lin; Cheung, Edwin; Ruan, Yijun			An oestrogen-receptor-alpha-bound human chromatin interactome	NATURE			English	Article							CHROMOSOME CONFORMATION; BINDING-SITES; HUMAN GENOME; TRANSCRIPTION; GENES; FOXA1; CHIP; ELEMENTS; REVEALS; DEFINES	Genomes are organized into high-level three-dimensional structures, and DNA elements separated by long genomic distances can in principle interact functionally. Many transcription factors bind to regulatory DNA elements distant from gene promoters. Although distal binding sites have been shown to regulate transcription by long-range chromatin interactions at a few loci, chromatin interactions and their impact on transcription regulation have not been investigated in a genome-wide manner. Here we describe the development of a new strategy, chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) for the de novo detection of global chromatin interactions, with which we have comprehensively mapped the chromatin interaction network bound by oestrogen receptor alpha (ER-alpha) in the human genome. We found that most high-confidence remote ER-alpha-binding sites are anchored at gene promoters through long-range chromatin interactions, suggesting that ER-alpha functions by extensive chromatin looping to bring genes together for coordinated transcriptional regulation. We propose that chromatin interactions constitute a primary mechanism for regulating transcription in mammalian genomes.	[Fullwood, Melissa J.; Liu, Mei Hui; Pan, You Fu; Liu, Jun; Xu, Han; Bin Mohamed, Yusoff; Orlov, Yuriy L.; Velkov, Stoyan; Ho, Andrea; Mei, Poh Huay; Chew, Elaine G. Y.; Huang, Phillips Yao Hui; Han, Yuyuan; Ooi, Hong Sain; Ariyaratne, Pramila N.; Vega, Vinsensius B.; Luo, Yanquan; Tan, Peck Yean; Choy, Pei Ye; Wansa, K. D. Senali Abayratna; Zhao, Bing; Lim, Kar Sian; Leow, Shi Chi; Yow, Jit Sin; Joseph, Roy; Li, Haixia; Desai, Kartiki V.; Thomsen, Jane S.; Lee, Yew Kok; Karuturi, R. Krishna Murthy; Herve, Thoreau; Bourque, Guillaume; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Sung, Wing-Kin; Liu, Edison T.; Wei, Chia-Lin; Cheung, Edwin; Ruan, Yijun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Welboren, Willem-Jan; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Dept Comp Sci, Singapore 117543, Singapore; [Cheung, Edwin; Ruan, Yijun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Cheung, Edwin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Radboud University Nijmegen; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ruan, YJ (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore.	cheungcwe@gis.a-star.edu.sg; ruanyj@gis.a-star.edu.sg	Velkov, Stoyan/ABV-5313-2022; Stunnenberg, Hendrik G./D-6875-2012; Desai, Kartiki/ABF-3538-2021; Liu, Mei Hui/J-9750-2013; Bourque, Guillaume/AFR-2927-2022; Orlov, Yuriy L/F-1520-2013; Xu, Han/H-1963-2012; Fullwood, Melissa/G-5713-2011; Liu, Edison/C-4141-2008	Stunnenberg, Hendrik G./0000-0002-0066-1576; Bourque, Guillaume/0000-0002-3933-9656; Orlov, Yuriy L/0000-0003-0587-1609; Fullwood, Melissa/0000-0003-0321-7865; Han, Brenda/0000-0002-3212-875X; Sung, Wing-Kin/0000-0001-7806-7086; Huang, Phillips Y./0000-0001-5807-1133; Pan, You-Fu/0000-0002-9996-8892; THOREAU, HERVE/0000-0001-6643-167X; Chew, Elaine/0000-0001-9763-703X; Liu, Mei Hui/0000-0001-7405-7008; Desai, Kartiki V/0000-0001-8974-0707; /0000-0001-9150-3954; Velkov, Stoyan/0000-0003-2390-7097	L'Oreal-UNESCO; A*STAR of Singapore; NIH [R01 HG004456-01, R01HG003521-01, 1U54HG004557-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003521, R01HG004456, U54HG004557] Funding Source: NIH RePORTER	L'Oreal-UNESCO(L'Oreal Group); A*STAR of Singapore(Agency for Science Technology & Research (A*STAR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors acknowledge the Genome Technology and Biology Group at the Genome Institute of Singapore for technical support; A. Shahab, C. C. Seng and F. H. Mulawadi for computing support; S. Luo and G. Schroth for Illumina sequencing support; and W. de Laat, B. Ren and X. S. Liu for advice. M. J. F., P. Y. H. H., Y. H., P. Y. T. and Y. K. L. are supported by A*STAR Scholarships. M. J. F. is supported by a L'Oreal-UNESCO For Women In Science National Fellowship. Y. R. and C. L. W. are supported by A*STAR of Singapore and NIH ENCODE grants (R01 HG004456-01, R01HG003521-01 and part of 1U54HG004557-01).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Collas P, 2008, FRONT BIOSCI-LANDMRK, V13, P929, DOI 10.2741/2733; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Massie CE, 2008, EMBO REP, V9, P337, DOI 10.1038/embor.2008.44; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	31	1151	1210	7	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					58	64		10.1038/nature08497	http://dx.doi.org/10.1038/nature08497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890323	Green Accepted			2022-12-24	WOS:000271419200031
J	Marshall, NM; Garner, DK; Wilson, TD; Gao, YG; Robinson, H; Nilges, MJ; Lu, Y				Marshall, Nicholas M.; Garner, Dewain K.; Wilson, Tiffany D.; Gao, Yi-Gui; Robinson, Howard; Nilges, Mark J.; Lu, Yi			Rationally tuning the reduction potential of a single cupredoxin beyond the natural range	NATURE			English	Article							BLUE COPPER CENTER; PI-PI-INTERACTION; ACTIVE-SITE; CRYSTAL-STRUCTURE; AXIAL METHIONINE; AZURIN; RUSTICYANIN; PROTEINS; MUTAGENESIS; GRAPHITE	Redox processes are at the heart of numerous functions in chemistry and biology, from long-range electron transfer in photosynthesis and respiration to catalysis in industrial and fuel cell research. These functions are accomplished in nature by only a limited number of redox-active agents. A long-standing issue in these fields is how redox potentials are fine-tuned over a broad range with little change to the redox-active site or electron-transfer properties. Resolving this issue will not only advance our fundamental understanding of the roles of long-range, non-covalent interactions in redox processes, but also allow for design of redox-active proteins having tailor-made redox potentials for applications such as artificial photosynthetic centres(1,2) or fuel cell catalysts(3) for energy conversion. Here we show that two important secondary coordination sphere interactions, hydrophobicity and hydrogen-bonding, are capable of tuning the reduction potential of the cupredoxin azurin over a 700 mV range, surpassing the highest and lowest reduction potentials reported for any mononuclear cupredoxin, without perturbing the metal binding site beyond what is typical for the cupredoxin family of proteins. We also demonstrate that the effects of individual structural features are additive and that redox potential tuning of azurin is now predictable across the full range of cupredoxin potentials.	[Marshall, Nicholas M.; Garner, Dewain K.; Wilson, Tiffany D.; Gao, Yi-Gui; Nilges, Mark J.; Lu, Yi] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Brookhaven National Laboratory	Lu, Y (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	yi-lu@illinois.edu	Lu, Yi/GQQ-1069-2022; liu, yi/GXE-9662-2022; Lu, Yi/B-5461-2010	Lu, Yi/0000-0003-1221-6709; Lu, Yi/0000-0003-1221-6709	US National Science Foundation [CHE 05-52008]; National Institutes of Health [5 T32 GM070421]; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based on work supported by the US National Science Foundation under award no. CHE 05-52008. We thank E. Marshall, D. Poe, A. Huang and J. Li for discussions, and for help in protein expression and purification, and in spectroscopic and electrochemical data collection. N. M. M. is an NIH Predoctoral trainee, supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award 5 T32 GM070421 from the National Institute of General Medical Sciences.	Abdelhamid RF, 2007, J BIOL INORG CHEM, V12, P165, DOI 10.1007/s00775-006-0176-8; Alcaraz LA, 2007, BIOINORG CHEM APPL, V2007, DOI 10.1155/2007/54232; Battistuzzi G, 1999, J AM CHEM SOC, V121, P501, DOI 10.1021/ja982126q; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; Berry SM, 2003, J AM CHEM SOC, V125, P8760, DOI 10.1021/ja029699u; Blanford CF, 2007, CHEM COMMUN, P1710, DOI 10.1039/b703114a; CHANG HR, 1988, J AM CHEM SOC, V110, P625, DOI 10.1021/ja00210a067; CHANG TK, 1991, P NATL ACAD SCI USA, V88, P1325, DOI 10.1073/pnas.88.4.1325; Dennison C, 2005, COORDIN CHEM REV, V249, P3025, DOI 10.1016/j.ccr.2005.04.021; Dey A, 2007, SCIENCE, V318, P1464, DOI 10.1126/science.1147753; Garner DK, 2006, J AM CHEM SOC, V128, P15608, DOI 10.1021/ja062732i; Giudici-Orticoni MT, 1999, J BIOL CHEM, V274, P30365, DOI 10.1074/jbc.274.43.30365; Gray HB, 2000, J BIOL INORG CHEM, V5, P551, DOI 10.1007/s007750000146; GROSSMANN JG, 1995, BIOCHEMISTRY-US, V34, P8406, DOI 10.1021/bi00026a023; Hall JF, 1998, BIOCHEMISTRY-US, V37, P11451, DOI 10.1021/bi980960m; Hall JF, 1999, BIOCHEMISTRY-US, V38, P12675, DOI 10.1021/bi990983g; Hart PJ, 1996, PROTEIN SCI, V5, P2175, DOI 10.1002/pro.5560051104; Jeuken LJC, 2001, J PHYS CHEM B, V105, P5271, DOI 10.1021/jp004283t; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kanbi LD, 2002, J MOL BIOL, V320, P263, DOI 10.1016/S0022-2836(02)00443-6; LOWERY MD, 1992, INORG CHIM ACTA, V198, P233, DOI 10.1016/S0020-1693(00)92365-X; Lu Y., 2003, COMPREHENSIVE COORDI, V8, P91; MIZOGUCHI TJ, 1992, J AM CHEM SOC, V114, P10076, DOI 10.1021/ja00051a059; NILGES MJ, 1979, THESIS U ILLINOIS; ROMERO A, 1993, J MOL BIOL, V229, P1007, DOI 10.1006/jmbi.1993.1101; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; Solomon EI, 2004, CHEM REV, V104, P419, DOI 10.1021/cr0206317; VARADARAJAN R, 1989, SCIENCE, V243, P69, DOI 10.1126/science.2563171; Vila AJ, 2001, HANDBOOK ON METALLOPROTEINS, P813; Walter RL, 1996, J MOL BIOL, V263, P730, DOI 10.1006/jmbi.1996.0612; Yanagisawa S, 2003, BIOCHEMISTRY-US, V42, P6853, DOI 10.1021/bi030030p; Yanagisawa S, 2006, BIOCHEMISTRY-US, V45, P8812, DOI 10.1021/bi0606851	32	229	229	1	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					113	U127		10.1038/nature08551	http://dx.doi.org/10.1038/nature08551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890331	Green Accepted			2022-12-24	WOS:000271419200043
J	Carro, MS; Lim, WK; Alvarez, MJ; Bollo, RJ; Zhao, XD; Snyder, EY; Sulman, EP; Anne, SL; Doetsch, F; Colman, H; Lasorella, A; Aldape, K; Califano, A; Iavarone, A				Carro, Maria Stella; Lim, Wei Keat; Alvarez, Mariano Javier; Bollo, Robert J.; Zhao, Xudong; Snyder, Evan Y.; Sulman, Erik P.; Anne, Sandrine L.; Doetsch, Fiona; Colman, Howard; Lasorella, Anna; Aldape, Ken; Califano, Andrea; Iavarone, Antonio			The transcriptional network for mesenchymal transformation of brain tumours	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; NEURAL STEM-CELL; C-MYC; EXPRESSION; DIFFERENTIATION; MECHANISMS; BINDING; SURVIVAL; PROLIFERATION; GLIOGENESIS	The inference of transcriptional networks that regulate transitions into physiological or pathological cellular states remains a central challenge in systems biology. A mesenchymal phenotype is the hallmark of tumour aggressiveness in human malignant glioma, but the regulatory programs responsible for implementing the associated molecular signature are largely unknown. Here we show that reverse-engineering and an unbiased interrogation of a glioma-specific regulatory network reveal the transcriptional module that activates expression of mesenchymal genes in malignant glioma. Two transcription factors (C/EBP beta and STAT3) emerge as synergistic initiators and master regulators of mesenchymal transformation. Ectopic co-expression of C/EBP beta and STAT3 reprograms neural stem cells along the aberrant mesenchymal lineage, whereas elimination of the two factors in glioma cells leads to collapse of the mesenchymal signature and reduces tumour aggressiveness. In human glioma, expression of C/EBP beta and STAT3 correlates with mesenchymal differentiation and predicts poor clinical outcome. These results show that the activation of a small regulatory module is necessary and sufficient to initiate and maintain an aberrant phenotypic state in cancer cells.	[Carro, Maria Stella; Zhao, Xudong; Anne, Sandrine L.; Lasorella, Anna; Califano, Andrea; Iavarone, Antonio] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Lim, Wei Keat; Califano, Andrea] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10032 USA; [Lim, Wei Keat; Alvarez, Mariano Javier; Califano, Andrea] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Alvarez, Mariano Javier; Califano, Andrea] Columbia Univ, Med Ctr, Joint Ctr Syst Biol, New York, NY 10032 USA; [Doetsch, Fiona; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Bollo, Robert J.] NYU, Sch Med, Dept Neurosurg, New York, NY 10016 USA; [Bollo, Robert J.] NYU, Langone Med Ctr, New York, NY 10016 USA; [Snyder, Evan Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Sulman, Erik P.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Colman, Howard] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Aldape, Ken] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York University; New York University; NYU Langone Medical Center; Sanford Burnham Prebys Medical Discovery Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Califano, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	califano@c2b2.columbia.edu; ai2102@columbia.edu	Stella, Maria Stella/GVS-1585-2022; Colman, Howard/L-5433-2019	Carro, Maria Stella/0000-0002-8570-7691; Sulman, Erik/0000-0003-4933-9120; Iavarone, Antonio/0000-0002-0683-4634; zhao, zhao xu dong/0000-0001-9126-7365; Califano, Andrea/0000-0003-4742-3679	National Institute of Health [R01CA109755, R01CA101644, R01CA085628, R01NS061776]; NCI Grand Opportunities TDDN Network [1RC2CA148308-01]; In Silico Research Centre of Excellence [NCI-caBIG 29XS192]; National Centers for Biomedical Computing NIH Roadmap Initiative [U54CA121852]; National Institute of General Medical Sciences [P20GM075059]; Italian Ministry of Welfare/Provincia di Benevento; Fondation de Recherche Medicale; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA101644, R01CA127643, R01CA190891, R01CA109755, R01CA085628, RC2CA148308, U01CA168426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM075059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Grand Opportunities TDDN Network; In Silico Research Centre of Excellence; National Centers for Biomedical Computing NIH Roadmap Initiative; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Italian Ministry of Welfare/Provincia di Benevento; Fondation de Recherche Medicale; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health grants R01CA109755 (A. C.), R01CA101644 (A. L.), R01CA085628 and R01NS061776 (A. I.), NCI Grand Opportunities TDDN Network 1RC2CA148308-01 (A. C.), In Silico Research Centre of Excellence NCI-caBIG 29XS192 (A. C.), National Centers for Biomedical Computing NIH Roadmap Initiative U54CA121852 (A. C.) and National Institute of General Medical Sciences grant P20GM075059 (E.Y.S.). M. S. C. is supported by a fellowship from the Italian Ministry of Welfare/Provincia di Benevento and S. L. A. by a fellowship from Fondation de Recherche Medicale. We thank N. Ramirez-Martinez for technical assistance with mouse husbandry and in vivo procedures.	Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Butte A J, 2000, Pac Symp Biocomput, P418; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Hanauer DA, 2007, CURR MOL MED, V7, P133, DOI 10.2174/156652407779940431; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Lander AD, 2004, PLOS BIOL, V2, P712, DOI 10.1371/journal.pbio.0020164; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Paquin A, 2005, J NEUROSCI, V25, P10747, DOI 10.1523/JNEUROSCI.2662-05.2005; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rothschild G, 2006, MOL CELL BIOL, V26, P4351, DOI 10.1128/MCB.01743-05; Simmons ML, 2001, CANCER RES, V61, P1122; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Zhao CH, 2009, CONTROL ENG PRACT, V17, P221, DOI 10.1016/j.conengprac.2008.07.001; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	52	877	905	3	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					318	U68		10.1038/nature08712	http://dx.doi.org/10.1038/nature08712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20032975	Green Accepted			2022-12-24	WOS:000273748100036
J	Youk, H; van Oudenaarden, A				Youk, Hyun; van Oudenaarden, Alexander			Growth landscape formed by perception and import of glucose in yeast	NATURE			English	Article							INDIVIDUAL HEXOSE TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; SYSTEMS BIOLOGY; METABOLIC PATHWAYS; NETWORK; PHENOTYPES; PROTEIN; GENES; EXPRESSION; MODELS	An important challenge in systems biology is to quantitatively describe microbial growth using a few measurable parameters that capture the essence of this complex phenomenon. Two key events at the cell membrane-extracellular glucose sensing and uptake-initiate the budding yeast's growth on glucose. However, conventional growth models focus almost exclusively on glucose uptake. Here we present results from growth-rate experiments that cannot be explained by focusing on glucose uptake alone. By imposing a glucose uptake rate independent of the sensed extracellular glucose level, we show that despite increasing both the sensed glucose concentration and uptake rate, the cell's growth rate can decrease or even approach zero. We resolve this puzzle by showing that the interaction between glucose perception and import, not their individual actions, determines the central features of growth, and characterize this interaction using a quantitative model. Disrupting this interaction by knocking out two key glucose sensors significantly changes the cell's growth rate, yet uptake rates are unchanged. This is due to a decrease in burden that glucose perception places on the cells. Our work shows that glucose perception and import are separate and pivotal modules of yeast growth, the interaction of which can be precisely tuned and measured.	[Youk, Hyun; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	Youk, Hyun/E-2661-2016; van Oudenaarden, Alexander/AAA-1705-2019	Youk, Hyun/0000-0003-1687-5760; 	National Institutes of Health (NIH); National Science Foundation (NSF); Natural Sciences and Engineering Research Council of Canada's (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada's (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Boles for the kind gift of strains. We also thank D. Botstein, D. Muzzey, J. Gore and S. Rifkin for critical reading of our manuscript and useful discussions. This work was funded by a National Institutes of Health (NIH) Director's Pioneer awarded to A. v. O., and grants from the NIH and National Science Foundation (NSF). H. Y. was supported by the Natural Sciences and Engineering Research Council of Canada's (NSERC) Graduate Fellowship.	Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257; Alon U, 2007, NATURE, V446, P497, DOI 10.1038/446497a; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; BILU Y, PLOS COMP BIOL, V2, pE106; BISSON LF, 1993, CRIT REV BIOCHEM MOL, V28, P259, DOI 10.3109/10409239309078437; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dickinson J.R., 2004, METABOLISM MOL PHYSL; Duarte NC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-63; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Fell D., 1997, UNDERSTANDING CONTRO; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Goyal S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.138105; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jiang Y, 1998, EMBO J, V17, P6942, DOI 10.1093/emboj/17.23.6942; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Levine E, 2007, P NATL ACAD SCI USA, V104, P9224, DOI 10.1073/pnas.0610987104; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; Maier A, 2002, FEMS YEAST RES, V2, P539, DOI 10.1016/S1567-1356(02)00140-X; Mallavarapu A, 2009, J R SOC INTERFACE, V6, P257, DOI 10.1098/rsif.2008.0205; Monod J., 1942, ACTUALITES SCI IND; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; NIELSEN J, 2003, BIOREACTION ENG PRIN, P235; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Savageau MA, 2009, P NATL ACAD SCI USA, V106, P6435, DOI 10.1073/pnas.0809869106; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Stelling J, 2004, CURR OPIN MICROBIOL, V7, P513, DOI 10.1016/j.mib.2004.08.004; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Van Hoek P, 1998, APPL ENVIRON MICROB, V64, P4226; WALSH MC, 1996, J BACTERIOL, V170, P2593; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	50	59	61	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					875	U65		10.1038/nature08653	http://dx.doi.org/10.1038/nature08653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016593	Green Accepted, Green Submitted			2022-12-24	WOS:000272795400033
J	Williams, AH; Valdez, G; Moresi, V; Qi, XX; McAnally, J; Elliott, JL; Bassel-Duby, R; Sanes, JR; Olson, EN				Williams, Andrew H.; Valdez, Gregorio; Moresi, Viviana; Qi, Xiaoxia; McAnally, John; Elliott, Jeffrey L.; Bassel-Duby, Rhonda; Sanes, Joshua R.; Olson, Eric N.			MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; SKELETAL-MUSCLE; RNA; EXPRESSION; MUTATIONS; DISEASE; TARGETS; PROTEIN; TDP-43	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by loss of motor neurons, denervation of target muscles, muscle atrophy, and paralysis. Understanding ALS pathogenesis may require a fuller understanding of the bidirectional signaling between motor neurons and skeletal muscle fibers at neuromuscular synapses. Here, we show that a key regulator of this signaling is miR-206, a skeletal muscle-specific microRNA that is dramatically induced in a mouse model of ALS. Mice that are genetically deficient in miR-206 form normal neuromuscular synapses during development, but deficiency of miR-206 in the ALS mouse model accelerates disease progression. miR-206 is required for efficient regeneration of neuromuscular synapses after acute nerve injury, which probably accounts for its salutary effects in ALS. miR-206 mediates these effects at least in part through histone deacetylase 4 and fibroblast growth factor signaling pathways. Thus, miR-206 slows ALS progression by sensing motor neuron injury and promoting the compensatory regeneration of neuromuscular synapses.	[Williams, Andrew H.; Moresi, Viviana; Qi, Xiaoxia; McAnally, John; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Valdez, Gregorio; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Valdez, Gregorio; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Elliott, Jeffrey L.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Moresi, Viviana/N-7977-2013	Moresi, viviana/0000-0003-1912-0339	National Cancer Institute [U24 CA126608]; Simmons Cancer Center; Department of Radiology; National Heart, Lung, and Blood Institute [T32HL007360]; National Institute of Neurological Disorders and Stroke (NINDS) [1F32NS061464-01A1]; National Institute on Aging; NIH; Donald W. Reynolds Center for Clinical Cardiovascular Research; Leducq Foundation; Robert A. Welch Foundation; NATIONAL CANCER INSTITUTE [U24CA126608] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360, R01HL093039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061464] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Simmons Cancer Center; Department of Radiology; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Leducq Foundation(Leducq Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Liu, E. van Rooij, M. Arnold, G. Huang, Z. Paroo, and M. Potthoff for scientific discussions; J. Cabrera for graphics; J. Backs for HDAC4 conditional mice; M. Lewis for assistance with x-rays; and J. Richardson and J. Shelton for help with histology. Imaging was facilitated by the University of Texas Southwestern Small Animal Imaging Resource, which is supported in part by the National Cancer Institute U24 CA126608, the Simmons Cancer Center, and Department of Radiology at University of Texas Southwestern. A. H. W is supported by National Heart, Lung, and Blood Institute grant T32HL007360. G. V is supported by National Institute of Neurological Disorders and Stroke (NINDS) grant 1F32NS061464-01A1. J. R. S. is supported by grants from the National Institute on Aging and NINDS. E. N. O. is supported by grants from NIH, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the Leducq Foundation, and the Robert A. Welch Foundation. E. N. O. is a cofounder of miRagen Therapeutics and holds equity in the company. A. H. W. and E. N. O. have filed a patent relating to this work. E. N. O. and J. R. S. dedicate this paper to their friend the late John Merlie, whose discovery of 7H4 (12) led directly to our work.	Beer HD, 2005, ONCOGENE, V24, P5269, DOI 10.1038/sj.onc.1208560; BENNETT MR, 1975, COLD SPRING HARB SYM, V40, P409, DOI 10.1101/SQB.1976.040.01.039; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; FRANK E, 1975, COLD SPRING HARB SYM, V40, P275, DOI 10.1101/SQB.1976.040.01.028; FRANK E, 1975, J PHYSIOL-LONDON, V247, P725, DOI 10.1113/jphysiol.1975.sp010954; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; SANES JR, 1985, TRENDS NEUROSCI, V8, P523, DOI 10.1016/0166-2236(85)90188-2; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; VELLECA MA, 1994, MOL CELL BIOL, V14, P7095, DOI 10.1128/MCB.14.11.7095; WOHLFART G, 1957, NEUROLOGY, V7, P124, DOI 10.1212/WNL.7.2.124	34	537	572	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1549	1554		10.1126/science.1181046	http://dx.doi.org/10.1126/science.1181046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007902	Green Accepted			2022-12-24	WOS:000272623600061
J	Farese, RV; Walther, TC				Farese, Robert V., Jr.; Walther, Tobias C.			Lipid Droplets Finally Get a Little R-E-S-P-E-C-T	CELL			English	Article							INFECTIOUS VIRUS; NEUTRAL LIPIDS; CORE PROTEIN; TRIACYLGLYCEROL; BIOGENESIS; STORAGE; METABOLISM; PERILIPIN; YEAST; BIOSYNTHESIS		[Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Walther, Tobias C.] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Max Planck Society	Farese, RV (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	bfarese@gladstone.ucsf.edu; twalther@biochem.mpg.de		Walther, Tobias/0000-0003-1442-1327	NIH [DK-056084]; Max Planck Society; German Research Council (DFG); Human Frontier Science Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056084, R56DK056084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); German Research Council (DFG)(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Farese and Walther laboratories, and in particular E. Currie, N. Krahmer, and C. Harris, for helpful discussions, and G. Howard for editorial assistance. This work was supported by NIH grant DK-056084 and the J. David Gladstone Institutes (to R. V. F.) and the Max Planck Society, the German Research Council (DFG), and the Human Frontier Science Program (to T. C. W.).	Altmann R, 1890, ELEMENTARORGANISEM I; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cho SY, 2007, J BIOL CHEM, V282, P2456, DOI 10.1074/jbc.M608042200; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Ostermeyer AG, 2004, J CELL BIOL, V164, P69, DOI 10.1083/jcb.200303037; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Robenek MJ, 2004, FASEB J, V18, P866, DOI 10.1096/fj.03-0782fje; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Service RF, 2009, SCIENCE, V325, P379, DOI 10.1126/science.325_379a; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Takeda Y, 2008, J BIOCHEM, V143, P803, DOI 10.1093/jb/mvn034; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wilson EB., 1896, CELL DEV INHERITANCE; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	46	664	676	4	166	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 25	2009	139	5					855	860		10.1016/j.cell.2009.11.005	http://dx.doi.org/10.1016/j.cell.2009.11.005			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945371	Bronze, Green Accepted			2022-12-24	WOS:000272169400008
J	Terret, ME; Sherwood, R; Rahman, S; Qin, J; Jallepalli, PV				Terret, Marie-Emilie; Sherwood, Rebecca; Rahman, Sadia; Qin, Jun; Jallepalli, Prasad V.			Cohesin acetylation speeds the replication fork	NATURE			English	Article							SISTER-CHROMATID COHESION; XENOPUS EGG EXTRACTS; HUMAN-CELLS; S-PHASE; SACCHAROMYCES-CEREVISIAE; ESTABLISHMENT; YEAST; CTCF; DNA; SENESCENCE	Cohesin not only links sister chromatids but also inhibits the transcriptional machinery's interaction with and movement along chromatin(1-6). In contrast, replication forks must traverse such cohesin-associated obstructions to duplicate the entire genome in S phase. How this occurs is unknown. Through single-molecule analysis, we demonstrate that the replication factor C (RFC)-CTF18 clamp loader (RFCCTF18)(1,7) controls the velocity, spacing and restart activity of replication forks in human cells and is required for robust acetylation of cohesin's SMC3 subunit and sister chromatid cohesion. Unexpectedly, we discovered that cohesin acetylation itself is a central determinant of fork processivity, as slow-moving replication forks were found in cells lacking the Eco1-related acetyltransferases ESCO1 or ESCO2 (refs 8 -10) (including those derived from Roberts' syndrome patients, in whom ESCO2 is biallelically mutated(11)) and in cells expressing a form of SMC3 that cannot be acetylated. This defect was a consequence of cohesin's hyperstable interaction with two regulatory cofactors, WAPL and PDS5A (refs 12, 13); removal of either cofactor allowed forks to progress rapidly without ESCO1, ESCO2, or RFCCTF18. Our results show a novel mechanism for clamp-loader-dependent fork progression, mediated by the post-translational modification and structural remodelling of the cohesin ring. Loss of this regulatory mechanism leads to the spontaneous accrual of DNA damage and may contribute to the abnormalities of the Roberts' syndrome cohesinopathy.	[Terret, Marie-Emilie; Sherwood, Rebecca; Rahman, Sadia; Jallepalli, Prasad V.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Qin, Jun] Baylor Coll Med, Dept Biochem & Mol Biol, Ctr Mol Discovery, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Baylor College of Medicine	Jallepalli, PV (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	jallepap@mskcc.org	TERRET, Marie-Emilie/R-5782-2017	TERRET, Marie-Emilie/0000-0001-5843-925X	National Institutes of Health; Pew Scholar in the Biochemical Sciences award; NATIONAL CANCER INSTITUTE [R01CA107342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar in the Biochemical Sciences award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Galloway, J. Hurwitz, J. Petrini, H. Nakao and H. Zou for reagents, and S. Keeney, K. Marians and J. Petrini for discussions and reading of the manuscript. We thank A. Viale, M. Hassimi and the MSKCC Genomics Core Laboratory for assistance with microarray experiments. This work was supported by a grant from the National Institutes of Health and a Pew Scholar in the Biochemical Sciences award to P. V. J.	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Papi M, 2005, NAT CELL BIOL, V7, P1029, DOI 10.1038/ncb1303; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Sakai A, 2003, EMBO J, V22, P2764, DOI 10.1093/emboj/cdg247; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	35	171	179	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					231	U106		10.1038/nature08550	http://dx.doi.org/10.1038/nature08550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907496	Green Accepted			2022-12-24	WOS:000271655100045
J	Chamberlain, NL; Hill, RI; Kapan, DD; Gilbert, LE; Kronforst, MR				Chamberlain, Nicola L.; Hill, Ryan I.; Kapan, Durrell D.; Gilbert, Lawrence E.; Kronforst, Marcus R.			Polymorphic Butterfly Reveals the Missing Link in Ecological Speciation	SCIENCE			English	Article							HYBRIDIZING HELICONIUS BUTTERFLIES; REPRODUCTIVE ISOLATION; MATE PREFERENCE; POPULATION; MIMICRY; FROGS	Ecological speciation occurs when ecologically based, divergent selection causes the evolution of reproductive isolation. There are many empirical examples of this process; however, there exists a poorly characterized stage during which the traits that distinguish species ecologically and reproductively segregate in a single population. By using a combination of genetic mapping, mate-choice experiments, field observations, and population genetics, we studied a butterfly population with a mimetic wing color polymorphism and found that the butterflies exhibited partial, color-based, assortative mate preference. These traits represent the divergent, ecologically based signal and preference components of sexual isolation that usually distinguish incipient and sibling species. The association between behavior and recognition trait in a single population may enhance the probability of speciation and provides an example of the missing link between an interbreeding population and isolated species.	[Chamberlain, Nicola L.; Hill, Ryan I.; Kronforst, Marcus R.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Kapan, Durrell D.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Gilbert, Lawrence E.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	Harvard University; University of Hawaii System; University of Hawaii Manoa; University of Texas System; University of Texas Austin	Kronforst, MR (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.	mkronforst@cgr.harvard.edu	Smola, Bohumil/P-7962-2016; Stulíková, Ivana/P-8010-2016	Smola, Bohumil/0000-0001-5551-2992; Stulíková, Ivana/0000-0002-4305-2041	NSF [DEB0640512]; NIH National Institute of General Medical Sciences [GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Olander and the staff of Heliconius Butterfly Works; T. and M. Quesenberry; and S. Villamar n, K. Kronforst, A. Gonzalez-Karlsson, I. Pagano, Ecuador's Ministerio del Ambiente, and the Museo Ecuatoriano de Ciencias Naturales for facilitating this work. We also thank C. Marshall for discussion and two anonymous reviewers for comments on the manuscript. Supported by NSF grant DEB0640512 and NIH National Institute of General Medical Sciences grant GM068763. DNA sequences have been deposited in GenBank with accession numbers GQ398158 through GQ398227.	Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; BUTLIN RK, 1989, BIOL J LINN SOC, V37, P237, DOI 10.1111/j.1095-8312.1989.tb01902.x; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Gilbert L.E., 1988, Journal of Research on the Lepidoptera, V26, P141; GILBERT LE, 2003, ECOLOGY EVOLUTION TA, P281; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Jiggins CD, 2008, BIOSCIENCE, V58, P541, DOI 10.1641/B580610; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kronforst MR, 2007, J EVOLUTION BIOL, V20, P278, DOI 10.1111/j.1420-9101.2006.01198.x; Kronforst MR, 2006, GENETICS, V174, P535, DOI 10.1534/genetics.106.059527; Kronforst MR, 2006, EVOLUTION, V60, P1254, DOI 10.1554/06-005.1; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Linzen B., 1974, ADV INSECT PHYSL, P117, DOI DOI 10.1016/S0065-2806(08)60130-7; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Pritchard JK, 2000, GENETICS, V155, P945; Reynolds RG, 2007, EVOLUTION, V61, P2253, DOI 10.1111/j.1558-5646.2007.00174.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; SNAYDON RW, 1976, HEREDITY, V37, P9, DOI 10.1038/hdy.1976.62; Snowberg LK, 2008, AM NAT, V172, P733, DOI 10.1086/591692; Summers K, 1999, P ROY SOC B-BIOL SCI, V266, P2141, DOI 10.1098/rspb.1999.0900; van der Sluijs I, 2008, BEHAV ECOL, V19, P177, DOI 10.1093/beheco/arm120	26	114	115	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					847	850		10.1126/science.1179141	http://dx.doi.org/10.1126/science.1179141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892982	Green Accepted			2022-12-24	WOS:000271468000042
J	Zapka, M; Heyers, D; Hein, CM; Engels, S; Schneider, NL; Hans, J; Weiler, S; Dreyer, D; Kishkinev, D; Wild, JM; Mouritsen, H				Zapka, Manuela; Heyers, Dominik; Hein, Christine M.; Engels, Svenja; Schneider, Nils-Lasse; Hans, Joerg; Weiler, Simon; Dreyer, David; Kishkinev, Dmitry; Wild, J. Martin; Mouritsen, Henrik			Visual but not trigeminal mediation of magnetic compass information in a migratory bird	NATURE			English	Article							HOMING PIGEONS; MAGNETORECEPTION; ORIENTATION; SONGBIRDS; BEAK; SENSITIVITY; INTENSITY; ANIMALS; NERVE; BRAIN	Magnetic compass information has a key role in bird orientation(1-3), but the physiological mechanisms enabling birds to sense the Earth's magnetic field remain one of the unresolved mysteries in biology(2,4). Two biophysical mechanisms have become established as the most promising magnetodetection candidates. The iron-mineral-based hypothesis suggests that magnetic information is detected by magnetoreceptors in the upper beak and transmitted through the ophthalmic branch of the trigeminal nerve to the brain(5-10). The light-dependent hypothesis suggests that magnetic field direction is sensed by radical pair-forming photopigments in the eyes(11-15) and that this visual signal is processed in cluster N, a specialized, night-time active, light-processing forebrain region(16-19). Here we report that European robins with bilateral lesions of cluster N are unable to show oriented magnetic-compass-guided behaviour but are able to perform sun compass and star compass orientation behaviour. In contrast, bilateral section of the ophthalmic branch of the trigeminal nerve in European robins did not influence the birds' ability to use their magnetic compass for orientation. These data show that cluster N is required for magnetic compass orientation in this species and indicate that it may be specifically involved in processing of magnetic compass information. Furthermore, the data strongly suggest that a vision-mediated mechanism underlies the magnetic compass in this migratory songbird, and that the putative iron-mineral-based receptors in the upper beak connected to the brain by the trigeminal nerve(6-8) are neither necessary nor sufficient for magnetic compass orientation in European robins.	[Zapka, Manuela; Heyers, Dominik; Hein, Christine M.; Engels, Svenja; Schneider, Nils-Lasse; Hans, Joerg; Weiler, Simon; Dreyer, David; Kishkinev, Dmitry; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensorik Anim Nav, D-26111 Oldenburg, Germany; [Wild, J. Martin] Univ Auckland, Fac Med & Hlth Sci, Dept Anat, Auckland 1142, New Zealand	Carl von Ossietzky Universitat Oldenburg; University of Auckland	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensorik Anim Nav, D-26111 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de	Heyers, Dominik/D-3885-2015; Mouritsen, Henrik/A-5401-2010; Kishkinev, Dmitry/S-1547-2016	Heyers, Dominik/0000-0002-2831-6985; Mouritsen, Henrik/0000-0001-7082-4839; Kishkinev, Dmitry/0000-0002-2619-1197	Volkswagenstiftung; Deutsche Forschungsgemeinschaft	Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Bourdonnais, D. Hugo, A. Kittel, C. Mora and several volunteer students for assistance, E. Jarvis for scientific discussions, Blumberg GmbH, Rattingen, Germany for providing the thermal paper, the workshops of the University of Oldenburg for building huts, magnetic coil systems and electronic controls and J. Rahn for assistance in the planetarium of the Fachhochschule Oldenburg/Elsfleth. Financial support was provided by the Volkswagenstiftung (to H. M. and D. H.) and by the Deutsche Forschungsgemeinschaft (to H. M.).	AKESSON S, 1994, ETHOLOGY, V98, P177; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Beason RC, 1996, J EXP BIOL, V199, P1241; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; EMLEN ST, 1966, AUK, V83, P361, DOI 10.2307/4083048; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; Fleissner G, 2007, NATURWISSENSCHAFTEN, V94, P631, DOI 10.1007/s00114-007-0236-0; Gagliardo A, 2006, J EXP BIOL, V209, P2888, DOI 10.1242/jeb.02313; Gagliardo A, 2008, J EXP BIOL, V211, P2046, DOI 10.1242/jeb.017608; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Mouritsen H, 2009, J ORNITHOL, V150, P713, DOI 10.1007/s10336-009-0421-3; PASTERNAK T, 1977, J COMP PHYSIOL PSYCH, V91, P485, DOI 10.1037/h0077349; PRESTI D, 1980, NATURE, V285, P99, DOI 10.1038/285099a0; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Williams MN, 2001, BRAIN RES, V889, P243, DOI 10.1016/S0006-8993(00)03114-0; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko W, 2002, NATURWISSENSCHAFTEN, V89, P445, DOI 10.1007/s00114-002-0356-5	30	188	194	7	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1274	U108		10.1038/nature08528	http://dx.doi.org/10.1038/nature08528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865170				2022-12-24	WOS:000271190800047
J	Neubauer, C; Gao, YG; Andersen, KR; Dunham, CM; Kelley, AC; Hentschel, J; Gerdes, K; Ramakrishnan, V; Brodersen, DE				Neubauer, Cajetan; Gao, Yong-Gui; Andersen, Kasper R.; Dunham, Christine M.; Kelley, Ann C.; Hentschel, Jendrik; Gerdes, Kenn; Ramakrishnan, V.; Brodersen, Ditlev E.			The Structural Basis for mRNA Recognition and Cleavage by the Ribosome-Dependent Endonuclease ReIE	CELL			English	Article							TOXIN-ANTITOXIN SYSTEM; AMINO-ACID STARVATION; ESCHERICHIA-COLI; A-SITE; TRANSLATION ELONGATION; CRYSTAL-STRUCTURE; MECHANISM; CODON; RELB; PURIFICATION	Translational control is widely used to adjust gene expression levels. During the stringent response in bacteria, mRNA is degraded on the ribosome by the ribosome-dependent endonuclease, ReIE. The molecular basis for recognition of the ribosome and mRNA by ReIE and the mechanism of cleavage are unknown. Here, we present crystal structures of E. coli ReIE in isolation (2.5 angstrom) and bound to programmed Thermus thermophilus 70S ribosomes before (3.3 angstrom) and after (3.6 angstrom) cleavage. ReIE occupies the A site and causes cleavage of mRNA after the second nucleotide of the codon by reorienting and activating the mRNA for 2'-OH-induced hydrolysis. Stacking of A site codon bases with conserved residues in ReIE and 16S rRNA explains the requirement for the ribosome in catalysis and the subtle sequence specificity of the reaction. These structures provide detailed insight into the translational regulation on the bacterial ribosome by mRNA cleavage.	[Neubauer, Cajetan; Gao, Yong-Gui; Dunham, Christine M.; Kelley, Ann C.; Hentschel, Jendrik; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Andersen, Kasper R.; Brodersen, Ditlev E.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Gerdes, Kenn] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	MRC Laboratory Molecular Biology; Aarhus University; Newcastle University - UK	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk; deb@mb.au.dk	Gerdes, Kenn/AAS-5548-2021; Gerdes, Kenn/M-2420-2014; Gao, Yonggui/A-9473-2015; Brodersen, Ditlev E./AAQ-5241-2020; Gao, Yong Gui/A-2187-2011; Neubauer, Cajetan/B-8935-2016	Gerdes, Kenn/0000-0002-7462-4612; Gerdes, Kenn/0000-0002-7462-4612; Gao, Yonggui/0000-0001-7298-0835; Neubauer, Cajetan/0000-0002-5348-5609; Brodersen, Ditlev/0000-0002-5413-4667; Andersen, Kasper Rojkjaer/0000-0002-4415-8067; Ramakrishnan, V/0000-0002-4699-2194	Medical Research Council (UK); Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Boehringer-Ingelheim Fonds fellowship; Lundbeck and Novo Nordisk Foundations; Medical Research Council [MC_U105184332] Funding Source: researchfish; MRC [MC_U105184332] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Boehringer-Ingelheim Fonds fellowship(Boehringer Ingelheim); Lundbeck and Novo Nordisk Foundations(Novo Nordisk Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	V. R. was supported by the Medical Research Council (UK), the Wellcome Trust, the Agouron Institute, and the Louis-Jeantet Foundation. C.N. was supported by a Boehringer-Ingelheim Fonds fellowship, D. E. B. received support from the Lundbeck and Novo Nordisk Foundations, and D. E. B. and K. G. were part of the Danish National Research Foundation Centre for mRNP Biogenesis and Metabolism. We thank beamline staff at Deutsches Elektronen-Synchrotron, Sandor Brockhauser at the ESRF, Clemens Schulze-Briese at Swiss Light Source, and Leong Ng for help with screening and data collection, as well as Martin Overgaard at Syddansk Universitet, Odense, Denmark for ReIE expression plasmids, Sew-Yeu Peak-Chew for help with MALDI mass spectrometry, and Kathrin Lang, Kurt Gothelf, and Sebastian Eustermann for useful discussions. V. R. is on the Scientific Advisory Board of Rib-X Pharmaceuticals, a company dedicated to making new antibiotics that target the ribosome.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andreev D, 2008, RNA, V14, P233, DOI 10.1261/rna.693208; Bauerova-Hlinkova V, 2009, FEBS J, V276, P4156, DOI 10.1111/j.1742-4658.2009.07125.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2008, NUCLEIC ACIDS RES, V36, P6472, DOI 10.1093/nar/gkn667; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2008, METHOD ENZYMOL, V447, P521, DOI 10.1016/S0076-6879(08)02225-8; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Cruz-Reyes J, 1998, BIOCHEMISTRY-US, V37, P6059, DOI 10.1021/bi972868g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galvani C, 2001, J BACTERIOL, V183, P2700, DOI 10.1128/JB.183.8.2700-2703.2001; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; HEINEMANN U, 1983, J BIOMOL STRUCT DYN, V1, P523, DOI 10.1080/07391102.1983.10507459; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; MURGOLA EJ, 1988, P NATL ACAD SCI USA, V85, P4162, DOI 10.1073/pnas.85.12.4162; Odaert B, 2007, J BIOL CHEM, V282, P2019, DOI 10.1074/jbc.M608271200; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; PRESCOTT C, 1991, NUCLEIC ACIDS RES, V19, P5281, DOI 10.1093/nar/19.19.5281; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sorensen MA, 2001, J MOL BIOL, V307, P785, DOI 10.1006/jmbi.2001.4525; Spottke B, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh089; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; ZEGERS I, 1994, J BIOL CHEM, V269, P127	45	161	163	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1084	1095		10.1016/j.cell.2009.11.015	http://dx.doi.org/10.1016/j.cell.2009.11.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005802	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000272622800011
J	Hale, CR; Zhao, P; Olson, S; Duff, MO; Graveley, BR; Wells, L; Terns, RM; Terns, MP				Hale, Caryn R.; Zhao, Peng; Olson, Sara; Duff, Michael O.; Graveley, Brenton R.; Wells, Lance; Terns, Rebecca M.; Terns, Michael P.			RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex	CELL			English	Article							PROVIDES ACQUIRED-RESISTANCE; NONCODING RNAS; PROKARYOTES; REPEATS; DNA; DEFENSE; IDENTIFICATION; INTERFERENCE; ELEMENTS; SYSTEM	Compelling evidence indicates that the CRISPR-Cas system protects prokaryotes from viruses and other potential genome invaders. This adaptive prokaryotic immune system arises from the clustered regularly interspaced short palindromic repeats (CRISPRs) found in prokaryotic genomes, which harbor short invader-derived sequences, and the CRISPR-associated (Cas) protein-coding genes. Here, we have identified a CRISPR-Cas effector complex that is comprised of small invader-targeting RNAs from the CRISPR loci (termed prokaryotic silencing (psi) RNAs) and the RAMP module (or Cmr) Cas proteins. The psiRNA-Cmr protein complexes cleave complementary target RNAs at a fixed distance from the 3' end of the integral psiRNAs. In Pyrococcus furiosus, psiRNAs occur in two size forms that share a common 5' sequence tag but have distinct 3' ends that direct cleavage of a given target RNA at two distinct sites. Our results indicate that prokaryotes possess a unique RNA silencing system that functions by homology-dependent cleavage of invader RNAs.	[Hale, Caryn R.; Zhao, Peng; Wells, Lance; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Biochem, Athens, GA 30602 USA; [Hale, Caryn R.; Zhao, Peng; Wells, Lance; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Mol Biol, Athens, GA 30602 USA; [Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Olson, Sara; Duff, Michael O.; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Connecticut	Terns, RM (corresponding author), Univ Georgia, Dept Biochem, Athens, GA 30602 USA.	rterns@bmb.uga.edu; mterns@bmb.uga.edu	Wells, Lance/H-3118-2013; Graveley, Brenton R/C-3108-2013; Terns, Michael/N-6435-2016	Ravel, Jacques/0000-0002-0851-2233; Wells, Lance/0000-0003-4956-5363; Graveley, Brenton/0000-0001-5777-5892; Zhao, Peng/0000-0002-9296-5293	National Institutes of Health [RO1GM54682, R01GM062516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062516, R01GM054682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We extend special thanks to Tim Davies (Director, University of Georgia Bioexpression & Fermentation Facility) for P. furiosus cells, the University of Connecticut Health Center Translational Genomics Core Facility for use of the Illumina Genome Analyzer, Frank Sugar (University of Georgia Bioexpression Facility) for expert advice on chromatography, Mike Adams and the Southeast Collaboratory for Structural Genomics (University of Georgia) for constructs, Lindsay Jones, Joshua Elmore and Sonali Majumdar (Terns Lab, University of Georgia) for generation of protein expression constructs, and Claiborne Glover (University of Georgia) for critical reading. L. W. is a Georgia Cancer Coalition Distinguished Scientist. This work was supported by National Institutes of Health grants RO1GM54682 (M. T. and R. T.) and R01GM062516 (B. R. G.).	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; LILLESTOL RK, 2009, MOL MICROBIOL; Lim JM, 2008, J PROTEOME RES, V7, P1251, DOI 10.1021/pr7006945; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	38	709	834	3	239	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					945	956		10.1016/j.cell.2009.07.040	http://dx.doi.org/10.1016/j.cell.2009.07.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945378	Green Accepted, Bronze			2022-12-24	WOS:000272169400018
J	Keiser, MJ; Setola, V; Irwin, JJ; Laggner, C; Abbas, AI; Hufeisen, SJ; Jensen, NH; Kuijer, MB; Matos, RC; Tran, TB; Whaley, R; Glennon, RA; Hert, J; Thomas, KLH; Edwards, DD; Shoichet, BK; Roth, BL				Keiser, Michael J.; Setola, Vincent; Irwin, John J.; Laggner, Christian; Abbas, Atheir I.; Hufeisen, Sandra J.; Jensen, Niels H.; Kuijer, Michael B.; Matos, Roberto C.; Tran, Thuy B.; Whaley, Ryan; Glennon, Richard A.; Hert, Jerome; Thomas, Kelan L. H.; Edwards, Douglas D.; Shoichet, Brian K.; Roth, Bryan L.			Predicting new molecular targets for known drugs	NATURE			English	Article							SEROTONIN RECEPTORS; REUPTAKE INHIBITOR; CHEMICAL BIOLOGY; DOUBLE-BLIND; AGONIST; N,N-DIMETHYLTRYPTAMINE; HALLUCINOGEN; PHARMACOLOGY; PROMISCUITY; MECHANISM	Although drugs are intended to be selective, at least some bind to several physiological targets, explaining side effects and efficacy. Because many drug-target combinations exist, it would be useful to explore possible interactions computationally. Here we compared 3,665 US Food and Drug Administration (FDA)-approved and investigational drugs against hundreds of targets, defining each target by its ligands. Chemical similarities between drugs and ligand sets predicted thousands of unanticipated associations. Thirty were tested experimentally, including the antagonism of the beta(1) receptor by the transporter inhibitor Prozac, the inhibition of the 5-hydroxytryptamine (5-HT) transporter by the ion channel drug Vadilex, and antagonism of the histamine H-4 receptor by the enzyme inhibitor Rescriptor. Overall, 23 new drug-target associations were confirmed, five of which were potent (<100 nM). The physiological relevance of one, the drug N,N-dimethyltryptamine (DMT) on serotonergic receptors, was confirmed in a knockout mouse. The chemical similarity approach is systematic and comprehensive, and may suggest side-effects and new indications for many drugs.	[Keiser, Michael J.; Irwin, John J.; Laggner, Christian; Hert, Jerome; Thomas, Kelan L. H.; Edwards, Douglas D.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Keiser, Michael J.] Univ Calif San Francisco, Grad Grp Bioinformat, San Francisco, CA 94143 USA; [Setola, Vincent; Kuijer, Michael B.; Matos, Roberto C.; Tran, Thuy B.; Whaley, Ryan; Roth, Bryan L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, NIMH Psychoact Drug Screening Program, Cleveland, OH 44106 USA; [Abbas, Atheir I.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Hufeisen, Sandra J.; Jensen, Niels H.; Roth, Bryan L.] Univ N Carolina, Chapel Hill Sch Med, Div Med Chem & Nat Prod, Chapel Hill, NC 27759 USA; [Hufeisen, Sandra J.; Jensen, Niels H.; Roth, Bryan L.] Univ N Carolina, Chapel Hill Sch Med, Dept Pharmacol, Chapel Hill, NC 27759 USA; [Glennon, Richard A.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Thomas, Kelan L. H.] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Virginia Commonwealth University; University of Michigan System; University of Michigan	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 1700 4th St, San Francisco, CA 94143 USA.	shoichet@cgl.ucsf.edu; bryan_roth@med.unc.edu	Roth, Bryan/ABE-7032-2020; Thomas, Kelan/AAZ-8575-2021; Abbas, Atheir/AAI-2158-2019; Roth, Bryan L/F-3928-2010; Keiser, Michael J./F-2825-2016; Hert, Jerome/A-8158-2008	Roth, Bryan/0000-0002-0561-6520; Thomas, Kelan/0000-0003-2818-270X; Keiser, Michael J./0000-0002-1240-2192; Abbas, Atheir/0000-0002-7080-3509; Setola, Vincent/0000-0002-9791-2270; Hert/0000-0003-3062-8029; Irwin, John/0000-0002-1195-6417	National Institutes of Health (NIH); National Science Foundation; European Commission; Max Kade Foundation; NARSAD; Michael Hooker Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH061887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Kade Foundation; NARSAD(NARSAD); Michael Hooker Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by grants from the National Institutes of Health (NIH) supporting chemoinformatics (to B. K. S. and J. J. I.) and NIH grants and contracts supporting drug discovery and receptor pharmacology (to B. L. R). M. J. K., J. H. and C. L. were supported by fellowships from the National Science Foundation, the 6th FP of the European Commission, and the Max Kade Foundation, respectively. B. L. R. was also supported by a Distinguished Investigator Award from the NARSAD and the Michael Hooker Chair. We thank T. Oprea of Sunset Molecular for WOMBAT, Elsevier MDL for the MDDR, Scitegic for PipelinePilot, J. Overington of the European Bioinformatics Institute (EMBL-EBI) for StARlite, Daylight Chemical Information Systems Inc. for the Daylight toolkit, and J. Gingrich for 5-HT2A knockout mice.	Abbas AI, 2009, J NEUROSCI, V29, P7124, DOI 10.1523/JNEUROSCI.1090-09.2009; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bajorath J, 2008, CURR OPIN CHEM BIOL, V12, P352, DOI 10.1016/j.cbpa.2008.01.044; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Dijkstra D, 2008, J INVEST DERMATOL, V128, P1696, DOI 10.1038/sj.jid.5701250; Ehrlich P., 1911, FOLIASEROLOGICA, V7, P697; *FDA, 2004, TALK PAP FDA WARNS W; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Gankina E. M., 1993, Eksperimental'naya i Klinicheskaya Farmakologiya, V56, P22; Gankina E. M., 1992, PHARM CHEM J, V26, P373; Hert J, 2008, J CHEM INF MODEL, V48, P755, DOI 10.1021/ci8000259; HEYKANTS J, 1981, European Journal of Drug Metabolism and Pharmacokinetics, V6, P61; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JAMES C, 1992, DAYLIGHT THEORY MANU; Jensen NH, 2008, NEUROPSYCHOPHARMACOL, V33, P2303, DOI 10.1038/sj.npp.1301646; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kohen R, 1996, J NEUROCHEM, V66, P47; Krejsa CM, 2003, CURR OPIN DRUG DISC, V6, P470; KURLAND A A, 1962, J New Drugs, V2, P352, DOI 10.1177/009127006200200605; LOMASNEY JW, 1991, J BIOL CHEM, V266, P6365; Marona-Lewicka D, 2007, PHARMACOL BIOCHEM BE, V87, P453, DOI 10.1016/j.pbb.2007.06.001; Marona-Lewicka D, 2009, BEHAV PHARMACOL, V20, P114, DOI 10.1097/FBP.0b013e3283242f1a; MASANORI I, 1987, BIOCHEM PHARMACOL, V36, P1947; MEHVAR R, 1987, DRUG METAB DISPOS, V15, P250; Michelson D, 2000, BRIT J PSYCHIAT, V176, P363, DOI 10.1192/bjp.176.4.363; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Nigsch F, 2008, J CHEM INF MODEL, V48, P2313, DOI 10.1021/ci800079x; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Olah M., 2007, CHEM BIOL SMALL MOL, P760; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Peterson RT, 2008, NAT CHEM BIOL, V4, P635, DOI 10.1038/nchembio1108-635; PIERCE PA, 1989, PSYCHOPHARMACOLOGY, V97, P118, DOI 10.1007/BF00443425; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Schuffenhauer A, 2002, J CHEM INF COMP SCI, V42, P947, DOI 10.1021/ci010385k; Scott LJ, 2000, DRUGS, V60, P1411, DOI 10.2165/00003495-200060060-00013; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel MG, 2007, DRUG DISCOV TODAY, V12, P71, DOI 10.1016/j.drudis.2006.11.011; Smith RL, 1998, PHARMACOL BIOCHEM BE, V61, P323, DOI 10.1016/S0091-3057(98)00110-5; Stork D, 2007, BRIT J PHARMACOL, V151, P1368, DOI 10.1038/sj.bjp.0707356; Su TP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe12; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Waldinger MD, 1998, J CLIN PSYCHOPHARM, V18, P274, DOI 10.1097/00004714-199808000-00004; Walsh CT, 2009, P NATL ACAD SCI USA, V106, P1689, DOI 10.1073/pnas.0813405106; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	53	1167	1203	6	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					175	U48		10.1038/nature08506	http://dx.doi.org/10.1038/nature08506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19881490	Green Accepted, Green Submitted			2022-12-24	WOS:000271655100034
J	Di Angelantonio, E; Sarwar, N; Perry, P; Kaptoge, S; Ray, KK; Thompson, A; Wood, AM; Lewington, S; Sattar, N; Packard, CJ; Collins, R; Thompson, SG; Danesh, J				Di Angelantonio, Emanuele; Sarwar, Nadeem; Perry, Philip; Kaptoge, Stephen; Ray, Kausik K.; Thompson, Alexander; Wood, Angela M.; Lewington, Sarah; Sattar, Naveed; Packard, Chris J.; Collins, Rory; Thompson, Simon G.; Danesh, John		Emerging Risk Factors Collaboratio	Major Lipids, Apolipoproteins, and Risk of Vascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ISCHEMIC-HEART-DISEASE; MYOCARDIAL-INFARCTION; NONFASTING TRIGLYCERIDES; CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; ASSOCIATION; CORONARY; STROKE; PARTICIPANTS	Context Associations of major lipids and apolipoproteins with the risk of vascular disease have not been reliably quantified. Objective To assess major lipids and apolipoproteins in vascular risk. Design, Setting, and Participants Individual records were supplied on 302 430 people without initial vascular disease from 68 long-term prospective studies, mostly in Europe and North America. During 2.79 million person-years of follow-up, there were 8857 nonfatal myocardial infarctions, 3928 coronary heart disease [CHD] deaths, 2534 ischemic strokes, 513 hemorrhagic strokes, and 2536 unclassified strokes. Main Outcome Measures Hazard ratios (HRs), adjusted for several conventional factors, were calculated for 1-SD higher values: 0.52 log(e) triglyceride, 15 mg/dL high-density lipoprotein cholesterol (HDL-C), 43 mg/dL non-HDL-C, 29 mg/dL apolipoprotein AI, 29 mg/dL apolipoprotein B, and 33 mg/dL directly measured low-density lipoprotein cholesterol (LDL-C). Within-study regression analyses were adjusted for within-person variation and combined using meta-analysis. Results The rates of CHD per 1000 person-years in the bottom and top thirds of baseline lipid distributions, respectively, were 2.6 and 6.2 with triglyceride, 6.4 and 2.4 with HDL-C, and 2.3 and 6.7 with non-HDL-C. Adjusted HRs for CHD were 0.99 (95% CI, 0.94-1.05) with triglyceride, 0.78 (95% CI, 0.74-0.82) with HDL-C, and 1.50 (95% CI, 1.39-1.61) with non-HDL-C. Hazard ratios were at least as strong in participants who did not fast as in those who did. The HR for CHD was 0.35 (95% CI, 0.30-0.42) with a combination of 80 mg/dL lower non-HDL-C and 15 mg/dL higher HDL-C. For the subset with apolipoproteins or directly measured LDL-C, HRs were 1.50 (95% CI, 1.38-1.62) with the ratio non-HDL-C/HDL-C, 1.49 (95% CI, 1.39-1.60) with the ratio apo B/apo AI, 1.42 (95% CI, 1.06-1.91) with non-HDL-C, and 1.38 (95% CI, 1.09-1.73) with directly measured LDL-C. Hazard ratios for ischemic stroke were 1.02 (95% CI, 0.94-1.11) with triglyceride, 0.93 (95% CI, 0.84-1.02) with HDL-C, and 1.12 (95% CI, 1.04-1.20) with non-HDL-C. Conclusion Lipid assessment in vascular disease can be simplified by measurement of either total and HDL cholesterol levels or apolipoproteins without the need to fast and without regard to triglyceride. JAMA. 2009; 302(18): 1993-2000	[Danesh, John] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Emerging Risk Factors Collaborat Coordinating Ctr, Cambridge CB1 8RN, England; [Lewington, Sarah; Collins, Rory] Univ Oxford, Oxford, England; [Sattar, Naveed; Packard, Chris J.] Univ Glasgow, Glasgow, Lanark, Scotland; [Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England	University of Cambridge; University of Oxford; University of Glasgow; MRC Biostatistics Unit	Danesh, J (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Emerging Risk Factors Collaborat Coordinating Ctr, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	Gudnason, Vilmundur/K-6885-2015; Benn, Marianne/O-4164-2019; Ulmer, Hanno/S-6615-2019; vhmpp, aks/F-9756-2012; Ray, Kausik/Z-2055-2019; Tikhonoff, Valerie/AAC-3728-2019; Meisinger, Christine/B-5358-2014; Dankner, Rachel/Q-5245-2019; Tanne, David/F-2560-2010; Lamarche, Benoit/ABA-4785-2021; Marmot, M G/Y-3920-2019; Thompson, Alexander/A-6109-2010; Wood, Angela/GZA-5762-2022; Lennon, Lucy/ABB-9433-2020; DiAngelantonio, Emanuele/ABE-6852-2020; de la Camara, Agustin Gomez/S-7123-2018; Brunner, Eric/H-2114-2011; Stefanadis, Christodoulos/ABH-2232-2020	Gudnason, Vilmundur/0000-0001-5696-0084; Benn, Marianne/0000-0002-1701-595X; Ulmer, Hanno/0000-0001-5911-1002; Tikhonoff, Valerie/0000-0001-7846-0101; Dankner, Rachel/0000-0001-6454-6000; Tanne, David/0000-0002-6699-2220; Lamarche, Benoit/0000-0002-4443-5378; Marmot, M G/0000-0002-2431-6419; Wood, Angela/0000-0002-7937-304X; Lennon, Lucy/0000-0002-1738-1351; Brunner, Eric/0000-0002-0595-4474; Amouyel, Philippe/0000-0001-9088-234X; Jespersen, Jorgen/0000-0002-3059-2356; Lawlor, Debbie A/0000-0002-6793-2262; Woodward, Mark/0000-0001-9800-5296; Bladbjerg, Else Marie/0000-0003-0912-2437; Chen, Zhengming/0000-0001-6423-105X; Pennells, Lisa Anne/0000-0002-8594-3061; Di Angelantonio, Emanuele/0000-0001-8776-6719; Engstrom, Gunnar/0000-0002-8618-9152; White, Ian/0000-0002-6718-7661; Lewington, Sarah/0000-0002-4496-4771; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Rothenbacher, Dietrich/0000-0002-3563-2791; Jorgensen, Torben/0000-0001-9453-2830; Stefanadis, Christodoulos/0000-0001-5974-6454; Ramachandran, Vasan/0000-0001-7357-5970; Sutherland, Susan/0000-0001-7184-8920; Wensley, Frances/0000-0003-4371-5340; Whincup, Peter/0000-0002-5589-4107	British Heart Foundation [RG/08/014]; UK Medical Research Council; BUPA Foundation; GlaxoSmithKline; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0501792, G0600705, MC_U137686853, MC_U137686851, MC_U137686857, MC_U105260792] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674, RG/08/014/24067, RG/08/013/25942] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G8802774, MC_U137686851, G0100222, G19/35, G0501792, G0600705, MC_U137686857, G0401527, MC_U105260792, MC_U137686853] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BUPA Foundation; GlaxoSmithKline(GlaxoSmithKline); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The ERFC Coordinating Centre is underpinned by a program grant from the British Heart Foundation (RG/08/014) and supported by grants from the UK Medical Research Council and the BUPA Foundation and an unrestricted educational grant from GlaxoSmithKline. A variety of sources have supported recruitment, follow-up, and laboratory measurements in the cohorts contributing to the ERFC. Investigators of several of these studies have contributed to a list naming some of these funding sources, which can be found at http://www.phpc.cam.ac.uk/MEU/. Drs Di Angelantonio, Sarwar, Perry, and Thompson have been supported by PhD studentships of the UK Medical Research Council. Dr Ray is supported by a BHF Intermediate Research Fellowship.	[Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2008, AM J CARDIOL, V101, P1428, DOI 10.1016/j.amjcard.2008.02.092; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Brunzell JD, 2008, J AM COLL CARDIOL, V51, P1512, DOI 10.1016/j.jacc.2008.02.034; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *CLINICALTRIALS GO, TREATM HDL RED INC V; *CLINICALTRIALS GO, AIM HIGH NIAC PLUS S; *CLINICALTRIALS GO, STUDY RO4607381 STAB; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Parish S, 2009, EUR HEART J, V30, P2137, DOI 10.1093/eurheartj/ehp221; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Tirschwell DL, 2004, NEUROLOGY, V63, P1868, DOI 10.1212/01.WNL.0000144282.42222.DA; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wang J, 2008, NAT CLIN PRACT CARD, V5, P730, DOI 10.1038/ncpcardio1326; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233	34	1819	1861	7	174	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					1993	2000						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903920	Green Accepted, Green Published			2022-12-24	WOS:000271619700026
J	Thomsen, ND; Berger, JM				Thomsen, Nathan D.; Berger, James M.			Running in Reverse: The Structural Basis for Translocation Polarity in Hexameric Helicases	CELL			English	Article							TRANSCRIPTION-TERMINATION FACTOR; RHO-DEPENDENT TERMINATION; ESCHERICHIA-COLI RHO; RNA PACKAGING MOTOR; SINGLE-STRANDED-DNA; BINDING SITE; ATP-BINDING; MACROMOLECULAR MACHINES; CRYSTAL-STRUCTURE; ARCHAEAL MCM	Hexameric helicases couple ATP hydrolysis to processive separation of nucleic acid duplexes, a process critical for gene expression, DNA replication, and repair. All hexameric helicases fall into two families with opposing translocation polarities: the 30/50 AAA+ and 5'/3' RecA-like enzymes. To understand how a RecA-like hexameric helicase engages and translocates along substrate, we determined the structure of the E. coli Rho transcription termination factor bound to RNA and nucleotide. Interior nucleic acid-binding elements spiral around six bases of RNA in a manner unexpectedly reminiscent of an AAA+ helicase, the papillomavirus E1 protein. Four distinct ATP-binding states, representing potential catalytic intermediates, are coupled to RNA positioning through a complex allosteric network. Comparative studies with E1 suggest that RecA and AAA+ hexameric helicases use different portions of their chemomechanical cycle for translocating nucleic acid and track in opposite directions by reversing the firing order of ATPase sites around the hexameric ring. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Thomsen, Nathan D.; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Quantitat Biosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Quantitat Biosci Inst, Berkeley, CA 94720 USA.	jmberger@berkeley.edu			NIH [GM071747]; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Keck, Andreas Martin, Allyn Schoeffler, and Nancy Crisona for helpful discussions and editing of the manuscript and Emmanuel Skordalakes and Berger lab members for assistance in various stages of the project. Special thanks go to the staff at SSRL beamlines 9.2 and 11.1; Scott Classen, George Meigs, and James Holton at ALS beamlines 12.3.1 and 8.3.1; Steve Gamblin for assistance with data processing; and Nat Echols for assistance with programs from the Yale Morph Server. This work was supported by funding from the NIH (GM071747) and the G. Harold and Leila Y. Mathers Foundation.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Berger JM, 2008, CELL, V134, DOI 10.1016/j.cell.2008.08.027; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN CYA, 1987, J BIOL CHEM, V262, P11292; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOLAN JW, 1990, J BIOL CHEM, V265, P5747; DOMBROSKI AJ, 1988, P NATL ACAD SCI USA, V85, P2538, DOI 10.1073/pnas.85.8.2538; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; GEISELMANN J, 1992, PROTEIN SCI, V1, P850, DOI 10.1002/pro.5560010703; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Huiskonen JT, 2007, J STRUCT BIOL, V158, P156, DOI 10.1016/j.jsb.2006.08.021; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; LAU LF, 1983, J BIOL CHEM, V258, P9391; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lisal J, 2004, J BIOL CHEM, V279, P1343, DOI 10.1074/jbc.M309587200; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; LOWERYGO.C, 1974, P NATL ACAD SCI USA, V71, P2003, DOI 10.1073/pnas.71.5.2003; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; MORGAN WD, 1983, J BIOL CHEM, V258, P9565; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; RICHARDSON JP, 1986, J MOL BIOL, V189, P413, DOI 10.1016/0022-2836(86)90313-X; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Sakakibara N, 2009, BIOCHEMISTRY-US, V48, P2330, DOI 10.1021/bi801921j; SEIFRIED SE, 1992, P NATL ACAD SCI USA, V89, P10454, DOI 10.1073/pnas.89.21.10454; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; STEINMETZ EJ, 1994, P NATL ACAD SCI USA, V91, P1401, DOI 10.1073/pnas.91.4.1401; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Weber TP, 2003, BIOCHEMISTRY-US, V42, P1652, DOI 10.1021/bi020601y; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; Xu Y, 2003, J BIOL CHEM, V278, P13719, DOI 10.1074/jbc.M212979200	67	221	223	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					523	534		10.1016/j.cell.2009.08.043	http://dx.doi.org/10.1016/j.cell.2009.08.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879839	Green Accepted, Bronze			2022-12-24	WOS:000271259600017
J	Stephens, PJ; McBride, DJ; Lin, ML; Varela, I; Pleasance, ED; Simpson, JT; Stebbings, LA; Leroy, C; Edkins, S; Mudie, LJ; Greenman, CD; Jia, MM; Latimer, C; Teague, JW; Lau, KW; Burton, J; Quail, MA; Swerdlow, H; Churcher, C; Natrajan, R; Sieuwerts, AM; Martens, JWM; Silver, DP; Langerod, A; Russnes, HEG; Foekens, JA; Reis-Filho, JS; van't Veer, L; Richardson, AL; Borresen-Dale, AL; Campbell, PJ; Futreal, PA; Stratton, MR				Stephens, Philip J.; McBride, David J.; Lin, Meng-Lay; Varela, Ignacio; Pleasance, Erin D.; Simpson, Jared T.; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Mudie, Laura J.; Greenman, Chris D.; Jia, Mingming; Latimer, Calli; Teague, Jon W.; Lau, King Wai; Burton, John; Quail, Michael A.; Swerdlow, Harold; Churcher, Carol; Natrajan, Rachael; Sieuwerts, Anieta M.; Martens, John W. M.; Silver, Daniel P.; Langerod, Anita; Russnes, Hege E. G.; Foekens, John A.; Reis-Filho, Jorge S.; van't Veer, Laura; Richardson, Andrea L.; Borresen-Dale, Anne-Lise; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.			Complex landscapes of somatic rearrangement in human breast cancer genomes	NATURE			English	Article							TANDEM DUPLICATION; MYELOID-LEUKEMIA; COPY NUMBER; FUSION GENE; PATTERNS; TRANSLOCATIONS; IDENTIFICATION; ABERRATIONS; ETV6-NTRK3; MUTATION	Multiple somatic rearrangements are often found in cancer genomes; however, the underlying processes of rearrangement and their contribution to cancer development are poorly characterized. Here we use a paired-end sequencing strategy to identify somatic rearrangements in breast cancer genomes. There are more rearrangements in some breast cancers than previously appreciated. Rearrangements are more frequent over gene footprints and most are intrachromosomal. Multiple rearrangement architectures are present, but tandem duplications are particularly common in some cancers, perhaps reflecting a specific defect in DNA maintenance. Short overlapping sequences at most rearrangement junctions indicate that these have been mediated by non-homologous end-joining DNA repair, although varying sequence patterns indicate that multiple processes of this type are operative. Several expressed in-frame fusion genes were identified but none was recurrent. The study provides a new perspective on cancer genomes, highlighting the diversity of somatic rearrangements and their potential contribution to cancer development.	[Stephens, Philip J.; McBride, David J.; Lin, Meng-Lay; Varela, Ignacio; Pleasance, Erin D.; Simpson, Jared T.; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Mudie, Laura J.; Greenman, Chris D.; Jia, Mingming; Latimer, Calli; Teague, Jon W.; Lau, King Wai; Burton, John; Quail, Michael A.; Swerdlow, Harold; Churcher, Carol; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Natrajan, Rachael; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Mol Pathol Lab, London SW3 6JB, England; [Sieuwerts, Anieta M.; Martens, John W. M.; Foekens, John A.] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Med Oncol, NL-3000 CA Rotterdam, Netherlands; [Silver, Daniel P.; Richardson, Andrea L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Langerod, Anita; Russnes, Hege E. G.; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Genet, N-0310 Oslo, Norway; [van't Veer, Laura] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Richardson, Andrea L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Borresen-Dale, Anne-Lise] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Erasmus University Rotterdam; Erasmus MC; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Oslo; Netherlands Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Russnes, Hege Elisabeth Giercksky/N-6170-2015; Quail, michael/ABE-6131-2020; Varela, Ignacio/AAA-7680-2021; Varela, Ignacio/G-1699-2016; Silver, Daniel/P-3443-2019	Russnes, Hege Elisabeth Giercksky/0000-0001-8724-1891; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Swerdlow, Harold/0000-0002-9510-160X; Natrajan, Rachael/0000-0002-9987-2946; Edsall, Lee Elizabeth/0000-0002-0326-2829; Edkins, Sarah/0000-0003-0717-1972	Kay Kendall Leukaemia Fund [KKL282]; Human Frontiers [LT000561/2009-L]; NCI [CA089393]; Breakthrough Breast Cancer; Research Council of Norway [155218, 175240]; Wellcome Trust [077012/Z/05/Z]; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER	Kay Kendall Leukaemia Fund; Human Frontiers; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breakthrough Breast Cancer; Research Council of Norway(Research Council of Norway); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to M. Lambros, F. Geyer and R. Vatcheva for their assistance in the FISH experiments. We would like to acknowledge the support of the Kay Kendall Leukaemia Fund under Grant KKL282, Human Frontiers Award reference LT000561/2009-L, the Dana-Farber/Harvard SPORE in breast cancer under NCI grant reference CA089393, Breakthrough Breast Cancer, the Research Council of Norway Grants no. 155218 and 175240, and the Wellcome Trust under grant reference 077012/Z/05/Z.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Basecke J, 2006, BRIT J HAEMATOL, V135, P438, DOI 10.1111/j.1365-2141.2006.06301.x; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Hoglund M, 2002, CANCER GENET CYTOGEN, V135, P103, DOI 10.1016/S0165-4608(01)00645-8; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kaye FJ, 2009, MOL CANCER THER, V8, P1399, DOI 10.1158/1535-7163.MCT-09-0135; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Lambros MBK, 2006, LAB INVEST, V86, P398, DOI 10.1038/labinvest.3700390; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; SCHOLZ FW, 1987, J AM STAT ASSOC, V82, P918, DOI 10.2307/2288805; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020	37	629	651	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1005	U60		10.1038/nature08645	http://dx.doi.org/10.1038/nature08645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033038	Green Accepted, Green Submitted			2022-12-24	WOS:000272996000036
J	Swiezewski, S; Liu, FQ; Magusin, A; Dean, C				Swiezewski, Szymon; Liu, Fuquan; Magusin, Andreas; Dean, Caroline			Cold-induced silencing by long antisense transcripts of an Arabidopsis Polycomb target	NATURE			English	Article							NONCODING RNAS; FLOWERING TIME; FLC; VERNALIZATION; PROTEIN; FCA; NORMALIZATION; METHYLATION; CEREVISIAE; EXPRESSION	Transcription in eukaryotic genomes generates an extensive array of non-protein-coding RNA, the functional significance of which is mostly unknown(1). We are investigating the link between non-coding RNA and chromatin regulation through analysis of FLC - a regulator of flowering time in Arabidopsis and a target of several chromatin pathways. Here we use an unbiased strategy to characterize non-coding transcripts of FLC and show that sense/antisense transcript levels correlate in a range of mutants and treatments, but change independently in cold-treated plants. Prolonged cold epigenetically silences FLC in a Polycomb-mediated process called vernalization(2). Our data indicate that upregulation of long non-coding antisense transcripts covering the entire FLC locus may be part of the cold-sensing mechanism. Induction of these antisense transcripts occurs earlier than, and is independent of, other vernalization markers(3) and coincides with a reduction in sense transcription. We show that addition of the FLC antisense promoter sequences to a reporter gene is sufficient to confer cold-induced silencing of the reporter. Our data indicate that cold-induced FLC antisense transcripts have an early role in the epigenetic silencing of FLC, acting to silence FLC transcription transiently. Recruitment of the Polycomb machinery then confers the epigenetic memory. Antisense transcription events originating from 3' ends of genes might be a general mechanism to regulate the corresponding sense transcription in a condition/stage-dependent manner.	[Swiezewski, Szymon; Liu, Fuquan; Magusin, Andreas; Dean, Caroline] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	caroline.dean@bbsrc.ac.uk	Liu, Fuquan/AGD-6751-2022	Dean, Caroline/0000-0002-6555-3525; Swiezewski, Szymon/0000-0002-2007-2779	BBSRC [BB/D010799/1]; NERC [NE/C507629]; EU SIROCCO [LSHG-CT-2006-037900]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA305, BB/D010799/1] Funding Source: researchfish; Natural Environment Research Council [NE/C507629/1] Funding Source: researchfish; BBSRC [BBS/E/J/000CA305] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU SIROCCO; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all members of the Dean laboratory for discussions, J. Ecker and B. Gregory (Salk Institute) for help with the RiboMinus technique, C. Lister for help with cloning steps, M. Lenhard and H. Breuninger for seeds of LUC control plants. This research was supported by the BBSRC Core Strategic Grant to the John Innes Centre and BBSRC BB/D010799/1, NERC NE/C507629 and EU SIROCCO LSHG-CT-2006-037900 grants to C. D.	Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Oeder S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-200; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pelz CR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-520; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; R Development Core Team, 2006, R LANG ENV STAT COMP; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sheldon CC, 2009, PLANT J, V59, P488, DOI 10.1111/j.1365-313X.2009.03883.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Volker A, 2001, J CELL SCI, V114, P3001; Yamamoto YY, 2003, PLANT J, V35, P273, DOI 10.1046/j.1365-313X.2003.01797.x	32	583	632	8	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					799	U122		10.1038/nature08618	http://dx.doi.org/10.1038/nature08618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010688				2022-12-24	WOS:000272559900041
J	Cao, B; Li, XW; Mao, Y; Wang, J; Lu, HZ; Chen, YS; Liang, ZA; Liang, LR; Zhang, SJ; Zhang, B; Gu, L; Lu, LH; Wang, DY; Wang, C				Cao, Bin; Li, Xing-Wang; Mao, Yu; Wang, Jian; Lu, Hong-Zhou; Chen, Yu-Sheng; Liang, Zong-An; Liang, Lirong; Zhang, Su-Juan; Zhang, Bin; Gu, Li; Lu, Lian-He; Wang, Da-Yan; Wang, Chen		Natl Influenza Pandemic H1N1 2009	Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITALIZED-PATIENTS; CALIFORNIA; OUTCOMES	BACKGROUND The first case of 2009 pandemic influenza A (H1N1) virus infection in China was documented on May 10. Subsequently, persons with suspected cases of infection and contacts of those with suspected infection were tested. Persons in whom infection was confirmed were hospitalized and quarantined, and some of them were closely observed for the purpose of investigating the nature and duration of the disease. METHODS During May and June 2009, we observed 426 persons infected with the 2009 pandemic influenza A (H1N1) virus who were quarantined in 61 hospitals in 20 provinces. Real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) testing was used to confirm infection, the clinical features of the disease were closely monitored, and 254 patients were treated with oseltamivir within 48 hours after the onset of disease. RESULTS The mean age of the 426 patients was 23.4 years, and 53.8% were male. The diagnosis was made at ports of entry (in 32.9% of the patients), during quarantine (20.2%), and in the hospital (46.9%). The median incubation period of the virus was 2 days (range, 1 to 7). The most common symptoms were fever (in 67.4% of the patients) and cough (69.5%). The incidence of diarrhea was 2.8%, and the incidence of nausea and vomiting was 1.9%. Lymphopenia, which was common in both adults (68.1%) and children (92.3%), typically occurred on day 2 (range, 1 to 3) and resolved by day 7 (range, 6 to 9). Hypokalemia was observed in 25.4% of the patients. Duration of fever was typically 3 days (range, 1 to 11). The median length of time during which patients had positive real-time RT-PCR test results was 6 days (range, 1 to 17). Independent risk factors for prolonged real-time RT-PCR positivity included an age of less than 14 years, male sex, and a delay from the onset of symptoms to treatment with oseltamivir of more than 48 hours. CONCLUSIONS Surveillance of the 2009 H1N1 virus in China shows that the majority of those infected have a mild illness. The typical period during which the virus can be detected with the use of real-time RT-PCR is 6 days (whether or not fever is present). The duration of infection may be shortened if oseltamivir is administered.	[Li, Xing-Wang; Mao, Yu; Zhang, Su-Juan; Zhang, Bin; Lu, Lian-He] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing 100015, Peoples R China; [Cao, Bin; Liang, Lirong; Gu, Li; Wang, Chen] Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Beijing 100020, Peoples R China; [Wang, Jian] Eighth Hosp Guangdong, Guangzhou, Guangdong, Peoples R China; [Lu, Hong-Zhou] Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Chen, Yu-Sheng] Fujian Prov Peoples Hosp, Fuzhou, Peoples R China; [Liang, Zong-An] Sichuan Univ, W China Med Sch, W China Hosp, Chengdu 610064, Peoples R China; [Wang, Da-Yan] Chinese Ctr Dis Control & Prevent, Chinese Natl Influenza Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Sichuan University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Li, XW (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, 8 Jingshun E St, Beijing 100015, Peoples R China.	ditanlxw@yahoo.com.cn; cyh-birm@263.net	zhang, weidong/N-1070-2014; wang, chen/GWM-9481-2022	zhang, weidong/0000-0002-8079-1185; 	Chinese Ministry of Science and Technology; Beijing Science and Technology Project [Z08050700020801]; Beijing Nova Program [2007A037]; Important National Science and Technology-Specific Projects [2009ZX10004-016]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Science and Technology Project; Beijing Nova Program(Beijing Municipal Science & Technology Commission); Important National Science and Technology-Specific Projects	Supported by grants from the Chinese Ministry of Science and Technology, the Beijing Science and Technology Project (Z08050700020801), the Beijing Nova Program (2007A037), and Important National Science and Technology-Specific Projects (2009ZX10004-016).	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P237; Boivin G, 2003, J INFECT DIS, V188, P578, DOI 10.1086/377046; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Cao B, 2009, EMERG INFECT DIS, V15, P1418, DOI 10.3201/eid1509.090794; CDC, 2009, CDC PROT REALT RTPCR; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Choi KW, 2003, ANN INTERN MED, V139, P715, DOI 10.7326/0003-4819-139-9-200311040-00005; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Naffakh N, 2009, MICROBES INFECT, V11, P725, DOI 10.1016/j.micinf.2009.05.002; Nichols JE, 2001, J VIROL, V75, P5921, DOI 10.1128/JVI.73.13.5921-5929.2001; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Trifonov V, 2009, EURO SURVEILL, V14; WHO, 2009, WKLY EPIDEMIOL REC, V84, P185; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; *WHO, 2009, INFL A H1N1 UPD 14 G; WHO, 2009, WHO GUID PHARM MAN P; 2009, MMWR MORB MORTAL WKL, V58, P431	22	444	530	2	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2507	2517		10.1056/NEJMoa0906612	http://dx.doi.org/10.1056/NEJMoa0906612			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	20007555	Bronze			2022-12-24	WOS:000273003700006
J	Rewitz, KF; Yamanaka, N; Gilbert, LI; O'Connor, MB				Rewitz, Kim F.; Yamanaka, Naoki; Gilbert, Lawrence I.; O'Connor, Michael B.			The Insect Neuropeptide PTTH Activates Receptor Tyrosine Kinase Torso to Initiate Metamorphosis	SCIENCE			English	Article							PROTHORACICOTROPIC HORMONE; BOMBYX-MORI; BODY-SIZE; DROSOPHILA; SIGNAL; ERK; ECDYSONE; PATHWAY; MECHANISMS	Holometabolous insects undergo complete metamorphosis to become sexually mature adults. Metamorphosis is initiated by brain-derived prothoracicotropic hormone ( PTTH), which stimulates the production of the molting hormone ecdysone via an incompletely defined signaling pathway. Here we demonstrate that Torso, a receptor tyrosine kinase that regulates embryonic terminal cell fate in Drosophila, is the PTTH receptor. Trunk, the embryonic Torso ligand, is related to PTTH, and ectopic expression of PTTH in the embryo partially rescues trunk mutants. In larvae, torso is expressed specifically in the prothoracic gland ( PG), and its loss phenocopies the removal of PTTH. The activation of Torso by PTTH stimulates extracellular signal-regulated kinase (ERK) phosphorylation, and the loss of ERK in the PG phenocopies the loss of PTTH and Torso. We conclude that PTTH initiates metamorphosis by activation of the Torso/ERK pathway.	[Rewitz, Kim F.; Yamanaka, Naoki; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Yamanaka, Naoki; O'Connor, Michael B.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA; [Gilbert, Lawrence I.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@umn.edu	O'Connor, Michael B/C-9977-2014; Yamanaka, Naoki/F-1358-2010; Rewitz, Kim F/M-6012-2014	O'Connor, Michael B/0000-0002-3067-5506; Yamanaka, Naoki/0000-0002-6244-2686; Rewitz, Kim F/0000-0002-4409-9941	Danish Natural Science Research Council [272-07-0340]; Howard Hughes Medical Institute	Danish Natural Science Research Council(Danish Natural Science Research Council); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	K. F. R. was supported by a postdoctoral fellowship from the Danish Natural Science Research Council ( grant no. 272-07-0340). M. B. O. is an investigator with the Howard Hughes Medical Institute. We are grateful to our collaborators J. T. Warren and R. Rybczynski and to reviewers for helpful comments. We also thank H. Kataoka for Bombyx PTTH. The GenBank accession number for Bombyx Torso is GQ477743.	Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Casali A, 2001, DEVELOPMENT, V128, P1709; CASANOVA J, 1989, GENE DEV, V3, P2025, DOI 10.1101/gad.3.12b.2025; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Li WX, 2005, DEV DYNAM, V232, P656, DOI 10.1002/dvdy.20295; Lin JL, 2007, J INSECT PHYSIOL, V53, P622, DOI 10.1016/j.jinsphys.2007.03.004; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Mishra S, 2005, CURR BIOL, V15, P366, DOI 10.1016/j.cub.2005.02.022; NOGUTI T, 1995, FEBS LETT, V376, P251, DOI 10.1016/0014-5793(95)01296-8; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Popa SM, 2008, ANNU REV PHYSIOL, V70, P213, DOI 10.1146/annurev.physiol.70.113006.100540; Rewitz KF, 2009, INSECT BIOCHEM MOLEC, V39, P475, DOI 10.1016/j.ibmb.2009.04.005; Rybczynski R, 2003, MOL CELL ENDOCRINOL, V205, P159, DOI 10.1016/S0303-7207(03)00090-X; Rybczynski R, 2001, MOL CELL ENDOCRINOL, V184, P1, DOI 10.1016/S0303-7207(01)00664-5; RYBCZYNSKI R, 2005, COMPREHENSIVE MOL IN, V3, P61; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0	20	213	234	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1403	1405		10.1126/science.1176450	http://dx.doi.org/10.1126/science.1176450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965758				2022-12-24	WOS:000272351100043
J	Cartier, N; Hacein-Bey-Abina, S; Bartholomae, CC; Veres, G; Schmidt, M; Kutschera, I; Vidaud, M; Abel, U; Dal-Cortivo, L; Caccavelli, L; Mahlaoui, N; Kiermer, V; Mittelstaedt, D; Bellesme, C; Lahlou, N; Lefrere, F; Blanche, S; Audit, M; Payen, E; Leboulch, P; l'Homme, B; Bougneres, P; Von Kalle, C; Fischer, A; Cavazzana-Calvo, M; Aubourg, P				Cartier, Nathalie; Hacein-Bey-Abina, Salima; Bartholomae, Cynthia C.; Veres, Gabor; Schmidt, Manfred; Kutschera, Ina; Vidaud, Michel; Abel, Ulrich; Dal-Cortivo, Liliane; Caccavelli, Laure; Mahlaoui, Nizar; Kiermer, Veronique; Mittelstaedt, Denice; Bellesme, Celine; Lahlou, Najiba; Lefrere, Francois; Blanche, Stephane; Audit, Muriel; Payen, Emmanuel; Leboulch, Philippe; l'Homme, Bruno; Bougneres, Pierre; Von Kalle, Christof; Fischer, Alain; Cavazzana-Calvo, Marina; Aubourg, Patrick			Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW-TRANSPLANTATION; INTEGRATION SITE SELECTION; LONG-TERM ENGRAFTMENT; HUMAN CD34(+) CELLS; NOD/SCID MICE; MOUSE MODEL; HIV VECTORS; MICROGLIA; DIFFERENTIATE	X-linked adrenoleukodystrophy (ALD) is a severe brain demyelinating disease in boys that is caused by a deficiency in ALD protein, an adenosine triphosphate-binding cassette transporter encoded by the ABCD1 gene. ALD progression can be halted by allogeneic hematopoietic cell transplantation (HCT). We initiated a gene therapy trial in two ALD patients for whom there were no matched donors. Autologous CD34(+) cells were removed from the patients, genetically corrected ex vivo with a lentiviral vector encoding wild-type ABCD1, and then re-infused into the patients after they had received myeloablative treatment. Over a span of 24 to 30 months of follow-up, we detected polyclonal reconstitution, with 9 to 14% of granulocytes, monocytes, and T and B lymphocytes expressing the ALD protein. These results strongly suggest that hematopoietic stem cells were transduced in the patients. Beginning 14 to 16 months after infusion of the genetically corrected cells, progressive cerebral demyelination in the two patients stopped, a clinical outcome comparable to that achieved by allogeneic HCT. Thus, lentiviral-mediated gene therapy of hematopoietic stem cells can provide clinical benefits in ALD.	[Cartier, Nathalie; Vidaud, Michel; l'Homme, Bruno; Aubourg, Patrick] Univ Paris 05, INSERM, UMR745, F-75279 Paris, France; [Cartier, Nathalie; Bellesme, Celine; Bougneres, Pierre; Aubourg, Patrick] Hop St Vincent de Paul, AP HP, Dept Pediat Endocrinol & Neurol, F-75674 Paris, France; [Hacein-Bey-Abina, Salima; Dal-Cortivo, Liliane; Caccavelli, Laure; Lefrere, Francois; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, Dept Biotherapy, F-75743 Paris, France; [Hacein-Bey-Abina, Salima; Fischer, Alain; Cavazzana-Calvo, Marina] Univ Paris 05, INSERM, UMR768, F-75743 Paris, France; [Hacein-Bey-Abina, Salima; Dal-Cortivo, Liliane; Caccavelli, Laure; Cavazzana-Calvo, Marina] Grp Hosp Univ Ouest, AP HP, INSERM, Clin Invest Ctr Biotherapy, F-75743 Paris, France; [Bartholomae, Cynthia C.; Schmidt, Manfred; Kutschera, Ina; Abel, Ulrich; Von Kalle, Christof] German Canc Res Ctr, Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; Schmidt, Manfred; Kutschera, Ina; Abel, Ulrich; Von Kalle, Christof] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Mahlaoui, Nizar; Blanche, Stephane; Fischer, Alain] Hop Necker Enfants Malad, Dept Pediat Immunohematol, F-75743 Paris, France; [Kiermer, Veronique] Nat Publishing Grp, New York, NY 10013 USA; [Lahlou, Najiba] Hop St Vincent de Paul, Dept Biochem, F-75674 Paris, France; [Payen, Emmanuel; Leboulch, Philippe] CEA, Inst Emerging Dis & Innovat Therapies iMETI, F-92265 Fontenay Aux Roses, France; [Audit, Muriel] Genosafe, F-91002 Evry, France; [Payen, Emmanuel; Leboulch, Philippe] INSERM, U962, F-92265 Fontenay Aux Roses, France; [Payen, Emmanuel; Leboulch, Philippe] Univ Paris 11, CEA, IMETI, F-92265 Fontenay Aux Roses, France; [Leboulch, Philippe] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Leboulch, Philippe] Harvard Univ, Sch Med, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Aubourg, P (corresponding author), Univ Paris 05, INSERM, UMR745, F-75279 Paris, France.	patrick.aubourg@inserm.fr	Payen, Emmanuel/S-5357-2018; Vidaud, Michel/O-7346-2017; MAHLAOUI, Nizar/AAH-6103-2020; cartier, nathalie/C-3103-2012; Mahlaoui, Nizar/J-7928-2017; Caccavelli, Laure/H-8880-2017	Payen, Emmanuel/0000-0002-1329-2327; MAHLAOUI, Nizar/0000-0002-0030-8094; cartier, nathalie/0000-0003-2298-5261; Mahlaoui, Nizar/0000-0002-0030-8094; Caccavelli, Laure/0000-0001-6324-2304; Kiermer, Veronique/0000-0001-8771-7239; Cavazzana, Marina/0000-0002-0264-0891	INSERM; European Leukodystrophy Association; Association Francaise contre les Myopathies; La Fondation de France; STOP-ALD foundation; La Fondation Avenir; Etablissement Francais des Greffes; Thermo Fisher Scientific; 6th Framework European Economic Community ( EEC) Programme [LSHM-CT2004-502987]; Programme Hospitalier de Recherche Clinique [AOM 3043]; Assistance Publique-H pitaux de Paris; Centre d' Investigation Clinique-Biotherapy, and Association Fran aise contre les Myopathies; Deutsche Forschungsgemeinschaft [SPP 1230]; German Ministry of Education and Research (TREATID); Helmholtz Association; 6th Framework EEC Programme (CONSERT, CLINIGENE)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Leukodystrophy Association; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); La Fondation de France(Fondation de France); STOP-ALD foundation; La Fondation Avenir; Etablissement Francais des Greffes; Thermo Fisher Scientific; 6th Framework European Economic Community ( EEC) Programme(European Commission); Programme Hospitalier de Recherche Clinique; Assistance Publique-H pitaux de Paris; Centre d' Investigation Clinique-Biotherapy, and Association Fran aise contre les Myopathies; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research (TREATID)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); 6th Framework EEC Programme (CONSERT, CLINIGENE)	We thank A. Salzman and R. Salzman for their continuous help and support in this project; the pediatricians and nurses of the Unite d'Endocrinologie et Neurologie Pediatriques, Hopital Saint-Vincent de Paul and the Unite d'Immunologie et d'Hematologie Pediatriques, Hopital Necker-Enfants Malades for patient care; A. Pujol and C. Sever Bermejo for patient referral; C. Adamsbaum for neuroimaging studies; F. Audat for cytapheresis; P. Lebon for HIV and VSV. G serologies; C. Lagresle-Peyrou for setting up the transduction protocol; P. Working and Cell Genesys staff for the lenti-MND-ALD vector; PeproTech for SCF, Flt-3, MGDF, and IL-3 cytokines; Takara Bio for the CH-296 fibronectin fragment; and E. Postaire and C. Sebastiani at INSERM. P. A. and N. C. were supported by grants from INSERM, European Leukodystrophy Association, Association Francaise contre les Myopathies, La Fondation de France, the STOP-ALD foundation, La Fondation Avenir, Etablissement Francais des Greffes, Thermo Fisher Scientific, the 6th Framework European Economic Community ( EEC) Programme (LSHM-CT2004-502987) and the Programme Hospitalier de Recherche Clinique (AOM 3043, French Health Ministry). S. H.-B.- A., L. D.-C., L. C., F. L., A. F., and M. C.-C. were supported by INSERM, Assistance Publique-H pitaux de Paris, Centre d' Investigation Clinique-Biotherapy, and Association Fran aise contre les Myopathies. C. V. K. and M. S. were supported by grants from the Deutsche Forschungsgemeinschaft (SPP 1230), the German Ministry of Education and Research (TREATID), the Helmholtz Association, and the 6th Framework EEC Programme (CONSERT, CLINIGENE). P. Leboulch owns stock in Genetix Pharmaceuticals, and G. Veres, V. Kiermer, and D. Mittelstaedt were formerly employed at Cell Genesys. This gene therapy trial was approved by AFSSAPS on 15 November 2005 and CCPPRB Paris- Cochin ( local Institutional Review Board) on 7 September 2004. Informed consent was obtained from the parents of the patients after the nature and possible consequences of the studies were explained.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; AUBOURG P, 1990, NEW ENGL J MED, V322, P1860, DOI 10.1056/NEJM199006283222607; Benhamida S, 2003, MOL THER, V7, P317, DOI 10.1016/S1525-0016(03)00002-9; Biffi A, 2006, J CLIN INVEST, V116, P3070, DOI 10.1172/JCI28873; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Davoust N, 2008, TRENDS IMMUNOL, V29, P227, DOI 10.1016/j.it.2008.01.010; De Palma M, 2005, BLOOD, V105, P2307, DOI 10.1182/blood-2004-03-0798; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; LOES DJ, 1994, AM J NEURORADIOL, V15, P1761; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shapiro E, 2000, LANCET, V356, P713, DOI 10.1016/S0140-6736(00)02629-5; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939	26	1075	1143	1	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					818	823		10.1126/science.1171242	http://dx.doi.org/10.1126/science.1171242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892975				2022-12-24	WOS:000271468000034
J	Lopez-Bueno, A; Tamames, J; Velazquez, D; Moya, A; Quesada, A; Alcami, A				Lopez-Bueno, Alberto; Tamames, Javier; Velazquez, David; Moya, Andres; Quesada, Antonio; Alcami, Antonio			High Diversity of the Viral Community from an Antarctic Lake	SCIENCE			English	Article							FRESH-WATER; MARINE VIRUSES; ECOSYSTEMS; BIODIVERSITY; ISLAND; LIFE	Viruses are the most abundant biological entities and can control microbial communities, but their identity in terrestrial and freshwater Antarctic ecosystems is unknown. The genetic structure of an Antarctic lake viral community revealed unexpected genetic richness distributed across the highest number of viral families that have been found to date in aquatic viral metagenomes. In contrast to other known aquatic viromes, which are dominated by bacteriophage sequences, this Antarctic virus assemblage had a large proportion of sequences related to eukaryotic viruses, including phycodnaviruses and single-stranded DNA (ssDNA) viruses not previously identified in aquatic environments. We also observed that the transition from an ice-covered lake in spring to an open-water lake in summer led to a change from a ssDNA- to a double-stranded DNA-virus-dominated assemblage, possibly reflecting a seasonal shift in host organisms.	[Lopez-Bueno, Alberto; Alcami, Antonio] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain; [Tamames, Javier; Moya, Andres] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Tamames, Javier; Moya, Andres] Generalitat Valenciana, Conselleria Sanidad, Ctr Super Invest Salud Publ, Valencia, Spain; [Tamames, Javier; Moya, Andres] Ctr Invest Biomed Red Epidemiol & Salud Publ, Barcelona, Spain; [Velazquez, David] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Alcami, Antonio] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Madrid; University of Cambridge	Alcami, A (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain.	aalcami@cbm.uam.es	Alcami, Antonio/F-8512-2015; Quesada, Antonio/L-2430-2013; Moya, Andrés/A-8190-2008; Velazquez, David/M-2309-2017	Alcami, Antonio/0000-0002-3333-6016; Quesada, Antonio/0000-0002-8913-5993; Moya, Andrés/0000-0002-2867-1119; Velazquez, David/0000-0002-4127-8370; Lopez-Bueno, Alberto/0000-0002-6324-8623; Lopez Bueno, Alberto/0000-0003-2449-4562; Tamames, Javier/0000-0003-4547-8932	Spanish Ministry of Science and Innovation [CGL2005-06549-C02-01/ANT, CGL200729843-E/ANT, CTM2008-05134-E/ANT, BFU200804501-E];  [FJ791185-247];  [FJ791175-84]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ; 	We thank the Maritime Technology Unit (CSIC) and Las Palmas crew (Spanish Navy) for the logistic help and support that made this expedition possible. We also thank M. Toro, A. Camacho, and other members of the Limnopolar Project for help and discussions; A. Alejo for helpful comments and reviewing the manuscript; and M. Pignatelli for technical support. This work was funded by grants from the Spanish Ministry of Science and Innovation (CGL2005-06549-C02-01/ANT, CGL200729843-E/ANT, CTM2008-05134-E/ANT, and BFU200804501-E). Spring and summer viral metagenomes from the Antarctic Lake Limnopolar have been submitted to GenBank and assigned the genome project accession number 34669. The metagenomes are also publicly accessible from the ftp server of the SEED public database (ftp://ftp.theseed.org/metagenomes) under the project accession numbers 4441778.3 and 4441558.3 for the spring and summer viromes, respectively. PCR-obtained sequences encoding the gp23 protein of Antarctic T4-phages and the MCP protein of Antarctic phycodnavirus have been also deposited at GenBank as "environmental sequences" and are listed under accession numbers FJ791185-247 and FJ791175-84, respectively.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Chown SL, 2007, PHILOS T R SOC B, V362, P2307, DOI 10.1098/rstb.2006.1949; Convey P, 2008, BIOL REV, V83, P103, DOI 10.1111/j.1469-185X.2008.00034.x; Convey P, 2007, SCIENCE, V317, P1877, DOI 10.1126/science.1147261; Cowan DA, 2004, ANNU REV MICROBIOL, V58, P649, DOI 10.1146/annurev.micro.57.030502.090811; Derelle E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002250; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Filee J, 2005, P NATL ACAD SCI USA, V102, P12471, DOI 10.1073/pnas.0503404102; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Kepner RL, 1998, LIMNOL OCEANOGR, V43, P1754, DOI 10.4319/lo.1998.43.7.1754; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Laybourn-Parry J, 2001, FRESHWATER BIOL, V46, P1279, DOI 10.1046/j.1365-2427.2001.00749.x; Laybourn-Parry J, 2007, PHILOS T R SOC B, V362, P2273, DOI 10.1098/rstb.2006.1945; Laybourn-Parry J, 2009, SCIENCE, V324, P1521, DOI 10.1126/science.1173645; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Pearce DA, 2003, ANTARCT SCI, V15, P319, DOI 10.1017/S0954102003001330; Peck LS, 2005, POLAR BIOL, V28, P351, DOI 10.1007/s00300-004-0671-8; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Sawstrom C, 2008, EXTREMOPHILES, V12, P167, DOI 10.1007/s00792-007-0134-6; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Toro M, 2007, POLAR BIOL, V30, P635, DOI 10.1007/s00300-006-0223-5; Wilson WH, 2000, POLAR BIOL, V23, P657, DOI 10.1007/s003000000152	26	287	308	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					858	861		10.1126/science.1179287	http://dx.doi.org/10.1126/science.1179287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892985				2022-12-24	WOS:000271468000045
J	Melcher, K; Ng, LM; Zhou, XE; Soon, FF; Xu, Y; Suino-Powell, KM; Park, SY; Weiner, JJ; Fujii, H; Chinnusamy, V; Kovach, A; Li, J; Wang, YH; Li, JY; Peterson, FC; Jensen, DR; Yong, EL; Volkman, BF; Cutler, SR; Zhu, JK; Xu, HE				Melcher, Karsten; Ng, Ley-Moy; Zhou, X. Edward; Soon, Fen-Fen; Xu, Yong; Suino-Powell, Kelly M.; Park, Sang-Youl; Weiner, Joshua J.; Fujii, Hiroaki; Chinnusamy, Viswanathan; Kovach, Amanda; Li, Jun; Wang, Yonghong; Li, Jiayang; Peterson, Francis C.; Jensen, Davin R.; Yong, Eu-Leong; Volkman, Brian F.; Cutler, Sean R.; Zhu, Jian-Kang; Xu, H. Eric			A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors	NATURE			English	Article							PHOSPHATASE-ACTIVITY; GENE-EXPRESSION; PROTEIN-KINASE; ARABIDOPSIS; BINDING; SYSTEM; TRANSDUCTION; DEHYDRATION; GERMINATION	Abscisic acid (ABA) is a ubiquitous hormone that regulates plant growth, development and responses to environmental stresses. Its action is mediated by the PYR/PYL/RCAR family of START proteins, but it remains unclear how these receptors bind ABA and, in turn, how hormone binding leads to inhibition of the downstream type 2C protein phosphatase (PP2C) effectors. Here we report crystal structures of apo and ABA-bound receptors as well as a ternary PYL2-ABA-PP2C complex. The apo receptors contain an open ligand-binding pocket flanked by a gate that closes in response to ABA by way of conformational changes in two highly conserved beta-loops that serve as a gate and latch. Moreover, ABA-induced closure of the gate creates a surface that enables the receptor to dock into and competitively inhibit the PP2C active site. A conserved tryptophan in the PP2C inserts directly between the gate and latch, which functions to further lock the receptor in a closed conformation. Together, our results identify a conserved gate-latch-lock mechanism underlying ABA signalling.	[Melcher, Karsten; Ng, Ley-Moy; Zhou, X. Edward; Soon, Fen-Fen; Xu, Yong; Suino-Powell, Kelly M.; Kovach, Amanda; Li, Jun; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Ng, Ley-Moy; Soon, Fen-Fen; Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Dept Obstet & Gynecol, Natl Univ Singapore Hosp, Yong Loo Lin Sch Med,Grad Sch Integrat Sci & Engn, Singapore 119074, Singapore; [Park, Sang-Youl; Fujii, Hiroaki; Chinnusamy, Viswanathan; Cutler, Sean R.; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Weiner, Joshua J.; Peterson, Francis C.; Jensen, Davin R.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Fujii, Hiroaki; Chinnusamy, Viswanathan; Zhu, Jian-Kang] King Abdullah Univ Sci & Technol, Ctr Plant Stress Genom & Technol, Thuwal 239556900, Saudi Arabia; [Wang, Yonghong; Li, Jiayang] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China	Van Andel Institute; National University of Singapore; University of California System; University of California Riverside; Medical College of Wisconsin; King Abdullah University of Science & Technology; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Xu, HE (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	eric.xu@vai.org	Volkman, Brian F./ABE-7312-2020; Cutler, Sean R/D-6617-2011; Xu, H. Eric/ABD-7487-2021; Volkman, Brian F./ABE-7306-2020; Zhu, Jian-Kang/F-7658-2011; Li, Jiayang/AAG-4377-2020; Melcher, Karsten/AAZ-3861-2020; Chinnusamy, Viswanathan/B-9079-2009	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Zhu, Jian-Kang/0000-0001-5134-731X; Melcher, Karsten/0000-0002-9125-4027; Chinnusamy, Viswanathan/0000-0003-2174-9064; Cutler, Sean/0000-0002-8593-0885; Fujii, Hiroaki/0000-0002-0013-5891; Yong, Eu-Leong/0000-0001-6511-770X; Xu, H. Eric/0000-0002-6829-8144	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Office of Science of the US Department of Energy; Jay and Betty Van Andel Foundation; National Institutes of Health; National Science Foundation; NUS Graduate School for Integrative Sciences & Engineering (NGS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087413] Funding Source: NIH RePORTER	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Jay and Betty Van Andel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NUS Graduate School for Integrative Sciences & Engineering (NGS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of LS-CAT for assistance in data collection at the beam lines of sector 21, which is in part funded by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor. Use of the Advanced Photon Source was supported by the Office of Science of the US Department of Energy. This work was supported by the Jay and Betty Van Andel Foundation ( H. E. X.), the National Institutes of Health (H. E. X., B. F. V. and J-K.Z.), and the National Science Foundation ( S. R. C.). L.-M.N. and F.-F.S. were supported by an overseas PhD scholarship from the NUS Graduate School for Integrative Sciences & Engineering (NGS).	Allen-Baume V, 2002, FEBS LETT, V531, P74, DOI 10.1016/S0014-5793(02)03412-9; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bartels C, 1997, J COMPUT CHEM, V18, P139, DOI 10.1002/(SICI)1096-987X(19970115)18:1<139::AID-JCC13>3.0.CO;2-H; Bertauche N, 1996, EUR J BIOCHEM, V241, P193, DOI 10.1111/j.1432-1033.1996.0193t.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chinnusamy V, 2008, J INTEGR PLANT BIOL, V50, P1187, DOI 10.1111/j.1744-7909.2008.00727.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pennisi E, 2009, SCIENCE, V324, P1012, DOI 10.1126/science.324_1012; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Seedorf U, 2000, BBA-MOL CELL BIOL L, V1486, P45, DOI 10.1016/S1388-1981(00)00047-0; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Wirtz KWA, 2006, FEBS LETT, V580, P5436, DOI 10.1016/j.febslet.2006.06.065; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	41	472	537	4	194	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					602	U72		10.1038/nature08613	http://dx.doi.org/10.1038/nature08613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19898420	Green Submitted, Green Accepted			2022-12-24	WOS:000272277900031
J	Seal, RP; Wang, XD; Guan, Y; Raja, SN; Woodbury, CJ; Basbaum, AI; Edwards, RH				Seal, Rebecca P.; Wang, Xidao; Guan, Yun; Raja, Srinivasa N.; Woodbury, C. Jeffery; Basbaum, Allan I.; Edwards, Robert H.			Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors	NATURE			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; SPINAL DORSAL-HORN; SUBSTANTIA-GELATINOSA; SENSORY NEURONS; MICE LACKING; INFLAMMATORY PAIN; NEUROPATHIC PAIN; AFFERENT-FIBERS; MARGINAL ZONE; PKC-GAMMA	Mechanical pain contributes to the morbidity associated with inflammation and trauma, but primary sensory neurons that convey the sensation of acute and persistentmechanical pain have not been identified. Dorsal root ganglion (DRG) neurons transmit sensory information to the spinal cord using the excitatory transmitter glutamate(1), a process that depends on glutamate transport into synaptic vesicles for regulated exocytotic release. Here we report that a small subset of cells in the DRG expresses the low abundance vesicular glutamate transporter VGLUT3 (also known as SLC17A8). In the dorsal horn of the spinal cord, these afferents project to lamina I and the innermost layer of lamina II, which has previously been implicated in persistent pain caused by injury(2). Because the different VGLUT isoforms generally have a non-redundant pattern of expression(3), we used Vglut3 knockout mice to assess the role of VGLUT3(+) primary afferents in the behavioural response to somatosensory input. The loss of VGLUT3 specifically impairs mechanical pain sensation, and in particular the mechanical hypersensitivity to normally innocuous stimuli that accompanies inflammation, nerve injury and trauma. Direct recording from VGLUT3(+) neurons in the DRG further identifies them as a poorly understood population of unmyelinated, low threshold mechanoreceptors (C-LTMRs)(4,5). The analysis of Vglut3(-/-) mice now indicates a critical role for C-LTMRs in the mechanical hypersensitivity caused by injury.	[Seal, Rebecca P.; Edwards, Robert H.] Univ Calif San Francisco, San Francisco Sch Med, Dept Physiol, San Francisco, CA 94143 USA; [Seal, Rebecca P.; Edwards, Robert H.] Univ Calif San Francisco, San Francisco Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Wang, Xidao; Basbaum, Allan I.] Univ Calif San Francisco, San Francisco Sch Med, Dept Anat, San Francisco, CA 94158 USA; [Wang, Xidao; Basbaum, Allan I.] Univ Calif San Francisco, San Francisco Sch Med, Dept Physiol, San Francisco, CA 94158 USA; [Guan, Yun; Raja, Srinivasa N.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Woodbury, C. Jeffery] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; University of Wyoming	Edwards, RH (corresponding author), Univ Calif San Francisco, San Francisco Sch Med, Dept Physiol, San Francisco, CA 94143 USA.	robert.edwards@ucsf.edu		Yang, Shuman/0000-0002-9638-0890; Seal, Rebecca/0000-0003-4955-703X	Johns Hopkins Blaustein Pain Research Fund; NARSAD; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712, F32MH068085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044094] Funding Source: NIH RePORTER	Johns Hopkins Blaustein Pain Research Fund; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Bautista, D. Julius and members of the Basbaum and Edwards laboratories for advice, and D. Woodbury and C. Cassidy from the Woodbury laboratory for help with experiments. The work was supported by the Johns Hopkins Blaustein Pain Research Fund (Y.G.) and by grants from NARSAD ( R. P. S., R. H. E.) and NIH ( R. P. S., Y. G., S. N. R., C. J. W., A. I. B. and R. H. E.).	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Albers KM, 2006, J NEUROSCI, V26, P2981, DOI 10.1523/JNEUROSCI.4863-05.2006; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; Boada MD, 2008, J NEUROSCI, V28, P2006, DOI 10.1523/JNEUROSCI.5609-07.2008; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHRISTENSEN BN, 1970, J NEUROPHYSIOL, V33, P293, DOI 10.1152/jn.1970.33.2.293; CHUNG JM, 1979, J NEUROPHYSIOL, V42, P1354, DOI 10.1152/jn.1979.42.5.1354; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Gras C, 2002, J NEUROSCI, V22, P5442; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; IGGO A, 1968, J PHYSL, V198; KAYSER V, 1987, PAIN, V28, P99, DOI 10.1016/0304-3959(87)91064-5; Li JL, 2003, J COMP NEUROL, V457, P236, DOI 10.1002/cne.10556; LIGHT AR, 1979, J COMP NEUROL, V186, P151, DOI 10.1002/cne.901860204; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Neumann S, 1996, NATURE, V384, P360, DOI 10.1038/384360a0; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; Schaible HG, 2002, ANN NY ACAD SCI, V966, P343, DOI 10.1111/j.1749-6632.2002.tb04234.x; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293	30	295	301	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					651	655		10.1038/nature08505	http://dx.doi.org/10.1038/nature08505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19915548	Green Accepted, Green Submitted			2022-12-24	WOS:000272277900041
J	Sato, A; Isaac, B; Phillips, CM; Rillo, R; Carlton, PM; Wynne, DJ; Kasad, RA; Dernburg, AF				Sato, Aya; Isaac, Berith; Phillips, Carolyn M.; Rillo, Regina; Carlton, Peter M.; Wynne, David J.; Kasad, Roshni A.; Dernburg, Abby F.			Cytoskeletal Forces Span the Nuclear Envelope to Coordinate Meiotic Chromosome Pairing and Synapsis	CELL			English	Article							C-ELEGANS MEIOSIS; FISSION YEAST; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; BOUQUET FORMATION; PROPHASE; RECOMBINATION; MOVEMENT; PROTEIN; MICROTUBULES	During meiosis, each chromosome must pair with its unique homologous partner, a process that usually culminates with the formation of the synaptonemal complex (SC). In the nematode Caenorhabditis elegans, special regions on each chromosome known as pairing centers are essential for both homologous pairing and synapsis. We report that during early meiosis, pairing centers establish transient connections to the cytoplasmic microtubule network. These connections through the intact nuclear envelope require the SUN/KASH domain protein pair SUN-1 and ZYG-12. Disruption of microtubules inhibits chromosome pairing, indicating that these connections promote interhomolog interactions. Dynein activity is essential to license formation of the SC once pairing has been accomplished, most likely by overcoming a barrier imposed by the chromosome-nuclear envelope connection. Our findings thus provide insight into how homolog pairing is accomplished in meiosis and into the mechanisms regulating synapsis so that it occurs selectively between homologs. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Sato, Aya; Rillo, Regina; Wynne, David J.; Kasad, Roshni A.; Dernburg, Abby F.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Sato, Aya; Phillips, Carolyn M.; Rillo, Regina; Wynne, David J.; Kasad, Roshni A.; Dernburg, Abby F.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Sato, Aya; Isaac, Berith; Rillo, Regina; Wynne, David J.; Kasad, Roshni A.; Dernburg, Abby F.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Isaac, Berith] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Carlton, Peter M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Weizmann Institute of Science; University of California System; University of California San Francisco	Dernburg, AF (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	afdernburg@lbl.gov	Carlton, Peter/AAD-2403-2021; Phillips, Carolyn/E-8305-2011	Carlton, Peter/0000-0002-5320-6024; Phillips, Carolyn/0000-0002-6228-6468; Wynne, David/0000-0001-6061-0730; Dernburg, Abby/0000-0001-8037-1079; Sato-Carlton, Aya/0000-0003-0593-5238	Japan Society for the Promotion of Science; National Science Foundation; Keck Laboratory for Advanced Microscopy at the University of California, San Francisco; American Cancer Society [RSG-07-187-01-GMC]; National Institutes of Health/National Institute of General Medical Sciences [R01 GM065591]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065591] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation(National Science Foundation (NSF)); Keck Laboratory for Advanced Microscopy at the University of California, San Francisco; American Cancer Society(American Cancer Society); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by graduate research fellowships from the Japan Society for the Promotion of Science (A. S.) and the National Science Foundation (C. M. P., D. J. W and R. K.), by a research grant from the Keck Laboratory for Advanced Microscopy at the University of California, San Francisco, to P. M. C, and by research grants from the American Cancer Society (RSG-07-187-01-GMC) and the National Institutes of Health/National Institute of General Medical Sciences (R01 GM065591) to A. F. D. We are grateful to John Sedat for the use of the OMX microscope and to Kent McDonald for expert assistance with EM sample preparation. We thank Chris Malone, Miles Pfaff, Verena Jantsch, Tito Fojo, Eva Nogales, Bruce Bowerman, Yossi Gruenbaum, Pierre Gonczy, Ahna Skop, Anthony Hyman, Anne Villeneuve, and the Caenorhabditis Genetic Center for providing antibodies, strains, reagents, and technical assistance. We thank Dan Starr, Aaron Severson, Anne Villeneuve, and members of the Dernburg lab for helpful discussions.	Bhalla N, 2008, ANNU REV CELL DEV BI, V24, P397, DOI 10.1146/annurev.cellbio.23.090506.123245; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Corredor E, 2007, GENETICS, V177, P699, DOI 10.1534/genetics.107.078121; Corredor E, 2007, CHROMOSOME RES, V15, P231, DOI 10.1007/s10577-006-1117-7; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Cowan CR, 2002, J CELL SCI, V115, P3747, DOI 10.1242/jcs.00055; Cowan CR, 2002, J CELL SCI, V115, P3757, DOI 10.1242/jcs.00054; Davis L, 2006, GENETICS, V174, P167, DOI 10.1534/genetics.106.059733; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ding DQ, 1998, J CELL SCI, V111, P701; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Kosaka H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000196; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Lo MC, 2004, J AM CHEM SOC, V126, P9898, DOI 10.1021/ja048619e; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; O'Rourke SM, 2007, PLOS GENET, V3, P1339, DOI 10.1371/journal.pgen.0030128; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Penkner AM, 2009, CELL, V139, P920, DOI 10.1016/j.cell.2009.10.045; Phillips CM, 2006, DEV CELL, V11, P817, DOI 10.1016/j.devcel.2006.09.020; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Smith CD, 1996, J BIOL CHEM, V271, P6192, DOI 10.1074/jbc.271.11.6192; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Tepperberg JH, 1997, CHROMOSOMA, V106, P183, DOI 10.1007/s004120050238; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wanat JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000188; Yamamoto A, 2001, MOL BIOL CELL, V12, P3933, DOI 10.1091/mbc.12.12.3933; Zhou K, 2009, J CELL BIOL, V186, P229, DOI 10.1083/jcb.200902101; Zubovych I, 2006, P NATL ACAD SCI USA, V103, P15523, DOI 10.1073/pnas.0607338103	47	194	216	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					907	919		10.1016/j.cell.2009.10.039	http://dx.doi.org/10.1016/j.cell.2009.10.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19913287	Green Accepted, Bronze			2022-12-24	WOS:000272169400015
J	Yamamoto-Kawai, M; McLaughlin, FA; Carmack, EC; Nishino, S; Shimada, K				Yamamoto-Kawai, Michiyo; McLaughlin, Fiona A.; Carmack, Eddy C.; Nishino, Shigeto; Shimada, Koji			Aragonite Undersaturation in the Arctic Ocean: Effects of Ocean Acidification and Sea Ice Melt	SCIENCE			English	Article							IMPACT; CYCLE	The increase in anthropogenic carbon dioxide emissions and attendant increase in ocean acidification and sea ice melt act together to decrease the saturation state of calcium carbonate in the Canada Basin of the Arctic Ocean. In 2008, surface waters were undersaturated with respect to aragonite, a relatively soluble form of calcium carbonate found in plankton and invertebrates. Undersaturation was found to be a direct consequence of the recent extensive melting of sea ice in the Canada Basin. In addition, the retreat of the ice edge well past the shelf-break has produced conditions favorable to enhanced upwelling of subsurface, aragonite-undersaturated water onto the Arctic continental shelf. Undersaturation will affect both planktonic and benthic calcifying biota and therefore the composition of the Arctic ecosystem.	[Yamamoto-Kawai, Michiyo; McLaughlin, Fiona A.; Carmack, Eddy C.] Inst Ocean Sci, Dept Fisheries & Oceans, Sidney, BC V8L 4B2, Canada; [Nishino, Shigeto; Shimada, Koji] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan; [Shimada, Koji] Tokyo Univ Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Fisheries & Oceans Canada; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Tokyo University of Marine Science & Technology	Yamamoto-Kawai, M (corresponding author), Inst Ocean Sci, Dept Fisheries & Oceans, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.	michiyo.kawai@dfo-mpo.gc.ca	Yamamoto-Kawai, Michiyo/F-7611-2013; SHIMADA, Koji/O-1913-2014	Yamamoto-Kawai, Michiyo/0000-0002-1035-2179; NISHINO, Shigeto/0000-0002-0560-241X	Fisheries and Oceans Canada; Canadian International Polar Year program; NSF	Fisheries and Oceans Canada; Canadian International Polar Year program; NSF(National Science Foundation (NSF))	We thank A. Proshutinsky as coinvestigator of the Beaufort Gyre project and acknowledge support provided by Fisheries and Oceans Canada, the Canadian International Polar Year program, and NSF. We are grateful to S. Zimmerman and other members of the scientific teams as well as the officers and crews on the CCGS Louis S. St-Laurent. We thank M. Davelaar, A. Ross, J. McKay, and K. Tamura for their careful analyses of TA, DIC, and delta<SUP>18</SUP>O and H. Yoshikawa, S. Noriki, N. Kurita, and T. Takamura for their help in delta<SUP>18</SUP>O analysis.	Anderson LG, 2001, POLAR RES, V20, P225, DOI 10.1111/j.1751-8369.2001.tb00060.x; Anderson LG, 1998, GLOBAL BIOGEOCHEM CY, V12, P455, DOI 10.1029/98GB01372; Bates NR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027028; Carmack E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017526; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Cooper LW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035007; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Jutterstrom S, 2005, MAR CHEM, V94, P101, DOI 10.1016/j.marchem.2004.08.010; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; KOBAYASHI HA, 1974, MAR BIOL, V26, P295, DOI 10.1007/BF00391513; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; McLaughlin FA, 2004, DEEP-SEA RES PT I, V51, P107, DOI 10.1016/j.dsr.2003.09.010; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Stroeve J., 2008, EOS T AM GEOPHYS UN, V89, P13, DOI [DOI 10.1029/2008E0020001, 10.1029/2008EO020001, DOI 10.1029/2008EO020001]; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; The Royal Society, 2005, 1205 ROYAL SOC; Yamamoto-Kawai M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005000; Yamamoto-Kawai M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003858	22	230	248	4	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1098	1100		10.1126/science.1174190	http://dx.doi.org/10.1126/science.1174190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965425				2022-12-24	WOS:000271951000039
J	Smith, RD; Keogh-Brown, MR; Barnett, T; Tait, J				Smith, Richard D.; Keogh-Brown, Marcus R.; Barnett, Tony; Tait, Joyce			The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MACROECONOMIC IMPACT; SCHOOL CLOSURE; SARS; OUTBREAK; COSTS; FLU	Objectives To estimate the potential economic impact of pandemic influenza, associated behavioural responses, school closures, and vaccination on the United Kingdom. Design A computable general equilibrium model of the UK economy was specified for various combinations of mortality and morbidity from pandemic influenza, vaccine efficacy, school closures, and prophylactic absenteeism using published data. Setting The 2004 UK economy (the most up to date available with suitable economic data). Main outcome measures The economic impact of various scenarios with different pandemic severity, vaccination, school closure, and prophylactic absenteeism specified in terms of gross domestic product, output from different economic sectors, and equivalent variation. Results The costs related to illness alone ranged between 0.5% and 1.0% of gross domestic product (8.4bn pound to 16.8bn) pound for low fatality scenarios, 3.3% and 4.3% (55.5bn pound to 72.3bn) pound for high fatality scenarios, and larger still for an extreme pandemic. School closure increases the economic impact, particularly for mild pandemics. If widespread behavioural change takes place and there is large scale prophylactic absence from work, the economic impact would be notably increased with few health benefits. Vaccination with a pre-pandemic vaccine could save 0.13% to 2.3% of gross domestic product (2.2bn pound to 38.6bn); pound a single dose of a matched vaccine could save 0.3% to 4.3% (5.0bn pound to 72.3bn); pound and two doses of a matched vaccine could limit the overall economic impact to about 1% of gross domestic product for all disease scenarios. Conclusion Balancing school closure against "business as usual" and obtaining sufficient stocks of effective vaccine are more important factors in determining the economic impact of an influenza pandemic than is the disease itself. Prophylactic absence from work in response to fear of infection can add considerably to the economic impact.	[Smith, Richard D.; Barnett, Tony] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England; [Barnett, Tony] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England; [Tait, Joyce] Univ Edinburgh, ESRC Innogen Ctr, Edinburgh EH1 1LZ, Midlothian, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Edinburgh	Smith, RD (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England.	Richard.Smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559; Barnett, Tony/0000-0001-9399-9607; Keogh-Brown, Marcus/0000-0002-7556-0016	ESRC [ES/F028180/1] Funding Source: UKRI; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2005, HHS PAND INFL PLAN; ARNDT C, 1999, 40 PERD U IFPRI U CO; Butler D, 2009, NATURE, V460, P562, DOI 10.1038/460562a; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Cheng C, 2004, ASIAN J SOC PSYCHOL, V7, P3, DOI 10.1111/j.1467-839X.2004.00130.x; COKER R, 2009, BMJ-BRIT MED J, V338, pB1797; DELAUWE PHC, 1953, REV FRANCAISE SCI PO, V3, P630; *DEP HLTH, 2007, PREP PAND INFL VACC; *DEP HLTH, 2009, AGR SEC PREP VACC UK; *DEP HLTH, 2005, UK HLTH DEP INFL PAN; *DEP HLTH, 2007, PAND INFL NAT FRAM R; *DEP HLTH SCI PAND, 2008, SUBGR MOD MOD SUMM; Dervis K., 1982, GEN EQUILIBRIUM MODE; *EUR CTR DIS PREV, 2007, TECHN REP EXP ADV GR; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; FOFONA I, 2005, BALANCING SOCIAL ACC; *HLTH PROT AG, 2006, PAND INFL CONT PLAN; Horridge M, 2008, EXERCISES CONTRIBUTI; Keogh-Brown MR, 2010, HEALTH ECON, V19, P1345, DOI 10.1002/hec.1554; Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Ko CH, 2006, PSYCHIAT CLIN NEUROS, V60, P397, DOI 10.1111/j.1440-1819.2006.01522.x; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Lofgren H., 2001, STANDARD COMPUTABLE; Macfarlane JT, 2005, BMJ-BRIT MED J, V331, P975, DOI 10.1136/bmj.38649.389005.DE; McLean AR., 2005, SARS CASE STUDY EMER, DOI [10.1093/shm/hki055, DOI 10.1093/SHM/HKI055]; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Postma MJ, 2005, VACCINE, V23, P5365, DOI 10.1016/j.vaccine.2005.06.007; Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; Spencer L., 2006, RETHINKING FRIENDSHI; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; The Public Health Agency of Canada, 2006, CAN PAND INFL PLAN H; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; WANG H, AM BEHAV SC IN PRESS	36	106	110	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2009	339								b4571	10.1136/bmj.b4571	http://dx.doi.org/10.1136/bmj.b4571			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523TD	19926697	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-24	WOS:000272096500005
J	Iliopoulos, D; Hirsch, HA; Struhl, K				Iliopoulos, Dimitrios; Hirsch, Heather A.; Struhl, Kevin			An Epigenetic Switch Involving NF-kappa B, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation	CELL			English	Article							IN-VITRO PROPAGATION; BREAST-CANCER CELLS; SURVIVAL; STAT3; TUMORIGENESIS; RAS; ACTIVATION; MECHANISMS; EXPRESSION; PATHWAY	Inflammation is linked clinically and epidemiologically to cancer, and NF-kappa B appears to play a causative role, but the mechanisms are poorly understood. We show that transient activation of Src oncoprotein can mediate an epigenetic switch from immortalized breast cells to a stably transformed line that forms self-renewing mammospheres that contain cancer stem cells. Src activation triggers an inflammatory response mediated by NF-kappa B that directly activates Lin28 transcription and rapidly reduces let-7 microRNA levels. Let-7 directly inhibits IL6 expression, resulting in higher levels of IL6 than achieved by NF-kappa B activation. IL6-mediated activation of the STAT3 transcription factor is necessary for transformation, and IL6 activates NF-kappa B, thereby completing a positive feedback loop. This regulatory circuit operates in other cancer cells lines, and its transcriptional signature is found in human cancer tissues. Thus, inflammation activates a positive feedback loop that maintains the epigenetic transformed state for many generations in the absence of the inducing signal.	[Iliopoulos, Dimitrios; Hirsch, Heather A.; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu	Iliopoulos, Dimitrios/AAE-9106-2019		American Cancer Society; National Institutes of Health [CA 107486]; NATIONAL CANCER INSTITUTE [R01CA107486] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Richard Gregory for suggesting the idea that lin-28 might be involved in the process, Philip N. Tsichlis for providing laboratory access and materials needed for the xenograft experiments, Fabio Petrocca for help in designing the mammosphere and cell sorting experiments, Savina A. Jaeger for bioinformatic analysis and identification of NF-KB binding sites in let-7a and lin-28B, Joan Brugge for providing the MCF10A ER-Src and control cell lines, William Farrar for providing the pGL3-IL6 luciferace vector, George Daley for providing the pBabe. Puro-Lin28B vector, Joshua T. Mendell for providing the Lin28B-P1 luciferase vector, and Koon Ho Wong for construction of the mutant luciferase vectors. This work was supported by a postdoctoral fellowship from the American Cancer Society to H. A. H. and a research grant to K. S. from the National Institutes of Health (CA 107486).	Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; HIRSCH HA, 2009, CANC RES IN PRESS, V69; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lee HS, 2007, J IMMUNOL, V179, P7001, DOI 10.4049/jimmunol.179.10.7001; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Nagel S, 2005, LEUKEMIA, V19, P841, DOI 10.1038/sj.leu.2403716; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; SOULE HD, 1990, CANCER RES, V50, P6075; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	42	1099	1149	1	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					693	706		10.1016/j.cell.2009.10.014	http://dx.doi.org/10.1016/j.cell.2009.10.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19878981	Bronze, Green Accepted			2022-12-24	WOS:000271747200014
J	Kitamura, T; Saitoh, Y; Takashima, N; Murayama, A; Niibori, Y; Ageta, H; Sekiguchi, M; Sugiyama, H; Inokuchi, K				Kitamura, Takashi; Saitoh, Yoshito; Takashima, Noriko; Murayama, Akiko; Niibori, Yosuke; Ageta, Hiroshi; Sekiguchi, Mariko; Sugiyama, Hiroyuki; Inokuchi, Kaoru			Adult Neurogenesis Modulates the Hippocampus-Dependent Period of Associative Fear Memory	CELL			English	Article							LONG-TERM POTENTIATION; ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; CONTEXTUAL FEAR; DENTATE GYRUS; RETROGRADE-AMNESIA; SPATIAL MEMORY; DENDRITIC SPINE; NEURONS BORN; BRAIN	Acquired memory initially depends on the hippocampus (HPC) for the process of cortical permanent memory formation. The mechanisms through which memory becomes progressively independent from the HPC remain unknown. In the HPC, adult neurogenesis has been described in many mammalian species, even at old ages. Using two mouse models in which hippocampal neurogenesis is physically or genetically suppressed, we show that decreased neurogenesis is accompanied by a prolonged HPC-dependent period of associative fear memory. Inversely, enhanced neurogenesis by voluntary exercise sped up the decay rate of HPC dependency of memory, without loss of memory. Consistently, decreased neurogenesis facilitated the long-lasting maintenance of rat hippocampal long-term potentiation in vivo. These independent lines of evidence strongly suggest that the level of hippocampal neurogenesis play a role in determination of the HPC-dependent period of memory in adult rodents. These observations provide a framework for understanding the mechanisms of the hippocampal-cortical complementary learning systems.	[Kitamura, Takashi; Saitoh, Yoshito; Takashima, Noriko; Murayama, Akiko; Niibori, Yosuke; Ageta, Hiroshi; Sekiguchi, Mariko; Inokuchi, Kaoru] MITILS, Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Kitamura, Takashi; Saitoh, Yoshito; Inokuchi, Kaoru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Fac Med, Dept Biochem, Toyama 9300194, Japan; [Kitamura, Takashi; Saitoh, Yoshito; Takashima, Noriko; Murayama, Akiko; Niibori, Yosuke; Sekiguchi, Mariko; Inokuchi, Kaoru] CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Sugiyama, Hiroyuki] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Toyama; Japan Science & Technology Agency (JST); Kyushu University	Inokuchi, K (corresponding author), MITILS, Mitsubishi Kagaku Inst Life Sci, 11 Minamiooya, Tokyo 1948511, Japan.	inokuchi@med.u-toyama.ac.jp	Inokuchi, Kaoru/AAI-9693-2020; Kitamura, Takashi/AAR-7837-2021	Inokuchi, Kaoru/0000-0002-5393-3133; Kitamura, Takashi/0000-0001-5597-859X	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank T. Hino, R. Migishima, and K. Nakamura from the Mouse Genome Technology Centre at Mitsubishi Kagaku Institute of Life Sciences (MITILS) for in vitro fertilization and embryo transfer; F. Hayashi for technical assistance with X-ray irradiation; R. Okubo-Suzuki for programming for the data analysis; and S. Kamijo and M. Matsuo for maintenance of the transgenic mice. We also thank N. Ohkawa for reading of the manuscript and discussion, and all members of the Inokuchi laboratory for daily discussion and advice; and P. W. Frankland, B.-K. Kaang, and A. J. Silva for critically reading the manuscript. This work was supported by the Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST) to K. I., a Grant-in-Aid for Scientific Research in Priority Area in "Molecular Brain Science'' to K. I., and by a Grant-in-Aid for Young Scientists B to T. K. T. K. was a fellow of the Japan Society for the Promotion of Science.	Abraham WC, 2002, J NEUROSCI, V22, P9626; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; FRANKLAND PW, 2007, DEV NEUROSCI, V1, P67, DOI DOI 10.1007/S11559-007-9004-8; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kitamura T, 2003, NEUROSCI RES, V47, P55, DOI 10.1016/S0168-0102(03)00171-8; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Meltzer LA, 2005, TRENDS NEUROSCI, V28, P653, DOI 10.1016/j.tins.2005.09.007; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Takehara K, 2003, J NEUROSCI, V23, P9897; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WILLSHAW DJ, 1990, PHILOS T R SOC B, V329, P205, DOI 10.1098/rstb.1990.0165; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; Winocur G, 2007, NAT NEUROSCI, V10, P555, DOI 10.1038/nn1880; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	71	349	369	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					814	827		10.1016/j.cell.2009.10.020	http://dx.doi.org/10.1016/j.cell.2009.10.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914173	Bronze			2022-12-24	WOS:000271747200024
J	Liu, Q; Tang, ZX; Surdenikova, L; Kim, S; Patel, KN; Kim, A; Ru, F; Guan, Y; Weng, HJ; Geng, YX; Undem, BJ; Kollarik, M; Chen, ZF; Anderson, DJ; Dong, XZ				Liu, Qin; Tang, Zongxiang; Surdenikova, Lenka; Kim, Seungil; Patel, Kush N.; Kim, Andrew; Ru, Fei; Guan, Yun; Weng, Hao-Jui; Geng, Yixun; Undem, Bradley J.; Kollarik, Marian; Chen, Zhou-Feng; Anderson, David J.; Dong, Xinzhong			Sensory Neuron-Specific GPCR Mrgprs Are Itch Receptors Mediating Chloroquine-Induced Pruritus	CELL			English	Article							MAST-CELLS; SCRATCHING BEHAVIOR; ADAPTIVE EVOLUTION; HUMAN SKIN; HISTAMINE; FAMILY; GENE; SENSATION; MALARIA; PATHWAY	The cellular and molecular mechanisms mediating histamine-independent itch in primary sensory neurons are largely unknown. Itch induced by chloroquine (CQ) is a common side effect of this widely used antimalarial drug. Here, we show that Mrgprs, a family of G protein-coupled receptors expressed exclusively in peripheral sensory neurons, function as itch receptors. Mice lacking a cluster of Mrgpr genes display significant deficits in itch induced by CQ but not histamine. CQ directly excites sensory neurons in an Mrgpr-dependent manner. CQ specifically activates mouse MrgprA3 and human MrgprX1. Loss- and gain-of-function studies demonstrate that MrgprA3 is required for CQ responsiveness in mice. Furthermore, MrgprA3-expressing neurons respond to histamine and coexpress gastrin-releasing peptide, a peptide involved in itch sensation, and MrgprC11. Activation of these neurons with the MrgprC11-specific agonist BAM8-22 induces itch in wild-type but not mutant mice. Therefore, Mrgprs may provide molecular access to itch-selective neurons and constitute novel targets for itch therapeutics.	[Liu, Qin; Tang, Zongxiang; Patel, Kush N.; Kim, Andrew; Weng, Hao-Jui; Geng, Yixun; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Surdenikova, Lenka; Ru, Fei; Undem, Bradley J.; Kollarik, Marian] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Guan, Yun] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Surdenikova, Lenka] Jessenius Med Sch, Dept Pathophysiol, Martin 03753, Slovakia; [Kim, Seungil; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; [Kim, Seungil; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; [Kim, Seungil; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Dev Biol, St Louis, MO 63110 USA; [Anderson, David J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Anderson, David J.; Dong, Xinzhong] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Comenius University Bratislava; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); California Institute of Technology; Howard Hughes Medical Institute	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	xdong2@jhmi.edu		Weng, Hao-Jui/0000-0002-7006-7599	Alfred P. Sloan Neuroscience; Whitehall Foundation; Blaustein Pain Research Fund award; National Institutes of Health [NS054791, HL038095, DK074480, AR056318, NS048499]; VEGA [1/0018/08]; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038095, R29HL038095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499, R01NS054791] Funding Source: NIH RePORTER	Alfred P. Sloan Neuroscience; Whitehall Foundation; Blaustein Pain Research Fund award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Shirley Pease and the staff of the Caltech transgenic mouse facility for assistance with embryonic stem cell manipulation. We also thank M. Ring-kamp and R. Meyer for helpful comments on the manuscript. The work was supported by an Alfred P. Sloan Neuroscience grant, a Whitehall Foundation grant, a Blaustein Pain Research Fund award, and grants from the National Institutes of Health to X.D. (NS054791), B.J.U. (HL038095), M.K. (DK074480), Z.F.C. (AR056318), and D.J.A. (NS048499). L.S. is supported by VEGA 1/0018/08. D.J.A and X.D. are an Investigator and an Early Career Scientist of the Howard Hughes Medical Institute, respectively.	Abila B, 1994, Afr J Med Med Sci, V23, P139; Adam M. E., 2004, Saudi Pharmaceutical Journal, V12, P130; Ademowo O, 1998, MALARIA INFECT DIS A, V8, P14; AJAYI AA, 1989, EUR J CLIN PHARMACOL, V37, P539, DOI 10.1007/BF00558141; ALVING K, 1991, CELL TISSUE RES, V264, P529, DOI 10.1007/BF00319042; Batanero E, 2002, ALLERGY, V57, P65, DOI 10.1034/j.1398-9995.2002.13368.x; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; DENCKER L, 1975, TOXICOLOGY, V5, P255, DOI 10.1016/0300-483X(75)90122-5; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Evans JA, 2005, QJM-INT J MED, V98, P789, DOI 10.1093/qjmed/hci121; EZEAMUZIE CI, 1990, J TROP MED HYG, V93, P423; Fujita F, 2007, BRIT J PHARMACOL, V151, P134, DOI 10.1038/sj.bjp.0707219; Green AD, 2006, PAIN, V124, P50, DOI 10.1016/j.pain.2006.03.023; GREEN K B, 1989, Skin Pharmacology, V2, P77; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Johanek LM, 2007, J NEUROSCI, V27, P7490, DOI 10.1523/JNEUROSCI.1249-07.2007; Kanny Gisele, 2003, Eur J Intern Med, V14, P395, DOI 10.1016/S0953-6205(03)90011-2; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Kwong K, 2008, AM J PHYSIOL-LUNG C, V295, pL858, DOI 10.1152/ajplung.90360.2008; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Liu Y, 2008, J NEUROSCI, V28, P125, DOI 10.1523/JNEUROSCI.4472-07.2008; MNYIKA KS, 1991, J TROP MED HYG, V94, P27; Nakayama Y, 2002, METHOD FIND EXP CLIN, V24, P267, DOI 10.1358/mf.2002.24.5.802303; Nicolson TA, 2002, NEUROSCIENCE, V110, P329, DOI 10.1016/S0306-4522(01)00561-9; NOSAL R, 1991, AGENTS ACTIONS, V33, P37, DOI 10.1007/BF01993121; OLATUNDE A, 1977, AFR J MED MED SCI, V6, P27; OLATUNDE IA, 1971, BRIT J PHARMACOL, V43, P335; Onyeji CO, 2001, EUR J PHARM SCI, V13, P195, DOI 10.1016/S0928-0987(01)00108-7; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; SAMS WM, 1965, J INVEST DERMATOL, V45, P482, DOI 10.1038/jid.1965.162; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Schmelz M, 1997, J NEUROSCI, V17, P8003; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Sowunmi A, 2000, ANN TROP MED PARASIT, V94, P209, DOI 10.1080/00034980050006375; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tanaka M, 2004, J PHARM PHARMACOL, V56, P977, DOI 10.1211/0022357043932; YAMAZAKI M, 1994, BLOOD, V83, P3509; Yang S, 2005, GENE, V352, P30, DOI 10.1016/j.gene.2005.03.001; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	49	523	552	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1353	1365		10.1016/j.cell.2009.11.034	http://dx.doi.org/10.1016/j.cell.2009.11.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20004959	Bronze, Green Accepted			2022-12-24	WOS:000273048700022
J	Kleiger, G; Saha, A; Lewis, S; Kuhlman, B; Deshaies, RJ				Kleiger, Gary; Saha, Anjanabha; Lewis, Steven; Kuhlman, Brian; Deshaies, Raymond J.			Rapid E2-E3 Assembly and Disassembly Enable Processive Ubiquitylation of Cullin-RING Ubiquitin Ligase Substrates	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CONJUGATING ENZYME; CDC34 UBC3; MULTIUBIQUITIN CHAIN; STRUCTURAL BASIS; PROTEIN; COMPLEX; DOMAIN; SCF; ASSOCIATION	Degradation by the ubiquitin-proteasome system requires assembly of a polyubiquitin chain upon substrate. However, the structural and mechanistic features that enable template-independent processive chain synthesis are unknown. We show that chain assembly by ubiquitin ligase SCF and ubiquitin-conjugating enzyme Cdc34 is facilitated by the unusual nature of Cdc34-SCF transactions: Cdc34 binds SCF with nanomolar affinity, nevertheless the complex is extremely dynamic. These properties are enabled by rapid association driven by electrostatic interactions between the acidic tail of Cdc34 and a basic 'canyon' in the Cul1 subunit of SCF. Ab initio docking between Cdc34 and Cul1 predicts intimate contact between the tail and the basic canyon, an arrangement confirmed by crosslinking and kinetic analysis of mutants. Basic canyon residues are conserved in both Cul1 paralogs and orthologs, suggesting that the same mechanism underlies processivity for all cullin-RING ubiquitin ligases. We discuss different strategies by which processive ubiquitin chain synthesis may be achieved.	[Kleiger, Gary; Saha, Anjanabha; Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Kleiger, Gary; Saha, Anjanabha; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Lewis, Steven; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill	Deshaies, RJ (corresponding author), CALTECH, Howard Hughes Med Inst, 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship [F32 GM074471-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074471, R01GM065997] Funding Source: NIH RePORTER	National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Sonja Hess and members of the Caltech PEL for mass spectrometry analysis. We also thank Jost Vielmetter and members of the Caltech PEC for protein expression. We thank Shu-ou Shan for expert advice on the kinetic analysis of the data, and members of the Deshaies lab for comments on the manuscript. G. K. is a recipient of a National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship (F32 GM074471-01). R. J. D. is an Investigator of the Howard Hughes Medical Institute. R. J. D. is also a founder and shareholder of Proteolix.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Creighton T. E., 1993, PROTEINS STRUCTURES; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Harel M, 2009, BIOPHYS J, V96, P4237, DOI 10.1016/j.bpj.2009.02.054; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2005, METHOD ENZYMOL, V398, P143, DOI 10.1016/S0076-6879(05)98013-0; Pohl C, 2008, Ernst Schering Found Symp Proc, P115; PTAK C, 1994, J BIOL CHEM, V269, P26539; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; SCHREIBER G, 2009, CHEM REV; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	51	146	148	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					957	968		10.1016/j.cell.2009.10.030	http://dx.doi.org/10.1016/j.cell.2009.10.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945379	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000272169400019
J	Mandelblatt, JS; Cronin, KA; Bailey, S; Berry, DA; de Koning, HJ; Draisma, G; Huang, H; Lee, SJ; Munsell, M; Plevritis, SK; Ravdin, P; Schechter, CB; Sigal, B; Stoto, MA; Stout, NK; van Ravesteyn, NT; Venier, J; Zelen, M; Feuer, EJ				Mandelblatt, Jeanne S.; Cronin, Kathleen A.; Bailey, Stephanie; Berry, Donald A.; de Koning, Harry J.; Draisma, Gerrit; Huang, Hui; Lee, Sandra J.; Munsell, Mark; Plevritis, Sylvia K.; Ravdin, Peter; Schechter, Clyde B.; Sigal, Bronislava; Stoto, Michael A.; Stout, Natasha K.; van Ravesteyn, Nicolien T.; Venier, John; Zelen, Marvin; Feuer, Eric J.		Canc Intervention Surveillance Mod	Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE	Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.	[Mandelblatt, Jeanne S.] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; NIH, Bethesda, MD 20892 USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Erasmus Univ, Med Ctr, Rotterdam, Netherlands; Harvard Univ, Sch Publ Hlth, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Stanford Univ, Palo Alto, CA 94304 USA; Albert Einstein Coll Med, New York, NY USA	Georgetown University; National Institutes of Health (NIH) - USA; University of Texas System; UTMD Anderson Cancer Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard Pilgrim Health Care; Stanford University; Yeshiva University	Mandelblatt, JS (corresponding author), Lombardi Comprehens Canc Ctr, 3300 Whitehaven St,NW,Suite 4100, Washington, DC 20007 USA.	mandelbj@georgetown.edu	de+Koning, Harry/AAF-9062-2019	de+Koning, Harry/0000-0003-4682-3646; Bailey, Ph.D., Stephanie L./0000-0003-0451-2057	NCI [2U01CA088270, 2U01CA088283, 2U01CA088248, F32 CA125984, HHSN261200800769P, HHSN261200800002C]; NCI-funded BCSC [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; U.S. state public health departments and cancer registries; NATIONAL CANCER INSTITUTE [U01CA063736, U01CA063740, U01CA088270, U01CA088248, U01CA069976, U01CA088283, U01CA070040, U01CA086076, U01CA063731, U01CA086082, U01CA070013, F32CA125984] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI-funded BCSC; U.S. state public health departments and cancer registries; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By NCI cooperative agreements (2U01CA088270, 2U01CA088283, 2U01CA088248, and F32 CA125984). Portions of this work were performed under contract HHSN261200800769P. Data collection in the BCSC was supported by NCI-funded BCSC cooperative agreements (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040) and several U.S. state public health departments and cancer registries. CISNET data management and Web site support were provided by Cornerstone Systems Northwest (NCI contract HHSN261200800002C).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; [Anonymous], PREV SERV COV PRIV H; Badgwell BD, 2008, J CLIN ONCOL, V26, P2482, DOI 10.1200/JCO.2007.12.8058; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Berry Donald A, 2006, J Natl Cancer Inst Monogr, P30, DOI 10.1093/jncimonographs/lgj006; Berry DA, 2009, J CLIN ONCOL, V27, P639, DOI 10.1200/JCO.2008.17.9341; Boer R, 1995, EUR J CANCER, V31A, P2040, DOI 10.1016/0959-8049(95)00457-2; Bonomi AE, 2008, QUAL LIFE RES, V17, P801, DOI 10.1007/s11136-008-9353-2; Breast Cancer Surveillance Consortium Website, PERF MEAS 3 884 059; Bryan BB, 2006, MODERN PATHOL, V19, P617, DOI 10.1038/modpathol.3800570; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Clarke Lauren D, 2006, J Natl Cancer Inst Monogr, P96, DOI 10.1093/jncimonographs/lgj013; Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0; Cronin Kathleen A, 2006, J Natl Cancer Inst Monogr, P112, DOI 10.1093/jncimonographs/lgj015; de Koning HJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1369; El-Tamer MB, 2007, ANN SURG, V245, P665, DOI 10.1097/01.sla.0000245833.48399.9a; Elmore JG, 2005, JNCI-J NATL CANCER I, V97, P1035, DOI 10.1093/jnci/dji183; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Feuer EJ, 2004, STAT METHODS MED RES, V13, P421, DOI 10.1191/0962280204sm376ra; Fracheboud J, 2006, INT J CANCER, V118, P2020, DOI 10.1002/ijc.21560; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Holford Theodore R, 2006, J Natl Cancer Inst Monogr, P19, DOI 10.1093/jncimonographs/lgj016; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones JL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1397; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Lash TL, 2007, J CLIN ONCOL, V25, P3001, DOI 10.1200/JCO.2006.09.9572; Lee S, 2004, STAT METHODS MED RES, V13, P443, DOI 10.1191/0962280204sm377ra; Lee Sandra, 2006, J Natl Cancer Inst Monogr, P79, DOI 10.1093/jncimonographs/lgj011; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2009, J CLIN ONCOL, V27, P487, DOI 10.1200/JCO.2008.19.4928; Mandelblatt JS, 1997, J GEN INTERN MED, V12, P551, DOI 10.1046/j.1525-1497.1997.07107.x; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; MANDELBLATT JS, 2009, DIS BREAST; Mariotto Angela B, 2006, J Natl Cancer Inst Monogr, P7, DOI 10.1093/jncimonographs/lgj003; McCarthy EP, 2000, J AM GERIATR SOC, V48, P1226, DOI 10.1111/j.1532-5415.2000.tb02595.x; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; *NAT CANC I, 2002, NCI STAT MAMM SCREEN; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Norman SA, 2007, CANCER CAUSE CONTROL, V18, P909, DOI 10.1007/s10552-007-9006-8; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Plevritis Sylvia K, 2006, J Natl Cancer Inst Monogr, P86, DOI 10.1093/jncimonographs/lgj012; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rosenberg Marjorie A, 2006, J Natl Cancer Inst Monogr, P15, DOI 10.1093/jncimonographs/lgj004; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; Schonberg MA, 2009, J CLIN ONCOL, V27, P640, DOI 10.1200/JCO.2008.17.9374; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; Smith-Bindman R, 2005, J MED SCREEN, V12, P50, DOI 10.1258/0969141053279130; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; VAINIO H, 2002, INT AGENCY RES CANC; Wai ES, 2005, BRIT J CANCER, V92, P961, DOI 10.1038/sj.bjc.6602393; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; White E, 2004, JNCI-J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337	62	464	477	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2009	151	10					738	W247		10.7326/0003-4819-151-10-200911170-00010	http://dx.doi.org/10.7326/0003-4819-151-10-200911170-00010			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524LP	19920274	Green Accepted			2022-12-24	WOS:000272145100007
J	Maslowski, KM; Vieira, AT; Ng, A; Kranich, J; Sierro, F; Yu, D; Schilter, HC; Rolph, MS; Mackay, F; Artis, D; Xavier, RJ; Teixeira, MM; Mackay, CR				Maslowski, Kendle M.; Vieira, Angelica T.; Ng, Aylwin; Kranich, Jan; Sierro, Frederic; Yu, Di; Schilter, Heidi C.; Rolph, Michael S.; Mackay, Fabienne; Artis, David; Xavier, Ramnik J.; Teixeira, Mauro M.; Mackay, Charles R.			Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43	NATURE			English	Article							CHAIN FATTY-ACIDS; DISTAL ULCERATIVE-COLITIS; NF-KAPPA-B; FUNCTIONAL-CHARACTERIZATION; INTESTINAL MICROBIOTA; BOWEL-DISEASE; MICE; EOSINOPHILS; IRRIGATION; INHIBITION	The immune system responds to pathogens by a variety of pattern recognition molecules such as the Toll-like receptors (TLRs), which promote recognition of dangerous foreign pathogens. However, recent evidence indicates that normal intestinal microbiota might also positively influence immune responses, and protect against the development of inflammatory diseases(1,2). One of these elements may be short-chain fatty acids (SCFAs), which are produced by fermentation of dietary fibre by intestinal microbiota. A feature of human ulcerative colitis and other colitic diseases is a change in 'healthy' microbiota such as Bifidobacterium and Bacteriodes(3), and a concurrent reduction in SCFAs4. Moreover, increased intake of fermentable dietary fibre, or SCFAs, seems to be clinically beneficial in the treatment of colitis(5-9). SCFAs bind the G-protein-coupled receptor 43 (GPR43, also known as FFAR2)(10,11), and here we show that SCFA-GPR43 interactions profoundly affect inflammatory responses. Stimulation of GPR43 by SCFAs was necessary for the normal resolution of certain inflammatory responses, because GPR43-deficient (Gpr43(-/-)) mice showed exacerbated or unresolving inflammation in models of colitis, arthritis and asthma. This seemed to relate to increased production of inflammatory mediators by Gpr43(-/-) immune cells, and increased immune cell recruitment. Germ-free mice, which are devoid of bacteria and express little or no SCFAs, showed a similar dysregulation of certain inflammatory responses. GPR43 binding of SCFAs potentially provides a molecular link between diet, gastrointestinal bacterial metabolism, and immune and inflammatory responses.	[Maslowski, Kendle M.; Vieira, Angelica T.; Kranich, Jan; Sierro, Frederic; Yu, Di; Schilter, Heidi C.; Rolph, Michael S.; Mackay, Fabienne; Mackay, Charles R.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Maslowski, Kendle M.; Kranich, Jan; Schilter, Heidi C.; Rolph, Michael S.; Mackay, Charles R.] Cooperat Res Ctr Asthma & Airways, Camperdown, NSW 2050, Australia; [Maslowski, Kendle M.; Schilter, Heidi C.; Mackay, Charles R.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Vieira, Angelica T.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil; [Ng, Aylwin; Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Mackay, Fabienne; Mackay, Charles R.] Monash Univ, Fac Med, Clayton, Vic 3800, Australia; [Artis, David] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Xavier, Ramnik J.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] Harvard Univ, Cambridge, MA 02142 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; Universidade Federal de Minas Gerais; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Monash University; University of Pennsylvania; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Mackay, CR (corresponding author), St Vincents Hosp, Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	charles.mackay@med.monash.edu.au	Sierro, Frederic/B-9742-2009; Ng, Aylwin/AAQ-6478-2020; Vieira, Angelica T/A-6227-2015; Mackay, Charles R/A-9673-2008; Eckhardt, Erik/G-1567-2010; Teixeira, Mauro M/A-4587-2008; Maslowski, Kendle M/R-9331-2018; Yu, Di/C-2163-2009; Mackay, Fabienne/B-7440-2008	Sierro, Frederic/0000-0001-5004-8414; Vieira, Angelica T/0000-0002-4556-7671; Mackay, Charles R/0000-0002-6338-7340; Teixeira, Mauro M/0000-0002-6944-3008; Maslowski, Kendle M/0000-0003-1995-5424; Yu, Di/0000-0003-1721-8922; Mackay, Fabienne/0000-0002-6074-2693; Kranich, Jan/0000-0002-9928-4132; Artis, David/0000-0002-1753-4100; Schilter, Heidi/0000-0003-3709-1631	Australian NHMRC; CRC for Asthma and Airways; Crohn's and Colitis Foundation of America; Cancer Institute NSW; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095466, R01AI061570, R01AI074878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CRC for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Crohn's and Colitis Foundation of America; Cancer Institute NSW; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank P. Silvera and S. Tangye for supply of certain Genechip data sets, L. Tsai for help with heatmaps, and D. Kobuley, J. Nicoli and M. Abt for help in the germ-free animal facilities. K. M. M. and C. R. M. are supported by the Australian NHMRC, and the CRC for Asthma and Airways. A. N. is a recipient of a Fellowship award from the Crohn's and Colitis Foundation of America. F. S. and D. Y. are Cancer Institute NSW Fellows.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BREUER RI, 1991, DIGEST DIS SCI, V36, P185, DOI 10.1007/BF01300754; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; COOPER HS, 1993, LAB INVEST, V69, P238; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kanauchi O, 2002, J GASTROENTEROL, V37, P67, DOI 10.1007/BF03326417; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu SM, 2006, J ALLERGY CLIN IMMUN, V118, P496, DOI 10.1016/j.jaci.2006.04.040; Luhrs H, 2002, ANTICANCER RES, V22, P1561; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; MORLAND B, 1984, INFECT IMMUN, V44, P750; POMARE EW, 1985, J CLIN INVEST, V75, P1448, DOI 10.1172/JCI111847; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scheppach W, 1996, DIGEST DIS SCI, V41, P2254, DOI 10.1007/BF02071409; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shreiner A, 2008, ADV EXP MED BIOL, V635, P113, DOI 10.1007/978-0-387-09550-9_10; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533; Souza DG, 2004, J IMMUNOL, V173, P4137, DOI 10.4049/jimmunol.173.6.4137; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; TREEM WR, 1994, J PEDIATR GASTR NUTR, V18, P159, DOI 10.1097/00005176-199402000-00007; VERNIA P, 1995, ALIMENT PHARM THERAP, V9, P309; Vieira AT, 2005, BRIT J PHARMACOL, V146, P244, DOI 10.1038/sj.bjp.0706321; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720	44	1975	2082	21	520	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1282	U119		10.1038/nature08530	http://dx.doi.org/10.1038/nature08530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865172	Green Accepted			2022-12-24	WOS:000271190800049
J	Li, JL; Browning, S; Mahal, SP; Oelschlegel, AM; Weissmann, C				Li, Jiali; Browning, Shawn; Mahal, Sukhvir P.; Oelschlegel, Anja M.; Weissmann, Charles			Darwinian Evolution of Prions in Cell Culture	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; MOUSE SCRAPIE; PROTEIN; STRAINS; ASSAY; CONFORMATION; HAMSTERS; AGENT	Prions are infectious proteins consisting mainly of PrPSc, a beta sheet-rich conformer of the normal host protein PrPC, and occur in different strains. Strain identity is thought to be encoded by PrPSc conformation. We found that biologically cloned prion populations gradually became heterogeneous by accumulating "mutants," and selective pressures resulted in the emergence of different mutants as major constituents of the evolving population. Thus, when transferred from brain to cultured cells, "cell-adapted" prions outcompeted their "brain-adapted" counterparts, and the opposite occurred when prions were returned from cells to brain. Similarly, the inhibitor swainsonine selected for a resistant substrain, whereas, in its absence, the susceptible substrain outgrew its resistant counterpart. Prions, albeit devoid of a nucleic acid genome, are thus subject to mutation and selective amplification.	[Li, Jiali; Browning, Shawn; Mahal, Sukhvir P.; Oelschlegel, Anja M.; Weissmann, Charles] Scripps Florida, Dept Infectol, Jupiter, FL 33458 USA	State University System of Florida; University of Florida	Weissmann, C (corresponding author), Scripps Florida, Dept Infectol, 130 Scripps Way, Jupiter, FL 33458 USA.	charlesw@scripps.edu	li, jiali/C-8811-2011		NIH [NSO59543]; Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059543, R01NS067214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. A. Demczyk for assistance with cell culture, E. Smith for assistance with the SSCA, I. Suponitsky-Kroyter for the proteolytic digestion analyses, and A. Sherman for histochemistry and animal work. We thank T. Bartfai, G. Joyce, and C. Lasmezas for critical reading of the manuscript and valuable suggestions. The project was supported by an R01 grant (# NSO59543) from the NIH and by a generous donation from the Alafi Family Foundation to C.	Arima K, 2005, J VIROL, V79, P7104, DOI 10.1128/JVI.79.11.7104-7112.2005; Arjona A, 2004, P NATL ACAD SCI USA, V101, P8768, DOI 10.1073/pnas.0400158101; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1992, E H S NEURO, P497; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Caughey B, 1999, MOL BIOTECHNOL, V13, P45, DOI 10.1385/MB:13:1:45; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Eigen M, 1996, TRENDS MICROBIOL, V4, P216, DOI 10.1016/0966-842X(96)20011-3; EPSTEIN IR, 1979, BIOPHYS CHEM, V10, P153, DOI 10.1016/0301-4622(79)85035-8; FRASER H, 1992, PRION DIS HUMANS ANI, P59; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kellershohn N, 1998, BIOCHEM J, V334, P539, DOI 10.1042/bj3340539; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; MCCONNELL I, COMMUNICATION; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TULSIANI DRP, 1983, J BIOL CHEM, V258, P7578; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	31	300	305	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					869	872		10.1126/science.1183218	http://dx.doi.org/10.1126/science.1183218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044542	Green Accepted			2022-12-24	WOS:000274408300063
J	Murchison, EP; Tovar, C; Hsu, A; Bender, HS; Kheradpour, P; Rebbeck, CA; Obendorf, D; Conlan, C; Bahlo, M; Blizzard, CA; Pyecroft, S; Kreiss, A; Kellis, M; Stark, A; Harkins, TT; Graves, JAM; Woods, GM; Hannon, GJ; Papenfuss, AT				Murchison, Elizabeth P.; Tovar, Cesar; Hsu, Arthur; Bender, Hannah S.; Kheradpour, Pouya; Rebbeck, Clare A.; Obendorf, David; Conlan, Carly; Bahlo, Melanie; Blizzard, Catherine A.; Pyecroft, Stephen; Kreiss, Alexandre; Kellis, Manolis; Stark, Alexander; Harkins, Timothy T.; Graves, Jennifer A. Marshall; Woods, Gregory M.; Hannon, Gregory J.; Papenfuss, Anthony T.			The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer	SCIENCE			English	Article							FACIAL-TUMOR DISEASE; SARCOPHILUS-HARRISII; IMMUNOHISTOCHEMICAL CHARACTERIZATION; VENEREAL TUMOR; MICRORNAS; DIVERSITY; NEOPLASMS; EVOLUTION; PROTEIN; SYSTEM	The Tasmanian devil, a marsupial carnivore, is endangered because of the emergence of a transmissible cancer known as devil facial tumor disease (DFTD). This fatal cancer is clonally derived and is an allograft transmitted between devils by biting. We performed a large-scale genetic analysis of DFTD with microsatellite genotyping, a mitochondrial genome analysis, and deep sequencing of the DFTD transcriptome and microRNAs. These studies confirm that DFTD is a monophyletic clonally transmissible tumor and suggest that the disease is of Schwann cell origin. On the basis of these results, we have generated a diagnostic marker for DFTD and identify a suite of genes relevant to DFTD pathology and transmission. We provide a genomic data set for the Tasmanian devil that is applicable to cancer diagnosis, disease evolution, and conservation biology.	[Murchison, Elizabeth P.; Bender, Hannah S.; Rebbeck, Clare A.; Conlan, Carly; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Murchison, Elizabeth P.; Bender, Hannah S.; Graves, Jennifer A. Marshall] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Murchison, Elizabeth P.; Bender, Hannah S.; Graves, Jennifer A. Marshall] Australian Natl Univ, ARC Ctr Excellence Kangaroo Genom, Canberra, ACT 0200, Australia; [Tovar, Cesar; Obendorf, David; Blizzard, Catherine A.; Kreiss, Alexandre; Woods, Gregory M.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Hsu, Arthur; Bahlo, Melanie; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3052, Australia; [Kheradpour, Pouya; Kellis, Manolis; Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Pyecroft, Stephen] Dept Primary Ind & Water, Mt Pleasant Anim Hlth Labs, Kings Meadows, Tas 7249, Australia; [Kellis, Manolis; Stark, Alexander] MIT, Broad Inst, Cambridge, MA 02141 USA; [Kellis, Manolis; Stark, Alexander] Harvard Univ, Cambridge, MA 02141 USA; [Harkins, Timothy T.] Roche Appl Sci, Indianapolis, IN 46250 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Australian National University; Australian National University; University of Tasmania; Menzies Institute for Medical Research; Walter & Eliza Hall Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Roche Holding	Murchison, EP (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England.	elizabeth.murchison@sanger.ac.uk	Papenfuss, Anthony T/C-6297-2008; Hannon, Gregory/AAB-3568-2019; Woods, Greg/J-7533-2014; Kellis, Manolis/ABE-7385-2020; Stark, Alexander/D-1473-2012	Papenfuss, Anthony T/0000-0002-1102-8506; Woods, Greg/0000-0001-8421-7917; Kellis, Manolis/0000-0001-7113-9630; Stark, Alexander/0000-0003-2611-0841; rebbeck, clare/0000-0002-2502-9622; Tovar Lopez, Cesar Dario/0000-0001-9555-2489; Blizzard, Catherine/0000-0002-8683-2937; Hsu, Arthur/0000-0001-8308-1106; Bender, Hannah/0000-0001-9458-4964; Murchison, Elizabeth Proby/0000-0001-7462-8907; Graves, Jennifer/0000-0001-6480-7856	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106, P01 CA013106-38] Funding Source: Medline; NHGRI NIH HHS [R01 HG004037] Funding Source: Medline; NIGMS NIH HHS [R01 GM062534, R01 GM062534-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CANFIELD PJ, 1993, J ZOO WILDLIFE MED, V24, P158; CLARK HB, 1985, AM J PATHOL, V121, P96; COOPER HL, 1964, J NATL CANCER I, V33, P691; Dahlin LB, 2008, SCAND J SURG, V97, P310, DOI 10.1177/145749690809700407; Gold R, 1999, BRAIN PATHOL, V9, P343; GRECO D, 1997, TXB VET PHYSL; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; GRINER LA, 1979, J NATL CANCER I, V62, P589, DOI 10.1093/jnci/62.3.589; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Marchal T, 1997, VET IMMUNOL IMMUNOP, V57, P1, DOI 10.1016/S0165-2427(96)05757-1; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; Mozos E, 1996, VET PATHOL, V33, P257, DOI 10.1177/030098589603300301; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Verrier JD, 2009, GLIA, V57, P1265, DOI 10.1002/glia.20846	25	156	225	1	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 1	2010	327	5961					84	87		10.1126/science.1180616	http://dx.doi.org/10.1126/science.1180616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044575	Green Submitted, Green Accepted			2022-12-24	WOS:000273395400036
J	Loarie, SR; Duffy, PB; Hamilton, H; Asner, GP; Field, CB; Ackerly, DD				Loarie, Scott R.; Duffy, Philip B.; Hamilton, Healy; Asner, Gregory P.; Field, Christopher B.; Ackerly, David D.			The velocity of climate change	NATURE			English	Article							MIGRATION CAPACITY; PROTECTED AREAS; CHANGE IMPACTS; DISPERSAL; MOUNTAIN; SYSTEMS; FOREST; SHIFTS; BIRDS; USA	The ranges of plants and animals are moving in response to recent changes in climate(1). As temperatures rise, ecosystems with 'nowhere to go', such as mountains, are considered to be more threatened(2,3). However, species survival may depend as much on keeping pace with moving climates as the climate's ultimate persistence(4,5). Here we present a new index of the velocity of temperature change (km yr(-1)), derived from spatial gradients (degrees C km(-1)) and multimodel ensemble forecasts of rates of temperature increase (degrees C yr(-1)) in the twenty-first century. This index represents the instantaneous local velocity along Earth's surface needed to maintain constant temperatures, and has a global mean of 0.42 km yr(-1) (A1B emission scenario). Owing to topographic effects, the velocity of temperature change is lowest in mountainous biomes such as tropical and subtropical coniferous forests (0.08 km yr(-1)), temperate coniferous forest, and montane grasslands. Velocities are highest in flooded grasslands (1.26 km yr(-1)), mangroves and deserts. High velocities suggest that the climates of only 8% of global protected areas have residence times exceeding 100 years. Small protected areas exacerbate the problem in Mediterranean-type and temperate coniferous forest biomes. Large protected areas may mitigate the problem in desert biomes. These results indicate management strategies for minimizing biodiversity loss from climate change. Montane landscapes may effectively shelter many species into the next century. Elsewhere, reduced emissions, a much expanded network of protected areas(6), or efforts to increase species movement may be necessary(7).	[Loarie, Scott R.; Duffy, Philip B.; Asner, Gregory P.; Field, Christopher B.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Duffy, Philip B.] Climate Cent Inc, Palo Alto, CA 94301 USA; [Hamilton, Healy] Calif Acad Sci, Ctr Appl Biodivers Informat, San Francisco, CA 94118 USA; [Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Carnegie Institution for Science; California Academy of Sciences; University of California System; University of California Berkeley	Loarie, SR (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	loarie@stanford.edu	Asner, Gregory/G-9268-2013; Ackerly, David/A-1247-2009	Asner, Gregory/0000-0001-7893-6421; Ackerly, David/0000-0002-1847-7398	Gordon and Betty Moore Foundation; Stanford University Global Climate and Energy Project	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Stanford University Global Climate and Energy Project	This work was made possible through the support of the Gordon and Betty Moore Foundation and the Stanford University Global Climate and Energy Project.	Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Burrough PA., 1998, PRINCIPLES GEOGRAPHI, P190; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Maurer EP, 2009, HYDROL EARTH SYST SC, V13, P183, DOI 10.5194/hess-13-183-2009; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Peterson DL, 1997, GLOBAL ECOL BIOGEOGR, V6, P7, DOI 10.2307/2997523; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; WEISS SB, 1988, ECOLOGY, V69, P1486, DOI 10.2307/1941646; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	31	1448	1497	39	1299	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 24	2009	462	7276					1052	U111		10.1038/nature08649	http://dx.doi.org/10.1038/nature08649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033047				2022-12-24	WOS:000272996000046
J	Kuroda, R; Endo, B; Abe, M; Shimizu, M				Kuroda, Reiko; Endo, Bunshiro; Abe, Masanori; Shimizu, Miho			Chiral blastomere arrangement dictates zygotic left-right asymmetry pathway in snails	NATURE			English	Article							LEFT-RIGHT AXIS; NODAL FLOW; UNCONVENTIONAL MYOSIN; HANDEDNESS; DROSOPHILA; MECHANISM; ELEGANS; EMBRYO; ORIGIN; SHELL	Most animals display internal and/or external left-right asymmetry. Several mechanisms for left-right asymmetry determination have been proposed for vertebrates(1-10) and invertebrates(1,2,4,9,11-14) but they are still not well characterized, particularly at the early developmental stage. The gastropods Lymnaea stagnalis and the closely related Lymnaea peregra have both the sinistral (recessive) and the dextral (dominant) snails within a species and the chirality is hereditary, determined by a single locus that functions maternally(15-18). Intriguingly, the handedness-determining gene(s) and the mechanisms are not yet identified. Here we show that in L. stagnalis, the chiral blastomere arrangement at the eight-cell stage (but not the two-or four-cell stage) determines the left-right asymmetry throughout the developmental programme, and acts upstream of the Nodal signalling pathway. Thus, we could demonstrate that mechanical micromanipulation of the third cleavage chirality (from the four-to the eight-cell stage) leads to reversal of embryonic handedness. These manipulated embryos grew to 'dextralized' sinistral and 'sinistralized' dextral snails-that is, normal healthy fertile organisms with all the usual left-right asymmetries reversed to that encoded by the mothers' genetic information. Moreover, manipulation reversed the embryonic nodal expression patterns. Using backcrossed F-7 congenic animals, we could demonstrate a strong genetic linkage between the handedness-determining gene( s) and the chiral cytoskeletal dynamics at the third cleavage that promotes the dominant-type blastomere arrangement. These results establish the crucial importance of the maternally determined blastomere arrangement at the eight-cell stage in dictating zygotic signalling pathways in the organismal chiromorphogenesis. Similar chiral blastomere configuration mechanisms may also operate upstream of the Nodal pathway in left-right patterning of deuterostomes/vertebrates.	[Kuroda, Reiko] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Kuroda, Reiko; Endo, Bunshiro; Abe, Masanori; Shimizu, Miho] JST, ERATO SORST, Kuroda Chiromorphol Team, Meguro Ku, Tokyo 1530041, Japan; [Kuroda, Reiko] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Kuroda, R (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan.	ckuroda@mail.ecc.u-tokyo.ac.jp	Shimizu, Miho/O-9903-2019; Shimizu, Miho/Q-8522-2017	Shimizu, Miho/0000-0003-4070-8209; Shimizu, Miho/0000-0003-4070-8209; Kuroda, Reiko/0000-0002-0268-7729				Bergmann DC, 2003, DEVELOPMENT, V130, P5731, DOI 10.1242/dev.00839; BOYCOTT A. E., 1930, PHIL TRANS ROY SOC LONDON B, V219, P51; BROWN NA, 1990, DEVELOPMENT, V109, P1; Christiaen L, 2002, GENE, V287, P107, DOI 10.1016/S0378-1119(01)00865-4; Crampton H. E., 1894, Annals of the New York Academy of Sciences, Vviii, P167; Duboc V, 2008, J EXP ZOOL PART B, V310B, P41, DOI 10.1002/jez.b.21121; FREEMAN G, 1992, J EVOLUTION BIOL, V5, P205, DOI 10.1046/j.1420-9101.1992.5020205.x; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hosoiri Y, 2003, DEV GENES EVOL, V213, P193, DOI 10.1007/s00427-003-0315-y; Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 2007, BIOESSAYS, V29, P271, DOI 10.1002/bies.20545; MESHCHERYAKOV VN, 1975, ROUX ARCH DEV BIOL, V177, P193, DOI 10.1007/BF00848080; Nederbragt AJ, 2002, DEV BIOL, V246, P341, DOI 10.1006/dbio.2002.0653; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623; Speder P, 2007, CURR OPIN GENET DEV, V17, P351, DOI 10.1016/j.gde.2007.05.008; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; Vandenberg LN, 2009, SEMIN CELL DEV BIOL, V20, P456, DOI 10.1016/j.semcdb.2008.11.010; Wandelt J, 2004, CURR BIOL, V14, pR654, DOI 10.1016/j.cub.2004.08.010; WOOD WB, 1991, NATURE, V349, P536, DOI 10.1038/349536a0	27	131	134	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					790	U112		10.1038/nature08597	http://dx.doi.org/10.1038/nature08597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	19940849				2022-12-24	WOS:000272559900039
J	Edwards, MJ; Flatman, RH; Mitchenall, LA; Stevenson, CEM; Le, TBK; Clarke, TA; McKay, AR; Fiedler, HP; Buttner, MJ; Lawson, DM; Maxwell, A				Edwards, Marcus J.; Flatman, Ruth H.; Mitchenall, Lesley A.; Stevenson, Clare E. M.; Le, Tung B. K.; Clarke, Thomas A.; McKay, Adam R.; Fiedler, Hans-Peter; Buttner, Mark J.; Lawson, David M.; Maxwell, Anthony			A Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8, Bound to DNA Gyrase	SCIENCE			English	Article							RESISTANCE-DETERMINING REGION; BIOSYNTHETIC GENE-CLUSTER; STREPTOMYCES-ANTIBIOTICUS; II TOPOISOMERASES; INHIBITORS; BINDING; ENERGY	Simocyclinones are bifunctional antibiotics that inhibit bacterial DNA gyrase by preventing DNA binding to the enzyme. We report the crystal structure of the complex formed between the N-terminal domain of the Escherichia coli gyrase A subunit and simocyclinone D8, revealing two binding pockets that separately accommodate the aminocoumarin and polyketide moieties of the antibiotic. These are close to, but distinct from, the quinolone-binding site, consistent with our observations that several mutations in this region confer resistance to both agents. Biochemical studies show that the individual moieties of simocyclinone D8 are comparatively weak inhibitors of gyrase relative to the parent compound, but their combination generates a more potent inhibitor. Our results should facilitate the design of drug molecules that target these unexploited binding pockets.	[Edwards, Marcus J.; Flatman, Ruth H.; Mitchenall, Lesley A.; Stevenson, Clare E. M.; Lawson, David M.; Maxwell, Anthony] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Le, Tung B. K.; Buttner, Mark J.] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; [Clarke, Thomas A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [McKay, Adam R.] UCL, Dept Chem, London WC1H 0AJ, England; [Fiedler, Hans-Peter] Univ Tubingen, Inst Mikrobiol, D-72076 Tubingen, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; University of London; University College London; Eberhard Karls University of Tubingen	Maxwell, A (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	tony.maxwell@bbsrc.ac.uk	clarke, tom/D-1837-2009; Lawson, David M/D-1810-2009	clarke, tom/0000-0002-6234-1914; Buttner, Mark/0000-0002-3505-2981; Mitchenall, Lesley/0000-0002-0063-1991; Le, Tung BK/0000-0003-4764-8851; Maxwell, Anthony/0000-0002-5756-6430; Edwards, Marcus/0000-0002-0243-3788	UK Biotechnology and Biological Sciences Research Council (BBSRC); European Commission [LSHB-CT-2004-503466]; Plant Bioscience Limited; John Innes Centre Rotation studentship; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Plant Bioscience Limited; John Innes Centre Rotation studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by UK Biotechnology and Biological Sciences Research Council (BBSRC) and the European Commission (CombiGyrase LSHB-CT-2004-503466); M.J.E. was supported by a CASE studentship funded by BBSRC and Plant Bioscience Limited, and T. B. K. L. was supported by a John Innes Centre Rotation studentship. We thank A. Zeeck ( University of Guttingen) for providing us with a sample of MGD8N2A; P. Johnson for assistance with CD experiments; R. Field, L. Heide, and D. Hopwood for helpful discussions; and N. Ruiz and T. Silhavy for their advice and for the E. coli imp4213 mutant. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession code 2WL2. We dedicate this paper to the memory of Chris Lamb, director of the John Innes Centre from 1999 to 2009.	Anderle C, 2008, ANTIMICROB AGENTS CH, V52, P1982, DOI 10.1128/AAC.01235-07; Bates A. D., 2005, DNA TOPOLOGY; Bates AD, 2007, BIOCHEMISTRY-US, V46, P7929, DOI 10.1021/bi700789g; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Flatman RH, 2006, ANTIMICROB AGENTS CH, V50, P1136, DOI 10.1128/AAC.50.4.1136-1142.2006; Flatman RH, 2005, ANTIMICROB AGENTS CH, V49, P1093, DOI 10.1128/AAC.49.3.1093-1100.2005; Galm U, 2002, ARCH MICROBIOL, V178, P102, DOI 10.1007/s00203-002-0429-z; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; HOOPER DC, 1993, QUINOLONE ANTIMICROB, P485; Lamour V, 2002, J BIOL CHEM, V277, P18947, DOI 10.1074/jbc.M111740200; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Lewis RJ, 1996, EMBO J, V15, P1412, DOI 10.1002/j.1460-2075.1996.tb00483.x; Li SM, 2005, CURR MED CHEM, V12, P419, DOI 10.2174/0929867053363063; Livermore D, 2007, J ANTIMICROB CHEMOTH, V60, pI59, DOI 10.1093/jac/dkm160; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455; Oppegard LM, 2009, ANTIMICROB AGENTS CH, V53, P2110, DOI 10.1128/AAC.01440-08; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Schimana J, 2000, J ANTIBIOT, V53, P779, DOI 10.7164/antibiotics.53.779; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Theobald U, 2000, ANTON LEEUW INT J G, V78, P307, DOI 10.1023/A:1010282818272; Trefzer A, 2002, ANTIMICROB AGENTS CH, V46, P1174, DOI 10.1128/AAC.46.5.1174-1182.2002; Tsai FTF, 1997, PROTEINS, V28, P41; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; YOSHIDA H, 1991, ANTIMICROB AGENTS CH, V35, P1647, DOI 10.1128/AAC.35.8.1647	26	72	77	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1415	1418		10.1126/science.1179123	http://dx.doi.org/10.1126/science.1179123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965760				2022-12-24	WOS:000272351100047
J	Miyazono, K; Miyakawa, T; Sawano, Y; Kubota, K; Kang, HJ; Asano, A; Miyauchi, Y; Takahashi, M; Zhi, YH; Fujita, Y; Yoshida, T; Kodaira, KS; Yamaguchi-Shinozaki, K; Tanokura, M				Miyazono, Ken-ichi; Miyakawa, Takuya; Sawano, Yoriko; Kubota, Keiko; Kang, Hee-Jin; Asano, Atsuko; Miyauchi, Yumiko; Takahashi, Mihoko; Zhi, Yuehua; Fujita, Yasunari; Yoshida, Takuya; Kodaira, Ken-Suke; Yamaguchi-Shinozaki, Kazuko; Tanokura, Masaru			Structural basis of abscisic acid signalling	NATURE			English	Article							PROTEIN-KINASES; STRESS; IDENTIFICATION; TRANSDUCTION; CALMODULIN; FAMILY; GROWTH	The phytohormone abscisic acid (ABA) mediates the adaptation of plants to environmental stresses such as drought and regulates developmental signals such as seed maturation. Within plants, the PYR/PYL/RCAR family of START proteins receives ABA to inhibit the phosphatase activity of the group-A protein phosphatases 2C (PP2Cs), which are major negative regulators in ABA signalling. Here we present the crystal structures of the ABA receptor PYL1 bound with (+)-ABA, and the complex formed by the further binding of (+)-ABA-bound PYL1 with the PP2C protein ABI1. PYL1 binds (+)-ABA using the START-protein-specific ligand-binding site, thereby forming a hydrophobic pocket on the surface of the closed lid. (+)-ABA-bound PYL1 tightly interacts with a PP2C domain of ABI1 by using the hydrophobic pocket to cover the active site of ABI1 like a plug. Our results reveal the structural basis of the mechanism of (+)-ABA-dependent inhibition of ABI1 by PYL1 in ABA signalling.	[Miyazono, Ken-ichi; Miyakawa, Takuya; Sawano, Yoriko; Kubota, Keiko; Kang, Hee-Jin; Asano, Atsuko; Miyauchi, Yumiko; Takahashi, Mihoko; Zhi, Yuehua; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Fujita, Yasunari; Yoshida, Takuya; Kodaira, Ken-Suke; Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Biol Resources Div, Tsukuba 3058686, Japan; [Yoshida, Takuya; Kodaira, Ken-Suke; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Tokyo 1138657, Japan	University of Tokyo; Japan International Research Center for Agricultural Sciences; University of Tokyo	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp	Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Yoshida, Takuya/AAX-6352-2020; Miyazono, Kenichi/P-9654-2019; Fujita, Yasunari/P-9861-2018	Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Yoshida, Takuya/0000-0003-0514-6941; Miyazono, Kenichi/0000-0002-9354-2604; Fujita, Yasunari/0000-0002-5036-8319; Tanokura, Masaru/0000-0001-5072-2480	Ministry of Education, Culture, Sports, Science, and Technology, Japan;  [2008S2-001]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	The synchrotron-radiation experiments were performed at BL5A in the Photon Factory (2008S2-001). This work was supported by the Targeted Proteins Research Program ( TPRP) of the Ministry of Education, Culture, Sports, Science, and Technology, Japan. We thank Y. Sakaguchi (DKSH Japan K. K.) and Y. Asami ( TA Instruments Japan Inc.) for the ITC measurements and T. Mitani (GE Healthcare Japan Corp.) for the SPR experiments.	Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pennisi E, 2009, SCIENCE, V324, P1012, DOI 10.1126/science.324_1012; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; TANOKURA M, 1993, J BIOL CHEM, V268, P7090; TANOKURA M, 1984, J BIOCHEM-TOKYO, V95, P643, DOI 10.1093/oxfordjournals.jbchem.a134653; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188	29	385	418	2	141	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					609	U79		10.1038/nature08583	http://dx.doi.org/10.1038/nature08583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19855379				2022-12-24	WOS:000272277900032
J	Pierce, NW; Kleiger, G; Shan, SO; Deshaies, RJ				Pierce, Nathan W.; Kleiger, Gary; Shan, Shu-ou; Deshaies, Raymond J.			Detection of sequential polyubiquitylation on a millisecond timescale	NATURE			English	Article							SUBSTRATE UBIQUITINATION; CONJUGATING ENZYME; COMPLEX; SCF; MECHANISM; RECOGNITION	The pathway by which ubiquitin chains are generated on substrate through a cascade of enzymes consisting of an E1, E2 and E3 remains unclear. Multiple distinct models involving chain assembly on E2 or substrate have been proposed. However, the speed and complexity of the reaction have precluded direct experimental tests to distinguish between potential pathways. Here we introduce new theoretical and experimental methodologies to address both limitations. A quantitative framework based on product distribution predicts that the really interesting new gene (RING) E3 enzymes SCFCdc4 and SCF beta-TrCP work with the E2 Cdc34 to build polyubiquitin chains on substrates by sequential transfers of single ubiquitins. Measurements with millisecond time resolution directly demonstrate that substrate polyubiquitylation proceeds sequentially. Our results present an unprecedented glimpse into the mechanism of RING ubiquitin ligases and illuminate the quantitative parameters that underlie the rate and pattern of ubiquitin chain assembly.	[Pierce, Nathan W.; Kleiger, Gary; Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Deshaies, RJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, MC 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	Gordon Ross Fellowship; National Institutes of Health [GM065997]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997] Funding Source: NIH RePORTER	Gordon Ross Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Vielmetter for providing SCF<SUP>Cdc4</SUP>, beta-TrCP-Skp1 and human E1; S. Hess, R. L. J. Graham and the Proteome Exploration Laboratory for providing assistance with mass spectrometry of CYCE and Cdc34 thioester. We thank S. Schwarz, B. Schulman and G. Wu for gifts of reagents. We thank D. Sprinzak and all the members of the Deshaies and Shan laboratories for support and discussions. N.W.P. was supported by the Gordon Ross Fellowship and a National Institutes of Health Training Grant. R. J. D. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by National Institutes of Health GM065997.	Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; FERSHT A, 1999, STRUCTURE MECH PROTE, pCH14; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; KATI WM, 1992, J BIOL CHEM, V267, P25988; KLEIGER G, CELL IN PRESS; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2005, METHOD ENZYMOL, V398, P143, DOI 10.1016/S0076-6879(05)98013-0; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	22	157	160	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					615	U85		10.1038/nature08595	http://dx.doi.org/10.1038/nature08595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956254	Green Accepted			2022-12-24	WOS:000272277900033
J	Black, S; Eskola, J; Siegrist, CA; Halsey, N; MacDonald, N; Law, B; Miller, E; Andrews, N; Stowe, J; Salmon, D; Vannice, K; Izurieta, HS; Akhtar, A; Gold, M; Oselka, G; Zuber, P; Pfeifer, D; Vellozzi, C				Black, Steven; Eskola, Juhani; Siegrist, Claire-Anne; Halsey, Neal; MacDonald, Noni; Law, Barbara; Miller, Elizabeth; Andrews, Nick; Stowe, Julia; Salmon, Daniel; Vannice, Kirsten; Izurieta, Hector S.; Akhtar, Aysha; Gold, Mike; Oselka, Gabriel; Zuber, Patrick; Pfeifer, Dina; Vellozzi, Claudia			Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines	LANCET			English	Article							GUILLAIN-BARRE-SYNDROME; MULTIPLE-SCLEROSIS; OPTIC NEURITIS; SUDDEN-DEATH; RISK; POPULATION; EPIDEMIOLOGY; ANAPHYLAXIS; PREVALENCE; STATES	Because of the advent of a new influenza A H1N1. strain, many countries have begun mass immunisation programmes. Awareness of the background rates of possible adverse events will be a crucial part of assessment of possible vaccine safety concerns and will help to separate legitimate safety concerns from events that are temporally associated with but not caused by vaccination. We identified background rates of selected medical events for several countries. Rates of disease events varied by age, sex, method of ascertainment, and geography. Highly visible health conditions, such as Guillain-Barre syndrome, spontaneous abortion, or even death, will occur in coincident temporal association with novel influenza vaccination. On the basis of the reviewed data, if a cohort of 10 million individuals was vaccinated in the UK, 21.5 cases of Guillain-Barre syndrome and 5.75 cases of sudden death would be expected to occur within 6 weeks of vaccination as coincident background cases. In female vaccinees in the USA, 86.3 cases of optic neuritis per 10 million population would be expected within 6 weeks of vaccination. 397 per 1 million vaccinated pregnant women would be predicted to have a spontaneous abortion within 1 day of vaccination.	[Black, Steven] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH 45229 USA; [Black, Steven] Cincinnati Childrens Hosp, Div Infect Dis, Cincinnati, OH 45229 USA; [Eskola, Juhani] Natl Inst Hlth & Welf, Helsinki, Finland; [Siegrist, Claire-Anne] Univ Geneva, Ctr Vaccinol & Neonatal Immunol, Dept Pediat, Geneva, Switzerland; [Halsey, Neal] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Vaccine Safety, Baltimore, MD USA; [MacDonald, Noni] Dalhousie Univ, Dept Pediat, Div Infect Dis, Halifax, NS, Canada; [Law, Barbara] Publ Hlth Agcy Canada, Vaccine Safety Sect, Ctr Immunizat & Resp Infect Dis, Ottawa, ON, Canada; [Miller, Elizabeth; Andrews, Nick; Stowe, Julia] Hlth Protect Agcy, Ctr Infect, London, England; [Salmon, Daniel; Vannice, Kirsten] Dept Hlth & Human Serv, Natl Vaccine Program Off, Washington, DC USA; [Izurieta, Hector S.; Akhtar, Aysha] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [Gold, Mike] Univ Adelaide, Discipline Paediat, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Oselka, Gabriel] Univ Sao Paulo, Dept Pediat, Fac Med, Sao Paulo, Brazil; [Zuber, Patrick; Pfeifer, Dina] WHO, Qual Safety & Stand Team, CH-1211 Geneva, Switzerland; [Vellozzi, Claudia] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Finland National Institute for Health & Welfare; University of Geneva; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Dalhousie University; Public Health Agency of Canada; Health Protection Agency; US Food & Drug Administration (FDA); University of Adelaide; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); World Health Organization; Centers for Disease Control & Prevention - USA	Black, S (corresponding author), Cincinnati Childrens Hosp, Ctr Global Hlth, 3333 Burnet Ave,MLC 2048, Cincinnati, OH 45229 USA.	Steven.Black1@cchmc.org		Stowe, Julia/0000-0002-3999-6461; salmon, daniel/0000-0002-1035-4422	Centers for Disease Control and Prevention; Department of Health and Human Services; WHO; US Food and Drug Administration; UK Health Protection Agency; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046405] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Health and Human Services; WHO(World Health Organization); US Food and Drug Administration; UK Health Protection Agency; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, the Department of Health and Human Services, WHO, the US Food and Drug Administration, or the UK Health Protection Agency.	Banwell B, 2009, NEUROLOGY, V72, P232, DOI 10.1212/01.wnl.0000339482.84392.bd; BERMAN M, 1981, NEUROLOGY, V31, P969; BHAN V, 2005, AM AC NEUR 57 ANN M; Bodnar LM, 2008, PAEDIATR PERINAT EP, V22, P538, DOI 10.1111/j.1365-3016.2008.00971.x; Bohlke K, 2003, PEDIATRICS, V112, P815, DOI 10.1542/peds.112.4.815; Bowker TJ, 2003, QJM-INT J MED, V96, P269, DOI 10.1093/qjmed/hcg038; Brotherton JML, 2008, CAN MED ASSOC J, V179, P525, DOI 10.1503/cmaj.080916; *CDC, PREGN WOM NOV INFL A; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; D'Souza RM, 2002, AUST NZ J PUBL HEAL, V26, P45, DOI 10.1111/j.1467-842X.2002.tb00269.x; Dias-Tosta E, 2002, ARQ NEURO-PSIQUIAT, V60, P367, DOI 10.1590/S0004-282X2002000300005; Eckart RE, 2004, ANN INTERN MED, V141, P829, DOI 10.7326/0003-4819-141-11-200412070-00005; FORSGREN L, 1990, ACTA PAEDIATR SCAND, V79, P550, DOI 10.1111/j.1651-2227.1990.tb11510.x; Gray RH, 2000, AM J PUBLIC HEALTH, V90, P1452, DOI 10.2105/AJPH.90.9.1452; HALSEY NA, 2002, SEMIN PEDIAT INFECT, V12, P205; Hauser WA, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2008.01443.x; Hemminki E, 1999, AM J OBSTET GYNECOL, V181, P396, DOI 10.1016/S0002-9378(99)70568-5; Herbert D, 2009, WOMEN HEALTH ISS, V19, P21, DOI 10.1016/j.whi.2008.08.007; Iskander JK, 2004, PEDIATR ANN, V33, P599, DOI 10.3928/0090-4481-20040901-11; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; JEFFERY DR, 1993, ARCH NEUROL-CHICAGO, V50, P532, DOI 10.1001/archneur.1993.00540050074019; Jin YP, 1998, J NEUROL SCI, V159, P107, DOI 10.1016/S0022-510X(98)00141-5; Kapp C, 2004, LANCET, V363, P709, DOI 10.1016/S0140-6736(04)15665-1; KLEIN N, 2009, NAT FDN INF DIS M BA; Kokia ES, 2007, VACCINE, V25, P8557, DOI 10.1016/j.vaccine.2007.10.021; LASKY T, INFLUENZA VACCINE GB; Lim SA, 2009, OPHTHAL EPIDEMIOL, V16, P65, DOI 10.1080/09286580902737516; Lower Johannes, 2008, MMW Fortschr Med, V150, P6; McNicholas A, 2007, HUM VACCINES, V3, P196, DOI 10.4161/hv.3.5.4458; Morken Nils-Halvdan, 2008, BMC Womens Health, V8, P16, DOI 10.1186/1472-6874-8-16; Mullooly J, 1999, AM J EPIDEMIOL, V149, P186; NEUTRA RR, 1990, AM J EPIDEMIOL, V132, P1; Papiernik E, 2004, CLIN OBSTET GYNECOL, V47, P755, DOI 10.1097/01.grf.0000141409.92711.11; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; RODRIGUEZ M, 1995, NEUROLOGY, V45, P244, DOI 10.1212/WNL.45.2.244; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Schoonen WM, 2009, BRIT J HAEMATOL, V145, P235, DOI 10.1111/j.1365-2141.2009.07615.x; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Wakefield AJ, 1999, LANCET, V354, P949, DOI 10.1016/S0140-6736(05)75696-8; Warren SA, 2008, MULT SCLER J, V14, P872, DOI 10.1177/1352458508089226; WILCOX AJ, 1981, AM J EPIDEMIOL, V114, P548, DOI 10.1093/oxfordjournals.aje.a113220; World Health Organization, WORLD HLTH STAT 2009; Zeller B, 2005, ACTA PAEDIATR, V94, P178, DOI 10.1080/08035250410025294	44	178	180	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2115	2122		10.1016/S0140-6736(09)61877-8	http://dx.doi.org/10.1016/S0140-6736(09)61877-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	19880172	Green Accepted, Green Submitted			2022-12-24	WOS:000273122900035
J	Meylan, E; Dooley, AL; Feldser, DM; Shen, L; Turk, E; Ouyang, C; Jacks, T				Meylan, Etienne; Dooley, Alison L.; Feldser, David M.; Shen, Lynn; Turk, Erin; Ouyang, Chensi; Jacks, Tyler			Requirement for NF-kappa B signalling in a mouse model of lung adenocarcinoma	NATURE			English	Article							IKK-BETA; CELLULAR-TRANSFORMATION; KINASE COMPLEX; K-RAS; CANCER; P53; ACTIVATION; INFLAMMATION; INTEGRATOR; INHIBITION	NF-kappa B transcription factors function as crucial regulators of inflammatory and immune responses as well as of cell survival(1). They have also been implicated in cellular transformation and tumorigenesis(2-6). However, despite extensive biochemical characterization of NF-kappa B signalling during the past twenty years, the requirement for NF-kappa B in tumour development in vivo, particularly in solid tumours, is not completely understood. Here we show that the NF-kappa B pathway is required for the development of tumours in a mouse model of lung adenocarcinoma. Concomitant loss of p53 (also known as Trp53) and expression of oncogenic Kras(G12D) resulted in NF-kappa B activation in primary mouse embryonic fibroblasts. Conversely, in lung tumour cell lines expressing Kras(G12D) and lacking p53, p53 restoration led to NF-kappa B inhibition. Furthermore, the inhibition of NF-kappa B signalling induced apoptosis in p53-null lung cancer cell lines. Inhibition of the pathway in lung tumours in vivo, from the time of tumour initiation or after tumour progression, resulted in significantly reduced tumour development. Together, these results indicate a critical function for NF-kappa B signalling in lung tumour development and, further, that this requirement depends on p53 status. These findings also provide support for the development of NF-kappa B inhibitory drugs as targeted therapies for the treatment of patients with defined mutations in Kras and p53.	[Meylan, Etienne; Dooley, Alison L.; Feldser, David M.; Shen, Lynn; Turk, Erin; Ouyang, Chensi; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Meylan, Etienne; Dooley, Alison L.; Feldser, David M.; Shen, Lynn; Turk, Erin; Ouyang, Chensi; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Meylan, Etienne; Dooley, Alison L.; Feldser, David M.; Shen, Lynn; Turk, Erin; Ouyang, Chensi; Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu		Meylan, Etienne/0000-0002-0899-2230; Piazza, Erin/0000-0002-3263-5946	Howard Hughes Medical Institute; NCI [P30-CA14051]; International Human Frontier Science Program Organization; Swiss National Science Foundation; Leukemia & Lymphoma Society Fellow Award; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); International Human Frontier Science Program Organization(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leukemia & Lymphoma Society Fellow Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. McFadden, T. Oliver, M. DuPage, K. Lane, A. Cheung, M. Kumar and E. Snyder for discussions and for sharing various reagents, A. Deconinck for critical reading of the manuscript, D. Crowley for preparation of tissue sections, and the entire Jacks laboratory for discussions. This work was supported by the Howard Hughes Medical Institute (T. J.) and partially by a Cancer Center Support grant from the NCI (P30-CA14051). T. J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar. E. M. is a recipient of fellowships from the International Human Frontier Science Program Organization and the Swiss National Science Foundation. D. M. F. is a recipient of a Leukemia & Lymphoma Society Fellow Award.	DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hanson JL, 2004, CANCER RES, V64, P7248, DOI 10.1158/0008-5472.CAN-03-3898; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ravi R, 1998, CANCER RES, V58, P4531; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wadgaonkar R, 1999, J BIOL CHEM, V274, P1879, DOI 10.1074/jbc.274.4.1879; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	30	416	431	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					104	U115		10.1038/nature08462	http://dx.doi.org/10.1038/nature08462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19847165	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000271419200041
J	Bang, HJ; Edwards, AM; Bomback, AS; Ballantyne, CM; Brillon, D; Callahan, MA; Teutsch, SM; Mushlin, AI; Kern, LM				Bang, Heejung; Edwards, Alison M.; Bomback, Andrew S.; Ballantyne, Christie M.; Brillon, David; Callahan, Mark A.; Teutsch, Steven M.; Mushlin, Alvin I.; Kern, Lisa M.			Development and Validation of a Patient Self-assessment Score for Diabetes Risk	ANNALS OF INTERNAL MEDICINE			English	Article							ATHEROSCLEROSIS RISK; TYPE-2; PERFORMANCE; PREVENTION; MELLITUS; REASONS; PREDICT; ADULTS; MODEL; CARE	Background: National guidelines disagree on who should be screened for undiagnosed diabetes. No existing diabetes risk score is highly generalizable or widely followed. Objective: To develop a new diabetes screening score and compare it with other available screening instruments (Centers for Disease Control and Prevention, American Diabetes Association, and U. S. Preventive Services Task Force guidelines; 2 American Diabetes Association risk questionnaires; and the Rotterdam model). Design: Cross-sectional data. Setting: NHANES (National Health and Nutrition Examination Survey) 1999 to 2004 for model development and 2005 to 2006, plus a combined cohort of 2 community studies, ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study), for validation. Participants: U. S. adults aged 20 years or older. Measurements: A risk-scoring algorithm for undiagnosed diabetes, defined as fasting plasma glucose level of 7.0 mmol/L (126 mg/dL) or greater without known diabetes, was developed in the development data set. Logistic regression was used to determine which participant characteristics were independently associated with undiagnosed diabetes. The new algorithm and other methods were evaluated by standard diagnostic and feasibility measures. Results: Age, sex, family history of diabetes, history of hypertension, obesity, and physical activity were associated with undiagnosed diabetes. In NHANES (ARIC/CHS), the cut-point of 5 or more points selected 35% (40%) of persons for diabetes screening and yielded a sensitivity of 79% (72%), specificity of 67% (62%), positive predictive value of 10% (10%), and positive likelihood ratio of 2.39 (1.89). In contrast, the comparison scores yielded a sensitivity of 44% to 100%, specificity of 10% to 73%, positive predictive value of 5% to 8%, and positive likelihood ratio of 1.11 to 1.98. Limitation: Data during pregnancy were not available. Conclusion: This easy-to-implement diabetes screening score seems to demonstrate improvements over existing methods. Studies are needed to evaluate it in diverse populations in real-world settings.	[Bang, Heejung] Columbia Univ, Weill Cornell Med Coll, Dept Publ Hlth, Cornell Univ,Coll Phys & Surg, New York, NY 10065 USA; FOJP Serv Corp, New York, NY USA; Baylor Coll Med, Houston, TX 77030 USA; Ctr Cardiovasc Dis Prevent, Methodist DeBakey Heart Ctr, Houston, TX USA; Los Angeles Cty Dept Publ Hlth, Los Angeles, CA USA	Columbia University; Cornell University; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Los Angeles County Department of Public Health	Bang, HJ (corresponding author), Columbia Univ, Weill Cornell Med Coll, Dept Publ Hlth, Cornell Univ,Coll Phys & Surg, 402 E 67th St, New York, NY 10065 USA.	heb2013@med.cornell.edu	Ballantyne, Christie/A-6599-2008	Ballantyne, Christie/0000-0002-6432-1730; Kern, Lisa/0000-0003-1191-8100	Centers for Disease Control and Prevention; National Heart, Lung and Blood Institute; Clinical and Translational Science Center at Weill Cornell Medical College [UL1-RR024996]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007750] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Clinical and Translational Science Center at Weill Cornell Medical College; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The NHANES were supported by the Centers for Disease Control and Prevention. The ARIC and CHS studies were supported by the National Heart, Lung and Blood Institute. This manuscript was prepared by using public-use data sets (for NHANES) and limited-access data sets (for ARIC and CHS) and does not necessarily reflect the opinions or views of these studies or agencies.; By the Clinical and Translational Science Center at Weill Cornell Medical College (UL1-RR024996).	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; [Anonymous], PREVENTING CHILDHOOD; [Anonymous], 2000, SAS STAT US GUID VER; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Bang H, 2007, ARCH INTERN MED, V167, P374, DOI 10.1001/archinte.167.4.374; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P833; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Feasel J, 2006, J AM COLL SURGEONS, V203, pS54, DOI 10.1016/j.jamcollsurg.2006.03.019; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-S301, 10.2337/dc09-9033]; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Glumer C, 2006, DIABETES CARE, V29, P410, DOI 10.2337/diacare.29.02.06.dc05-0945; Gonen M, 2007, ANAL RECEIVER OPERAT; Goyder EC, 1998, BRIT MED J, V316, P1505, DOI 10.1136/bmj.316.7143.1505; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; GRUNDY SM, NHLBI WORKSH CARD RI; Heikes KE, 2008, DIABETES CARE, V31, P1040, DOI 10.2337/dc07-1150; HERMAN WH, 1995, DIABETES CARE, V18, P382, DOI 10.2337/diacare.18.3.382; Herman WH, 2009, ANN INTERN MED, V150, P812, DOI 10.7326/0003-4819-150-11-200906020-00010; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knudson PE, 1998, DIABETES CARE, V21, P1029, DOI 10.2337/diacare.21.6.1029b; Kshirsagar AV, 2008, ARCH INTERN MED, V168, P2466, DOI 10.1001/archinte.168.22.2466; Lawler FH, 2009, MAYO CLIN PROC, V84, P34, DOI 10.1016/S0025-6196(11)60805-7; Little R. J. A., 1987, STAT ANAL MISSING DA; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Norris SL, 2008, ANN INTERN MED, V148, P855, DOI 10.7326/0003-4819-148-11-200806030-00008; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Rathmann W, 2005, ARCH INTERN MED, V165, P436, DOI 10.1001/archinte.165.4.436; Rolka DB, 2001, DIABETES CARE, V24, P1899, DOI 10.2337/diacare.24.11.1899; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Sheehy AM, 2009, MAYO CLIN PROC, V84, P38, DOI 10.1016/S0025-6196(11)60806-9; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; 2003, CLIN MODIFICATION	47	187	188	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2009	151	11					775	W255		10.7326/0003-4819-151-11-200912010-00005	http://dx.doi.org/10.7326/0003-4819-151-11-200912010-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EJ	19949143				2022-12-24	WOS:000272727900003
J	McMichael, AJ; Neira, M; Bertollini, R; Campbell-Lendrum, D; Hales, S				McMichael, A. J.; Neira, M.; Bertollini, R.; Campbell-Lendrum, D.; Hales, S.			Climate change: a time of need and opportunity for the health sector	LANCET			English	Editorial Material									[McMichael, A. J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; [Neira, M.; Bertollini, R.; Campbell-Lendrum, D.; Hales, S.] WHO, CH-1211 Geneva, Switzerland	Australian National University; World Health Organization	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au	hales, simon/E-5768-2010	Hales, Simon/0000-0002-4529-7595				Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; CSDH, 2008, CLOS GAP GEN HLTH EQ; Egger G, 2003, Obes Rev, V4, P115, DOI 10.1046/j.1467-789X.2003.00100.x; *GLOB HUM FOR, 2009, HUM IMP REP CLIM CHA, P116; KELLAM K, 2001, MICROBIOL TODAY, V28, P16; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING HL; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Stern N. H., 2006, STERN REV EC CLIMATE; *UN, 1992, UN FRAM CONV CLIM CH; *UNFCC, 2009, SUBM PART ADH WORK G; Virchow R, 1941, MED HUMAN WELFARE, P93; WHO, 2008, CLIM CHANG HLTH RES	12	40	41	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2009	374	9707					2123	2125		10.1016/S0140-6736(09)62031-6	http://dx.doi.org/10.1016/S0140-6736(09)62031-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	537OO	19942278				2022-12-24	WOS:000273122900036
J	Byeon, IJL; Meng, X; Jung, JW; Zhao, GP; Yang, RF; Ahn, JW; Shi, J; Concel, J; Aiken, C; Zhang, PJ; Gronenborn, AM				Byeon, In-Ja L.; Meng, Xin; Jung, Jinwon; Zhao, Gongpu; Yang, Ruifeng; Ahn, Jinwoo; Shi, Jiong; Concel, Jason; Aiken, Christopher; Zhang, Peijun; Gronenborn, Angela M.			Structural Convergence between Cryo-EM and NMR Reveals Intersubunit Interactions Critical for HIV-1 Capsid Function	CELL			English	Article							C-TERMINAL DOMAIN; DIMERIZATION DOMAIN; CRYSTAL-STRUCTURES; MEMBRANE-PROTEINS; TUBULAR CRYSTALS; GAG POLYPROTEIN; VIRUS; RESOLUTION; ALIGNMENT; RECONSTRUCTIONS	Mature HIV-1 particles contain conical-shaped capsids that enclose the viral RNA genome and perform essential functions in the virus life cycle. Previous structural analysis of two-and three-dimensional arrays of the capsid protein (CA) hexamer revealed three interfaces. Here, we present a cryoEM study of a tubular assembly of CA and a high-resolution NMR structure of the CA C-terminal domain (CTD) dimer. In the solution dimer structure, the monomers exhibit different relative orientations compared to previous X-ray structures. The solution structure fits well into the EM density map, suggesting that the dimer interface is retained in the assembled CA. We also identified a CTD-CTD interface at the local three-fold axis in the cryoEM map and confirmed its functional importance by mutagenesis. In the tubular assembly, CA intermolecular interfaces vary slightly, accommodating the asymmetry present in tubes. This provides the necessary plasticity to allow for controlled virus capsid dis/assembly.	[Byeon, In-Ja L.; Meng, Xin; Jung, Jinwon; Zhao, Gongpu; Ahn, Jinwoo; Concel, Jason; Zhang, Peijun; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Yang, Ruifeng; Shi, Jiong; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Zhang, PJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	pez7@pitt.edu; amg100@pitt.edu	Aiken, Christopher/Y-9252-2019; zhao, gongpu/B-8151-2012; Jung, Jinwon/F-6038-2010	Gronenborn, Angela M/0000-0001-9072-3525; Jung, Jinwon/0000-0002-7981-3316	National Institutes of Health [GM082251, AI076121, GM085043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085043, P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Joanne Yeh for useful discussions and Dr. Teresa Brosenitsch for critical reading of the manuscript. We thank Drs. Koji Yonekura, Edward Egelman, and Niko Grigorieff for sharing their image processing software and Dr. Jing Zhou for technical assistance. This work is a contribution from the Pittsburgh Center for HIV Protein Interactions and was supported by the National Institutes of Health (GM082251, AI076121, and GM085043).	Aiken Christopher, 2009, V485, P41, DOI 10.1007/978-1-59745-170-3_4; Alcaraz LA, 2007, BIOPHYS J, V93, P1264, DOI 10.1529/biophysj.106.101089; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bosco DA, 2004, BIOCHEMISTRY-US, V43, P6110, DOI 10.1021/bi049841z; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; ERICKSONVIITANEN S, 1989, AIDS RES HUM RETROV, V5, P577, DOI 10.1089/aid.1989.5.577; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Goddard T.D., 2004, SPARKY 3; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Nermut MV, 1998, J STRUCT BIOL, V123, P143, DOI 10.1006/jsbi.1998.4024; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JM, 2008, EMBO J, V27, P1411, DOI 10.1038/emboj.2008.71; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; ROSE S, 1992, PROTEINS, V13, P112, DOI 10.1002/prot.340130204; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; SATTLER M, 1995, J BIOMOL NMR, V5, P97, DOI 10.1007/BF00227475; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tang JH, 2006, J STRUCT BIOL, V154, P59, DOI 10.1016/j.jsb.2005.10.013; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wong HC, 2008, BIOCHEMISTRY-US, V47, P2289, DOI 10.1021/bi7022128; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yang RF, 2007, J VIROL, V81, P3749, DOI 10.1128/JVI.02634-06; Yonekura K, 2000, ULTRAMICROSCOPY, V84, P15, DOI 10.1016/S0304-3991(00)00009-7; Yonekura K, 2007, ULTRAMICROSCOPY, V107, P1141, DOI 10.1016/j.ultramic.2007.01.013; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	56	194	198	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					780	790		10.1016/j.cell.2009.10.010	http://dx.doi.org/10.1016/j.cell.2009.10.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914170	Green Accepted, Bronze			2022-12-24	WOS:000271747200021
J	Barbie, DA; Tamayo, P; Boehm, JS; Kim, SY; Moody, SE; Dunn, IF; Schinzel, AC; Sandy, P; Meylan, E; Scholl, C; Frohling, S; Chan, EM; Sos, ML; Michel, K; Mermel, C; Silver, SJ; Weir, BA; Reiling, JH; Sheng, Q; Gupta, PB; Wadlow, RC; Le, H; Hoersch, S; Wittner, BS; Ramaswamy, S; Livingston, DM; Sabatini, DM; Meyerson, M; Thomas, RK; Lander, ES; Mesirov, JP; Root, DE; Gilliland, DG; Jacks, T; Hahn, WC				Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Kim, So Young; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Sandy, Peter; Meylan, Etienne; Scholl, Claudia; Froehling, Stefan; Chan, Edmond M.; Sos, Martin L.; Michel, Kathrin; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Reiling, Jan H.; Sheng, Qing; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Hoersch, Sebastian; Wittner, Ben S.; Ramaswamy, Sridhar; Livingston, David M.; Sabatini, David M.; Meyerson, Matthew; Thomas, Roman K.; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.			Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1	NATURE			English	Article							NF-KAPPA-B; TUMOR-CELL SURVIVAL; LUNG ADENOCARCINOMA; ESSENTIAL GENES; K-RAS; ACTIVATION; SCREEN; PHOSPHORYLATION; CLASSIFICATION; APOPTOSIS	The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. A complementary strategy for targeting KRAS is to identify gene products that, when inhibited, result in cell death only in the presence of an oncogenic allele(1,2). Here we have used systematic RNA interference to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical I kappa B kinase TBK1 was selectively essential in cells that contain mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappa B anti-apoptotic signals involving c-Rel and BCL-XL (also known as BCL2L1) that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations indicate that TBK1 and NF-kappa B signalling are essential in KRAS mutant tumours, and establish a general approach for the rational identification of co-dependent pathways in cancer.	[Barbie, David A.; Kim, So Young; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Mermel, Craig; Sheng, Qing; Livingston, David M.; Meyerson, Matthew; Gilliland, D. Gary; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, So Young; Meyerson, Matthew; Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Chan, Edmond M.; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Wittner, Ben S.; Ramaswamy, Sridhar; Sabatini, David M.; Meyerson, Matthew; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.] Broad Inst Harvard, Cambridge, MA 02142 USA; [Barbie, David A.; Tamayo, Pablo; Boehm, Jesse S.; Moody, Susan E.; Dunn, Ian F.; Schinzel, Anna C.; Chan, Edmond M.; Mermel, Craig; Silver, Serena J.; Weir, Barbara A.; Gupta, Piyush B.; Wadlow, Raymond C.; Le, Hanh; Wittner, Ben S.; Ramaswamy, Sridhar; Sabatini, David M.; Meyerson, Matthew; Lander, Eric S.; Mesirov, Jill P.; Root, David E.; Gilliland, D. Gary; Jacks, Tyler; Hahn, William C.] MIT, Cambridge, MA 02142 USA; [Barbie, David A.; Wadlow, Raymond C.; Wittner, Ben S.; Ramaswamy, Sridhar] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Scholl, Claudia; Froehling, Stefan; Gilliland, D. Gary; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Sandy, Peter; Meylan, Etienne; Reiling, Jan H.; Sabatini, David M.; Lander, Eric S.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Sandy, Peter; Meylan, Etienne; Hoersch, Sebastian; Jacks, Tyler] Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Sos, Martin L.; Michel, Kathrin; Thomas, Roman K.] Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, D-50931 Cologne, Germany; [Sos, Martin L.; Michel, Kathrin; Thomas, Roman K.] Univ Cologne, Fac Med, D-50931 Cologne, Germany; [Reiling, Jan H.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sabatini, David M.; Gilliland, D. Gary; Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Thomas, Roman K.] Max Planck Soc, Chem Genom Ctr, D-44227 Dortmund, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Max Planck Society; University of Cologne; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; University of Cologne; University of Cologne; Max Planck Society	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Sos, Martin L/I-1852-2014; Meyerson, Matthew L/E-7123-2012; Mermel, Craig/AAZ-7322-2020; Mesirov, Jill/AGF-7626-2022	Mermel, Craig/0000-0002-0816-3395; /0000-0002-1446-7256; Boehm, Jesse/0000-0002-6795-6336; Chan, Edmond/0000-0002-7460-2560; Wadlow, Raymond/0000-0003-1959-5406; Meylan, Etienne/0000-0002-0899-2230	US National Cancer Institute [R33 CA128625, R01 CA130988]; NIH [T32 CA09172-33]; Starr Cancer Consortium [I1-A11]; Susan Madden Fund; ASCO YIA; Department of Defense Prostate Cancer Postdoctoral Fellowship; Brain Science Foundation Fellowship; Deutsche Krebshilfe [107954]; Fritz-Thyssen-Stiftung [10.08.2.175]; German Ministry of Science and Education [01GS08100]; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA130988, T32CA009172, R33CA128625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Susan Madden Fund; ASCO YIA; Department of Defense Prostate Cancer Postdoctoral Fellowship(United States Department of Defense); Brain Science Foundation Fellowship; Deutsche Krebshilfe(Deutsche Krebshilfe); Fritz-Thyssen-Stiftung; German Ministry of Science and Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the US National Cancer Institute (R33 CA128625, R01 CA130988) (W. C. H.) and NIH T32 CA09172-33 (D. A. B., S. E. M.), the Starr Cancer Consortium (I1-A11; W. C. H., D. G. G.), the Susan Madden Fund and an ASCO YIA (D. A. B.), a Department of Defense Prostate Cancer Postdoctoral Fellowship (S. Y. K.), a Brain Science Foundation Fellowship (I. F. D.), the Deutsche Krebshilfe (grant 107954) (R. K. T.), the Fritz-Thyssen-Stiftung (grant 10.08.2.175; R. K. T.) and the NGFNplus-program of the German Ministry of Science and Education (BMBF, grant 01GS08100; R. K. T.). We thank C. Yu, G. Wei and members of the Hahn laboratory for discussions. High-throughput RNAi screening was conducted at the RNAi Platform of the Broad Institute of MIT and Harvard.	Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Zhang J, 2002, J ROY STAT SOC B, V64, P281, DOI 10.1111/1467-9868.00337	31	1761	1825	8	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					108	U122		10.1038/nature08460	http://dx.doi.org/10.1038/nature08460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19847166	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000271419200042
J	Siegenthaler, JA; Ashique, AM; Zarbalis, K; Patterson, KP; Hecht, JH; Kane, MA; Folias, AE; Choe, Y; May, SR; Kume, T; Napoli, JL; Peterson, AS; Pleasure, SJ				Siegenthaler, Julie A.; Ashique, Amir M.; Zarbalis, Konstantinos; Patterson, Katelin P.; Hecht, Jonathan H.; Kane, Maureen A.; Folias, Alexandra E.; Choe, Youngshik; May, Scott R.; Kume, Tsutomu; Napoli, Joseph L.; Peterson, Andrew S.; Pleasure, Samuel J.			Retinoic Acid from the Meninges Regulates Cortical Neuron Generation	CELL			English	Article							CAJAL-RETZIUS CELLS; FOREBRAIN DEVELOPMENT; BINDING PROTEINS; PROGENITOR CELLS; STEM-CELLS; MOUSE; EXPRESSION; RECEPTORS; DEFECTS; CREST	Extrinsic signals controlling generation of neocortical neurons during embryonic life have been difficult to identify. In this study we demonstrate that the dorsal forebrain meninges communicate with the adjacent radial glial endfeet and influence cortical development. We took advantage of Foxc1 mutant mice with defects in forebrain meningeal formation. Foxc1 dosage and loss of meninges correlated with a dramatic reduction in both neuron and intermediate progenitor production and elongation of the neuroepithelium. Several types of experiments demonstrate that retinoic acid (RA) is the key component of this secreted activity. In addition, Rdh10- and Raldh2-expressing cells in the dorsal meninges were either reduced or absent in the Foxc1 mutants, and Rdh10 mutants had a cortical phenotype similar to the Foxc1 null mutants. Lastly, in utero RA treatment rescued the cortical phenotype in Foxc1 mutants. These results establish RA as a potent, meningeal-derived cue required for successful corticogenesis.	[Siegenthaler, Julie A.; Zarbalis, Konstantinos; Patterson, Katelin P.; Hecht, Jonathan H.; Choe, Youngshik; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, Program Neurosci, Inst Regenerat Med, San Francisco, CA 94158 USA; [Siegenthaler, Julie A.; Zarbalis, Konstantinos; Patterson, Katelin P.; Hecht, Jonathan H.; Choe, Youngshik; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, Program Dev Biol, Inst Regenerat Med, San Francisco, CA 94158 USA; [Hecht, Jonathan H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Ashique, Amir M.; Peterson, Andrew S.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kane, Maureen A.; Folias, Alexandra E.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Kume, Tsutomu] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37232 USA; [May, Scott R.] Salk Inst Biol Studies, San Diego, CA 92186 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; University of California System; University of California Berkeley; Vanderbilt University; Salk Institute	Pleasure, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, Program Neurosci, Inst Regenerat Med, San Francisco, CA 94158 USA.	sam.pleasure@ucsf.edu		, Julie/0000-0003-3700-6441	NIH [R01DA017627]; Autism Speaks; AHA/AAN; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH074958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA017627, R01DA017627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; AHA/AAN(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Grant Li for technical assistance and helpful discussions, Dr. Brad Pawlikowski for critical review of the manuscript, and Drs. John Rubenstein and Arturo Alvarez-Buylla for helpful discussion. This work was supported by grants from the NIH (R01DA017627), Autism Speaks, and the AHA/AAN.	Anchan RM, 1997, J COMP NEUROL, V379, P171; BALKAN W, 1992, P NATL ACAD SCI USA, V89, P3347, DOI 10.1073/pnas.89.8.3347; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Dickman ED, 1997, DEVELOPMENT, V124, P3111; DOLLE P, 1994, MECH DEVELOP, V45, P91, DOI 10.1016/0925-4773(94)90023-X; Folkers GE, 1998, J BIOL CHEM, V273, P32200, DOI 10.1074/jbc.273.48.32200; Haskell GT, 2005, J NEUROSCI, V25, P7636, DOI 10.1523/JNEUROSCI.0485-05.2005; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kawaguchi A, 2004, J NEUROSCI RES, V78, P784, DOI 10.1002/jnr.20347; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Li WW, 1998, J NEUROSCI, V18, P8853; Liao WL, 2005, DEV DYNAM, V232, P887, DOI 10.1002/dvdy.20281; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; Luo TL, 2004, J COMP NEUROL, V470, P297, DOI 10.1002/cne.20013; Maden M, 2001, INT REV CYTOL, V209, P1; Mehrara BJ, 1999, PLAST RECONSTR SURG, V104, P435, DOI 10.1097/00006534-199908000-00017; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Molotkova N, 2007, DEV BIOL, V303, P601, DOI 10.1016/j.ydbio.2006.11.035; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; NAPOLI JL, 2004, VITAMIN A RETINOIDS, V4; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2002, P NATL ACAD SCI USA, V99, P16111, DOI 10.1073/pnas.252626599; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Romand R, 2008, J COMP NEUROL, V508, P879, DOI 10.1002/cne.21707; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; RUBERTE E, 1993, DEVELOPMENT, V118, P267; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Vivatbutsiri P, 2008, J ANAT, V212, P603, DOI 10.1111/j.1469-7580.2008.00893.x; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zarbalis K, 2000, MECH DEVELOP, V93, P165, DOI 10.1016/S0925-4773(00)00252-5; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104; Zhang JH, 2003, J NEUROSCI, V23, P7610	51	286	292	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					597	609		10.1016/j.cell.2009.10.004	http://dx.doi.org/10.1016/j.cell.2009.10.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879845	Bronze, Green Accepted			2022-12-24	WOS:000271259600023
J	Parvanov, ED; Petkov, PM; Paigen, K				Parvanov, Emil D.; Petkov, Petko M.; Paigen, Kenneth			Prdm9 Controls Activation of Mammalian Recombination Hotspots	SCIENCE			English	Article							HISTONE H3 METHYLTRANSFERASE; MEIOTIC RECOMBINATION; MOUSE		[Parvanov, Emil D.; Petkov, Petko M.; Paigen, Kenneth] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Petkov, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Petko.Petkov@jax.org; Ken.Paigen@jax.org		Parvanov, Emil/0000-0001-6744-0949; Petkov, Petko/0000-0002-6694-9150	NIH [GM 078643, GM 083408, GM 078452, GM 076468, CA 34196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078452, R01GM083408, R01GM078643, P50GM076468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are indebted to E. Sargent, T. Billings, and G. Gilbert for technical assistance. The work was supported in part by NIH grants GM 078643, 083408, 078452, and 076468 and CA 34196.	Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x	9	388	394	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					835	835		10.1126/science.1181495	http://dx.doi.org/10.1126/science.1181495			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044538	Green Accepted			2022-12-24	WOS:000274408300052
J	Li, RQ; Fan, W; Tian, G; Zhu, HM; He, L; Cai, J; Huang, QF; Cai, QL; Li, B; Bai, YQ; Zhang, ZH; Zhang, YP; Wang, W; Li, J; Wei, FW; Li, H; Jian, M; Li, JW; Zhang, ZL; Nielsen, R; Li, DW; Gu, WJ; Yang, ZT; Xuan, ZL; Ryder, OA; Leung, FCC; Zhou, Y; Cao, JJ; Sun, X; Fu, YG; Fang, XD; Guo, XS; Wang, B; Hou, R; Shen, FJ; Mu, B; Ni, PX; Lin, RM; Qian, WB; Wang, GD; Yu, C; Nie, WH; Wang, JH; Wu, ZG; Liang, HQ; Min, JM; Wu, Q; Cheng, SF; Ruan, J; Wang, MW; Shi, ZB; Wen, M; Liu, BH; Ren, XL; Zheng, HS; Dong, D; Cook, K; Shan, G; Zhang, H; Kosiol, C; Xie, XY; Lu, ZH; Zheng, HC; Li, YR; Steiner, CC; Lam, TTY; Lin, SY; Zhang, QH; Li, GQ; Tian, J; Gong, TM; Liu, HD; Zhang, DJ; Fang, L; Ye, C; Zhang, JB; Hu, WB; Xu, AL; Ren, YY; Zhang, GJ; Bruford, MW; Li, QB; Ma, LJ; Guo, YR; An, N; Hu, YJ; Zheng, Y; Shi, YY; Li, ZQ; Liu, Q; Chen, YL; Zhao, J; Qu, N; Zhao, SC; Tian, F; Wang, XL; Wang, HY; Xu, LZ; Liu, X; Vinar, T; Wang, YJ; Lam, TW; Yiu, SM; Liu, SP; Zhang, HM; Li, DS; Huang, Y; Wang, X; Yang, GH; Jiang, Z; Wang, JY; Qin, N; Li, L; Li, JX; Bolund, L; Kristiansen, K; Wong, GKS; Olson, M; Zhang, XQ; Li, SG; Yang, HM; Wang, J; Wang, J				Li, Ruiqiang; Fan, Wei; Tian, Geng; Zhu, Hongmei; He, Lin; Cai, Jing; Huang, Quanfei; Cai, Qingle; Li, Bo; Bai, Yinqi; Zhang, Zhihe; Zhang, Yaping; Wang, Wen; Li, Jun; Wei, Fuwen; Li, Heng; Jian, Min; Li, Jianwen; Zhang, Zhaolei; Nielsen, Rasmus; Li, Dawei; Gu, Wanjun; Yang, Zhentao; Xuan, Zhaoling; Ryder, Oliver A.; Leung, Frederick Chi-Ching; Zhou, Yan; Cao, Jianjun; Sun, Xiao; Fu, Yonggui; Fang, Xiaodong; Guo, Xiaosen; Wang, Bo; Hou, Rong; Shen, Fujun; Mu, Bo; Ni, Peixiang; Lin, Runmao; Qian, Wubin; Wang, Guodong; Yu, Chang; Nie, Wenhui; Wang, Jinhuan; Wu, Zhigang; Liang, Huiqing; Min, Jiumeng; Wu, Qi; Cheng, Shifeng; Ruan, Jue; Wang, Mingwei; Shi, Zhongbin; Wen, Ming; Liu, Binghang; Ren, Xiaoli; Zheng, Huisong; Dong, Dong; Cook, Kathleen; Shan, Gao; Zhang, Hao; Kosiol, Carolin; Xie, Xueying; Lu, Zuhong; Zheng, Hancheng; Li, Yingrui; Steiner, Cynthia C.; Lam, Tommy Tsan-Yuk; Lin, Siyuan; Zhang, Qinghui; Li, Guoqing; Tian, Jing; Gong, Timing; Liu, Hongde; Zhang, Dejin; Fang, Lin; Ye, Chen; Zhang, Juanbin; Hu, Wenbo; Xu, Anlong; Ren, Yuanyuan; Zhang, Guojie; Bruford, Michael W.; Li, Qibin; Ma, Lijia; Guo, Yiran; An, Na; Hu, Yujie; Zheng, Yang; Shi, Yongyong; Li, Zhiqiang; Liu, Qing; Chen, Yanling; Zhao, Jing; Qu, Ning; Zhao, Shancen; Tian, Feng; Wang, Xiaoling; Wang, Haiyin; Xu, Lizhi; Liu, Xiao; Vinar, Tomas; Wang, Yajun; Lam, Tak-Wah; Yiu, Siu-Ming; Liu, Shiping; Zhang, Hemin; Li, Desheng; Huang, Yan; Wang, Xia; Yang, Guohua; Jiang, Zhi; Wang, Junyi; Qin, Nan; Li, Li; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Wong, Gane Ka-Shu; Olson, Maynard; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Wang, Jian; Wang, Jun			The sequence and de novo assembly of the giant panda genome	NATURE			English	Article							TASTE RECEPTOR; EVOLUTION; FAMILIES; DNA	Using next-generation sequencing technology alone, we have successfully generated and assembled a draft sequence of the giant panda genome. The assembled contigs (2.25 gigabases (Gb)) cover approximately 94% of the whole genome, and the remaining gaps (0.05 Gb) seem to contain carnivore-specific repeats and tandem repeats. Comparisons with the dog and human showed that the panda genome has a lower divergence rate. The assessment of panda genes potentially underlying some of its unique traits indicated that its bamboo diet might be more dependent on its gut microbiome than its own genetic composition. We also identified more than 2.7 million heterozygous single nucleotide polymorphisms in the diploid genome. Our data and analyses provide a foundation for promoting mammalian genetic research, and demonstrate the feasibility for using next-generation sequencing technologies for accurate, cost-effective and rapid de novo assembly of large eukaryotic genomes.	[Li, Ruiqiang; Fan, Wei; Tian, Geng; Zhu, Hongmei; Huang, Quanfei; Cai, Qingle; Li, Bo; Bai, Yinqi; Li, Jun; Jian, Min; Li, Jianwen; Li, Dawei; Yang, Zhentao; Xuan, Zhaoling; Zhou, Yan; Cao, Jianjun; Fang, Xiaodong; Guo, Xiaosen; Wang, Bo; Mu, Bo; Ni, Peixiang; Lin, Runmao; Qian, Wubin; Yu, Chang; Wu, Zhigang; Liang, Huiqing; Min, Jiumeng; Cheng, Shifeng; Ruan, Jue; Wang, Mingwei; Shi, Zhongbin; Wen, Ming; Liu, Binghang; Ren, Xiaoli; Zheng, Huisong; Shan, Gao; Zhang, Hao; Zheng, Hancheng; Li, Yingrui; Lin, Siyuan; Zhang, Qinghui; Li, Guoqing; Tian, Jing; Gong, Timing; Fang, Lin; Ye, Chen; Zhang, Juanbin; Ren, Yuanyuan; Zhang, Guojie; Li, Qibin; Ma, Lijia; Guo, Yiran; An, Na; Hu, Yujie; Zheng, Yang; Liu, Qing; Chen, Yanling; Zhao, Jing; Qu, Ning; Zhao, Shancen; Tian, Feng; Wang, Xiaoling; Wang, Haiyin; Xu, Lizhi; Liu, Xiao; Wang, Xia; Yang, Guohua; Jiang, Zhi; Wang, Junyi; Qin, Nan; Li, Li; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Wong, Gane Ka-Shu; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Ruiqiang; Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Tian, Geng; Cai, Jing; Wang, Guodong; Ruan, Jue; Li, Yingrui; Zhang, Guojie; Li, Qibin; Ma, Lijia; Guo, Yiran; Hu, Yujie; Zheng, Yang] Chinese Acad Sci, Grad Univ, Beijing 100062, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [He, Lin; Shi, Yongyong; Li, Zhiqiang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, BioX Ctr, Shanghai 200030, Peoples R China; [Cai, Jing; Zhang, Yaping; Wang, Wen; Wang, Guodong; Nie, Wenhui; Wang, Jinhuan; Zhang, Guojie] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Cai, Qingle; Min, Jiumeng; Cheng, Shifeng; Qu, Ning] Shenzhen Univ, Sch Med, Genome Res Inst, Shenzhen 518000, Peoples R China; [Zhang, Zhihe; Hou, Rong; Shen, Fujun] Chengdu Res Base Giant Panda Breeding, Chengdu 610081, Peoples R China; [Wei, Fuwen; Wu, Qi] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China; [Li, Heng] Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Zhang, Zhaolei; Dong, Dong; Cook, Kathleen] Univ Toronto, Dept Mol Genet, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Gu, Wanjun; Xie, Xueying; Lu, Zuhong] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing 210096, Peoples R China; [Ryder, Oliver A.; Steiner, Cynthia C.] San Diego Zoos Inst Conservat Res, Escondido, CA 92027 USA; [Leung, Frederick Chi-Ching; Lam, Tommy Tsan-Yuk] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Sun, Xiao; Liu, Hongde; Zhang, Dejin] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Peoples R China; [Fu, Yonggui; Hu, Wenbo; Xu, Anlong] Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Kosiol, Carolin] Vet Med Univ Wien, Inst Populat Genet, A-1210 Vienna, Austria; [Bruford, Michael W.] Cardiff Univ, Cardiff Sch Biosci, Biodivers & Ecol Proc Grp, Cardiff CF10 3AX, Wales; [Vinar, Tomas] Comenius Univ, Dept Appl Informat, Fac Math Phys & Informat, Bratislava 84248, Slovakia; [Wang, Yajun] Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China; [Lam, Tak-Wah; Yiu, Siu-Ming] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Liu, Shiping] S China Univ Technol, Guangzhou 510641, Peoples R China; [Zhang, Hemin; Li, Desheng; Huang, Yan] China Conservat & Res Ctr Giant Panda, Wolong Nat Reserve 623006, Peoples R China; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB T6G 2E9, Canada; [Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Olson, Maynard] Univ Washington, Genome Ctr, Seattle, WA USA	Beijing Genomics Institute (BGI); University of Copenhagen; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Kunming Institute of Zoology; Shenzhen University; Chinese Academy of Sciences; Institute of Zoology, CAS; Wellcome Trust Sanger Institute; University of Toronto; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Southeast University - China; Zoological Society of San Diego; University of Hong Kong; Southeast University - China; Sun Yat Sen University; University of Veterinary Medicine Vienna; Cardiff University; Comenius University Bratislava; Sichuan University; University of Hong Kong; South China University of Technology; University of Alberta; University of Alberta; University of Washington; University of Washington Seattle	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangjian@genomics.org.cn; wangj@genomics.org.cn	Li, Yingrui/K-1064-2015; Lin, Runmao/I-5049-2014; Yiu, Siu Ming/C-1843-2009; Fang, Xiaodong/K-6743-2018; Zhang, Guojie/J-7273-2019; Lu, Zuhong/A-5448-2013; Gu, Wanjun/B-3998-2010; Vinar, Tomas/I-3695-2014; chen, yanling/GRE-8287-2022; Gu, Wanjun/P-5389-2019; Liu, Xiao/P-2732-2015; Guo, Yiran/H-4120-2011; Bruford, Michael/Y-7463-2019; Li, Zhiqiang/AAI-4003-2021; Zhang, Guojie/B-6188-2014; Nielsen, Rasmus/D-4405-2009; wang, junyi/GYA-3213-2022; Yu, Chang/AAE-8538-2019; WONG, Gane Ka-Shu/G-5784-2013; Kristiansen, Karsten/J-5148-2014; Li, Heng/D-9344-2011; Shi, Yongyong/GSO-1627-2022; Bruford, Michael W/D-3750-2009; Wang, Jun/C-8434-2016; Lam, Tsan Yuk/D-4837-2012; Wang, Jun/B-9503-2016	Lin, Runmao/0000-0003-1999-0035; Yiu, Siu Ming/0000-0002-3975-8500; Fang, Xiaodong/0000-0001-7061-3337; Zhang, Guojie/0000-0001-6860-1521; Vinar, Tomas/0000-0003-3898-3447; Gu, Wanjun/0000-0003-4501-0539; Liu, Xiao/0000-0002-8073-0534; Bruford, Michael/0000-0001-6357-6080; Li, Zhiqiang/0000-0002-0174-9254; Zhang, Guojie/0000-0001-6860-1521; Nielsen, Rasmus/0000-0003-0513-6591; WONG, Gane Ka-Shu/0000-0001-6108-5560; Kristiansen, Karsten/0000-0002-6024-0917; Li, Heng/0000-0003-4874-2874; Shi, Yongyong/0000-0003-1710-1505; Bruford, Michael W/0000-0001-6357-6080; Li, Jun/0000-0001-7218-429X; liu, bh/0000-0002-4948-2835; Wang, Jun/0000-0002-8540-8931; Lam, Tsan Yuk/0000-0002-9769-1527; Ruan, Jue/0000-0003-3713-3192; Lu, Zuhong/0000-0003-3332-2615; Lam, Tak-Wah/0000-0003-4676-8587; Cook, Kate/0000-0002-0174-1113; Cai, Jing/0000-0002-2496-4731; Wang, Jun/0000-0002-2113-5874; LIU, Shiping/0000-0003-0019-619X; Fan, Wei/0000-0001-5036-8733	Shenzhen Municipal Government; Yantian District local government of Shenzhen; National Natural Science Foundation of China [30725008]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Danish Strategic Research Council [2106-07-0021]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Shenzhen Municipal Government; Yantian District local government of Shenzhen; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are indebted to the faculty and staff of Beijing Genomics Institute at Shenzhen, whose names were not included in the author list, but who contributed to this team work. This project is funded by the Shenzhen Municipal Government and the Yantian District local government of Shenzhen. This project is supported by the National Natural Science Foundation of China (30725008), Ole Romer grant from the Danish Natural Science Research Council, the Solexa project (272-07-0196), and Danish Strategic Research Council (2106-07-0021). We thank C. Wang, X. Huang and L. Luo for their assistance in collecting the blood sample. We thank D. D. Pollock for repeat content estimation. We thank M. Shi, Y. Wang and M. Ting Wong for analysis of the reproduction related genes. We also thank L. Goodman for editing the manuscript.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Go Y, 2006, MOL BIOL EVOL, V23, P964, DOI 10.1093/molbev/msj106; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Nash WG, 1998, CYTOGENET CELL GENET, V83, P182, DOI 10.1159/000015176; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yasuo T, 2008, BIOL PHARM BULL, V31, P1833, DOI 10.1248/bpb.31.1833; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099; Zheng Y, 2010, SCI CHINA LIFE SCI, V53, P107, DOI 10.1007/s11427-010-0001-z	30	796	919	12	549	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					311	317		10.1038/nature08696	http://dx.doi.org/10.1038/nature08696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20010809	hybrid, Green Accepted			2022-12-24	WOS:000273748100035
J	Zeqiraj, E; Filippi, BM; Deak, M; Alessi, DR; van Aalten, DMF				Zeqiraj, Elton; Filippi, Beatrice Maria; Deak, Maria; Alessi, Dario R.; van Aalten, Daan M. F.			Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; LKB1; STRAD	The LKB1 tumor suppressor is a protein kinase that controls the activity of adenosine monophosphate-activated protein kinase (AMPK). LKB1 activity is regulated by the pseudokinase STRAD alpha and the scaffolding protein MO25 alpha through an unknown, phosphorylation-independent, mechanism. We describe the structure of the core heterotrimeric LKB1-STRAD alpha-MO25 alpha complex, revealing an unusual allosteric mechanism of LKB1 activation. STRAD alpha adopts a closed conformation typical of active protein kinases and binds LKB1 as a pseudosubstrate. STRAD alpha and MO25 alpha promote the active conformation of LKB1, which is stabilized by MO25 alpha interacting with the LKB1 activation loop. This previously undescribed mechanism of kinase activation may be relevant to understanding the evolution of other pseudokinases. The structure also reveals how mutations found in Peutz-Jeghers syndrome and in various sporadic cancers impair LKB1 function.	[Zeqiraj, Elton; van Aalten, Daan M. F.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland; [Zeqiraj, Elton; Filippi, Beatrice Maria; Deak, Maria; Alessi, Dario R.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	van Aalten, DMF (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland.	dmfvanaalten@dundee.ac.uk		Alessi, Dario/0000-0002-2140-9185; van Aalten, Daan/0000-0002-1499-6908; Zeqiraj, Elton/0000-0003-0239-5926; Filippi, Beatrice Maria/0000-0002-8816-1559	TENOVUS Scotland; Wellcome Trust; Medical Research Council; Cancer Research UK [C33794/A10969]; MRC [G0900138, MC_U127070193] Funding Source: UKRI; Medical Research Council [G0900138, MC_U127070193] Funding Source: researchfish	TENOVUS Scotland; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the European Synchrotron Radiation Facility, Grenoble, for beam time at station ID14-3 and T. J. Richmond and I. Berger (ETH Zurich) for providing the MultiBac expression vectors. Supported by a TENOVUS Scotland studentship (E. Z.), a Wellcome Trust Senior Research Fellowship (D. M. F. v. A.), the Medical Research Council (D. R. A.), Cancer Research UK grant C33794/A10969, and the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck & Co. Inc., Merck KgaA, and Pfizer). The coordinates and structure factors have been deposited with PDB entry 2WTK.	Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	25	230	241	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1707	1711		10.1126/science.1178377	http://dx.doi.org/10.1126/science.1178377			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19892943	Green Accepted			2022-12-24	WOS:000272839000057
J	Li, WL; Tucker, AE; Sung, W; Thomas, WK; Lynch, M				Li, Wenli; Tucker, Abraham E.; Sung, Way; Thomas, W. Kelley; Lynch, Michael			Extensive, Recent Intron Gains in Daphnia Populations	SCIENCE			English	Article							EUKARYOTIC EVOLUTION; SPLICEOSOMAL INTRON; GENES; POSITIONS; CAENORHABDITIS; CONSERVATION; PATTERNS; PULEX	Rates and mechanisms of intron gain and loss have traditionally been inferred from alignments of highly conserved genes sampled from phylogenetically distant taxa. We report a population-genomic approach that detected 24 discordant intron/exon boundaries between the whole-genome sequences of two Daphnia pulex isolates. Sequencing of presence/absence loci across a collection of D. pulex isolates and outgroup Daphnia species shows that most polymorphisms are a consequence of recent gains, with parallel gains often occurring at the same locations in independent allelic lineages. More than half of the recent gains are associated with short sequence repeats, suggesting an origin via repair of staggered double-strand breaks. By comparing the allele-frequency spectrum of intron-gain alleles with that for derived single-base substitutions, we also provide evidence that newly arisen introns are intrinsically deleterious and tend to accumulate in population-genetic settings where random genetic drift is a relatively strong force.	[Li, Wenli; Tucker, Abraham E.; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Sung, Way; Thomas, W. Kelley] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA	Indiana University System; Indiana University Bloomington; University System Of New Hampshire; University of New Hampshire	Lynch, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	milynch@indiana.edu		Li, Wenli/0000-0002-9006-0634	NSF [MCB-0342431, EF-082741, EF-0328516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NSF grants MCB-0342431, EF-082741, and EF-0328516 (M. L.). We thank F. Catania, T. Doak, J. Colbourne, and K. Montooth for discussions, and A. Seyfert, S. Schaack, A. Omilian, and E. Williams for early contributions to this project. Genome sequences and annotation are available through the collaboration of JGI and the Daphnia Genomics Consortium at http://genome.jgi-psf.org/Dappu1/Dappu1. home.html. Intron data are provided in the online supplement. Sequences have been deposited in GenBank, accession numbers GQ984366 to GQ985204 (for details see tables S6 and S7).	Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Carmel L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-192; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Hankeln T, 1997, GENE, V205, P151, DOI 10.1016/S0378-1119(97)00518-0; Hazkani-Covo E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000237; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Llopart A, 2002, P NATL ACAD SCI USA, V99, P8121, DOI 10.1073/pnas.122570299; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Lynch M, 1999, EVOLUTION, V53, P100, DOI 10.1111/j.1558-5646.1999.tb05336.x; Lynch M, 2007, ORIGINS GENOME ARCHI; Nguyen HD, 2005, PLOS COMPUT BIOL, V1, P631, DOI 10.1371/journal.pcbi.0010079; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Omilian AR, 2008, MOL BIOL EVOL, V25, P2129, DOI 10.1093/molbev/msn164; Paland S, 2005, EVOLUTION, V59, P800; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2007, MOL BIOL EVOL, V24, P1447, DOI 10.1093/molbev/msm048; Roy SW, 2007, MOL BIOL EVOL, V24, P1926, DOI 10.1093/molbev/msm102; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Tarrio R, 2003, P NATL ACAD SCI USA, V100, P6580, DOI 10.1073/pnas.0731952100; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4	30	99	100	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1260	1262		10.1126/science.1179302	http://dx.doi.org/10.1126/science.1179302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965475	Green Accepted			2022-12-24	WOS:000272117900047
J	Remus, D; Beuron, F; Tolun, G; Griffith, JD; Morris, EP; Diffley, JFX				Remus, Dirk; Beuron, Fabienne; Tolun, Goekhan; Griffith, Jack D.; Morris, Edward P.; Diffley, John F. X.			Concerted Loading of Mcm2-7 Double Hexamers around DNA during DNA Replication Origin Licensing	CELL			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; RECOGNITION COMPLEX INTERACTS; SACCHAROMYCES-CEREVISIAE; HELICASE ACTIVITY; STRUCTURAL-CHANGES; DORMANT ORIGINS; ATP-HYDROLYSIS; EXCESS MCM2-7; BINDING SITE; ORC	The licensing of eukaryotic DNA replication origins, which ensures once-per-cell-cycle replication, involves the loading of six related minichromosome maintenance proteins (Mcm2-7) into prereplicative complexes (pre-RCs). Mcm2-7 forms the core of the replicative DNA helicase, which is inactive in the pre-RC. The loading of Mcm2-7 onto DNA requires the origin recognition complex (ORC), Cdc6, and Cdt1, and depends on ATP. We have reconstituted Mcm2-7 loading with purified budding yeast proteins. Using biochemical approaches and electron microscopy, we show that single heptamers of Cdt1 center dot Mcm2-7 are loaded cooperatively and result in association of stable, head-to-head Mcm2-7 double hexamers connected via their N-terminal rings. DNA runs through a central channel in the double hexamer, and, once loaded, Mcm2-7 can slide passively along double-stranded DNA. Our work has significant implications for understanding how eukaryotic DNA replication origins are chosen and licensed, how replisomes assemble during initiation, and how unwinding occurs during DNA replication.	[Remus, Dirk; Diffley, John F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Beuron, Fabienne; Morris, Edward P.] Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; [Tolun, Goekhan; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of North Carolina; University of North Carolina Chapel Hill	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	john.diffley@cancer.org.uk	TOLUN, Gökhan/D-1971-2012; Tolun, Gokhan/AAG-9606-2021	TOLUN, Gökhan/0000-0001-6166-9451; Tolun, Gokhan/0000-0001-6166-9451; Remus, Dirk/0000-0002-5155-181X; Morris, Edward/0000-0003-3544-0041; Diffley, John/0000-0001-5184-7680	Cancer Research UK; Institute of Cancer Research; National Institutes of Health [GM31819, ES13773]; European Molecular Biology Organization long-term fellowship; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Institute of Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Cancer Research UK (D. R., J.F. X. D., F. B., and E. P. M.), the Institute of Cancer Research (F. B. and E. P. M.), and National Institutes of Health grants to J.D.G. (GM31819 and ES13773). D. R. was supported by European Molecular Biology Organization long-term fellowship. We are grateful to Dale Wigley for help and advice in the early stages of this project and to Paula da Fonseca for advice on image processing. We thank Mark Skehel and colleagues for mass spectrometry and Karim Labib for antibodies. We are also grateful to members of the Diffley laboratory for helpful discussions.	Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; BREWER BJ, 1994, CURR OPIN GENET DEV, V4, P196, DOI 10.1016/S0959-437X(05)80045-0; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Chuang RY, 2002, J BIOL CHEM, V277, P16920, DOI 10.1074/jbc.M107710200; Costa A, 2008, EMBO J, V27, P2250, DOI 10.1038/emboj.2008.135; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; DEAN FB, 1992, J BIOL CHEM, V267, P14129; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Fouts ET, 1999, J BIOL CHEM, V274, P4447, DOI 10.1074/jbc.274.7.4447; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Geraghty DS, 2000, J BIOL CHEM, V275, P18011, DOI 10.1074/jbc.M909787199; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Klemm RD, 2001, P NATL ACAD SCI USA, V98, P8361, DOI 10.1073/pnas.131006898; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Liu JS, 1998, J BIOL CHEM, V273, P30704, DOI 10.1074/jbc.273.46.30704; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; Schuck S, 2005, MOL CELL, V20, P377, DOI 10.1016/j.molcel.2005.09.020; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tatsumi Y, 2008, GENES CELLS, V13, P1045, DOI 10.1111/j.1365-2443.2008.01224.x; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; VanLoock MS, 2002, CURR BIOL, V12, P472, DOI 10.1016/S0960-9822(02)00696-6; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wigley DB, 2009, CURR OPIN STRUC BIOL, V19, P72, DOI 10.1016/j.sbi.2008.12.010; Wilmes GM, 2002, P NATL ACAD SCI USA, V99, P101, DOI 10.1073/pnas.012578499; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	74	438	449	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					719	730		10.1016/j.cell.2009.10.015	http://dx.doi.org/10.1016/j.cell.2009.10.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19896182	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000271747200016
J	Bochukova, EG; Huang, N; Keogh, J; Henning, E; Purmann, C; Blaszczyk, K; Saeed, S; Hamilton-Shield, J; Clayton-Smith, J; O'Rahilly, S; Hurles, ME; Farooqi, IS				Bochukova, Elena G.; Huang, Ni; Keogh, Julia; Henning, Elana; Purmann, Carolin; Blaszczyk, Kasia; Saeed, Sadia; Hamilton-Shield, Julian; Clayton-Smith, Jill; O'Rahilly, Stephen; Hurles, Matthew E.; Farooqi, I. Sadaf			Large, rare chromosomal deletions associated with severe early-onset obesity	NATURE			English	Article							CLINICAL SPECTRUM; ADULT OBESITY; AUTISM; MICRODELETION; RECEPTOR; 16P11.2; GENE; REARRANGEMENTS; SENSITIVITY; CHILDHOOD	Obesity is a highly heritable and genetically heterogeneous disorder(1). Here we investigated the contribution of copy number variation to obesity in 300 Caucasian patients with severe early-onset obesity, 143 of whom also had developmental delay. Large (>500 kilobases), rare (<1%) deletions were significantly enriched in patients compared to 7,366 controls (P<0.001). We identified several rare copy number variants that were recurrent in patients but absent or at much lower prevalence in controls. We identified five patients with overlapping deletions on chromosome 16p11.2 that were found in 2 out of 7,366 controls (P<5 x 10(-5)). In three patients the deletion co-segregated with severe obesity. Two patients harboured a larger de novo 16p11.2 deletion, extending through a 593-kilobase region previously associated with autism(2-4) and mental retardation(5); both of these patients had mild developmental delay in addition to severe obesity. In an independent sample of 1,062 patients with severe obesity alone, the smaller 16p11.2 deletion was found in an additional two patients. All 16p11.2 deletions encompass several genes but include SH2B1, which is known to be involved in leptin and insulin signalling(6). Deletion carriers exhibited hyperphagia and severe insulin resistance disproportionate for the degree of obesity. We show that copy number variation contributes significantly to the genetic architecture of human obesity.	[Bochukova, Elena G.; Keogh, Julia; Henning, Elana; Purmann, Carolin; Blaszczyk, Kasia; Saeed, Sadia; O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 0QQ, England; [Huang, Ni; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Hamilton-Shield, Julian] Bristol Childrens Hosp, Bristol BS2 8BG, Avon, England; [Clayton-Smith, Jill] St Marys Hosp, Manchester M13 9WL, Lancs, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Bristol Royal Hospital For Children; University of Manchester	Farooqi, IS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 0QQ, England.	meh@sanger.ac.uk; isf20@cam.ac.uk	Shield, Julian PH/D-6297-2014; Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	Shield, Julian PH/0000-0003-2601-7575; O'Rahilly, Stephen/0000-0003-2199-4449; Bochukova, Elena/0000-0003-0275-1548; Saeed, Sadia/0000-0003-3144-7772; Farooqi, Sadaf/0000-0001-7609-3504	Wellcome Trust [077014/Z/05/0Z, 082390/Z/07/Z, 085475]; MRC Centre for Obesity and Related Disorders; NIHR Cambridge Biomedical Research Centre; NIH; MRC [G0900554] Funding Source: UKRI; Medical Research Council [G0900554] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Obesity and Related Disorders(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the patients, their families and all the Physicians who have referred patients to the Genetics of Obesity Study (GOOS). E. G. B., N.H., M. E. H. (grant no. 077014/Z/05/0Z) and I. S. F. (grant no. 082390/Z/07/Z) were funded by the Wellcome Trust. I. S. F. and S.O.R. are funded by the MRC Centre for Obesity and Related Disorders and NIHR Cambridge Biomedical Research Centre. We would like to thank L. Mavrogiannis for advice on MLPA analysis and V. Trowse for help with clinical studies. This study makes use of control data provided by the Genetic Association Information Network (GAIN) and the Wellcome Trust Case Control Consortium 2 (WTCCC2), through work funded by NIH and the Wellcome Trust (under award 085475). The GAIN General Research Use data sets used for the analyses described in this manuscript were obtained from the database of Genotype and Phenotype (dbGaP; http://www.ncbi.nlm.nih.gov/gap, dbGaP accession numbers phs000017 and phs000021). A full list of the investigators who contributed to the generation of the WTCCC2 data is available from http://www.wtccc.org.uk/ccc2.	Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Hirschhorn JN, 2002, J CLIN ENDOCR METAB, V87, P4438, DOI 10.1210/jc.2002-021329; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Morris DL, 2009, DIABETES, V58, P2039, DOI 10.2337/db08-1388; Poot M, 2010, EUR J HUM GENET, V18, P39, DOI 10.1038/ejhg.2009.120; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	25	364	392	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					666	670		10.1038/nature08689	http://dx.doi.org/10.1038/nature08689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	19966786	Green Accepted			2022-12-24	WOS:000274193900037
J	Lieb, W; Beiser, AS; Vasan, RS; Tan, ZS; Au, R; Harris, TB; Roubenoff, R; Auerbach, S; DeCarli, C; Wolf, PA; Seshadri, S				Lieb, Wolfgang; Beiser, Alexa S.; Vasan, Ramachandran S.; Tan, Zaldy S.; Au, Rhoda; Harris, Tamara B.; Roubenoff, Ronenn; Auerbach, Sanford; DeCarli, Charles; Wolf, Philip A.; Seshadri, Sudha			Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; CENTRAL-NERVOUS-SYSTEM; COGNITIVE FUNCTION; CENTRAL OBESITY; HEART-DISEASE; RISK; DEMENTIA; NEUROPATHOLOGY; MORTALITY; NEURONS	Context The adipokine leptin facilitates long-term potentiation and synaptic plasticity in the hippocampus, promotes beta-amyloid clearance, and improves memory function in animal models of aging and Alzheimer disease (AD). Objective To relate baseline circulating leptin concentrations in a community-based sample of individuals without dementia to incident dementia and AD during follow-up and magnetic resonance imaging (MRI) measures of brain aging in survivors. Design, Setting, and Participants Prospective study of plasma leptin concentrations measured in 785 persons without dementia (mean [SD] age, 79 [5] years; 62% female), who were in the Framingham original cohort at the 22nd examination cycle (1990-1994). A subsample of 198 dementia-free survivors underwent volumetric brain MRI between 1999 and 2005, approximately 7.7 years after leptin was assayed. Two measures of brain aging, total cerebral brain volume and temporal horn volume (which is inversely related to hippocampal volume) were assessed. Main Outcome Measure Incidence of dementia and AD during follow-up until December 31, 2007. Results During a median follow-up of 8.3 years (range, 0-15.5 years), 111 participants developed incident dementia; 89 had AD. Higher leptin levels were associated with a lower risk of incident dementia and AD in multivariable models (hazard ratio per 1-SD increment in log leptin was 0.68 [95% confidence interval, 0.54-0.87] for all-cause dementia and 0.60 [95% confidence interval, 0.46-0.79] for AD). This corresponds to an absolute AD risk over a 12-year follow-up of 25% for persons in the lowest quartile (first quartile) vs 6% for persons in the fourth quartile of sex-specific leptin levels. In addition, a 1-SD elevation in plasma leptin level was associated with higher total cerebral brain volume and lower temporal horn volume, although the association of leptin level with temporal horn volume did not reach statistical significance. Conclusion Circulating leptin was associated with a reduced incidence of dementia and AD and with cerebral brain volume in asymptomatic older adults. JAMA. 2009;302(23):2565-2572	[Beiser, Alexa S.; Au, Rhoda; Auerbach, Sanford; Wolf, Philip A.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Lieb, Wolfgang; Beiser, Alexa S.; Vasan, Ramachandran S.; Wolf, Philip A.; Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Beiser, Alexa S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA; [Tan, Zaldy S.] Brigham & Womens Hosp, Boston VA Healthcare Syst, Boston, MA 02115 USA; [Tan, Zaldy S.] Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA; [Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Roubenoff, Ronenn] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA	Boston University; Framingham Heart Study; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Tufts University; University of California System; University of California Davis; University of California System; University of California Davis	Seshadri, S (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 E Concord St,B602, Boston, MA 02118 USA.	suseshad@bu.edu	Kennedy, Kristen M/B-4699-2008; Ramachandran, Vasan/Y-2527-2019; DeCarli, Charles/B-5541-2009; Lieb, Wolfgang/AAC-7650-2022	Kennedy, Kristen M/0000-0001-5373-9026; Ramachandran, Vasan/0000-0001-7357-5970; Roubenoff, Ronenn/0000-0002-3959-3179; Auerbach, Sanford/0000-0003-2962-6405; Seshadri, Sudha/0000-0001-6135-2622; Beiser, Alexa/0000-0001-8551-7778; Au, Rhoda/0000-0001-7742-4491; Wolf, Philip/0000-0002-3628-301X	National Institutes of Health [N01-HC-25195, N01HV28178, RO1DK080739, 2K24HL04334]; National Heart, Lung, and Blood Institute; National Institute on Aging [R01 AG16495, AG08122, AG033193, AG031287]; National Institute of Neurological Disorders and Stroke [R01 NS17950]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028178, K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, R01AG031287, R01AG008122, R01AG016495, R01AG033193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by contracts N01-HC-25195, N01HV28178, RO1DK080739, and 2K24HL04334 (awarded to Dr Vasan) from the National Institutes of Health and the National Heart, Lung, and Blood Institute; grants R01 AG16495, AG08122, AG033193, and AG031287 from the National Institute on Aging; and grant R01 NS17950 from the National Institute of Neurological Disorders and Stroke.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barrett-Connor E, 1998, J Nutr Health Aging, V2, P113; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; DAVIS PC, 1995, NEUROLOGY, V45, P178, DOI 10.1212/WNL.45.1.178; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Doherty GH, 2008, NEUROSCIENCE, V154, P1297, DOI 10.1016/j.neuroscience.2008.04.052; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; Frisoni GB, 2002, AM J NEURORADIOL, V23, P35; Geerlings SW, 2002, PSYCHOL MED, V32, P609, DOI 10.1017/S0033291702005585; Giesel FL, 2008, EUR J RADIOL, V66, P268, DOI 10.1016/j.ejrad.2007.06.009; Gosche KM, 2002, NEUROLOGY, V58, P1476, DOI 10.1212/WNL.58.10.1476; Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026; Harvey J, 2005, BIOCHEM SOC T, V33, P1029, DOI 10.1042/BST0331029; Harvey J, 2006, PROG LIPID RES, V45, P369, DOI 10.1016/j.plipres.2006.03.001; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Lee SA, 2007, CANCER EPIDEM BIOMAR, V16, P2464, DOI 10.1158/1055-9965.EPI-07-0374; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Linkov F, 2009, EUR CYTOKINE NETW, V20, P21, DOI 10.1684/ecn.2009.0146; Ma ZM, 1996, CLIN CHEM, V42, P942; Maslow K, 2008, ALZHEIMERS DEMENT, V4, P110, DOI 10.1016/j.jalz.2008.02.005; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nam SY, 2001, J CLIN ENDOCR METAB, V86, P4849, DOI 10.1210/jc.86.10.4849; Narita K, 2009, BIOL PSYCHIAT, V65, P992, DOI 10.1016/j.biopsych.2008.10.006; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Peltz G, 2007, ARCH MED RES, V38, P563, DOI 10.1016/j.arcmed.2006.12.009; Power DA, 2001, DEMENT GERIATR COGN, V12, P167, DOI 10.1159/000051252; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Seshadri S, 2004, NEUROLOGY, V63, P1591, DOI 10.1212/01.WNL.0000142968.22691.70; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Stattin P, 2004, INT J CANCER, V109, P149, DOI 10.1002/ijc.11668; Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da; Tang BL, 2008, BIOCHEM BIOPH RES CO, V368, P181, DOI 10.1016/j.bbrc.2008.01.063; Tezapsidis N, 2009, NEUROLOGY, V72, P1030; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263; Wulsin LR, 2005, PSYCHOSOM MED, V67, P697, DOI 10.1097/01.psy.0000181274.56785.28	45	294	299	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2565	2572		10.1001/jama.2009.1836	http://dx.doi.org/10.1001/jama.2009.1836			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009056	Green Accepted, Bronze			2022-12-24	WOS:000272737200024
J	Martin, A; Troadec, C; Boualem, A; Rajab, M; Fernandez, R; Morin, H; Pitrat, M; Dogimont, C; Bendahmane, A				Martin, Antoine; Troadec, Christelle; Boualem, Adnane; Rajab, Mazen; Fernandez, Ronan; Morin, Halima; Pitrat, Michel; Dogimont, Catherine; Bendahmane, Abdelhafid			A transposon-induced epigenetic change leads to sex determination in melon	NATURE			English	Article							DNA METHYLATION; ARABIDOPSIS-THALIANA; MUTATION; PLANTS; GENE; CIS	Sex determination in plants leads to the development of unisexual flowers from an originally bisexual floral meristem(1,2). This mechanism results in the enhancement of outcrossing and promotes genetic variability, the consequences of which are advantageous to the evolution of a species(3). In melon, sexual forms are controlled by identity of the alleles at the andromonoecious (a) and gynoecious (g) loci(4). We previously showed that the a gene encodes an ethylene biosynthesis enzyme, CmACS-7, that represses stamen development in female flowers(5). Here we show that the transition from male to female flowers in gynoecious lines results from epigenetic changes in the promoter of a transcription factor, CmWIP1. This natural and heritable epigenetic change resulted from the insertion of a transposon, which is required for initiation and maintenance of the spreading of DNA methylation to the CmWIP1 promoter. Expression of CmWIP1 leads to carpel abortion, resulting in the development of unisexual male flowers. Moreover, we show that CmWIP1 indirectly represses the expression of the andromonoecious gene, CmACS-7, to allow stamen development. Together our data indicate a model in which CmACS-7 and CmWIP1 interact to control the development of male, female and hermaphrodite flowers in melon.	[Martin, Antoine; Troadec, Christelle; Boualem, Adnane; Rajab, Mazen; Fernandez, Ronan; Bendahmane, Abdelhafid] INRA, CNRS, UMR1165, Unite Rech Genom Vegetale, F-91057 Evry, France; [Morin, Halima] INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Pitrat, Michel; Dogimont, Catherine] INRA, UR 1052, Unite Genet & Ameliorat Fruits & Legumes, F-84143 Montfavet, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Bendahmane, A (corresponding author), INRA, CNRS, UMR1165, Unite Rech Genom Vegetale, 2 Rue Gaston Cremieux, F-91057 Evry, France.	bendahm@evry.inra.fr	Boualem, Adnane/ABC-5019-2021	Boualem, Adnane/0000-0003-4428-6496; Bendahmane, Abdelhafid/0000-0003-3246-868X; Catherine, DOGIMONT/0000-0001-7399-768X; Martin, Antoine/0000-0002-6956-2904; TROADEC, Christelle/0000-0003-1927-7352	GAP department	GAP department	We thank D. Bradley, M. Purugganan, P. Laufs, J. C. Palauqui and colleagues from Unite de Recherche en Genomique Vegetale (URGV) for discussions and comments on the manuscript, and F. Teixeira and V. Colot for helpful assistance on DNA methylation assays. This work was supported by GAP department in INRA and by a grant from Genopole (A.M.).	Ainsworth C, 1998, CURR TOP DEV BIOL, V38, P167; Arnaud P, 2000, MOL CELL BIOL, V20, P3434, DOI 10.1128/MCB.20.10.3434-3441.2000; Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; CHRISTMAN JK, 1995, P NATL ACAD SCI USA, V92, P7347, DOI 10.1073/pnas.92.16.7347; Crawford BCW, 2007, CURR BIOL, V17, P1101, DOI 10.1016/j.cub.2007.05.079; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; DELLAPORTA SL, 1993, PLANT CELL, V5, P1241, DOI 10.1105/tpc.5.10.1241; DELLAPORTA SL, 1994, SCIENCE, V266, P1501, DOI 10.1126/science.7985019; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martienssen RA, 2005, CHROMOSOME RES, V13, P299, DOI 10.1007/s10577-005-1507-2; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Poole CF, 1939, J HERED, V30, P21, DOI 10.1093/oxfordjournals.jhered.a104626; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Staden R, 2000, Methods Mol Biol, V132, P115; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; Weil C, 2008, CURR OPIN GENET DEV, V18, P188, DOI 10.1016/j.gde.2008.01.015	27	401	434	14	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1135	U237		10.1038/nature08498	http://dx.doi.org/10.1038/nature08498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847267				2022-12-24	WOS:000270987600047
J	Tanaka, S; Sawaya, MR; Yeates, TO				Tanaka, Shiho; Sawaya, Michael R.; Yeates, Todd O.			Structure and Mechanisms of a Protein-Based Organelle in Escherichia coli	SCIENCE			English	Article							SALMONELLA-TYPHIMURIUM LT2; CARBOXYSOME SHELL; THIOBACILLUS-NEAPOLITANUS; CRYSTAL-STRUCTURE; ETHANOLAMINE; MICROCOMPARTMENTS; 1,2-PROPANEDIOL; PROKARYOTES; PROPIONATE; INSIGHTS	Many bacterial cells contain proteinaceous microcompartments that act as simple organelles by sequestering specific metabolic processes involving volatile or toxic metabolites. Here we report the three-dimensional (3D) crystal structures, with resolutions between 1.65 and 2.5 angstroms, of the four homologous proteins (EutS, EutL, EutK, and EutM) that are thought to be the major shell constituents of a functionally complex ethanolamine utilization (Eut) microcompartment. The Eut microcompartment is used to sequester the metabolism of ethanolamine in bacteria such as Escherichia coli and Salmonella enterica. The four Eut shell proteins share an overall similar 3D fold, but they have distinguishing structural features that help explain the specific roles they play in the microcompartment. For example, EutL undergoes a conformational change that is probably involved in gating molecular transport through shell protein pores, whereas structural evidence suggests that EutK might bind a nucleic acid component. Together these structures give mechanistic insight into bacterial microcompartments.	[Tanaka, Shiho; Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Yeates, Todd O.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles Young Dr E, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839	Howard Hughes Medical Institute Funding Source: Medline; Direct For Biological Sciences [0843065] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; ENGLISH RS, 1994, MOL MICROBIOL, V12, P647, DOI 10.1111/j.1365-2958.1994.tb01052.x; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; RONDON MR, 1995, J BACTERIOL, V177, P7119, DOI 10.1128/JB.177.24.7119-7124.1995; RONDON MR, 1995, J BACTERIOL, V177, P5434, DOI 10.1128/jb.177.19.5434-5439.1995; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; SHIVELY JM, 1988, INT REV CYTOL, V113, P35; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200	26	168	174	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					81	84		10.1126/science.1179513	http://dx.doi.org/10.1126/science.1179513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044574				2022-12-24	WOS:000273395400035
J	Cauchemez, S; Donnelly, CA; Reed, C; Ghani, AC; Fraser, C; Kent, CK; Finelli, L; Ferguson, NM				Cauchemez, Simon; Donnelly, Christl A.; Reed, Carrie; Ghani, Azra C.; Fraser, Christophe; Kent, Charlotte K.; Finelli, Lyn; Ferguson, Neil M.			Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASIAN INFLUENZA; OSELTAMIVIR; CONTACTS; PATTERNS; STRAIN; MODEL	BACKGROUND As of June 11, 2009, a total of 17,855 probable or confirmed cases of 2009 pandemic influenza A (H1N1) had been reported in the United States. Risk factors for transmission remain largely uncharacterized. We characterize the risk factors and describe the transmission of the virus within households. METHODS Probable and confirmed cases of infection with the 2009 H1N1 virus in the United States were reported to the Centers for Disease Control and Prevention with the use of a standardized case form. We investigated transmission of infection in 216 households - including 216 index patients and their 600 household contacts - in which the index patient was the first case patient and complete information on symptoms and age was available for all household members. RESULTS An acute respiratory illness developed in 78 of 600 household contacts (13%). In 156 households (72% of the 216 households), an acute respiratory illness developed in none of the household contacts; in 46 households (21%), illness developed in one contact; and in 14 households (6%), illness developed in more than one contact. The proportion of household contacts in whom acute respiratory illness developed decreased with the size of the household, from 28% in two-member households to 9% in six-member households. Household contacts 18 years of age or younger were twice as susceptible as those 19 to 50 years of age ( relative susceptibility, 1.96; Bayesian 95% credible interval, 1.05 to 3.78; P = 0.005), and household contacts older than 50 years of age were less susceptible than those who were 19 to 50 years of age ( relative susceptibility, 0.17; 95% credible interval, 0.02 to 0.92; P = 0.03). Infectivity did not vary with age. The mean time between the onset of symptoms in a case patient and the onset of symptoms in the household contacts infected by that patient was 2.6 days ( 95% credible interval, 2.2 to 3.5). CONCLUSIONS The transmissibility of the 2009 H1N1 influenza virus in households is lower than that seen in past pandemics. Most transmissions occur soon before or after the onset of symptoms in a case patient.	[Cauchemez, Simon; Donnelly, Christl A.; Ghani, Azra C.; Fraser, Christophe; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Reed, Carrie; Kent, Charlotte K.; Finelli, Lyn] Ctr Dis Control & Prevent, Atlanta, GA USA	Imperial College London; Centers for Disease Control & Prevention - USA	Cauchemez, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, Norfolk Pl, London W2 1PG, England.	s.cauchemez@imperial.ac.uk	Ferguson, Neil/B-8578-2008; Finelli, Lyn/AAK-2360-2020; Fraser, Christophe/A-8109-2008; Ghani, Azra/B-8560-2009	Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; Donnelly, Christl/0000-0002-0195-2463; Ghani, Azra/0000-0002-0007-4910	Medical Research Council; Bill and Melinda Gates Foundation; European Union; Models of Infectious Disease Agent Study initiative of the National Institute of General Medical Sciences; Royal Society; Research Councils U. K.; Medical Research Council [G0600719B] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Union(European Commission); Models of Infectious Disease Agent Study initiative of the National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Royal Society(Royal Society of London); Research Councils U. K.(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the Medical Research Council, the Bill and Melinda Gates Foundation, the European Union Framework 7 program (FluModCont), and the Models of Infectious Disease Agent Study initiative of the National Institute of General Medical Sciences ( all for the work at Imperial College), the Royal Society ( to Dr. Fraser), and Research Councils U. K. ( to Dr. Cauchemez).	Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; *CDCP, 2009 H1N1 FLU SIT UP; *CDCP, H1N1 FLU CLIN PUBL H; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Centers for Disease Control and Prevention (CDC), 2009, CDC REC AM TIM PERS; CHIN TDY, 1960, PUBLIC HEALTH REP, V75, P149, DOI 10.2307/4590751; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; HALL CB, 1979, J INFECT DIS, V140, P610, DOI 10.1093/infdis/140.4.610; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; RAMPEY AH, 1992, BIOMETRICS, V48, P117, DOI 10.2307/2532743; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; WOODALL J, 1958, BRIT MED J, V2, P1316, DOI 10.1136/bmj.2.5108.1316	23	357	366	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2619	2627		10.1056/NEJMoa0905498	http://dx.doi.org/10.1056/NEJMoa0905498			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042753	Green Accepted			2022-12-24	WOS:000273181300009
J	Hensley, SE; Das, SR; Bailey, AL; Schmidt, LM; Hickman, HD; Jayaraman, A; Viswanathan, K; Raman, R; Sasisekharan, R; Bennink, JR; Yewdell, JW				Hensley, Scott E.; Das, Suman R.; Bailey, Adam L.; Schmidt, Loren M.; Hickman, Heather D.; Jayaraman, Akila; Viswanathan, Karthik; Raman, Rahul; Sasisekharan, Ram; Bennink, Jack R.; Yewdell, Jonathan W.			Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift	SCIENCE			English	Article							VARIANTS; NEUTRALIZATION; RECOGNITION; ANTIBODIES	Rapid antigenic evolution in the influenza A virus hemagglutinin precludes effective vaccination with existing vaccines. To understand this phenomenon, we passaged virus in mice immunized with influenza vaccine. Neutralizing antibodies selected mutants with single-amino acid hemagglutinin substitutions that increased virus binding to cell surface glycan receptors. Passaging these high-avidity binding mutants in naive mice, but not immune mice, selected for additional hemagglutinin substitutions that decreased cellular receptor binding avidity. Analyzing a panel of monoclonal antibody hemagglutinin escape mutants revealed a positive correlation between receptor binding avidity and escape from polyclonal antibodies. We propose that in response to variation in neutralizing antibody pressure between individuals, influenza A virus evolves by adjusting receptor binding avidity via amino acid substitutions throughout the hemagglutinin globular domain, many of which simultaneously alter antigenicity.	[Hensley, Scott E.; Das, Suman R.; Bailey, Adam L.; Schmidt, Loren M.; Hickman, Heather D.; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; [Jayaraman, Akila; Viswanathan, Karthik; Raman, Rahul; Sasisekharan, Ram] MIT, Harvard Mit Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jayaraman, Akila; Viswanathan, Karthik; Raman, Rahul; Sasisekharan, Ram] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.	jyewdell@mail.nih.gov	Das, Suman R/C-8760-2009; yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Das, Suman/ABB-7273-2020	Das, Suman/0000-0003-2496-9724; Hickman, Heather/0000-0003-4168-4894	Division of Intramural Research, NIAID; Singapore-Massachusetts Institute of Technology Alliance for Research and Technology; National Institute of General Medical Sciences [GM 57073, U54 GM62116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001014, Z01AI001014, ZIAAI001055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Singapore-Massachusetts Institute of Technology Alliance for Research and Technology; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of the National Institute of Allergy and Infectious Diseases (NIAID) Comparative Medical Branch for assistance with animal studies, G. Reynoso for technical assistance, the Consortium for Functional Glycomics for glycan standards, and S. Epstein (U. S. Food and Drug Administration) for insightful reading of the manuscript. This work was supported by Division of Intramural Research, NIAID (J.R.B. and J.W.Y.), the Singapore-Massachusetts Institute of Technology Alliance for Research and Technology (R. S.), and the National Institute of General Medical Sciences (GM 57073 and U54 GM62116) (R. S.).	Air G M, 1987, Contrib Microbiol Immunol, V8, P20; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; DESTGROTH SF, 1977, TOPICS INFECTIOUS DI, V3, P25; DIMMOCK NJ, 1984, J GEN VIROL, V65, P1015, DOI 10.1099/0022-1317-65-6-1015; Gambaryan AS, 1998, VIROLOGY, V247, P223, DOI 10.1006/viro.1998.9274; GERBER P, 1955, J EXP MED, V101, P627, DOI 10.1084/jem.101.6.627; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; UNDERWOOD PA, 1987, J VIROL, V61, P206, DOI 10.1128/JVI.61.1.206-208.1987; WANG ML, 1986, J VIROL, V57, P124, DOI 10.1128/JVI.57.1.124-128.1986; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; YEWDELL JW, 1986, J VIROL, V57, P623, DOI 10.1128/JVI.57.2.623-628.1986; YEWDELL JW, 1979, NATURE, V279, P246, DOI 10.1038/279246a0	18	340	356	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					734	736		10.1126/science.1178258	http://dx.doi.org/10.1126/science.1178258			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19900932	Green Accepted, Green Published			2022-12-24	WOS:000271233200039
J	Aldeco-Perez, E; Rosenthal, AJ; Donnadieu, B; Parameswaran, P; Frenking, G; Bertrand, G				Aldeco-Perez, Eugenia; Rosenthal, Amos J.; Donnadieu, Bruno; Parameswaran, Pattiyil; Frenking, Gernot; Bertrand, Guy			Isolation of a C5-Deprotonated Imidazolium, a Crystalline "Abnormal" N-Heterocyclic Carbene	SCIENCE			English	Article							OLEFIN-METATHESIS CATALYSTS; ORGANIC-SYNTHESIS; STABLE CARBENES; LIGANDS; COMPLEXES; POLYMERIZATION; BINDING; SALT	The discovery two decades ago of metal-free stable carbenes, especially imidazol-2-ylidenes [N-heterocyclic carbenes (NHCs)], has led to numerous breakthroughs in organic and organometallic catalysis. More recently, a small range of complexes has been prepared in which alternative NHC isomers, namely imidazol-5-ylidenes ( also termed abnormal NHCs or aNHCs, because the carbene center is no longer located between the two nitrogens), coordinate to a transition metal. Here we report the synthesis of a metal-free aNHC that is stable at room temperature, both in the solid state and in solution. Calculations show that the aNHC is more basic than its normal NHC isomer. Because the substituent at the carbon next to the carbene center is a nonbulky phenyl group, a variety of substitution patterns should be tolerated without precluding the isolation of the corresponding aNHC.	[Aldeco-Perez, Eugenia; Rosenthal, Amos J.; Donnadieu, Bruno; Bertrand, Guy] Univ Calif Riverside, CNRS, Joint Res Chem Lab, Dept Chem,UMI 2957, Riverside, CA 92521 USA; [Parameswaran, Pattiyil; Frenking, Gernot] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany	University of California System; University of California Riverside; Philipps University Marburg	Bertrand, G (corresponding author), Univ Calif Riverside, CNRS, Joint Res Chem Lab, Dept Chem,UMI 2957, Riverside, CA 92521 USA.	guy.bertrand@ucr.edu	Parameswaran, Pattiyil/H-8134-2013	Parameswaran, Pattiyil/0000-0003-2065-2463	NIH [R01 GM 68825]; Deutsche Forschungsgemeinschaft; Consejo Nacional de Ciencia y Tecnologia; Alexander von Humboldt Foundation;  [CCDC-735754];  [CCDC-735755];  [CCDC-735756];  [CCDC-744123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank NIH ( grant R01 GM 68825) and the Deutsche Forschungsgemeinschaft for financial support of this work and the Consejo Nacional de Ciencia y Tecnologia ( E. A. P.) and Alexander von Humboldt Foundation ( P. P.) for postdoctoral fellowships. Metrical data for the solid-state structures of 6 (Br-), 8, 9, and 10 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-735754, CCDC-735755, CCDC-735756, and CCDC-744123, respectively.	Albrecht M, 2008, CHEM COMMUN, P3601, DOI 10.1039/b806924g; Alcarazo M, 2005, J AM CHEM SOC, V127, P3290, DOI 10.1021/ja0423769; Alder RW, 2004, ANGEW CHEM INT EDIT, V43, P5896, DOI 10.1002/anie.200400654; Appelhans LN, 2005, J AM CHEM SOC, V127, P16299, DOI 10.1021/ja055317j; Arduengo AJ, 1999, ACCOUNTS CHEM RES, V32, P913, DOI 10.1021/ar980126p; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P3122; Arnold PL, 2007, COORDIN CHEM REV, V251, P596, DOI 10.1016/j.ccr.2006.08.006; Bambirra S, 2003, CHEM COMMUN, P522, DOI 10.1039/b208502j; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; Delaude L, 2009, EUR J INORG CHEM, P1681, DOI 10.1002/ejic.200801227; Denmark SE, 2008, ANGEW CHEM INT EDIT, V47, P1560, DOI 10.1002/anie.200604943; Diez-Gonzalez S, 2009, CHEM REV, V109, P3612, DOI 10.1021/cr900074m; Enders D, 2007, CHEM REV, V107, P5606, DOI 10.1021/cr068372z; Grubbs RH, 2006, ANGEW CHEM INT EDIT, V45, P3760, DOI 10.1002/anie.200600680; Grundemann S, 2001, CHEM COMMUN, P2274, DOI 10.1039/b107881j; Hahn FE, 2008, ANGEW CHEM INT EDIT, V47, P3122, DOI 10.1002/anie.200703883; Heckenroth M, 2007, ANGEW CHEM INT EDIT, V46, P6293, DOI 10.1002/anie.200702199; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Kamber NE, 2007, CHEM REV, V107, P5813, DOI 10.1021/cr068415b; KOROTKIKH MI, 2001, UKRAINSKII KHIM Z, V67, P97; Lavallo V, 2006, SCIENCE, V312, P722, DOI 10.1126/science.1126675; Lavallo V, 2006, ANGEW CHEM INT EDIT, V45, P6652, DOI 10.1002/anie.200602701; Lebel H, 2004, J AM CHEM SOC, V126, P5046, DOI 10.1021/ja049759r; Lin JCY, 2009, CHEM REV, V109, P3561, DOI 10.1021/cr8005153; Lipshutz BH, 2008, CHEM REV, V108, P2793, DOI 10.1021/cr800415x; Magill AM, 2004, AUST J CHEM, V57, P1205, DOI 10.1071/CH04159; Magill AM, 2004, J AM CHEM SOC, V126, P8717, DOI 10.1021/ja038973x; Marion N, 2007, ANGEW CHEM INT EDIT, V46, P2988, DOI 10.1002/anie.200603380; McNaught AD, 1997, COMPENDIUM CHEM TERM, DOI DOI 10.1351/GOLDBOOK; Prades A, 2008, ORGANOMETALLICS, V27, P4254, DOI 10.1021/om800377m; Riduan SN, 2009, ANGEW CHEM INT EDIT, V48, P3322, DOI 10.1002/anie.200806058; Samojlowicz C, 2009, CHEM REV, V109, P3708, DOI 10.1021/cr800524f; Schuster O, 2009, CHEM REV, V109, P3445, DOI 10.1021/cr8005087; Sini G, 2002, INORG CHEM, V41, P602, DOI 10.1021/ic010714q; Tonner R, 2008, CHEMPHYSCHEM, V9, P1474, DOI 10.1002/cphc.200800208; Tonner R, 2007, CHEM-ASIAN J, V2, P1555, DOI 10.1002/asia.200700235	37	333	335	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					556	559		10.1126/science.1178206	http://dx.doi.org/10.1126/science.1178206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	509LN	19900893	Green Accepted			2022-12-24	WOS:000271019400036
J	Li, WKW; McLaughlin, FA; Lovejoy, C; Carmack, EC				Li, William K. W.; McLaughlin, Fiona A.; Lovejoy, Connie; Carmack, Eddy C.			Smallest Algae Thrive As the Arctic Ocean Freshens	SCIENCE			English	Article									[Li, William K. W.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [McLaughlin, Fiona A.; Carmack, Eddy C.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; [Lovejoy, Connie] Univ Laval, Dept Biol, Quebec Ocean & Inst Biol Integrat & Syst, Quebec City, PQ G1V 0A6, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Laval University	Li, WKW (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	LiB@mar.dfo-mpo.gc.ca	Lovejoy, Connie/A-3756-2008	Lovejoy, Connie/0000-0001-8027-2281	Fisheries and Oceans Canada; International Polar Year Program Canada's Three Oceans project; U. S. NSF Beaufort Gyre Exploration Project; Japan Agency for Marine-Earth Science and Technology	Fisheries and Oceans Canada; International Polar Year Program Canada's Three Oceans project; U. S. NSF Beaufort Gyre Exploration Project; Japan Agency for Marine-Earth Science and Technology	Financial and ship time support were provided by Fisheries and Oceans Canada, International Polar Year Program Canada's Three Oceans project, U. S. NSF Beaufort Gyre Exploration Project, and the Japan Agency for Marine-Earth Science and Technology. We thank S. Zimmermann, J. Eert, K. Scarcella, D. Horn, T. Perry, and the men and women of Canadian Coast Guard Ship Louis S. St-Laurent.	Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Carmack E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017526; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Tremblay G, 2009, AQUAT MICROB ECOL, V54, P55, DOI 10.3354/ame01257; Tremblay JE, 2009, NATO SCI PEACE SECUR, P73, DOI 10.1007/978-1-4020-9460-6_7; Uitz J, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003207; Yamamoto-Kawai M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005000	9	524	563	4	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					539	539		10.1126/science.1179798	http://dx.doi.org/10.1126/science.1179798			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900890				2022-12-24	WOS:000271019400031
J	Fujii, H; Chinnusamy, V; Rodrigues, A; Rubio, S; Antoni, R; Park, SY; Cutler, SR; Sheen, J; Rodriguez, PL; Zhu, JK				Fujii, Hiroaki; Chinnusamy, Viswanathan; Rodrigues, Americo; Rubio, Silvia; Antoni, Regina; Park, Sang-Youl; Cutler, Sean R.; Sheen, Jen; Rodriguez, Pedro L.; Zhu, Jian-Kang			In vitro reconstitution of an abscisic acid signalling pathway	NATURE			English	Article							PROTEIN PHOSPHATASES; GENE-EXPRESSION; IDENTIFICATION; TRANSDUCTION; RECEPTORS; INTERACTS; GROWTH; ABA	The phytohormone abscisic acid (ABA) regulates the expression of many genes in plants; it has critical functions in stress resistance and in growth and development(1-7). Several proteins have been reported to function as ABA receptors(8-13), and many more are known to be involved in ABA signalling(3,4,14). However, the identities of ABA receptors remain controversial and the mechanism of signalling from perception to downstream gene expression is unclear(15,16). Here we show that by combining the recently identified ABA receptor PYR1 with the type 2C protein phosphatase (PP2C) ABI1, the serine/threonine protein kinase SnRK2.6/OST1 and the transcription factor ABF2/AREB1, we can reconstitute ABA-triggered phosphorylation of the transcription factor in vitro. Introduction of these four components into plant protoplasts results in ABA-responsive gene expression. Protoplast and test-tube reconstitution assays were used to test the function of various members of the receptor, protein phosphatase and kinase families. Our results suggest that the default state of the SnRK2 kinases is an autophosphorylated, active state and that the SnRK2 kinases are kept inactive by the PP2Cs through physical interaction and dephosphorylation. We found that in the presence of ABA, the PYR/PYL (pyrabactin resistance 1/PYR1-like) receptor proteins can disrupt the interaction between the SnRK2s and PP2Cs, thus preventing the PP2C-mediated dephosphorylation of the SnRK2s and resulting in the activation of the SnRK2 kinases. Our results reveal new insights into ABA signalling mechanisms and define a minimal set of core components of a complete major ABA signalling pathway.	[Fujii, Hiroaki; Chinnusamy, Viswanathan; Park, Sang-Youl; Cutler, Sean R.; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Fujii, Hiroaki; Chinnusamy, Viswanathan; Zhu, Jian-Kang] 4700 King Abdullah Univ Sci & Technol, Ctr Plant Stress Genom & Technol, Thuwal 239556900, Saudi Arabia; [Rodrigues, Americo; Rubio, Silvia; Antoni, Regina; Rodriguez, Pedro L.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, ES-46022 Valencia, Spain; [Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	University of California System; University of California Riverside; King Abdullah University of Science & Technology; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Harvard University; Massachusetts General Hospital	Zhu, JK (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Zhu, Jian-Kang/F-7658-2011; Rodrigues, Americo/F-9573-2010; Rodriguez, Pedro L./K-4605-2014; Chinnusamy, Viswanathan/B-9079-2009; Cutler, Sean R/D-6617-2011	Zhu, Jian-Kang/0000-0001-5134-731X; Rodrigues, Americo/0000-0002-5293-5583; Rodriguez, Pedro L./0000-0002-5886-9425; Chinnusamy, Viswanathan/0000-0003-2174-9064; Fujii, Hiroaki/0000-0002-0013-5891; Cutler, Sean/0000-0002-8593-0885	National Institutes of Health; MICIIN; CSIC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MICIIN; CSIC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Bressan for helpful discussions and for editing of the manuscript. This work was supported by National Institutes of Health grants ( J.- K. Z.) and MICIIN and CSIC fellowships ( S. R. and R. A.).	Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Kuhn JM, 2003, CURR OPIN PLANT BIOL, V6, P463, DOI 10.1016/S1369-5266(03)00084-0; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pennisi E, 2009, SCIENCE, V324, P1012, DOI 10.1126/science.324_1012; Roelfsema MRG, 2005, NEW PHYTOL, V167, P665, DOI 10.1111/j.1469-8137.2005.01460.x; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	30	824	891	10	338	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					660	U138		10.1038/nature08599	http://dx.doi.org/10.1038/nature08599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19924127	Green Accepted, Green Submitted			2022-12-24	WOS:000272277900043
J	Netzer, N; Goodenbour, JM; David, A; Dittmar, KA; Jones, RB; Schneider, JR; Boone, D; Eves, EM; Rosner, MR; Gibbs, JS; Embry, A; Dolan, B; Das, S; Hickman, HD; Berglund, P; Bennink, JR; Yewdell, JW; Pan, T				Netzer, Nir; Goodenbour, Jeffrey M.; David, Alexandre; Dittmar, Kimberly A.; Jones, Richard B.; Schneider, Jeffrey R.; Boone, David; Eves, Eva M.; Rosner, Marsha R.; Gibbs, James S.; Embry, Alan; Dolan, Brian; Das, Suman; Hickman, Heather D.; Berglund, Peter; Bennink, Jack R.; Yewdell, Jonathan W.; Pan, Tao			Innate immune and chemically triggered oxidative stress modifies translational fidelity	NATURE			English	Article							GENETIC-CODE; QUALITY-CONTROL; CELLS; EVOLUTION; ANTIOXIDANTS; MITOCHONDRIA; PROTEINS; CANDIDA	Translational fidelity, essential for protein and cell function, requires accurate transfer RNA (tRNA) aminoacylation. Purified aminoacyl-tRNA synthetases exhibit a fidelity of one error per 10,000 to 100,000 couplings(1,2). The accuracy of tRNA aminoacylation in vivo is uncertain, however, and might be considerably lower(3-6). Here we show that in mammalian cells, approximately 1% of methionine (Met) residues used in protein synthesis are aminoacylated to non-methionyl-tRNAs. Remarkably, Met-misacylation increases up to tenfold upon exposing cells to live or non-infectious viruses, toll-like receptor ligands or chemically induced oxidative stress. Met is misacylated to specific non-methionyl-tRNA families, and these Met-misacylated tRNAs are used in translation. Met-misacylation is blocked by an inhibitor of cellular oxidases, implicating reactive oxygen species (ROS) as the misacylation trigger. Among six amino acids tested, tRNA misacylation occurs exclusively with Met. As Met residues are known to protect proteins against ROS-mediated damage(7), we propose that Met-misacylation functions adaptively to increase Met incorporation into proteins to protect cells against oxidative stress. In demonstrating an unexpected conditional aspect of decoding mRNA, our findings illustrate the importance of considering alternative iterations of the genetic code.	[Netzer, Nir; David, Alexandre; Gibbs, James S.; Embry, Alan; Dolan, Brian; Das, Suman; Hickman, Heather D.; Berglund, Peter; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; [Goodenbour, Jeffrey M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dittmar, Kimberly A.; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Jones, Richard B.; Eves, Eva M.; Rosner, Marsha R.] Univ Chicago, Ben May Inst, Chicago, IL 60637 USA; [Schneider, Jeffrey R.; Boone, David] Univ Chicago, Dept Med, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Chicago; University of Chicago; University of Chicago; University of Chicago	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.	jyewdell@nih.gov; taopan@uchicago.edu	David, Alexandre/B-2447-2013; yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Das, Suman/ABB-7273-2020; Das, Suman R/C-8760-2009; David, Alexandre/AAL-2758-2021	David, Alexandre/0000-0003-3365-1339; Das, Suman/0000-0003-2496-9724; David, Alexandre/0000-0003-3365-1339; Netzer, Nikolaus/0000-0001-7534-3575; Hickman, Heather/0000-0003-4168-4894	Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001014, ZIAAI000542, ZIAAI000653, ZIAAI000658] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to D. Klinman for his gift of CpG oligonucleotides and advice, A. Schilling for supervision and advice on mass spectrometry experiments, and C. Nicchitta, T. Pierson, P. Cluzel, R. Levine, A. Iwasaki and S. Amigorena for insight and advice. This work was supported by the Division of Intramural Research, the National Institute of Allergy and Infectious Diseases, and by National Institutes of Health extramural pilot projects.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Bender A, 2008, P NATL ACAD SCI USA, V105, P16496, DOI 10.1073/pnas.0802779105; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Cochella L, 2005, CURR BIOL, V15, pR536, DOI 10.1016/j.cub.2005.07.018; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Finkelstein JD, 2007, CLIN CHEM LAB MED, V45, P1694, DOI 10.1515/CCLM.2007.341; Freist W, 1998, J THEOR BIOL, V193, P19, DOI 10.1006/jtbi.1998.0672; HOFFMANN GW, 1974, J MOL BIOL, V86, P349, DOI 10.1016/0022-2836(74)90024-2; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Miranda I, 2006, YEAST, V23, P203, DOI 10.1002/yea.1350; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Santos MAS, 1999, MOL MICROBIOL, V31, P937, DOI 10.1046/j.1365-2958.1999.01233.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; USSERY MA, 1977, EUR J BIOCHEM, V72, P491, DOI 10.1111/j.1432-1033.1977.tb11272.x; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005	24	231	236	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2009	462	7272					522	526		10.1038/nature08576	http://dx.doi.org/10.1038/nature08576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524LG	19940929	Green Accepted			2022-12-24	WOS:000272144200048
J	Spite, M; Norling, LV; Summers, L; Yang, R; Cooper, D; Petasis, NA; Flower, RJ; Perretti, M; Serhan, CN				Spite, Matthew; Norling, Lucy V.; Summers, Lisa; Yang, Rong; Cooper, Dianne; Petasis, Nicos A.; Flower, Roderick J.; Perretti, Mauro; Serhan, Charles N.			Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis	NATURE			English	Article							NITRIC-OXIDE; LIPID MEDIATORS; ACUTE-INFLAMMATION; ENDOTOXIC-SHOCK; IN-VIVO; MACROPHAGES; ACTIVATION; RESOLUTION; RECEPTORS; MORTALITY	A growing body of evidence indicates that resolution of acute inflammation is an active process(1,2). Resolvins are a new family of lipid mediators enzymatically generated within resolution networks that possess unique and specific functions to orchestrate catabasis, the phase in which disease declines(2,3). Resolvin D2 (RvD2) was originally identified in resolving exudates, yet its individual contribution in resolution remained to be elucidated. Here, we establish RvD2's potent stereoselective actions in reducing excessive neutrophil trafficking to inflammatory loci. RvD2 decreased leukocyte-endothelial interactions in vivo by endothelial-dependent nitric oxide production, and by direct modulation of leukocyte adhesion receptor expression. In mice with microbial sepsis initiated by caecal ligation and puncture, RvD2 sharply decreased both local and systemic bacterial burden, excessive cytokine production and neutrophil recruitment, while increasing peritoneal mononuclear cells and macrophage phagocytosis. These multi-level pro-resolving actions of RvD2 translate to increased survival from sepsis induced by caecal ligation and puncture and surgery. Together, these results identify RvD2 as a potent endogenous regulator of excessive inflammatory responses that acts via multiple cellular targets to stimulate resolution and preserve immune vigilance.	[Spite, Matthew; Norling, Lucy V.; Summers, Lisa; Yang, Rong; Serhan, Charles N.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Spite, Matthew; Norling, Lucy V.; Summers, Lisa; Yang, Rong; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Norling, Lucy V.; Cooper, Dianne; Flower, Roderick J.; Perretti, Mauro] Queen Mary Univ London, Barts & London Med Sch, William Harvey Res Inst, London EC1M 6BQ, England; [Petasis, Nicos A.] Univ So Calif, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA; [Petasis, Nicos A.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of London; Queen Mary University London; University of Southern California; University of Southern California	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Yang, Rong/ABA-7587-2021; Norling, Lucy/W-9523-2019; Norling, Lucy/AAO-4645-2020; Spite, Matthew/B-3337-2010; Petasis, Nicos/B-3162-2009	Norling, Lucy/0000-0001-5316-9115; Petasis, Nicos/0000-0002-8864-4446; Yang, Rong/0000-0001-8837-0089	National Institutes of Health [GM-38765, P50-DE016191]; Welcome Trust [086867/Z/08/Z, 085903/Z/08]; Arthritis Research Campaign UK [18445, 18103]; NHLBI [HL087526]; Versus Arthritis [18103] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL087526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, R29GM038765, R37GM038765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welcome Trust(Wellcome Trust); Arthritis Research Campaign UK(Versus Arthritis); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Versus Arthritis(Versus Arthritis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from National Institutes of Health grants GM-38765 and P50-DE016191 (C. N. S.), Welcome Trust Programme grant 086867/Z/08/Z (R. J. F. and M. P.) and Project grant 085903/Z/08 (R. J. F.) and Arthritis Research Campaign UK fellowships 18445 and 18103 (to L. V. N. and D. C., respectively). M. S. received a National Research Service Award from the NHLBI (HL087526). We thank J. W. Winkler and J. Uddin for work related to RvD2 synthesis, P. Pillai, K. Martinod, G. Fredman and J. Dalli for technical assistance, and M. H. Small for assistance with the manuscript. We also thank B. Schmidt for histopathology, Children's Hospital Boston.	Bucci M, 2005, P NATL ACAD SCI USA, V102, P904, DOI 10.1073/pnas.0408906102; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Farolan LR, 1996, SHOCK, V6, P263, DOI 10.1097/00024382-199610000-00007; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; Pluess TT, 2007, INTENS CARE MED, V33, P789, DOI 10.1007/s00134-007-0591-5; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rodriguez AR, 2004, TETRAHEDRON LETT, V45, P8717, DOI 10.1016/j.tetlet.2004.09.129; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, METHOD ENZYMOL, V432, P275, DOI 10.1016/S0076-6879(07)32012-0; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Singer P, 2008, INTENS CARE MED, V34, P1580, DOI 10.1007/s00134-008-1142-4; Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533; Takano T, 1998, J CLIN INVEST, V101, P819, DOI 10.1172/JCI1578; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415	32	488	506	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1287	U125		10.1038/nature08541	http://dx.doi.org/10.1038/nature08541			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	511TF	19865173	Green Accepted, Green Submitted			2022-12-24	WOS:000271190800050
J	Yang, G; Pan, F; Gan, WB				Yang, Guang; Pan, Feng; Gan, Wen-Biao			Stably maintained dendritic spines are associated with lifelong memories	NATURE			English	Article							CEREBRAL-CORTEX; SOMATOSENSORY CORTEX; SYNAPTIC PLASTICITY; OCULAR DOMINANCE; DIVERSE REGIONS; STRIATE CORTEX; MOTOR CORTEX; ADULT CORTEX; IN-VIVO; SYNAPSES	Changes in synaptic connections are considered essential for learning and memory formation(1-6). However, it is unknown how neural circuits undergo continuous synaptic changes during learning while maintaining lifelong memories. Here we show, by following postsynaptic dendritic spines over time in the mouse cortex(7,8), that learning and novel sensory experience lead to spine formation and elimination by a protracted process. The extent of spine remodelling correlates with behavioural improvement after learning, suggesting a crucial role of synaptic structural plasticity in memory formation. Importantly, a small fraction of new spines induced by novel experience, together with most spines formed early during development and surviving experience-dependent elimination, are preserved and provide a structural basis for memory retention throughout the entire life of an animal. These studies indicate that learning and daily sensory experience leave minute but permanent marks on cortical connections and suggest that lifelong memories are stored in largely stably connected synaptic networks.	[Yang, Guang; Pan, Feng; Gan, Wen-Biao] NYU, Sch Med,Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Dept Physiol & Neurosci, Mol Neurobiol Program, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med,Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Dept Physiol & Neurosci, Mol Neurobiol Program, New York, NY 10016 USA.	gan@saturn.med.nyu.edu		Yang, Guang/0000-0002-5739-9126	National Institutes of Health [R01 NS047325]; Dart Foundation Fellowship; Ellison/AFAR Postdoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dart Foundation Fellowship; Ellison/AFAR Postdoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health R01 NS047325 and a Dart Foundation Fellowship to W.-B. G. and by an Ellison/AFAR Postdoctoral Fellowship to G. Y. We thank members of the Gan laboratory for their comments.	Anderson BJ, 2002, LEARN MEMORY, V9, P1, DOI 10.1101/lm.43402; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Grossman AW, 2002, PROG BRAIN RES, V138, P91, DOI 10.1016/S0079-6123(02)38073-7; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kleim JA, 1997, J NEUROSCI, V17, P717; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P290, DOI 10.1006/nlme.1998.3828; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	35	751	759	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					920	U114		10.1038/nature08577	http://dx.doi.org/10.1038/nature08577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	19946265	Green Accepted			2022-12-24	WOS:000272795400043
J	Chun, YS; Vauthey, JN; Boonsirikamchai, P; Maru, DM; Kopetz, S; Palavecino, M; Curley, SA; Abdalla, EK; Kaur, H; Charnsangavej, C; Loyer, EM				Chun, Yun Shin; Vauthey, Jean-Nicolas; Boonsirikamchai, Piyaporn; Maru, Dipen M.; Kopetz, Scott; Palavecino, Martin; Curley, Steven A.; Abdalla, Eddie K.; Kaur, Harmeet; Charnsangavej, Chusilp; Loyer, Evelyne M.			Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OXALIPLATIN-BASED CHEMOTHERAPY; ANTIANGIOGENIC THERAPY; CANCER; PERFUSION; CT; IRINOTECAN; RESECTION; TUMORS	Context The standard criteria used to evaluate tumor response, the Response Evaluation Criteria in Solid Tumors (RECIST), were developed to assess tumor shrinkage after cytotoxic chemotherapy and may be limited in assessing response to biologic agents, which have a cytostatic mechanism of action. Objective To validate novel tumor response criteria based on morphologic changes observed on computed tomography (CT) in patients with colorectal liver metastases treated with bevacizumab-containing chemotherapy regimens. Design, Setting, and Patients A total of 234 colorectal liver metastases were analyzed from 50 patients who underwent hepatic resection after preoperative chemotherapy that included bevacizumab at a comprehensive US cancer center from 2004 to 2007; date of last follow-up was March 2008. All patients underwent routine contrast-enhanced CT at the start and end of preoperative therapy. Three blinded, independent radiologists evaluated images for morphologic response, based on metastases changing from heterogeneous masses with ill-defined margins into homogeneous hypoattenuating lesions with sharp borders. These criteria were validated with a separate cohort of 82 patients with unresectable colorectal liver metastases treated with bevacizumab-containing chemotherapy. Main Outcome Measures Response determined using morphologic criteria and RECIST was correlated with pathologic response in resected liver specimens and with patient survival. Results Interobserver agreement for scoring morphologic changes was good among 3 radiologists (kappa, 0.68-0.78; 95% confidence interval [CI], 0.51-0.93). In resected tumor specimens, the median (interquartile range [IQR]) percentages of residual tumor cells for optimal morphologic response was 20% (10%-30%); for incomplete response, 50% (30%-60%); and no response, 70% (60%-70%; P < .001). With RECIST, the median (IQR) percentages of residual tumor cells were for partial response 30% (10%-60%); for stable disease, 50% (20%-70%); and for progressive disease, 70% (65%-70%; P = .04). Among patients who underwent hepatic resection, median overall survival was not yet reached with optimal morphologic response and 25 months (95% CI, 20.2-29.8 months) with incomplete or no morphologic response (P = .03). In the validation cohort, patients with optimal morphologic response had median overall survival of 31 months (95% CI, 26.8-35.2 months) compared with 19 months (95% CI, 14.6-23.4 months) with incomplete or no morphologic response (P = .009). RECIST did not correlate with survival in either the surgical or validation cohort. Conclusion Among patients with colorectal liver metastases treated with bevacizumab-containing chemotherapy, CT-based morphologic criteria had a statistically significant association with pathologic response and overall survival. JAMA. 2009;302(21):2338-2344	[Chun, Yun Shin; Vauthey, Jean-Nicolas; Palavecino, Martin; Curley, Steven A.; Abdalla, Eddie K.] Baylor Coll Med, Dept Surg Oncol, Houston, TX 77030 USA; [Boonsirikamchai, Piyaporn; Kaur, Harmeet; Charnsangavej, Chusilp; Loyer, Evelyne M.] Baylor Coll Med, Dept Diagnost Radiol, Houston, TX 77030 USA; [Maru, Dipen M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Kopetz, Scott] Baylor Coll Med, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Vauthey, JN (corresponding author), Baylor Coll Med, Dept Surg Oncol, 1515 Holcombe Blvd,Unit 444, Houston, TX 77030 USA.	jvauthey@mdanderson.org; eloyer@mdanderson.org	Kopetz, Scott/AAC-1387-2019	Kopetz, Scott/0000-0001-9647-3416; Kaur, Harmeet/0000-0002-3461-5316; Palavecino, Martin/0000-0002-5152-0159	AstraZeneca; Genentech; Roche; Sanofi-Aventis; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Genentech(Roche HoldingGenentech); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Kopetz reports receiving research grants and honoraria from AstraZeneca and honoraria from Genentech, Roche, and Sanofi-Aventis. Dr Abdalla reports receiving honoraria from Sanofi-Aventis. Dr Vauthey reports receiving grants and honoraria from Sanofi-Aventis, Genentech, and Roche. No other authors reported disclosures.	Adam R, 2004, ANN SURG, V240, P1052, DOI 10.1097/01.sla.0000145964.08365.01; Adam R, 2008, J CLIN ONCOL, V26, P1635, DOI 10.1200/JCO.2007.13.7471; Ajani JA, 2005, J CLIN ONCOL, V23, P1237, DOI 10.1200/JCO.2005.01.305; Blazer DG, 2008, J CLIN ONCOL, V26, P5344, DOI 10.1200/JCO.2008.17.5299; Charnsangavej C, 2006, ANN SURG ONCOL, V13, P1261, DOI 10.1245/s10434-006-9023-y; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Grothey A, 2008, J CLIN ONCOL, V26, P183, DOI 10.1200/JCO.2007.13.8099; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kan ZX, 2005, RADIOLOGY, V237, P151, DOI 10.1148/radiol.2363041293; Miles KA, 1998, BRIT J RADIOL, V71, P276, DOI 10.1259/bjr.71.843.9616236; MURAMATSU Y, 1986, RADIOLOGY, V160, P49, DOI 10.1148/radiology.160.1.3012632; OUTWATER E, 1991, RADIOLOGY, V180, P327, DOI 10.1148/radiology.180.2.2068294; Provenzale JM, 2007, AM J ROENTGENOL, V188, P11, DOI 10.2214/AJR.06.0280; Ribero D, 2007, CANCER-AM CANCER SOC, V110, P2761, DOI 10.1002/cncr.23099; Rubbia-Brandt L, 2007, ANN ONCOL, V18, P299, DOI 10.1093/annonc/mdl386; Sabir A, 2008, AM J ROENTGENOL, V191, P133, DOI 10.2214/AJR.07.2848; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sathornsumetee S, 2008, J CLIN ONCOL, V26, P271, DOI 10.1200/JCO.2007.13.3652; Swisher SG, 2005, ANN SURG, V241, P810, DOI 10.1097/01.sla.0000161983.82345.85; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205	20	371	380	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 2	2009	302	21					2338	2344		10.1001/jama.2009.1755	http://dx.doi.org/10.1001/jama.2009.1755			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525TK	19952320	Bronze, Green Accepted			2022-12-24	WOS:000272239000022
J	Moellering, RE; Cornejo, M; Davis, TN; Del Bianco, C; Aster, JC; Blacklow, SC; Kung, AL; Gilliland, DG; Verdine, GL; Bradner, JE				Moellering, Raymond E.; Cornejo, Melanie; Davis, Tina N.; Del Bianco, Cristina; Aster, Jon C.; Blacklow, Stephen C.; Kung, Andrew L.; Gilliland, D. Gary; Verdine, Gregory L.; Bradner, James E.			Direct inhibition of the NOTCH transcription factor complex	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITORS; T-CELL LEUKEMIA; PROGENITOR CELLS; HUMAN HOMOLOG; C-MYC; MUTATIONS; GENE; MASTERMIND; ACTIVATION	Direct inhibition of transcription factor complexes remains a central challenge in the discipline of ligand discovery. In general, these proteins lack surface involutions suitable for high-affinity binding by small molecules. Here we report the design of synthetic, cell-permeable, stabilized alpha-helical peptides that target a critical protein-protein interface in the NOTCH transactivation complex. We demonstrate that direct, high-affinity binding of the hydrocarbon-stapled peptide SAHM1 prevents assembly of the active transcriptional complex. Inappropriate NOTCH activation is directly implicated in the pathogenesis of several disease states, including T-cell acute lymphoblastic leukaemia (T-ALL). The treatment of leukaemic cells with SAHM1 results in genome-wide suppression of NOTCH-activated genes. Direct antagonism of the NOTCH transcriptional program causes potent, NOTCH-specific anti-proliferative effects in cultured cells and in a mouse model of NOTCH1-driven T-ALL.	[Moellering, Raymond E.; Bradner, James E.] Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA 02142 USA; [Moellering, Raymond E.; Verdine, Gregory L.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Moellering, Raymond E.; Verdine, Gregory L.; Bradner, James E.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Cornejo, Melanie; Gilliland, D. Gary] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Del Bianco, Cristina; Aster, Jon C.; Blacklow, Stephen C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Davis, Tina N.; Kung, Andrew L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Davis, Tina N.; Kung, Andrew L.] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; [Gilliland, D. Gary] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Hematol Neoplasia, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Bradner, JE (corresponding author), Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA 02142 USA.	gregory_verdine@harvard.edu; james_bradner@dfci.harvard.edu	Del Bianco, Cristina/J-4665-2012; Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Moellering, Raymond/0000-0002-2043-7838; Cornejo, Melanie/0000-0001-6094-2719	Leukaemia & Lymphoma Society; AACR Centennial Pre-doctoral Research Fellowship in Cancer Research; American Society of Hematology; MCCB-NIH [5T32GM007598]; Human Frontier Science Program; Harvard & Dana Farber Program in Cancer Chemical Biology; National Cancer Institute's Initiative for Chemical Genetics, National Institutes of Health [N01-CO-12400]; NATIONAL CANCER INSTITUTE [R01CA092433, P01CA119070, R56CA092433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598] Funding Source: NIH RePORTER	Leukaemia & Lymphoma Society; AACR Centennial Pre-doctoral Research Fellowship in Cancer Research; American Society of Hematology; MCCB-NIH; Human Frontier Science Program(Human Frontier Science Program); Harvard & Dana Farber Program in Cancer Chemical Biology; National Cancer Institute's Initiative for Chemical Genetics, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Schreiber and the Broad Institute Chemical Biology Program for discussions and access to instrumentation; J. Rocnik for assistance in the establishment of the T-ALL murine model; A. Ferrando for providing GSI microarray data; M. Hancock and Invitrogen for providing beta-lactamase HeLa reporter clones; K. Ross and A. Subramanian for conversations and guidance about GSEA; and S. Gupta and the Broad Institute Microarray Core. This work was supported by a Specialized Center of Research grant from the Leukaemia & Lymphoma Society (to J. E. B., J. C. A., S. C. B.), an AACR Centennial Pre-doctoral Research Fellowship in Cancer Research (to R. E. M.), the American Society of Hematology (to J. E. B.), MCCB-NIH Training Grant No. 5T32GM007598 (to R. E. M.), the Human Frontier Science Program (to C. D.), and the Harvard & Dana Farber Program in Cancer Chemical Biology (to J. E. B., R. E. M., G. L. V.). The project has been funded in part with Federal funds from the National Cancer Institute's Initiative for Chemical Genetics, National Institutes of Health, under Contract No. N01-CO-12400. Histology and immunohistochemical staining was performed in the Dana Farber/Harvard Cancer Center Specialized Histopathology Services Core Laboratory.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Becker CM, 2006, AM J PATHOL, V168, P2074, DOI 10.2353/ajpath.2006.051133; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DE SB, 1999, NATURE, V398, P518; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Hallis TM, 2007, J BIOMOL SCREEN, V12, P635, DOI 10.1177/1087057107301499; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lleo A, 2008, CURR TOP MED CHEM, V8, P9; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Stubbs MC, 2008, LEUKEMIA, V22, P66, DOI 10.1038/sj.leu.2404951; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WILLIAMS RM, 1991, J AM CHEM SOC, V113, P9276, DOI 10.1021/ja00024a038; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	50	607	652	3	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					182	U57		10.1038/nature08543	http://dx.doi.org/10.1038/nature08543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19907488	Green Accepted			2022-12-24	WOS:000271655100035
J	Elser, JJ; Andersen, T; Baron, JS; Bergstrom, AK; Jansson, M; Kyle, M; Nydick, KR; Steger, L; Hessen, DO				Elser, James J.; Andersen, Tom; Baron, Jill S.; Bergstroem, Ann-Kristin; Jansson, Mats; Kyle, Marcia; Nydick, Koren R.; Steger, Laura; Hessen, Dag O.			Shifts in Lake N:P Stoichiometry and Nutrient Limitation Driven by Atmospheric Nitrogen Deposition	SCIENCE			English	Article							PHOSPHORUS LIMITATION; PHYTOPLANKTON; EUTROPHICATION; ENRICHMENT; DIVERSITY; GRADIENT; CYCLE	Human activities have more than doubled the amount of nitrogen (N) circulating in the biosphere. One major pathway of this anthropogenic N input into ecosystems has been increased regional deposition from the atmosphere. Here we show that atmospheric N deposition increased the stoichiometric ratio of N and phosphorus (P) in lakes in Norway, Sweden, and Colorado, United States, and, as a result, patterns of ecological nutrient limitation were shifted. Under low N deposition, phytoplankton growth is generally N-limited; however, in high-N deposition lakes, phytoplankton growth is consistently P-limited. Continued anthropogenic amplification of the global N cycle will further alter ecological processes, such as biogeochemical cycling, trophic dynamics, and biological diversity, in the world's lakes, even in lakes far from direct human disturbance.	[Elser, James J.; Kyle, Marcia; Steger, Laura] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Andersen, Tom; Hessen, Dag O.] Univ Oslo, Dept Biol, N-0316 Oslo, Norway; [Baron, Jill S.] Colorado State Univ, US Geol Survey, Ft Collins, CO 80523 USA; [Baron, Jill S.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Bergstroem, Ann-Kristin; Jansson, Mats] Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; [Nydick, Koren R.] Mt Studies Inst, Silverton, CO 81433 USA	Arizona State University; Arizona State University-Tempe; University of Oslo; Colorado State University; United States Department of the Interior; United States Geological Survey; Colorado State University; Umea University	Elser, JJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	j.elser@asu.edu	Elser, James J/AAL-6199-2020; Elser, James/A-7082-2008; Baron, Jill/C-5270-2016; Hessen, Dag/F-4039-2011	Elser, James J/0000-0002-1460-2155; Elser, James/0000-0002-1460-2155; Baron, Jill/0000-0002-5902-6251; 	NSF; Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning	NSF(National Science Foundation (NSF)); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning(Swedish Research Council Formas)	We are grateful to all those who helped with the field and laboratory work, including staff of the Mountain Research Station, the Rocky Mountain Biological Station, and the Mountain Studies Institute; the U. S. National Park Service; the U. S. Geological Survey; and the Norwegian Institute for Water Research. We also thank S. Fisher, M. McCrackin, and A. Jonsson for useful comments and discussion. Funding was provided by NSF and the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning.	Bergstrom AK, 2008, AQUAT BIOL, V4, P55, DOI 10.3354/ab00099; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, ECOLOGY, V90, P3062, DOI 10.1890/08-1742.1; Elser JJ, 2001, ECOLOGY, V82, P898, DOI 10.1890/0012-9658(2001)082[0898:NLRFQF]2.0.CO;2; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grover J. P., 1997, RESOURCE COMPETITION; Hessen DO, 2009, LIMNOL OCEANOGR, V54, P2520, DOI 10.4319/lo.2009.54.6_part_2.2520; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; MullerNavarra DC, 1995, LIMNOL OCEANOGR, V40, P1209; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Sterner Robert W., 1998, Aquatic Ecology, V32, P261, DOI 10.1023/A:1009949400573	23	543	591	29	683	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					835	837		10.1126/science.1176199	http://dx.doi.org/10.1126/science.1176199			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892979				2022-12-24	WOS:000271468000039
J	Sharif-Naeini, R; Folgering, JHA; Bichet, D; Duprat, F; Lauritzen, I; Arhatte, M; Jodar, M; Dedman, A; Chatelain, FC; Schulte, U; Retailleau, K; Loufrani, L; Patel, A; Sachs, F; Delmas, P; Peters, DJM; Honore, E				Sharif-Naeini, Reza; Folgering, Joost H. A.; Bichet, Delphine; Duprat, Fabrice; Lauritzen, Inger; Arhatte, Malika; Jodar, Martine; Dedman, Alexandra; Chatelain, Franck C.; Schulte, Uwe; Retailleau, Kevin; Loufrani, Laurent; Patel, Amanda; Sachs, Frederick; Delmas, Patrick; Peters, Dorien J. M.; Honore, Eric			Polycystin-1 and-2 Dosage Regulates Pressure Sensing	CELL			English	Article							KIDNEY-DISEASE; CATION CHANNEL; TRP CHANNELS; FILAMIN-A; MECHANOSENSATION; CELLS; ACTIVATION; MEMBRANE; PROTEIN; GENE	Autosomal-dominant polycystic kidney disease, the most frequent monogenic cause of kidney failure, is induced by mutations in the PKD1 or PKD2 genes, encoding polycystins TRPP1 and TRPP2, respectively. Polycystins are proposed to form a flow-sensitive ion channel complex in the primary cilium of both epithelial and endothelial cells. However, how polycystins contribute to cellular mechanosensitivity remains obscure. Here, we show that TRPP2 inhibits stretch-activated ion channels (SACs). This specific effect is reversed by coexpression with TRPP1, indicating that the TRPP1/TRPP2 ratio regulates pressure sensing. Moreover, deletion of TRPP1 in smooth muscle cells reduces SAC activity and the arterial myogenic tone. Inversely, depletion of TRPP2 in TRPP1-deficient arteries rescues both SAC opening and the myogenic response. Finally, we show that TRPP2 interacts with filamin A and demonstrate that this actin crosslinking protein is critical for SAC regulation. This work uncovers a role for polycystins in regulating pressure sensing.	[Sharif-Naeini, Reza; Folgering, Joost H. A.; Bichet, Delphine; Duprat, Fabrice; Lauritzen, Inger; Arhatte, Malika; Jodar, Martine; Dedman, Alexandra; Chatelain, Franck C.; Patel, Amanda; Honore, Eric] Univ Nice Sophia Antipolis, UMR CNRS 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Schulte, Uwe] Logopharm, D-79232 March, Germany; [Retailleau, Kevin; Loufrani, Laurent] Inst Natl Sante & Rech Med 771, UMR CNRS 6214, Fac Med, F-49045 Angers, France; [Sachs, Frederick] SUNY Buffalo, Buffalo, NY 14214 USA; [Delmas, Patrick] Univ Aix Marseille 2, Ctr Rech Neurophysiol & Neurobiol Marseille, UMR CNRS 6231, Fac Med,CS80011, F-13344 Marseille 15, France; [Peters, Dorien J. M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; UDICE-French Research Universities; Aix-Marseille Universite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Honore, E (corresponding author), Univ Nice Sophia Antipolis, UMR CNRS 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France.	honore@ipmc.cnrs.fr	loufrani, laurent/K-1713-2015; DUPRAT, Fabrice/D-1221-2013	DUPRAT, Fabrice/0000-0001-8774-1220; Bichet, Delphine/0000-0002-9601-089X; CHATELAIN, Franck C./0000-0002-8426-8893; HONORE, Eric/0000-0002-8007-0919; lauritzen, inger/0000-0002-2011-1387	ANR 2005 cardiovasculaire-obesite-diabete; ANR 2008 du gene a la physiopathologie; Association for information and research on genetic kidney disease France; Fondation del Duca; Fondation de la recherche medicale; Fondation de France; EEC Marie-Curie [039328]; Fondation de recherche sur l'hypertension arterielle; Fondation de la recherche sur le cerveau; Human Frontier Science [LT-00555]; Societe Generale AM; Universite de Nice Sophia Antipolis; Centre National de la Recherche Scientifique; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887] Funding Source: NIH RePORTER	ANR 2005 cardiovasculaire-obesite-diabete(French National Research Agency (ANR)); ANR 2008 du gene a la physiopathologie(French National Research Agency (ANR)); Association for information and research on genetic kidney disease France; Fondation del Duca; Fondation de la recherche medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); EEC Marie-Curie(European Commission); Fondation de recherche sur l'hypertension arterielle; Fondation de la recherche sur le cerveau; Human Frontier Science(Human Frontier Science Program); Societe Generale AM; Universite de Nice Sophia Antipolis; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to the ANR 2005 cardiovasculaire-obesite-diabete, to the ANR 2008 du gene a la physiopathologie, to the Association for information and research on genetic kidney disease France, to the Fondation del Duca, to the Fondation de la recherche medicale, to the Fondation de France, to EEC Marie-Curie fellowship 039328 (J. H. A. F.), to the Fondation de recherche sur l'hypertension arterielle, to the Fondation de la recherche sur le cerveau, to the Human Frontier Science Program long-term fellowship LT-00555 (R.S.N.), to the Societe Generale AM, to the Universite de Nice Sophia Antipolis, and to the Centre National de la Recherche Scientifique for financial support. We are grateful to T. P. Stossel for providing the M2 and A7 cell lines and FLNa constructs and to L. Tsokias for providing the human and mouse Pkd2 clones. We are grateful to G. Romey and J. Barhanin for valuable discussions.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Arnaout MA, 2001, ANNU REV MED, V52, P93, DOI 10.1146/annurev.med.52.1.93; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Brayden JE, 2008, CLIN EXP PHARMACOL P, V35, P1116, DOI 10.1111/j.1440-1681.2007.04855.x; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chen XZ, 2008, FEBS J, V275, P4675, DOI 10.1111/j.1742-4658.2008.06616.x; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; D'Addario M, 2001, J BIOL CHEM, V276, P31969, DOI 10.1074/jbc.M102715200; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Delmas P, 2004, CELL, V118, P145, DOI 10.1016/j.cell.2004.07.007; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; HALPERN W, 1991, BLOOD VESSELS, V28, P245; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hill MA, 2006, CLIN HEMORHEOL MICRO, V34, P67; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Honore E, 2006, P NATL ACAD SCI USA, V103, P6859, DOI 10.1073/pnas.0600463103; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lee BY, 2007, BIOCHIP J, V1, P76; Lee HA, 2007, CARDIOVASC RES, V76, P224, DOI 10.1016/j.cardiores.2007.06.021; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Morel N, 2009, PFLUG ARCH EUR J PHY, V457, P845, DOI 10.1007/s00424-008-0561-y; Morris CE, 2001, CELL MOL BIOL LETT, V6, P703; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Qian Q, 2003, J AM SOC NEPHROL, V14, P2280, DOI 10.1097/01.ASN.0000080185.38113.A3; Sachs F, 1998, REV PHYSIOL BIOCH P, V132, P1, DOI 10.1007/BFb0004985; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Voets T, 2009, EMBO J, V28, P4, DOI 10.1038/emboj.2008.261; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161	49	221	224	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					587	596		10.1016/j.cell.2009.08.045	http://dx.doi.org/10.1016/j.cell.2009.08.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879844	Green Submitted, Bronze			2022-12-24	WOS:000271259600022
J	Kawashima, SA; Yamagishi, Y; Honda, T; Ishiguro, K; Watanabe, Y				Kawashima, Shigehiro A.; Yamagishi, Yuya; Honda, Takashi; Ishiguro, Kei-ichiro; Watanabe, Yoshinori			Phosphorylation of H2A by Bub1 Prevents Chromosomal Instability Through Localizing Shugoshin	SCIENCE			English	Article							SISTER-CHROMATID COHESION; PROTEIN PHOSPHATASE 2A; FISSION YEAST BUB1; SPINDLE CHECKPOINT; MEIOSIS-I; CENTROMERIC PROTECTION; KINASE-ACTIVITY; KINETOCHORE; MITOSIS; LOCALIZATION	Bub1 is a multi-task protein kinase required for proper chromosome segregation in eukaryotes. Impairment of Bub1 in humans may lead to chromosomal instability (CIN) or tumorigenesis. Yet, the primary cellular substrate of Bub1 has remained elusive. Here, we show that Bub1 phosphorylates the conserved serine 121 of histone H2A in fission yeast Schizosaccharomyces pombe. The h2a-SA mutant, in which all cellular H2A-S121 is replaced by alanine, phenocopies the bub1 kinase-dead mutant (bub1-KD) in losing the centromeric localization of shugoshin proteins. Artificial tethering of shugoshin to centromeres largely restores the h2a-SA or bub1-KD-related CIN defects, a function that is evolutionally conserved. Thus, Bub1 kinase creates a mark for shugoshin localization and the correct partitioning of chromosomes.	[Kawashima, Shigehiro A.; Yamagishi, Yuya; Honda, Takashi; Ishiguro, Kei-ichiro; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Yamagishi, Yuya; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan; [Honda, Takashi; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Kawashima, Shigehiro/Q-6937-2017; Ishiguro, Kei-ichiro/K-3340-2019	Ishiguro, Kei-ichiro/0000-0002-7515-1511; Watanabe, Yoshinori/0000-0002-5488-4812	Japan Society for the Promotion of Science; Global Centers of Excellence Program; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript, F. Winston and the Yeast Genetic Resource Center for yeast strains, H. Masumoto for methods, and S. Ihara for injection instructions. We also thank all the members of our laboratory for their valuable support and discussion. This work was supported in part by the Japan Society for the Promotion of Science Research Fellowship (to. S. A. K. and Y.Y.) and Grant-in-Aid for Young Scientists (to K. I.), the Global Centers of Excellence Program, and a Grant-in-Aid for Specially Promoted Research (to Y.W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Bernard P, 2001, NAT CELL BIOL, V3, P522, DOI 10.1038/35074598; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Brittle AL, 2007, EXP CELL RES, V313, P2780, DOI 10.1016/j.yexcr.2007.04.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Fernius J, 2007, PLOS GENET, V3, P2312, DOI 10.1371/journal.pgen.0030213; Harvey AC, 2005, GENETICS, V170, P543, DOI 10.1534/genetics.104.038570; Hauf S, 2007, EMBO J, V26, P4475, DOI 10.1038/sj.emboj.7601880; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Warren CD, 2002, MOL BIOL CELL, V13, P3029, DOI 10.1091/mbc.E02-04-0203; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Williams GL, 2007, CELL CYCLE, V6, P1699, DOI 10.4161/cc.6.14.4493; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamaguchi S, 2003, EMBO J, V22, P1075, DOI 10.1093/emboj/cdg100; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	40	337	347	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					172	177		10.1126/science.1180189	http://dx.doi.org/10.1126/science.1180189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965387				2022-12-24	WOS:000273394000026
J	Tran, TS; Rubio, ME; Clem, RL; Johnson, D; Case, L; Tessier-Lavigne, M; Huganir, RL; Ginty, DD; Kolodkin, AL				Tran, Tracy S.; Rubio, Maria E.; Clem, Roger L.; Johnson, Dontais; Case, Lauren; Tessier-Lavigne, Marc; Huganir, Richard L.; Ginty, David D.; Kolodkin, Alex L.			Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS	NATURE			English	Article							DENDRITIC SPINES; PYRAMIDAL NEURONS; MORPHOLOGY; PLEXIN-A3; CORTEX	The majority of excitatory synapses in the mammalian CNS (central nervous system) are formed on dendritic spines(1), and spine morphology and distribution are critical for synaptic transmission(2-6), synaptic integration and plasticity(7). Here, we show that a secreted semaphorin, Sema3F, is a negative regulator of spine development and synaptic structure. Mice with null mutations in genes encoding Sema3F, and its holoreceptor components neuropilin-2 (Npn-2, also known as Nrp2) and plexin A3 (PlexA3, also known as Plxna3), exhibit increased dentate gyrus (DG) granule cell (GC) and cortical layer V pyramidal neuron spine number and size, and also aberrant spine distribution. Moreover, Sema3F promotes loss of spines and excitatory synapses in dissociated neurons in vitro, and in Npn-2(-/-) brain slices cortical layer V and DG GCs exhibit increased mEPSC (miniature excitatory postsynaptic current) frequency. In contrast, a distinct Sema3A-Npn-1/PlexA4 signalling cascade controls basal dendritic arborization in layer V cortical neurons, but does not influence spine morphogenesis or distribution. These disparate effects of secreted semaphorins are reflected in the restricted dendritic localization of Npn-2 to apical dendrites and of Npn-1 (also known as Nrp1) to all dendrites of cortical pyramidal neurons. Therefore, Sema3F signalling controls spine distribution along select dendritic processes, and distinct secreted semaphorin signalling events orchestrate CNS connectivity through the differential control of spine morphogenesis, synapse formation, and the elaboration of dendritic morphology.	[Tran, Tracy S.; Clem, Roger L.; Johnson, Dontais; Huganir, Richard L.; Ginty, David D.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Tran, Tracy S.; Clem, Roger L.; Johnson, Dontais; Huganir, Richard L.; Ginty, David D.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Rubio, Maria E.] Univ Connecticut, Dept Physiol, Storrs, CT 06269 USA; [Rubio, Maria E.] Univ Connecticut, Dept Neurobiol, Storrs, CT 06269 USA; [Case, Lauren; Tessier-Lavigne, Marc] Stanford Univ, Grad Program Neurosci, Stanford, CA 94305 USA; [Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Connecticut; University of Connecticut; Stanford University; Roche Holding; Genentech	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu; kolodkin@jhmi.edu	Tran, Tracy/M-2173-2019	Tran, Tracy/0000-0002-2179-5725	NRSA [F32 NS051003, R01 DC-006881]; NSF [DB1-0420580, P50 MH06883];  [R01 MH59199]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199, F32MH087037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274, F32NS051003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006881] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Delannoy and the Johns Hopkins University School of Medicine Microscope Facility for assistance with EM analysis; M. Pucak and the NINDS Multi-photon Core Facility at JHMI; D. Bergles and D. Linden for comments on the manuscript; R. Yuste for helpful discussions; K. Chak and members of the Kolodkin and Ginty laboratories for assistance throughout the course of this project. This work was supported by R01 MH59199 to D. D. G. and A. L. K.; NRSA F32 NS051003 to T. S. T.; R01 DC-006881 and NSF DB1-0420580 to M. E. R.; and P50 MH06883 to R. L. H. and D. D. G. D. D. G., R. L. H. and A. L. K. are investigators of the Howard Hughes Medical Institute.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Ballesteros-Yanez I, 2006, NEUROSCIENCE, V138, P403, DOI 10.1016/j.neuroscience.2005.11.038; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Elston GN, 2002, PROG BRAIN RES, V136, P109; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Fishell G, 2008, NEURON, V57, P333, DOI 10.1016/j.neuron.2008.01.018; Gao WJ, 2004, J COMP NEUROL, V476, P174, DOI 10.1002/cne.20224; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	24	180	184	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1065	U128		10.1038/nature08628	http://dx.doi.org/10.1038/nature08628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20010807	Green Accepted			2022-12-24	WOS:000272996000049
J	Yeung, N; Lin, YW; Gao, YG; Zhao, X; Russell, BS; Lei, LY; Miner, KD; Robinson, H; Lu, Y				Yeung, Natasha; Lin, Ying-Wu; Gao, Yi-Gui; Zhao, Xuan; Russell, Brandy S.; Lei, Lanyu; Miner, Kyle D.; Robinson, Howard; Lu, Yi			Rational design of a structural and functional nitric oxide reductase	NATURE			English	Article							DE-NOVO DESIGN; HEME-COPPER OXIDASE; 4-HELIX BUNDLE PROTEIN; CU-B CENTER; MYOGLOBIN; SITE; CONSTRUCTION; MODELS; O-2	Protein design provides a rigorous test of our knowledge about proteins and allows the creation of novel enzymes for biotechnological applications. Whereas progress has been made in designing proteins that mimic native proteins structurally(1-3), it is more difficult to design functional proteins(4-8). In comparison to recent successes in designing non-metalloproteins(4,6,7,9,10), it is even more challenging to rationally design metalloproteins that reproduce both the structure and function of native metalloenzymes(5,8,11-20). This is because protein metal-binding sites are much more varied than non-metal-containing sites, in terms of different metal ion oxidation states, preferred geometry and metal ion ligand donor sets. Because of their variability, it has been difficult to predict metal-binding site properties in silico, as many of the parameters, such as force fields, are ill-defined. Therefore, the successful design of a structural and functional metalloprotein would greatly advance the field of protein design and our understanding of enzymes. Here we report a successful, rational design of a structural and functional model of a metalloprotein, nitric oxide reductase (NOR), by introducing three histidines and one glutamate, predicted as ligands in the active site of NOR, into the distal pocket of myoglobin. A crystal structure of the designed protein confirms that the minimized computer model contains a haem/non-haem Fe-B centre that is remarkably similar to that in the crystal structure. This designed protein also exhibits NO reduction activity, and so models both the structure and function of NOR, offering insight that the active site glutamate is required for both iron binding and activity. These results show that structural and functional metalloproteins can be rationally designed in silico.	[Yeung, Natasha; Lin, Ying-Wu; Zhao, Xuan; Russell, Brandy S.; Lei, Lanyu; Lu, Yi] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gao, Yi-Gui] Univ Illinois, George L Clark Xray Facil, Urbana, IL 61801 USA; [Gao, Yi-Gui] Univ Illinois, Mat Lab 3M, Urbana, IL 61801 USA; [Miner, Kyle D.; Lu, Yi] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; 3M; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Brookhaven National Laboratory	Lu, Y (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	yi-lu@illinois.edu	Lu, Yi/GQQ-1069-2022; Lu, Yi/B-5461-2010; liu, yi/GXE-9662-2022	Lu, Yi/0000-0003-1221-6709; Lu, Yi/0000-0003-1221-6709; Miner, Kyle/0000-0001-9562-2459	US National Institutes of Health [GM062211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062211] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. J. Nilges for help with EPR analysis, S. L. Mullen and F. Sun for aiding in GC/MS data collection, E. Lee for help with computational modelling, N. M. Marshall for providing Azurin protein, J. R. Askim for help in Fe<INF>B</INF>Mb expression and purification, and T. Hayashi and P. Moenne-Loccoz for suggestions regarding N<INF>2</INF>O detection in solution. This work was supported by the US National Institutes of Health (GM062211).	Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Bonner FT, 1996, METHOD ENZYMOL, V268, P50; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case MA, 2004, ACCOUNTS CHEM RES, V37, P754, DOI 10.1021/ar960245+; Cochran FV, 2005, J AM CHEM SOC, V127, P1346, DOI 10.1021/ja044129a; Collman JP, 2008, P NATL ACAD SCI USA, V105, P15660, DOI 10.1073/pnas.0808606105; Ghosh D, 2005, CURR OPIN CHEM BIOL, V9, P97, DOI 10.1016/j.cbpa.2005.02.005; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Giuffre A, 1999, P NATL ACAD SCI USA, V96, P14718, DOI 10.1073/pnas.96.26.14718; Hay M, 1996, P NATL ACAD SCI USA, V93, P461, DOI 10.1073/pnas.93.1.461; HECHT MH, 1990, SCIENCE, V249, P884, DOI 10.1126/science.2392678; Hendriks J, 1998, J BIOENERG BIOMEMBR, V30, P15, DOI 10.1023/A:1020547225398; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang SG, 2007, CURR OPIN CHEM BIOL, V11, P329, DOI 10.1016/j.cbpa.2007.05.006; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Moenne-Loccoz P, 2000, J AM CHEM SOC, V122, P9344, DOI 10.1021/ja0016295; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petros AK, 2006, INORG CHEM, V45, P9941, DOI 10.1021/ic052190q; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Sigman JA, 2000, J AM CHEM SOC, V122, P8192, DOI 10.1021/ja0015343; Taboy CH, 2002, METHOD ENZYMOL, V353, P187; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Wasser IM, 2005, J AM CHEM SOC, V127, P3310, DOI 10.1021/ja0458773; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Watanabe Y, 2005, PROG INORG CHEM, V54, P449, DOI 10.1002/0471725560.ch7; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8; Yeung BKS, 1997, CHEM BIOL, V4, P215, DOI 10.1016/S1074-5521(97)90291-X; Zhao X, 2005, BIOCHEMISTRY-US, V44, P1210, DOI 10.1021/bi0479151; Zhao X, 2006, J AM CHEM SOC, V128, P6766, DOI 10.1021/ja058822p; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	41	194	195	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1079	U144		10.1038/nature08620	http://dx.doi.org/10.1038/nature08620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	19940850	Green Accepted			2022-12-24	WOS:000272996000052
J	Becker, T; Bhushan, S; Jarasch, A; Armache, JP; Funes, S; Jossinet, F; Gumbart, J; Mielke, T; Berninghausen, O; Schulten, K; Westhof, E; Gilmore, R; Mandon, EC; Beckmann, R				Becker, Thomas; Bhushan, Shashi; Jarasch, Alexander; Armache, Jean-Paul; Funes, Soledad; Jossinet, Fabrice; Gumbart, James; Mielke, Thorsten; Berninghausen, Otto; Schulten, Klaus; Westhof, Eric; Gilmore, Reid; Mandon, Elisabet C.; Beckmann, Roland			Structure of Monomeric Yeast and Mammalian Sec61 Complexes Interacting with the Translating Ribosome	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM; PROTEIN-TRANSLOCATION; SEQUENCE RECOGNITION; CHANNEL COMPLEX; BINDING; MEMBRANE; SECYEG; ARCHITECTURE; RECEPTOR	The trimeric Sec61/SecY complex is a protein-conducting channel (PCC) for secretory and membrane proteins. Although Sec complexes can form oligomers, it has been suggested that a single copy may serve as an active PCC. We determined subnanometer-resolution cryo-electron microscopy structures of eukaryotic ribosome-Sec61 complexes. In combination with biochemical data, we found that in both idle and active states, the Sec complex is not oligomeric and interacts mainly via two cytoplasmic loops with the universal ribosomal adaptor site. In the active state, the ribosomal tunnel and a central pore of the monomeric PCC were occupied by the nascent chain, contacting loop 6 of the Sec complex. This provides a structural basis for the activity of a solitary Sec complex in cotranslational protein translocation.	[Gilmore, Reid; Mandon, Elisabet C.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Becker, Thomas; Bhushan, Shashi; Jarasch, Alexander; Armache, Jean-Paul; Funes, Soledad; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Becker, Thomas; Bhushan, Shashi; Jarasch, Alexander; Armache, Jean-Paul; Funes, Soledad; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Ctr Integrated Prot Sci, Dept Chem & Biochem, D-81377 Munich, Germany; [Funes, Soledad] Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Jossinet, Fabrice; Westhof, Eric] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France; [Gumbart, James; Schulten, Klaus] Univ Illinois, Beckman Inst, Dept Phys, Urbana, IL 61801 USA; [Mielke, Thorsten] Max Planck Inst Mol Genet, Ultrastrukturnetzwerk, D-14195 Berlin, Germany; [Mielke, Thorsten] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	University of Massachusetts System; University of Massachusetts Worcester; University of Munich; University of Munich; Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mandon, EC (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, 364 Plantat St, Worcester, MA 01605 USA.	elisabet.mandon@umassmed.edu; beckmann@lmb.uni-muenchen.de	Armache, Jean-Paul/U-3113-2019; Schulten, Klaus/D-5561-2009; Funes, Soledad/A-1278-2010	Funes, Soledad/0000-0003-1815-1977; Jarasch, Alexander/0000-0002-6810-0425; Bhushan, Shashi/0000-0002-8514-5959; Armache, Jean-Paul/0000-0001-9195-2282	Deutsche Forschungsgemeinschaft [SFB594, SFB646, SFB 740]; Knut and Alice Wallenberg Foundation, Stockholm, Sweden; NIH [P41-RR05969, R01-GM067887, GM35687]; NSF [PHY0822613, MCA93S028]; European Union; Senatsverwaltung fur Wissenschaft; Forschung und Kultur Berlin; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035687, R01GM067887] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Knut and Alice Wallenberg Foundation, Stockholm, Sweden(Knut & Alice Wallenberg Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Union(European Commission); Senatsverwaltung fur Wissenschaft; Forschung und Kultur Berlin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Dobberstein (Zentrum fur Molekulare Biologie der Universitat Heidelberg, Heidelberg, Germany) for microsomal membranes, B. Brugger (Biochemie-Zentrum der Universit at Heidelberg, Heidelberg, Germany) for lipid analysis, and J. Frauenfeld and E. van der Sluis for critical discussions. This research was supported by Deutsche Forschungsgemeinschaft grants SFB594, SFB646 ( to R. B. and T. B.), and SFB 740 ( to T. M.); Knut and Alice Wallenberg Foundation, Stockholm, Sweden ( to S. B.); NIH grants P41-RR05969, R01-GM067887 ( to K. S.), and GM35687 ( to R. G.); NSF grant PHY0822613 ( to K. S.); and the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum). Computer time for MDFF was provided through an NSF Large Resources Allocation Committee grant (MCA93S028). Coordinates of the atomic models and cryo-EM maps have been deposited in the PDB [ with accession numbers 2ww9 ( active Ssh), 2wwa ( inactive Ssh), and 2wwb ( mammalian translocon)] and in the 3D-EM database [EMD-1651 ( yeast) and EMD-1652 ( Mammalia)], respectively.	Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kalies KU, 2008, BBA-MOL CELL RES, V1783, P2375, DOI 10.1016/j.bbamcr.2008.08.005; Karaoglu D, 2001, BIOCHEMISTRY-US, V40, P12193, DOI 10.1021/bi0111911; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Mandon EC, 2009, CURR OPIN CELL BIOL, V21, P501, DOI 10.1016/j.ceb.2009.04.010; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Yahr TL, 2000, EMBO J, V19, P4393, DOI 10.1093/emboj/19.16.4393; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	36	222	227	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1369	1373		10.1126/science.1178535	http://dx.doi.org/10.1126/science.1178535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19933108	Green Accepted			2022-12-24	WOS:000272351100033
J	Venter, O; Laurance, WF; Iwamura, T; Wilson, KA; Fuller, RA; Possingham, HP				Venter, Oscar; Laurance, William F.; Iwamura, Takuya; Wilson, Kerrie A.; Fuller, Richard A.; Possingham, Hugh P.			Harnessing Carbon Payments to Protect Biodiversity	SCIENCE			English	Article									[Venter, Oscar; Iwamura, Takuya; Wilson, Kerrie A.; Fuller, Richard A.; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, Brisbane, Qld 4072, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4870, Australia; [Laurance, William F.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	University of Queensland; James Cook University; Smithsonian Institution; Smithsonian Tropical Research Institute	Venter, O (corresponding author), Univ Queensland, Ctr Ecol, Brisbane, Qld 4072, Australia.	oventer@uq.edu.au	Possingham, Hugh/B-1337-2008; Venter, Oscar/G-6893-2011; Fuller, Richard/B-7971-2008; Wilson, Kerrie/W-4181-2019; Wilson, Kerrie A/C-8058-2009; Laurance, William F/B-2709-2012; POSSINGHAM, HUGH/R-8310-2019; Venter, Oscar/ABE-1477-2021; Iwamura, Takuya/D-1125-2018	Possingham, Hugh/0000-0001-7755-996X; Fuller, Richard/0000-0001-9468-9678; Wilson, Kerrie/0000-0002-0092-935X; Wilson, Kerrie A/0000-0002-0092-935X; Laurance, William F/0000-0003-4430-9408; POSSINGHAM, HUGH/0000-0001-7755-996X; Iwamura, Takuya/0000-0002-3740-7758				Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Laurance WF, 2008, BIOSCIENCE, V58, P286, DOI 10.1641/B580402; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366	6	167	172	8	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1368	1368		10.1126/science.1180289	http://dx.doi.org/10.1126/science.1180289			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965752				2022-12-24	WOS:000272351100032
J	Aziz, A; Soucie, E; Sarrazin, S; Sieweke, MH				Aziz, Athar; Soucie, Erinn; Sarrazin, Sandrine; Sieweke, Michael H.			MafB/c-Maf Deficiency Enables Self-Renewal of Differentiated Functional Macrophages	SCIENCE			English	Article							CELL-CYCLE EXIT; STEM-CELLS; MONOCYTIC DIFFERENTIATION; TERMINAL DIFFERENTIATION; DENDRITIC CELLS; BONE-MARROW; IMMORTALIZATION; TRANSFORMATION; PLURIPOTENCY; MECHANISM	In metazoan organisms, terminal differentiation is generally tightly linked to cell cycle exit, whereas the undifferentiated state of pluripotent stem cells is associated with unlimited self-renewal. Here, we report that combined deficiency for the transcription factors MafB and c-Maf enables extended expansion of mature monocytes and macrophages in culture without loss of differentiated phenotype and function. Upon transplantation, the expanded cells are nontumorigenic and contribute to functional macrophage populations in vivo. Small hairpin RNA inactivation shows that continuous proliferation of MafB/c-Maf deficient macrophages requires concomitant up-regulation of two pluripotent stem cell-inducing factors, KLF4 and c-Myc. Our results indicate that MafB/c-MafB deficiency renders self-renewal compatible with terminal differentiation. It thus appears possible to amplify functional differentiated cells without malignant transformation or stem cell intermediates.	[Aziz, Athar; Soucie, Erinn; Sarrazin, Sandrine; Sieweke, Michael H.] Univ Aix Marseille, CIML, F-13288 Marseille 09, France; [Aziz, Athar; Soucie, Erinn; Sarrazin, Sandrine; Sieweke, Michael H.] INSERM, U631, F-13258 Marseille, France; [Aziz, Athar; Soucie, Erinn; Sarrazin, Sandrine; Sieweke, Michael H.] CNRS, UMR6102, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Sieweke, MH (corresponding author), Univ Aix Marseille, CIML, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sieweke@ciml.univ-mrs.fr	Soucie, Erinn L/R-1731-2016; Sieweke, Michael/AAR-7515-2020	Soucie, Erinn L/0000-0001-6347-3954; Sieweke, Michael/0000-0002-3228-9537	Ministere d'Enseignement Superieur et de la Recherche and the Societe Francaise de la Hematologie (SFH); E. S. from the Leukemia and Lymphoma Society of America [5204-06]; Fondation de France (FdF) [2004004150]; SFH; Association for International Cancer Research [05-0079]; Association pour la Recherche sur le Cancer [3857, 3422]; Agence Biomedecine. M. S. directs an Equipe FRM (Fondation pour la Recherche Medicale) [20071210559]	Ministere d'Enseignement Superieur et de la Recherche and the Societe Francaise de la Hematologie (SFH); E. S. from the Leukemia and Lymphoma Society of America; Fondation de France (FdF)(Fondation de France); SFH; Association for International Cancer Research; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Biomedecine. M. S. directs an Equipe FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale)	We thank L. Chasson for immunofluorescence staining; E. Bertosio for leukocyte counts; C. Otto for communication of preliminary results; T. Benoukraf for microarray analysis; P. Grenot, M. Barad, N. Brun, and A. Zouine for cell sorting; L. Glimcher, A.-M. Schmitt-Verhulst, and F. Maina for c-Maf+/-, Ink4a-/-,and p53-/- mice; and J.-P. Gorvel and S. Meresse for FP-expressing S. typhimurium. Histological analyses were performed in the mouse functional genomics platform Reunion Interorganisme/ Marseille-Nice Genopole with support from the Institut National du Cancer. Miame (minimum information about a microarray experiment)-compliant gene expression data have been deposited at the European Bioinformatics Institute ArrayExpress database under accession no. E-MEXP-2419. A. A. received fellowships from the Ministere d'Enseignement Superieur et de la Recherche and the Societe Francaise de la Hematologie (SFH), E. S. from the Leukemia and Lymphoma Society of America (5204-06), and S. S. from the Fondation de France (FdF) and SFH. We gratefully acknowledge grants from FdF ( 2004004150), the Association for International Cancer Research (05-0079), the Association pour la Recherche sur le Cancer (3857, 3422), and the Agence Biomedecine. M. S. directs an Equipe FRM ( Fondation pour la Recherche Medicale, Deq 20071210559).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Auffray C, 2008, NAT IMMUNOL, V9, P584, DOI 10.1038/ni0608-584; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Buttitta LA, 2007, DEV CELL, V12, P631, DOI 10.1016/j.devcel.2007.02.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2007, NAT IMMUNOL, V8, P558, DOI 10.1038/ni0607-558; GRAF T, 1981, EXP CELL RES, V131, P331, DOI 10.1016/0014-4827(81)90236-6; Hegde SP, 1999, BLOOD, V94, P1578, DOI 10.1182/blood.V94.5.1578.417k18_1578_1589; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Khan SA, 2001, MICROB PATHOGENESIS, V30, P29, DOI 10.1006/mpat.2000.0405; Klappacher GW, 2002, CELL, V109, P169, DOI 10.1016/S0092-8674(02)00714-6; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; ROUSSEL MF, 1994, J CELL SCI, P105; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012	29	178	185	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					867	871		10.1126/science.1176056	http://dx.doi.org/10.1126/science.1176056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892988				2022-12-24	WOS:000271468000048
J	Thyme, SB; Jarjour, J; Takeuchi, R; Havranek, JJ; Ashworth, J; Scharenberg, AM; Stoddard, BL; Baker, D				Thyme, Summer B.; Jarjour, Jordan; Takeuchi, Ryo; Havranek, James J.; Ashworth, Justin; Scharenberg, Andrew M.; Stoddard, Barry L.; Baker, David			Exploitation of binding energy for catalysis and design	NATURE			English	Article							HOMING ENDONUCLEASE; PROTEIN; DNA; MUTAGENESIS; SPECIFICITY; PREDICTION	Enzymes use substrate-binding energy both to promote ground-state association and to stabilize the reaction transition state selectively1. The monomeric homing endonuclease I-AniI cleaves with high sequence specificity in the centre of a 20-base-pair ( bp) DNA target site, with the amino (N)-terminal domain of the enzyme making extensive binding interactions with the left (-) side of the target site and the similarly structured carboxy (C)-terminal domain interacting with the right (+) side(2). Here we show that, despite the approximate twofold symmetry of the enzyme-DNA complex, there is almost complete segregation of interactions responsible for substrate binding to the (-) side of the interface and interactions responsible for transition-state stabilization to the (+) side. Although single base-pair substitutions throughout the entire DNA target site reduce catalytic efficiency, mutations in the (-) DNA half-site almost exclusively increase the dissociation constant (K-D) and the Michaelis constant under single-turnover conditions (K-M*), and those in the (+) half-site primarily decrease the turnover number (k(cat)*). The reduction of activity produced by mutations on the (-) side, but not mutations on the (+) side, can be suppressed by tethering the substrate to the endonuclease displayed on the surface of yeast. This dramatic asymmetry in the use of enzyme-substrate binding energy for catalysis has direct relevance to the redesign of endonucleases to cleave genomic target sites for gene therapy and other applications. Computationally redesigned enzymes that achieve new specificities on the (-) side do so by modulating K-M*, whereas redesigns with altered specificities on the (+) side modulate k(cat)*. Our results illustrate how classical enzymology and modern protein design can each inform the other.	[Thyme, Summer B.; Ashworth, Justin; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Jarjour, Jordan; Scharenberg, Andrew M.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Thyme, Summer B.; Ashworth, Justin; Stoddard, Barry L.; Baker, David] Univ Washington, Grad Program Biomol Struct & Design, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Jarjour, Jordan; Scharenberg, Andrew M.] Seattle Childrens Hosp Res Inst, Seattle, WA 98177 USA; [Takeuchi, Ryo; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Havranek, James J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Fred Hutchinson Cancer Center; Washington University (WUSTL)	Thyme, SB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	sthyme@u.washington.edu; dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Thyme, Summer/0000-0003-3593-4148; Ashworth, Justin/0000-0003-4835-6551	National Science Foundation; US National Institutes of Health [GM084433, RL1CA133832]; Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [RL1CA133832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R00RR024107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084433] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation graduate research fellowship to S. B. T., the US National Institutes of Health (GM084433 and RL1CA133832), the Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative, and the Howard Hughes Medical Institute. We thank A. Quadri for help with plasmid substrate preparation and M. Scalley-Kim for I-AniI cleavage data collected in the presence of Mn<SUP>2+</SUP>.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp242; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bolduc JM, 2003, GENE DEV, V17, P2875, DOI 10.1101/gad.1109003; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Collins CH, 2003, CURR OPIN BIOTECH, V14, P371, DOI 10.1016/S0958-1669(03)00091-0; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Fersht A., 1999, STRUCTURE MECH PROTE; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1577, DOI 10.1021/bi00405a027; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Geese WJ, 2003, EUR J BIOCHEM, V270, P1543, DOI 10.1046/j.1432-1033.2003.03518.x; HALFORD SE, 1980, BIOCHEM J, V191, P581, DOI 10.1042/bj1910581; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; JENCKS WP, 1963, ANNU REV BIOCHEM, V32, P639, DOI 10.1146/annurev.bi.32.070163.003231; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Mitchell, 1996, INTRO GENETIC ALGORI; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeuchi R, 2009, NUCLEIC ACIDS RES, V37, P877, DOI 10.1093/nar/gkn1007; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; Zhao L, 2009, J MOL BIOL, V385, P1498, DOI 10.1016/j.jmb.2008.10.096	28	76	76	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1300	U142		10.1038/nature08508	http://dx.doi.org/10.1038/nature08508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865174	Green Accepted			2022-12-24	WOS:000271190800053
J	Wang, LM; Anderson, DJ				Wang, Liming; Anderson, David J.			Identification of an aggression-promoting pheromone and its receptor neurons in Drosophila	NATURE			English	Article							BEHAVIORAL-RESPONSES; SENSITIVE NEURONS; MELANOGASTER; ACETATE; PROTEIN; FLIES	Aggression is regulated by pheromones in many animal species(1-3). However, in no system have aggression pheromones, their cognate receptors and corresponding sensory neurons been identified. Here we show that 11-cis-vaccenyl acetate (cVA), a male-specific volatile pheromone, robustly promotes male-male aggression in the vinegar fly Drosophila melanogaster. The aggression-promoting effect of synthetic cVA requires olfactory sensory neurons (OSNs) expressing the receptor Or67d(4-6), as well as the receptor itself. Activation of Or67d-expressing OSNs, either by genetic manipulation of their excitability or by exposure to male pheromones in the absence of other classes of OSNs, is sufficient to promote aggression. High densities of male flies can promote aggression by the release of volatile cVA. In turn, cVA-promoted aggression can promote male fly dispersal from a food resource, in a manner dependent on Or67d-expressing OSNs. These data indicate that cVA may mediate negative-feedback control of male population density, through its effect on aggression. Identification of a pheromone-OSN pair controlling aggression in a genetic organism opens the way to unravelling the neurobiology of this evolutionarily conserved behaviour.	[Wang, Liming; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	lmwang@caltech.edu; wuwei@caltech.edu	Wang, Liming/C-8402-2011		NSF [EF-0623527, MCB-0418479]; Howard Hughes Medical Institute	NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank B. Dickson, M. Heisenberg and L. Vosshall for providing fly stocks, R. Axel, C. Bargmann, J. Levine and L. Vosshall for comments on the manuscript and L. Zipursky for discussions. This work was supported in part by NSF grants EF-0623527 and MCB-0418479. D. J. A. is an Investigator of the Howard Hughes Medical Institute.	Baier A, 2002, J EXP BIOL, V205, P1233; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Keverne EB, 2002, CURR BIOL, V12, pR807, DOI 10.1016/S0960-9822(02)01314-3; Kou R, 2006, NATURWISSENSCHAFTEN, V93, P286, DOI 10.1007/s00114-006-0095-0; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Ono M, 2003, NATURE, V424, P637, DOI 10.1038/424637a; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; SHOREY HH, 1973, ANNU REV ENTOMOL, V18, P349, DOI 10.1146/annurev.en.18.010173.002025; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	30	190	193	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					227	U114		10.1038/nature08678	http://dx.doi.org/10.1038/nature08678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	19966787	Green Accepted			2022-12-24	WOS:000273582700035
J	Rebeiz, M; Pool, JE; Kassner, VA; Aquadro, CF; Carroll, SB				Rebeiz, Mark; Pool, John E.; Kassner, Victoria A.; Aquadro, Charles F.; Carroll, Sean B.			Stepwise Modification of a Modular Enhancer Underlies Adaptation in a Drosophila Population	SCIENCE			English	Article							MORPHOLOGICAL EVOLUTION; LACTASE PERSISTENCE; REGULATORY CHANGES; PROTEIN; PIGMENTATION; EBONY; GAIN	The evolution of cis regulatory elements (enhancers) of developmentally regulated genes plays a large role in the evolution of animal morphology. However, the mutational path of enhancer evolution-the number, origin, effect, and order of mutations that alter enhancer function-has not been elucidated. Here, we localized a suite of substitutions in a modular enhancer of the ebony locus responsible for adaptive melanism in a Ugandan Drosophila population. We show that at least five mutations with varied effects arose recently from a combination of standing variation and new mutations and combined to create an allele of large phenotypic effect. We underscore how enhancers are distinct macromolecular entities, subject to fundamentally different, and generally more relaxed, functional constraints relative to protein sequences.	[Rebeiz, Mark; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Rebeiz, Mark; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Pool, John E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Pool, John E.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Aquadro, Charles F.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; University of California System; University of California Davis; Cornell University	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	sbcarrol@wisc.edu		Pool, John/0000-0003-2968-9545; Rebeiz, Mark/0000-0001-5731-5570	NIH [F32GM78972, F32HG004182, GM036431]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078972, R01GM036431] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Dufour and T. Williams for discussions and comments on the manuscript and K. Vaccaro for technical assistance. This work was supported by NIH postdoctoral fellowships F32GM78972 ( M. R.) and F32HG004182 (J.E.P.), NIH grant GM036431 ( C. F. A.), and the Howard Hughes Medical Institute ( S. B. C.).	Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Davidson EH, 2006, REG GEN GEN REG; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Richardt A, 2003, J BIOL CHEM, V278, P41160, DOI 10.1074/jbc.M304303200; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	26	183	184	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1663	1667		10.1126/science.1178357	http://dx.doi.org/10.1126/science.1178357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019281	Green Accepted			2022-12-24	WOS:000272839000045
J	Morris, JR; Boutell, C; Keppler, M; Densham, R; Weekes, D; Alamshah, A; Butler, L; Galanty, Y; Pangon, L; Kiuchi, T; Ng, T; Solomon, E				Morris, Joanna R.; Boutell, Chris; Keppler, Melanie; Densham, Ruth; Weekes, Daniel; Alamshah, Amin; Butler, Laura; Galanty, Yaron; Pangon, Laurent; Kiuchi, Tai; Ng, Tony; Solomon, Ellen			The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress	NATURE			English	Article							UBIQUITIN STRUCTURES; LIGASE ACTIVITY; TARGETS BRCA1; DNA-REPAIR; ACTIVATION; BINDING; SUMOYLATION; COMPLEX; UBIQUITYLATION; BRCA1-BARD1	Mutations in BRCA1 are associated with a high risk of breast and ovarian cancer. BRCA1 participates in the DNA damage response and acts as a ubiquitin ligase. However, its regulation remains poorly understood. Here we report that BRCA1 is modified by small ubiquitin-like modifier ( SUMO) in response to genotoxic stress, and co-localizes at sites of DNA damage with SUMO1, SUMO2/3 and the SUMO-conjugating enzyme Ubc9. PIAS SUMO E3 ligases co-localize with and modulate SUMO modification of BRCA1, and are required for BRCA1 ubiquitin ligase activity in cells. In vitro SUMO modification of the BRCA1/BARD1 heterodimer greatly increases its ligase activity, identifying it as a SUMO-regulated ubiquitin ligase (SRUbL). Further, PIAS SUMO ligases are required for complete accumulation of double-stranded DNA (dsDNA) damage-repair proteins subsequent to RNF8 accrual, and for proficient double-strand break repair. These data demonstrate that the SUMOylation pathway plays a significant role in mammalian DNA damage response.	[Morris, Joanna R.; Densham, Ruth; Weekes, Daniel; Alamshah, Amin; Butler, Laura; Pangon, Laurent; Solomon, Ellen] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Boutell, Chris] MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Keppler, Melanie; Kiuchi, Tai; Ng, Tony] Kings Coll London, Richard Dimbleby Dept Canc Res, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Galanty, Yaron] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Galanty, Yaron] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of London; King's College London; University of London; King's College London; University of Cambridge; University of Cambridge	Morris, JR (corresponding author), Kings Coll London, Dept Med & Mol Genet, Guys Med Sch Campus, London SE1 9RT, England.	jo.morris@genetics.kcl.ac.uk	Morris, Joanna/AAK-3388-2021; Densham, Ruth/AAO-1971-2020	Densham, Ruth/0000-0003-4490-2842; Ng, Tony/0000-0003-3894-5619; Boutell, Chris/0000-0002-2970-7785; Morris, Joanna/0000-0001-9762-8133; Weekes, Daniel/0000-0001-8083-7617; , Laura/0000-0001-7508-9650; Galanty, Yaron/0000-0001-7167-9004	Breast Cancer Campaign [SF06, 06NovPHD13Morris]; Cancer Research UK [C8820/A9494]; Medical Research Council [6900577]; Richard Dimbleby Cancer Fund; Breakthrough Breast Cancer; MRC Co-operative Group [G0100152, 56891]; UK Research Councils Basic Technology Research Programme [GR/R87901/01]; MRC [G9600577] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/R87901/01] Funding Source: researchfish; Medical Research Council [G9600577] Funding Source: researchfish	Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Richard Dimbleby Cancer Fund; Breakthrough Breast Cancer; MRC Co-operative Group(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Research Councils Basic Technology Research Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to V. De Laurenzi for the PIAS1 expression constructs, to R. Hay for His-SUMO1 and His-SUMO2 cells, to D. Durocher for anti-RNF168 antibody, to G. Stewart for discussions and S. Jackson for sharing results before publication. The work was supported by grants from Breast Cancer Campaign ( to J.R.M.,A.A., # SF06, and L. B., # 06NovPHD13Morris), Cancer Research UK ( to R. D., # C8820/A9494), the Medical Research Council ( to E. S. and D. W., # 6900577, and C. B.), the Richard Dimbleby Cancer Fund to King's College London ( to M. K. and T. N.) and Breakthrough Breast Cancer ( to T. K). Multiphoton FLIM systems and acquisition/analysis software were built by S. Ameer-Beg, P. Barber and B. Vojnovic, with support from MRC Co-operative Group Grant G0100152 # 56891 and UK Research Councils Basic Technology Research Programme Grant GR/R87901/01.	Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Jaffray EG, 2006, METHODS, V38, P35, DOI 10.1016/j.ymeth.2005.07.020; Kim HT, 2008, MOL CELLS, V25, P457; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; NISHIKAWA H, 2003, J BIOL CHEM; Park MA, 2008, NUCLEIC ACIDS RES, V36, P263, DOI 10.1093/nar/gkm969; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Peter M, 2004, BIOL CELL, V96, P231, DOI 10.1016/j.biolcel.2003.12.006; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Solomon E, 2009, CANCER GENET-SER, P75, DOI 10.1007/978-1-4419-0477-5_4; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	50	314	335	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					886	U77		10.1038/nature08593	http://dx.doi.org/10.1038/nature08593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016594				2022-12-24	WOS:000272795400035
J	Ren, Y; Yip, CK; Tripathi, A; Huie, D; Jeffrey, PD; Walz, T; Hughson, FM				Ren, Yi; Yip, Calvin K.; Tripathi, Arati; Huie, David; Jeffrey, Philip D.; Walz, Thomas; Hughson, Frederick M.			A Structure-Based Mechanism for Vesicle Capture by the Multisubunit Tethering Complex Dsl1	CELL			English	Article							ENDOPLASMIC RETICULUM RETRIEVAL; CRYSTAL-STRUCTURE; SNARE COMPLEX; TRANSPORT-VESICLE; PROTEIN-STRUCTURE; YEAST; EXOCYST; INTERACTS; COMPONENT; SUBUNIT	Vesicle trafficking requires membrane fusion, mediated by SNARE proteins, and upstream events that probably include "tethering,'' an initial long-range attachment between a vesicle and its target organelle. Among the factors proposed to mediate tethering are a set of multisubunit tethering complexes (MTCs). The Dsl1 complex, with only three subunits, is the simplest known MTC and is essential for the retrograde traffic of COPI-coated vesicles from the Golgi to the ER. To elucidate structural principles underlying MTC function, we have determined the structure of the Dsl1 complex, revealing a tower containing at its base the binding sites for two ER SNAREs and at its tip a flexible lasso for capturing vesicles. The Dsl1 complex binds to individual SNAREs via their N-terminal regulatory domains and also to assembled SNARE complexes; moreover, it is capable of accelerating SNARE complex assembly. Our results suggest that even the simplest MTC may be capable of orchestrating vesicle capture, uncoating, and fusion.	[Ren, Yi; Tripathi, Arati; Huie, David; Jeffrey, Philip D.; Hughson, Frederick M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Yip, Calvin K.; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Princeton University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu		Walz, Thomas/0000-0003-2606-2835; Jeffrey, Philip/0000-0002-4351-5341; Yip, Calvin/0000-0003-1779-9501	National Institutes of Health [GM071574]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the staff of the National Synchrotron Light Source X29 beamline for assistance with x-ray data collection; Zong Lin and Hays Rye for assistance and discussion regarding fluorescence anisotropy experiments; Hans Dieter Schmitt for sharing results prior to publication; and Sean Munro, Mary Munson, Anne Spang, and Daniel Ungar for critical comments on the manuscript. This work was supported by a grant to F. M. H. from the National Institutes of Health (GM071574). C.K.Y. acknowledges a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. T. W. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200; Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Aoki T, 2008, BIOCHEM J, V410, P93, DOI 10.1042/BJ20071304; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cavanaugh LF, 2007, J BIOL CHEM, V282, P23418, DOI 10.1074/jbc.M703716200; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Richardson BC, 2009, P NATL ACAD SCI USA, V106, P13329, DOI 10.1073/pnas.0901966106; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; VanRheenen SM, 2001, TRAFFIC, V2, P212, DOI 10.1034/j.1600-0854.2001.020307.x; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	45	116	118	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 11	2009	139	6					1119	1129		10.1016/j.cell.2009.11.002	http://dx.doi.org/10.1016/j.cell.2009.11.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005805	Green Accepted, Bronze			2022-12-24	WOS:000272622800014
J	Kee, K; Angeles, VT; Flores, M; Nguyen, HN; Pera, RAR				Kee, Kehkooi; Angeles, Vanessa T.; Flores, Martha; Nguyen, Ha Nam; Pera, Renee A. Reijo			Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation	NATURE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; PROTEIN GENE; Y-CHROMOSOME; DERIVATION; MOUSE; LINEAGE; SPERMATOGENESIS; DIFFERENTIATION; ESTABLISHMENT	The leading cause of infertility in men and women is quantitative and qualitative defects in human germ-cell (oocyte and sperm) development. Yet, it has not been possible to examine the unique developmental genetics of human germ-cell formation and differentiation owing to inaccessibility of germ cells during fetal development. Although several studies have shown that germ cells can be differentiated from mouse and human embryonic stem cells, human germ cells differentiated in these studies generally did not develop beyond the earliest stages(1-8). Here we used a germ-cell reporter to quantify and isolate primordial germ cells derived from both male and female human embryonic stem cells. By silencing and overexpressing genes that encode germ-cell-specific cytoplasmic RNA-binding proteins (not transcription factors), we modulated human germ-cell formation and developmental progression. We observed that human DAZL (deleted in azoospermia-like) functions in primordial germ cell formation, whereas closely related genes DAZ and BOULE (also called BOLL) promote later stages of meiosis and development of haploid gametes. These results are significant to the generation of gametes for future basic science and potential clinical applications.	[Kee, Kehkooi; Angeles, Vanessa T.; Flores, Martha; Nguyen, Ha Nam; Pera, Renee A. Reijo] Stanford Univ, Sch Med,Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Ctr Human Embryon Stem Cell Res & Educ, Palo Alto, CA 94305 USA	Stanford University	Pera, RAR (corresponding author), Stanford Univ, Sch Med,Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Ctr Human Embryon Stem Cell Res & Educ, Palo Alto, CA 94305 USA.	reneer@stanford.edu		Reijo Pera, Renee/0000-0002-6487-1329; KEE, KEHKOOI/0000-0001-6926-7203	California TRDRP [14RT0159]; National Institutes of Health [RO1HD047721, U54HD055764]; California Institute for Regenerative Medicine [RC1-00137]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055764] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047721] Funding Source: NIH RePORTER	California TRDRP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank D. Suter for the p2k7 vectors, B. Behr for procurement of clinical samples, C. Nicholas for assistance with SCP3 staining, and S. Jiang and P. Lovelace for FACS expertise. K. K. was supported by a California TRDRP postdoctoral fellowship; V. T. A. was supported by an NIH fellowship. This work was supported by the National Institutes of Health (RO1HD047721, U54HD055764 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research), the California TRDRP (14RT0159) and the California Institute for Regenerative Medicine (RC1-00137) to R. A. R. P.	Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Darzynkiewicz Z, 2001, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0705s00; FLORKEGERLOFF S, 1983, HUM GENET, V65, P61, DOI 10.1007/BF00285030; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gonsalves J, 2004, HUM MOL GENET, V13, P2875, DOI 10.1093/hmg/ddh302; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Heyting C, 1996, CURR OPIN CELL BIOL, V8, P389, DOI 10.1016/S0955-0674(96)80015-9; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Miyamoto T, 2002, J ASSIST REPROD GEN, V19, P531, DOI 10.1023/A:1020963919596; Oakes CC, 2006, EPIGENETICS-US, V1, P146, DOI 10.4161/epi.1.3.3392; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Perrett RM, 2008, BIOL REPROD, V78, P852, DOI 10.1095/biolreprod.107.066175; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	33	362	409	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					222	U95		10.1038/nature08562	http://dx.doi.org/10.1038/nature08562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19865085	Green Accepted			2022-12-24	WOS:000271655100043
J	Hood, E; Fellman, J; Spencer, RGM; Hernes, PJ; Edwards, R; D'Amore, D; Scott, D				Hood, Eran; Fellman, Jason; Spencer, Robert G. M.; Hernes, Peter J.; Edwards, Rick; D'Amore, David; Scott, Durelle			Glaciers as a source of ancient and labile organic matter to the marine environment	NATURE			English	Article							CARBON; ALASKA; EXPORT; FATE	Riverine organic matter supports of the order of one-fifth of estuarine metabolism(1). Coastal ecosystems are therefore sensitive to alteration of both the quantity and lability of terrigenous dissolved organic matter (DOM) delivered by rivers. The lability of DOM is thought to vary with age, with younger, relatively unaltered organic matter being more easily metabolized by aquatic heterotrophs than older, heavily modified material(2-4). This view is developed exclusively from work in watersheds where terrestrial plant and soil sources dominate streamwater DOM. Here we characterize streamwater DOM from 11 coastal watersheds on the Gulf of Alaska that vary widely in glacier coverage (0-64 per cent). In contrast to non-glacial rivers, we find that the bioavailability of DOM to marine microorganisms is significantly correlated with increasing C-14 age. Moreover, the most heavily glaciated watersheds are the source of the oldest (similar to 4 kyr C-14 age) and most labile (66 per cent bioavailable) DOM. These glacial watersheds have extreme runoff rates, in part because they are subject to some of the highest rates of glacier volume loss on Earth(5). We estimate the cumulative flux of dissolved organic carbon derived from glaciers contributing runoff to the Gulf of Alaska at 0.13 +/- 0.01 Tg yr(-1) (1 Tg = 10(12) g), of which similar to 0.10 Tg is highly labile. This indicates that glacial runoff is a quantitatively important source of labile reduced carbon to marine ecosystems. Moreover, because glaciers and ice sheets represent the second largest reservoir of water in the global hydrologic system, our findings indicate that climatically driven changes in glacier volume could alter the age, quantity and reactivity of DOM entering coastal oceans.	[Hood, Eran] Univ Alaska SE, Environm Sci & Geog Program, Juneau, AK 99801 USA; [Fellman, Jason] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Spencer, Robert G. M.; Hernes, Peter J.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Edwards, Rick; D'Amore, David] US Forest Serv, Pacific NW Res Stn, USDA, Juneau, AK 99801 USA; [Scott, Durelle] Virginia Tech, Blacksburg, VA 24061 USA	University of Alaska System; University of Alaska Southeastern; University of Alaska System; University of Alaska Fairbanks; University of California System; University of California Davis; United States Department of Agriculture (USDA); United States Forest Service; Virginia Polytechnic Institute & State University	Hood, E (corresponding author), Univ Alaska SE, Environm Sci & Geog Program, Juneau, AK 99801 USA.	eran.hood@uas.alaska.edu			US National Science Foundation [EAR-0838587]; University of Alaska Seed Grant; USDA Forest Service, Pacific Northwest Research Station; Division Of Earth Sciences [0838587, 0838497] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); University of Alaska Seed Grant; USDA Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	E. Neal and K. Smikrud contributed to the GOA glacier water flux estimates and K. Smikrud also provided Fig. 1. A. Arendt provided data on glacial wastage. We thank X. Xu at the KCCAMS facility for <SUP>14</SUP>C analyses, and R. Dyda and B. Holmes at UC Davis for assistance with lignin and <SUP>13</SUP>C-DOC analyses, respectively. Funding came from the US National Science Foundation (EAR-0838587), a University of Alaska Seed Grant ( to E. H.) and the USDA Forest Service, Pacific Northwest Research Station. The use of trade or firm names in this publication does not imply endorsement by the US Department of Agriculture.	Anesio AM, 2009, GLOBAL CHANGE BIOL, V15, P955, DOI 10.1111/j.1365-2486.2008.01758.x; Arendt AA, 2002, SCIENCE, V297, P382, DOI 10.1126/science.1072497; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Barker JD, 2006, ARCT ANTARCT ALP RES, V38, P163, DOI 10.1657/1523-0430(2006)38[163:AADODO]2.0.CO;2; CHINLEO G, 1992, MAR ECOL PROG SER, V87, P87, DOI 10.3354/meps087087; DEEVEY ES, 1957, SCIENCE, V125, P182, DOI 10.1126/science.125.3240.182; Druffel ERM, 2000, GEOPHYS RES LETT, V27, P1495, DOI 10.1029/1999GL002398; Fellman JB, 2008, BIOGEOCHEMISTRY, V88, P169, DOI 10.1007/s10533-008-9203-x; Hanna E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005641; Hernes PJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001421; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Holmes RM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032837; Hood E, 2008, NAT GEOSCI, V1, P583, DOI 10.1038/ngeo280; Hood E, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000971; Larsen CF, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000586; Ludwig W, 1996, GLOBAL BIOGEOCHEM CY, V10, P23, DOI 10.1029/95GB02925; Mayorga E, 2005, NATURE, V436, P538, DOI 10.1038/nature03880; MCKNIGHT DM, 1994, LIMNOL OCEANOGR, V39, P1972, DOI 10.4319/lo.1994.39.8.1972; McKnight DM., 2003, AQUATIC ECOSYSTEMS, P71, DOI 10.1016/B978-012256371-3/50004-4; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Neal EG, 2002, J HYDROL, V263, P188, DOI 10.1016/S0022-1694(02)00058-6; Opsahl S, 1999, LIMNOL OCEANOGR, V44, P2017, DOI 10.4319/lo.1999.44.8.2017; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002934; Royer TC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026767; Schiff SL, 1997, BIOGEOCHEMISTRY, V36, P43, DOI 10.1023/A:1005744131385; Simpson JJ, 2005, ARCTIC, V58, P137; SKIDMORE ML, 2000, APPL ENVIRON MICROB, V66, P3124; SMITH SV, 1993, REV GEOPHYS, V31, P75, DOI 10.1029/92RG02584; Sondergaard M, 2003, OPHELIA, V57, P161, DOI 10.1080/00785236.2003.10409512; Spencer RGM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036831; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x	34	366	379	10	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1044	U100		10.1038/nature08580	http://dx.doi.org/10.1038/nature08580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033045				2022-12-24	WOS:000272996000044
J	Tzeng, SR; Kalodimos, CG				Tzeng, Shiou-Ru; Kalodimos, Charalampos G.			Dynamic activation of an allosteric regulatory protein	NATURE			English	Article							CAMP RECEPTOR PROTEIN; CAP-DNA COMPLEX; ESCHERICHIA-COLI; ROTATIONAL DIFFUSION; CHEMICAL-EXCHANGE; NMR-SPECTROSCOPY; ORDER PARAMETERS; BINDING PROTEIN; CONFORMATIONAL ENTROPY; ANGSTROM RESOLUTION	Allosteric regulation is used as a very efficient mechanism to control protein activity in most biological processes, including signal transduction, metabolism, catalysis and gene regulation(1-6). Allosteric proteins can exist in several conformational states with distinct binding or enzymatic activity. Effectors are considered to function in a purely structural manner by selectively stabilizing a specific conformational state, thereby regulating protein activity. Here we show that allosteric proteins can be regulated predominantly by changes in their structural dynamics. We have used NMR spectroscopy and isothermal titration calorimetry to characterize cyclic AMP (cAMP) binding to the catabolite activator protein (CAP), a transcriptional activator that has been a prototype for understanding effector-mediated allosteric control of protein activity(7). cAMP switches CAP from the 'off' state (inactive), which binds DNA weakly and non-specifically, to the 'on' state (active), which binds DNA strongly and specifically. In contrast, cAMP binding to a single CAP mutant, CAP-S62F, fails to elicit the active conformation; yet, cAMP binding to CAP-S62F strongly activates the protein for DNA binding. NMR and thermodynamic analyses show that despite the fact that CAP-S62F-cAMP(2) adopts the inactive conformation, its strong binding to DNA is driven by a large conformational entropy originating in enhanced protein motions induced by DNA binding. The results provide strong evidence that changes in protein motions may activate allosteric proteins that are otherwise structurally inactive.	[Tzeng, Shiou-Ru; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Tzeng, Shiou-Ru; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kalodimos, CG (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Kalodimos, Charalampos/Q-9846-2018	Kalodimos, Charalampos/0000-0001-6354-2796; TZENG, SHIOU-RU/0000-0002-7180-0190	National Science Foundation (NSF) [MCB618259]	National Science Foundation (NSF)(National Science Foundation (NSF))	We are grateful to L. Kay for critical reading of the manuscript and valuable suggestions. We thank R. H. Ebright and Y. Ebright for providing the DNA fragment and N. Popovych for her help with the preparation of some CAP mutants. This work was supported by National Science Foundation (NSF) grant MCB618259 to C. G. K.	AIBA H, 1985, EMBO J, V4, P3329, DOI 10.1002/j.1460-2075.1985.tb04084.x; AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Baichoo N, 1997, BIOCHEMISTRY-US, V36, P10830, DOI 10.1021/bi970714v; Berg JM, 2006, BIOCHEMISTRY; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cavanagh J, 2000, NAT STRUCT BIOL, V7, P11, DOI 10.1038/71202; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; Dai JY, 2004, BIOCHEMISTRY-US, V43, P8901, DOI 10.1021/bi0499359; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hwang PM, 2001, J BIOMOL NMR, V20, P83, DOI 10.1023/A:1011226512421; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kay LE, 1998, NAT STRUCT BIOL, V5, P156, DOI 10.1038/nsb0298-156; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KIM J, 1992, P NATL ACAD SCI USA, V89, P9700, DOI 10.1073/pnas.89.20.9700; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; MacRaild CA, 2007, J MOL BIOL, V368, P822, DOI 10.1016/j.jmb.2007.02.055; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PALMER AG, MODELFREE; PALMER AG, CPMGFIT; PALMER AG, QUADRIC DIFFUSION; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Takeuchi K, 2007, J BIOMOL NMR, V38, P89, DOI 10.1007/s10858-007-9152-z; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Won HS, 2009, BBA-PROTEINS PROTEOM, V1794, P1299, DOI 10.1016/j.bbapap.2009.04.015; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Zhang FL, 2002, J AM CHEM SOC, V124, P12654, DOI 10.1021/ja027847a	53	289	291	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					368	U139		10.1038/nature08560	http://dx.doi.org/10.1038/nature08560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924217				2022-12-24	WOS:000271899300048
J	Voyles, J; Young, S; Berger, L; Campbell, C; Voyles, WF; Dinudom, A; Cook, D; Webb, R; Alford, RA; Skerratt, LF; Speare, R				Voyles, Jamie; Young, Sam; Berger, Lee; Campbell, Craig; Voyles, Wyatt F.; Dinudom, Anuwat; Cook, David; Webb, Rebecca; Alford, Ross A.; Skerratt, Lee F.; Speare, Rick			Pathogenesis of Chytridiomycosis, a Cause of Catastrophic Amphibian Declines	SCIENCE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; INFECTIOUS-DISEASE; RANA-PIPIENS; EXTINCTION; SKIN; FROG; SODIUM; VARIES	The pathogen Batrachochytrium dendrobatidis (Bd), which causes the skin disease chytridiomycosis, is one of the few highly virulent fungi in vertebrates and has been implicated in worldwide amphibian declines. However, the mechanism by which Bd causes death has not been determined. We show that Bd infection is associated with pathophysiological changes that lead to mortality in green tree frogs (Litoria caerulea). In diseased individuals, electrolyte transport across the epidermis was inhibited by > 50%, plasma sodium and potassium concentrations were respectively reduced by similar to 20% and similar to 50%, and asystolic cardiac arrest resulted in death. Because the skin is critical in maintaining amphibian homeostasis, disruption to cutaneous function may be the mechanism by which Bd produces morbidity and mortality across a wide range of phylogenetically distant amphibian taxa.	[Voyles, Jamie; Young, Sam; Berger, Lee; Webb, Rebecca; Skerratt, Lee F.; Speare, Rick] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Amphibian Dis Ecol Grp, Townsville, Qld 4811, Australia; [Campbell, Craig; Dinudom, Anuwat; Cook, David] Univ Sydney, Fac Med, Bosch Inst, Discipline Physiol, Sydney, NSW 2006, Australia; [Voyles, Wyatt F.] Univ New Mexico, Div Cardiol, Sch Med, Albuquerque, NM 87131 USA; [Alford, Ross A.] James Cook Univ, Sch Marine & Trop Biol, Amphibian Dis Ecol Grp, Townsville, Qld 4811, Australia	James Cook University; University of Sydney; University of New Mexico; James Cook University	Voyles, J (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Amphibian Dis Ecol Grp, Townsville, Qld 4811, Australia.	jamie.voyles@gmail.com	Alford, Ross A/H-1577-2011; webb, rebecca/A-7458-2012; Skerratt, Lee Francis/L-2797-2013; Campbell, Craig R/B-5983-2012	Alford, Ross A/0000-0002-3010-6768; Campbell, Craig R/0000-0002-0843-7579; Skerratt, Lee/0000-0003-3471-7512; Speare, Rick/0000-0002-9993-1213; Webb, Rebecca/0000-0002-2539-2755; Berger, Lee/0000-0001-9227-5439	Australian Research Council Discovery Project [DP0452826]; Australian Government Department of Environment and Heritage [RFT 43/2004]; Wildlife Preservation Society of Australia; Queensland Parks and Wildlife Service [WISP03866106, WISP04143907, WIWM04381507]; New South Wales Parks and Wildlife Service [IE0705693]	Australian Research Council Discovery Project(Australian Research Council); Australian Government Department of Environment and Heritage(Australian Government); Wildlife Preservation Society of Australia; Queensland Parks and Wildlife Service; New South Wales Parks and Wildlife Service	We thank A. Hyatt and V. Olsen for assistance with PCR and S. Bell, J. Browne, S. Cashins, S. Garland, M. Holdsworth, C. Manicom, L. Owens, R. Puschendorf, K. Rose, E. Rosenblum, D. Rudd, A. Storfer, J. VanDerwal, B. Voyles, and J. Warner for project assistance and editing. Supported by Australian Research Council Discovery Project grant DP0452826, Australian Government Department of Environment and Heritage grant RFT 43/2004, and the Wildlife Preservation Society of Australia. Animals were collected with permission from Queensland Parks and Wildlife Service ( scientific permits WISP03866106 and WISP04143907; movement permit WIWM04381507) and New South Wales Parks and Wildlife Service ( import license IE0705693).	ALVARADO RH, 1975, AM J PHYSIOL, V229, P869, DOI 10.1152/ajplegacy.1975.229.3.869; BENOS DJ, 1979, J GEN PHYSIOL, V73, P307, DOI 10.1085/jgp.73.3.307; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boutilier Robert G., 1992, P81; Castillo GA, 1997, COMP BIOCHEM PHYS A, V118, P1145, DOI 10.1016/S0300-9629(97)86799-0; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; DEYRUP IJ, 1964, PHYSL AMPHIBIA, V1, P251; Gennari FJ, 1998, NEW ENGL J MED, V339, P451, DOI 10.1056/NEJM199808133390707; HEATWOLE H, 1994, AMPHIBIAN BIOL, V1, P98; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; McCallum H, 2005, CONSERV BIOL, V19, P1421, DOI 10.1111/j.1523-1739.2005.00217.x; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; PARADIS NA, 1996, CARDIAC ARREST SCI P, P621; ROBERTSON DR, 1978, COMP BIOCHEM PHYS A, V60, P387, DOI 10.1016/0300-9629(78)90005-1; Rosenman S, 2008, AUSTRALAS PSYCHIATRY, V16, P1, DOI 10.1080/10398560701760219; SCHAECHTER M, 1998, MECH MICROBIAL DIS, P419; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; WRIGHT KM, 2001, AMPHIBIAN MED CAPTIV, P318	27	446	462	3	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					582	585		10.1126/science.1176765	http://dx.doi.org/10.1126/science.1176765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900897				2022-12-24	WOS:000271019400044
J	Libster, R; Bugna, J; Coviello, S; Hijano, DR; Dunaiewsky, M; Reynoso, N; Cavalieri, ML; Guglielmo, MC; Areso, MS; Gilligan, T; Santucho, F; Cabral, G; Gregorio, GL; Moreno, R; Lutz, MI; Panigasi, AL; Saligari, L; Caballero, MT; Almeida, RME; Meyer, MEG; Neder, MD; Davenport, MC; Del Valle, MP; Santidrian, VS; Mosca, G; Dominguez, MG; Alvarez, L; Landa, P; Pota, A; Bolonati, N; Dalamon, R; Mercol, VIS; Espinoza, M; Peuchot, JC; Karolinski, A; Bruno, M; Borsa, A; Ferrero, F; Bonina, A; Ramonet, M; Albano, LC; Luedicke, N; Alterman, E; Savy, V; Baumeister, E; Chappell, JD; Edwards, KM; Melendi, GA; Polack, FP				Libster, Romina; Bugna, Jimena; Coviello, Silvina; Hijano, Diego R.; Dunaiewsky, Mariana; Reynoso, Natalia; Cavalieri, Maria L.; Guglielmo, Maria C.; Soledad Areso, M.; Gilligan, Tomas; Santucho, Fernanda; Cabral, Graciela; Gregorio, Gabriela L.; Moreno, Rina; Lutz, Maria I.; Panigasi, Alicia L.; Saligari, Liliana; Caballero, Mauricio T.; Eguees Almeida, Rodrigo M.; Gutierrez Meyer, Maria E.; Neder, Maria D.; Davenport, Maria C.; Del Valle, Maria P.; Santidrian, Valeria S.; Mosca, Guillermina; Garcia Dominguez, Mercedes; Alvarez, Liliana; Landa, Patricia; Pota, Ana; Bolonati, Norma; Dalamon, Ricardo; Sanchez Mercol, Victoria I.; Espinoza, Marco; Carlos Peuchot, Juan; Karolinski, Ariel; Bruno, Miriam; Borsa, Ana; Ferrero, Fernando; Bonina, Angel; Ramonet, Margarita; Albano, Lidia C.; Luedicke, Nora; Alterman, Elias; Savy, Vilma; Baumeister, Elsa; Chappell, James D.; Edwards, Kathryn M.; Melendi, Guillermina A.; Polack, Fernando P.			Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1) in Argentina	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; CHILDREN; VIRUS; INFECTION; MORTALITY; ILLNESS; WAVE	BACKGROUND While the Northern Hemisphere experiences the effects of the 2009 pandemic influenza A (H1N1) virus, data from the recent influenza season in the Southern Hemisphere can provide important information on the burden of disease in children. METHODS We conducted a retrospective case series involving children with acute infection of the lower respiratory tract or fever in whom 2009 H1N1 influenza was diagnosed on reverse-transcriptase polymerase-chain-reaction assay and who were admitted to one of six pediatric hospitals serving a catchment area of 1.2 million children. We compared rates of admission and death with those among age-matched children who had been infected with seasonal influenza strains in previous years. RESULTS Between May and July 2009, a total of 251 children were hospitalized with 2009 H1N1 influenza. Rates of hospitalization were double those for seasonal influenza in 2008. Of the children who were hospitalized, 47 (19%) were admitted to an intensive care unit, 42 (17%) required mechanical ventilation, and 13 (5%) died. The overall rate of death was 1.1 per 100,000 children, as compared with 0.1 per 100,000 children for seasonal influenza in 2007. (No pediatric deaths associated with seasonal influenza were reported in 2008.) Most deaths were caused by refractory hypoxemia in infants under 1 year of age (death rate, 7.6 per 100,000). CONCLUSIONS Pandemic 2009 H1N1 influenza was associated with pediatric death rates that were 10 times the rates for seasonal influenza in previous years.	[Polack, Fernando P.] Vanderbilt Univ, Dept Pediat, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Libster, Romina; Bugna, Jimena; Coviello, Silvina; Espinoza, Marco; Alterman, Elias; Melendi, Guillermina A.; Polack, Fernando P.] Fdn INFANT, Buenos Aires, DF, Argentina; [Hijano, Diego R.] Hosp Ninos Sor Ludovica La Plata, Inst Desarrollo & Invest Pediat, Buenos Aires, DF, Argentina; [Hijano, Diego R.; Dunaiewsky, Mariana; Reynoso, Natalia; Cavalieri, Maria L.; Guglielmo, Maria C.; Soledad Areso, M.; Caballero, Mauricio T.; Eguees Almeida, Rodrigo M.; Gutierrez Meyer, Maria E.; Mosca, Guillermina; Sanchez Mercol, Victoria I.] Minist Ciencia Tecn & Innovac Prod, Programa INFANT, Buenos Aires, DF, Argentina; [Dunaiewsky, Mariana; Guglielmo, Maria C.; Neder, Maria D.; Davenport, Maria C.; Del Valle, Maria P.; Santidrian, Valeria S.; Ferrero, Fernando; Bonina, Angel] Hosp Ninos Pedro de Elizalde, Buenos Aires, DF, Argentina; [Reynoso, Natalia; Mosca, Guillermina; Garcia Dominguez, Mercedes; Luedicke, Nora] Hosp Materno Infantil Dr Carlos Gianantonio, Buenos Aires, DF, Argentina; [Cavalieri, Maria L.; Soledad Areso, M.; Sanchez Mercol, Victoria I.; Carlos Peuchot, Juan] Hosp Eva Peron, Buenos Aires, DF, Argentina; [Gilligan, Tomas; Santucho, Fernanda; Saligari, Liliana; Landa, Patricia; Pota, Ana; Bolonati, Norma; Dalamon, Ricardo; Karolinski, Ariel; Bruno, Miriam] Hosp Durand, Buenos Aires, DF, Argentina; [Cabral, Graciela; Gregorio, Gabriela L.; Moreno, Rina; Lutz, Maria I.; Panigasi, Alicia L.; Saligari, Liliana; Ramonet, Margarita; Albano, Lidia C.] Hosp Posadas, Buenos Aires, DF, Argentina; [Caballero, Mauricio T.; Eguees Almeida, Rodrigo M.; Gutierrez Meyer, Maria E.; Borsa, Ana] Hosp Ninos Sor Maria Ludovica, Buenos Aires, DF, Argentina; [Savy, Vilma; Baumeister, Elsa] Dr Carlos G Malbran Inst, Buenos Aires, DF, Argentina; [Chappell, James D.] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; University of Buenos Aires; University of Buenos Aires; Vanderbilt University	Polack, FP (corresponding author), Vanderbilt Univ, Dept Pediat, Vanderbilt Vaccine Ctr, 1161 21st Ave,D-7235 MCN, Nashville, TN 37232 USA.	fernando.p.polack@vanderbilt.edu	Ferrero, Fernando/AAE-1886-2020; Hijano, Diego/N-2665-2018	Ferrero, Fernando/0000-0001-6335-0102; Hijano, Diego/0000-0002-2903-666X; Davenport, Maria Carolina/0000-0002-6675-8813	Fundacion INFANT 2008 Fundraising Campaign; National Institute of Environmental Health Sciences; Argentine National Ministry of Health; Thrasher Research Fund; Fogarty International Center Clinical Research Fellow Program at Vanderbilt University	Fundacion INFANT 2008 Fundraising Campaign; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Argentine National Ministry of Health; Thrasher Research Fund; Fogarty International Center Clinical Research Fellow Program at Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Supported by the Fundacion INFANT 2008 Fundraising Campaign and the Director's Challenge Award from the National Institute of Environmental Health Sciences (to Dr. Polack); the Carrillo - Onativia Scholarship, Argentine National Ministry of Health (to Dr. Bugna); and an Early Career Thrasher Award from the Thrasher Research Fund and the Fogarty International Center Clinical Research Fellow Program at Vanderbilt University (to Dr. Melendi).	Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cordova-Villalobos Jose A, 2009, Health Res Policy Syst, V7, P21, DOI 10.1186/1478-4505-7-21; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Hackett S, 2009, LANCET, V374, P605, DOI 10.1016/S0140-6736(09)61511-7; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Lister P, 2009, LANCET, V374, P605, DOI [10.1016/S0140-6736(09)61512-9, 10.1016/S0140-6736(09)61513-0]; Martinez FD, 2001, J ALLERGY CLIN IMMUN, V107, pS449, DOI 10.1067/mai.2001.114993; *MIN SAL, IN PAND INFL 2009; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Rahman M, 2008, DIAGN MICR INFEC DIS, V62, P162, DOI 10.1016/j.diagmicrobio.2007.10.012; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2005, THREAT PANDEMIC INFL, P89, DOI DOI 10.2105/AJPH.2007.119933; *SOC ARG PED, CAL VAC; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; RESULTADOS PROVINCIA; GEOGRAPHIC SPREAD IN; 2009, MMWR MORB MORTAL WKL, V58, P521; 2009, SITUACION INFLUENZA; 2009 H1N1 VACCINATIO; H1N1 FLU CLIN PUBLIC; CASES HUMAN INFECT P; SWINE INFLUENZA CASE	30	314	335	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					45	55		10.1056/NEJMoa0907673	http://dx.doi.org/10.1056/NEJMoa0907673			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20032320				2022-12-24	WOS:000273345500008
J	Skelhorn, J; Rowland, HM; Speed, MP; Ruxton, GD				Skelhorn, John; Rowland, Hannah M.; Speed, Michael P.; Ruxton, Graeme D.			Masquerade: Camouflage Without Crypsis	SCIENCE			English	Article							MIMICRY		[Skelhorn, John; Ruxton, Graeme D.] Univ Glasgow, Fac Biomed & Life Sci, Div Ecol & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; [Rowland, Hannah M.; Speed, Michael P.] Univ Liverpool, Sch Biol Sci, Div Populat & Evolutionary Biol, Liverpool L69 7ZB, Merseyside, England	University of Glasgow; University of Liverpool	Ruxton, GD (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Div Ecol & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland.	G.Ruxton@bio.gla.ac.uk	Rowland, Hannah/D-8114-2012	Rowland, Hannah/0000-0002-1040-555X; Ruxton, Graeme/0000-0001-8943-6609	NERC [NE/F002653/1] Funding Source: UKRI; Natural Environment Research Council [NE/F002653/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ALLEN JA, 1985, J BIOL EDUC, V19, P268, DOI 10.1080/00219266.1985.9654747; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; SPEED MP, 1993, ANIM BEHAV, V46, P1246, DOI 10.1006/anbe.1993.1321; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; [No title captured]	6	156	161	6	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					51	51		10.1126/science.1181931	http://dx.doi.org/10.1126/science.1181931			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044568				2022-12-24	WOS:000273395400026
J	Jorgensen, C; Sherman, A; Chen, GI; Pasculescu, A; Poliakov, A; Hsiung, M; Larsen, B; Wilkinson, DG; Linding, R; Pawson, T				Jorgensen, Claus; Sherman, Andrew; Chen, Ginny I.; Pasculescu, Adrian; Poliakov, Alexei; Hsiung, Marilyn; Larsen, Brett; Wilkinson, David G.; Linding, Rune; Pawson, Tony			Cell-Specific Information Processing in Segregating Populations of Eph Receptor Ephrin-Expressing Cells	SCIENCE			English	Article							PHOSPHORYLATION NETWORKS; TYROSINE PHOSPHORYLATION; TRANSMEMBRANE LIGANDS; PROTEINS; FAMILY; ACTIVATION; ADHESION; KINASE; RESPONSES; PATHWAY	Cells have self-organizing properties that control their behavior in complex tissues. Contact between cells expressing either B-type Eph receptors or their transmembrane ephrin ligands initiates bidirectional signals that regulate cell positioning. However, simultaneously investigating how information is processed in two interacting cell types remains a challenge. We implemented a proteomic strategy to systematically determine cell-specific signaling networks underlying EphB2-and ephrin-B1-controlled cell sorting. Quantitative mass spectrometric analysis of mixed populations of EphB2-and ephrin-B1-expressing cells that were labeled with different isotopes revealed cell-specific tyrosine phosphorylation events. Functional associations between these phosphotyrosine signaling networks and cell sorting were established with small interfering RNA screening. Data-driven network modeling revealed that signaling between mixed EphB2-and ephrin-B1-expressing cells is asymmetric and that the distinct cell types use different tyrosine kinases and targets to process signals induced by cell-cell contact. We provide systems- and cell-specific network models of contact-initiated signaling between two distinct cell types.	[Linding, Rune] Inst Canc Res, Sect Cell & Mol Biol, Cellular & Mol Log Team, London SW3 6JB, England; [Jorgensen, Claus; Sherman, Andrew; Chen, Ginny I.; Pasculescu, Adrian; Hsiung, Marilyn; Larsen, Brett; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Sherman, Andrew; Chen, Ginny I.; Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Poliakov, Alexei; Wilkinson, David G.] Natl Inst Med Res, Div Dev Neurobiol, MRC, London NW7 1AA, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; MRC National Institute for Medical Research	Linding, R (corresponding author), Inst Canc Res, Sect Cell & Mol Biol, Cellular & Mol Log Team, London SW3 6JB, England.	linding@icr.ac.uk; pawson@lunenfeld.ca	Pawson, Tony J/E-4578-2013; Poliakov, Alexei/C-6362-2008	Poliakov, Alexei/0000-0001-7428-4040; Wilkinson, David/0000-0001-6757-7080; Linding, Rune/0000-0003-0420-4839; Jorgensen, Claus/0000-0002-7841-943X	Canadian Cancer Society; Canadian Institutes for Health [MOP-6849]; Canada Foundation for Innovation; Human Frontiers Science Program; Lundbeck Foundation; Medical Research Council [MC_U117532048] Funding Source: researchfish; MRC [MC_U117532048] Funding Source: UKRI	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Human Frontiers Science Program(Human Frontier Science Program); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Bakal, J. Erler, C. Marshall, R. Marais (ICR), and K. Colwill (SLRI) for critical input on this manuscript. The authors are further indebted to O. Rocks, A. James, V. Nguyen, R. Bagshaw, A.-C. Gingras (SLRI), P. Huang (ICR), L. Foster (University of British Columbia), L. J Jensen (Center for Protein Research), S. Tate (Applied Biosystems/Sciex), and Thermo Scientific (in particular A. Sullivan) for technical assistance. This project was supported by Genome Canada through the Ontario Genomics Institute, a Terry Fox Programme grant from the Canadian Cancer Society, the Canadian Institutes for Health Research (grant MOP-6849), the Canada Foundation for Innovation, the Human Frontiers Science Program, and The Lundbeck Foundation. C.J. conceived and implemented the qBidS approach. R. L. conceived and performed the modeling work. C.J, A. S., and T. P. conceived and designed the siRNA screen. D. G. W. and A. P. (MRC NIMR) provided cell lines and advice on cell sorting. C.J., A. S., G. I. C., M. H., and B. L. conceived, designed, and performed the experiments. A. P., C.J., and R. L. conceived, designed, and performed the computational experiments. T. P. and R. L. oversaw the project. C.J., R. L., and T. P. wrote the paper. Mass spectrometric data has been submitted to the Proteomics Identifications (PRIDE) database under accession numbers 10295-10296.	Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Gelfand MV, 2009, TRENDS CELL BIOL, V19, P99, DOI 10.1016/j.tcb.2009.01.001; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jorgensen Claus, 2008, Briefings in Functional Genomics & Proteomics, V7, P17, DOI 10.1093/bfgp/eln001; Kim L, 1998, J BIOL CHEM, V273, P23542, DOI 10.1074/jbc.273.36.23542; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	39	184	189	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1502	1509		10.1126/science.1176615	http://dx.doi.org/10.1126/science.1176615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007894				2022-12-24	WOS:000272623600049
J	Penkner, AM; Fridkin, A; Gloggnitzer, J; Baudrimont, A; Machacek, T; Woglar, A; Csaszar, E; Pasierbek, P; Ammerer, G; Gruenbaum, Y; Jantsch, V				Penkner, Alexandra M.; Fridkin, Alexandra; Gloggnitzer, Jiradet; Baudrimont, Antoine; Machacek, Thomas; Woglar, Alexander; Csaszar, Edina; Pasierbek, Pawel; Ammerer, Gustav; Gruenbaum, Yosef; Jantsch, Verena			Meiotic Chromosome Homology Search Involves Modifications of the Nuclear Envelope Protein Matefin/SUN-1	CELL			English	Article							C-ELEGANS MEIOSIS; CAENORHABDITIS-ELEGANS; FISSION YEAST; SUN-DOMAIN; SACCHAROMYCES-CEREVISIAE; SYNAPSIS; PROPHASE; RECOMBINATION; TELOMERES; ATTACHMENT	Genome haploidization during meiosis depends on recognition and association of parental homologous chromosomes. The C. elegans SUN/KASH domain proteins Matefin/SUN-1 and ZYG-12 have a conserved role in this process. They bridge the nuclear envelope, connecting the cytoplasm and the nucleoplasm to transmit forces that allow chromosome movement and homolog pairing and prevent nonhomologous synapsis. Here, we show that Matefin/SUN-1 forms rapidly moving aggregates at putative chromosomal attachment sites in the meiotic transition zone (TZ). We analyzed requirements for aggregate formation and identified multiple phosphotarget residues in the nucleoplasmic domain of Matefin/SUN-1. These CHK-2 dependent phosphorylations occur in leptotene/zygotene, diminish during pachytene and are involved in pairing. Mimicking phosphorylation causes an extended TZ and univalents at diakinesis. Our data suggest that the properties of the nuclear envelope are altered during the time window when homologs are sorted and Matefin/SUN-1 aggregates form, thereby controling the movement, homologous pairing and interhomolog recombination of chromosomes.	[Penkner, Alexandra M.; Gloggnitzer, Jiradet; Baudrimont, Antoine; Machacek, Thomas; Woglar, Alexander; Jantsch, Verena] Univ Vienna, Max F Perutz Labs, Dept Chromosome Biol, A-1030 Vienna, Austria; [Fridkin, Alexandra; Gruenbaum, Yosef] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Csaszar, Edina; Ammerer, Gustav] Univ Vienna, Max F Perutz Labs, Mass Spectrometry Unit, A-1030 Vienna, Austria; [Pasierbek, Pawel] Res Inst Mol Pathol, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Hebrew University of Jerusalem; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Penkner, AM (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Chromosome Biol, Waehringer Guertel 18, A-1030 Vienna, Austria.	alexandra.penkner@univie.ac.at; moloko@cc.huji.ac.il; verena.jantsch@univie.ac.at	Jantsch, Verena/A-3910-2017	Jantsch, Verena/0000-0002-1978-682X; Baudrimont, Antoine/0000-0001-9410-6356	FWF [P-21107, SFB-F3402]; WWTF [LS05009]; University of Vienna [I031-B]; Elise-Richter; DOC; Israel Science Foundation; Clore scholarship	FWF(Austrian Science Fund (FWF)); WWTF; University of Vienna; Elise-Richter(Austrian Science Fund (FWF)); DOC; Israel Science Foundation(Israel Science Foundation); Clore scholarship	We thank Christian Pflugl, Ella Kaplan, Sonja Kolar, and Sophie Wohrer for technical assistance. We are grateful to Chris Malone, Tony Hyman, Abby Dernburg, Anton Gartner, Anne Villeneuve, Monique Zetka, and the Caenorhabditis Genetics Center for strains, plasmids, and antibodies. We are indebted to Abby Dernburg for sharing unpublished results. We are grateful to Peter Carlton, Cecile Brocard, and Simon Boulton for helpful suggestions. We thank Iain Wilson, Maria Siomos, Yudith Yanowitz, and Josef Loidl for discussion. This work was supported by grants from the FWF (P-21107 and SFB-F3402), the WWTF (LS05009), the University of Vienna (I031-B), as well as an Elise-Richter grant to V. J., a DOC scholarship to A. W., an Israel Science Foundation grant to Y. G., and a Clore scholarship to A. F.	Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Alsheimer M., 2009, V5, P81, DOI 10.1159/000166621; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; Bhalla N, 2008, ANNU REV CELL DEV BI, V24, P397, DOI 10.1146/annurev.cellbio.23.090506.123245; Carlton PM, 2006, PLOS GENET, V2, P119, DOI 10.1371/journal.pgen.0020012; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Ding DQ, 1998, J CELL SCI, V111, P701; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101; Fridkin A, 2009, CELL MOL LIFE SCI, V66, P1518, DOI 10.1007/s00018-008-8713-y; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; GOLDSTEIN P, 1982, CHROMOSOMA, V84, P585, DOI 10.1007/BF00292857; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Kosaka H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000196; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Pawlowski WP, 2005, TRENDS CELL BIOL, V15, P674, DOI 10.1016/j.tcb.2005.10.005; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Perona R, 2008, CLIN TRANSL ONCOL, V10, P538, DOI 10.1007/s12094-008-0248-5; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Phillips CM, 2006, DEV CELL, V11, P817, DOI 10.1016/j.devcel.2006.09.020; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smolikov S, 2007, GENETICS, V176, P2015, DOI 10.1534/genetics.107.072413; Smolikov S, 2007, GENETICS, V176, P2027, DOI 10.1534/genetics.107.076968; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; Tang X, 2006, J CELL BIOL, V173, P845, DOI 10.1083/jcb.200602152; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; Wanat JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000188; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233	52	142	155	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					920	933		10.1016/j.cell.2009.10.045	http://dx.doi.org/10.1016/j.cell.2009.10.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19913286	Bronze			2022-12-24	WOS:000272169400016
J	Rudoy, JD; Voss, JL; Westerberg, CE; Paller, KA				Rudoy, John D.; Voss, Joel L.; Westerberg, Carmen E.; Paller, Ken A.			Strengthening Individual Memories by Reactivating Them During Sleep	SCIENCE			English	Article							CONSOLIDATION		[Rudoy, John D.; Voss, Joel L.; Westerberg, Carmen E.; Paller, Ken A.] Northwestern Univ, Evanston, IL 60208 USA; [Voss, Joel L.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign	Paller, KA (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.	kap@northwestern.edu	Paller, Ken/M-2676-2019	Voss, Joel/0000-0003-4180-9335; Paller, Ken/0000-0003-4415-4143	NSF [BCS-0818912]; National Institute of Neurological Disorders and Stroke; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066725] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NSF under grant BCS-0818912, by the National Institute of Neurological Disorders and Stroke, and by the Alzheimer's Association.	Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Paller K.A., 2009, ENCY NEUROSCIENCE, P741, DOI [DOI 10.1016/B978-008045046-9.00770-1, 10.1016/B978-008045046-9.00770-1]; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004	6	303	325	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1079	1079		10.1126/science.1179013	http://dx.doi.org/10.1126/science.1179013			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965421	Green Accepted			2022-12-24	WOS:000271951000032
J	Kesavan, G; Sand, FW; Greiner, TU; Johansson, JK; Kobberup, S; Wu, XW; Brakebusch, C; Semb, H				Kesavan, Gokul; Sand, Fredrik Wolfhagen; Greiner, Thomas Uwe; Johansson, Jenny Kristina; Kobberup, Sune; Wu, Xunwei; Brakebusch, Cord; Semb, Henrik			Cdc42-Mediated Tubulogenesis Controls Cell Specification	CELL			English	Article							EPITHELIAL POLARITY; CDC42; LINEAGE; MORPHOGENESIS; EXPRESSION; COMPLEX; PAR-3; PKC	Understanding how cells polarize and coordinate tubulogenesis during organ formation is a central question in biology. Tubulogenesis often coincides with cell-lineage specification during organ development. Hence, an elementary question is whether these two processes are independently controlled, or whether proper cell specification depends on formation of tubes. To address these fundamental questions, we have studied the functional role of Cdc42 in pancreatic tubulogenesis. We present evidence that Cdc42 is essential for tube formation, specifically for initiating microlumen formation and later for maintaining apical cell polarity. Finally, we show that Cdc42 controls cell specification non-cell-autonomously by providing the correct microenvironment for proper control of cell-fate choices of multipotent progenitors. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Kesavan, Gokul; Sand, Fredrik Wolfhagen; Greiner, Thomas Uwe; Johansson, Jenny Kristina; Kobberup, Sune; Semb, Henrik] Lund Univ, BMC, Stem Cell Ctr, SE-22184 Lund, Sweden; [Wu, Xunwei; Brakebusch, Cord] Univ Copenhagen, BRIC, Inst Biomed, DK-2100 Copenhagen, Denmark	Lund University; University of Copenhagen	Semb, H (corresponding author), Lund Univ, BMC, Stem Cell Ctr, SE-22184 Lund, Sweden.	henrik.semb@med.lu.se	Wu, Xunwei/J-9014-2018	Wu, Xunwei/0000-0002-0822-1700; Semb, Henrik/0000-0002-6747-787X; Kesavan, Gokul/0000-0002-2828-1460; Brakebusch, Cord/0000-0002-9342-1634	Swedish Research Council; Stem Cell Center Lund University; Swedish Foundation for Strategic Research; NIH Beta Cell Biology Consortium	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stem Cell Center Lund University; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NIH Beta Cell Biology Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Durbeej, B. Margolis, S. Ohno, C. Wright, and the Beta Cell Biology Consortium for providing antibodies; G. Gu and P. Serup for providing Cre lines; I. Artner, P. Nyeng, and Y. Fischer for comments on the manuscript; V. F. Gregoire for quantifying mitotic index; J. Ameri for QPCR; M. Magnusson and C. Ekenstierna for mouse breeding; U. Hacker for helpful discussions; and R. Wallen for the TEM analysis. This work was supported by the Swedish Research Council, Stem Cell Center Lund University, Swedish Foundation for Strategic Research, and NIH Beta Cell Biology Consortium.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Chung S, 2008, J CELL SCI, V121, P3501, DOI 10.1242/jcs.037887; Crisera CA, 2000, DIABETES, V49, P936, DOI 10.2337/diabetes.49.6.936; Duvillie B, 2006, DIABETES, V55, P582, DOI 10.2337/diabetes.55.03.06.db05-0839; Edsbagge J, 2005, DEVELOPMENT, V132, P1085, DOI 10.1242/dev.01643; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Gittes GK, 1996, DEVELOPMENT, V122, P439; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Li ZX, 2004, DEV BIOL, V269, P252, DOI 10.1016/j.ydbio.2004.01.043; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Percival AC, 1999, EXP CELL RES, V247, P123, DOI 10.1006/excr.1998.4322; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SOROKIN LM, 1992, EXP CELL RES, V201, P137, DOI 10.1016/0014-4827(92)90357-E; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Wu XW, 2007, DEV DYNAM, V236, P2767, DOI 10.1002/dvdy.21309; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	35	183	183	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					791	801		10.1016/j.cell.2009.08.049	http://dx.doi.org/10.1016/j.cell.2009.08.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914171	Bronze, Green Submitted			2022-12-24	WOS:000271747200022
J	Louie, JK; Acosta, M; Winter, K; Jean, C; Gavali, S; Schechter, R; Vugia, D; Harriman, K; Matyas, B; Glaser, CA; Samuel, MC; Rosenberg, J; Talarico, J; Hatch, D				Louie, Janice K.; Acosta, Meileen; Winter, Kathleen; Jean, Cynthia; Gavali, Shilpa; Schechter, Robert; Vugia, Duc; Harriman, Kathleen; Matyas, Bela; Glaser, Carol A.; Samuel, Michael C.; Rosenberg, Jon; Talarico, John; Hatch, Douglas		Calif Pandemic (H1N1) Working Grp	Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEASONAL INFLUENZA; OBESE-PATIENTS; OUTCOMES; COMPLICATIONS; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; MORTALITY; CHILDREN; INFANTS	Context Pandemic influenza A(H1N1) emerged rapidly in California in April 2009. Preliminary comparisons with seasonal influenza suggest that pandemic 2009 influenza A(H1N1) disproportionately affects younger ages and causes generally mild disease. Objective To describe the clinical and epidemiologic features of pandemic 2009 influenza A(H1N1) cases that led to hospitalization or death. Design, Setting, and Participants Statewide enhanced public health surveillance of California residents who were hospitalized or died with laboratory evidence of pandemic 2009 influenza A(H1N1) infection reported to the California Department of Public Health between April 23 and August 11, 2009. Main Outcome Measure Characteristics of hospitalized and fatal cases. Results During the study period there were 1088 cases of hospitalization or death due to pandemic 2009 influenza A(H1N1) infection reported in California. The median age was 27 years (range, <1-92 years) and 68% (741/1088) had risk factors for seasonal influenza complications. Sixty-six percent (547/833) of those with chest radiographs performed had infiltrates and 31% (340/1088) required intensive care. Rapid antigen tests were falsely negative in 34% (208/618) of cases evaluated. Secondary bacterial infection was identified in 4% (46/1088). Twenty-one percent (183/884) received no antiviral treatment. Overall fatality was 11% (118/1088) and was highest (18%-20%) in persons aged 50 years or older. The most common causes of death were viral pneumonia and acute respiratory distress syndrome. Conclusions In the first 16 weeks of the current pandemic, the median age of hospitalized infected cases was younger than is common with seasonal influenza. Infants had the highest hospitalization rates and persons aged 50 years or older had the highest mortality rates once hospitalized. Most cases had established risk factors for complications of seasonal influenza. JAMA. 2009;302(17):1896-1902	[Louie, Janice K.; Acosta, Meileen; Winter, Kathleen; Jean, Cynthia; Gavali, Shilpa; Schechter, Robert; Vugia, Duc; Harriman, Kathleen; Matyas, Bela; Glaser, Carol A.; Samuel, Michael C.; Rosenberg, Jon; Talarico, John; Hatch, Douglas; Calif Pandemic (H1N1) Working Grp] Calif Dept Publ Hlth, Richmond, CA 94804 USA	California Department of Public Health	Louie, JK (corresponding author), Calif Dept Publ Hlth, 850 Marina Bay Pkwy, Richmond, CA 94804 USA.	Janice.Louie@cdph.ca.gov		Pan, Chao-Yang/0000-0003-1584-4233	CDPH	CDPH	This study was fully sponsored by the CDPH.	Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], UPD INT REC US ANT M; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Duarte AG, 2007, CRIT CARE MED, V35, P732, DOI 10.1097/01.CCM.0000256842.39767.41; El-Solh A, 2001, CHEST, V120, P1989, DOI 10.1378/chest.120.6.1989; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Ho YC, 2009, J INFECTION, V58, P439, DOI 10.1016/j.jinf.2009.03.007; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Koenig SM, 2001, AM J MED SCI, V321, P249, DOI 10.1097/00000441-200104000-00006; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Morris AE, 2007, CHEST, V131, P342, DOI 10.1378/chest.06-1709; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Poirier P, 2009, CIRCULATION, V120, P86, DOI 10.1161/CIRCULATIONAHA.109.192575; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; VGONTZAS AN, 1994, ARCH INTERN MED, V154, P1705, DOI 10.1001/archinte.154.15.1705; World Health Organization, 2010, GLOB AL RESP PAND H1; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P301	33	771	824	0	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1896	1902		10.1001/jama.2009.1583	http://dx.doi.org/10.1001/jama.2009.1583			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19887665	Bronze			2022-12-24	WOS:000271375300021
J	Marshall, JC; Abraham, E; Adikhari, N; Aikawa, N; al Rahma, HN; Amin, P; Angus, DC; Annane, D; Argent, A; Bernard, GR; Bertolini, G; Bhagwanjee, S; Burns, KA; Calandra, T; Ceraso, D; Chan, K; Chiche, JD; Cobb, JP; Cook, DJ; Cuthbertson, BH; da Silva, E; de Backer, D; Dellinger, RP; Divatia, JV; Fedson, D; Festa, M; Ferguson, ND; Finfer, S; Fowler, R; Gomerall, C; Granton, J; Hammer, B; Hudson, LD; Jimenez, E; Kissoon, N; Koh, Y; Kumar, A; Langer, M; Latronico, N; Levy, MM; Lowry, S; Mamdani, M; Marsh, B; McAuley, DF; Meduri, GU; Menon, D; Mira, JP; Morales-Alava, F; Moreno, R; Morrison, L; Myburgh, J; Opal, S; Perkins, G; Perner, A; Randolph, A; Reinhart, K; Rello, J; Rice, T; Rowan, K; Sanchez-Nava, VM; Schuettler, J; Shukri, K; Slutsky, AS; Sprung, C; Sybrecht, GW; Taylor, BI; Thompson, AE; Thompson, BT; Tomicic, V; Ugarte, S; van der Poll, T; Vernon, DD; Vincent, JL; Walsh, T; Webb, S; Welte, T; Yung, M				Marshall, John C.; Abraham, Edward; Adikhari, Neill; Aikawa, Naoki; al Rahma, Hussain Nasser; Amin, Pravin; Angus, Derek C.; Annane, Djillali; Argent, Andrew; Bernard, Gordon R.; Bertolini, Guido; Bhagwanjee, Satish; Burns, Karen A.; Calandra, Thierry; Ceraso, Daniel; Chan, Kenneth; Chiche, Jean-Daniel; Cobb, J. Perren; Cook, Deborah J.; Cuthbertson, Brian H.; da Silva, Eliezer; de Backer, Daniel; Dellinger, R. Phillip; Divatia, Jigeeshu V.; Fedson, David; Festa, Marino; Ferguson, Niall D.; Finfer, Simon; Fowler, Robert; Gomerall, Charles; Granton, John; Hammer, Beth; Hudson, Leonard D.; Jimenez, Edgar; Kissoon, Niranjan; Koh, Younsuck; Kumar, Anand; Langer, Martin; Latronico, Nicola; Levy, Mitchell M.; Lowry, Stephen; Mamdani, Muhammad; Marsh, Brian; McAuley, Daniel F.; Meduri, G. Umberto; Menon, David; Mira, Jean-Paul; Morales-Alava, Freddy; Moreno, Rui; Morrison, Laurie; Myburgh, John; Opal, Steven; Perkins, Gavin; Perner, Anders; Randolph, Adrienne; Reinhart, Konrad; Rello, Jordi; Rice, Todd; Rowan, Kathy; Sanchez-Nava, Victor M.; Schuettler, Juergen; Shukri, Khalid; Slutsky, Arthur S.; Sprung, Charles; Sybrecht, Gerhard W.; Taylor, Bruce I.; Thompson, Ann E.; Thompson, B. Taylor; Tomicic, Vinko; Ugarte, Sebastian; van der Poll, Tom; Vernon, Donald D.; Vincent, Jean-Louis; Walsh, Timothy; Webb, Steven; Welte, Tobias; Yung, Michael		InFACT Global H1N1 Collaboration	InFACT: a global critical care research response to H1N1	LANCET			English	Editorial Material									[Annane, Djillali] Sch Med Paris Ile France Ouest, Paris, France; [Chan, Kenneth] SICM Singapore, Singapore, Singapore; [Finfer, Simon; Myburgh, John] George Inst Int Hlth, Sydney, NSW, Australia; [Gomerall, Charles] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [InFACT Global H1N1 Collaboration] St Michaels Hosp, Toronto, ON M5B 1W8, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; University of Sydney; Chinese University of Hong Kong; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto		marshallj@smh.toronto.on.ca	Kissoon, Niranjan/AAC-6140-2021; De Backer, Daniel/AAF-4177-2020; Annane, Djillali/R-7947-2019; Slutsky, Arthur/M-3325-2019; Gomersall, Charles D/J-1540-2012; Angus, Derek C/E-9671-2012; Rice, Todd/X-7853-2019; Rello, Jordi/P-2402-2019; Chiche, Jean-Daniel/P-5220-2017; Calandra, Thierry/D-9017-2015; Argent, Andrew/J-1605-2019; Latronico, Nicola/F-1557-2010; Perkins, Gavin/E-7613-2010; Ferguson, Niall/D-7619-2019	De Backer, Daniel/0000-0001-9841-5762; Gomersall, Charles D/0000-0002-8494-8063; Rello, Jordi/0000-0003-0676-6210; Chiche, Jean-Daniel/0000-0002-6433-6254; Calandra, Thierry/0000-0003-3051-1285; Argent, Andrew/0000-0001-9333-2036; Latronico, Nicola/0000-0002-2521-5871; Ferguson, Niall/0000-0002-6213-5264; Finfer, Simon/0000-0002-2785-5864; Randolph, Adrienne/0000-0002-3084-3071; Kissoon, Niranjan/0000-0001-8847-9973; Perner, Anders/0000-0002-4668-0123; Vincent, Jean-Louis/0000-0001-6011-6951				Baker MG, 2009, EUROSURVEILLANCE, V14, P6; Fedson DS, 2009, INFLUENZA OTHER RESP, V3, P129, DOI 10.1111/j.1750-2659.2009.00090.x; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lynn J., 2009, REUTERS         0804; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, 2009, PAND H1N1 2009 UPD 6	9	38	38	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					11	13		10.1016/S0140-6736(09)61792-X	http://dx.doi.org/10.1016/S0140-6736(09)61792-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	539BZ	19906418				2022-12-24	WOS:000273229700008
J	Drmanac, R; Sparks, AB; Callow, MJ; Halpern, AL; Burns, NL; Kermani, BG; Carnevali, P; Nazarenko, I; Nilsen, GB; Yeung, G; Dahl, F; Fernandez, A; Staker, B; Pant, KP; Baccash, J; Borcherding, AP; Brownley, A; Cedeno, R; Chen, LS; Chernikoff, D; Cheung, A; Chirita, R; Curson, B; Ebert, JC; Hacker, CR; Hartlage, R; Hauser, B; Huang, S; Jiang, Y; Karpinchyk, V; Koenig, M; Kong, C; Landers, T; Le, C; Liu, J; McBride, CE; Morenzoni, M; Morey, RE; Mutch, K; Perazich, H; Perry, K; Peters, BA; Peterson, J; Pethiyagoda, CL; Pothuraju, K; Richter, C; Rosenbaum, AM; Roy, S; Shafto, J; Sharanhovich, U; Shannon, KW; Sheppy, CG; Sun, M; Thakuria, JV; Tran, A; Vu, D; Zaranek, AW; Wu, XD; Drmanac, S; Oliphant, AR; Banyai, WC; Martin, B; Ballinger, DG; Church, GM; Reid, CA				Drmanac, Radoje; Sparks, Andrew B.; Callow, Matthew J.; Halpern, Aaron L.; Burns, Norman L.; Kermani, Bahram G.; Carnevali, Paolo; Nazarenko, Igor; Nilsen, Geoffrey B.; Yeung, George; Dahl, Fredrik; Fernandez, Andres; Staker, Bryan; Pant, Krishna P.; Baccash, Jonathan; Borcherding, Adam P.; Brownley, Anushka; Cedeno, Ryan; Chen, Linsu; Chernikoff, Dan; Cheung, Alex; Chirita, Razvan; Curson, Benjamin; Ebert, Jessica C.; Hacker, Coleen R.; Hartlage, Robert; Hauser, Brian; Huang, Steve; Jiang, Yuan; Karpinchyk, Vitali; Koenig, Mark; Kong, Calvin; Landers, Tom; Le, Catherine; Liu, Jia; McBride, Celeste E.; Morenzoni, Matt; Morey, Robert E.; Mutch, Karl; Perazich, Helena; Perry, Kimberly; Peters, Brock A.; Peterson, Joe; Pethiyagoda, Charit L.; Pothuraju, Kaliprasad; Richter, Claudia; Rosenbaum, Abraham M.; Roy, Shaunak; Shafto, Jay; Sharanhovich, Uladzislau; Shannon, Karen W.; Sheppy, Conrad G.; Sun, Michel; Thakuria, Joseph V.; Tran, Anne; Vu, Dylan; Zaranek, Alexander Wait; Wu, Xiaodi; Drmanac, Snezana; Oliphant, Arnold R.; Banyai, William C.; Martin, Bruce; Ballinger, Dennis G.; Church, George M.; Reid, Clifford A.			Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays	SCIENCE			English	Article							GENE-EXPRESSION; HYBRIDIZATION; POLYMERASE	Genome sequencing of large numbers of individuals promises to advance the understanding, treatment, and prevention of human diseases, among other applications. We describe a genome sequencing platform that achieves efficient imaging and low reagent consumption with combinatorial probe anchor ligation chemistry to independently assay each base from patterned nanoarrays of self-assembling DNA nanoballs. We sequenced three human genomes with this platform, generating an average of 45- to 87-fold coverage per genome and identifying 3.2 to 4.5 million sequence variants per genome. Validation of one genome data set demonstrates a sequence accuracy of about 1 false variant per 100 kilobases. The high accuracy, affordable cost of $4400 for sequencing consumables, and scalability of this platform enable complete human genome sequencing for the detection of rare variants in large-scale genetic studies.	[Drmanac, Radoje; Sparks, Andrew B.; Callow, Matthew J.; Halpern, Aaron L.; Burns, Norman L.; Kermani, Bahram G.; Carnevali, Paolo; Nazarenko, Igor; Nilsen, Geoffrey B.; Yeung, George; Dahl, Fredrik; Fernandez, Andres; Staker, Bryan; Pant, Krishna P.; Baccash, Jonathan; Borcherding, Adam P.; Brownley, Anushka; Cedeno, Ryan; Chen, Linsu; Chernikoff, Dan; Cheung, Alex; Chirita, Razvan; Curson, Benjamin; Ebert, Jessica C.; Hacker, Coleen R.; Hartlage, Robert; Hauser, Brian; Huang, Steve; Jiang, Yuan; Karpinchyk, Vitali; Koenig, Mark; Kong, Calvin; Landers, Tom; Le, Catherine; Liu, Jia; McBride, Celeste E.; Morenzoni, Matt; Morey, Robert E.; Mutch, Karl; Perazich, Helena; Perry, Kimberly; Peters, Brock A.; Peterson, Joe; Pethiyagoda, Charit L.; Pothuraju, Kaliprasad; Richter, Claudia; Roy, Shaunak; Shafto, Jay; Sharanhovich, Uladzislau; Shannon, Karen W.; Sheppy, Conrad G.; Sun, Michel; Tran, Anne; Vu, Dylan; Drmanac, Snezana; Oliphant, Arnold R.; Banyai, William C.; Martin, Bruce; Ballinger, Dennis G.; Reid, Clifford A.] Complete Genom Inc, Mountain View, CA 94043 USA; [Rosenbaum, Abraham M.; Thakuria, Joseph V.; Zaranek, Alexander Wait; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02115 USA; [Wu, Xiaodi] Washington Univ, Sch Med, St Louis, MO 63110 USA	Harvard University; Washington University (WUSTL)	Drmanac, R (corresponding author), Complete Genom Inc, 2071 Stierlin Court, Mountain View, CA 94043 USA.	rdrmanac@completegenomics.com; dballinger@completegenomics.com		Peters, Brock/0000-0002-5137-3902; Zaranek, Alexander (Sasha) Wait/0000-0002-0415-9655; church, george/0000-0001-6232-9969				ADAMS CP, 1997, Patent No. 5641658; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; CHEESMAN PC, 1994, Patent No. 5302509; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; DRMANAC R, 1989, GENOMICS, V4, P114; DRMANAC R, 1995, Patent No. 1995009248; DRMANAC R, 1990, SCI YUGOSL, V16, P97; DRMANAC R, 2004, Patent No. 2004076683; Drmanac S, 1998, NAT BIOTECHNOL, V16, P54, DOI 10.1038/nbt0198-54; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; MACEVICZ SC, 1998, Patent No. 5750341; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Pihlak A, 2008, NAT BIOTECHNOL, V26, P676, DOI 10.1038/nbt1405; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	37	835	992	7	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					78	81		10.1126/science.1181498	http://dx.doi.org/10.1126/science.1181498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	19892942				2022-12-24	WOS:000273395400034
J	Chandran, V; Fronzes, R; Duquerroy, S; Cronin, N; Navaza, J; Waksman, G				Chandran, Vidya; Fronzes, Remi; Duquerroy, Stephane; Cronin, Nora; Navaza, Jorge; Waksman, Gabriel			Structure of the outer membrane complex of a type IV secretion system	NATURE			English	Article							AGROBACTERIUM VIRB10; PROTEINS; BIOGENESIS; MACHINERY; SOFTWARE	Type IV secretion systems are secretion nanomachines spanning the two membranes of Gram-negative bacteria. Three proteins, VirB7, VirB9 and VirB10, assemble into a 1.05 megadalton (MDa) core spanning the inner and outer membranes. This core consists of 14 copies of each of the proteins and forms two layers, the I and O layers, inserting in the inner and outer membrane, respectively. Here we present the crystal structure of a similar to 0.6 MDa outer-membrane complex containing the entire O layer. This structure is the largest determined for an outer-membrane channel and is unprecedented in being composed of three proteins. Unexpectedly, this structure identifies VirB10 as the outer-membrane channel with a unique hydrophobic double-helical transmembrane region. This structure establishes VirB10 as the only known protein crossing both membranes of Gram-negative bacteria. Comparison of the cryo-electron microscopy (cryo-EM) and crystallographic structures points to conformational changes regulating channel opening and closing.	[Chandran, Vidya; Fronzes, Remi; Cronin, Nora; Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [Chandran, Vidya; Fronzes, Remi; Cronin, Nora; Waksman, Gabriel] Univ London Birkbeck Coll, London WC1E 7HX, England; [Duquerroy, Stephane] Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris, France; [Duquerroy, Stephane] CNRS, URA 3015, F-75724 Paris, France; [Duquerroy, Stephane] Univ Paris 11, F-91405 Orsay, France; [Navaza, Jorge] Inst Biol Struct JP Ebel, Lab Microscopie Elect, F-38027 Grenoble 1, France	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	g.waksman@ucl.ac.uk	Fronzes, Remi/T-2578-2019; Fronzes, Rémi/GLS-0406-2022	Fronzes, Remi/0000-0003-3031-9824; Cronin, Nora/0000-0002-4249-7313; Duquerroy, Stephane/0000-0003-4386-8013; Darbari, Vidya/0000-0002-3387-5108	Wellcome Trust [082227]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Wellcome Trust grant 082227 to G. W. We thank A. Thompson and the staff of beamline PROXIMA 1 at Soleil, the staff of beamline ID14.4 at the European Synchrotron Radiation Facility, and H. Saibil, E. Orlova and P. Christie for comments on the manuscript. We thank A. Kumar for help in implementing the immunofluorescence experiments.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2005, CCP4 NEWSL, V42; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2007, P NATL ACAD SCI USA, V104, P1673, DOI 10.1073/pnas.0609535104; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; JONES TA, 1992, CCP4 STUDY WEEKEND 1, P91; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KJELDGAARD M, 1994, CCP4 P, P59; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Meng GY, 2009, MOL MEMBR BIOL, V26, P136, DOI 10.1080/09687680802712422; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Sharff AJ, 2000, ACTA CRYSTALLOGR D, V56, P785, DOI 10.1107/S090744490000370X; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Gomis-Ruth FX, 2006, CURR OPIN STRUC BIOL, V16, P744, DOI 10.1016/j.sbi.2006.10.004	33	239	246	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1011	U66		10.1038/nature08588	http://dx.doi.org/10.1038/nature08588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	19946264	Green Submitted, Green Accepted			2022-12-24	WOS:000272996000037
J	Wu, DY; Hugenholtz, P; Mavromatis, K; Pukall, R; Dalin, E; Ivanova, NN; Kunin, V; Goodwin, L; Wu, M; Tindall, BJ; Hooper, SD; Pati, A; Lykidis, A; Spring, S; Anderson, IJ; D'haeseleer, P; Zemla, A; Singer, M; Lapidus, A; Nolan, M; Copeland, A; Han, C; Chen, F; Cheng, JF; Lucas, S; Kerfeld, C; Lang, E; Gronow, S; Chain, P; Bruce, D; Rubin, EM; Kyrpides, NC; Klenk, HP; Eisen, JA				Wu, Dongying; Hugenholtz, Philip; Mavromatis, Konstantinos; Pukall, Ruediger; Dalin, Eileen; Ivanova, Natalia N.; Kunin, Victor; Goodwin, Lynne; Wu, Martin; Tindall, Brian J.; Hooper, Sean D.; Pati, Amrita; Lykidis, Athanasios; Spring, Stefan; Anderson, Iain J.; D'haeseleer, Patrik; Zemla, Adam; Singer, Mitchell; Lapidus, Alla; Nolan, Matt; Copeland, Alex; Han, Cliff; Chen, Feng; Cheng, Jan-Fang; Lucas, Susan; Kerfeld, Cheryl; Lang, Elke; Gronow, Sabine; Chain, Patrick; Bruce, David; Rubin, Edward M.; Kyrpides, Nikos C.; Klenk, Hans-Peter; Eisen, Jonathan A.			A phylogeny-driven genomic encyclopaedia of Bacteria and Archaea	NATURE			English	Article							MICROBIAL DIVERSITY; PROTEIN FAMILIES; DATABASE GOLD; PROJECTS; SEQUENCE	Sequencing of bacterial and archaeal genomes has revolutionized our understanding of the many roles played by microorganisms(1). There are now nearly 1,000 completed bacterial and archaeal genomes available(2), most of which were chosen for sequencing on the basis of their physiology. As a result, the perspective provided by the currently available genomes is limited by a highly biased phylogenetic distribution(3-5). To explore the value added by choosing microbial genomes for sequencing on the basis of their evolutionary relationships, we have sequenced and analysed the genomes of 56 culturable species of Bacteria and Archaea selected to maximize phylogenetic coverage. Analysis of these genomes demonstrated pronounced benefits ( compared to an equivalent set of genomes randomly selected from the existing database) in diverse areas including the reconstruction of phylogenetic history, the discovery of new protein families and biological properties, and the prediction of functions for known genes from other organisms. Our results strongly support the need for systematic 'phylogenomic' efforts to compile a phylogeny-driven 'Genomic Encyclopedia of Bacteria and Archaea' in order to derive maximum knowledge from existing microbial genome data as well as from genome sequences to come.	[Wu, Dongying; Hugenholtz, Philip; Mavromatis, Konstantinos; Dalin, Eileen; Ivanova, Natalia N.; Kunin, Victor; Hooper, Sean D.; Pati, Amrita; Lykidis, Athanasios; Anderson, Iain J.; D'haeseleer, Patrik; Lapidus, Alla; Nolan, Matt; Copeland, Alex; Chen, Feng; Cheng, Jan-Fang; Lucas, Susan; Kerfeld, Cheryl; Chain, Patrick; Rubin, Edward M.; Kyrpides, Nikos C.; Eisen, Jonathan A.] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Wu, Dongying; Singer, Mitchell; Eisen, Jonathan A.] Univ Calif Davis, Davis, CA 95616 USA; [Pukall, Ruediger; Tindall, Brian J.; Spring, Stefan; Lang, Elke; Gronow, Sabine; Klenk, Hans-Peter] Deutsch Sammlung Mikroorganism Zellkultur GmbH, German Collect Microorganisms & Cell Cultures, D-38124 Braunschweig, Germany; [Goodwin, Lynne; Han, Cliff; Chain, Patrick; Bruce, David] Los Alamos Natl Lab, DOE Joint Genome Inst, Los Alamos, NM 87545 USA; [D'haeseleer, Patrik; Zemla, Adam] Univ Virginia, Charlottesville, VA 22904 USA; [Wu, Martin] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	United States Department of Energy (DOE); University of California System; University of California Davis; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); United States Department of Energy (DOE); Los Alamos National Laboratory; University of Virginia; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Eisen, JA (corresponding author), DOE Joint Genome Inst, Walnut Creek, CA 94598 USA.	jaeisen@ucdavis.edu	Chain, Patrick/O-4140-2019; Lapidus, Alla L/I-4348-2013; Kyrpides, Nikos C./A-6305-2014; Spring, Stefan/N-6933-2013; Hugenholtz, Philip/AAD-9138-2019; Eisen, Jonathan A./H-2706-2019; chain, patrick/B-9777-2013	Chain, Patrick/0000-0003-3949-3634; Lapidus, Alla L/0000-0003-0427-8731; Kyrpides, Nikos C./0000-0002-6131-0462; Spring, Stefan/0000-0001-6247-0938; Hugenholtz, Philip/0000-0001-5386-7925; Eisen, Jonathan A./0000-0002-0159-2197; Han, Cliff/0000-0003-1972-0692; Wu, Martin/0000-0003-3093-4077; Kunin, Victor/0000-0002-8741-7866; Ivanova, Natalia/0000-0002-5802-9485; Mavrommatis, Konstantinos/0000-0003-4549-385X; Cheng, Jan-Fang/0000-0001-7315-7613	US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Gordon and Betty Moore Foundation [1660]; DFG INST [599/1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067012, R01GM054592] Funding Source: NIH RePORTER	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); DFG INST(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following people for assistance in aspects of the project including planning and discussions ( R. Stevens, G. Olsen, R. Edwards, J. Bristow, N. Ward, S. Baker, T. Lowe, J. Tiedje, G. Garrity, A. Darling, S. Giovannoni), analysis of genomes whose work could not be included in this report ( B. Henrissat, G. Xie, J. Kinney, I. Paulsen, N. Rawlings, M. Huntemann), project management ( M. Miller, M. Fenner, M. McGowen, A. Greiner), sequencing and finishing ( K. Ikeda, M. Chovatia, P. Richardson, T. Glavinadelrio, C. Detter), culture growth, DNA extraction, and metadata ( D. Gleim, E. Brambilla, S. Schneider, M. Schroder, M. Jando, G. Gehrich-Schroter, C. Wahrenburg, K. Steenblock, S. Welnitz, M. Kopitz, R. Fahnrich,H. Pomrenke, A. Schutze, M. Rohde, M. Goker), and manuscript editing ( M. Youle). This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. Support for J. A. E., D. W. and M. W. was provided by the Gordon and Betty Moore Foundation Grant no. 1660 to J. A. E. Support for work at DSMZ was provided under DFG INST 599/1-1.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doolittle RF, 2002, BIOESSAYS, V24, P293, DOI 10.1002/bies.10079; Eisen JA, 2000, CURR OPIN MICROBIOL, V3, P475, DOI 10.1016/S1369-5274(00)00125-9; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Fraser CM, 2000, NATURE, V406, P799, DOI 10.1038/35021244; Hugenholtz P, 2002, GENOME BIOL, V3; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P551, DOI 10.1111/j.1462-2920.2009.01888.x; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lapage SP, 1992, INT CODE NOMENCLATUR; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Moulton V, 2007, J THEOR BIOL, V246, P186, DOI 10.1016/j.jtbi.2006.12.021; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pardi F, 2007, SYSTEMATIC BIOL, V56, P431, DOI 10.1080/10635150701411279; Sasse F, 1998, J NATL CANCER I, V90, P1559, DOI 10.1093/jnci/90.20.1559; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Waino M, 2003, EXTREMOPHILES, V7, P87, DOI 10.1007/s00792-002-0299-y; Ward N, 2001, NATURE, V414, P148, DOI 10.1038/35102737; Wu DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004207; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	30	698	709	1	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1056	1060		10.1038/nature08656	http://dx.doi.org/10.1038/nature08656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033048	Green Accepted, hybrid, Green Published			2022-12-24	WOS:000272996000047
J	Santiago, J; Dupeux, F; Round, A; Antoni, R; Park, SY; Jamin, M; Cutler, SR; Rodriguez, PL; Marquez, JA				Santiago, Julia; Dupeux, Florine; Round, Adam; Antoni, Regina; Park, Sang-Youl; Jamin, Marc; Cutler, Sean R.; Luis Rodriguez, Pedro; Marquez, Jose Antonio			The abscisic acid receptor PYR1 in complex with abscisic acid	NATURE			English	Article							PROTEIN PHOSPHATASES; ARABIDOPSIS; BINDING; START; SCATTERING; PROGRAM; DOMAIN; FOLD	The plant hormone abscisic acid (ABA) has a central role in coordinating the adaptive response in situations of decreased water availability as well as the regulation of plant growth and development. Recently, a 14-member family of intracellular ABA receptors, named PYR/PYL/RCAR(1-3), has been identified. These proteins inhibit in an ABA-dependent manner the activity of a family of key negative regulators of the ABA signalling pathway: the group-A protein phosphatases type 2C (PP2Cs)(4-6). Here we present the crystal structure of Arabidopsis thaliana PYR1, which consists of a dimer in which one of the subunits is bound to ABA. In the ligand-bound subunit, the loops surrounding the entry to the binding cavity fold over the ABA molecule, enclosing it inside, whereas in the empty subunit they form a channel leaving an open access to the cavity, indicating that conformational changes in these loops have a critical role in the stabilization of the hormone-receptor complex. By providing structural details on the ABA-binding pocket, this work paves the way for the development of new small molecules able to activate the plant stress response.	[Dupeux, Florine; Round, Adam; Marquez, Jose Antonio] UJF, EMBL, CNRS, European Mol Biol Lab,Grenoble Outstn, F-38042 Grenoble 9, France; [Dupeux, Florine; Round, Adam; Marquez, Jose Antonio] UJF, EMBL, CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France; [Santiago, Julia; Antoni, Regina; Luis Rodriguez, Pedro] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, ES-46022 Valencia, Spain; [Park, Sang-Youl; Cutler, Sean R.] Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Jamin, Marc] Univ Grenoble 1, CNRS, EMBL, Virus Host Cell Interact UVHCI UMI 3265, F-38042 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of California System; University of California Riverside; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Marquez, JA (corresponding author), UJF, EMBL, CNRS, European Mol Biol Lab,Grenoble Outstn, 6 Rue Jules Horowitz,BP181, F-38042 Grenoble 9, France.	marquez@embl.fr	Cutler, Sean R/D-6617-2011; Marquez, Jose/C-5826-2015; Rodriguez, Pedro L./K-4605-2014	Rodriguez, Pedro L./0000-0002-5886-9425; Jamin, Marc/0000-0002-8677-2110; Santiago, Julia/0000-0002-5765-6495; Round, Adam/0000-0002-0723-8228	Ministerio de Educacion y Ciencia [BIO2008-00221]; Fondo Europeo de Desarrollo Regional; Consejo Superior de Investigaciones Cientificas; European Community-Research Infrastructure Action PCUBE	Ministerio de Educacion y Ciencia(Spanish Government); Fondo Europeo de Desarrollo Regional(European Commission); Consejo Superior de Investigaciones Cientificas; European Community-Research Infrastructure Action PCUBE	We thank A. McArthy and S. Brockhauser for support during X- ray data collection and R. Serrano and S. Cusack for critical reading of the manuscript. We are grateful to the European Synchrotron radiation facility ( ESRF) and the EMBL for access to the macromolecular crystallography and BioSAXS beamlines. This work was supported by grant BIO2008-00221 from Ministerio de Educacion y Ciencia and Fondo Europeo de Desarrollo Regional and Consejo Superior de Investigaciones Cientificas (fellowships to J. S. and R. A.). Access to the high throughput crystallization facility of the Partnership for Structural Biology in Grenoble (PSB) (https://htxlab.embl.fr) was supported by the European Community-Research Infrastructure Action PCUBE under the FP7 'Capacities' specific programme.	Christmann A, 2009, CELL, V136, P21, DOI 10.1016/j.cell.2008.12.033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerard FCA, 2007, BIOCHEMISTRY-US, V46, P10328, DOI 10.1021/bi7007799; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; MILBORROW BV, 1974, ANNU REV PLANT PHYS, V25, P259, DOI 10.1146/annurev.pp.25.060174.001355; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2008, PLANT CELL, V20, P2972, DOI 10.1105/tpc.107.056705; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; UEDA H, 1977, B CHEM SOC JPN, V50, P1506, DOI 10.1246/bcsj.50.1506; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	23	363	395	6	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					665	U143		10.1038/nature08591	http://dx.doi.org/10.1038/nature08591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19898494				2022-12-24	WOS:000272277900044
J	Leveille, SG; Jones, RN; Kiely, DK; Hausdorff, JM; Shmerling, RH; Guralnik, JM; Kiel, DP; Lipsitz, LA; Bean, JF				Leveille, Suzanne G.; Jones, Richard N.; Kiely, Dan K.; Hausdorff, Jeffrey M.; Shmerling, Robert H.; Guralnik, Jack M.; Kiel, Douglas P.; Lipsitz, Lewis A.; Bean, Jonathan F.			Chronic Musculoskeletal Pain and the Occurrence of Falls in an Older Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER-EXTREMITY FUNCTION; EXECUTIVE FUNCTION; PREVENTING FALLS; DISABLED WOMEN; KNEE PAIN; COMMUNITY; RISK; OSTEOARTHRITIS; HEALTH; CLASSIFICATION	Context Chronic pain is a major contributor to disability in older adults; however, the potential role of chronic pain as a risk factor for falls is poorly understood. Objective To determine whether chronic musculoskeletal pain is associated with an increased occurrence of falls in a cohort of community-living older adults. Design, Setting, and Participants The Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly (MOBILIZE) Boston Study is a population-based longitudinal study of falls involving 749 adults aged 70 years and older. Participants were enrolled from September 2005 through January 2008. Main Outcome Measure Participants recorded falls on monthly calendar postcards mailed to the study center during an 18-month period. Results There were 1029 falls reported during the follow-up. A report of 2 or more locations of musculoskeletal pain at baseline was associated with greater occurrence of falls. The age-adjusted rates of falls per person-year were 1.18 (95% confidence interval [CI], 1.13-1.23) for the 300 participants with 2 or more sites of joint pain, 0.90 (95% CI, 0.87-0.92) for the 181 participants with single-site pain, and 0.78 (95% CI, 0.74-0.81) for the 267 participants with no joint pain. Similarly, more severe or disabling pain at baseline was associated with higher fall rates (P < .05). The association persisted after adjusting for multiple confounders and fall risk factors. The greatest risk for falls was observed in persons who had 2 or more pain sites (adjusted rate ratio [RR], 1.53; 95% CI, 1.17-1.99), and those in the highest tertiles of pain severity (adjusted RR, 1.53; 95% CI, 1.12-2.08) and pain interference with activities (adjusted RR, 1.53; 95% CI, 1.15-2.05), compared with their peers with no pain or those in the lowest tertiles of pain scores. Conclusions Chronic pain measured according to number of locations, severity, or pain interference with daily activities was associated with greater risk of falls in older adults. JAMA. 2009;302(20):2214-2221	[Leveille, Suzanne G.] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Leveille, Suzanne G.; Jones, Richard N.; Shmerling, Robert H.; Kiel, Douglas P.; Lipsitz, Lewis A.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Leveille, Suzanne G.; Jones, Richard N.; Hausdorff, Jeffrey M.; Shmerling, Robert H.; Kiel, Douglas P.; Lipsitz, Lewis A.; Bean, Jonathan F.] Harvard Univ, Sch Med, Boston, MA USA; [Jones, Richard N.; Kiely, Dan K.; Kiel, Douglas P.; Lipsitz, Lewis A.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Bean, Jonathan F.] Spaulding Rehabil Hosp, Boston, MA USA; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA	University of Massachusetts System; University of Massachusetts Boston; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Hebrew SeniorLife; Harvard University; Spaulding Rehabilitation Hospital; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Leveille, SG (corresponding author), Univ Massachusetts, Coll Nursing & Hlth Sci, 100 Morrissey Blvd, Boston, MA 02125 USA.	suzanne.leveille@umb.edu	Leveille, Suzanne G/ACS-6588-2022; Bean, Jonathan F/F-5798-2017; Jones, Richard Norman/J-3488-2013	Leveille, Suzanne G/0000-0003-0427-1580; Bean, Jonathan F/0000-0001-8385-8210; Jones, Richard Norman/0000-0002-1049-218X; Kiel, Douglas/0000-0001-8474-0310	National Institute on Aging Research Nursing Home Program Project [P01AG004390]; Intramural Research Program, National Institute on Aging, NIH; Pfizer Inc; NATIONAL INSTITUTE ON AGING [ZIAAG007310, P01AG004390] Funding Source: NIH RePORTER	National Institute on Aging Research Nursing Home Program Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural Research Program, National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pfizer Inc(Pfizer); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant P01AG004390 from the National Institute on Aging Research Nursing Home Program Project. Dr Guralnik's time was funded by the Intramural Research Program, National Institute on Aging, NIH. The coding of the medication data for the MOBILIZE Boston Study was supported by an unrestricted grant from Pfizer Inc, none of which was to support salary, stipends, or other funding except for salaries for research staff who were not involved in this article.	ALTMAN R, 1990, ARTHRITIS RHEUM, V33, P1601, DOI 10.1002/art.1780331101; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Arden NK, 2006, ARTHRIT RHEUM-ARTHR, V55, P610, DOI 10.1002/art.22088; Ben-Itzhak R, 2008, J AM GERIATR SOC, V56, P695, DOI 10.1111/j.1532-5415.2007.01623.x; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Blyth FM, 2007, EUR J PAIN, V11, P564, DOI 10.1016/j.ejpain.2006.08.001; Cleeland CS, 1989, ADV PAIN RES THER, P391, DOI DOI 10.1093/BRAIN/113.5.1589; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; Curtin L R, 1995, Healthy People 2000 Stat Notes, P1; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Eaton W.W., 2004, USE PSYCHOL TESTING, V3; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Eggermont LHP, 2009, J GERONTOL A-BIOL, V64, P763, DOI 10.1093/gerona/glp016; ESCOBAR JI, 1986, J NERV MENT DIS, V174, P607, DOI 10.1097/00005053-198610000-00005; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Gorina Yelena, 2005, Aging Trends, P1; Graven-Nielsen T, 2002, MUSCLE NERVE, V26, P708, DOI 10.1002/mus.10225; Guralnik J.M., 1995, WOMENS HLTH AGING ST; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Lamb SE, 2000, ANN RHEUM DIS, V59, P331, DOI 10.1136/ard.59.5.331; Leveille S. G., 2009, J PAIN MANAGEMENT, V1, P329; Leveille SG, 2002, J AM GERIATR SOC, V50, P671, DOI 10.1046/j.1532-5415.2002.50161.x; Leveille SG, 2001, ANN INTERN MED, V135, P1038, DOI 10.7326/0003-4819-135-12-200112180-00007; Leveille SG, 2007, PAIN, V128, P69, DOI 10.1016/j.pain.2006.08.031; Leveille Suzanne G, 2008, BMC Geriatr, V8, P16, DOI 10.1186/1471-2318-8-16; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Pahor M, 1999, AM J PUBLIC HEALTH, V89, P930, DOI 10.2105/AJPH.89.6.930; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Samelson EJ, 2008, AM J EPIDEMIOL, V168, P1444, DOI 10.1093/aje/kwn277; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; The American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x	48	330	340	3	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2214	2221		10.1001/jama.2009.1738	http://dx.doi.org/10.1001/jama.2009.1738			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523NI	19934422	Green Accepted			2022-12-24	WOS:000272080500025
J	Loh, E; Dussurget, O; Gripenland, J; Vaitkevicius, K; Tiensuu, T; Mandin, P; Repoila, F; Buchrieser, C; Cossart, P; Johansson, J				Loh, Edmund; Dussurget, Olivier; Gripenland, Jonas; Vaitkevicius, Karolis; Tiensuu, Teresa; Mandin, Pierre; Repoila, Francis; Buchrieser, Carmen; Cossart, Pascale; Johansson, Jorgen			A trans-Acting Riboswitch Controls Expression of the Virulence Regulator PrfA in Listeria monocytogenes	CELL			English	Article							SMALL NONCODING RNAS; GENE-EXPRESSION; S-ADENOSYLMETHIONINE; ANTISENSE MECHANISM; RIBOSOME-BINDING; VIBRIO-CHOLERAE; OUTER-MEMBRANE; TRANSLATION; TRANSCRIPTION; IDENTIFICATION	Riboswitches are RNA elements acting in cis, controlling expression of their downstream genes through a metabolite-induced alteration of their secondary structure. Here, we demonstrate that two S-adenosylmethionine (SAM) riboswitches, SreA and SreB, can also function in trans and act as noncoding RNAs in Listeria monocytogenes. SreA and SreB control expression of the virulence regulator PrfA by binding to the 5'-untranslated region of its mRNA. Absence of the SAM riboswitches SreA and SreB increases the level of PrfA and virulence gene expression in L. monocytogenes. Thus, the impact of the SAM riboswitches on PrfA expression highlights a link between bacterial virulence and nutrient availability. Together, our results uncover an unexpected role for riboswitches and a distinct class of regulatory noncoding RNAs in bacteria.	[Dussurget, Olivier; Mandin, Pierre; Repoila, Francis; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Loh, Edmund; Gripenland, Jonas; Vaitkevicius, Karolis; Tiensuu, Teresa; Johansson, Jorgen] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Loh, Edmund; Gripenland, Jonas; Vaitkevicius, Karolis; Tiensuu, Teresa; Johansson, Jorgen] Umea Univ, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden; [Dussurget, Olivier; Mandin, Pierre; Repoila, Francis; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Dussurget, Olivier; Mandin, Pierre; Repoila, Francis; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Buchrieser, Carmen] Inst Pasteur, CNRS, URA 2171, UP Biol Bacteries Intracellulaires, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Umea University; Umea University; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr; jorgen.johansson@molbiol.umu.se	Vaitkevicius, Karolis/R-9714-2016	Vaitkevicius, Karolis/0000-0001-9309-3653; Johansson, Jorgen/0000-0002-0904-497X; Dussurget, Olivier/0000-0001-9924-0837; gripenland, jonas/0000-0002-9445-8586; Mandin, Pierre/0000-0002-4870-941X; Loh, Edmund/0000-0001-7050-566X; Buchrieser, Carmen/0000-0003-3477-9190; Repoila, Francis/0000-0001-5149-9698	Wenner-Gren Foundations, Umea University; Swedish Research Council [2008-58X-15144-05-3, 621-2006-4450]; EU (BacRNA 2005) [018618]; Institut Pasteur (GPH 9); INSERM; INRA; ERC; ANR [ANR-05-MIIM-026-01]	Wenner-Gren Foundations, Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU (BacRNA 2005)(European Commission); Institut Pasteur (GPH 9); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; ERC(European Research Council (ERC)European Commission); ANR(French National Research Agency (ANR))	We thank S. Gottesman, T. Geissmann, and B. Guo, for critical reading of the manuscript. We thank A. Toledo-Arana and M. Vergassola for computer predictions, Christophe Rusniok for data submission, N. Sesto and T. Geissmann for technical assistance, and S. Engelmann for SigB antibody. J.J. is supported by the Wenner-Gren Foundations, Umea University, the Swedish Research Council (grants 2008-58X-15144-05-3 and 621-2006-4450), and EU (BacRNA 2005 contract number 018618). Work in the laboratory of P. C. received financial support from Institut Pasteur (GPH 9), INSERM, INRA, EU (BacRNA 2005 contract number 018618), ERC, and ANR (ANR-05-MIIM-026-01). P. C. is an international research scholar from the Howard Hughes Medical Institute.	Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Darfeuille F, 2007, MOL CELL, V26, P381, DOI 10.1016/j.molcel.2007.04.003; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Johansson J, 2003, TRENDS MICROBIOL, V11, P280, DOI 10.1016/S0966-842X(03)00118-5; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lu C, 2008, NAT STRUCT MOL BIOL, V15, P1076, DOI 10.1038/nsmb.1494; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Nudler E, 2006, CELL, V126, P19, DOI 10.1016/j.cell.2006.06.024; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Renzoni A, 1999, MOL MICROBIOL, V34, P552, DOI 10.1046/j.1365-2958.1999.01621.x; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Whitford PC, 2009, BIOPHYS J, V96, pL7, DOI 10.1016/j.bpj.2008.10.033; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967	32	264	274	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					770	779		10.1016/j.cell.2009.08.046	http://dx.doi.org/10.1016/j.cell.2009.08.046			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914169	Bronze			2022-12-24	WOS:000271747200020
J	Vardi, A; Van Mooy, BAS; Fredricks, HF; Popendorf, KJ; Ossolinski, JE; Haramaty, L; Bidle, KD				Vardi, Assaf; Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Popendorf, Kimberly J.; Ossolinski, Justin E.; Haramaty, Liti; Bidle, Kay D.			Viral Glycosphingolipids Induce Lytic Infection and Cell Death in Marine Phytoplankton	SCIENCE			English	Article							EMILIANIA-HUXLEYI; SERINE PALMITOYLTRANSFERASE; NITRIC-OXIDE; ALGAL VIRUS; COCCOLITHOPHORE; PHYCODNAVIRIDAE; METABOLISM; EXPRESSION; STRATEGY; STRESS	Marine viruses that infect phytoplankton are recognized as a major ecological and evolutionary driving force, shaping community structure and nutrient cycling in the marine environment. Little is known about the signal transduction pathways mediating viral infection. We show that viral glycosphingolipids regulate infection of Emiliania huxleyi, a cosmopolitan coccolithophore that plays a major role in the global carbon cycle. These sphingolipids derive from an unprecedented cluster of biosynthetic genes in Coccolithovirus genomes, are synthesized de novo during lytic infection, and are enriched in virion membranes. Purified glycosphingolipids induced biochemical hallmarks of programmed cell death in an uninfected host. These lipids were detected in coccolithophore populations in the North Atlantic, which highlights their potential as biomarkers for viral infection in the oceans.	[Vardi, Assaf; Haramaty, Liti; Bidle, Kay D.] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, New Brunswick, NJ 08901 USA; [Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Popendorf, Kimberly J.; Ossolinski, Justin E.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Rutgers State University New Brunswick; Woods Hole Oceanographic Institution	Bidle, KD (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	bidle@marine.rutgers.edu		Vardi, Assaf/0000-0002-7079-0234; Popendorf, Kimberly/0000-0002-5581-9043	NSF's [OCE-0619608, IOS-0717494, OCE-0646944]; Gordon and Betty Moore Foundation	NSF's(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	The authors acknowledge M. Soule and E. Kujawinski and the funding sources of the Woods Hole Oceanographic Institution Fourier-Transform Mass Spectrometry Facility (NSF's Major Research Instrumentation Program OCE-0619608 and the Gordon and Betty Moore Foundation) for assistance with MS data acquisition. We thank D. Repeta for assistance and advice on pigment analysis, V. Starovoytov for TEM analysis, and C. Brown and M. Frada for helpful discussions and valuable feedback. This work was supported by NSF grant IOS-0717494 to K. D. B. and A. V., as well as NSF grant OCE-0646944 to B. V.M.	Allen MJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-11; Allen MJ, 2006, J VIROL, V80, P7699, DOI 10.1128/JVI.00491-06; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; MONIER A, 2009, GENOME BIOL, DOI DOI 10.1101/GR.091686.109; PAGARETE A, 2009, ENVIRON MICROBIOL, DOI DOI 10.1111/J.1462; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Turkoglu M, 2008, J MAR BIOL ASSOC UK, V88, P433, DOI 10.1017/S0025315408000866; Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vardi A, 1999, CURR BIOL, V9, P1061, DOI 10.1016/S0960-9822(99)80459-X; Vardi A, 2008, CURR BIOL, V18, P895, DOI 10.1016/j.cub.2008.05.037; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109	27	153	165	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					861	865		10.1126/science.1177322	http://dx.doi.org/10.1126/science.1177322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19892986				2022-12-24	WOS:000271468000046
J	Beaumont, HJE; Gallie, J; Kost, C; Ferguson, GC; Rainey, PB				Beaumont, Hubertus J. E.; Gallie, Jenna; Kost, Christian; Ferguson, Gayle C.; Rainey, Paul B.			Experimental evolution of bet hedging	NATURE			English	Article							PSEUDOMONAS-FLUORESCENS; EXPERIMENTAL POPULATIONS; ADAPTIVE DIVERGENCE; ESCHERICHIA-COLI; FLUCTUATING ENVIRONMENTS; DIVERSITY; STRATEGY	Bet hedging-stochastic switching between phenotypic states(1-3)-is a canonical example of an evolutionary adaptation that facilitates persistence in the face of fluctuating environmental conditions. Although bet hedging is found in organisms ranging from bacteria to humans(4-10), direct evidence for an adaptive origin of this behaviour is lacking(11). Here we report the de novo evolution of bet hedging in experimental bacterial populations. Bacteria were subjected to an environment that continually favoured new phenotypic states. Initially, our regime drove the successive evolution of novel phenotypes by mutation and selection; however, in two (of 12) replicates this trend was broken by the evolution of bet-hedging genotypes that persisted because of rapid stochastic phenotype switching. Genome re-sequencing of one of these switching types revealed nine mutations that distinguished it from the ancestor. The final mutation was both necessary and sufficient for rapid phenotype switching; nonetheless, the evolution of bet hedging was contingent upon earlier mutations that altered the relative fitness effect of the final mutation. These findings capture the adaptive evolution of bet hedging in the simplest of organisms, and suggest that risk-spreading strategies may have been among the earliest evolutionary solutions to life in fluctuating environments.	[Beaumont, Hubertus J. E.; Gallie, Jenna; Kost, Christian; Ferguson, Gayle C.; Rainey, Paul B.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, N Shore Mail Ctr, North Shore 0745, Auckland, New Zealand; [Beaumont, Hubertus J. E.; Gallie, Jenna; Kost, Christian; Ferguson, Gayle C.; Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, N Shore Mail Ctr, N Shore City 0745, Auckland, New Zealand; [Beaumont, Hubertus J. E.] Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands	Massey University; Massey University; Leiden University; Leiden University - Excl LUMC	Beaumont, HJE (corresponding author), Leiden Univ, Inst Biol Leiden, POB 9505, NL-2300 RA Leiden, Netherlands.	h.j.e.beaumont@biology.leidenuniv.nl	Gallie, Jenna/ABH-7516-2020; Rainey, Paul/A-3207-2008; Kost, Christian/N-1553-2014	Rainey, Paul/0000-0003-0879-5795; Kost, Christian/0000-0002-7870-7343; Ferguson, Gayle/0000-0002-7858-6190	Royal Society of New Zealand; Netherlands Organisation for Scientific Research(NWO); New Zealand Foundation for Research, Science and Technology; Alexander von Humboldt Foundation, Germany	Royal Society of New Zealand(Royal Society of New Zealand); Netherlands Organisation for Scientific Research(NWO)(Netherlands Organization for Scientific Research (NWO)); New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	We thank T. F. Cooper, M. R. Goddard and D. Refardt for discussion; M. Gray, A. Hurman and G. E. M. Lamers for technical assistance; M. Ackermann, P. M. Brakefield, T. Fukami, S. Rossell and B. J. Zwaan for comments on the manuscript; T. J. M. Van Dooren for statistical advice; F. Bertels for computational analysis of Solexa data; and E. Libby for theoretical insight. This work was supported by the Marsden Fund Council from government funding administered by the Royal Society of New Zealand. H. J. E. B. is supported by a Veni Fellowship from The Netherlands Organisation for Scientific Research(NWO). J. G. was supported by a Bright Futures Scholarship from the New Zealand Foundation for Research, Science and Technology. C. K. was supported by a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation, Germany. G. C. F. is supported by a Postdoctoral Fellowship from the New Zealand Foundation for Research, Science and Technology.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Danforth BN, 1999, P ROY SOC B-BIOL SCI, V266, P1985, DOI 10.1098/rspb.1999.0876; Friedenberg NA, 2003, ECOL LETT, V6, P953, DOI 10.1046/j.1461-0248.2003.00524.x; Giddens SR, 2007, P NATL ACAD SCI USA, V104, P18247, DOI 10.1073/pnas.0706739104; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; HAIRSTON NG, 1984, AM NAT, V123, P733, DOI 10.1086/284236; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; MCDONALD MJ, GENETICS IN PRESS; MERGEAY M, 1974, MOL GEN GENET, V133, P299, DOI 10.1007/BF00332706; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; SLATKIN M, 1974, NATURE, V250, P704, DOI 10.1038/250704b0; Spiers AJ, 2002, GENETICS, V161, P33; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Zhang XX, 2007, J MICROBIOL METH, V71, P78, DOI 10.1016/j.mimet.2007.07.001	30	406	413	2	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 5	2009	462	7269					90	U97		10.1038/nature08504	http://dx.doi.org/10.1038/nature08504			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890329	Green Published			2022-12-24	WOS:000271419200038
J	Zinzen, RP; Girardot, C; Gagneur, J; Braun, M; Furlong, EEM				Zinzen, Robert P.; Girardot, Charles; Gagneur, Julien; Braun, Martina; Furlong, Eileen E. M.			Combinatorial binding predicts spatio-temporal cis-regulatory activity	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; MUSCLE-CELL LINEAGES; GENOME-WIDE ANALYSIS; MESODERM DEVELOPMENT; GENE MEF2; DROSOPHILA; INTEGRATION; ELEMENTS; TINMAN; TWIST	Development requires the establishment of precise patterns of gene expression, which are primarily controlled by transcription factors binding to cis-regulatory modules. Although transcription factor occupancy can now be identified at genome-wide scales, decoding this regulatory landscape remains a daunting challenge. Here we used a novel approach to predict spatio-temporal cis-regulatory activity based only on in vivo transcription factor binding and enhancer activity data. We generated a high-resolution atlas of cis-regulatory modules describing their temporal and combinatorial occupancy during Drosophila mesoderm development. The binding profiles of cis-regulatory modules with characterized expression were used to train support vector machines to predict five spatio-temporal expression patterns. In vivo transgenic reporter assays demonstrate the high accuracy of these predictions and reveal an unanticipated plasticity in transcription factor binding leading to similar expression. This data-driven approach does not require previous knowledge of transcription factor sequence affinity, function or expression, making it widely applicable.	[Zinzen, Robert P.; Girardot, Charles; Gagneur, Julien; Braun, Martina; Furlong, Eileen E. M.] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Furlong, EEM (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	furlong@embl.de	Zinzen, Robert P/A-3130-2015; Girardot, Charles/AAF-2417-2020; Zinzen, Robert/AAG-2784-2020	Zinzen, Robert P/0000-0002-8638-5102; Girardot, Charles/0000-0003-4301-3920; Furlong, Eileen/0000-0002-9544-8339; Gagneur, Julien/0000-0002-8924-8365	Human Frontiers Science Program	Human Frontiers Science Program(Human Frontier Science Program)	We are grateful to M. Leptin for providing an independent assessment of the expression patterns driven by tested CRMs. We thank H. Gustafson for fly work, J. de Graaf for array hybridizations, S. Muller for embryo injections, and R. Bourgon for sharing code on signal peak identification. We thank all members of the Furlong laboratory for discussions and comments on the manuscript. This work was supported by a grant to E. E. M. F. and by a fellowship to R. P. Z. from the Human Frontiers Science Program.	Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Arnosti DN, 1996, DEVELOPMENT, V122, P205; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Celniker SE, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0079; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Cripps RM, 1999, DEV BIOL, V215, P420, DOI 10.1006/dbio.1999.9446; Davidson B, 2003, P NATL ACAD SCI USA, V100, P11469, DOI 10.1073/pnas.1634991100; Davidson EH, 2006, REG GEN GEN REG; Furlong EE, 2004, CURR OPIN GENET DEV, V14, P343, DOI 10.1016/j.gde.2004.06.011; Hadchouel J, 2003, DEVELOPMENT, V130, P3415, DOI 10.1242/dev.00552; Halfon MS, 2008, NUCLEIC ACIDS RES, V36, pD594, DOI 10.1093/nar/gkm876; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Knirr S, 2001, DEV BIOL, V238, P13, DOI 10.1006/dbio.2001.0397; Lee HH, 2005, DEVELOPMENT, V132, P1429, DOI 10.1242/dev.01687; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Li LP, 2007, BIOINFORMATICS, V23, P1188, DOI 10.1093/bioinformatics/btm080; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Lloyd CJ, 1998, J AM STAT ASSOC, V93, P1356, DOI 10.2307/2670051; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Ochoa-Espinosa A, 2006, CURR OPIN GENET DEV, V16, P165, DOI 10.1016/j.gde.2006.02.014; Oliveri P, 2002, DEV BIOL, V246, P209, DOI 10.1006/dbio.2002.0627; Reiss DJ, 2008, BIOINFORMATICS, V24, P396, DOI 10.1093/bioinformatics/btm592; Rothbacher U, 2007, DEVELOPMENT, V134, P4023, DOI 10.1242/dev.010850; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sink H., 2006, MUSCLE DEV DROSOPHIL; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Yin ZZ, 1997, DEVELOPMENT, V124, P4971; Yuh CH, 2001, DEVELOPMENT, V128, P617; Zaffran S, 2001, GENE DEV, V15, P2900; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	57	283	286	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					65	U72		10.1038/nature08531	http://dx.doi.org/10.1038/nature08531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19890324				2022-12-24	WOS:000271419200032
J	Walsh, DA; Zaikova, E; Howes, CG; Song, YC; Wright, JJ; Tringe, SG; Tortell, PD; Hallam, SJ				Walsh, David A.; Zaikova, Elena; Howes, Charles G.; Song, Young C.; Wright, Jody J.; Tringe, Susannah G.; Tortell, Philippe D.; Hallam, Steven J.			Metagenome of a Versatile Chemolithoautotroph from Expanding Oceanic Dead Zones	SCIENCE			English	Article							SULFIDE OXIDATION; ESCHERICHIA-COLI; WATERS; NITRATE; SULFUR; DIVERSITY; BACTERIAL; SYMBIONT	Oxygen minimum zones, also known as oceanic "dead zones," are widespread oceanographic features currently expanding because of global warming. Although inhospitable to metazoan life, they support a cryptic microbiota whose metabolic activities affect nutrient and trace gas cycling within the global ocean. Here, we report metagenomic analyses of a ubiquitous and abundant but uncultivated oxygen minimum zone microbe (SUP05) related to chemoautotrophic gill symbionts of deep-sea clams and mussels. The SUP05 metagenome harbors a versatile repertoire of genes mediating autotrophic carbon assimilation, sulfur oxidation, and nitrate respiration responsive to a wide range of water-column redox states. Our analysis provides a genomic foundation for understanding the ecological and biogeochemical role of pelagic SUP05 in oxygen-deficient oceanic waters and its potential sensitivity to environmental changes.	[Walsh, David A.; Zaikova, Elena; Howes, Charles G.; Song, Young C.; Wright, Jody J.; Hallam, Steven J.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Tringe, Susannah G.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Tortell, Philippe D.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Tortell, Philippe D.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Hallam, Steven J.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of British Columbia; University of British Columbia; University of British Columbia	Hallam, SJ (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada.	shallam@interchange.ubc.ca		Walsh, David/0000-0002-9951-5447; Tortell, Philippe/0000-0003-0212-2151	U. S. Department of Energy's Office of Science, Biological, and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory, Lawrence Livermore National Laboratory [DE-AC02-05CH11231, DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Natural Sciences and Engineering Research Council (NSERC) of Canada [328256-07, STPSC 356988]; Canada Foundation for Innovation (CFI) [Canada Foundation for Innovation (CFI) 17444]; Canadian Institute for Advanced Research ( CIFAR); Center for Bioinorganic Chemistry (CEBIC); NSERC; Killam Trust; Tula Foundation-funded Centre for Microbial Diversity and Evolution (CMDE); DNA DataBank of Japan and European Molecular Biology Laboratory;  [ACSG00000000]	U. S. Department of Energy's Office of Science, Biological, and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory, Lawrence Livermore National Laboratory(University of California System); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institute for Advanced Research ( CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Center for Bioinorganic Chemistry (CEBIC); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Trust; Tula Foundation-funded Centre for Microbial Diversity and Evolution (CMDE); DNA DataBank of Japan and European Molecular Biology Laboratory; 	This work was performed under the auspices of the U. S. Department of Energy's Office of Science, Biological, and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory, Lawrence Livermore National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. This work was also supported by grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada 328256-07 and STPSC 356988, Canada Foundation for Innovation (CFI) 17444; Canadian Institute for Advanced Research ( CIFAR), and the Center for Bioinorganic Chemistry (CEBIC). D. A. W. was supported by NSERC, Killam Trust, and the Tula Foundation-funded Centre for Microbial Diversity and Evolution (CMDE). We thank M. Robert ( Institute of Ocean Sciences, Sidney, BC, Canada), C. Payne, L. Pakhomova, and J. Granger (UBC) for help in sampling and chemical analyses and the captains and crews of the CCGS John P. Tulley and HMS John Strickland for logistical support. We thank the Joint Genome Institute, including K. Barry, S. Pitluck, and E. Kirton, for technical assistance and A. Page, K. Mitchell, and S. Lee in the Hallam laboratory for reading the manuscript. This metagenome project has been deposited at the DNA DataBank of Japan and European Molecular Biology Laboratory, and GenBank, under the project accession ACSG00000000. The version described in this paper is the first version, ACSG01000000. SSU rRNA gene sequences were deposited at GenBank under the accession numbers GQ345343-GQ351265, and fosmid sequences were deposited under the accession numbers GQ351266 to GQ351269 and GQ369726.	ANDERSON J J, 1973, Estuarine and Coastal Marine Science, V1, P1, DOI 10.1016/0302-3524(73)90052-2; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Cardoso RB, 2006, BIOTECHNOL BIOENG, V95, P1148, DOI 10.1002/bit.21084; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Fuchs BM, 2005, AQUAT MICROB ECOL, V39, P145, DOI 10.3354/ame039145; Jost G, 2008, LIMNOL OCEANOGR, V53, P14, DOI 10.4319/lo.2008.53.1.0014; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; Stevens H, 2008, ENVIRON MICROBIOL, V10, P1244, DOI 10.1111/j.1462-2920.2007.01539.x; Stewart V, 2002, J BACTERIOL, V184, P1314, DOI 10.1128/JB.184.5.1314-1323.2002; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041; Wang HN, 1999, J BACTERIOL, V181, P5303, DOI 10.1128/JB.181.17.5303-5308.1999; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; Zopfi J, 2001, MAR CHEM, V74, P29, DOI 10.1016/S0304-4203(00)00091-8	29	236	243	4	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					578	582		10.1126/science.1175309	http://dx.doi.org/10.1126/science.1175309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19900896	Green Submitted			2022-12-24	WOS:000271019400043
J	van Doorn, GS; Edelaar, P; Weissing, FJ				van Doorn, G. Sander; Edelaar, Pim; Weissing, Franz J.			On the Origin of Species by Natural and Sexual Selection	SCIENCE			English	Article							SYMPATRIC SPECIATION; HANDICAP PRINCIPLE; FEMALE CHOICE; MATE CHOICE; EVOLUTION; ENVIRONMENT; PREFERENCES; HYPOTHESIS; PARADOX; ECOLOGY	Ecological speciation is considered an adaptive response to selection for local adaptation. However, besides suitable ecological conditions, the process requires assortative mating to protect the nascent species from homogenization by gene flow. By means of a simple model, we demonstrate that disruptive ecological selection favors the evolution of sexual preferences for ornaments that signal local adaptation. Such preferences induce assortative mating with respect to ecological characters and enhance the strength of disruptive selection. Natural and sexual selection thus work in concert to achieve local adaptation and reproductive isolation, even in the presence of substantial gene flow. The resulting speciation process ensues without the divergence of mating preferences, avoiding problems that have plagued previous models of speciation by sexual selection.	[van Doorn, G. Sander] Santa Fe Inst, Santa Fe, NM 87501 USA; [van Doorn, G. Sander] Univ Bern, Inst Ecol & Evolut, CH-3032 Hinterkappelen, Switzerland; [Edelaar, Pim; Weissing, Franz J.] Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9750 AA Haren, Netherlands; [Edelaar, Pim] Uppsala Univ, Dept Anim Ecol, S-75236 Uppsala, Sweden; [Edelaar, Pim] CSIC, Estac Biol Donana, Dept Conservat Biol, Seville 41092, Spain	The Santa Fe Institute; University of Bern; University of Groningen; Uppsala University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	van Doorn, GS (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	sander.vandoorn@iee.unibe.ch	Edelaar, Pim/P-5650-2014; van Doorn, G. Sander/G-3247-2011	Edelaar, Pim/0000-0003-4649-6366; van Doorn, G. Sander/0000-0002-4703-3788; Weissing, Franz J./0000-0003-3281-663X	Netherlands Organization for Scientific Research; European Commission Marie Curie Outgoing International Fellowship	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission Marie Curie Outgoing International Fellowship(European Commission)	This work was supported by a Rubicon grant from the Netherlands Organization for Scientific Research (G. S. v. D.) and a European Commission Marie Curie Outgoing International Fellowship grant (P. E.). This paper reflects the authors' opinion only. We thank A. Leeuw for exploratory simulations; D. Visser for creating Fig. 1; and I. Olivieri, T. van Dooren, M. Maan, and two anonymous reviewers for constructive comments.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Bussiere LF, 2008, GENETICA, V134, P69, DOI 10.1007/s10709-007-9220-z; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Coyne JA, 2004, SPECIATION, V37; Darwin C., 1859, ORIGIN SPECIES MEANS; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dolgin ES, 2006, J EVOLUTION BIOL, V19, P1894, DOI 10.1111/j.1420-9101.2006.01168.x; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Gavrilets S, 2005, EVOLUTION, V59, P696; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; Higashi M, 1999, NATURE, V402, P523, DOI 10.1038/990087; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI 10.1111/j.1558-5646.1991.tb02646.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kokko H, 2008, GENETICA, V134, P55, DOI 10.1007/s10709-008-9249-7; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Proulx SR, 2001, EVOLUTION, V55, P2401; Reinhold K, 2004, ORG DIVERS EVOL, V4, P157, DOI 10.1016/j.ode.2003.10.002; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; van Doorn GS, 2004, AM NAT, V163, P709, DOI 10.1086/383619	29	236	239	1	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1704	1707		10.1126/science.1181661	http://dx.doi.org/10.1126/science.1181661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	19965377	Green Submitted, Bronze			2022-12-24	WOS:000272839000056
J	Guell, M; van Noort, V; Yus, E; Chen, WH; Leigh-Bell, J; Michalodimitrakis, K; Yamada, T; Arumugam, M; Doerks, T; Kuhner, S; Rode, M; Suyama, M; Schmidt, S; Gavin, AC; Bork, P; Serrano, L				Gueell, Marc; van Noort, Vera; Yus, Eva; Chen, Wei-Hua; Leigh-Bell, Justine; Michalodimitrakis, Konstantinos; Yamada, Takuji; Arumugam, Manimozhiyan; Doerks, Tobias; Kuehner, Sebastian; Rode, Michaela; Suyama, Mikita; Schmidt, Sabine; Gavin, Anne-Claude; Bork, Peer; Serrano, Luis			Transcriptome Complexity in a Genome-Reduced Bacterium	SCIENCE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; ESCHERICHIA-COLI; IDENTIFICATION; EXPRESSION; GENES	To study basic principles of transcriptome organization in bacteria, we analyzed one of the smallest self-replicating organisms, Mycoplasma pneumoniae. We combined strand-specific tiling arrays, complemented by transcriptome sequencing, with more than 252 spotted arrays. We detected 117 previously undescribed, mostly noncoding transcripts, 89 of them in antisense configuration to known genes. We identified 341 operons, of which 139 are polycistronic; almost half of the latter show decaying expression in a staircase-like manner. Under various conditions, operons could be divided into 447 smaller transcriptional units, resulting in many alternative transcripts. Frequent antisense transcripts, alternative transcripts, and multiple regulators per gene imply a highly dynamic transcriptome, more similar to that of eukaryotes than previously thought.	[van Noort, Vera; Chen, Wei-Hua; Yamada, Takuji; Arumugam, Manimozhiyan; Doerks, Tobias; Kuehner, Sebastian; Rode, Michaela; Suyama, Mikita; Schmidt, Sabine; Gavin, Anne-Claude; Bork, Peer] EMBL, Heidelberg, Germany; [Gueell, Marc; Yus, Eva; Leigh-Bell, Justine; Michalodimitrakis, Konstantinos; Serrano, Luis] Univ Pompeu Fabra, CRG, Barcelona, Spain; [Serrano, Luis] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Bork, P (corresponding author), EMBL, Heidelberg, Germany.	bork@embl.de; luis.serrano@crg.es	Arumugam, Manimozhiyan/AAJ-2394-2020; Serrano, Luis/B-3355-2013; Güell, Marc/AAB-3054-2021; Arumugam, Manimozhiyan/E-1211-2011; Güell, Marc/J-2970-2017; van Noort, Vera/E-1053-2011; van Noort, Vera/GWZ-9038-2022; Chen, Weihua/GRS-9256-2022; Bork, Peer/F-1813-2013	Arumugam, Manimozhiyan/0000-0002-0886-9101; Serrano, Luis/0000-0002-5276-1392; Güell, Marc/0000-0003-4000-7912; Arumugam, Manimozhiyan/0000-0002-0886-9101; Güell, Marc/0000-0003-4000-7912; van Noort, Vera/0000-0002-8436-6602; Bork, Peer/0000-0002-2627-833X; Schmidt, Steffen/0000-0001-9077-6010; Suyama, Mikita/0000-0001-9526-3193; Chen, Wei-Hua/0000-0003-2168-6147; Gavin, Anne-Claude/0000-0003-4917-2340	Foundation Marcelino Botin; Ministry of Education of Spain (MEC)-Consolider; European Research Council; Spanish MEC-Formacion Profesorado Universitario; Netherlands Organization for Scientific Research; ICREA Funding Source: Custom	Foundation Marcelino Botin; Ministry of Education of Spain (MEC)-Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council(European Research Council (ERC)European Commission); Spanish MEC-Formacion Profesorado Universitario; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ICREA(ICREA)	We thank the Genomics core facility at EMBL (Heidelberg, Germany), J. Lozano for help with statistical analysis, and the Ultrasequencing Unit at CRG. This work was funded by the Foundation Marcelino Botin, the Ministry of Education of Spain (MEC)-Consolider, and the European Research Council. M. G. is funded by the Spanish MEC-Formacion Profesorado Universitario. V.N. is funded by the Netherlands Organization for Scientific Research.	Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Boue S, 2003, BIOESSAYS, V25, P1031, DOI 10.1002/bies.10371; BRANTL S, 1994, EMBO J, V13, P3599, DOI 10.1002/j.1460-2075.1994.tb06667.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Budin-Verneuil A, 2004, LAIT, V84, P61, DOI 10.1051/lait:2003033; Chang LJ, 2008, BIOCHEM BIOPH RES CO, V367, P213, DOI 10.1016/j.bbrc.2007.12.124; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429; Henz SR, 2007, PLANT PHYSIOL, V144, P1247, DOI 10.1104/pp.107.100396; Hooper SD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100112; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Washio T, 1998, NUCLEIC ACIDS RES, V26, P5456, DOI 10.1093/nar/26.23.5456; Weiner J, 2000, NUCLEIC ACIDS RES, V28, P4488, DOI 10.1093/nar/28.22.4488; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	25	325	339	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2009	326	5957					1268	1271		10.1126/science.1176951	http://dx.doi.org/10.1126/science.1176951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	524BD	19965477				2022-12-24	WOS:000272117900049
J	Gill, JL; Williams, JW; Jackson, ST; Lininger, KB; Robinson, GS				Gill, Jacquelyn L.; Williams, John W.; Jackson, Stephen T.; Lininger, Katherine B.; Robinson, Guy S.			Pleistocene Megafaunal Collapse, Novel Plant Communities, and Enhanced Fire Regimes in North America	SCIENCE			English	Article							LATE QUATERNARY EXTINCTIONS; CLIMATE-CHANGE; SPORORMIELLA; VEGETATION; STATE; USA	Although the North American megafaunal extinctions and the formation of novel plant communities are well-known features of the last deglaciation, the causal relationships between these phenomena are unclear. Using the dung fungus Sporormiella and other paleoecological proxies from Appleman Lake, Indiana, and several New York sites, we established that the megafaunal decline closely preceded enhanced fire regimes and the development of plant communities that have no modern analogs. The loss of keystone megaherbivores may thus have altered ecosystem structure and function by the release of palatable hardwoods from herbivory pressure and by fuel accumulation. Megafaunal populations collapsed from 14,800 to 13,700 years ago, well before the final extinctions and during the Bolling-Allerod warm period. Human impacts remain plausible, but the decline predates Younger Dryas cooling and the extraterrestrial impact event proposed to have occurred 12,900 years ago.	[Gill, Jacquelyn L.; Williams, John W.; Lininger, Katherine B.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Gill, Jacquelyn L.; Williams, John W.] Univ Wisconsin, Ctr Climat Res, Madison, WI 53706 USA; [Jackson, Stephen T.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Robinson, Guy S.] Fordham Univ, Dept Nat Sci, New York, NY 10023 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wyoming; Fordham University	Gill, JL (corresponding author), Univ Wisconsin, Dept Geog, Madison, WI 53706 USA.		Lininger, Katherine/GNM-6596-2022; GIll, Jacquelyn/F-1454-2011; Gill, Jacquelyn/HCH-8486-2022	Lininger, Katherine/0000-0003-0378-9505; robinson, guy/0000-0002-0007-4785; Jackson, Stephen/0000-0002-1487-4652	NSF [DEB-0716471, DEB-0716951]; Graduate School; Climate, People and Environment Program at the University of Wisconsin	NSF(National Science Foundation (NSF)); Graduate School; Climate, People and Environment Program at the University of Wisconsin	We thank E. Grimm, J. Mason, and S. Hotchkiss for discussions and T. Minckley, S. Lucas, J. Marsicek, D. Alhambra, G. Schellinger, and S. Hernandez for field and laboratory assistance. Initial core analyses were performed at the National Lacustrine Core Facility at the University of Minnesota. This work was supported by NSF (grants DEB-0716471 and DEB-0716951)and the Graduate School and the Climate, People and Environment Program at the University of Wisconsin.	AHMED SI, 1972, CAN J BOTANY, V50, P419, DOI 10.1139/b72-061; Alroy John, 1999, P105; Bartlein PJ, 1998, QUATERNARY SCI REV, V17, P549, DOI 10.1016/S0277-3791(98)00012-2; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Burney DA, 2003, P NATL ACAD SCI USA, V100, P10800, DOI 10.1073/pnas.1534700100; COLEY PD, 1987, NEW PHYTOL, V106, P251; Danell K., 2006, LARGE HERBIVORE ECOL; Davis OK, 2006, PALAEOGEOGR PALAEOCL, V237, P40, DOI 10.1016/j.palaeo.2005.11.028; Fiedel S, 2004, J ARCHAEOL SCI, V31, P121, DOI 10.1016/j.jas.2003.06.004; Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Grimm EC, 2009, QUATERNARY RES, V72, P301, DOI 10.1016/j.yqres.2009.05.006; Johnson CN, 2009, P ROY SOC B-BIOL SCI, V276, P2509, DOI 10.1098/rspb.2008.1921; Joyce DJ, 2006, QUATERN INT, V142, P44, DOI 10.1016/j.quaint.2005.03.004; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Marlon JR, 2009, P NATL ACAD SCI USA, V106, P2519, DOI 10.1073/pnas.0808212106; Martin PS, 1984, QUATERNARY EXTINCTIO; MCINNES PF, 1992, ECOLOGY, V73, P2059, DOI 10.2307/1941455; Overstreet David F., 1997, Current Research in the Pleistocene, V14, P70; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Pinter N., 2008, GSA TODAY, V18, P37, DOI [10.1130/GSAT01801GW.1, DOI 10.1130/GSAT01801GW.1]; PRENTICE IC, 1991, ECOLOGY, V72, P2038, DOI 10.2307/1941558; Raper D, 2009, QUATERNARY RES, V71, P490, DOI 10.1016/j.yqres.2009.01.010; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Robinson GS, 2005, ECOL MONOGR, V75, P295, DOI 10.1890/03-4064; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; van Geel B, 2008, QUATERNARY RES, V69, P361, DOI 10.1016/j.yqres.2008.02.004; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Williams JW, 2001, ECOLOGY, V82, P3346	30	376	391	7	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1100	1103		10.1126/science.1179504	http://dx.doi.org/10.1126/science.1179504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965426	Green Published			2022-12-24	WOS:000271951000040
J	Colgin, LL; Denninger, T; Fyhn, M; Hafting, T; Bonnevie, T; Jensen, O; Moser, MB; Moser, EI				Colgin, Laura Lee; Denninger, Tobias; Fyhn, Marianne; Hafting, Torkel; Bonnevie, Tora; Jensen, Ole; Moser, May-Britt; Moser, Edvard I.			Frequency of gamma oscillations routes flow of information in the hippocampus	NATURE			English	Article							ENTORHINAL CORTEX; BEHAVING RAT; NEURONAL SYNCHRONIZATION; SPATIAL REPRESENTATION; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; THETA-RHYTHM; CA1; MEMORY; MODULATION	Gamma oscillations are thought to transiently link distributed cell assemblies that are processing related information(1,2), a function that is probably important for network processes such as perception(1-3), attentional selection(4) and memory(5,6). This 'binding' mechanism requires that spatially distributed cells fire together with millisecond range precision(7,8); however, it is not clear how such coordinated timing is achieved given that the frequency of gamma oscillations varies substantially across space and time, from similar to 25 to almost 150 Hz(1,9-13). Here we show that gamma oscillations in the CA1 area of the hippocampus split into distinct fast and slow frequency components that differentially couple CA1 to inputs from the medial entorhinal cortex, an area that provides information about the animal's current position(14-17), and CA3, a hippocampal subfield essential for storage of such information(14,18,19). Fast gamma oscillations in CA1 were synchronized with fast gamma in medial entorhinal cortex, and slow gamma oscillations in CA1 were coherent with slow gamma in CA3. Significant proportions of cells in medial entorhinal cortex and CA3 were phase-locked to fast and slow CA1 gamma waves, respectively. The two types of gamma occurred at different phases of the CA1 theta rhythm and mostly on different theta cycles. These results point to routeing of information as a possible function of gamma frequency variations in the brain and provide a mechanism for temporal segregation of potentially interfering information from different sources.	[Colgin, Laura Lee; Denninger, Tobias; Fyhn, Marianne; Hafting, Torkel; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway; [Colgin, Laura Lee; Denninger, Tobias; Fyhn, Marianne; Hafting, Torkel; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol Memory, MTFS, NO-7489 Trondheim, Norway; [Jensen, Ole] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Radboud University Nijmegen	Colgin, LL (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, NO-7489 Trondheim, Norway.	laura.colgin@ntnu.no; edvard.moser@ntnu.no	Jensenq, Ole/D-2120-2010	Jensenq, Ole/0000-0001-8193-8348; Colgin, Laura/0000-0002-4853-8913; Hafting, Torkel/0000-0002-0928-3487	Kavli Foundation; Norwegian Research Council	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank A. M. Amundsgaard, K. Haugen, K. Jenssen, E. Sjulstad, R. Skjerpeng and H. Waade for technical assistance, M. P. Witter for assistance with recording site localization, E. J. Henriksen and K. Jezek for donating rats for supplementary analyses, C. A. Barnes for helpful comments on the manuscript and G. Buzsaki and a number of other colleagues for helpful discussions. This work was supported by the Kavli Foundation and a Centre of Excellence grant from the Norwegian Research Council.	Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CHARPAK S, 1995, EUR J NEUROSCI, V7, P1548, DOI 10.1111/j.1460-9568.1995.tb01150.x; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kay Leslie M, 2003, J Integr Neurosci, V2, P31, DOI 10.1142/S0219635203000196; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Senior TJ, 2008, J NEUROSCI, V28, P2274, DOI 10.1523/JNEUROSCI.4669-07.2008; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; von der Malsburg C., 1994, MODELS NEURAL NETWOR, P95, DOI [DOI 10.1007/978-1-4612-4320-5_2, 10.1007/978-1-4612-4320-5_2]; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	30	847	861	3	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 19	2009	462	7271					353	U119		10.1038/nature08573	http://dx.doi.org/10.1038/nature08573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924214				2022-12-24	WOS:000271899300045
J	Gouridis, G; Karamanou, S; Gelis, I; Kalodimos, CG; Economou, A				Gouridis, Giorgos; Karamanou, Spyridoula; Gelis, Ioannis; Kalodimos, Charalampos G.; Economou, Anastassios			Signal peptides are allosteric activators of the protein translocase	NATURE			English	Article							ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; SEQUENCE RECOGNITION; SECY COMPLEX; SECRETION; MEMBRANE; CHANNEL; MOTOR; MUTATIONS; DOMAINS	Extra-cytoplasmic polypeptides are usually synthesized as 'preproteins' carrying amino-terminal, cleavable signal peptides(1) and secreted across membranes by translocases. The main bacterial translocase comprises the SecYEG protein-conducting channel and the peripheral ATPase motor SecA(2,3). Most proteins destined for the periplasm and beyond are exported post-translationally by SecA(2,3). Preprotein targeting to SecA is thought to involve signal peptides(4) and chaperones like SecB(5,6). Here we show that signal peptides have a new role beyond targeting: they are essential allosteric activators of the translocase. On docking on their binding groove on SecA, signal peptides act in trans to drive three successive states: first, 'triggering' that drives the translocase to a lower activation energy state; second, 'trapping' that engages non-native preprotein mature domains docked with high affinity on the secretion apparatus; and third, 'secretion' during which trapped mature domains undergo several turnovers of translocation in segments(7). A significant contribution by mature domains renders signal peptides less critical in bacterial secretory protein targeting than currently assumed. Rather, it is their function as allosteric activators of the translocase that renders signal peptides essential for protein secretion. A role for signal peptides and targeting sequences as allosteric activators may be universal in protein translocases.	[Gouridis, Giorgos; Karamanou, Spyridoula; Economou, Anastassios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; [Gouridis, Giorgos; Economou, Anastassios] Univ Crete, Dept Biol, Iraklion 71409, Crete, Greece; [Gelis, Ioannis; Kalodimos, Charalampos G.] Rutgers State Univ, Piscataway, NJ 08854 USA	Foundation for Research & Technology - Hellas (FORTH); University of Crete; Rutgers State University New Brunswick	Economou, A (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	aeconomo@imbb.forth.gr	Karamanou, Spyridoula/H-7485-2018; Economou, Anastassios/P-8292-2017; Kalodimos, Charalampos/Q-9846-2018; Gouridis, GIORGOS/ABF-7948-2021	Karamanou, Spyridoula/0000-0002-8803-1404; Economou, Anastassios/0000-0002-1770-507X; Kalodimos, Charalampos/0000-0001-6354-2796; Gouridis, GIORGOS/0000-0002-2255-0455	European Community [LSHC-CT-2006-037834/Streptomics]; Greek General Secretariat of Research and the European Regional Development Fund [PENED03ED623]; US National Institutes of Health [GM73854]; American Heart Association; Onassis Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073854] Funding Source: NIH RePORTER	European Community(European Commission); Greek General Secretariat of Research and the European Regional Development Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Onassis Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We are grateful to G. Dimitrakopoulos for help with MATLAB; M. Koukaki for constructs and materials; D. Boyd, S. Schulman and V. Koronakis for gifts of strains, plasmids and protocols; A. Kohen for advice on Arrhenius plots; A. Kuhn and K. Tokatlidis for comments. The research leading to these results has received funding from the European Community's Sixth Framework Programme (FP6/2002-2007) under grant agreement LSHC-CT-2006-037834/Streptomics (to A. E.), the Greek General Secretariat of Research and the European Regional Development Fund (PENED03ED623; to A. E.), the US National Institutes of Health grant GM73854 (to C. G. K.) and a Scientist Development Grant by the American Heart Association (to C. G. K.). G. G. is an Onassis Foundation predoctoral fellow.	AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Cooper DB, 2008, J MOL BIOL, V382, P74, DOI 10.1016/j.jmb.2008.06.049; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; FLOWER AM, 1994, J BACTERIOL, V176, P5607, DOI 10.1128/JB.176.18.5607-5614.1994; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Karamanou S, 2007, EMBO J, V26, P2904, DOI 10.1038/sj.emboj.7601721; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; OSBORNE RS, 1993, EMBO J, V12, P3391, DOI 10.1002/j.1460-2075.1993.tb06013.x; Papanikou E, 2005, J BIOL CHEM, V280, P43209, DOI 10.1074/jbc.M509990200; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; Prinz WA, 1996, EMBO J, V15, P5209, DOI 10.1002/j.1460-2075.1996.tb00906.x; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Shimizu H, 1997, MOL MICROBIOL, V26, P1013, DOI 10.1046/j.1365-2958.1997.6392003.x; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Stan G, 2006, P NATL ACAD SCI USA, V103, P4433, DOI 10.1073/pnas.0600433103; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; Vrontou E, 2004, J BIOL CHEM, V279, P22490, DOI 10.1074/jbc.M401008200; Zhou JH, 2005, MOL MICROBIOL, V58, P349, DOI 10.1111/j.1365-2958.2005.04842.x	30	105	106	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					363	U132		10.1038/nature08559	http://dx.doi.org/10.1038/nature08559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924216	Green Accepted			2022-12-24	WOS:000271899300047
J	Messiaen, L; Yao, S; Brems, H; Callens, T; Sathienkijkanchai, A; Denayer, E; Spencer, E; Arn, P; Babovic-Vuksanovic, D; Bay, C; Bobele, G; Cohen, BH; Escobar, L; Eunpu, D; Grebe, T; Greenstein, R; Hachen, R; Irons, M; Kronn, D; Lemire, E; Leppig, K; Lim, C; McDonald, M; Narayanan, V; Pearn, A; Pedersen, R; Powell, B; Shapiro, LR; Skidmore, D; Tegay, D; Thiese, H; Zackai, EH; Vijzelaar, R; Taniguchi, K; Ayada, T; Okamoto, F; Yoshimura, A; Parret, A; Korf, B; Legius, E				Messiaen, Ludwine; Yao, Suxia; Brems, Hilde; Callens, Tom; Sathienkijkanchai, Achara; Denayer, Ellen; Spencer, Emily; Arn, Pamela; Babovic-Vuksanovic, Dusica; Bay, Carolyn; Bobele, Gary; Cohen, Bruce H.; Escobar, Luis; Eunpu, Deborah; Grebe, Theresa; Greenstein, Robert; Hachen, Rachel; Irons, Mira; Kronn, David; Lemire, Edmond; Leppig, Kathleen; Lim, Cynthia; McDonald, Marie; Narayanan, Vinodh; Pearn, Amy; Pedersen, Robert; Powell, Berkley; Shapiro, Lawrence R.; Skidmore, David; Tegay, David; Thiese, Heidi; Zackai, Elaine H.; Vijzelaar, Raymon; Taniguchi, Koji; Ayada, Toranoshin; Okamoto, Fuyuki; Yoshimura, Akihiko; Parret, Annabel; Korf, Bruce; Legius, Eric			Clinical and Mutational Spectrum of Neurofibromatosis Type 1-like Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPRED1; RASA1	Context Autosomal dominant inactivating sprouty-related EVH1 domain containing protein 1 (SPRED1) mutations have recently been described in individuals presenting mainly with cafe au lait macules (CALMs), axillary freckling, and macrocephaly. The extent of the clinical spectrum of this new disorder needs further delineation. Objective To determine the frequency, mutational spectrum, and phenotype of neurofibromatosis type 1-like syndrome (NFLS) in a large cohort of patients. Design, Setting, and Participants In a cross-sectional study, 23 unrelated probands carrying a SPRED1 mutation identified through clinical testing participated with their families in a genotype-phenotype study (2007-2008). In a second cross-sectional study, 1318 unrelated anonymous samples collected in 2003-2007 from patients with a broad range of signs typically found in neurofibromatosis type 1 (NF1) but no detectable NF1 germline mutation underwent SPRED1 mutation analysis. Main Outcome Measures Comparison of aggregated clinical features in patients with or without a SPRED1 or NF1 mutation. Functional assays were used to evaluate the pathogenicity of missense mutations. Results Among 42 SPRED1-positive individuals from the clinical cohort, 20 (48%; 95% confidence interval [CI], 32%-64%) fulfilled National Institutes of Health (NIH) NF1 diagnostic criteria based on the presence of more than 5 CALMs with or without freckling or an NF1-compatible family history. None of the 42 SPRED1-positive individuals (0%; 95% CI, 0%-7%) had discrete cutaneous or plexiform neurofibromas, typical NF1 osseous lesions, or symptomatic optic pathway gliomas. In the anonymous cohort of 1318 individuals, 34 different SPRED1 mutations in 43 probands were identified: 27 pathogenic mutations in 34 probands and 7 probable nonpathogenic missense mutations in 9 probands. Of 94 probands with familial CALMs with or without freckling and no other NF1 features, 69 (73%; 95% CI, 63%-80%) had an NF1 mutation and 18 (19%; 95% CI, 12%-29%) had a pathogenic SPRED1 mutation. In the anonymous cohort, 1.9% (95% CI, 1.2%-2.9%) of individuals with the clinical diagnosis of NF1 according to the NIH criteria had NFLS. Conclusions A high SPRED1 mutation detection rate was found in NF1 mutation negative families with an autosomal dominant phenotype of CALMs with or without freckling and no other NF1 features. Among individuals in this study, NFLS was not associated with the peripheral and central nervous system tumors seen in NF1. JAMA. 2009; 302(19): 2111-2118	[Messiaen, Ludwine] Univ Alabama Birmingham, Dept Genet, Med Genom Lab, Birmingham, AL 35294 USA; [Brems, Hilde; Denayer, Ellen; Legius, Eric] Catholic Univ Louvain, Dept Human Genet, B-3000 Leuven, Belgium; [Arn, Pamela; Eunpu, Deborah] Nemours Childrens Clin, Jacksonville, FL USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Coll Med, Rochester, MN USA; [Bay, Carolyn] Univ Kentucky, Dept Pediat, Div Clin Biochem Genet & Dysmorphol, Lexington, KY 40506 USA; [Bobele, Gary] Driscoll Childrens Hosp, Corpus Christi, TX USA; [Cohen, Bruce H.] Cleveland Clin, Neurol Inst, Cleveland, OH 44106 USA; [Escobar, Luis] St Vincent Childrens Hosp, Med Genet & Neurodev Ctr, Indianapolis, IN USA; [Grebe, Theresa; Lim, Cynthia; Narayanan, Vinodh] St Josephs Hosp, Phoenix Genet Program & Child Neurol, Phoenix, AZ USA; [Greenstein, Robert] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Div Human Genet, Hartford, CT USA; [Hachen, Rachel; Zackai, Elaine H.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Human Genet, Philadelphia, PA 19104 USA; [Irons, Mira] Childrens Hosp Boston, Div Genet, Boston, MA USA; [Kronn, David; Shapiro, Lawrence R.] New York Med Coll, Div Med Genet & Inherited Metab Dis, Dept Pediat, Valhalla, NY 10595 USA; [Kronn, David; Shapiro, Lawrence R.] Maria Fareri Childrens Hosp, Westchester Med Ctr, Valhalla, NY USA; [Lemire, Edmond; Pearn, Amy] Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada; [Leppig, Kathleen; Thiese, Heidi] Univ Washington, Genet Serv, Grp Hlth Cooperat, Seattle, WA 98195 USA; [Leppig, Kathleen; Thiese, Heidi] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [McDonald, Marie] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Pedersen, Robert] Tripler AMC, Honolulu, HI USA; [Powell, Berkley] Childrens Hosp Cent Calif, Madera, CA USA; [Skidmore, David] Dalhousie Univ, Dept Pediat, Maritime Med Genet Serv, Halifax, NS, Canada; [Tegay, David] New York Coll Osteopath Med, Old Westbury, NY USA; [Vijzelaar, Raymon] MRC Holland, Amsterdam, Netherlands; [Taniguchi, Koji; Ayada, Toranoshin; Okamoto, Fuyuki; Yoshimura, Akihiko] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 812, Japan; [Taniguchi, Koji; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo, Japan; [Taniguchi, Koji; Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Parret, Annabel] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany	University of Alabama System; University of Alabama Birmingham; Mayo Clinic; University of Kentucky; Cleveland Clinic Foundation; St. Joseph's Hospital and Medical Center; University of Connecticut; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Boston Children's Hospital; New York Medical College; Westchester Medical Center; University of Saskatchewan; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; Dalhousie University; New York Institute Technology; Kyushu University; Keio University; Japan Science & Technology Agency (JST); European Molecular Biology Laboratory (EMBL)	Messiaen, L (corresponding author), Univ Alabama Birmingham, Dept Genet, Med Genom Lab, 720 20th St S, Birmingham, AL 35294 USA.	lmessiaen@genetics.uab.edu	Vijzelaar, Raymon/D-6311-2016; Korf, Bruce R/H-4882-2012; Brems, Hilde/AAN-4075-2020; Yoshimura, Akihiko/K-5515-2013; Legius, Eric/H-1735-2011	Parret, Annabel/0000-0003-0635-8890; Arn, Pamela/0000-0002-8441-7764; Narayanan, Vinodh/0000-0002-0658-3847; Tegay, David/0000-0002-1573-9954; Pearn, Amy/0000-0001-9566-0463; Spencer, Emily/0000-0003-2650-4357	National Institute of Child Health and Human Development UAB Intellectual and Developmental Disabilities Research Center [P30-HD038985]; Institute for Promotion of Innovation Through Science and Technology, Flanders, Belgium; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0096.02]; Federal Office for Scientific, Technical and Cultural Affairs of Belgium [P5/25]; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation in Japan; Children's Tumor Foundation Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD038985] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development UAB Intellectual and Developmental Disabilities Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Institute for Promotion of Innovation Through Science and Technology, Flanders, Belgium; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Federal Office for Scientific, Technical and Cultural Affairs of Belgium; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation in Japan(National Institute of Biomedical Innovation); Children's Tumor Foundation Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding/Support: This work was supported by National Institute of Child Health and Human Development UAB Intellectual and Developmental Disabilities Research Center grant P30-HD038985(to Drs Messiaen and Korf); the Institute for Promotion of Innovation Through Science and Technology, Flanders, Belgium (to Ms Brems); research grants from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0096.02; to Dr Legius); the Interuniversity Attraction Poles, granted by the Federal Office for Scientific, Technical and Cultural Affairs of Belgium (2007-2011; P5/25; to Dr Legius); a Concerted Action Grant from Katholieke Universiteit Leuven; special Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Dr Yoshimura); and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation in Japan (to Dr Yoshimura); and a Children's Tumor Foundation Young Investigator Award (to Dr Parret). The Wilderman family provided a donation (to Dr Messiaen) to help support NF1 research for children with cafe au lait spots only.	ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Bremmer JN, 2007, STUD HIS ANTH REL, V1, P1; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Denayer E, 2008, J MED GENET, V45, P695, DOI 10.1136/jmg.2007.055772; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Friedman JM, 1999, AM J MED GENET, V89, P1; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Lammert M, 2005, ARCH DERMATOL, V141, P71, DOI 10.1001/archderm.141.1.71; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Pasmant E, 2009, J MED GENET, V46, P425, DOI 10.1136/jmg.2008.065243; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	17	119	122	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 18	2009	302	19					2111	2118		10.1001/jama.2009.1663	http://dx.doi.org/10.1001/jama.2009.1663			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520UG	19920235	Bronze			2022-12-24	WOS:000271873900020
J	Gartner, R; Jensen, MB; Nielsen, J; Ewertz, M; Kroman, N; Kehlet, H				Gartner, Rune; Jensen, Maj-Britt; Nielsen, Jeanette; Ewertz, Marianne; Kroman, Niels; Kehlet, Henrik			Prevalence of and Factors Associated With Persistent Pain Following Breast Cancer Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LYMPH-NODE DISSECTION; QUALITY-OF-LIFE; POSTMASTECTOMY PAIN; RISK-FACTORS; INTERCOSTOBRACHIAL NERVE; AXILLARY DISSECTION; COOPERATIVE GROUP; RANDOMIZED-TRIAL; PHANTOM BREAST; DBCG	Context Persistent pain and sensory disturbances following surgical treatment for breast cancer is a significant clinical problem. The pathogenic mechanisms are complex and may be related to patient characteristics, surgical technique, and adjuvant therapy. Objective To examine prevalence of and factors associated with persistent pain after surgical treatment for breast cancer. Design, Setting, and Patients A nationwide cross-sectional questionnaire study of 3754 women aged 18 to 70 years who received surgery and adjuvant therapy (if indicated) for primary breast cancer in Denmark between January 1, 2005, and December 31, 2006. A study questionnaire was sent to the women between January and April 2008. Main Outcome Measures Prevalence, location, and severity of persistent pain and sensory disturbances in 12 well-defined treatment groups assessed an average of 26 months after surgery, and adjusted odds ratio (OR) of reported pain and sensory disturbances with respect to age, surgical technique, chemotherapy, and radiotherapy. Results By June 2008, 3253 of 3754 eligible women (87%) returned the questionnaire. A total of 1543 patients (47%) reported pain, of whom 201 (13%) had severe pain, 595 (39%) had moderate pain, and 733 (48%) had light pain. Factors associated with chronic pain included young age (18-39 years: OR, 3.62; 95% confidence interval [CI], 2.25-5.82; P<.001) and adjuvant radiotherapy (OR, 1.50; 95% CI, 1.08-2.07; P=.03), but not chemotherapy (OR, 1.01; 95% CI, 0.85-1.21; P=.91). Axillary lymph node dissection (ALND) was associated with increased likelihood of pain (OR, 1.77; 95% CI, 1.43-2.19; P<.001) compared with sentinel lymph node dissection. Risk of sensory disturbances was associated with young age (18-39 years: OR, 5.00; 95% CI, 2.87-8.69; P<.001) and ALND (OR, 4.97; 95% CI, 3.92-6.30; P<.001). Pain complaints from other parts of the body were associated with increased risk of pain in the surgical area (P<.001). A total of 306 patients (20%) with pain had contacted a physician within the prior 3 months for pain complaints in the surgical area. Conclusion Two to 3 years after breast cancer treatment, persistent pain and sensory disturbances remain clinically significant problems among Danish women who received surgery in 2005 and 2006. JAMA. 2009;302(18):1985-1992	[Gartner, Rune; Nielsen, Jeanette; Kroman, Niels] Univ Copenhagen, Rigshosp, Dept Breast Surg, DK-2100 Copenhagen, Denmark; [Kehlet, Henrik] Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, DK-2100 Copenhagen, Denmark; [Jensen, Maj-Britt] Danish Breast Canc Cooperat Grp, Copenhagen, Denmark; [Ewertz, Marianne] Univ So Denmark, Odense Univ Hosp, Dept Oncol, Odense, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Danish Breast Cancer Cooperative Group (DBCG); University of Southern Denmark; Odense University Hospital	Gartner, R (corresponding author), Univ Copenhagen, Rigshosp 2101, Dept Breast Surg, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	runegartner@gmail.com		Ewertz, Marianne/0000-0002-5965-969X; Kehlet, Henrik/0000-0002-2209-1711	Danish Cancer Society; Breast Friends; Lundbeck Foundation	Danish Cancer Society(Danish Cancer Society); Breast Friends; Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Danish Cancer Society, Breast Friends, and the Lundbeck Foundation. The grants exclusively covered salaries.	Abdullah TI, 1998, BRIT J SURG, V85, P1443; Bjorkman B, 2008, J PAIN, V9, P1018, DOI 10.1016/j.jpain.2008.06.003; Blichert-Toft M, 2008, ACTA ONCOL, V47, P497, DOI 10.1080/02841860802068615; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Carpenter JS, 1998, J CLIN EPIDEMIOL, V51, P1285, DOI 10.1016/S0895-4356(98)00121-8; Dijkstra PU, 2007, EUR J PAIN, V11, P99, DOI 10.1016/j.ejpain.2006.01.002; Eisenberg E, 2007, J PAIN, V8, P223, DOI 10.1016/j.jpain.2006.08.003; Fassoulaki A, 2005, ANESTH ANALG, V101, P1427, DOI 10.1213/01.ANE.0000180200.11626.8E; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Gottrup H, 2000, PAIN, V87, P275, DOI 10.1016/S0304-3959(00)00291-8; Jung BF, 2005, PAIN, V118, P10, DOI 10.1016/j.pain.2005.09.014; Jung BF, 2003, PAIN, V104, P1, DOI 10.1016/S0304-3959(03)00241-0; Kairaluoma PM, 2006, ANESTH ANALG, V103, P703, DOI 10.1213/01.ane.0000230603.92574.4e; Katz J, 2005, PAIN, V119, P16, DOI 10.1016/j.pain.2005.09.008; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; KREMER E, 1981, PAIN, V10, P241, DOI 10.1016/0304-3959(81)90199-8; Kudel I, 2007, J PAIN SYMPTOM MANAG, V34, P619, DOI 10.1016/j.jpainsymman.2007.01.013; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Montazeri A, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-32; Overgaard M, 2008, ACTA ONCOL, V47, P639, DOI 10.1080/02841860802078085; Peuckmann V, 2009, EUR J PAIN, V13, P478, DOI 10.1016/j.ejpain.2008.05.015; Peuckmann V, 2007, BREAST CANCER RES TR, V104, P39, DOI 10.1007/s10549-006-9386-6; Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007; Romundstad L, 2006, PAIN, V124, P92, DOI 10.1016/j.pain.2006.03.020; Rostgaard K, 2000, CANCER CAUSE CONTROL, V11, P669, DOI 10.1023/A:1008928204121; Salmon RJ, 1998, EUR J SURG ONCOL, V24, P158, DOI 10.1016/S0748-7983(98)92793-7; Steegers MA, 2008, J PAIN, V9, P813, DOI 10.1016/j.jpain.2008.04.001; Tasmuth T, 1996, BRIT J CANCER, V74, P2024, DOI 10.1038/bjc.1996.671; Tasmuth T, 1999, EUR J SURG ONCOL, V25, P38, DOI 10.1053/ejso.1998.0597; Taylor KO, 2004, ANZ J SURG, V74, P314, DOI 10.1111/j.1445-1433.2004.02992.x; Torresan Renato Zocchio, 2003, Breast J, V9, P389, DOI 10.1046/j.1524-4741.2003.09505.x; VECHT CJ, 1989, PAIN, V38, P171, DOI 10.1016/0304-3959(89)90235-2; Ververs JMMA, 2001, EUR J CANCER, V37, P991, DOI 10.1016/S0959-8049(01)00067-3; Vilholm OJ, 2008, BRIT J CANCER, V99, P604, DOI 10.1038/sj.bjc.6604534; WATSON CPN, 1992, PAIN, V51, P375, DOI 10.1016/0304-3959(92)90223-X	35	529	552	1	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					1985	1992						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19903919				2022-12-24	WOS:000271619700025
J	Moro, K; Yamada, T; Tanabe, M; Takeuchi, T; Ikawa, T; Kawamoto, H; Furusawa, J; Ohtani, M; Fujii, H; Koyasu, S				Moro, Kazuyo; Yamada, Taketo; Tanabe, Masanobu; Takeuchi, Tsutomu; Ikawa, Tomokatsu; Kawamoto, Hiroshi; Furusawa, Jun-ichi; Ohtani, Masashi; Fujii, Hideki; Koyasu, Shigeo			Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells	NATURE			English	Article							NATURAL-KILLER-CELLS; ROR-GAMMA-T; INDUCER CELLS; MICE LACKING; IL-33; EXPRESSION; DIFFERENTIATION; LYMPHOCYTES; GENERATION; EXPULSION	Innate immune responses are important in combating various microbes during the early phases of infection. Natural killer (NK) cells are innate lymphocytes that, unlike T and B lymphocytes, do not express antigen receptors but rapidly exhibit cytotoxic activities against virus-infected cells and produce various cytokines(1,2). Here we report a new type of innate lymphocyte present in a novel lymphoid structure associated with adipose tissues in the peritoneal cavity. These cells do not express lineage (Lin) markers but do express c-Kit, Sca-1 (also known as Ly6a), IL7R and IL33R. Similar lymphoid clusters were found in both human and mouse mesentery and we term this tissue 'FALC' (fat-associated lymphoid cluster). FALC Lin(-)c-Kit(+)Sca-1(+) cells are distinct from lymphoid progenitors(3) and lymphoid tissue inducer cells(4). These cells proliferate in response to IL2 and produce large amounts of T(H)2 cytokines such as IL5, IL6 and IL13. IL5 and IL6 regulate B-cell antibody production and self-renewal of B1 cells(5-7). Indeed, FALC Lin(-)c-Kit(+)Sca-1(+) cells support the self-renewal of B1 cells and enhance IgA production. IL5 and IL13 mediate allergic inflammation and protection against helminth infection(8,9). After helminth infection and in response to IL33, FALC Lin(-)c-Kit(+)Sca-1(+) cells produce large amounts of IL13, which leads to goblet cell hyperplasia-a critical step for helminth expulsion. In mice devoid of FALC Lin(-)c-Kit(+)Sca-1(+) cells, such goblet cell hyperplasia was not induced. Thus, FALC Lin(-)c-Kit(+)Sca-1(+) cells are T(H)2-type innate lymphocytes, and we propose that these cells be called 'natural helper cells'.	[Moro, Kazuyo; Furusawa, Jun-ichi; Ohtani, Masashi; Fujii, Hideki; Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan; [Tanabe, Masanobu; Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo 1608582, Japan; [Moro, Kazuyo] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ikawa, Tomokatsu; Kawamoto, Hiroshi] Riken Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Kanagawa 2300045, Japan; [Ohtani, Masashi] Kansai Med Univ, Inst Biomed Sci, Dept Cell Signalling, Osaka 5708506, Japan; [Koyasu, Shigeo] Japan Soc Promot Sci, Res Ctr Sci Syst, Chiyoda Ku, Tokyo 1028472, Japan	Keio University; Keio University; Keio University; Japan Science & Technology Agency (JST); RIKEN; Kansai Medical University; Japan Society for the Promotion of Science	Koyasu, S (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan.	koyasu@sc.itc.keio.ac.jp	Koyasu, Shigeo/J-5583-2015; Moro, Kazuyo/A-5987-2016	Koyasu, Shigeo/0000-0001-9585-3038; Moro, Kazuyo/0000-0002-7377-1303	Japan Society for the Promotion of Science [20790378, 14370116, 16390146, 18390155]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [22590437] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Yokota and H. Kiyono for Id2<SUP>-/-</SUP> mice, D. Littman and S. Fagarasan for Rorc GFP/GFP mice, T. W. Mak for Il2/15rb<SUP>-/-</SUP> mice, K. Ikuta for Il7<SUP>-/-</SUP> mice, and K. Ishiwata for N. brasiliensis. Thanks are also owed to L. K. Clayton for critical reading of the manuscript and valuable suggestions, M. Fujiwara for help with microarray analysis, Y. Baba and A. Minowa for help with some experiments, and K. Takei and K. Hidaka for animal care. This work was supported by a Keio University Grant-in-Aid for Encouragement of Young Medical Scientists (to K. M.), a Grant-in Aid for Young Scientist (B) (20790378 to K. M.), Grants-in-Aid for Scientific Research (B) (14370116, 16390146, 18390155 to S. K.) from the Japan Society for the Promotion of Science, and a Scientific Frontier Research Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan. K. M. is a postdoctoral fellow of the Global COE program supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Andoniou CE, 2006, IMMUNOL REV, V214, P239, DOI 10.1111/j.1600-065X.2006.00465.x; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Erickson LD, 2001, J IMMUNOL, V166, P1531, DOI 10.4049/jimmunol.166.3.1531; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; HAYASHI C, 1985, DEV BIOL, V109, P234, DOI 10.1016/0012-1606(85)90363-X; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Ishiwata K, 2007, EXP PARASITOL, V117, P80, DOI 10.1016/j.exppara.2007.03.019; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Knight PA, 2008, PARASITOLOGY, V135, P655, DOI 10.1017/S0031182008004319; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Nishikawa SI, 2003, IMMUNOL REV, V195, P72, DOI 10.1034/j.1600-065X.2003.00063.x; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; WATANABE Y, 1992, CELL IMMUNOL, V142, P385, DOI 10.1016/0008-8749(92)90299-5; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	33	1405	1458	1	98	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					540	U160		10.1038/nature08636	http://dx.doi.org/10.1038/nature08636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20023630				2022-12-24	WOS:000273981100051
J	Crossley, S; Faria, J; Shen, M; Resasco, DE				Crossley, Steven; Faria, Jimmy; Shen, Min; Resasco, Daniel E.			Solid Nanoparticles that Catalyze Biofuel Upgrade Reactions at the Water/Oil Interface	SCIENCE			English	Article							STABILIZED EMULSIONS; LIQUID ALKANES; BIO-OIL; BIOMASS; ADSORPTION; PARTICLES; PYROLYSIS	A recoverable catalyst that simultaneously stabilizes emulsions would be highly advantageous in streamlining processes such as biomass refining, in which the immiscibility and thermal instability of crude products greatly complicates purification procedures. Here, we report a family of solid catalysts that can stabilize water-oil emulsions and catalyze reactions at the liquid/liquid interface. By depositing palladium onto carbon nanotube-inorganic oxide hybrid nanoparticles, we demonstrate biphasic hydrodeoxygenation and condensation catalysis in three substrate classes of interest in biomass refining. Microscopic characterization of the emulsions supports localization of the hybrid particles at the interface.	[Crossley, Steven; Faria, Jimmy; Shen, Min; Resasco, Daniel E.] Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Resasco, DE (corresponding author), Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA.	resasco@ou.edu	Faria, J./J-3428-2017; Resasco, Daniel E/AAS-6213-2021; Shen, Min/A-1394-2010	Faria, J./0000-0002-8920-3538; Resasco, Daniel/0000-0001-5342-0621; Crossley, Steven/0000-0002-1017-9839	EPSCoR [0814361] Funding Source: National Science Foundation	EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))		Binks BP, 2005, LANGMUIR, V21, P3296, DOI 10.1021/la046915z; Binks BP, 2004, LANGMUIR, V20, P1130, DOI 10.1021/la0303557; Binks BP, 2000, LANGMUIR, V16, P8622, DOI 10.1021/la000189s; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; BRUCKNER R, 2002, ADV ORGANIC CHEM REA, P283; BRUNELLE JP, 1978, PURE APPL CHEM, V50, P1211, DOI 10.1351/pac197850091211; CHEN NY, 1979, J AM CHEM SOC, V101, P6783, DOI 10.1021/ja00516a065; Dai LL, 2005, LANGMUIR, V21, P2641, DOI 10.1021/la047256t; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Elliott DC, 2007, ENERG FUEL, V21, P1792, DOI 10.1021/ef070044u; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Huber GW, 2006, CATAL TODAY, V111, P119, DOI 10.1016/j.cattod.2005.10.010; Iglesia E, 1997, APPL CATAL A-GEN, V161, P59, DOI 10.1016/S0926-860X(97)00186-5; Lambert S, 2009, J CATAL, V261, P23, DOI 10.1016/j.jcat.2008.10.014; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Regalbuto JR, 1999, J CATAL, V184, P335, DOI 10.1006/jcat.1999.2471; Resasco DE, 2002, J NANOPART RES, V4, P131, DOI 10.1023/A:1020174126542; SAIZJIMENEZ C, 1986, ORG GEOCHEM, V10, P869, DOI 10.1016/S0146-6380(86)80024-9; Shen M, 2009, LANGMUIR, V25, P10843, DOI 10.1021/la901380b; Simonetti DA, 2008, CHEMSUSCHEM, V1, P725, DOI 10.1002/cssc.200800105; STARKS CM, 1971, J AM CHEM SOC, V93, P195, DOI 10.1021/ja00730a033; Wang RK, 2008, J AM CHEM SOC, V130, P14721, DOI 10.1021/ja804982b; West RM, 2008, CHEMSUSCHEM, V1, P417, DOI 10.1002/cssc.200800001; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Zhao C, 2009, ANGEW CHEM INT EDIT, V48, P3987, DOI 10.1002/anie.200900404	26	625	642	29	940	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					68	72		10.1126/science.1180769	http://dx.doi.org/10.1126/science.1180769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044571				2022-12-24	WOS:000273395400031
J	Ziemann, AE; Allen, JE; Dahdaleh, NS; Drebot, II; Coryell, MW; Wunsch, AM; Lynch, CM; Faraci, FM; Howard, MA; Welsh, MJ; Wemmie, JA				Ziemann, Adam E.; Allen, Jason E.; Dahdaleh, Nader S.; Drebot, Iuliia I.; Coryell, Matthew W.; Wunsch, Amanda M.; Lynch, Cynthia M.; Faraci, Frank M.; Howard, Matthew A., III; Welsh, Michael J.; Wemmie, John A.			The Amygdala Is a Chemosensor that Detects Carbon Dioxide and Acidosis to Elicit Fear Behavior	CELL			English	Article							SENSING ION CHANNELS; PANIC DISORDER; EXOCYTOSED PROTONS; BRAIN; 1A; HYPERVENTILATION; NEURONS; MEMORY; CELLS; PH	The amygdala processes and directs inputs and outputs that are key to fear behavior. However, whether it directly senses fear-evoking stimuli is unknown. Because the amygdala expresses acid-sensing ion channel-1a (ASIC1a), and ASIC1a is required for normal fear responses, we hypothesized that the amygdala might detect a reduced pH. We found that inhaled CO2 reduced brain pH and evoked fear behavior in mice. Eliminating or inhibiting ASIC1a markedly impaired this activity, and localized ASIC1a expression in the amygdala rescued the CO2-induced fear deficit of ASIC1a null animals. Buffering pH attenuated fear behavior, whereas directly reducing pH with amygdala microinjections reproduced the effect of CO2. These data identify the amygdala as an important chemosensor that detects hypercarbia and acidosis and initiates behavioral responses. They also give a molecular explanation for how rising CO2 concentrations elicit intense fear and provide a foundation for dissecting the bases of anxiety and panic disorders.	[Ziemann, Adam E.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Ziemann, Adam E.] Univ Iowa, Med Scientist Training Program, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Dahdaleh, Nader S.; Howard, Matthew A., III; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Neurosurg, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Allen, Jason E.; Drebot, Iuliia I.; Wunsch, Amanda M.; Wemmie, John A.] Univ Iowa, Dept Psychiat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Lynch, Cynthia M.; Faraci, Frank M.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Coryell, Matthew W.; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Neurosci Program, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Welsh, MJ (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu; john-wemmie@uiowa.edu		Howard, Matthew/0000-0003-3935-8889; Faraci, Frank/0000-0002-0203-1690; Welsh, Michael/0000-0002-1646-6206; Wunsch, Amanda/0000-0002-2292-439X; Wemmie, John/0000-0001-7531-9065	ADAA; NARSAD; VA Merit Award; University of Iowa Interdisciplinary Training Program in Pain Research NINDS [T32NS045549];  [1R01MH085724-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045549] Funding Source: NIH RePORTER	ADAA; NARSAD(NARSAD); VA Merit Award(US Department of Veterans Affairs); University of Iowa Interdisciplinary Training Program in Pain Research NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Sam Hartman, Huiyu Gong, and Runping Wang for assistance. We also thank Dr. Mark Chapleau for use of the plethysmography and the University of Iowa Gene Vector Core. This work was supported by Young Investigator Awards from ADAA and NARSAD, VA Merit Award, and 1R01MH085724-01 (to J. A. W.) and by the University of Iowa Interdisciplinary Training Program in Pain Research NINDS T32NS045549 (to A. E. Z.). M. J. W. is an Investigator of the Howard Hughes Medical Institute.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; [Anonymous], [No title captured]; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Chen CH, 2009, J PHYSIOL-LONDON, V587, P1727, DOI 10.1113/jphysiol.2008.166918; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Dratcu L, 2000, PROG NEURO-PSYCHOPH, V24, P1069, DOI 10.1016/S0278-5846(00)00130-5; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; Friedman SD, 2006, AM J PSYCHIAT, V163, P710, DOI 10.1176/appi.ajp.163.4.710; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Griez E, 1998, J PSYCHOSOM RES, V45, P493, DOI 10.1016/S0022-3999(98)00027-0; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kaila Kai, 1998, P309; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Maddock RJ, 2001, J NEUROPSYCH CLIN N, V13, P22, DOI 10.1176/appi.neuropsych.13.1.22; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; MAYHAN WG, 1988, MICROVASC RES, V35, P179, DOI 10.1016/0026-2862(88)90061-1; MITCHELL RA, 1965, J APPL PHYSIOL, V20, P443, DOI 10.1152/jappl.1965.20.3.443; Mongeluzi DL, 2003, BEHAV MODIF, V27, P620, DOI 10.1177/0145445503256316; Nattie Eugene, 1998, P535; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Palmer MJ, 2003, J NEUROSCI, V23, P11332; PAPP LA, 1993, AM J PSYCHIAT, V150, P1149; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; Rabinak CA, 2008, BEHAV NEUROSCI, V122, P1284, DOI 10.1037/a0012903; Rassovsky Y, 2003, J ANXIETY DISORD, V17, P1, DOI 10.1016/S0887-6185(02)00181-0; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; SANDERSON WC, 1989, ARCH GEN PSYCHIAT, V46, P157; Schnizler MK, 2009, J BIOL CHEM, V284, P2697, DOI 10.1074/jbc.M805110200; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Smoller JW, 1996, AM J RESP CRIT CARE, V154, P6, DOI 10.1164/ajrccm.154.1.8680700; Sullivan GM, 2003, BIOL PSYCHIAT, V53, P863, DOI 10.1016/S0006-3223(02)01733-X; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; ZANDBERGEN J, 1989, Hillside Journal of Clinical Psychiatry, V11, P185; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zha XM, 2009, J NEUROSCI, V29, P8438, DOI 10.1523/JNEUROSCI.1284-09.2009	56	286	291	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					1012	1021		10.1016/j.cell.2009.10.029	http://dx.doi.org/10.1016/j.cell.2009.10.029			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945383	Bronze, Green Accepted			2022-12-24	WOS:000272169400023
J	Srinivasan, L; Sasaki, Y; Calado, DP; Zhang, BC; Paik, JH; DePinho, RA; Kutok, JL; Kearney, JF; Otipoby, KL; Rajewsky, K				Srinivasan, Lakshmi; Sasaki, Yoshiteru; Calado, Dinis Pedro; Zhang, Baochun; Paik, Ji Hye; DePinho, Ronald A.; Kutok, Jeffrey L.; Kearney, John F.; Otipoby, Kevin L.; Rajewsky, Klaus			PI3 Kinase Signals BCR-Dependent Mature B Cell Survival	CELL			English	Article							NF-KAPPA-B; FOXO TRANSCRIPTION FACTORS; CLASS-SWITCH RECOMBINATION; ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MARGINAL ZONE; POSITIVE SELECTION; CRITICAL ROLES; LYMPHOCYTES; ACTIVATION	Previous work has shown that mature B cells depend upon survival signals delivered to the cells by their antigen receptor (BCR). To identify the molecular nature of this survival signal, we have developed a genetic approach in which ablation of the BCR is combined with the activation of specific, BCR dependent signaling cascades in mature B cells in vivo. Using this system, we provide evidence that the survival of BCR deficient mature B cells can be rescued by a single signaling pathway downstream of the BCR, namely PI3K signaling, with the FOXO1 transcription factor playing a central role.	[Srinivasan, Lakshmi; Sasaki, Yoshiteru; Calado, Dinis Pedro; Zhang, Baochun; Otipoby, Kevin L.; Rajewsky, Klaus] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Srinivasan, Lakshmi; Sasaki, Yoshiteru; Calado, Dinis Pedro; Zhang, Baochun; Otipoby, Kevin L.; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Paik, Ji Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kutok, Jeffrey L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kearney, John F.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Alabama System; University of Alabama Birmingham	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	rajewsky@idi.harvard.edu	Kearney, John/GOV-3123-2022; Calado, Dinis/U-8379-2019	Calado, Dinis/0000-0001-8239-7184; Rajewsky, Klaus/0000-0002-6633-6370; Zhang, Baochun/0000-0003-1759-1161; DePinho, Ronald/0000-0002-5625-577X; Srinivasan, Lakshmi/0000-0003-1351-7407	NIH [AI054636, CA092625, AI014782-31]; Leukemia and Lymphoma Society; European Union through MUGEN; Hematology and Transfusion Medicine at Harvard Medical School; Portuguese Foundation for Science and Technology; Robert A. and Renee E. Belfer Foundation; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014782, R37AI054636, R21AI014782] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); European Union through MUGEN(European Commission); Hematology and Transfusion Medicine at Harvard Medical School; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Robert A. and Renee E. Belfer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Ghitza, A. Pellerin, A. Monti, A. Tetreault, J. Grundy, J. Wang, J. Xia and W. F. Jia for expert technical assistance; E. Derudder for reagents; all Rajewsky lab members for discussions; and M. Janz for critical reading of the manuscript; A. Klippel for the MP110* cDNA; and K. Kaibuchi for Rac1DA cDNA. K. R. is supported by NIH grants AI054636 and CA092625, the Leukemia and Lymphoma Society and the European Union through MUGEN; L. S. by the T32 training grant of the Joint Program in Hematology and Transfusion Medicine at Harvard Medical School; J. F. K. by NIH grant AI014782-31; D. P. C. by a postdoctoral fellowship from the Portuguese Foundation for Science and Technology (FCT-MCES); B. Z. by a postdoctoral fellowship of the Leukemia and Lymphoma Society; and RAD by the NIH and the Robert A. and Renee E. Belfer Foundation.	Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Bannish G, 2001, J EXP MED, V194, P1583, DOI 10.1084/jem.194.11.1583; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brummer T, 2002, EMBO J, V21, P5611, DOI 10.1093/emboj/cdf588; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Delgado P, 2009, NAT IMMUNOL, V10, P880, DOI 10.1038/ni.1749; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dye JR, 2007, J IMMUNOL, V179, P229, DOI 10.4049/jimmunol.179.1.229; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Grande SM, 2007, IMMUNOL REV, V218, P214, DOI 10.1111/j.1600-065X.2007.00535.x; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Matsuda S, 2009, BLOOD, V113, P1037, DOI 10.1182/blood-2008-06-163725; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Oliver AM, 1999, J IMMUNOL, V162, P7198; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Suzuki A, 2008, CANCER SCI, V99, P209, DOI 10.1111/j.1349-7006.2007.00670.x; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	58	484	516	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					573	586		10.1016/j.cell.2009.08.041	http://dx.doi.org/10.1016/j.cell.2009.08.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19879843	Bronze, Green Accepted			2022-12-24	WOS:000271259600021
J	Lanford, RE; Hildebrandt-Eriksen, ES; Petri, A; Persson, R; Lindow, M; Munk, ME; Kauppinen, S; Orum, H				Lanford, Robert E.; Hildebrandt-Eriksen, Elisabeth S.; Petri, Andreas; Persson, Robert; Lindow, Morten; Munk, Martin E.; Kauppinen, Sakari; Orum, Henrik			Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection	SCIENCE			English	Article							GENE-EXPRESSION; INTERFERON-ALPHA; CHIMPANZEES; RIBAVIRIN; LIVER; KINETICS	The liver-expressed microRNA-122 (miR-122) is essential for hepatitis C virus (HCV) RNA accumulation in cultured liver cells, but its potential as a target for antiviral intervention has not been assessed. We found that treatment of chronically infected chimpanzees with a locked nucleic acid (LNA)-modified oligonucleotide (SPC3649) complementary to miR-122 leads to long-lasting suppression of HCV viremia, with no evidence of viral resistance or side effects in the treated animals. Furthermore, transcriptome and histological analyses of liver biopsies demonstrated derepression of target mRNAs with miR-122 seed sites, down-regulation of interferon-regulated genes, and improvement of HCV-induced liver pathology. The prolonged virological response to SPC3649 treatment without HCV rebound holds promise of a new antiviral therapy with a high barrier to resistance.	[Hildebrandt-Eriksen, Elisabeth S.; Petri, Andreas; Persson, Robert; Lindow, Morten; Munk, Martin E.; Kauppinen, Sakari; Orum, Henrik] Santaris Pharma, DK-2970 Horsholm, Denmark; [Lanford, Robert E.] SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX 78227 USA; [Lanford, Robert E.] SW Fdn Biomed Res, SW Natl Primate Res Ctr, San Antonio, TX 78227 USA; [Kauppinen, Sakari] Univ Aalborg, Copenhagen Inst Technol, DK-2750 Ballerup, Denmark	Texas Biomedical Research Institute; Texas Biomedical Research Institute; Aalborg University	Orum, H (corresponding author), Santaris Pharma, Kogle Alle 6, DK-2970 Horsholm, Denmark.	hoe@santaris.com			Danish National Advanced Technology Foundation; NIH [P51 RR13986]; National Center for Research Resources [C06 RR 12087]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986, C06RR012087] Funding Source: NIH RePORTER	Danish National Advanced Technology Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank D. Chavez, B. Guerra, and H. Lee for excellent technical assistance; K. Brasky for veterinary support; L. Giavedoni for immunological analyses; P. Giclas for complement analyses; and E. Dick for pathology examinations. Supported by a grant from the Danish National Advanced Technology Foundation (S. K.); the primate studies performed at the Southwest National Primate Research Center are supported by NIH base grant P51 RR13986 and by the National Center for Research Resources (Research Facilities Improvement Program grant C06 RR 12087). The expression microarray data have been deposited in the ArrayExpress repository under accession number E-MEXP-2375. The GEO accession number for the sequencing data is GSE18919. E. S. H-E., A. P., and S. K. have a pending patent on the method of treatment.	Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126; Chen CM, 2007, ANTIMICROB AGENTS CH, V51, P4290, DOI 10.1128/AAC.00723-07; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; Lanford RE, 2007, HEPATOLOGY, V46, P999, DOI 10.1002/hep.21776; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105	18	1301	1419	1	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					198	201		10.1126/science.1178178	http://dx.doi.org/10.1126/science.1178178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	19965718	Green Accepted			2022-12-24	WOS:000273394000034
J	Liu, FQ; Marquardt, S; Lister, C; Swiezewski, S; Dean, C				Liu, Fuquan; Marquardt, Sebastian; Lister, Clare; Swiezewski, Szymon; Dean, Caroline			Targeted 3 ' Processing of Antisense Transcripts Triggers Arabidopsis FLC Chromatin Silencing	SCIENCE			English	Article							AUTONOMOUS PATHWAY; FLOWERING-TIME; RNA; FCA; TERMINATION; REGULATORS; PROTEINS; REQUIRES; REVEALS; LOCUS	Noncoding RNA is emerging as an important regulator of gene expression in many organisms. We are characterizing RNA-mediated chromatin silencing of the Arabidopsis major floral repressor gene, FLC. Through suppressor mutagenesis, we identify a requirement for CstF64 and CstF77, two conserved RNA 3'-end-processing factors, in FLC silencing. However, FLC sense transcript 3' processing is not affected in the mutants. Instead, CstF64 and CstF77 are required for 3' processing of FLC antisense transcripts. A specific RNA-binding protein directs their activity to a proximal antisense polyadenylation site. This targeted processing triggers localized histone demethylase activity and results in reduced FLC sense transcription. Targeted 3' processing of antisense transcripts may be a common mechanism triggering transcriptional silencing of the corresponding sense gene.	[Liu, Fuquan; Marquardt, Sebastian; Lister, Clare; Swiezewski, Szymon; Dean, Caroline] John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	caroline.dean@bbsrc.ac.uk	Liu, Fuquan/AGD-6751-2022; Marquardt, Sebastian/AAU-8009-2021; Marquardt, Sebastian/C-2902-2015; Marquardt, Sebastian/B-7606-2013	Marquardt, Sebastian/0000-0003-1709-2717; Marquardt, Sebastian/0000-0003-1709-2717; Swiezewski, Szymon/0000-0002-2007-2779; Dean, Caroline/0000-0002-6555-3525	BBSRC [BBS/E/J/000CA305, BB/G01406X/1, BB/D010799/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D010799/1, BB/G01406X/1, BBS/E/J/000CA305] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Bai Y, 2007, MOL CELL, V25, P863, DOI 10.1016/j.molcel.2007.01.034; Baurle I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002733; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Manzano D, 2009, P NATL ACAD SCI USA, V106, P8772, DOI 10.1073/pnas.0903444106; MINVIELLESEBASTIA L, 1991, MOL CELL BIOL, V11, P3075, DOI 10.1128/MCB.11.6.3075; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Mylne J, 2004, COLD SPRING HARB SYM, V69, P457, DOI 10.1101/sqb.2004.69.457; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Simonelig M, 1996, GENETICS, V142, P1225; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	26	300	318	11	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					94	97		10.1126/science.1180278	http://dx.doi.org/10.1126/science.1180278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	19965720				2022-12-24	WOS:000273395400039
J	Barwick, B; Flannigan, DJ; Zewail, AH				Barwick, Brett; Flannigan, David J.; Zewail, Ahmed H.			Photon-induced near-field electron microscopy	NATURE			English	Article							DIFFRACTION	In materials science and biology, optical near-field microscopies enable spatial resolutions beyond the diffraction limit(1,2), but they cannot provide the atomic-scale imaging capabilities of electron microscopy(3). Given the nature of interactions(4-8) between electrons and photons, and considering their connections(9,10) through nanostructures, it should be possible to achieve imaging of evanescent electromagnetic fields with electron pulses when such fields are resolved in both space (nanometre and below) and time (femtosecond) (11-13). Here we report the development of photon-induced near-field electron microscopy (PINEM), and the associated phenomena. We show that the precise spatiotemporal overlap of femtosecond single-electron packets with intense optical pulses at a nanostructure (individual carbon nanotube or silver nanowire in this instance) results in the direct absorption of integer multiples of photon quanta (nh omega) by the relativistic electrons accelerated to 200 keV. By energy-filtering only those electrons resulting from this absorption, it is possible to image directly in space the near-field electric field distribution, obtain the temporal behaviour of the field on the femtosecond timescale, and map its spatial polarization dependence. We believe that the observation of the photon-induced near-field effect in ultrafast electron microscopy demonstrates the potential for many applications, including those of direct space-time imaging of localized fields at interfaces and visualization of phenomena related to photonics, plasmonics and nanostructures.	[Barwick, Brett; Flannigan, David J.; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Flannigan, David/E-4449-2014	Flannigan, David/0000-0002-1829-1868; gaber, sarah/0000-0002-5995-7291	National Science Foundation; Air Force Office of Scientific Research in the Gordon; Betty Moore Center for Physical Biology at the California Institute of Technology	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Gordon(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Betty Moore Center for Physical Biology at the California Institute of Technology	This work was supported by the National Science Foundation and the Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology. We thank S. Skrabalak for synthesizing and providing the silver nanowires.	AGOSTINI P, 1979, PHYS REV LETT, V42, P1127, DOI 10.1103/PhysRevLett.42.1127; Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Baum P, 2008, CHEM PHYS LETT, V462, P14, DOI 10.1016/j.cplett.2008.07.072; Baum P, 2007, P NATL ACAD SCI USA, V104, P18409, DOI 10.1073/pnas.0709019104; BETZIG E, 1992, SCIENCE, V257, P189, DOI 10.1126/science.257.5067.189; BOERSCH H, 1966, PHYS REV LETT, V17, P379, DOI 10.1103/PhysRevLett.17.379; BUCKSBAUM PH, 1988, PHYS REV LETT, V61, P1182, DOI 10.1103/PhysRevLett.61.1182; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Carbone F, 2009, SCIENCE, V325, P181, DOI 10.1126/science.1175005; de Abajo FJG, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073035; DRAVID VP, 1993, SCIENCE, V259, P1601, DOI 10.1126/science.259.5101.1601; Freimund DL, 2001, NATURE, V413, P142, DOI 10.1038/35093065; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Howie A, 1999, INST PHYS CONF SER, P311; HUMPHREYS CJ, 2002, UNDERSTANDING MAT; Ishikawa R, 2001, J APPL PHYS, V89, P4065, DOI 10.1063/1.1345851; Kapitza PL, 1933, P CAMB PHILOS SOC, V29, P297, DOI 10.1017/S0305004100011105; Kawata S, 2009, NAT PHOTONICS, V3, P388, DOI 10.1038/NPHOTON.2009.111; Kim S, 2008, NATURE, V453, P757, DOI 10.1038/nature07012; Korte KE, 2008, J MATER CHEM, V18, P437, DOI 10.1039/b714072j; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Maier SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1951057; MIDGLEY PA, 1995, ULTRAMICROSCOPY, V59, P1, DOI 10.1016/0304-3991(95)00014-R; MULLER HG, 1986, J PHYS B-AT MOL OPT, V19, pL733, DOI 10.1088/0022-3700/19/21/003; Novotny L, 1997, PHYS REV LETT, V79, P645, DOI 10.1103/PhysRevLett.79.645; Park HS, 2007, NANO LETT, V7, P2545, DOI 10.1021/nl071369q; Saathoff G, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022903; Spence J.C.H., 2003, HIGH RESOLUTION ELEC, V3rd; Veisz L, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/451; Zewail A H, 2009, 4D ELECT MICROSCOPY	30	391	399	10	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					902	906		10.1038/nature08662	http://dx.doi.org/10.1038/nature08662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016598	Green Accepted			2022-12-24	WOS:000272795400039
J	Fraser, JS; Clarkson, MW; Degnan, SC; Erion, R; Kern, D; Alber, T				Fraser, James S.; Clarkson, Michael W.; Degnan, Sheena C.; Erion, Renske; Kern, Dorothee; Alber, Tom			Hidden alternative structures of proline isomerase essential for catalysis	NATURE			English	Article							CYCLOPHILIN-A INSIGHTS; X-RAY-DIFFRACTION; CHEMICAL-EXCHANGE; NMR-SPECTROSCOPY; RIBONUCLEASE-A; PROTEIN; DYNAMICS; TEMPERATURE; SIMULATIONS; TRANSITION	A long-standing challenge is to understand at the atomic level how protein dynamics contribute to enzyme catalysis. X-ray crystallography can provide snapshots of conformational substates sampled during enzymatic reactions(1), while NMR relaxation methods reveal the rates of interconversion between substates and the corresponding relative populations(1,2). However, these current methods cannot simultaneously reveal the detailed atomic structures of the rare states and rationalize the finding that intrinsic motions in the free enzyme occur on a timescale similar to the catalytic turnover rate. Here we introduce dual strategies of ambient-temperature X-ray crystallographic data collection and automated electron-density sampling to structurally unravel interconverting substates of the human proline isomerase, cyclophilin A (CYPA, also known as PPIA). A conservative mutation outside the active site was designed to stabilize features of the previously hidden minor conformation. This mutation not only inverts the equilibrium between the substates, but also causes large, parallel reductions in the conformational interconversion rates and the catalytic rate. These studies introduce crystallographic approaches to define functional minor protein conformations and, in combination with NMR analysis of the enzyme dynamics in solution, show how collective motions directly contribute to the catalytic power of an enzyme.	[Fraser, James S.; Degnan, Sheena C.; Erion, Renske; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol QB3, Berkeley, CA 94720 USA; [Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	University of California System; University of California Berkeley; Brandeis University; Howard Hughes Medical Institute	Alber, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol QB3, Berkeley, CA 94720 USA.	dkern@brandeis.edu; tom@ucxray.berkeley.edu		Clarkson, Michael W/0000-0002-4323-3424; Fraser, James/0000-0002-5080-2859	US NSF; Canadian NSERC; US National Institutes of Health; US Department of Energy Office of Basic Energy Sciences; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048958] Funding Source: NIH RePORTER	US NSF(National Science Foundation (NSF)); Canadian NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Marqusee and B. Krantz for discussions; S. Classen, G. Meigs, J. Holton, A. Samelson, N. Echols, P. Afonine, and the Phenix team for technical support; J. Tainer for access to Rigaku free-mounting device at ALS Beamline 12.3.1; J. Pelton and D. Wemmer for providing essential help and access to NMR facilities. J. S. F. was supported by US NSF and Canadian NSERC fellowships. This work was funded by the US National Institutes of Health ( to T. A.) and the US National Institutes of Health, the US Department of Energy Office of Basic Energy Sciences, and the Howard Hughes Medical Institute ( to D. K.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agarwal PK, 2004, PROTEINS, V56, P449, DOI 10.1002/prot.20135; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; FRAUENFELDER H, 1987, BIOCHEMISTRY-US, V26, P254, DOI 10.1021/bi00375a035; FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0; Halle B, 2004, P NATL ACAD SCI USA, V101, P4793, DOI 10.1073/pnas.0308315101; Hamelberg D, 2009, J AM CHEM SOC, V131, P147, DOI 10.1021/ja806146g; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Ke HM, 2004, FRONT BIOSCI-LANDMRK, V9, P2285, DOI 10.2741/1396; Kiefersauer R, 2000, J APPL CRYSTALLOGR, V33, P1223, DOI 10.1107/S0021889800008049; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; LANG PT, PROTEIN SCI UNPUB; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Schramm VL, 2001, CURR OPIN STRUC BIOL, V11, P657, DOI 10.1016/S0959-440X(01)00269-X; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; TILTON RF, 1992, BIOCHEMISTRY-US, V31, P2469, DOI 10.1021/bi00124a006; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Trzesniak D, 2006, PROTEIN SCI, V15, P2544, DOI 10.1110/ps.062356406; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	45	347	348	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2009	462	7273					669	U149		10.1038/nature08615	http://dx.doi.org/10.1038/nature08615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	526HH	19956261	Green Accepted, Green Submitted			2022-12-24	WOS:000272277900045
J	Schnable, PS; Ware, D; Fulton, RS; Stein, JC; Wei, FS; Pasternak, S; Liang, CZ; Zhang, JW; Fulton, L; Graves, TA; Minx, P; Reily, AD; Courtney, L; Kruchowski, SS; Tomlinson, C; Strong, C; Delehaunty, K; Fronick, C; Courtney, B; Rock, SM; Belter, E; Du, FY; Kim, K; Abbott, RM; Cotton, M; Levy, A; Marchetto, P; Ochoa, K; Jackson, SM; Gillam, B; Chen, WZ; Yan, L; Higginbotham, J; Cardenas, M; Waligorski, J; Applebaum, E; Phelps, L; Falcone, J; Kanchi, K; Thane, T; Scimone, A; Thane, N; Henke, J; Wang, T; Ruppert, J; Shah, N; Rotter, K; Hodges, J; Ingenthron, E; Cordes, M; Kohlberg, S; Sgro, J; Delgado, B; Mead, K; Chinwalla, A; Leonard, S; Crouse, K; Collura, K; Kudrna, D; Currie, J; He, RF; Angelova, A; Rajasekar, S; Mueller, T; Lomeli, R; Scara, G; Ko, A; Delaney, K; Wissotski, M; Lopez, G; Campos, D; Braidotti, M; Ashley, E; Golser, W; Kim, H; Lee, S; Lin, JK; Dujmic, Z; Kim, W; Talag, J; Zuccolo, A; Fan, C; Sebastian, A; Kramer, M; Spiegel, L; Nascimento, L; Zutavern, T; Miller, B; Ambroise, C; Muller, S; Spooner, W; Narechania, A; Ren, LY; Wei, S; Kumari, S; Faga, B; Levy, MJ; McMahan, L; Van Buren, P; Vaughn, MW; Ying, K; Yeh, CT; Emrich, SJ; Jia, Y; Kalyanaraman, A; Hsia, AP; Barbazuk, WB; Baucom, RS; Brutnell, TP; Carpita, NC; Chaparro, C; Chia, JM; Deragon, JM; Estill, JC; Fu, Y; Jeddeloh, JA; Han, YJ; Lee, H; Li, PH; Lisch, DR; Liu, SZ; Liu, ZJ; Nagel, DH; McCann, MC; SanMiguel, P; Myers, AM; Nettleton, D; Nguyen, J; Penning, BW; Ponnala, L; Schneider, KL; Schwartz, DC; Sharma, A; Soderlund, C; Springer, NM; Sun, Q; Wang, H; Waterman, M; Westerman, R; Wolfgruber, TK; Yang, LX; Yu, Y; Zhang, LF; Zhou, SG; Zhu, Q; Bennetzen, JL; Dawe, RK; Jiang, JM; Jiang, N; Presting, GG; Wessler, SR; Aluru, S; Martienssen, RA; Clifton, SW; McCombie, WR; Wing, RA; Wilson, RK				Schnable, Patrick S.; Ware, Doreen; Fulton, Robert S.; Stein, Joshua C.; Wei, Fusheng; Pasternak, Shiran; Liang, Chengzhi; Zhang, Jianwei; Fulton, Lucinda; Graves, Tina A.; Minx, Patrick; Reily, Amy Denise; Courtney, Laura; Kruchowski, Scott S.; Tomlinson, Chad; Strong, Cindy; Delehaunty, Kim; Fronick, Catrina; Courtney, Bill; Rock, Susan M.; Belter, Eddie; Du, Feiyu; Kim, Kyung; Abbott, Rachel M.; Cotton, Marc; Levy, Andy; Marchetto, Pamela; Ochoa, Kerri; Jackson, Stephanie M.; Gillam, Barbara; Chen, Weizu; Yan, Le; Higginbotham, Jamey; Cardenas, Marco; Waligorski, Jason; Applebaum, Elizabeth; Phelps, Lindsey; Falcone, Jason; Kanchi, Krishna; Thane, Thynn; Scimone, Adam; Thane, Nay; Henke, Jessica; Wang, Tom; Ruppert, Jessica; Shah, Neha; Rotter, Kelsi; Hodges, Jennifer; Ingenthron, Elizabeth; Cordes, Matt; Kohlberg, Sara; Sgro, Jennifer; Delgado, Brandon; Mead, Kelly; Chinwalla, Asif; Leonard, Shawn; Crouse, Kevin; Collura, Kristi; Kudrna, Dave; Currie, Jennifer; He, Ruifeng; Angelova, Angelina; Rajasekar, Shanmugam; Mueller, Teri; Lomeli, Rene; Scara, Gabriel; Ko, Ara; Delaney, Krista; Wissotski, Marina; Lopez, Georgina; Campos, David; Braidotti, Michele; Ashley, Elizabeth; Golser, Wolfgang; Kim, HyeRan; Lee, Seunghee; Lin, Jinke; Dujmic, Zeljko; Kim, Woojin; Talag, Jayson; Zuccolo, Andrea; Fan, Chuanzhu; Sebastian, Aswathy; Kramer, Melissa; Spiegel, Lori; Nascimento, Lidia; Zutavern, Theresa; Miller, Beth; Ambroise, Claude; Muller, Stephanie; Spooner, Will; Narechania, Apurva; Ren, Liya; Wei, Sharon; Kumari, Sunita; Faga, Ben; Levy, Michael J.; McMahan, Linda; Van Buren, Peter; Vaughn, Matthew W.; Ying, Kai; Yeh, Cheng-Ting; Emrich, Scott J.; Jia, Yi; Kalyanaraman, Ananth; Hsia, An-Ping; Barbazuk, W. Brad; Baucom, Regina S.; Brutnell, Thomas P.; Carpita, Nicholas C.; Chaparro, Cristian; Chia, Jer-Ming; Deragon, Jean-Marc; Estill, James C.; Fu, Yan; Jeddeloh, Jeffrey A.; Han, Yujun; Lee, Hyeran; Li, Pinghua; Lisch, Damon R.; Liu, Sanzhen; Liu, Zhijie; Nagel, Dawn Holligan; McCann, Maureen C.; SanMiguel, Phillip; Myers, Alan M.; Nettleton, Dan; Nguyen, John; Penning, Bryan W.; Ponnala, Lalit; Schneider, Kevin L.; Schwartz, David C.; Sharma, Anupma; Soderlund, Carol; Springer, Nathan M.; Sun, Qi; Wang, Hao; Waterman, Michael; Westerman, Richard; Wolfgruber, Thomas K.; Yang, Lixing; Yu, Yeisoo; Zhang, Lifang; Zhou, Shiguo; Zhu, Qihui; Bennetzen, Jeffrey L.; Dawe, R. Kelly; Jiang, Jiming; Jiang, Ning; Presting, Gernot G.; Wessler, Susan R.; Aluru, Srinivas; Martienssen, Robert A.; Clifton, Sandra W.; McCombie, W. Richard; Wing, Rod A.; Wilson, Richard K.			The B73 Maize Genome: Complexity, Diversity, and Dynamics	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; ARABIDOPSIS-THALIANA; PLANT; GENES; RETROTRANSPOSONS; METHYLATION; DIVERGENCE; GENETICS; SORGHUM; CORN	We report an improved draft nucleotide sequence of the 2.3-gigabase genome of maize, an important crop plant and model for biological research. Over 32,000 genes were predicted, of which 99.8% were placed on reference chromosomes. Nearly 85% of the genome is composed of hundreds of families of transposable elements, dispersed nonuniformly across the genome. These were responsible for the capture and amplification of numerous gene fragments and affect the composition, sizes, and positions of centromeres. We also report on the correlation of methylation-poor regions with Mu transposon insertions and recombination, and copy number variants with insertions and/or deletions, as well as how uneven gene losses between duplicated regions were involved in returning an ancient allotetraploid to a genetically diploid state. These analyses inform and set the stage for further investigations to improve our understanding of the domestication and agricultural improvements of maize.	[Wilson, Richard K.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; Iowa State Univ, Ctr Plant Genom, Ames, IA 50011 USA; Iowa State Univ, Dept Agron, Ames, IA 50011 USA; Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; Iowa State Univ, Ctr Carbon Capturing Crops, Ames, IA 50011 USA; Robert Holley Ctr Agr & Hlth, N Atlantic Area, USDA, Ithaca, NY 14853 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Arizona, Arizona Genom Inst, Sch Plant Sci, Tucson, AZ 85721 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, BIO5 Inst Collaborat Res, Tucson, AZ 85721 USA; Iowa State Univ, Dept Elect & Comp Engn, Ames, IA 50011 USA; Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; Univ Florida, Dept Bot, Gainesville, FL 32611 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA; Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; Univ Perpignan, CNRS, F-66025 Perpignan, France; Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; NimbleGen, Madison, WI 53711 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Univ Calif Berkeley, Dept Plant Biol, Berkeley, CA 94720 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; Iowa State Univ, Dept Stat, Ames, IA 50011 USA; Univ So Calif, Dept Math, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Comp Sci, Los Angeles, CA 90089 USA; Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14850 USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Wisconsin, Lab Mol & Computat Genom, Dept Chem, Genet Lab, Madison, WI 53706 USA; Univ Arizona, BIO5 Inst Collaborat Res, Tucson, AZ 85721 USA; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; Indian Inst Technol, Bombay 400076, Maharashtra, India; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Cold Spring Harbor Laboratory; University of Arizona; University of Arizona; Iowa State University; University of Notre Dame; Washington State University; State University System of Florida; University of Florida; University System of Georgia; University of Georgia; Cornell University; Boyce Thompson Institute for Plant Research; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; University System of Georgia; University of Georgia; Roche Holding; Roche NimbleGen; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; Iowa State University; University of Southern California; University of Southern California; University of Southern California; Cornell University; University of Hawaii System; University of Wisconsin System; University of Wisconsin Madison; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Washington University (WUSTL)	Wilson, RK (corresponding author), Washington Univ, Genome Ctr, St Louis, MO 63108 USA.	rwilson@wustl.edu	Rajasekar, Shanmugam/U-2222-2019; Li, Ping/GYV-4914-2022; SanMiguel, Phillip J/I-2196-2015; Yang, Lixing/A-7073-2013; Wilson, Matthew H/K-3193-2013; Wilson, Richard K./AAF-4139-2019; Deragon, Jean-Marc/C-5174-2008; Ponnala, Lalit/B-2354-2010; Jiang, Jiming/A-9614-2009; JIA, YI/E-9675-2010; Chaparro, Cristian/D-1427-2015; Chia, Jer-Ming/C-9992-2012; Lisch, Damon/A-9414-2010; Brutnell, Thomas/M-2840-2013; Zhang, Jianwei/D-2488-2009; Zhu, Qihui/N-2625-2013; Wing, Rod A/Z-2885-2019; Springer, Nathan/F-2680-2013; He, Ruifeng/F-1418-2010; Jiang, Ning/G-6546-2012; Stern, David B/H-7852-2012; Jiang, Jiming/V-6060-2019; Zhou, Shiguo/B-3832-2011; McCann, Maureen C/T-9258-2017; Sharma, Anupma/F-1221-2015; Jia, Yi/F-7476-2010; Zuccolo, Andrea/H-5636-2019; Wang, Hao/C-7651-2009	SanMiguel, Phillip J/0000-0002-3742-9527; Wilson, Richard K./0000-0002-1992-1358; Jiang, Jiming/0000-0002-6435-6140; Chaparro, Cristian/0000-0002-5162-349X; Brutnell, Thomas/0000-0002-3581-8211; Wing, Rod A/0000-0001-6633-6226; Springer, Nathan/0000-0002-7301-4759; Jiang, Jiming/0000-0002-6435-6140; Zhou, Shiguo/0000-0001-7421-2506; McCann, Maureen C/0000-0001-6956-4216; Sharma, Anupma/0000-0002-6201-7639; Zuccolo, Andrea/0000-0001-7574-0714; Estill, James/0000-0003-1020-2928; Yu, Yeisoo/0000-0002-8410-0310; Baucom, Regina/0000-0001-7960-498X; Penning, Bryan/0000-0002-0374-8693; Yeh, Cheng-Ting/0000-0002-1392-2018; Wang, Hao/0000-0002-9634-8778; Chinwalla, Asif/0000-0001-7831-3996; , Dawn/0000-0001-8996-3572; Nettleton, Dan/0000-0002-6045-1036; Zhang, Jianwei/0000-0001-8030-5346; Waligorski, Jason/0000-0001-8422-6004; Barbazuk, William/0000-0002-0909-4563; Schnable, Patrick/0000-0001-9169-5204; McCombie, W. Richard/0000-0003-1899-0682; Vaughn, Matthew/0000-0002-1384-4283; Lisch, Damon/0000-0002-8693-8651; Deragon, Jean-Marc/0000-0002-2476-4932	NSF [DBI-0527192, DBI-0607123, DBI-0421671, DBI-0321467, DBI-0321711, DBI-0333074, DBI-0501818, DBI-0501857, DBI-0701736, DBI-0703273, DBI-0703908]; USDA Cooperative State Research, Education, and Extension Service [2005-35301-15715, 2007-35301-18372]; USDA-ARS [408934, 413089]; Office of Science (Biological and Environmental Research); U. S. Department of Energy [DE-FG02-08ER64702]	NSF(National Science Foundation (NSF)); USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Office of Science (Biological and Environmental Research)(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE))	The Maize Genome Sequencing Project supported by NSF award DBI-0527192 (R. K. W., S. W. C., R. S. F., R. A. W., P. S. S., S. A., L. S., D. W., W. R. M., R. A. M.). The Maize Transposable Element Consortium and the Maize Centromere Consortium supported by NSF awards DBI-0607123 (S. R. W., J. L. B., R. K. D., N. J., P. S. M.) and DBI-0421671 (R. K. D., J. J., G. G. P.). Also supported by NSF grants DBI-0321467 (D. W.), DBI-0321711 (P. S. S.), DBI-0333074 (D. W.), DBI-0501818 (D. C. S.), DBI-0501857 (Y. Y.), DBI-0701736 (T. P. B., Q. S.), DBI-0703273 (R. A. M.), and DBI-0703908 (D. W.), and by USDA National Research Initiative Grants 2005-35301-15715 and 2007-35301-18372 from the USDA Cooperative State Research, Education, and Extension Service (P. S. S.) and from the USDA-ARS (408934 and 413089) to D. W., and from the Office of Science (Biological and Environmental Research), U. S. Department of Energy, grant DE-FG02-08ER64702 to N. C. C. and M. C. M. Sequences of the reference chromosomes have been deposited in GenBank as accession numbers CM000777 to CM000786. RNA-sequence reads have been deposited in the Gene Expression Omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo) as accession numbers GSE16136, GSE16868, and GSE16916. Centromeric sequences have been deposited in the National Center for Biotechnology Information, NIH, Trace Archive as accessions 1757396377 to 1757412600 and 2185189231 to 2185200942.	Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; BENNETZEN J, 2009, HDB MAIZE GENETICS G; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; *CP NAT CORN GROW, TABL SHOW CORN HARV; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Duvick DN, 1999, SCIENCE, V286, P418, DOI 10.1126/science.286.5439.418; Emrich SJ, 2007, GENETICS, V175, P429, DOI 10.1534/genetics.106.064006; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fu Y, 2005, P NATL ACAD SCI USA, V102, P12282, DOI 10.1073/pnas.0503394102; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Jia Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000737; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; LAL S, 2008, HDB MAIZE GENETICS G, P329; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; McClintock B, 1929, SCIENCE, V69, P629, DOI 10.1126/science.69.1798.629; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Penning BW, 2009, PLANT PHYSIOL, V151, P1703, DOI 10.1104/pp.109.136804; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Sharma A, 2008, P NATL ACAD SCI USA, V105, P15470, DOI 10.1073/pnas.0805694105; Sharma A, 2008, MOL GENET GENOMICS, V279, P133, DOI 10.1007/s00438-007-0302-5; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Swanson-Wagner RA, 2009, SCIENCE, V326, P1118, DOI 10.1126/science.1178294; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tate JA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-80; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Tian Chao-Guang, 2005, Acta Genetica Sinica, V32, P519; Troyer AF, 2006, CROP SCI, V46, P528, DOI 10.2135/cropsci2005.0065; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000728; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000715; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Yang LX, 2009, P NATL ACAD SCI USA, V106, P19922, DOI 10.1073/pnas.0908008106; Yang LX, 2009, P NATL ACAD SCI USA, V106, P12832, DOI 10.1073/pnas.0905563106; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang WL, 2008, PLANT CELL, V20, P25, DOI 10.1105/tpc.107.057083; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711	51	2732	2983	18	619	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1112	1115		10.1126/science.1178534	http://dx.doi.org/10.1126/science.1178534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19965430				2022-12-24	WOS:000271951000044
J	Baudat, F; Buard, J; Grey, C; Fledel-Alon, A; Ober, C; Przeworski, M; Coop, G; de Massy, B				Baudat, F.; Buard, J.; Grey, C.; Fledel-Alon, A.; Ober, C.; Przeworski, M.; Coop, G.; de Massy, B.			PRDM9 Is a Major Determinant of Meiotic Recombination Hotspots in Humans and Mice	SCIENCE			English	Article							HISTONE H3 METHYLTRANSFERASE; ZINC FINGERS; HUMAN GENOME; HOT-SPOTS; RATES; CHIMPANZEES; INITIATION; PATTERNS; MEIOSIS; SITES	Meiotic recombination events cluster into narrow segments of the genome, defined as hotspots. Here, we demonstrate that a major player for hotspot specification is the Prdm9 gene. First, two mouse strains that differ in hotspot usage are polymorphic for the zinc finger DNA binding array of PRDM9. Second, the human consensus PRDM9 allele is predicted to recognize the 13-mer motif enriched at human hotspots; this DNA binding specificity is verified by in vitro studies. Third, allelic variants of PRDM9 zinc fingers are significantly associated with variability in genome-wide hotspot usage among humans. Our results provide a molecular basis for the distribution of meiotic recombination in mammals, in which the binding of PRDM9 to specific DNA sequences targets the initiation of recombination at specific locations in the genome.	[Baudat, F.; Buard, J.; Grey, C.; de Massy, B.] CNRS, UPR1142, Inst Genet Humaine, Montpellier, France; [Fledel-Alon, A.; Ober, C.; Przeworski, M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Przeworski, M.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Coop, G.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Coop, G.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of California System; University of California Davis; University of California System; University of California Davis	de Massy, B (corresponding author), CNRS, UPR1142, Inst Genet Humaine, Montpellier, France.	bernard.de-massy@igh.cnrs.fr		Ober, Carole/0000-0003-4626-9809; Coop, Graham/0000-0001-8431-0302; Baudat, Frederic/0000-0003-2415-8366	CNRS; Association pour la Recherche sur le Cancer [ARC 3939]; Fondation Jer me Lejeune; Agence Nationale de la Recherche [ANR-06-BLAN-0160-01, ANR-09-BLAN-0269-01]; Electricite de France; NIH [HD21244, HL085197, GM83098]; American Recovery and Reinvestment Act [03S1]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083098] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation Jer me Lejeune; Agence Nationale de la Recherche(French National Research Agency (ANR)); Electricite de France; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of our laboratories for discussions, J. Pritchard for comments on an earlier version of the manuscript, R. Hernandez and E. Leffler for their help with bioinformatics, E. Leffler for generating fig. S7, E. Brun for technical assistance on PRDM9 in vitro assays, and D. Haddou and F. Arnal for mouse facility service. This study was supported by a grant from CNRS; the Association pour la Recherche sur le Cancer (grant ARC 3939); the Fondation Jer me Lejeune and the Agence Nationale de la Recherche (grants ANR-06-BLAN-0160-01 and ANR-09-BLAN-0269-01) to B.d.M. C. G. was supported by a grant from Electricite de France. This research was further was supported by NIH grants HD21244 and HL085197 to C.O., a Sloan Foundation Fellowship to G. C., NIH grant GM83098, American Recovery and Reinvestment Act supplement 03S1, and a Howard Hughes Medical Institute Early Career Scientist Award to M. P. Sequences generated for this study are deposited in GenBank with the following accession numbers: GU216222, GU216223, GU216224, GU216225, GU216226, GU216227, GU216228, GU216229, and GU216230.	Arnheim N, 2007, ANNU REV GENET, V41, P369, DOI 10.1146/annurev.genet.41.110306.130301; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HUNTER N, 2007, MOL GENETICS RECOMBI, P381; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3	30	639	651	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					836	840		10.1126/science.1183439	http://dx.doi.org/10.1126/science.1183439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044539	Green Accepted			2022-12-24	WOS:000274408300053
J	Louie, JK; Acosta, M; Jamieson, DJ; Honein, MA				Louie, Janice K.; Acosta, Meileen; Jamieson, Denise J.; Honein, Margaret A.		Calif Pandemic H1N1 Working Grp	Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							A(H1N1) INFECTION; UNITED-STATES; IMMUNIZATION; ADMISSIONS; IMPACT; VIRUS; TESTS	BACKGROUND Like previous epidemic and pandemic diseases, 2009 pandemic influenza A (H1N1) may pose an increased risk of severe illness in pregnant women. METHODS Statewide surveillance for patients who were hospitalized with or died from 2009 H1N1 influenza was initiated by the California Department of Public Health. We reviewed demographic and clinical data reported from April 23 through August 11, 2009, for all H1N1-infected, reproductive-age women who were hospitalized or died -nonpregnant women, pregnant women, and postpartum women (those who had delivered <= 2 weeks previously). RESULTS Data were reported for 94 pregnant women, 8 postpartum women, and 137 nonpregnant women of reproductive age who were hospitalized with 2009 H1N1 influenza. Rapid antigen tests were falsely negative in 38% of the patients tested (58 of 153). Most pregnant patients (89 of 94 [95%]) were in the second or third trimester, and approximately one third (32 of 93 [34%]) had established risk factors for complications from influenza other than pregnancy. As compared with early antiviral treatment (administered <= 2 days after symptom onset) in pregnant women, later treatment was associated with admission to an intensive care unit (ICU) or death (relative risk, 4.3). In all, 18 pregnant women and 4 postpartum women (total, 22 of 102 [22%]) required intensive care, and 8 (8%) died. Six deliveries occurred in the ICU, including four emergency cesarean deliveries. The 2009 H1N1 influenza-specific maternal mortality ratio (the number of maternal deaths per 100,000 live births) was 4.3. CONCLUSIONS 2009 H1N1 influenza can cause severe illness and death in pregnant and postpartum women; regardless of the results of rapid antigen testing, prompt evaluation and antiviral treatment of influenza-like illness should be considered in such women. The high cause-specific maternal mortality rate suggests that 2009 H1N1 influenza may increase the 2009 maternal mortality ratio in the United States.	[Louie, Janice K.; Acosta, Meileen] Calif Dept Publ Hlth, Richmond, CA 94804 USA; [Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA	California Department of Public Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Louie, JK (corresponding author), Calif Dept Publ Hlth, 850 Marina Bay Pkwy, Richmond, CA 94804 USA.	janice.louie@cdph.ca.gov		Jamieson, Denise/0000-0003-2597-1201				[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P826; *CAL DEP PUBL HLTH, 2005, VIT STAT POP SUMM TA; *CDCP, CDC HLTH AL NETW HAN; Centers for Disease Control and Prevention, UPD INT REC OBST HLT; Centers for Disease Control and Prevention, 2009 H1N1 INFL VACC; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mahutte NG, 1999, OBSTET GYNECOL, V94, P263, DOI 10.1016/S0029-7844(99)00274-4; *NAT I ALL INF DIS, H1N1 VACC CLIN STUD; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Saleeby E, 2009, OBSTET GYNECOL, V114, P885, DOI 10.1097/AOG.0b013e3181bb44bb; TAMMA PD, 2009, AM J OBSTET GYN 1020; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; 2009, MMWR MORB MORTAL WKL, V58, P497	24	473	509	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					27	35		10.1056/NEJMoa0910444	http://dx.doi.org/10.1056/NEJMoa0910444			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20032319				2022-12-24	WOS:000273345500006
J	Grandison, RC; Piper, MDW; Partridge, L				Grandison, Richard C.; Piper, Matthew D. W.; Partridge, Linda			Amino-acid imbalance explains extension of lifespan by dietary restriction in Drosophila	NATURE			English	Article							NATURAL-SELECTION; REPRODUCTION; FOOD; MELANOGASTER; LONGEVITY; SURVIVAL; GROWTH	Dietary restriction extends healthy lifespan in diverse organisms and reduces fecundity(1,2). It is widely assumed to induce adaptive reallocation of nutrients from reproduction to somatic maintenance, aiding survival of food shortages in nature(3-6). If this were the case, long life under dietary restriction and high fecundity under full feeding would be mutually exclusive, through competition for the same limiting nutrients. Here we report a test of this idea in which we identified the nutrients producing the responses of lifespan and fecundity to dietary restriction in Drosophila. Adding essential amino acids to the dietary restriction condition increased fecundity and decreased lifespan, similar to the effects of full feeding, with other nutrients having little or no effect. However, methionine alone was necessary and sufficient to increase fecundity as much as did full feeding, but without reducing lifespan. Reallocation of nutrients therefore does not explain the responses to dietary restriction. Lifespan was decreased by the addition of amino acids, with an interaction between methionine and other essential amino acids having a key role. Hence, an imbalance in dietary amino acids away from the ratio optimal for reproduction shortens lifespan during full feeding and limits fecundity during dietary restriction. Reduced activity of the insulin/insulin-like growth factor signalling pathway extends lifespan in diverse organisms(7), and we find that it also protects against the shortening of lifespan with full feeding. In other organisms, including mammals, it may be possible to obtain the benefits to lifespan of dietary restriction without incurring a reduction in fecundity, through a suitable balance of nutrients in the diet.	[Grandison, Richard C.; Piper, Matthew D. W.; Partridge, Linda] UCL, Inst Healthy Ageing, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Partridge, L (corresponding author), UCL, Inst Healthy Ageing, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England.	l.partridge@ucl.ac.uk	Partridge, Linda/A-5501-2010; Piper, Matthew/C-1714-2008; Partridge, Linda/E-7342-2015	Piper, Matthew/0000-0003-3245-7219; Partridge, Linda/0000-0001-9615-0094; Grandison, Richard/0000-0002-4552-0494	Wellcome Trust Strategic Award; Research into Ageing	Wellcome Trust Strategic Award(Wellcome Trust); Research into Ageing	We acknowledge funding from a Wellcome Trust Strategic Award to L. P. ( M. D. W. P. and L. P.) and Research into Ageing ( R. C. G. and L. P.). We would also like to thank M. Hoddinott for technical support as well as S. Pletcher and E. Blanc for assistance with statistical analyses.	Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Clancy David J., 2001, Drosophila Information Service, V84, P168; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Crawley MJ, 2005, STAT INTRO USING R, P103; DEMARTE ML, 1986, MECH AGEING DEV, V36, P161, DOI 10.1016/0047-6374(86)90017-5; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Grandison RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004067; HARRISON DE, 1989, GROWTH DEVELOP AGING, V53, P3; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P334, DOI 10.1002/bit.10054; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Millward DJ, 2008, AM J CLIN NUTR, V87, p1576S, DOI 10.1093/ajcn/87.5.1576S; O'Brien DM, 2008, CURR BIOL, V18, pR155, DOI 10.1016/j.cub.2008.01.021; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; R Development Core Team, 2005, R LANG ENV STAT COMP; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Sang J.H., 1978, P159; SANG JH, 1961, J EXP BIOL, V38, P793; Selesniemi K, 2008, AGING CELL, V7, P622, DOI 10.1111/j.1474-9726.2008.00409.x; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Weindruch R., 1988, RETARDATION AGING DI; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	36	500	515	3	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1061	U121		10.1038/nature08619	http://dx.doi.org/10.1038/nature08619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	19956092	Green Submitted, Green Accepted			2022-12-24	WOS:000272996000048
J	Boch, J; Scholze, H; Schornack, S; Landgraf, A; Hahn, S; Kay, S; Lahaye, T; Nickstadt, A; Bonas, U				Boch, Jens; Scholze, Heidi; Schornack, Sebastian; Landgraf, Angelika; Hahn, Simone; Kay, Sabine; Lahaye, Thomas; Nickstadt, Anja; Bonas, Ulla			Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors	SCIENCE			English	Article							ORYZAE PV. ORYZAE; BACTERIAL AVIRULENCE PROTEIN; GENE-EXPRESSION; HOST-PLANT; RECOGNITION; AVRBS3; RICE; ACTIVATION; RESISTANCE; CELL	The pathogenicity of many bacteria depends on the injection of effector proteins via type III secretion into eukaryotic cells in order to manipulate cellular processes. TAL (transcription activator-like) effectors from plant pathogenic Xanthomonas are important virulence factors that act as transcriptional activators in the plant cell nucleus, where they directly bind to DNA via a central domain of tandem repeats. Here, we show how target DNA specificity of TAL effectors is encoded. Two hypervariable amino acid residues in each repeat recognize one base pair in the target DNA. Recognition sequences of TAL effectors were predicted and experimentally confirmed. The modular protein architecture enabled the construction of artificial effectors with new specificities. Our study describes the functionality of a distinct type of DNA binding domain and allows the design of DNA binding domains for biotechnology.	[Boch, Jens; Scholze, Heidi; Schornack, Sebastian; Landgraf, Angelika; Hahn, Simone; Kay, Sabine; Lahaye, Thomas; Nickstadt, Anja; Bonas, Ulla] Univ Halle Wittenberg, Inst Biol, Dept Genet, D-06099 Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Boch, J (corresponding author), Univ Halle Wittenberg, Inst Biol, Dept Genet, Weinbergweg 10, D-06099 Halle, Saale, Germany.	jens.boch@genetik.uni-halle.de	Wilson, Matthew H/K-3193-2013; Schornack, Sebastian/A-3650-2011; Ha, Dat Thinh/D-4995-2015; Schornack, Sebastian/AAE-4897-2020	Schornack, Sebastian/0000-0002-7836-5881; Ha, Dat Thinh/0000-0003-4260-4876; Schornack, Sebastian/0000-0002-7836-5881	Deutsche Forschungsgemeinschaft [SPP 1212, SFB 648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Streubel, A. Richter, and P. Romer for kindly providing constructs; T. Gonzalez for advice on anthocyanin synthesis; and R. Kahmann for helpful suggestions on the manuscript. A patent covering the findings is pending. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SPP 1212 to J. B. and U. B. and SFB 648 to U. B.).	Bai JF, 2000, MOL PLANT MICROBE IN, V13, P1322, DOI 10.1094/MPMI.2000.13.12.1322; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kay S, 2005, MOL PLANT MICROBE IN, V18, P838, DOI 10.1094/MPMI-18-0838; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Schornack S, 2005, MOL PLANT MICROBE IN, V18, P1215, DOI 10.1094/MPMI-18-1215; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Yang B, 2005, MOL PLANT MICROBE IN, V18, P142, DOI 10.1094/MPMI-18-0142; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Zhu WG, 1998, MOL PLANT MICROBE IN, V11, P824, DOI 10.1094/MPMI.1998.11.8.824	26	1748	2278	26	501	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1509	1512		10.1126/science.1178811	http://dx.doi.org/10.1126/science.1178811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	19933107				2022-12-24	WOS:000272623600050
J	Qi, Y; Spong, MC; Nam, K; Banerjee, A; Jiralerspong, S; Karplus, M; Verdine, GL				Qi, Yan; Spong, Marie C.; Nam, Kwangho; Banerjee, Anirban; Jiralerspong, Sao; Karplus, Martin; Verdine, Gregory L.			Encounter and extrusion of an intrahelical lesion by a DNA repair enzyme	NATURE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; EMPIRICAL FORCE-FIELD; ESCHERICHIA-COLI; FREE-ENERGY; STRUCTURAL BASIS; NUCLEIC-ACIDS; FPG PROTEIN; DAMAGED DNA; DUPLEX DNA; RECOGNITION	How living systems detect the presence of genotoxic damage embedded in a million-fold excess of undamaged DNA is an unresolved question in biology. Here we have captured and structurally elucidated a base-excision DNA repair enzyme, MutM, at the stage of initial encounter with a damaged nucleobase, 8-oxoguanine (oxoG), nested within a DNA duplex. Three structures of intrahelical oxoG-encounter complexes are compared with sequence-matched structures containing a normal G base in place of an oxoG lesion. Although the protein-DNA interfaces in the matched complexes differ by only two atoms-those that distinguish oxoG from G-their pronounced structural differences indicate that MutM can detect a lesion in DNA even at the earliest stages of encounter. All-atom computer simulations show the pathway by which encounter of the enzyme with the lesion causes extrusion from the DNA duplex, and they elucidate the critical free energy difference between oxoG and G along the extrusion pathway.	[Spong, Marie C.; Nam, Kwangho; Banerjee, Anirban; Jiralerspong, Sao; Karplus, Martin; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Qi, Yan; Verdine, Gregory L.] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Chem Biol Initiat, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Karplus, Martin] Univ Strasbourg, ISIS, F-67000 Strasbourg, France	Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	marci@tammy.harvard.edu; gregory_verdine@harvard.edu	Banerjee, Anirban/AAC-4286-2020	banerjee, anirban/0000-0003-1494-6801; Jiralerspong, Sao/0000-0001-6032-3109; Banerjee, Anirban/0000-0002-9314-2862	NIH [GM044853, GM047467, CA100742, GM030804]; the National Science Foundation; Howard Hughes Medical Institute; National Cancer Center; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030804, R01GM030804, R01GM044853, P01GM047467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); the National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH: GM044853, GM047467, CA100742 ( G. L. V.) and GM030804 ( M. K.). Y. Q. is supported by a predoctoral fellowship from the National Science Foundation; M. C. S. by a predoctoral fellowship from the Howard Hughes Medical Institute; K. N. by a postdoctoral fellowship from National Cancer Center. We thank the staff of the NSLS, APS and CHESS synchrotron facilities. These experiments made use of the computing facilities at NERSC and Harvard FAS. We are grateful to J. Jin for experimental assistance and J. Pu, V. Ovchinnikov and other members of the Karplus and Verdine groups for helpful advice.	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Banavali NK, 2002, J MOL BIOL, V319, P141, DOI 10.1016/S0022-2836(02)00194-8; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman BR, 2008, STRUCTURE, V16, P1166, DOI 10.1016/j.str.2008.04.012; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng XL, 2005, J AM CHEM SOC, V127, P13906, DOI 10.1021/ja052542s; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorova OS, 2002, BIOCHEMISTRY-US, V41, P1520, DOI 10.1021/bi011524u; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Hu J, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2335640; Hu J, 2008, P NATL ACAD SCI USA, V105, P4615, DOI 10.1073/pnas.0708058105; Ishchenko AA, 2002, BIOCHEMISTRY-US, V41, P7540, DOI 10.1021/bi0121297; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Loeb LA, 2001, CANCER RES, V61, P3230; Macke TJ, 1998, ACS SYM SER, V682, P379; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Minetti CASA, 2003, J MOL BIOL, V328, P1047, DOI 10.1016/S0022-2836(03)00365-6; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Priyakumar UD, 2006, J AM CHEM SOC, V128, P678, DOI 10.1021/ja056445a; Rajamani R, 2003, J COMPUT CHEM, V24, P1775, DOI 10.1002/jcc.10315; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; van der Vaart A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1861885; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	47	116	116	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					762	U79		10.1038/nature08561	http://dx.doi.org/10.1038/nature08561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010681	Green Accepted			2022-12-24	WOS:000272559900032
J	Rohs, R; West, SM; Sosinsky, A; Liu, P; Mann, RS; Honig, B				Rohs, Remo; West, Sean M.; Sosinsky, Alona; Liu, Peng; Mann, Richard S.; Honig, Barry			The role of DNA shape in protein-DNA recognition	NATURE			English	Article							CRYSTAL-STRUCTURE; NUCLEOSOME CORE; BINDING-SITES; A-TRACT; NUCLEIC-ACIDS; MINOR-GROOVE; SEQUENCE; COMPLEX; RESOLUTION; REPRESSOR	The recognition of specific DNA sequences by proteins is thought to depend on two types of mechanism: one that involves the formation of hydrogen bonds with specific bases, primarily in the major groove, and one involving sequence-dependent deformations of the DNA helix. By comprehensively analysing the three-dimensional structures of protein-DNA complexes, here we show that the binding of arginine residues to narrow minor grooves is a widely used mode for protein-DNA recognition. This readout mechanism exploits the phenomenon that narrow minor grooves strongly enhance the negative electrostatic potential of the DNA. The nucleosome core particle offers a prominent example of this effect. Minor-groove narrowing is often associated with the presence of A-tracts, AT-rich sequences that exclude the flexible TpA step. These findings indicate that the ability to detect local variations in DNA shape and electrostatic potential is a general mechanism that enables proteins to use information in the minor groove, which otherwise offers few opportunities for the formation of base-specific hydrogen bonds, to achieve DNA-binding specificity.	[Rohs, Remo; West, Sean M.; Sosinsky, Alona; Liu, Peng; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Honig, B (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, Howard Hughes Med Inst, 1130 St Nicholas Ave, New York, NY 10032 USA.	rsm10@columbia.edu; bh6@columbia.edu	Rohs, Remo/F-5752-2011	West, Sean/0000-0003-1038-0222	National Institutes of Health (NIH) [GM54510, U54 CA121852]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030518, R01GM054510] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM54510 (R. S. M.) and U54 CA121852 (B. H. and R. S. M.). The authors thank A. Califano for many helpful conversations.	AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gearhart MD, 2003, J MOL BIOL, V327, P819, DOI 10.1016/S0022-2836(03)00183-9; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JAYARAM B, 1989, BIOPOLYMERS, V28, P975, DOI 10.1002/bip.360280506; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Li T, 1998, NUCLEIC ACIDS RES, V26, P5707, DOI 10.1093/nar/26.24.5707; Locasale JW, 2009, J MOL BIOL, V386, P1054, DOI 10.1016/j.jmb.2009.01.007; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Meinke G, 1999, NAT STRUCT BIOL, V6, P471; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rohs R, 2005, STRUCTURE, V13, P1499, DOI 10.1016/j.str.2005.07.005; Rohs R, 2009, CURR OPIN STRUC BIOL, V19, P171, DOI 10.1016/j.sbi.2009.03.002; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; SHAKKED Z, 1994, NATURE, V368, P469, DOI 10.1038/368469a0; Shakked Z., 1999, OXFORD HDB NUCL ACID, P455; Shen A, 2009, STRUCTURE, V17, P769, DOI 10.1016/j.str.2009.02.018; Stefl R, 2004, P NATL ACAD SCI USA, V101, P1177, DOI 10.1073/pnas.0308143100; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; Tolstorukov MY, 2005, NUCLEIC ACIDS RES, V33, P3907, DOI 10.1093/nar/gki699; Travers A. A., 1990, DNA TOPOLOGY ITS BIO, P57; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Watkins S, 2004, NUCLEIC ACIDS RES, V32, P4306, DOI 10.1093/nar/gkh770	49	687	694	4	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1248	U81		10.1038/nature08473	http://dx.doi.org/10.1038/nature08473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19865164	Green Accepted			2022-12-24	WOS:000271190800041
J	Vecsey, CG; Baillie, GS; Jaganath, D; Havekes, R; Daniels, A; Wimmer, M; Huang, T; Brown, KM; Li, XY; Descalzi, G; Kim, SS; Chen, T; Shang, YZ; Zhuo, M; Houslay, MD; Abel, T				Vecsey, Christopher G.; Baillie, George S.; Jaganath, Devan; Havekes, Robbert; Daniels, Andrew; Wimmer, Mathieu; Huang, Ted; Brown, Kim M.; Li, Xiang-Yao; Descalzi, Giannina; Kim, Susan S.; Chen, Tao; Shang, Yu-Ze; Zhuo, Min; Houslay, Miles D.; Abel, Ted			Sleep deprivation impairs cAMP signalling in the hippocampus	NATURE			English	Article							LONG-TERM POTENTIATION; CYCLIC-AMP PHOSPHODIESTERASE; SYNAPTIC PLASTICITY; PROTEIN-KINASE; LATE-PHASE; INSUFFICIENT SLEEP; CA1 REGION; MEMORY; RECEPTOR; ACTIVATION	Millions of people regularly obtain insufficient sleep(1). Given the effect of sleep deprivation on our lives, understanding the cellular and molecular pathways affected by sleep deprivation is clearly of social and clinical importance. One of the major effects of sleep deprivation on the brain is to produce memory deficits in learning models that are dependent on the hippocampus(2-5). Here we have identified a molecular mechanism by which brief sleep deprivation alters hippocampal function. Sleep deprivation selectively impaired 3',5'-cyclic AMP (cAMP)- and protein kinase A (PKA)-dependent forms of synaptic plasticity(6) in the mouse hippocampus, reduced cAMP signalling, and increased activity and protein levels of phosphodiesterase 4 (PDE4), an enzyme that degrades cAMP. Treatment of mice with phosphodiesterase inhibitors rescued the sleep-deprivation-induced deficits in cAMP signalling, synaptic plasticity and hippocampus-dependent memory. These findings demonstrate that brief sleep deprivation disrupts hippocampal function by interfering with cAMP signalling through increased PDE4 activity. Thus, drugs that enhance cAMP signalling may provide a new therapeutic approach to counteract the cognitive effects of sleep deprivation.	[Vecsey, Christopher G.; Jaganath, Devan; Havekes, Robbert; Daniels, Andrew; Wimmer, Mathieu; Huang, Ted; Abel, Ted] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Vecsey, Christopher G.; Wimmer, Mathieu; Huang, Ted] Univ Penn, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Baillie, George S.; Brown, Kim M.; Houslay, Miles D.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Li, Xiang-Yao; Descalzi, Giannina; Kim, Susan S.; Chen, Tao; Shang, Yu-Ze; Zhuo, Min] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Pennsylvania; University of Pennsylvania; University of Glasgow; University of Toronto	Abel, T (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	abele@sas.upenn.edu	DTC, Cell & Proteomics/C-8374-2011; Abel, Ted/AAX-2825-2021; Houslay, Miles D/A-6825-2011; Wimmer, Mathieu E/P-8091-2018; Zhuo, Min/A-2072-2008; Li, xiang-Yao/B-7622-2011; Houslay, Miles/AAM-5281-2020; Vecsey, Christopher/AAP-6002-2020	Abel, Ted/0000-0003-2423-4592; Zhuo, Min/0000-0001-9062-3241; Li, xiang-Yao/0000-0002-4793-0550; Havekes, Robbert/0000-0003-0757-4739; Baillie, George/0000-0003-2469-6316; Houslay, Miles/0000-0002-3826-8091; Descalzi, Giannina/0000-0003-3734-394X; Jaganath, Devan/0000-0002-8555-5667	Systems and Integrative Biology Training [GM07517]; NIH; Netherlands Organization for Scientific Research NWO-Rubicon [825.07.029]; National Institutes of Health [AG017628]; SCOR [HL060287]; HFSP [RGSP/2005]; Medical Research Council (UK); European Union [LSHB-CT-2006-037189]; Fondation Leducq [06CVD02, CIHR84256]; UK Engineering and Physical Sciences Research Council; Medical Research Council [G0600765] Funding Source: researchfish; MRC [G0600765] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007953, P50HL060287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER	Systems and Integrative Biology Training; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research NWO-Rubicon(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCOR; HFSP(Human Frontier Science Program); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq(Leducq Foundation); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Sehgal and J. Hawk for their comments on the manuscript. We thank J. O'Donnell for his help with planning rolipram treatment experiments. We thank J. Bibb for discussions and comments on the manuscript. We thank S. Fluharty and J. Lindstrom for the use of their gamma scintillation counters, and T. Bale, N. Goel, K. Semsar and S. Teegarden for their help with corticosterone assays. We also thank P. Hernandez, N. Khatib, A. Park, J. Lederman, C. Florian and W. Lu for their help with experiments. This research was supported by Systems and Integrative Biology Training grant GM07517 ( to C. G. V., M. Nusbaum PI), NIH training grant HL07953 ( to C. G. V., A. I. Pack PI), the Netherlands Organization for Scientific Research NWO-Rubicon grant 825.07.029 ( to R. H.), the National Institutes of Health (AG017628; to T. A., A. I. Pack PI), SCOR grant HL060287 ( to T. A., A. I. Pack PI), HFSP grant RGSP/2005 ( to T. A.), the Medical Research Council (UK) grant G0600765 ( to M. D. H. and G. S. B.), the European Union grant LSHB-CT-2006-037189 ( to M. D. H.), the Fondation Leducq grant 06CVD02 ( to M. D. H. and G. S. B.), CIHR84256 ( to M. Z.), and a UK Engineering and Physical Sciences Research Council training grant ( to K. M. B.).	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BEAVO JA, 1971, ANN NY ACAD SCI, V185, P129; Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073; Chen C, 2006, BIOCHEM BIOPH RES CO, V340, P435, DOI 10.1016/j.bbrc.2005.12.021; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DALY JW, 1982, J NEUROCHEM, V38, P532, DOI 10.1111/j.1471-4159.1982.tb08660.x; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Guan ZW, 2004, BRAIN RES, V1018, P38, DOI 10.1016/j.brainres.2004.05.032; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Huang Y Y, 1994, Learn Mem, V1, P74; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Hublin C, 2001, SLEEP, V24, P392, DOI 10.1093/sleep/24.4.392; Huston E, 2000, J BIOL CHEM, V275, P28063; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Ledoux L, 1996, BRAIN RES, V735, P108; LOBBAN M, 1994, BIOCHEM J, V304, P399, DOI 10.1042/bj3040399; LYNCH G, 1983, FED PROC, V42, P2886; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MARCHMONT RJ, 1980, NATURE, V286, P904, DOI 10.1038/286904a0; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matthies H, 1997, J NEUROSCI METH, V78, P173, DOI 10.1016/S0165-0270(97)00149-0; McDermott CM, 2006, J PHYSIOL-LONDON, V570, P553, DOI 10.1113/jphysiol.2005.093781; McDermott CM, 2003, J NEUROSCI, V23, P9687; McPhee I, 2001, CELL SIGNAL, V13, P911, DOI 10.1016/S0898-6568(01)00217-0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Tartar JL, 2006, EUR J NEUROSCI, V23, P2739, DOI 10.1111/j.1460-9568.2006.04808.x; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wallace DA, 2005, MOL PHARMACOL, V67, P1920, DOI 10.1124/mol.104.009423; Woo NH, 2003, HIPPOCAMPUS, V13, P293, DOI 10.1002/hipo.10086; Wu LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001407	41	276	291	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1122	U221		10.1038/nature08488	http://dx.doi.org/10.1038/nature08488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847264	Green Accepted, Green Submitted			2022-12-24	WOS:000270987600044
J	Myers, S; Bowden, R; Tumian, A; Bontrop, RE; Freeman, C; MacFie, TS; McVean, G; Donnelly, P				Myers, Simon; Bowden, Rory; Tumian, Afidalina; Bontrop, Ronald E.; Freeman, Colin; MacFie, Tammie S.; McVean, Gil; Donnelly, Peter			Drive Against Hotspot Motifs in Primates Implicates the PRDM9 Gene in Meiotic Recombination	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HISTONE H3 METHYLTRANSFERASE; HUMAN GENOME; EVOLUTION; CONVERSION; INITIATION; HUMANS; MOUSE; CHIMPANZEES	Although present in both humans and chimpanzees, recombination hotspots, at which meiotic crossover events cluster, differ markedly in their genomic location between the species. We report that a 13-base pair sequence motif previously associated with the activity of 40% of human hotspots does not function in chimpanzees and is being removed by self-destructive drive in the human lineage. Multiple lines of evidence suggest that the rapidly evolving zinc-finger protein PRDM9 binds to this motif and that sequence changes in the protein may be responsible for hotspot differences between species. The involvement of PRDM9, which causes histone H3 lysine 4 trimethylation, implies that there is a common mechanism for recombination hotspots in eukaryotes but raises questions about what forces have driven such rapid change.	[Myers, Simon; Bowden, Rory; Tumian, Afidalina; McVean, Gil; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Myers, Simon; Bowden, Rory; Freeman, Colin; McVean, Gil; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bontrop, Ronald E.] Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, NL-2288 GJ Rijswijk, Netherlands; [MacFie, Tammie S.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge	Myers, S (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.	myers@stats.ox.ac.uk	Bontrop, Ronald E/J-3628-2012; Myers, Simon R/A-6792-2015; Bontrop, Ronald E./D-4844-2011; Tumian, Afidalina/J-4404-2014	Bontrop, Ronald E/0000-0003-0874-6467; Myers, Simon R/0000-0002-2585-9626; Donnelly, Peter/0000-0001-9495-3408; Tumian, Afidalina/0000-0003-2763-6677	Leverhulme Trust; Royal Society; Wellcome Trust	Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust)	We thank N. Mundy for advice and provision of chimpanzee samples and C. Mitchell and E. Nerrienet for assisting in chimpanzee sample collection. We thank D. Falush and G. Coop for helpful conversations. Part of the work was completed while S. M. was a fellow at the Broad Institute. We would like to acknowledge funding from the Leverhulme Trust (to G. M.), the Royal Society (to P. D.), and the Wellcome Trust (to S. M., C. F., G. M., and P. D.). The chimpanzee genotype data for 22 hotspot candidate regions generated is available online with the SOM as Database S1.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; NAGYLAKI T, 1983, P NATL ACAD SCI-BIOL, V80, P6278, DOI 10.1073/pnas.80.20.6278; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; Presgraves DC, 2007, BIOESSAYS, V29, P386, DOI 10.1002/bies.20555; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Schimenti J, 2000, TRENDS GENET, V16, P240, DOI 10.1016/S0168-9525(00)02020-5; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	26	432	438	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					876	879		10.1126/science.1182363	http://dx.doi.org/10.1126/science.1182363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044541	Green Accepted			2022-12-24	WOS:000274408300065
J	Kirsch, DG; Santiago, PM; di Tomaso, E; Sullivan, JM; Hou, WS; Dayton, T; Jeffords, LB; Sodha, P; Mercer, KL; Cohen, R; Takeuchi, O; Korsmeyer, SJ; Bronson, RT; Kim, CF; Haigis, KM; Jain, RK; Jacks, T				Kirsch, David G.; Santiago, Philip M.; di Tomaso, Emmanuelle; Sullivan, Julie M.; Hou, Wu-Shiun; Dayton, Talya; Jeffords, Laura B.; Sodha, Pooja; Mercer, Kim L.; Cohen, Rhianna; Takeuchi, Osamu; Korsmeyer, Stanley J.; Bronson, Roderick T.; Kim, Carla F.; Haigis, Kevin M.; Jain, Rakesh K.; Jacks, Tyler			p53 Controls Radiation-Induced Gastrointestinal Syndrome in Mice Independent of Apoptosis	SCIENCE			English	Article							CELL-DEATH; ENDOTHELIAL APOPTOSIS; DNA-DAMAGE; PUMA; RADIOSENSITIVITY; PROLIFERATION; RADIOTHERAPY; SENSITIVITY; PROTECTS; MOUSE	Acute exposure to ionizing radiation can cause lethal damage to the gastrointestinal (GI) tract, a condition called the GI syndrome. Whether the target cells affected by radiation to cause the GI syndrome are derived from the epithelium or endothelium and whether the target cells die by apoptosis or other mechanisms are controversial issues. Studying mouse models, we found that selective deletion of the proapoptotic genes Bak1 and Bax from the GI epithelium or from endothelial cells did not protect mice from developing the GI syndrome after sub-total-body gamma irradiation. In contrast, selective deletion of p53 from the GI epithelium, but not from endothelial cells, sensitized irradiated mice to the GI syndrome. Transgenic mice overexpressing p53 in all tissues were protected from the GI syndrome after irradiation. These results suggest that the GI syndrome is caused by the death of GI epithelial cells and that these epithelial cells die by a mechanism that is regulated by p53 but independent of apoptosis.	[Kirsch, David G.; Santiago, Philip M.; Hou, Wu-Shiun; Dayton, Talya; Sodha, Pooja; Mercer, Kim L.; Cohen, Rhianna; Kim, Carla F.; Haigis, Kevin M.; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kirsch, David G.; di Tomaso, Emmanuelle; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Kirsch, David G.; di Tomaso, Emmanuelle; Jain, Rakesh K.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Kirsch, David G.; Sullivan, Julie M.; Jeffords, Laura B.] Duke Univ, Med Ctr, Dept Radiat Oncol & Pharmacol, Durham, NC 27708 USA; [Kirsch, David G.; Sullivan, Julie M.; Jeffords, Laura B.] Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27708 USA; [Takeuchi, Osamu; Korsmeyer, Stanley J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bronson, Roderick T.] Tufts Univ, Sch Med & Vet Med, North Grafton, MA 01536 USA; [Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; Duke University; Harvard University; Dana-Farber Cancer Institute; Tufts University; Howard Hughes Medical Institute	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Jain, Rakesh K/I-1384-2017; Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011	Jain, Rakesh K/0000-0001-7571-3548; Takeuchi, Osamu/0000-0002-1260-6232; Dayton, Talya/0000-0002-7994-7963	Howard Hughes Medical Institute; National Cancer Institute [P30-CA14051, KO8 CA 114176, P01 CA80124]; Dana Farber Cancer Center for Medical Countermeasures Against Radiation [U19-AI06775]; National Institute of Allergy and Infectious Diseases [RC1-AI078521]; American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE [P30CA014051, K08CA114176, P01CA080124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI078521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana Farber Cancer Center for Medical Countermeasures Against Radiation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Serrano for the super-p53 mice; A. Berns for the p53<SUP>FL</SUP> mice; P. Crawford and J. Gordon for advice; E. Travis for providing a model jig; J. Down, C. Pope, and K. Doppke for performing dosimetry measurements; and K. Held for critically reading the manuscript. This work is funded by the Howard Hughes Medical Institute (T. J.), partially funded by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute (NCI) (T. J.), NCI grant KO8 CA 114176 (D. G. K.), the pilot project from the Dana Farber Cancer Center for Medical Countermeasures Against Radiation U19-AI06775 (D. G. K.), grant RC1-AI078521 from the National Institute of Allergy and Infectious Diseases (D. G. K.), an American Society of Clinical Oncology Young Investigator Award (D. G. K.), and NCI grant P01 CA80124 (R. K. J.). T. J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar.	Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brown M, 2008, INT J RADIAT ONCOL, V70, P799, DOI 10.1016/j.ijrobp.2007.12.001; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2006, CANCER RES, V66, P9356, DOI 10.1158/0008-5472.CAN-06-1223; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Coderre JA, 2006, RADIAT RES, V166, P495, DOI 10.1667/RR3597.1; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; HENDRY JH, 1982, INT J RADIAT BIOL, V42, P621, DOI 10.1080/09553008214551601; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; LESHER J, 1974, RADIAT RES, V57, P148, DOI 10.2307/3573763; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; MERRITT AJ, 1994, CANCER RES, V54, P614; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; VANBEKKUM DW, 1974, INT J RADIAT BIOL, V25, P361, DOI 10.1080/09553007414550431; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072	33	176	187	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					593	596		10.1126/science.1166202	http://dx.doi.org/10.1126/science.1166202			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20019247	Green Accepted, Green Submitted			2022-12-24	WOS:000274020500042
J	Knowles, TPJ; Waudby, CA; Devlin, GL; Cohen, SIA; Aguzzi, A; Vendruscolo, M; Terentjev, EM; Welland, ME; Dobson, CM				Knowles, Tuomas P. J.; Waudby, Christopher A.; Devlin, Glyn L.; Cohen, Samuel I. A.; Aguzzi, Adriano; Vendruscolo, Michele; Terentjev, Eugene M.; Welland, Mark E.; Dobson, Christopher M.			An Analytical Solution to the Kinetics of Breakable Filament Assembly	SCIENCE			English	Article							AMYLOID FIBRIL FORMATION; MECHANISM; AGGREGATION; NUCLEATION; SCRAPIE; POLYMERIZATION; PATHWAY; DISEASE; GROWTH; TIME	We present an analytical treatment of a set of coupled kinetic equations that governs the self-assembly of filamentous molecular structures. Application to the case of protein aggregation demonstrates that the kinetics of amyloid growth can often be dominated by secondary rather than by primary nucleation events. Our results further reveal a range of general features of the growth kinetics of fragmenting filamentous structures, including the existence of generic scaling laws that provide mechanistic information in contexts ranging from in vitro amyloid growth to the in vivo development of mammalian prion diseases.	[Knowles, Tuomas P. J.; Welland, Mark E.] Univ Cambridge, Nanosci Ctr, Cambridge CB3 0FF, England; [Knowles, Tuomas P. J.; Terentjev, Eugene M.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Waudby, Christopher A.; Devlin, Glyn L.; Cohen, Samuel I. A.; Vendruscolo, Michele; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Cambridge; University of Cambridge; University of Cambridge; University of Zurich; University Zurich Hospital	Welland, ME (corresponding author), Univ Cambridge, Nanosci Ctr, JJ Thomson Ave, Cambridge CB3 0FF, England.	mew10@cam.ac.uk; cmd44@cam.ac.uk	Waudby, Christopher/AAT-1736-2021; Terentjev, Eugene M/B-7623-2011; Knowles, Tuomas/C-6663-2009; Vendruscolo, Michele/F-5901-2012; Aguzzi, Adriano/A-3351-2008	Waudby, Christopher/0000-0001-7810-3753; Terentjev, Eugene M/0000-0003-3517-6578; Knowles, Tuomas/0000-0002-7879-0140; Vendruscolo, Michele/0000-0002-3616-1610; Aguzzi, Adriano/0000-0002-0344-6708	St John's College, Cambridge; Leverhulme; Wellcome Trusts; EPSRC [EP/F032773/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish	St John's College, Cambridge; Leverhulme; Wellcome Trusts(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	T. P. J. K. acknowledges support from St John's College, Cambridge through a Research Fellowship. C. M. D. acknowledges support from the Leverhulme and Wellcome Trusts. We are grateful to A. Craig, A. Knowles, D. White, A. Buell, F. Chiti, A. Miranker, and J. Falsig for valuable discussions, and to M. Sandal for preparing a Web server, which is publicly available at www-vendruscolo. ch.cam.ac.uk/cgi-bin/nef/nefcgi.cgi, to enable the use of the equations presented in this work to fit experimental measurements and to predict aggregation kinetics.	Aguzzi A, 1997, NATURE, V389, P795, DOI 10.1038/39758; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Fandrich M, 2007, J MOL BIOL, V365, P1266, DOI 10.1016/j.jmb.2006.11.009; Ferguson N, 2003, P NATL ACAD SCI USA, V100, P9814, DOI 10.1073/pnas.1333907100; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fodera V, 2008, J PHYS CHEM B, V112, P3853, DOI 10.1021/jp710131u; Granas A., 2003, FIXED POINT THEORY; Hill EK, 2006, BIOMACROMOLECULES, V7, P10, DOI 10.1021/bm0505078; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kunes KC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051915; Oosawa F., 1975, THERMODYNAMICS POLYM; Pedersen JS, 2008, PROTEIN SCI, V17, P2, DOI 10.1110/ps.073127808; Poschel T, 2003, BIOPHYS J, V85, P3460, DOI 10.1016/S0006-3495(03)74767-5; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	28	773	775	8	281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1533	1537		10.1126/science.1178250	http://dx.doi.org/10.1126/science.1178250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007899				2022-12-24	WOS:000272623600057
J	Dang, L; White, DW; Gross, S; Bennett, BD; Bittinger, MA; Driggers, EM; Fantin, VR; Jang, HG; Jin, S; Keenan, MC; Marks, KM; Prins, RM; Ward, PS; Yen, KE; Liau, LM; Rabinowitz, JD; Cantley, LC; Thompson, CB; Heiden, MGV; Su, SM				Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Heiden, Matthew G. Vander; Su, Shinsan M.			Cancer-associated IDH1 mutations produce 2-hydroxyglutarate	NATURE			English	Article							TANDEM MASS-SPECTROMETRY; ACID; D-2-HYDROXYGLUTARATE	Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature of a major subset of primary human brain cancers. These mutations occur at a single amino acid residue of the IDH1 active site, resulting in loss of the enzyme's ability to catalyse conversion of isocitrate to alpha-ketoglutarate. However, only a single copy of the gene is mutated in tumours, raising the possibility that the mutations do not result in a simple loss of function. Here we show that cancer-associated IDH1 mutations result in a new ability of the enzyme to catalyse the NADPH-dependent reduction of alpha-ketoglutarate to R(2)-2-hydroxyglutarate (2HG). Structural studies demonstrate that when arginine 132 is mutated to histidine, residues in the active site are shifted to produce structural changes consistent with reduced oxidative decarboxylation of isocitrate and acquisition of the ability to convert alpha-ketoglutarate to 2HG. Excess accumulation of 2HG has been shown to lead to an elevated risk of malignant brain tumours in patients with inborn errors of 2HG metabolism. Similarly, in human malignant gliomas harbouring IDH1 mutations, we find markedly elevated levels of 2HG. These data demonstrate that the IDH1 mutations result in production of the onco-metabolite 2HG, and indicate that the excess 2HG which accumulates in vivo contributes to the formation and malignant progression of gliomas.	[Dang, Lenny; White, David W.; Gross, Stefan; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Yen, Katharine E.; Heiden, Matthew G. Vander; Su, Shinsan M.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Bennett, Bryson D.; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem & Integrat Genom, Princeton, NJ 08544 USA; [Prins, Robert M.; Liau, Linda M.] Univ Calif Los Angeles, Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Ward, Patrick S.; Thompson, Craig B.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Agios Pharmaceuticals; Princeton University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Su, SM (corresponding author), Agios Pharmaceut, Cambridge, MA 02139 USA.	michael.su@agios.com	Rabinowitz, Joshua/GPP-4019-2022; Prins, Robert/AAX-1155-2021; Cantley, Lewis C/D-1800-2014; Ward, Patrick/H-2361-2014	Rabinowitz, Joshua/0000-0002-1247-4727; Cantley, Lewis C/0000-0002-1298-7653; Prins, Robert/0000-0002-6282-6583; Liau, Linda/0000-0002-4053-0052; Dang, Lenny/0000-0002-2073-6109; Ward, Patrick/0000-0001-6437-8174	NIH [R21 CA128620]; NATIONAL CANCER INSTITUTE [R21CA128620, R01CA105463, P01CA104838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank R. K. Suto, R. S. Brown and E. Fontano at Xtal BioStructures for performing crystallographic studies, and S. Wang at ChemPartner for assistance with biochemical experiments. Wethank G. Petsko for his review of the structure data. We also thank T. Mak, N. Wu, L. Tartaglia, J. Saunders, F. Salituro and D. Schenkein for discussions and/or comments on the manuscript. Asterand, PLC provided some of the glioma specimens and SeqWright Inc. assisted with genomic DNA SNP analysis. J. D. R. is supported by NIH R21 CA128620.	Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Aktas DF, 2009, BIOCHEMISTRY-US, V48, P3565, DOI 10.1021/bi8022976; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Kolker S, 2002, NEUROPEDIATRICS, V33, P225, DOI 10.1055/s-2002-36741; Kolker S, 2002, EUR J NEUROSCI, V16, P21, DOI 10.1046/j.1460-9568.2002.02055.x; Latini A, 2003, EUR J NEUROSCI, V17, P2017, DOI 10.1046/j.1460-9568.2003.02639.x; Lu WY, 2006, J AM SOC MASS SPECTR, V17, P37, DOI 10.1016/j.jasms.2005.09.001; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; Tsacopoulos M, 2002, J PHYSIOL-PARIS, V96, P283, DOI 10.1016/S0928-4257(02)00017-7; Wajner M, 2004, J INHERIT METAB DIS, V27, P427, DOI 10.1023/B:BOLI.0000037353.13085.e2; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	26	2463	2613	5	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					739	U52		10.1038/nature08617	http://dx.doi.org/10.1038/nature08617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	19935646	Green Accepted			2022-12-24	WOS:000272559900029
J	Bonifazi, P; Goldin, M; Picardo, MA; Jorquera, I; Cattani, A; Bianconi, G; Represa, A; Ben-Ari, Y; Cossart, R				Bonifazi, P.; Goldin, M.; Picardo, M. A.; Jorquera, I.; Cattani, A.; Bianconi, G.; Represa, A.; Ben-Ari, Y.; Cossart, R.			GABAergic Hub Neurons Orchestrate Synchrony in Developing Hippocampal Networks	SCIENCE			English	Article							SMALL-WORLD NETWORKS; PYRAMIDAL NEURONS; IN-VITRO; INTERNEURONS; OSCILLATIONS; GABA; CONNECTIVITY; POTENTIALS; DYNAMICS; GENERATION	Brain function operates through the coordinated activation of neuronal assemblies. Graph theory predicts that scale-free topologies, which include "hubs" (superconnected nodes), are an effective design to orchestrate synchronization. Whether hubs are present in neuronal assemblies and coordinate network activity remains unknown. Using network dynamics imaging, online reconstruction of functional connectivity, and targeted whole-cell recordings in rats and mice, we found that developing hippocampal networks follow a scale-free topology, and we demonstrated the existence of functional hubs. Perturbation of a single hub influenced the entire network dynamics. Morphophysiological analysis revealed that hub cells are a subpopulation of gamma-aminobutyric acid-releasing (GABAergic) interneurons possessing widespread axonal arborizations. These findings establish a central role for GABAergic interneurons in shaping developing networks and help provide a conceptual framework for studying neuronal synchrony.	[Bonifazi, P.; Goldin, M.; Picardo, M. A.; Jorquera, I.; Cattani, A.; Represa, A.; Ben-Ari, Y.; Cossart, R.] Univ Mediterranee, INSERM, U901, Inst Neurobiol Mediterradee, F-13273 Marseille 9, France; [Bianconi, G.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Northeastern University	Cossart, R (corresponding author), Univ Mediterranee, INSERM, U901, Inst Neurobiol Mediterradee, Parc Sci Luminy,Boite Postale 13, F-13273 Marseille 9, France.	cossart@inmed.univ-mrs.fr	Cossart, Rosa/AAT-7934-2020; Bianconi, Ginestra/AAE-4114-2020; Bonifazi, Paolo/N-9737-2018; Cossart, Rosa/E-7674-2014; Bianconi, Ginestra/I-5742-2018; Represa, Alfonso/M-7383-2016; Bonifazi, Paolo/AAA-8035-2020	Cossart, Rosa/0000-0003-2111-6638; Bianconi, Ginestra/0000-0002-3380-887X; Bonifazi, Paolo/0000-0001-6374-8997; Cossart, Rosa/0000-0003-2111-6638; Bianconi, Ginestra/0000-0002-3380-887X; Represa, Alfonso/0000-0002-5096-8939; Bonifazi, Paolo/0000-0001-6374-8997; Goldin, Miri/0000-0002-4228-9944; Ben-Ari, Yehezkel/0000-0001-6208-8480; picardo, michel/0000-0003-1198-3930	INSERM; Ville de Marseille and Region Provence Alpes Cote d'Azur; Fondation pour la Recherche Medicale; Agence Nationale pour la Recherche; Fondation pour la Recherche sur le Cerveau; Fondation Bettencourt Schueller; CNRS; European Fellowships	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ville de Marseille and Region Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche sur le Cerveau; Fondation Bettencourt Schueller; CNRS(Centre National de la Recherche Scientifique (CNRS)); European Fellowships	We thank D. Aronov, M. Colonnese, J. Epsztein, B. Fernandez, G. Fishell, C. Holmgren, B. Gutkin, M. Milh, and R. Khazipov for helpful suggestions and critical comments; C. Allene, K. Bennouar, and F. Michel for help with the experiments; and K. Obata and K. Vogt for kindly providing GAD67-EGFP Ki mice. This work was supported by grants from INSERM, the Ville de Marseille and Region Provence Alpes Cote d'Azur, the Fondation pour la Recherche Medicale, the Agence Nationale pour la Recherche, the Fondation pour la Recherche sur le Cerveau, and the Fondation Bettencourt Schueller. R. C. and A. R. were funded by the CNRS. M. Goldin and P. Bonifazi were funded by Framework Program 6 (FP6) and FP7-Intra-European Fellowships for career development.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bolea S, 2006, J NEUROPHYSIOL, V95, P552, DOI 10.1152/jn.00321.2005; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G., 2006, RHYTHMS BRAIN; Canepari M, 2000, CELL CALCIUM, V27, P25, DOI 10.1054/ceca.1999.0086; Cattani AA, 2007, J NEUROPHYSIOL, V98, P2324, DOI 10.1152/jn.00378.2007; Crepel V, 2007, NEURON, V54, P105, DOI 10.1016/j.neuron.2007.03.007; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; de la Prida LM, 1999, J NEUROPHYSIOL, V82, P202, DOI 10.1152/jn.1999.82.1.202; de la Prida LM, 1998, EUR J NEUROSCI, V10, P899, DOI 10.1046/j.1460-9568.1998.00097.x; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Grinstein G, 2005, P NATL ACAD SCI USA, V102, P9948, DOI 10.1073/pnas.0504127102; Groc L, 2003, EUR J NEUROSCI, V17, P1873, DOI 10.1046/j.1460-9568.2003.02635.x; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Jeong HY, 2007, NEURAL COMPUT, V19, P706, DOI 10.1162/neco.2007.19.3.706; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Molnar G, 2008, PLOS BIOL, V6, P1842, DOI 10.1371/journal.pbio.0060222; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; PRICE DJD, 1965, SCIENCE, V149, P510; Rheims S, 2008, J NEUROPHYSIOL, V100, P609, DOI 10.1152/jn.90402.2008; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Strata F, 1997, J NEUROSCI, V17, P1435; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wittner L, 2007, J PHYSIOL-LONDON, V584, P867, DOI 10.1113/jphysiol.2007.138131; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	44	456	458	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1419	1424		10.1126/science.1175509	http://dx.doi.org/10.1126/science.1175509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965761	Green Published			2022-12-24	WOS:000272351100048
J	Jonkers, I; Barakat, TS; Achame, EM; Monkhorst, K; Kenter, A; Rentmeester, E; Grosveld, F; Grootegoed, JA; Gribnau, J				Jonkers, Iris; Barakat, Tahsin Stefan; Achame, Eskeatnaf Mulugeta; Monkhorst, Kim; Kenter, Annegien; Rentmeester, Eveline; Grosveld, Frank; Grootegoed, J. Anton; Gribnau, Joost			RNF12 Is an X-Encoded Dose-Dependent Activator of X Chromosome Inactivation	CELL			English	Article							XIST GENE; ANTISENSE TRANSCRIPTION; ES CELLS; RNA; CHOICE; PLURIPOTENCY; PROBABILITY; TRANSGENE; NUCLEUS; REPEAT	In somatic cells of female placental mammals, one X chromosome is inactivated to minimize sex-related dosage differences of X-encoded genes. Random X chromosome inactivation (XCI) in the embryo is a stochastic process, in which each X has an independent probability to initiate XCI, triggered by the nuclear concentration of one or more X-encoded XCI-activators. Here, we identify the E3 ubiquitin ligase RNF12 as an important XCI-activator. Additional copies of mouse Rnf12 or human RNF12 result in initiation of XCI in male mouse ES cells and on both X chromosomes in a substantial percentage of female mouse ES cells. This activity is dependent on an intact open reading frame of Rnf12 and correlates with the transgenic expression level of RNF12. Initiation of XCI is markedly reduced in differentiating female heterozygous Rnf12(+/-) ES cells. These findings provide evidence for a dose-dependent role of RNF12 in the XCI counting and initiation process.	[Jonkers, Iris; Barakat, Tahsin Stefan; Achame, Eskeatnaf Mulugeta; Kenter, Annegien; Rentmeester, Eveline; Grootegoed, J. Anton; Gribnau, Joost] Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands; [Jonkers, Iris; Grosveld, Frank] Univ Med Ctr, Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Monkhorst, Kim] Univ Med Ctr, Erasmus MC, Dept Expt Pathol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gribnau, J (corresponding author), Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands.	j.gribnau@erasmusmc.nl	Mulugeta, Eskeatnaf/AAZ-7471-2020; Barakat, Stefan/X-8234-2019; Mulugeta, Eskeatnaf/H-2640-2016	Mulugeta, Eskeatnaf/0000-0003-4045-4835; Barakat, Stefan/0000-0003-1231-1562; Mulugeta, Eskeatnaf/0000-0003-4045-4835	HFSP CDA; NWO-VIDI; TOP; Dutch government [03038]	HFSP CDA; NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); TOP; Dutch government	We would like to thank Nilhan Gunhanlar, Cristina Gontan Pardo, Akiko Inagaki, Bas de Hoon, and Maureen Eijpe for help with experiments. We also thank all department members for helpful discussions. This work was supported by HFSP CDA, NWO-VIDI, and TOP grants to J. G. and a grant from the Dutch government (BSIK programme 03038, SCDD).	Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Becker Thomas, 2003, Methods in Cell Science, V25, P85, DOI 10.1023/B:MICS.0000006895.03556.9b; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Heard E, 1999, MOL CELL BIOL, V19, P3156; Her YR, 2009, J BIOL CHEM, V284, P8557, DOI 10.1074/jbc.M806702200; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Jonkers I, 2008, MOL CELL BIOL, V28, P5583, DOI 10.1128/MCB.02269-07; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Migeon BR, 2001, GENOMICS, V71, P156, DOI 10.1006/geno.2000.6421; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Monkhorst K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005616; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nesterova TB, 2003, GENE DEV, V17, P2177, DOI 10.1101/gad.271203; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ohhata T, 2008, DEVELOPMENT, V135, P227, DOI 10.1242/dev.008490; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Sado T, 2002, CYTOGENET GENOME RES, V99, P115, DOI 10.1159/000071582; Sado T, 2006, DEVELOPMENT, V133, P4925, DOI 10.1242/dev.02670; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	36	172	175	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					999	1011		10.1016/j.cell.2009.10.034	http://dx.doi.org/10.1016/j.cell.2009.10.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19945382	Bronze			2022-12-24	WOS:000272169400022
J	Levental, KR; Yu, HM; Kass, L; Lakins, JN; Egeblad, M; Erler, JT; Fong, SFT; Csiszar, K; Giaccia, A; Weninger, W; Yamauchi, M; Gasser, DL; Weaver, VM				Levental, Kandice R.; Yu, Hongmei; Kass, Laura; Lakins, Johnathon N.; Egeblad, Mikala; Erler, Janine T.; Fong, Sheri F. T.; Csiszar, Katalin; Giaccia, Amato; Weninger, Wolfgang; Yamauchi, Mitsuo; Gasser, David L.; Weaver, Valerie M.			Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling	CELL			English	Article							FOCAL ADHESION KINASE; BREAST-CANCER CELLS; LYSYL OXIDASE; MAMMARY TUMORIGENESIS; EXTRACELLULAR-MATRIX; MALIGNANT PHENOTYPE; FIBROTIC FOCUS; TGF-BETA; METASTASIS; CARCINOMA	Tumors are characterized by extracellular matrix (ECM) remodeling and stiffening. The importance of ECM remodeling to cancer is appreciated; the relevance of stiffening is less clear. We found that breast tumorigenesis is accompanied by collagen crosslinking, ECM stiffening, and increased focal adhesions. Induction of collagen crosslinking stiffened the ECM, promoted focal adhesions, enhanced PI3 kinase (PI3K) activity, and induced the invasion of an oncogene-initiated epithelium. Inhibition of integrin signaling repressed the invasion of a premalignant epithelium into a stiffened, crosslinked ECM and forced integrin clustering promoted focal adhesions, enhanced PI3K signaling, and induced the invasion of a premalignant epithelium. Consistently, reduction of lysyl oxidase-mediated collagen crosslinking prevented MMTV-Neu-induced fibrosis, decreased focal adhesions and PI3K activity, impeded malignancy, and lowered tumor incidence. These data show how collagen crosslinking can modulate tissue fibrosis and stiffness to force focal adhesions, growth factor signaling and breast malignancy.	[Levental, Kandice R.; Weaver, Valerie M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Levental, Kandice R.; Weaver, Valerie M.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Yu, Hongmei; Kass, Laura; Lakins, Johnathon N.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Erler, Janine T.; Giaccia, Amato] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Egeblad, Mikala; Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Fong, Sheri F. T.; Csiszar, Katalin] Univ Hawaii Manoa, John A Burns Sch Med, Cardiovasc Res Ctr, Honolulu, HI 96822 USA; [Weninger, Wolfgang] Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; [Yamauchi, Mitsuo] Univ N Carolina, Dent Res Ctr, Chapel Hill, NC 27599 USA; [Gasser, David L.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of Hawaii System; University of Hawaii Manoa; The Wistar Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Weaver, VM (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	valerie.weaver@ucsfmedctr.org	Peng, Chunwei/F-6788-2010; Egeblad, Mikala/GNP-0620-2022	Weaver, Valerie marie/0000-0003-4786-6752; Levental, Kandice/0000-0002-2234-3683; Egeblad, Mikala/0000-0002-3371-1445; Weninger, Wolfgang/0000-0003-3133-8699; Erler, Janine/0000-0001-8675-6527	NIH [R01-CA078731, T32HL00795404, R01-CA057621]; DOD [W81XWH-05-1-330]; DOE [A107165]; CIRM [RS1-00449]; NCI [U54CA143836]; NATIONAL CANCER INSTITUTE [R01CA078731, U54CA143836, R01CA057621, R01CA138818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); DOE(United States Department of Energy (DOE)); CIRM(California Institute for Regenerative Medicine); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Ignatoski for the ErbB2 construct, M. P. Marinkovich for the BM165 antibody, P. Mrass for two-photon microscopy guidance, and R. G. Wells for mentoring of K. R. L. The work was supported by grants NIH R01-CA078731, DOD W81XWH-05-1-330, DOE A107165, CIRM RS1-00449, and NCI U54CA143836 to V. M. W. NIH T32HL00795404 supported K. R. L., and NIH R01-CA057621 supported M. E.	Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bierie B, 2009, J CLIN INVEST, V119, P1571, DOI 10.1172/JCI37480; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Colpaert CG, 2003, BREAST CANCER RES TR, V81, P137, DOI 10.1023/A:1025702330207; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Decitre M, 1998, LAB INVEST, V78, P143; Erler JT, 2006, CANCER RES, V66, P10238, DOI 10.1158/0008-5472.CAN-06-3197; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K; Hasebe T, 1997, JPN J CANCER RES, V88, P590, DOI 10.1111/j.1349-7006.1997.tb00423.x; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Jodele S, 2006, CANCER METAST REV, V25, P35, DOI 10.1007/s10555-006-7887-8; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kim H, 1999, EXP CELL RES, V253, P78, DOI 10.1006/excr.1999.4706; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kolacna L, 2007, PHYSIOL RES, V56, pS51, DOI 10.33549/physiolres.931302; KOUKOULIS GK, 1993, J SUBMICR CYTOL PATH, V25, P285; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Madan R, 2006, HUM PATHOL, V37, P9, DOI 10.1016/j.humpath.2005.09.024; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Oleggini R, 2007, MATRIX BIOL, V26, P494, DOI 10.1016/j.matbio.2007.02.003; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Pfeiffer BJ, 2005, MATRIX BIOL, V24, P451, DOI 10.1016/j.matbio.2005.07.001; Postovit LM, 2008, J CELL BIOCHEM, V103, P1369, DOI 10.1002/jcb.21517; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Szauter KM, 2005, PATHOL BIOL, V53, P448, DOI 10.1016/j.patbio.2004.12.033; Tetu B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1503; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200; Zutter MM, 1998, J MAMMARY GLAND BIOL, V3, P191, DOI 10.1023/A:1018798907544	60	2615	2673	20	531	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 25	2009	139	5					891	906		10.1016/j.cell.2009.10.027	http://dx.doi.org/10.1016/j.cell.2009.10.027			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	524UR	19931152	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000272169400014
J	Bollenbach, T; Quan, S; Chait, R; Kishony, R				Bollenbach, Tobias; Quan, Selwyn; Chait, Remy; Kishony, Roy			Nonoptimal Microbial Response to Antibiotics Underlies Suppressive Drug Interactions	CELL			English	Article							RIBOSOMAL-RNA SYNTHESIS; RATE-DEPENDENT CONTROL; ESCHERICHIA-COLI; GENE-EXPRESSION; GROWTH-RATE; SUBINHIBITORY CONCENTRATIONS; TRANSCRIPTIONAL MODULATION; CELL-SIZE; DNA; REPLICATION	Suppressive drug interactions, in which one antibiotic can actually help bacterial cells to grow faster in the presence of another, occur between protein and DNA synthesis inhibitors. Here, we show that this suppression results from nonoptimal regulation of ribosomal genes in the presence of DNA stress. Using GFP-tagged transcription reporters in Escherichia coli, we find that ribosomal genes are not directly regulated by DNA stress, leading to an imbalance between cellular DNA and protein content. To test whether ribosomal gene expression under DNA stress is nonoptimal for growth rate, we sequentially deleted up to six of the seven ribosomal RNA operons. These synthetic manipulations of ribosomal gene expression correct the protein-DNA imbalance, lead to improved survival and growth, and completely remove the suppressive drug interaction. A simple mathematical model explains the nonoptimal regulation in different nutrient environments. These results reveal the genetic mechanism underlying an important class of suppressive drug interactions.	[Bollenbach, Tobias; Chait, Remy; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Quan, Selwyn] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Harvard University; Stanford University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu	Bollenbach, Tobias/AAK-3206-2020	Bollenbach, Tobias/0000-0003-4398-476X; Chait, Remy/0000-0003-0876-3187	National Institutes of Health [R01GM081617]; Alexander von Humboldt foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank U. Alon, J. Collins, M. Elowitz, M. Ernebjerg, A. Gassett, A. Hilfinger, E. Kelsic, M. Kohanski, D. Landgraf, R. Milo, A. Palmer, D. Rudner, M. Springer, M. Staller, C. Squires, E. Toprak, I. Wapinski, R. Ward, P. Yeh, and all members of the Kishony lab for discussions, comments, and technical help; and M. Traxler for his gift of strains. This work was supported in part by National Institutes of Health Grant R01GM081617 (to R. K.). T. B. acknowledges funding from the Alexander von Humboldt foundation.	Asai T, 1999, J BACTERIOL, V181, P3803, DOI 10.1128/JB.181.12.3803-3809.1999; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; BARTLETT MS, 1994, J BACTERIOL, V176, P5560, DOI 10.1128/JB.176.17.5560-5564.1994; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Brazas MD, 2005, DRUG DISCOV TODAY, V10, P1245, DOI 10.1016/S1359-6446(05)03566-X; Bremer H, 1996, ESCHERICHIA COLI SAL; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; CONDON C, 1993, EMBO J, V12, P4305, DOI 10.1002/j.1460-2075.1993.tb06115.x; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; FRAENKEL DG, 1961, BIOCHIM BIOPHYS ACTA, V53, P96, DOI 10.1016/0006-3002(61)90797-1; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GAAL T, 1990, P NATL ACAD SCI USA, V87, P5533, DOI 10.1073/pnas.87.14.5533; GEORGOPAPADAKOU NH, 1991, ANTIMICROB AGENTS CH, V35, P2645, DOI 10.1128/AAC.35.12.2645; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Gralla JD, 2005, MOL MICROBIOL, V55, P973, DOI 10.1111/j.1365-2958.2004.04455.x; GUAN LN, 1992, J ANTIMICROB CHEMOTH, V29, P529, DOI 10.1093/jac/29.5.529; Guido NJ, 2007, BIOPHYS J, V93, pL55, DOI 10.1529/biophysj.107.118687; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Izutsu K, 2001, GENES CELLS, V6, P665, DOI 10.1046/j.1365-2443.2001.00457.x; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Keener J, 1996, ESCHERICHIA COLI SAL, V2, P1417; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; KHAN SR, 1972, BIOCHEM BIOPH RES CO, V48, P169, DOI 10.1016/0006-291X(72)90358-0; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; KURLAND CG, 1962, J MOL BIOL, V4, P388, DOI 10.1016/S0022-2836(62)80019-9; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; Liebermeister W, 2004, BIOSYSTEMS, V76, P261, DOI 10.1016/j.biosystems.2004.05.022; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Loewe S., 1928, ERGEBN PHYSL, V27, P47, DOI [10.1007/BF02322290, DOI 10.1007/BF02322290]; MASON DJ, 1995, ANTIMICROB AGENTS CH, V39, P2752, DOI 10.1128/AAC.39.12.2752; Mesak LR, 2008, ANTIMICROB AGENTS CH, V52, P3394, DOI 10.1128/AAC.01599-07; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120; PIDDOCK LJV, 1990, ANTIMICROB AGENTS CH, V34, P2331, DOI 10.1128/AAC.34.12.2331; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Radman M, 1975, Basic Life Sci, V5A, P355; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Schneider DA, 2002, P NATL ACAD SCI USA, V99, P8602, DOI 10.1073/pnas.132285199; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; SMITH RJ, 1973, BIOCHEM J, V136, P249, DOI 10.1042/bj1360249; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P6670, DOI 10.1128/AEM.70.11.6670-6677.2004; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tippin B, 2004, TRENDS MICROBIOL, V12, P288, DOI 10.1016/j.tim.2004.04.004; Tsui WHW, 2004, CHEM BIOL, V11, P1307, DOI 10.1016/j.chembiol.2004.07.010; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	76	156	156	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					707	718		10.1016/j.cell.2009.10.025	http://dx.doi.org/10.1016/j.cell.2009.10.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914165	Green Accepted, Bronze			2022-12-24	WOS:000271747200015
J	Webb, CHT; Riccitelli, NJ; Ruminski, DJ; Luptak, A				Webb, Chiu-Ho T.; Riccitelli, Nathan J.; Ruminski, Dana J.; Luptak, Andrej			Widespread Occurrence of Self-Cleaving Ribozymes	SCIENCE			English	Article							HEPATITIS-DELTA-VIRUS; RNA		[Webb, Chiu-Ho T.; Luptak, Andrej] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Riccitelli, Nathan J.; Luptak, Andrej] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Ruminski, Dana J.; Luptak, Andrej] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Luptak, A (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	aluptak@uci.edu			University of California, Irvine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094929] Funding Source: NIH RePORTER	University of California, Irvine(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Luptak laboratory, G. Weiss, and J. Kieft for comments and A. James for A. gambiae samples. This work was supported by the University of California, Irvine. A. L. is a member of the Chao Family Comprehensive Cancer Center. The GenBank accession numbers for the confirmed ribozymes are BK006878 to BK006897.	BEEN MD, 1992, BIOCHEMISTRY-US, V31, P11843, DOI 10.1021/bi00162a024; Fedor MJ, 2009, ANNU REV BIOPHYS, V38, P271, DOI 10.1146/annurev.biophys.050708.133710; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; GAUTHERET D, 1990, COMPUT APPL BIOSCI, V6, P325; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308	5	134	134	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					953	953		10.1126/science.1178084	http://dx.doi.org/10.1126/science.1178084			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19965505	Green Accepted, Green Submitted			2022-12-24	WOS:000271712300026
J	Naito, K; Zhang, F; Tsukiyama, T; Saito, H; Hancock, CN; Richardson, AO; Okumoto, Y; Tanisaka, T; Wessler, SR				Naito, Ken; Zhang, Feng; Tsukiyama, Takuji; Saito, Hiroki; Hancock, C. Nathan; Richardson, Aaron O.; Okumoto, Yutaka; Tanisaka, Takatoshi; Wessler, Susan R.			Unexpected consequences of a sudden and massive transposon amplification on rice gene expression	NATURE			English	Article							NUCLEOSOME ORGANIZATION; ELEMENTS; INSERTION; GENOME; REGIONS; SYSTEM	High-copy-number transposable elements comprise the majority of eukaryotic genomes where they are major contributors to gene and genome evolution(1). However, it remains unclear how a host genome can survive a rapid burst of hundreds or thousands of insertions because such bursts are exceedingly rare in nature and therefore difficult to observe in real time(2). In a previous study we reported that in a few rice strains the DNA transposon mPing was increasing its copy number by similar to 40 per plant per generation(3). Here we exploit the completely sequenced rice genome to determine 1,664 insertion sites using high-throughput sequencing of 24 individual rice plants and assess the impact of insertion on the expression of 710 genes by comparative microarray analysis. We find that the vast majority of transposable element insertions either upregulate or have no detectable effect on gene transcription. This modest impact reflects a surprising avoidance of exon insertions by mPing and a preference for insertion into 5' flanking sequences of genes. Furthermore, we document the generation of new regulatory networks by a subset of mPing insertions that render adjacent genes stress inducible. As such, this study provides evidence for models first proposed previously(4-6) for the involvement of transposable elements and other repetitive sequences in genome restructuring and gene regulation.	[Naito, Ken; Zhang, Feng; Hancock, C. Nathan; Richardson, Aaron O.; Wessler, Susan R.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Naito, Ken; Tsukiyama, Takuji; Saito, Hiroki; Okumoto, Yutaka; Tanisaka, Takatoshi] Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan	University System of Georgia; University of Georgia; Kyoto University	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	tanisaka@kais.kyoto-u.ac.jp; sue@plantbio.uga.edu	Hancock, Charles/AAA-5249-2020	Hancock, Charles Nathan/0000-0002-0875-8495; Naito, Ken/0000-0002-0273-7837	National Institute of Agrobiological Science in Japan [A123, A157]; NSF Plant Genome; University of Georgia Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	National Institute of Agrobiological Science in Japan; NSF Plant Genome(National Science Foundation (NSF)); University of Georgia Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the Rice Genome Resource Center for the use of the rice microarray system and Y. Nagamura and R. Motoyama for technical support; the GenBank project of the National Institute of Agrobiological Science in Japan for providing seeds of Gimbozu landraces (A123 and A157); and X. Zhang and C. Feschotte for critical discussions and reading of the manuscript. S. R. W. is funded by a NSF Plant Genome grant and the University of Georgia Research Foundation and T. Tanisaka by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arnold C, 1991, PCR Methods Appl, V1, P39; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CRESSE AD, 1995, GENETICS, V140, P315; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jiang N, 2002, GENETICS, V161, P1293; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Kolesnik T, 2004, PLANT J, V37, P301, DOI 10.1046/j.1365-313X.2003.01948.x; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McClintock B, 1944, GENETICS, V29, P478; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Monden Y, 2009, DNA RES, V16, P131, DOI 10.1093/dnares/dsp004; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Piffanelli P, 2007, PLANT MOL BIOL, V65, P587, DOI 10.1007/s11103-007-9222-3; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	30	322	334	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1130	U232		10.1038/nature08479	http://dx.doi.org/10.1038/nature08479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19847266				2022-12-24	WOS:000270987600046
J	Ossowski, S; Schneeberger, K; Lucas-Lledo, JI; Warthmann, N; Clark, RM; Shaw, RG; Weigel, D; Lynch, M				Ossowski, Stephan; Schneeberger, Korbinian; Lucas-Lledo, Jose Ignacio; Warthmann, Norman; Clark, Richard M.; Shaw, Ruth G.; Weigel, Detlef; Lynch, Michael			The Rate and Molecular Spectrum of Spontaneous Mutations in Arabidopsis thaliana	SCIENCE			English	Article							GENOME-WIDE VIEW; SHORT READS; DIVERSITY; SEQUENCE	To take complete advantage of information on within-species polymorphism and divergence from close relatives, one needs to know the rate and the molecular spectrum of spontaneous mutations. To this end, we have searched for de novo spontaneous mutations in the complete nuclear genomes of five Arabidopsis thaliana mutation accumulation lines that had been maintained by single-seed descent for 30 generations. We identified and validated 99 base substitutions and 17 small and large insertions and deletions. Our results imply a spontaneous mutation rate of 7 x 10(-9) base substitutions per site per generation, the majority of which are G:C -> A:T transitions. We explain this very biased spectrum of base substitution mutations as a result of two main processes: deamination of methylated cytosines and ultraviolet light-induced mutagenesis.	[Lucas-Lledo, Jose Ignacio; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Ossowski, Stephan; Schneeberger, Korbinian; Warthmann, Norman; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Clark, Richard M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Shaw, Ruth G.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Indiana University System; Indiana University Bloomington; Max Planck Society; Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Twin Cities	Lucas-Lledo, JI (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	joslucas@indiana.edu; weigel@weigelworld.org	Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Ossowski, Stephan/E-2139-2011; Schneeberger, Korbinian/U-6329-2019; Lledó, José Ignacio Lucas/AAA-5392-2019; Warthmann, Norman/E-1069-2011; Lucas Lledó, José Ignacio/L-3112-2014	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Ossowski, Stephan/0000-0002-7416-9568; Schneeberger, Korbinian/0000-0002-5512-0443; Lledó, José Ignacio Lucas/0000-0001-6254-8942; Warthmann, Norman/0000-0002-1178-8409; Lucas Lledó, José Ignacio/0000-0001-6254-8942	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36827, R01 GM036827] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Marriage TN, 2009, HEREDITY, V103, P310, DOI 10.1038/hdy.2009.67; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Schultz ST, 1999, P NATL ACAD SCI USA, V96, P11393, DOI 10.1073/pnas.96.20.11393; Shaw FH, 2002, EVOLUTION, V56, P453, DOI 10.1111/j.0014-3820.2002.tb01358.x; Shaw RG, 2000, GENETICS, V155, P369; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204	21	719	728	8	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					92	94		10.1126/science.1180677	http://dx.doi.org/10.1126/science.1180677			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044577	Green Published, Green Accepted			2022-12-24	WOS:000273395400038
J	Sobolevsky, AI; Rosconi, MP; Gouaux, E				Sobolevsky, Alexander I.; Rosconi, Michael P.; Gouaux, Eric			X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor	NATURE			English	Article							LIGAND-BINDING DOMAIN; KAINATE RECEPTORS; NMDA RECEPTORS; FUNCTIONAL EXPRESSION; ALLOSTERIC MODULATORS; MOLECULAR-MECHANISMS; SUBUNIT COMPOSITION; CRYSTAL-STRUCTURES; K+ CHANNELS; DESENSITIZATION	Ionotropic glutamate receptors mediate most excitatory neurotransmission in the central nervous system and function by opening a transmembrane ion channel upon binding of glutamate. Despite their crucial role in neurobiology, the architecture and atomic structure of an intact ionotropic glutamate receptor are unknown. Here we report the crystal structure of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive, homotetrameric, rat GluA2 receptor at 3.6 angstrom resolution in complex with a competitive antagonist. The receptor harbours an overall axis of two-fold symmetry with the extracellular domains organized as pairs of local dimers and with the ion channel domain exhibiting four-fold symmetry. A symmetry mismatch between the extracellular and ion channel domains is mediated by two pairs of conformationally distinct subunits, A/C and B/D. Therefore, the stereochemical manner in which the A/C subunits are coupled to the ion channel gate is different from the B/D subunits. Guided by the GluA2 structure and site-directed cysteine mutagenesis, we suggest that GluN1 and GluN2A NMDA (N-methyl-D-aspartate) receptors have a similar architecture, with subunits arranged in a 1-2-1-2 pattern. We exploit the GluA2 structure to develop mechanisms of ion channel activation, desensitization and inhibition by non-competitive antagonists and pore blockers.	[Sobolevsky, Alexander I.; Rosconi, Michael P.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	NIH National Research Service Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS049767, R01NS038631] Funding Source: NIH RePORTER	NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the personnel at beamlines 5.0.2, 8.2.1 and 8.2.2 of the Advanced Light Source and at beamline 24-ID-E of the Advanced Photon Source. We also thank T. Homrichhausen for help with cloning and FSEC screening; L. Vaskalis for assistance with illustrations; and Gouaux laboratory members for discussion. M. P. R. was supported by an individual NIH National Research Service Award. This work was supported by the NIH. E. G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alt A, 2006, BIOCHEM PHARMACOL, V71, P1273, DOI 10.1016/j.bcp.2005.12.022; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Chang HR, 2008, J NEUROSCI, V28, P1546, DOI 10.1523/JNEUROSCI.3485-07.2008; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christensen JK, 2004, J NEUROSCI, V24, P8986, DOI 10.1523/JNEUROSCI.2156-04.2004; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cowan WM, 2001, SYNAPSES, P1; CURTIS DR, 1959, NATURE, V183, P611, DOI 10.1038/183611a0; DINGLEDINE R, 1999, PHARMACOL REV, V7, P61; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Hayashi T, 1954, KEIO J MED, V3; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Labrie V, 2010, NEUROSCI BIOBEHAV R, V34, P351, DOI 10.1016/j.neubiorev.2009.08.002; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miu P, 2001, NEUROPHARMACOLOGY, V40, P976, DOI 10.1016/S0028-3908(01)00027-2; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky A.I., 2003, RECENT RES DEV PHYSL, P1; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sobolevsky AI, 2003, J NEUROSCI, V23, P7559; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	89	778	789	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					745	U66		10.1038/nature08624	http://dx.doi.org/10.1038/nature08624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	19946266	Green Accepted			2022-12-24	WOS:000272559900030
J	Lu, R; Markowetz, F; Unwin, RD; Leek, JT; Airoldi, EM; MacArthur, BD; Lachmann, A; Rozov, R; Ma'ayan, A; Boyer, LA; Troyanskaya, OG; Whetton, AD; Lemischka, IR				Lu, Rong; Markowetz, Florian; Unwin, Richard D.; Leek, Jeffrey T.; Airoldi, Edoardo M.; MacArthur, Ben D.; Lachmann, Alexander; Rozov, Roye; Ma'ayan, Avi; Boyer, Laurie A.; Troyanskaya, Olga G.; Whetton, Anthony D.; Lemischka, Ihor R.			Systems-level dynamic analyses of fate change in murine embryonic stem cells	NATURE			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; SELF-RENEWAL; GENE-EXPRESSION; NANOG; PLURIPOTENCY; NETWORK; MOUSE; CHROMATIN; OCT4; DIFFERENTIATION	Molecular regulation of embryonic stem cell (ESC) fate involves a coordinated interaction between epigenetic(1-4), transcriptional(5-10) and translational(11,12) mechanisms. It is unclear how these different molecular regulatory mechanisms interact to regulate changes in stem cell fate. Here we present a dynamic systems-level study of cell fate change in murine ESCs following a well-defined perturbation. Global changes in histone acetylation, chromatin-bound RNA polymerase II, messenger RNA (mRNA), and nuclear protein levels were measured over 5 days after downregulation of Nanog, a key pluripotency regulator(13-15). Our data demonstrate how a single genetic perturbation leads to progressive widespread changes in several molecular regulatory layers, and provide a dynamic view of information flow in the epigenome, transcriptome and proteome. We observe that a large proportion of changes in nuclear protein levels are not accompanied by concordant changes in the expression of corresponding mRNAs, indicating important roles for translational and post-translational regulation of ESC fate. Gene-ontology analysis across different molecular layers indicates that although chromatin reconfiguration is important for altering cell fate, it is preceded by transcription-factor- mediated regulatory events. The temporal order of gene expression alterations shows the order of the regulatory network reconfiguration and offers further insight into the gene regulatory network. Our studies extend the conventional systems biology approach to include many molecular species, regulatory layers and temporal series, and underscore the complexity of the multi-layer regulatory mechanisms responsible for changes in protein expression that determine stem cell fate.	[Lu, Rong; Lemischka, Ihor R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Markowetz, Florian; Airoldi, Edoardo M.; Troyanskaya, Olga G.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Markowetz, Florian; Airoldi, Edoardo M.; Troyanskaya, Olga G.] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Unwin, Richard D.; Whetton, Anthony D.] Univ Manchester, Wolfson Mol Imaging Ctr,Sch Canc & Imaging Sci, Manchester Acad Hlth Sci Ctr, Stem Cell & Leukaemia Prote Lab, Manchester M20 4QL, Lancs, England; [Leek, Jeffrey T.; MacArthur, Ben D.; Rozov, Roye; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Leek, Jeffrey T.; MacArthur, Ben D.; Rozov, Roye; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [MacArthur, Ben D.; Lachmann, Alexander; Ma'ayan, Avi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [MacArthur, Ben D.; Lachmann, Alexander; Ma'ayan, Avi] Mt Sinai Sch Med, Syst Biol Ctr New York, New York, NY 10029 USA; [Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Princeton University; Princeton University; Princeton University; University of Manchester; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT)	Lemischka, IR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	rlu@stanford.edu; ihor.lemischka@mssm.edu	Markowetz, Florian/H-6883-2019; Airoldi, Edoardo/A-8575-2009; Unwin, Richard/C-1258-2008; Troyanskaya, Olga G/B-1968-2010; Ma'ayan, Avi/AAG-3131-2019; Lachmann, Alexander/AAF-1940-2020	Markowetz, Florian/0000-0002-2784-5308; Unwin, Richard/0000-0001-7955-9111; Ma'ayan, Avi/0000-0002-6904-1017; Lachmann, Alexander/0000-0002-1982-7652; MacArthur, Ben/0000-0002-5396-9750; Leek, Jeffrey/0000-0002-2873-2671; WHETTON, ANTHONY D/0000-0002-1098-3878; Troyanskaya, Olga/0000-0002-5676-5737; Airoldi, Edoardo/0000-0002-3512-0542	NIH; BBSRC; Leukaemia Research UK; US National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia Research UK; US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Storton for technical support, and E. Wieschaus, Y. Shi, S. Tavazoie and N. Slavov for constructive discussions. We also acknowledge the laboratories of the following people for providing antibodies for western blot: A. Okuda, J. Flint and Y. Kang. This work was supported by the NIH, and in part supported by the BBSRC and Leukaemia Research UK. O.G.T., F. M. and E. M. A. were partially supported by the NIH and US National Science Foundation.	Airoldi EM, 2007, PLOS COMPUT BIOL, V3, P2421, DOI 10.1371/journal.pcbi.0030252; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang WY, 2008, CELL STEM CELL, V2, P410, DOI 10.1016/j.stem.2008.04.009; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spooncer E, 2008, MOL CELL PROTEOMICS, V7, P573, DOI 10.1074/mcp.M700292-MCP200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	37	215	220	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					358	U126		10.1038/nature08575	http://dx.doi.org/10.1038/nature08575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19924215	Green Published, Green Accepted			2022-12-24	WOS:000271899300046
J	Zhou, RY; Niwa, S; Homma, N; Takei, Y; Hirokawa, N				Zhou, Ruyun; Niwa, Shinsuke; Homma, Noriko; Takei, Yosuke; Hirokawa, Nobutaka			KIF26A Is an Unconventional Kinesin and Regulates GDNF-Ret Signaling in Enteric Neuronal Development	CELL			English	Article							MICE LACKING GDNF; MICROTUBULE-ASSOCIATED PROTEINS; MULTIPLE ENDOCRINE NEOPLASIA; TYROSINE KINASE; NERVOUS-SYSTEM; HIRSCHSPRUNGS-DISEASE; PATHWAY; TRANSPORT; KIDNEY; MOTOR	The kinesin superfamily proteins (KIFs) are motor proteins that transport organelles and protein complexes in a microtubule- and ATP-dependent manner. We identified KIF26A as a new member of the murine KIFs. KIF26A is a rather atypical member as it lacks ATPase activity. Mice with a homozygous deletion of Kif26a developed a megacolon with enteric nerve hyperplasia. Kif26a(-/-) enteric neurons showed hypersensitivity for GDNF-Ret signaling, and we find that KIF26A suppressed GDNF-Ret signaling by direct binding and inhibition of Grb2, an essential component of GDNF/Akt/ERK signaling. We therefore propose that the unconventional kinesin KIF26A plays a key role in enteric nervous system development by repressing a cell growth signaling pathway.	[Zhou, Ruyun; Niwa, Shinsuke; Homma, Noriko; Takei, Yosuke; Hirokawa, Nobutaka] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Takei, Yosuke/I-1828-2015	Takei, Yosuke/0000-0002-5026-8027; NIWA, SHINSUKE/0000-0002-8367-9228	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Miyajima (University of Tokyo) for GST-RBD, J. Miyazaki (Osaka University) for the CAG-Cre mice, Kazusa DNA Research Institute for the KIAA1236 clone, and L. E. Samelson (National Institutes of Health) for Grb2 cDNA. We also thank Y. Tanaka, K. Nakajima, R. Nitta, and H. Ueno for their supervision and discussion, H. Sato, H. Fukuda, M. Sugaya, N. Onouchi, T. Akamatsu, and T. Aizawa for their technical assistance, and all other members of the Hirokawa laboratory for their help and discussion. This work was supported by a grant in aid for specially promoted research to N. H. and also by a Global COE Program from the Ministry of Education, Science, Sports, and Culture of Japan.	ATHOW AC, 1991, ARCH DIS CHILD, V66, P1300, DOI 10.1136/adc.66.11.1300; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CARNEY JA, 1977, MAYO CLIN PROC, V52, P543; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Focke PJ, 2001, J NEUROBIOL, V47, P306, DOI 10.1002/neu.1037; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HIDAKA M, 1991, BIOCHEM BIOPH RES CO, V180, P1490, DOI 10.1016/S0006-291X(05)81364-6; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lin Z, 2003, AUTON NEUROSCI-BASIC, V107, P9, DOI 10.1016/S1566-0702(03)00077-8; Matsui T, 2002, EMBO J, V21, P1021, DOI 10.1093/emboj/21.5.1021; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Ohiwa M, 1997, BIOCHEM BIOPH RES CO, V237, P747, DOI 10.1006/bbrc.1997.7225; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHLIWA M, 2002, MOL MOTORS; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; TAKEMURA R, 1992, J CELL SCI, V103, P953; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3	39	73	80	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 13	2009	139	4					802	813		10.1016/j.cell.2009.10.023	http://dx.doi.org/10.1016/j.cell.2009.10.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	519EG	19914172	Bronze			2022-12-24	WOS:000271747200023
J	Caplan, AL				Caplan, Arthur L.			Unlicensed pandemic influenza A H1N1 vaccines	LANCET			English	Editorial Material									[Caplan, Arthur L.] Univ Penn, Ctr Vaccine Eth & Policy, Philadelphia, PA 19104 USA; [Caplan, Arthur L.] Childrens Hosp Philadelphia, Wistar Inst Vaccine Ctr, Philadelphia, PA 19104 USA; [Caplan, Arthur L.] Childrens Hosp Philadelphia, Vaccine Educ Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Caplan, AL (corresponding author), Univ Penn, Ctr Vaccine Eth & Policy, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu						[Anonymous], 2009, LANCET, V374, P358; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; *MSNBC, 2009, US SHAR SWIN FLU VAC; Neuzil KM, 2009, J INFECT DIS, V200, P835, DOI 10.1086/605507; Nightingale SL, 2007, EMERG INFECT DIS, V13, P1046, DOI 10.3201/eid1307.061188; *STRAT ADV GROUP E, 2009, WKLY EPIDEMIOL REC, V84, P301; *WHO, 2009, B WORLD HEALTH ORGAN, V87, P645	7	196	209	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 6	2010	375	9713					444	445		10.1016/S0140-6736(09)61675-5	http://dx.doi.org/10.1016/S0140-6736(09)61675-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	558PV	19914708				2022-12-24	WOS:000274757900009
